QTLs in Region (GRCh38)
| 597271449 | GWAS1367523_H | systolic blood pressure QTL GWAS1367523 (human) | | 1e-11 | systolic blood pressure | | 4 | 110485340 | 110485341 | Human |
| 407099463 | GWAS748439_H | mean corpuscular hemoglobin QTL GWAS748439 (human) | | 1e-62 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121849522 | 121849523 | Human |
| 407312451 | GWAS961427_H | body height QTL GWAS961427 (human) | | 5e-08 | body height | | 4 | 128687133 | 128687134 | Human |
| 407312449 | GWAS961425_H | body height QTL GWAS961425 (human) | | 2e-09 | body height | | 4 | 126045727 | 126045728 | Human |
| 598074274 | GWAS1793573_H | left atrium capacity QTL GWAS1793573 (human) | | 1e-08 | left atrium capacity | | 4 | 110744627 | 110744628 | Human |
| 407312448 | GWAS961424_H | body height QTL GWAS961424 (human) | | 1e-14 | body height | | 4 | 124018099 | 124018100 | Human |
| 407099466 | GWAS748442_H | mean corpuscular hemoglobin QTL GWAS748442 (human) | | 7e-27 | mean corpuscular hemoglobin | | 4 | 127625245 | 127625246 | Human |
| 407099465 | GWAS748441_H | mean corpuscular hemoglobin QTL GWAS748441 (human) | | 3e-08 | mean corpuscular hemoglobin | | 4 | 123845801 | 123845802 | Human |
| 598090668 | GWAS1809967_H | glomerular filtration rate QTL GWAS1809967 (human) | | 9e-09 | glomerular filtration rate | | 4 | 128246249 | 128246250 | Human |
| 617030860 | GWAS2048359_H | oligodendroglioma QTL GWAS2048359 (human) | | 0.000004 | oligodendroglioma | | 4 | 116139159 | 116139160 | Human |
| 617194692 | GWAS2175132_H | R wave amplitude QTL GWAS2175132 (human) | | 3e-10 | R wave amplitude | | 4 | 113507558 | 113507559 | Human |
| 628925810 | GWAS2834039_H | erythrocyte volume QTL GWAS2834039 (human) | | 2e-18 | erythrocyte volume | | 4 | 109975446 | 109975447 | Human |
| 597336970 | GWAS1433044_H | COVID-19, mortality QTL GWAS1433044 (human) | | 0.000005 | COVID-19, mortality | | 4 | 127021337 | 127021338 | Human |
| 597222281 | GWAS1318355_H | platelet count QTL GWAS1318355 (human) | | 1e-12 | platelet count | | 4 | 109938024 | 109938025 | Human |
| 628696424 | GWAS2604653_H | vaginal microbiome measurement QTL GWAS2604653 (human) | | 0.000008 | vaginal microbiome measurement | | 4 | 120143632 | 120143633 | Human |
| 597222282 | GWAS1318356_H | platelet count QTL GWAS1318356 (human) | | 1e-21 | platelet count | | 4 | 109945564 | 109945565 | Human |
| 597222283 | GWAS1318357_H | platelet count QTL GWAS1318357 (human) | | 2e-35 | platelet count | | 4 | 109990751 | 109990752 | Human |
| 597222284 | GWAS1318358_H | platelet count QTL GWAS1318358 (human) | | 2e-100 | platelet count | | 4 | 110008938 | 110008939 | Human |
| 597222285 | GWAS1318359_H | platelet count QTL GWAS1318359 (human) | | 4e-09 | platelet count | | 4 | 119502932 | 119502933 | Human |
| 628811117 | GWAS2719346_H | ulcerative colitis QTL GWAS2719346 (human) | | 2e-09 | intestine integrity trait (VT:0010554) | | 4 | 122523884 | 122523885 | Human |
| 597074830 | GWAS1170904_H | lateral ventricle volume measurement, response to trauma exposure QTL GWAS1170904 (human) | | 0.0000002 | stress-related behavior trait (VT:0010451) | | 4 | 117069298 | 117069299 | Human |
| 617063646 | GWAS2081145_H | diastolic blood pressure QTL GWAS2081145 (human) | | 2e-11 | diastolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 628958567 | GWAS2866796_H | bilirubin measurement QTL GWAS2866796 (human) | | 1e-08 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 128126567 | 128126568 | Human |
| 628958566 | GWAS2866795_H | bilirubin measurement QTL GWAS2866795 (human) | | 6e-18 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 109921984 | 109921985 | Human |
| 597074827 | GWAS1170901_H | response to trauma exposure, nucleus accumbens volume QTL GWAS1170901 (human) | | 0.0000003 | response to trauma exposure, nucleus accumbens volume | | 4 | 130610205 | 130610206 | Human |
| 628696423 | GWAS2604652_H | vaginal microbiome measurement QTL GWAS2604652 (human) | | 0.0000002 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 597386174 | GWAS1482248_H | atrial fibrillation QTL GWAS1482248 (human) | | 6e-38 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
| 616998127 | GWAS2015626_H | open-angle glaucoma QTL GWAS2015626 (human) | | 6e-10 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 407394401 | GWAS1043377_H | smoking status measurement QTL GWAS1043377 (human) | | 2e-10 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
| 598057871 | GWAS1777170_H | body height QTL GWAS1777170 (human) | | 5e-08 | body height | | 4 | 119517147 | 119517148 | Human |
| 598057870 | GWAS1777169_H | body height QTL GWAS1777169 (human) | | 3e-08 | body height | | 4 | 113901423 | 113901424 | Human |
| 597582766 | GWAS1639626_H | body height QTL GWAS1639626 (human) | | 6e-13 | body height | | 4 | 119709781 | 119709782 | Human |
| 597582767 | GWAS1639627_H | body height QTL GWAS1639627 (human) | | 3e-14 | body height | | 4 | 121876108 | 121876109 | Human |
| 597582765 | GWAS1639625_H | body height QTL GWAS1639625 (human) | | 2e-22 | body height | | 4 | 108503691 | 108503692 | Human |
| 406902899 | GWAS551875_H | fat body mass QTL GWAS551875 (human) | | 0.0000001 | fat body mass | | 4 | 114674241 | 114674242 | Human |
| 407033969 | GWAS682945_H | thyroid stimulating hormone measurement QTL GWAS682945 (human) | | 2e-19 | thyroid stimulating hormone measurement | | 4 | 121691318 | 121691319 | Human |
| 626451822 | GWAS2265755_H | serum creatinine amount QTL GWAS2265755 (human) | | 4e-11 | serum creatinine amount | | 4 | 114577301 | 114577302 | Human |
| 406935673 | GWAS584649_H | anxiety QTL GWAS584649 (human) | | 2e-08 | anxiety | | 4 | 118133633 | 118133634 | Human |
| 407066744 | GWAS715720_H | gut microbiome measurement QTL GWAS715720 (human) | | 0.000008 | gut microbiome measurement | | 4 | 119132069 | 119132070 | Human |
| 628647237 | GWAS2555466_H | gut microbiome measurement, environmental exposure measurement QTL GWAS2555466 (human) | | 0.000005 | gut microbiome measurement, environmental exposure measurement | | 4 | 123477380 | 123477381 | Human |
| 628909378 | GWAS2817607_H | multiple sclerosis QTL GWAS2817607 (human) | | 4e-08 | multiple sclerosis | | 4 | 108174396 | 108174397 | Human |
| 597435298 | GWAS1531372_H | atrial fibrillation QTL GWAS1531372 (human) | | 2e-101 | atrial fibrillation | | 4 | 110789946 | 110789947 | Human |
| 407263352 | GWAS912328_H | asthma QTL GWAS912328 (human) | | 0.000008 | asthma | | 4 | 122456327 | 122456328 | Human |
| 407378038 | GWAS1027014_H | facial morphology measurement QTL GWAS1027014 (human) | | 2e-08 | facial morphology measurement | | 4 | 126939204 | 126939205 | Human |
| 628811077 | GWAS2719306_H | neutrophil percentage of leukocytes QTL GWAS2719306 (human) | | 9e-17 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 4 | 112142370 | 112142371 | Human |
| 598090726 | GWAS1810025_H | body height QTL GWAS1810025 (human) | | 4e-08 | body height | | 4 | 112647388 | 112647389 | Human |
| 616359164 | GWAS1843879_H | gut microbiome measurement, breastfeeding duration QTL GWAS1843879 (human) | | 0.0000001 | gut microbiome measurement, breastfeeding duration | | 4 | 118957068 | 118957069 | Human |
| 617030791 | GWAS2048290_H | color vision disorder QTL GWAS2048290 (human) | | 0.0000004 | color vision disorder | | 4 | 123509639 | 123509640 | Human |
| 628466996 | GWAS2375225_H | open-angle glaucoma QTL GWAS2375225 (human) | | 6e-10 | eye integrity trait (VT:0011107) | | 4 | 111042563 | 111042564 | Human |
| 598090727 | GWAS1810026_H | body height QTL GWAS1810026 (human) | | 3e-14 | body height | | 4 | 113975748 | 113975749 | Human |
| 598090725 | GWAS1810024_H | body height QTL GWAS1810024 (human) | | 3e-19 | body height | | 4 | 108508323 | 108508324 | Human |
| 625829134 | GWAS2250056_H | cardiac arrhythmia QTL GWAS2250056 (human) | | 2e-12 | cardiac arrhythmia | | 4 | 110750654 | 110750655 | Human |
| 625829129 | GWAS2250051_H | Bradycardia QTL GWAS2250051 (human) | | 4e-08 | Bradycardia | | 4 | 110755753 | 110755754 | Human |
| 597402590 | GWAS1498664_H | congestive heart failure QTL GWAS1498664 (human) | | 1e-08 | heart integrity trait (VT:0010757) | | 4 | 110783043 | 110783044 | Human |
| 407377933 | GWAS1026909_H | brain connectivity measurement QTL GWAS1026909 (human) | | 6e-11 | brain connectivity measurement | | 4 | 125820645 | 125820646 | Human |
| 598008812 | GWAS1728111_H | CD40LG/EGF protein level ratio in blood QTL GWAS1728111 (human) | | 3e-289 | CD40LG/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 598090734 | GWAS1810033_H | body height QTL GWAS1810033 (human) | | 5e-08 | body height | | 4 | 128687133 | 128687134 | Human |
| 616375540 | GWAS1855782_H | obsolete_blood protein measurement QTL GWAS1855782 (human) | | 8e-54 | obsolete_blood protein measurement | | 4 | 109737911 | 109737912 | Human |
| 628467007 | GWAS2375236_H | Myopia QTL GWAS2375236 (human) | | 0.000005 | Myopia | | 4 | 125625005 | 125625006 | Human |
| 598090732 | GWAS1810031_H | body height QTL GWAS1810031 (human) | | 2e-09 | body height | | 4 | 126045727 | 126045728 | Human |
| 407066632 | GWAS715608_H | alopecia QTL GWAS715608 (human) | | 2e-09 | alopecia | | 4 | 106967631 | 106967632 | Human |
| 598090730 | GWAS1810029_H | body height QTL GWAS1810029 (human) | | 1e-17 | body height | | 4 | 122906887 | 122906888 | Human |
| 598090731 | GWAS1810030_H | body height QTL GWAS1810030 (human) | | 1e-14 | body height | | 4 | 124018099 | 124018100 | Human |
| 597468114 | GWAS1564188_H | response to antiviral drug QTL GWAS1564188 (human) | | 0.000002 | response to antiviral drug | | 4 | 110212212 | 110212213 | Human |
| 598090728 | GWAS1810027_H | body height QTL GWAS1810027 (human) | | 2e-14 | body height | | 4 | 119796398 | 119796399 | Human |
| 598090729 | GWAS1810028_H | body height QTL GWAS1810028 (human) | | 2e-21 | body height | | 4 | 121829906 | 121829907 | Human |
| 407001104 | GWAS650080_H | PR interval QTL GWAS650080 (human) | | 3e-09 | PR interval | | 4 | 113496850 | 113496851 | Human |
| 597222351 | GWAS1318425_H | platelet count QTL GWAS1318425 (human) | | 2e-33 | platelet count | | 4 | 110023574 | 110023575 | Human |
| 628778274 | GWAS2686503_H | BMI-adjusted waist-hip ratio QTL GWAS2686503 (human) | | 6e-09 | body size trait (VT:0100005) | | 4 | 121702910 | 121702911 | Human |
| 407377936 | GWAS1026912_H | brain connectivity measurement QTL GWAS1026912 (human) | | 2e-11 | brain connectivity measurement | | 4 | 125825074 | 125825075 | Human |
| 407394321 | GWAS1043297_H | vaginal microbiome measurement QTL GWAS1043297 (human) | | 0.000001 | vaginal microbiome measurement | | 4 | 113045828 | 113045829 | Human |
| 628909349 | GWAS2817578_H | body height QTL GWAS2817578 (human) | | 3e-08 | body height | | 4 | 113901423 | 113901424 | Human |
| 628778275 | GWAS2686504_H | BMI-adjusted waist-hip ratio QTL GWAS2686504 (human) | | 5e-08 | body size trait (VT:0100005) | | 4 | 122860717 | 122860718 | Human |
| 628909350 | GWAS2817579_H | body height QTL GWAS2817579 (human) | | 5e-08 | body height | | 4 | 119517147 | 119517148 | Human |
| 628778272 | GWAS2686501_H | BMI-adjusted waist-hip ratio QTL GWAS2686501 (human) | | 2e-08 | body size trait (VT:0100005) | | 4 | 119591353 | 119591354 | Human |
| 628630819 | GWAS2539048_H | risk-taking behaviour QTL GWAS2539048 (human) | | 2e-08 | exploratory behavior trait (VT:0010471) | | 4 | 109690042 | 109690043 | Human |
| 628778273 | GWAS2686502_H | BMI-adjusted waist-hip ratio QTL GWAS2686502 (human) | | 2e-09 | body size trait (VT:0100005) | | 4 | 119763897 | 119763898 | Human |
| 628778278 | GWAS2686507_H | BMI-adjusted waist-hip ratio QTL GWAS2686507 (human) | | 1e-08 | body size trait (VT:0100005) | | 4 | 124118741 | 124118742 | Human |
| 617194647 | GWAS2175087_H | electrocardiography QTL GWAS2175087 (human) | | 3e-10 | electrocardiography | | 4 | 113508251 | 113508252 | Human |
| 628778276 | GWAS2686505_H | BMI-adjusted waist-hip ratio QTL GWAS2686505 (human) | | 2e-11 | body size trait (VT:0100005) | | 4 | 123124286 | 123124287 | Human |
| 628778277 | GWAS2686506_H | BMI-adjusted waist-hip ratio QTL GWAS2686506 (human) | | 1e-11 | body size trait (VT:0100005) | | 4 | 123166618 | 123166619 | Human |
| 597156852 | GWAS1252926_H | testosterone measurement QTL GWAS1252926 (human) | | 0.000004 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 597091314 | GWAS1187388_H | Ischemic stroke QTL GWAS1187388 (human) | | 3e-14 | Ischemic stroke | | 4 | 110755885 | 110755886 | Human |
| 407148577 | GWAS797553_H | platelet count QTL GWAS797553 (human) | | 9e-21 | platelet count | | 4 | 109945564 | 109945565 | Human |
| 628778271 | GWAS2686500_H | BMI-adjusted waist-hip ratio QTL GWAS2686500 (human) | | 2e-10 | body size trait (VT:0100005) | | 4 | 119213641 | 119213642 | Human |
| 628499728 | GWAS2407957_H | endometriosis, major depressive disorder QTL GWAS2407957 (human) | | 5e-08 | uterus integrity trait (VT:0010575) | | 4 | 130288732 | 130288733 | Human |
| 628729104 | GWAS2637333_H | corneal resistance factor QTL GWAS2637333 (human) | | 2e-08 | cornea morphology trait (VT:0001312) | | 4 | 118802505 | 118802506 | Human |
| 597091323 | GWAS1187397_H | intelligence QTL GWAS1187397 (human) | | 0.0000009 | intelligence | | 4 | 117956978 | 117956979 | Human |
| 597156839 | GWAS1252913_H | testosterone measurement QTL GWAS1252913 (human) | | 3e-13 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 628663560 | GWAS2571789_H | facial morphology trait QTL GWAS2571789 (human) | | 3e-08 | facial morphology trait | | 4 | 125211057 | 125211058 | Human |
| 407050295 | GWAS699271_H | cortical thickness QTL GWAS699271 (human) | | 4e-10 | cortical thickness | | 4 | 120704578 | 120704579 | Human |
| 407263283 | GWAS912259_H | brain measurement QTL GWAS912259 (human) | | 9e-09 | brain measurement | | 4 | 112432129 | 112432130 | Human |
| 407197757 | GWAS846733_H | deoxycholate measurement QTL GWAS846733 (human) | | 0.000001 | deoxycholate measurement | | 4 | 119855597 | 119855598 | Human |
| 407312447 | GWAS961423_H | body height QTL GWAS961423 (human) | | 1e-17 | body height | | 4 | 122906887 | 122906888 | Human |
| 407312446 | GWAS961422_H | body height QTL GWAS961422 (human) | | 2e-21 | body height | | 4 | 121829906 | 121829907 | Human |
| 407312445 | GWAS961421_H | body height QTL GWAS961421 (human) | | 2e-14 | body height | | 4 | 119796398 | 119796399 | Human |
| 407312444 | GWAS961420_H | body height QTL GWAS961420 (human) | | 3e-14 | body height | | 4 | 113975748 | 113975749 | Human |
| 407312443 | GWAS961419_H | body height QTL GWAS961419 (human) | | 3e-19 | body height | | 4 | 108508323 | 108508324 | Human |
| 617079879 | GWAS2097378_H | neuroimaging measurement QTL GWAS2097378 (human) | | 2e-11 | neuroimaging measurement | | 4 | 112495627 | 112495628 | Human |
| 628614654 | GWAS2522883_H | atrial fibrillation QTL GWAS2522883 (human) | | 2e-101 | atrial fibrillation | | 4 | 110789946 | 110789947 | Human |
| 617063500 | GWAS2080999_H | ceramide amount QTL GWAS2080999 (human) | | 6e-13 | ceramide amount | | 4 | 114469978 | 114469979 | Human |
| 407148751 | GWAS797727_H | childhood onset asthma QTL GWAS797727 (human) | | 3e-13 | childhood onset asthma | | 4 | 122639784 | 122639785 | Human |
| 597615378 | GWAS1672238_H | pyogenic granuloma QTL GWAS1672238 (human) | | 3e-11 | pyogenic granuloma | | 4 | 117340216 | 117340217 | Human |
| 407001293 | GWAS650269_H | celiac disease QTL GWAS650269 (human) | | 3e-11 | intestine integrity trait (VT:0010554) | | 4 | 122194347 | 122194348 | Human |
| 617112664 | GWAS2130163_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2130163 (human) | | 3e-12 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 116507955 | 116507956 | Human |
| 597336842 | GWAS1432916_H | S-7-hydroxywarfarin measurement QTL GWAS1432916 (human) | | 0.000009 | S-7-hydroxywarfarin measurement | | 4 | 121518134 | 121518135 | Human |
| 596960006 | GWAS1079525_H | glomerular filtration rate QTL GWAS1079525 (human) | | 1e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
| 597615372 | GWAS1672232_H | platelet count QTL GWAS1672232 (human) | | 3e-12 | platelet count | | 4 | 123835365 | 123835366 | Human |
| 596960007 | GWAS1079526_H | glomerular filtration rate QTL GWAS1079526 (human) | | 2e-08 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 597615371 | GWAS1672231_H | platelet count QTL GWAS1672231 (human) | | 4e-16 | platelet count | | 4 | 119439096 | 119439097 | Human |
| 597222158 | GWAS1318232_H | Thrombocytopenia QTL GWAS1318232 (human) | | 1e-44 | Thrombocytopenia | | 4 | 110026904 | 110026905 | Human |
| 597992253 | GWAS1711552_H | caudal anterior cingulate cortex volume QTL GWAS1711552 (human) | | 0.000002 | caudal anterior cingulate cortex volume | | 4 | 125708052 | 125708053 | Human |
| 617194581 | GWAS2175021_H | electrocardiography QTL GWAS2175021 (human) | | 3e-10 | electrocardiography | | 4 | 113523238 | 113523239 | Human |
| 596960008 | GWAS1079527_H | glomerular filtration rate QTL GWAS1079527 (human) | | 4e-08 | glomerular filtration rate | | 4 | 125673826 | 125673827 | Human |
| 596960009 | GWAS1079528_H | glomerular filtration rate QTL GWAS1079528 (human) | | 2e-20 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 407099613 | GWAS748589_H | Erythema nodosum QTL GWAS748589 (human) | | 5e-08 | Erythema nodosum | | 4 | 117413463 | 117413464 | Human |
| 617194600 | GWAS2175040_H | electrocardiography QTL GWAS2175040 (human) | | 3e-10 | electrocardiography | | 4 | 113465982 | 113465983 | Human |
| 617063525 | GWAS2081024_H | suicide QTL GWAS2081024 (human) | | 0.000004 | suicide | | 4 | 125969849 | 125969850 | Human |
| 407214306 | GWAS863282_H | Hypermetropia, Myopia QTL GWAS863282 (human) | | 0.0000007 | Hypermetropia, Myopia | | 4 | 119987548 | 119987549 | Human |
| 597156670 | GWAS1252744_H | electrocardiography QTL GWAS1252744 (human) | | 2e-08 | electrocardiography | | 4 | 115646453 | 115646454 | Human |
| 407312619 | GWAS961595_H | ceramide measurement QTL GWAS961595 (human) | | 1e-08 | ceramide measurement | | 4 | 114573629 | 114573630 | Human |
| 407312618 | GWAS961594_H | ceramide measurement QTL GWAS961594 (human) | | 9e-60 | ceramide measurement | | 4 | 114564528 | 114564529 | Human |
| 597123897 | GWAS1219971_H | clear cell renal carcinoma QTL GWAS1219971 (human) | | 8e-11 | clear cell renal carcinoma | | 4 | 108791438 | 108791439 | Human |
| 407312617 | GWAS961593_H | ceramide measurement QTL GWAS961593 (human) | | 2e-09 | ceramide measurement | | 4 | 114559783 | 114559784 | Human |
| 407312616 | GWAS961592_H | ceramide measurement QTL GWAS961592 (human) | | 4e-08 | ceramide measurement | | 4 | 114407538 | 114407539 | Human |
| 616358922 | GWAS1843637_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1843637 (human) | | 4e-09 | gut microbiome measurement, allergen exposure measurement | | 4 | 111174542 | 111174543 | Human |
| 628696512 | GWAS2604741_H | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement QTL GWAS2604741 (human) | | 5e-18 | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | | 4 | 123849566 | 123849567 | Human |
| 597140269 | GWAS1236343_H | QT interval QTL GWAS1236343 (human) | | 4e-08 | QT interval | | 4 | 113523545 | 113523546 | Human |
| 407378165 | GWAS1027141_H | insular cortex volume measurement QTL GWAS1027141 (human) | | 0.000003 | insular cortex volume measurement | | 4 | 125775267 | 125775268 | Human |
| 597042004 | GWAS1138078_H | appendicular lean mass QTL GWAS1138078 (human) | | 5e-10 | appendicular lean mass | | 4 | 110660471 | 110660472 | Human |
| 407197825 | GWAS846801_H | lipid measurement QTL GWAS846801 (human) | | 0.000006 | lipid measurement | | 4 | 130393791 | 130393792 | Human |
| 628909497 | GWAS2817726_H | docosahexaenoic acid to total fatty acids percentage QTL GWAS2817726 (human) | | 2e-09 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 4 | 109717668 | 109717669 | Human |
| 407312513 | GWAS961489_H | neutrophil percentage of leukocytes QTL GWAS961489 (human) | | 3e-17 | neutrophil percentage of leukocytes | | 4 | 122760001 | 122760002 | Human |
| 628696510 | GWAS2604739_H | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement QTL GWAS2604739 (human) | | 2e-27 | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | | 4 | 123872632 | 123872633 | Human |
| 407378050 | GWAS1027026_H | facial morphology measurement QTL GWAS1027026 (human) | | 3e-10 | facial morphology measurement | | 4 | 127027041 | 127027042 | Human |
| 597386071 | GWAS1482145_H | susceptibility to scarlet fever measurement QTL GWAS1482145 (human) | | 0.000003 | susceptibility to scarlet fever measurement | | 4 | 109403118 | 109403119 | Human |
| 598074217 | GWAS1793516_H | left atrium capacity QTL GWAS1793516 (human) | | 2e-08 | left atrium capacity | | 4 | 110744627 | 110744628 | Human |
| 628647348 | GWAS2555577_H | gut microbiome measurement, breastfeeding duration QTL GWAS2555577 (human) | | 0.0000005 | lactation duration (VT:1000653) | | 4 | 112409784 | 112409785 | Human |
| 597500755 | GWAS1596829_H | body height QTL GWAS1596829 (human) | | 1e-09 | body height | | 4 | 121739866 | 121739867 | Human |
| 597451603 | GWAS1547677_H | heel bone mineral density, urate measurement QTL GWAS1547677 (human) | | 4e-08 | heel bone mineral density, urate measurement | | 4 | 107158166 | 107158167 | Human |
| 597500754 | GWAS1596828_H | body height QTL GWAS1596828 (human) | | 3e-08 | body height | | 4 | 119693141 | 119693142 | Human |
| 628729257 | GWAS2637486_H | diastolic blood pressure QTL GWAS2637486 (human) | | 2e-12 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 108096372 | 108096373 | Human |
| 617096217 | GWAS2113716_H | body height QTL GWAS2113716 (human) | | 1e-13 | body height | | 4 | 119665953 | 119665954 | Human |
| 628729259 | GWAS2637488_H | diastolic blood pressure QTL GWAS2637488 (human) | | 2e-13 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110400371 | 110400372 | Human |
| 628729258 | GWAS2637487_H | diastolic blood pressure QTL GWAS2637487 (human) | | 2e-13 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110319122 | 110319123 | Human |
| 597369679 | GWAS1465753_H | erectile dysfunction QTL GWAS1465753 (human) | | 0.000009 | erectile dysfunction | | 4 | 123943461 | 123943462 | Human |
| 598090611 | GWAS1809910_H | leukocyte quantity QTL GWAS1809910 (human) | | 1e-10 | leukocyte quantity | | 4 | 109996470 | 109996471 | Human |
| 617194527 | GWAS2174967_H | S wave amplitude QTL GWAS2174967 (human) | | 3e-10 | S wave amplitude | | 4 | 113518738 | 113518739 | Human |
| 597156672 | GWAS1252746_H | electrocardiography QTL GWAS1252746 (human) | | 1e-08 | electrocardiography | | 4 | 115646453 | 115646454 | Human |
| 617194512 | GWAS2174952_H | dilated cardiomyopathy QTL GWAS2174952 (human) | | 6e-08 | dilated cardiomyopathy | | 4 | 110782987 | 110782988 | Human |
| 616359014 | GWAS1843729_H | gut microbiome measurement, breastfeeding duration QTL GWAS1843729 (human) | | 2e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 129911920 | 129911921 | Human |
| 597992312 | GWAS1711611_H | glomerular filtration rate QTL GWAS1711611 (human) | | 6e-08 | glomerular filtration rate | | 4 | 108772299 | 108772300 | Human |
| 597041994 | GWAS1138068_H | appendicular lean mass QTL GWAS1138068 (human) | | 1e-11 | appendicular lean mass | | 4 | 124044107 | 124044108 | Human |
| 617030682 | GWAS2048181_H | cannabis dependence QTL GWAS2048181 (human) | | 8e-11 | cannabis dependence | | 4 | 111546456 | 111546457 | Human |
| 597041995 | GWAS1138069_H | appendicular lean mass QTL GWAS1138069 (human) | | 2e-12 | appendicular lean mass | | 4 | 119325534 | 119325535 | Human |
| 597074761 | GWAS1170835_H | major depressive disorder QTL GWAS1170835 (human) | | 0.000005 | major depressive disorder | | 4 | 127836228 | 127836229 | Human |
| 617063448 | GWAS2080947_H | ceramide amount QTL GWAS2080947 (human) | | 2e-08 | ceramide amount | | 4 | 129692156 | 129692157 | Human |
| 628696472 | GWAS2604701_H | cerebral cortex area attribute QTL GWAS2604701 (human) | | 3e-18 | cerebral cortex area attribute | | 4 | 118359012 | 118359013 | Human |
| 617030691 | GWAS2048190_H | opioid use disorder QTL GWAS2048190 (human) | | 1e-11 | opioid use disorder | | 4 | 111546456 | 111546457 | Human |
| 628893080 | GWAS2801309_H | metabolite measurement QTL GWAS2801309 (human) | | 3e-52 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 597386110 | GWAS1482184_H | Parkinson disease QTL GWAS1482184 (human) | | 5e-11 | Parkinson disease | | 4 | 113439216 | 113439217 | Human |
| 628778386 | GWAS2686615_H | neutrophil-to-lymphocyte ratio QTL GWAS2686615 (human) | | 1e-15 | neutrophil quantity (VT:0000222) | | 4 | 112194095 | 112194096 | Human |
| 617030703 | GWAS2048202_H | glioblastoma multiforme QTL GWAS2048202 (human) | | 0.000005 | glioblastoma multiforme | | 4 | 128287977 | 128287978 | Human |
| 617194528 | GWAS2174968_H | S wave amplitude QTL GWAS2174968 (human) | | 3e-10 | S wave amplitude | | 4 | 113535350 | 113535351 | Human |
| 616539216 | GWAS1935799_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1935799 (human) | | 1e-13 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 118965701 | 118965702 | Human |
| 407378087 | GWAS1027063_H | hip bone mineral density, hip bone size QTL GWAS1027063 (human) | | 5e-09 | hip bone mineral density, hip bone size | | 4 | 129257175 | 129257176 | Human |
| 616539215 | GWAS1935798_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1935798 (human) | | 6e-17 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 120049137 | 120049138 | Human |
| 616539213 | GWAS1935796_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1935796 (human) | | 6e-37 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119779454 | 119779455 | Human |
| 616539212 | GWAS1935795_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1935795 (human) | | 1e-25 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119029200 | 119029201 | Human |
| 616539210 | GWAS1935793_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1935793 (human) | | 7e-228 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119359462 | 119359463 | Human |
| 628893066 | GWAS2801295_H | chromosome, telomeric region length QTL GWAS2801295 (human) | | 0.000009 | chromosome, telomeric region length | | 4 | 110290116 | 110290117 | Human |
| 407328944 | GWAS977920_H | very low density lipoprotein cholesterol measurement QTL GWAS977920 (human) | | 1e-08 | very low density lipoprotein cholesterol measurement | | 4 | 109717709 | 109717710 | Human |
| 598156127 | GWAS1835197_H | osteoarthritis QTL GWAS1835197 (human) | | 7e-15 | osteoarthritis | | 4 | 120700994 | 120700995 | Human |
| 628860291 | GWAS2768520_H | body surface area QTL GWAS2768520 (human) | | 3e-11 | body surface area | | 4 | 122906887 | 122906888 | Human |
| 628860290 | GWAS2768519_H | body surface area QTL GWAS2768519 (human) | | 5e-15 | body surface area | | 4 | 121792708 | 121792709 | Human |
| 407247033 | GWAS896009_H | low density lipoprotein cholesterol measurement QTL GWAS896009 (human) | | 1e-09 | low density lipoprotein cholesterol measurement | | 4 | 119202262 | 119202263 | Human |
| 406919488 | GWAS568464_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS568464 (human) | | 3e-12 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129143723 | 129143724 | Human |
| 597435033 | GWAS1531107_H | facial morphology measurement QTL GWAS1531107 (human) | | 8e-09 | facial morphology measurement | | 4 | 119407511 | 119407512 | Human |
| 628991092 | GWAS2899321_H | prothrombin time measurement QTL GWAS2899321 (human) | | 6e-52 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110791530 | 110791531 | Human |
| 406919496 | GWAS568472_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS568472 (human) | | 1e-12 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129113772 | 129113775 | Human |
| 597435031 | GWAS1531105_H | lower face morphology measurement QTL GWAS1531105 (human) | | 4e-11 | lower face morphology measurement | | 4 | 126014320 | 126014321 | Human |
| 407165256 | GWAS814232_H | FEV/FVC ratio, response to bronchodilator QTL GWAS814232 (human) | | 0.000005 | FEV/FVC ratio, response to bronchodilator | | 4 | 109767656 | 109767657 | Human |
| 617276870 | GWAS2213646_H | saturated fatty acids to total fatty acids percentage QTL GWAS2213646 (human) | | 7e-13 | saturated fatty acids to total fatty acids percentage | | 4 | 110189522 | 110189523 | Human |
| 617063882 | GWAS2081381_H | ceramide amount QTL GWAS2081381 (human) | | 1e-16 | ceramide amount | | 4 | 114598115 | 114598116 | Human |
| 617014742 | GWAS2032241_H | cardioembolic stroke QTL GWAS2032241 (human) | | 2e-21 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 406886736 | GWAS535712_H | BMI-adjusted hip circumference QTL GWAS535712 (human) | | 0.0000005 | BMI-adjusted hip circumference | | 4 | 113634919 | 113634920 | Human |
| 597615246 | GWAS1672106_H | bladder calculus QTL GWAS1672106 (human) | | 4e-17 | bladder calculus | | 4 | 114696462 | 114696463 | Human |
| 617014743 | GWAS2032242_H | cardioembolic stroke QTL GWAS2032242 (human) | | 2e-25 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 628647017 | GWAS2555246_H | gut microbiome measurement, environmental exposure measurement QTL GWAS2555246 (human) | | 0.000008 | gut microbiome measurement, environmental exposure measurement | | 4 | 113407959 | 113407960 | Human |
| 617014740 | GWAS2032239_H | cardioembolic stroke QTL GWAS2032239 (human) | | 3e-25 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597402249 | GWAS1498323_H | total brain volume change measurement, age at assessment QTL GWAS1498323 (human) | | 0.000002 | total brain volume change measurement, age at assessment | | 4 | 111512339 | 111512340 | Human |
| 407247188 | GWAS896164_H | HbA1c measurement QTL GWAS896164 (human) | | 6e-10 | HbA1c measurement | | 4 | 116926523 | 116926524 | Human |
| 617014741 | GWAS2032240_H | cardioembolic stroke QTL GWAS2032240 (human) | | 6e-24 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 407050582 | GWAS699558_H | cortical surface area measurement QTL GWAS699558 (human) | | 5e-15 | cortical surface area measurement | | 4 | 112496345 | 112496346 | Human |
| 628696165 | GWAS2604394_H | body weight QTL GWAS2604394 (human) | | 2e-13 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 121829906 | 121829907 | Human |
| 598024838 | GWAS1744137_H | heart rate QTL GWAS1744137 (human) | | 0.000003 | heart rate | | 4 | 114106683 | 114106684 | Human |
| 628941914 | GWAS2850143_H | retinal degeneration QTL GWAS2850143 (human) | | 2e-11 | retinal degeneration | | 4 | 114161723 | 114161724 | Human |
| 597140159 | GWAS1236233_H | heart failure QTL GWAS1236233 (human) | | 2e-18 | heart failure | | 4 | 110843816 | 110843817 | Human |
| 407066984 | GWAS715960_H | blood protein measurement QTL GWAS715960 (human) | | 8e-13 | blood protein measurement | | 4 | 122625127 | 122625128 | Human |
| 407263607 | GWAS912583_H | body height QTL GWAS912583 (human) | | 8e-11 | body height | | 4 | 113824425 | 113824426 | Human |
| 597402285 | GWAS1498359_H | gut microbiome measurement QTL GWAS1498359 (human) | | 0.0000003 | gut microbiome measurement | | 4 | 112357355 | 112357356 | Human |
| 407066996 | GWAS715972_H | blood protein measurement QTL GWAS715972 (human) | | 3e-12 | blood protein measurement | | 4 | 119503425 | 119503426 | Human |
| 616523141 | GWAS1919724_H | level of carboxypeptidase A1 in blood serum QTL GWAS1919724 (human) | | 2e-14 | level of carboxypeptidase A1 in blood serum | | 4 | 109921984 | 109921985 | Human |
| 598041243 | GWAS1760542_H | cerebrovascular disorder QTL GWAS1760542 (human) | | 3e-09 | cerebrovascular disorder | | 4 | 110776659 | 110776660 | Human |
| 616359299 | GWAS1844014_H | gut microbiome measurement, breastfeeding duration QTL GWAS1844014 (human) | | 7e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 112425037 | 112425038 | Human |
| 597402330 | GWAS1498404_H | mean reticulocyte volume QTL GWAS1498404 (human) | | 1e-09 | mean reticulocyte volume | | 4 | 128306129 | 128306130 | Human |
| 597402329 | GWAS1498403_H | mean reticulocyte volume QTL GWAS1498403 (human) | | 3e-10 | mean reticulocyte volume | | 4 | 127552302 | 127552303 | Human |
| 407050496 | GWAS699472_H | triacylglycerol 54:1 measurement QTL GWAS699472 (human) | | 0.000001 | triacylglycerol 54:1 measurement | | 4 | 122671701 | 122671702 | Human |
| 628827199 | GWAS2735428_H | Red cell distribution width QTL GWAS2735428 (human) | | 2e-21 | erythrocyte size trait (VT:0000248) | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
| 407410958 | GWAS1059934_H | body height QTL GWAS1059934 (human) | | 2e-13 | body height | | 4 | 121799844 | 121799845 | Human |
| 625828874 | GWAS2249796_H | cerebrovascular disorder, stroke QTL GWAS2249796 (human) | | 0.0000003 | brain integrity trait (VT:0010579) | | 4 | 110793263 | 110793264 | Human |
| 406919436 | GWAS568412_H | balding measurement QTL GWAS568412 (human) | | 9e-15 | balding measurement | | 4 | 106348870 | 106348871 | Human |
| 597336791 | GWAS1432865_H | COVID-19 QTL GWAS1432865 (human) | | 0.000009 | COVID-19 | | 4 | 122020759 | 122020760 | Human |
| 407378202 | GWAS1027178_H | endometriosis QTL GWAS1027178 (human) | | 0.000007 | endometriosis | | 4 | 126617656 | 126617657 | Human |
| 597140161 | GWAS1236235_H | heart failure QTL GWAS1236235 (human) | | 4e-16 | heart failure | | 4 | 110707472 | 110707473 | Human |
| 597222094 | GWAS1318168_H | major depressive disorder QTL GWAS1318168 (human) | | 3e-16 | major depressive disorder | | 4 | 122467738 | 122467739 | Human |
| 628630565 | GWAS2538794_H | sexual activity behaviour attribute QTL GWAS2538794 (human) | | 4e-10 | sexual activity behaviour attribute | | 4 | 129108051 | 129108052 | Human |
| 407378199 | GWAS1027175_H | endometriosis QTL GWAS1027175 (human) | | 0.000006 | endometriosis | | 4 | 126617656 | 126617657 | Human |
| 616965540 | GWAS1983039_H | self reported educational attainment QTL GWAS1983039 (human) | | 0.000007 | self reported educational attainment | | 4 | 119344104 | 119344105 | Human |
| 597205756 | GWAS1301830_H | generalized anxiety disorder QTL GWAS1301830 (human) | | 4e-08 | generalized anxiety disorder | | 4 | 122265238 | 122265239 | Human |
| 597336830 | GWAS1432904_H | alcohol consumption measurement QTL GWAS1432904 (human) | | 2e-11 | alcohol consumption measurement | | 4 | 129324733 | 129324734 | Human |
| 597336828 | GWAS1432902_H | alcohol consumption measurement QTL GWAS1432902 (human) | | 4e-10 | alcohol consumption measurement | | 4 | 112392830 | 112392831 | Human |
| 597336829 | GWAS1432903_H | alcohol consumption measurement QTL GWAS1432903 (human) | | 4e-10 | alcohol consumption measurement | | 4 | 128811970 | 128811971 | Human |
| 597402355 | GWAS1498429_H | Crohn's disease QTL GWAS1498429 (human) | | 2e-09 | intestine integrity trait (VT:0010554) | | 4 | 122240464 | 122240465 | Human |
| 406919470 | GWAS568446_H | body height QTL GWAS568446 (human) | | 7e-09 | body height | | 4 | 121772597 | 121772598 | Human |
| 407116086 | GWAS765062_H | protein measurement QTL GWAS765062 (human) | | 2e-15 | protein measurement | | 4 | 121395817 | 121395818 | Human |
| 617047477 | GWAS2064976_H | cerebral cortex area attribute QTL GWAS2064976 (human) | | 1e-10 | cerebral cortex area attribute | | 4 | 126658527 | 126658528 | Human |
| 617047476 | GWAS2064975_H | cerebral cortex area attribute QTL GWAS2064975 (human) | | 2e-13 | cerebral cortex area attribute | | 4 | 112509596 | 112509597 | Human |
| 596959969 | GWAS1079488_H | glomerular filtration rate QTL GWAS1079488 (human) | | 1e-12 | glomerular filtration rate | | 4 | 108783751 | 108783752 | Human |
| 407329087 | GWAS978063_H | diastolic blood pressure QTL GWAS978063 (human) | | 6e-12 | diastolic blood pressure | | 4 | 110427909 | 110427910 | Human |
| 597123818 | GWAS1219892_H | blood protein measurement QTL GWAS1219892 (human) | | 8e-54 | blood protein measurement | | 4 | 109737911 | 109737912 | Human |
| 628777991 | GWAS2686220_H | alkaline phosphatase measurement QTL GWAS2686220 (human) | | 4e-23 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110199010 | 110199011 | Human |
| 407017789 | GWAS666765_H | body height QTL GWAS666765 (human) | | 1e-14 | body height | | 4 | 108180849 | 108180850 | Human |
| 617096523 | GWAS2114022_H | prothrombin time measurement QTL GWAS2114022 (human) | | 2e-31 | prothrombin time measurement | | 4 | 110791276 | 110791277 | Human |
| 407198146 | GWAS847122_H | venous thromboembolism QTL GWAS847122 (human) | | 0.0000007 | venous thromboembolism | | 4 | 122619586 | 122619587 | Human |
| 407050692 | GWAS699668_H | airway imaging measurement QTL GWAS699668 (human) | | 5e-09 | airway imaging measurement | | 4 | 126402153 | 126402154 | Human |
| 628679920 | GWAS2588149_H | testicular hydrocele, filarial elephantiasis QTL GWAS2588149 (human) | | 0.0000009 | response to parasitic infection trait (VT:0010437) | | 4 | 112132236 | 112132237 | Human |
| 407411136 | GWAS1060112_H | glycerophospholipid measurement QTL GWAS1060112 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114598670 | 114598671 | Human |
| 407312847 | GWAS961823_H | ceramide measurement QTL GWAS961823 (human) | | 1e-11 | ceramide measurement | | 4 | 114725282 | 114725283 | Human |
| 407411137 | GWAS1060113_H | glycerophospholipid measurement QTL GWAS1060113 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114598684 | 114598685 | Human |
| 407312846 | GWAS961822_H | ceramide measurement QTL GWAS961822 (human) | | 3e-18 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
| 407411138 | GWAS1060114_H | glycerophospholipid measurement QTL GWAS1060114 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114598400 | 114598401 | Human |
| 407181775 | GWAS830751_H | lip morphology measurement QTL GWAS830751 (human) | | 1e-08 | lip morphology measurement | | 4 | 121076949 | 121076950 | Human |
| 407411139 | GWAS1060115_H | glycerophospholipid measurement QTL GWAS1060115 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114598194 | 114598195 | Human |
| 617293127 | GWAS2229903_H | saturated fatty acids to total fatty acids percentage QTL GWAS2229903 (human) | | 6e-09 | saturated fatty acids to total fatty acids percentage | | 4 | 110191632 | 110191633 | Human |
| 407411140 | GWAS1060116_H | glycerophospholipid measurement QTL GWAS1060116 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594792 | 114594793 | Human |
| 407067090 | GWAS716066_H | alopecia QTL GWAS716066 (human) | | 1e-10 | alopecia | | 4 | 107131838 | 107131839 | Human |
| 628909295 | GWAS2817524_H | S wave amplitude QTL GWAS2817524 (human) | | 3e-10 | S wave amplitude | S wave amplitude (CMO:0000272) | 4 | 113518738 | 113518739 | Human |
| 407312852 | GWAS961828_H | ceramide measurement QTL GWAS961828 (human) | | 3e-13 | ceramide measurement | | 4 | 114553199 | 114553200 | Human |
| 628958446 | GWAS2866675_H | erythrocyte volume QTL GWAS2866675 (human) | | 2e-33 | erythrocyte volume | | 4 | 121854912 | 121854913 | Human |
| 628909290 | GWAS2817519_H | electrocardiography QTL GWAS2817519 (human) | | 3e-10 | electrocardiography | | 4 | 113523238 | 113523239 | Human |
| 626451649 | GWAS2265582_H | serum creatinine amount QTL GWAS2265582 (human) | | 4e-22 | serum creatinine amount | | 4 | 127022078 | 127022079 | Human |
| 617145680 | GWAS2163179_H | cardiac arrhythmia QTL GWAS2163179 (human) | | 3e-130 | cardiac arrhythmia | | 4 | 110796911 | 110796912 | Human |
| 616359201 | GWAS1843916_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1843916 (human) | | 4e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 111174542 | 111174543 | Human |
| 407394775 | GWAS1043751_H | heel bone mineral density, urate measurement QTL GWAS1043751 (human) | | 4e-08 | heel bone mineral density, urate measurement | | 4 | 107158166 | 107158167 | Human |
| 407329254 | GWAS978230_H | alpha fetoprotein measurement QTL GWAS978230 (human) | | 9e-12 | alpha fetoprotein measurement | | 4 | 108749156 | 108749157 | Human |
| 407312866 | GWAS961842_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS961842 (human) | | 4e-08 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 597336639 | GWAS1432713_H | RS-10-hydroxywarfarin to RS-warfarin ratio measurement QTL GWAS1432713 (human) | | 0.000003 | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | | 4 | 121903623 | 121903624 | Human |
| 407296480 | GWAS945456_H | testosterone measurement QTL GWAS945456 (human) | | 2e-11 | testosterone measurement | | 4 | 109717668 | 109717669 | Human |
| 597271103 | GWAS1367177_H | cardioembolic stroke QTL GWAS1367177 (human) | | 3e-48 | cardioembolic stroke | | 4 | 110775495 | 110775496 | Human |
| 407181805 | GWAS830781_H | heart failure QTL GWAS830781 (human) | | 9e-17 | heart failure | | 4 | 110776497 | 110776498 | Human |
| 597385778 | GWAS1481852_H | red blood cell density measurement QTL GWAS1481852 (human) | | 2e-15 | red blood cell density measurement | | 4 | 114598115 | 114598116 | Human |
| 596976188 | GWAS1095707_H | body height QTL GWAS1095707 (human) | | 2e-10 | body height | | 4 | 121736832 | 121736833 | Human |
| 628532441 | GWAS2440670_H | erythrocyte volume QTL GWAS2440670 (human) | | 2e-09 | erythrocyte volume | | 4 | 119629914 | 119629915 | Human |
| 407230965 | GWAS879941_H | Epstein-Barr virus infection QTL GWAS879941 (human) | | 0.000001 | Epstein-Barr virus infection | | 4 | 129344227 | 129344228 | Human |
| 617031030 | GWAS2048529_H | pain QTL GWAS2048529 (human) | | 6e-10 | pain | | 4 | 111582716 | 111582717 | Human |
| 407050737 | GWAS699713_H | cortical surface area measurement QTL GWAS699713 (human) | | 5e-10 | cortical surface area measurement | | 4 | 112493715 | 112493716 | Human |
| 406886908 | GWAS535884_H | body mass index QTL GWAS535884 (human) | | 4e-10 | body mass index | | 4 | 119398279 | 119398280 | Human |
| 597287463 | GWAS1383537_H | ulcerative colitis QTL GWAS1383537 (human) | | 2e-09 | ulcerative colitis | | 4 | 122523884 | 122523885 | Human |
| 596976213 | GWAS1095732_H | cardiovascular disease QTL GWAS1095732 (human) | | 1e-08 | cardiovascular disease | | 4 | 109616095 | 109616096 | Human |
| 628827323 | GWAS2735552_H | platelet crit QTL GWAS2735552 (human) | | 4e-46 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 109927638 | 109927639 | Human |
| 616375676 | GWAS1855918_H | obsolete_serum metabolite measurement QTL GWAS1855918 (human) | | 8e-11 | obsolete_serum metabolite measurement | | 4 | 110430068 | 110430069 | Human |
| 597615199 | GWAS1672059_H | nephrolithiasis QTL GWAS1672059 (human) | | 3e-16 | nephrolithiasis | | 4 | 114696462 | 114696463 | Human |
| 597336667 | GWAS1432741_H | COVID-19 QTL GWAS1432741 (human) | | 0.000007 | COVID-19 | | 4 | 117237956 | 117237957 | Human |
| 407378313 | GWAS1027289_H | appendicular lean mass QTL GWAS1027289 (human) | | 1e-09 | appendicular lean mass | | 4 | 119455163 | 119455164 | Human |
| 406903170 | GWAS552146_H | COVID-19 QTL GWAS552146 (human) | | 0.000007 | COVID-19 | | 4 | 117237956 | 117237957 | Human |
| 628909246 | GWAS2817475_H | Cognitive impairment QTL GWAS2817475 (human) | | 0.0000003 | Cognitive impairment | | 4 | 124309484 | 124309485 | Human |
| 407017862 | GWAS666838_H | body height QTL GWAS666838 (human) | | 2e-10 | body height | | 4 | 109834165 | 109834166 | Human |
| 406886788 | GWAS535764_H | neurofibrillary tangles measurement QTL GWAS535764 (human) | | 0.000003 | neurofibrillary tangles measurement | | 4 | 129358580 | 129358581 | Human |
| 617096461 | GWAS2113960_H | body mass index QTL GWAS2113960 (human) | | 1e-14 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129818987 | 129818988 | Human |
| 407017860 | GWAS666836_H | body height QTL GWAS666836 (human) | | 1e-16 | body height | | 4 | 108355674 | 108355675 | Human |
| 628516016 | GWAS2424245_H | sex hormone-binding globulin measurement QTL GWAS2424245 (human) | | 7e-23 | sex hormone-binding globulin measurement | | 4 | 109321740 | 109321741 | Human |
| 628597937 | GWAS2506166_H | triglyceride:HDL cholesterol ratio QTL GWAS2506166 (human) | | 1e-09 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109648464 | 109648465 | Human |
| 616375675 | GWAS1855917_H | obsolete_serum metabolite measurement QTL GWAS1855917 (human) | | 5e-13 | obsolete_serum metabolite measurement | | 4 | 110414566 | 110414567 | Human |
| 407017866 | GWAS666842_H | body height QTL GWAS666842 (human) | | 7e-09 | body height | | 4 | 119085821 | 119085822 | Human |
| 407017867 | GWAS666843_H | body height QTL GWAS666843 (human) | | 4e-09 | body height | | 4 | 119356945 | 119356946 | Human |
| 407017864 | GWAS666840_H | body height QTL GWAS666840 (human) | | 1e-15 | body height | | 4 | 113968218 | 113968219 | Human |
| 407017865 | GWAS666841_H | body height QTL GWAS666841 (human) | | 3e-09 | body height | | 4 | 118235326 | 118235327 | Human |
| 597090906 | GWAS1186980_H | mean corpuscular volume QTL GWAS1186980 (human) | | 1e-10 | mean corpuscular volume | | 4 | 128082220 | 128082221 | Human |
| 628696244 | GWAS2604473_H | cerebral cortex area attribute QTL GWAS2604473 (human) | | 1e-09 | cerebral cortex area attribute | | 4 | 126658527 | 126658528 | Human |
| 628909229 | GWAS2817458_H | body height QTL GWAS2817458 (human) | | 1e-09 | body height | | 4 | 112488114 | 112488115 | Human |
| 597516878 | GWAS1612952_H | Parkinson disease QTL GWAS1612952 (human) | | 3e-11 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
| 406968722 | GWAS617698_H | lung carcinoma QTL GWAS617698 (human) | | 0.0000005 | lung carcinoma | | 4 | 128666151 | 128666152 | Human |
| 407148955 | GWAS797931_H | brain measurement QTL GWAS797931 (human) | | 2e-08 | brain measurement | | 4 | 123335936 | 123335937 | Human |
| 407001507 | GWAS650483_H | forced expiratory volume QTL GWAS650483 (human) | | 3e-13 | forced expiratory volume | | 4 | 127731072 | 127731073 | Human |
| 407017894 | GWAS666870_H | atrial fibrillation QTL GWAS666870 (human) | | 8e-11 | atrial fibrillation | | 4 | 110334761 | 110334762 | Human |
| 597303934 | GWAS1400008_H | mean corpuscular volume QTL GWAS1400008 (human) | | 2e-09 | mean corpuscular volume | | 4 | 119629914 | 119629915 | Human |
| 616555866 | GWAS1952449_H | body height QTL GWAS1952449 (human) | | 1e-13 | body height | | 4 | 108560745 | 108560746 | Human |
| 407017895 | GWAS666871_H | atrial fibrillation QTL GWAS666871 (human) | | 1e-28 | atrial fibrillation | | 4 | 110603473 | 110603474 | Human |
| 596976240 | GWAS1095759_H | stroke QTL GWAS1095759 (human) | | 0.0000004 | stroke | | 4 | 112810934 | 112810935 | Human |
| 596976243 | GWAS1095762_H | cardioembolic stroke QTL GWAS1095762 (human) | | 2e-47 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 617145646 | GWAS2163145_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2163145 (human) | | 6e-12 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 125992444 | 125992445 | Human |
| 616998190 | GWAS2015689_H | protein measurement QTL GWAS2015689 (human) | | 2e-183 | protein measurement | | 4 | 119360222 | 119360223 | Human |
| 617260323 | GWAS2197099_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2197099 (human) | | 4e-08 | polyunsaturated fatty acids to monounsaturated fatty acids ratio | | 4 | 109603883 | 109603884 | Human |
| 628647057 | GWAS2555286_H | gut microbiome measurement, breastfeeding duration QTL GWAS2555286 (human) | | 0.0000002 | lactation duration (VT:1000653) | | 4 | 115471326 | 115471327 | Human |
| 597615220 | GWAS1672080_H | platelet count QTL GWAS1672080 (human) | | 4e-36 | platelet count | | 4 | 109927496 | 109927497 | Human |
| 597140092 | GWAS1236166_H | facial morphology measurement QTL GWAS1236166 (human) | | 5e-08 | facial morphology measurement | | 4 | 125202598 | 125202599 | Human |
| 597140091 | GWAS1236165_H | facial morphology measurement QTL GWAS1236165 (human) | | 4e-08 | facial morphology measurement | | 4 | 125199979 | 125199980 | Human |
| 597140090 | GWAS1236164_H | facial morphology measurement QTL GWAS1236164 (human) | | 3e-08 | facial morphology measurement | | 4 | 125220568 | 125220569 | Human |
| 407099822 | GWAS748798_H | color vision disorder QTL GWAS748798 (human) | | 0.000009 | color vision disorder | | 4 | 129061664 | 129061665 | Human |
| 407017901 | GWAS666877_H | atrial fibrillation QTL GWAS666877 (human) | | 9e-09 | atrial fibrillation | | 4 | 112408189 | 112408190 | Human |
| 406903215 | GWAS552191_H | COVID-19 QTL GWAS552191 (human) | | 0.000005 | COVID-19 | | 4 | 113911048 | 113911049 | Human |
| 597402228 | GWAS1498302_H | protein measurement QTL GWAS1498302 (human) | | 6e-10 | protein measurement | | 4 | 132286668 | 132286669 | Human |
| 597402217 | GWAS1498291_H | systolic blood pressure QTL GWAS1498291 (human) | | 2e-16 | systolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 407378362 | GWAS1027338_H | lifestyle measurement QTL GWAS1027338 (human) | | 8e-09 | lifestyle measurement | | 4 | 129365346 | 129365348 | Human |
| 597107299 | GWAS1203373_H | cytokine measurement QTL GWAS1203373 (human) | | 0.000003 | cytokine amount (VT:0008713) | blood cytokine measurement (CMO:0001924) | 4 | 113032921 | 113032922 | Human |
| 597385837 | GWAS1481911_H | myeloid white cell count QTL GWAS1481911 (human) | | 6e-11 | myeloid white cell count | | 4 | 110020646 | 110020647 | Human |
| 597516906 | GWAS1612980_H | testosterone measurement QTL GWAS1612980 (human) | | 6e-16 | testosterone measurement | | 4 | 109345757 | 109345758 | Human |
| 407067060 | GWAS716036_H | systolic blood pressure QTL GWAS716036 (human) | | 0.000003 | mean arterial pressure | | 4 | 110460482 | 110460483 | Human |
| 598090334 | GWAS1809633_H | glomerular filtration rate QTL GWAS1809633 (human) | | 5e-13 | glomerular filtration rate | | 4 | 128601363 | 128601364 | Human |
| 596976236 | GWAS1095755_H | Ischemic stroke QTL GWAS1095755 (human) | | 0.0000001 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
| 597500519 | GWAS1596593_H | memory performance QTL GWAS1596593 (human) | | 0.000001 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124874941 | 124874942 | Human |
| 407263674 | GWAS912650_H | atrial fibrillation QTL GWAS912650 (human) | | 1e-48 | atrial fibrillation | | 4 | 110707883 | 110707884 | Human |
| 407165370 | GWAS814346_H | cardiac troponin T measurement QTL GWAS814346 (human) | | 0.0000001 | cardiac troponin T measurement | | 4 | 118958433 | 118958434 | Human |
| 407099837 | GWAS748813_H | mathematical ability QTL GWAS748813 (human) | | 2e-14 | mathematical ability | | 4 | 128819435 | 128819436 | Human |
| 407099836 | GWAS748812_H | mathematical ability QTL GWAS748812 (human) | | 2e-09 | mathematical ability | | 4 | 115132583 | 115132584 | Human |
| 617014585 | GWAS2032084_H | triglyceride measurement QTL GWAS2032084 (human) | | 2e-09 | triglyceride measurement | | 4 | 123822104 | 123822105 | Human |
| 597451165 | GWAS1547239_H | conotruncal heart malformations QTL GWAS1547239 (human) | | 0.000003 | conotruncal heart malformations | | 4 | 111868878 | 111868879 | Human |
| 616965831 | GWAS1983330_H | hippocampal sclerosis of aging QTL GWAS1983330 (human) | | 0.000005 | brain morphology trait (VT:0002152) | | 4 | 126441942 | 126441943 | Human |
| 406985281 | GWAS634257_H | body height QTL GWAS634257 (human) | | 2e-24 | body height | | 4 | 122904764 | 122904765 | Human |
| 616965836 | GWAS1983335_H | cerebral amyloid angiopathy QTL GWAS1983335 (human) | | 0.000007 | artery integrity trait (VT:0010639) | | 4 | 129419725 | 129419726 | Human |
| 597483920 | GWAS1579994_H | periodontitis QTL GWAS1579994 (human) | | 0.000009 | periodontitis | | 4 | 110885393 | 110885394 | Human |
| 597320086 | GWAS1416160_H | executive function measurement QTL GWAS1416160 (human) | | 1e-08 | executive function measurement | | 4 | 118025394 | 118025395 | Human |
| 628926321 | GWAS2834550_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2834550 (human) | | 4e-08 | fatty acid amount (VT:0010046) | | 4 | 109657070 | 109657071 | Human |
| 616507056 | GWAS1903639_H | blood protein amount QTL GWAS1903639 (human) | | 5e-08 | blood protein amount | | 4 | 110079447 | 110079448 | Human |
| 628959085 | GWAS2867314_H | mean corpuscular hemoglobin concentration QTL GWAS2867314 (human) | | 2e-42 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121854912 | 121854913 | Human |
| 597434761 | GWAS1530835_H | upper face morphology measurement QTL GWAS1530835 (human) | | 2e-09 | upper face morphology measurement | | 4 | 110922515 | 110922516 | Human |
| 598057395 | GWAS1776694_H | body height QTL GWAS1776694 (human) | | 4e-13 | body height | | 4 | 124017347 | 124017348 | Human |
| 597401996 | GWAS1498070_H | hair colour measurement QTL GWAS1498070 (human) | | 5e-23 | hair colour measurement | | 4 | 108561329 | 108561330 | Human |
| 598057394 | GWAS1776693_H | body height QTL GWAS1776693 (human) | | 1e-10 | body height | | 4 | 121817966 | 121817967 | Human |
| 626452303 | GWAS2266236_H | bilirubin measurement QTL GWAS2266236 (human) | | 9e-12 | bilirubin measurement | | 4 | 109985415 | 109985416 | Human |
| 597090700 | GWAS1186774_H | mean corpuscular volume QTL GWAS1186774 (human) | | 9e-33 | mean corpuscular volume | | 4 | 109947179 | 109947180 | Human |
| 616982236 | GWAS1999735_H | atrial fibrillation QTL GWAS1999735 (human) | | 2e-134 | atrial fibrillation | | 4 | 110793733 | 110793734 | Human |
| 598057407 | GWAS1776706_H | body height QTL GWAS1776706 (human) | | 2e-11 | body height | | 4 | 119840636 | 119840637 | Human |
| 597074316 | GWAS1170390_H | type 2 diabetes mellitus QTL GWAS1170390 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 121739095 | 121739096 | Human |
| 597090701 | GWAS1186775_H | mean corpuscular volume QTL GWAS1186775 (human) | | 2e-58 | mean corpuscular volume | | 4 | 121877258 | 121877259 | Human |
| 616982234 | GWAS1999733_H | atrial fibrillation QTL GWAS1999733 (human) | | 1e-126 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597090699 | GWAS1186773_H | mean corpuscular volume QTL GWAS1186773 (human) | | 4e-11 | mean corpuscular volume | | 4 | 109717668 | 109717669 | Human |
| 407378517 | GWAS1027493_H | BMI-adjusted waist-hip ratio QTL GWAS1027493 (human) | | 1e-11 | BMI-adjusted waist-hip ratio | | 4 | 124270608 | 124270609 | Human |
| 598057402 | GWAS1776701_H | body height QTL GWAS1776701 (human) | | 1e-09 | body height | | 4 | 112488114 | 112488115 | Human |
| 597434755 | GWAS1530829_H | lip morphology measurement QTL GWAS1530829 (human) | | 1e-08 | lip morphology measurement | | 4 | 121076949 | 121076950 | Human |
| 617047779 | GWAS2065278_H | erythrocyte volume QTL GWAS2065278 (human) | | 4e-16 | erythrocyte volume | | 4 | 127534974 | 127534975 | Human |
| 407231072 | GWAS880048_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS880048 (human) | | 4e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 122122507 | 122122508 | Human |
| 407116387 | GWAS765363_H | protein measurement QTL GWAS765363 (human) | | 2e-08 | protein measurement | | 4 | 112377272 | 112377273 | Human |
| 407018085 | GWAS667061_H | sex hormone-binding globulin measurement QTL GWAS667061 (human) | | 2e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 628664136 | GWAS2572365_H | Tinnitus QTL GWAS2572365 (human) | | 0.0000004 | Tinnitus | | 4 | 110681577 | 110681578 | Human |
| 406919792 | GWAS568768_H | cardiovascular disease biomarker measurement, ankle brachial index QTL GWAS568768 (human) | | 0.000007 | cardiovascular disease biomarker measurement, ankle brachial index | | 4 | 126012137 | 126012138 | Human |
| 628598597 | GWAS2506826_H | fatty acid amount QTL GWAS2506826 (human) | | 3e-08 | fatty acid amount | | 4 | 109657070 | 109657071 | Human |
| 628614978 | GWAS2523207_H | brain attribute QTL GWAS2523207 (human) | | 2e-09 | brain attribute | | 4 | 123226927 | 123226928 | Human |
| 597336492 | GWAS1432566_H | Hepatitis QTL GWAS1432566 (human) | | 1e-09 | Hepatitis | | 4 | 125282172 | 125282173 | Human |
| 597811607 | GWAS1678998_H | colorectal cancer, tea consumption measurement QTL GWAS1678998 (human) | | 0.000006 | colorectal cancer, tea consumption measurement | | 4 | 131412330 | 131412331 | Human |
| 406903415 | GWAS552391_H | diastolic blood pressure, systolic blood pressure QTL GWAS552391 (human) | | 2e-08 | diastolic blood pressure, systolic blood pressure | | 4 | 119856151 | 119856152 | Human |
| 407198333 | GWAS847309_H | Ischemic stroke, tissue plasminogen activator measurement QTL GWAS847309 (human) | | 1e-16 | Ischemic stroke, tissue plasminogen activator measurement | | 4 | 110775495 | 110775496 | Human |
| 598024607 | GWAS1743906_H | CRKL/EGF protein level ratio in blood QTL GWAS1743906 (human) | | 3e-202 | CRKL/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 616556284 | GWAS1952867_H | reticulocyte count QTL GWAS1952867 (human) | | 7e-17 | reticulocyte count | | 4 | 109970517 | 109970518 | Human |
| 628729661 | GWAS2637890_H | BMI-adjusted waist-hip ratio QTL GWAS2637890 (human) | | 6e-10 | body size trait (VT:0100005) | | 4 | 119763897 | 119763898 | Human |
| 628401969 | GWAS2310198_H | mean corpuscular hemoglobin concentration QTL GWAS2310198 (human) | | 5e-15 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109944312 | 109944313 | Human |
| 628729660 | GWAS2637889_H | BMI-adjusted waist-hip ratio QTL GWAS2637889 (human) | | 2e-08 | body size trait (VT:0100005) | | 4 | 119595538 | 119595539 | Human |
| 407198210 | GWAS847186_H | Alzheimer disease, educational attainment QTL GWAS847186 (human) | | 0.0000004 | Alzheimer disease, educational attainment | | 4 | 129748953 | 129748954 | Human |
| 616490743 | GWAS1887326_H | level of phosphatidylethanolamine QTL GWAS1887326 (human) | | 2e-08 | level of phosphatidylethanolamine | | 4 | 126594255 | 126594256 | Human |
| 625829638 | GWAS2250560_H | cardiac arrhythmia QTL GWAS2250560 (human) | | 1e-26 | cardiac arrhythmia | | 4 | 110739038 | 110739039 | Human |
| 616523506 | GWAS1920089_H | level of desmoglein-4 in blood serum QTL GWAS1920089 (human) | | 4e-12 | level of desmoglein-4 in blood serum | | 4 | 106786338 | 106786339 | Human |
| 616982155 | GWAS1999654_H | atrial fibrillation QTL GWAS1999654 (human) | | 2e-62 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 616982152 | GWAS1999651_H | atrial fibrillation QTL GWAS1999651 (human) | | 3e-155 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407181844 | GWAS830820_H | coronary artery disease QTL GWAS830820 (human) | | 3e-16 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 616982164 | GWAS1999663_H | atrial fibrillation QTL GWAS1999663 (human) | | 4e-08 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 616982165 | GWAS1999664_H | atrial fibrillation QTL GWAS1999664 (human) | | 8e-57 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597090757 | GWAS1186831_H | concussion QTL GWAS1186831 (human) | | 1e-10 | brain integrity trait (VT:0010579) | | 4 | 123151329 | 123151330 | Human |
| 407411228 | GWAS1060204_H | glycerophospholipid measurement QTL GWAS1060204 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594500 | 114594501 | Human |
| 628959016 | GWAS2867245_H | serum creatinine amount QTL GWAS2867245 (human) | | 2e-23 | serum creatinine amount | | 4 | 108791438 | 108791439 | Human |
| 407411229 | GWAS1060205_H | glycerophospholipid measurement QTL GWAS1060205 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594055 | 114594056 | Human |
| 407411230 | GWAS1060206_H | glycerophospholipid measurement QTL GWAS1060206 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114598115 | 114598116 | Human |
| 628942634 | GWAS2850863_H | body height QTL GWAS2850863 (human) | | 4e-63 | body height | | 4 | 121800257 | 121800258 | Human |
| 616982161 | GWAS1999660_H | atrial fibrillation QTL GWAS1999660 (human) | | 7e-136 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 407411231 | GWAS1060207_H | glycerophospholipid measurement QTL GWAS1060207 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114595467 | 114595468 | Human |
| 597811702 | GWAS1679093_H | phosphatidylcholine measurement QTL GWAS1679093 (human) | | 2e-08 | phosphatidylcholine measurement | | 4 | 126274953 | 126274954 | Human |
| 407329311 | GWAS978287_H | ceramide measurement QTL GWAS978287 (human) | | 2e-13 | ceramide measurement | | 4 | 114549176 | 114549177 | Human |
| 407214620 | GWAS863596_H | calcium measurement QTL GWAS863596 (human) | | 4e-09 | calcium measurement | | 4 | 114458289 | 114458290 | Human |
| 597303744 | GWAS1399818_H | mean corpuscular volume QTL GWAS1399818 (human) | | 3e-13 | mean corpuscular volume | | 4 | 109921984 | 109921985 | Human |
| 407018008 | GWAS666984_H | atrial fibrillation QTL GWAS666984 (human) | | 4e-52 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
| 597352902 | GWAS1448976_H | bone density QTL GWAS1448976 (human) | | 8e-16 | bone density | | 4 | 107727835 | 107727836 | Human |
| 628647716 | GWAS2555945_H | gut microbiome measurement, breastfeeding duration QTL GWAS2555945 (human) | | 0.0000005 | lactation duration (VT:1000653) | | 4 | 115471326 | 115471327 | Human |
| 628647717 | GWAS2555946_H | gut microbiome measurement, breastfeeding duration QTL GWAS2555946 (human) | | 8e-08 | lactation duration (VT:1000653) | | 4 | 115599484 | 115599485 | Human |
| 597303807 | GWAS1399881_H | brain measurement QTL GWAS1399881 (human) | | 9e-44 | brain measurement | | 4 | 123332634 | 123332635 | Human |
| 597533172 | GWAS1629246_H | rheumatoid arthritis QTL GWAS1629246 (human) | | 0.000005 | rheumatoid arthritis | | 4 | 124601887 | 124601888 | Human |
| 407001640 | GWAS650616_H | diastolic blood pressure QTL GWAS650616 (human) | | 6e-08 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 108104223 | 108104224 | Human |
| 406985262 | GWAS634238_H | cortical surface area measurement QTL GWAS634238 (human) | | 7e-10 | cortical surface area measurement | | 4 | 118328680 | 118328681 | Human |
| 616965800 | GWAS1983299_H | trait in response to cytarabine QTL GWAS1983299 (human) | | 0.000007 | trait in response to cytarabine | | 4 | 119691563 | 119691564 | Human |
| 597533165 | GWAS1629239_H | rheumatoid arthritis QTL GWAS1629239 (human) | | 0.000002 | rheumatoid arthritis | | 4 | 108192758 | 108192759 | Human |
| 407181877 | GWAS830853_H | asthma QTL GWAS830853 (human) | | 2e-14 | asthma | | 4 | 122415763 | 122415764 | Human |
| 407149109 | GWAS798085_H | S-7-hydroxywarfarin measurement QTL GWAS798085 (human) | | 0.000009 | S-7-hydroxywarfarin measurement | | 4 | 121518134 | 121518135 | Human |
| 628500226 | GWAS2408455_H | APP/EGF protein level ratio in blood QTL GWAS2408455 (human) | | 4e-192 | APP/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 597320162 | GWAS1416236_H | very low density lipoprotein cholesterol measurement QTL GWAS1416236 (human) | | 1e-08 | very low density lipoprotein cholesterol measurement | | 4 | 109717709 | 109717710 | Human |
| 628418316 | GWAS2326545_H | hemoglobin measurement QTL GWAS2326545 (human) | | 3e-09 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114647874 | 114647875 | Human |
| 628369166 | GWAS2290010_H | chronic lymphocytic leukemia QTL GWAS2290010 (human) | | 2e-11 | chronic lymphocytic leukemia | | 4 | 108168668 | 108168669 | Human |
| 628434703 | GWAS2342932_H | adolescent idiopathic scoliosis QTL GWAS2342932 (human) | | 9e-12 | adolescent idiopathic scoliosis | | 4 | 116480238 | 116480239 | Human |
| 407394867 | GWAS1043843_H | metabolite measurement QTL GWAS1043843 (human) | | 2e-22 | metabolite measurement | | 4 | 129118729 | 129118730 | Human |
| 628729848 | GWAS2638077_H | trait in response to carbamazepine QTL GWAS2638077 (human) | | 0.0000009 | trait in response to carbamazepine | | 4 | 127124380 | 127124381 | Human |
| 407165635 | GWAS814611_H | cardiac troponin T measurement QTL GWAS814611 (human) | | 0.0000008 | cardiac troponin T measurement | | 4 | 118958433 | 118958434 | Human |
| 597434644 | GWAS1530718_H | Antithrombotic agent use measurement QTL GWAS1530718 (human) | | 6e-19 | Antithrombotic agent use measurement | | 4 | 110791080 | 110791081 | Human |
| 407296716 | GWAS945692_H | response to selective serotonin reuptake inhibitor, openness measurement QTL GWAS945692 (human) | | 0.0000004 | response to selective serotonin reuptake inhibitor, openness measurement | | 4 | 129115280 | 129115281 | Human |
| 625829830 | GWAS2250752_H | congestive heart failure QTL GWAS2250752 (human) | | 0.0000002 | congestive heart failure | | 4 | 110787733 | 110787734 | Human |
| 596975902 | GWAS1095421_H | Ischemic stroke QTL GWAS1095421 (human) | | 1e-15 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 628647925 | GWAS2556154_H | cerebrovascular disorder QTL GWAS2556154 (human) | | 3e-09 | cerebrovascular disorder | | 4 | 110776659 | 110776660 | Human |
| 628549606 | GWAS2457835_H | cup-to-disc ratio measurement QTL GWAS2457835 (human) | | 5e-17 | optic disc morphology trait (VT:0006215) | | 4 | 125486143 | 125486144 | Human |
| 628484068 | GWAS2392297_H | atrial fibrillation QTL GWAS2392297 (human) | | 2e-427 | atrial fibrillation | | 4 | 110775495 | 110775496 | Human |
| 617195096 | GWAS2175536_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2175536 (human) | | 3e-15 | glioma pathogenesis-related protein 1 measurement | | 4 | 112179581 | 112179582 | Human |
| 597172489 | GWAS1268563_H | body mass index QTL GWAS1268563 (human) | | 7e-10 | body mass index | | 4 | 112392830 | 112392831 | Human |
| 406919888 | GWAS568864_H | neutrophil count QTL GWAS568864 (human) | | 0.000008 | neutrophil count | | 4 | 117730668 | 117730669 | Human |
| 597336331 | GWAS1432405_H | COVID-19 QTL GWAS1432405 (human) | | 0.000009 | COVID-19 | | 4 | 127021337 | 127021338 | Human |
| 616982100 | GWAS1999599_H | acute myeloid leukemia QTL GWAS1999599 (human) | | 5e-20 | leukocyte integrity trait (VT:0010898) | | 4 | 121985860 | 121985861 | Human |
| 616572500 | GWAS1969083_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1969083 (human) | | 3e-13 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 115961513 | 115961514 | Human |
| 616982098 | GWAS1999597_H | acute myeloid leukemia QTL GWAS1999597 (human) | | 2e-19 | leukocyte integrity trait (VT:0010898) | | 4 | 117598611 | 117598612 | Human |
| 616982099 | GWAS1999598_H | acute myeloid leukemia QTL GWAS1999598 (human) | | 5e-08 | leukocyte integrity trait (VT:0010898) | | 4 | 117598611 | 117598612 | Human |
| 628484067 | GWAS2392296_H | atrial fibrillation QTL GWAS2392296 (human) | | 4e-427 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 628434914 | GWAS2343143_H | BMI-adjusted waist circumference QTL GWAS2343143 (human) | | 6e-11 | body size trait (VT:0100005) | | 4 | 119759795 | 119759796 | Human |
| 597352706 | GWAS1448780_H | body height QTL GWAS1448780 (human) | | 1e-32 | body height | | 4 | 123312229 | 123312230 | Human |
| 617080414 | GWAS2097913_H | body mass index QTL GWAS2097913 (human) | | 4e-12 | body mass index | | 4 | 111792280 | 111792281 | Human |
| 597352704 | GWAS1448778_H | body height QTL GWAS1448778 (human) | | 2e-96 | body height | | 4 | 122830862 | 122830863 | Human |
| 597352705 | GWAS1448779_H | body height QTL GWAS1448779 (human) | | 7e-150 | body height | | 4 | 122917603 | 122917604 | Human |
| 407296730 | GWAS945706_H | fatty acid measurement QTL GWAS945706 (human) | | 3e-08 | fatty acid measurement | | 4 | 109657070 | 109657071 | Human |
| 597172487 | GWAS1268561_H | body mass index QTL GWAS1268561 (human) | | 4e-12 | body mass index | | 4 | 111792280 | 111792281 | Human |
| 406903523 | GWAS552499_H | information processing speed, response to cranial radiation therapy QTL GWAS552499 (human) | | 0.000004 | information processing speed, response to cranial radiation therapy | | 4 | 117423051 | 117423052 | Human |
| 628664284 | GWAS2572513_H | bone tissue density QTL GWAS2572513 (human) | | 2e-09 | bone tissue density | | 4 | 108138358 | 108138359 | Human |
| 617080417 | GWAS2097916_H | body mass index QTL GWAS2097916 (human) | | 3e-15 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 617080416 | GWAS2097915_H | body mass index QTL GWAS2097915 (human) | | 6e-10 | body mass index | | 4 | 119372621 | 119372622 | Human |
| 628697041 | GWAS2605270_H | vaginal microbiome measurement QTL GWAS2605270 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 598008076 | GWAS1727375_H | EGF/PPIB protein level ratio in blood QTL GWAS1727375 (human) | | 2e-272 | EGF/PPIB protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 596992319 | GWAS1111838_H | eosinophil percentage of leukocytes QTL GWAS1111838 (human) | | 2e-22 | eosinophil percentage of leukocytes | | 4 | 122680542 | 122680543 | Human |
| 597139772 | GWAS1235846_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS1235846 (human) | | 1e-12 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129113772 | 129113775 | Human |
| 597107002 | GWAS1203076_H | protein measurement QTL GWAS1203076 (human) | | 1e-08 | protein amount (VT:0010120) | | 4 | 112859722 | 112859723 | Human |
| 628434907 | GWAS2343136_H | BMI-adjusted waist circumference QTL GWAS2343136 (human) | | 1e-14 | body size trait (VT:0100005) | | 4 | 119354508 | 119354509 | Human |
| 407116522 | GWAS765498_H | body mass index QTL GWAS765498 (human) | | 2e-14 | body mass index | | 4 | 129843450 | 129843451 | Human |
| 407329512 | GWAS978488_H | ceramide measurement QTL GWAS978488 (human) | | 2e-25 | ceramide measurement | | 4 | 114549176 | 114549177 | Human |
| 628434906 | GWAS2343135_H | BMI-adjusted waist circumference QTL GWAS2343135 (human) | | 5e-08 | body size trait (VT:0100005) | | 4 | 121696338 | 121696339 | Human |
| 597401908 | GWAS1497982_H | neutrophil percentage of leukocytes QTL GWAS1497982 (human) | | 3e-17 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 4 | 122760001 | 122760002 | Human |
| 597254441 | GWAS1350515_H | alkaline phosphatase measurement QTL GWAS1350515 (human) | | 8e-15 | alkaline phosphatase measurement | | 4 | 128168289 | 128168290 | Human |
| 617145977 | GWAS2163476_H | cardiac arrest QTL GWAS2163476 (human) | | 2e-12 | cardiac arrest | | 4 | 129618474 | 129618475 | Human |
| 617145979 | GWAS2163478_H | cardiac arrhythmia QTL GWAS2163478 (human) | | 4e-14 | cardiac arrhythmia | | 4 | 110784139 | 110784140 | Human |
| 407182064 | GWAS831040_H | lower face morphology measurement QTL GWAS831040 (human) | | 4e-11 | lower face morphology measurement | | 4 | 126014320 | 126014321 | Human |
| 628926411 | GWAS2834640_H | waist circumference QTL GWAS2834640 (human) | | 1e-08 | waist circumference | | 4 | 131517122 | 131517123 | Human |
| 617080446 | GWAS2097945_H | schizophrenia QTL GWAS2097945 (human) | | 0.0000005 | schizophrenia | | 4 | 117697551 | 117697552 | Human |
| 407395059 | GWAS1044035_H | ceramide measurement QTL GWAS1044035 (human) | | 2e-21 | ceramide measurement | | 4 | 114598115 | 114598116 | Human |
| 628942787 | GWAS2851016_H | body height QTL GWAS2851016 (human) | | 1e-26 | body height | | 4 | 113894181 | 113894182 | Human |
| 628402100 | GWAS2310329_H | lymphocyte count QTL GWAS2310329 (human) | | 6e-20 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109914892 | 109914893 | Human |
| 628402101 | GWAS2310330_H | lymphocyte count QTL GWAS2310330 (human) | | 1e-25 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112152543 | 112152544 | Human |
| 628402102 | GWAS2310331_H | lymphocyte count QTL GWAS2310331 (human) | | 6e-10 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 122579931 | 122579932 | Human |
| 628402103 | GWAS2310332_H | lymphocyte count QTL GWAS2310332 (human) | | 2e-14 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 122760001 | 122760002 | Human |
| 597582171 | GWAS1639031_H | pulse pressure measurement, sex interaction measurement QTL GWAS1639031 (human) | | 0.000007 | pulse pressure measurement, sex interaction measurement | | 4 | 110755885 | 110755886 | Human |
| 597188948 | GWAS1285022_H | body mass index QTL GWAS1285022 (human) | | 8e-09 | body mass index | | 4 | 110683327 | 110683328 | Human |
| 628549563 | GWAS2457792_H | cup-to-disc ratio measurement QTL GWAS2457792 (human) | | 7e-09 | optic disc morphology trait (VT:0006215) | | 4 | 111478355 | 111478356 | Human |
| 597188949 | GWAS1285023_H | body mass index QTL GWAS1285023 (human) | | 2e-18 | body mass index | | 4 | 111781479 | 111781480 | Human |
| 597188950 | GWAS1285024_H | body mass index QTL GWAS1285024 (human) | | 1e-11 | body mass index | | 4 | 112339309 | 112339310 | Human |
| 597139776 | GWAS1235850_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS1235850 (human) | | 3e-12 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129143723 | 129143724 | Human |
| 407100058 | GWAS749034_H | vital capacity QTL GWAS749034 (human) | | 4e-11 | vital capacity | | 4 | 127731072 | 127731073 | Human |
| 407378578 | GWAS1027554_H | balding measurement QTL GWAS1027554 (human) | | 4e-32 | balding measurement | | 4 | 106635172 | 106635173 | Human |
| 407100057 | GWAS749033_H | vital capacity QTL GWAS749033 (human) | | 2e-10 | vital capacity | | 4 | 122906887 | 122906888 | Human |
| 407100056 | GWAS749032_H | vital capacity QTL GWAS749032 (human) | | 0.0000001 | vital capacity | | 4 | 112674713 | 112674714 | Human |
| 617096744 | GWAS2114243_H | forced expiratory volume QTL GWAS2114243 (human) | | 1e-12 | forced expiratory volume | | 4 | 123898452 | 123898453 | Human |
| 597401979 | GWAS1498053_H | corneal topography QTL GWAS1498053 (human) | | 0.0000003 | corneal topography | | 4 | 127192269 | 127192270 | Human |
| 598040902 | GWAS1760201_H | leukocyte quantity QTL GWAS1760201 (human) | | 8e-12 | leukocyte quantity | | 4 | 109912954 | 109912955 | Human |
| 597156210 | GWAS1252284_H | sex hormone-binding globulin measurement QTL GWAS1252284 (human) | | 0.000005 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
| 597369203 | GWAS1465277_H | cortical surface area measurement QTL GWAS1465277 (human) | | 0.0000006 | cortical surface area measurement | | 4 | 126616579 | 126616580 | Human |
| 616982063 | GWAS1999562_H | glycerophospholipid measurement QTL GWAS1999562 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114501231 | 114501232 | Human |
| 617211424 | GWAS2191864_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2191864 (human) | | 7e-228 | level of fatty acid-binding protein, intestinal in blood | | 4 | 119359462 | 119359463 | Human |
| 617211427 | GWAS2191867_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2191867 (human) | | 6e-37 | level of fatty acid-binding protein, intestinal in blood | | 4 | 119779454 | 119779455 | Human |
| 617211426 | GWAS2191866_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2191866 (human) | | 1e-25 | level of fatty acid-binding protein, intestinal in blood | | 4 | 119029200 | 119029201 | Human |
| 628844437 | GWAS2752666_H | schizophrenia QTL GWAS2752666 (human) | | 0.0000005 | schizophrenia | | 4 | 117697551 | 117697552 | Human |
| 626452409 | GWAS2266342_H | hemoglobin measurement QTL GWAS2266342 (human) | | 6e-22 | hemoglobin measurement | | 4 | 114598670 | 114598671 | Human |
| 617211430 | GWAS2191870_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2191870 (human) | | 1e-13 | level of fatty acid-binding protein, intestinal in blood | | 4 | 118965701 | 118965702 | Human |
| 597205367 | GWAS1301441_H | protein measurement QTL GWAS1301441 (human) | | 2e-15 | protein measurement | | 4 | 121395817 | 121395818 | Human |
| 616965685 | GWAS1983184_H | neutrophil measurement, lymphocyte amount QTL GWAS1983184 (human) | | 3e-14 | neutrophil measurement, lymphocyte amount | | 4 | 122707302 | 122707305 | Human |
| 628418433 | GWAS2326662_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS2326662 (human) | | 4e-12 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 4 | 111202547 | 111202548 | Human |
| 407345853 | GWAS994829_H | eosinophil count QTL GWAS994829 (human) | | 4e-21 | eosinophil count | | 4 | 122408207 | 122408208 | Human |
| 617195061 | GWAS2175501_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2175501 (human) | | 3e-13 | glioma pathogenesis-related protein 1 measurement | | 4 | 115961513 | 115961514 | Human |
| 628860805 | GWAS2769034_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS2769034 (human) | | 5e-19 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129143723 | 129143724 | Human |
| 628647545 | GWAS2555774_H | gut microbiome measurement, breastfeeding duration QTL GWAS2555774 (human) | | 6e-11 | lactation duration (VT:1000653) | | 4 | 110717326 | 110717327 | Human |
| 596992151 | GWAS1111670_H | hemoglobin measurement QTL GWAS1111670 (human) | | 1e-12 | hemoglobin measurement | | 4 | 123835365 | 123835366 | Human |
| 628958846 | GWAS2867075_H | platelet volume QTL GWAS2867075 (human) | | 2e-13 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 617113542 | GWAS2131041_H | level of TP53-binding protein 1 in blood QTL GWAS2131041 (human) | | 7e-12 | level of TP53-binding protein 1 in blood | | 4 | 122618282 | 122618284 | Human |
| 407182154 | GWAS831130_H | Antithrombotic agent use measurement QTL GWAS831130 (human) | | 6e-19 | Antithrombotic agent use measurement | | 4 | 110791080 | 110791081 | Human |
| 628631148 | GWAS2539377_H | pulse pressure measurement QTL GWAS2539377 (human) | | 1e-52 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 112822498 | 112822499 | Human |
| 597057666 | GWAS1153740_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS1153740 (human) | | 6e-20 | Eczematoid dermatitis, allergic rhinitis | | 4 | 122219915 | 122219916 | Human |
| 597385359 | GWAS1481433_H | gastric carcinoma QTL GWAS1481433 (human) | | 9e-10 | gastric carcinoma | | 4 | 124535968 | 124535969 | Human |
| 597483658 | GWAS1579732_H | ceramide measurement QTL GWAS1579732 (human) | | 9e-60 | ceramide measurement | | 4 | 114564528 | 114564529 | Human |
| 616998878 | GWAS2016377_H | atrial fibrillation QTL GWAS2016377 (human) | | 6e-09 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 597401730 | GWAS1497804_H | Ischemic stroke, cardiac embolism QTL GWAS1497804 (human) | | 3e-32 | Ischemic stroke, cardiac embolism | | 4 | 110789013 | 110789014 | Human |
| 597057676 | GWAS1153750_H | rosacea severity measurement QTL GWAS1153750 (human) | | 0.000004 | rosacea severity measurement | | 4 | 122146898 | 122146899 | Human |
| 597188738 | GWAS1284812_H | educational attainment QTL GWAS1284812 (human) | | 0.000008 | educational attainment | | 4 | 131866663 | 131866664 | Human |
| 616998874 | GWAS2016373_H | atrial fibrillation QTL GWAS2016373 (human) | | 2e-39 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
| 628860517 | GWAS2768746_H | hypertension, COVID-19 QTL GWAS2768746 (human) | | 5e-08 | blood pressure trait (VT:0000183) | | 4 | 110493243 | 110493244 | Human |
| 597532803 | GWAS1628877_H | atrial fibrillation QTL GWAS1628877 (human) | | 2e-210 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 406985570 | GWAS634546_H | intelligence QTL GWAS634546 (human) | | 5e-09 | intelligence | | 4 | 112490199 | 112490200 | Human |
| 407083875 | GWAS732851_H | osteoarthritis, knee QTL GWAS732851 (human) | | 0.000001 | osteoarthritis, knee | | 4 | 115123255 | 115123256 | Human |
| 597532860 | GWAS1628934_H | metabolite measurement QTL GWAS1628934 (human) | | 6e-08 | metabolite measurement | | 4 | 129868385 | 129868386 | Human |
| 406969190 | GWAS618166_H | underweight body mass index status QTL GWAS618166 (human) | | 0.000006 | underweight body mass index status | | 4 | 113088430 | 113088431 | Human |
| 597156031 | GWAS1252105_H | fatty acid measurement QTL GWAS1252105 (human) | | 3e-08 | fatty acid measurement | | 4 | 109657070 | 109657071 | Human |
| 597483700 | GWAS1579774_H | mean corpuscular volume QTL GWAS1579774 (human) | | 8e-17 | mean corpuscular volume | | 4 | 127625245 | 127625246 | Human |
| 628860500 | GWAS2768729_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS2768729 (human) | | 2e-08 | joint integrity trait (VT:0010548) | | 4 | 122122507 | 122122508 | Human |
| 628827732 | GWAS2735961_H | platelet count QTL GWAS2735961 (human) | | 9e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
| 407034738 | GWAS683714_H | red blood cell density measurement QTL GWAS683714 (human) | | 2e-16 | red blood cell density measurement | | 4 | 121804148 | 121804149 | Human |
| 597074083 | GWAS1170157_H | coronary artery disease QTL GWAS1170157 (human) | | 6e-14 | coronary artery disease | | 4 | 119980181 | 119980182 | Human |
| 597123232 | GWAS1219306_H | endothelial growth factor measurement QTL GWAS1219306 (human) | | 3e-105 | endothelial growth factor measurement | | 4 | 109924607 | 109924608 | Human |
| 597254308 | GWAS1350382_H | apolipoprotein A 1 measurement QTL GWAS1350382 (human) | | 3e-15 | apolipoprotein A 1 measurement | | 4 | 109648464 | 109648465 | Human |
| 406969214 | GWAS618190_H | cannabis dependence QTL GWAS618190 (human) | | 8e-11 | cannabis dependence | | 4 | 111546456 | 111546457 | Human |
| 597156051 | GWAS1252125_H | lifestyle measurement, depressive symptom measurement QTL GWAS1252125 (human) | | 3e-08 | lifestyle measurement, depressive symptom measurement | | 4 | 117961493 | 117961494 | Human |
| 628926009 | GWAS2834238_H | body height QTL GWAS2834238 (human) | | 4e-08 | body height | | 4 | 113877699 | 113877700 | Human |
| 628926004 | GWAS2834233_H | body height QTL GWAS2834233 (human) | | 7e-17 | body height | | 4 | 121801951 | 121801952 | Human |
| 628729395 | GWAS2637624_H | corneal resistance factor QTL GWAS2637624 (human) | | 4e-08 | cornea morphology trait (VT:0001312) | | 4 | 118802505 | 118802506 | Human |
| 407182088 | GWAS831064_H | Beta blocking agent use measurement QTL GWAS831064 (human) | | 1e-12 | Beta blocking agent use measurement | | 4 | 110789013 | 110789014 | Human |
| 617064330 | GWAS2081829_H | smoking cessation QTL GWAS2081829 (human) | | 3e-12 | smoking cessation | | 4 | 112123310 | 112123311 | Human |
| 407280393 | GWAS929369_H | vaginal microbiome measurement QTL GWAS929369 (human) | | 0.000001 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 597106883 | GWAS1202957_H | systemic lupus erythematosus QTL GWAS1202957 (human) | | 4e-11 | systemic lupus erythematosus | | 4 | 108125804 | 108125805 | Human |
| 407149330 | GWAS798306_H | platelet count QTL GWAS798306 (human) | | 6e-38 | platelet count | | 4 | 110039895 | 110039896 | Human |
| 617064346 | GWAS2081845_H | metabolite measurement QTL GWAS2081845 (human) | | 6e-08 | metabolite measurement | | 4 | 129868385 | 129868386 | Human |
| 407247640 | GWAS896616_H | complement factor H-related protein 2 measurement QTL GWAS896616 (human) | | 0.000009 | complement factor H-related protein 2 measurement | | 4 | 127922325 | 127922326 | Human |
| 597467331 | GWAS1563405_H | systolic blood pressure QTL GWAS1563405 (human) | | 2e-08 | systolic blood pressure | | 4 | 110439533 | 110439534 | Human |
| 616998809 | GWAS2016308_H | erythrocyte volume QTL GWAS2016308 (human) | | 1e-08 | erythrocyte volume | | 4 | 121766083 | 121766084 | Human |
| 598008004 | GWAS1727303_H | EGF/MGLL protein level ratio in blood QTL GWAS1727303 (human) | | 2e-239 | EGF/MGLL protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 597352698 | GWAS1448772_H | body height QTL GWAS1448772 (human) | | 3e-23 | body height | | 4 | 120882137 | 120882138 | Human |
| 597352699 | GWAS1448773_H | body height QTL GWAS1448773 (human) | | 7e-19 | body height | | 4 | 121693600 | 121693601 | Human |
| 628696603 | GWAS2604832_H | annexin A5 measurement QTL GWAS2604832 (human) | | 5e-36 | annexin A5 measurement | | 4 | 121673919 | 121673920 | Human |
| 597352697 | GWAS1448771_H | body height QTL GWAS1448771 (human) | | 2e-19 | body height | | 4 | 120734912 | 120734913 | Human |
| 407329571 | GWAS978547_H | lipoprotein measurement QTL GWAS978547 (human) | | 3e-10 | lipoprotein measurement | | 4 | 109657070 | 109657071 | Human |
| 597352702 | GWAS1448776_H | body height QTL GWAS1448776 (human) | | 1e-12 | body height | | 4 | 122600025 | 122600026 | Human |
| 407378733 | GWAS1027709_H | chronic kidney disease QTL GWAS1027709 (human) | | 0.0000009 | chronic kidney disease | | 4 | 117920116 | 117920117 | Human |
| 628696604 | GWAS2604833_H | annexin A5 measurement QTL GWAS2604833 (human) | | 9e-51 | annexin A5 measurement | | 4 | 121659570 | 121659571 | Human |
| 597352703 | GWAS1448777_H | body height QTL GWAS1448777 (human) | | 0.0000001 | body height | | 4 | 122824456 | 122824457 | Human |
| 597352700 | GWAS1448774_H | body height QTL GWAS1448774 (human) | | 4e-49 | body height | | 4 | 121772932 | 121772933 | Human |
| 407083812 | GWAS732788_H | stroke QTL GWAS732788 (human) | | 2e-13 | stroke | | 4 | 110793263 | 110793264 | Human |
| 597074161 | GWAS1170235_H | major depressive disorder QTL GWAS1170235 (human) | | 0.000007 | major depressive disorder | | 4 | 115213661 | 115213662 | Human |
| 597352701 | GWAS1448775_H | body height QTL GWAS1448775 (human) | | 9e-190 | body height | | 4 | 121799844 | 121799845 | Human |
| 597385458 | GWAS1481532_H | hypothyroidism QTL GWAS1481532 (human) | | 8e-10 | Thyroid preparation use measurement | | 4 | 122625127 | 122625128 | Human |
| 628942352 | GWAS2850581_H | platelet count QTL GWAS2850581 (human) | | 8e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 128241378 | 128241379 | Human |
| 628925969 | GWAS2834198_H | body height QTL GWAS2834198 (human) | | 4e-10 | body height | | 4 | 108536277 | 108536278 | Human |
| 598008011 | GWAS1727310_H | EGF/MPIG6B protein level ratio in blood QTL GWAS1727310 (human) | | 5e-348 | EGF/MPIG6B protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 597352693 | GWAS1448767_H | bone density QTL GWAS1448767 (human) | | 5e-16 | bone density | | 4 | 131691474 | 131691475 | Human |
| 617031600 | GWAS2049099_H | attention deficit hyperactivity disorder, risk-taking behaviour QTL GWAS2049099 (human) | | 7e-11 | attention deficit hyperactivity disorder, risk-taking behaviour | | 4 | 111296367 | 111296368 | Human |
| 597450981 | GWAS1547055_H | platelet count QTL GWAS1547055 (human) | | 9e-11 | platelet count | | 4 | 109813770 | 109813771 | Human |
| 628631043 | GWAS2539272_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2539272 (human) | | 2e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 106567633 | 106567634 | Human |
| 617195442 | GWAS2175882_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2175882 (human) | | 5e-13 | glioma pathogenesis-related protein 1 measurement | | 4 | 128282916 | 128282917 | Human |
| 406919996 | GWAS568972_H | appendicular lean mass QTL GWAS568972 (human) | | 9e-13 | appendicular lean mass | | 4 | 119206606 | 119206607 | Human |
| 628647429 | GWAS2555658_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2555658 (human) | | 0.0000006 | gut microbiome measurement, allergen exposure measurement | | 4 | 121979374 | 121979375 | Human |
| 628647430 | GWAS2555659_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2555659 (human) | | 0.0000004 | gut microbiome measurement, allergen exposure measurement | | 4 | 121979374 | 121979375 | Human |
| 628876805 | GWAS2785034_H | acne QTL GWAS2785034 (human) | | 0.000008 | acne | | 4 | 123213554 | 123213555 | Human |
| 407231429 | GWAS880405_H | mosquito bite reaction size measurement QTL GWAS880405 (human) | | 0.000003 | mosquito bite reaction size measurement | | 4 | 130874394 | 130874395 | Human |
| 407231428 | GWAS880404_H | mosquito bite reaction size measurement QTL GWAS880404 (human) | | 4e-08 | mosquito bite reaction size measurement | | 4 | 129337181 | 129337182 | Human |
| 407116742 | GWAS765718_H | body mass index QTL GWAS765718 (human) | | 1e-08 | body mass index | | 4 | 112335581 | 112335582 | Human |
| 407116743 | GWAS765719_H | body mass index QTL GWAS765719 (human) | | 7e-13 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 407231427 | GWAS880403_H | mosquito bite reaction size measurement QTL GWAS880403 (human) | | 0.0000003 | mosquito bite reaction size measurement | | 4 | 122182953 | 122182955 | Human |
| 628745969 | GWAS2654198_H | BMI-adjusted hip circumference QTL GWAS2654198 (human) | | 2e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 123145793 | 123145794 | Human |
| 628745968 | GWAS2654197_H | BMI-adjusted hip circumference QTL GWAS2654197 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 119759405 | 119759406 | Human |
| 597352464 | GWAS1448538_H | body height QTL GWAS1448538 (human) | | 6e-46 | body height | | 4 | 119733676 | 119733677 | Human |
| 597401616 | GWAS1497690_H | hippocampus volume change measurement QTL GWAS1497690 (human) | | 0.000001 | hippocampus volume change measurement | | 4 | 117571720 | 117571722 | Human |
| 597352465 | GWAS1448539_H | body height QTL GWAS1448539 (human) | | 2e-128 | body height | | 4 | 119834940 | 119834941 | Human |
| 407280598 | GWAS929574_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS929574 (human) | | 8e-12 | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407378904 | GWAS1027880_H | protein measurement QTL GWAS1027880 (human) | | 1e-08 | protein measurement | | 4 | 109735574 | 109735575 | Human |
| 597336074 | GWAS1432148_H | smoking initiation QTL GWAS1432148 (human) | | 8e-16 | smoking initiation | | 4 | 129269203 | 129269204 | Human |
| 597336075 | GWAS1432149_H | smoking initiation QTL GWAS1432149 (human) | | 5e-09 | smoking initiation | | 4 | 130533359 | 130533360 | Human |
| 597336072 | GWAS1432146_H | smoking initiation QTL GWAS1432146 (human) | | 3e-12 | smoking initiation | | 4 | 115630160 | 115630161 | Human |
| 407411675 | GWAS1060651_H | response to calcium channel blocker QTL GWAS1060651 (human) | | 0.000002 | response to calcium channel blocker | | 4 | 119116902 | 119116903 | Human |
| 597336073 | GWAS1432147_H | smoking initiation QTL GWAS1432147 (human) | | 8e-12 | smoking initiation | | 4 | 122105714 | 122105715 | Human |
| 617064276 | GWAS2081775_H | smoking initiation QTL GWAS2081775 (human) | | 3e-10 | smoking initiation | | 4 | 126727157 | 126727158 | Human |
| 597516297 | GWAS1612371_H | protein measurement QTL GWAS1612371 (human) | | 6e-17 | protein measurement | | 4 | 110555545 | 110555546 | Human |
| 617064275 | GWAS2081774_H | smoking initiation QTL GWAS2081774 (human) | | 4e-09 | smoking initiation | | 4 | 117868703 | 117868704 | Human |
| 597532680 | GWAS1628754_H | smoking initiation QTL GWAS1628754 (human) | | 2e-11 | smoking initiation | | 4 | 111546456 | 111546457 | Human |
| 597352463 | GWAS1448537_H | body height QTL GWAS1448537 (human) | | 7e-88 | body height | | 4 | 119680576 | 119680577 | Human |
| 597336076 | GWAS1432150_H | smoking initiation QTL GWAS1432150 (human) | | 3e-11 | smoking initiation | | 4 | 131604639 | 131604640 | Human |
| 597516298 | GWAS1612372_H | protein measurement QTL GWAS1612372 (human) | | 9e-46 | protein measurement | | 4 | 110414448 | 110414449 | Human |
| 617211742 | GWAS2192182_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2192182 (human) | | 6e-17 | level of fatty acid-binding protein, intestinal in blood | | 4 | 120049137 | 120049138 | Human |
| 407083992 | GWAS732968_H | platelet count QTL GWAS732968 (human) | | 2e-28 | platelet count | | 4 | 110010783 | 110010784 | Human |
| 617064284 | GWAS2081783_H | mannitol measurement, sorbitol measurement QTL GWAS2081783 (human) | | 0.000003 | mannitol measurement, sorbitol measurement | | 4 | 112447703 | 112447704 | Human |
| 597237820 | GWAS1333894_H | neutrophil-to-lymphocyte ratio QTL GWAS1333894 (human) | | 1e-15 | neutrophil-to-lymphocyte ratio | | 4 | 112194095 | 112194096 | Human |
| 628745950 | GWAS2654179_H | hypertension QTL GWAS2654179 (human) | | 6e-12 | blood pressure trait (VT:0000183) | | 4 | 110484920 | 110484925 | Human |
| 597401648 | GWAS1497722_H | vital capacity QTL GWAS1497722 (human) | | 8e-12 | vital capacity | | 4 | 124209285 | 124209286 | Human |
| 617047915 | GWAS2065414_H | eosinophil count QTL GWAS2065414 (human) | | 5e-27 | eosinophil count | | 4 | 122680359 | 122680360 | Human |
| 628369114 | GWAS2289958_H | fibroblast growth factor 2 level QTL GWAS2289958 (human) | | 6e-39 | fibroblast growth factor 2 level | | 4 | 122836593 | 122836594 | Human |
| 407346164 | GWAS995140_H | lymphocyte count QTL GWAS995140 (human) | | 5e-15 | lymphocyte count | | 4 | 122760001 | 122760002 | Human |
| 407346163 | GWAS995139_H | lymphocyte count QTL GWAS995139 (human) | | 6e-16 | lymphocyte count | | 4 | 112153589 | 112153590 | Human |
| 597401647 | GWAS1497721_H | vital capacity QTL GWAS1497721 (human) | | 0.0000001 | vital capacity | | 4 | 112674713 | 112674714 | Human |
| 597401646 | GWAS1497720_H | vital capacity QTL GWAS1497720 (human) | | 5e-08 | vital capacity | | 4 | 108557833 | 108557834 | Human |
| 407346162 | GWAS995138_H | lymphocyte count QTL GWAS995138 (human) | | 1e-18 | lymphocyte count | | 4 | 109921984 | 109921985 | Human |
| 406920180 | GWAS569156_H | pulse pressure measurement QTL GWAS569156 (human) | | 1e-08 | pulse pressure measurement | | 4 | 110465042 | 110465043 | Human |
| 407215103 | GWAS864079_H | hemoglobin measurement QTL GWAS864079 (human) | | 0.000009 | hemoglobin measurement | | 4 | 120934416 | 120934417 | Human |
| 598073369 | GWAS1792668_H | socioeconomic status QTL GWAS1792668 (human) | | 3e-08 | socioeconomic status | | 4 | 121774163 | 121774164 | Human |
| 407182328 | GWAS831304_H | mean corpuscular volume QTL GWAS831304 (human) | | 4e-11 | mean corpuscular volume | | 4 | 109717668 | 109717669 | Human |
| 598073371 | GWAS1792670_H | socioeconomic status QTL GWAS1792670 (human) | | 8e-09 | socioeconomic status | | 4 | 122105714 | 122105715 | Human |
| 598073370 | GWAS1792669_H | socioeconomic status QTL GWAS1792669 (human) | | 2e-10 | socioeconomic status | | 4 | 122042189 | 122042190 | Human |
| 596959316 | GWAS1078835_H | glomerular filtration rate QTL GWAS1078835 (human) | | 2e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
| 596959317 | GWAS1078836_H | glomerular filtration rate QTL GWAS1078836 (human) | | 0.0000002 | glomerular filtration rate | | 4 | 125673826 | 125673827 | Human |
| 598007911 | GWAS1727210_H | EGF/MANF protein level ratio in blood QTL GWAS1727210 (human) | | 3e-195 | EGF/MANF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 406887299 | GWAS536275_H | treatment resistant depression, response to antidepressant QTL GWAS536275 (human) | | 0.000004 | treatment resistant depression, response to antidepressant | | 4 | 130515632 | 130515633 | Human |
| 598007905 | GWAS1727204_H | EGF/GP6 protein level ratio in blood QTL GWAS1727204 (human) | | 1e-336 | EGF/GP6 protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 616982287 | GWAS1999786_H | schizophrenia QTL GWAS1999786 (human) | | 0.000008 | schizophrenia | | 4 | 117723665 | 117723666 | Human |
| 597499988 | GWAS1596062_H | protein measurement QTL GWAS1596062 (human) | | 1e-146 | protein measurement | | 4 | 119446728 | 119446729 | Human |
| 628369087 | GWAS2289931_H | fibroblast growth factor 2 level QTL GWAS2289931 (human) | | 8e-667 | fibroblast growth factor 2 level | | 4 | 122827461 | 122827462 | Human |
| 598089834 | GWAS1809133_H | glomerular filtration rate QTL GWAS1809133 (human) | | 2e-24 | glomerular filtration rate | | 4 | 108782393 | 108782394 | Human |
| 597499987 | GWAS1596061_H | protein measurement QTL GWAS1596061 (human) | | 7e-1675 | protein measurement | | 4 | 119342003 | 119342004 | Human |
| 597221449 | GWAS1317523_H | platelet count QTL GWAS1317523 (human) | | 2e-19 | platelet count | | 4 | 109945564 | 109945565 | Human |
| 597221450 | GWAS1317524_H | platelet count QTL GWAS1317524 (human) | | 2e-30 | platelet count | | 4 | 109990751 | 109990752 | Human |
| 406887314 | GWAS536290_H | lung adenocarcinoma, family history of lung cancer QTL GWAS536290 (human) | | 0.000009 | lung adenocarcinoma, family history of lung cancer | | 4 | 111828356 | 111828357 | Human |
| 597418057 | GWAS1514131_H | gastric carcinoma QTL GWAS1514131 (human) | | 3e-11 | gastric carcinoma | | 4 | 124530209 | 124530210 | Human |
| 597221451 | GWAS1317525_H | platelet count QTL GWAS1317525 (human) | | 2e-80 | platelet count | | 4 | 110027819 | 110027820 | Human |
| 597221452 | GWAS1317526_H | platelet count QTL GWAS1317526 (human) | | 1e-11 | platelet count | | 4 | 119622957 | 119622958 | Human |
| 628811438 | GWAS2719667_H | Thyroid preparation use measurement QTL GWAS2719667 (human) | | 4e-09 | Thyroid preparation use measurement | | 4 | 122466445 | 122466446 | Human |
| 406969239 | GWAS618215_H | smoking initiation QTL GWAS618215 (human) | | 2e-11 | smoking initiation | | 4 | 130541408 | 130541409 | Human |
| 406969241 | GWAS618217_H | smoking initiation QTL GWAS618217 (human) | | 8e-12 | smoking initiation | | 4 | 131635724 | 131635725 | Human |
| 406969240 | GWAS618216_H | smoking initiation QTL GWAS618216 (human) | | 1e-11 | smoking initiation | | 4 | 130542181 | 130542182 | Human |
| 596975695 | GWAS1095214_H | body height QTL GWAS1095214 (human) | | 1e-34 | body height | | 4 | 121801213 | 121801214 | Human |
| 598007935 | GWAS1727234_H | EGF/TNFSF14 protein level ratio in blood QTL GWAS1727234 (human) | | 2e-152 | EGF/TNFSF14 protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 628696742 | GWAS2604971_H | waist-hip ratio QTL GWAS2604971 (human) | | 0.00001 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 108607724 | 108607725 | Human |
| 406969246 | GWAS618222_H | smoking initiation QTL GWAS618222 (human) | | 8e-11 | smoking initiation | | 4 | 129681552 | 129681553 | Human |
| 597155959 | GWAS1252033_H | open-angle glaucoma QTL GWAS1252033 (human) | | 2e-08 | open-angle glaucoma | | 4 | 125465224 | 125465225 | Human |
| 616523614 | GWAS1920197_H | neutrophil percentage of leukocytes QTL GWAS1920197 (human) | | 8e-16 | neutrophil percentage of leukocytes | | 4 | 122702286 | 122702287 | Human |
| 597532798 | GWAS1628872_H | atrial fibrillation QTL GWAS1628872 (human) | | 2e-249 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 407198625 | GWAS847601_H | Ischemic stroke, plasminogen activator inhibitor 1 measurement QTL GWAS847601 (human) | | 6e-17 | Ischemic stroke, plasminogen activator inhibitor 1 measurement | | 4 | 110775495 | 110775496 | Human |
| 617064227 | GWAS2081726_H | brain attribute QTL GWAS2081726 (human) | | 1e-10 | brain attribute | | 4 | 124548568 | 124548569 | Human |
| 407002020 | GWAS650996_H | vital capacity QTL GWAS650996 (human) | | 2e-09 | vital capacity | | 4 | 108545191 | 108545192 | Human |
| 597827653 | GWAS1695044_H | ethanolamine measurement QTL GWAS1695044 (human) | | 8e-16 | ethanolamine measurement | | 4 | 108795684 | 108795685 | Human |
| 617293603 | GWAS2230379_H | degree of unsaturation measurement QTL GWAS2230379 (human) | | 3e-09 | degree of unsaturation measurement | | 4 | 109657070 | 109657071 | Human |
| 597123199 | GWAS1219273_H | gestational age QTL GWAS1219273 (human) | | 0.00001 | gestational age | | 4 | 112354624 | 112354625 | Human |
| 617113377 | GWAS2130876_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2130876 (human) | | 6e-14 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 124228421 | 124228422 | Human |
| 406887339 | GWAS536315_H | mood instability measurement QTL GWAS536315 (human) | | 3e-08 | mood instability measurement | | 4 | 122258745 | 122258746 | Human |
| 597614704 | GWAS1671564_H | skin disease QTL GWAS1671564 (human) | | 2e-11 | skin disease | | 4 | 124660603 | 124660604 | Human |
| 616982313 | GWAS1999812_H | atrial fibrillation QTL GWAS1999812 (human) | | 7e-92 | atrial fibrillation | | 4 | 110789386 | 110789387 | Human |
| 407411640 | GWAS1060616_H | age-related macular degeneration, COVID-19 QTL GWAS1060616 (human) | | 3e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
| 598040660 | GWAS1759959_H | carotid artery thickness QTL GWAS1759959 (human) | | 0.000002 | carotid artery thickness | | 4 | 107366087 | 107366088 | Human |
| 407411641 | GWAS1060617_H | age-related macular degeneration, COVID-19 QTL GWAS1060617 (human) | | 4e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
| 597074023 | GWAS1170097_H | coronary artery disease QTL GWAS1170097 (human) | | 3e-15 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 407411642 | GWAS1060618_H | age-related macular degeneration, COVID-19 QTL GWAS1060618 (human) | | 2e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
| 628729483 | GWAS2637712_H | BMI-adjusted waist-hip ratio QTL GWAS2637712 (human) | | 5e-11 | body size trait (VT:0100005) | | 4 | 119213641 | 119213642 | Human |
| 597057636 | GWAS1153710_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS1153710 (human) | | 2e-30 | Eczematoid dermatitis, allergic rhinitis | | 4 | 122432277 | 122432278 | Human |
| 597319785 | GWAS1415859_H | X-24422 measurement QTL GWAS1415859 (human) | | 3e-13 | X-24422 measurement | | 4 | 122894208 | 122894209 | Human |
| 617031475 | GWAS2048974_H | FEV/FVC ratio QTL GWAS2048974 (human) | | 3e-18 | FEV/FVC ratio | | 4 | 123898452 | 123898453 | Human |
| 628663949 | GWAS2572178_H | bone tissue density QTL GWAS2572178 (human) | | 2e-10 | bone tissue density | | 4 | 122897478 | 122897479 | Human |
| 617080625 | GWAS2098124_H | osteoarthritis, knee QTL GWAS2098124 (human) | | 1e-08 | osteoarthritis, knee | | 4 | 129381399 | 129381400 | Human |
| 617064254 | GWAS2081753_H | cerebral cortex area attribute QTL GWAS2081753 (human) | | 6e-14 | cerebral cortex area attribute | | 4 | 112497482 | 112497483 | Human |
| 628811395 | GWAS2719624_H | stroke QTL GWAS2719624 (human) | | 0.000001 | brain integrity trait (VT:0010579) | | 4 | 112810934 | 112810935 | Human |
| 596959341 | GWAS1078860_H | glomerular filtration rate QTL GWAS1078860 (human) | | 3e-15 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 628926087 | GWAS2834316_H | low density lipoprotein cholesterol measurement QTL GWAS2834316 (human) | | 3e-12 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 110021440 | 110021441 | Human |
| 628811393 | GWAS2719622_H | small vessel stroke QTL GWAS2719622 (human) | | 0.0000007 | artery integrity trait (VT:0010639) | | 4 | 113472094 | 113472095 | Human |
| 406952890 | GWAS601866_H | protein measurement QTL GWAS601866 (human) | | 5e-47 | protein measurement | | 4 | 119501939 | 119501940 | Human |
| 406952893 | GWAS601869_H | protein measurement QTL GWAS601869 (human) | | 2e-78 | protein measurement | | 4 | 119638137 | 119638138 | Human |
| 597467233 | GWAS1563307_H | tooth agenesis QTL GWAS1563307 (human) | | 6e-10 | tooth agenesis | | 4 | 108350621 | 108350622 | Human |
| 406952892 | GWAS601868_H | protein measurement QTL GWAS601868 (human) | | 1e-162 | protein measurement | | 4 | 119635312 | 119635313 | Human |
| 406952895 | GWAS601871_H | protein measurement QTL GWAS601871 (human) | | 4e-75 | protein measurement | | 4 | 119501939 | 119501940 | Human |
| 597450851 | GWAS1546925_H | large artery stroke QTL GWAS1546925 (human) | | 0.000002 | large artery stroke | | 4 | 107143047 | 107143048 | Human |
| 628859259 | GWAS2767488_H | heart failure QTL GWAS2767488 (human) | | 5e-14 | heart integrity trait (VT:0010757) | | 4 | 110927114 | 110927115 | Human |
| 597125015 | GWAS1221089_H | glycerophospholipid measurement QTL GWAS1221089 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114598684 | 114598685 | Human |
| 597141398 | GWAS1237472_H | epidermal growth factor measurement QTL GWAS1237472 (human) | | 5e-08 | epidermal growth factor measurement | | 4 | 109973293 | 109973294 | Human |
| 597125014 | GWAS1221088_H | glycerophospholipid measurement QTL GWAS1221088 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114577512 | 114577513 | Human |
| 407084097 | GWAS733073_H | Ischemic stroke QTL GWAS733073 (human) | | 5e-14 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 626467157 | GWAS2281090_H | body weight QTL GWAS2281090 (human) | | 3e-13 | body weight | | 4 | 112335581 | 112335582 | Human |
| 597125013 | GWAS1221087_H | glycerophospholipid measurement QTL GWAS1221087 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114522087 | 114522088 | Human |
| 597125012 | GWAS1221086_H | glycerophospholipid measurement QTL GWAS1221086 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114522147 | 114522148 | Human |
| 628859263 | GWAS2767492_H | heart failure QTL GWAS2767492 (human) | | 9e-12 | heart integrity trait (VT:0010757) | | 4 | 110665822 | 110665823 | Human |
| 597125011 | GWAS1221085_H | glycerophospholipid measurement QTL GWAS1221085 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114537012 | 114537013 | Human |
| 597125010 | GWAS1221084_H | glycerophospholipid measurement QTL GWAS1221084 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114512391 | 114512392 | Human |
| 406969412 | GWAS618388_H | eosinophil percentage of leukocytes QTL GWAS618388 (human) | | 5e-09 | eosinophil percentage of leukocytes | | 4 | 122639784 | 122639785 | Human |
| 597125009 | GWAS1221083_H | glycerophospholipid measurement QTL GWAS1221083 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114512224 | 114512225 | Human |
| 616521913 | GWAS1918496_H | serum creatinine amount QTL GWAS1918496 (human) | | 2e-14 | serum creatinine amount | | 4 | 128601363 | 128601364 | Human |
| 597419933 | GWAS1516007_H | protein measurement QTL GWAS1516007 (human) | | 7e-09 | protein measurement | | 4 | 132318854 | 132318855 | Human |
| 597125008 | GWAS1221082_H | glycerophospholipid measurement QTL GWAS1221082 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114496527 | 114496528 | Human |
| 617095375 | GWAS2112874_H | asthma QTL GWAS2112874 (human) | | 2e-17 | asthma | | 4 | 122123526 | 122123527 | Human |
| 616554680 | GWAS1951263_H | seasonal allergic rhinitis QTL GWAS1951263 (human) | | 6e-14 | seasonal allergic rhinitis | | 4 | 122307977 | 122307978 | Human |
| 597125023 | GWAS1221097_H | glycerophospholipid measurement QTL GWAS1221097 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114574339 | 114574340 | Human |
| 597125022 | GWAS1221096_H | glycerophospholipid measurement QTL GWAS1221096 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114527954 | 114527955 | Human |
| 597125021 | GWAS1221095_H | glycerophospholipid measurement QTL GWAS1221095 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114493975 | 114493976 | Human |
| 597125020 | GWAS1221094_H | glycerophospholipid measurement QTL GWAS1221094 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114534996 | 114534997 | Human |
| 597125019 | GWAS1221093_H | glycerophospholipid measurement QTL GWAS1221093 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114535080 | 114535081 | Human |
| 597403543 | GWAS1499617_H | inflammatory bowel disease QTL GWAS1499617 (human) | | 2e-13 | intestine integrity trait (VT:0010554) | | 4 | 122240464 | 122240465 | Human |
| 626467163 | GWAS2281096_H | body weight QTL GWAS2281096 (human) | | 3e-11 | body weight | | 4 | 129838492 | 129838493 | Human |
| 597125018 | GWAS1221092_H | glycerophospholipid measurement QTL GWAS1221092 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114534955 | 114534956 | Human |
| 628826486 | GWAS2734715_H | blood cobalt amount QTL GWAS2734715 (human) | | 0.000009 | blood cobalt amount | | 4 | 121015640 | 121015641 | Human |
| 597125017 | GWAS1221091_H | glycerophospholipid measurement QTL GWAS1221091 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114499194 | 114499195 | Human |
| 597125016 | GWAS1221090_H | glycerophospholipid measurement QTL GWAS1221090 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114493876 | 114493877 | Human |
| 628367719 | GWAS2288563_H | ubiquitin+1, truncated mutation for UBB measurement QTL GWAS2288563 (human) | | 2e-22 | ubiquitin+1, truncated mutation for UBB measurement | | 4 | 119349548 | 119349549 | Human |
| 625828185 | GWAS2249107_H | atrial flutter, atrial fibrillation QTL GWAS2249107 (human) | | 2e-75 | atrial flutter, atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407231571 | GWAS880547_H | bone density QTL GWAS880547 (human) | | 2e-17 | bone density | | 4 | 123616626 | 123616628 | Human |
| 628433250 | GWAS2341479_H | squamous cell lung carcinoma QTL GWAS2341479 (human) | | 0.0000005 | lung integrity trait (VT:0010906) | | 4 | 121873960 | 121873961 | Human |
| 597125007 | GWAS1221081_H | glycerophospholipid measurement QTL GWAS1221081 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114526022 | 114526023 | Human |
| 628416879 | GWAS2325108_H | appendicular lean mass QTL GWAS2325108 (human) | | 2e-08 | body lean mass (VT:0010483) | | 4 | 119742494 | 119742495 | Human |
| 616521889 | GWAS1918472_H | dopamine beta-hydroxylase measurement QTL GWAS1918472 (human) | | 5e-24 | dopamine beta-hydroxylase measurement | | 4 | 123844106 | 123844107 | Human |
| 597206970 | GWAS1303044_H | protein measurement QTL GWAS1303044 (human) | | 2e-08 | protein amount (VT:0010120) | | 4 | 118048334 | 118048335 | Human |
| 628597074 | GWAS2505303_H | open-angle glaucoma QTL GWAS2505303 (human) | | 1e-08 | eye integrity trait (VT:0011107) | | 4 | 127613850 | 127613851 | Human |
| 628613457 | GWAS2521686_H | platelet count QTL GWAS2521686 (human) | | 1e-43 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110020646 | 110020647 | Human |
| 628597073 | GWAS2505302_H | open-angle glaucoma QTL GWAS2505302 (human) | | 1e-09 | eye integrity trait (VT:0011107) | | 4 | 125994594 | 125994595 | Human |
| 628597072 | GWAS2505301_H | open-angle glaucoma QTL GWAS2505301 (human) | | 1e-09 | eye integrity trait (VT:0011107) | | 4 | 125451587 | 125451588 | Human |
| 617046254 | GWAS2063753_H | childhood trauma measurement, alcohol consumption quality QTL GWAS2063753 (human) | | 8e-09 | childhood trauma measurement, alcohol consumption quality | | 4 | 127440030 | 127440031 | Human |
| 617046253 | GWAS2063752_H | childhood trauma measurement, alcohol consumption quality QTL GWAS2063752 (human) | | 1e-08 | childhood trauma measurement, alcohol consumption quality | | 4 | 126655945 | 126655946 | Human |
| 617259238 | GWAS2196014_H | linoleic acid measurement QTL GWAS2196014 (human) | | 2e-09 | docosahexaenoic acid to total fatty acids percentage | | 4 | 109717668 | 109717669 | Human |
| 407313515 | GWAS962491_H | cortical surface area measurement QTL GWAS962491 (human) | | 1e-09 | cortical surface area measurement | | 4 | 126658527 | 126658528 | Human |
| 597125029 | GWAS1221103_H | glycerophospholipid measurement QTL GWAS1221103 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114555226 | 114555227 | Human |
| 597125028 | GWAS1221102_H | glycerophospholipid measurement QTL GWAS1221102 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114579576 | 114579577 | Human |
| 597125027 | GWAS1221101_H | glycerophospholipid measurement QTL GWAS1221101 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114488186 | 114488187 | Human |
| 597125026 | GWAS1221100_H | glycerophospholipid measurement QTL GWAS1221100 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114556972 | 114556973 | Human |
| 597206958 | GWAS1303032_H | attempted suicide QTL GWAS1303032 (human) | | 0.000004 | behavior trait (VT:0010442) | | 4 | 110361260 | 110361261 | Human |
| 597125025 | GWAS1221099_H | glycerophospholipid measurement QTL GWAS1221099 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114493973 | 114493974 | Human |
| 597125024 | GWAS1221098_H | glycerophospholipid measurement QTL GWAS1221098 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114531061 | 114531062 | Human |
| 617029872 | GWAS2047371_H | reticulocyte count QTL GWAS2047371 (human) | | 3e-12 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 128330896 | 128330897 | Human |
| 628597071 | GWAS2505300_H | open-angle glaucoma QTL GWAS2505300 (human) | | 4e-12 | eye integrity trait (VT:0011107) | | 4 | 111886876 | 111886877 | Human |
| 628597070 | GWAS2505299_H | open-angle glaucoma QTL GWAS2505299 (human) | | 7e-15 | eye integrity trait (VT:0011107) | | 4 | 111042563 | 111042564 | Human |
| 626450799 | GWAS2264732_H | hemoglobin measurement QTL GWAS2264732 (human) | | 3e-14 | hemoglobin measurement | | 4 | 124004016 | 124004017 | Human |
| 617292017 | GWAS2228793_H | docosahexaenoic acid to total fatty acids percentage QTL GWAS2228793 (human) | | 7e-12 | docosahexaenoic acid to total fatty acids percentage | | 4 | 109717668 | 109717669 | Human |
| 617292016 | GWAS2228792_H | docosahexaenoic acid to total fatty acids percentage QTL GWAS2228792 (human) | | 2e-09 | docosahexaenoic acid to total fatty acids percentage | | 4 | 109321740 | 109321741 | Human |
| 407018623 | GWAS667599_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS667599 (human) | | 5e-17 | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | | 4 | 109737911 | 109737912 | Human |
| 617062649 | GWAS2080148_H | schizophrenia QTL GWAS2080148 (human) | | 0.000002 | schizophrenia | | 4 | 113059651 | 113059652 | Human |
| 407379063 | GWAS1028039_H | childhood onset asthma QTL GWAS1028039 (human) | | 9e-12 | childhood onset asthma | | 4 | 122219915 | 122219916 | Human |
| 628728121 | GWAS2636350_H | atrial fibrillation QTL GWAS2636350 (human) | | 2e-305 | atrial fibrillation | | 4 | 110789386 | 110789387 | Human |
| 597125079 | GWAS1221153_H | glycerophospholipid measurement QTL GWAS1221153 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114528894 | 114528895 | Human |
| 597125078 | GWAS1221152_H | glycerophospholipid measurement QTL GWAS1221152 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114487028 | 114487029 | Human |
| 628728123 | GWAS2636352_H | atrial fibrillation QTL GWAS2636352 (human) | | 4e-34 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 597125077 | GWAS1221151_H | glycerophospholipid measurement QTL GWAS1221151 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114486755 | 114486756 | Human |
| 628728122 | GWAS2636351_H | atrial fibrillation QTL GWAS2636351 (human) | | 1e-31 | atrial fibrillation | | 4 | 112093836 | 112093837 | Human |
| 597125076 | GWAS1221150_H | glycerophospholipid measurement QTL GWAS1221150 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114484189 | 114484190 | Human |
| 597125075 | GWAS1221149_H | glycerophospholipid measurement QTL GWAS1221149 (human) | | 2e-24 | glycerophospholipid measurement | | 4 | 114565923 | 114565924 | Human |
| 597125074 | GWAS1221148_H | glycerophospholipid measurement QTL GWAS1221148 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114519057 | 114519058 | Human |
| 628728124 | GWAS2636353_H | atrial fibrillation QTL GWAS2636353 (human) | | 3e-08 | atrial fibrillation | | 4 | 115260980 | 115260981 | Human |
| 597125073 | GWAS1221147_H | glycerophospholipid measurement QTL GWAS1221147 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114494469 | 114494470 | Human |
| 597125072 | GWAS1221146_H | glycerophospholipid measurement QTL GWAS1221146 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114554143 | 114554144 | Human |
| 598009827 | GWAS1729126_H | AGRN/BTN2A1 protein level ratio in blood QTL GWAS1729126 (human) | | 2e-43 | AGRN/BTN2A1 protein level ratio in blood | | 4 | 118376502 | 118376503 | Human |
| 407051274 | GWAS700250_H | cortical thickness QTL GWAS700250 (human) | | 2e-11 | cortical thickness | | 4 | 120704578 | 120704579 | Human |
| 628875569 | GWAS2783798_H | complement factor I measurement QTL GWAS2783798 (human) | | 7e-85 | complement protein amount (VT:0010033) | | 4 | 109735574 | 109735575 | Human |
| 597125083 | GWAS1221157_H | glycerophospholipid measurement QTL GWAS1221157 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114545757 | 114545758 | Human |
| 597125082 | GWAS1221156_H | glycerophospholipid measurement QTL GWAS1221156 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114541947 | 114541948 | Human |
| 597125081 | GWAS1221155_H | glycerophospholipid measurement QTL GWAS1221155 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114540109 | 114540110 | Human |
| 597125080 | GWAS1221154_H | glycerophospholipid measurement QTL GWAS1221154 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114540002 | 114540003 | Human |
| 597125063 | GWAS1221137_H | glycerophospholipid measurement QTL GWAS1221137 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594792 | 114594793 | Human |
| 597157825 | GWAS1253899_H | cardiovascular age measurement QTL GWAS1253899 (human) | | 3e-11 | cardiovascular age measurement | | 4 | 113465982 | 113465983 | Human |
| 597206990 | GWAS1303064_H | major depressive disorder QTL GWAS1303064 (human) | | 0.0000004 | major depressive disorder | | 4 | 130232015 | 130232016 | Human |
| 597125071 | GWAS1221145_H | glycerophospholipid measurement QTL GWAS1221145 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114547620 | 114547621 | Human |
| 597125070 | GWAS1221144_H | glycerophospholipid measurement QTL GWAS1221144 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114566777 | 114566778 | Human |
| 406903834 | GWAS552810_H | R-warfarin measurement QTL GWAS552810 (human) | | 0.000009 | R-warfarin measurement | | 4 | 108984279 | 108984280 | Human |
| 628662562 | GWAS2570791_H | Pain QTL GWAS2570791 (human) | | 6e-10 | Pain | | 4 | 111582716 | 111582717 | Human |
| 597125069 | GWAS1221143_H | glycerophospholipid measurement QTL GWAS1221143 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114575280 | 114575281 | Human |
| 616997020 | GWAS2014519_H | BMI-adjusted waist-hip ratio QTL GWAS2014519 (human) | | 7e-08 | BMI-adjusted waist-hip ratio | | 4 | 119441806 | 119441807 | Human |
| 617046173 | GWAS2063672_H | hemoglobin measurement QTL GWAS2063672 (human) | | 2e-10 | hemoglobin measurement | | 4 | 123846352 | 123846353 | Human |
| 597125068 | GWAS1221142_H | glycerophospholipid measurement QTL GWAS1221142 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114519211 | 114519212 | Human |
| 628744485 | GWAS2652714_H | platelet count QTL GWAS2652714 (human) | | 1e-105 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110027819 | 110027820 | Human |
| 597125067 | GWAS1221141_H | glycerophospholipid measurement QTL GWAS1221141 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114549280 | 114549281 | Human |
| 628744484 | GWAS2652713_H | platelet count QTL GWAS2652713 (human) | | 1e-38 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109990751 | 109990752 | Human |
| 597125066 | GWAS1221140_H | glycerophospholipid measurement QTL GWAS1221140 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114583571 | 114583572 | Human |
| 597125065 | GWAS1221139_H | glycerophospholipid measurement QTL GWAS1221139 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114538077 | 114538078 | Human |
| 597387205 | GWAS1483279_H | smoking status measurement, diastolic blood pressure QTL GWAS1483279 (human) | | 4e-08 | smoking status measurement, diastolic blood pressure | | 4 | 123660107 | 123660108 | Human |
| 407002141 | GWAS651117_H | monocyte count QTL GWAS651117 (human) | | 9e-22 | monocyte count | | 4 | 109966833 | 109966834 | Human |
| 597125064 | GWAS1221138_H | glycerophospholipid measurement QTL GWAS1221138 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114554629 | 114554630 | Human |
| 628744486 | GWAS2652715_H | platelet count QTL GWAS2652715 (human) | | 9e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119502932 | 119502933 | Human |
| 597583870 | GWAS1640730_H | mean corpuscular hemoglobin concentration QTL GWAS1640730 (human) | | 7e-12 | mean corpuscular hemoglobin concentration | | 4 | 121827841 | 121827842 | Human |
| 597108726 | GWAS1204800_H | response to radiation, Abnormality of the urinary system QTL GWAS1204800 (human) | | 0.0000003 | response to radiation, Abnormality of the urinary system | | 4 | 122999342 | 122999343 | Human |
| 597305329 | GWAS1401403_H | cortical surface area measurement QTL GWAS1401403 (human) | | 3e-18 | cortical surface area measurement | | 4 | 118359012 | 118359013 | Human |
| 597207030 | GWAS1303104_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1303104 (human) | | 2e-12 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110485340 | 110485341 | Human |
| 407378982 | GWAS1027958_H | dental caries QTL GWAS1027958 (human) | | 0.000003 | dental caries | | 4 | 111359586 | 111359587 | Human |
| 628973843 | GWAS2882072_H | seborrheic keratosis QTL GWAS2882072 (human) | | 2e-20 | seborrheic keratosis | | 4 | 124698876 | 124698877 | Human |
| 628728073 | GWAS2636302_H | BMI-adjusted waist-hip ratio QTL GWAS2636302 (human) | | 4e-08 | body size trait (VT:0100005) | | 4 | 123002800 | 123002801 | Human |
| 628728072 | GWAS2636301_H | BMI-adjusted waist-hip ratio QTL GWAS2636301 (human) | | 5e-09 | body size trait (VT:0100005) | | 4 | 121701445 | 121701446 | Human |
| 628728075 | GWAS2636304_H | BMI-adjusted waist-hip ratio QTL GWAS2636304 (human) | | 2e-11 | body size trait (VT:0100005) | | 4 | 123166618 | 123166619 | Human |
| 628728074 | GWAS2636303_H | BMI-adjusted waist-hip ratio QTL GWAS2636303 (human) | | 9e-11 | body size trait (VT:0100005) | | 4 | 123124286 | 123124287 | Human |
| 597518313 | GWAS1614387_H | gestational diabetes QTL GWAS1614387 (human) | | 0.000001 | gestational diabetes | | 4 | 106609371 | 106609372 | Human |
| 616358088 | GWAS1842803_H | gut microbiome measurement, breastfeeding duration QTL GWAS1842803 (human) | | 2e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 123477905 | 123477906 | Human |
| 628728076 | GWAS2636305_H | BMI-adjusted waist-hip ratio QTL GWAS2636305 (human) | | 7e-09 | body size trait (VT:0100005) | | 4 | 124118741 | 124118742 | Human |
| 628613391 | GWAS2521620_H | facial morphology trait QTL GWAS2521620 (human) | | 8e-09 | facial morphology trait | | 4 | 119407511 | 119407512 | Human |
| 628695296 | GWAS2603525_H | bilirubin measurement QTL GWAS2603525 (human) | | 2e-09 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 109921728 | 109921729 | Human |
| 617259185 | GWAS2195961_H | fatty acid amount QTL GWAS2195961 (human) | | 8e-10 | fatty acid amount | | 4 | 109345757 | 109345758 | Human |
| 407313466 | GWAS962442_H | body weight QTL GWAS962442 (human) | | 1e-11 | body weight | | 4 | 121792708 | 121792709 | Human |
| 407313465 | GWAS962441_H | body weight QTL GWAS962441 (human) | | 1e-08 | body weight | | 4 | 114217955 | 114217956 | Human |
| 407313464 | GWAS962440_H | body weight QTL GWAS962440 (human) | | 3e-08 | body weight | | 4 | 109829417 | 109829418 | Human |
| 628547849 | GWAS2456078_H | lymphocyte count QTL GWAS2456078 (human) | | 3e-17 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 122656905 | 122656906 | Human |
| 406953154 | GWAS602130_H | wet macular degeneration QTL GWAS602130 (human) | | 6e-09 | retina integrity trait (VT:0010771) | | 4 | 109737911 | 109737912 | Human |
| 597124884 | GWAS1220958_H | glycerophospholipid measurement QTL GWAS1220958 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114482175 | 114482176 | Human |
| 597124883 | GWAS1220957_H | glycerophospholipid measurement QTL GWAS1220957 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114482122 | 114482123 | Human |
| 625828297 | GWAS2249219_H | vascular endothelial growth factor D measurement QTL GWAS2249219 (human) | | 0.00001 | vascular endothelial growth factor D measurement | | 4 | 130028211 | 130028212 | Human |
| 597124882 | GWAS1220956_H | glycerophospholipid measurement QTL GWAS1220956 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114490577 | 114490578 | Human |
| 407084229 | GWAS733205_H | mean corpuscular volume QTL GWAS733205 (human) | | 7e-10 | mean corpuscular volume | | 4 | 109977659 | 109977660 | Human |
| 597124881 | GWAS1220955_H | glycerophospholipid measurement QTL GWAS1220955 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114490374 | 114490375 | Human |
| 406953158 | GWAS602134_H | atrophic macular degeneration QTL GWAS602134 (human) | | 0.000004 | retina integrity trait (VT:0010771) | | 4 | 109737911 | 109737912 | Human |
| 597124880 | GWAS1220954_H | glycerophospholipid measurement QTL GWAS1220954 (human) | | 1e-28 | glycerophospholipid measurement | | 4 | 114520865 | 114520866 | Human |
| 628826608 | GWAS2734837_H | cardiac troponin T measurement QTL GWAS2734837 (human) | | 0.0000001 | heart molecular composition trait (VT:0010755) | blood troponin T level (CMO:0001284) | 4 | 118958433 | 118958434 | Human |
| 597141275 | GWAS1237349_H | major depressive disorder QTL GWAS1237349 (human) | | 3e-08 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
| 407362763 | GWAS1011739_H | creatinine measurement QTL GWAS1011739 (human) | | 3e-09 | creatinine measurement | | 4 | 128603358 | 128603359 | Human |
| 407362762 | GWAS1011738_H | creatinine measurement QTL GWAS1011738 (human) | | 1e-13 | creatinine measurement | | 4 | 127243324 | 127243325 | Human |
| 407362761 | GWAS1011737_H | creatinine measurement QTL GWAS1011737 (human) | | 2e-15 | creatinine measurement | | 4 | 108782393 | 108782394 | Human |
| 597993259 | GWAS1712558_H | glomerular filtration rate QTL GWAS1712558 (human) | | 1e-15 | glomerular filtration rate | | 4 | 108772770 | 108772771 | Human |
| 597124871 | GWAS1220945_H | glycerophospholipid measurement QTL GWAS1220945 (human) | | 1e-32 | glycerophospholipid measurement | | 4 | 114518110 | 114518111 | Human |
| 597124870 | GWAS1220944_H | glycerophospholipid measurement QTL GWAS1220944 (human) | | 6e-41 | glycerophospholipid measurement | | 4 | 114483120 | 114483121 | Human |
| 597124869 | GWAS1220943_H | glycerophospholipid measurement QTL GWAS1220943 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114546112 | 114546113 | Human |
| 597124868 | GWAS1220942_H | glycerophospholipid measurement QTL GWAS1220942 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114546303 | 114546304 | Human |
| 597124867 | GWAS1220941_H | glycerophospholipid measurement QTL GWAS1220941 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114486174 | 114486175 | Human |
| 406985943 | GWAS634919_H | behavioural disinhibition measurement QTL GWAS634919 (human) | | 0.0000009 | behavioural disinhibition measurement | | 4 | 113934816 | 113934817 | Human |
| 597124866 | GWAS1220940_H | glycerophospholipid measurement QTL GWAS1220940 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114488433 | 114488434 | Human |
| 597124865 | GWAS1220939_H | glycerophospholipid measurement QTL GWAS1220939 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114487644 | 114487645 | Human |
| 597124864 | GWAS1220938_H | glycerophospholipid measurement QTL GWAS1220938 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114560759 | 114560760 | Human |
| 597124879 | GWAS1220953_H | glycerophospholipid measurement QTL GWAS1220953 (human) | | 7e-41 | glycerophospholipid measurement | | 4 | 114515190 | 114515191 | Human |
| 407166173 | GWAS815149_H | renin measurement, hypertension QTL GWAS815149 (human) | | 0.000006 | renin measurement, hypertension | | 4 | 108375058 | 108375059 | Human |
| 597124878 | GWAS1220952_H | glycerophospholipid measurement QTL GWAS1220952 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114598670 | 114598671 | Human |
| 597124877 | GWAS1220951_H | glycerophospholipid measurement QTL GWAS1220951 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114531393 | 114531394 | Human |
| 597124876 | GWAS1220950_H | glycerophospholipid measurement QTL GWAS1220950 (human) | | 2e-31 | glycerophospholipid measurement | | 4 | 114531300 | 114531301 | Human |
| 597124875 | GWAS1220949_H | glycerophospholipid measurement QTL GWAS1220949 (human) | | 2e-31 | glycerophospholipid measurement | | 4 | 114527990 | 114527991 | Human |
| 597124874 | GWAS1220948_H | glycerophospholipid measurement QTL GWAS1220948 (human) | | 2e-32 | glycerophospholipid measurement | | 4 | 114527831 | 114527832 | Human |
| 597124873 | GWAS1220947_H | glycerophospholipid measurement QTL GWAS1220947 (human) | | 2e-32 | glycerophospholipid measurement | | 4 | 114527690 | 114527691 | Human |
| 597124872 | GWAS1220946_H | glycerophospholipid measurement QTL GWAS1220946 (human) | | 6e-41 | glycerophospholipid measurement | | 4 | 114507972 | 114507973 | Human |
| 597124919 | GWAS1220993_H | glycerophospholipid measurement QTL GWAS1220993 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114513555 | 114513556 | Human |
| 597124918 | GWAS1220992_H | glycerophospholipid measurement QTL GWAS1220992 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114513322 | 114513323 | Human |
| 597124917 | GWAS1220991_H | glycerophospholipid measurement QTL GWAS1220991 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114492288 | 114492289 | Human |
| 597124916 | GWAS1220990_H | glycerophospholipid measurement QTL GWAS1220990 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114492246 | 114492247 | Human |
| 407362785 | GWAS1011761_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1011761 (human) | | 4e-13 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110485340 | 110485341 | Human |
| 597124927 | GWAS1221001_H | glycerophospholipid measurement QTL GWAS1221001 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114489752 | 114489753 | Human |
| 597124926 | GWAS1221000_H | glycerophospholipid measurement QTL GWAS1221000 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114514184 | 114514185 | Human |
| 597124925 | GWAS1220999_H | glycerophospholipid measurement QTL GWAS1220999 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114575934 | 114575935 | Human |
| 617209955 | GWAS2190395_H | level of agrin in blood QTL GWAS2190395 (human) | | 6e-12 | level of agrin in blood | | 4 | 118386005 | 118386006 | Human |
| 407330028 | GWAS979004_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS979004 (human) | | 7e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 108140462 | 108140463 | Human |
| 597124924 | GWAS1220998_H | glycerophospholipid measurement QTL GWAS1220998 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114517650 | 114517651 | Human |
| 597124923 | GWAS1220997_H | glycerophospholipid measurement QTL GWAS1220997 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114512821 | 114512822 | Human |
| 597124922 | GWAS1220996_H | glycerophospholipid measurement QTL GWAS1220996 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114484592 | 114484593 | Human |
| 597124921 | GWAS1220995_H | glycerophospholipid measurement QTL GWAS1220995 (human) | | 1e-12 | glycerophospholipid measurement | | 4 | 114512809 | 114512810 | Human |
| 597124920 | GWAS1220994_H | glycerophospholipid measurement QTL GWAS1220994 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114491902 | 114491903 | Human |
| 617209958 | GWAS2190398_H | level of agrin in blood QTL GWAS2190398 (human) | | 4e-28 | level of agrin in blood | | 4 | 118434249 | 118434250 | Human |
| 628941261 | GWAS2849490_H | retinopathy QTL GWAS2849490 (human) | | 1e-11 | retina integrity trait (VT:0010771) | | 4 | 109764664 | 109764665 | Human |
| 617144444 | GWAS2161943_H | atrial flutter QTL GWAS2161943 (human) | | 7e-207 | atrial flutter | | 4 | 110793263 | 110793264 | Human |
| 407182577 | GWAS831553_H | histidine measurement QTL GWAS831553 (human) | | 3e-08 | histidine measurement | | 4 | 122051907 | 122051908 | Human |
| 628433344 | GWAS2341573_H | non-small cell lung carcinoma QTL GWAS2341573 (human) | | 0.000004 | lung integrity trait (VT:0010906) | | 4 | 121873960 | 121873961 | Human |
| 625828347 | GWAS2249269_H | atrial fibrillation QTL GWAS2249269 (human) | | 7e-70 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 617144446 | GWAS2161945_H | bundle branch block QTL GWAS2161945 (human) | | 4e-11 | bundle branch block | | 4 | 114685927 | 114685928 | Human |
| 407182579 | GWAS831555_H | tryptophan measurement QTL GWAS831555 (human) | | 6e-09 | tryptophan measurement | | 4 | 122051907 | 122051908 | Human |
| 406920441 | GWAS569417_H | triglyceride measurement QTL GWAS569417 (human) | | 2e-09 | triglyceride measurement | | 4 | 123822104 | 123822105 | Human |
| 626467310 | GWAS2281243_H | body weight QTL GWAS2281243 (human) | | 3e-20 | body weight | | 4 | 121792708 | 121792709 | Human |
| 596977449 | GWAS1096968_H | body height QTL GWAS1096968 (human) | | 8e-15 | body height | | 4 | 113968498 | 113968499 | Human |
| 628990400 | GWAS2898629_H | Barrett's esophagus QTL GWAS2898629 (human) | | 6e-14 | Barrett's esophagus | | 4 | 123628089 | 123628090 | Human |
| 628892089 | GWAS2800318_H | eosinophil count QTL GWAS2800318 (human) | | 8e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122639784 | 122639785 | Human |
| 597993314 | GWAS1712613_H | glomerular filtration rate QTL GWAS1712613 (human) | | 3e-14 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 628908475 | GWAS2816704_H | amount of iron in brain QTL GWAS2816704 (human) | | 4e-08 | amount of iron in brain | | 4 | 119210489 | 119210490 | Human |
| 407280769 | GWAS929745_H | vaginal microbiome measurement QTL GWAS929745 (human) | | 0.00001 | vaginal microbiome measurement | | 4 | 126069793 | 126069794 | Human |
| 628515260 | GWAS2423489_H | atrial fibrillation QTL GWAS2423489 (human) | | 9e-10 | atrial fibrillation | | 4 | 110491909 | 110491910 | Human |
| 617111556 | GWAS2129055_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2129055 (human) | | 7e-18 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 119810601 | 119810602 | Human |
| 406920335 | GWAS569311_H | systolic blood pressure QTL GWAS569311 (human) | | 2e-08 | systolic blood pressure | | 4 | 108099542 | 108099543 | Human |
| 617078793 | GWAS2096292_H | information processing speed, response to cranial radiation therapy QTL GWAS2096292 (human) | | 0.000004 | information processing speed, response to cranial radiation therapy | | 4 | 117423051 | 117423052 | Human |
| 625828226 | GWAS2249148_H | congestive heart failure QTL GWAS2249148 (human) | | 0.0000001 | congestive heart failure | | 4 | 110768624 | 110768625 | Human |
| 617111580 | GWAS2129079_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2129079 (human) | | 2e-23 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 112358525 | 112358526 | Human |
| 597124929 | GWAS1221003_H | glycerophospholipid measurement QTL GWAS1221003 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114557343 | 114557344 | Human |
| 597124928 | GWAS1221002_H | glycerophospholipid measurement QTL GWAS1221002 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114556918 | 114556919 | Human |
| 406985883 | GWAS634859_H | mean corpuscular hemoglobin concentration QTL GWAS634859 (human) | | 5e-64 | mean corpuscular hemoglobin concentration | | 4 | 121854912 | 121854913 | Human |
| 628875681 | GWAS2783910_H | protein measurement QTL GWAS2783910 (human) | | 9e-46 | protein amount (VT:0010120) | | 4 | 110414448 | 110414449 | Human |
| 628875680 | GWAS2783909_H | protein measurement QTL GWAS2783909 (human) | | 1e-149 | protein amount (VT:0010120) | | 4 | 110489326 | 110489327 | Human |
| 616357991 | GWAS1842706_H | gut microbiome measurement, birth weight QTL GWAS1842706 (human) | | 0.0000003 | gut microbiome measurement, birth weight | | 4 | 130900217 | 130900218 | Human |
| 598075256 | GWAS1794555_H | bone density QTL GWAS1794555 (human) | | 4e-186 | bone density | | 4 | 107807550 | 107807551 | Human |
| 628384169 | GWAS2304393_H | waist-hip ratio QTL GWAS2304393 (human) | | 9e-12 | waist-hip ratio | | 4 | 121705035 | 121705036 | Human |
| 406985884 | GWAS634860_H | mean corpuscular hemoglobin concentration QTL GWAS634860 (human) | | 2e-10 | mean corpuscular hemoglobin concentration | | 4 | 123835365 | 123835366 | Human |
| 407379095 | GWAS1028071_H | unipolar depression, mood disorder QTL GWAS1028071 (human) | | 1e-10 | unipolar depression, mood disorder | | 4 | 122201701 | 122201702 | Human |
| 597501762 | GWAS1597836_H | chronic obstructive pulmonary disease QTL GWAS1597836 (human) | | 5e-19 | chronic obstructive pulmonary disease | | 4 | 123900578 | 123900579 | Human |
| 598075206 | GWAS1794505_H | bone density QTL GWAS1794505 (human) | | 1e-194 | bone density | | 4 | 107799654 | 107799655 | Human |
| 596977526 | GWAS1097045_H | Ischemic stroke QTL GWAS1097045 (human) | | 5e-14 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 597059445 | GWAS1155519_H | memory impairment QTL GWAS1155519 (human) | | 0.000009 | memory impairment | | 4 | 125446831 | 125446832 | Human |
| 628875679 | GWAS2783908_H | protein measurement QTL GWAS2783908 (human) | | 6e-17 | protein amount (VT:0010120) | | 4 | 110555545 | 110555546 | Human |
| 628875678 | GWAS2783907_H | protein measurement QTL GWAS2783907 (human) | | 2e-152 | protein amount (VT:0010120) | | 4 | 110510288 | 110510289 | Human |
| 628400541 | GWAS2308770_H | cortical thickness QTL GWAS2308770 (human) | | 0.0000001 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120722084 | 120722085 | Human |
| 406920363 | GWAS569339_H | heel bone mineral density QTL GWAS569339 (human) | | 4e-11 | heel bone mineral density | | 4 | 123613837 | 123613838 | Human |
| 628613532 | GWAS2521761_H | monocyte count QTL GWAS2521761 (human) | | 5e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 110035176 | 110035177 | Human |
| 406920364 | GWAS569340_H | heel bone mineral density QTL GWAS569340 (human) | | 3e-11 | heel bone mineral density | | 4 | 124600184 | 124600185 | Human |
| 597387107 | GWAS1483181_H | primary biliary cirrhosis QTL GWAS1483181 (human) | | 4e-13 | primary biliary cirrhosis | | 4 | 122667371 | 122667372 | Human |
| 628859266 | GWAS2767495_H | heart failure QTL GWAS2767495 (human) | | 4e-16 | heart integrity trait (VT:0010757) | | 4 | 110707472 | 110707473 | Human |
| 596977519 | GWAS1097038_H | cardioembolic stroke QTL GWAS1097038 (human) | | 5e-41 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 598042463 | GWAS1761762_H | body mass index QTL GWAS1761762 (human) | | 0.000001 | body mass index | | 4 | 131333599 | 131333600 | Human |
| 407379272 | GWAS1028248_H | blood protein measurement QTL GWAS1028248 (human) | | 4e-192 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 407117123 | GWAS766099_H | peptic ulcer disease QTL GWAS766099 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616965 | 123616966 | Human |
| 407002442 | GWAS651418_H | systolic blood pressure QTL GWAS651418 (human) | | 0.000005 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 108104223 | 108104224 | Human |
| 407084363 | GWAS733339_H | sex hormone-binding globulin measurement QTL GWAS733339 (human) | | 4e-18 | sex hormone-binding globulin measurement | | 4 | 109345757 | 109345758 | Human |
| 407231817 | GWAS880793_H | wellbeing measurement, alcohol consumption measurement QTL GWAS880793 (human) | | 5e-08 | wellbeing measurement, alcohol consumption measurement | | 4 | 121669289 | 121669290 | Human |
| 407133513 | GWAS782489_H | post-traumatic stress disorder QTL GWAS782489 (human) | | 0.000002 | post-traumatic stress disorder | | 4 | 106419681 | 106419682 | Human |
| 597485201 | GWAS1581275_H | body height QTL GWAS1581275 (human) | | 2e-16 | body height | | 4 | 108560745 | 108560746 | Human |
| 597190293 | GWAS1286367_H | hippocampal amigdala transition area volume QTL GWAS1286367 (human) | | 5e-08 | hippocampus morphology trait (VT:0000807) | | 4 | 110099246 | 110099247 | Human |
| 598091432 | GWAS1810731_H | erythrocyte volume QTL GWAS1810731 (human) | | 3e-13 | erythrocyte volume | | 4 | 109921984 | 109921985 | Human |
| 598091433 | GWAS1810732_H | erythrocyte volume QTL GWAS1810732 (human) | | 2e-09 | erythrocyte volume | | 4 | 119629914 | 119629915 | Human |
| 407231831 | GWAS880807_H | childhood trauma measurement, alcohol consumption measurement QTL GWAS880807 (human) | | 8e-09 | childhood trauma measurement, alcohol consumption measurement | | 4 | 127440030 | 127440031 | Human |
| 407231830 | GWAS880806_H | childhood trauma measurement, alcohol consumption measurement QTL GWAS880806 (human) | | 1e-08 | childhood trauma measurement, alcohol consumption measurement | | 4 | 126655945 | 126655946 | Human |
| 597321356 | GWAS1417430_H | 2-linoleoyl-GPC (18:2) measurement QTL GWAS1417430 (human) | | 1e-08 | 2-linoleoyl-GPC (18:2) measurement | | 4 | 107543736 | 107543737 | Human |
| 597157504 | GWAS1253578_H | triglyceride:HDL cholesterol ratio QTL GWAS1253578 (human) | | 1e-09 | high density lipoprotein cholesterol measurement | | 4 | 109648464 | 109648465 | Human |
| 597075585 | GWAS1171659_H | selective IgA deficiency disease QTL GWAS1171659 (human) | | 0.000001 | selective IgA deficiency disease | | 4 | 122571262 | 122571263 | Human |
| 597091969 | GWAS1188043_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1188043 (human) | | 0.000002 | lung capacity (VT:0001942) | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 131140615 | 131140616 | Human |
| 628498540 | GWAS2406769_H | body mass index QTL GWAS2406769 (human) | | 2e-09 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 119292875 | 119292876 | Human |
| 407412052 | GWAS1061028_H | total cholesterol measurement QTL GWAS1061028 (human) | | 2e-08 | total cholesterol measurement | | 4 | 127977878 | 127977879 | Human |
| 628727908 | GWAS2636137_H | atrial fibrillation QTL GWAS2636137 (human) | | 8e-27 | atrial fibrillation | | 4 | 109738763 | 109738764 | Human |
| 407199064 | GWAS848040_H | lipid measurement QTL GWAS848040 (human) | | 0.000005 | lipid measurement | | 4 | 126630119 | 126630120 | Human |
| 597288582 | GWAS1384656_H | Ischemic stroke QTL GWAS1384656 (human) | | 0.0000001 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
| 597124791 | GWAS1220865_H | glycerophospholipid measurement QTL GWAS1220865 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114566454 | 114566455 | Human |
| 597124790 | GWAS1220864_H | glycerophospholipid measurement QTL GWAS1220864 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114581427 | 114581428 | Human |
| 597124789 | GWAS1220863_H | glycerophospholipid measurement QTL GWAS1220863 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114554497 | 114554498 | Human |
| 597124788 | GWAS1220862_H | glycerophospholipid measurement QTL GWAS1220862 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594500 | 114594501 | Human |
| 597124787 | GWAS1220861_H | glycerophospholipid measurement QTL GWAS1220861 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114556583 | 114556584 | Human |
| 597124786 | GWAS1220860_H | glycerophospholipid measurement QTL GWAS1220860 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533453 | 114533454 | Human |
| 597272255 | GWAS1368329_H | epidermal growth factor measurement QTL GWAS1368329 (human) | | 5e-17 | epidermal growth factor measurement | | 4 | 109961320 | 109961321 | Human |
| 597124785 | GWAS1220859_H | glycerophospholipid measurement QTL GWAS1220859 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533510 | 114533511 | Human |
| 597124784 | GWAS1220858_H | glycerophospholipid measurement QTL GWAS1220858 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533531 | 114533532 | Human |
| 598140545 | GWAS1827273_H | bone tissue density QTL GWAS1827273 (human) | | 2e-17 | bone tissue density | | 4 | 123616626 | 123616628 | Human |
| 406969702 | GWAS618678_H | trait in response to hydrochlorothiazide, fasting blood glucose measurement QTL GWAS618678 (human) | | 0.000004 | trait in response to hydrochlorothiazide, fasting blood glucose measurement | | 4 | 128775066 | 128775067 | Human |
| 597124799 | GWAS1220873_H | glycerophospholipid measurement QTL GWAS1220873 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511785 | 114511786 | Human |
| 597092031 | GWAS1188105_H | chronic lymphocytic leukemia QTL GWAS1188105 (human) | | 0.0000001 | leukocyte integrity trait (VT:0010898) | | 4 | 108105258 | 108105259 | Human |
| 597124798 | GWAS1220872_H | glycerophospholipid measurement QTL GWAS1220872 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511945 | 114511946 | Human |
| 597124797 | GWAS1220871_H | glycerophospholipid measurement QTL GWAS1220871 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114509770 | 114509771 | Human |
| 597206707 | GWAS1302781_H | Beta blocking agent use measurement QTL GWAS1302781 (human) | | 5e-09 | Beta blocking agent use measurement | | 4 | 110743002 | 110743003 | Human |
| 597616309 | GWAS1673169_H | appendicitis QTL GWAS1673169 (human) | | 3e-21 | appendicitis | | 4 | 110804662 | 110804663 | Human |
| 597386928 | GWAS1483002_H | platelet-derived growth factor BB measurement QTL GWAS1483002 (human) | | 0.000002 | platelet-derived growth factor BB measurement | | 4 | 111263595 | 111263596 | Human |
| 597124796 | GWAS1220870_H | glycerophospholipid measurement QTL GWAS1220870 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114538112 | 114538113 | Human |
| 597124795 | GWAS1220869_H | glycerophospholipid measurement QTL GWAS1220869 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114581520 | 114581521 | Human |
| 597124794 | GWAS1220868_H | glycerophospholipid measurement QTL GWAS1220868 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114519018 | 114519019 | Human |
| 628990032 | GWAS2898261_H | abnormal result of function studies QTL GWAS2898261 (human) | | 2e-11 | abnormal result of function studies | | 4 | 131498407 | 131498408 | Human |
| 407199083 | GWAS848059_H | Ischemic stroke, fibrinogen measurement QTL GWAS848059 (human) | | 1e-15 | Ischemic stroke, fibrinogen measurement | | 4 | 110775495 | 110775496 | Human |
| 616358290 | GWAS1843005_H | gut microbiome measurement, environmental exposure measurement QTL GWAS1843005 (human) | | 0.000008 | gut microbiome measurement, environmental exposure measurement | | 4 | 113313524 | 113313525 | Human |
| 597124793 | GWAS1220867_H | glycerophospholipid measurement QTL GWAS1220867 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114594055 | 114594056 | Human |
| 628645975 | GWAS2554204_H | growth rate attribute, age at assessment QTL GWAS2554204 (human) | | 0.000004 | growth rate attribute, age at assessment | | 4 | 108011006 | 108011007 | Human |
| 597616305 | GWAS1673165_H | appendicitis QTL GWAS1673165 (human) | | 6e-20 | appendicitis | | 4 | 110810809 | 110810810 | Human |
| 628891731 | GWAS2799960_H | schizophrenia QTL GWAS2799960 (human) | | 0.000002 | schizophrenia | | 4 | 113059651 | 113059652 | Human |
| 597124792 | GWAS1220866_H | glycerophospholipid measurement QTL GWAS1220866 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114548111 | 114548112 | Human |
| 625827961 | GWAS2248883_H | level of vascular endothelial growth factor receptor 1 in blood serum QTL GWAS2248883 (human) | | 0.000003 | level of vascular endothelial growth factor receptor 1 in blood serum | | 4 | 122068318 | 122068319 | Human |
| 407330162 | GWAS979138_H | cortical surface area measurement QTL GWAS979138 (human) | | 4e-08 | cortical surface area measurement | | 4 | 127191068 | 127191069 | Human |
| 597042849 | GWAS1138923_H | appendicular lean mass QTL GWAS1138923 (human) | | 2e-12 | appendicular lean mass | | 4 | 119638715 | 119638716 | Human |
| 407149948 | GWAS798924_H | platelet count QTL GWAS798924 (human) | | 2e-19 | platelet count | | 4 | 109945564 | 109945565 | Human |
| 597124783 | GWAS1220857_H | glycerophospholipid measurement QTL GWAS1220857 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114555821 | 114555822 | Human |
| 597124782 | GWAS1220856_H | glycerophospholipid measurement QTL GWAS1220856 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114530452 | 114530453 | Human |
| 597124781 | GWAS1220855_H | glycerophospholipid measurement QTL GWAS1220855 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496204 | 114496205 | Human |
| 616358274 | GWAS1842989_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1842989 (human) | | 2e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 106567633 | 106567634 | Human |
| 597370533 | GWAS1466607_H | mean corpuscular hemoglobin concentration QTL GWAS1466607 (human) | | 2e-28 | mean corpuscular volume | | 4 | 127625245 | 127625246 | Human |
| 406920574 | GWAS569550_H | BMI-adjusted waist-hip ratio QTL GWAS569550 (human) | | 6e-09 | BMI-adjusted waist-hip ratio | | 4 | 122854222 | 122854223 | Human |
| 407313670 | GWAS962646_H | body weight QTL GWAS962646 (human) | | 9e-10 | body weight | | 4 | 122906887 | 122906888 | Human |
| 407395596 | GWAS1044572_H | cup-to-disc ratio measurement QTL GWAS1044572 (human) | | 2e-09 | cup-to-disc ratio measurement | | 4 | 111478355 | 111478356 | Human |
| 598091488 | GWAS1810787_H | erythrocyte volume QTL GWAS1810787 (human) | | 8e-17 | erythrocyte volume | | 4 | 127625245 | 127625246 | Human |
| 628596798 | GWAS2505027_H | open-angle glaucoma QTL GWAS2505027 (human) | | 8e-10 | eye integrity trait (VT:0011107) | | 4 | 126000490 | 126000491 | Human |
| 628596797 | GWAS2505026_H | open-angle glaucoma QTL GWAS2505026 (human) | | 2e-08 | eye integrity trait (VT:0011107) | | 4 | 125465224 | 125465225 | Human |
| 628596796 | GWAS2505025_H | open-angle glaucoma QTL GWAS2505025 (human) | | 1e-08 | eye integrity trait (VT:0011107) | | 4 | 111886876 | 111886877 | Human |
| 597321425 | GWAS1417499_H | testosterone measurement QTL GWAS1417499 (human) | | 1e-09 | testosterone measurement | | 4 | 124046883 | 124046884 | Human |
| 628596795 | GWAS2505024_H | open-angle glaucoma QTL GWAS2505024 (human) | | 4e-15 | eye integrity trait (VT:0011107) | | 4 | 111042563 | 111042564 | Human |
| 597321431 | GWAS1417505_H | testosterone measurement QTL GWAS1417505 (human) | | 7e-09 | testosterone measurement | | 4 | 109108768 | 109108769 | Human |
| 597288663 | GWAS1384737_H | blood urea nitrogen measurement QTL GWAS1384737 (human) | | 4e-08 | blood urea nitrogen measurement | | 4 | 119076757 | 119076758 | Human |
| 628547641 | GWAS2455870_H | lymphocyte count QTL GWAS2455870 (human) | | 3e-16 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109967851 | 109967852 | Human |
| 597616332 | GWAS1673192_H | congenital anomaly of cardiovascular system QTL GWAS1673192 (human) | | 3e-11 | congenital anomaly of cardiovascular system | | 4 | 112981089 | 112981090 | Human |
| 407330067 | GWAS979043_H | QT interval QTL GWAS979043 (human) | | 4e-08 | QT interval | | 4 | 113523545 | 113523546 | Human |
| 628613155 | GWAS2521384_H | facial morphology trait QTL GWAS2521384 (human) | | 4e-11 | facial morphology trait | | 4 | 126014320 | 126014321 | Human |
| 597124801 | GWAS1220875_H | glycerophospholipid measurement QTL GWAS1220875 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511985 | 114511986 | Human |
| 597124800 | GWAS1220874_H | glycerophospholipid measurement QTL GWAS1220874 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511787 | 114511788 | Human |
| 597190393 | GWAS1286467_H | testosterone measurement QTL GWAS1286467 (human) | | 4e-09 | testosterone measurement | | 4 | 108146742 | 108146743 | Human |
| 628678681 | GWAS2586910_H | color vision disorder QTL GWAS2586910 (human) | | 0.0000004 | color vision disorder | | 4 | 123509639 | 123509640 | Human |
| 407182630 | GWAS831606_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS831606 (human) | | 1e-11 | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407149863 | GWAS798839_H | Thrombocytopenia QTL GWAS798839 (human) | | 1e-44 | Thrombocytopenia | | 4 | 110026904 | 110026905 | Human |
| 616997282 | GWAS2014781_H | balding measurement QTL GWAS2014781 (human) | | 2e-10 | balding measurement | | 4 | 124156708 | 124156709 | Human |
| 628891673 | GWAS2799902_H | non-high density lipoprotein cholesterol measurement QTL GWAS2799902 (human) | | 3e-10 | blood non-HDL cholesterol amount (VT:0010474) | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 4 | 109174464 | 109174465 | Human |
| 597223165 | GWAS1319239_H | platelet count QTL GWAS1319239 (human) | | 6e-38 | platelet count | | 4 | 110039895 | 110039896 | Human |
| 628908057 | GWAS2816286_H | R wave amplitude QTL GWAS2816286 (human) | | 3e-10 | R wave amplitude | R wave amplitude (CMO:0000270) | 4 | 113507558 | 113507559 | Human |
| 616997280 | GWAS2014779_H | balding measurement QTL GWAS2014779 (human) | | 1e-09 | balding measurement | | 4 | 106449528 | 106449529 | Human |
| 628891674 | GWAS2799903_H | non-high density lipoprotein cholesterol measurement QTL GWAS2799903 (human) | | 2e-13 | blood non-HDL cholesterol amount (VT:0010474) | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 4 | 109717668 | 109717669 | Human |
| 616997281 | GWAS2014780_H | balding measurement QTL GWAS2014780 (human) | | 3e-22 | balding measurement | | 4 | 106645118 | 106645119 | Human |
| 617144751 | GWAS2162250_H | keratoconus QTL GWAS2162250 (human) | | 2e-12 | keratoconus | | 4 | 117877256 | 117877257 | Human |
| 407100708 | GWAS749684_H | FEV/FVC ratio, response to bronchodilator QTL GWAS749684 (human) | | 0.000002 | FEV/FVC ratio, response to bronchodilator | | 4 | 131140615 | 131140616 | Human |
| 597386992 | GWAS1483066_H | mean arterial pressure QTL GWAS1483066 (human) | | 0.000003 | mean arterial pressure | | 4 | 110460482 | 110460483 | Human |
| 628678676 | GWAS2586905_H | color vision disorder QTL GWAS2586905 (human) | | 0.0000002 | color vision disorder | | 4 | 130864190 | 130864191 | Human |
| 407133482 | GWAS782458_H | memory performance QTL GWAS782458 (human) | | 0.0000005 | memory performance | | 4 | 109067562 | 109067563 | Human |
| 407051569 | GWAS700545_H | sexual dimorphism measurement QTL GWAS700545 (human) | | 5e-09 | sexual dimorphism measurement | | 4 | 121792708 | 121792709 | Human |
| 617095612 | GWAS2113111_H | eosinophil count QTL GWAS2113111 (human) | | 1e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122663791 | 122663792 | Human |
| 407133491 | GWAS782467_H | memory performance QTL GWAS782467 (human) | | 0.0000003 | memory performance | | 4 | 130946957 | 130946958 | Human |
| 616997310 | GWAS2014809_H | celiac disease QTL GWAS2014809 (human) | | 3e-36 | celiac disease | | 4 | 122629959 | 122629960 | Human |
| 598091487 | GWAS1810786_H | erythrocyte volume QTL GWAS1810786 (human) | | 2e-52 | erythrocyte volume | | 4 | 121877258 | 121877259 | Human |
| 407133503 | GWAS782479_H | post-traumatic stress disorder QTL GWAS782479 (human) | | 0.000001 | post-traumatic stress disorder | | 4 | 106417893 | 106417894 | Human |
| 617046458 | GWAS2063957_H | hemoglobin measurement QTL GWAS2063957 (human) | | 1e-12 | hemoglobin measurement | | 4 | 123835365 | 123835366 | Human |
| 597403162 | GWAS1499236_H | cardiac arrhythmia QTL GWAS1499236 (human) | | 1e-187 | cardiac arrhythmia | | 4 | 110795357 | 110795358 | Human |
| 597304859 | GWAS1400933_H | erythrocyte count QTL GWAS1400933 (human) | | 3e-15 | erythrocyte count | | 4 | 121827841 | 121827842 | Human |
| 628941048 | GWAS2849277_H | platelet count QTL GWAS2849277 (human) | | 5e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
| 628908281 | GWAS2816510_H | dilated cardiomyopathy QTL GWAS2816510 (human) | | 6e-08 | heart integrity trait (VT:0010757) | | 4 | 110782987 | 110782988 | Human |
| 628416754 | GWAS2324983_H | heart failure QTL GWAS2324983 (human) | | 6e-20 | heart integrity trait (VT:0010757) | | 4 | 110747470 | 110747471 | Human |
| 597124639 | GWAS1220713_H | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement QTL GWAS1220713 (human) | | 2e-23 | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | | 4 | 111485805 | 111485806 | Human |
| 597124638 | GWAS1220712_H | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement QTL GWAS1220712 (human) | | 1e-09 | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | | 4 | 129484578 | 129484579 | Human |
| 597108252 | GWAS1204326_H | cocaine dependence QTL GWAS1204326 (human) | | 0.000006 | cocaine dependence | | 4 | 116685914 | 116685915 | Human |
| 407002574 | GWAS651550_H | eosinophil percentage of leukocytes QTL GWAS651550 (human) | | 3e-41 | eosinophil percentage of leukocytes | | 4 | 122263256 | 122263257 | Human |
| 406920655 | GWAS569631_H | platelet count QTL GWAS569631 (human) | | 5e-62 | platelet count | | 4 | 110003178 | 110003179 | Human |
| 597059096 | GWAS1155170_H | adolescent idiopathic scoliosis QTL GWAS1155170 (human) | | 2e-16 | adolescent idiopathic scoliosis | | 4 | 129325525 | 129325526 | Human |
| 628941036 | GWAS2849265_H | prothrombin time measurement QTL GWAS2849265 (human) | | 1e-33 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110796911 | 110796912 | Human |
| 406920656 | GWAS569632_H | platelet count QTL GWAS569632 (human) | | 1e-09 | platelet count | | 4 | 119334573 | 119334574 | Human |
| 597403146 | GWAS1499220_H | corneal topography QTL GWAS1499220 (human) | | 1e-18 | corneal topography | | 4 | 127192269 | 127192270 | Human |
| 407002576 | GWAS651552_H | BMI-adjusted waist-hip ratio QTL GWAS651552 (human) | | 5e-09 | BMI-adjusted waist-hip ratio | | 4 | 119607172 | 119607173 | Human |
| 628908271 | GWAS2816500_H | response to statin, LDL cholesterol change measurement QTL GWAS2816500 (human) | | 2e-08 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 108720535 | 108720536 | Human |
| 597255693 | GWAS1351767_H | urate measurement, bone density QTL GWAS1351767 (human) | | 8e-09 | urate measurement, bone density | | 4 | 113560916 | 113560917 | Human |
| 407363026 | GWAS1012002_H | Antithrombotic agent use measurement QTL GWAS1012002 (human) | | 4e-20 | Antithrombotic agent use measurement | | 4 | 110784139 | 110784140 | Human |
| 628826349 | GWAS2734578_H | reticulocyte amount QTL GWAS2734578 (human) | | 2e-15 | reticulocyte amount | | 4 | 109966833 | 109966834 | Human |
| 617144670 | GWAS2162169_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2162169 (human) | | 1e-26 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 125365950 | 125365951 | Human |
| 628728037 | GWAS2636266_H | cardiovascular disease QTL GWAS2636266 (human) | | 9e-09 | cardiovascular disease | | 4 | 110764459 | 110764460 | Human |
| 628990176 | GWAS2898405_H | esophageal ulcer QTL GWAS2898405 (human) | | 1e-11 | esophageal ulcer | | 4 | 130688376 | 130688377 | Human |
| 616964441 | GWAS1981940_H | atrial fibrillation QTL GWAS1981940 (human) | | 3e-28 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 406904289 | GWAS553265_H | triglyceride measurement QTL GWAS553265 (human) | | 6e-27 | triglyceride measurement | | 4 | 109603883 | 109603884 | Human |
| 406904290 | GWAS553266_H | triglyceride measurement QTL GWAS553266 (human) | | 6e-10 | triglyceride measurement | | 4 | 123895285 | 123895286 | Human |
| 616997231 | GWAS2014730_H | coronary artery calcification QTL GWAS2014730 (human) | | 0.000006 | coronary artery integrity trait (VT:0010746) | | 4 | 117351922 | 117351923 | Human |
| 628809939 | GWAS2718168_H | pelvic organ prolapse QTL GWAS2718168 (human) | | 2e-23 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
| 598025737 | GWAS1745036_H | body height QTL GWAS1745036 (human) | | 2e-10 | body height | | 4 | 129838492 | 129838493 | Human |
| 597108283 | GWAS1204357_H | pulmonary function measurement QTL GWAS1204357 (human) | | 0.000003 | respiratory function trait (VT:0002327) | | 4 | 130774276 | 130774277 | Human |
| 628891857 | GWAS2800086_H | high density lipoprotein cholesterol measurement QTL GWAS2800086 (human) | | 1e-21 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109174464 | 109174465 | Human |
| 598025736 | GWAS1745035_H | body height QTL GWAS1745035 (human) | | 1e-08 | body height | | 4 | 112402274 | 112402275 | Human |
| 628891858 | GWAS2800087_H | high density lipoprotein cholesterol measurement QTL GWAS2800087 (human) | | 1e-25 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
| 628809940 | GWAS2718169_H | pelvic organ prolapse QTL GWAS2718169 (human) | | 1e-11 | pelvic organ prolapse | | 4 | 126146934 | 126146935 | Human |
| 407379431 | GWAS1028407_H | unipolar depression QTL GWAS1028407 (human) | | 2e-10 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
| 597403179 | GWAS1499253_H | alopecia QTL GWAS1499253 (human) | | 1e-10 | alopecia | | 4 | 107131838 | 107131839 | Human |
| 597419563 | GWAS1515637_H | mathematical ability QTL GWAS1515637 (human) | | 1e-08 | mathematical ability | | 4 | 111859867 | 111859868 | Human |
| 616554767 | GWAS1951350_H | FEV/FVC ratio QTL GWAS1951350 (human) | | 7e-12 | FEV/FVC ratio | | 4 | 123898452 | 123898453 | Human |
| 406920692 | GWAS569668_H | cardioembolic stroke QTL GWAS569668 (human) | | 4e-20 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597403181 | GWAS1499255_H | alopecia QTL GWAS1499255 (human) | | 6e-10 | alopecia | | 4 | 106706914 | 106706915 | Human |
| 597403180 | GWAS1499254_H | alopecia QTL GWAS1499254 (human) | | 1e-10 | alopecia | | 4 | 106590268 | 106590269 | Human |
| 597386796 | GWAS1482870_H | Epstein-Barr virus infection QTL GWAS1482870 (human) | | 0.000001 | response to viral infection trait (VT:0010439) | | 4 | 107189709 | 107189710 | Human |
| 597419564 | GWAS1515638_H | mathematical ability QTL GWAS1515638 (human) | | 1e-08 | mathematical ability | | 4 | 132101754 | 132101755 | Human |
| 597386787 | GWAS1482861_H | Cleft palate QTL GWAS1482861 (human) | | 0.000004 | Cleft palate | | 4 | 116802931 | 116802932 | Human |
| 406937081 | GWAS586057_H | body height QTL GWAS586057 (human) | | 3e-08 | body height | | 4 | 119693141 | 119693142 | Human |
| 628662465 | GWAS2570694_H | peptic ulcer disease QTL GWAS2570694 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616965 | 123616966 | Human |
| 406937085 | GWAS586061_H | body height QTL GWAS586061 (human) | | 1e-09 | body height | | 4 | 121739866 | 121739867 | Human |
| 626466967 | GWAS2280900_H | body weight QTL GWAS2280900 (human) | | 3e-10 | body weight | | 4 | 124018099 | 124018100 | Human |
| 597501533 | GWAS1597607_H | diet measurement QTL GWAS1597607 (human) | | 2e-08 | diet measurement | | 4 | 129906935 | 129906936 | Human |
| 597124694 | GWAS1220768_H | glycerophospholipid measurement QTL GWAS1220768 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493245 | 114493246 | Human |
| 597124693 | GWAS1220767_H | glycerophospholipid measurement QTL GWAS1220767 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493734 | 114493735 | Human |
| 597124692 | GWAS1220766_H | glycerophospholipid measurement QTL GWAS1220766 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493571 | 114493572 | Human |
| 407149952 | GWAS798928_H | platelet count QTL GWAS798928 (human) | | 2e-30 | platelet count | | 4 | 109990751 | 109990752 | Human |
| 597124691 | GWAS1220765_H | glycerophospholipid measurement QTL GWAS1220765 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114490891 | 114490892 | Human |
| 407149953 | GWAS798929_H | platelet count QTL GWAS798929 (human) | | 2e-80 | platelet count | | 4 | 110027819 | 110027820 | Human |
| 597124690 | GWAS1220764_H | glycerophospholipid measurement QTL GWAS1220764 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114512090 | 114512091 | Human |
| 628613298 | GWAS2521527_H | erythrocyte volume QTL GWAS2521527 (human) | | 2e-09 | erythrocyte volume | | 4 | 121773981 | 121773982 | Human |
| 628613296 | GWAS2521525_H | erythrocyte volume QTL GWAS2521525 (human) | | 2e-11 | erythrocyte volume | | 4 | 109979991 | 109979992 | Human |
| 407149955 | GWAS798931_H | platelet count QTL GWAS798931 (human) | | 1e-11 | platelet count | | 4 | 119622957 | 119622958 | Human |
| 597141086 | GWAS1237160_H | irritable bowel syndrome QTL GWAS1237160 (human) | | 3e-08 | irritable bowel syndrome | | 4 | 122201701 | 122201702 | Human |
| 616571145 | GWAS1967728_H | fibroblast growth factor 2 amount QTL GWAS1967728 (human) | | 9e-40 | fibroblast growth factor 2 amount | | 4 | 122868214 | 122868215 | Human |
| 617095426 | GWAS2112925_H | mean reticulocyte volume QTL GWAS2112925 (human) | | 9e-67 | mean reticulocyte volume | | 4 | 121808257 | 121808258 | Human |
| 616571146 | GWAS1967729_H | fibroblast growth factor 2 amount QTL GWAS1967729 (human) | | 4e-40 | fibroblast growth factor 2 amount | | 4 | 122826155 | 122826156 | Human |
| 616571147 | GWAS1967730_H | fibroblast growth factor 2 amount QTL GWAS1967730 (human) | | 2e-12 | fibroblast growth factor 2 amount | | 4 | 121789225 | 121789226 | Human |
| 625827968 | GWAS2248890_H | respiratory system disease QTL GWAS2248890 (human) | | 6e-09 | respiratory system disease | | 4 | 109137407 | 109137408 | Human |
| 616571149 | GWAS1967732_H | fibroblast growth factor 2 amount QTL GWAS1967732 (human) | | 9e-165 | fibroblast growth factor 2 amount | | 4 | 122842746 | 122842747 | Human |
| 616571150 | GWAS1967733_H | fibroblast growth factor 2 amount QTL GWAS1967733 (human) | | 5e-157 | fibroblast growth factor 2 amount | | 4 | 122859108 | 122859109 | Human |
| 598156904 | GWAS1835974_H | depressive symptom measurement, social risk factor QTL GWAS1835974 (human) | | 0.000004 | depressive symptom measurement, social risk factor | | 4 | 128297339 | 128297340 | Human |
| 616571152 | GWAS1967735_H | fibroblast growth factor 2 amount QTL GWAS1967735 (human) | | 5e-15 | fibroblast growth factor 2 amount | | 4 | 122496141 | 122496142 | Human |
| 616571153 | GWAS1967736_H | fibroblast growth factor 2 amount QTL GWAS1967736 (human) | | 6e-18 | fibroblast growth factor 2 amount | | 4 | 122786283 | 122786284 | Human |
| 597599820 | GWAS1656680_H | mean corpuscular hemoglobin concentration QTL GWAS1656680 (human) | | 2e-17 | mean corpuscular hemoglobin concentration | | 4 | 109912954 | 109912955 | Human |
| 616571154 | GWAS1967737_H | fibroblast growth factor 2 amount QTL GWAS1967737 (human) | | 3e-13 | fibroblast growth factor 2 amount | | 4 | 122807648 | 122807649 | Human |
| 616571155 | GWAS1967738_H | fibroblast growth factor 2 amount QTL GWAS1967738 (human) | | 3e-18 | fibroblast growth factor 2 amount | | 4 | 122718148 | 122718149 | Human |
| 616571156 | GWAS1967739_H | fibroblast growth factor 2 amount QTL GWAS1967739 (human) | | 4e-13 | fibroblast growth factor 2 amount | | 4 | 122652747 | 122652748 | Human |
| 597141058 | GWAS1237132_H | diastolic blood pressure, systolic blood pressure QTL GWAS1237132 (human) | | 0.000007 | diastolic blood pressure, systolic blood pressure | | 4 | 119856151 | 119856152 | Human |
| 616571157 | GWAS1967740_H | fibroblast growth factor 2 amount QTL GWAS1967740 (human) | | 6e-22 | fibroblast growth factor 2 amount | | 4 | 122785605 | 122785606 | Human |
| 616571158 | GWAS1967741_H | fibroblast growth factor 2 amount QTL GWAS1967741 (human) | | 4e-17 | fibroblast growth factor 2 amount | | 4 | 122769150 | 122769151 | Human |
| 616571159 | GWAS1967742_H | fibroblast growth factor 2 amount QTL GWAS1967742 (human) | | 1e-35 | fibroblast growth factor 2 amount | | 4 | 122495046 | 122495047 | Human |
| 616571160 | GWAS1967743_H | fibroblast growth factor 2 amount QTL GWAS1967743 (human) | | 2e-22 | fibroblast growth factor 2 amount | | 4 | 122685018 | 122685019 | Human |
| 616571161 | GWAS1967744_H | fibroblast growth factor 2 amount QTL GWAS1967744 (human) | | 2e-55 | fibroblast growth factor 2 amount | | 4 | 121996120 | 121996121 | Human |
| 597157452 | GWAS1253526_H | high density lipoprotein cholesterol measurement QTL GWAS1253526 (human) | | 7e-09 | high density lipoprotein cholesterol measurement | | 4 | 109603883 | 109603884 | Human |
| 597059149 | GWAS1155223_H | adolescent idiopathic scoliosis QTL GWAS1155223 (human) | | 9e-12 | adolescent idiopathic scoliosis | | 4 | 116480238 | 116480239 | Human |
| 616571163 | GWAS1967746_H | fibroblast growth factor 2 amount QTL GWAS1967746 (human) | | 5e-34 | fibroblast growth factor 2 amount | | 4 | 123107513 | 123107514 | Human |
| 616571164 | GWAS1967747_H | fibroblast growth factor 2 amount QTL GWAS1967747 (human) | | 2e-33 | fibroblast growth factor 2 amount | | 4 | 122815622 | 122815623 | Human |
| 616571165 | GWAS1967748_H | fibroblast growth factor 2 amount QTL GWAS1967748 (human) | | 5e-17 | fibroblast growth factor 2 amount | | 4 | 122424054 | 122424055 | Human |
| 616571166 | GWAS1967749_H | fibroblast growth factor 2 amount QTL GWAS1967749 (human) | | 2e-20 | fibroblast growth factor 2 amount | | 4 | 122663955 | 122663956 | Human |
| 406969758 | GWAS618734_H | parental longevity QTL GWAS618734 (human) | | 0.000008 | total life span (VT:0001661) | | 4 | 113151748 | 113151749 | Human |
| 616571167 | GWAS1967750_H | fibroblast growth factor 2 amount QTL GWAS1967750 (human) | | 5e-21 | fibroblast growth factor 2 amount | | 4 | 122629385 | 122629386 | Human |
| 616571168 | GWAS1967751_H | fibroblast growth factor 2 amount QTL GWAS1967751 (human) | | 2e-22 | fibroblast growth factor 2 amount | | 4 | 122843079 | 122843080 | Human |
| 617079078 | GWAS2096577_H | drug allergy, trait in response to platinum QTL GWAS2096577 (human) | | 0.000004 | drug allergy, trait in response to platinum | | 4 | 113445575 | 113445576 | Human |
| 617062692 | GWAS2080191_H | bone tissue density QTL GWAS2080191 (human) | | 1e-21 | bone tissue density | | 4 | 128419095 | 128419096 | Human |
| 628482193 | GWAS2390422_H | erythrocyte volume QTL GWAS2390422 (human) | | 1e-08 | erythrocyte volume | | 4 | 121766083 | 121766084 | Human |
| 628531344 | GWAS2439573_H | cystatin-M measurement QTL GWAS2439573 (human) | | 5e-19 | blood cystatin amount (VT:0010742) | | 4 | 106848777 | 106848778 | Human |
| 617029921 | GWAS2047420_H | protein measurement QTL GWAS2047420 (human) | | 1e-08 | protein amount (VT:0010120) | | 4 | 121980476 | 121980477 | Human |
| 597370492 | GWAS1466566_H | mean corpuscular hemoglobin concentration QTL GWAS1466566 (human) | | 2e-10 | mean corpuscular hemoglobin concentration | | 4 | 123835365 | 123835366 | Human |
| 628908180 | GWAS2816409_H | amount of iron in brain QTL GWAS2816409 (human) | | 4e-09 | amount of iron in brain | | 4 | 119113317 | 119113318 | Human |
| 406904232 | GWAS553208_H | COVID-19 QTL GWAS553208 (human) | | 0.000009 | COVID-19 | | 4 | 122020759 | 122020760 | Human |
| 407035307 | GWAS684283_H | self reported educational attainment QTL GWAS684283 (human) | | 2e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
| 626467005 | GWAS2280938_H | diastolic blood pressure QTL GWAS2280938 (human) | | 7e-34 | diastolic blood pressure | | 4 | 110417121 | 110417122 | Human |
| 597599859 | GWAS1656719_H | mean corpuscular hemoglobin concentration QTL GWAS1656719 (human) | | 5e-14 | mean corpuscular hemoglobin concentration | | 4 | 121827841 | 121827842 | Human |
| 407035309 | GWAS684285_H | self reported educational attainment QTL GWAS684285 (human) | | 4e-09 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 616554830 | GWAS1951413_H | BH3-interacting domain death agonist measurement QTL GWAS1951413 (human) | | 9e-13 | BH3-interacting domain death agonist measurement | | 4 | 109746434 | 109746435 | Human |
| 597026403 | GWAS1122477_H | appendicitis QTL GWAS1122477 (human) | | 2e-23 | appendicitis | | 4 | 110799841 | 110799842 | Human |
| 616997169 | GWAS2014668_H | protein measurement QTL GWAS2014668 (human) | | 1e-40 | protein measurement | | 4 | 106826356 | 106826357 | Human |
| 628973701 | GWAS2881930_H | platelet count QTL GWAS2881930 (human) | | 2e-61 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109927496 | 109927497 | Human |
| 617128240 | GWAS2145739_H | platelet crit QTL GWAS2145739 (human) | | 7e-12 | platelet crit | | 4 | 123849566 | 123849567 | Human |
| 628514959 | GWAS2423188_H | atrial fibrillation QTL GWAS2423188 (human) | | 2e-09 | atrial fibrillation | | 4 | 110485663 | 110485664 | Human |
| 617079101 | GWAS2096600_H | eosinophil count QTL GWAS2096600 (human) | | 8e-11 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 628957315 | GWAS2865544_H | blood coagulation disease QTL GWAS2865544 (human) | | 2e-11 | blood coagulation disease | | 4 | 110761735 | 110761736 | Human |
| 617029945 | GWAS2047444_H | appendectomy QTL GWAS2047444 (human) | | 4e-12 | appendectomy | | 4 | 111904289 | 111904290 | Human |
| 617046726 | GWAS2064225_H | household income QTL GWAS2064225 (human) | | 4e-08 | household income | | 4 | 131729441 | 131729442 | Human |
| 616358591 | GWAS1843306_H | gut microbiome measurement, number of siblings QTL GWAS1843306 (human) | | 0.0000003 | gut microbiome measurement, number of siblings | | 4 | 112947027 | 112947028 | Human |
| 628827005 | GWAS2735234_H | platelet crit QTL GWAS2735234 (human) | | 7e-12 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 123849566 | 123849567 | Human |
| 406904391 | GWAS553367_H | R-6-hydroxywarfarin measurement QTL GWAS553367 (human) | | 0.000005 | R-6-hydroxywarfarin measurement | | 4 | 123651871 | 123651872 | Human |
| 407051850 | GWAS700826_H | atrial fibrillation QTL GWAS700826 (human) | | 3e-28 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 628401017 | GWAS2309246_H | erythrocyte volume QTL GWAS2309246 (human) | | 1e-17 | erythrocyte volume | | 4 | 109933275 | 109933276 | Human |
| 628515707 | GWAS2423936_H | sex hormone-binding globulin measurement QTL GWAS2423936 (human) | | 9e-09 | sex hormone-binding globulin measurement | | 4 | 123871744 | 123871745 | Human |
| 628401018 | GWAS2309247_H | erythrocyte volume QTL GWAS2309247 (human) | | 1e-79 | erythrocyte volume | | 4 | 121814898 | 121814899 | Human |
| 628564835 | GWAS2473064_H | renal carcinoma QTL GWAS2473064 (human) | | 9e-10 | renal carcinoma | | 4 | 108791438 | 108791439 | Human |
| 625828693 | GWAS2249615_H | atrial flutter QTL GWAS2249615 (human) | | 3e-21 | atrial flutter | | 4 | 110791080 | 110791081 | Human |
| 628941669 | GWAS2849898_H | macular degeneration QTL GWAS2849898 (human) | | 9e-27 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 597173635 | GWAS1269709_H | sclerosing cholangitis QTL GWAS1269709 (human) | | 2e-10 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
| 628695911 | GWAS2604140_H | cerebral cortex area attribute QTL GWAS2604140 (human) | | 4e-09 | cerebral cortex area attribute | | 4 | 120653052 | 120653053 | Human |
| 407215706 | GWAS864682_H | protein measurement QTL GWAS864682 (human) | | 1e-08 | protein measurement | | 4 | 121980476 | 121980477 | Human |
| 597992837 | GWAS1712136_H | postcentral gyrus volume QTL GWAS1712136 (human) | | 0.000003 | postcentral gyrus volume | | 4 | 114960671 | 114960672 | Human |
| 407346790 | GWAS995766_H | cortical thickness QTL GWAS995766 (human) | | 5e-10 | cortical thickness | | 4 | 127022223 | 127022224 | Human |
| 407051873 | GWAS700849_H | lung disease severity measurement QTL GWAS700849 (human) | | 0.000007 | lung disease severity measurement | | 4 | 119664980 | 119664981 | Human |
| 628368215 | GWAS2289059_H | breast carcinoma, hormone replacement therapy QTL GWAS2289059 (human) | | 0.000009 | breast carcinoma, hormone replacement therapy | | 4 | 131597356 | 131597358 | Human |
| 597992834 | GWAS1712133_H | temporal horn of lateral ventricle volume QTL GWAS1712133 (human) | | 0.0000005 | temporal horn of lateral ventricle volume | | 4 | 121297822 | 121297823 | Human |
| 407379552 | GWAS1028528_H | dental caries QTL GWAS1028528 (human) | | 0.000002 | dental caries | | 4 | 130183917 | 130183918 | Human |
| 628433758 | GWAS2341987_H | mood disorder, major depressive disorder QTL GWAS2341987 (human) | | 1e-10 | behavior trait (VT:0010442) | | 4 | 122201701 | 122201702 | Human |
| 597157307 | GWAS1253381_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1253381 (human) | | 3e-11 | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | | 4 | 109603883 | 109603884 | Human |
| 626467707 | GWAS2281640_H | body weight QTL GWAS2281640 (human) | | 4e-08 | body weight | | 4 | 110523790 | 110523791 | Human |
| 628450138 | GWAS2358367_H | alpha synuclein measurement QTL GWAS2358367 (human) | | 0.000005 | cerebrospinal fluid homeostasis trait (VT:0010443) | | 4 | 119884972 | 119884973 | Human |
| 628826953 | GWAS2735182_H | body height QTL GWAS2735182 (human) | | 1e-34 | body height | | 4 | 121801213 | 121801214 | Human |
| 407182967 | GWAS831943_H | IGFBP-3 measurement QTL GWAS831943 (human) | | 0.0000002 | IGFBP-3 measurement | | 4 | 123840924 | 123840925 | Human |
| 628679499 | GWAS2587728_H | appendicitis QTL GWAS2587728 (human) | | 5e-58 | appendicitis | | 4 | 110810780 | 110810781 | Human |
| 626451298 | GWAS2265231_H | serum albumin amount QTL GWAS2265231 (human) | | 2e-12 | serum albumin amount | | 4 | 110027510 | 110027511 | Human |
| 628679502 | GWAS2587731_H | appendectomy QTL GWAS2587731 (human) | | 4e-12 | appendectomy | | 4 | 111904289 | 111904290 | Human |
| 628679503 | GWAS2587732_H | appendectomy QTL GWAS2587732 (human) | | 6e-34 | appendectomy | | 4 | 110799663 | 110799664 | Human |
| 597058990 | GWAS1155064_H | age at menarche QTL GWAS1155064 (human) | | 1e-08 | age at menarche | | 4 | 115075517 | 115075518 | Human |
| 626451310 | GWAS2265243_H | serum creatinine amount QTL GWAS2265243 (human) | | 4e-12 | serum creatinine amount | | 4 | 123424648 | 123424649 | Human |
| 597058991 | GWAS1155065_H | age at menarche QTL GWAS1155065 (human) | | 1e-10 | age at menarche | | 4 | 131843326 | 131843327 | Human |
| 617095922 | GWAS2113421_H | eosinophil count QTL GWAS2113421 (human) | | 5e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122663791 | 122663792 | Human |
| 617194226 | GWAS2174666_H | saturated fatty acids to total fatty acids percentage QTL GWAS2174666 (human) | | 3e-11 | saturated fatty acids to total fatty acids percentage | | 4 | 110189522 | 110189523 | Human |
| 407068287 | GWAS717263_H | metabolite measurement QTL GWAS717263 (human) | | 6e-08 | metabolite measurement | | 4 | 129868385 | 129868386 | Human |
| 628958012 | GWAS2866241_H | prothrombin time measurement QTL GWAS2866241 (human) | | 1e-54 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110796911 | 110796912 | Human |
| 597992934 | GWAS1712233_H | glomerular filtration rate QTL GWAS1712233 (human) | | 5e-09 | glomerular filtration rate | | 4 | 108772299 | 108772300 | Human |
| 616358650 | GWAS1843365_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1843365 (human) | | 6e-09 | gut microbiome measurement, allergen exposure measurement | | 4 | 123477380 | 123477381 | Human |
| 406937097 | GWAS586073_H | trait in response to venlafaxine QTL GWAS586073 (human) | | 0.000006 | trait in response to venlafaxine | | 4 | 113431725 | 113431726 | Human |
| 626451230 | GWAS2265163_H | abdominal adipose tissue measurement QTL GWAS2265163 (human) | | 7e-10 | abdominal adipose tissue measurement | | 4 | 121656615 | 121656616 | Human |
| 626467614 | GWAS2281547_H | body mass index QTL GWAS2281547 (human) | | 6e-09 | body mass index | | 4 | 119405930 | 119405931 | Human |
| 628728629 | GWAS2636858_H | health trait QTL GWAS2636858 (human) | | 5e-08 | health trait | | 4 | 118196105 | 118196106 | Human |
| 626451227 | GWAS2265160_H | abdominal adipose tissue measurement QTL GWAS2265160 (human) | | 8e-11 | abdominal adipose tissue measurement | | 4 | 123210946 | 123210947 | Human |
| 597124569 | GWAS1220643_H | glycerophospholipid measurement QTL GWAS1220643 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496175 | 114496176 | Human |
| 597304789 | GWAS1400863_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1400863 (human) | | 2e-12 | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597124568 | GWAS1220642_H | glycerophospholipid measurement QTL GWAS1220642 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496530 | 114496531 | Human |
| 626451225 | GWAS2265158_H | abdominal adipose tissue measurement QTL GWAS2265158 (human) | | 6e-11 | abdominal adipose tissue measurement | | 4 | 124261535 | 124261536 | Human |
| 616555247 | GWAS1951830_H | reticulocyte amount QTL GWAS1951830 (human) | | 2e-15 | reticulocyte amount | | 4 | 109966833 | 109966834 | Human |
| 597075398 | GWAS1171472_H | trait in response to allopurinol, uric acid measurement QTL GWAS1171472 (human) | | 0.000009 | blood uric acid amount (VT:0010302) | blood uric acid level (CMO:0000501) | 4 | 115481897 | 115481898 | Human |
| 628417319 | GWAS2325548_H | protein measurement QTL GWAS2325548 (human) | | 1e-08 | protein amount (VT:0010120) | | 4 | 109735574 | 109735575 | Human |
| 628941609 | GWAS2849838_H | obesity QTL GWAS2849838 (human) | | 4e-13 | eating behavior trait (VT:0001431) | | 4 | 129818987 | 129818988 | Human |
| 617079455 | GWAS2096954_H | total cholesterol measurement QTL GWAS2096954 (human) | | 3e-09 | total cholesterol measurement | | 4 | 119202262 | 119202263 | Human |
| 407133724 | GWAS782700_H | neuroticism measurement QTL GWAS782700 (human) | | 0.000004 | neuroticism measurement | | 4 | 124054077 | 124054078 | Human |
| 628859683 | GWAS2767912_H | educational attainment QTL GWAS2767912 (human) | | 1e-11 | educational attainment | | 4 | 129713268 | 129713269 | Human |
| 628859682 | GWAS2767911_H | educational attainment QTL GWAS2767911 (human) | | 2e-09 | educational attainment | | 4 | 129621796 | 129621797 | Human |
| 597075404 | GWAS1171478_H | type 2 diabetes mellitus QTL GWAS1171478 (human) | | 0.0000001 | type 2 diabetes mellitus | | 4 | 121739095 | 121739096 | Human |
| 628859681 | GWAS2767910_H | educational attainment QTL GWAS2767910 (human) | | 5e-08 | educational attainment | | 4 | 129452572 | 129452573 | Human |
| 628859680 | GWAS2767909_H | educational attainment QTL GWAS2767909 (human) | | 1e-08 | educational attainment | | 4 | 129387520 | 129387521 | Human |
| 628859687 | GWAS2767916_H | educational attainment QTL GWAS2767916 (human) | | 0.000008 | educational attainment | | 4 | 131866663 | 131866664 | Human |
| 628859686 | GWAS2767915_H | educational attainment QTL GWAS2767915 (human) | | 3e-09 | educational attainment | | 4 | 130394262 | 130394263 | Human |
| 628859685 | GWAS2767914_H | educational attainment QTL GWAS2767914 (human) | | 0.000009 | educational attainment | | 4 | 107916747 | 107916748 | Human |
| 616358626 | GWAS1843341_H | gut microbiome measurement, breastfeeding duration QTL GWAS1843341 (human) | | 0.0000004 | gut microbiome measurement, breastfeeding duration | | 4 | 109916364 | 109916365 | Human |
| 628859684 | GWAS2767913_H | educational attainment QTL GWAS2767913 (human) | | 1e-08 | educational attainment | | 4 | 129875770 | 129875771 | Human |
| 628859675 | GWAS2767904_H | educational attainment QTL GWAS2767904 (human) | | 2e-10 | educational attainment | | 4 | 122480614 | 122480615 | Human |
| 628859674 | GWAS2767903_H | educational attainment QTL GWAS2767903 (human) | | 5e-11 | educational attainment | | 4 | 122259374 | 122259375 | Human |
| 628859673 | GWAS2767902_H | educational attainment QTL GWAS2767902 (human) | | 4e-20 | educational attainment | | 4 | 122105714 | 122105715 | Human |
| 628597525 | GWAS2505754_H | sex hormone-binding globulin measurement QTL GWAS2505754 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 628597524 | GWAS2505753_H | sex hormone-binding globulin measurement QTL GWAS2505753 (human) | | 6e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 625828654 | GWAS2249576_H | migraine disorder QTL GWAS2249576 (human) | | 0.0000003 | migraine disorder | | 4 | 121006381 | 121006382 | Human |
| 628859672 | GWAS2767901_H | educational attainment QTL GWAS2767901 (human) | | 5e-10 | educational attainment | | 4 | 121851158 | 121851159 | Human |
| 628859679 | GWAS2767908_H | educational attainment QTL GWAS2767908 (human) | | 1e-10 | educational attainment | | 4 | 129330640 | 129330641 | Human |
| 628908825 | GWAS2817054_H | HbA1c measurement QTL GWAS2817054 (human) | | 2e-23 | blood hemoglobin amount (VT:0001588) | blood hemoglobin A1c level (CMO:0002786) | 4 | 110035176 | 110035177 | Human |
| 597370366 | GWAS1466440_H | atrial fibrillation QTL GWAS1466440 (human) | | 2e-74 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
| 628859678 | GWAS2767907_H | educational attainment QTL GWAS2767907 (human) | | 2e-09 | educational attainment | | 4 | 129239551 | 129239552 | Human |
| 407084581 | GWAS733557_H | serum non-albumin protein measurement QTL GWAS733557 (human) | | 2e-10 | serum non-albumin protein measurement | | 4 | 109984820 | 109984821 | Human |
| 628859677 | GWAS2767906_H | educational attainment QTL GWAS2767906 (human) | | 2e-15 | educational attainment | | 4 | 128836670 | 128836671 | Human |
| 628859676 | GWAS2767905_H | educational attainment QTL GWAS2767905 (human) | | 2e-08 | educational attainment | | 4 | 126904030 | 126904031 | Human |
| 628859667 | GWAS2767896_H | educational attainment QTL GWAS2767896 (human) | | 0.000002 | educational attainment | | 4 | 115489506 | 115489507 | Human |
| 597321202 | GWAS1417276_H | QRS duration QTL GWAS1417276 (human) | | 4e-09 | QRS duration | | 4 | 124797072 | 124797073 | Human |
| 407248431 | GWAS897407_H | COVID-19 QTL GWAS897407 (human) | | 0.000009 | COVID-19 | | 4 | 109566395 | 109566396 | Human |
| 628859666 | GWAS2767895_H | educational attainment QTL GWAS2767895 (human) | | 2e-08 | educational attainment | | 4 | 115086647 | 115086648 | Human |
| 628859665 | GWAS2767894_H | educational attainment QTL GWAS2767894 (human) | | 4e-11 | educational attainment | | 4 | 114059072 | 114059073 | Human |
| 628859664 | GWAS2767893_H | educational attainment QTL GWAS2767893 (human) | | 1e-10 | educational attainment | | 4 | 112220279 | 112220280 | Human |
| 597255666 | GWAS1351740_H | schizophrenia QTL GWAS1351740 (human) | | 0.0000005 | schizophrenia | | 4 | 117697551 | 117697552 | Human |
| 628859671 | GWAS2767900_H | educational attainment QTL GWAS2767900 (human) | | 0.000001 | educational attainment | | 4 | 121774163 | 121774164 | Human |
| 628859670 | GWAS2767899_H | educational attainment QTL GWAS2767899 (human) | | 6e-10 | educational attainment | | 4 | 119987548 | 119987549 | Human |
| 596977147 | GWAS1096666_H | body height QTL GWAS1096666 (human) | | 4e-10 | body height | | 4 | 108146742 | 108146743 | Human |
| 628433691 | GWAS2341920_H | cervical carcinoma QTL GWAS2341920 (human) | | 0.0000007 | uterus integrity trait (VT:0010575) | | 4 | 113726137 | 113726138 | Human |
| 616997544 | GWAS2015043_H | FEV change measurement, response to bronchodilator QTL GWAS2015043 (human) | | 0.0000007 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 4 | 116884973 | 116884974 | Human |
| 628859669 | GWAS2767898_H | educational attainment QTL GWAS2767898 (human) | | 3e-10 | educational attainment | | 4 | 117508319 | 117508320 | Human |
| 628859668 | GWAS2767897_H | educational attainment QTL GWAS2767897 (human) | | 5e-08 | educational attainment | | 4 | 117355510 | 117355511 | Human |
| 407133748 | GWAS782724_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS782724 (human) | | 6e-10 | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 628957967 | GWAS2866196_H | monocyte count QTL GWAS2866196 (human) | | 1e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109966833 | 109966834 | Human |
| 597321192 | GWAS1417266_H | JT interval QTL GWAS1417266 (human) | | 2e-08 | JT interval | | 4 | 113464520 | 113464521 | Human |
| 406969907 | GWAS618883_H | cannabis dependence measurement QTL GWAS618883 (human) | | 0.000004 | response to addictive substance trait (VT:0010488) | | 4 | 118795795 | 118795796 | Human |
| 597157348 | GWAS1253422_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1253422 (human) | | 4e-13 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 406969906 | GWAS618882_H | cannabis dependence measurement QTL GWAS618882 (human) | | 0.0000002 | response to addictive substance trait (VT:0010488) | | 4 | 118795795 | 118795796 | Human |
| 628859663 | GWAS2767892_H | educational attainment QTL GWAS2767892 (human) | | 1e-11 | educational attainment | | 4 | 111489199 | 111489200 | Human |
| 628859662 | GWAS2767891_H | educational attainment QTL GWAS2767891 (human) | | 4e-10 | educational attainment | | 4 | 109603314 | 109603315 | Human |
| 617046706 | GWAS2064205_H | hematocrit QTL GWAS2064205 (human) | | 1e-10 | hematocrit | | 4 | 123846352 | 123846353 | Human |
| 407019060 | GWAS668036_H | electrocardiography QTL GWAS668036 (human) | | 5e-09 | electrocardiography | | 4 | 110793263 | 110793264 | Human |
| 407363121 | GWAS1012097_H | appendicitis QTL GWAS1012097 (human) | | 2e-11 | appendicitis | | 4 | 110799841 | 110799842 | Human |
| 617046705 | GWAS2064204_H | hematocrit QTL GWAS2064204 (human) | | 2e-16 | hematocrit | | 4 | 114598115 | 114598116 | Human |
| 628744961 | GWAS2653190_H | Eczematoid dermatitis QTL GWAS2653190 (human) | | 3e-13 | Eczematoid dermatitis | | 4 | 122415763 | 122415764 | Human |
| 628744960 | GWAS2653189_H | Eczematoid dermatitis QTL GWAS2653189 (human) | | 0.000002 | Eczematoid dermatitis | | 4 | 122109428 | 122109429 | Human |
| 598074846 | GWAS1794145_H | bone density QTL GWAS1794145 (human) | | 1e-21 | bone density | | 4 | 128419095 | 128419096 | Human |
| 617063099 | GWAS2080598_H | cerebral cortex area attribute QTL GWAS2080598 (human) | | 4e-08 | cerebral cortex area attribute | | 4 | 127191068 | 127191069 | Human |
| 597468643 | GWAS1564717_H | coffee consumption measurement QTL GWAS1564717 (human) | | 0.000003 | coffee consumption measurement | | 4 | 117421219 | 117421220 | Human |
| 628646907 | GWAS2555136_H | gut microbiome measurement, breastfeeding duration QTL GWAS2555136 (human) | | 4e-10 | lactation duration (VT:1000653) | | 4 | 121972794 | 121972795 | Human |
| 407281346 | GWAS930322_H | cup-to-disc ratio measurement QTL GWAS930322 (human) | | 1e-11 | cup-to-disc ratio measurement | | 4 | 125318831 | 125318832 | Human |
| 617030211 | GWAS2047710_H | oligodendroglioma QTL GWAS2047710 (human) | | 0.000002 | oligodendroglioma | | 4 | 132099972 | 132099973 | Human |
| 628925435 | GWAS2833664_H | mean corpuscular hemoglobin concentration QTL GWAS2833664 (human) | | 1e-09 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109996470 | 109996471 | Human |
| 628990964 | GWAS2899193_H | chronic laryngitis QTL GWAS2899193 (human) | | 4e-12 | chronic laryngitis | | 4 | 129677938 | 129677939 | Human |
| 597107997 | GWAS1204071_H | cytokine measurement QTL GWAS1204071 (human) | | 0.000003 | cytokine measurement | | 4 | 113030253 | 113030254 | Human |
| 407248586 | GWAS897562_H | mosquito bite reaction itch intensity measurement QTL GWAS897562 (human) | | 4e-09 | mosquito bite reaction itch intensity measurement | | 4 | 122359705 | 122359706 | Human |
| 597517584 | GWAS1613658_H | attention deficit hyperactivity disorder, risk-taking behaviour QTL GWAS1613658 (human) | | 7e-11 | attention deficit hyperactivity disorder, risk-taking behaviour | | 4 | 111296367 | 111296368 | Human |
| 628990963 | GWAS2899192_H | chronic laryngitis QTL GWAS2899192 (human) | | 7e-14 | chronic laryngitis | | 4 | 114913365 | 114913366 | Human |
| 628466682 | GWAS2374911_H | Ischemic stroke QTL GWAS2374911 (human) | | 0.000002 | Ischemic stroke | | 4 | 110308365 | 110308366 | Human |
| 407248585 | GWAS897561_H | mosquito bite reaction itch intensity measurement QTL GWAS897561 (human) | | 3e-09 | mosquito bite reaction itch intensity measurement | | 4 | 122182953 | 122182955 | Human |
| 407117525 | GWAS766501_H | alcohol consumption measurement QTL GWAS766501 (human) | | 2e-08 | alcohol consumption measurement | | 4 | 112674713 | 112674714 | Human |
| 597091588 | GWAS1187662_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS1187662 (human) | | 5e-17 | retina integrity trait (VT:0010771) | | 4 | 109737911 | 109737912 | Human |
| 597091589 | GWAS1187663_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS1187663 (human) | | 6e-10 | retina integrity trait (VT:0010771) | | 4 | 109764664 | 109764665 | Human |
| 597484810 | GWAS1580884_H | body height QTL GWAS1580884 (human) | | 8e-10 | body height | | 4 | 108355674 | 108355675 | Human |
| 628646895 | GWAS2555124_H | retinal layer thickness QTL GWAS2555124 (human) | | 1e-17 | retinal layer thickness | | 4 | 109019365 | 109019366 | Human |
| 628909029 | GWAS2817258_H | electrocardiography QTL GWAS2817258 (human) | | 3e-10 | electrocardiography | | 4 | 113465982 | 113465983 | Human |
| 616571485 | GWAS1968068_H | fibroblast growth factor 2 amount QTL GWAS1968068 (human) | | 6e-15 | fibroblast growth factor 2 amount | | 4 | 123433862 | 123433863 | Human |
| 616571486 | GWAS1968069_H | fibroblast growth factor 2 amount QTL GWAS1968069 (human) | | 6e-16 | fibroblast growth factor 2 amount | | 4 | 122834403 | 122834404 | Human |
| 616571487 | GWAS1968070_H | fibroblast growth factor 2 amount QTL GWAS1968070 (human) | | 3e-15 | fibroblast growth factor 2 amount | | 4 | 123258267 | 123258268 | Human |
| 616571488 | GWAS1968071_H | fibroblast growth factor 2 amount QTL GWAS1968071 (human) | | 5e-13 | fibroblast growth factor 2 amount | | 4 | 122640324 | 122640325 | Human |
| 616571489 | GWAS1968072_H | fibroblast growth factor 2 amount QTL GWAS1968072 (human) | | 7e-12 | fibroblast growth factor 2 amount | | 4 | 122083028 | 122083029 | Human |
| 616571490 | GWAS1968073_H | fibroblast growth factor 2 amount QTL GWAS1968073 (human) | | 4e-43 | fibroblast growth factor 2 amount | | 4 | 122430398 | 122430399 | Human |
| 597992717 | GWAS1712016_H | insular cortex volume QTL GWAS1712016 (human) | | 0.000003 | insular cortex volume | | 4 | 125775267 | 125775268 | Human |
| 407363307 | GWAS1012283_H | Thyroid preparation use measurement QTL GWAS1012283 (human) | | 4e-09 | Thyroid preparation use measurement | | 4 | 122466445 | 122466446 | Human |
| 616358416 | GWAS1843131_H | gut microbiome measurement, environmental exposure measurement QTL GWAS1843131 (human) | | 4e-08 | gut microbiome measurement, environmental exposure measurement | | 4 | 123477905 | 123477906 | Human |
| 407035628 | GWAS684604_H | unipolar depression QTL GWAS684604 (human) | | 5e-12 | unipolar depression | | 4 | 122265238 | 122265239 | Human |
| 407035629 | GWAS684605_H | unipolar depression QTL GWAS684605 (human) | | 2e-09 | unipolar depression | | 4 | 130316226 | 130316227 | Human |
| 407379704 | GWAS1028680_H | atopic asthma QTL GWAS1028680 (human) | | 8e-19 | atopic asthma | | 4 | 122084379 | 122084380 | Human |
| 628401092 | GWAS2309321_H | cerebral cortex area attribute QTL GWAS2309321 (human) | | 0.0000006 | cerebral cortex area attribute | | 4 | 126616579 | 126616580 | Human |
| 598041879 | GWAS1761178_H | retinal layer thickness QTL GWAS1761178 (human) | | 2e-09 | retinal layer thickness | | 4 | 108908293 | 108908294 | Human |
| 597386535 | GWAS1482609_H | interleukin 16 measurement QTL GWAS1482609 (human) | | 0.000003 | blood interleukin-16 amount (VT:0008631) | | 4 | 112762711 | 112762712 | Human |
| 597075242 | GWAS1171316_H | endometriosis QTL GWAS1171316 (human) | | 0.000004 | uterus integrity trait (VT:0010575) | | 4 | 119706266 | 119706267 | Human |
| 407068414 | GWAS717390_H | smoking behaviour measurement QTL GWAS717390 (human) | | 2e-11 | smoking behaviour measurement | | 4 | 111500989 | 111500990 | Human |
| 597386534 | GWAS1482608_H | interleukin 16 measurement QTL GWAS1482608 (human) | | 0.0000007 | interleukin 16 measurement | | 4 | 112649483 | 112649484 | Human |
| 628843462 | GWAS2751691_H | low density lipoprotein cholesterol measurement QTL GWAS2751691 (human) | | 2e-08 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 127741641 | 127741642 | Human |
| 628843461 | GWAS2751690_H | low density lipoprotein cholesterol measurement QTL GWAS2751690 (human) | | 6e-09 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 119206905 | 119206906 | Human |
| 628843460 | GWAS2751689_H | low density lipoprotein cholesterol measurement QTL GWAS2751689 (human) | | 1e-10 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 110021121 | 110021122 | Human |
| 407379703 | GWAS1028679_H | atopic asthma QTL GWAS1028679 (human) | | 5e-16 | atopic asthma | | 4 | 122219915 | 122219916 | Human |
| 407150213 | GWAS799189_H | platelet count QTL GWAS799189 (human) | | 2e-100 | platelet count | | 4 | 110008938 | 110008939 | Human |
| 407150214 | GWAS799190_H | platelet count QTL GWAS799190 (human) | | 4e-09 | platelet count | | 4 | 119502932 | 119502933 | Human |
| 597091668 | GWAS1187742_H | facial hair thickness measurement QTL GWAS1187742 (human) | | 0.000004 | facial hair thickness measurement | | 4 | 120705958 | 120705959 | Human |
| 407150208 | GWAS799184_H | platelet count QTL GWAS799184 (human) | | 1e-12 | platelet count | | 4 | 109938024 | 109938025 | Human |
| 597402975 | GWAS1499049_H | hippocampal sclerosis of aging QTL GWAS1499049 (human) | | 0.000005 | hippocampal sclerosis of aging | | 4 | 126441942 | 126441943 | Human |
| 407150209 | GWAS799185_H | platelet count QTL GWAS799185 (human) | | 1e-21 | platelet count | | 4 | 109945564 | 109945565 | Human |
| 625828744 | GWAS2249666_H | cerebrovascular disorder, stroke QTL GWAS2249666 (human) | | 0.0000001 | brain integrity trait (VT:0010579) | | 4 | 110793263 | 110793264 | Human |
| 407150210 | GWAS799186_H | platelet count QTL GWAS799186 (human) | | 2e-35 | platelet count | | 4 | 109990751 | 109990752 | Human |
| 407068293 | GWAS717269_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS717269 (human) | | 4e-12 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 4 | 111202547 | 111202548 | Human |
| 406986372 | GWAS635348_H | intelligence QTL GWAS635348 (human) | | 6e-09 | intelligence | | 4 | 112573451 | 112573452 | Human |
| 407019146 | GWAS668122_H | electrocardiography QTL GWAS668122 (human) | | 6e-09 | electrocardiography | | 4 | 113489984 | 113489985 | Human |
| 407068297 | GWAS717273_H | alopecia QTL GWAS717273 (human) | | 0.000005 | alopecia | | 4 | 106961892 | 106961893 | Human |
| 628663218 | GWAS2571447_H | cannabis dependence QTL GWAS2571447 (human) | | 8e-11 | cannabis dependence | | 4 | 111546456 | 111546457 | Human |
| 625828742 | GWAS2249664_H | cerebrovascular disorder, stroke QTL GWAS2249664 (human) | | 2e-08 | brain integrity trait (VT:0010579) | | 4 | 110793263 | 110793264 | Human |
| 617275910 | GWAS2212686_H | saturated fatty acids to total fatty acids percentage QTL GWAS2212686 (human) | | 1e-13 | saturated fatty acids to total fatty acids percentage | | 4 | 110191454 | 110191455 | Human |
| 597501267 | GWAS1597341_H | heart failure QTL GWAS1597341 (human) | | 5e-42 | heart failure | | 4 | 110787848 | 110787849 | Human |
| 597435731 | GWAS1531805_H | Beta blocking agent use measurement QTL GWAS1531805 (human) | | 1e-12 | Beta blocking agent use measurement | | 4 | 110789013 | 110789014 | Human |
| 407084684 | GWAS733660_H | Ischemic stroke QTL GWAS733660 (human) | | 1e-15 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 597501266 | GWAS1597340_H | heart failure QTL GWAS1597340 (human) | | 5e-14 | heart failure | | 4 | 110927114 | 110927115 | Human |
| 628794293 | GWAS2702522_H | age at first sexual intercourse measurement QTL GWAS2702522 (human) | | 4e-16 | sexual interaction trait (VT:0002566) | | 4 | 111582716 | 111582717 | Human |
| 597189961 | GWAS1286035_H | systemic lupus erythematosus QTL GWAS1286035 (human) | | 9e-12 | systemic lupus erythematosus | | 4 | 122089432 | 122089433 | Human |
| 628646826 | GWAS2555055_H | gut microbiome measurement, breastfeeding duration QTL GWAS2555055 (human) | | 0.0000005 | lactation duration (VT:1000653) | | 4 | 122820505 | 122820506 | Human |
| 628892584 | GWAS2800813_H | insomnia QTL GWAS2800813 (human) | | 1e-09 | sleep behavior trait (VT:0001501) | | 4 | 111871413 | 111871414 | Human |
| 628892585 | GWAS2800814_H | insomnia QTL GWAS2800814 (human) | | 2e-12 | sleep behavior trait (VT:0001501) | | 4 | 111901237 | 111901238 | Human |
| 406986388 | GWAS635364_H | intelligence QTL GWAS635364 (human) | | 6e-09 | intelligence | | 4 | 112699050 | 112699051 | Human |
| 628958122 | GWAS2866351_H | erythrocyte volume QTL GWAS2866351 (human) | | 6e-33 | erythrocyte volume | | 4 | 121854912 | 121854913 | Human |
| 616981021 | GWAS1998520_H | brain attribute, neuroimaging measurement QTL GWAS1998520 (human) | | 3e-08 | nervous system morphology trait (VT:0003632) | | 4 | 112509596 | 112509597 | Human |
| 407281306 | GWAS930282_H | small vessel stroke QTL GWAS930282 (human) | | 0.000008 | small vessel stroke | | 4 | 125155988 | 125155989 | Human |
| 597353798 | GWAS1449872_H | bone density QTL GWAS1449872 (human) | | 4e-08 | bone density | | 4 | 131155333 | 131155334 | Human |
| 628401065 | GWAS2309294_H | erythrocyte volume QTL GWAS2309294 (human) | | 8e-26 | erythrocyte volume | | 4 | 127647811 | 127647812 | Human |
| 407084707 | GWAS733683_H | atrial fibrillation QTL GWAS733683 (human) | | 3e-08 | atrial fibrillation | | 4 | 110742777 | 110742778 | Human |
| 628401040 | GWAS2309269_H | cerebral cortex area attribute QTL GWAS2309269 (human) | | 4e-10 | cerebral cortex area attribute | | 4 | 112495627 | 112495628 | Human |
| 597992768 | GWAS1712067_H | rostral anterior cingulate cortex volume QTL GWAS1712067 (human) | | 0.000009 | rostral anterior cingulate cortex volume | | 4 | 129254856 | 129254857 | Human |
| 598025536 | GWAS1744835_H | body height QTL GWAS1744835 (human) | | 3e-08 | body height | | 4 | 111755929 | 111755930 | Human |
| 597992780 | GWAS1712079_H | posterior cingulate cortex volume QTL GWAS1712079 (human) | | 0.000004 | posterior cingulate cortex volume | | 4 | 115248533 | 115248534 | Human |
| 407314093 | GWAS963069_H | JT interval QTL GWAS963069 (human) | | 2e-08 | JT interval | | 4 | 113464520 | 113464521 | Human |
| 597828936 | GWAS1696327_H | cystatin C measurement QTL GWAS1696327 (human) | | 3e-12 | cystatin C measurement | | 4 | 127420965 | 127420966 | Human |
| 597992779 | GWAS1712078_H | posterior cingulate cortex volume QTL GWAS1712078 (human) | | 0.000008 | posterior cingulate cortex volume | | 4 | 115129051 | 115129052 | Human |
| 407002813 | GWAS651789_H | sex hormone-binding globulin measurement QTL GWAS651789 (human) | | 6e-16 | sex hormone-binding globulin measurement | | 4 | 128110633 | 128110634 | Human |
| 628482679 | GWAS2390908_H | worry measurement QTL GWAS2390908 (human) | | 4e-08 | emotion/affect behavior trait (VT:0002572) | | 4 | 118048732 | 118048733 | Human |
| 597337241 | GWAS1433315_H | breast density QTL GWAS1433315 (human) | | 0.000006 | breast density | | 4 | 121949054 | 121949055 | Human |
| 626451026 | GWAS2264959_H | bilirubin measurement QTL GWAS2264959 (human) | | 1e-14 | bilirubin measurement | | 4 | 123882996 | 123882997 | Human |
| 597206160 | GWAS1302234_H | hemoglobin measurement QTL GWAS1302234 (human) | | 0.000009 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 120934416 | 120934417 | Human |
| 617194432 | GWAS2174872_H | dilated cardiomyopathy QTL GWAS2174872 (human) | | 0.0000001 | dilated cardiomyopathy | | 4 | 110796911 | 110796912 | Human |
| 628433532 | GWAS2341761_H | brain connectivity attribute QTL GWAS2341761 (human) | | 2e-11 | brain connectivity attribute | | 4 | 125825074 | 125825075 | Human |
| 597206162 | GWAS1302236_H | hemoglobin measurement QTL GWAS1302236 (human) | | 0.000008 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 120850980 | 120850981 | Human |
| 628925047 | GWAS2833276_H | body mass index QTL GWAS2833276 (human) | | 4e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112389479 | 112389480 | Human |
| 628712044 | GWAS2620273_H | level of BPI fold-containing family B member 2 in blood QTL GWAS2620273 (human) | | 2e-38 | level of BPI fold-containing family B member 2 in blood | | 4 | 109603883 | 109603884 | Human |
| 616555433 | GWAS1952016_H | body height QTL GWAS1952016 (human) | | 1e-12 | body height | | 4 | 108362858 | 108362859 | Human |
| 407166812 | GWAS815788_H | factor XI measurement, Ischemic stroke QTL GWAS815788 (human) | | 2e-16 | factor XI measurement, Ischemic stroke | | 4 | 110775495 | 110775496 | Human |
| 406986590 | GWAS635566_H | drug allergy, trait in response to platinum QTL GWAS635566 (human) | | 0.000004 | drug allergy, trait in response to platinum | | 4 | 113445575 | 113445576 | Human |
| 616965080 | GWAS1982579_H | Ischemic stroke, cardiac embolism QTL GWAS1982579 (human) | | 3e-32 | Ischemic stroke, cardiac embolism | | 4 | 110789013 | 110789014 | Human |
| 628548201 | GWAS2456430_H | lymphocyte percentage of leukocytes QTL GWAS2456430 (human) | | 3e-21 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 4 | 112142370 | 112142371 | Human |
| 628449877 | GWAS2358106_H | mathematical ability QTL GWAS2358106 (human) | | 4e-08 | cognitive behavior trait (VT:0010450) | | 4 | 111950250 | 111950251 | Human |
| 617030630 | GWAS2048129_H | urate measurement QTL GWAS2048129 (human) | | 6e-09 | urate measurement | | 4 | 127147534 | 127147535 | Human |
| 628449879 | GWAS2358108_H | mathematical ability QTL GWAS2358108 (human) | | 2e-14 | cognitive behavior trait (VT:0010450) | | 4 | 128819435 | 128819436 | Human |
| 625828462 | GWAS2249384_H | stroke QTL GWAS2249384 (human) | | 0.000008 | brain integrity trait (VT:0010579) | | 4 | 110793263 | 110793264 | Human |
| 628826712 | GWAS2734941_H | cardiac troponin I measurement QTL GWAS2734941 (human) | | 0.000006 | cardiac troponin I measurement | blood troponin level (CMO:0001283) | 4 | 110926834 | 110926835 | Human |
| 628449878 | GWAS2358107_H | mathematical ability QTL GWAS2358107 (human) | | 2e-09 | cognitive behavior trait (VT:0010450) | | 4 | 115132583 | 115132584 | Human |
| 616539034 | GWAS1935617_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1935617 (human) | | 4e-24 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 107844119 | 107844120 | Human |
| 617014240 | GWAS2031739_H | Parkinson disease QTL GWAS2031739 (human) | | 0.0000005 | Parkinson disease | | 4 | 113422713 | 113422714 | Human |
| 617128930 | GWAS2146429_H | encounter with health service QTL GWAS2146429 (human) | | 9e-14 | encounter with health service | | 4 | 110796911 | 110796912 | Human |
| 628695634 | GWAS2603863_H | triglyceride measurement QTL GWAS2603863 (human) | | 3e-20 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109603883 | 109603884 | Human |
| 407035753 | GWAS684729_H | body mass index QTL GWAS684729 (human) | | 4e-12 | body mass index | | 4 | 129805678 | 129805679 | Human |
| 628974157 | GWAS2882386_H | platelet count QTL GWAS2882386 (human) | | 4e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109916511 | 109916512 | Human |
| 617145336 | GWAS2162835_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2162835 (human) | | 5e-13 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 128282916 | 128282917 | Human |
| 617210876 | GWAS2191316_H | level of sphingomyelin phosphodiesterase in blood QTL GWAS2191316 (human) | | 4e-24 | level of sphingomyelin phosphodiesterase in blood | | 4 | 109717668 | 109717669 | Human |
| 407052150 | GWAS701126_H | eosinophil percentage of leukocytes QTL GWAS701126 (human) | | 6e-21 | eosinophil percentage of leukocytes | | 4 | 122111201 | 122111202 | Human |
| 628728399 | GWAS2636628_H | health trait QTL GWAS2636628 (human) | | 9e-11 | health trait | | 4 | 118084947 | 118084948 | Human |
| 628646479 | GWAS2554708_H | height growth attribute, age at assessment QTL GWAS2554708 (human) | | 0.000007 | height growth attribute, age at assessment | | 4 | 108119392 | 108119393 | Human |
| 628728398 | GWAS2636627_H | health trait QTL GWAS2636627 (human) | | 1e-08 | health trait | | 4 | 108552413 | 108552414 | Human |
| 628793922 | GWAS2702151_H | smoking cessation QTL GWAS2702151 (human) | | 9e-13 | smoking cessation | | 4 | 112122274 | 112122275 | Human |
| 628646466 | GWAS2554695_H | height growth attribute, age at assessment QTL GWAS2554695 (human) | | 0.0000005 | height growth attribute, age at assessment | | 4 | 108011006 | 108011007 | Human |
| 617260016 | GWAS2196792_H | fatty acid amount QTL GWAS2196792 (human) | | 3e-08 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 628793921 | GWAS2702150_H | smoking cessation QTL GWAS2702150 (human) | | 1e-10 | smoking cessation | | 4 | 112087702 | 112087703 | Human |
| 407232261 | GWAS881237_H | depressive symptom measurement QTL GWAS881237 (human) | | 4e-09 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
| 597353688 | GWAS1449762_H | body height QTL GWAS1449762 (human) | | 3e-42 | body height | | 4 | 121840699 | 121840700 | Human |
| 407150343 | GWAS799319_H | non-small cell lung carcinoma QTL GWAS799319 (human) | | 0.000004 | non-small cell lung carcinoma | | 4 | 121873960 | 121873961 | Human |
| 597353689 | GWAS1449763_H | body height QTL GWAS1449763 (human) | | 5e-10 | body height | | 4 | 128751543 | 128751544 | Human |
| 597451992 | GWAS1548066_H | diastolic blood pressure QTL GWAS1548066 (human) | | 2e-12 | diastolic blood pressure | | 4 | 108096372 | 108096373 | Human |
| 597451993 | GWAS1548067_H | diastolic blood pressure QTL GWAS1548067 (human) | | 2e-13 | diastolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 597451994 | GWAS1548068_H | diastolic blood pressure QTL GWAS1548068 (human) | | 2e-13 | diastolic blood pressure | | 4 | 110400371 | 110400372 | Human |
| 628744753 | GWAS2652982_H | frailty measurement QTL GWAS2652982 (human) | | 1e-16 | frailty measurement | | 4 | 110466703 | 110466704 | Human |
| 628728369 | GWAS2636598_H | atrial fibrillation QTL GWAS2636598 (human) | | 2e-10 | atrial fibrillation | | 4 | 121839813 | 121839814 | Human |
| 628957749 | GWAS2865978_H | mean corpuscular hemoglobin concentration QTL GWAS2865978 (human) | | 4e-41 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121854912 | 121854913 | Human |
| 628433468 | GWAS2341697_H | brain connectivity attribute QTL GWAS2341697 (human) | | 6e-11 | brain connectivity attribute | | 4 | 125820645 | 125820646 | Human |
| 407101193 | GWAS750169_H | eosinophil count QTL GWAS750169 (human) | | 1e-23 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 628728371 | GWAS2636600_H | atrial fibrillation QTL GWAS2636600 (human) | | 4e-10 | atrial fibrillation | | 4 | 128545263 | 128545264 | Human |
| 628744754 | GWAS2652983_H | frailty measurement QTL GWAS2652983 (human) | | 5e-09 | frailty measurement | | 4 | 119228681 | 119228682 | Human |
| 628728370 | GWAS2636599_H | atrial fibrillation QTL GWAS2636599 (human) | | 1e-10 | atrial fibrillation | | 4 | 122917603 | 122917604 | Human |
| 597337302 | GWAS1433376_H | Ischemic stroke QTL GWAS1433376 (human) | | 5e-09 | Ischemic stroke | | 4 | 110744760 | 110744761 | Human |
| 597353686 | GWAS1449760_H | body height QTL GWAS1449760 (human) | | 3e-15 | body height | | 4 | 112381201 | 112381202 | Human |
| 597353687 | GWAS1449761_H | body height QTL GWAS1449761 (human) | | 3e-14 | body height | | 4 | 112431472 | 112431473 | Human |
| 628728372 | GWAS2636601_H | atrial fibrillation QTL GWAS2636601 (human) | | 4e-08 | atrial fibrillation | | 4 | 129810129 | 129810130 | Human |
| 596960452 | GWAS1079971_H | glomerular filtration rate QTL GWAS1079971 (human) | | 3e-14 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 625828380 | GWAS2249302_H | allergic conjunctivitis QTL GWAS2249302 (human) | | 2e-08 | allergic conjunctivitis | | 4 | 114728111 | 114728112 | Human |
| 596960450 | GWAS1079969_H | glomerular filtration rate QTL GWAS1079969 (human) | | 3e-19 | glomerular filtration rate | | 4 | 108783751 | 108783752 | Human |
| 597451978 | GWAS1548052_H | anti-Epstein Barr virus antibody measurement QTL GWAS1548052 (human) | | 0.0000008 | anti-Epstein Barr virus antibody measurement | | 4 | 110793733 | 110793734 | Human |
| 597370061 | GWAS1466135_H | obesity QTL GWAS1466135 (human) | | 0.0000002 | obesity | | 4 | 129810129 | 129810130 | Human |
| 596960451 | GWAS1079970_H | glomerular filtration rate QTL GWAS1079970 (human) | | 4e-09 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 628482604 | GWAS2390833_H | schizophrenia QTL GWAS2390833 (human) | | 0.000003 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
| 628630049 | GWAS2538278_H | gut microbiome measurement, breastfeeding duration QTL GWAS2538278 (human) | | 3e-13 | lactation duration (VT:1000653) | | 4 | 121369093 | 121369094 | Human |
| 628695589 | GWAS2603818_H | bilirubin measurement QTL GWAS2603818 (human) | | 7e-11 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 123849638 | 123849639 | Human |
| 616997798 | GWAS2015297_H | cancer QTL GWAS2015297 (human) | | 0.0000007 | cancer | | 4 | 106909104 | 106909105 | Human |
| 628843035 | GWAS2751264_H | complement factor I measurement QTL GWAS2751264 (human) | | 5e-12 | complement protein amount (VT:0010033) | | 4 | 109799365 | 109799366 | Human |
| 628498966 | GWAS2407195_H | alcohol consumption quality QTL GWAS2407195 (human) | | 2e-08 | alcohol consumption quality | | 4 | 112674713 | 112674714 | Human |
| 628843034 | GWAS2751263_H | complement factor I measurement QTL GWAS2751263 (human) | | 4e-20 | complement protein amount (VT:0010033) | | 4 | 109737911 | 109737912 | Human |
| 616997799 | GWAS2015298_H | cancer QTL GWAS2015298 (human) | | 0.0000006 | cancer | | 4 | 122660080 | 122660081 | Human |
| 628843033 | GWAS2751262_H | complement factor I measurement QTL GWAS2751262 (human) | | 7e-21 | complement protein amount (VT:0010033) | | 4 | 109737700 | 109737701 | Human |
| 597468409 | GWAS1564483_H | breast carcinoma QTL GWAS1564483 (human) | | 1e-09 | breast carcinoma | | 4 | 125922349 | 125922350 | Human |
| 597075185 | GWAS1171259_H | common carotid intimal medial thickness QTL GWAS1171259 (human) | | 0.0000009 | common carotid intimal medial thickness | | 4 | 109159865 | 109159866 | Human |
| 617063328 | GWAS2080827_H | body height QTL GWAS2080827 (human) | | 7e-09 | body height | | 4 | 121772597 | 121772598 | Human |
| 616981409 | GWAS1998908_H | protein measurement QTL GWAS1998908 (human) | | 7e-09 | protein amount (VT:0010120) | | 4 | 132286668 | 132286669 | Human |
| 597026045 | GWAS1122119_H | posterior cingulate cortex volume measurement QTL GWAS1122119 (human) | | 0.000008 | posterior cingulate cortex volume measurement | | 4 | 115129051 | 115129052 | Human |
| 597026046 | GWAS1122120_H | posterior cingulate cortex volume measurement QTL GWAS1122120 (human) | | 0.000004 | posterior cingulate cortex volume measurement | | 4 | 115248533 | 115248534 | Human |
| 597026040 | GWAS1122114_H | postcentral gyrus volume measurement QTL GWAS1122114 (human) | | 0.000003 | postcentral gyrus volume measurement | | 4 | 114960671 | 114960672 | Human |
| 406986540 | GWAS635516_H | blood protein measurement QTL GWAS635516 (human) | | 2e-83 | blood protein measurement | | 4 | 106943827 | 106943828 | Human |
| 407379750 | GWAS1028726_H | anxiety QTL GWAS1028726 (human) | | 7e-09 | anxiety | | 4 | 118015036 | 118015037 | Human |
| 596976891 | GWAS1096410_H | Crohn's disease QTL GWAS1096410 (human) | | 2e-16 | Crohn's disease | | 4 | 122523884 | 122523885 | Human |
| 598156488 | GWAS1835558_H | heart failure QTL GWAS1835558 (human) | | 3e-55 | heart failure | | 4 | 110776497 | 110776498 | Human |
| 596976868 | GWAS1096387_H | ulcerative colitis QTL GWAS1096387 (human) | | 2e-09 | ulcerative colitis | | 4 | 122523884 | 122523885 | Human |
| 406937392 | GWAS586368_H | breast density QTL GWAS586368 (human) | | 0.000001 | breast density | | 4 | 124653133 | 124653134 | Human |
| 407150390 | GWAS799366_H | BMI-adjusted waist-hip ratio QTL GWAS799366 (human) | | 9e-12 | waist-hip ratio | | 4 | 121705035 | 121705036 | Human |
| 628515329 | GWAS2423558_H | anthropometric measurement QTL GWAS2423558 (human) | | 3e-10 | body size trait (VT:0100005) | body morphological measurement (CMO:0000021) | 4 | 108565997 | 108565998 | Human |
| 628777472 | GWAS2685701_H | blood protein amount QTL GWAS2685701 (human) | | 8e-13 | blood protein amount | | 4 | 122625127 | 122625128 | Human |
| 598041823 | GWAS1761122_H | body mass index QTL GWAS1761122 (human) | | 0.000002 | body mass index | | 4 | 132108281 | 132108282 | Human |
| 628630266 | GWAS2538495_H | gut microbiome measurement, breastfeeding duration QTL GWAS2538495 (human) | | 1e-09 | lactation duration (VT:1000653) | | 4 | 107900280 | 107900281 | Human |
| 628728573 | GWAS2636802_H | diastolic blood pressure QTL GWAS2636802 (human) | | 2e-21 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110414448 | 110414449 | Human |
| 616522554 | GWAS1919137_H | erythrocyte volume QTL GWAS1919137 (human) | | 2e-14 | erythrocyte volume | | 4 | 110066281 | 110066282 | Human |
| 628728574 | GWAS2636803_H | diastolic blood pressure QTL GWAS2636803 (human) | | 1e-08 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119037654 | 119037655 | Human |
| 597402652 | GWAS1498726_H | ulcerative colitis QTL GWAS1498726 (human) | | 5e-10 | intestine integrity trait (VT:0010554) | | 4 | 122240464 | 122240465 | Human |
| 597074971 | GWAS1171045_H | coronary artery disease QTL GWAS1171045 (human) | | 1e-08 | coronary artery integrity trait (VT:0010746) | | 4 | 119988346 | 119988347 | Human |
| 597091353 | GWAS1187427_H | seasonal gut microbiome measurement QTL GWAS1187427 (human) | | 0.000007 | seasonal gut microbiome measurement | | 4 | 108464247 | 108464248 | Human |
| 628777708 | GWAS2685937_H | blood protein amount QTL GWAS2685937 (human) | | 3e-12 | blood protein amount | | 4 | 119503425 | 119503426 | Human |
| 407330781 | GWAS979757_H | schizophrenia QTL GWAS979757 (human) | | 0.000002 | schizophrenia | | 4 | 122467361 | 122467362 | Human |
| 407232473 | GWAS881449_H | bone density QTL GWAS881449 (human) | | 9e-74 | bone density | | 4 | 116630743 | 116630744 | Human |
| 597140490 | GWAS1236564_H | heart failure QTL GWAS1236564 (human) | | 9e-12 | heart failure | | 4 | 110665822 | 110665823 | Human |
| 597320711 | GWAS1416785_H | body surface area QTL GWAS1416785 (human) | | 3e-11 | body surface area | | 4 | 122906887 | 122906888 | Human |
| 617079655 | GWAS2097154_H | protein measurement QTL GWAS2097154 (human) | | 7e-1675 | protein measurement | | 4 | 119342003 | 119342004 | Human |
| 617030502 | GWAS2048001_H | vital capacity QTL GWAS2048001 (human) | | 8e-11 | vital capacity | | 4 | 124209285 | 124209286 | Human |
| 597337144 | GWAS1433218_H | COVID-19, mortality QTL GWAS1433218 (human) | | 0.000002 | COVID-19, mortality | | 4 | 127021337 | 127021338 | Human |
| 597435448 | GWAS1531522_H | lipid measurement QTL GWAS1531522 (human) | | 0.000005 | lipid measurement | | 4 | 126630119 | 126630120 | Human |
| 628728540 | GWAS2636769_H | coronary artery calcification QTL GWAS2636769 (human) | | 0.0000002 | coronary artery integrity trait (VT:0010746) | | 4 | 128541212 | 128541213 | Human |
| 407003119 | GWAS652095_H | lymphocyte percentage of leukocytes QTL GWAS652095 (human) | | 3e-21 | lymphocyte percentage of leukocytes | | 4 | 112190016 | 112190017 | Human |
| 598156298 | GWAS1835368_H | heart failure QTL GWAS1835368 (human) | | 1e-13 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 597206069 | GWAS1302143_H | type 2 diabetes mellitus QTL GWAS1302143 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 122911999 | 122912000 | Human |
| 617079656 | GWAS2097155_H | protein measurement QTL GWAS2097155 (human) | | 1e-146 | protein measurement | | 4 | 119446728 | 119446729 | Human |
| 598008848 | GWAS1728147_H | ANGPT1/EGF protein level ratio in blood QTL GWAS1728147 (human) | | 6e-205 | ANGPT1/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 616964976 | GWAS1982475_H | triacylglycerol 54:1 measurement QTL GWAS1982475 (human) | | 0.000001 | blood triglyceride amount (VT:0002644) | | 4 | 122671701 | 122671702 | Human |
| 617128819 | GWAS2146318_H | platelet count QTL GWAS2146318 (human) | | 3e-14 | platelet count | | 4 | 123837618 | 123837619 | Human |
| 597287973 | GWAS1384047_H | coronary artery disease QTL GWAS1384047 (human) | | 2e-09 | coronary artery disease | | 4 | 109616095 | 109616096 | Human |
| 597337126 | GWAS1433200_H | cardioembolic stroke QTL GWAS1433200 (human) | | 0.0000009 | cardioembolic stroke | | 4 | 110778170 | 110778171 | Human |
| 628908737 | GWAS2816966_H | osteoarthritis QTL GWAS2816966 (human) | | 1e-08 | osteoarthritis | | 4 | 129335647 | 129335648 | Human |
| 407199739 | GWAS848715_H | wellbeing measurement, alcohol consumption measurement QTL GWAS848715 (human) | | 3e-08 | wellbeing measurement, alcohol consumption measurement | | 4 | 121662557 | 121662558 | Human |
| 407199738 | GWAS848714_H | wellbeing measurement, alcohol consumption measurement QTL GWAS848714 (human) | | 2e-08 | wellbeing measurement, alcohol consumption measurement | | 4 | 117309754 | 117309755 | Human |
| 407150468 | GWAS799444_H | breast carcinoma QTL GWAS799444 (human) | | 7e-10 | breast carcinoma | | 4 | 125922349 | 125922350 | Human |
| 628679354 | GWAS2587583_H | aspartate measurement QTL GWAS2587583 (human) | | 4e-18 | blood L-aspartic acid amount (VT:0010969) | | 4 | 110414566 | 110414567 | Human |
| 628679355 | GWAS2587584_H | aspartate measurement QTL GWAS2587584 (human) | | 9e-31 | blood L-aspartic acid amount (VT:0010969) | | 4 | 110510288 | 110510289 | Human |
| 598090851 | GWAS1810150_H | glomerular filtration rate QTL GWAS1810150 (human) | | 1e-13 | glomerular filtration rate | | 4 | 127272519 | 127272520 | Human |
| 407347072 | GWAS996048_H | diastolic blood pressure QTL GWAS996048 (human) | | 1e-12 | diastolic blood pressure | | 4 | 110430068 | 110430069 | Human |
| 628810429 | GWAS2718658_H | Antithrombotic agent use measurement QTL GWAS2718658 (human) | | 4e-20 | Antithrombotic agent use measurement | | 4 | 110784139 | 110784140 | Human |
| 407379855 | GWAS1028831_H | Abnormality of refraction QTL GWAS1028831 (human) | | 1e-08 | Abnormality of refraction | | 4 | 111208199 | 111208200 | Human |
| 597042267 | GWAS1138341_H | hemoglobin measurement QTL GWAS1138341 (human) | | 3e-09 | hemoglobin measurement | | 4 | 114647874 | 114647875 | Human |
| 406953870 | GWAS602846_H | platelet crit QTL GWAS602846 (human) | | 6e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 119559078 | 119559079 | Human |
| 628630184 | GWAS2538413_H | gut microbiome measurement, breastfeeding duration QTL GWAS2538413 (human) | | 5e-08 | lactation duration (VT:1000653) | | 4 | 108743511 | 108743512 | Human |
| 406986646 | GWAS635622_H | mean corpuscular hemoglobin concentration QTL GWAS635622 (human) | | 6e-14 | mean corpuscular hemoglobin concentration | | 4 | 109944312 | 109944313 | Human |
| 628613795 | GWAS2522024_H | Antithrombotic agent use measurement QTL GWAS2522024 (human) | | 6e-19 | Antithrombotic agent use measurement | | 4 | 110791080 | 110791081 | Human |
| 597075010 | GWAS1171084_H | body mass index QTL GWAS1171084 (human) | | 1e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112392830 | 112392831 | Human |
| 597402703 | GWAS1498777_H | Erythema nodosum QTL GWAS1498777 (human) | | 5e-08 | Erythema nodosum | | 4 | 117413463 | 117413464 | Human |
| 406937497 | GWAS586473_H | hip bone mineral density QTL GWAS586473 (human) | | 0.000006 | hip bone mineral density | | 4 | 128365448 | 128365449 | Human |
| 597222465 | GWAS1318539_H | spleen volume QTL GWAS1318539 (human) | | 4e-14 | spleen volume | | 4 | 109912954 | 109912955 | Human |
| 617095955 | GWAS2113454_H | Red cell distribution width QTL GWAS2113454 (human) | | 2e-21 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 597582915 | GWAS1639775_H | body height QTL GWAS1639775 (human) | | 8e-23 | body height | | 4 | 108536277 | 108536278 | Human |
| 597042248 | GWAS1138322_H | response to diuretic, low density lipoprotein cholesterol measurement QTL GWAS1138322 (human) | | 0.0000002 | response to diuretic, low density lipoprotein cholesterol measurement | | 4 | 107408461 | 107408462 | Human |
| 407183259 | GWAS832235_H | leukocyte count QTL GWAS832235 (human) | | 1e-10 | leukocyte count | | 4 | 109996470 | 109996471 | Human |
| 616358754 | GWAS1843469_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS1843469 (human) | | 5e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 116882110 | 116882111 | Human |
| 407330724 | GWAS979700_H | rheumatoid arthritis QTL GWAS979700 (human) | | 5e-14 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
| 407183265 | GWAS832241_H | blood protein measurement QTL GWAS832241 (human) | | 6e-54 | blood protein measurement | | 4 | 118376502 | 118376503 | Human |
| 597042290 | GWAS1138364_H | triglyceride measurement, response to diuretic QTL GWAS1138364 (human) | | 6e-08 | triglyceride measurement, response to diuretic | | 4 | 129379460 | 129379461 | Human |
| 407052198 | GWAS701174_H | metabolite measurement QTL GWAS701174 (human) | | 7e-13 | metabolite measurement | | 4 | 110413574 | 110413575 | Human |
| 598090816 | GWAS1810115_H | glomerular filtration rate QTL GWAS1810115 (human) | | 5e-09 | glomerular filtration rate | | 4 | 125483011 | 125483012 | Human |
| 598041666 | GWAS1760965_H | retinal layer thickness QTL GWAS1760965 (human) | | 1e-17 | retinal layer thickness | | 4 | 109019365 | 109019366 | Human |
| 617014058 | GWAS2031557_H | waist-hip ratio QTL GWAS2031557 (human) | | 8e-12 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 124299553 | 124299554 | Human |
| 628990611 | GWAS2898840_H | bile duct disorder QTL GWAS2898840 (human) | | 4e-11 | bile duct disorder | | 4 | 129611431 | 129611432 | Human |
| 628810378 | GWAS2718607_H | neutrophil percentage of leukocytes QTL GWAS2718607 (human) | | 8e-16 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 4 | 122702286 | 122702287 | Human |
| 598156374 | GWAS1835444_H | osteoarthritis, hip, osteoarthritis, knee QTL GWAS1835444 (human) | | 5e-10 | osteoarthritis, hip, osteoarthritis, knee | | 4 | 120722084 | 120722085 | Human |
| 617259832 | GWAS2196608_H | fatty acid amount QTL GWAS2196608 (human) | | 3e-12 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 617095995 | GWAS2113494_H | hypertension QTL GWAS2113494 (human) | | 3e-12 | hypertension | | 4 | 110510288 | 110510289 | Human |
| 616981297 | GWAS1998796_H | cardiac arrhythmia QTL GWAS1998796 (human) | | 1e-187 | heart integrity trait (VT:0010757) | | 4 | 110795357 | 110795358 | Human |
| 597517415 | GWAS1613489_H | neuroimaging measurement QTL GWAS1613489 (human) | | 0.000001 | neuroimaging measurement | | 4 | 120211752 | 120211753 | Human |
| 597517414 | GWAS1613488_H | neuroimaging measurement QTL GWAS1613488 (human) | | 6e-09 | neuroimaging measurement | | 4 | 120199264 | 120199265 | Human |
| 628646531 | GWAS2554760_H | gut microbiome measurement, breastfeeding duration QTL GWAS2554760 (human) | | 2e-09 | lactation duration (VT:1000653) | | 4 | 129911920 | 129911921 | Human |
| 617259831 | GWAS2196607_H | fatty acid amount QTL GWAS2196607 (human) | | 7e-10 | fatty acid amount | | 4 | 109174464 | 109174465 | Human |
| 628662917 | GWAS2571146_H | atopic eczema QTL GWAS2571146 (human) | | 1e-62 | atopic eczema | | 4 | 122465565 | 122465566 | Human |
| 628960637 | GWAS2868866_H | monocyte count QTL GWAS2868866 (human) | | 3e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109927496 | 109927497 | Human |
| 407244871 | GWAS893847_H | neutrophil-to-lymphocyte ratio QTL GWAS893847 (human) | | 1e-15 | neutrophil-to-lymphocyte ratio | | 4 | 112194095 | 112194096 | Human |
| 597519257 | GWAS1615331_H | serum gamma-glutamyl transferase measurement QTL GWAS1615331 (human) | | 7e-13 | serum gamma-glutamyl transferase measurement | | 4 | 111793842 | 111793843 | Human |
| 628698493 | GWAS2606722_H | cortical thickness QTL GWAS2606722 (human) | | 6e-18 | cerebral cortex morphology trait (VT:0000788) | | 4 | 118393759 | 118393760 | Human |
| 628829567 | GWAS2737796_H | body height QTL GWAS2737796 (human) | | 5e-14 | body height | | 4 | 119501252 | 119501253 | Human |
| 616524986 | GWAS1921569_H | serum creatinine amount QTL GWAS1921569 (human) | | 5e-13 | serum creatinine amount | | 4 | 127312122 | 127312123 | Human |
| 628370812 | GWAS2291656_H | fibroblast growth factor 2 level QTL GWAS2291656 (human) | | 4e-11 | fibroblast growth factor 2 level | | 4 | 120649137 | 120649138 | Human |
| 407015496 | GWAS664472_H | Beta blocking agent use measurement QTL GWAS664472 (human) | | 5e-09 | Beta blocking agent use measurement | | 4 | 110743002 | 110743003 | Human |
| 628567421 | GWAS2475650_H | sleep quality QTL GWAS2475650 (human) | | 0.000006 | sleep quality | | 4 | 118160921 | 118160922 | Human |
| 628370814 | GWAS2291658_H | fibroblast growth factor 2 level QTL GWAS2291658 (human) | | 8e-09 | fibroblast growth factor 2 level | | 4 | 121394587 | 121394588 | Human |
| 597109660 | GWAS1205734_H | Red cell distribution width QTL GWAS1205734 (human) | | 3e-09 | erythrocyte size trait (VT:0000248) | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 122438414 | 122438415 | Human |
| 628370815 | GWAS2291659_H | fibroblast growth factor 2 level QTL GWAS2291659 (human) | | 3e-08 | fibroblast growth factor 2 level | | 4 | 123380906 | 123380907 | Human |
| 598141867 | GWAS1828595_H | bone tissue density QTL GWAS1828595 (human) | | 2e-44 | bone tissue density | | 4 | 111086102 | 111086103 | Human |
| 616492211 | GWAS1888794_H | ceramide amount QTL GWAS1888794 (human) | | 2e-25 | ceramide amount | | 4 | 114549176 | 114549177 | Human |
| 616524976 | GWAS1921559_H | epidermal growth factor measurement QTL GWAS1921559 (human) | | 4e-18 | epidermal growth factor measurement | | 4 | 110012720 | 110012721 | Human |
| 597470092 | GWAS1566166_H | chronotype measurement QTL GWAS1566166 (human) | | 4e-09 | chronotype measurement | | 4 | 117394404 | 117394405 | Human |
| 628977000 | GWAS2885229_H | fatty acid amount QTL GWAS2885229 (human) | | 6e-09 | fatty acid amount | | 4 | 109657070 | 109657071 | Human |
| 628698479 | GWAS2606708_H | cortical thickness QTL GWAS2606708 (human) | | 6e-19 | cerebral cortex morphology trait (VT:0000788) | | 4 | 112512138 | 112512139 | Human |
| 407015514 | GWAS664490_H | Calcium channel blocker use measurement QTL GWAS664490 (human) | | 6e-12 | Calcium channel blocker use measurement | | 4 | 110467945 | 110467946 | Human |
| 406966361 | GWAS615337_H | smoking initiation QTL GWAS615337 (human) | | 2e-11 | smoking initiation | | 4 | 111546456 | 111546457 | Human |
| 617016542 | GWAS2034041_H | BMI-adjusted waist circumference QTL GWAS2034041 (human) | | 4e-09 | BMI-adjusted waist circumference | | 4 | 119805780 | 119805781 | Human |
| 596978572 | GWAS1098091_H | body height QTL GWAS1098091 (human) | | 3e-28 | body height | | 4 | 108535458 | 108535459 | Human |
| 617016540 | GWAS2034039_H | BMI-adjusted waist circumference QTL GWAS2034039 (human) | | 2e-14 | BMI-adjusted waist circumference | | 4 | 119674620 | 119674621 | Human |
| 617016541 | GWAS2034040_H | BMI-adjusted waist circumference QTL GWAS2034040 (human) | | 5e-10 | BMI-adjusted waist circumference | | 4 | 119761309 | 119761310 | Human |
| 597191555 | GWAS1287629_H | atopic eczema QTL GWAS1287629 (human) | | 6e-11 | atopic eczema | | 4 | 122111486 | 122111487 | Human |
| 616361122 | GWAS1845837_H | gut microbiome measurement, environmental exposure measurement QTL GWAS1845837 (human) | | 3e-08 | gut microbiome measurement, environmental exposure measurement | | 4 | 120561055 | 120561056 | Human |
| 406917219 | GWAS566195_H | serum IgG glycosylation measurement QTL GWAS566195 (human) | | 0.000005 | serum IgG glycosylation measurement | | 4 | 127545545 | 127545546 | Human |
| 597404607 | GWAS1500681_H | corneal topography QTL GWAS1500681 (human) | | 8e-09 | corneal topography | | 4 | 127192269 | 127192270 | Human |
| 597273521 | GWAS1369595_H | schizophrenia QTL GWAS1369595 (human) | | 0.000002 | schizophrenia | | 4 | 113059651 | 113059652 | Human |
| 616492182 | GWAS1888765_H | ceramide amount QTL GWAS1888765 (human) | | 2e-08 | ceramide amount | | 4 | 129692156 | 129692157 | Human |
| 407228527 | GWAS877503_H | allergic disease QTL GWAS877503 (human) | | 5e-14 | allergic disease | | 4 | 122532955 | 122532959 | Human |
| 407228526 | GWAS877502_H | allergic disease QTL GWAS877502 (human) | | 9e-27 | allergic disease | | 4 | 122394921 | 122394922 | Human |
| 628632908 | GWAS2541137_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2541137 (human) | | 3e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 114888640 | 114888641 | Human |
| 628452673 | GWAS2360902_H | mathematical ability QTL GWAS2360902 (human) | | 1e-08 | cognitive behavior trait (VT:0010450) | | 4 | 132101754 | 132101755 | Human |
| 628452672 | GWAS2360901_H | mathematical ability QTL GWAS2360901 (human) | | 4e-13 | cognitive behavior trait (VT:0010450) | | 4 | 128819435 | 128819436 | Human |
| 616983806 | GWAS2001305_H | endometriosis QTL GWAS2001305 (human) | | 0.000006 | endometriosis | | 4 | 126617656 | 126617657 | Human |
| 616983805 | GWAS2001304_H | endometriosis QTL GWAS2001304 (human) | | 0.0000008 | endometriosis | | 4 | 114744719 | 114744720 | Human |
| 597289890 | GWAS1385964_H | inflammatory bowel disease QTL GWAS1385964 (human) | | 4e-11 | inflammatory bowel disease | | 4 | 122523884 | 122523885 | Human |
| 406933628 | GWAS582604_H | reaction time measurement QTL GWAS582604 (human) | | 0.000004 | reaction time measurement | | 4 | 109249480 | 109249481 | Human |
| 628649285 | GWAS2557514_H | CCL11 measurement QTL GWAS2557514 (human) | | 0.000003 | chemokine amount (VT:0008721) | | 4 | 113652791 | 113652792 | Human |
| 406933630 | GWAS582606_H | reaction time measurement QTL GWAS582606 (human) | | 0.0000002 | reaction time measurement | | 4 | 117419552 | 117419553 | Human |
| 407195653 | GWAS844629_H | open-angle glaucoma QTL GWAS844629 (human) | | 2e-09 | open-angle glaucoma | | 4 | 127549411 | 127549412 | Human |
| 597306331 | GWAS1402405_H | platelet count QTL GWAS1402405 (human) | | 1e-52 | platelet count | | 4 | 110024810 | 110024811 | Human |
| 597306332 | GWAS1402406_H | platelet count QTL GWAS1402406 (human) | | 6e-10 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 617032846 | GWAS2050345_H | interleukin 10 measurement QTL GWAS2050345 (human) | | 2e-08 | interleukin 10 measurement | | 4 | 106774728 | 106774729 | Human |
| 597158875 | GWAS1254949_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1254949 (human) | | 1e-10 | total cholesterol measurement, high density lipoprotein cholesterol measurement | | 4 | 109603883 | 109603884 | Human |
| 406966285 | GWAS615261_H | nitric oxide exhalation measurement QTL GWAS615261 (human) | | 5e-13 | nitric oxide exhalation measurement | | 4 | 112934321 | 112934322 | Human |
| 598109162 | GWAS1818045_H | glioblastoma multiforme QTL GWAS1818045 (human) | | 0.00001 | glioblastoma multiforme | | 4 | 123310516 | 123310517 | Human |
| 406917133 | GWAS566109_H | risky sexual behaviour measurement QTL GWAS566109 (human) | | 4e-10 | risky sexual behaviour measurement | | 4 | 129108051 | 129108052 | Human |
| 628616504 | GWAS2524733_H | response to antiviral drug QTL GWAS2524733 (human) | | 0.000002 | response to antiviral drug | | 4 | 110212212 | 110212213 | Human |
| 617147527 | GWAS2165026_H | knee fracture QTL GWAS2165026 (human) | | 7e-13 | knee fracture | | 4 | 117485221 | 117485222 | Human |
| 628419899 | GWAS2328128_H | trait in response to zonisamide, motor function measurement, response to levodopa QTL GWAS2328128 (human) | | 0.000006 | motor coordination/balance trait (VT:0001516) | | 4 | 130211377 | 130211378 | Human |
| 628780328 | GWAS2688557_H | apolipoprotein A 1 measurement QTL GWAS2688557 (human) | | 3e-15 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109648464 | 109648465 | Human |
| 628600101 | GWAS2508330_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS2508330 (human) | | 0.0000009 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 127714844 | 127714845 | Human |
| 406966290 | GWAS615266_H | nitric oxide exhalation measurement QTL GWAS615266 (human) | | 8e-08 | nitric oxide exhalation measurement | | 4 | 112934321 | 112934322 | Human |
| 407261201 | GWAS910177_H | childhood trauma measurement QTL GWAS910177 (human) | | 1e-08 | childhood trauma measurement | | 4 | 118266477 | 118266478 | Human |
| 597617606 | GWAS1674466_H | prothrombin time measurement QTL GWAS1674466 (human) | | 6e-36 | prothrombin time measurement | | 4 | 110780277 | 110780278 | Human |
| 597814264 | GWAS1681655_H | decreased attention QTL GWAS1681655 (human) | | 0.000003 | decreased attention | | 4 | 125938393 | 125938394 | Human |
| 407326750 | GWAS975726_H | beverage consumption measurement QTL GWAS975726 (human) | | 1e-08 | beverage consumption measurement | | 4 | 128935692 | 128935693 | Human |
| 617049244 | GWAS2066743_H | corneal resistance factor QTL GWAS2066743 (human) | | 2e-09 | corneal resistance factor | | 4 | 111768358 | 111768359 | Human |
| 628927772 | GWAS2836001_H | obesity QTL GWAS2836001 (human) | | 3e-08 | eating behavior trait (VT:0001431) | | 4 | 114213612 | 114213613 | Human |
| 628813082 | GWAS2721311_H | trefoil factor 3 measurement QTL GWAS2721311 (human) | | 3e-09 | trefoil factor 3 measurement | | 4 | 120726405 | 120726406 | Human |
| 617196712 | GWAS2177152_H | level of beta-glucuronidase in blood QTL GWAS2177152 (human) | | 5e-46 | level of beta-glucuronidase in blood | | 4 | 118842717 | 118842718 | Human |
| 597519356 | GWAS1615430_H | bone density QTL GWAS1615430 (human) | | 2e-17 | bone density | | 4 | 123616626 | 123616628 | Human |
| 597486586 | GWAS1582660_H | Cleft palate, cleft lip QTL GWAS1582660 (human) | | 0.00001 | Cleft palate, cleft lip | | 4 | 112223293 | 112223294 | Human |
| 597093361 | GWAS1189435_H | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement QTL GWAS1189435 (human) | | 0.0000006 | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | | 4 | 124819554 | 124819555 | Human |
| 628796690 | GWAS2704919_H | COVID-19 QTL GWAS2704919 (human) | | 0.000009 | COVID-19 | | 4 | 122020759 | 122020760 | Human |
| 407031855 | GWAS680831_H | insulin resistance QTL GWAS680831 (human) | | 0.000001 | insulin resistance | | 4 | 112927886 | 112927887 | Human |
| 407195700 | GWAS844676_H | cardiac troponin I measurement QTL GWAS844676 (human) | | 0.0000004 | cardiac troponin I measurement | | 4 | 118958433 | 118958434 | Human |
| 628485383 | GWAS2393612_H | level of serum globulin type protein QTL GWAS2393612 (human) | | 2e-10 | level of serum globulin type protein | | 4 | 109984820 | 109984821 | Human |
| 616361161 | GWAS1845876_H | height growth attribute, age at assessment QTL GWAS1845876 (human) | | 0.0000005 | height growth attribute, age at assessment | | 4 | 108011006 | 108011007 | Human |
| 407097406 | GWAS746382_H | common carotid intimal medial thickness QTL GWAS746382 (human) | | 0.0000009 | common carotid intimal medial thickness | | 4 | 109159865 | 109159866 | Human |
| 597371679 | GWAS1467753_H | mean corpuscular volume QTL GWAS1467753 (human) | | 1e-79 | mean corpuscular volume | | 4 | 121814898 | 121814899 | Human |
| 597158673 | GWAS1254747_H | testosterone measurement QTL GWAS1254747 (human) | | 2e-13 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 406900936 | GWAS549912_H | caproate 6:0 measurement QTL GWAS549912 (human) | | 0.000005 | caproate 6:0 measurement | | 4 | 132246564 | 132246565 | Human |
| 616983628 | GWAS2001127_H | acute myeloid leukemia QTL GWAS2001127 (human) | | 9e-18 | leukocyte integrity trait (VT:0010898) | | 4 | 112776849 | 112776850 | Human |
| 617098308 | GWAS2115807_H | systolic blood pressure QTL GWAS2115807 (human) | | 6e-13 | systolic blood pressure | | 4 | 110791276 | 110791277 | Human |
| 597519120 | GWAS1615194_H | open-angle glaucoma QTL GWAS1615194 (human) | | 8e-09 | open-angle glaucoma | | 4 | 111039218 | 111039219 | Human |
| 407359690 | GWAS1008666_H | atopic eczema QTL GWAS1008666 (human) | | 1e-14 | atopic eczema | | 4 | 122263256 | 122263257 | Human |
| 597469970 | GWAS1566044_H | calcium measurement QTL GWAS1566044 (human) | | 4e-09 | calcium measurement | | 4 | 114458289 | 114458290 | Human |
| 597601038 | GWAS1657898_H | body mass index QTL GWAS1657898 (human) | | 3e-21 | body weight | | 4 | 129818987 | 129818988 | Human |
| 597617419 | GWAS1674279_H | Shock QTL GWAS1674279 (human) | | 9e-12 | Shock | | 4 | 108255692 | 108255693 | Human |
| 406900955 | GWAS549931_H | COVID-19 QTL GWAS549931 (human) | | 0.000001 | COVID-19 | | 4 | 113129435 | 113129436 | Human |
| 628731364 | GWAS2639593_H | cognitive function measurement QTL GWAS2639593 (human) | | 1e-12 | cognitive behavior trait (VT:0010450) | | 4 | 118020587 | 118020588 | Human |
| 597093174 | GWAS1189248_H | exploratory eye movement measurement QTL GWAS1189248 (human) | | 0.000008 | exploratory eye movement measurement | | 4 | 114477044 | 114477045 | Human |
| 597994245 | GWAS1713544_H | obsolete_common carotid intimal medial thickness QTL GWAS1713544 (human) | | 0.0000009 | obsolete_common carotid intimal medial thickness | | 4 | 109159865 | 109159866 | Human |
| 628796891 | GWAS2705120_H | high density lipoprotein cholesterol measurement QTL GWAS2705120 (human) | | 4e-08 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109648464 | 109648465 | Human |
| 407015655 | GWAS664631_H | protein measurement QTL GWAS664631 (human) | | 1e-08 | protein measurement | | 4 | 112859722 | 112859723 | Human |
| 616983662 | GWAS2001161_H | Erythema nodosum QTL GWAS2001161 (human) | | 5e-08 | Erythema nodosum | | 4 | 117413463 | 117413464 | Human |
| 628714961 | GWAS2623190_H | retinal vasculature measurement QTL GWAS2623190 (human) | | 7e-58 | retina blood vessel morphology trait (VT:0002792) | | 4 | 119356945 | 119356946 | Human |
| 617278560 | GWAS2215336_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2215336 (human) | | 3e-09 | polyunsaturated fatty acids to total fatty acids percentage | | 4 | 109603883 | 109603884 | Human |
| 628420063 | GWAS2328292_H | venous thromboembolism QTL GWAS2328292 (human) | | 0.0000002 | blood integrity trait (VT:0010779) | | 4 | 112933404 | 112933405 | Human |
| 407015662 | GWAS664638_H | protein measurement QTL GWAS664638 (human) | | 1e-08 | protein measurement | | 4 | 131591604 | 131591605 | Human |
| 628846027 | GWAS2754256_H | alcohol consumption quality QTL GWAS2754256 (human) | | 7e-12 | alcohol consumption quality | | 4 | 112674713 | 112674714 | Human |
| 628846026 | GWAS2754255_H | alcohol consumption quality QTL GWAS2754255 (human) | | 4e-10 | alcohol consumption quality | | 4 | 112392830 | 112392831 | Human |
| 597191467 | GWAS1287541_H | sex hormone-binding globulin measurement QTL GWAS1287541 (human) | | 7e-09 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
| 628862415 | GWAS2770644_H | heart failure QTL GWAS2770644 (human) | | 2e-18 | heart integrity trait (VT:0010757) | | 4 | 110843816 | 110843817 | Human |
| 407294195 | GWAS943171_H | vaginal microbiome measurement QTL GWAS943171 (human) | | 0.0000007 | vaginal microbiome measurement | | 4 | 116138019 | 116138020 | Human |
| 616983667 | GWAS2001166_H | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis QTL GWAS2001166 (human) | | 3e-08 | joint integrity trait (VT:0010548) | | 4 | 122639784 | 122639785 | Human |
| 597338915 | GWAS1434989_H | neuroticism measurement, cognitive function measurement QTL GWAS1434989 (human) | | 4e-14 | cognitive behavior trait (VT:0010450) | | 4 | 122201701 | 122201702 | Human |
| 617081980 | GWAS2099479_H | protein measurement QTL GWAS2099479 (human) | | 2e-78 | protein measurement | | 4 | 119638137 | 119638138 | Human |
| 628452789 | GWAS2361018_H | chronotype measurement QTL GWAS2361018 (human) | | 1e-08 | sleep behavior trait (VT:0001501) | | 4 | 113069787 | 113069788 | Human |
| 597109591 | GWAS1205665_H | Inhalant adrenergic use measurement QTL GWAS1205665 (human) | | 2e-14 | Inhalant adrenergic use measurement | | 4 | 122446734 | 122446735 | Human |
| 407048326 | GWAS697302_H | heart failure QTL GWAS697302 (human) | | 2e-09 | heart failure | | 4 | 113463172 | 113463173 | Human |
| 628895162 | GWAS2803391_H | metabolite measurement QTL GWAS2803391 (human) | | 7e-18 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 628878768 | GWAS2786997_H | physical activity measurement QTL GWAS2786997 (human) | | 3e-09 | wellness/fitness trait (VT:1000152) | voluntary body mobility/immobility measurement (CMO:0000954) | 4 | 108177667 | 108177668 | Human |
| 617049098 | GWAS2066597_H | eosinophil percentage of leukocytes QTL GWAS2066597 (human) | | 2e-22 | eosinophil percentage of leukocytes | | 4 | 122680542 | 122680543 | Human |
| 597388117 | GWAS1484191_H | smoking status measurement, systolic blood pressure QTL GWAS1484191 (human) | | 0.000006 | smoking status measurement, systolic blood pressure | | 4 | 123660107 | 123660108 | Human |
| 617065480 | GWAS2082979_H | level of glutamyl aminopeptidase in blood serum QTL GWAS2082979 (human) | | 3e-16 | level of glutamyl aminopeptidase in blood serum | | 4 | 110520270 | 110520271 | Human |
| 597371726 | GWAS1467800_H | atrial fibrillation QTL GWAS1467800 (human) | | 1e-14 | atrial fibrillation | | 4 | 110789013 | 110789014 | Human |
| 597371724 | GWAS1467798_H | atrial fibrillation QTL GWAS1467798 (human) | | 4e-63 | atrial fibrillation | | 4 | 110787131 | 110787132 | Human |
| 597060427 | GWAS1156501_H | optic disc size measurement QTL GWAS1156501 (human) | | 2e-13 | optic disc size measurement | | 4 | 111481402 | 111481403 | Human |
| 628518313 | GWAS2426542_H | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS2426542 (human) | | 0.000009 | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel | survival measurement (CMO:0001021) | 4 | 113992588 | 113992589 | Human |
| 597994308 | GWAS1713607_H | waist circumference QTL GWAS1713607 (human) | | 0.000009 | waist circumference | | 4 | 129883949 | 129883950 | Human |
| 597027700 | GWAS1123774_H | blood protein measurement QTL GWAS1123774 (human) | | 2e-83 | blood protein measurement | | 4 | 106943827 | 106943828 | Human |
| 616377435 | GWAS1857677_H | obsolete_blood protein measurement QTL GWAS1857677 (human) | | 1e-164 | obsolete_blood protein measurement | | 4 | 106917957 | 106917958 | Human |
| 598059842 | GWAS1779141_H | phospholipids:total lipids ratio, blood VLDL cholesterol amount QTL GWAS1779141 (human) | | 1e-11 | phospholipids:total lipids ratio, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 628501918 | GWAS2410147_H | appendicular lean mass QTL GWAS2410147 (human) | | 3e-11 | body lean mass (VT:0010483) | | 4 | 107939926 | 107939927 | Human |
| 597502833 | GWAS1598907_H | insomnia QTL GWAS1598907 (human) | | 2e-12 | insomnia | | 4 | 111901237 | 111901238 | Human |
| 628682132 | GWAS2590361_H | IGFBP-3 measurement QTL GWAS2590361 (human) | | 0.0000002 | IGFBP-3 measurement | | 4 | 123840924 | 123840925 | Human |
| 628829590 | GWAS2737819_H | platelet component distribution width QTL GWAS2737819 (human) | | 9e-21 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 4 | 109989924 | 109989925 | Human |
| 597502832 | GWAS1598906_H | insomnia QTL GWAS1598906 (human) | | 1e-09 | insomnia | | 4 | 111871413 | 111871414 | Human |
| 597502834 | GWAS1598908_H | insomnia QTL GWAS1598908 (human) | | 2e-10 | insomnia | | 4 | 129856909 | 129856910 | Human |
| 628370820 | GWAS2291664_H | fibroblast growth factor 2 level QTL GWAS2291664 (human) | | 1e-19 | fibroblast growth factor 2 level | | 4 | 126345135 | 126345136 | Human |
| 628370821 | GWAS2291665_H | fibroblast growth factor 2 level QTL GWAS2291665 (human) | | 2e-08 | fibroblast growth factor 2 level | | 4 | 120247814 | 120247815 | Human |
| 628370822 | GWAS2291666_H | fibroblast growth factor 2 level QTL GWAS2291666 (human) | | 4e-11 | fibroblast growth factor 2 level | | 4 | 122518815 | 122518816 | Human |
| 628370823 | GWAS2291667_H | fibroblast growth factor 2 level QTL GWAS2291667 (human) | | 1e-09 | fibroblast growth factor 2 level | | 4 | 118377173 | 118377174 | Human |
| 616508492 | GWAS1905075_H | persephin measurement QTL GWAS1905075 (human) | | 2e-19 | persephin measurement | | 4 | 119129607 | 119129608 | Human |
| 628370816 | GWAS2291660_H | fibroblast growth factor 2 level QTL GWAS2291660 (human) | | 6e-14 | fibroblast growth factor 2 level | | 4 | 121977042 | 121977043 | Human |
| 628370817 | GWAS2291661_H | fibroblast growth factor 2 level QTL GWAS2291661 (human) | | 5e-141 | fibroblast growth factor 2 level | | 4 | 122776139 | 122776140 | Human |
| 407179455 | GWAS828431_H | protein measurement QTL GWAS828431 (human) | | 1e-08 | protein measurement | | 4 | 107913373 | 107913374 | Human |
| 597306208 | GWAS1402282_H | bilirubin measurement QTL GWAS1402282 (human) | | 2e-09 | bilirubin measurement | | 4 | 109921728 | 109921729 | Human |
| 628370824 | GWAS2291668_H | fibroblast growth factor 2 level QTL GWAS2291668 (human) | | 1e-10 | fibroblast growth factor 2 level | | 4 | 119087072 | 119087073 | Human |
| 597191325 | GWAS1287399_H | sex hormone-binding globulin measurement QTL GWAS1287399 (human) | | 5e-25 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 406966596 | GWAS615572_H | respiratory quotient QTL GWAS615572 (human) | | 0.000008 | respiratory quotient | | 4 | 127420965 | 127420966 | Human |
| 616967616 | GWAS1985115_H | intelligence QTL GWAS1985115 (human) | | 0.000008 | intelligence | | 4 | 128544541 | 128544542 | Human |
| 628452477 | GWAS2360706_H | self reported educational attainment QTL GWAS2360706 (human) | | 3e-08 | self reported educational attainment | | 4 | 111402093 | 111402094 | Human |
| 628550783 | GWAS2459012_H | cup-to-disc ratio measurement QTL GWAS2459012 (human) | | 4e-08 | optic disc morphology trait (VT:0006215) | | 4 | 111904784 | 111904785 | Human |
| 628452479 | GWAS2360708_H | self reported educational attainment QTL GWAS2360708 (human) | | 9e-12 | self reported educational attainment | | 4 | 122042189 | 122042190 | Human |
| 628452478 | GWAS2360707_H | self reported educational attainment QTL GWAS2360707 (human) | | 2e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
| 628649056 | GWAS2557285_H | gut microbiome measurement QTL GWAS2557285 (human) | | 4e-08 | gut microbiome measurement | | 4 | 130031153 | 130031154 | Human |
| 626453583 | GWAS2267516_H | hemoglobin measurement QTL GWAS2267516 (human) | | 3e-20 | hemoglobin measurement | | 4 | 110021958 | 110021959 | Human |
| 597158541 | GWAS1254615_H | chylomicron measurement, very low density lipoprotein cholesterol measurement QTL GWAS1254615 (human) | | 1e-10 | chylomicron measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407048537 | GWAS697513_H | neurofibrillary tangles measurement QTL GWAS697513 (human) | | 0.000001 | neurofibrillary tangles measurement | | 4 | 129315616 | 129315617 | Human |
| 597994175 | GWAS1713474_H | glomerular filtration rate QTL GWAS1713474 (human) | | 4e-16 | glomerular filtration rate | | 4 | 108782393 | 108782394 | Human |
| 616492453 | GWAS1889036_H | ceramide amount QTL GWAS1889036 (human) | | 3e-08 | ceramide amount | | 4 | 114533531 | 114533532 | Human |
| 407048536 | GWAS697512_H | hippocampal sclerosis of aging QTL GWAS697512 (human) | | 0.000005 | hippocampal sclerosis of aging | | 4 | 126441942 | 126441943 | Human |
| 597387910 | GWAS1483984_H | initial pursuit acceleration QTL GWAS1483984 (human) | | 0.000005 | initial pursuit acceleration | | 4 | 130399088 | 130399089 | Human |
| 597207686 | GWAS1303760_H | Diuretic use measurement QTL GWAS1303760 (human) | | 9e-09 | Diuretic use measurement | | 4 | 110504739 | 110504740 | Human |
| 616492448 | GWAS1889031_H | ceramide amount QTL GWAS1889031 (human) | | 2e-21 | ceramide amount | | 4 | 114598115 | 114598116 | Human |
| 407408982 | GWAS1057958_H | X-26054 measurement QTL GWAS1057958 (human) | | 1e-125 | X-26054 measurement | | 4 | 129143723 | 129143724 | Human |
| 628468830 | GWAS2377059_H | lipoprotein A measurement QTL GWAS2377059 (human) | | 1e-11 | lipoprotein A measurement | | 4 | 109717668 | 109717669 | Human |
| 617000427 | GWAS2017926_H | body mass index QTL GWAS2017926 (human) | | 0.000003 | body mass index | | 4 | 129838492 | 129838493 | Human |
| 597240488 | GWAS1336562_H | Eczematoid dermatitis QTL GWAS1336562 (human) | | 3e-13 | Eczematoid dermatitis | | 4 | 122415763 | 122415764 | Human |
| 626453603 | GWAS2267536_H | total cholesterol measurement QTL GWAS2267536 (human) | | 6e-10 | total cholesterol measurement | | 4 | 119185611 | 119185612 | Human |
| 407359871 | GWAS1008847_H | Beta blocking agent use measurement QTL GWAS1008847 (human) | | 1e-19 | Beta blocking agent use measurement | | 4 | 110789765 | 110789766 | Human |
| 628911169 | GWAS2819398_H | testosterone measurement QTL GWAS2819398 (human) | | 9e-16 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
| 407277831 | GWAS926807_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS926807 (human) | | 4e-20 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 628829241 | GWAS2737470_H | glomerular filtration rate QTL GWAS2737470 (human) | | 2e-24 | glomerular filtration rate | | 4 | 108782393 | 108782394 | Human |
| 597584603 | GWAS1641463_H | mean corpuscular hemoglobin concentration QTL GWAS1641463 (human) | | 1e-36 | mean corpuscular hemoglobin concentration | | 4 | 121854912 | 121854913 | Human |
| 617262466 | GWAS2199242_H | saturated fatty acids to total fatty acids percentage QTL GWAS2199242 (human) | | 2e-09 | saturated fatty acids to total fatty acids percentage | | 4 | 110191632 | 110191633 | Human |
| 598076141 | GWAS1795440_H | sleep duration trait QTL GWAS1795440 (human) | | 0.0000003 | sleep duration trait | | 4 | 115085956 | 115085957 | Human |
| 597994220 | GWAS1713519_H | nucleus accumbens volume, response to trauma exposure QTL GWAS1713519 (human) | | 0.0000003 | stress-related behavior trait (VT:0010451) | | 4 | 130610205 | 130610206 | Human |
| 598010602 | GWAS1729901_H | APP/EGF protein level ratio in blood QTL GWAS1729901 (human) | | 4e-192 | APP/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 597060294 | GWAS1156368_H | vital capacity QTL GWAS1156368 (human) | | 4e-11 | vital capacity | | 4 | 127731072 | 127731073 | Human |
| 597060293 | GWAS1156367_H | vital capacity QTL GWAS1156367 (human) | | 2e-10 | vital capacity | | 4 | 122906887 | 122906888 | Human |
| 597109442 | GWAS1205516_H | mathematical ability QTL GWAS1205516 (human) | | 8e-10 | mathematical ability | | 4 | 129215768 | 129215769 | Human |
| 407359761 | GWAS1008737_H | erythrocyte count QTL GWAS1008737 (human) | | 4e-09 | erythrocyte count | | 4 | 127869642 | 127869643 | Human |
| 616492518 | GWAS1889101_H | ceramide amount QTL GWAS1889101 (human) | | 2e-09 | ceramide amount | | 4 | 114559783 | 114559784 | Human |
| 616492519 | GWAS1889102_H | ceramide amount QTL GWAS1889102 (human) | | 9e-60 | ceramide amount | | 4 | 114564528 | 114564529 | Human |
| 616492517 | GWAS1889100_H | ceramide amount QTL GWAS1889100 (human) | | 4e-08 | ceramide amount | | 4 | 114407538 | 114407539 | Human |
| 628648996 | GWAS2557225_H | gut microbiome measurement, breastfeeding duration QTL GWAS2557225 (human) | | 2e-11 | lactation duration (VT:1000653) | | 4 | 110717326 | 110717327 | Human |
| 407261465 | GWAS910441_H | Bell's palsy QTL GWAS910441 (human) | | 0.000006 | Bell's palsy | | 4 | 123516321 | 123516322 | Human |
| 617262506 | GWAS2199282_H | Cognitive impairment QTL GWAS2199282 (human) | | 0.0000003 | Cognitive impairment | | 4 | 124309484 | 124309485 | Human |
| 407146789 | GWAS795765_H | diet measurement, HOMA-IR QTL GWAS795765 (human) | | 0.000005 | eating behavior trait (VT:0001431) | Homeostatic Model Assessment of Insulin Resistance (CMO:0003002) | 4 | 109806404 | 109806405 | Human |
| 626453557 | GWAS2267490_H | serum creatinine amount QTL GWAS2267490 (human) | | 2e-23 | serum creatinine amount | | 4 | 108791438 | 108791439 | Human |
| 616525275 | GWAS1921858_H | neutrophil percentage of leukocytes QTL GWAS1921858 (human) | | 9e-17 | neutrophil percentage of leukocytes | | 4 | 112142370 | 112142371 | Human |
| 597175036 | GWAS1271110_H | calcium/calmodulin-dependent protein kinase type II subunit delta measurement QTL GWAS1271110 (human) | | 2e-12 | calcium/calmodulin-dependent protein kinase type II subunit delta measurement | | 4 | 113747320 | 113747321 | Human |
| 616492503 | GWAS1889086_H | level of phosphatidylcholine QTL GWAS1889086 (human) | | 4e-08 | level of phosphatidylcholine | | 4 | 112567861 | 112567862 | Human |
| 628550687 | GWAS2458916_H | cup-to-disc ratio measurement QTL GWAS2458916 (human) | | 2e-18 | optic disc morphology trait (VT:0006215) | | 4 | 125478843 | 125478844 | Human |
| 406982956 | GWAS631932_H | cervical carcinoma QTL GWAS631932 (human) | | 0.0000007 | cervical carcinoma | | 4 | 113726137 | 113726138 | Human |
| 597207798 | GWAS1303872_H | protein measurement QTL GWAS1303872 (human) | | 2e-08 | protein amount (VT:0010120) | | 4 | 124985713 | 124985714 | Human |
| 597617390 | GWAS1674250_H | bile duct disorder QTL GWAS1674250 (human) | | 4e-11 | bile duct disorder | | 4 | 129611431 | 129611432 | Human |
| 628599810 | GWAS2508039_H | total cholesterol measurement, blood VLDL cholesterol amount QTL GWAS2508039 (human) | | 4e-08 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 109717668 | 109717669 | Human |
| 616361418 | GWAS1846133_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1846133 (human) | | 0.0000007 | gut microbiome measurement, allergen exposure measurement | | 4 | 130688068 | 130688069 | Human |
| 628927492 | GWAS2835721_H | breast carcinoma, hormone replacement therapy QTL GWAS2835721 (human) | | 0.000009 | mammary gland integrity trait (VT:0010552) | | 4 | 131597356 | 131597358 | Human |
| 407359803 | GWAS1008779_H | Diuretic use measurement QTL GWAS1008779 (human) | | 4e-10 | Diuretic use measurement | | 4 | 110465271 | 110465272 | Human |
| 407376182 | GWAS1025158_H | response to diuretic, low density lipoprotein cholesterol measurement QTL GWAS1025158 (human) | | 0.0000008 | response to diuretic, low density lipoprotein cholesterol measurement | | 4 | 107388616 | 107388617 | Human |
| 407114042 | GWAS763018_H | hair color QTL GWAS763018 (human) | | 2e-09 | coat/hair pigmentation trait (VT:0010463) | | 4 | 108099646 | 108099647 | Human |
| 617295284 | GWAS2232060_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2232060 (human) | | 4e-08 | polyunsaturated fatty acids to total fatty acids percentage | | 4 | 109657070 | 109657071 | Human |
| 617065796 | GWAS2083295_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS2083295 (human) | | 6e-58 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119373929 | 119373930 | Human |
| 616361273 | GWAS1845988_H | height growth attribute, age at assessment QTL GWAS1845988 (human) | | 0.000007 | height growth attribute, age at assessment | | 4 | 108119392 | 108119393 | Human |
| 616541492 | GWAS1938075_H | level of chymotrypsin-like elastase family member 3A in blood QTL GWAS1938075 (human) | | 4e-14 | level of chymotrypsin-like elastase family member 3A in blood | | 4 | 109945352 | 109945353 | Human |
| 617082199 | GWAS2099698_H | educational attainment QTL GWAS2099698 (human) | | 0.000001 | educational attainment | | 4 | 121774163 | 121774164 | Human |
| 617082198 | GWAS2099697_H | educational attainment QTL GWAS2099697 (human) | | 3e-10 | educational attainment | | 4 | 117508319 | 117508320 | Human |
| 617082197 | GWAS2099696_H | educational attainment QTL GWAS2099696 (human) | | 5e-08 | educational attainment | | 4 | 117355510 | 117355511 | Human |
| 406966739 | GWAS615715_H | mean corpuscular volume QTL GWAS615715 (human) | | 5e-09 | mean corpuscular volume | | 4 | 127647811 | 127647812 | Human |
| 617082196 | GWAS2099695_H | educational attainment QTL GWAS2099695 (human) | | 0.000009 | educational attainment | | 4 | 107916747 | 107916748 | Human |
| 407032273 | GWAS681249_H | free androgen index QTL GWAS681249 (human) | | 4e-09 | free androgen index | | 4 | 109174464 | 109174465 | Human |
| 628501733 | GWAS2409962_H | ANGPT1/EGF protein level ratio in blood QTL GWAS2409962 (human) | | 6e-205 | ANGPT1/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 406966738 | GWAS615714_H | mean corpuscular volume QTL GWAS615714 (human) | | 9e-21 | mean corpuscular volume | | 4 | 121808258 | 121808259 | Human |
| 628600035 | GWAS2508264_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2508264 (human) | | 3e-14 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 407196112 | GWAS845088_H | androsterone sulfate measurement QTL GWAS845088 (human) | | 0.000004 | androsterone sulfate measurement | | 4 | 119318723 | 119318724 | Human |
| 628829420 | GWAS2737649_H | Cleft palate, cleft lip QTL GWAS2737649 (human) | | 0.00001 | Cleft palate, cleft lip | | 4 | 112223293 | 112223294 | Human |
| 406933974 | GWAS582950_H | allergic rhinitis QTL GWAS582950 (human) | | 5e-15 | allergic rhinitis | | 4 | 122415763 | 122415764 | Human |
| 407146972 | GWAS795948_H | diet measurement, fasting blood insulin measurement QTL GWAS795948 (human) | | 0.000009 | diet measurement, fasting blood insulin measurement | | 4 | 109806404 | 109806405 | Human |
| 617082206 | GWAS2099705_H | educational attainment QTL GWAS2099705 (human) | | 0.000008 | educational attainment | | 4 | 131866663 | 131866664 | Human |
| 617082205 | GWAS2099704_H | educational attainment QTL GWAS2099704 (human) | | 3e-09 | educational attainment | | 4 | 130394262 | 130394263 | Human |
| 617065820 | GWAS2083319_H | lysophosphatidylcholine 20:2 measurement QTL GWAS2083319 (human) | | 2e-08 | lysophosphatidylcholine 20:2 measurement | | 4 | 126651788 | 126651789 | Human |
| 617082204 | GWAS2099703_H | educational attainment QTL GWAS2099703 (human) | | 1e-08 | educational attainment | | 4 | 129875770 | 129875771 | Human |
| 617082203 | GWAS2099702_H | educational attainment QTL GWAS2099702 (human) | | 1e-11 | educational attainment | | 4 | 129713268 | 129713269 | Human |
| 597371399 | GWAS1467473_H | HVA measurement, MHPG measurement QTL GWAS1467473 (human) | | 0.000009 | HVA measurement, MHPG measurement | | 4 | 130105333 | 130105334 | Human |
| 617082202 | GWAS2099701_H | educational attainment QTL GWAS2099701 (human) | | 2e-09 | educational attainment | | 4 | 129621796 | 129621797 | Human |
| 617082201 | GWAS2099700_H | educational attainment QTL GWAS2099700 (human) | | 5e-08 | educational attainment | | 4 | 129452572 | 129452573 | Human |
| 628468970 | GWAS2377199_H | Hypermetropia QTL GWAS2377199 (human) | | 0.000002 | Hypermetropia | | 4 | 108429724 | 108429725 | Human |
| 617082200 | GWAS2099699_H | educational attainment QTL GWAS2099699 (human) | | 1e-08 | educational attainment | | 4 | 129387520 | 129387521 | Human |
| 598141447 | GWAS1828175_H | bone tissue density QTL GWAS1828175 (human) | | 8e-16 | bone tissue density | | 4 | 107727835 | 107727836 | Human |
| 597387833 | GWAS1483907_H | susceptibility to cold sores measurement QTL GWAS1483907 (human) | | 0.000004 | susceptibility to cold sores measurement | | 4 | 120332709 | 120332710 | Human |
| 597584441 | GWAS1641301_H | mean corpuscular hemoglobin concentration QTL GWAS1641301 (human) | | 2e-42 | mean corpuscular hemoglobin concentration | | 4 | 121854912 | 121854913 | Human |
| 597600822 | GWAS1657682_H | body mass index QTL GWAS1657682 (human) | | 6e-19 | body mass index | | 4 | 129818987 | 129818988 | Human |
| 597371437 | GWAS1467511_H | stroke QTL GWAS1467511 (human) | | 3e-16 | stroke | | 4 | 110796911 | 110796912 | Human |
| 597371436 | GWAS1467510_H | stroke QTL GWAS1467510 (human) | | 0.0000002 | stroke | | 4 | 110796911 | 110796912 | Human |
| 597518885 | GWAS1614959_H | forced expiratory volume QTL GWAS1614959 (human) | | 6e-13 | forced expiratory volume | | 4 | 123917030 | 123917031 | Human |
| 597142062 | GWAS1238136_H | HbA1c measurement QTL GWAS1238136 (human) | | 7e-15 | HbA1c measurement | | 4 | 110010783 | 110010784 | Human |
| 597076561 | GWAS1172635_H | lobe attachment QTL GWAS1172635 (human) | | 0.0000007 | ear lobe morphology trait (VT:0003677) | ear measurement (CMO:0002667) | 4 | 121107629 | 121107630 | Human |
| 597617241 | GWAS1674101_H | joint disease QTL GWAS1674101 (human) | | 1e-11 | joint disease | | 4 | 123048237 | 123048238 | Human |
| 597420627 | GWAS1516701_H | systolic blood pressure QTL GWAS1516701 (human) | | 1e-10 | systolic blood pressure | | 4 | 110368093 | 110368094 | Human |
| 616492406 | GWAS1888989_H | ceramide amount QTL GWAS1888989 (human) | | 3e-13 | ceramide amount | | 4 | 114553199 | 114553200 | Human |
| 597420626 | GWAS1516700_H | systolic blood pressure QTL GWAS1516700 (human) | | 6e-12 | systolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 597420625 | GWAS1516699_H | systolic blood pressure QTL GWAS1516699 (human) | | 2e-10 | systolic blood pressure | | 4 | 108117498 | 108117499 | Human |
| 597420631 | GWAS1516705_H | systolic blood pressure QTL GWAS1516705 (human) | | 2e-08 | systolic blood pressure | | 4 | 123878327 | 123878328 | Human |
| 597420630 | GWAS1516704_H | systolic blood pressure QTL GWAS1516704 (human) | | 5e-09 | systolic blood pressure | | 4 | 119996191 | 119996192 | Human |
| 616492400 | GWAS1888983_H | ceramide amount QTL GWAS1888983 (human) | | 1e-11 | ceramide amount | | 4 | 114725282 | 114725283 | Human |
| 597420629 | GWAS1516703_H | systolic blood pressure QTL GWAS1516703 (human) | | 7e-11 | systolic blood pressure | | 4 | 119633559 | 119633560 | Human |
| 597420628 | GWAS1516702_H | systolic blood pressure QTL GWAS1516702 (human) | | 5e-17 | systolic blood pressure | | 4 | 110414448 | 110414449 | Human |
| 628501689 | GWAS2409918_H | calcium measurement QTL GWAS2409918 (human) | | 4e-09 | calcium amount (VT:0010499) | blood calcium level (CMO:0000502) | 4 | 114458289 | 114458290 | Human |
| 616492398 | GWAS1888981_H | ceramide amount QTL GWAS1888981 (human) | | 1e-08 | ceramide amount | | 4 | 114573629 | 114573630 | Human |
| 616492399 | GWAS1888982_H | ceramide amount QTL GWAS1888982 (human) | | 3e-18 | ceramide amount | | 4 | 114663873 | 114663874 | Human |
| 628829353 | GWAS2737582_H | body height QTL GWAS2737582 (human) | | 2e-16 | body height | | 4 | 108560745 | 108560746 | Human |
| 597256779 | GWAS1352853_H | schizophrenia QTL GWAS1352853 (human) | | 2e-09 | schizophrenia | | 4 | 117931831 | 117931832 | Human |
| 597600844 | GWAS1657704_H | 3-hydroxybutyrate measurement QTL GWAS1657704 (human) | | 0.000005 | urine ketone body amount (VT:0010724) | | 4 | 126344537 | 126344538 | Human |
| 617032980 | GWAS2050479_H | glioblastoma multiforme QTL GWAS2050479 (human) | | 0.000007 | glioblastoma multiforme | | 4 | 117476867 | 117476868 | Human |
| 628452525 | GWAS2360754_H | self reported educational attainment QTL GWAS2360754 (human) | | 4e-09 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 628452524 | GWAS2360753_H | self reported educational attainment QTL GWAS2360753 (human) | | 1e-11 | self reported educational attainment | | 4 | 122105714 | 122105715 | Human |
| 628616364 | GWAS2524593_H | mean arterial pressure QTL GWAS2524593 (human) | | 0.000002 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 110460482 | 110460483 | Human |
| 628616361 | GWAS2524590_H | mean arterial pressure QTL GWAS2524590 (human) | | 7e-09 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110422107 | 110422108 | Human |
| 628452523 | GWAS2360752_H | mathematical ability QTL GWAS2360752 (human) | | 5e-09 | cognitive behavior trait (VT:0010450) | | 4 | 114994461 | 114994462 | Human |
| 628452522 | GWAS2360751_H | mathematical ability QTL GWAS2360751 (human) | | 1e-08 | cognitive behavior trait (VT:0010450) | | 4 | 111859867 | 111859868 | Human |
| 597813886 | GWAS1681277_H | hip bone mineral density QTL GWAS1681277 (human) | | 5e-09 | hip bone mineral density | | 4 | 129257175 | 129257176 | Human |
| 628747419 | GWAS2655648_H | respiratory system disease QTL GWAS2655648 (human) | | 5e-36 | lung integrity trait (VT:0010906) | | 4 | 122432277 | 122432278 | Human |
| 406983078 | GWAS632054_H | protein measurement QTL GWAS632054 (human) | | 2e-09 | protein measurement | | 4 | 110722577 | 110722578 | Human |
| 628649118 | GWAS2557347_H | delivery measurement, gut microbiome measurement QTL GWAS2557347 (human) | | 0.000002 | delivery measurement, gut microbiome measurement | | 4 | 110717326 | 110717327 | Human |
| 597387901 | GWAS1483975_H | smoking status measurement, diastolic blood pressure QTL GWAS1483975 (human) | | 3e-08 | smoking status measurement, diastolic blood pressure | | 4 | 123660107 | 123660108 | Human |
| 628550814 | GWAS2459043_H | cup-to-disc ratio measurement QTL GWAS2459043 (human) | | 6e-10 | optic disc morphology trait (VT:0006215) | | 4 | 125318831 | 125318832 | Human |
| 628649105 | GWAS2557334_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS2557334 (human) | | 6e-09 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 110961148 | 110961149 | Human |
| 617082165 | GWAS2099664_H | heart failure QTL GWAS2099664 (human) | | 2e-15 | heart failure | | 4 | 110787848 | 110787849 | Human |
| 617082164 | GWAS2099663_H | heart failure QTL GWAS2099663 (human) | | 5e-42 | heart failure | | 4 | 110787848 | 110787849 | Human |
| 617082163 | GWAS2099662_H | heart failure QTL GWAS2099662 (human) | | 5e-14 | heart failure | | 4 | 110927114 | 110927115 | Human |
| 628403330 | GWAS2311559_H | pelvic organ prolapse QTL GWAS2311559 (human) | | 5e-16 | pelvic organ prolapse | | 4 | 126037217 | 126037218 | Human |
| 407048635 | GWAS697611_H | mean arterial pressure, response to high sodium diet, response to dietary potassium supplementation QTL GWAS697611 (human) | | 0.000003 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 113940144 | 113940145 | Human |
| 597322338 | GWAS1418412_H | systolic blood pressure QTL GWAS1418412 (human) | | 4e-08 | systolic blood pressure | | 4 | 120018331 | 120018332 | Human |
| 407179709 | GWAS828685_H | BMI-adjusted waist-hip ratio QTL GWAS828685 (human) | | 2e-10 | BMI-adjusted waist-hip ratio | | 4 | 124118741 | 124118742 | Human |
| 407048636 | GWAS697612_H | heart failure QTL GWAS697612 (human) | | 4e-29 | heart failure | | 4 | 110748064 | 110748065 | Human |
| 616984262 | GWAS2001761_H | breast carcinoma QTL GWAS2001761 (human) | | 7e-10 | breast carcinoma | | 4 | 125922349 | 125922350 | Human |
| 597436829 | GWAS1532903_H | atrial fibrillation QTL GWAS1532903 (human) | | 6e-306 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 628944766 | GWAS2852995_H | body weight QTL GWAS2852995 (human) | | 3e-11 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129838492 | 129838493 | Human |
| 407376462 | GWAS1025438_H | asthma QTL GWAS1025438 (human) | | 4e-15 | asthma | | 4 | 122084379 | 122084380 | Human |
| 407376448 | GWAS1025424_H | triglyceride measurement, response to diuretic QTL GWAS1025424 (human) | | 6e-08 | triglyceride measurement, response to diuretic | | 4 | 129379460 | 129379461 | Human |
| 597174675 | GWAS1270749_H | intelligence QTL GWAS1270749 (human) | | 5e-09 | intelligence | | 4 | 112490199 | 112490200 | Human |
| 406983241 | GWAS632217_H | endometriosis QTL GWAS632217 (human) | | 0.0000006 | endometriosis | | 4 | 114744719 | 114744720 | Human |
| 406901323 | GWAS550299_H | COVID-19 QTL GWAS550299 (human) | | 0.000009 | COVID-19 | | 4 | 127021337 | 127021338 | Human |
| 597617043 | GWAS1673903_H | disorder of appendix QTL GWAS1673903 (human) | | 2e-21 | disorder of appendix | | 4 | 110810809 | 110810810 | Human |
| 407392839 | GWAS1041815_H | osteoarthritis QTL GWAS1041815 (human) | | 5e-09 | osteoarthritis | | 4 | 120663127 | 120663128 | Human |
| 628830057 | GWAS2738286_H | erythrocyte count QTL GWAS2738286 (human) | | 4e-18 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 121808257 | 121808258 | Human |
| 597240204 | GWAS1336278_H | treprostinil dose measurement QTL GWAS1336278 (human) | | 0.000005 | treprostinil dose measurement | | 4 | 113625548 | 113625549 | Human |
| 628649839 | GWAS2558068_H | dental caries QTL GWAS2558068 (human) | | 0.000003 | dental caries | | 4 | 129415045 | 129415046 | Human |
| 628682593 | GWAS2590822_H | diastolic blood pressure QTL GWAS2590822 (human) | | 3e-17 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110510288 | 110510289 | Human |
| 407376465 | GWAS1025441_H | asthma QTL GWAS1025441 (human) | | 1e-12 | asthma | | 4 | 122219915 | 122219916 | Human |
| 598108604 | GWAS1817487_H | vascular dementia QTL GWAS1817487 (human) | | 0.000009 | vascular dementia | | 4 | 117625893 | 117625894 | Human |
| 597993913 | GWAS1713212_H | alcohol consumption quality QTL GWAS1713212 (human) | | 0.000008 | alcohol consumption quality | | 4 | 108819029 | 108819030 | Human |
| 596961712 | GWAS1081231_H | gestational age QTL GWAS1081231 (human) | | 0.000007 | gestational age | | 4 | 112357355 | 112357356 | Human |
| 626454387 | GWAS2268320_H | high density lipoprotein cholesterol measurement QTL GWAS2268320 (human) | | 6e-09 | high density lipoprotein cholesterol measurement | | 4 | 112062569 | 112062570 | Human |
| 596961713 | GWAS1081232_H | gestational age QTL GWAS1081232 (human) | | 0.00001 | gestational age | | 4 | 112354624 | 112354625 | Human |
| 628551519 | GWAS2459748_H | cup-to-disc ratio measurement QTL GWAS2459748 (human) | | 2e-09 | optic disc morphology trait (VT:0006215) | | 4 | 111478355 | 111478356 | Human |
| 616984303 | GWAS2001802_H | Red cell distribution width QTL GWAS2001802 (human) | | 6e-21 | erythrocyte size trait (VT:0000248) | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
| 597207474 | GWAS1303548_H | PR interval QTL GWAS1303548 (human) | | 3e-09 | heart excitatory physiology trait (VT:0000231) | PR interval (CMO:0000233) | 4 | 113496850 | 113496851 | Human |
| 617262817 | GWAS2199593_H | saturated fatty acids to total fatty acids percentage QTL GWAS2199593 (human) | | 1e-10 | fatty acid amount | | 4 | 110191454 | 110191455 | Human |
| 616492686 | GWAS1889269_H | phospholipid amount, blood VLDL cholesterol amount QTL GWAS1889269 (human) | | 8e-09 | phospholipid amount, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 407196276 | GWAS845252_H | fibroblast growth factor 2 measurement QTL GWAS845252 (human) | | 6e-39 | fibroblast growth factor 2 measurement | | 4 | 122836593 | 122836594 | Human |
| 628420423 | GWAS2328652_H | hip bone size QTL GWAS2328652 (human) | | 7e-09 | hip bone size | | 4 | 129257175 | 129257176 | Human |
| 597485992 | GWAS1582066_H | cardiac troponin I measurement QTL GWAS1582066 (human) | | 0.000006 | cardiac troponin I measurement | | 4 | 110926834 | 110926835 | Human |
| 406917751 | GWAS566727_H | serum IgG glycosylation measurement QTL GWAS566727 (human) | | 0.000002 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
| 617049841 | GWAS2067340_H | cortical thickness QTL GWAS2067340 (human) | | 5e-09 | cortical thickness | | 4 | 127101149 | 127101150 | Human |
| 617017084 | GWAS2034583_H | open-angle glaucoma QTL GWAS2034583 (human) | | 8e-10 | open-angle glaucoma | | 4 | 126000490 | 126000491 | Human |
| 406999673 | GWAS648649_H | reticulocyte measurement QTL GWAS648649 (human) | | 2e-10 | reticulocyte measurement | | 4 | 119185193 | 119185194 | Human |
| 628797249 | GWAS2705478_H | rheumatoid arthritis QTL GWAS2705478 (human) | | 0.000005 | joint integrity trait (VT:0010548) | | 4 | 124601887 | 124601888 | Human |
| 616476293 | GWAS1872876_H | glycerol amount QTL GWAS1872876 (human) | | 0.000004 | glycerol amount | | 4 | 125494759 | 125494760 | Human |
| 617017082 | GWAS2034581_H | open-angle glaucoma QTL GWAS2034581 (human) | | 4e-15 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 617017083 | GWAS2034582_H | open-angle glaucoma QTL GWAS2034582 (human) | | 1e-08 | open-angle glaucoma | | 4 | 111886876 | 111886877 | Human |
| 406917756 | GWAS566732_H | cup-to-disc ratio measurement QTL GWAS566732 (human) | | 3e-10 | cup-to-disc ratio measurement | | 4 | 125475115 | 125475116 | Human |
| 597076438 | GWAS1172512_H | lobe attachment QTL GWAS1172512 (human) | | 0.000002 | ear lobe morphology trait (VT:0003677) | ear measurement (CMO:0002667) | 4 | 121212944 | 121212945 | Human |
| 406983173 | GWAS632149_H | cervical carcinoma QTL GWAS632149 (human) | | 0.000001 | cervical carcinoma | | 4 | 113726137 | 113726138 | Human |
| 598092270 | GWAS1811569_H | erythrocyte volume QTL GWAS1811569 (human) | | 2e-11 | erythrocyte volume | | 4 | 109979991 | 109979992 | Human |
| 617000590 | GWAS2018089_H | glucose-dependent insulinotropic peptide measurement QTL GWAS2018089 (human) | | 4e-10 | glucose-dependent insulinotropic peptide measurement | | 4 | 123717198 | 123717199 | Human |
| 598092271 | GWAS1811570_H | erythrocyte volume QTL GWAS1811570 (human) | | 2e-09 | erythrocyte volume | | 4 | 121773981 | 121773982 | Human |
| 597453264 | GWAS1549338_H | urate measurement, spine bone mineral density QTL GWAS1549338 (human) | | 0.000001 | urate measurement, spine bone mineral density | | 4 | 123516413 | 123516414 | Human |
| 597076442 | GWAS1172516_H | lobe attachment QTL GWAS1172516 (human) | | 0.000004 | ear lobe morphology trait (VT:0003677) | ear measurement (CMO:0002667) | 4 | 124943164 | 124943165 | Human |
| 597191125 | GWAS1287199_H | testosterone measurement QTL GWAS1287199 (human) | | 2e-11 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 597076443 | GWAS1172517_H | lobe attachment QTL GWAS1172517 (human) | | 0.000009 | ear lobe morphology trait (VT:0003677) | ear measurement (CMO:0002667) | 4 | 125111064 | 125111065 | Human |
| 617098905 | GWAS2116404_H | dopamine beta-hydroxylase measurement QTL GWAS2116404 (human) | | 5e-24 | dopamine beta-hydroxylase measurement | | 4 | 123844106 | 123844107 | Human |
| 628928296 | GWAS2836525_H | anthropometric measurement QTL GWAS2836525 (human) | | 2e-08 | body size trait (VT:0100005) | body morphological measurement (CMO:0000021) | 4 | 119230297 | 119230298 | Human |
| 628928299 | GWAS2836528_H | anthropometric measurement QTL GWAS2836528 (human) | | 3e-09 | body size trait (VT:0100005) | body morphological measurement (CMO:0000021) | 4 | 108368032 | 108368033 | Human |
| 597518794 | GWAS1614868_H | colorectal cancer QTL GWAS1614868 (human) | | 0.000003 | colorectal cancer | | 4 | 123587620 | 123587621 | Human |
| 617033372 | GWAS2050871_H | body mass index QTL GWAS2050871 (human) | | 2e-12 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597535169 | GWAS1631243_H | bone density QTL GWAS1631243 (human) | | 1e-130 | bone density | | 4 | 119406123 | 119406124 | Human |
| 628485928 | GWAS2394157_H | nicotine withdrawal symptom count QTL GWAS2394157 (human) | | 0.000003 | withdrawal response to addictive substance trait (VT:0010722) | | 4 | 107843866 | 107843867 | Human |
| 617148053 | GWAS2165552_H | level of sphingomyelin phosphodiesterase in blood serum QTL GWAS2165552 (human) | | 4e-24 | level of sphingomyelin phosphodiesterase in blood serum | | 4 | 109717668 | 109717669 | Human |
| 616525536 | GWAS1922119_H | eosinophil percentage of leukocytes QTL GWAS1922119 (human) | | 2e-29 | eosinophil percentage of leukocytes | | 4 | 122263256 | 122263257 | Human |
| 598141382 | GWAS1828110_H | bone tissue density QTL GWAS1828110 (human) | | 6e-24 | bone tissue density | | 4 | 129519676 | 129519677 | Human |
| 598141383 | GWAS1828111_H | bone tissue density QTL GWAS1828111 (human) | | 6e-24 | bone tissue density | | 4 | 107818840 | 107818841 | Human |
| 597584383 | GWAS1641243_H | mean corpuscular volume QTL GWAS1641243 (human) | | 8e-30 | mean corpuscular volume | | 4 | 121854912 | 121854913 | Human |
| 628567827 | GWAS2476056_H | carotid artery disease QTL GWAS2476056 (human) | | 1e-11 | carotid artery disease | | 4 | 119576145 | 119576146 | Human |
| 628567826 | GWAS2476055_H | carotid artery disease QTL GWAS2476055 (human) | | 1e-16 | carotid artery disease | | 4 | 106712535 | 106712536 | Human |
| 597584372 | GWAS1641232_H | mean corpuscular hemoglobin concentration QTL GWAS1641232 (human) | | 4e-41 | mean corpuscular hemoglobin concentration | | 4 | 121854912 | 121854913 | Human |
| 597486071 | GWAS1582145_H | lysophosphatidylcholine 20:2 measurement QTL GWAS1582145 (human) | | 2e-08 | lysophosphatidylcholine 20:2 measurement | | 4 | 126651788 | 126651789 | Human |
| 597600752 | GWAS1657612_H | body mass index QTL GWAS1657612 (human) | | 1e-14 | body mass index | | 4 | 129818987 | 129818988 | Human |
| 407376440 | GWAS1025416_H | appendicular lean mass QTL GWAS1025416 (human) | | 2e-12 | appendicular lean mass | | 4 | 119638715 | 119638716 | Human |
| 628420359 | GWAS2328588_H | appendicular lean mass QTL GWAS2328588 (human) | | 2e-12 | body lean mass (VT:0010483) | | 4 | 119638715 | 119638716 | Human |
| 597371374 | GWAS1467448_H | stroke QTL GWAS1467448 (human) | | 2e-10 | stroke | | 4 | 110789013 | 110789014 | Human |
| 598141395 | GWAS1828123_H | bone tissue density QTL GWAS1828123 (human) | | 6e-12 | bone tissue density | | 4 | 122289915 | 122289916 | Human |
| 407015989 | GWAS664965_H | Diuretic use measurement QTL GWAS664965 (human) | | 9e-09 | Diuretic use measurement | | 4 | 110504739 | 110504740 | Human |
| 407097915 | GWAS746891_H | fibrinopeptide A measurement QTL GWAS746891 (human) | | 7e-15 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 407376432 | GWAS1025408_H | appendicular lean mass QTL GWAS1025408 (human) | | 5e-10 | appendicular lean mass | | 4 | 110660471 | 110660472 | Human |
| 407409201 | GWAS1058177_H | electrocardiography QTL GWAS1058177 (human) | | 3e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 407409202 | GWAS1058178_H | electrocardiography QTL GWAS1058178 (human) | | 7e-12 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 407081529 | GWAS730505_H | X-24422 measurement QTL GWAS730505 (human) | | 3e-13 | X-24422 measurement | | 4 | 122894208 | 122894209 | Human |
| 407409203 | GWAS1058179_H | electrocardiography QTL GWAS1058179 (human) | | 1e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 597502432 | GWAS1598506_H | triglyceride measurement QTL GWAS1598506 (human) | | 6e-10 | triglyceride measurement | | 4 | 123895285 | 123895286 | Human |
| 628944643 | GWAS2852872_H | total cholesterol measurement QTL GWAS2852872 (human) | | 1e-13 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 109962188 | 109962189 | Human |
| 407097916 | GWAS746892_H | fibrinopeptide A measurement QTL GWAS746892 (human) | | 6e-17 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 597174759 | GWAS1270833_H | insulin resistance QTL GWAS1270833 (human) | | 0.000001 | insulin resistance | | 4 | 112927886 | 112927887 | Human |
| 597420314 | GWAS1516388_H | cognitive function measurement QTL GWAS1516388 (human) | | 1e-12 | cognitive function measurement | | 4 | 118020587 | 118020588 | Human |
| 628862973 | GWAS2771202_H | juvenile idiopathic arthritis QTL GWAS2771202 (human) | | 0.0000007 | joint integrity trait (VT:0010548) | | 4 | 122535302 | 122535303 | Human |
| 628617215 | GWAS2525444_H | systolic blood pressure QTL GWAS2525444 (human) | | 0.000003 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 110460482 | 110460483 | Human |
| 628879345 | GWAS2787574_H | drug allergy, trait in response to platinum QTL GWAS2787574 (human) | | 0.000004 | response to xenobiotic stimulus trait (VT:0010487) | | 4 | 113445575 | 113445576 | Human |
| 597223698 | GWAS1319772_H | cystatin C measurement QTL GWAS1319772 (human) | | 4e-09 | cystatin C measurement | | 4 | 119754004 | 119754005 | Human |
| 628420606 | GWAS2328835_H | hip bone mineral density, hip bone size QTL GWAS2328835 (human) | | 5e-09 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 129257175 | 129257176 | Human |
| 628649974 | GWAS2558203_H | systolic blood pressure QTL GWAS2558203 (human) | | 1e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110510288 | 110510289 | Human |
| 597076231 | GWAS1172305_H | atopic eczema QTL GWAS1172305 (human) | | 0.000004 | atopic eczema | | 4 | 122576542 | 122576543 | Human |
| 616984148 | GWAS2001647_H | endometriosis QTL GWAS2001647 (human) | | 0.000007 | endometriosis | | 4 | 126617656 | 126617657 | Human |
| 597256458 | GWAS1352532_H | cardiovascular disease QTL GWAS1352532 (human) | | 9e-09 | cardiovascular disease | | 4 | 110764459 | 110764460 | Human |
| 628699117 | GWAS2607346_H | cortical thickness QTL GWAS2607346 (human) | | 9e-16 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120645452 | 120645453 | Human |
| 616984147 | GWAS2001646_H | endometriosis QTL GWAS2001646 (human) | | 0.0000006 | endometriosis | | 4 | 114744719 | 114744720 | Human |
| 628404193 | GWAS2312422_H | reticulocyte count QTL GWAS2312422 (human) | | 1e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 128330896 | 128330897 | Human |
| 597813559 | GWAS1680950_H | diet measurement QTL GWAS1680950 (human) | | 0.000009 | diet measurement | | 4 | 109806404 | 109806405 | Human |
| 616984159 | GWAS2001658_H | childhood onset asthma QTL GWAS2001658 (human) | | 3e-13 | childhood onset asthma | | 4 | 122639784 | 122639785 | Human |
| 596977935 | GWAS1097454_H | body height QTL GWAS1097454 (human) | | 2e-14 | body height | | 4 | 119759795 | 119759796 | Human |
| 628731875 | GWAS2640104_H | major depressive disorder QTL GWAS2640104 (human) | | 3e-16 | major depressive disorder | | 4 | 122467738 | 122467739 | Human |
| 616525345 | GWAS1921928_H | HbA1c measurement QTL GWAS1921928 (human) | | 9e-20 | HbA1c measurement | | 4 | 109906786 | 109906787 | Human |
| 628502505 | GWAS2410734_H | AGRN/BTN2A1 protein level ratio in blood QTL GWAS2410734 (human) | | 2e-43 | AGRN/BTN2A1 protein level ratio in blood | | 4 | 118376502 | 118376503 | Human |
| 407343847 | GWAS992823_H | clear cell renal carcinoma QTL GWAS992823 (human) | | 8e-11 | clear cell renal carcinoma | | 4 | 108791438 | 108791439 | Human |
| 597223736 | GWAS1319810_H | BMI-adjusted waist circumference QTL GWAS1319810 (human) | | 4e-08 | BMI-adjusted waist circumference | | 4 | 123169108 | 123169109 | Human |
| 597223737 | GWAS1319811_H | BMI-adjusted waist circumference QTL GWAS1319811 (human) | | 3e-11 | BMI-adjusted waist circumference | | 4 | 123124286 | 123124287 | Human |
| 597223738 | GWAS1319812_H | BMI-adjusted waist circumference QTL GWAS1319812 (human) | | 5e-12 | BMI-adjusted waist circumference | | 4 | 123166618 | 123166619 | Human |
| 628371410 | GWAS2292254_H | Insulin resistance QTL GWAS2292254 (human) | | 0.000001 | Insulin resistance | | 4 | 112927886 | 112927887 | Human |
| 406983396 | GWAS632372_H | coffee consumption measurement QTL GWAS632372 (human) | | 0.000003 | coffee consumption measurement | | 4 | 117421219 | 117421220 | Human |
| 407098090 | GWAS747066_H | fibrinopeptide A measurement QTL GWAS747066 (human) | | 3e-15 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 407114478 | GWAS763454_H | mean corpuscular volume QTL GWAS763454 (human) | | 9e-33 | mean corpuscular volume | | 4 | 109947179 | 109947180 | Human |
| 407278316 | GWAS927292_H | alkaline phosphatase measurement QTL GWAS927292 (human) | | 8e-16 | alkaline phosphatase measurement | | 4 | 110190912 | 110190913 | Human |
| 597223730 | GWAS1319804_H | BMI-adjusted waist circumference QTL GWAS1319804 (human) | | 4e-11 | BMI-adjusted waist circumference | | 4 | 119213641 | 119213642 | Human |
| 616967788 | GWAS1985287_H | susceptibility to rubella infection measurement QTL GWAS1985287 (human) | | 0.000009 | response to viral infection trait (VT:0010439) | | 4 | 127589123 | 127589124 | Human |
| 628404191 | GWAS2312420_H | reticulocyte count QTL GWAS2312420 (human) | | 2e-13 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109944309 | 109944310 | Human |
| 597223731 | GWAS1319805_H | BMI-adjusted waist circumference QTL GWAS1319805 (human) | | 2e-13 | BMI-adjusted waist circumference | | 4 | 119649123 | 119649124 | Human |
| 407114479 | GWAS763455_H | mean corpuscular volume QTL GWAS763455 (human) | | 2e-58 | mean corpuscular volume | | 4 | 121877258 | 121877259 | Human |
| 407278317 | GWAS927293_H | alkaline phosphatase measurement QTL GWAS927293 (human) | | 4e-19 | alkaline phosphatase measurement | | 4 | 128065247 | 128065248 | Human |
| 597223732 | GWAS1319806_H | BMI-adjusted waist circumference QTL GWAS1319806 (human) | | 2e-08 | BMI-adjusted waist-hip ratio | | 4 | 119595538 | 119595539 | Human |
| 597223733 | GWAS1319807_H | BMI-adjusted waist circumference QTL GWAS1319807 (human) | | 2e-09 | BMI-adjusted waist circumference | | 4 | 119768762 | 119768763 | Human |
| 597092667 | GWAS1188741_H | neurofibrillary tangles measurement QTL GWAS1188741 (human) | | 0.000001 | brain integrity trait (VT:0010579) | | 4 | 129315616 | 129315617 | Human |
| 597223734 | GWAS1319808_H | BMI-adjusted waist circumference QTL GWAS1319808 (human) | | 1e-09 | BMI-adjusted waist circumference | | 4 | 121700964 | 121700965 | Human |
| 597223735 | GWAS1319809_H | BMI-adjusted waist circumference QTL GWAS1319809 (human) | | 5e-09 | BMI-adjusted waist circumference | | 4 | 122858186 | 122858187 | Human |
| 407098096 | GWAS747072_H | fibrinopeptide A measurement QTL GWAS747072 (human) | | 8e-15 | fibrinopeptide A measurement | | 4 | 110485340 | 110485341 | Human |
| 598092053 | GWAS1811352_H | serum albumin amount QTL GWAS1811352 (human) | | 3e-09 | serum albumin amount | | 4 | 123779234 | 123779235 | Human |
| 407048951 | GWAS697927_H | systolic blood pressure, response to high sodium diet, response to dietary potassium supplementation QTL GWAS697927 (human) | | 0.0000002 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 113940144 | 113940145 | Human |
| 407114480 | GWAS763456_H | mean corpuscular volume QTL GWAS763456 (human) | | 1e-10 | mean corpuscular volume | | 4 | 128082220 | 128082221 | Human |
| 407098102 | GWAS747078_H | fibrinopeptide A measurement QTL GWAS747078 (human) | | 1e-12 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 598075664 | GWAS1794963_H | bone density QTL GWAS1794963 (human) | | 8e-29 | bone density | | 4 | 131238783 | 131238784 | Human |
| 407098107 | GWAS747083_H | fibrinopeptide A measurement QTL GWAS747083 (human) | | 1e-42 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 407098106 | GWAS747082_H | fibrinopeptide A measurement QTL GWAS747082 (human) | | 2e-25 | fibrinopeptide A measurement | | 4 | 110434637 | 110434638 | Human |
| 596977964 | GWAS1097483_H | body height QTL GWAS1097483 (human) | | 5e-14 | body height | | 4 | 119501252 | 119501253 | Human |
| 616476167 | GWAS1872750_H | body mass index QTL GWAS1872750 (human) | | 7e-13 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597993752 | GWAS1713051_H | glomerular filtration rate QTL GWAS1713051 (human) | | 4e-13 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 597125418 | GWAS1221492_H | osteoarthritis QTL GWAS1221492 (human) | | 5e-09 | osteoarthritis | | 4 | 120663127 | 120663128 | Human |
| 597240102 | GWAS1336176_H | anxiety QTL GWAS1336176 (human) | | 2e-09 | anxiety | | 4 | 131717648 | 131717649 | Human |
| 617033222 | GWAS2050721_H | pulse pressure measurement QTL GWAS2050721 (human) | | 0.0000008 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 110416708 | 110416709 | Human |
| 616476287 | GWAS1872870_H | glycerol amount QTL GWAS1872870 (human) | | 0.0000002 | glycerol amount | | 4 | 125351750 | 125351751 | Human |
| 617033221 | GWAS2050720_H | pulse pressure measurement QTL GWAS2050720 (human) | | 0.000002 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 110319122 | 110319123 | Human |
| 597141854 | GWAS1237928_H | facial morphology measurement QTL GWAS1237928 (human) | | 3e-08 | facial morphology measurement | | 4 | 125210511 | 125210512 | Human |
| 597141853 | GWAS1237927_H | facial morphology measurement QTL GWAS1237927 (human) | | 3e-08 | facial morphology measurement | | 4 | 125217310 | 125217311 | Human |
| 407360140 | GWAS1009116_H | nephrolithiasis QTL GWAS1009116 (human) | | 3e-14 | nephrolithiasis | | 4 | 114667805 | 114667806 | Human |
| 597141852 | GWAS1237926_H | facial morphology measurement QTL GWAS1237926 (human) | | 3e-08 | facial morphology measurement | | 4 | 125211057 | 125211058 | Human |
| 407327371 | GWAS976347_H | insomnia QTL GWAS976347 (human) | | 5e-09 | insomnia | | 4 | 125465671 | 125465672 | Human |
| 407196298 | GWAS845274_H | lipid measurement QTL GWAS845274 (human) | | 0.000003 | lipid measurement | | 4 | 124732439 | 124732440 | Human |
| 407179924 | GWAS828900_H | skin aging measurement QTL GWAS828900 (human) | | 7e-08 | skin aging measurement | | 4 | 123010723 | 123010724 | Human |
| 598141300 | GWAS1828028_H | depressive symptom measurement QTL GWAS1828028 (human) | | 0.000004 | depressive symptom measurement | | 4 | 128297339 | 128297340 | Human |
| 407179926 | GWAS828902_H | skin aging measurement QTL GWAS828902 (human) | | 0.000001 | skin aging measurement | | 4 | 122984812 | 122984813 | Human |
| 407179921 | GWAS828897_H | skin aging measurement QTL GWAS828897 (human) | | 5e-10 | skin aging measurement | | 4 | 123250668 | 123250669 | Human |
| 597305679 | GWAS1401753_H | metabolite measurement QTL GWAS1401753 (human) | | 2e-22 | metabolite measurement | | 4 | 129118729 | 129118730 | Human |
| 407179923 | GWAS828899_H | skin aging measurement QTL GWAS828899 (human) | | 3e-08 | skin aging measurement | | 4 | 123350987 | 123350988 | Human |
| 407179922 | GWAS828898_H | skin aging measurement QTL GWAS828898 (human) | | 4e-09 | skin aging measurement | | 4 | 123122397 | 123122398 | Human |
| 628649888 | GWAS2558117_H | gut microbiome measurement, breastfeeding duration QTL GWAS2558117 (human) | | 4e-08 | lactation duration (VT:1000653) | | 4 | 120360504 | 120360505 | Human |
| 628715426 | GWAS2623655_H | vaginal microbiome measurement QTL GWAS2623655 (human) | | 0.000001 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 407016092 | GWAS665068_H | inflammatory bowel disease QTL GWAS665068 (human) | | 2e-13 | inflammatory bowel disease | | 4 | 122240464 | 122240465 | Human |
| 407229092 | GWAS878068_H | BMI-adjusted hip circumference QTL GWAS878068 (human) | | 2e-09 | BMI-adjusted hip circumference | | 4 | 123145793 | 123145794 | Human |
| 628830104 | GWAS2738333_H | body height QTL GWAS2738333 (human) | | 4e-08 | body height | | 4 | 128700992 | 128700993 | Human |
| 407327394 | GWAS976370_H | QT interval QTL GWAS976370 (human) | | 2e-09 | QT interval | | 4 | 113464520 | 113464521 | Human |
| 597371261 | GWAS1467335_H | mean corpuscular hemoglobin QTL GWAS1467335 (human) | | 7e-27 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 127625245 | 127625246 | Human |
| 597371260 | GWAS1467334_H | mean corpuscular hemoglobin QTL GWAS1467334 (human) | | 3e-08 | mean corpuscular hemoglobin | | 4 | 123845801 | 123845802 | Human |
| 406901417 | GWAS550393_H | COVID-19 QTL GWAS550393 (human) | | 0.00001 | COVID-19 | | 4 | 127789647 | 127789648 | Human |
| 617066029 | GWAS2083528_H | glomerular filtration rate QTL GWAS2083528 (human) | | 3e-14 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 617066028 | GWAS2083527_H | glomerular filtration rate QTL GWAS2083527 (human) | | 4e-09 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 617033259 | GWAS2050758_H | bone tissue density QTL GWAS2050758 (human) | | 4e-40 | bone tissue density | | 4 | 126002708 | 126002709 | Human |
| 628797335 | GWAS2705564_H | alcohol consumption quality QTL GWAS2705564 (human) | | 9e-11 | alcohol consumption quality | | 4 | 112673525 | 112673526 | Human |
| 597436785 | GWAS1532859_H | open-angle glaucoma QTL GWAS1532859 (human) | | 1e-08 | open-angle glaucoma | | 4 | 127613850 | 127613851 | Human |
| 628666253 | GWAS2574482_H | bone tissue density QTL GWAS2574482 (human) | | 4e-11 | bone tissue density | | 4 | 108147096 | 108147097 | Human |
| 616967743 | GWAS1985242_H | platelet-derived growth factor complex BB dimer amount QTL GWAS1985242 (human) | | 0.000002 | platelet-derived growth factor complex BB dimer amount | | 4 | 111263595 | 111263596 | Human |
| 628748165 | GWAS2656394_H | health trait QTL GWAS2656394 (human) | | 1e-09 | health trait | | 4 | 119820087 | 119820088 | Human |
| 628748164 | GWAS2656393_H | health trait QTL GWAS2656393 (human) | | 2e-10 | health trait | | 4 | 118717973 | 118717974 | Human |
| 628797316 | GWAS2705545_H | alcohol consumption quality QTL GWAS2705545 (human) | | 1e-10 | alcohol consumption quality | | 4 | 117942113 | 117942114 | Human |
| 628748167 | GWAS2656396_H | health trait QTL GWAS2656396 (human) | | 4e-12 | health trait | | 4 | 123991477 | 123991478 | Human |
| 628748166 | GWAS2656395_H | health trait QTL GWAS2656395 (human) | | 1e-15 | health trait | | 4 | 121801213 | 121801214 | Human |
| 628518793 | GWAS2427022_H | esophageal adenocarcinoma, Barrett's esophagus QTL GWAS2427022 (human) | | 6e-13 | esophageal adenocarcinoma, Barrett's esophagus | | 4 | 123640998 | 123640999 | Human |
| 407376715 | GWAS1025691_H | response to diuretic, low density lipoprotein cholesterol measurement QTL GWAS1025691 (human) | | 0.0000002 | response to diuretic, low density lipoprotein cholesterol measurement | | 4 | 107408461 | 107408462 | Human |
| 628420209 | GWAS2328438_H | hemoglobin measurement QTL GWAS2328438 (human) | | 1e-09 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114596387 | 114596388 | Human |
| 628846206 | GWAS2754435_H | alcohol consumption quality QTL GWAS2754435 (human) | | 2e-11 | alcohol consumption quality | | 4 | 129324733 | 129324734 | Human |
| 628846205 | GWAS2754434_H | alcohol consumption quality QTL GWAS2754434 (human) | | 4e-10 | alcohol consumption quality | | 4 | 128811970 | 128811971 | Human |
| 596977820 | GWAS1097339_H | Ischemic stroke QTL GWAS1097339 (human) | | 1e-08 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
| 617033678 | GWAS2051177_H | body mass index QTL GWAS2051177 (human) | | 8e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 628797040 | GWAS2705269_H | rheumatoid arthritis QTL GWAS2705269 (human) | | 0.000002 | joint integrity trait (VT:0010548) | | 4 | 108192758 | 108192759 | Human |
| 407163726 | GWAS812702_H | coronary artery disease QTL GWAS812702 (human) | | 1e-14 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 407393091 | GWAS1042067_H | cup-to-disc ratio measurement QTL GWAS1042067 (human) | | 4e-08 | cup-to-disc ratio measurement | | 4 | 111904784 | 111904785 | Human |
| 597223571 | GWAS1319645_H | Parkinson's disease symptom measurement QTL GWAS1319645 (human) | | 0.000006 | Parkinson's disease symptom measurement | | 4 | 115200194 | 115200195 | Human |
| 407147337 | GWAS796313_H | body height QTL GWAS796313 (human) | | 6e-15 | body height | | 4 | 108487452 | 108487453 | Human |
| 597436562 | GWAS1532636_H | lipid measurement QTL GWAS1532636 (human) | | 0.000007 | lipid measurement | | 4 | 107039415 | 107039416 | Human |
| 406967118 | GWAS616094_H | chronic lymphocytic leukemia QTL GWAS616094 (human) | | 6e-09 | leukocyte integrity trait (VT:0010898) | | 4 | 108104709 | 108104710 | Human |
| 406999885 | GWAS648861_H | vital capacity QTL GWAS648861 (human) | | 8e-11 | vital capacity | | 4 | 124209285 | 124209286 | Human |
| 597125255 | GWAS1221329_H | glycerophospholipid measurement QTL GWAS1221329 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114514205 | 114514206 | Human |
| 407245654 | GWAS894630_H | glycerophospholipid measurement QTL GWAS894630 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114580433 | 114580434 | Human |
| 407245655 | GWAS894631_H | glycerophospholipid measurement QTL GWAS894631 (human) | | 5e-11 | glycerophospholipid measurement | | 4 | 114538308 | 114538309 | Human |
| 597125254 | GWAS1221328_H | glycerophospholipid measurement QTL GWAS1221328 (human) | | 4e-22 | glycerophospholipid measurement | | 4 | 114571876 | 114571877 | Human |
| 597125253 | GWAS1221327_H | glycerophospholipid measurement QTL GWAS1221327 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114571532 | 114571533 | Human |
| 407245653 | GWAS894629_H | glycerophospholipid measurement QTL GWAS894629 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114525610 | 114525611 | Human |
| 597125252 | GWAS1221326_H | glycerophospholipid measurement QTL GWAS1221326 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114570559 | 114570560 | Human |
| 597125251 | GWAS1221325_H | glycerophospholipid measurement QTL GWAS1221325 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114568870 | 114568871 | Human |
| 406901589 | GWAS550565_H | COVID-19 QTL GWAS550565 (human) | | 0.000008 | COVID-19 | | 4 | 110000832 | 110000833 | Human |
| 597125250 | GWAS1221324_H | glycerophospholipid measurement QTL GWAS1221324 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114544945 | 114544946 | Human |
| 597125249 | GWAS1221323_H | glycerophospholipid measurement QTL GWAS1221323 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114544338 | 114544339 | Human |
| 597125248 | GWAS1221322_H | glycerophospholipid measurement QTL GWAS1221322 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114549176 | 114549177 | Human |
| 598141118 | GWAS1827846_H | bone tissue density QTL GWAS1827846 (human) | | 1e-21 | bone tissue density | | 4 | 128419095 | 128419096 | Human |
| 597125262 | GWAS1221336_H | glycerophospholipid measurement QTL GWAS1221336 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114491625 | 114491626 | Human |
| 407245663 | GWAS894639_H | glycerophospholipid measurement QTL GWAS894639 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114528667 | 114528668 | Human |
| 407245660 | GWAS894636_H | glycerophospholipid measurement QTL GWAS894636 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114517522 | 114517523 | Human |
| 597125261 | GWAS1221335_H | glycerophospholipid measurement QTL GWAS1221335 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529308 | 114529309 | Human |
| 407245661 | GWAS894637_H | glycerophospholipid measurement QTL GWAS894637 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114515499 | 114515500 | Human |
| 597125260 | GWAS1221334_H | glycerophospholipid measurement QTL GWAS1221334 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529420 | 114529421 | Human |
| 597813434 | GWAS1680825_H | body mass index QTL GWAS1680825 (human) | | 0.000008 | body mass index | | 4 | 117158751 | 117158752 | Human |
| 407245658 | GWAS894634_H | glycerophospholipid measurement QTL GWAS894634 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114522432 | 114522433 | Human |
| 597125259 | GWAS1221333_H | glycerophospholipid measurement QTL GWAS1221333 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529766 | 114529767 | Human |
| 628567659 | GWAS2475888_H | sleep quality QTL GWAS2475888 (human) | | 0.000005 | sleep quality | | 4 | 118053665 | 118053666 | Human |
| 597125258 | GWAS1221332_H | glycerophospholipid measurement QTL GWAS1221332 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529776 | 114529777 | Human |
| 407245659 | GWAS894635_H | glycerophospholipid measurement QTL GWAS894635 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114553199 | 114553200 | Human |
| 407245656 | GWAS894632_H | glycerophospholipid measurement QTL GWAS894632 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114479583 | 114479584 | Human |
| 597125257 | GWAS1221331_H | glycerophospholipid measurement QTL GWAS1221331 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114489100 | 114489101 | Human |
| 407245657 | GWAS894633_H | glycerophospholipid measurement QTL GWAS894633 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114481442 | 114481443 | Human |
| 597125256 | GWAS1221330_H | glycerophospholipid measurement QTL GWAS1221330 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114571551 | 114571552 | Human |
| 628665959 | GWAS2574188_H | bone tissue density QTL GWAS2574188 (human) | | 9e-11 | bone tissue density | | 4 | 119112788 | 119112789 | Human |
| 407245670 | GWAS894646_H | glycerophospholipid measurement QTL GWAS894646 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114495078 | 114495079 | Human |
| 628682328 | GWAS2590557_H | body height QTL GWAS2590557 (human) | | 4e-22 | body height | | 4 | 122904764 | 122904765 | Human |
| 407245671 | GWAS894647_H | glycerophospholipid measurement QTL GWAS894647 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114483807 | 114483808 | Human |
| 597584063 | GWAS1640923_H | mean corpuscular volume QTL GWAS1640923 (human) | | 2e-33 | mean corpuscular volume | | 4 | 121854912 | 121854913 | Human |
| 596961462 | GWAS1080981_H | metabolic syndrome QTL GWAS1080981 (human) | | 1e-08 | metabolic syndrome | | 4 | 111770620 | 111770621 | Human |
| 407245668 | GWAS894644_H | glycerophospholipid measurement QTL GWAS894644 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114494754 | 114494755 | Human |
| 407245669 | GWAS894645_H | glycerophospholipid measurement QTL GWAS894645 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114502041 | 114502042 | Human |
| 596961463 | GWAS1080982_H | metabolic syndrome QTL GWAS1080982 (human) | | 2e-09 | metabolic syndrome | | 4 | 118238526 | 118238527 | Human |
| 407245666 | GWAS894642_H | glycerophospholipid measurement QTL GWAS894642 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114501793 | 114501794 | Human |
| 407245664 | GWAS894640_H | glycerophospholipid measurement QTL GWAS894640 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114495098 | 114495099 | Human |
| 407245665 | GWAS894641_H | glycerophospholipid measurement QTL GWAS894641 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114531582 | 114531583 | Human |
| 597289139 | GWAS1385213_H | glomerular filtration rate, bipolar disorder QTL GWAS1385213 (human) | | 3e-08 | glomerular filtration rate, bipolar disorder | | 4 | 122596491 | 122596492 | Human |
| 407245674 | GWAS894650_H | glycerophospholipid measurement QTL GWAS894650 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114557814 | 114557815 | Human |
| 596961464 | GWAS1080983_H | metabolic syndrome QTL GWAS1080983 (human) | | 4e-08 | metabolic syndrome | | 4 | 119318723 | 119318724 | Human |
| 597190837 | GWAS1286911_H | cesarean section, anxiety QTL GWAS1286911 (human) | | 1e-09 | cesarean section, anxiety | | 4 | 106962429 | 106962430 | Human |
| 407245675 | GWAS894651_H | glycerophospholipid measurement QTL GWAS894651 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114569301 | 114569302 | Human |
| 596961465 | GWAS1080984_H | metabolic syndrome QTL GWAS1080984 (human) | | 1e-11 | metabolic syndrome | | 4 | 129810129 | 129810130 | Human |
| 407245673 | GWAS894649_H | glycerophospholipid measurement QTL GWAS894649 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114484294 | 114484295 | Human |
| 597174440 | GWAS1270514_H | body mass index QTL GWAS1270514 (human) | | 1e-08 | body mass index | | 4 | 129399809 | 129399810 | Human |
| 597174441 | GWAS1270515_H | body mass index QTL GWAS1270515 (human) | | 6e-09 | body mass index | | 4 | 130097733 | 130097734 | Human |
| 597321896 | GWAS1417970_H | colorectal cancer QTL GWAS1417970 (human) | | 2e-08 | colorectal cancer | | 4 | 114581250 | 114581251 | Human |
| 628518468 | GWAS2426697_H | Barrett's esophagus QTL GWAS2426697 (human) | | 3e-09 | Barrett's esophagus | | 4 | 123619833 | 123619834 | Human |
| 628846158 | GWAS2754387_H | mannitol measurement, sorbitol measurement QTL GWAS2754387 (human) | | 0.000003 | mannitol measurement, sorbitol measurement | | 4 | 112447703 | 112447704 | Human |
| 628502080 | GWAS2410309_H | appendicular lean mass QTL GWAS2410309 (human) | | 3e-22 | body lean mass (VT:0010483) | | 4 | 124035957 | 124035958 | Human |
| 628715072 | GWAS2623301_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2623301 (human) | | 1e-13 | level of fatty acid-binding protein, intestinal in blood | | 4 | 118965701 | 118965702 | Human |
| 407360382 | GWAS1009358_H | bilirubin measurement QTL GWAS1009358 (human) | | 7e-11 | bilirubin measurement | | 4 | 123849638 | 123849639 | Human |
| 407360381 | GWAS1009357_H | bilirubin measurement QTL GWAS1009357 (human) | | 2e-09 | bilirubin measurement | | 4 | 109921728 | 109921729 | Human |
| 628960838 | GWAS2869067_H | macular degeneration QTL GWAS2869067 (human) | | 1e-25 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 597174438 | GWAS1270512_H | body mass index QTL GWAS1270512 (human) | | 7e-10 | body mass index | | 4 | 118298754 | 118298755 | Human |
| 597174439 | GWAS1270513_H | body mass index QTL GWAS1270513 (human) | | 8e-11 | body mass index | | 4 | 119292875 | 119292876 | Human |
| 407065347 | GWAS714323_H | retinal vasculature measurement QTL GWAS714323 (human) | | 7e-58 | retinal vasculature measurement | | 4 | 119356945 | 119356946 | Human |
| 617000839 | GWAS2018338_H | childhood trauma measurement QTL GWAS2018338 (human) | | 1e-08 | childhood trauma measurement | | 4 | 118266477 | 118266478 | Human |
| 597371097 | GWAS1467171_H | respiratory quotient QTL GWAS1467171 (human) | | 0.000008 | respiratory quotient | | 4 | 127420965 | 127420966 | Human |
| 406917890 | GWAS566866_H | Astigmatism QTL GWAS566866 (human) | | 0.000009 | Astigmatism | | 4 | 119266456 | 119266457 | Human |
| 628715066 | GWAS2623295_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2623295 (human) | | 7e-228 | level of fatty acid-binding protein, intestinal in blood | | 4 | 119359462 | 119359463 | Human |
| 628715069 | GWAS2623298_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2623298 (human) | | 6e-37 | level of fatty acid-binding protein, intestinal in blood | | 4 | 119779454 | 119779455 | Human |
| 628403760 | GWAS2311989_H | erythrocyte volume QTL GWAS2311989 (human) | | 4e-73 | erythrocyte volume | | 4 | 121814898 | 121814899 | Human |
| 628715068 | GWAS2623297_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2623297 (human) | | 1e-25 | level of fatty acid-binding protein, intestinal in blood | | 4 | 119029200 | 119029201 | Human |
| 628403761 | GWAS2311990_H | erythrocyte volume QTL GWAS2311990 (human) | | 2e-28 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 127625245 | 127625246 | Human |
| 628715071 | GWAS2623300_H | level of fatty acid-binding protein, intestinal in blood QTL GWAS2623300 (human) | | 6e-17 | level of fatty acid-binding protein, intestinal in blood | | 4 | 120049137 | 120049138 | Human |
| 628846141 | GWAS2754370_H | opioid dependence QTL GWAS2754370 (human) | | 0.0000006 | response to addictive substance trait (VT:0010488) | | 4 | 125271758 | 125271759 | Human |
| 597043422 | GWAS1139496_H | schizophrenia QTL GWAS1139496 (human) | | 8e-09 | schizophrenia | | 4 | 117906596 | 117906597 | Human |
| 616525813 | GWAS1922396_H | cathepsin F measurement QTL GWAS1922396 (human) | | 7e-36 | cathepsin F measurement | | 4 | 118811292 | 118811293 | Human |
| 628862512 | GWAS2770741_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS2770741 (human) | | 7e-08 | joint integrity trait (VT:0010548) | | 4 | 108140462 | 108140463 | Human |
| 597829870 | GWAS1697261_H | CCL11 measurement QTL GWAS1697261 (human) | | 0.000003 | CCL11 measurement | | 4 | 113652791 | 113652792 | Human |
| 628469285 | GWAS2377514_H | brain attribute QTL GWAS2377514 (human) | | 4e-10 | brain attribute | | 4 | 118393759 | 118393760 | Human |
| 616525806 | GWAS1922389_H | mean reticulocyte volume QTL GWAS1922389 (human) | | 9e-67 | mean reticulocyte volume | | 4 | 121808257 | 121808258 | Human |
| 617082772 | GWAS2100271_H | QRS duration QTL GWAS2100271 (human) | | 2e-09 | QRS duration | | 4 | 123829743 | 123829744 | Human |
| 597403848 | GWAS1499922_H | neurofibrillary tangles measurement QTL GWAS1499922 (human) | | 0.000004 | brain integrity trait (VT:0010579) | | 4 | 129315073 | 129315074 | Human |
| 597272783 | GWAS1368857_H | schizophrenia QTL GWAS1368857 (human) | | 0.000002 | schizophrenia | | 4 | 122467361 | 122467362 | Human |
| 628715054 | GWAS2623283_H | coronary artery disease QTL GWAS2623283 (human) | | 3e-16 | coronary artery integrity trait (VT:0010746) | | 4 | 119988346 | 119988347 | Human |
| 628403759 | GWAS2311988_H | erythrocyte volume QTL GWAS2311988 (human) | | 9e-14 | erythrocyte volume | | 4 | 109933275 | 109933276 | Human |
| 406983452 | GWAS632428_H | endometriosis QTL GWAS632428 (human) | | 0.0000008 | endometriosis | | 4 | 114744719 | 114744720 | Human |
| 628796964 | GWAS2705193_H | COVID-19 QTL GWAS2705193 (human) | | 0.000007 | COVID-19 | | 4 | 122087606 | 122087607 | Human |
| 616984486 | GWAS2001985_H | triglyceride measurement, response to diuretic QTL GWAS2001985 (human) | | 6e-08 | triglyceride measurement, response to diuretic | | 4 | 129379460 | 129379461 | Human |
| 617263019 | GWAS2199795_H | fatty acid amount QTL GWAS2199795 (human) | | 8e-14 | fatty acid amount | | 4 | 109174464 | 109174465 | Human |
| 406901537 | GWAS550513_H | seasonal allergic rhinitis QTL GWAS550513 (human) | | 0.000001 | seasonal allergic rhinitis | | 4 | 122451978 | 122451979 | Human |
| 628796953 | GWAS2705182_H | COVID-19 QTL GWAS2705182 (human) | | 0.000009 | COVID-19 | | 4 | 127021337 | 127021338 | Human |
| 617263022 | GWAS2199798_H | fatty acid amount QTL GWAS2199798 (human) | | 3e-08 | fatty acid amount | | 4 | 110186345 | 110186346 | Human |
| 407327523 | GWAS976499_H | blood urea nitrogen measurement QTL GWAS976499 (human) | | 4e-08 | blood urea nitrogen measurement | | 4 | 119076757 | 119076758 | Human |
| 617263023 | GWAS2199799_H | fatty acid amount QTL GWAS2199799 (human) | | 2e-08 | omega-6 polyunsaturated fatty acid measurement | | 4 | 110191632 | 110191633 | Human |
| 617263021 | GWAS2199797_H | fatty acid amount QTL GWAS2199797 (human) | | 3e-17 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 407229218 | GWAS878194_H | bone density QTL GWAS878194 (human) | | 2e-10 | bone density | | 4 | 122897478 | 122897479 | Human |
| 597403900 | GWAS1499974_H | pelvic organ prolapse QTL GWAS1499974 (human) | | 0.000002 | pelvic organ prolapse | | 4 | 123466324 | 123466325 | Human |
| 628682256 | GWAS2590485_H | body mass index QTL GWAS2590485 (human) | | 2e-09 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
| 597371121 | GWAS1467195_H | metabolite measurement QTL GWAS1467195 (human) | | 7e-13 | metabolite measurement | | 4 | 110413574 | 110413575 | Human |
| 616361942 | GWAS1846657_H | breast carcinoma QTL GWAS1846657 (human) | | 0.000003 | breast carcinoma | | 4 | 116639835 | 116639836 | Human |
| 628469273 | GWAS2377502_H | brain attribute QTL GWAS2377502 (human) | | 2e-08 | brain attribute | | 4 | 123335936 | 123335937 | Human |
| 616361932 | GWAS1846647_H | growth rate attribute, age at assessment QTL GWAS1846647 (human) | | 0.000004 | growth rate attribute, age at assessment | | 4 | 108011006 | 108011007 | Human |
| 407376699 | GWAS1025675_H | appendicular lean mass QTL GWAS1025675 (human) | | 2e-08 | appendicular lean mass | | 4 | 119742494 | 119742495 | Human |
| 407114544 | GWAS763520_H | neutrophil percentage of leukocytes QTL GWAS763520 (human) | | 1e-16 | neutrophil percentage of leukocytes | | 4 | 112183604 | 112183605 | Human |
| 597289196 | GWAS1385270_H | stroke QTL GWAS1385270 (human) | | 0.0000004 | stroke | | 4 | 112810934 | 112810935 | Human |
| 616542150 | GWAS1938733_H | glypican-1 measurement QTL GWAS1938733 (human) | | 1e-13 | glypican-1 measurement | | 4 | 128276344 | 128276345 | Human |
| 628796929 | GWAS2705158_H | COVID-19 QTL GWAS2705158 (human) | | 0.000008 | COVID-19 | | 4 | 110000832 | 110000833 | Human |
| 597321957 | GWAS1418031_H | cup-to-disc ratio measurement QTL GWAS1418031 (human) | | 6e-10 | cup-to-disc ratio measurement | | 4 | 125318831 | 125318832 | Human |
| 597370907 | GWAS1466981_H | mean corpuscular volume QTL GWAS1466981 (human) | | 4e-73 | mean corpuscular volume | | 4 | 121814898 | 121814899 | Human |
| 407196609 | GWAS845585_H | coronary artery calcification QTL GWAS845585 (human) | | 0.0000002 | coronary artery calcification | | 4 | 128541212 | 128541213 | Human |
| 598075427 | GWAS1794726_H | electrocardiography, magnetic resonance imaging of the heart QTL GWAS1794726 (human) | | 4e-31 | electrocardiography, magnetic resonance imaging of the heart | | 4 | 113508251 | 113508252 | Human |
| 597288978 | GWAS1385052_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1385052 (human) | | 1e-09 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 598075433 | GWAS1794732_H | electrocardiography, magnetic resonance imaging of the heart QTL GWAS1794732 (human) | | 2e-08 | electrocardiography, magnetic resonance imaging of the heart | | 4 | 110782354 | 110782355 | Human |
| 628649717 | GWAS2557946_H | height growth attribute QTL GWAS2557946 (human) | | 0.000003 | height growth attribute | | 4 | 108080989 | 108080990 | Human |
| 616968008 | GWAS1985507_H | monokine induced by gamma interferon measurement QTL GWAS1985507 (human) | | 0.000004 | chemokine amount (VT:0008721) | | 4 | 122707083 | 122707084 | Human |
| 597583887 | GWAS1640747_H | mean corpuscular volume QTL GWAS1640747 (human) | | 6e-33 | mean corpuscular volume | | 4 | 121854912 | 121854913 | Human |
| 407016400 | GWAS665376_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS665376 (human) | | 2e-12 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110485340 | 110485341 | Human |
| 598157365 | GWAS1836435_H | osteoarthritis, knee QTL GWAS1836435 (human) | | 1e-11 | osteoarthritis, knee | | 4 | 120722084 | 120722085 | Human |
| 407147479 | GWAS796455_H | mosquito bite reaction size measurement QTL GWAS796455 (human) | | 4e-11 | mosquito bite reaction size measurement | | 4 | 123250679 | 123250680 | Human |
| 616984402 | GWAS2001901_H | mean corpuscular hemoglobin QTL GWAS2001901 (human) | | 3e-08 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 123845801 | 123845802 | Human |
| 597616646 | GWAS1673506_H | gastric ulcer, hemorrhage QTL GWAS1673506 (human) | | 2e-11 | gastric ulcer, hemorrhage | | 4 | 115240446 | 115240447 | Human |
| 407147486 | GWAS796462_H | mosquito bite reaction size measurement QTL GWAS796462 (human) | | 0.0000002 | mosquito bite reaction size measurement | | 4 | 123041811 | 123041812 | Human |
| 407147481 | GWAS796457_H | mosquito bite reaction size measurement QTL GWAS796457 (human) | | 0.000004 | mosquito bite reaction size measurement | | 4 | 123350979 | 123350980 | Human |
| 628780772 | GWAS2689001_H | apolipoprotein A 1 measurement QTL GWAS2689001 (human) | | 9e-13 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109717608 | 109717609 | Human |
| 628682470 | GWAS2590699_H | heart failure QTL GWAS2590699 (human) | | 2e-24 | heart integrity trait (VT:0010757) | | 4 | 110780277 | 110780278 | Human |
| 597125175 | GWAS1221249_H | glycerophospholipid measurement QTL GWAS1221249 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114542460 | 114542461 | Human |
| 597125174 | GWAS1221248_H | glycerophospholipid measurement QTL GWAS1221248 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114541220 | 114541221 | Human |
| 407213031 | GWAS862007_H | Ischemic stroke QTL GWAS862007 (human) | | 0.000002 | Ischemic stroke | | 4 | 110308365 | 110308366 | Human |
| 597125173 | GWAS1221247_H | glycerophospholipid measurement QTL GWAS1221247 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114576504 | 114576505 | Human |
| 597387321 | GWAS1483395_H | primary biliary cirrhosis QTL GWAS1483395 (human) | | 1e-11 | primary biliary cirrhosis | | 4 | 122628544 | 122628545 | Human |
| 597125172 | GWAS1221246_H | glycerophospholipid measurement QTL GWAS1221246 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114546228 | 114546229 | Human |
| 597125171 | GWAS1221245_H | glycerophospholipid measurement QTL GWAS1221245 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114579403 | 114579404 | Human |
| 597125170 | GWAS1221244_H | glycerophospholipid measurement QTL GWAS1221244 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114560598 | 114560599 | Human |
| 597125183 | GWAS1221257_H | glycerophospholipid measurement QTL GWAS1221257 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114493049 | 114493050 | Human |
| 597338162 | GWAS1434236_H | total cholesterol measurement QTL GWAS1434236 (human) | | 2e-08 | total cholesterol measurement | | 4 | 127977878 | 127977879 | Human |
| 597125182 | GWAS1221256_H | glycerophospholipid measurement QTL GWAS1221256 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114492998 | 114492999 | Human |
| 628502236 | GWAS2410465_H | biological sex QTL GWAS2410465 (human) | | 5e-13 | biological sex | | 4 | 111485805 | 111485806 | Human |
| 597125181 | GWAS1221255_H | glycerophospholipid measurement QTL GWAS1221255 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114552771 | 114552772 | Human |
| 597125180 | GWAS1221254_H | glycerophospholipid measurement QTL GWAS1221254 (human) | | 4e-26 | glycerophospholipid measurement | | 4 | 114494204 | 114494205 | Human |
| 597125179 | GWAS1221253_H | glycerophospholipid measurement QTL GWAS1221253 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114578461 | 114578462 | Human |
| 617066347 | GWAS2083846_H | schizophrenia QTL GWAS2083846 (human) | | 2e-11 | schizophrenia | | 4 | 117906596 | 117906597 | Human |
| 597125178 | GWAS1221252_H | glycerophospholipid measurement QTL GWAS1221252 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114578518 | 114578519 | Human |
| 598091784 | GWAS1811083_H | body height QTL GWAS1811083 (human) | | 1e-12 | body height | | 4 | 108494980 | 108494981 | Human |
| 597125177 | GWAS1221251_H | glycerophospholipid measurement QTL GWAS1221251 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114560232 | 114560233 | Human |
| 597125176 | GWAS1221250_H | glycerophospholipid measurement QTL GWAS1221250 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114542537 | 114542538 | Human |
| 598091785 | GWAS1811084_H | body height QTL GWAS1811084 (human) | | 2e-09 | body height | | 4 | 124024877 | 124024878 | Human |
| 598009876 | GWAS1729175_H | AGRN/HSPG2 protein level ratio in blood QTL GWAS1729175 (human) | | 6e-54 | AGRN/HSPG2 protein level ratio in blood | | 4 | 118376502 | 118376503 | Human |
| 407409659 | GWAS1058635_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1058635 (human) | | 0.000002 | severe acute respiratory syndrome, COVID-19 | | 4 | 119432971 | 119432972 | Human |
| 628862671 | GWAS2770900_H | heart failure QTL GWAS2770900 (human) | | 5e-42 | heart integrity trait (VT:0010757) | | 4 | 110787848 | 110787849 | Human |
| 617262962 | GWAS2199738_H | fatty acid amount QTL GWAS2199738 (human) | | 2e-08 | fatty acid amount | | 4 | 110191021 | 110191022 | Human |
| 617262960 | GWAS2199736_H | fatty acid amount QTL GWAS2199736 (human) | | 4e-11 | fatty acid amount | | 4 | 109345757 | 109345758 | Human |
| 617262961 | GWAS2199737_H | fatty acid amount QTL GWAS2199737 (human) | | 3e-14 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 597338149 | GWAS1434223_H | irritable bowel syndrome, major depressive disorder QTL GWAS1434223 (human) | | 3e-09 | intestine integrity trait (VT:0010554) | | 4 | 122201701 | 122201702 | Human |
| 407245702 | GWAS894678_H | glycerophospholipid measurement QTL GWAS894678 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114542460 | 114542461 | Human |
| 406934401 | GWAS583377_H | heel bone mineral density QTL GWAS583377 (human) | | 2e-10 | heel bone mineral density | | 4 | 118871804 | 118871805 | Human |
| 597993572 | GWAS1712871_H | body height QTL GWAS1712871 (human) | | 5e-13 | body height | | 4 | 123228081 | 123228082 | Human |
| 407245703 | GWAS894679_H | glycerophospholipid measurement QTL GWAS894679 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114542537 | 114542538 | Human |
| 597993573 | GWAS1712872_H | body height QTL GWAS1712872 (human) | | 5e-16 | body height | | 4 | 123987076 | 123987077 | Human |
| 407245700 | GWAS894676_H | glycerophospholipid measurement QTL GWAS894676 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114576504 | 114576505 | Human |
| 597993574 | GWAS1712873_H | body height QTL GWAS1712873 (human) | | 2e-08 | body height | | 4 | 128700411 | 128700412 | Human |
| 407245701 | GWAS894677_H | glycerophospholipid measurement QTL GWAS894677 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114541220 | 114541221 | Human |
| 407245698 | GWAS894674_H | glycerophospholipid measurement QTL GWAS894674 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114579403 | 114579404 | Human |
| 597993568 | GWAS1712867_H | body height QTL GWAS1712867 (human) | | 2e-08 | body height | | 4 | 119700262 | 119700263 | Human |
| 407245699 | GWAS894675_H | glycerophospholipid measurement QTL GWAS894675 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114546228 | 114546229 | Human |
| 597993569 | GWAS1712868_H | body height QTL GWAS1712868 (human) | | 4e-19 | body height | | 4 | 119834940 | 119834941 | Human |
| 597207133 | GWAS1303207_H | wellbeing measurement QTL GWAS1303207 (human) | | 0.000005 | wellness/fitness trait (VT:1000152) | | 4 | 125346188 | 125346189 | Human |
| 407245696 | GWAS894672_H | glycerophospholipid measurement QTL GWAS894672 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114555226 | 114555227 | Human |
| 597993570 | GWAS1712869_H | body height QTL GWAS1712869 (human) | | 9e-08 | body height | | 4 | 121657567 | 121657568 | Human |
| 407245697 | GWAS894673_H | glycerophospholipid measurement QTL GWAS894673 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114560598 | 114560599 | Human |
| 628682431 | GWAS2590660_H | sarcoidosis QTL GWAS2590660 (human) | | 0.000004 | sarcoidosis | | 4 | 122800348 | 122800349 | Human |
| 597993571 | GWAS1712870_H | body height QTL GWAS1712870 (human) | | 2e-24 | body height | | 4 | 122904764 | 122904765 | Human |
| 406934406 | GWAS583382_H | heel bone mineral density QTL GWAS583382 (human) | | 4e-14 | heel bone mineral density | | 4 | 123706225 | 123706226 | Human |
| 407245710 | GWAS894686_H | glycerophospholipid measurement QTL GWAS894686 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114493049 | 114493050 | Human |
| 407245711 | GWAS894687_H | glycerophospholipid measurement QTL GWAS894687 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114493188 | 114493189 | Human |
| 407245708 | GWAS894684_H | glycerophospholipid measurement QTL GWAS894684 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114552771 | 114552772 | Human |
| 407245709 | GWAS894685_H | glycerophospholipid measurement QTL GWAS894685 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114492998 | 114492999 | Human |
| 407180174 | GWAS829150_H | BMI-adjusted waist-hip ratio QTL GWAS829150 (human) | | 4e-08 | BMI-adjusted waist-hip ratio | | 4 | 123002800 | 123002801 | Human |
| 407245706 | GWAS894682_H | glycerophospholipid measurement QTL GWAS894682 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114578461 | 114578462 | Human |
| 407245707 | GWAS894683_H | glycerophospholipid measurement QTL GWAS894683 (human) | | 4e-26 | glycerophospholipid measurement | | 4 | 114494204 | 114494205 | Human |
| 617049866 | GWAS2067365_H | blood protein amount QTL GWAS2067365 (human) | | 8e-13 | blood protein amount | | 4 | 122625127 | 122625128 | Human |
| 407311241 | GWAS960217_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS960217 (human) | | 3e-11 | total cholesterol measurement, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 628797108 | GWAS2705337_H | alcohol consumption quality QTL GWAS2705337 (human) | | 9e-13 | alcohol consumption quality | | 4 | 112386757 | 112386758 | Human |
| 407245704 | GWAS894680_H | glycerophospholipid measurement QTL GWAS894680 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114560232 | 114560233 | Human |
| 625831555 | GWAS2252477_H | breast cancer QTL GWAS2252477 (human) | | 1e-08 | breast cancer | | 4 | 121827841 | 121827842 | Human |
| 407245705 | GWAS894681_H | glycerophospholipid measurement QTL GWAS894681 (human) | | 2e-26 | glycerophospholipid measurement | | 4 | 114578518 | 114578519 | Human |
| 597993579 | GWAS1712878_H | body height QTL GWAS1712878 (human) | | 4e-44 | body height | | 4 | 121800257 | 121800258 | Human |
| 597125190 | GWAS1221264_H | glycerophospholipid measurement QTL GWAS1221264 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495547 | 114495548 | Human |
| 407245716 | GWAS894692_H | glycerophospholipid measurement QTL GWAS894692 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532641 | 114532642 | Human |
| 597125189 | GWAS1221263_H | glycerophospholipid measurement QTL GWAS1221263 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532641 | 114532642 | Human |
| 617033493 | GWAS2050992_H | neuroimaging measurement QTL GWAS2050992 (human) | | 0.000001 | neuroimaging measurement | | 4 | 120211752 | 120211753 | Human |
| 597125188 | GWAS1221262_H | glycerophospholipid measurement QTL GWAS1221262 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495414 | 114495415 | Human |
| 407245717 | GWAS894693_H | glycerophospholipid measurement QTL GWAS894693 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114549757 | 114549758 | Human |
| 617033492 | GWAS2050991_H | neuroimaging measurement QTL GWAS2050991 (human) | | 6e-09 | neuroimaging measurement | | 4 | 120199264 | 120199265 | Human |
| 407180182 | GWAS829158_H | BMI-adjusted waist-hip ratio QTL GWAS829158 (human) | | 2e-11 | BMI-adjusted waist-hip ratio | | 4 | 123166618 | 123166619 | Human |
| 598157428 | GWAS1836498_H | osteoarthritis, hip QTL GWAS1836498 (human) | | 3e-09 | osteoarthritis, hip | | 4 | 123863724 | 123863725 | Human |
| 407376795 | GWAS1025771_H | body mass index QTL GWAS1025771 (human) | | 4e-08 | body mass index | | 4 | 130102129 | 130102130 | Human |
| 407245714 | GWAS894690_H | glycerophospholipid measurement QTL GWAS894690 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532620 | 114532621 | Human |
| 597125187 | GWAS1221261_H | glycerophospholipid measurement QTL GWAS1221261 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532620 | 114532621 | Human |
| 407245715 | GWAS894691_H | glycerophospholipid measurement QTL GWAS894691 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495414 | 114495415 | Human |
| 597125186 | GWAS1221260_H | glycerophospholipid measurement QTL GWAS1221260 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532551 | 114532552 | Human |
| 407180176 | GWAS829152_H | BMI-adjusted waist-hip ratio QTL GWAS829152 (human) | | 9e-11 | BMI-adjusted waist-hip ratio | | 4 | 123124286 | 123124287 | Human |
| 407245712 | GWAS894688_H | glycerophospholipid measurement QTL GWAS894688 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532477 | 114532478 | Human |
| 597125185 | GWAS1221259_H | glycerophospholipid measurement QTL GWAS1221259 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532477 | 114532478 | Human |
| 628584097 | GWAS2492326_H | carotid artery thickness QTL GWAS2492326 (human) | | 0.000006 | carotid artery thickness | | 4 | 118504756 | 118504757 | Human |
| 597125184 | GWAS1221258_H | glycerophospholipid measurement QTL GWAS1221258 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114493188 | 114493189 | Human |
| 407245713 | GWAS894689_H | glycerophospholipid measurement QTL GWAS894689 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114532551 | 114532552 | Human |
| 628797090 | GWAS2705319_H | alcohol consumption quality QTL GWAS2705319 (human) | | 8e-11 | alcohol consumption quality | | 4 | 112673472 | 112673473 | Human |
| 628797091 | GWAS2705320_H | alcohol consumption quality QTL GWAS2705320 (human) | | 1e-10 | alcohol consumption quality | | 4 | 128806522 | 128806523 | Human |
| 628567722 | GWAS2475951_H | gout QTL GWAS2475951 (human) | | 3e-08 | joint integrity trait (VT:0010548) | | 4 | 123815050 | 123815051 | Human |
| 628797092 | GWAS2705321_H | alcohol consumption quality QTL GWAS2705321 (human) | | 5e-14 | alcohol consumption quality | | 4 | 129324733 | 129324734 | Human |
| 407376791 | GWAS1025767_H | body mass index QTL GWAS1025767 (human) | | 3e-11 | body mass index | | 4 | 111826763 | 111826764 | Human |
| 628420267 | GWAS2328496_H | hemoglobin measurement QTL GWAS2328496 (human) | | 2e-11 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 123844107 | 123844108 | Human |
| 617148183 | GWAS2165682_H | body weight QTL GWAS2165682 (human) | | 3e-15 | body weight | | 4 | 129824994 | 129824995 | Human |
| 628633242 | GWAS2541471_H | gut microbiome measurement, breastfeeding duration QTL GWAS2541471 (human) | | 4e-08 | lactation duration (VT:1000653) | | 4 | 112409784 | 112409785 | Human |
| 617049891 | GWAS2067390_H | BMI-adjusted waist circumference QTL GWAS2067390 (human) | | 2e-09 | BMI-adjusted waist circumference | | 4 | 119768762 | 119768763 | Human |
| 617049890 | GWAS2067389_H | BMI-adjusted waist circumference QTL GWAS2067389 (human) | | 2e-13 | BMI-adjusted waist circumference | | 4 | 119649123 | 119649124 | Human |
| 628846236 | GWAS2754465_H | brain physiology trait QTL GWAS2754465 (human) | | 7e-09 | brain physiology trait | | 4 | 116995997 | 116995998 | Human |
| 597125247 | GWAS1221321_H | glycerophospholipid measurement QTL GWAS1221321 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114532227 | 114532228 | Human |
| 597125246 | GWAS1221320_H | glycerophospholipid measurement QTL GWAS1221320 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114503010 | 114503011 | Human |
| 597125245 | GWAS1221319_H | glycerophospholipid measurement QTL GWAS1221319 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490702 | 114490703 | Human |
| 597125244 | GWAS1221318_H | glycerophospholipid measurement QTL GWAS1221318 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114568887 | 114568888 | Human |
| 597125243 | GWAS1221317_H | glycerophospholipid measurement QTL GWAS1221317 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490912 | 114490913 | Human |
| 597125242 | GWAS1221316_H | glycerophospholipid measurement QTL GWAS1221316 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490871 | 114490872 | Human |
| 617049898 | GWAS2067397_H | blood protein amount QTL GWAS2067397 (human) | | 4e-16 | blood protein amount | | 4 | 119210489 | 119210490 | Human |
| 597125241 | GWAS1221315_H | glycerophospholipid measurement QTL GWAS1221315 (human) | | 2e-23 | glycerophospholipid measurement | | 4 | 114485894 | 114485895 | Human |
| 407294888 | GWAS943864_H | brain measurement QTL GWAS943864 (human) | | 4e-12 | brain measurement | | 4 | 120306999 | 120307000 | Human |
| 597076068 | GWAS1172142_H | late-onset Alzheimers disease QTL GWAS1172142 (human) | | 0.000004 | late-onset Alzheimers disease | | 4 | 109534350 | 109534351 | Human |
| 628846217 | GWAS2754446_H | alcohol consumption quality QTL GWAS2754446 (human) | | 4e-09 | alcohol consumption quality | | 4 | 117942113 | 117942114 | Human |
| 597502063 | GWAS1598137_H | suicide QTL GWAS1598137 (human) | | 0.000004 | suicide | | 4 | 125969849 | 125969850 | Human |
| 597436520 | GWAS1532594_H | open-angle glaucoma QTL GWAS1532594 (human) | | 7e-15 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 597436521 | GWAS1532595_H | open-angle glaucoma QTL GWAS1532595 (human) | | 4e-12 | open-angle glaucoma | | 4 | 111886876 | 111886877 | Human |
| 597436522 | GWAS1532596_H | open-angle glaucoma QTL GWAS1532596 (human) | | 1e-09 | open-angle glaucoma | | 4 | 125994594 | 125994595 | Human |
| 617131828 | GWAS2149327_H | complement factor I measurement QTL GWAS2149327 (human) | | 9e-78 | complement factor I measurement | | 4 | 109764664 | 109764665 | Human |
| 617131829 | GWAS2149328_H | complement factor I measurement QTL GWAS2149328 (human) | | 1e-11 | complement factor I measurement | | 4 | 109815148 | 109815149 | Human |
| 597239908 | GWAS1335982_H | Myopia QTL GWAS1335982 (human) | | 0.000005 | Myopia | | 4 | 125625005 | 125625006 | Human |
| 597076072 | GWAS1172146_H | late-onset Alzheimers disease QTL GWAS1172146 (human) | | 0.0000008 | late-onset Alzheimers disease | | 4 | 109251730 | 109251731 | Human |
| 597585820 | GWAS1642680_H | creatinine measurement QTL GWAS1642680 (human) | | 1e-11 | creatinine measurement | | 4 | 108787299 | 108787300 | Human |
| 616491196 | GWAS1887779_H | ceramide amount QTL GWAS1887779 (human) | | 6e-13 | ceramide amount | | 4 | 114469978 | 114469979 | Human |
| 616491197 | GWAS1887780_H | ceramide amount QTL GWAS1887780 (human) | | 2e-20 | ceramide amount | | 4 | 114663873 | 114663874 | Human |
| 597585821 | GWAS1642681_H | creatinine measurement QTL GWAS1642681 (human) | | 4e-12 | creatinine measurement | | 4 | 127291035 | 127291036 | Human |
| 407245891 | GWAS894867_H | glycerophospholipid measurement QTL GWAS894867 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114479168 | 114479169 | Human |
| 598077346 | GWAS1796645_H | bone density QTL GWAS1796645 (human) | | 9e-11 | bone density | | 4 | 119112788 | 119112789 | Human |
| 407311439 | GWAS960415_H | testosterone measurement QTL GWAS960415 (human) | | 5e-13 | testosterone measurement | | 4 | 114419750 | 114419751 | Human |
| 407196751 | GWAS845727_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS845727 (human) | | 4e-12 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119320694 | 119320695 | Human |
| 597159835 | GWAS1255909_H | lipid measurement QTL GWAS1255909 (human) | | 0.000003 | lipid measurement | | 4 | 124732439 | 124732440 | Human |
| 628451704 | GWAS2359933_H | atrial fibrillation QTL GWAS2359933 (human) | | 8e-18 | atrial fibrillation | | 4 | 111244056 | 111244057 | Human |
| 616999126 | GWAS2016625_H | atrial fibrillation QTL GWAS2016625 (human) | | 4e-427 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407032912 | GWAS681888_H | chronic lymphocytic leukemia QTL GWAS681888 (human) | | 0.0000001 | chronic lymphocytic leukemia | | 4 | 108105258 | 108105259 | Human |
| 597307278 | GWAS1403352_H | body height QTL GWAS1403352 (human) | | 2e-10 | body height | | 4 | 121736832 | 121736833 | Human |
| 628517228 | GWAS2425457_H | platelet count QTL GWAS2425457 (human) | | 2e-80 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110027819 | 110027820 | Human |
| 617064669 | GWAS2082168_H | X-24422 measurement QTL GWAS2082168 (human) | | 3e-13 | X-24422 measurement | | 4 | 122894208 | 122894209 | Human |
| 628517229 | GWAS2425458_H | platelet count QTL GWAS2425458 (human) | | 1e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119622957 | 119622958 | Human |
| 407049304 | GWAS698280_H | cortical thickness QTL GWAS698280 (human) | | 5e-15 | cortical thickness | | 4 | 120793484 | 120793485 | Human |
| 628943200 | GWAS2851429_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2851429 (human) | | 2e-10 | fatty acid amount (VT:0010046) | | 4 | 109345757 | 109345758 | Human |
| 628943201 | GWAS2851430_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2851430 (human) | | 6e-13 | fatty acid amount (VT:0010046) | | 4 | 109603883 | 109603884 | Human |
| 628517227 | GWAS2425456_H | platelet count QTL GWAS2425456 (human) | | 2e-30 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109990751 | 109990752 | Human |
| 407245926 | GWAS894902_H | glycerophospholipid measurement QTL GWAS894902 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114494469 | 114494470 | Human |
| 628418901 | GWAS2327130_H | Abnormality of refraction QTL GWAS2327130 (human) | | 1e-08 | Abnormality of refraction | | 4 | 111208199 | 111208200 | Human |
| 407245927 | GWAS894903_H | glycerophospholipid measurement QTL GWAS894903 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114519057 | 114519058 | Human |
| 407213156 | GWAS862132_H | concussion QTL GWAS862132 (human) | | 1e-10 | concussion | | 4 | 123151329 | 123151330 | Human |
| 407245924 | GWAS894900_H | glycerophospholipid measurement QTL GWAS894900 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114495600 | 114495601 | Human |
| 628418902 | GWAS2327131_H | Abnormality of refraction QTL GWAS2327131 (human) | | 5e-18 | Abnormality of refraction | | 4 | 119980371 | 119980372 | Human |
| 407245925 | GWAS894901_H | glycerophospholipid measurement QTL GWAS894901 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114554143 | 114554144 | Human |
| 407245922 | GWAS894898_H | glycerophospholipid measurement QTL GWAS894898 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495547 | 114495548 | Human |
| 628697437 | GWAS2605666_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2605666 (human) | | 5e-13 | glioma pathogenesis-related protein 1 measurement | | 4 | 128282916 | 128282917 | Human |
| 407245923 | GWAS894899_H | glycerophospholipid measurement QTL GWAS894899 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495590 | 114495591 | Human |
| 596979635 | GWAS1099154_H | body height QTL GWAS1099154 (human) | | 6e-23 | body height | | 4 | 122904764 | 122904765 | Human |
| 407245934 | GWAS894910_H | glycerophospholipid measurement QTL GWAS894910 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114540109 | 114540110 | Human |
| 407245935 | GWAS894911_H | glycerophospholipid measurement QTL GWAS894911 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114541947 | 114541948 | Human |
| 407245932 | GWAS894908_H | glycerophospholipid measurement QTL GWAS894908 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114528894 | 114528895 | Human |
| 597995407 | GWAS1714706_H | body height QTL GWAS1714706 (human) | | 1e-14 | body height | | 4 | 108180849 | 108180850 | Human |
| 407245933 | GWAS894909_H | glycerophospholipid measurement QTL GWAS894909 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114540002 | 114540003 | Human |
| 407245930 | GWAS894906_H | glycerophospholipid measurement QTL GWAS894906 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114486755 | 114486756 | Human |
| 407245931 | GWAS894907_H | glycerophospholipid measurement QTL GWAS894907 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114487028 | 114487029 | Human |
| 407245928 | GWAS894904_H | glycerophospholipid measurement QTL GWAS894904 (human) | | 2e-24 | glycerophospholipid measurement | | 4 | 114565923 | 114565924 | Human |
| 407245929 | GWAS894905_H | glycerophospholipid measurement QTL GWAS894905 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114484189 | 114484190 | Human |
| 597356458 | GWAS1452532_H | medication adherence behavior QTL GWAS1452532 (human) | | 0.000001 | medication adherence behavior | | 4 | 111199502 | 111199503 | Human |
| 597995412 | GWAS1714711_H | body height QTL GWAS1714711 (human) | | 1e-15 | body height | | 4 | 113968218 | 113968219 | Human |
| 407245942 | GWAS894918_H | glycerophospholipid measurement QTL GWAS894918 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490702 | 114490703 | Human |
| 407245943 | GWAS894919_H | glycerophospholipid measurement QTL GWAS894919 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114503010 | 114503011 | Human |
| 597995413 | GWAS1714712_H | body height QTL GWAS1714712 (human) | | 3e-09 | body height | | 4 | 118235326 | 118235327 | Human |
| 407409785 | GWAS1058761_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS1058761 (human) | | 5e-19 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129143723 | 129143724 | Human |
| 407245940 | GWAS894916_H | glycerophospholipid measurement QTL GWAS894916 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490912 | 114490913 | Human |
| 597995414 | GWAS1714713_H | body height QTL GWAS1714713 (human) | | 7e-09 | body height | | 4 | 119085821 | 119085822 | Human |
| 407245941 | GWAS894917_H | glycerophospholipid measurement QTL GWAS894917 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114491050 | 114491051 | Human |
| 597995415 | GWAS1714714_H | body height QTL GWAS1714714 (human) | | 4e-09 | body height | | 4 | 119356945 | 119356946 | Human |
| 407327860 | GWAS976836_H | testosterone measurement QTL GWAS976836 (human) | | 1e-14 | testosterone measurement | | 4 | 124126476 | 124126477 | Human |
| 597995408 | GWAS1714707_H | body height QTL GWAS1714707 (human) | | 1e-16 | body height | | 4 | 108355674 | 108355675 | Human |
| 407245938 | GWAS894914_H | glycerophospholipid measurement QTL GWAS894914 (human) | | 2e-23 | glycerophospholipid measurement | | 4 | 114485894 | 114485895 | Human |
| 597995409 | GWAS1714708_H | body height QTL GWAS1714708 (human) | | 1e-32 | body height | | 4 | 108535458 | 108535459 | Human |
| 616999155 | GWAS2016654_H | cerebral cortex area attribute QTL GWAS2016654 (human) | | 6e-12 | cerebral cortex area attribute | | 4 | 112495627 | 112495628 | Human |
| 407245939 | GWAS894915_H | glycerophospholipid measurement QTL GWAS894915 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490871 | 114490872 | Human |
| 597995410 | GWAS1714709_H | body height QTL GWAS1714709 (human) | | 2e-10 | body height | | 4 | 109834165 | 109834166 | Human |
| 407245936 | GWAS894912_H | glycerophospholipid measurement QTL GWAS894912 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114545757 | 114545758 | Human |
| 597995411 | GWAS1714710_H | body height QTL GWAS1714710 (human) | | 8e-11 | body height | | 4 | 113824425 | 113824426 | Human |
| 407245937 | GWAS894913_H | glycerophospholipid measurement QTL GWAS894913 (human) | | 4e-24 | glycerophospholipid measurement | | 4 | 114568887 | 114568888 | Human |
| 597094319 | GWAS1190393_H | emphysema imaging measurement QTL GWAS1190393 (human) | | 0.000001 | lung integrity trait (VT:0010906) | | 4 | 122028172 | 122028173 | Human |
| 598060956 | GWAS1780255_H | body height QTL GWAS1780255 (human) | | 0.0000008 | body height | | 4 | 125346842 | 125346843 | Human |
| 407147647 | GWAS796623_H | atrial fibrillation QTL GWAS796623 (human) | | 9e-09 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 597307297 | GWAS1403371_H | body height QTL GWAS1403371 (human) | | 8e-15 | body height | | 4 | 113968498 | 113968499 | Human |
| 597995416 | GWAS1714715_H | body height QTL GWAS1714715 (human) | | 2e-10 | body height | | 4 | 119636718 | 119636719 | Human |
| 597372839 | GWAS1468913_H | estradiol measurement QTL GWAS1468913 (human) | | 0.000009 | estradiol measurement | | 4 | 127399753 | 127399754 | Human |
| 616360065 | GWAS1844780_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1844780 (human) | | 4e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 112965969 | 112965970 | Human |
| 407245944 | GWAS894920_H | glycerophospholipid measurement QTL GWAS894920 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114532227 | 114532228 | Human |
| 617146614 | GWAS2164113_H | pyogenic granuloma QTL GWAS2164113 (human) | | 3e-11 | pyogenic granuloma | | 4 | 117340216 | 117340217 | Human |
| 598060955 | GWAS1780254_H | body height QTL GWAS1780254 (human) | | 5e-15 | body height | | 4 | 125767588 | 125767589 | Human |
| 598060954 | GWAS1780253_H | body height QTL GWAS1780253 (human) | | 4e-17 | body height | | 4 | 125758137 | 125758138 | Human |
| 597274587 | GWAS1370661_H | high density lipoprotein cholesterol measurement QTL GWAS1370661 (human) | | 1e-25 | high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 597274586 | GWAS1370660_H | high density lipoprotein cholesterol measurement QTL GWAS1370660 (human) | | 1e-21 | high density lipoprotein cholesterol measurement | | 4 | 109174464 | 109174465 | Human |
| 598077409 | GWAS1796708_H | bone density QTL GWAS1796708 (human) | | 2e-09 | bone density | | 4 | 108138358 | 108138359 | Human |
| 628943156 | GWAS2851385_H | body mass index QTL GWAS2851385 (human) | | 5e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 128248889 | 128248890 | Human |
| 616556790 | GWAS1953373_H | total blood protein measurement QTL GWAS1953373 (human) | | 7e-20 | total blood protein measurement | | 4 | 119206905 | 119206906 | Human |
| 617130114 | GWAS2147613_H | properdin measurement QTL GWAS2147613 (human) | | 3e-16 | properdin measurement | | 4 | 109793426 | 109793427 | Human |
| 407147528 | GWAS796504_H | platelet count QTL GWAS796504 (human) | | 1e-38 | platelet count | | 4 | 109990751 | 109990752 | Human |
| 407016462 | GWAS665438_H | Calcium channel blocker use measurement QTL GWAS665438 (human) | | 5e-10 | Calcium channel blocker use measurement | | 4 | 110510288 | 110510289 | Human |
| 617277575 | GWAS2214351_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2214351 (human) | | 3e-12 | polyunsaturated fatty acids to monounsaturated fatty acids ratio | | 4 | 109345757 | 109345758 | Human |
| 628451623 | GWAS2359852_H | self reported educational attainment QTL GWAS2359852 (human) | | 1e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
| 628451622 | GWAS2359851_H | self reported educational attainment QTL GWAS2359851 (human) | | 2e-09 | self reported educational attainment | | 4 | 111500989 | 111500990 | Human |
| 407147536 | GWAS796512_H | platelet count QTL GWAS796512 (human) | | 9e-11 | platelet count | | 4 | 119502932 | 119502933 | Human |
| 407147537 | GWAS796513_H | platelet count QTL GWAS796513 (human) | | 1e-105 | platelet count | | 4 | 110027819 | 110027820 | Human |
| 628451616 | GWAS2359845_H | atrial fibrillation QTL GWAS2359845 (human) | | 9e-11 | atrial fibrillation | | 4 | 110675204 | 110675205 | Human |
| 628484396 | GWAS2392625_H | sex interaction measurement, bilirubin measurement QTL GWAS2392625 (human) | | 0.000005 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 109805166 | 109805167 | Human |
| 628451628 | GWAS2359857_H | self reported educational attainment QTL GWAS2359857 (human) | | 4e-08 | self reported educational attainment | | 4 | 130401277 | 130401278 | Human |
| 628435246 | GWAS2343475_H | adolescent idiopathic scoliosis QTL GWAS2343475 (human) | | 2e-16 | adolescent idiopathic scoliosis | | 4 | 129325525 | 129325526 | Human |
| 628451625 | GWAS2359854_H | self reported educational attainment QTL GWAS2359854 (human) | | 6e-12 | self reported educational attainment | | 4 | 122105714 | 122105715 | Human |
| 628451624 | GWAS2359853_H | self reported educational attainment QTL GWAS2359853 (human) | | 1e-08 | self reported educational attainment | | 4 | 118084947 | 118084948 | Human |
| 628451627 | GWAS2359856_H | self reported educational attainment QTL GWAS2359856 (human) | | 1e-08 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 628451626 | GWAS2359855_H | self reported educational attainment QTL GWAS2359855 (human) | | 1e-08 | self reported educational attainment | | 4 | 128884001 | 128884002 | Human |
| 597127159 | GWAS1223233_H | glycerophospholipid measurement QTL GWAS1223233 (human) | | 9e-10 | glycerophospholipid measurement | | 4 | 114551671 | 114551672 | Human |
| 597127158 | GWAS1223232_H | glycerophospholipid measurement QTL GWAS1223232 (human) | | 8e-10 | glycerophospholipid measurement | | 4 | 114510521 | 114510522 | Human |
| 597127157 | GWAS1223231_H | glycerophospholipid measurement QTL GWAS1223231 (human) | | 8e-10 | glycerophospholipid measurement | | 4 | 114580888 | 114580889 | Human |
| 597127156 | GWAS1223230_H | glycerophospholipid measurement QTL GWAS1223230 (human) | | 7e-10 | glycerophospholipid measurement | | 4 | 114514506 | 114514507 | Human |
| 597127155 | GWAS1223229_H | glycerophospholipid measurement QTL GWAS1223229 (human) | | 6e-10 | glycerophospholipid measurement | | 4 | 114485362 | 114485363 | Human |
| 597127154 | GWAS1223228_H | glycerophospholipid measurement QTL GWAS1223228 (human) | | 5e-10 | glycerophospholipid measurement | | 4 | 114550195 | 114550196 | Human |
| 617195692 | GWAS2176132_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2176132 (human) | | 3e-14 | glioma pathogenesis-related protein 1 measurement | | 4 | 117846456 | 117846457 | Human |
| 597127153 | GWAS1223227_H | glycerophospholipid measurement QTL GWAS1223227 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114539953 | 114539954 | Human |
| 597127152 | GWAS1223226_H | glycerophospholipid measurement QTL GWAS1223226 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114540944 | 114540945 | Human |
| 407295009 | GWAS943985_H | Alzheimer disease, polygenic risk score QTL GWAS943985 (human) | | 7e-09 | Alzheimer disease, polygenic risk score | | 4 | 118306104 | 118306105 | Human |
| 628451615 | GWAS2359844_H | atrial fibrillation QTL GWAS2359844 (human) | | 1e-28 | atrial fibrillation | | 4 | 110603473 | 110603474 | Human |
| 628451614 | GWAS2359843_H | atrial fibrillation QTL GWAS2359843 (human) | | 8e-11 | atrial fibrillation | | 4 | 110334761 | 110334762 | Human |
| 407049256 | GWAS698232_H | glycerol measurement QTL GWAS698232 (human) | | 0.0000002 | glycerol measurement | | 4 | 125351750 | 125351751 | Human |
| 628795671 | GWAS2703900_H | spleen volume QTL GWAS2703900 (human) | | 4e-14 | spleen volume | | 4 | 109912954 | 109912955 | Human |
| 407049262 | GWAS698238_H | glycerol measurement QTL GWAS698238 (human) | | 0.000004 | glycerol measurement | | 4 | 125494759 | 125494760 | Human |
| 407163946 | GWAS812922_H | BMI-adjusted waist-hip ratio QTL GWAS812922 (human) | | 4e-08 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
| 628418842 | GWAS2327071_H | facial morphology trait QTL GWAS2327071 (human) | | 3e-10 | facial morphology trait | | 4 | 127027041 | 127027042 | Human |
| 628435204 | GWAS2343433_H | adolescent idiopathic scoliosis QTL GWAS2343433 (human) | | 9e-37 | adolescent idiopathic scoliosis | | 4 | 114347014 | 114347015 | Human |
| 597127151 | GWAS1223225_H | glycerophospholipid measurement QTL GWAS1223225 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114492647 | 114492648 | Human |
| 597127150 | GWAS1223224_H | glycerophospholipid measurement QTL GWAS1223224 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114492457 | 114492458 | Human |
| 407049279 | GWAS698255_H | phosphatidylcholine 38:2 measurement QTL GWAS698255 (human) | | 0.000006 | phosphatidylcholine 38:2 measurement | | 4 | 117433671 | 117433672 | Human |
| 407376951 | GWAS1025927_H | smoking status measurement QTL GWAS1025927 (human) | | 5e-08 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
| 628959739 | GWAS2867968_H | hemoglobin measurement QTL GWAS2867968 (human) | | 6e-22 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114598670 | 114598671 | Human |
| 617277506 | GWAS2214282_H | saturated fatty acids to total fatty acids percentage QTL GWAS2214282 (human) | | 3e-09 | saturated fatty acids to total fatty acids percentage | | 4 | 110151902 | 110151903 | Human |
| 597094171 | GWAS1190245_H | airway imaging measurement QTL GWAS1190245 (human) | | 5e-09 | airway imaging measurement | respiratory system measurement (CMO:0000094) | 4 | 126402153 | 126402154 | Human |
| 616523826 | GWAS1920409_H | erythrocyte volume QTL GWAS1920409 (human) | | 3e-20 | erythrocyte volume | | 4 | 127690477 | 127690478 | Human |
| 617097285 | GWAS2114784_H | body fat percentage QTL GWAS2114784 (human) | | 3e-12 | body fat percentage | | 4 | 129803747 | 129803748 | Human |
| 617277508 | GWAS2214284_H | saturated fatty acids to total fatty acids percentage QTL GWAS2214284 (human) | | 1e-18 | saturated fatty acids to total fatty acids percentage | | 4 | 110191454 | 110191455 | Human |
| 628730344 | GWAS2638573_H | Anxiety QTL GWAS2638573 (human) | | 2e-09 | Anxiety | | 4 | 131717648 | 131717649 | Human |
| 628746731 | GWAS2654960_H | nephrolithiasis QTL GWAS2654960 (human) | | 3e-15 | kidney integrity trait (VT:0010580) | | 4 | 114577301 | 114577302 | Human |
| 616359983 | GWAS1844698_H | gut microbiome measurement, environmental exposure measurement QTL GWAS1844698 (human) | | 3e-08 | gut microbiome measurement, environmental exposure measurement | | 4 | 116169734 | 116169735 | Human |
| 597405454 | GWAS1501528_H | body mass index QTL GWAS1501528 (human) | | 1e-11 | body mass index | | 4 | 129838492 | 129838493 | Human |
| 616966224 | GWAS1983723_H | glycine measurement QTL GWAS1983723 (human) | | 0.000003 | blood glycine amount (VT:0010965) | blood amino acid measurement (CMO:0003730) | 4 | 107930418 | 107930419 | Human |
| 617097296 | GWAS2114795_H | FEV/FVC ratio QTL GWAS2114795 (human) | | 7e-12 | FEV/FVC ratio | | 4 | 123898452 | 123898453 | Human |
| 597061386 | GWAS1157460_H | adolescent idiopathic scoliosis QTL GWAS1157460 (human) | | 5e-11 | adolescent idiopathic scoliosis | | 4 | 112239118 | 112239119 | Human |
| 598077240 | GWAS1796539_H | bone density QTL GWAS1796539 (human) | | 4e-11 | bone density | | 4 | 108147096 | 108147097 | Human |
| 598110008 | GWAS1818891_H | oligodendroglioma QTL GWAS1818891 (human) | | 0.000005 | oligodendroglioma | | 4 | 122853801 | 122853802 | Human |
| 407262438 | GWAS911414_H | body height QTL GWAS911414 (human) | | 8e-35 | body height | | 4 | 123891742 | 123891743 | Human |
| 407262439 | GWAS911415_H | body height QTL GWAS911415 (human) | | 4e-78 | body height | | 4 | 123987076 | 123987077 | Human |
| 628582868 | GWAS2491097_H | calcium measurement, diet measurement QTL GWAS2491097 (human) | | 0.000006 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 111131258 | 111131259 | Human |
| 597536569 | GWAS1632643_H | body height QTL GWAS1632643 (human) | | 2e-19 | body height | | 4 | 123707660 | 123707661 | Human |
| 617113709 | GWAS2131208_H | level of inactive C-alpha-formylglycine-generating enzyme 2 in blood serum QTL GWAS2131208 (human) | | 8e-16 | level of inactive C-alpha-formylglycine-generating enzyme 2 in blood serum | | 4 | 118813029 | 118813030 | Human |
| 597536568 | GWAS1632642_H | body height QTL GWAS1632642 (human) | | 2e-37 | body height | | 4 | 122757847 | 122757848 | Human |
| 628681182 | GWAS2589411_H | body height QTL GWAS2589411 (human) | | 1e-11 | body height | | 4 | 122848013 | 122848014 | Human |
| 407114988 | GWAS763964_H | diastolic blood pressure QTL GWAS763964 (human) | | 0.000001 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 113288576 | 113288577 | Human |
| 597536565 | GWAS1632639_H | body height QTL GWAS1632639 (human) | | 9e-12 | body height | | 4 | 119937025 | 119937026 | Human |
| 597520181 | GWAS1616255_H | urate measurement QTL GWAS1616255 (human) | | 6e-09 | urate measurement | | 4 | 127147534 | 127147535 | Human |
| 597536564 | GWAS1632638_H | body height QTL GWAS1632638 (human) | | 6e-09 | body height | | 4 | 119774304 | 119774305 | Human |
| 597536567 | GWAS1632641_H | body height QTL GWAS1632641 (human) | | 8e-20 | body height | | 4 | 122626386 | 122626387 | Human |
| 597536566 | GWAS1632640_H | body height QTL GWAS1632640 (human) | | 7e-18 | body height | | 4 | 120068926 | 120068927 | Human |
| 407262440 | GWAS911416_H | body height QTL GWAS911416 (human) | | 4e-17 | body height | | 4 | 124666406 | 124666407 | Human |
| 617064565 | GWAS2082064_H | brain attribute QTL GWAS2082064 (human) | | 1e-20 | brain attribute | | 4 | 127076729 | 127076730 | Human |
| 597094180 | GWAS1190254_H | cerebral amyloid angiopathy QTL GWAS1190254 (human) | | 0.000007 | cerebral amyloid angiopathy | | 4 | 129419725 | 129419726 | Human |
| 628533698 | GWAS2441927_H | radiation-induced disorder QTL GWAS2441927 (human) | | 0.000006 | radiation-induced disorder | | 4 | 118888417 | 118888418 | Human |
| 407147763 | GWAS796739_H | glycine measurement QTL GWAS796739 (human) | | 0.000003 | glycine measurement | | 4 | 107930418 | 107930419 | Human |
| 628550081 | GWAS2458310_H | cup-to-disc ratio measurement QTL GWAS2458310 (human) | | 1e-11 | optic disc morphology trait (VT:0006215) | | 4 | 125318831 | 125318832 | Human |
| 597815062 | GWAS1682453_H | response to trauma exposure QTL GWAS1682453 (human) | | 0.0000003 | response to trauma exposure | | 4 | 130610205 | 130610206 | Human |
| 407098497 | GWAS747473_H | fibrinopeptide A, des-ala(1) measurement QTL GWAS747473 (human) | | 2e-14 | fibrinopeptide A, des-ala(1) measurement | | 4 | 110446685 | 110446686 | Human |
| 628664763 | GWAS2572992_H | lean body mass QTL GWAS2572992 (human) | | 4e-13 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 4 | 123145793 | 123145794 | Human |
| 407098503 | GWAS747479_H | fibrinopeptide A, des-ala(1) measurement QTL GWAS747479 (human) | | 1e-21 | fibrinopeptide A, des-ala(1) measurement | | 4 | 110510288 | 110510289 | Human |
| 407147648 | GWAS796624_H | atrial fibrillation QTL GWAS796624 (human) | | 2e-09 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 598060908 | GWAS1780207_H | body height QTL GWAS1780207 (human) | | 4e-17 | body height | | 4 | 124666406 | 124666407 | Human |
| 597192534 | GWAS1288608_H | cortical surface area measurement QTL GWAS1288608 (human) | | 5e-10 | cortical surface area measurement | | 4 | 112493715 | 112493716 | Human |
| 598060907 | GWAS1780206_H | body height QTL GWAS1780206 (human) | | 4e-78 | body height | | 4 | 123987076 | 123987077 | Human |
| 598060906 | GWAS1780205_H | body height QTL GWAS1780205 (human) | | 8e-35 | body height | | 4 | 123891742 | 123891743 | Human |
| 406967440 | GWAS616416_H | QRS-T angle QTL GWAS616416 (human) | | 4e-09 | QRS-T angle | | 4 | 110635274 | 110635275 | Human |
| 628402593 | GWAS2310822_H | mean corpuscular hemoglobin concentration QTL GWAS2310822 (human) | | 6e-14 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109944312 | 109944313 | Human |
| 406967444 | GWAS616420_H | QRS-T angle QTL GWAS616420 (human) | | 3e-31 | QRS-T angle | | 4 | 113523590 | 113523591 | Human |
| 628631968 | GWAS2540197_H | pulse pressure measurement QTL GWAS2540197 (human) | | 1e-08 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 110465042 | 110465043 | Human |
| 597421891 | GWAS1517965_H | atrial fibrillation QTL GWAS1517965 (human) | | 1e-12 | atrial fibrillation | | 4 | 111172387 | 111172388 | Human |
| 407295134 | GWAS944110_H | vaginal microbiome measurement QTL GWAS944110 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 407262366 | GWAS911342_H | glucose-dependent insulinotropic peptide measurement QTL GWAS911342 (human) | | 4e-10 | glucose-dependent insulinotropic peptide measurement | | 4 | 123717198 | 123717199 | Human |
| 597421890 | GWAS1517964_H | atrial fibrillation QTL GWAS1517964 (human) | | 7e-13 | atrial fibrillation | | 4 | 111085761 | 111085762 | Human |
| 597389120 | GWAS1485194_H | lung carcinoma QTL GWAS1485194 (human) | | 0.000002 | lung carcinoma | | 4 | 110592565 | 110592566 | Human |
| 628500906 | GWAS2409135_H | appendicular lean mass QTL GWAS2409135 (human) | | 3e-26 | body lean mass (VT:0010483) | | 4 | 121792708 | 121792709 | Human |
| 597241668 | GWAS1337742_H | high density lipoprotein cholesterol measurement QTL GWAS1337742 (human) | | 3e-09 | sex hormone-binding globulin measurement | | 4 | 109717608 | 109717609 | Human |
| 597421893 | GWAS1517967_H | atrial fibrillation QTL GWAS1517967 (human) | | 6e-13 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 597421892 | GWAS1517966_H | atrial fibrillation QTL GWAS1517966 (human) | | 2e-08 | atrial fibrillation | | 4 | 111257689 | 111257690 | Human |
| 628500905 | GWAS2409134_H | appendicular lean mass QTL GWAS2409134 (human) | | 7e-22 | body lean mass (VT:0010483) | | 4 | 119221151 | 119221152 | Human |
| 628779429 | GWAS2687658_H | urate measurement, spine bone mineral density QTL GWAS2687658 (human) | | 0.000001 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 123516413 | 123516414 | Human |
| 616966182 | GWAS1983681_H | size QTL GWAS1983681 (human) | | 5e-08 | size | | 4 | 118204297 | 118204298 | Human |
| 628648344 | GWAS2556573_H | prostate specific antigen amount QTL GWAS2556573 (human) | | 2e-13 | prostate specific antigen amount | | 4 | 120805979 | 120805980 | Human |
| 407344295 | GWAS993271_H | platelet count QTL GWAS993271 (human) | | 1e-13 | platelet count | | 4 | 123837618 | 123837619 | Human |
| 628648345 | GWAS2556574_H | prostate specific antigen amount QTL GWAS2556574 (human) | | 1e-15 | prostate specific antigen amount | | 4 | 121854912 | 121854913 | Human |
| 407344294 | GWAS993270_H | platelet count QTL GWAS993270 (human) | | 6e-10 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 407344293 | GWAS993269_H | platelet count QTL GWAS993269 (human) | | 1e-52 | platelet count | | 4 | 110024810 | 110024811 | Human |
| 628648346 | GWAS2556575_H | prostate specific antigen amount QTL GWAS2556575 (human) | | 8e-09 | prostate specific antigen amount | | 4 | 123950358 | 123950359 | Human |
| 597061491 | GWAS1157565_H | adolescent idiopathic scoliosis QTL GWAS1157565 (human) | | 0.0000002 | adolescent idiopathic scoliosis | | 4 | 113329637 | 113329638 | Human |
| 628582801 | GWAS2491030_H | fatty acid amount QTL GWAS2491030 (human) | | 2e-09 | blood IDL cholesterol amount (VT:0010503) | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 4 | 109657070 | 109657071 | Human |
| 628861331 | GWAS2769560_H | heart failure QTL GWAS2769560 (human) | | 2e-15 | heart integrity trait (VT:0010757) | | 4 | 110787848 | 110787849 | Human |
| 628877715 | GWAS2785944_H | insomnia QTL GWAS2785944 (human) | | 2e-10 | sleep behavior trait (VT:0001501) | | 4 | 122265238 | 122265239 | Human |
| 628746640 | GWAS2654869_H | circulating cell free DNA measurement QTL GWAS2654869 (human) | | 0.000007 | circulating cell free DNA measurement | | 4 | 119406669 | 119406670 | Human |
| 628877714 | GWAS2785943_H | insomnia QTL GWAS2785943 (human) | | 1e-08 | sleep behavior trait (VT:0001501) | | 4 | 122259374 | 122259375 | Human |
| 406951080 | GWAS600056_H | trait in response to omacetaxine mepesuccinate, cytotoxicity measurement QTL GWAS600056 (human) | | 0.0000003 | trait in response to omacetaxine mepesuccinate, cytotoxicity measurement | | 4 | 126075715 | 126075716 | Human |
| 407229615 | GWAS878591_H | bone density QTL GWAS878591 (human) | | 4e-11 | bone density | | 4 | 108147096 | 108147097 | Human |
| 628877713 | GWAS2785942_H | insomnia QTL GWAS2785942 (human) | | 2e-08 | sleep behavior trait (VT:0001501) | | 4 | 112329113 | 112329114 | Human |
| 628648342 | GWAS2556571_H | prostate specific antigen amount QTL GWAS2556571 (human) | | 3e-16 | prostate specific antigen amount | | 4 | 109877415 | 109877416 | Human |
| 628648343 | GWAS2556572_H | prostate specific antigen amount QTL GWAS2556572 (human) | | 2e-13 | prostate specific antigen amount | | 4 | 111519061 | 111519062 | Human |
| 625830306 | GWAS2251228_H | grip strength measurement QTL GWAS2251228 (human) | | 7e-09 | grip strength measurement | | 4 | 118834466 | 118834467 | Human |
| 628877716 | GWAS2785945_H | insomnia QTL GWAS2785945 (human) | | 2e-10 | sleep behavior trait (VT:0001501) | | 4 | 129856909 | 129856910 | Human |
| 597061497 | GWAS1157571_H | adolescent idiopathic scoliosis QTL GWAS1157571 (human) | | 0.000001 | adolescent idiopathic scoliosis | | 4 | 130877448 | 130877449 | Human |
| 628828555 | GWAS2736784_H | body height QTL GWAS2736784 (human) | | 3e-28 | body height | | 4 | 108535458 | 108535459 | Human |
| 628812170 | GWAS2720399_H | platelet count QTL GWAS2720399 (human) | | 4e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123749526 | 123749527 | Human |
| 597307241 | GWAS1403315_H | body height QTL GWAS1403315 (human) | | 2e-14 | body height | | 4 | 119759795 | 119759796 | Human |
| 616966197 | GWAS1983696_H | alcohol dependence QTL GWAS1983696 (human) | | 0.000004 | alcohol dependence | | 4 | 130091985 | 130091986 | Human |
| 597192557 | GWAS1288631_H | cortical thickness QTL GWAS1288631 (human) | | 6e-11 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120708831 | 120708832 | Human |
| 597159787 | GWAS1255861_H | lipid measurement QTL GWAS1255861 (human) | | 0.000008 | lipid measurement | | 4 | 122878832 | 122878833 | Human |
| 628451723 | GWAS2359952_H | atrial fibrillation QTL GWAS2359952 (human) | | 4e-52 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
| 628484212 | GWAS2392441_H | atrial fibrillation QTL GWAS2392441 (human) | | 2e-09 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 407262530 | GWAS911506_H | brain measurement QTL GWAS911506 (human) | | 4e-10 | brain measurement | | 4 | 118393759 | 118393760 | Human |
| 406902084 | GWAS551060_H | COVID-19, mortality QTL GWAS551060 (human) | | 0.000005 | COVID-19, mortality | | 4 | 127021337 | 127021338 | Human |
| 407409997 | GWAS1058973_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1058973 (human) | | 2e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 122122507 | 122122508 | Human |
| 628484211 | GWAS2392440_H | atrial fibrillation QTL GWAS2392440 (human) | | 9e-09 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 628369533 | GWAS2290377_H | fibroblast growth factor 2 level QTL GWAS2290377 (human) | | 2e-11 | fibroblast growth factor 2 level | | 4 | 122682145 | 122682146 | Human |
| 628369534 | GWAS2290378_H | fibroblast growth factor 2 level QTL GWAS2290378 (human) | | 6e-36 | fibroblast growth factor 2 level | | 4 | 122827461 | 122827462 | Human |
| 628959347 | GWAS2867576_H | prothrombin time measurement QTL GWAS2867576 (human) | | 5e-51 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110784139 | 110784140 | Human |
| 628795497 | GWAS2703726_H | COVID-19 QTL GWAS2703726 (human) | | 0.000009 | COVID-19 | | 4 | 109566395 | 109566396 | Human |
| 597503625 | GWAS1599699_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1599699 (human) | | 0.000002 | severe acute respiratory syndrome, COVID-19 | | 4 | 119432971 | 119432972 | Human |
| 597225100 | GWAS1321174_H | BMI-adjusted waist-hip ratio QTL GWAS1321174 (human) | | 3e-08 | BMI-adjusted waist-hip ratio | | 4 | 119607172 | 119607173 | Human |
| 597995184 | GWAS1714483_H | erythrocyte volume QTL GWAS1714483 (human) | | 1e-08 | erythrocyte volume | | 4 | 121766083 | 121766084 | Human |
| 617212383 | GWAS2192823_H | household income QTL GWAS2192823 (human) | | 3e-10 | household income | | 4 | 122175535 | 122175536 | Human |
| 628598880 | GWAS2507109_H | total cholesterol measurement, diet measurement QTL GWAS2507109 (human) | | 0.000004 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 118492283 | 118492284 | Human |
| 616491431 | GWAS1888014_H | ceramide amount QTL GWAS1888014 (human) | | 2e-13 | ceramide amount | | 4 | 114549176 | 114549177 | Human |
| 628697186 | GWAS2605415_H | brain attribute QTL GWAS2605415 (human) | | 4e-12 | brain attribute | | 4 | 120306999 | 120307000 | Human |
| 407082333 | GWAS731309_H | body mass index QTL GWAS731309 (human) | | 1e-08 | body mass index | | 4 | 112392830 | 112392831 | Human |
| 597372549 | GWAS1468623_H | HIV viral set point measurement QTL GWAS1468623 (human) | | 0.000006 | HIV viral set point measurement | | 4 | 120120131 | 120120132 | Human |
| 616999384 | GWAS2016883_H | cerebral cortex area attribute QTL GWAS2016883 (human) | | 4e-11 | cerebral cortex area attribute | | 4 | 128406387 | 128406388 | Human |
| 597192379 | GWAS1288453_H | cortical thickness QTL GWAS1288453 (human) | | 5e-15 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120793484 | 120793485 | Human |
| 407229793 | GWAS878769_H | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement QTL GWAS878769 (human) | | 0.0000003 | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | | 4 | 127602809 | 127602810 | Human |
| 597487288 | GWAS1583362_H | mean corpuscular hemoglobin QTL GWAS1583362 (human) | | 3e-17 | mean corpuscular hemoglobin | | 4 | 127625245 | 127625246 | Human |
| 597601977 | GWAS1658837_H | mean platelet volume QTL GWAS1658837 (human) | | 3e-27 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 407246189 | GWAS895165_H | body height QTL GWAS895165 (human) | | 3e-19 | body height | | 4 | 108540829 | 108540830 | Human |
| 406984041 | GWAS633017_H | brain measurement, neuroimaging measurement QTL GWAS633017 (human) | | 3e-08 | brain measurement, neuroimaging measurement | | 4 | 112509596 | 112509597 | Human |
| 628959318 | GWAS2867547_H | erythrocyte volume QTL GWAS2867547 (human) | | 8e-30 | erythrocyte volume | | 4 | 121854912 | 121854913 | Human |
| 616507793 | GWAS1904376_H | reticulocyte amount QTL GWAS1904376 (human) | | 4e-12 | reticulocyte amount | | 4 | 128330896 | 128330897 | Human |
| 616507792 | GWAS1904375_H | reticulocyte amount QTL GWAS1904375 (human) | | 8e-09 | reticulocyte amount | | 4 | 119770233 | 119770234 | Human |
| 616507791 | GWAS1904374_H | reticulocyte amount QTL GWAS1904374 (human) | | 4e-17 | reticulocyte amount | | 4 | 109944309 | 109944310 | Human |
| 407000432 | GWAS649408_H | adult onset asthma QTL GWAS649408 (human) | | 8e-10 | adult onset asthma | | 4 | 122438414 | 122438415 | Human |
| 407016821 | GWAS665797_H | gastric carcinoma QTL GWAS665797 (human) | | 3e-11 | gastric carcinoma | | 4 | 124530209 | 124530210 | Human |
| 407246206 | GWAS895182_H | glycerophospholipid measurement QTL GWAS895182 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114549176 | 114549177 | Human |
| 407246207 | GWAS895183_H | glycerophospholipid measurement QTL GWAS895183 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114536699 | 114536700 | Human |
| 597307047 | GWAS1403121_H | body height QTL GWAS1403121 (human) | | 4e-10 | body height | | 4 | 108146742 | 108146743 | Human |
| 628779077 | GWAS2687306_H | erythrocyte volume QTL GWAS2687306 (human) | | 8e-44 | erythrocyte volume | | 4 | 121875762 | 121875763 | Human |
| 407049475 | GWAS698451_H | cortical thickness QTL GWAS698451 (human) | | 1e-13 | cortical thickness | | 4 | 120793484 | 120793485 | Human |
| 597225179 | GWAS1321253_H | chronotype measurement QTL GWAS1321253 (human) | | 1e-08 | chronotype measurement | | 4 | 113069787 | 113069788 | Human |
| 616999301 | GWAS2016800_H | Parkinson disease QTL GWAS2016800 (human) | | 5e-11 | Parkinson disease | | 4 | 113439216 | 113439217 | Human |
| 597618394 | GWAS1675254_H | artificial cardiac pacemaker QTL GWAS1675254 (human) | | 3e-12 | artificial cardiac pacemaker | | 4 | 113504778 | 113504779 | Human |
| 597618393 | GWAS1675253_H | artificial cardiac pacemaker QTL GWAS1675253 (human) | | 3e-12 | artificial cardiac pacemaker | | 4 | 110780642 | 110780643 | Human |
| 406983947 | GWAS632923_H | alkaline phosphatase measurement QTL GWAS632923 (human) | | 3e-11 | alkaline phosphatase measurement | | 4 | 110207431 | 110207432 | Human |
| 628369471 | GWAS2290315_H | sex interaction measurement, age of onset of cardiac rhythm disease QTL GWAS2290315 (human) | | 3e-20 | sex interaction measurement, age of onset of cardiac rhythm disease | | 4 | 110755885 | 110755886 | Human |
| 406983948 | GWAS632924_H | alkaline phosphatase measurement QTL GWAS632924 (human) | | 1e-13 | alkaline phosphatase measurement | | 4 | 128110416 | 128110417 | Human |
| 628369467 | GWAS2290311_H | sex interaction measurement, age of onset of cardiac rhythm disease QTL GWAS2290311 (human) | | 5e-17 | sex interaction measurement, age of onset of cardiac rhythm disease | | 4 | 110744627 | 110744628 | Human |
| 407049490 | GWAS698466_H | neurofibrillary tangles measurement QTL GWAS698466 (human) | | 0.000004 | neurofibrillary tangles measurement | | 4 | 129315073 | 129315074 | Human |
| 628467750 | GWAS2375979_H | CLEC1B/EGF protein level ratio in blood QTL GWAS2375979 (human) | | 6e-375 | CLEC1B/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 616966546 | GWAS1984045_H | longitudinal BMI measurement QTL GWAS1984045 (human) | | 0.000009 | longitudinal BMI measurement | | 4 | 118506802 | 118506803 | Human |
| 617097619 | GWAS2115118_H | atrial fibrillation QTL GWAS2115118 (human) | | 6e-56 | atrial fibrillation | | 4 | 110787848 | 110787849 | Human |
| 407213342 | GWAS862318_H | erythrocyte count QTL GWAS862318 (human) | | 1e-15 | erythrocyte count | | 4 | 114598669 | 114598670 | Human |
| 407311643 | GWAS960619_H | testosterone measurement QTL GWAS960619 (human) | | 7e-09 | testosterone measurement | | 4 | 109108768 | 109108769 | Human |
| 617097620 | GWAS2115119_H | atrial fibrillation QTL GWAS2115119 (human) | | 3e-33 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597618370 | GWAS1675230_H | humerus fracture QTL GWAS1675230 (human) | | 7e-12 | humerus fracture | | 4 | 113504938 | 113504939 | Human |
| 628369450 | GWAS2290294_H | fibroblast growth factor 2 level QTL GWAS2290294 (human) | | 9e-18 | fibroblast growth factor 2 level | | 4 | 122836593 | 122836594 | Human |
| 628729883 | GWAS2638112_H | smoking status measurement QTL GWAS2638112 (human) | | 2e-10 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
| 597110515 | GWAS1206589_H | Calcium channel blocker use measurement QTL GWAS1206589 (human) | | 5e-10 | Calcium channel blocker use measurement | | 4 | 110510288 | 110510289 | Human |
| 407000358 | GWAS649334_H | Crohn's disease QTL GWAS649334 (human) | | 0.0000009 | Crohn's disease | | 4 | 122430276 | 122430277 | Human |
| 406983974 | GWAS632950_H | unipolar depression QTL GWAS632950 (human) | | 2e-10 | unipolar depression | | 4 | 130316226 | 130316227 | Human |
| 628697116 | GWAS2605345_H | cerebral cortex area attribute QTL GWAS2605345 (human) | | 3e-15 | cerebral cortex area attribute | | 4 | 123326251 | 123326252 | Human |
| 597585656 | GWAS1642516_H | body height QTL GWAS1642516 (human) | | 1e-13 | body height | | 4 | 121876108 | 121876109 | Human |
| 628697118 | GWAS2605347_H | cortical thickness QTL GWAS2605347 (human) | | 5e-10 | cerebral cortex morphology trait (VT:0000788) | | 4 | 127022223 | 127022224 | Human |
| 597585654 | GWAS1642514_H | body height QTL GWAS1642514 (human) | | 5e-29 | body height | | 4 | 108503691 | 108503692 | Human |
| 628434973 | GWAS2343202_H | BMI-adjusted waist circumference QTL GWAS2343202 (human) | | 1e-08 | body size trait (VT:0100005) | | 4 | 119026033 | 119026034 | Human |
| 597061374 | GWAS1157448_H | metabolic syndrome QTL GWAS1157448 (human) | | 4e-08 | metabolic syndrome | | 4 | 119318723 | 119318724 | Human |
| 628434972 | GWAS2343201_H | BMI-adjusted waist circumference QTL GWAS2343201 (human) | | 3e-11 | body size trait (VT:0100005) | | 4 | 108535458 | 108535459 | Human |
| 597585655 | GWAS1642515_H | body height QTL GWAS1642515 (human) | | 2e-13 | body height | | 4 | 119696257 | 119696258 | Human |
| 597978829 | GWAS1698128_H | platelet volume QTL GWAS1698128 (human) | | 8e-10 | platelet volume | | 4 | 122263672 | 122263673 | Human |
| 617277856 | GWAS2214632_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2214632 (human) | | 6e-13 | polyunsaturated fatty acids to monounsaturated fatty acids ratio | | 4 | 109603883 | 109603884 | Human |
| 597061372 | GWAS1157446_H | metabolic syndrome QTL GWAS1157446 (human) | | 1e-08 | metabolic syndrome | | 4 | 111770620 | 111770621 | Human |
| 597978830 | GWAS1698129_H | platelet volume QTL GWAS1698129 (human) | | 2e-10 | platelet volume | | 4 | 122595396 | 122595397 | Human |
| 597061373 | GWAS1157447_H | metabolic syndrome QTL GWAS1157447 (human) | | 2e-09 | metabolic syndrome | | 4 | 118238526 | 118238527 | Human |
| 407295277 | GWAS944253_H | systolic blood pressure QTL GWAS944253 (human) | | 5e-09 | systolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 407082280 | GWAS731256_H | unipolar depression QTL GWAS731256 (human) | | 0.000005 | unipolar depression | | 4 | 127836228 | 127836229 | Human |
| 628434968 | GWAS2343197_H | BMI-adjusted waist circumference QTL GWAS2343197 (human) | | 7e-11 | body size trait (VT:0100005) | | 4 | 119820812 | 119820813 | Human |
| 628434971 | GWAS2343200_H | BMI-adjusted waist circumference QTL GWAS2343200 (human) | | 4e-08 | body size trait (VT:0100005) | | 4 | 108556623 | 108556624 | Human |
| 597618417 | GWAS1675277_H | atrial fibrillation QTL GWAS1675277 (human) | | 1e-323 | atrial fibrillation | | 4 | 110720030 | 110720031 | Human |
| 616360392 | GWAS1845107_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1845107 (human) | | 5e-10 | gut microbiome measurement, allergen exposure measurement | | 4 | 112965969 | 112965970 | Human |
| 598109907 | GWAS1818790_H | astrocytoma QTL GWAS1818790 (human) | | 0.000005 | astrocytoma | | 4 | 120634028 | 120634029 | Human |
| 597290735 | GWAS1386809_H | Crohn's disease QTL GWAS1386809 (human) | | 6e-09 | Crohn's disease | | 4 | 122420959 | 122420960 | Human |
| 597487333 | GWAS1583407_H | serum albumin measurement QTL GWAS1583407 (human) | | 3e-09 | serum albumin measurement | | 4 | 123779234 | 123779235 | Human |
| 616999356 | GWAS2016855_H | atrial fibrillation QTL GWAS2016855 (human) | | 3e-525 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 597585636 | GWAS1642496_H | eosinophil count QTL GWAS1642496 (human) | | 6e-18 | eosinophil count | | 4 | 122680359 | 122680360 | Human |
| 628647941 | GWAS2556170_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2556170 (human) | | 7e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 129320668 | 129320669 | Human |
| 598142499 | GWAS1829227_H | bone tissue density QTL GWAS1829227 (human) | | 5e-18 | bone tissue density | | 4 | 110503132 | 110503133 | Human |
| 597192223 | GWAS1288297_H | heart failure QTL GWAS1288297 (human) | | 4e-29 | heart failure | | 4 | 110748064 | 110748065 | Human |
| 597044764 | GWAS1140838_H | refractive error QTL GWAS1140838 (human) | | 1e-10 | refractive error | | 4 | 119680603 | 119680604 | Human |
| 597044765 | GWAS1140839_H | refractive error QTL GWAS1140839 (human) | | 3e-12 | refractive error | | 4 | 119987548 | 119987549 | Human |
| 597192212 | GWAS1288286_H | heart failure QTL GWAS1288286 (human) | | 2e-09 | heart failure | | 4 | 113463172 | 113463173 | Human |
| 407377348 | GWAS1026324_H | posterior cingulate cortex volume measurement QTL GWAS1026324 (human) | | 0.000004 | posterior cingulate cortex volume measurement | | 4 | 115248533 | 115248534 | Human |
| 597306902 | GWAS1402976_H | cortical surface area measurement QTL GWAS1402976 (human) | | 3e-15 | cortical surface area measurement | | 4 | 123326251 | 123326252 | Human |
| 597093915 | GWAS1189989_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1189989 (human) | | 0.000002 | lung capacity (VT:0001942) | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 129479620 | 129479621 | Human |
| 628566245 | GWAS2474474_H | social inhibition quality, attention deficit hyperactivity disorder, substance abuse QTL GWAS2474474 (human) | | 1e-09 | behavior trait (VT:0010442) | | 4 | 129484578 | 129484579 | Human |
| 628566244 | GWAS2474473_H | social inhibition quality, attention deficit hyperactivity disorder, substance abuse QTL GWAS2474473 (human) | | 2e-23 | behavior trait (VT:0010442) | | 4 | 111485805 | 111485806 | Human |
| 628369634 | GWAS2290478_H | alpha-fetoprotein level QTL GWAS2290478 (human) | | 9e-12 | alpha-fetoprotein level | | 4 | 108749156 | 108749157 | Human |
| 597093888 | GWAS1189962_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1189962 (human) | | 0.000001 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 4 | 123994124 | 123994125 | Human |
| 597192192 | GWAS1288266_H | cortical thickness QTL GWAS1288266 (human) | | 3e-09 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120704578 | 120704579 | Human |
| 407393744 | GWAS1042720_H | atopic eczema QTL GWAS1042720 (human) | | 9e-11 | atopic eczema | | 4 | 122219899 | 122219900 | Human |
| 406902235 | GWAS551211_H | COVID-19 QTL GWAS551211 (human) | | 0.00001 | COVID-19 | | 4 | 107157415 | 107157416 | Human |
| 628828391 | GWAS2736620_H | platelet count QTL GWAS2736620 (human) | | 7e-38 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109966833 | 109966834 | Human |
| 616999258 | GWAS2016757_H | celiac disease QTL GWAS2016757 (human) | | 2e-38 | intestine integrity trait (VT:0010554) | | 4 | 122629959 | 122629960 | Human |
| 407229924 | GWAS878900_H | FEV change measurement, response to bronchodilator QTL GWAS878900 (human) | | 0.0000007 | FEV change measurement, response to bronchodilator | | 4 | 116884973 | 116884974 | Human |
| 597519928 | GWAS1616002_H | IGFBP-3 measurement QTL GWAS1616002 (human) | | 0.0000002 | IGFBP-3 measurement | | 4 | 123840924 | 123840925 | Human |
| 597143088 | GWAS1239162_H | Antihypertensive use measurement QTL GWAS1239162 (human) | | 2e-10 | Antihypertensive use measurement | | 4 | 108123712 | 108123713 | Human |
| 597290547 | GWAS1386621_H | lymphocyte measurement, neutrophil measurement QTL GWAS1386621 (human) | | 2e-14 | lymphocyte measurement, neutrophil measurement | | 4 | 112190016 | 112190017 | Human |
| 406902257 | GWAS551233_H | COVID-19, mortality QTL GWAS551233 (human) | | 0.000002 | COVID-19, mortality | | 4 | 127021337 | 127021338 | Human |
| 406935026 | GWAS584002_H | high density lipoprotein cholesterol measurement QTL GWAS584002 (human) | | 3e-13 | high density lipoprotein cholesterol measurement | | 4 | 109648464 | 109648465 | Human |
| 617277808 | GWAS2214584_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2214584 (human) | | 4e-15 | polyunsaturated fatty acids to monounsaturated fatty acids ratio | | 4 | 109717668 | 109717669 | Human |
| 617277814 | GWAS2214590_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2214590 (human) | | 2e-10 | polyunsaturated fatty acids to monounsaturated fatty acids ratio | | 4 | 109345757 | 109345758 | Human |
| 598011416 | GWAS1730715_H | FABP2/RBP2 protein level ratio in blood QTL GWAS1730715 (human) | | 6e-894 | FABP2/RBP2 protein level ratio in blood | | 4 | 119309995 | 119309996 | Human |
| 407180792 | GWAS829768_H | cup-to-disc ratio measurement QTL GWAS829768 (human) | | 6e-10 | cup-to-disc ratio measurement | | 4 | 125318831 | 125318832 | Human |
| 407246214 | GWAS895190_H | glycerophospholipid measurement QTL GWAS895190 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114538869 | 114538870 | Human |
| 616966406 | GWAS1983905_H | BMI-adjusted hip circumference QTL GWAS1983905 (human) | | 5e-09 | BMI-adjusted hip circumference | | 4 | 119820087 | 119820088 | Human |
| 597487196 | GWAS1583270_H | ceramide measurement QTL GWAS1583270 (human) | | 2e-08 | ceramide measurement | | 4 | 129692156 | 129692157 | Human |
| 628484276 | GWAS2392505_H | atrial fibrillation QTL GWAS2392505 (human) | | 6e-113 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
| 407246215 | GWAS895191_H | glycerophospholipid measurement QTL GWAS895191 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114526758 | 114526759 | Human |
| 616966407 | GWAS1983906_H | BMI-adjusted hip circumference QTL GWAS1983906 (human) | | 4e-10 | BMI-adjusted hip circumference | | 4 | 119798713 | 119798714 | Human |
| 407246212 | GWAS895188_H | glycerophospholipid measurement QTL GWAS895188 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114532837 | 114532838 | Human |
| 407246213 | GWAS895189_H | glycerophospholipid measurement QTL GWAS895189 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114563572 | 114563573 | Human |
| 616966405 | GWAS1983904_H | BMI-adjusted hip circumference QTL GWAS1983904 (human) | | 1e-08 | BMI-adjusted hip circumference | | 4 | 119821103 | 119821104 | Human |
| 407246210 | GWAS895186_H | glycerophospholipid measurement QTL GWAS895186 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114490021 | 114490022 | Human |
| 407246211 | GWAS895187_H | glycerophospholipid measurement QTL GWAS895187 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114532769 | 114532770 | Human |
| 407246208 | GWAS895184_H | glycerophospholipid measurement QTL GWAS895184 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114544338 | 114544339 | Human |
| 628959419 | GWAS2867648_H | serum albumin amount QTL GWAS2867648 (human) | | 6e-20 | serum albumin amount | | 4 | 128155663 | 128155664 | Human |
| 407246209 | GWAS895185_H | glycerophospholipid measurement QTL GWAS895185 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114563873 | 114563874 | Human |
| 597978723 | GWAS1698022_H | chin morphology trait QTL GWAS1698022 (human) | | 1e-08 | chin morphology trait | | 4 | 126033497 | 126033498 | Human |
| 407246222 | GWAS895198_H | glycerophospholipid measurement QTL GWAS895198 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114546019 | 114546020 | Human |
| 407246223 | GWAS895199_H | glycerophospholipid measurement QTL GWAS895199 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114553520 | 114553521 | Human |
| 625830020 | GWAS2250942_H | forced expiratory volume QTL GWAS2250942 (human) | | 5e-08 | forced expiratory volume | | 4 | 124118741 | 124118742 | Human |
| 407246220 | GWAS895196_H | glycerophospholipid measurement QTL GWAS895196 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114553424 | 114553425 | Human |
| 407246221 | GWAS895197_H | glycerophospholipid measurement QTL GWAS895197 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114493059 | 114493060 | Human |
| 407246218 | GWAS895194_H | glycerophospholipid measurement QTL GWAS895194 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114558326 | 114558327 | Human |
| 407246219 | GWAS895195_H | glycerophospholipid measurement QTL GWAS895195 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114493217 | 114493218 | Human |
| 597306964 | GWAS1403038_H | creatinine measurement QTL GWAS1403038 (human) | | 2e-15 | creatinine measurement | | 4 | 108782393 | 108782394 | Human |
| 407246216 | GWAS895192_H | glycerophospholipid measurement QTL GWAS895192 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114552518 | 114552519 | Human |
| 616966408 | GWAS1983907_H | BMI-adjusted hip circumference QTL GWAS1983907 (human) | | 3e-11 | BMI-adjusted hip circumference | | 4 | 121774530 | 121774531 | Human |
| 625830019 | GWAS2250941_H | forced expiratory volume QTL GWAS2250941 (human) | | 5e-13 | forced expiratory volume | | 4 | 123891170 | 123891171 | Human |
| 407098765 | GWAS747741_H | level of N-acetylgalactosamine in blood, level of N-acetylglucosamine in blood QTL GWAS747741 (human) | | 7e-31 | level of N-acetylgalactosamine in blood, level of N-acetylglucosamine in blood | | 4 | 129109789 | 129109790 | Human |
| 407246217 | GWAS895193_H | glycerophospholipid measurement QTL GWAS895193 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114554137 | 114554138 | Human |
| 616556912 | GWAS1953495_H | whole body water mass QTL GWAS1953495 (human) | | 9e-12 | whole body water mass | | 4 | 122848013 | 122848014 | Human |
| 597306965 | GWAS1403039_H | creatinine measurement QTL GWAS1403039 (human) | | 3e-09 | creatinine measurement | | 4 | 128603358 | 128603359 | Human |
| 616556911 | GWAS1953494_H | Abnormality of the skeletal system QTL GWAS1953494 (human) | | 1e-16 | Abnormality of the skeletal system | | 4 | 119742494 | 119742495 | Human |
| 407246228 | GWAS895204_H | glycerophospholipid measurement QTL GWAS895204 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114552206 | 114552207 | Human |
| 407246226 | GWAS895202_H | glycerophospholipid measurement QTL GWAS895202 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114541864 | 114541865 | Human |
| 407377309 | GWAS1026285_H | blood protein measurement QTL GWAS1026285 (human) | | 1e-98 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 407246227 | GWAS895203_H | glycerophospholipid measurement QTL GWAS895203 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114573271 | 114573272 | Human |
| 407246224 | GWAS895200_H | glycerophospholipid measurement QTL GWAS895200 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114563925 | 114563926 | Human |
| 407246225 | GWAS895201_H | glycerophospholipid measurement QTL GWAS895201 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114547331 | 114547332 | Human |
| 628484268 | GWAS2392497_H | erosive tooth wear attribute QTL GWAS2392497 (human) | | 3e-08 | erosive tooth wear attribute | | 4 | 117643607 | 117643608 | Human |
| 628418735 | GWAS2326964_H | facial morphology trait QTL GWAS2326964 (human) | | 2e-08 | facial morphology trait | | 4 | 126939204 | 126939205 | Human |
| 597618240 | GWAS1675100_H | chronic pancreatitis QTL GWAS1675100 (human) | | 2e-12 | chronic pancreatitis | | 4 | 116090374 | 116090375 | Human |
| 628467861 | GWAS2376090_H | brain attribute QTL GWAS2376090 (human) | | 9e-09 | brain attribute | | 4 | 112432129 | 112432130 | Human |
| 617097505 | GWAS2115004_H | prothrombin time measurement QTL GWAS2115004 (human) | | 5e-51 | prothrombin time measurement | | 4 | 110784139 | 110784140 | Human |
| 617130275 | GWAS2147774_H | cystatin-M measurement QTL GWAS2147774 (human) | | 5e-19 | cystatin-M measurement | | 4 | 106848777 | 106848778 | Human |
| 617097508 | GWAS2115007_H | prothrombin time measurement QTL GWAS2115007 (human) | | 1e-54 | prothrombin time measurement | | 4 | 110796911 | 110796912 | Human |
| 628959377 | GWAS2867606_H | serum creatinine amount QTL GWAS2867606 (human) | | 4e-22 | serum creatinine amount | | 4 | 127022078 | 127022079 | Human |
| 597323380 | GWAS1419454_H | cup-to-disc ratio measurement QTL GWAS1419454 (human) | | 5e-17 | cup-to-disc ratio measurement | | 4 | 125486143 | 125486144 | Human |
| 628533380 | GWAS2441609_H | level of carboxypeptidase Q in blood QTL GWAS2441609 (human) | | 2e-14 | level of carboxypeptidase Q in blood | | 4 | 118868269 | 118868270 | Human |
| 597290606 | GWAS1386680_H | coronary artery disease QTL GWAS1386680 (human) | | 4e-08 | coronary artery disease | | 4 | 110757945 | 110757946 | Human |
| 628533388 | GWAS2441617_H | cytokine receptor-like factor 1 measurement QTL GWAS2441617 (human) | | 7e-13 | cytokine receptor-like factor 1 measurement | | 4 | 109976379 | 109976380 | Human |
| 407360954 | GWAS1009930_H | BMI-adjusted waist-hip ratio QTL GWAS1009930 (human) | | 5e-11 | BMI-adjusted waist-hip ratio | | 4 | 119213641 | 119213642 | Human |
| 617031992 | GWAS2049491_H | bone tissue density QTL GWAS2049491 (human) | | 8e-16 | bone tissue density | | 4 | 107727835 | 107727836 | Human |
| 406885953 | GWAS534929_H | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis QTL GWAS534929 (human) | | 3e-08 | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | | 4 | 122639784 | 122639785 | Human |
| 628452215 | GWAS2360444_H | chronotype measurement QTL GWAS2360444 (human) | | 1e-08 | sleep behavior trait (VT:0001501) | | 4 | 131590963 | 131590964 | Human |
| 616983246 | GWAS2000745_H | acute myeloid leukemia QTL GWAS2000745 (human) | | 1e-13 | leukocyte integrity trait (VT:0010898) | | 4 | 121985860 | 121985861 | Human |
| 628681585 | GWAS2589814_H | systolic blood pressure QTL GWAS2589814 (human) | | 4e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 120018331 | 120018332 | Human |
| 628927344 | GWAS2835573_H | body height QTL GWAS2835573 (human) | | 8e-14 | body height | | 4 | 121876108 | 121876109 | Human |
| 617081546 | GWAS2099045_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS2099045 (human) | | 2e-19 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119349548 | 119349549 | Human |
| 628648822 | GWAS2557051_H | gut microbiome measurement, breastfeeding duration QTL GWAS2557051 (human) | | 1e-08 | lactation duration (VT:1000653) | | 4 | 115599484 | 115599485 | Human |
| 628648808 | GWAS2557037_H | retinal layer thickness QTL GWAS2557037 (human) | | 2e-09 | retinal layer thickness | | 4 | 108908293 | 108908294 | Human |
| 628927342 | GWAS2835571_H | body height QTL GWAS2835571 (human) | | 3e-28 | body height | | 4 | 108503691 | 108503692 | Human |
| 597814707 | GWAS1682098_H | beta-amyloid 1-42 measurement QTL GWAS1682098 (human) | | 0.0000006 | beta-amyloid 1-42 measurement | | 4 | 124819554 | 124819555 | Human |
| 628927343 | GWAS2835572_H | body height QTL GWAS2835572 (human) | | 1e-13 | body height | | 4 | 119665953 | 119665954 | Human |
| 598142386 | GWAS1829114_H | bone tissue density QTL GWAS1829114 (human) | | 4e-08 | bone tissue density | | 4 | 131155333 | 131155334 | Human |
| 597126536 | GWAS1222610_H | Crohn's disease QTL GWAS1222610 (human) | | 0.0000007 | Crohn's disease | | 4 | 113154532 | 113154533 | Human |
| 407295591 | GWAS944567_H | body mass index QTL GWAS944567 (human) | | 9e-10 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 407230055 | GWAS879031_H | autoimmune thyroid disease, type 1 diabetes mellitus QTL GWAS879031 (human) | | 4e-10 | autoimmune thyroid disease, type 1 diabetes mellitus | | 4 | 121392885 | 121392886 | Human |
| 407344740 | GWAS993716_H | lateral ventricle volume measurement, response to trauma exposure QTL GWAS993716 (human) | | 0.0000002 | lateral ventricle volume measurement, response to trauma exposure | | 4 | 117069298 | 117069299 | Human |
| 407098983 | GWAS747959_H | peak expiratory flow QTL GWAS747959 (human) | | 4e-08 | peak expiratory flow | | 4 | 118203565 | 118203566 | Human |
| 407410285 | GWAS1059261_H | electrocardiography QTL GWAS1059261 (human) | | 2e-08 | electrocardiography | | 4 | 115646453 | 115646454 | Human |
| 598142339 | GWAS1829067_H | bone tissue density QTL GWAS1829067 (human) | | 4e-40 | bone tissue density | | 4 | 126002708 | 126002709 | Human |
| 407344738 | GWAS993714_H | response to trauma exposure, nucleus accumbens volume QTL GWAS993714 (human) | | 0.0000003 | response to trauma exposure, nucleus accumbens volume | | 4 | 130610205 | 130610206 | Human |
| 407410286 | GWAS1059262_H | electrocardiography QTL GWAS1059262 (human) | | 1e-08 | electrocardiography | | 4 | 115646453 | 115646454 | Human |
| 407246447 | GWAS895423_H | glycerophospholipid measurement QTL GWAS895423 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114493994 | 114493995 | Human |
| 407246444 | GWAS895420_H | alkaline phosphatase measurement QTL GWAS895420 (human) | | 8e-17 | alkaline phosphatase measurement | | 4 | 110191454 | 110191455 | Human |
| 597503414 | GWAS1599488_H | caproate 6:0 measurement QTL GWAS1599488 (human) | | 0.000005 | caproate 6:0 measurement | | 4 | 132246564 | 132246565 | Human |
| 597405110 | GWAS1501184_H | uterine prolapse QTL GWAS1501184 (human) | | 4e-17 | uterine prolapse | | 4 | 126003911 | 126003912 | Human |
| 407295592 | GWAS944568_H | body mass index QTL GWAS944568 (human) | | 3e-08 | body mass index | | 4 | 114269666 | 114269667 | Human |
| 407295593 | GWAS944569_H | body mass index QTL GWAS944569 (human) | | 1e-11 | body mass index | | 4 | 129838492 | 129838493 | Human |
| 598060437 | GWAS1779736_H | total cholesterol measurement, blood VLDL cholesterol amount QTL GWAS1779736 (human) | | 4e-08 | total cholesterol measurement, blood VLDL cholesterol amount | | 4 | 109717668 | 109717669 | Human |
| 407246450 | GWAS895426_H | glycerophospholipid measurement QTL GWAS895426 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114494051 | 114494052 | Human |
| 407246448 | GWAS895424_H | glycerophospholipid measurement QTL GWAS895424 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114553935 | 114553936 | Human |
| 407246449 | GWAS895425_H | glycerophospholipid measurement QTL GWAS895425 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114552321 | 114552322 | Human |
| 597142959 | GWAS1239033_H | triglyceride measurement QTL GWAS1239033 (human) | | 7e-11 | triglyceride measurement | | 4 | 109648464 | 109648465 | Human |
| 597093804 | GWAS1189878_H | myocardial infarction QTL GWAS1189878 (human) | | 0.000009 | heart integrity trait (VT:0010757) | | 4 | 118789266 | 118789267 | Human |
| 597093805 | GWAS1189879_H | myocardial infarction QTL GWAS1189879 (human) | | 0.0000006 | heart integrity trait (VT:0010757) | | 4 | 118789266 | 118789267 | Human |
| 616360576 | GWAS1845291_H | gut microbiome measurement, breastfeeding duration QTL GWAS1845291 (human) | | 5e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 117990855 | 117990856 | Human |
| 597093802 | GWAS1189876_H | myocardial infarction QTL GWAS1189876 (human) | | 0.000007 | heart integrity trait (VT:0010757) | | 4 | 118770469 | 118770470 | Human |
| 407115385 | GWAS764361_H | obesity QTL GWAS764361 (human) | | 0.000003 | obesity | | 4 | 131830983 | 131830984 | Human |
| 407000582 | GWAS649558_H | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement QTL GWAS649558 (human) | | 0.000004 | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | | 4 | 119026891 | 119026892 | Human |
| 598109667 | GWAS1818550_H | oligodendroglioma QTL GWAS1818550 (human) | | 0.000004 | oligodendroglioma | | 4 | 116139159 | 116139160 | Human |
| 628747059 | GWAS2655288_H | educational attainment QTL GWAS2655288 (human) | | 2e-09 | educational attainment | | 4 | 121769129 | 121769130 | Human |
| 616999560 | GWAS2017059_H | intraocular pressure measurement QTL GWAS2017059 (human) | | 3e-10 | intraocular pressure measurement | | 4 | 111042563 | 111042564 | Human |
| 407016978 | GWAS665954_H | Inhalant adrenergic use measurement QTL GWAS665954 (human) | | 2e-14 | Inhalant adrenergic use measurement | | 4 | 122446734 | 122446735 | Human |
| 407213591 | GWAS862567_H | high density lipoprotein cholesterol measurement QTL GWAS862567 (human) | | 2e-44 | high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 617130650 | GWAS2148149_H | platelet crit QTL GWAS2148149 (human) | | 3e-16 | platelet crit | | 4 | 123749526 | 123749527 | Human |
| 407098907 | GWAS747883_H | aspartate measurement QTL GWAS747883 (human) | | 4e-18 | aspartate measurement | | 4 | 110414566 | 110414567 | Human |
| 407311902 | GWAS960878_H | low density lipoprotein cholesterol measurement QTL GWAS960878 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | | 4 | 127741641 | 127741642 | Human |
| 407311901 | GWAS960877_H | low density lipoprotein cholesterol measurement QTL GWAS960877 (human) | | 1e-10 | low density lipoprotein cholesterol measurement | | 4 | 110021121 | 110021122 | Human |
| 597257671 | GWAS1353745_H | atrial fibrillation QTL GWAS1353745 (human) | | 9e-10 | atrial fibrillation | | 4 | 110491909 | 110491910 | Human |
| 597257670 | GWAS1353744_H | atrial fibrillation QTL GWAS1353744 (human) | | 2e-09 | atrial fibrillation | | 4 | 110485663 | 110485664 | Human |
| 407016994 | GWAS665970_H | heel bone mineral density QTL GWAS665970 (human) | | 8e-11 | heel bone mineral density | | 4 | 123613837 | 123613838 | Human |
| 597536253 | GWAS1632327_H | body height QTL GWAS1632327 (human) | | 9e-20 | body height | | 4 | 127073768 | 127073769 | Human |
| 407016995 | GWAS665971_H | heel bone mineral density QTL GWAS665971 (human) | | 8e-13 | heel bone mineral density | | 4 | 124619337 | 124619338 | Human |
| 597536252 | GWAS1632326_H | body height QTL GWAS1632326 (human) | | 5e-15 | body height | | 4 | 125767588 | 125767589 | Human |
| 407016992 | GWAS665968_H | heel bone mineral density QTL GWAS665968 (human) | | 3e-09 | heel bone mineral density | | 4 | 108249911 | 108249912 | Human |
| 617065125 | GWAS2082624_H | memory performance QTL GWAS2082624 (human) | | 0.0000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 128552943 | 128552944 | Human |
| 597536255 | GWAS1632329_H | body height QTL GWAS1632329 (human) | | 2e-20 | body height | | 4 | 131543872 | 131543873 | Human |
| 407016993 | GWAS665969_H | heel bone mineral density QTL GWAS665969 (human) | | 5e-09 | heel bone mineral density | | 4 | 118868269 | 118868270 | Human |
| 597536254 | GWAS1632328_H | body height QTL GWAS1632328 (human) | | 7e-11 | body height | | 4 | 129860515 | 129860516 | Human |
| 597257724 | GWAS1353798_H | aminoadipic acid measurement QTL GWAS1353798 (human) | | 0.000001 | aminoadipic acid measurement | | 4 | 117057786 | 117057787 | Human |
| 628992789 | GWAS2901018_H | triglyceride measurement QTL GWAS2901018 (human) | | 5e-19 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
| 597224944 | GWAS1321018_H | platelet count QTL GWAS1321018 (human) | | 9e-21 | platelet count | | 4 | 109945564 | 109945565 | Human |
| 597421555 | GWAS1517629_H | blood protein measurement QTL GWAS1517629 (human) | | 8e-13 | blood protein measurement | | 4 | 122625127 | 122625128 | Human |
| 597224945 | GWAS1321019_H | platelet count QTL GWAS1321019 (human) | | 1e-38 | platelet count | | 4 | 109990751 | 109990752 | Human |
| 597224946 | GWAS1321020_H | platelet count QTL GWAS1321020 (human) | | 1e-105 | platelet count | | 4 | 110027819 | 110027820 | Human |
| 407279148 | GWAS928124_H | urolithiasis QTL GWAS928124 (human) | | 1e-09 | urolithiasis | | 4 | 114460763 | 114460764 | Human |
| 597290483 | GWAS1386557_H | BMI-adjusted waist-hip ratio QTL GWAS1386557 (human) | | 5e-09 | BMI-adjusted waist-hip ratio | | 4 | 121701445 | 121701446 | Human |
| 597454327 | GWAS1550401_H | total cholesterol measurement QTL GWAS1550401 (human) | | 2e-09 | total cholesterol measurement | | 4 | 119210489 | 119210490 | Human |
| 597224947 | GWAS1321021_H | platelet count QTL GWAS1321021 (human) | | 9e-11 | platelet count | | 4 | 119502932 | 119502933 | Human |
| 597290485 | GWAS1386559_H | BMI-adjusted waist-hip ratio QTL GWAS1386559 (human) | | 9e-11 | BMI-adjusted waist-hip ratio | | 4 | 123124286 | 123124287 | Human |
| 597290484 | GWAS1386558_H | BMI-adjusted waist-hip ratio QTL GWAS1386558 (human) | | 4e-08 | BMI-adjusted waist-hip ratio | | 4 | 123002800 | 123002801 | Human |
| 597290487 | GWAS1386561_H | BMI-adjusted waist-hip ratio QTL GWAS1386561 (human) | | 7e-09 | BMI-adjusted waist-hip ratio | | 4 | 124118741 | 124118742 | Human |
| 597290486 | GWAS1386560_H | BMI-adjusted waist-hip ratio QTL GWAS1386560 (human) | | 2e-11 | BMI-adjusted waist-hip ratio | | 4 | 123166618 | 123166619 | Human |
| 598142420 | GWAS1829148_H | bone tissue density QTL GWAS1829148 (human) | | 1e-12 | bone tissue density | | 4 | 115936664 | 115936665 | Human |
| 406935093 | GWAS584069_H | prostate carcinoma QTL GWAS584069 (human) | | 0.000001 | prostate carcinoma | | 4 | 109927496 | 109927497 | Human |
| 617081522 | GWAS2099021_H | total cholesterol measurement QTL GWAS2099021 (human) | | 6e-10 | total cholesterol measurement | | 4 | 119192945 | 119192946 | Human |
| 617196220 | GWAS2176660_H | tumor necrosis factor receptor superfamily member 8 amount QTL GWAS2176660 (human) | | 5e-13 | tumor necrosis factor receptor superfamily member 8 amount | | 4 | 122216079 | 122216080 | Human |
| 597241327 | GWAS1337401_H | educational attainment QTL GWAS1337401 (human) | | 2e-09 | educational attainment | | 4 | 121769129 | 121769130 | Human |
| 597618152 | GWAS1675012_H | heart rate QTL GWAS1675012 (human) | | 2e-12 | heart rate | | 4 | 128289982 | 128289983 | Human |
| 598027743 | GWAS1747042_H | heart rate QTL GWAS1747042 (human) | | 2e-12 | heart rate | | 4 | 128289982 | 128289983 | Human |
| 597994971 | GWAS1714270_H | erythrocyte volume QTL GWAS1714270 (human) | | 7e-10 | erythrocyte volume | | 4 | 109977659 | 109977660 | Human |
| 628861945 | GWAS2770174_H | executive function measurement QTL GWAS2770174 (human) | | 1e-08 | cognitive behavior trait (VT:0010450) | | 4 | 118025394 | 118025395 | Human |
| 597404959 | GWAS1501033_H | bilirubin measurement QTL GWAS1501033 (human) | | 7e-11 | bilirubin measurement | | 4 | 123849638 | 123849639 | Human |
| 626453468 | GWAS2267401_H | serum gamma-glutamyl transferase measurement QTL GWAS2267401 (human) | | 3e-08 | serum gamma-glutamyl transferase measurement | | 4 | 111793842 | 111793843 | Human |
| 407000782 | GWAS649758_H | optic disc area measurement QTL GWAS649758 (human) | | 2e-08 | optic disc area measurement | | 4 | 114560759 | 114560760 | Human |
| 597437714 | GWAS1533788_H | nucleotide measurement QTL GWAS1533788 (human) | | 0.000003 | nucleotide measurement | | 4 | 110518121 | 110518122 | Human |
| 617146950 | GWAS2164449_H | stricture QTL GWAS2164449 (human) | | 2e-11 | stricture | | 4 | 114481688 | 114481689 | Human |
| 628567033 | GWAS2475262_H | urate measurement QTL GWAS2475262 (human) | | 3e-11 | urate measurement | blood uric acid level (CMO:0000501) | 4 | 119599549 | 119599550 | Human |
| 596978949 | GWAS1098468_H | body mass index QTL GWAS1098468 (human) | | 2e-09 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 628468711 | GWAS2376940_H | Hypermetropia, Myopia QTL GWAS2376940 (human) | | 0.0000007 | Hypermetropia, Myopia | | 4 | 119987548 | 119987549 | Human |
| 407377626 | GWAS1026602_H | rostral anterior cingulate cortex volume measurement QTL GWAS1026602 (human) | | 0.000009 | rostral anterior cingulate cortex volume measurement | | 4 | 129254856 | 129254857 | Human |
| 406984401 | GWAS633377_H | disorder of pharynx QTL GWAS633377 (human) | | 2e-08 | disorder of pharynx | | 4 | 112220279 | 112220280 | Human |
| 407361234 | GWAS1010210_H | Calcium channel blocker use measurement QTL GWAS1010210 (human) | | 8e-14 | Calcium channel blocker use measurement | | 4 | 110465042 | 110465043 | Human |
| 406902487 | GWAS551463_H | COVID-19 QTL GWAS551463 (human) | | 0.000008 | COVID-19 | | 4 | 129389669 | 129389670 | Human |
| 597191936 | GWAS1288010_H | lung disease severity measurement QTL GWAS1288010 (human) | | 0.000007 | lung disease severity measurement | | 4 | 119664980 | 119664981 | Human |
| 628435949 | GWAS2344178_H | memory impairment QTL GWAS2344178 (human) | | 0.000009 | learning/memory/conditioning trait (VT:0002063) | | 4 | 125446831 | 125446832 | Human |
| 597044493 | GWAS1140567_H | venous thromboembolism QTL GWAS1140567 (human) | | 0.0000002 | venous thromboembolism | | 4 | 112933404 | 112933405 | Human |
| 598109498 | GWAS1818381_H | glioblastoma multiforme QTL GWAS1818381 (human) | | 0.000005 | glioblastoma multiforme | | 4 | 128287977 | 128287978 | Human |
| 597503235 | GWAS1599309_H | right ventricular systolic volume measurement QTL GWAS1599309 (human) | | 7e-08 | right ventricular systolic volume measurement | | 4 | 113507558 | 113507559 | Human |
| 628517844 | GWAS2426073_H | stroke QTL GWAS2426073 (human) | | 1e-13 | brain integrity trait (VT:0010579) | | 4 | 110791276 | 110791277 | Human |
| 597191997 | GWAS1288071_H | systemic lupus erythematosus QTL GWAS1288071 (human) | | 1e-09 | systemic lupus erythematosus | | 4 | 122587346 | 122587347 | Human |
| 597159217 | GWAS1255291_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1255291 (human) | | 4e-10 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597306684 | GWAS1402758_H | total cholesterol measurement QTL GWAS1402758 (human) | | 4e-10 | total cholesterol measurement | | 4 | 119185611 | 119185612 | Human |
| 407082725 | GWAS731701_H | obsolete_red blood cell distribution width QTL GWAS731701 (human) | | 3e-09 | obsolete_red blood cell distribution width | | 4 | 122438414 | 122438415 | Human |
| 598142209 | GWAS1828937_H | bone tissue density QTL GWAS1828937 (human) | | 8e-29 | bone tissue density | | 4 | 131238783 | 131238784 | Human |
| 407049962 | GWAS698938_H | cortical surface area measurement QTL GWAS698938 (human) | | 6e-10 | cortical surface area measurement | | 4 | 112496345 | 112496346 | Human |
| 628501469 | GWAS2409698_H | FABP2/RBP2 protein level ratio in blood QTL GWAS2409698 (human) | | 6e-894 | FABP2/RBP2 protein level ratio in blood | | 4 | 119309995 | 119309996 | Human |
| 407017198 | GWAS666174_H | platelet count QTL GWAS666174 (human) | | 3e-43 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109952770 | 109952771 | Human |
| 597257525 | GWAS1353599_H | cardioembolic stroke QTL GWAS1353599 (human) | | 8e-237 | cardioembolic stroke | | 4 | 110743002 | 110743003 | Human |
| 407017199 | GWAS666175_H | platelet count QTL GWAS666175 (human) | | 2e-25 | platelet count | | 4 | 119337052 | 119337053 | Human |
| 597454125 | GWAS1550199_H | age at first sexual intercourse measurement QTL GWAS1550199 (human) | | 4e-16 | age at first sexual intercourse measurement | | 4 | 111582716 | 111582717 | Human |
| 407017200 | GWAS666176_H | platelet count QTL GWAS666176 (human) | | 7e-14 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 628698061 | GWAS2606290_H | vaginal microbiome measurement QTL GWAS2606290 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 616524295 | GWAS1920878_H | level of carboxypeptidase Q in blood serum QTL GWAS1920878 (human) | | 2e-14 | level of carboxypeptidase Q in blood serum | | 4 | 118868269 | 118868270 | Human |
| 407181053 | GWAS830029_H | carotid artery disease QTL GWAS830029 (human) | | 1e-11 | carotid artery disease | | 4 | 119576145 | 119576146 | Human |
| 597290272 | GWAS1386346_H | Crohn's disease QTL GWAS1386346 (human) | | 2e-16 | Crohn's disease | | 4 | 122523884 | 122523885 | Human |
| 597028137 | GWAS1124211_H | atrial fibrillation QTL GWAS1124211 (human) | | 8e-12 | atrial fibrillation | | 4 | 110733185 | 110733186 | Human |
| 628714437 | GWAS2622666_H | vaginal microbiome measurement QTL GWAS2622666 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 617146997 | GWAS2164496_H | level of receptor-type tyrosine-protein phosphatase F in blood QTL GWAS2164496 (human) | | 8e-18 | level of receptor-type tyrosine-protein phosphatase F in blood | | 4 | 108873562 | 108873563 | Human |
| 628714436 | GWAS2622665_H | vaginal microbiome measurement QTL GWAS2622665 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 407181051 | GWAS830027_H | carotid artery disease QTL GWAS830027 (human) | | 1e-16 | carotid artery disease | | 4 | 106712535 | 106712536 | Human |
| 406918911 | GWAS567887_H | Antihypertensive use measurement QTL GWAS567887 (human) | | 2e-10 | Antihypertensive use measurement | | 4 | 108123712 | 108123713 | Human |
| 597306719 | GWAS1402793_H | mean corpuscular volume QTL GWAS1402793 (human) | | 2e-52 | mean corpuscular volume | | 4 | 121877258 | 121877259 | Human |
| 628665268 | GWAS2573497_H | bone tissue density QTL GWAS2573497 (human) | | 6e-12 | bone tissue density | | 4 | 122289915 | 122289916 | Human |
| 616983049 | GWAS2000548_H | basophil count, eosinophil count QTL GWAS2000548 (human) | | 4e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122678166 | 122678167 | Human |
| 407066252 | GWAS715228_H | body mass index QTL GWAS715228 (human) | | 0.000003 | body mass index | | 4 | 129838492 | 129838493 | Human |
| 407213717 | GWAS862693_H | appendicular lean mass QTL GWAS862693 (human) | | 7e-22 | appendicular lean mass | | 4 | 119221151 | 119221152 | Human |
| 407213719 | GWAS862695_H | appendicular lean mass QTL GWAS862695 (human) | | 3e-22 | appendicular lean mass | | 4 | 124035957 | 124035958 | Human |
| 407213718 | GWAS862694_H | appendicular lean mass QTL GWAS862694 (human) | | 3e-26 | appendicular lean mass | | 4 | 121792708 | 121792709 | Human |
| 407377563 | GWAS1026539_H | asthma QTL GWAS1026539 (human) | | 2e-08 | asthma | | 4 | 122194117 | 122194118 | Human |
| 597470536 | GWAS1566610_H | Bell's palsy QTL GWAS1566610 (human) | | 0.000006 | Bell's palsy | | 4 | 123516321 | 123516322 | Human |
| 406951577 | GWAS600553_H | platelet count QTL GWAS600553 (human) | | 3e-09 | platelet count | | 4 | 123806369 | 123806370 | Human |
| 596979020 | GWAS1098539_H | coronary artery disease QTL GWAS1098539 (human) | | 2e-09 | coronary artery disease | | 4 | 109616095 | 109616096 | Human |
| 407377554 | GWAS1026530_H | Epithelioid Cell Uveal Melanoma QTL GWAS1026530 (human) | | 0.000002 | Epithelioid Cell Uveal Melanoma | | 4 | 130547531 | 130547532 | Human |
| 628992931 | GWAS2901160_H | triglyceride measurement QTL GWAS2901160 (human) | | 2e-20 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
| 617146922 | GWAS2164421_H | connective tissue disease QTL GWAS2164421 (human) | | 2e-14 | connective tissue disease | | 4 | 129687742 | 129687743 | Human |
| 407344803 | GWAS993779_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS993779 (human) | | 1e-12 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597486970 | GWAS1583044_H | ceramide measurement QTL GWAS1583044 (human) | | 2e-21 | ceramide measurement | | 4 | 114598115 | 114598116 | Human |
| 628534161 | GWAS2442390_H | erythrocyte volume QTL GWAS2442390 (human) | | 3e-13 | erythrocyte volume | | 4 | 109921984 | 109921985 | Human |
| 406918825 | GWAS567801_H | heel bone mineral density QTL GWAS567801 (human) | | 3e-09 | heel bone mineral density | | 4 | 118869362 | 118869363 | Human |
| 628501405 | GWAS2409634_H | GLB1/GUSB protein level ratio in blood QTL GWAS2409634 (human) | | 7e-50 | GLB1/GUSB protein level ratio in blood | | 4 | 118808670 | 118808671 | Human |
| 596979064 | GWAS1098583_H | stroke QTL GWAS1098583 (human) | | 0.000001 | stroke | | 4 | 112810934 | 112810935 | Human |
| 628566936 | GWAS2475165_H | depressive symptom measurement, stressful life event measurement QTL GWAS2475165 (human) | | 0.000008 | depression-related behavior trait (VT:0015015) | | 4 | 110061116 | 110061117 | Human |
| 407180983 | GWAS829959_H | diastolic blood pressure QTL GWAS829959 (human) | | 2e-11 | diastolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 617015860 | GWAS2033359_H | BMI-adjusted hip circumference QTL GWAS2033359 (human) | | 1e-08 | BMI-adjusted hip circumference | | 4 | 119759405 | 119759406 | Human |
| 406902451 | GWAS551427_H | lung carcinoma QTL GWAS551427 (human) | | 0.000002 | lung carcinoma | | 4 | 110592565 | 110592566 | Human |
| 407197360 | GWAS846336_H | open-angle glaucoma QTL GWAS846336 (human) | | 7e-09 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 616983091 | GWAS2000590_H | platelet volume QTL GWAS2000590 (human) | | 2e-10 | platelet volume | | 4 | 122595396 | 122595397 | Human |
| 617097777 | GWAS2115276_H | reticulocyte amount QTL GWAS2115276 (human) | | 8e-13 | reticulocyte amount | | 4 | 109970517 | 109970518 | Human |
| 407131839 | GWAS780815_H | triglyceride:HDL cholesterol ratio QTL GWAS780815 (human) | | 1e-09 | high density lipoprotein cholesterol measurement | | 4 | 109648464 | 109648465 | Human |
| 597437599 | GWAS1533673_H | Ventricular arrhythmia QTL GWAS1533673 (human) | | 4e-11 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
| 617130955 | GWAS2148454_H | atrial fibrillation QTL GWAS2148454 (human) | | 1e-33 | atrial fibrillation | | 4 | 110793263 | 110793264 | Human |
| 628533874 | GWAS2442103_H | erythrocyte volume QTL GWAS2442103 (human) | | 2e-52 | erythrocyte volume | | 4 | 121877258 | 121877259 | Human |
| 628533875 | GWAS2442104_H | erythrocyte volume QTL GWAS2442104 (human) | | 8e-17 | erythrocyte volume | | 4 | 127625245 | 127625246 | Human |
| 616967112 | GWAS1984611_H | cognitive decline measurement QTL GWAS1984611 (human) | | 0.0000009 | cognitive behavior trait (VT:0010450) | | 4 | 110589931 | 110589932 | Human |
| 597617809 | GWAS1674669_H | prothrombin time measurement QTL GWAS1674669 (human) | | 1e-16 | prothrombin time measurement | | 4 | 110791530 | 110791531 | Human |
| 407344968 | GWAS993944_H | sleep duration QTL GWAS993944 (human) | | 0.0000003 | sleep duration | | 4 | 115085956 | 115085957 | Human |
| 597060743 | GWAS1156817_H | reaction time measurement QTL GWAS1156817 (human) | | 0.000004 | reaction time measurement | | 4 | 109249480 | 109249481 | Human |
| 407000912 | GWAS649888_H | polychlorinated biphenyls measurement QTL GWAS649888 (human) | | 0.0000001 | polychlorinated biphenyls measurement | | 4 | 117114403 | 117114404 | Human |
| 406919000 | GWAS567976_H | venous thromboembolism QTL GWAS567976 (human) | | 0.0000002 | venous thromboembolism | | 4 | 112933404 | 112933405 | Human |
| 597503110 | GWAS1599184_H | systolic blood pressure QTL GWAS1599184 (human) | | 0.0000001 | systolic blood pressure | | 4 | 132120954 | 132120955 | Human |
| 597175429 | GWAS1271503_H | acne QTL GWAS1271503 (human) | | 0.000008 | acne | | 4 | 123213554 | 123213555 | Human |
| 597060744 | GWAS1156818_H | reaction time measurement QTL GWAS1156818 (human) | | 0.000001 | reaction time measurement | | 4 | 110649067 | 110649068 | Human |
| 597077128 | GWAS1173202_H | P wave duration QTL GWAS1173202 (human) | | 4e-08 | heart excitatory physiology trait (VT:0000231) | P wave duration (CMO:0000264) | 4 | 113467664 | 113467665 | Human |
| 617016293 | GWAS2033792_H | platelet count QTL GWAS2033792 (human) | | 9e-11 | platelet count | | 4 | 109813770 | 109813771 | Human |
| 626453118 | GWAS2267051_H | autoimmune thrombocytopenic purpura QTL GWAS2267051 (human) | | 0.000004 | autoimmune thrombocytopenic purpura | | 4 | 108354670 | 108354671 | Human |
| 407000938 | GWAS649914_H | protein measurement QTL GWAS649914 (human) | | 8e-09 | protein measurement | | 4 | 112234608 | 112234609 | Human |
| 597585076 | GWAS1641936_H | body height QTL GWAS1641936 (human) | | 1e-13 | body height | | 4 | 119665953 | 119665954 | Human |
| 597585077 | GWAS1641937_H | body height QTL GWAS1641937 (human) | | 8e-14 | body height | | 4 | 121876108 | 121876109 | Human |
| 597355702 | GWAS1451776_H | self reported educational attainment QTL GWAS1451776 (human) | | 0.000007 | self reported educational attainment | | 4 | 119344104 | 119344105 | Human |
| 597585075 | GWAS1641935_H | body height QTL GWAS1641935 (human) | | 3e-28 | body height | | 4 | 108503691 | 108503692 | Human |
| 407115636 | GWAS764612_H | protein measurement QTL GWAS764612 (human) | | 2e-08 | protein measurement | | 4 | 112377503 | 112377504 | Human |
| 407099255 | GWAS748231_H | body mass index QTL GWAS748231 (human) | | 8e-11 | body mass index | | 4 | 119292875 | 119292876 | Human |
| 407099254 | GWAS748230_H | body mass index QTL GWAS748230 (human) | | 7e-10 | body mass index | | 4 | 118298754 | 118298755 | Human |
| 406902645 | GWAS551621_H | response to cranial radiation therapy, short-term memory QTL GWAS551621 (human) | | 0.0000007 | response to cranial radiation therapy, short-term memory | | 4 | 120035508 | 120035509 | Human |
| 407099259 | GWAS748235_H | body mass index QTL GWAS748235 (human) | | 6e-09 | body mass index | | 4 | 130097733 | 130097734 | Human |
| 407099258 | GWAS748234_H | body mass index QTL GWAS748234 (human) | | 9e-21 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 407099257 | GWAS748233_H | body mass index QTL GWAS748233 (human) | | 1e-08 | body mass index | | 4 | 129399809 | 129399810 | Human |
| 407099256 | GWAS748232_H | body mass index QTL GWAS748232 (human) | | 3e-08 | body mass index | | 4 | 121743168 | 121743169 | Human |
| 597028009 | GWAS1124083_H | atrial fibrillation QTL GWAS1124083 (human) | | 5e-88 | atrial fibrillation | | 4 | 110631977 | 110631978 | Human |
| 406918913 | GWAS567889_H | Antihypertensive use measurement QTL GWAS567889 (human) | | 1e-17 | Antihypertensive use measurement | | 4 | 110469660 | 110469661 | Human |
| 597306587 | GWAS1402661_H | coronary artery disease QTL GWAS1402661 (human) | | 3e-16 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 407213830 | GWAS862806_H | cup-to-disc ratio measurement QTL GWAS862806 (human) | | 5e-17 | cup-to-disc ratio measurement | | 4 | 125486143 | 125486144 | Human |
| 406886147 | GWAS535123_H | susceptibility to vaginal yeast infection measurement QTL GWAS535123 (human) | | 0.000001 | susceptibility to vaginal yeast infection measurement | | 4 | 128039093 | 128039112 | Human |
| 597535963 | GWAS1632037_H | body height QTL GWAS1632037 (human) | | 4e-17 | body height | | 4 | 125758137 | 125758138 | Human |
| 597535962 | GWAS1632036_H | body height QTL GWAS1632036 (human) | | 8e-35 | body height | | 4 | 123891742 | 123891743 | Human |
| 406886152 | GWAS535128_H | sclerosing cholangitis QTL GWAS535128 (human) | | 9e-13 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
| 628845105 | GWAS2753334_H | epidermal growth factor measurement QTL GWAS2753334 (human) | | 5e-17 | epidermal growth factor measurement | | 4 | 109961320 | 109961321 | Human |
| 616983435 | GWAS2000934_H | acute myeloid leukemia QTL GWAS2000934 (human) | | 4e-25 | leukocyte integrity trait (VT:0010898) | | 4 | 112776849 | 112776850 | Human |
| 597355735 | GWAS1451809_H | trait in response to cytarabine QTL GWAS1451809 (human) | | 0.000007 | trait in response to cytarabine | | 4 | 119691563 | 119691564 | Human |
| 616967051 | GWAS1984550_H | Alzheimer disease QTL GWAS1984550 (human) | | 0.000008 | Alzheimer disease | | 4 | 122647254 | 122647255 | Human |
| 597322964 | GWAS1419038_H | mannitol measurement, sorbitol measurement QTL GWAS1419038 (human) | | 0.000003 | mannitol measurement, sorbitol measurement | | 4 | 112447703 | 112447704 | Human |
| 628451877 | GWAS2360106_H | atrial fibrillation QTL GWAS2360106 (human) | | 3e-09 | atrial fibrillation | | 4 | 111533139 | 111533140 | Human |
| 628451879 | GWAS2360108_H | atrial fibrillation QTL GWAS2360108 (human) | | 9e-09 | atrial fibrillation | | 4 | 112408189 | 112408190 | Human |
| 628451878 | GWAS2360107_H | atrial fibrillation QTL GWAS2360107 (human) | | 9e-09 | atrial fibrillation | | 4 | 111683665 | 111683666 | Human |
| 628451875 | GWAS2360104_H | atrial fibrillation QTL GWAS2360104 (human) | | 2e-18 | atrial fibrillation | | 4 | 111004500 | 111004501 | Human |
| 597617862 | GWAS1674722_H | knee fracture QTL GWAS1674722 (human) | | 7e-13 | knee fracture | | 4 | 117485221 | 117485222 | Human |
| 407000859 | GWAS649835_H | optic disc area measurement QTL GWAS649835 (human) | | 0.0000004 | optic disc area measurement | | 4 | 114560759 | 114560760 | Human |
| 407312158 | GWAS961134_H | QRS duration QTL GWAS961134 (human) | | 4e-09 | QRS duration | | 4 | 124797072 | 124797073 | Human |
| 628959783 | GWAS2868012_H | prothrombin time measurement QTL GWAS2868012 (human) | | 2e-31 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110791276 | 110791277 | Human |
| 407230239 | GWAS879215_H | Cleft palate QTL GWAS879215 (human) | | 0.000004 | Cleft palate | | 4 | 116802931 | 116802932 | Human |
| 628779552 | GWAS2687781_H | bipolar disorder QTL GWAS2687781 (human) | | 5e-09 | bipolar disorder | | 4 | 117534962 | 117534963 | Human |
| 628517396 | GWAS2425625_H | Thrombocytopenia QTL GWAS2425625 (human) | | 1e-44 | Thrombocytopenia | | 4 | 110026904 | 110026905 | Human |
| 406918949 | GWAS567925_H | triglyceride measurement QTL GWAS567925 (human) | | 6e-12 | triglyceride:HDL cholesterol ratio | | 4 | 109648464 | 109648465 | Human |
| 628861459 | GWAS2769688_H | QRS duration QTL GWAS2769688 (human) | | 4e-09 | QRS duration | | 4 | 124797072 | 124797073 | Human |
| 597028094 | GWAS1124168_H | atrial fibrillation QTL GWAS1124168 (human) | | 1e-15 | atrial fibrillation | | 4 | 110815726 | 110815727 | Human |
| 597388528 | GWAS1484602_H | fat body mass QTL GWAS1484602 (human) | | 0.000003 | fat body mass | | 4 | 129885831 | 129885832 | Human |
| 597028088 | GWAS1124162_H | atrial fibrillation QTL GWAS1124162 (human) | | 1e-38 | atrial fibrillation | | 4 | 110859850 | 110859851 | Human |
| 628402688 | GWAS2310917_H | erythrocyte volume QTL GWAS2310917 (human) | | 1e-10 | erythrocyte volume | | 4 | 121774530 | 121774531 | Human |
| 628697615 | GWAS2605844_H | cerebral cortex area attribute QTL GWAS2605844 (human) | | 4e-08 | cerebral cortex area attribute | | 4 | 127191068 | 127191069 | Human |
| 598109401 | GWAS1818284_H | glioblastoma multiforme QTL GWAS1818284 (human) | | 0.000006 | glioblastoma multiforme | | 4 | 123019629 | 123019630 | Human |
| 597027861 | GWAS1123935_H | blood protein measurement QTL GWAS1123935 (human) | | 5e-62 | blood protein measurement | | 4 | 109965187 | 109965188 | Human |
| 617098057 | GWAS2115556_H | epidermal growth factor measurement QTL GWAS2115556 (human) | | 4e-18 | epidermal growth factor measurement | | 4 | 110012720 | 110012721 | Human |
| 617147212 | GWAS2164711_H | Shock QTL GWAS2164711 (human) | | 9e-12 | Shock | | 4 | 108255692 | 108255693 | Human |
| 628566770 | GWAS2474999_H | cerebral cortex area attribute QTL GWAS2474999 (human) | | 1e-10 | cerebral cortex area attribute | | 4 | 126658527 | 126658528 | Human |
| 616491835 | GWAS1888418_H | body mass index QTL GWAS1888418 (human) | | 6e-09 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 628566769 | GWAS2474998_H | cerebral cortex area attribute QTL GWAS2474998 (human) | | 2e-17 | cerebral cortex area attribute | | 4 | 123326251 | 123326252 | Human |
| 628566768 | GWAS2474997_H | cerebral cortex area attribute QTL GWAS2474997 (human) | | 8e-10 | cerebral cortex area attribute | | 4 | 120653052 | 120653053 | Human |
| 597617682 | GWAS1674542_H | prothrombin time measurement QTL GWAS1674542 (human) | | 7e-37 | prothrombin time measurement | | 4 | 110780277 | 110780278 | Human |
| 597814318 | GWAS1681709_H | insulin sensitivity measurement QTL GWAS1681709 (human) | | 0.0000005 | insulin sensitivity measurement | | 4 | 127922325 | 127922326 | Human |
| 407115734 | GWAS764710_H | cognitive decline measurement QTL GWAS764710 (human) | | 0.0000005 | cognitive behavior trait (VT:0010450) | | 4 | 121687103 | 121687104 | Human |
| 597978161 | GWAS1697460_H | erythrocyte volume QTL GWAS1697460 (human) | | 9e-21 | erythrocyte volume | | 4 | 121808258 | 121808259 | Human |
| 616966995 | GWAS1984494_H | uric acid measurement QTL GWAS1984494 (human) | | 0.000006 | blood uric acid amount (VT:0010302) | blood uric acid level (CMO:0000501) | 4 | 124261535 | 124261536 | Human |
| 597978162 | GWAS1697461_H | erythrocyte volume QTL GWAS1697461 (human) | | 5e-09 | erythrocyte volume | | 4 | 127647811 | 127647812 | Human |
| 407082971 | GWAS731947_H | prostate carcinoma QTL GWAS731947 (human) | | 4e-08 | prostate carcinoma | | 4 | 109927496 | 109927497 | Human |
| 628566767 | GWAS2474996_H | cerebral cortex area attribute QTL GWAS2474996 (human) | | 1e-17 | cerebral cortex area attribute | | 4 | 118393759 | 118393760 | Human |
| 628566766 | GWAS2474995_H | cerebral cortex area attribute QTL GWAS2474995 (human) | | 2e-13 | cerebral cortex area attribute | | 4 | 112509596 | 112509597 | Human |
| 628878050 | GWAS2786279_H | total cholesterol measurement QTL GWAS2786279 (human) | | 3e-09 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 119202262 | 119202263 | Human |
| 628566765 | GWAS2474994_H | cerebral cortex area attribute QTL GWAS2474994 (human) | | 2e-08 | cerebral cortex area attribute | | 4 | 107131838 | 107131839 | Human |
| 597437447 | GWAS1533521_H | lipid measurement QTL GWAS1533521 (human) | | 0.000009 | lipid measurement | | 4 | 107039415 | 107039416 | Human |
| 628697830 | GWAS2606059_H | brain attribute QTL GWAS2606059 (human) | | 1e-10 | brain attribute | | 4 | 124548568 | 124548569 | Human |
| 628452049 | GWAS2360278_H | chronotype measurement QTL GWAS2360278 (human) | | 4e-09 | sleep behavior trait (VT:0001501) | | 4 | 113518738 | 113518739 | Human |
| 597077053 | GWAS1173127_H | Epstein-Barr virus infection QTL GWAS1173127 (human) | | 0.000001 | response to viral infection trait (VT:0010439) | | 4 | 129344227 | 129344228 | Human |
| 407312362 | GWAS961338_H | ceramide measurement QTL GWAS961338 (human) | | 3e-08 | ceramide measurement | | 4 | 114533531 | 114533532 | Human |
| 407394278 | GWAS1043254_H | cortical thickness QTL GWAS1043254 (human) | | 6e-19 | cortical thickness | | 4 | 112512138 | 112512139 | Human |
| 407082989 | GWAS731965_H | obsolete_red blood cell distribution width QTL GWAS731965 (human) | | 7e-19 | obsolete_red blood cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 616508175 | GWAS1904758_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS1904758 (human) | | 2e-11 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119864597 | 119864598 | Human |
| 616508173 | GWAS1904756_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS1904756 (human) | | 2e-12 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119380081 | 119380082 | Human |
| 407230455 | GWAS879431_H | response to darapladib, cardiovascular event measurement QTL GWAS879431 (human) | | 0.000002 | response to darapladib, cardiovascular event measurement | | 4 | 124644124 | 124644125 | Human |
| 616508172 | GWAS1904755_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS1904755 (human) | | 2e-108 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119635207 | 119635208 | Human |
| 628452038 | GWAS2360267_H | chronotype measurement QTL GWAS2360267 (human) | | 1e-10 | sleep behavior trait (VT:0001501) | | 4 | 129982356 | 129982357 | Human |
| 616508171 | GWAS1904754_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS1904754 (human) | | 1e-17 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119424923 | 119424924 | Human |
| 628992712 | GWAS2900941_H | lymphocyte count QTL GWAS2900941 (human) | | 2e-14 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112183886 | 112183887 | Human |
| 616508170 | GWAS1904753_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS1904753 (human) | | 1e-12 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119508517 | 119508518 | Human |
| 597322799 | GWAS1418873_H | cup-to-disc ratio measurement QTL GWAS1418873 (human) | | 2e-18 | cup-to-disc ratio measurement | | 4 | 125478843 | 125478844 | Human |
| 628484803 | GWAS2393032_H | atrial fibrillation QTL GWAS2393032 (human) | | 6e-09 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 616508169 | GWAS1904752_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS1904752 (human) | | 4e-13 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119502654 | 119502655 | Human |
| 407246847 | GWAS895823_H | neonatal abstinence syndrome QTL GWAS895823 (human) | | 0.000003 | neonatal abstinence syndrome | | 4 | 115468815 | 115468816 | Human |
| 597388321 | GWAS1484395_H | pursuit maintenance gain measurement QTL GWAS1484395 (human) | | 0.000003 | pursuit maintenance gain measurement | | 4 | 110340886 | 110340887 | Human |
| 597535782 | GWAS1631856_H | bone density QTL GWAS1631856 (human) | | 4e-40 | bone density | | 4 | 126002708 | 126002709 | Human |
| 597109803 | GWAS1205877_H | Calcium channel blocker use measurement QTL GWAS1205877 (human) | | 5e-08 | Calcium channel blocker use measurement | | 4 | 108081403 | 108081404 | Human |
| 407230459 | GWAS879435_H | response to darapladib, cardiovascular event measurement QTL GWAS879435 (human) | | 6e-09 | response to darapladib, cardiovascular event measurement | | 4 | 124644124 | 124644125 | Human |
| 596978772 | GWAS1098291_H | stroke QTL GWAS1098291 (human) | | 2e-15 | stroke | | 4 | 110793263 | 110793264 | Human |
| 616491903 | GWAS1888486_H | ceramide amount QTL GWAS1888486 (human) | | 1e-16 | ceramide amount | | 4 | 114598115 | 114598116 | Human |
| 597519452 | GWAS1615526_H | body fat percentage QTL GWAS1615526 (human) | | 3e-08 | body fat percentage | | 4 | 123822104 | 123822105 | Human |
| 616491901 | GWAS1888484_H | ceramide amount QTL GWAS1888484 (human) | | 2e-08 | ceramide amount | | 4 | 114553199 | 114553200 | Human |
| 407000966 | GWAS649942_H | systolic blood pressure QTL GWAS649942 (human) | | 1e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 108104223 | 108104224 | Human |
| 616491898 | GWAS1888481_H | ceramide amount QTL GWAS1888481 (human) | | 2e-11 | ceramide amount | | 4 | 114663873 | 114663874 | Human |
| 617278220 | GWAS2214996_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2214996 (human) | | 5e-08 | polyunsaturated fatty acids to total fatty acids percentage | | 4 | 107486430 | 107486431 | Human |
| 616491897 | GWAS1888480_H | ceramide amount QTL GWAS1888480 (human) | | 5e-38 | ceramide amount | | 4 | 114564528 | 114564529 | Human |
| 597470294 | GWAS1566368_H | leukocyte count QTL GWAS1566368 (human) | | 4e-12 | leukocyte count | | 4 | 119409000 | 119409001 | Human |
| 616541045 | GWAS1937628_H | blood protein amount QTL GWAS1937628 (human) | | 5e-13 | blood protein amount | | 4 | 122216079 | 122216080 | Human |
| 407361431 | GWAS1010407_H | insomnia QTL GWAS1010407 (human) | | 3e-10 | insomnia | | 4 | 130028211 | 130028212 | Human |
| 406902673 | GWAS551649_H | diastolic blood pressure QTL GWAS551649 (human) | | 9e-19 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
| 628828842 | GWAS2737071_H | body height QTL GWAS2737071 (human) | | 6e-23 | body height | | 4 | 122904764 | 122904765 | Human |
| 407361430 | GWAS1010406_H | insomnia QTL GWAS1010406 (human) | | 2e-11 | insomnia | | 4 | 129856909 | 129856910 | Human |
| 597535820 | GWAS1631894_H | body height QTL GWAS1631894 (human) | | 7e-09 | body height | | 4 | 132314995 | 132314996 | Human |
| 407361429 | GWAS1010405_H | insomnia QTL GWAS1010405 (human) | | 5e-09 | insomnia | | 4 | 118318250 | 118318251 | Human |
| 597535819 | GWAS1631893_H | body height QTL GWAS1631893 (human) | | 3e-19 | body height | | 4 | 108540829 | 108540830 | Human |
| 628959909 | GWAS2868138_H | degeneration of macula and posterior pole QTL GWAS2868138 (human) | | 1e-18 | degeneration of macula and posterior pole | | 4 | 109764664 | 109764665 | Human |
| 597257283 | GWAS1353357_H | hair colour measurement QTL GWAS1353357 (human) | | 6e-11 | hair colour measurement | | 4 | 108107769 | 108107770 | Human |
| 628959911 | GWAS2868140_H | retinopathy QTL GWAS2868140 (human) | | 3e-12 | retina integrity trait (VT:0010771) | | 4 | 109764664 | 109764665 | Human |
| 628664998 | GWAS2573227_H | able to hear with hearing aids QTL GWAS2573227 (human) | | 0.0000003 | hearing physiology trait (VT:0002104) | | 4 | 116261685 | 116261686 | Human |
| 407377814 | GWAS1026790_H | hip bone size QTL GWAS1026790 (human) | | 7e-09 | hip bone size | | 4 | 129257175 | 129257176 | Human |
| 598027386 | GWAS1746685_H | heart rate QTL GWAS1746685 (human) | | 7e-21 | heart rate | | 4 | 110796911 | 110796912 | Human |
| 628419243 | GWAS2327472_H | triglyceride measurement, response to diuretic QTL GWAS2327472 (human) | | 6e-08 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 129379460 | 129379461 | Human |
| 597208184 | GWAS1304258_H | childhood onset asthma QTL GWAS1304258 (human) | | 2e-14 | childhood onset asthma | | 4 | 122456327 | 122456328 | Human |
| 597814339 | GWAS1681730_H | triglyceride change measurement QTL GWAS1681730 (human) | | 0.000001 | triglyceride change measurement | | 4 | 128638644 | 128638645 | Human |
| 628419217 | GWAS2327446_H | response to diuretic, low density lipoprotein cholesterol measurement QTL GWAS2327446 (human) | | 0.0000008 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 107388616 | 107388617 | Human |
| 597126270 | GWAS1222344_H | renal carcinoma QTL GWAS1222344 (human) | | 9e-10 | renal carcinoma | | 4 | 108791438 | 108791439 | Human |
| 407001000 | GWAS649976_H | eosinophil count QTL GWAS649976 (human) | | 5e-23 | eosinophil count | | 4 | 122263256 | 122263257 | Human |
| 597159035 | GWAS1255109_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS1255109 (human) | | 5e-11 | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | | 4 | 109657070 | 109657071 | Human |
| 597322858 | GWAS1418932_H | non-high density lipoprotein cholesterol measurement QTL GWAS1418932 (human) | | 5e-12 | non-high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 597470317 | GWAS1566391_H | rheumatoid arthritis QTL GWAS1566391 (human) | | 4e-08 | rheumatoid arthritis | | 4 | 112286121 | 112286122 | Human |
| 617196344 | GWAS2176784_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2176784 (human) | | 1e-26 | glioma pathogenesis-related protein 1 measurement | | 4 | 125365950 | 125365951 | Human |
| 597814355 | GWAS1681746_H | insulin sensitivity measurement QTL GWAS1681746 (human) | | 0.000003 | insulin sensitivity measurement | | 4 | 127922325 | 127922326 | Human |
| 597322857 | GWAS1418931_H | non-high density lipoprotein cholesterol measurement QTL GWAS1418931 (human) | | 5e-10 | non-high density lipoprotein cholesterol measurement | | 4 | 109174464 | 109174465 | Human |
| 617032499 | GWAS2049998_H | astrocytoma QTL GWAS2049998 (human) | | 0.000008 | astrocytoma | | 4 | 125560531 | 125560532 | Human |
| 628419210 | GWAS2327439_H | response to diuretic, low density lipoprotein cholesterol measurement QTL GWAS2327439 (human) | | 0.0000002 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 107408461 | 107408462 | Human |
| 628566665 | GWAS2474894_H | body height QTL GWAS2474894 (human) | | 2e-14 | body height | | 4 | 119501252 | 119501253 | Human |
| 628372852 | GWAS2293696_H | fibroblast growth factor 2 level QTL GWAS2293696 (human) | | 3e-18 | fibroblast growth factor 2 level | | 4 | 122718148 | 122718149 | Human |
| 628372853 | GWAS2293697_H | fibroblast growth factor 2 level QTL GWAS2293697 (human) | | 4e-13 | fibroblast growth factor 2 level | | 4 | 122652747 | 122652748 | Human |
| 628372854 | GWAS2293698_H | fibroblast growth factor 2 level QTL GWAS2293698 (human) | | 6e-22 | fibroblast growth factor 2 level | | 4 | 122785605 | 122785606 | Human |
| 628372855 | GWAS2293699_H | fibroblast growth factor 2 level QTL GWAS2293699 (human) | | 4e-17 | fibroblast growth factor 2 level | | 4 | 122769150 | 122769151 | Human |
| 598061985 | GWAS1781284_H | alcohol consumption quality QTL GWAS1781284 (human) | | 4e-09 | alcohol consumption quality | | 4 | 117942113 | 117942114 | Human |
| 598061984 | GWAS1781283_H | alcohol consumption quality QTL GWAS1781283 (human) | | 7e-12 | alcohol consumption quality | | 4 | 112674713 | 112674714 | Human |
| 628372849 | GWAS2293693_H | fibroblast growth factor 2 level QTL GWAS2293693 (human) | | 5e-15 | fibroblast growth factor 2 level | | 4 | 122496141 | 122496142 | Human |
| 628372850 | GWAS2293694_H | fibroblast growth factor 2 level QTL GWAS2293694 (human) | | 6e-18 | fibroblast growth factor 2 level | | 4 | 122786283 | 122786284 | Human |
| 598061987 | GWAS1781286_H | alcohol consumption quality QTL GWAS1781286 (human) | | 2e-11 | alcohol consumption quality | | 4 | 129324733 | 129324734 | Human |
| 628372851 | GWAS2293695_H | fibroblast growth factor 2 level QTL GWAS2293695 (human) | | 3e-13 | fibroblast growth factor 2 level | | 4 | 122807648 | 122807649 | Human |
| 598061986 | GWAS1781285_H | alcohol consumption quality QTL GWAS1781285 (human) | | 4e-10 | alcohol consumption quality | | 4 | 128811970 | 128811971 | Human |
| 628569471 | GWAS2477700_H | glycerophospholipid measurement QTL GWAS2477700 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114582721 | 114582722 | Human |
| 628372860 | GWAS2293704_H | fibroblast growth factor 2 level QTL GWAS2293704 (human) | | 5e-34 | fibroblast growth factor 2 level | | 4 | 123107513 | 123107514 | Human |
| 628569470 | GWAS2477699_H | glycerophospholipid measurement QTL GWAS2477699 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114515499 | 114515500 | Human |
| 628372861 | GWAS2293705_H | fibroblast growth factor 2 level QTL GWAS2293705 (human) | | 2e-33 | fibroblast growth factor 2 level | | 4 | 122815622 | 122815623 | Human |
| 617051342 | GWAS2068841_H | vaginal microbiome measurement QTL GWAS2068841 (human) | | 0.000004 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
| 628569469 | GWAS2477698_H | glycerophospholipid measurement QTL GWAS2477698 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114517522 | 114517523 | Human |
| 628372862 | GWAS2293706_H | fibroblast growth factor 2 level QTL GWAS2293706 (human) | | 5e-17 | fibroblast growth factor 2 level | | 4 | 122424054 | 122424055 | Human |
| 597390224 | GWAS1486298_H | diet measurement QTL GWAS1486298 (human) | | 3e-08 | diet measurement | | 4 | 112518056 | 112518057 | Human |
| 628569468 | GWAS2477697_H | glycerophospholipid measurement QTL GWAS2477697 (human) | | 1e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114553199 | 114553200 | Human |
| 628372863 | GWAS2293707_H | fibroblast growth factor 2 level QTL GWAS2293707 (human) | | 2e-20 | fibroblast growth factor 2 level | | 4 | 122663955 | 122663956 | Human |
| 628569467 | GWAS2477696_H | glycerophospholipid measurement QTL GWAS2477696 (human) | | 1e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114522432 | 114522433 | Human |
| 597046170 | GWAS1142244_H | atopic asthma QTL GWAS1142244 (human) | | 9e-13 | atopic asthma | | 4 | 122466445 | 122466446 | Human |
| 628372856 | GWAS2293700_H | fibroblast growth factor 2 level QTL GWAS2293700 (human) | | 1e-35 | fibroblast growth factor 2 level | | 4 | 122495046 | 122495047 | Human |
| 617002186 | GWAS2019685_H | Bell's palsy QTL GWAS2019685 (human) | | 0.000006 | Bell's palsy | | 4 | 123516321 | 123516322 | Human |
| 596964249 | GWAS1083768_H | major depressive disorder QTL GWAS1083768 (human) | | 0.000007 | major depressive disorder | | 4 | 115213661 | 115213662 | Human |
| 597062555 | GWAS1158629_H | depressive symptom measurement QTL GWAS1158629 (human) | | 4e-09 | depression-related behavior trait (VT:0015015) | | 4 | 122201701 | 122201702 | Human |
| 597046171 | GWAS1142245_H | atopic asthma QTL GWAS1142245 (human) | | 5e-08 | atopic asthma | | 4 | 122387310 | 122387311 | Human |
| 628372857 | GWAS2293701_H | fibroblast growth factor 2 level QTL GWAS2293701 (human) | | 2e-22 | fibroblast growth factor 2 level | | 4 | 122685018 | 122685019 | Human |
| 628372858 | GWAS2293702_H | fibroblast growth factor 2 level QTL GWAS2293702 (human) | | 2e-55 | fibroblast growth factor 2 level | | 4 | 121996120 | 121996121 | Human |
| 597046169 | GWAS1142243_H | atopic asthma QTL GWAS1142243 (human) | | 5e-16 | atopic asthma | | 4 | 122219915 | 122219916 | Human |
| 406964302 | GWAS613278_H | facial morphology measurement QTL GWAS613278 (human) | | 1e-19 | facial morphology measurement | | 4 | 127005360 | 127005361 | Human |
| 596964251 | GWAS1083770_H | major depressive disorder QTL GWAS1083770 (human) | | 0.000005 | major depressive disorder | | 4 | 127836228 | 127836229 | Human |
| 628372836 | GWAS2293680_H | fibroblast growth factor 2 level QTL GWAS2293680 (human) | | 1e-15 | fibroblast growth factor 2 level | | 4 | 122808855 | 122808856 | Human |
| 628372837 | GWAS2293681_H | fibroblast growth factor 2 level QTL GWAS2293681 (human) | | 6e-13 | fibroblast growth factor 2 level | | 4 | 122830982 | 122830983 | Human |
| 628372838 | GWAS2293682_H | fibroblast growth factor 2 level QTL GWAS2293682 (human) | | 2e-14 | fibroblast growth factor 2 level | | 4 | 122971709 | 122971710 | Human |
| 628372839 | GWAS2293683_H | fibroblast growth factor 2 level QTL GWAS2293683 (human) | | 5e-13 | fibroblast growth factor 2 level | | 4 | 121760907 | 121760908 | Human |
| 628372832 | GWAS2293676_H | fibroblast growth factor 2 level QTL GWAS2293676 (human) | | 6e-13 | fibroblast growth factor 2 level | | 4 | 124215762 | 124215763 | Human |
| 628372833 | GWAS2293677_H | fibroblast growth factor 2 level QTL GWAS2293677 (human) | | 1e-38 | fibroblast growth factor 2 level | | 4 | 122711350 | 122711351 | Human |
| 597422990 | GWAS1519064_H | cortical thickness QTL GWAS1519064 (human) | | 5e-09 | cortical thickness | | 4 | 127101149 | 127101150 | Human |
| 597422989 | GWAS1519063_H | cortical thickness QTL GWAS1519063 (human) | | 7e-17 | cortical thickness | | 4 | 112512138 | 112512139 | Human |
| 628372834 | GWAS2293678_H | fibroblast growth factor 2 level QTL GWAS2293678 (human) | | 1e-11 | fibroblast growth factor 2 level | | 4 | 122813836 | 122813837 | Human |
| 628372835 | GWAS2293679_H | fibroblast growth factor 2 level QTL GWAS2293679 (human) | | 3e-12 | fibroblast growth factor 2 level | | 4 | 122764765 | 122764766 | Human |
| 628372844 | GWAS2293688_H | fibroblast growth factor 2 level QTL GWAS2293688 (human) | | 2e-12 | fibroblast growth factor 2 level | | 4 | 121789225 | 121789226 | Human |
| 406898776 | GWAS547752_H | primary biliary cirrhosis QTL GWAS547752 (human) | | 4e-13 | primary biliary cirrhosis | | 4 | 122667371 | 122667372 | Human |
| 406898777 | GWAS547753_H | primary biliary cirrhosis QTL GWAS547753 (human) | | 1e-11 | primary biliary cirrhosis | | 4 | 122628544 | 122628545 | Human |
| 406980699 | GWAS629675_H | caudate nucleus volume QTL GWAS629675 (human) | | 0.000004 | caudate nucleus volume | | 4 | 122735253 | 122735254 | Human |
| 628372846 | GWAS2293690_H | fibroblast growth factor 2 level QTL GWAS2293690 (human) | | 9e-165 | fibroblast growth factor 2 level | | 4 | 122842746 | 122842747 | Human |
| 628372847 | GWAS2293691_H | fibroblast growth factor 2 level QTL GWAS2293691 (human) | | 5e-157 | fibroblast growth factor 2 level | | 4 | 122859108 | 122859109 | Human |
| 628372840 | GWAS2293684_H | fibroblast growth factor 2 level QTL GWAS2293684 (human) | | 9e-40 | fibroblast growth factor 2 level | | 4 | 122868214 | 122868215 | Human |
| 628847974 | GWAS2756203_H | metabolite measurement QTL GWAS2756203 (human) | | 6e-08 | metabolite measurement | | 4 | 129868385 | 129868386 | Human |
| 597357445 | GWAS1453519_H | longitudinal BMI measurement QTL GWAS1453519 (human) | | 0.000009 | longitudinal BMI measurement | | 4 | 118506802 | 118506803 | Human |
| 628372843 | GWAS2293687_H | fibroblast growth factor 2 level QTL GWAS2293687 (human) | | 4e-40 | fibroblast growth factor 2 level | | 4 | 122826155 | 122826156 | Human |
| 406947937 | GWAS596913_H | PR interval QTL GWAS596913 (human) | | 2e-25 | heart excitatory physiology trait (VT:0000231) | PR interval (CMO:0000233) | 4 | 113504778 | 113504779 | Human |
| 628372821 | GWAS2293665_H | fibroblast growth factor 2 level QTL GWAS2293665 (human) | | 4e-50 | fibroblast growth factor 2 level | | 4 | 123210593 | 123210594 | Human |
| 407062625 | GWAS711601_H | glycine measurement QTL GWAS711601 (human) | | 4e-11 | glycine measurement | | 4 | 110510288 | 110510289 | Human |
| 628372822 | GWAS2293666_H | fibroblast growth factor 2 level QTL GWAS2293666 (human) | | 2e-14 | fibroblast growth factor 2 level | | 4 | 122792575 | 122792576 | Human |
| 628372823 | GWAS2293667_H | fibroblast growth factor 2 level QTL GWAS2293667 (human) | | 2e-22 | fibroblast growth factor 2 level | | 4 | 122820831 | 122820832 | Human |
| 407079015 | GWAS727991_H | pulmonary embolism QTL GWAS727991 (human) | | 8e-17 | pulmonary embolism | | 4 | 119320747 | 119320748 | Human |
| 407079012 | GWAS727988_H | hair colour measurement QTL GWAS727988 (human) | | 9e-38 | hair colour measurement | | 4 | 108429724 | 108429725 | Human |
| 628372828 | GWAS2293672_H | fibroblast growth factor 2 level QTL GWAS2293672 (human) | | 9e-16 | fibroblast growth factor 2 level | | 4 | 122773901 | 122773902 | Human |
| 628372829 | GWAS2293673_H | fibroblast growth factor 2 level QTL GWAS2293673 (human) | | 2e-32 | fibroblast growth factor 2 level | | 4 | 122807694 | 122807695 | Human |
| 407144557 | GWAS793533_H | mosquito bite reaction itch intensity measurement QTL GWAS793533 (human) | | 2e-11 | mosquito bite reaction itch intensity measurement | | 4 | 123047357 | 123047358 | Human |
| 407144558 | GWAS793534_H | mosquito bite reaction itch intensity measurement QTL GWAS793534 (human) | | 1e-10 | mosquito bite reaction itch intensity measurement | | 4 | 123249252 | 123249253 | Human |
| 628372830 | GWAS2293674_H | fibroblast growth factor 2 level QTL GWAS2293674 (human) | | 2e-22 | fibroblast growth factor 2 level | | 4 | 123434666 | 123434667 | Human |
| 628372831 | GWAS2293675_H | fibroblast growth factor 2 level QTL GWAS2293675 (human) | | 7e-15 | fibroblast growth factor 2 level | | 4 | 122834463 | 122834464 | Human |
| 407144559 | GWAS793535_H | mosquito bite reaction itch intensity measurement QTL GWAS793535 (human) | | 8e-08 | mosquito bite reaction itch intensity measurement | | 4 | 123350979 | 123350980 | Human |
| 597078973 | GWAS1175047_H | triglyceride measurement QTL GWAS1175047 (human) | | 0.000005 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 125211924 | 125211925 | Human |
| 616494229 | GWAS1890812_H | X-16935 measurement QTL GWAS1890812 (human) | | 0.000007 | X-16935 measurement | | 4 | 128729697 | 128729698 | Human |
| 628372824 | GWAS2293668_H | fibroblast growth factor 2 level QTL GWAS2293668 (human) | | 2e-72 | fibroblast growth factor 2 level | | 4 | 123006761 | 123006762 | Human |
| 597980040 | GWAS1699339_H | tumor necrosis factor alpha amount QTL GWAS1699339 (human) | | 0.0000008 | tumor necrosis factor alpha amount | | 4 | 123440293 | 123440294 | Human |
| 628372825 | GWAS2293669_H | fibroblast growth factor 2 level QTL GWAS2293669 (human) | | 2e-26 | fibroblast growth factor 2 level | | 4 | 123218415 | 123218416 | Human |
| 617051370 | GWAS2068869_H | vaginal microbiome measurement QTL GWAS2068869 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
| 628372826 | GWAS2293670_H | fibroblast growth factor 2 level QTL GWAS2293670 (human) | | 7e-18 | fibroblast growth factor 2 level | | 4 | 123310196 | 123310197 | Human |
| 628372827 | GWAS2293671_H | fibroblast growth factor 2 level QTL GWAS2293671 (human) | | 1e-15 | fibroblast growth factor 2 level | | 4 | 121830362 | 121830363 | Human |
| 628798794 | GWAS2707023_H | atrial fibrillation QTL GWAS2707023 (human) | | 4e-15 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 407226485 | GWAS875461_H | bone density QTL GWAS875461 (human) | | 5e-133 | bone density | | 4 | 120625611 | 120625612 | Human |
| 407095410 | GWAS744386_H | bipolar I disorder QTL GWAS744386 (human) | | 0.0000006 | bipolar I disorder | | 4 | 117624232 | 117624233 | Human |
| 596964262 | GWAS1083781_H | mood disorder, major depressive disorder QTL GWAS1083781 (human) | | 1e-10 | mood disorder, major depressive disorder | | 4 | 122201701 | 122201702 | Human |
| 628798793 | GWAS2707022_H | atrial fibrillation QTL GWAS2707022 (human) | | 4e-714 | atrial fibrillation | | 4 | 110789811 | 110789812 | Human |
| 617067764 | GWAS2085263_H | platelet count QTL GWAS2085263 (human) | | 1e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119334573 | 119334574 | Human |
| 597324719 | GWAS1420793_H | systolic blood pressure QTL GWAS1420793 (human) | | 9e-17 | systolic blood pressure | | 4 | 110510288 | 110510289 | Human |
| 407210096 | GWAS859072_H | brain measurement QTL GWAS859072 (human) | | 1e-10 | brain measurement | | 4 | 123263477 | 123263478 | Human |
| 617100542 | GWAS2118041_H | cathepsin F measurement QTL GWAS2118041 (human) | | 1e-17 | cathepsin F measurement | | 4 | 109657070 | 109657071 | Human |
| 407095413 | GWAS744389_H | bipolar I disorder QTL GWAS744389 (human) | | 0.0000008 | bipolar I disorder | | 4 | 117548415 | 117548416 | Human |
| 598061983 | GWAS1781282_H | alcohol consumption quality QTL GWAS1781282 (human) | | 4e-10 | alcohol consumption quality | | 4 | 112392830 | 112392831 | Human |
| 407406707 | GWAS1055683_H | glomerular filtration rate QTL GWAS1055683 (human) | | 1e-11 | glomerular filtration rate | | 4 | 127420965 | 127420966 | Human |
| 407275526 | GWAS924502_H | vaginal microbiome measurement QTL GWAS924502 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 131705323 | 131705324 | Human |
| 407144455 | GWAS793431_H | Ischemic stroke QTL GWAS793431 (human) | | 1e-08 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
| 597128148 | GWAS1224222_H | carotid artery disease QTL GWAS1224222 (human) | | 1e-11 | carotid artery disease | | 4 | 119576145 | 119576146 | Human |
| 628503861 | GWAS2412090_H | systolic blood pressure QTL GWAS2412090 (human) | | 9e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 123873489 | 123873490 | Human |
| 597128159 | GWAS1224233_H | glycerophospholipid measurement QTL GWAS1224233 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114573271 | 114573272 | Human |
| 597128158 | GWAS1224232_H | glycerophospholipid measurement QTL GWAS1224232 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114541864 | 114541865 | Human |
| 406898697 | GWAS547673_H | colorectal cancer QTL GWAS547673 (human) | | 2e-08 | colorectal cancer | | 4 | 114581250 | 114581251 | Human |
| 597128157 | GWAS1224231_H | glycerophospholipid measurement QTL GWAS1224231 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114547331 | 114547332 | Human |
| 628634931 | GWAS2543160_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2543160 (human) | | 4e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 112965969 | 112965970 | Human |
| 597128156 | GWAS1224230_H | glycerophospholipid measurement QTL GWAS1224230 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114563925 | 114563926 | Human |
| 597128155 | GWAS1224229_H | glycerophospholipid measurement QTL GWAS1224229 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114553520 | 114553521 | Human |
| 597128154 | GWAS1224228_H | glycerophospholipid measurement QTL GWAS1224228 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114546019 | 114546020 | Human |
| 597455826 | GWAS1551900_H | lymphocyte count QTL GWAS1551900 (human) | | 7e-23 | lymphocyte count | | 4 | 110020646 | 110020647 | Human |
| 597128153 | GWAS1224227_H | glycerophospholipid measurement QTL GWAS1224227 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114493059 | 114493060 | Human |
| 598012907 | GWAS1732206_H | AIFM1/EGF protein level ratio in blood QTL GWAS1732206 (human) | | 9e-124 | AIFM1/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 597160901 | GWAS1256975_H | monocyte count QTL GWAS1256975 (human) | | 5e-10 | monocyte count | | 4 | 110035176 | 110035177 | Human |
| 628602147 | GWAS2510376_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS2510376 (human) | | 1e-10 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109603883 | 109603884 | Human |
| 597160898 | GWAS1256972_H | factor XI measurement, coronary artery disease QTL GWAS1256972 (human) | | 2e-11 | factor XI measurement, coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 406997015 | GWAS645991_H | intelligence QTL GWAS645991 (human) | | 0.000007 | intelligence | | 4 | 129813235 | 129813236 | Human |
| 628503854 | GWAS2412083_H | systolic blood pressure QTL GWAS2412083 (human) | | 8e-15 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 108146742 | 108146743 | Human |
| 407357471 | GWAS1006447_H | vital capacity QTL GWAS1006447 (human) | | 5e-08 | vital capacity | | 4 | 108557833 | 108557834 | Human |
| 628553004 | GWAS2461233_H | cortical thickness QTL GWAS2461233 (human) | | 2e-10 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120722571 | 120722572 | Human |
| 597324736 | GWAS1420810_H | methionine measurement QTL GWAS1420810 (human) | | 0.0000002 | blood L-methionine amount (VT:0010981) | blood amino acid measurement (CMO:0003730) | 4 | 122052538 | 122052539 | Human |
| 597324737 | GWAS1420811_H | phenylalanine measurement QTL GWAS1420811 (human) | | 1e-08 | blood L-phenylalanine amount (VT:0010982) | | 4 | 122052538 | 122052539 | Human |
| 407095326 | GWAS744302_H | chromosome-type aberration frequency QTL GWAS744302 (human) | | 0.000008 | chromosome-type aberration frequency | | 4 | 131649836 | 131649837 | Human |
| 407046173 | GWAS695149_H | red blood cell density measurement QTL GWAS695149 (human) | | 1e-15 | erythrocyte count | | 4 | 121811061 | 121811062 | Human |
| 597308356 | GWAS1404430_H | body height QTL GWAS1404430 (human) | | 4e-08 | body height | | 4 | 128700992 | 128700993 | Human |
| 406997027 | GWAS646003_H | intelligence QTL GWAS646003 (human) | | 0.000007 | intelligence | | 4 | 112683802 | 112683803 | Human |
| 597390328 | GWAS1486402_H | appendicular lean mass QTL GWAS1486402 (human) | | 9e-13 | appendicular lean mass | | 4 | 119206606 | 119206607 | Human |
| 407177249 | GWAS826225_H | multiple sclerosis QTL GWAS826225 (human) | | 2e-11 | multiple sclerosis | | 4 | 108137562 | 108137563 | Human |
| 628798750 | GWAS2706979_H | R-warfarin measurement QTL GWAS2706979 (human) | | 5e-09 | R-warfarin measurement | | 4 | 112902858 | 112902859 | Human |
| 628831518 | GWAS2739747_H | body height QTL GWAS2739747 (human) | | 2e-14 | body height | | 4 | 119759795 | 119759796 | Human |
| 628552977 | GWAS2461206_H | acid sphingomyelinase-like phosphodiesterase 3a measurement QTL GWAS2461206 (human) | | 1e-19 | acid sphingomyelinase-like phosphodiesterase 3a measurement | | 4 | 109657070 | 109657071 | Human |
| 597128176 | GWAS1224250_H | glycerophospholipid measurement QTL GWAS1224250 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114517522 | 114517523 | Human |
| 628552990 | GWAS2461219_H | cortical thickness QTL GWAS2461219 (human) | | 4e-12 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120758655 | 120758656 | Human |
| 407324718 | GWAS973694_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS973694 (human) | | 1e-08 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | | 4 | 109717668 | 109717669 | Human |
| 406947883 | GWAS596859_H | PR interval QTL GWAS596859 (human) | | 2e-08 | heart excitatory physiology trait (VT:0000231) | PR interval (CMO:0000233) | 4 | 119148924 | 119148925 | Human |
| 597029883 | GWAS1125957_H | glomerular filtration rate QTL GWAS1125957 (human) | | 6e-08 | glomerular filtration rate | | 4 | 108772299 | 108772300 | Human |
| 407390247 | GWAS1039223_H | X-26054 measurement QTL GWAS1039223 (human) | | 5e-87 | X-26054 measurement | | 4 | 129143723 | 129143724 | Human |
| 597128167 | GWAS1224241_H | glycerophospholipid measurement QTL GWAS1224241 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114580433 | 114580434 | Human |
| 407013427 | GWAS662403_H | testosterone measurement QTL GWAS662403 (human) | | 2e-08 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 597128166 | GWAS1224240_H | glycerophospholipid measurement QTL GWAS1224240 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114525610 | 114525611 | Human |
| 598143956 | GWAS1830684_H | bone tissue density QTL GWAS1830684 (human) | | 2e-14 | bone tissue density | | 4 | 111670693 | 111670694 | Human |
| 597128165 | GWAS1224239_H | glycerophospholipid measurement QTL GWAS1224239 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114494051 | 114494052 | Human |
| 597128164 | GWAS1224238_H | glycerophospholipid measurement QTL GWAS1224238 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114552321 | 114552322 | Human |
| 597128163 | GWAS1224237_H | glycerophospholipid measurement QTL GWAS1224237 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114553935 | 114553936 | Human |
| 597128162 | GWAS1224236_H | glycerophospholipid measurement QTL GWAS1224236 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114493994 | 114493995 | Human |
| 407013428 | GWAS662404_H | testosterone measurement QTL GWAS662404 (human) | | 6e-09 | testosterone measurement | | 4 | 109321740 | 109321741 | Human |
| 597128161 | GWAS1224235_H | glycerophospholipid measurement QTL GWAS1224235 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114552206 | 114552207 | Human |
| 407013429 | GWAS662405_H | testosterone measurement QTL GWAS662405 (human) | | 2e-10 | testosterone measurement | | 4 | 113035247 | 113035248 | Human |
| 597128160 | GWAS1224234_H | glycerophospholipid measurement QTL GWAS1224234 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114554137 | 114554138 | Human |
| 597128175 | GWAS1224249_H | glycerophospholipid measurement QTL GWAS1224249 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114553424 | 114553425 | Human |
| 597128174 | GWAS1224248_H | glycerophospholipid measurement QTL GWAS1224248 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114553199 | 114553200 | Human |
| 597128173 | GWAS1224247_H | glycerophospholipid measurement QTL GWAS1224247 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114522432 | 114522433 | Human |
| 597128172 | GWAS1224246_H | glycerophospholipid measurement QTL GWAS1224246 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114481442 | 114481443 | Human |
| 598094813 | GWAS1812206_H | fat pad mass QTL GWAS1812206 (human) | | 0.0000001 | fat pad mass | | 4 | 114674241 | 114674242 | Human |
| 628962561 | GWAS2870790_H | lymphocyte count QTL GWAS2870790 (human) | | 1e-14 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109912954 | 109912955 | Human |
| 597128171 | GWAS1224245_H | glycerophospholipid measurement QTL GWAS1224245 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114493217 | 114493218 | Human |
| 628831495 | GWAS2739724_H | body height QTL GWAS2739724 (human) | | 4e-15 | body height | | 4 | 122823209 | 122823210 | Human |
| 597128170 | GWAS1224244_H | glycerophospholipid measurement QTL GWAS1224244 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114558326 | 114558327 | Human |
| 597128169 | GWAS1224243_H | glycerophospholipid measurement QTL GWAS1224243 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114479583 | 114479584 | Human |
| 628962562 | GWAS2870791_H | lymphocyte count QTL GWAS2870791 (human) | | 1e-14 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112194663 | 112194664 | Human |
| 597128168 | GWAS1224242_H | glycerophospholipid measurement QTL GWAS1224242 (human) | | 5e-11 | glycerophospholipid measurement | | 4 | 114538308 | 114538309 | Human |
| 407357639 | GWAS1006615_H | serum gamma-glutamyl transferase measurement QTL GWAS1006615 (human) | | 1e-08 | serum gamma-glutamyl transferase measurement | | 4 | 111793842 | 111793843 | Human |
| 597275417 | GWAS1371491_H | insomnia QTL GWAS1371491 (human) | | 2e-08 | insomnia | | 4 | 112329113 | 112329114 | Human |
| 597439260 | GWAS1535334_H | FEV change measurement, response to bronchodilator QTL GWAS1535334 (human) | | 0.0000007 | FEV change measurement, response to bronchodilator | | 4 | 116884973 | 116884974 | Human |
| 407193797 | GWAS842773_H | blood cobalt measurement QTL GWAS842773 (human) | | 0.000009 | blood cobalt measurement | | 4 | 121015640 | 121015641 | Human |
| 597275419 | GWAS1371493_H | insomnia QTL GWAS1371493 (human) | | 2e-10 | insomnia | | 4 | 122265238 | 122265239 | Human |
| 407095488 | GWAS744464_H | tiglylcarnitine (C5:1-DC) measurement QTL GWAS744464 (human) | | 6e-08 | tiglylcarnitine (C5:1-DC) measurement | | 4 | 110977273 | 110977274 | Human |
| 597275418 | GWAS1371492_H | insomnia QTL GWAS1371492 (human) | | 1e-08 | insomnia | | 4 | 122259374 | 122259375 | Human |
| 597537561 | GWAS1633635_H | body height QTL GWAS1633635 (human) | | 1e-277 | body height | | 4 | 108540829 | 108540830 | Human |
| 597537560 | GWAS1633634_H | body height QTL GWAS1633634 (human) | | 8e-74 | body height | | 4 | 108355674 | 108355675 | Human |
| 597537563 | GWAS1633637_H | body height QTL GWAS1633637 (human) | | 3e-10 | body height | | 4 | 109411761 | 109411762 | Human |
| 597537562 | GWAS1633636_H | body height QTL GWAS1633636 (human) | | 4e-144 | body height | | 4 | 108554818 | 108554819 | Human |
| 597537557 | GWAS1633631_H | body height QTL GWAS1633631 (human) | | 8e-18 | body height | | 4 | 107970830 | 107970831 | Human |
| 617018446 | GWAS2035945_H | total cholesterol measurement, diet measurement QTL GWAS2035945 (human) | | 0.000004 | total cholesterol measurement, diet measurement | | 4 | 118492283 | 118492284 | Human |
| 597537556 | GWAS1633630_H | body height QTL GWAS1633630 (human) | | 2e-19 | body height | | 4 | 106649253 | 106649254 | Human |
| 597537559 | GWAS1633633_H | body height QTL GWAS1633633 (human) | | 5e-36 | body height | | 4 | 108315298 | 108315299 | Human |
| 597537558 | GWAS1633632_H | body height QTL GWAS1633632 (human) | | 6e-13 | body height | | 4 | 108198626 | 108198627 | Human |
| 407374019 | GWAS1022995_H | neuroticism measurement QTL GWAS1022995 (human) | | 2e-08 | neuroticism measurement | | 4 | 118015036 | 118015037 | Human |
| 597406479 | GWAS1502553_H | BMI-adjusted hip circumference QTL GWAS1502553 (human) | | 3e-12 | BMI-adjusted hip circumference | | 4 | 121792708 | 121792709 | Human |
| 597406478 | GWAS1502552_H | BMI-adjusted hip circumference QTL GWAS1502552 (human) | | 3e-11 | BMI-adjusted hip circumference | | 4 | 121774530 | 121774531 | Human |
| 617116752 | GWAS2134251_H | fibroblast growth factor 19 amount QTL GWAS2134251 (human) | | 2e-12 | fibroblast growth factor 19 amount | | 4 | 109321740 | 109321741 | Human |
| 597439236 | GWAS1535310_H | mosquito bite reaction size measurement QTL GWAS1535310 (human) | | 4e-08 | mosquito bite reaction size measurement | | 4 | 129337181 | 129337182 | Human |
| 597324547 | GWAS1420621_H | 1-oleoylglycerophosphocholine measurement QTL GWAS1420621 (human) | | 0.0000008 | 1-oleoylglycerophosphocholine measurement | | 4 | 130062033 | 130062034 | Human |
| 597439234 | GWAS1535308_H | mosquito bite reaction size measurement QTL GWAS1535308 (human) | | 3e-39 | mosquito bite reaction size measurement | | 4 | 122707847 | 122707848 | Human |
| 628766181 | GWAS2674410_H | blood protein amount QTL GWAS2674410 (human) | | 8e-54 | blood protein amount | | 4 | 109737911 | 109737912 | Human |
| 597439235 | GWAS1535309_H | mosquito bite reaction size measurement QTL GWAS1535309 (human) | | 0.000004 | mosquito bite reaction size measurement | | 4 | 123350979 | 123350980 | Human |
| 628553172 | GWAS2461401_H | cortical thickness QTL GWAS2461401 (human) | | 9e-10 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120654416 | 120654417 | Human |
| 406980843 | GWAS629819_H | systolic blood pressure QTL GWAS629819 (human) | | 5e-08 | systolic blood pressure | | 4 | 108146742 | 108146743 | Human |
| 407374050 | GWAS1023026_H | optic disc size measurement QTL GWAS1023026 (human) | | 2e-13 | optic disc size measurement | | 4 | 111481402 | 111481403 | Human |
| 598078222 | GWAS1797521_H | bone density QTL GWAS1797521 (human) | | 2e-14 | bone density | | 4 | 111670693 | 111670694 | Human |
| 406980844 | GWAS629820_H | systolic blood pressure QTL GWAS629820 (human) | | 2e-16 | systolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 628962765 | GWAS2870994_H | lymphocyte count QTL GWAS2870994 (human) | | 2e-12 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109927496 | 109927497 | Human |
| 628438469 | GWAS2346698_H | endometriosis QTL GWAS2346698 (human) | | 0.000007 | uterus integrity trait (VT:0010575) | | 4 | 126617656 | 126617657 | Human |
| 628438468 | GWAS2346697_H | endometriosis QTL GWAS2346697 (human) | | 0.0000006 | uterus integrity trait (VT:0010575) | | 4 | 114744719 | 114744720 | Human |
| 628962766 | GWAS2870995_H | lymphocyte count QTL GWAS2870995 (human) | | 3e-13 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112198650 | 112198651 | Human |
| 617002101 | GWAS2019600_H | FABP2/RBP2 protein level ratio in blood QTL GWAS2019600 (human) | | 6e-894 | FABP2/RBP2 protein level ratio in blood | | 4 | 119309995 | 119309996 | Human |
| 616969342 | GWAS1986841_H | beta-nerve growth factor amount QTL GWAS1986841 (human) | | 0.000008 | beta-nerve growth factor amount | | 4 | 123921959 | 123921960 | Human |
| 407390450 | GWAS1039426_H | urate measurement, spine bone mineral density QTL GWAS1039426 (human) | | 0.000001 | urate measurement, spine bone mineral density | | 4 | 123516413 | 123516414 | Human |
| 598111002 | GWAS1819885_H | glioblastoma multiforme QTL GWAS1819885 (human) | | 0.000008 | glioblastoma multiforme | | 4 | 108697554 | 108697555 | Human |
| 617002107 | GWAS2019606_H | FABP1/FABP2 protein level ratio in blood QTL GWAS2019606 (human) | | 1e-289 | FABP1/FABP2 protein level ratio in blood | | 4 | 119309995 | 119309996 | Human |
| 628553163 | GWAS2461392_H | cortical thickness QTL GWAS2461392 (human) | | 3e-08 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120748941 | 120748942 | Human |
| 598143771 | GWAS1830499_H | bone tissue density QTL GWAS1830499 (human) | | 7e-82 | bone tissue density | | 4 | 124697561 | 124697562 | Human |
| 597406502 | GWAS1502576_H | cortical surface area measurement QTL GWAS1502576 (human) | | 4e-08 | cortical surface area measurement | | 4 | 127191068 | 127191069 | Human |
| 597979930 | GWAS1699229_H | tumor necrosis factor alpha amount QTL GWAS1699229 (human) | | 0.000009 | tumor necrosis factor alpha amount | | 4 | 123921955 | 123921960 | Human |
| 597816094 | GWAS1683485_H | bipolar disorder QTL GWAS1683485 (human) | | 3e-08 | bipolar disorder | | 4 | 122596491 | 122596492 | Human |
| 597439324 | GWAS1535398_H | body height QTL GWAS1535398 (human) | | 0.000001 | body height | | 4 | 119687809 | 119687810 | Human |
| 407226503 | GWAS875479_H | bone density QTL GWAS875479 (human) | | 1e-130 | bone density | | 4 | 119406123 | 119406124 | Human |
| 598061921 | GWAS1781220_H | body height QTL GWAS1781220 (human) | | 3e-09 | body height | | 4 | 119494521 | 119494522 | Human |
| 598061920 | GWAS1781219_H | body height QTL GWAS1781219 (human) | | 4e-28 | body height | | 4 | 119474818 | 119474819 | Human |
| 598061923 | GWAS1781222_H | body height QTL GWAS1781222 (human) | | 1e-22 | body height | | 4 | 109940771 | 109940772 | Human |
| 598061922 | GWAS1781221_H | body height QTL GWAS1781221 (human) | | 7e-90 | body height | | 4 | 119652067 | 119652068 | Human |
| 597128031 | GWAS1224105_H | glycerophospholipid measurement QTL GWAS1224105 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114548870 | 114548871 | Human |
| 597128030 | GWAS1224104_H | glycerophospholipid measurement QTL GWAS1224104 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493830 | 114493831 | Human |
| 617100290 | GWAS2117789_H | gut microbiome measurement, breastfeeding duration QTL GWAS2117789 (human) | | 1e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 111640701 | 111640702 | Human |
| 617067532 | GWAS2085031_H | open-angle glaucoma QTL GWAS2085031 (human) | | 8e-09 | open-angle glaucoma | | 4 | 111039218 | 111039219 | Human |
| 406915210 | GWAS564186_H | unipolar depression QTL GWAS564186 (human) | | 0.000003 | unipolar depression | | 4 | 124344158 | 124344159 | Human |
| 598094710 | GWAS1812103_H | fibroblast growth factor 2 amount QTL GWAS1812103 (human) | | 0.000002 | fibroblast growth factor 2 amount | | 4 | 107833368 | 107833369 | Human |
| 628536739 | GWAS2444968_H | body height QTL GWAS2444968 (human) | | 5e-08 | body height | | 4 | 128687133 | 128687134 | Human |
| 628536736 | GWAS2444965_H | body height QTL GWAS2444965 (human) | | 1e-14 | body height | | 4 | 124018099 | 124018100 | Human |
| 628815277 | GWAS2723506_H | inflammatory bowel disease QTL GWAS2723506 (human) | | 6e-19 | intestine integrity trait (VT:0010554) | | 4 | 122523884 | 122523885 | Human |
| 628536737 | GWAS2444966_H | body height QTL GWAS2444966 (human) | | 2e-09 | body height | | 4 | 126045727 | 126045728 | Human |
| 616985628 | GWAS2003127_H | diet measurement QTL GWAS2003127 (human) | | 3e-08 | diet measurement | | 4 | 112518056 | 112518057 | Human |
| 597504890 | GWAS1600964_H | Alzheimer disease QTL GWAS1600964 (human) | | 1e-10 | Alzheimer disease | | 4 | 108219159 | 108219160 | Human |
| 628536734 | GWAS2444963_H | body height QTL GWAS2444963 (human) | | 2e-21 | body height | | 4 | 121829906 | 121829907 | Human |
| 628897173 | GWAS2805402_H | epidermal growth factor measurement QTL GWAS2805402 (human) | | 5e-25 | epidermal growth factor measurement | | 4 | 109938419 | 109938420 | Human |
| 628536735 | GWAS2444964_H | body height QTL GWAS2444964 (human) | | 1e-17 | body height | | 4 | 122906887 | 122906888 | Human |
| 628438428 | GWAS2346657_H | endometriosis QTL GWAS2346657 (human) | | 0.000006 | uterus integrity trait (VT:0010575) | | 4 | 126617656 | 126617657 | Human |
| 616494164 | GWAS1890747_H | serum metabolite level QTL GWAS1890747 (human) | | 8e-11 | serum metabolite level | | 4 | 110430068 | 110430069 | Human |
| 628536732 | GWAS2444961_H | body height QTL GWAS2444961 (human) | | 3e-14 | body height | | 4 | 113975748 | 113975749 | Human |
| 597226354 | GWAS1322428_H | chronotype measurement QTL GWAS1322428 (human) | | 1e-10 | chronotype measurement | | 4 | 129982356 | 129982357 | Human |
| 597439351 | GWAS1535425_H | coronary artery calcification QTL GWAS1535425 (human) | | 0.000006 | coronary artery calcification | | 4 | 117351922 | 117351923 | Human |
| 628536733 | GWAS2444962_H | body height QTL GWAS2444962 (human) | | 2e-14 | body height | | 4 | 119796398 | 119796399 | Human |
| 628536730 | GWAS2444959_H | body height QTL GWAS2444959 (human) | | 3e-19 | body height | | 4 | 108508323 | 108508324 | Human |
| 628454809 | GWAS2363038_H | glucose-dependent insulinotropic peptide measurement QTL GWAS2363038 (human) | | 4e-10 | blood gastric inhibitory polypeptide amount (VT:0010916) | | 4 | 123717198 | 123717199 | Human |
| 616494163 | GWAS1890746_H | serum metabolite level QTL GWAS1890746 (human) | | 5e-13 | serum metabolite level | | 4 | 110414566 | 110414567 | Human |
| 628536731 | GWAS2444960_H | body height QTL GWAS2444960 (human) | | 4e-08 | body height | | 4 | 112647388 | 112647389 | Human |
| 598029131 | GWAS1748430_H | obsolete_facial morphology quality QTL GWAS1748430 (human) | | 8e-09 | obsolete_facial morphology quality | | 4 | 119407511 | 119407512 | Human |
| 597226359 | GWAS1322433_H | chronotype measurement QTL GWAS1322433 (human) | | 4e-09 | chronotype measurement | | 4 | 113518738 | 113518739 | Human |
| 598061909 | GWAS1781208_H | body height QTL GWAS1781208 (human) | | 2e-105 | body height | | 4 | 113901423 | 113901424 | Human |
| 628569479 | GWAS2477708_H | glycerophospholipid measurement QTL GWAS2477708 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114502041 | 114502042 | Human |
| 597128039 | GWAS1224113_H | glycerophospholipid measurement QTL GWAS1224113 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114563572 | 114563573 | Human |
| 628897164 | GWAS2805393_H | fibroblast growth factor 2 level QTL GWAS2805393 (human) | | 9e-18 | fibroblast growth factor 2 level | | 4 | 122836593 | 122836594 | Human |
| 406997170 | GWAS646146_H | reticulocyte measurement QTL GWAS646146 (human) | | 1e-09 | reticulocyte measurement | | 4 | 127789418 | 127789419 | Human |
| 598061908 | GWAS1781207_H | body height QTL GWAS1781207 (human) | | 2e-12 | body height | | 4 | 113740525 | 113740526 | Human |
| 628569478 | GWAS2477707_H | glycerophospholipid measurement QTL GWAS2477707 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114494754 | 114494755 | Human |
| 597128038 | GWAS1224112_H | glycerophospholipid measurement QTL GWAS1224112 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114532837 | 114532838 | Human |
| 598061911 | GWAS1781210_H | body height QTL GWAS1781210 (human) | | 2e-89 | body height | | 4 | 113970601 | 113970602 | Human |
| 597128037 | GWAS1224111_H | glycerophospholipid measurement QTL GWAS1224111 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114532769 | 114532770 | Human |
| 628569477 | GWAS2477706_H | glycerophospholipid measurement QTL GWAS2477706 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114582848 | 114582849 | Human |
| 406997169 | GWAS646145_H | reticulocyte measurement QTL GWAS646145 (human) | | 2e-12 | reticulocyte measurement | | 4 | 109944309 | 109944310 | Human |
| 598061910 | GWAS1781209_H | body height QTL GWAS1781209 (human) | | 3e-56 | body height | | 4 | 113958625 | 113958626 | Human |
| 597128036 | GWAS1224110_H | glycerophospholipid measurement QTL GWAS1224110 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114490021 | 114490022 | Human |
| 628569476 | GWAS2477705_H | glycerophospholipid measurement QTL GWAS2477705 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114501793 | 114501794 | Human |
| 616543308 | GWAS1939891_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1939891 (human) | | 6e-14 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 124228421 | 124228422 | Human |
| 598061905 | GWAS1781204_H | body height QTL GWAS1781204 (human) | | 1e-20 | body height | | 4 | 110649067 | 110649068 | Human |
| 628569475 | GWAS2477704_H | glycerophospholipid measurement QTL GWAS2477704 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114531582 | 114531583 | Human |
| 597128035 | GWAS1224109_H | glycerophospholipid measurement QTL GWAS1224109 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114563873 | 114563874 | Human |
| 628372864 | GWAS2293708_H | fibroblast growth factor 2 level QTL GWAS2293708 (human) | | 5e-21 | fibroblast growth factor 2 level | | 4 | 122629385 | 122629386 | Human |
| 597472104 | GWAS1568178_H | body mass index QTL GWAS1568178 (human) | | 0.000003 | body mass index | | 4 | 129838492 | 129838493 | Human |
| 628569474 | GWAS2477703_H | glycerophospholipid measurement QTL GWAS2477703 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114495098 | 114495099 | Human |
| 597128034 | GWAS1224108_H | glycerophospholipid measurement QTL GWAS1224108 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114551237 | 114551238 | Human |
| 628372865 | GWAS2293709_H | fibroblast growth factor 2 level QTL GWAS2293709 (human) | | 2e-22 | fibroblast growth factor 2 level | | 4 | 122843079 | 122843080 | Human |
| 598061907 | GWAS1781206_H | body height QTL GWAS1781206 (human) | | 1e-08 | body height | | 4 | 113079800 | 113079801 | Human |
| 628569473 | GWAS2477702_H | glycerophospholipid measurement QTL GWAS2477702 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114528667 | 114528668 | Human |
| 597128033 | GWAS1224107_H | glycerophospholipid measurement QTL GWAS1224107 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114576580 | 114576581 | Human |
| 598061906 | GWAS1781205_H | body height QTL GWAS1781205 (human) | | 3e-13 | body height | | 4 | 112538249 | 112538250 | Human |
| 597128032 | GWAS1224106_H | glycerophospholipid measurement QTL GWAS1224106 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114572686 | 114572687 | Human |
| 628569472 | GWAS2477701_H | glycerophospholipid measurement QTL GWAS2477701 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114582806 | 114582807 | Human |
| 598061917 | GWAS1781216_H | body height QTL GWAS1781216 (human) | | 3e-09 | body height | | 4 | 118718546 | 118718547 | Human |
| 628569486 | GWAS2477715_H | glycerophospholipid measurement QTL GWAS2477715 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114479168 | 114479169 | Human |
| 598061916 | GWAS1781215_H | body height QTL GWAS1781215 (human) | | 2e-17 | body height | | 4 | 118088739 | 118088740 | Human |
| 628569485 | GWAS2477714_H | glycerophospholipid measurement QTL GWAS2477714 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114569301 | 114569302 | Human |
| 597373793 | GWAS1469867_H | resistin measurement QTL GWAS1469867 (human) | | 6e-18 | resistin measurement | | 4 | 115275150 | 115275151 | Human |
| 598061919 | GWAS1781218_H | body height QTL GWAS1781218 (human) | | 6e-22 | body height | | 4 | 119033555 | 119033556 | Human |
| 628569484 | GWAS2477713_H | glycerophospholipid measurement QTL GWAS2477713 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114557814 | 114557815 | Human |
| 598061918 | GWAS1781217_H | body height QTL GWAS1781217 (human) | | 4e-17 | body height | | 4 | 118815641 | 118815642 | Human |
| 628569483 | GWAS2477712_H | glycerophospholipid measurement QTL GWAS2477712 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114484294 | 114484295 | Human |
| 598061913 | GWAS1781212_H | body height QTL GWAS1781212 (human) | | 2e-10 | body height | | 4 | 114683908 | 114683909 | Human |
| 628536715 | GWAS2444944_H | corticoliberin measurement QTL GWAS2444944 (human) | | 1e-15 | corticoliberin measurement | | 4 | 108425227 | 108425228 | Human |
| 598061912 | GWAS1781211_H | body height QTL GWAS1781211 (human) | | 1e-12 | body height | | 4 | 114398989 | 114398990 | Human |
| 597128042 | GWAS1224116_H | glycerophospholipid measurement QTL GWAS1224116 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114552518 | 114552519 | Human |
| 628569482 | GWAS2477711_H | glycerophospholipid measurement QTL GWAS2477711 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114598115 | 114598116 | Human |
| 616952888 | GWAS1970387_H | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement QTL GWAS1970387 (human) | | 0.0000003 | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | milk trans fatty acid measurement (CMO:0000824) | 4 | 127602809 | 127602810 | Human |
| 628569481 | GWAS2477710_H | glycerophospholipid measurement QTL GWAS2477710 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114483807 | 114483808 | Human |
| 597128041 | GWAS1224115_H | glycerophospholipid measurement QTL GWAS1224115 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114526758 | 114526759 | Human |
| 598061915 | GWAS1781214_H | body height QTL GWAS1781214 (human) | | 0.000001 | body height | | 4 | 117055123 | 117055124 | Human |
| 628569480 | GWAS2477709_H | glycerophospholipid measurement QTL GWAS2477709 (human) | | 2e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114495078 | 114495079 | Human |
| 597128040 | GWAS1224114_H | glycerophospholipid measurement QTL GWAS1224114 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114538869 | 114538870 | Human |
| 598061914 | GWAS1781213_H | body height QTL GWAS1781213 (human) | | 2e-11 | body height | | 4 | 115342108 | 115342109 | Human |
| 597373595 | GWAS1469669_H | intelligence QTL GWAS1469669 (human) | | 0.000008 | intelligence | | 4 | 128544541 | 128544542 | Human |
| 628520055 | GWAS2428284_H | small vessel stroke QTL GWAS2428284 (human) | | 0.000008 | artery integrity trait (VT:0010639) | | 4 | 125014098 | 125014099 | Human |
| 628798585 | GWAS2706814_H | R-warfarin measurement QTL GWAS2706814 (human) | | 0.000009 | R-warfarin measurement | | 4 | 108984279 | 108984280 | Human |
| 597324447 | GWAS1420521_H | non-high density lipoprotein cholesterol measurement QTL GWAS1420521 (human) | | 3e-10 | non-high density lipoprotein cholesterol measurement | | 4 | 109174464 | 109174465 | Human |
| 407374158 | GWAS1023134_H | mathematical ability QTL GWAS1023134 (human) | | 8e-10 | mathematical ability | | 4 | 129215768 | 129215769 | Human |
| 597357202 | GWAS1453276_H | Alzheimer disease QTL GWAS1453276 (human) | | 0.000008 | Alzheimer disease | | 4 | 122647254 | 122647255 | Human |
| 628552831 | GWAS2461060_H | persephin measurement QTL GWAS2461060 (human) | | 2e-19 | persephin measurement | | 4 | 119129607 | 119129608 | Human |
| 628896887 | GWAS2805116_H | facial width measurement QTL GWAS2805116 (human) | | 0.000004 | facial morphology trait (VT:0003743) | | 4 | 130195033 | 130195034 | Human |
| 597357206 | GWAS1453280_H | asthma, response to diisocyanate QTL GWAS1453280 (human) | | 0.000001 | asthma, response to diisocyanate | | 4 | 123742201 | 123742202 | Human |
| 596980357 | GWAS1099876_H | memory performance QTL GWAS1099876 (human) | | 0.000004 | memory performance | | 4 | 112467350 | 112467351 | Human |
| 597226120 | GWAS1322194_H | electrocardiography QTL GWAS1322194 (human) | | 2e-18 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 628372580 | GWAS2293424_H | fibroblast growth factor 2 level QTL GWAS2293424 (human) | | 5e-13 | fibroblast growth factor 2 level | | 4 | 122640324 | 122640325 | Human |
| 597226121 | GWAS1322195_H | electrocardiography QTL GWAS1322195 (human) | | 8e-21 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 628372581 | GWAS2293425_H | fibroblast growth factor 2 level QTL GWAS2293425 (human) | | 7e-12 | fibroblast growth factor 2 level | | 4 | 122083028 | 122083029 | Human |
| 597226122 | GWAS1322196_H | electrocardiography QTL GWAS1322196 (human) | | 2e-12 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 628372582 | GWAS2293426_H | fibroblast growth factor 2 level QTL GWAS2293426 (human) | | 4e-43 | fibroblast growth factor 2 level | | 4 | 122430398 | 122430399 | Human |
| 597226123 | GWAS1322197_H | electrocardiography QTL GWAS1322197 (human) | | 7e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 597389960 | GWAS1486034_H | hemoglobin measurement QTL GWAS1486034 (human) | | 2e-11 | hemoglobin measurement | | 4 | 123844107 | 123844108 | Human |
| 597226124 | GWAS1322198_H | electrocardiography QTL GWAS1322198 (human) | | 1e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 628962408 | GWAS2870637_H | Increased total eosinophil count QTL GWAS2870637 (human) | | 2e-12 | Increased total eosinophil count | | 4 | 108762086 | 108762087 | Human |
| 597226125 | GWAS1322199_H | electrocardiography QTL GWAS1322199 (human) | | 2e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 628372577 | GWAS2293421_H | fibroblast growth factor 2 level QTL GWAS2293421 (human) | | 6e-15 | fibroblast growth factor 2 level | | 4 | 123433862 | 123433863 | Human |
| 597226126 | GWAS1322200_H | electrocardiography QTL GWAS1322200 (human) | | 1e-24 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 628929642 | GWAS2837871_H | abdominal adipose tissue measurement QTL GWAS2837871 (human) | | 7e-10 | abdominal adipose mass (VT:0010897) | | 4 | 121656615 | 121656616 | Human |
| 628372578 | GWAS2293422_H | fibroblast growth factor 2 level QTL GWAS2293422 (human) | | 6e-16 | fibroblast growth factor 2 level | | 4 | 122834403 | 122834404 | Human |
| 597275278 | GWAS1371352_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1371352 (human) | | 7e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 108140462 | 108140463 | Human |
| 628372579 | GWAS2293423_H | fibroblast growth factor 2 level QTL GWAS2293423 (human) | | 3e-15 | fibroblast growth factor 2 level | | 4 | 123258267 | 123258268 | Human |
| 407390544 | GWAS1039520_H | cortical surface area measurement QTL GWAS1039520 (human) | | 4e-09 | cortical surface area measurement | | 4 | 120653052 | 120653053 | Human |
| 628864098 | GWAS2772327_H | diastolic blood pressure, systolic blood pressure QTL GWAS2772327 (human) | | 2e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 119856151 | 119856152 | Human |
| 628929637 | GWAS2837866_H | abdominal adipose tissue measurement QTL GWAS2837866 (human) | | 6e-11 | abdominal adipose mass (VT:0010897) | | 4 | 124261535 | 124261536 | Human |
| 598061759 | GWAS1781058_H | body height QTL GWAS1781058 (human) | | 4e-10 | body height | | 4 | 109096050 | 109096051 | Human |
| 628520045 | GWAS2428274_H | large artery stroke QTL GWAS2428274 (human) | | 0.000002 | brain integrity trait (VT:0010579) | | 4 | 107143047 | 107143048 | Human |
| 628929639 | GWAS2837868_H | abdominal adipose tissue measurement QTL GWAS2837868 (human) | | 8e-11 | abdominal adipose mass (VT:0010897) | | 4 | 123210946 | 123210947 | Human |
| 597390011 | GWAS1486085_H | Parkinson disease QTL GWAS1486085 (human) | | 0.0000005 | Parkinson disease | | 4 | 113422713 | 113422714 | Human |
| 596964021 | GWAS1083540_H | allergic disease QTL GWAS1083540 (human) | | 7e-13 | allergic disease | | 4 | 122219915 | 122219916 | Human |
| 597471930 | GWAS1568004_H | aortic vascular smooth muscle cell calcification measurement QTL GWAS1568004 (human) | | 3e-08 | aortic vascular smooth muscle cell calcification measurement | | 4 | 118880492 | 118880493 | Human |
| 628372572 | GWAS2293416_H | fibroblast growth factor 2 level QTL GWAS2293416 (human) | | 2e-24 | fibroblast growth factor 2 level | | 4 | 122680969 | 122680970 | Human |
| 628700240 | GWAS2608469_H | brain attribute QTL GWAS2608469 (human) | | 6e-11 | brain attribute | | 4 | 107131838 | 107131839 | Human |
| 628372573 | GWAS2293417_H | fibroblast growth factor 2 level QTL GWAS2293417 (human) | | 1e-20 | fibroblast growth factor 2 level | | 4 | 123619151 | 123619152 | Human |
| 597521076 | GWAS1617150_H | open-angle glaucoma QTL GWAS1617150 (human) | | 2e-09 | open-angle glaucoma | | 4 | 127549411 | 127549412 | Human |
| 597619381 | GWAS1676241_H | cardiac arrhythmia QTL GWAS1676241 (human) | | 3e-130 | cardiac arrhythmia | | 4 | 110796911 | 110796912 | Human |
| 597406389 | GWAS1502463_H | Ischemic stroke QTL GWAS1502463 (human) | | 1e-15 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 628372570 | GWAS2293414_H | fibroblast growth factor 2 level QTL GWAS2293414 (human) | | 1e-18 | fibroblast growth factor 2 level | | 4 | 123649214 | 123649215 | Human |
| 628372571 | GWAS2293415_H | fibroblast growth factor 2 level QTL GWAS2293415 (human) | | 3e-16 | fibroblast growth factor 2 level | | 4 | 123081630 | 123081631 | Human |
| 617068023 | GWAS2085522_H | bone tissue density QTL GWAS2085522 (human) | | 1e-12 | bone tissue density | | 4 | 115936664 | 115936665 | Human |
| 628864074 | GWAS2772303_H | diastolic blood pressure, systolic blood pressure QTL GWAS2772303 (human) | | 0.000007 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 119856151 | 119856152 | Human |
| 597521070 | GWAS1617144_H | bone density QTL GWAS1617144 (human) | | 2e-14 | bone density | | 4 | 111670693 | 111670694 | Human |
| 597275306 | GWAS1371380_H | testosterone measurement QTL GWAS1371380 (human) | | 1e-14 | testosterone measurement | | 4 | 124126476 | 124126477 | Human |
| 628438081 | GWAS2346310_H | Anxiety QTL GWAS2346310 (human) | | 7e-09 | Anxiety | | 4 | 118015036 | 118015037 | Human |
| 616510859 | GWAS1907442_H | blood urea nitrogen amount QTL GWAS1907442 (human) | | 2e-09 | blood urea nitrogen amount | | 4 | 119092116 | 119092117 | Human |
| 628732993 | GWAS2641222_H | gut microbiome measurement QTL GWAS2641222 (human) | | 7e-08 | gut microbiome measurement | | 4 | 117122262 | 117122263 | Human |
| 628896836 | GWAS2805065_H | metabolite measurement QTL GWAS2805065 (human) | | 7e-57 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 597324448 | GWAS1420522_H | non-high density lipoprotein cholesterol measurement QTL GWAS1420522 (human) | | 2e-13 | non-high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 597521056 | GWAS1617130_H | bone density QTL GWAS1617130 (human) | | 8e-15 | bone density | | 4 | 132222891 | 132222892 | Human |
| 628798532 | GWAS2706761_H | COVID-19 QTL GWAS2706761 (human) | | 0.00001 | COVID-19 | | 4 | 127789647 | 127789648 | Human |
| 628896828 | GWAS2805057_H | metabolite measurement QTL GWAS2805057 (human) | | 1e-21 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 597422809 | GWAS1518883_H | HbA1c measurement QTL GWAS1518883 (human) | | 6e-10 | HbA1c measurement | | 4 | 116926523 | 116926524 | Human |
| 597144276 | GWAS1240350_H | COVID-19 QTL GWAS1240350 (human) | | 0.0000006 | COVID-19 | | 4 | 107888805 | 107888806 | Human |
| 597111508 | GWAS1207582_H | asthma QTL GWAS1207582 (human) | | 0.000008 | asthma | | 4 | 122456327 | 122456328 | Human |
| 407193869 | GWAS842845_H | glycerophospholipid measurement QTL GWAS842845 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529766 | 114529767 | Human |
| 407193868 | GWAS842844_H | glycerophospholipid measurement QTL GWAS842844 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529776 | 114529777 | Human |
| 407193871 | GWAS842847_H | glycerophospholipid measurement QTL GWAS842847 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529308 | 114529309 | Human |
| 407193870 | GWAS842846_H | glycerophospholipid measurement QTL GWAS842846 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114529420 | 114529421 | Human |
| 407193867 | GWAS842843_H | glycerophospholipid measurement QTL GWAS842843 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114489100 | 114489101 | Human |
| 628487226 | GWAS2395455_H | intraocular pressure measurement QTL GWAS2395455 (human) | | 3e-10 | intraocular pressure (VT:0005257) | | 4 | 111042563 | 111042564 | Human |
| 407193877 | GWAS842853_H | glycerophospholipid measurement QTL GWAS842853 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496175 | 114496176 | Human |
| 617084311 | GWAS2101810_H | lung disease severity measurement QTL GWAS2101810 (human) | | 0.000007 | lung integrity trait (VT:0010906) | | 4 | 119664980 | 119664981 | Human |
| 597291721 | GWAS1387795_H | size QTL GWAS1387795 (human) | | 2e-10 | size | | 4 | 123999891 | 123999892 | Human |
| 407193876 | GWAS842852_H | glycerophospholipid measurement QTL GWAS842852 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114495902 | 114495903 | Human |
| 407193879 | GWAS842855_H | glycerophospholipid measurement QTL GWAS842855 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114530452 | 114530453 | Human |
| 407193878 | GWAS842854_H | glycerophospholipid measurement QTL GWAS842854 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496204 | 114496205 | Human |
| 407193873 | GWAS842849_H | glycerophospholipid measurement QTL GWAS842849 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114561897 | 114561898 | Human |
| 407193872 | GWAS842848_H | glycerophospholipid measurement QTL GWAS842848 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114491625 | 114491626 | Human |
| 407193875 | GWAS842851_H | glycerophospholipid measurement QTL GWAS842851 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114495803 | 114495804 | Human |
| 407193874 | GWAS842850_H | glycerophospholipid measurement QTL GWAS842850 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496530 | 114496531 | Human |
| 598029054 | GWAS1748353_H | lifestyle measurement, alcohol consumption quality QTL GWAS1748353 (human) | | 8e-08 | lifestyle measurement, anxiety disorder measurement | | 4 | 127457977 | 127457978 | Human |
| 407193881 | GWAS842857_H | glycerophospholipid measurement QTL GWAS842857 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533531 | 114533532 | Human |
| 407193880 | GWAS842856_H | glycerophospholipid measurement QTL GWAS842856 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114555821 | 114555822 | Human |
| 407193883 | GWAS842859_H | glycerophospholipid measurement QTL GWAS842859 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533453 | 114533454 | Human |
| 407193882 | GWAS842858_H | glycerophospholipid measurement QTL GWAS842858 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114533510 | 114533511 | Human |
| 407226650 | GWAS875626_H | schizophrenia QTL GWAS875626 (human) | | 3e-08 | schizophrenia | | 4 | 117725752 | 117725753 | Human |
| 617035160 | GWAS2052659_H | pulse pressure measurement QTL GWAS2052659 (human) | | 0.0000009 | pulse pressure measurement | | 4 | 132110786 | 132110787 | Human |
| 407062816 | GWAS711792_H | familial sick sinus syndrome QTL GWAS711792 (human) | | 2e-15 | sick sinus syndrome | | 4 | 110782354 | 110782355 | Human |
| 628765726 | GWAS2673955_H | blood protein amount QTL GWAS2673955 (human) | | 1e-164 | blood protein amount | | 4 | 106917957 | 106917958 | Human |
| 597291773 | GWAS1387847_H | BMI-adjusted waist-hip ratio QTL GWAS1387847 (human) | | 5e-11 | BMI-adjusted waist-hip ratio | | 4 | 119213641 | 119213642 | Human |
| 598061760 | GWAS1781059_H | body height QTL GWAS1781059 (human) | | 3e-10 | body height | | 4 | 109411761 | 109411762 | Human |
| 598061762 | GWAS1781061_H | body height QTL GWAS1781061 (human) | | 1e-25 | body height | | 4 | 109096026 | 109096027 | Human |
| 597291774 | GWAS1387848_H | BMI-adjusted waist-hip ratio QTL GWAS1387848 (human) | | 6e-10 | BMI-adjusted waist-hip ratio | | 4 | 119763897 | 119763898 | Human |
| 597422835 | GWAS1518909_H | atrial fibrillation QTL GWAS1518909 (human) | | 5e-29 | atrial fibrillation | | 4 | 110401104 | 110401105 | Human |
| 628552734 | GWAS2460963_H | cortical thickness QTL GWAS2460963 (human) | | 3e-08 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120722084 | 120722085 | Human |
| 628438040 | GWAS2346269_H | breast carcinoma QTL GWAS2346269 (human) | | 7e-10 | mammary gland integrity trait (VT:0010552) | | 4 | 125922349 | 125922350 | Human |
| 407406887 | GWAS1055863_H | bipolar disorder QTL GWAS1055863 (human) | | 2e-09 | bipolar I disorder | | 4 | 122154852 | 122154853 | Human |
| 628749334 | GWAS2657563_H | rheumatoid arthritis QTL GWAS2657563 (human) | | 0.0000007 | joint integrity trait (VT:0010548) | | 4 | 122297158 | 122297159 | Human |
| 597455598 | GWAS1551672_H | lymphocyte measurement, neutrophil measurement QTL GWAS1551672 (human) | | 3e-14 | lymphocyte measurement, neutrophil measurement | | 4 | 122707302 | 122707305 | Human |
| 626455586 | GWAS2269519_H | bilirubin measurement QTL GWAS2269519 (human) | | 1e-08 | bilirubin measurement | | 4 | 128126567 | 128126568 | Human |
| 626455585 | GWAS2269518_H | bilirubin measurement QTL GWAS2269518 (human) | | 6e-18 | bilirubin measurement | | 4 | 109921984 | 109921985 | Human |
| 598094558 | GWAS1811951_H | carotid artery thickness QTL GWAS1811951 (human) | | 0.0000009 | carotid artery thickness | | 4 | 109159865 | 109159866 | Human |
| 628765697 | GWAS2673926_H | hemorrhoid QTL GWAS2673926 (human) | | 4e-09 | anorectal integrity trait (VT:0010734) | | 4 | 123825222 | 123825223 | Human |
| 617199029 | GWAS2179469_H | level of hydroxyacyl-coenzyme A dehydrogenase, mitochondrial in blood QTL GWAS2179469 (human) | | 5e-18 | level of hydroxyacyl-coenzyme A dehydrogenase, mitochondrial in blood | | 4 | 107991560 | 107991561 | Human |
| 628929537 | GWAS2837766_H | anthropometric measurement QTL GWAS2837766 (human) | | 5e-11 | body size trait (VT:0100005) | body morphological measurement (CMO:0000021) | 4 | 123981152 | 123981153 | Human |
| 616986040 | GWAS2003539_H | strand of hair color QTL GWAS2003539 (human) | | 1e-15 | strand of hair color | | 4 | 108327206 | 108327207 | Human |
| 628732935 | GWAS2641164_H | conotruncal heart malformations QTL GWAS2641164 (human) | | 0.000003 | conotruncal heart malformations | | 4 | 111868878 | 111868879 | Human |
| 616986041 | GWAS2003540_H | strand of hair color QTL GWAS2003540 (human) | | 5e-23 | strand of hair color | | 4 | 108561329 | 108561330 | Human |
| 597258780 | GWAS1354854_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1354854 (human) | | 3e-14 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 628897018 | GWAS2805247_H | aspartate measurement QTL GWAS2805247 (human) | | 0.0000001 | blood L-aspartic acid amount (VT:0010969) | | 4 | 110477052 | 110477053 | Human |
| 597307932 | GWAS1404006_H | cardiovascular age measurement QTL GWAS1404006 (human) | | 3e-14 | cardiovascular age measurement | | 4 | 113465982 | 113465983 | Human |
| 407259584 | GWAS908560_H | inflammatory bowel disease QTL GWAS908560 (human) | | 6e-19 | inflammatory bowel disease | | 4 | 122523884 | 122523885 | Human |
| 406964678 | GWAS613654_H | COVID-19 QTL GWAS613654 (human) | | 4e-08 | COVID-19 | | 4 | 108838313 | 108838314 | Human |
| 598028834 | GWAS1748133_H | brain attribute QTL GWAS1748133 (human) | | 1e-10 | brain attribute | | 4 | 123263477 | 123263478 | Human |
| 597979690 | GWAS1698989_H | platelet-derived growth factor complex BB dimer amount QTL GWAS1698989 (human) | | 0.000002 | platelet-derived growth factor complex BB dimer amount | | 4 | 111263595 | 111263596 | Human |
| 597078534 | GWAS1174608_H | sex interaction measurement, bilirubin measurement QTL GWAS1174608 (human) | | 0.000005 | sex interaction measurement, bilirubin measurement | | 4 | 109805166 | 109805167 | Human |
| 628700392 | GWAS2608621_H | cerebral cortex area attribute QTL GWAS2608621 (human) | | 6e-14 | cerebral cortex area attribute | | 4 | 112497482 | 112497483 | Human |
| 617018708 | GWAS2036207_H | sex hormone-binding globulin measurement QTL GWAS2036207 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 617018707 | GWAS2036206_H | sex hormone-binding globulin measurement QTL GWAS2036206 (human) | | 6e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 617117008 | GWAS2134507_H | platelet count QTL GWAS2134507 (human) | | 1e-13 | platelet count | | 4 | 119439096 | 119439097 | Human |
| 617100625 | GWAS2118124_H | gut microbiome measurement, breastfeeding duration QTL GWAS2118124 (human) | | 2e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 121972794 | 121972795 | Human |
| 616953180 | GWAS1970679_H | Cleft palate, cleft lip QTL GWAS1970679 (human) | | 0.0000009 | Cleft palate, cleft lip | | 4 | 123789429 | 123789430 | Human |
| 597619205 | GWAS1676065_H | stricture QTL GWAS1676065 (human) | | 2e-11 | stricture | | 4 | 114481688 | 114481689 | Human |
| 628552936 | GWAS2461165_H | cortical thickness QTL GWAS2461165 (human) | | 4e-11 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120730658 | 120730659 | Human |
| 628536534 | GWAS2444763_H | hemoglobin A1 measurement QTL GWAS2444763 (human) | | 2e-17 | blood hemoglobin amount (VT:0001588) | | 4 | 109908302 | 109908303 | Human |
| 598110726 | GWAS1819609_H | glioblastoma multiforme QTL GWAS1819609 (human) | | 0.000007 | glioblastoma multiforme | | 4 | 117476867 | 117476868 | Human |
| 406997474 | GWAS646450_H | reticulocyte count QTL GWAS646450 (human) | | 1e-09 | reticulocyte count | | 4 | 128330896 | 128330897 | Human |
| 597258810 | GWAS1354884_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1354884 (human) | | 8e-09 | very low density lipoprotein cholesterol measurement, phospholipid measurement | | 4 | 109657070 | 109657071 | Human |
| 406997473 | GWAS646449_H | reticulocyte count QTL GWAS646449 (human) | | 2e-13 | reticulocyte count | | 4 | 109944309 | 109944310 | Human |
| 598061569 | GWAS1780868_H | body height QTL GWAS1780868 (human) | | 5e-36 | body height | | 4 | 108315298 | 108315299 | Human |
| 598061568 | GWAS1780867_H | body height QTL GWAS1780867 (human) | | 6e-13 | body height | | 4 | 108198626 | 108198627 | Human |
| 597619259 | GWAS1676119_H | congestive heart failure QTL GWAS1676119 (human) | | 5e-15 | congestive heart failure | | 4 | 110761735 | 110761736 | Human |
| 597619256 | GWAS1676116_H | sinoatrial node disorder QTL GWAS1676116 (human) | | 1e-17 | sinoatrial node disorder | | 4 | 110774266 | 110774267 | Human |
| 596963900 | GWAS1083419_H | major depressive disorder QTL GWAS1083419 (human) | | 0.000003 | major depressive disorder | | 4 | 124344158 | 124344159 | Human |
| 407112174 | GWAS761150_H | respiratory system disease QTL GWAS761150 (human) | | 6e-17 | respiratory system disease | | 4 | 122432277 | 122432278 | Human |
| 597619251 | GWAS1676111_H | congestive heart failure QTL GWAS1676111 (human) | | 6e-16 | congestive heart failure | | 4 | 110737902 | 110737903 | Human |
| 406931950 | GWAS580926_H | pulse pressure measurement QTL GWAS580926 (human) | | 3e-73 | pulse pressure measurement | | 4 | 115629004 | 115629005 | Human |
| 597586481 | GWAS1643341_H | eosinophil count QTL GWAS1643341 (human) | | 1e-17 | eosinophil count | | 4 | 122663791 | 122663792 | Human |
| 617018742 | GWAS2036241_H | calcium measurement, diet measurement QTL GWAS2036241 (human) | | 0.000009 | calcium measurement, diet measurement | | 4 | 111131258 | 111131259 | Human |
| 598061589 | GWAS1780888_H | body height QTL GWAS1780888 (human) | | 1e-32 | body height | | 4 | 123312229 | 123312230 | Human |
| 598061588 | GWAS1780887_H | body height QTL GWAS1780887 (human) | | 7e-150 | body height | | 4 | 122917603 | 122917604 | Human |
| 616559885 | GWAS1956468_H | acid sphingomyelinase-like phosphodiesterase 3a measurement QTL GWAS1956468 (human) | | 1e-19 | acid sphingomyelinase-like phosphodiesterase 3a measurement | | 4 | 109657070 | 109657071 | Human |
| 407374331 | GWAS1023307_H | schizophrenia QTL GWAS1023307 (human) | | 8e-09 | schizophrenia | | 4 | 117906596 | 117906597 | Human |
| 598061590 | GWAS1780889_H | body height QTL GWAS1780889 (human) | | 2e-19 | body height | | 4 | 123707660 | 123707661 | Human |
| 598061585 | GWAS1780884_H | body height QTL GWAS1780884 (human) | | 2e-37 | body height | | 4 | 122757847 | 122757848 | Human |
| 598061587 | GWAS1780886_H | body height QTL GWAS1780886 (human) | | 2e-96 | body height | | 4 | 122830862 | 122830863 | Human |
| 598061586 | GWAS1780885_H | body height QTL GWAS1780885 (human) | | 0.0000001 | body height | | 4 | 122824456 | 122824457 | Human |
| 598143584 | GWAS1830312_H | bone tissue density QTL GWAS1830312 (human) | | 8e-15 | bone tissue density | | 4 | 132222891 | 132222892 | Human |
| 407193996 | GWAS842972_H | glycerophospholipid measurement QTL GWAS842972 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114513322 | 114513323 | Human |
| 628864178 | GWAS2772407_H | facial morphology trait QTL GWAS2772407 (human) | | 3e-08 | facial morphology trait | | 4 | 125210511 | 125210512 | Human |
| 628864177 | GWAS2772406_H | facial morphology trait QTL GWAS2772406 (human) | | 3e-08 | facial morphology trait | | 4 | 125219863 | 125219864 | Human |
| 407013769 | GWAS662745_H | periodontitis QTL GWAS662745 (human) | | 0.000009 | periodontitis | | 4 | 110885393 | 110885394 | Human |
| 616953102 | GWAS1970601_H | platelet count QTL GWAS1970601 (human) | | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123806369 | 123806370 | Human |
| 628864176 | GWAS2772405_H | facial morphology trait QTL GWAS2772405 (human) | | 3e-08 | facial morphology trait | | 4 | 125217310 | 125217311 | Human |
| 407193995 | GWAS842971_H | glycerophospholipid measurement QTL GWAS842971 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114492288 | 114492289 | Human |
| 596963930 | GWAS1083449_H | bipolar disorder, major depressive disorder QTL GWAS1083449 (human) | | 0.000008 | bipolar disorder, major depressive disorder | | 4 | 125438301 | 125438302 | Human |
| 407193994 | GWAS842970_H | glycerophospholipid measurement QTL GWAS842970 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114492246 | 114492247 | Human |
| 617067798 | GWAS2085297_H | memory performance QTL GWAS2085297 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 112467350 | 112467351 | Human |
| 628569254 | GWAS2477483_H | glycerophospholipid measurement QTL GWAS2477483 (human) | | 1e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114481442 | 114481443 | Human |
| 628569253 | GWAS2477482_H | glycerophospholipid measurement QTL GWAS2477482 (human) | | 1e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114479583 | 114479584 | Human |
| 628602020 | GWAS2510249_H | phospholipid level, blood VLDL cholesterol amount QTL GWAS2510249 (human) | | 8e-09 | phospholipid level, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 628569252 | GWAS2477481_H | glycerophospholipid measurement QTL GWAS2477481 (human) | | 5e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114538308 | 114538309 | Human |
| 628569251 | GWAS2477480_H | glycerophospholipid measurement QTL GWAS2477480 (human) | | 4e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114580433 | 114580434 | Human |
| 628864175 | GWAS2772404_H | facial morphology trait QTL GWAS2772404 (human) | | 3e-08 | facial morphology trait | | 4 | 125198582 | 125198583 | Human |
| 628569250 | GWAS2477479_H | glycerophospholipid measurement QTL GWAS2477479 (human) | | 4e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114525610 | 114525611 | Human |
| 628864174 | GWAS2772403_H | facial morphology trait QTL GWAS2772403 (human) | | 3e-08 | facial morphology trait | | 4 | 125198542 | 125198543 | Human |
| 597324364 | GWAS1420438_H | cup-to-disc ratio measurement QTL GWAS1420438 (human) | | 7e-09 | cup-to-disc ratio measurement | | 4 | 111478355 | 111478356 | Human |
| 407374224 | GWAS1023200_H | unipolar depression QTL GWAS1023200 (human) | | 0.0000004 | unipolar depression | | 4 | 130232015 | 130232016 | Human |
| 628765859 | GWAS2674088_H | vascular endothelial growth factor A level QTL GWAS2674088 (human) | | 3e-105 | vascular endothelial growth factor A level | | 4 | 109924607 | 109924608 | Human |
| 597439040 | GWAS1535114_H | BMI-adjusted hip circumference QTL GWAS1535114 (human) | | 0.000003 | BMI-adjusted hip circumference | | 4 | 110946968 | 110946969 | Human |
| 598078072 | GWAS1797371_H | bone density QTL GWAS1797371 (human) | | 2e-10 | bone density | | 4 | 122897478 | 122897479 | Human |
| 598061637 | GWAS1780936_H | body height QTL GWAS1780936 (human) | | 0.000002 | body height | | 4 | 108823766 | 108823767 | Human |
| 597029493 | GWAS1125567_H | sugar consumption measurement QTL GWAS1125567 (human) | | 0.000004 | eating behavior trait (VT:0001431) | sucrose drink intake volume (CMO:0002200) | 4 | 130735539 | 130735540 | Human |
| 598061636 | GWAS1780935_H | body height QTL GWAS1780935 (human) | | 4e-144 | body height | | 4 | 108554818 | 108554819 | Human |
| 407243175 | GWAS892151_H | systolic blood pressure QTL GWAS892151 (human) | | 3e-12 | systolic blood pressure | | 4 | 110417121 | 110417122 | Human |
| 598061639 | GWAS1780938_H | body height QTL GWAS1780938 (human) | | 2e-31 | body height | | 4 | 108330552 | 108330553 | Human |
| 598061638 | GWAS1780937_H | body height QTL GWAS1780937 (human) | | 6e-21 | body height | | 4 | 108860632 | 108860633 | Human |
| 407243173 | GWAS892149_H | susceptibility to mononucleosis measurement QTL GWAS892149 (human) | | 0.000008 | susceptibility to mononucleosis measurement | | 4 | 124860479 | 124860480 | Human |
| 628421783 | GWAS2330012_H | decreased attention, quality of life cycle QTL GWAS2330012 (human) | | 0.000003 | decreased attention, quality of life cycle | | 4 | 125938393 | 125938394 | Human |
| 598061633 | GWAS1780932_H | body height QTL GWAS1780932 (human) | | 8e-74 | body height | | 4 | 108355674 | 108355675 | Human |
| 598061632 | GWAS1780931_H | body height QTL GWAS1780931 (human) | | 0.00001 | body height | | 4 | 108342899 | 108342900 | Human |
| 598061635 | GWAS1780934_H | body height QTL GWAS1780934 (human) | | 1e-277 | body height | | 4 | 108540829 | 108540830 | Human |
| 407243168 | GWAS892144_H | susceptibility to mononucleosis measurement QTL GWAS892144 (human) | | 0.000008 | susceptibility to mononucleosis measurement | | 4 | 121625333 | 121625334 | Human |
| 597275263 | GWAS1371337_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS1371337 (human) | | 5e-19 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129143723 | 129143724 | Human |
| 598061634 | GWAS1780933_H | body height QTL GWAS1780933 (human) | | 2e-44 | body height | | 4 | 108458572 | 108458573 | Human |
| 596963955 | GWAS1083474_H | major depressive disorder QTL GWAS1083474 (human) | | 0.000007 | major depressive disorder | | 4 | 124494379 | 124494380 | Human |
| 597029501 | GWAS1125575_H | body mass index QTL GWAS1125575 (human) | | 1e-08 | body mass index | | 4 | 112335581 | 112335582 | Human |
| 597029500 | GWAS1125574_H | body mass index QTL GWAS1125574 (human) | | 1e-10 | body mass index | | 4 | 111765198 | 111765199 | Human |
| 406931880 | GWAS580856_H | pulse pressure measurement QTL GWAS580856 (human) | | 1e-52 | pulse pressure measurement | | 4 | 112822498 | 112822499 | Human |
| 597979727 | GWAS1699026_H | platelet-derived growth factor complex BB dimer amount QTL GWAS1699026 (human) | | 0.000009 | platelet-derived growth factor complex BB dimer amount | | 4 | 116687083 | 116687084 | Human |
| 597029502 | GWAS1125576_H | body mass index QTL GWAS1125576 (human) | | 4e-08 | body mass index | | 4 | 130102129 | 130102130 | Human |
| 598110795 | GWAS1819678_H | oligodendroglioma QTL GWAS1819678 (human) | | 0.000003 | oligodendroglioma | | 4 | 107054820 | 107054821 | Human |
| 628814986 | GWAS2723215_H | trait in response to warfarin QTL GWAS2723215 (human) | | 0.0000006 | trait in response to warfarin | | 4 | 130374797 | 130374798 | Human |
| 407095728 | GWAS744704_H | aspartate measurement QTL GWAS744704 (human) | | 9e-31 | aspartate measurement | | 4 | 110510288 | 110510289 | Human |
| 628814985 | GWAS2723214_H | trait in response to warfarin QTL GWAS2723214 (human) | | 0.000007 | trait in response to warfarin | | 4 | 112988363 | 112988364 | Human |
| 597291630 | GWAS1387704_H | lymphocyte count QTL GWAS1387704 (human) | | 1e-14 | lymphocyte count | | 4 | 109919540 | 109919541 | Human |
| 616527175 | GWAS1923758_H | lymphocyte percentage of leukocytes QTL GWAS1923758 (human) | | 7e-19 | lymphocyte percentage of leukocytes | | 4 | 122760001 | 122760002 | Human |
| 616953149 | GWAS1970648_H | Cleft palate, cleft lip QTL GWAS1970648 (human) | | 4e-08 | Cleft palate, cleft lip | | 4 | 123985102 | 123985103 | Human |
| 628765826 | GWAS2674055_H | body mass index QTL GWAS2674055 (human) | | 0.000003 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129838492 | 129838493 | Human |
| 598078045 | GWAS1797344_H | bone density QTL GWAS1797344 (human) | | 8e-15 | bone density | | 4 | 132222891 | 132222892 | Human |
| 628372622 | GWAS2293466_H | vascular endothelial growth factor A level QTL GWAS2293466 (human) | | 3e-105 | vascular endothelial growth factor A level | | 4 | 109924607 | 109924608 | Human |
| 597193314 | GWAS1289388_H | executive function measurement QTL GWAS1289388 (human) | | 0.000002 | executive function measurement | | 4 | 130874841 | 130874842 | Human |
| 406899131 | GWAS548107_H | epidermal growth factor measurement QTL GWAS548107 (human) | | 5e-08 | epidermal growth factor measurement | | 4 | 109973293 | 109973294 | Human |
| 597308006 | GWAS1404080_H | brain measurement QTL GWAS1404080 (human) | | 7e-10 | brain measurement | | 4 | 124015375 | 124015376 | Human |
| 407013952 | GWAS662928_H | open-angle glaucoma QTL GWAS662928 (human) | | 8e-10 | open-angle glaucoma | | 4 | 126000490 | 126000491 | Human |
| 597258651 | GWAS1354725_H | total cholesterol measurement QTL GWAS1354725 (human) | | 9e-10 | total cholesterol measurement | | 4 | 128078464 | 128078465 | Human |
| 597324190 | GWAS1420264_H | histidine measurement QTL GWAS1420264 (human) | | 3e-08 | blood L-hisitidine amount (VT:0010976) | blood amino acid measurement (CMO:0003730) | 4 | 122051907 | 122051908 | Human |
| 628963194 | GWAS2871423_H | blood coagulation disease QTL GWAS2871423 (human) | | 1e-13 | blood coagulation disease | | 4 | 110796911 | 110796912 | Human |
| 628832113 | GWAS2740342_H | factor VIII measurement, Ischemic stroke QTL GWAS2740342 (human) | | 9e-17 | blood coagulation trait (VT:0002551) | | 4 | 110775495 | 110775496 | Human |
| 628701033 | GWAS2609262_H | fibroblast growth factor 19 level QTL GWAS2609262 (human) | | 2e-12 | fibroblast growth factor 19 level | | 4 | 109321740 | 109321741 | Human |
| 407341650 | GWAS990626_H | mean arterial pressure QTL GWAS990626 (human) | | 1e-15 | mean arterial pressure | | 4 | 110430068 | 110430069 | Human |
| 628995947 | GWAS2904176_H | alopecia areata QTL GWAS2904176 (human) | | 1e-11 | alopecia areata | | 4 | 126045378 | 126045379 | Human |
| 596980109 | GWAS1099628_H | memory performance QTL GWAS1099628 (human) | | 0.000002 | memory performance | | 4 | 124874941 | 124874942 | Human |
| 597406082 | GWAS1502156_H | cardioembolic stroke QTL GWAS1502156 (human) | | 2e-47 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 628799328 | GWAS2707557_H | COVID-19, mortality QTL GWAS2707557 (human) | | 0.000002 | life span trait (VT:0005372) | ratio of deaths to total study population during a period of time (CMO:0001023) | 4 | 127021337 | 127021338 | Human |
| 597406080 | GWAS1502154_H | stroke QTL GWAS1502154 (human) | | 2e-13 | stroke | | 4 | 110793263 | 110793264 | Human |
| 597045645 | GWAS1141719_H | hemoglobin measurement QTL GWAS1141719 (human) | | 1e-09 | hemoglobin measurement | | 4 | 114596387 | 114596388 | Human |
| 597389696 | GWAS1485770_H | bipolar disorder QTL GWAS1485770 (human) | | 0.000005 | bipolar disorder | | 4 | 122589611 | 122589612 | Human |
| 628504406 | GWAS2412635_H | systolic blood pressure QTL GWAS2412635 (human) | | 6e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 119588124 | 119588125 | Human |
| 628504407 | GWAS2412636_H | systolic blood pressure QTL GWAS2412636 (human) | | 2e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 120018118 | 120018119 | Human |
| 597160374 | GWAS1256448_H | 3-methyl-2-oxobutyrate measurement QTL GWAS1256448 (human) | | 0.000009 | 3-methyl-2-oxobutyrate measurement | | 4 | 124716785 | 124716786 | Human |
| 628635484 | GWAS2543713_H | gut microbiome measurement, breastfeeding duration QTL GWAS2543713 (human) | | 4e-08 | lactation duration (VT:1000653) | | 4 | 123562675 | 123562676 | Human |
| 407390830 | GWAS1039806_H | telomere length QTL GWAS1039806 (human) | | 0.000009 | telomere length | | 4 | 110290116 | 110290117 | Human |
| 628848451 | GWAS2756680_H | triglyceride measurement QTL GWAS2756680 (human) | | 2e-09 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 123720672 | 123720673 | Human |
| 628848450 | GWAS2756679_H | triglyceride measurement QTL GWAS2756679 (human) | | 9e-33 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109717668 | 109717669 | Human |
| 628848449 | GWAS2756678_H | triglyceride measurement QTL GWAS2756678 (human) | | 7e-26 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109174464 | 109174465 | Human |
| 597324192 | GWAS1420266_H | tryptophan measurement QTL GWAS1420266 (human) | | 6e-09 | blood amino acid amount (VT:0005311) | | 4 | 122051907 | 122051908 | Human |
| 597438886 | GWAS1534960_H | tumor necrosis factor-alpha measurement QTL GWAS1534960 (human) | | 0.000009 | tumor necrosis factor-alpha measurement | | 4 | 123921955 | 123921960 | Human |
| 597619108 | GWAS1675968_H | body weight QTL GWAS1675968 (human) | | 4e-19 | body weight | | 4 | 129818987 | 129818988 | Human |
| 628635452 | GWAS2543681_H | gut microbiome measurement, breastfeeding duration QTL GWAS2543681 (human) | | 6e-09 | lactation duration (VT:1000653) | | 4 | 112407707 | 112407708 | Human |
| 617133709 | GWAS2151208_H | exostosis QTL GWAS2151208 (human) | | 4e-11 | exostosis | | 4 | 125701864 | 125701865 | Human |
| 597291486 | GWAS1387560_H | hypertension QTL GWAS1387560 (human) | | 6e-12 | hypertension | | 4 | 110484920 | 110484925 | Human |
| 597537237 | GWAS1633311_H | body height QTL GWAS1633311 (human) | | 4e-28 | body height | | 4 | 119474818 | 119474819 | Human |
| 628668208 | GWAS2576437_H | vascular endothelial function measurement QTL GWAS2576437 (human) | | 8e-08 | blood vessel physiology trait (VT:0000170) | | 4 | 132241773 | 132241774 | Human |
| 597602775 | GWAS1659635_H | drug use measurement, cardiovascular disease QTL GWAS1659635 (human) | | 8e-18 | drug use measurement, cardiovascular disease | | 4 | 110775495 | 110775496 | Human |
| 597537236 | GWAS1633310_H | body height QTL GWAS1633310 (human) | | 4e-17 | body height | | 4 | 118815641 | 118815642 | Human |
| 617133697 | GWAS2151196_H | abnormal result of function studies QTL GWAS2151196 (human) | | 2e-11 | abnormal result of function studies | | 4 | 131498407 | 131498408 | Human |
| 597537238 | GWAS1633312_H | body height QTL GWAS1633312 (human) | | 3e-09 | body height | | 4 | 119494521 | 119494522 | Human |
| 628619066 | GWAS2527295_H | balding measurement QTL GWAS2527295 (human) | | 3e-22 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106645118 | 106645119 | Human |
| 628619065 | GWAS2527294_H | balding measurement QTL GWAS2527294 (human) | | 1e-09 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106449528 | 106449529 | Human |
| 597537235 | GWAS1633309_H | body height QTL GWAS1633309 (human) | | 1e-12 | body height | | 4 | 114398989 | 114398990 | Human |
| 597537234 | GWAS1633308_H | body height QTL GWAS1633308 (human) | | 3e-13 | body height | | 4 | 112538249 | 112538250 | Human |
| 407128597 | GWAS777573_H | color vision disorder QTL GWAS777573 (human) | | 0.0000002 | color vision disorder | | 4 | 130864190 | 130864191 | Human |
| 616969872 | GWAS1987371_H | interleukin 16 measurement QTL GWAS1987371 (human) | | 0.0000007 | blood interleukin-16 amount (VT:0008631) | | 4 | 112649483 | 112649484 | Human |
| 598077938 | GWAS1797237_H | bone density QTL GWAS1797237 (human) | | 6e-12 | bone density | | 4 | 122289915 | 122289916 | Human |
| 598061565 | GWAS1780864_H | body height QTL GWAS1780864 (human) | | 2e-12 | body height | | 4 | 107793654 | 107793655 | Human |
| 598061564 | GWAS1780863_H | body height QTL GWAS1780863 (human) | | 2e-19 | body height | | 4 | 106649253 | 106649254 | Human |
| 598061567 | GWAS1780866_H | body height QTL GWAS1780866 (human) | | 2e-48 | body height | | 4 | 108125804 | 108125805 | Human |
| 598061566 | GWAS1780865_H | body height QTL GWAS1780865 (human) | | 8e-18 | body height | | 4 | 107970830 | 107970831 | Human |
| 597291461 | GWAS1387535_H | monocyte count QTL GWAS1387535 (human) | | 2e-26 | monocyte count | | 4 | 110035176 | 110035177 | Human |
| 616986266 | GWAS2003765_H | lifestyle measurement QTL GWAS2003765 (human) | | 3e-09 | lifestyle measurement | | 4 | 117436249 | 117436250 | Human |
| 616986267 | GWAS2003766_H | lifestyle measurement QTL GWAS2003766 (human) | | 8e-09 | lifestyle measurement | | 4 | 129365346 | 129365348 | Human |
| 597291463 | GWAS1387537_H | monocyte count QTL GWAS1387537 (human) | | 5e-16 | monocyte count | | 4 | 109926568 | 109926569 | Human |
| 597373380 | GWAS1469454_H | asthma, age at diagnosis QTL GWAS1469454 (human) | | 0.0000002 | asthma, age at diagnosis | | 4 | 122680257 | 122680258 | Human |
| 628913950 | GWAS2822179_H | testosterone measurement QTL GWAS2822179 (human) | | 4e-11 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 109321740 | 109321741 | Human |
| 628913951 | GWAS2822180_H | testosterone measurement QTL GWAS2822180 (human) | | 1e-12 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 110002761 | 110002762 | Human |
| 407095850 | GWAS744826_H | body mass index QTL GWAS744826 (human) | | 3e-10 | body mass index | | 4 | 112392830 | 112392831 | Human |
| 617019050 | GWAS2036549_H | sex hormone-binding globulin measurement QTL GWAS2036549 (human) | | 3e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 617100965 | GWAS2118464_H | atrial fibrillation QTL GWAS2118464 (human) | | 5e-30 | atrial fibrillation | | 4 | 110271840 | 110271841 | Human |
| 617100966 | GWAS2118465_H | atrial fibrillation QTL GWAS2118465 (human) | | 2e-1141 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 617100967 | GWAS2118466_H | atrial fibrillation QTL GWAS2118466 (human) | | 5e-16 | atrial fibrillation | | 4 | 112102428 | 112102429 | Human |
| 617019049 | GWAS2036548_H | sex hormone-binding globulin measurement QTL GWAS2036548 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 617019063 | GWAS2036562_H | open-angle glaucoma QTL GWAS2036562 (human) | | 7e-15 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 407226932 | GWAS875908_H | BMI-adjusted waist circumference QTL GWAS875908 (human) | | 9e-11 | BMI-adjusted waist circumference | | 4 | 123166618 | 123166619 | Human |
| 617084596 | GWAS2102095_H | cerebral cortex area attribute QTL GWAS2102095 (human) | | 5e-10 | cerebral cortex area attribute | | 4 | 112493715 | 112493716 | Human |
| 626456355 | GWAS2270288_H | serum albumin amount QTL GWAS2270288 (human) | | 2e-10 | serum albumin amount | | 4 | 123867301 | 123867302 | Human |
| 407226930 | GWAS875906_H | BMI-adjusted waist circumference QTL GWAS875906 (human) | | 3e-08 | BMI-adjusted waist circumference | | 4 | 123121264 | 123121265 | Human |
| 628553486 | GWAS2461715_H | cortical thickness QTL GWAS2461715 (human) | | 3e-12 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120722571 | 120722572 | Human |
| 597111277 | GWAS1207351_H | mathematical ability QTL GWAS1207351 (human) | | 2e-14 | mathematical ability | | 4 | 128819435 | 128819436 | Human |
| 597406183 | GWAS1502257_H | cortical surface area measurement QTL GWAS1502257 (human) | | 1e-09 | cortical surface area measurement | | 4 | 126658527 | 126658528 | Human |
| 617019066 | GWAS2036565_H | open-angle glaucoma QTL GWAS2036565 (human) | | 1e-08 | open-angle glaucoma | | 4 | 127613850 | 127613851 | Human |
| 407013951 | GWAS662927_H | open-angle glaucoma QTL GWAS662927 (human) | | 2e-08 | open-angle glaucoma | | 4 | 125465224 | 125465225 | Human |
| 407013948 | GWAS662924_H | open-angle glaucoma QTL GWAS662924 (human) | | 1e-08 | open-angle glaucoma | | 4 | 111886876 | 111886877 | Human |
| 617019064 | GWAS2036563_H | open-angle glaucoma QTL GWAS2036563 (human) | | 4e-12 | open-angle glaucoma | | 4 | 111886876 | 111886877 | Human |
| 406964798 | GWAS613774_H | alcohol use disorder measurement QTL GWAS613774 (human) | | 3e-12 | alcohol use disorder measurement | | 4 | 111546456 | 111546457 | Human |
| 617019065 | GWAS2036564_H | open-angle glaucoma QTL GWAS2036564 (human) | | 1e-09 | open-angle glaucoma | | 4 | 125994594 | 125994595 | Human |
| 597504482 | GWAS1600556_H | body mass index QTL GWAS1600556 (human) | | 4e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 616969798 | GWAS1987297_H | asthma, age at diagnosis QTL GWAS1987297 (human) | | 0.0000002 | asthma, age at diagnosis | | 4 | 122680257 | 122680258 | Human |
| 597127444 | GWAS1223518_H | glycerophospholipid measurement QTL GWAS1223518 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480792 | 114480793 | Human |
| 407063239 | GWAS712215_H | retinal vasculature measurement QTL GWAS712215 (human) | | 4e-08 | retinal vasculature measurement | | 4 | 119151914 | 119151915 | Human |
| 628619263 | GWAS2527492_H | treatment resistant depression, response to antidepressant QTL GWAS2527492 (human) | | 0.000004 | treatment resistant depression, response to antidepressant | | 4 | 130496927 | 130496928 | Human |
| 597487895 | GWAS1583969_H | Ventricular arrhythmia QTL GWAS1583969 (human) | | 2e-10 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
| 628619260 | GWAS2527489_H | treatment resistant depression, response to antidepressant QTL GWAS2527489 (human) | | 0.0000001 | treatment resistant depression, response to antidepressant | | 4 | 130459962 | 130459963 | Human |
| 597586191 | GWAS1643051_H | creatinine measurement QTL GWAS1643051 (human) | | 1e-11 | creatinine measurement | | 4 | 108783863 | 108783864 | Human |
| 597307663 | GWAS1403737_H | triglyceride measurement QTL GWAS1403737 (human) | | 3e-20 | triglyceride measurement | | 4 | 109603883 | 109603884 | Human |
| 597225728 | GWAS1321802_H | smoking status measurement QTL GWAS1321802 (human) | | 2e-15 | smoking status measurement | | 4 | 111500989 | 111500990 | Human |
| 597225729 | GWAS1321803_H | smoking status measurement QTL GWAS1321803 (human) | | 5e-08 | smoking status measurement | | 4 | 120722084 | 120722085 | Human |
| 616953432 | GWAS1970931_H | eosinophil percentage of leukocytes QTL GWAS1970931 (human) | | 5e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122639784 | 122639785 | Human |
| 597160201 | GWAS1256275_H | 4-ethylphenylsulfate measurement QTL GWAS1256275 (human) | | 0.000004 | 4-ethylphenylsulfate measurement | | 4 | 108059616 | 108059617 | Human |
| 597487932 | GWAS1584006_H | gut microbiome measurement, bone density QTL GWAS1584006 (human) | | 2e-09 | gut microbiome measurement, bone density | | 4 | 116039953 | 116039954 | Human |
| 597487930 | GWAS1584004_H | gut microbiome measurement, bone density QTL GWAS1584004 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116019324 | 116019325 | Human |
| 597619001 | GWAS1675861_H | artificial cardiac pacemaker QTL GWAS1675861 (human) | | 1e-16 | artificial cardiac pacemaker | | 4 | 110780642 | 110780643 | Human |
| 597487931 | GWAS1584005_H | gut microbiome measurement, bone density QTL GWAS1584005 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116034483 | 116034484 | Human |
| 598143243 | GWAS1829971_H | bone tissue density QTL GWAS1829971 (human) | | 1e-130 | bone tissue density | | 4 | 119406123 | 119406124 | Human |
| 597815567 | GWAS1682958_H | neuroimaging measurement QTL GWAS1682958 (human) | | 3e-08 | neuroimaging measurement | | 4 | 112509596 | 112509597 | Human |
| 628602821 | GWAS2511050_H | post-traumatic stress disorder QTL GWAS2511050 (human) | | 0.000002 | behavior trait (VT:0010442) | | 4 | 106419681 | 106419682 | Human |
| 628602819 | GWAS2511048_H | post-traumatic stress disorder QTL GWAS2511048 (human) | | 0.000001 | behavior trait (VT:0010442) | | 4 | 106417893 | 106417894 | Human |
| 597618984 | GWAS1675844_H | atrial flutter QTL GWAS1675844 (human) | | 7e-207 | atrial flutter | | 4 | 110793263 | 110793264 | Human |
| 596980009 | GWAS1099528_H | memory performance QTL GWAS1099528 (human) | | 0.000009 | memory performance | | 4 | 109134293 | 109134294 | Human |
| 406964988 | GWAS613964_H | age-related macular degeneration QTL GWAS613964 (human) | | 4e-10 | retina integrity trait (VT:0010771) | | 4 | 109737911 | 109737912 | Human |
| 626456555 | GWAS2270488_H | total cholesterol measurement QTL GWAS2270488 (human) | | 1e-13 | total cholesterol measurement | | 4 | 109962188 | 109962189 | Human |
| 597324068 | GWAS1420142_H | complement factor I measurement QTL GWAS1420142 (human) | | 4e-20 | complement factor I measurement | | 4 | 109737911 | 109737912 | Human |
| 628586441 | GWAS2494670_H | lipoprotein A measurement, diet measurement QTL GWAS2494670 (human) | | 0.000002 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 129572458 | 129572459 | Human |
| 597324069 | GWAS1420143_H | complement factor I measurement QTL GWAS1420143 (human) | | 5e-12 | complement factor I measurement | | 4 | 109799365 | 109799366 | Human |
| 598061413 | GWAS1780712_H | body height QTL GWAS1780712 (human) | | 9e-190 | body height | | 4 | 121799844 | 121799845 | Human |
| 407325318 | GWAS974294_H | Alzheimer disease QTL GWAS974294 (human) | | 1e-10 | Alzheimer disease | | 4 | 108219159 | 108219160 | Human |
| 598061412 | GWAS1780711_H | body height QTL GWAS1780711 (human) | | 4e-49 | body height | | 4 | 121772932 | 121772933 | Human |
| 598061415 | GWAS1780714_H | body height QTL GWAS1780714 (human) | | 8e-20 | body height | | 4 | 122626386 | 122626387 | Human |
| 598061414 | GWAS1780713_H | body height QTL GWAS1780713 (human) | | 1e-12 | body height | | 4 | 122600025 | 122600026 | Human |
| 597504347 | GWAS1600421_H | low density lipoprotein cholesterol measurement QTL GWAS1600421 (human) | | 6e-09 | low density lipoprotein cholesterol measurement | | 4 | 119206905 | 119206906 | Human |
| 597504346 | GWAS1600420_H | low density lipoprotein cholesterol measurement QTL GWAS1600420 (human) | | 1e-10 | low density lipoprotein cholesterol measurement | | 4 | 110021121 | 110021122 | Human |
| 407308942 | GWAS957918_H | hemoglobin A1 measurement QTL GWAS957918 (human) | | 2e-17 | hemoglobin A1 measurement | | 4 | 109908302 | 109908303 | Human |
| 628897719 | GWAS2805948_H | testosterone measurement QTL GWAS2805948 (human) | | 5e-13 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 114419750 | 114419751 | Human |
| 597111132 | GWAS1207206_H | diastolic blood pressure QTL GWAS1207206 (human) | | 3e-09 | diastolic blood pressure | | 4 | 119037654 | 119037655 | Human |
| 598061416 | GWAS1780715_H | body height QTL GWAS1780715 (human) | | 7e-19 | body height | | 4 | 121693600 | 121693601 | Human |
| 628635560 | GWAS2543789_H | gut microbiome measurement, breastfeeding duration QTL GWAS2543789 (human) | | 1e-08 | lactation duration (VT:1000653) | | 4 | 111640701 | 111640702 | Human |
| 598077812 | GWAS1797111_H | bone density QTL GWAS1797111 (human) | | 1e-12 | bone density | | 4 | 115936664 | 115936665 | Human |
| 407145110 | GWAS794086_H | BMI-adjusted waist-hip ratio QTL GWAS794086 (human) | | 5e-09 | BMI-adjusted waist-hip ratio | | 4 | 123145793 | 123145794 | Human |
| 628422562 | GWAS2330791_H | body mass index QTL GWAS2330791 (human) | | 4e-12 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129805678 | 129805679 | Human |
| 628520877 | GWAS2429106_H | Parkinson's disease symptom measurement QTL GWAS2429106 (human) | | 0.000006 | Parkinson's disease symptom measurement | | 4 | 115200194 | 115200195 | Human |
| 406948509 | GWAS597485_H | spermidine measurement QTL GWAS597485 (human) | | 4e-08 | spermidine measurement | | 4 | 109176399 | 109176400 | Human |
| 597373254 | GWAS1469328_H | BMI-adjusted waist circumference QTL GWAS1469328 (human) | | 1e-14 | BMI-adjusted waist circumference | | 4 | 119354508 | 119354509 | Human |
| 407243430 | GWAS892406_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS892406 (human) | | 2e-12 | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407194277 | GWAS843253_H | glycerophospholipid measurement QTL GWAS843253 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114484592 | 114484593 | Human |
| 1643256 | BW127_H | Body Weight QTL 127 (human) | 1.31 | 0.007 | Body weight | body mass index | 4 | 106319694 | 132319694 | Human |
| 407194276 | GWAS843252_H | glycerophospholipid measurement QTL GWAS843252 (human) | | 1e-12 | glycerophospholipid measurement | | 4 | 114512809 | 114512810 | Human |
| 407194279 | GWAS843255_H | glycerophospholipid measurement QTL GWAS843255 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114517650 | 114517651 | Human |
| 406964898 | GWAS613874_H | reticulocyte count QTL GWAS613874 (human) | | 3e-10 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109990411 | 109990412 | Human |
| 597406072 | GWAS1502146_H | stroke QTL GWAS1502146 (human) | | 2e-15 | stroke | | 4 | 110793263 | 110793264 | Human |
| 407194278 | GWAS843254_H | glycerophospholipid measurement QTL GWAS843254 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114512821 | 114512822 | Human |
| 407194275 | GWAS843251_H | glycerophospholipid measurement QTL GWAS843251 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114491902 | 114491903 | Human |
| 407194274 | GWAS843250_H | glycerophospholipid measurement QTL GWAS843250 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114513555 | 114513556 | Human |
| 597979459 | GWAS1698758_H | beta-nerve growth factor amount QTL GWAS1698758 (human) | | 0.000008 | beta-nerve growth factor amount | | 4 | 123921959 | 123921960 | Human |
| 407194285 | GWAS843261_H | glycerophospholipid measurement QTL GWAS843261 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114564668 | 114564669 | Human |
| 628537247 | GWAS2445476_H | mean corpuscular hemoglobin concentration QTL GWAS2445476 (human) | | 5e-12 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109921984 | 109921985 | Human |
| 407194284 | GWAS843260_H | glycerophospholipid measurement QTL GWAS843260 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114557343 | 114557344 | Human |
| 407194287 | GWAS843263_H | glycerophospholipid measurement QTL GWAS843263 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114538077 | 114538078 | Human |
| 598061391 | GWAS1780690_H | body height QTL GWAS1780690 (human) | | 6e-46 | body height | | 4 | 119733676 | 119733677 | Human |
| 407194286 | GWAS843262_H | glycerophospholipid measurement QTL GWAS843262 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114554629 | 114554630 | Human |
| 628717458 | GWAS2625687_H | retinal vasculature measurement QTL GWAS2625687 (human) | | 4e-08 | retina blood vessel morphology trait (VT:0002792) | | 4 | 119151914 | 119151915 | Human |
| 598061390 | GWAS1780689_H | body height QTL GWAS1780689 (human) | | 7e-88 | body height | | 4 | 119680576 | 119680577 | Human |
| 407194281 | GWAS843257_H | glycerophospholipid measurement QTL GWAS843257 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114514184 | 114514185 | Human |
| 407194280 | GWAS843256_H | glycerophospholipid measurement QTL GWAS843256 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114575934 | 114575935 | Human |
| 407194283 | GWAS843259_H | glycerophospholipid measurement QTL GWAS843259 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114556918 | 114556919 | Human |
| 407194282 | GWAS843258_H | glycerophospholipid measurement QTL GWAS843258 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114489752 | 114489753 | Human |
| 407194293 | GWAS843269_H | glycerophospholipid measurement QTL GWAS843269 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114547620 | 114547621 | Human |
| 598061397 | GWAS1780696_H | body height QTL GWAS1780696 (human) | | 3e-23 | body height | | 4 | 120882137 | 120882138 | Human |
| 407194292 | GWAS843268_H | glycerophospholipid measurement QTL GWAS843268 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114566777 | 114566778 | Human |
| 598061396 | GWAS1780695_H | body height QTL GWAS1780695 (human) | | 2e-19 | body height | | 4 | 120734912 | 120734913 | Human |
| 597143909 | GWAS1239983_H | Alzheimer disease, APOE carrier status QTL GWAS1239983 (human) | | 0.000006 | Alzheimer disease, APOE carrier status | | 4 | 129588615 | 129588616 | Human |
| 407210678 | GWAS859654_H | blood protein measurement QTL GWAS859654 (human) | | 5e-08 | blood protein measurement | | 4 | 110079447 | 110079448 | Human |
| 616511051 | GWAS1907634_H | fatty acid amount QTL GWAS1907634 (human) | | 3e-08 | fatty acid amount | | 4 | 109657070 | 109657071 | Human |
| 407194289 | GWAS843265_H | glycerophospholipid measurement QTL GWAS843265 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114549280 | 114549281 | Human |
| 598061393 | GWAS1780692_H | body height QTL GWAS1780692 (human) | | 2e-128 | body height | | 4 | 119834940 | 119834941 | Human |
| 407407293 | GWAS1056269_H | corneal resistance factor QTL GWAS1056269 (human) | | 2e-09 | corneal resistance factor | | 4 | 111768358 | 111768359 | Human |
| 407194288 | GWAS843264_H | glycerophospholipid measurement QTL GWAS843264 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114583571 | 114583572 | Human |
| 598061392 | GWAS1780691_H | body height QTL GWAS1780691 (human) | | 6e-09 | body height | | 4 | 119774304 | 119774305 | Human |
| 407194291 | GWAS843267_H | glycerophospholipid measurement QTL GWAS843267 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114575280 | 114575281 | Human |
| 598061395 | GWAS1780694_H | body height QTL GWAS1780694 (human) | | 7e-18 | body height | | 4 | 120068926 | 120068927 | Human |
| 597160288 | GWAS1256362_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1256362 (human) | | 3e-11 | total cholesterol measurement, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407112371 | GWAS761347_H | cardiovascular disease QTL GWAS761347 (human) | | 7e-13 | cardiovascular disease | | 4 | 110467945 | 110467946 | Human |
| 407194290 | GWAS843266_H | glycerophospholipid measurement QTL GWAS843266 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114519211 | 114519212 | Human |
| 598061394 | GWAS1780693_H | body height QTL GWAS1780693 (human) | | 9e-12 | body height | | 4 | 119937025 | 119937026 | Human |
| 407308990 | GWAS957966_H | diastolic blood pressure QTL GWAS957966 (human) | | 3e-09 | diastolic blood pressure | | 4 | 119037654 | 119037655 | Human |
| 616543813 | GWAS1940396_H | level of hypoxia up-regulated protein 1 in blood serum QTL GWAS1940396 (human) | | 1e-11 | level of hypoxia up-regulated protein 1 in blood serum | | 4 | 110420710 | 110420711 | Human |
| 628717442 | GWAS2625671_H | level of chymotrypsin-like elastase family member 3A in blood QTL GWAS2625671 (human) | | 4e-14 | level of chymotrypsin-like elastase family member 3A in blood | | 4 | 109945352 | 109945353 | Human |
| 597520737 | GWAS1616811_H | able to hear with hearing aids QTL GWAS1616811 (human) | | 0.0000003 | able to hear with hearing aids | | 4 | 116261685 | 116261686 | Human |
| 407374517 | GWAS1023493_H | hemorrhoid QTL GWAS1023493 (human) | | 3e-11 | hemorrhoid | | 4 | 126003844 | 126003845 | Human |
| 628963203 | GWAS2871432_H | encounter with health service QTL GWAS2871432 (human) | | 7e-141 | encounter with health service | | 4 | 110778170 | 110778171 | Human |
| 617051704 | GWAS2069203_H | waist-hip ratio QTL GWAS2069203 (human) | | 0.00001 | waist-hip ratio | | 4 | 108607724 | 108607725 | Human |
| 628651911 | GWAS2560140_H | forced expiratory volume, 25-hydroxyvitamin D3 measurement QTL GWAS2560140 (human) | | 5e-08 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 113577873 | 113577874 | Human |
| 628488074 | GWAS2396303_H | selective IgA deficiency disease QTL GWAS2396303 (human) | | 0.000001 | selective IgA deficiency disease | | 4 | 122571262 | 122571263 | Human |
| 597127313 | GWAS1223387_H | glycerophospholipid measurement QTL GWAS1223387 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480417 | 114480418 | Human |
| 407374670 | GWAS1023646_H | allergic rhinitis QTL GWAS1023646 (human) | | 3e-15 | allergic rhinitis | | 4 | 122496409 | 122496410 | Human |
| 597127312 | GWAS1223386_H | glycerophospholipid measurement QTL GWAS1223386 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480357 | 114480358 | Human |
| 597110941 | GWAS1207015_H | self reported educational attainment QTL GWAS1207015 (human) | | 1e-11 | self reported educational attainment | | 4 | 122105714 | 122105715 | Human |
| 597110940 | GWAS1207014_H | self reported educational attainment QTL GWAS1207014 (human) | | 9e-12 | self reported educational attainment | | 4 | 122042189 | 122042190 | Human |
| 597110939 | GWAS1207013_H | self reported educational attainment QTL GWAS1207013 (human) | | 3e-08 | self reported educational attainment | | 4 | 111402093 | 111402094 | Human |
| 597094553 | GWAS1190627_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1190627 (human) | | 0.000002 | 3-hydroxypropylmercapturic acid measurement | | 4 | 121999890 | 121999891 | Human |
| 597127303 | GWAS1223377_H | glycerophospholipid measurement QTL GWAS1223377 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114535366 | 114535367 | Human |
| 597127302 | GWAS1223376_H | glycerophospholipid measurement QTL GWAS1223376 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114535359 | 114535360 | Human |
| 597127301 | GWAS1223375_H | glycerophospholipid measurement QTL GWAS1223375 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114508383 | 114508384 | Human |
| 597127300 | GWAS1223374_H | glycerophospholipid measurement QTL GWAS1223374 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114480704 | 114480705 | Human |
| 597127299 | GWAS1223373_H | glycerophospholipid measurement QTL GWAS1223373 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114523566 | 114523567 | Human |
| 597127298 | GWAS1223372_H | glycerophospholipid measurement QTL GWAS1223372 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114528134 | 114528135 | Human |
| 597127297 | GWAS1223371_H | glycerophospholipid measurement QTL GWAS1223371 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114516461 | 114516462 | Human |
| 597127296 | GWAS1223370_H | glycerophospholipid measurement QTL GWAS1223370 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114533303 | 114533304 | Human |
| 597127311 | GWAS1223385_H | glycerophospholipid measurement QTL GWAS1223385 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114511670 | 114511671 | Human |
| 597127310 | GWAS1223384_H | glycerophospholipid measurement QTL GWAS1223384 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114519788 | 114519789 | Human |
| 597127309 | GWAS1223383_H | glycerophospholipid measurement QTL GWAS1223383 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114532438 | 114532439 | Human |
| 406981464 | GWAS630440_H | postcentral gyrus volume measurement QTL GWAS630440 (human) | | 0.000003 | postcentral gyrus volume measurement | | 4 | 114960671 | 114960672 | Human |
| 597127308 | GWAS1223382_H | glycerophospholipid measurement QTL GWAS1223382 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114522914 | 114522915 | Human |
| 597127307 | GWAS1223381_H | glycerophospholipid measurement QTL GWAS1223381 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114506467 | 114506468 | Human |
| 597127306 | GWAS1223380_H | glycerophospholipid measurement QTL GWAS1223380 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114569441 | 114569442 | Human |
| 597127305 | GWAS1223379_H | glycerophospholipid measurement QTL GWAS1223379 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114487736 | 114487737 | Human |
| 597127304 | GWAS1223378_H | glycerophospholipid measurement QTL GWAS1223378 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114530264 | 114530265 | Human |
| 407128933 | GWAS777909_H | color vision disorder QTL GWAS777909 (human) | | 0.0000004 | color vision disorder | | 4 | 123509639 | 123509640 | Human |
| 596979891 | GWAS1099410_H | body height QTL GWAS1099410 (human) | | 2e-16 | body height | | 4 | 108560745 | 108560746 | Human |
| 617134062 | GWAS2151561_H | level of odontogenic ameloblast-associated protein in blood QTL GWAS2151561 (human) | | 3e-15 | level of odontogenic ameloblast-associated protein in blood | | 4 | 111864198 | 111864199 | Human |
| 407358304 | GWAS1007280_H | sugar consumption measurement QTL GWAS1007280 (human) | | 0.000004 | sugar consumption measurement | | 4 | 130735539 | 130735540 | Human |
| 407014250 | GWAS663226_H | mean corpuscular volume QTL GWAS663226 (human) | | 2e-58 | mean corpuscular volume | | 4 | 121875762 | 121875763 | Human |
| 407014251 | GWAS663227_H | mean corpuscular volume QTL GWAS663227 (human) | | 8e-25 | mean corpuscular volume | | 4 | 128177881 | 128177882 | Human |
| 407030632 | GWAS679608_H | Ischemic stroke, cardiac embolism QTL GWAS679608 (human) | | 3e-32 | Ischemic stroke, cardiac embolism | | 4 | 110789013 | 110789014 | Human |
| 616970218 | GWAS1987717_H | lung carcinoma QTL GWAS1987717 (human) | | 0.000002 | lung integrity trait (VT:0010906) | | 4 | 110592565 | 110592566 | Human |
| 628504134 | GWAS2412363_H | systolic blood pressure QTL GWAS2412363 (human) | | 1e-24 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110461529 | 110461530 | Human |
| 598143127 | GWAS1829855_H | bone tissue density QTL GWAS1829855 (human) | | 5e-133 | bone tissue density | | 4 | 120625611 | 120625612 | Human |
| 628504132 | GWAS2412361_H | systolic blood pressure QTL GWAS2412361 (human) | | 6e-17 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110319122 | 110319123 | Human |
| 628504133 | GWAS2412362_H | systolic blood pressure QTL GWAS2412362 (human) | | 3e-24 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110416708 | 110416709 | Human |
| 407178102 | GWAS827078_H | multiple sclerosis QTL GWAS827078 (human) | | 0.0000002 | multiple sclerosis | | 4 | 112153589 | 112153590 | Human |
| 597389486 | GWAS1485560_H | susceptibility to rubella infection measurement QTL GWAS1485560 (human) | | 0.000009 | susceptibility to rubella infection measurement | | 4 | 127589123 | 127589124 | Human |
| 597487839 | GWAS1583913_H | glomerular filtration rate QTL GWAS1583913 (human) | | 1e-13 | glomerular filtration rate | | 4 | 127272519 | 127272520 | Human |
| 628487729 | GWAS2395958_H | erythrocyte volume QTL GWAS2395958 (human) | | 7e-10 | erythrocyte volume | | 4 | 109977659 | 109977660 | Human |
| 407030534 | GWAS679510_H | electrocardiography QTL GWAS679510 (human) | | 2e-12 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 407030535 | GWAS679511_H | electrocardiography QTL GWAS679511 (human) | | 7e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 407030532 | GWAS679508_H | electrocardiography QTL GWAS679508 (human) | | 2e-18 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 597487834 | GWAS1583908_H | glomerular filtration rate QTL GWAS1583908 (human) | | 5e-13 | glomerular filtration rate | | 4 | 128601363 | 128601364 | Human |
| 407030533 | GWAS679509_H | electrocardiography QTL GWAS679509 (human) | | 8e-21 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 407030536 | GWAS679512_H | electrocardiography QTL GWAS679512 (human) | | 1e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 597602515 | GWAS1659375_H | cardiovascular disease QTL GWAS1659375 (human) | | 3e-12 | cardiovascular disease | | 4 | 110787848 | 110787849 | Human |
| 597078233 | GWAS1174307_H | nicotine withdrawal symptom count QTL GWAS1174307 (human) | | 0.000003 | nicotine withdrawal symptom count | | 4 | 107843866 | 107843867 | Human |
| 597258441 | GWAS1354515_H | atrial fibrillation QTL GWAS1354515 (human) | | 1e-09 | atrial fibrillation | | 4 | 110743002 | 110743003 | Human |
| 597094592 | GWAS1190666_H | schizophrenia QTL GWAS1190666 (human) | | 0.000008 | schizophrenia | | 4 | 117723665 | 117723666 | Human |
| 597111028 | GWAS1207102_H | mathematical ability QTL GWAS1207102 (human) | | 2e-09 | mathematical ability | | 4 | 115132583 | 115132584 | Human |
| 628487697 | GWAS2395926_H | atrial fibrillation QTL GWAS2395926 (human) | | 2e-340 | atrial fibrillation | | 4 | 110737238 | 110737239 | Human |
| 597520635 | GWAS1616709_H | interleukin 10 measurement QTL GWAS1616709 (human) | | 2e-08 | interleukin 10 measurement | | 4 | 106774728 | 106774729 | Human |
| 597176564 | GWAS1272638_H | response to sertraline, psychotic symptom measurement, response to olanzapine QTL GWAS1272638 (human) | | 0.000005 | response to sertraline, psychotic symptom measurement, response to olanzapine | | 4 | 119052935 | 119052936 | Human |
| 628749844 | GWAS2658073_H | coronary artery disease QTL GWAS2658073 (human) | | 4e-08 | coronary artery integrity trait (VT:0010746) | | 4 | 110757945 | 110757946 | Human |
| 628815383 | GWAS2723612_H | eosinophil count QTL GWAS2723612 (human) | | 4e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122408207 | 122408208 | Human |
| 628717079 | GWAS2625308_H | vaginal microbiome measurement QTL GWAS2625308 (human) | | 0.000005 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 597029115 | GWAS1125189_H | BMI-adjusted waist-hip ratio QTL GWAS1125189 (human) | | 6e-13 | BMI-adjusted waist-hip ratio | | 4 | 124261535 | 124261536 | Human |
| 407112500 | GWAS761476_H | waist-hip ratio QTL GWAS761476 (human) | | 2e-09 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 119185193 | 119185194 | Human |
| 628995596 | GWAS2903825_H | seborrheic keratosis QTL GWAS2903825 (human) | | 2e-16 | seborrheic keratosis | | 4 | 124698876 | 124698877 | Human |
| 597258475 | GWAS1354549_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1354549 (human) | | 1e-08 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | | 4 | 109717668 | 109717669 | Human |
| 407112502 | GWAS761478_H | waist-hip ratio QTL GWAS761478 (human) | | 4e-17 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 122836593 | 122836594 | Human |
| 628635149 | GWAS2543378_H | gut microbiome measurement, number of siblings QTL GWAS2543378 (human) | | 8e-10 | gut microbiome measurement, number of siblings | | 4 | 128749842 | 128749843 | Human |
| 616495048 | GWAS1891631_H | serum alanine aminotransferase amount QTL GWAS1891631 (human) | | 0.000004 | serum alanine aminotransferase amount | | 4 | 115087321 | 115087322 | Human |
| 597979347 | GWAS1698646_H | obsolete_fibroblast growth factor basic measurement QTL GWAS1698646 (human) | | 0.000002 | obsolete_fibroblast growth factor basic measurement | | 4 | 107833368 | 107833369 | Human |
| 597471467 | GWAS1567541_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1567541 (human) | | 3e-11 | schizophrenia, intelligence, self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 628553228 | GWAS2461457_H | cortical thickness QTL GWAS2461457 (human) | | 6e-09 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120730658 | 120730659 | Human |
| 628798976 | GWAS2707205_H | gluteofemoral adipose tissue measurement QTL GWAS2707205 (human) | | 3e-08 | femoral fat pad morphology trait (VT:0015001) | | 4 | 122891032 | 122891033 | Human |
| 597995743 | GWAS1715042_H | life span trait QTL GWAS1715042 (human) | | 0.000009 | life span trait | | 4 | 124576758 | 124576759 | Human |
| 628635142 | GWAS2543371_H | gut microbiome measurement, breastfeeding duration QTL GWAS2543371 (human) | | 0.0000008 | lactation duration (VT:1000653) | | 4 | 110717326 | 110717327 | Human |
| 407178042 | GWAS827018_H | response to radiation, Abnormality of the urinary system QTL GWAS827018 (human) | | 0.0000003 | response to radiation, Abnormality of the urinary system | | 4 | 122999342 | 122999343 | Human |
| 628913919 | GWAS2822148_H | testosterone measurement QTL GWAS2822148 (human) | | 5e-15 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
| 598011938 | GWAS1731237_H | FABP1/FABP2 protein level ratio in blood QTL GWAS1731237 (human) | | 1e-289 | FABP1/FABP2 protein level ratio in blood | | 4 | 119309995 | 119309996 | Human |
| 598110255 | GWAS1819138_H | astrocytoma QTL GWAS1819138 (human) | | 0.000008 | astrocytoma | | 4 | 125560531 | 125560532 | Human |
| 597159961 | GWAS1256035_H | amino acid measurement QTL GWAS1256035 (human) | | 0.000009 | amino acid measurement | | 4 | 118154781 | 118154782 | Human |
| 407210965 | GWAS859941_H | lipid measurement QTL GWAS859941 (human) | | 0.000006 | lipid measurement | | 4 | 122960709 | 122960710 | Human |
| 628963054 | GWAS2871283_H | hematocrit QTL GWAS2871283 (human) | | 1e-21 | erythrocyte morphology trait (VT:0002447) | hematocrit (CMO:0000037) | 4 | 114598670 | 114598671 | Human |
| 407210966 | GWAS859942_H | lipid measurement QTL GWAS859942 (human) | | 0.000002 | lipid measurement | | 4 | 123250547 | 123250548 | Human |
| 596979713 | GWAS1099232_H | body height QTL GWAS1099232 (human) | | 8e-10 | body height | | 4 | 108355674 | 108355675 | Human |
| 406916053 | GWAS565029_H | type 1 diabetes mellitus QTL GWAS565029 (human) | | 0.000002 | type 1 diabetes mellitus | | 4 | 122277280 | 122277281 | Human |
| 407243731 | GWAS892707_H | susceptibility to rubella infection measurement QTL GWAS892707 (human) | | 0.000009 | susceptibility to rubella infection measurement | | 4 | 127589123 | 127589124 | Human |
| 597045248 | GWAS1141322_H | Abnormality of refraction QTL GWAS1141322 (human) | | 5e-18 | Abnormality of refraction | | 4 | 119980371 | 119980372 | Human |
| 597618695 | GWAS1675555_H | cardiac arrhythmia QTL GWAS1675555 (human) | | 4e-14 | cardiac arrhythmia | | 4 | 110784139 | 110784140 | Human |
| 597192762 | GWAS1288836_H | cortical thickness QTL GWAS1288836 (human) | | 2e-08 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120722084 | 120722085 | Human |
| 596979767 | GWAS1099286_H | Red cell distribution width QTL GWAS1099286 (human) | | 3e-09 | Red cell distribution width | | 4 | 122438414 | 122438415 | Human |
| 628963033 | GWAS2871262_H | fatty acid amount QTL GWAS2871262 (human) | | 4e-11 | fatty acid amount | | 4 | 109345757 | 109345758 | Human |
| 628963035 | GWAS2871264_H | fatty acid amount QTL GWAS2871264 (human) | | 2e-08 | fatty acid amount | | 4 | 110191021 | 110191022 | Human |
| 407178211 | GWAS827187_H | cortical thickness QTL GWAS827187 (human) | | 1e-11 | cortical thickness | | 4 | 123258359 | 123258360 | Human |
| 628963034 | GWAS2871263_H | fatty acid amount QTL GWAS2871263 (human) | | 3e-14 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 628946646 | GWAS2854875_H | total cholesterol measurement QTL GWAS2854875 (human) | | 6e-10 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 119185611 | 119185612 | Human |
| 598061071 | GWAS1780370_H | obsolete_fibroblast growth factor 2 measurement QTL GWAS1780370 (human) | | 9e-18 | obsolete_fibroblast growth factor 2 measurement | | 4 | 122836593 | 122836594 | Human |
| 597405744 | GWAS1501818_H | body weight QTL GWAS1501818 (human) | | 2e-12 | body weight | | 4 | 129838492 | 129838493 | Human |
| 597028921 | GWAS1124995_H | rheumatoid arthritis QTL GWAS1124995 (human) | | 0.000004 | joint integrity trait (VT:0010548) | | 4 | 122478336 | 122478337 | Human |
| 407227368 | GWAS876344_H | susceptibility to Mycobacterium tuberculosis infection measurement QTL GWAS876344 (human) | | 0.000003 | susceptibility to Mycobacterium tuberculosis infection measurement | | 4 | 120002322 | 120002323 | Human |
| 596979768 | GWAS1099287_H | Red cell distribution width QTL GWAS1099287 (human) | | 7e-19 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 616544014 | GWAS1940597_H | level of hydroxyacyl-coenzyme A dehydrogenase, mitochondrial in blood serum QTL GWAS1940597 (human) | | 5e-18 | level of hydroxyacyl-coenzyme A dehydrogenase, mitochondrial in blood serum | | 4 | 107991560 | 107991561 | Human |
| 616970103 | GWAS1987602_H | platelet count QTL GWAS1987602 (human) | | 2e-25 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119337052 | 119337053 | Human |
| 617002869 | GWAS2020368_H | Ischemic stroke QTL GWAS2020368 (human) | | 0.000002 | Ischemic stroke | | 4 | 110308365 | 110308366 | Human |
| 597405743 | GWAS1501817_H | body weight QTL GWAS1501817 (human) | | 1e-11 | body weight | | 4 | 121792708 | 121792709 | Human |
| 407276529 | GWAS925505_H | serum alanine aminotransferase measurement QTL GWAS925505 (human) | | 0.000004 | serum alanine aminotransferase measurement | | 4 | 115087321 | 115087322 | Human |
| 597504037 | GWAS1600111_H | response to cranial radiation therapy, short-term memory QTL GWAS1600111 (human) | | 0.0000007 | response to cranial radiation therapy, short-term memory | | 4 | 120035508 | 120035509 | Human |
| 597110829 | GWAS1206903_H | protein measurement QTL GWAS1206903 (human) | | 8e-09 | protein amount (VT:0010120) | | 4 | 112234608 | 112234609 | Human |
| 597504038 | GWAS1600112_H | intelligence, response to cranial radiation therapy QTL GWAS1600112 (human) | | 0.000001 | intelligence, response to cranial radiation therapy | | 4 | 120035508 | 120035509 | Human |
| 616380161 | GWAS1860403_H | obsolete_blood protein measurement QTL GWAS1860403 (human) | | 5e-08 | obsolete_blood protein measurement | | 4 | 110079447 | 110079448 | Human |
| 407014398 | GWAS663374_H | mean platelet volume QTL GWAS663374 (human) | | 2e-10 | mean platelet volume | | 4 | 121336787 | 121336788 | Human |
| 597520419 | GWAS1616493_H | appendectomy QTL GWAS1616493 (human) | | 4e-12 | appendectomy | | 4 | 111904289 | 111904290 | Human |
| 616970104 | GWAS1987603_H | platelet count QTL GWAS1987603 (human) | | 7e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
| 628864708 | GWAS2772937_H | body mass index, vital capacity QTL GWAS2772937 (human) | | 5e-08 | lung capacity (VT:0001942) | body mass index (BMI) (CMO:0000105) | 4 | 107934672 | 107934673 | Human |
| 617002758 | GWAS2020257_H | mathematical ability QTL GWAS2020257 (human) | | 1e-08 | mathematical ability | | 4 | 132101754 | 132101755 | Human |
| 406899586 | GWAS548562_H | atrial fibrillation QTL GWAS548562 (human) | | 2e-210 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 617002757 | GWAS2020256_H | mathematical ability QTL GWAS2020256 (human) | | 1e-08 | mathematical ability | | 4 | 111859867 | 111859868 | Human |
| 598143074 | GWAS1829802_H | bone tissue density QTL GWAS1829802 (human) | | 9e-74 | bone tissue density | | 4 | 116630743 | 116630744 | Human |
| 407243649 | GWAS892625_H | carotid artery intima media thickness QTL GWAS892625 (human) | | 0.000006 | carotid artery intima media thickness | | 4 | 118504756 | 118504757 | Human |
| 406981514 | GWAS630490_H | posterior cingulate cortex volume measurement QTL GWAS630490 (human) | | 0.000008 | posterior cingulate cortex volume measurement | | 4 | 115129051 | 115129052 | Human |
| 598061167 | GWAS1780466_H | body height QTL GWAS1780466 (human) | | 2e-24 | body height | | 4 | 128708095 | 128708096 | Human |
| 407030671 | GWAS679647_H | facial hair thickness measurement QTL GWAS679647 (human) | | 0.000004 | facial hair thickness measurement | | 4 | 120705958 | 120705959 | Human |
| 406932370 | GWAS581346_H | apolipoprotein B measurement QTL GWAS581346 (human) | | 1e-10 | apolipoprotein B measurement | | 4 | 123837618 | 123837619 | Human |
| 598061169 | GWAS1780468_H | body height QTL GWAS1780468 (human) | | 2e-20 | body height | | 4 | 131543872 | 131543873 | Human |
| 598061168 | GWAS1780467_H | body height QTL GWAS1780467 (human) | | 7e-11 | body height | | 4 | 129860515 | 129860516 | Human |
| 598061171 | GWAS1780470_H | body height QTL GWAS1780470 (human) | | 1e-18 | body height | | 4 | 128691709 | 128691710 | Human |
| 597389379 | GWAS1485453_H | monokine induced by gamma interferon measurement QTL GWAS1485453 (human) | | 0.000004 | monokine induced by gamma interferon measurement | | 4 | 122707083 | 122707084 | Human |
| 597471296 | GWAS1567370_H | chronotype measurement QTL GWAS1567370 (human) | | 1e-08 | chronotype measurement | | 4 | 131590963 | 131590964 | Human |
| 616953624 | GWAS1971123_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS1971123 (human) | | 5e-08 | intestine integrity trait (VT:0010554) | | 4 | 122629959 | 122629960 | Human |
| 628946594 | GWAS2854823_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2854823 (human) | | 3e-09 | fatty acid amount (VT:0010046) | | 4 | 109603883 | 109603884 | Human |
| 406997923 | GWAS646899_H | wellbeing measurement QTL GWAS646899 (human) | | 0.000005 | wellbeing measurement | | 4 | 125346188 | 125346189 | Human |
| 628700826 | GWAS2609055_H | vaginal microbiome measurement QTL GWAS2609055 (human) | | 5e-09 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 628455057 | GWAS2363286_H | protein measurement QTL GWAS2363286 (human) | | 1e-08 | protein amount (VT:0010120) | | 4 | 107913373 | 107913374 | Human |
| 596979825 | GWAS1099344_H | small vessel stroke QTL GWAS1099344 (human) | | 0.0000007 | small vessel stroke | | 4 | 113472094 | 113472095 | Human |
| 628405904 | GWAS2314133_H | reticulocyte amount QTL GWAS2314133 (human) | | 1e-09 | reticulocyte amount | | 4 | 127789418 | 127789419 | Human |
| 597291135 | GWAS1387209_H | size QTL GWAS1387209 (human) | | 1e-09 | size | | 4 | 119820087 | 119820088 | Human |
| 597225584 | GWAS1321658_H | smoking initiation QTL GWAS1321658 (human) | | 3e-09 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
| 597127295 | GWAS1223369_H | glycerophospholipid measurement QTL GWAS1223369 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114596387 | 114596388 | Human |
| 597340275 | GWAS1436349_H | heart failure QTL GWAS1436349 (human) | | 2e-24 | heart failure | | 4 | 110780277 | 110780278 | Human |
| 616953647 | GWAS1971146_H | ulcerative colitis QTL GWAS1971146 (human) | | 0.0000008 | intestine integrity trait (VT:0010554) | | 4 | 116929300 | 116929301 | Human |
| 628749972 | GWAS2658201_H | Crohn's disease QTL GWAS2658201 (human) | | 6e-09 | intestine integrity trait (VT:0010554) | | 4 | 122420959 | 122420960 | Human |
| 598061141 | GWAS1780440_H | body height QTL GWAS1780440 (human) | | 3e-29 | body height | | 4 | 126054046 | 126054047 | Human |
| 406916016 | GWAS564992_H | celiac disease QTL GWAS564992 (human) | | 1e-14 | celiac disease | | 4 | 122588266 | 122588267 | Human |
| 598061143 | GWAS1780442_H | body height QTL GWAS1780442 (human) | | 0.0000004 | body height | | 4 | 128239161 | 128239162 | Human |
| 598061142 | GWAS1780441_H | body height QTL GWAS1780441 (human) | | 9e-20 | body height | | 4 | 127073768 | 127073769 | Human |
| 598143058 | GWAS1829786_H | bone tissue density QTL GWAS1829786 (human) | | 5e-16 | bone tissue density | | 4 | 131691474 | 131691475 | Human |
| 597274732 | GWAS1370806_H | fibroblast growth factor 2 measurement QTL GWAS1370806 (human) | | 6e-36 | fibroblast growth factor 2 measurement | | 4 | 122827461 | 122827462 | Human |
| 407374783 | GWAS1023759_H | protein measurement QTL GWAS1023759 (human) | | 2e-08 | protein measurement | | 4 | 130879344 | 130879345 | Human |
| 617051967 | GWAS2069466_H | vaginal microbiome measurement QTL GWAS2069466 (human) | | 3e-10 | vaginal microbiome measurement | | 4 | 107261570 | 107261571 | Human |
| 617035582 | GWAS2053081_H | trait in response to warfarin QTL GWAS2053081 (human) | | 0.000007 | trait in response to warfarin | | 4 | 112988363 | 112988364 | Human |
| 406899642 | GWAS548618_H | atrial fibrillation QTL GWAS548618 (human) | | 6e-47 | atrial fibrillation | | 4 | 110776497 | 110776498 | Human |
| 597323873 | GWAS1419947_H | complement factor I measurement QTL GWAS1419947 (human) | | 7e-21 | complement factor I measurement | | 4 | 109737700 | 109737701 | Human |
| 628405903 | GWAS2314132_H | reticulocyte amount QTL GWAS2314132 (human) | | 2e-12 | reticulocyte amount | | 4 | 109944309 | 109944310 | Human |
| 628864647 | GWAS2772876_H | facial morphology trait QTL GWAS2772876 (human) | | 5e-08 | facial morphology trait | | 4 | 125202598 | 125202599 | Human |
| 628864646 | GWAS2772875_H | facial morphology trait QTL GWAS2772875 (human) | | 4e-08 | facial morphology trait | | 4 | 125199979 | 125199980 | Human |
| 628799111 | GWAS2707340_H | COVID-19, mortality QTL GWAS2707340 (human) | | 0.000005 | life span trait (VT:0005372) | ratio of deaths to total study population during a period of time (CMO:0001023) | 4 | 127021337 | 127021338 | Human |
| 628864645 | GWAS2772874_H | facial morphology trait QTL GWAS2772874 (human) | | 3e-08 | facial morphology trait | | 4 | 125220568 | 125220569 | Human |
| 617051960 | GWAS2069459_H | age at onset, major depressive disorder QTL GWAS2069459 (human) | | 0.000007 | age at onset, major depressive disorder | | 4 | 127602809 | 127602810 | Human |
| 628928892 | GWAS2837121_H | body height QTL GWAS2837121 (human) | | 8e-23 | body height | | 4 | 108536277 | 108536278 | Human |
| 597981092 | GWAS1700391_H | obsolete_fasting blood glucose measurement QTL GWAS1700391 (human) | | 0.000005 | obsolete_fasting blood glucose measurement | | 4 | 120880635 | 120880636 | Human |
| 628617589 | GWAS2525818_H | systolic blood pressure QTL GWAS2525818 (human) | | 2e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110439533 | 110439534 | Human |
| 407391306 | GWAS1040282_H | educational attainment QTL GWAS1040282 (human) | | 2e-09 | educational attainment | | 4 | 121769129 | 121769130 | Human |
| 628781433 | GWAS2689662_H | type 1 diabetes mellitus QTL GWAS2689662 (human) | | 1e-08 | type 1 diabetes mellitus | | 4 | 124578751 | 124578752 | Human |
| 628781438 | GWAS2689667_H | alkaline phosphatase measurement QTL GWAS2689667 (human) | | 8e-17 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110191454 | 110191455 | Human |
| 628961659 | GWAS2869888_H | response to stimulus QTL GWAS2869888 (human) | | 4e-11 | response to stimulus | | 4 | 106731302 | 106731303 | Human |
| 597194654 | GWAS1290728_H | free androgen index QTL GWAS1290728 (human) | | 4e-09 | free androgen index | | 4 | 109174464 | 109174465 | Human |
| 616362170 | GWAS1846885_H | osteoarthritis QTL GWAS1846885 (human) | | 1e-08 | osteoarthritis | | 4 | 129335647 | 129335648 | Human |
| 617066688 | GWAS2084187_H | colorectal cancer QTL GWAS2084187 (human) | | 0.000003 | colorectal cancer | | 4 | 123587620 | 123587621 | Human |
| 597211039 | GWAS1307113_H | pelvic organ prolapse QTL GWAS1307113 (human) | | 1e-10 | pelvic organ prolapse | | 4 | 126155033 | 126155034 | Human |
| 407293006 | GWAS941982_H | phosphatidylcholine measurement QTL GWAS941982 (human) | | 4e-08 | phosphatidylcholine measurement | | 4 | 112567861 | 112567862 | Human |
| 628846967 | GWAS2755196_H | 2-linoleoyl-GPC (18:2) measurement QTL GWAS2755196 (human) | | 1e-08 | glycerophosphocholine amount (VT:0011004) | | 4 | 107543736 | 107543737 | Human |
| 628978035 | GWAS2886264_H | body mass index QTL GWAS2886264 (human) | | 2e-28 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129818987 | 129818988 | Human |
| 628535654 | GWAS2443883_H | hematocrit QTL GWAS2443883 (human) | | 6e-12 | erythrocyte morphology trait (VT:0002447) | hematocrit (CMO:0000037) | 4 | 114598669 | 114598670 | Human |
| 598095794 | GWAS1813187_H | facial morphology trait QTL GWAS1813187 (human) | | 2e-09 | facial morphology trait | | 4 | 110922515 | 110922516 | Human |
| 597211021 | GWAS1307095_H | protein measurement QTL GWAS1307095 (human) | | 9e-14 | protein amount (VT:0010120) | | 4 | 120729320 | 120729321 | Human |
| 407096411 | GWAS745387_H | educational attainment QTL GWAS745387 (human) | | 5e-11 | educational attainment | | 4 | 122259374 | 122259375 | Human |
| 407096410 | GWAS745386_H | educational attainment QTL GWAS745386 (human) | | 4e-20 | educational attainment | | 4 | 122105714 | 122105715 | Human |
| 407096409 | GWAS745385_H | educational attainment QTL GWAS745385 (human) | | 5e-10 | educational attainment | | 4 | 121851158 | 121851159 | Human |
| 617033948 | GWAS2051447_H | alcohol use disorder measurement QTL GWAS2051447 (human) | | 3e-12 | alcohol use disorder measurement | | 4 | 111546456 | 111546457 | Human |
| 628797787 | GWAS2706016_H | R-warfarin measurement QTL GWAS2706016 (human) | | 0.000005 | R-warfarin measurement | | 4 | 129054159 | 129054160 | Human |
| 616476826 | GWAS1873409_H | thyroxine amount QTL GWAS1873409 (human) | | 0.000005 | thyroxine amount | | 4 | 112622996 | 112622997 | Human |
| 628863326 | GWAS2771555_H | QT interval QTL GWAS2771555 (human) | | 2e-09 | heart electrical impulse conduction trait (VT:2000017) | QT interval (CMO:0000235) | 4 | 113464520 | 113464521 | Human |
| 597276597 | GWAS1372671_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1372671 (human) | | 8e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 108140462 | 108140463 | Human |
| 407374949 | GWAS1023925_H | schizophrenia QTL GWAS1023925 (human) | | 4e-08 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
| 407080046 | GWAS729022_H | longevity QTL GWAS729022 (human) | | 0.000009 | longevity | | 4 | 124576758 | 124576759 | Human |
| 597981076 | GWAS1700375_H | obsolete_fasting blood glucose measurement QTL GWAS1700375 (human) | | 0.000006 | obsolete_fasting blood glucose measurement | | 4 | 120880635 | 120880636 | Human |
| 616984818 | GWAS2002317_H | appendicular lean mass QTL GWAS2002317 (human) | | 2e-12 | appendicular lean mass | | 4 | 119325534 | 119325535 | Human |
| 628633935 | GWAS2542164_H | Alzheimer disease, family history of Alzheimer’s disease QTL GWAS2542164 (human) | | 5e-10 | Alzheimer disease, family history of Alzheimer’s disease | | 4 | 114959008 | 114959009 | Human |
| 597424034 | GWAS1520108_H | cortical surface area measurement QTL GWAS1520108 (human) | | 1e-10 | cortical surface area measurement | | 4 | 126658527 | 126658528 | Human |
| 597424033 | GWAS1520107_H | cortical surface area measurement QTL GWAS1520107 (human) | | 2e-13 | cortical surface area measurement | | 4 | 112509596 | 112509597 | Human |
| 597424032 | GWAS1520106_H | cortical surface area measurement QTL GWAS1520106 (human) | | 2e-08 | cortical surface area measurement | | 4 | 107131838 | 107131839 | Human |
| 597145515 | GWAS1241589_H | high density lipoprotein cholesterol measurement QTL GWAS1241589 (human) | | 4e-08 | high density lipoprotein cholesterol measurement | | 4 | 109648464 | 109648465 | Human |
| 596965289 | GWAS1084808_H | total cholesterol measurement, diet measurement QTL GWAS1084808 (human) | | 0.000003 | total cholesterol measurement, diet measurement | | 4 | 118490708 | 118490709 | Human |
| 616984825 | GWAS2002324_H | appendicular lean mass QTL GWAS2002324 (human) | | 9e-13 | appendicular lean mass | | 4 | 119206606 | 119206607 | Human |
| 407374861 | GWAS1023837_H | Myopia QTL GWAS1023837 (human) | | 0.000005 | Myopia | | 4 | 125625005 | 125625006 | Human |
| 407292940 | GWAS941916_H | healthspan QTL GWAS941916 (human) | | 0.000003 | healthspan | | 4 | 110234426 | 110234427 | Human |
| 597325776 | GWAS1421850_H | color vision disorder QTL GWAS1421850 (human) | | 0.0000009 | color vision disorder | | 4 | 131063773 | 131063774 | Human |
| 597227476 | GWAS1323550_H | atrial fibrillation QTL GWAS1323550 (human) | | 7e-443 | atrial fibrillation | | 4 | 110778529 | 110778530 | Human |
| 628420921 | GWAS2329150_H | smoking status measurement QTL GWAS2329150 (human) | | 5e-08 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
| 597227477 | GWAS1323551_H | atrial fibrillation QTL GWAS1323551 (human) | | 2e-13 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 617017483 | GWAS2034982_H | Alzheimer disease, educational attainment QTL GWAS2034982 (human) | | 0.0000004 | Alzheimer disease, educational attainment | | 4 | 129748953 | 129748954 | Human |
| 406932496 | GWAS581472_H | high density lipoprotein cholesterol measurement QTL GWAS581472 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | | 4 | 119112961 | 119112962 | Human |
| 628863272 | GWAS2771501_H | asthma QTL GWAS2771501 (human) | | 4e-09 | asthma | | 4 | 122451978 | 122451979 | Human |
| 628535584 | GWAS2443813_H | IGF-1 measurement QTL GWAS2443813 (human) | | 3e-13 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 4 | 120801880 | 120801886 | Human |
| 628830508 | GWAS2738737_H | erythrocyte count QTL GWAS2738737 (human) | | 5e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598115 | 114598116 | Human |
| 597620678 | GWAS1677538_H | keratoconus QTL GWAS1677538 (human) | | 2e-12 | keratoconus | | 4 | 117877256 | 117877257 | Human |
| 597587910 | GWAS1644770_H | eosinophil count QTL GWAS1644770 (human) | | 7e-21 | eosinophil count | | 4 | 122680542 | 122680543 | Human |
| 617197712 | GWAS2178152_H | level of hypoxia up-regulated protein 1 in blood QTL GWAS2178152 (human) | | 1e-11 | level of hypoxia up-regulated protein 1 in blood | | 4 | 110420710 | 110420711 | Human |
| 406916120 | GWAS565096_H | asthma QTL GWAS565096 (human) | | 4e-09 | asthma | | 4 | 122451978 | 122451979 | Human |
| 628797732 | GWAS2705961_H | episodic memory QTL GWAS2705961 (human) | | 0.000002 | learning/memory/conditioning trait (VT:0002063) | | 4 | 114002480 | 114002481 | Human |
| 597194694 | GWAS1290768_H | cortical thickness QTL GWAS1290768 (human) | | 2e-11 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120704578 | 120704579 | Human |
| 628420886 | GWAS2329115_H | lifestyle measurement QTL GWAS2329115 (human) | | 3e-09 | lifestyle measurement | | 4 | 117436249 | 117436250 | Human |
| 628420887 | GWAS2329116_H | lifestyle measurement QTL GWAS2329116 (human) | | 8e-09 | lifestyle measurement | | 4 | 129365346 | 129365348 | Human |
| 628617490 | GWAS2525719_H | hypertension QTL GWAS2525719 (human) | | 3e-08 | blood pressure trait (VT:0000183) | | 4 | 110409934 | 110409935 | Human |
| 407096360 | GWAS745336_H | X-14189--leucylalanine measurement QTL GWAS745336 (human) | | 6e-12 | X-14189--leucylalanine measurement | | 4 | 110510288 | 110510289 | Human |
| 597424119 | GWAS1520193_H | BMI-adjusted waist circumference QTL GWAS1520193 (human) | | 8e-09 | BMI-adjusted waist circumference | | 4 | 123359695 | 123359696 | Human |
| 407030831 | GWAS679807_H | electrocardiography QTL GWAS679807 (human) | | 2e-09 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 617033897 | GWAS2051396_H | bone tissue density QTL GWAS2051396 (human) | | 2e-44 | bone tissue density | | 4 | 111086102 | 111086103 | Human |
| 597096441 | GWAS1192515_H | sex hormone-binding globulin measurement QTL GWAS1192515 (human) | | 0.000002 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
| 407030832 | GWAS679808_H | electrocardiography QTL GWAS679808 (human) | | 1e-24 | electrocardiography | | 4 | 113523605 | 113523606 | Human |
| 598030288 | GWAS1749587_H | brain attribute QTL GWAS1749587 (human) | | 2e-09 | brain attribute | | 4 | 123226927 | 123226928 | Human |
| 407342142 | GWAS991118_H | renal carcinoma QTL GWAS991118 (human) | | 9e-10 | renal carcinoma | | 4 | 108791438 | 108791439 | Human |
| 407292984 | GWAS941960_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS941960 (human) | | 4e-10 | triglyceride measurement, phospholipid measurement | | 4 | 109657070 | 109657071 | Human |
| 628764932 | GWAS2673161_H | serum gamma-glutamyl transferase measurement QTL GWAS2673161 (human) | | 7e-13 | blood gamma-glutamyltransferase amount (VT:0010607) | serum gamma-glutamyltransferase activity level (CMO:0002241) | 4 | 111793842 | 111793843 | Human |
| 597423903 | GWAS1519977_H | cleft lip QTL GWAS1519977 (human) | | 0.000001 | cleft lip | | 4 | 125904223 | 125904224 | Human |
| 597210909 | GWAS1306983_H | birth weight, parental genotype effect measurement QTL GWAS1306983 (human) | | 9e-09 | body mass (VT:0001259) | neonatal body weight (CMO:0002079) | 4 | 119695650 | 119695651 | Human |
| 598112033 | GWAS1820916_H | periodontal disorder QTL GWAS1820916 (human) | | 0.000001 | periodontal disorder | | 4 | 128066678 | 128066679 | Human |
| 616525875 | GWAS1922458_H | lymphocyte count QTL GWAS1922458 (human) | | 2e-13 | lymphocyte count | | 4 | 122579931 | 122579932 | Human |
| 616951882 | GWAS1969381_H | level of serum globulin type protein QTL GWAS1969381 (human) | | 8e-11 | level of serum globulin type protein | | 4 | 119210489 | 119210490 | Human |
| 628568551 | GWAS2476780_H | glycerophospholipid measurement QTL GWAS2476780 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114535366 | 114535367 | Human |
| 597178120 | GWAS1274194_H | smoking initiation QTL GWAS1274194 (human) | | 2e-16 | smoking initiation | | 4 | 115062097 | 115062098 | Human |
| 407227605 | GWAS876581_H | bronchopulmonary dysplasia QTL GWAS876581 (human) | | 0.000001 | bronchopulmonary dysplasia | | 4 | 116954105 | 116954106 | Human |
| 628568550 | GWAS2476779_H | glycerophospholipid measurement QTL GWAS2476779 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114535359 | 114535360 | Human |
| 597178121 | GWAS1274195_H | smoking initiation QTL GWAS1274195 (human) | | 3e-09 | smoking initiation | | 4 | 117028412 | 117028413 | Human |
| 628568549 | GWAS2476778_H | glycerophospholipid measurement QTL GWAS2476778 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114508383 | 114508384 | Human |
| 597178122 | GWAS1274196_H | smoking initiation QTL GWAS1274196 (human) | | 3e-16 | smoking initiation | | 4 | 120722571 | 120722572 | Human |
| 628568548 | GWAS2476777_H | glycerophospholipid measurement QTL GWAS2476777 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114480704 | 114480705 | Human |
| 597178123 | GWAS1274197_H | smoking initiation QTL GWAS1274197 (human) | | 5e-11 | smoking initiation | | 4 | 122105714 | 122105715 | Human |
| 407178454 | GWAS827430_H | lower face morphology measurement QTL GWAS827430 (human) | | 5e-08 | lower face morphology measurement | | 4 | 123252480 | 123252481 | Human |
| 628568547 | GWAS2476776_H | glycerophospholipid measurement QTL GWAS2476776 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114495706 | 114495707 | Human |
| 597178124 | GWAS1274198_H | smoking initiation QTL GWAS1274198 (human) | | 8e-15 | smoking initiation | | 4 | 129269203 | 129269204 | Human |
| 628568546 | GWAS2476775_H | glycerophospholipid measurement QTL GWAS2476775 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114523566 | 114523567 | Human |
| 597178125 | GWAS1274199_H | smoking initiation QTL GWAS1274199 (human) | | 4e-11 | smoking initiation | | 4 | 129534689 | 129534690 | Human |
| 628568545 | GWAS2476774_H | glycerophospholipid measurement QTL GWAS2476774 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114528134 | 114528135 | Human |
| 598079282 | GWAS1798581_H | cerebral cortex area attribute QTL GWAS1798581 (human) | | 5e-15 | cerebral cortex area attribute | | 4 | 112496345 | 112496346 | Human |
| 628568544 | GWAS2476773_H | glycerophospholipid measurement QTL GWAS2476773 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114501231 | 114501232 | Human |
| 597604102 | GWAS1660962_H | prothrombin time measurement QTL GWAS1660962 (human) | | 2e-20 | prothrombin time measurement | | 4 | 110796911 | 110796912 | Human |
| 628568557 | GWAS2476786_H | glycerophospholipid measurement QTL GWAS2476786 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114532438 | 114532439 | Human |
| 597620485 | GWAS1677345_H | corneal ulcer QTL GWAS1677345 (human) | | 2e-11 | corneal ulcer | | 4 | 112325350 | 112325351 | Human |
| 628568556 | GWAS2476785_H | glycerophospholipid measurement QTL GWAS2476785 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114522914 | 114522915 | Human |
| 407293149 | GWAS942125_H | total cholesterol measurement QTL GWAS942125 (human) | | 9e-10 | total cholesterol measurement | | 4 | 128078464 | 128078465 | Human |
| 597178116 | GWAS1274190_H | smoking initiation QTL GWAS1274190 (human) | | 6e-24 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
| 628568555 | GWAS2476784_H | glycerophospholipid measurement QTL GWAS2476784 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114506467 | 114506468 | Human |
| 597178117 | GWAS1274191_H | smoking initiation QTL GWAS1274191 (human) | | 4e-09 | smoking initiation | | 4 | 114063555 | 114063556 | Human |
| 628568554 | GWAS2476783_H | glycerophospholipid measurement QTL GWAS2476783 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114569441 | 114569442 | Human |
| 407194843 | GWAS843819_H | atrial fibrillation QTL GWAS843819 (human) | | 9e-10 | atrial fibrillation | | 4 | 110491909 | 110491910 | Human |
| 628568553 | GWAS2476782_H | glycerophospholipid measurement QTL GWAS2476782 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114487736 | 114487737 | Human |
| 597178118 | GWAS1274192_H | smoking initiation QTL GWAS1274192 (human) | | 2e-16 | smoking initiation | | 4 | 115058312 | 115058313 | Human |
| 407194842 | GWAS843818_H | atrial fibrillation QTL GWAS843818 (human) | | 2e-09 | atrial fibrillation | | 4 | 110485663 | 110485664 | Human |
| 628568552 | GWAS2476781_H | glycerophospholipid measurement QTL GWAS2476781 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114530264 | 114530265 | Human |
| 597178119 | GWAS1274193_H | smoking initiation QTL GWAS1274193 (human) | | 2e-16 | smoking initiation | | 4 | 115060393 | 115060394 | Human |
| 407325925 | GWAS974901_H | lysophosphatidylcholine 20:2 measurement QTL GWAS974901 (human) | | 2e-08 | lysophosphatidylcholine 20:2 measurement | | 4 | 126651788 | 126651789 | Human |
| 596981553 | GWAS1101072_H | memory performance QTL GWAS1101072 (human) | | 0.000003 | memory performance | | 4 | 113305092 | 113305093 | Human |
| 407211234 | GWAS860210_H | acne QTL GWAS860210 (human) | | 6e-16 | acne | | 4 | 123258364 | 123258365 | Human |
| 628568543 | GWAS2476772_H | glycerophospholipid measurement QTL GWAS2476772 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114516461 | 114516462 | Human |
| 628568542 | GWAS2476771_H | glycerophospholipid measurement QTL GWAS2476771 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114533303 | 114533304 | Human |
| 597309235 | GWAS1405309_H | body mass index QTL GWAS1405309 (human) | | 1e-08 | body mass index | | 4 | 119738082 | 119738083 | Human |
| 628568541 | GWAS2476770_H | glycerophospholipid measurement QTL GWAS2476770 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114595467 | 114595468 | Human |
| 628568540 | GWAS2476769_H | glycerophospholipid measurement QTL GWAS2476769 (human) | | 3e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114596387 | 114596388 | Human |
| 617066602 | GWAS2084101_H | colorectal cancer QTL GWAS2084101 (human) | | 0.0000007 | colorectal cancer | | 4 | 123506329 | 123506330 | Human |
| 597325623 | GWAS1421697_H | color vision disorder QTL GWAS1421697 (human) | | 0.000009 | color vision disorder | | 4 | 129061664 | 129061665 | Human |
| 616476686 | GWAS1873269_H | C-C motif chemokine 7 level QTL GWAS1873269 (human) | | 0.000002 | C-C motif chemokine 7 level | | 4 | 110137551 | 110137552 | Human |
| 407391480 | GWAS1040456_H | cup-to-disc ratio measurement QTL GWAS1040456 (human) | | 7e-09 | cup-to-disc ratio measurement | | 4 | 111478355 | 111478356 | Human |
| 597030694 | GWAS1126768_H | BMI-adjusted waist-hip ratio QTL GWAS1126768 (human) | | 1e-14 | BMI-adjusted waist-hip ratio | | 4 | 121702910 | 121702911 | Human |
| 597112612 | GWAS1208686_H | erythrocyte count QTL GWAS1208686 (human) | | 5e-14 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 121811061 | 121811062 | Human |
| 597112611 | GWAS1208685_H | erythrocyte count QTL GWAS1208685 (human) | | 1e-15 | erythrocyte count | | 4 | 114598669 | 114598670 | Human |
| 616542215 | GWAS1938798_H | tenascin measurement QTL GWAS1938798 (human) | | 9e-13 | tenascin measurement | | 4 | 123739489 | 123739490 | Human |
| 628961732 | GWAS2869961_H | lymphocyte count QTL GWAS2869961 (human) | | 2e-11 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112183886 | 112183887 | Human |
| 407325948 | GWAS974924_H | testosterone measurement QTL GWAS974924 (human) | | 1e-16 | testosterone measurement | | 4 | 124126476 | 124126477 | Human |
| 407096575 | GWAS745551_H | educational attainment QTL GWAS745551 (human) | | 2e-09 | educational attainment | | 4 | 129239551 | 129239552 | Human |
| 597194533 | GWAS1290607_H | cortical surface area measurement QTL GWAS1290607 (human) | | 6e-10 | cortical surface area measurement | | 4 | 112496345 | 112496346 | Human |
| 598095643 | GWAS1813036_H | facial morphology trait QTL GWAS1813036 (human) | | 8e-09 | facial morphology trait | | 4 | 119407511 | 119407512 | Human |
| 407096574 | GWAS745550_H | educational attainment QTL GWAS745550 (human) | | 2e-15 | educational attainment | | 4 | 128836670 | 128836671 | Human |
| 407096573 | GWAS745549_H | educational attainment QTL GWAS745549 (human) | | 2e-08 | educational attainment | | 4 | 126904030 | 126904031 | Human |
| 628765125 | GWAS2673354_H | body mass index QTL GWAS2673354 (human) | | 3e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112335581 | 112335582 | Human |
| 407096572 | GWAS745548_H | educational attainment QTL GWAS745548 (human) | | 2e-10 | educational attainment | | 4 | 122480614 | 122480615 | Human |
| 628617655 | GWAS2525884_H | hypertension QTL GWAS2525884 (human) | | 0.000005 | blood pressure trait (VT:0000183) | | 4 | 110460482 | 110460483 | Human |
| 597276505 | GWAS1372579_H | Alzheimer disease, polygenic risk score QTL GWAS1372579 (human) | | 7e-09 | Alzheimer disease, polygenic risk score | | 4 | 118306104 | 118306105 | Human |
| 407276678 | GWAS925654_H | vaginal microbiome measurement QTL GWAS925654 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 118330002 | 118330003 | Human |
| 617017351 | GWAS2034850_H | diet measurement, bilirubin measurement QTL GWAS2034850 (human) | | 0.000002 | diet measurement, bilirubin measurement | | 4 | 114333088 | 114333089 | Human |
| 407276674 | GWAS925650_H | vaginal microbiome measurement QTL GWAS925650 (human) | | 0.000005 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 616984579 | GWAS2002078_H | gut microbiome measurement QTL GWAS2002078 (human) | | 0.000005 | gut microbiome measurement | | 4 | 127613641 | 127613642 | Human |
| 406981764 | GWAS630740_H | cardiac arrhythmia QTL GWAS630740 (human) | | 1e-187 | cardiac arrhythmia | | 4 | 110795357 | 110795358 | Human |
| 407161987 | GWAS810963_H | endometriosis QTL GWAS810963 (human) | | 0.000004 | endometriosis | | 4 | 119706266 | 119706267 | Human |
| 406965385 | GWAS614361_H | chronic lymphocytic leukemia QTL GWAS614361 (human) | | 4e-10 | leukocyte integrity trait (VT:0010898) | | 4 | 108095668 | 108095669 | Human |
| 406899848 | GWAS548824_H | heart failure QTL GWAS548824 (human) | | 5e-14 | heart failure | | 4 | 110927114 | 110927115 | Human |
| 596965213 | GWAS1084732_H | calcium measurement, diet measurement QTL GWAS1084732 (human) | | 0.000009 | calcium measurement, diet measurement | | 4 | 111131258 | 111131259 | Human |
| 617033739 | GWAS2051238_H | color vision disorder QTL GWAS2051238 (human) | | 0.000003 | color vision disorder | | 4 | 108200574 | 108200575 | Human |
| 628437435 | GWAS2345664_H | Anxiety QTL GWAS2345664 (human) | | 2e-08 | Anxiety | | 4 | 118133633 | 118133634 | Human |
| 598095721 | GWAS1813114_H | facial morphology trait QTL GWAS1813114 (human) | | 3e-29 | facial morphology trait | | 4 | 127007438 | 127007439 | Human |
| 407063698 | GWAS712674_H | protein measurement QTL GWAS712674 (human) | | 1e-09 | protein measurement | | 4 | 120939887 | 120939888 | Human |
| 597178186 | GWAS1274260_H | platelet count QTL GWAS1274260 (human) | | 4e-19 | platelet count | | 4 | 110027510 | 110027511 | Human |
| 596965190 | GWAS1084709_H | diet measurement, bilirubin measurement QTL GWAS1084709 (human) | | 0.000002 | diet measurement, bilirubin measurement | | 4 | 114333088 | 114333089 | Human |
| 628945321 | GWAS2853550_H | body height QTL GWAS2853550 (human) | | 1e-10 | body height | | 4 | 119600883 | 119600884 | Human |
| 628945322 | GWAS2853551_H | body height QTL GWAS2853551 (human) | | 8e-09 | body height | | 4 | 119834940 | 119834941 | Human |
| 407227548 | GWAS876524_H | bone density QTL GWAS876524 (human) | | 9e-11 | bone density | | 4 | 119112788 | 119112789 | Human |
| 598095739 | GWAS1813132_H | facial morphology trait QTL GWAS1813132 (human) | | 2e-09 | facial morphology trait | | 4 | 121076949 | 121076950 | Human |
| 597342021 | GWAS1438095_H | appendectomy QTL GWAS1438095 (human) | | 6e-34 | appendectomy | | 4 | 110799663 | 110799664 | Human |
| 628519318 | GWAS2427547_H | esophageal adenocarcinoma QTL GWAS2427547 (human) | | 1e-08 | esophageal adenocarcinoma | | 4 | 123623035 | 123623036 | Human |
| 628928925 | GWAS2837154_H | autoimmune thrombocytopenic purpura QTL GWAS2837154 (human) | | 0.000004 | autoimmune thrombocytopenic purpura | | 4 | 108354670 | 108354671 | Human |
| 616984615 | GWAS2002114_H | Hallux valgus QTL GWAS2002114 (human) | | 0.000003 | Hallux valgus | | 4 | 126494361 | 126494362 | Human |
| 616984612 | GWAS2002111_H | Hallux valgus QTL GWAS2002111 (human) | | 0.000001 | Hallux valgus | | 4 | 125790890 | 125790891 | Human |
| 598013760 | GWAS1733059_H | alcohol consumption quality QTL GWAS1733059 (human) | | 2e-08 | alcohol consumption quality | | 4 | 112674713 | 112674714 | Human |
| 407112864 | GWAS761840_H | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment QTL GWAS761840 (human) | | 7e-08 | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | | 4 | 123145793 | 123145794 | Human |
| 628797840 | GWAS2706069_H | atrial fibrillation QTL GWAS2706069 (human) | | 2e-249 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 407342253 | GWAS991229_H | urate measurement QTL GWAS991229 (human) | | 6e-09 | urate measurement | | 4 | 127147534 | 127147535 | Human |
| 598013781 | GWAS1733080_H | vascular endothelial growth factor A amount QTL GWAS1733080 (human) | | 3e-105 | vascular endothelial growth factor A amount | | 4 | 109924607 | 109924608 | Human |
| 407063734 | GWAS712710_H | monocyte percentage of leukocytes QTL GWAS712710 (human) | | 3e-09 | monocyte percentage of leukocytes | | 4 | 109990411 | 109990412 | Human |
| 406998203 | GWAS647179_H | mean corpuscular volume QTL GWAS647179 (human) | | 1e-17 | mean corpuscular volume | | 4 | 109933275 | 109933276 | Human |
| 406981819 | GWAS630795_H | cardiac arrhythmia QTL GWAS630795 (human) | | 3e-41 | cardiac arrhythmia | | 4 | 110840331 | 110840332 | Human |
| 406899900 | GWAS548876_H | heart failure QTL GWAS548876 (human) | | 4e-16 | heart failure | | 4 | 110707472 | 110707473 | Human |
| 406981823 | GWAS630799_H | cardiac arrhythmia QTL GWAS630799 (human) | | 6e-37 | cardiac arrhythmia | | 4 | 110809256 | 110809257 | Human |
| 406998204 | GWAS647180_H | mean corpuscular volume QTL GWAS647180 (human) | | 1e-79 | mean corpuscular volume | | 4 | 121814898 | 121814899 | Human |
| 407260344 | GWAS909320_H | asthma QTL GWAS909320 (human) | | 8e-12 | asthma | | 4 | 122432277 | 122432278 | Human |
| 597161833 | GWAS1257907_H | gut microbiome measurement QTL GWAS1257907 (human) | | 9e-09 | gut microbiome measurement | | 4 | 126866560 | 126866561 | Human |
| 597161832 | GWAS1257906_H | gut microbiome measurement QTL GWAS1257906 (human) | | 3e-08 | gut microbiome measurement | | 4 | 126866560 | 126866561 | Human |
| 406998205 | GWAS647181_H | mean corpuscular volume QTL GWAS647181 (human) | | 8e-26 | mean corpuscular volume | | 4 | 127647811 | 127647812 | Human |
| 597603998 | GWAS1660858_H | prothrombin time measurement QTL GWAS1660858 (human) | | 2e-36 | prothrombin time measurement | | 4 | 110796911 | 110796912 | Human |
| 628502646 | GWAS2410875_H | AGRN/HSPG2 protein level ratio in blood QTL GWAS2410875 (human) | | 6e-54 | AGRN/HSPG2 protein level ratio in blood | | 4 | 118376502 | 118376503 | Human |
| 628371572 | GWAS2292416_H | Thyroid stimulating hormone level QTL GWAS2292416 (human) | | 2e-19 | Thyroid stimulating hormone level | | 4 | 121691318 | 121691319 | Human |
| 596965008 | GWAS1084527_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS1084527 (human) | | 0.0000007 | diet measurement, sex hormone-binding globulin measurement | | 4 | 127714844 | 127714845 | Human |
| 406965577 | GWAS614553_H | serum IgE measurement QTL GWAS614553 (human) | | 0.000008 | serum IgE measurement | | 4 | 118942321 | 118942322 | Human |
| 616952264 | GWAS1969763_H | phosphatidylcholine 38:2 measurement QTL GWAS1969763 (human) | | 0.000006 | glycerophosphocholine amount (VT:0011004) | | 4 | 117433671 | 117433672 | Human |
| 628519015 | GWAS2427244_H | coronary artery disease QTL GWAS2427244 (human) | | 3e-08 | coronary artery integrity trait (VT:0010746) | | 4 | 119980181 | 119980182 | Human |
| 407375194 | GWAS1024170_H | Hypermetropia QTL GWAS1024170 (human) | | 0.000002 | Hypermetropia | | 4 | 108429724 | 108429725 | Human |
| 628420711 | GWAS2328940_H | refractive error QTL GWAS2328940 (human) | | 1e-10 | refractive error | | 4 | 119680603 | 119680604 | Human |
| 628650095 | GWAS2558324_H | periodontal disorder QTL GWAS2558324 (human) | | 0.000001 | periodontal disorder | | 4 | 128066678 | 128066679 | Human |
| 407014747 | GWAS663723_H | Calcium channel blocker use measurement QTL GWAS663723 (human) | | 5e-08 | Calcium channel blocker use measurement | | 4 | 108081403 | 108081404 | Human |
| 628650082 | GWAS2558311_H | dental caries QTL GWAS2558311 (human) | | 0.000004 | dental caries | | 4 | 128761504 | 128761505 | Human |
| 407309659 | GWAS958635_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS958635 (human) | | 5e-11 | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | | 4 | 109657070 | 109657071 | Human |
| 628420712 | GWAS2328941_H | refractive error QTL GWAS2328941 (human) | | 3e-12 | refractive error | | 4 | 119987548 | 119987549 | Human |
| 597620355 | GWAS1677215_H | triglyceride measurement QTL GWAS1677215 (human) | | 2e-15 | triglyceride measurement | | 4 | 109657070 | 109657071 | Human |
| 616985049 | GWAS2002548_H | myeloid leukocyte count QTL GWAS2002548 (human) | | 1e-15 | myeloid leukocyte count | | 4 | 119342160 | 119342161 | Human |
| 407047516 | GWAS696492_H | cortical thickness QTL GWAS696492 (human) | | 3e-17 | cortical thickness | | 4 | 120793484 | 120793485 | Human |
| 628994141 | GWAS2902370_H | congenital anomaly of cardiovascular system QTL GWAS2902370 (human) | | 3e-11 | congenital anomaly of cardiovascular system | | 4 | 112981089 | 112981090 | Human |
| 407031138 | GWAS680114_H | systemic lupus erythematosus QTL GWAS680114 (human) | | 9e-12 | systemic lupus erythematosus | | 4 | 122089432 | 122089433 | Human |
| 406916451 | GWAS565427_H | serum IgG glycosylation measurement QTL GWAS565427 (human) | | 0.000003 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
| 616952294 | GWAS1969793_H | glycerol amount QTL GWAS1969793 (human) | | 0.000004 | glycerol amount | | 4 | 125494759 | 125494760 | Human |
| 628584528 | GWAS2492757_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2492757 (human) | | 1e-16 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 617099759 | GWAS2117258_H | IGF-1 measurement QTL GWAS2117258 (human) | | 3e-13 | IGF-1 measurement | | 4 | 120801880 | 120801886 | Human |
| 407227746 | GWAS876722_H | Cleft palate, cleft lip QTL GWAS876722 (human) | | 4e-08 | Cleft palate, cleft lip | | 4 | 123985102 | 123985103 | Human |
| 407096687 | GWAS745663_H | Epstein-Barr virus infection QTL GWAS745663 (human) | | 0.000001 | Epstein-Barr virus infection | | 4 | 107189709 | 107189710 | Human |
| 597505712 | GWAS1601786_H | heart failure QTL GWAS1601786 (human) | | 2e-15 | heart failure | | 4 | 110787848 | 110787849 | Human |
| 406916466 | GWAS565442_H | asthma QTL GWAS565442 (human) | | 7e-13 | allergic disease | | 4 | 122219915 | 122219916 | Human |
| 628830279 | GWAS2738508_H | platelet crit QTL GWAS2738508 (human) | | 3e-16 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 123749526 | 123749527 | Human |
| 407096579 | GWAS745555_H | educational attainment QTL GWAS745555 (human) | | 2e-09 | educational attainment | | 4 | 129621796 | 129621797 | Human |
| 407096578 | GWAS745554_H | educational attainment QTL GWAS745554 (human) | | 5e-08 | educational attainment | | 4 | 129452572 | 129452573 | Human |
| 616952199 | GWAS1969698_H | serum creatinine amount QTL GWAS1969698 (human) | | 0.000008 | serum creatinine amount | | 4 | 106565904 | 106565905 | Human |
| 597423833 | GWAS1519907_H | atrial fibrillation QTL GWAS1519907 (human) | | 5e-09 | atrial fibrillation | | 4 | 110992909 | 110992910 | Human |
| 597505759 | GWAS1601833_H | facial morphology measurement QTL GWAS1601833 (human) | | 3e-08 | facial morphology measurement | | 4 | 125198542 | 125198543 | Human |
| 407096577 | GWAS745553_H | educational attainment QTL GWAS745553 (human) | | 1e-08 | educational attainment | | 4 | 129387520 | 129387521 | Human |
| 407096576 | GWAS745552_H | educational attainment QTL GWAS745552 (human) | | 1e-10 | educational attainment | | 4 | 129330640 | 129330641 | Human |
| 407096583 | GWAS745559_H | educational attainment QTL GWAS745559 (human) | | 1e-11 | educational attainment | | 4 | 129713268 | 129713269 | Human |
| 597276383 | GWAS1372457_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1372457 (human) | | 2e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 122122507 | 122122508 | Human |
| 628994106 | GWAS2902335_H | mean corpuscular hemoglobin concentration QTL GWAS2902335 (human) | | 2e-17 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109912954 | 109912955 | Human |
| 406916358 | GWAS565334_H | neuroimaging measurement QTL GWAS565334 (human) | | 2e-11 | neuroimaging measurement | | 4 | 112495627 | 112495628 | Human |
| 597374675 | GWAS1470749_H | mean corpuscular volume QTL GWAS1470749 (human) | | 1e-10 | mean corpuscular volume | | 4 | 121774530 | 121774531 | Human |
| 407096586 | GWAS745562_H | educational attainment QTL GWAS745562 (human) | | 0.000008 | educational attainment | | 4 | 131866663 | 131866664 | Human |
| 407096585 | GWAS745561_H | educational attainment QTL GWAS745561 (human) | | 3e-09 | educational attainment | | 4 | 130394262 | 130394263 | Human |
| 407096584 | GWAS745560_H | educational attainment QTL GWAS745560 (human) | | 1e-08 | educational attainment | | 4 | 129875770 | 129875771 | Human |
| 407014671 | GWAS663647_H | Thyroid preparation use measurement QTL GWAS663647 (human) | | 8e-10 | hypothyroidism | | 4 | 122625127 | 122625128 | Human |
| 597391051 | GWAS1487125_H | systolic blood pressure QTL GWAS1487125 (human) | | 6e-18 | systolic blood pressure | | 4 | 110416322 | 110416323 | Human |
| 407031057 | GWAS680033_H | electrocardiography QTL GWAS680033 (human) | | 2e-29 | electrocardiography | | 4 | 113504778 | 113504779 | Human |
| 407325972 | GWAS974948_H | retinal drusen QTL GWAS974948 (human) | | 0.00001 | retinal drusen | | 4 | 128129997 | 128129998 | Human |
| 597259980 | GWAS1356054_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1356054 (human) | | 2e-13 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | | 4 | 109657070 | 109657071 | Human |
| 616952210 | GWAS1969709_H | cyclic adenosine monophosphate measurement QTL GWAS1969709 (human) | | 0.000002 | cyclic adenosine monophosphate measurement | | 4 | 121525001 | 121525002 | Human |
| 628633647 | GWAS2541876_H | gut microbiome measurement, breastfeeding duration QTL GWAS2541876 (human) | | 2e-09 | lactation duration (VT:1000653) | | 4 | 121972794 | 121972795 | Human |
| 407407889 | GWAS1056865_H | unipolar depression QTL GWAS1056865 (human) | | 3e-08 | unipolar depression | | 4 | 122265238 | 122265239 | Human |
| 407145752 | GWAS794728_H | schizophrenia, age at onset QTL GWAS794728 (human) | | 0.000004 | schizophrenia, age at onset | | 4 | 108959574 | 108959575 | Human |
| 617050523 | GWAS2068022_H | eosinophil count QTL GWAS2068022 (human) | | 1e-21 | eosinophil count | | 4 | 122365072 | 122365073 | Human |
| 598079226 | GWAS1798525_H | cerebral cortex area attribute QTL GWAS1798525 (human) | | 5e-10 | cerebral cortex area attribute | | 4 | 112493715 | 112493716 | Human |
| 407014691 | GWAS663667_H | sex hormone-binding globulin measurement QTL GWAS663667 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 4 | 128110633 | 128110634 | Human |
| 597096178 | GWAS1192252_H | sex hormone-binding globulin measurement QTL GWAS1192252 (human) | | 2e-13 | sex hormone-binding globulin measurement | | 4 | 119185611 | 119185612 | Human |
| 616968608 | GWAS1986107_H | susceptibility to scarlet fever measurement QTL GWAS1986107 (human) | | 0.000003 | response to bacterial infection trait (VT:0010435) | | 4 | 109403118 | 109403119 | Human |
| 407194925 | GWAS843901_H | lymphocyte count QTL GWAS843901 (human) | | 3e-09 | lymphocyte count | | 4 | 110003204 | 110003205 | Human |
| 407031084 | GWAS680060_H | balding measurement QTL GWAS680060 (human) | | 1e-13 | balding measurement | | 4 | 106940792 | 106940793 | Human |
| 597423850 | GWAS1519924_H | trait in response to carbamazepine QTL GWAS1519924 (human) | | 0.0000009 | trait in response to carbamazepine | | 4 | 127124380 | 127124381 | Human |
| 598111957 | GWAS1820840_H | dental caries QTL GWAS1820840 (human) | | 0.000004 | dental caries | | 4 | 128761504 | 128761505 | Human |
| 598111952 | GWAS1820835_H | dental caries QTL GWAS1820835 (human) | | 0.000003 | dental caries | | 4 | 129415045 | 129415046 | Human |
| 407293244 | GWAS942220_H | healthspan QTL GWAS942220 (human) | | 0.000002 | healthspan | | 4 | 110234426 | 110234427 | Human |
| 598013662 | GWAS1732961_H | renal transplant outcome measurement, glomerular filtration rate, donor genotype effect measurement QTL GWAS1732961 (human) | | 0.000004 | renal transplant outcome measurement, glomerular filtration rate, donor genotype effect measurement | | 4 | 119026891 | 119026892 | Human |
| 597505761 | GWAS1601835_H | facial morphology measurement QTL GWAS1601835 (human) | | 3e-08 | facial morphology measurement | | 4 | 125219863 | 125219864 | Human |
| 597505760 | GWAS1601834_H | facial morphology measurement QTL GWAS1601834 (human) | | 3e-08 | facial morphology measurement | | 4 | 125198582 | 125198583 | Human |
| 407178692 | GWAS827668_H | diastolic blood pressure QTL GWAS827668 (human) | | 2e-13 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 616526142 | GWAS1922725_H | platelet volume QTL GWAS1922725 (human) | | 3e-37 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 616526141 | GWAS1922724_H | platelet volume QTL GWAS1922724 (human) | | 1e-29 | platelet volume | | 4 | 122265238 | 122265239 | Human |
| 597063196 | GWAS1159270_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1159270 (human) | | 0.000002 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 123047357 | 123047358 | Human |
| 597063194 | GWAS1159268_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1159268 (human) | | 5e-13 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692515 | 122692516 | Human |
| 597063195 | GWAS1159269_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1159269 (human) | | 0.0000007 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122806140 | 122806141 | Human |
| 597423638 | GWAS1519712_H | type 1 diabetes mellitus QTL GWAS1519712 (human) | | 1e-08 | type 1 diabetes mellitus | | 4 | 124578751 | 124578752 | Human |
| 628584679 | GWAS2492908_H | phospholipids:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS2492908 (human) | | 7e-13 | blood IDL cholesterol amount (VT:0010503) | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 4 | 109657070 | 109657071 | Human |
| 597227017 | GWAS1323091_H | atrial fibrillation QTL GWAS1323091 (human) | | 4e-52 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
| 407375321 | GWAS1024297_H | rosacea severity measurement QTL GWAS1024297 (human) | | 0.000004 | rosacea severity measurement | | 4 | 122146898 | 122146899 | Human |
| 407178711 | GWAS827687_H | BMI-adjusted waist-hip ratio QTL GWAS827687 (human) | | 4e-15 | BMI-adjusted waist-hip ratio | | 4 | 121702910 | 121702911 | Human |
| 406998487 | GWAS647463_H | level of glutamyl aminopeptidase in blood serum QTL GWAS647463 (human) | | 3e-16 | level of glutamyl aminopeptidase in blood serum | | 4 | 110520270 | 110520271 | Human |
| 597227023 | GWAS1323097_H | atrial fibrillation QTL GWAS1323097 (human) | | 9e-09 | atrial fibrillation | | 4 | 112408189 | 112408190 | Human |
| 598111804 | GWAS1820687_H | cardiac arrest QTL GWAS1820687 (human) | | 2e-12 | cardiac arrest | | 4 | 129618474 | 129618475 | Human |
| 406998494 | GWAS647470_H | BMI-adjusted waist circumference QTL GWAS647470 (human) | | 1e-08 | BMI-adjusted waist circumference | | 4 | 119026033 | 119026034 | Human |
| 616362275 | GWAS1846990_H | multiple sclerosis QTL GWAS1846990 (human) | | 4e-08 | multiple sclerosis | | 4 | 108174396 | 108174397 | Human |
| 616526105 | GWAS1922688_H | eosinophil count QTL GWAS1922688 (human) | | 9e-16 | eosinophil count | | 4 | 122698534 | 122698535 | Human |
| 407145955 | GWAS794931_H | age-related macular degeneration QTL GWAS794931 (human) | | 0.0000003 | retina integrity trait (VT:0010771) | | 4 | 109717654 | 109717655 | Human |
| 597603894 | GWAS1660754_H | prothrombin time measurement QTL GWAS1660754 (human) | | 1e-33 | prothrombin time measurement | | 4 | 110796911 | 110796912 | Human |
| 406965736 | GWAS614712_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS614712 (human) | | 2e-19 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119349548 | 119349549 | Human |
| 616968557 | GWAS1986056_H | tumor necrosis factor alpha amount QTL GWAS1986056 (human) | | 0.000009 | tumor necrosis factor alpha amount | | 4 | 123921955 | 123921960 | Human |
| 597243442 | GWAS1339516_H | small vessel stroke QTL GWAS1339516 (human) | | 0.000008 | small vessel stroke | | 4 | 125014098 | 125014099 | Human |
| 617066857 | GWAS2084356_H | serum gamma-glutamyl transferase measurement QTL GWAS2084356 (human) | | 7e-13 | serum gamma-glutamyl transferase measurement | | 4 | 111793842 | 111793843 | Human |
| 617099641 | GWAS2117140_H | lipoprotein measurement QTL GWAS2117140 (human) | | 2e-41 | lipoprotein measurement | | 4 | 109717668 | 109717669 | Human |
| 628650189 | GWAS2558418_H | depressive symptom measurement, social risk factor QTL GWAS2558418 (human) | | 0.000004 | depression-related behavior trait (VT:0015015) | | 4 | 128297339 | 128297340 | Human |
| 597325356 | GWAS1421430_H | fibrinopeptide A, des-ala(1) measurement QTL GWAS1421430 (human) | | 1e-21 | fibrinopeptide A, des-ala(1) measurement | | 4 | 110510288 | 110510289 | Human |
| 628453580 | GWAS2361809_H | rheumatoid arthritis QTL GWAS2361809 (human) | | 4e-08 | joint integrity trait (VT:0010548) | | 4 | 112286121 | 112286122 | Human |
| 407178745 | GWAS827721_H | vaginal microbiome measurement QTL GWAS827721 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 123235757 | 123235758 | Human |
| 597243428 | GWAS1339502_H | gut microbiome measurement QTL GWAS1339502 (human) | | 7e-08 | gut microbiome measurement | | 4 | 117122262 | 117122263 | Human |
| 597997082 | GWAS1716381_H | level of serum globulin type protein QTL GWAS1716381 (human) | | 8e-11 | level of serum globulin type protein | | 4 | 119210489 | 119210490 | Human |
| 597046824 | GWAS1142898_H | erythrocyte count QTL GWAS1142898 (human) | | 1e-15 | red blood cell density measurement | red blood cell count (CMO:0000025) | 4 | 121811061 | 121811062 | Human |
| 597276251 | GWAS1372325_H | healthspan QTL GWAS1372325 (human) | | 0.000003 | healthspan | | 4 | 110234426 | 110234427 | Human |
| 598013543 | GWAS1732842_H | brain attribute QTL GWAS1732842 (human) | | 4e-10 | brain attribute | | 4 | 118393759 | 118393760 | Human |
| 628797630 | GWAS2705859_H | COVID-19 QTL GWAS2705859 (human) | | 0.000005 | COVID-19 | | 4 | 113129435 | 113129436 | Human |
| 616362360 | GWAS1847075_H | cystatin C measurement QTL GWAS1847075 (human) | | 9e-15 | cystatin C measurement | | 4 | 127176068 | 127176069 | Human |
| 616362361 | GWAS1847076_H | cystatin C measurement QTL GWAS1847076 (human) | | 2e-08 | cystatin C measurement | | 4 | 128611038 | 128611039 | Human |
| 597276254 | GWAS1372328_H | healthspan QTL GWAS1372328 (human) | | 0.000002 | healthspan | | 4 | 110234426 | 110234427 | Human |
| 597030492 | GWAS1126566_H | glomerular filtration rate QTL GWAS1126566 (human) | | 4e-13 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 598095468 | GWAS1812861_H | blood glucose amount, trait in response to hydrochlorothiazide QTL GWAS1812861 (human) | | 0.000004 | blood glucose amount, trait in response to hydrochlorothiazide | | 4 | 128775066 | 128775067 | Human |
| 628928695 | GWAS2836924_H | lung carcinoma QTL GWAS2836924 (human) | | 0.0000006 | lung integrity trait (VT:0010906) | | 4 | 117059518 | 117059519 | Human |
| 628846772 | GWAS2755001_H | suicide QTL GWAS2755001 (human) | | 0.000004 | behavior trait (VT:0010442) | | 4 | 125969849 | 125969850 | Human |
| 598013557 | GWAS1732856_H | brain attribute QTL GWAS1732856 (human) | | 2e-08 | brain attribute | | 4 | 123335936 | 123335937 | Human |
| 407326101 | GWAS975077_H | lysophosphatidylcholine 20:2 measurement QTL GWAS975077 (human) | | 4e-09 | lysophosphatidylcholine 20:2 measurement | | 4 | 126754772 | 126754773 | Human |
| 597407299 | GWAS1503373_H | vaginal microbiome measurement QTL GWAS1503373 (human) | | 0.00001 | vaginal microbiome measurement | | 4 | 126069793 | 126069794 | Human |
| 407227804 | GWAS876780_H | bone density QTL GWAS876780 (human) | | 1e-300 | bone density | | 4 | 113769407 | 113769408 | Human |
| 407227807 | GWAS876783_H | bone density QTL GWAS876783 (human) | | 1e-300 | bone density | | 4 | 130129906 | 130129907 | Human |
| 407227806 | GWAS876782_H | bone density QTL GWAS876782 (human) | | 1e-300 | bone density | | 4 | 116998483 | 116998484 | Human |
| 598062712 | GWAS1782011_H | QRS duration QTL GWAS1782011 (human) | | 2e-09 | QRS duration | | 4 | 123829743 | 123829744 | Human |
| 407178651 | GWAS827627_H | foot muscle strength measurement QTL GWAS827627 (human) | | 0.0000008 | foot muscle strength measurement | | 4 | 123234042 | 123234043 | Human |
| 617066789 | GWAS2084288_H | hip geometry QTL GWAS2084288 (human) | | 3e-08 | body size trait (VT:0100005) | hip circumference (CMO:0000014) | 4 | 121074997 | 121074998 | Human |
| 617017632 | GWAS2035131_H | total cholesterol measurement, diet measurement QTL GWAS2035131 (human) | | 0.000003 | total cholesterol measurement, diet measurement | | 4 | 118490708 | 118490709 | Human |
| 617050415 | GWAS2067914_H | cleft lip QTL GWAS2067914 (human) | | 0.000001 | cleft lip | | 4 | 125904223 | 125904224 | Human |
| 628895889 | GWAS2804118_H | diastolic blood pressure QTL GWAS2804118 (human) | | 3e-16 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110414448 | 110414449 | Human |
| 628682901 | GWAS2591130_H | Abnormality of the skeletal system QTL GWAS2591130 (human) | | 6e-16 | Abnormality of the skeletal system | | 4 | 119326939 | 119326940 | Human |
| 597341812 | GWAS1437886_H | appendicitis QTL GWAS1437886 (human) | | 5e-58 | appendicitis | | 4 | 110810780 | 110810781 | Human |
| 597309035 | GWAS1405109_H | glomerular filtration rate QTL GWAS1405109 (human) | | 1e-12 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 407375291 | GWAS1024267_H | refractive error QTL GWAS1024267 (human) | | 1e-10 | refractive error | | 4 | 119680603 | 119680604 | Human |
| 597489263 | GWAS1585337_H | brain measurement QTL GWAS1585337 (human) | | 1e-20 | brain measurement | | 4 | 127076729 | 127076730 | Human |
| 617279806 | GWAS2216582_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2216582 (human) | | 1e-08 | polyunsaturated fatty acids to total fatty acids percentage | | 4 | 109345757 | 109345758 | Human |
| 628928649 | GWAS2836878_H | body height QTL GWAS2836878 (human) | | 2e-22 | body height | | 4 | 108503691 | 108503692 | Human |
| 617279807 | GWAS2216583_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2216583 (human) | | 9e-11 | polyunsaturated fatty acids to total fatty acids percentage | | 4 | 109603883 | 109603884 | Human |
| 628928650 | GWAS2836879_H | body height QTL GWAS2836879 (human) | | 6e-13 | body height | | 4 | 119709781 | 119709782 | Human |
| 597194350 | GWAS1290424_H | cortical thickness QTL GWAS1290424 (human) | | 3e-17 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120793484 | 120793485 | Human |
| 628928651 | GWAS2836880_H | body height QTL GWAS2836880 (human) | | 3e-14 | body height | | 4 | 121876108 | 121876109 | Human |
| 406916534 | GWAS565510_H | lean body mass QTL GWAS565510 (human) | | 0.0000002 | lean body mass | | 4 | 122904764 | 122904765 | Human |
| 628863107 | GWAS2771336_H | tiglylcarnitine (C5:1-DC) measurement QTL GWAS2771336 (human) | | 6e-08 | tiglylcarnitine (C5:1-DC) measurement | | 4 | 110977273 | 110977274 | Human |
| 597341795 | GWAS1437869_H | Brugada syndrome QTL GWAS1437869 (human) | | 2e-08 | Brugada syndrome | | 4 | 113523590 | 113523591 | Human |
| 597030504 | GWAS1126578_H | glomerular filtration rate QTL GWAS1126578 (human) | | 5e-09 | glomerular filtration rate | | 4 | 108772299 | 108772300 | Human |
| 628420746 | GWAS2328975_H | response to anticonvulsant QTL GWAS2328975 (human) | | 0.0000001 | response to anticonvulsant | | 4 | 113140380 | 113140381 | Human |
| 407227973 | GWAS876949_H | breast carcinoma QTL GWAS876949 (human) | | 1e-09 | breast carcinoma | | 4 | 125922349 | 125922350 | Human |
| 597276056 | GWAS1372130_H | diet measurement QTL GWAS1372130 (human) | | 3e-08 | diet measurement | | 4 | 112402274 | 112402275 | Human |
| 597423507 | GWAS1519581_H | atrial fibrillation QTL GWAS1519581 (human) | | 5e-18 | atrial fibrillation | | 4 | 110908811 | 110908812 | Human |
| 597423506 | GWAS1519580_H | atrial fibrillation QTL GWAS1519580 (human) | | 3e-35 | atrial fibrillation | | 4 | 110882594 | 110882595 | Human |
| 597423505 | GWAS1519579_H | atrial fibrillation QTL GWAS1519579 (human) | | 7e-109 | atrial fibrillation | | 4 | 110844339 | 110844340 | Human |
| 597423504 | GWAS1519578_H | atrial fibrillation QTL GWAS1519578 (human) | | 9e-35 | atrial fibrillation | | 4 | 110823850 | 110823851 | Human |
| 597423509 | GWAS1519583_H | atrial fibrillation QTL GWAS1519583 (human) | | 7e-12 | atrial fibrillation | | 4 | 110978126 | 110978127 | Human |
| 597079448 | GWAS1175522_H | mean corpuscular hemoglobin QTL GWAS1175522 (human) | | 3e-51 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121818028 | 121818029 | Human |
| 597423508 | GWAS1519582_H | atrial fibrillation QTL GWAS1519582 (human) | | 8e-21 | atrial fibrillation | | 4 | 110941992 | 110941993 | Human |
| 597079449 | GWAS1175523_H | mean corpuscular hemoglobin QTL GWAS1175523 (human) | | 3e-27 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 128177881 | 128177882 | Human |
| 628716393 | GWAS2624622_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2624622 (human) | | 3e-15 | glioma pathogenesis-related protein 1 measurement | | 4 | 112179581 | 112179582 | Human |
| 597276040 | GWAS1372114_H | beverage consumption measurement QTL GWAS1372114 (human) | | 1e-08 | beverage consumption measurement | | 4 | 128935692 | 128935693 | Human |
| 628487014 | GWAS2395243_H | platelet count QTL GWAS2395243 (human) | | 2e-28 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110010783 | 110010784 | Human |
| 616985301 | GWAS2002800_H | Parkinson disease QTL GWAS2002800 (human) | | 1e-12 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
| 597063040 | GWAS1159114_H | depressive symptom measurement QTL GWAS1159114 (human) | | 3e-09 | depression-related behavior trait (VT:0015015) | | 4 | 122265238 | 122265239 | Human |
| 628716399 | GWAS2624628_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2624628 (human) | | 6e-14 | glioma pathogenesis-related protein 1 measurement | | 4 | 124228421 | 124228422 | Human |
| 597423491 | GWAS1519565_H | atrial fibrillation QTL GWAS1519565 (human) | | 9e-57 | atrial fibrillation | | 4 | 110809291 | 110809292 | Human |
| 597423490 | GWAS1519564_H | atrial fibrillation QTL GWAS1519564 (human) | | 6e-35 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
| 628929381 | GWAS2837610_H | anthropometric measurement QTL GWAS2837610 (human) | | 1e-26 | body size trait (VT:0100005) | body morphological measurement (CMO:0000021) | 4 | 121827153 | 121827154 | Human |
| 597423489 | GWAS1519563_H | atrial fibrillation QTL GWAS1519563 (human) | | 2e-18 | atrial fibrillation | | 4 | 110766821 | 110766822 | Human |
| 407031391 | GWAS680367_H | platelet count QTL GWAS680367 (human) | | 2e-63 | platelet count | | 4 | 110021121 | 110021122 | Human |
| 628372330 | GWAS2293174_H | Anxiety QTL GWAS2293174 (human) | | 2e-09 | Anxiety | | 4 | 131717648 | 131717649 | Human |
| 597423492 | GWAS1519566_H | atrial fibrillation QTL GWAS1519566 (human) | | 4e-14 | atrial fibrillation | | 4 | 110822697 | 110822698 | Human |
| 407031394 | GWAS680370_H | platelet count QTL GWAS680370 (human) | | 8e-16 | platelet count | | 4 | 123749526 | 123749527 | Human |
| 616968935 | GWAS1986434_H | tooth agenesis QTL GWAS1986434 (human) | | 6e-10 | tooth agenesis | | 4 | 108350621 | 108350622 | Human |
| 617280235 | GWAS2217011_H | degree of unsaturation measurement QTL GWAS2217011 (human) | | 7e-09 | degree of unsaturation measurement | | 4 | 109345757 | 109345758 | Human |
| 407031392 | GWAS680368_H | platelet count QTL GWAS680368 (human) | | 3e-27 | platelet count | | 4 | 119622957 | 119622958 | Human |
| 406916706 | GWAS565682_H | balding measurement QTL GWAS565682 (human) | | 4e-26 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106961911 | 106961912 | Human |
| 407031393 | GWAS680369_H | platelet count QTL GWAS680369 (human) | | 1e-11 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 406916709 | GWAS565685_H | risk-taking behaviour QTL GWAS565685 (human) | | 2e-08 | risk-taking behaviour | | 4 | 109690042 | 109690043 | Human |
| 406949477 | GWAS598453_H | complement factor I measurement QTL GWAS598453 (human) | | 7e-85 | complement factor I measurement | | 4 | 109735574 | 109735575 | Human |
| 628437841 | GWAS2346070_H | neuroticism measurement QTL GWAS2346070 (human) | | 3e-08 | behavior trait (VT:0010442) | | 4 | 118263414 | 118263415 | Human |
| 597489080 | GWAS1585154_H | phosphatidylethanolamine measurement QTL GWAS1585154 (human) | | 2e-08 | phosphatidylethanolamine measurement | | 4 | 126594255 | 126594256 | Human |
| 616362649 | GWAS1847364_H | glomerular filtration rate QTL GWAS1847364 (human) | | 3e-10 | glomerular filtration rate | | 4 | 108792494 | 108792495 | Human |
| 628716380 | GWAS2624609_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2624609 (human) | | 3e-13 | glioma pathogenesis-related protein 1 measurement | | 4 | 115961513 | 115961514 | Human |
| 616362650 | GWAS1847365_H | glomerular filtration rate QTL GWAS1847365 (human) | | 4e-08 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 598095233 | GWAS1812626_H | blood glucose amount QTL GWAS1812626 (human) | | 0.000005 | blood glucose amount | | 4 | 120880635 | 120880636 | Human |
| 616362651 | GWAS1847366_H | glomerular filtration rate QTL GWAS1847366 (human) | | 4e-20 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 617116386 | GWAS2133885_H | platelet count QTL GWAS2133885 (human) | | 2e-14 | platelet count | | 4 | 119653719 | 119653720 | Human |
| 597194163 | GWAS1290237_H | cortical thickness QTL GWAS1290237 (human) | | 4e-10 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120704578 | 120704579 | Human |
| 597276087 | GWAS1372161_H | retinal drusen QTL GWAS1372161 (human) | | 0.00001 | retinal drusen | | 4 | 128129997 | 128129998 | Human |
| 617050856 | GWAS2068355_H | forced expiratory volume, 25-hydroxyvitamin D3 measurement QTL GWAS2068355 (human) | | 5e-08 | forced expiratory volume, 25-hydroxyvitamin D3 measurement | | 4 | 113577873 | 113577874 | Human |
| 407129719 | GWAS778695_H | neuroticism measurement, cognitive function measurement QTL GWAS778695 (human) | | 4e-14 | neuroticism measurement, cognitive function measurement | | 4 | 122201701 | 122201702 | Human |
| 406900343 | GWAS549319_H | rheumatoid arthritis QTL GWAS549319 (human) | | 0.000005 | rheumatoid arthritis | | 4 | 124601887 | 124601888 | Human |
| 597177760 | GWAS1273834_H | fibroblast growth factor 2 measurement QTL GWAS1273834 (human) | | 8e-667 | fibroblast growth factor 2 measurement | | 4 | 122827461 | 122827462 | Human |
| 407015032 | GWAS664008_H | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement QTL GWAS664008 (human) | | 0.0000006 | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | | 4 | 124819554 | 124819555 | Human |
| 628372296 | GWAS2293140_H | fibroblast growth factor 19 level QTL GWAS2293140 (human) | | 2e-12 | fibroblast growth factor 19 level | | 4 | 109321740 | 109321741 | Human |
| 597194148 | GWAS1290222_H | cortical thickness QTL GWAS1290222 (human) | | 8e-11 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120708831 | 120708832 | Human |
| 616477315 | GWAS1873898_H | blood protein amount QTL GWAS1873898 (human) | | 5e-62 | blood protein amount | | 4 | 109965187 | 109965188 | Human |
| 597980571 | GWAS1699870_H | serum creatinine amount QTL GWAS1699870 (human) | | 0.000008 | serum creatinine amount | | 4 | 106565904 | 106565905 | Human |
| 407391755 | GWAS1040731_H | BMI-adjusted hip circumference QTL GWAS1040731 (human) | | 1e-08 | BMI-adjusted hip circumference | | 4 | 119821103 | 119821104 | Human |
| 407391756 | GWAS1040732_H | BMI-adjusted hip circumference QTL GWAS1040732 (human) | | 5e-09 | BMI-adjusted hip circumference | | 4 | 119820087 | 119820088 | Human |
| 407391757 | GWAS1040733_H | BMI-adjusted hip circumference QTL GWAS1040733 (human) | | 4e-10 | BMI-adjusted hip circumference | | 4 | 119798713 | 119798714 | Human |
| 616985230 | GWAS2002729_H | vital capacity QTL GWAS2002729 (human) | | 8e-12 | vital capacity | | 4 | 124209285 | 124209286 | Human |
| 616985228 | GWAS2002727_H | vital capacity QTL GWAS2002727 (human) | | 5e-08 | vital capacity | | 4 | 108557833 | 108557834 | Human |
| 597439958 | GWAS1536032_H | susceptibility to vaginal yeast infection measurement QTL GWAS1536032 (human) | | 0.000004 | response to fungal infection trait (VT:0010436) | | 4 | 120477000 | 120477001 | Human |
| 407064073 | GWAS713049_H | hemorrhoid QTL GWAS713049 (human) | | 4e-09 | hemorrhoid | | 4 | 123825222 | 123825223 | Human |
| 616985229 | GWAS2002728_H | vital capacity QTL GWAS2002728 (human) | | 0.0000001 | vital capacity | | 4 | 112674713 | 112674714 | Human |
| 597128646 | GWAS1224720_H | mean corpuscular volume QTL GWAS1224720 (human) | | 8e-44 | mean corpuscular volume | | 4 | 121875762 | 121875763 | Human |
| 597538252 | GWAS1634326_H | body height QTL GWAS1634326 (human) | | 1e-08 | body height | | 4 | 128547347 | 128547348 | Human |
| 407227927 | GWAS876903_H | bone density QTL GWAS876903 (human) | | 2e-09 | bone density | | 4 | 108138358 | 108138359 | Human |
| 628962089 | GWAS2870318_H | appendicitis QTL GWAS2870318 (human) | | 1e-20 | appendicitis | | 4 | 110810809 | 110810810 | Human |
| 597538249 | GWAS1634323_H | body height QTL GWAS1634323 (human) | | 8e-23 | body height | | 4 | 113826994 | 113826995 | Human |
| 628962088 | GWAS2870317_H | disorder of appendix QTL GWAS2870317 (human) | | 4e-21 | disorder of appendix | | 4 | 110810809 | 110810810 | Human |
| 628405026 | GWAS2313255_H | reticulocyte amount QTL GWAS2313255 (human) | | 2e-10 | reticulocyte amount | | 4 | 119185193 | 119185194 | Human |
| 597538251 | GWAS1634325_H | body height QTL GWAS1634325 (human) | | 2e-09 | body height | | 4 | 123557804 | 123557805 | Human |
| 628962090 | GWAS2870319_H | appendicitis QTL GWAS2870319 (human) | | 4e-19 | appendicitis | | 4 | 110804662 | 110804663 | Human |
| 597538250 | GWAS1634324_H | body height QTL GWAS1634324 (human) | | 1e-19 | body height | | 4 | 123398036 | 123398037 | Human |
| 626455309 | GWAS2269242_H | serum albumin amount QTL GWAS2269242 (human) | | 1e-09 | serum albumin amount | | 4 | 109113640 | 109113641 | Human |
| 628831008 | GWAS2739237_H | platelet count QTL GWAS2739237 (human) | | 1e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123849566 | 123849567 | Human |
| 597210564 | GWAS1306638_H | protein measurement QTL GWAS1306638 (human) | | 2e-08 | protein amount (VT:0010120) | | 4 | 130879344 | 130879345 | Human |
| 407195173 | GWAS844149_H | gut microbiome measurement, bone density QTL GWAS844149 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116019324 | 116019325 | Human |
| 628552470 | GWAS2460699_H | cortical thickness QTL GWAS2460699 (human) | | 8e-09 | cerebral cortex morphology trait (VT:0000788) | | 4 | 119920489 | 119920490 | Human |
| 628552471 | GWAS2460700_H | cortical thickness QTL GWAS2460700 (human) | | 3e-11 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120773757 | 120773758 | Human |
| 616362718 | GWAS1847433_H | glomerular filtration rate QTL GWAS1847433 (human) | | 5e-12 | glomerular filtration rate | | 4 | 128601363 | 128601364 | Human |
| 407195174 | GWAS844150_H | gut microbiome measurement, bone density QTL GWAS844150 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116034483 | 116034484 | Human |
| 616985251 | GWAS2002750_H | autoimmune disease QTL GWAS2002750 (human) | | 1e-09 | autoimmune disease | | 4 | 122633552 | 122633553 | Human |
| 628945691 | GWAS2853920_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2853920 (human) | | 9e-11 | fatty acid amount (VT:0010046) | | 4 | 109603883 | 109603884 | Human |
| 597227007 | GWAS1323081_H | protein measurement QTL GWAS1323081 (human) | | 9e-09 | protein amount (VT:0010120) | | 4 | 124985713 | 124985714 | Human |
| 597308914 | GWAS1404988_H | Thyroid preparation use measurement QTL GWAS1404988 (human) | | 4e-09 | Thyroid preparation use measurement | | 4 | 122466445 | 122466446 | Human |
| 616379093 | GWAS1859335_H | obsolete_glycerol measurement QTL GWAS1859335 (human) | | 0.000004 | obsolete_glycerol measurement | | 4 | 125494759 | 125494760 | Human |
| 597439989 | GWAS1536063_H | trait in response to venlafaxine QTL GWAS1536063 (human) | | 0.000006 | trait in response to venlafaxine | | 4 | 113431725 | 113431726 | Human |
| 628962071 | GWAS2870300_H | hemoglobin measurement QTL GWAS2870300 (human) | | 3e-20 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 110021958 | 110021959 | Human |
| 628798224 | GWAS2706453_H | atrial fibrillation QTL GWAS2706453 (human) | | 6e-47 | atrial fibrillation | | 4 | 110776497 | 110776498 | Human |
| 597063164 | GWAS1159238_H | smoking behavior, BMI-adjusted waist-hip ratio QTL GWAS1159238 (human) | | 0.000008 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
| 597194227 | GWAS1290301_H | memory performance QTL GWAS1290301 (human) | | 0.000004 | memory performance | | 4 | 112467350 | 112467351 | Human |
| 597145081 | GWAS1241155_H | body height QTL GWAS1241155 (human) | | 4e-08 | body height | | 4 | 122841742 | 122841743 | Human |
| 616379087 | GWAS1859329_H | obsolete_glycerol measurement QTL GWAS1859329 (human) | | 0.0000002 | obsolete_glycerol measurement | | 4 | 125351750 | 125351751 | Human |
| 406900276 | GWAS549252_H | rheumatoid arthritis QTL GWAS549252 (human) | | 0.000002 | rheumatoid arthritis | | 4 | 108192758 | 108192759 | Human |
| 628699917 | GWAS2608146_H | cardiovascular age measurement QTL GWAS2608146 (human) | | 3e-14 | cardiovascular age measurement | | 4 | 113465982 | 113465983 | Human |
| 628454147 | GWAS2362376_H | atrial fibrillation QTL GWAS2362376 (human) | | 2e-13 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 597374435 | GWAS1470509_H | pulmonary function measurement QTL GWAS1470509 (human) | | 0.000001 | pulmonary function measurement | | 4 | 108296773 | 108296774 | Human |
| 616968894 | GWAS1986393_H | susceptibility to cold sores measurement QTL GWAS1986393 (human) | | 0.000004 | response to viral infection trait (VT:0010439) | | 4 | 120332709 | 120332710 | Human |
| 617116336 | GWAS2133835_H | systemic inflammatory response syndrome QTL GWAS2133835 (human) | | 1e-11 | systemic inflammatory response syndrome | | 4 | 131864363 | 131864364 | Human |
| 628962054 | GWAS2870283_H | atrial fibrillation QTL GWAS2870283 (human) | | 1e-33 | atrial fibrillation | | 4 | 110793263 | 110793264 | Human |
| 616985158 | GWAS2002657_H | appendicular lean mass QTL GWAS2002657 (human) | | 2e-12 | appendicular lean mass | | 4 | 119638715 | 119638716 | Human |
| 406965956 | GWAS614932_H | HIV viral set point measurement QTL GWAS614932 (human) | | 0.000006 | HIV viral set point measurement | | 4 | 120120131 | 120120132 | Human |
| 406982340 | GWAS631316_H | protein measurement QTL GWAS631316 (human) | | 5e-10 | protein measurement | | 4 | 118904979 | 118904980 | Human |
| 628962298 | GWAS2870527_H | cardiac arrhythmia QTL GWAS2870527 (human) | | 3e-19 | heart integrity trait (VT:0010757) | | 4 | 110774266 | 110774267 | Human |
| 628913136 | GWAS2821365_H | high density lipoprotein cholesterol measurement QTL GWAS2821365 (human) | | 6e-09 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 112062569 | 112062570 | Human |
| 407162568 | GWAS811544_H | coronary artery disease QTL GWAS811544 (human) | | 3e-15 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 628929523 | GWAS2837752_H | anthropometric measurement QTL GWAS2837752 (human) | | 3e-22 | body size trait (VT:0100005) | body morphological measurement (CMO:0000021) | 4 | 108540829 | 108540830 | Human |
| 597619980 | GWAS1676840_H | triglyceride measurement QTL GWAS1676840 (human) | | 2e-20 | triglyceride measurement | | 4 | 109657070 | 109657071 | Human |
| 617132639 | GWAS2150138_H | Abnormality of the skeletal system QTL GWAS2150138 (human) | | 6e-16 | Abnormality of the skeletal system | | 4 | 119326939 | 119326940 | Human |
| 616985182 | GWAS2002681_H | appendicular lean mass QTL GWAS2002681 (human) | | 1e-09 | appendicular lean mass | | 4 | 119455163 | 119455164 | Human |
| 407228121 | GWAS877097_H | bone density QTL GWAS877097 (human) | | 4e-107 | bone density | | 4 | 119246472 | 119246473 | Human |
| 407015132 | GWAS664108_H | Crohn's disease QTL GWAS664108 (human) | | 2e-09 | Crohn's disease | | 4 | 122240464 | 122240465 | Human |
| 598144262 | GWAS1830990_H | bone tissue density QTL GWAS1830990 (human) | | 1e-300 | bone tissue density | | 4 | 130129906 | 130129907 | Human |
| 598144260 | GWAS1830988_H | bone tissue density QTL GWAS1830988 (human) | | 1e-300 | bone tissue density | | 4 | 113769407 | 113769408 | Human |
| 628732890 | GWAS2641119_H | neonatal abstinence syndrome QTL GWAS2641119 (human) | | 0.000003 | neonatal abstinence syndrome | | 4 | 115468815 | 115468816 | Human |
| 598144261 | GWAS1830989_H | bone tissue density QTL GWAS1830989 (human) | | 1e-300 | bone tissue density | | 4 | 116998483 | 116998484 | Human |
| 617034338 | GWAS2051837_H | vital capacity QTL GWAS2051837 (human) | | 2e-09 | vital capacity | | 4 | 108545191 | 108545192 | Human |
| 628650973 | GWAS2559202_H | forced expiratory volume, 25-hydroxyvitamin D3 measurement QTL GWAS2559202 (human) | | 1e-08 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 123996704 | 123996705 | Human |
| 407277281 | GWAS926257_H | brain measurement QTL GWAS926257 (human) | | 1e-20 | brain measurement | | 4 | 127076729 | 127076730 | Human |
| 597259571 | GWAS1355645_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1355645 (human) | | 6e-13 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | | 4 | 109657070 | 109657071 | Human |
| 407211759 | GWAS860735_H | aortic vascular smooth muscle cell calcification measurement QTL GWAS860735 (human) | | 3e-08 | aortic vascular smooth muscle cell calcification measurement | | 4 | 118880492 | 118880493 | Human |
| 597128509 | GWAS1224583_H | pulse pressure measurement QTL GWAS1224583 (human) | | 1e-13 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 120018118 | 120018119 | Human |
| 407391970 | GWAS1040946_H | complement factor H-related protein 3 measurement QTL GWAS1040946 (human) | | 0.000009 | complement factor H-related protein 3 measurement | | 4 | 128538939 | 128538940 | Human |
| 597128508 | GWAS1224582_H | pulse pressure measurement QTL GWAS1224582 (human) | | 0.000002 | pulse pressure measurement | | 4 | 110319122 | 110319123 | Human |
| 628552669 | GWAS2460898_H | cortical thickness QTL GWAS2460898 (human) | | 3e-08 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120730658 | 120730659 | Human |
| 597374256 | GWAS1470330_H | hemoglobin measurement QTL GWAS1470330 (human) | | 3e-10 | hemoglobin measurement | | 4 | 123844107 | 123844108 | Human |
| 597128507 | GWAS1224581_H | pulse pressure measurement QTL GWAS1224581 (human) | | 0.0000002 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 108146742 | 108146743 | Human |
| 597226804 | GWAS1322878_H | atrial fibrillation QTL GWAS1322878 (human) | | 8e-11 | atrial fibrillation | | 4 | 110334761 | 110334762 | Human |
| 597226805 | GWAS1322879_H | atrial fibrillation QTL GWAS1322879 (human) | | 9e-11 | atrial fibrillation | | 4 | 110675204 | 110675205 | Human |
| 628487131 | GWAS2395360_H | blood protein amount QTL GWAS2395360 (human) | | 2e-83 | blood protein amount | | 4 | 106943827 | 106943828 | Human |
| 628667350 | GWAS2575579_H | body mass index QTL GWAS2575579 (human) | | 2e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
| 597275946 | GWAS1372020_H | rheumatoid arthritis QTL GWAS1372020 (human) | | 5e-14 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
| 407326450 | GWAS975426_H | testosterone measurement QTL GWAS975426 (human) | | 2e-08 | testosterone measurement | | 4 | 109108768 | 109108769 | Human |
| 597439785 | GWAS1535859_H | lobe attachment QTL GWAS1535859 (human) | | 0.0000001 | ear lobe morphology trait (VT:0003677) | ear measurement (CMO:0002667) | 4 | 124806384 | 124806385 | Human |
| 407342833 | GWAS991809_H | systolic blood pressure QTL GWAS991809 (human) | | 1e-11 | systolic blood pressure | | 4 | 110485340 | 110485341 | Human |
| 406900472 | GWAS549448_H | atrial fibrillation QTL GWAS549448 (human) | | 2e-249 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 598029669 | GWAS1748968_H | obsolete_facial morphology quality QTL GWAS1748968 (human) | | 3e-29 | obsolete_facial morphology quality | | 4 | 127007438 | 127007439 | Human |
| 628569013 | GWAS2477242_H | glycerophospholipid measurement QTL GWAS2477242 (human) | | 9e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114551671 | 114551672 | Human |
| 628569012 | GWAS2477241_H | glycerophospholipid measurement QTL GWAS2477241 (human) | | 8e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114510521 | 114510522 | Human |
| 628569011 | GWAS2477240_H | glycerophospholipid measurement QTL GWAS2477240 (human) | | 8e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114580888 | 114580889 | Human |
| 406982278 | GWAS631254_H | hemoglobin measurement QTL GWAS631254 (human) | | 3e-10 | hemoglobin measurement | | 4 | 123844107 | 123844108 | Human |
| 628569010 | GWAS2477239_H | glycerophospholipid measurement QTL GWAS2477239 (human) | | 7e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114514506 | 114514507 | Human |
| 597488986 | GWAS1585060_H | brain measurement QTL GWAS1585060 (human) | | 3e-30 | brain measurement | | 4 | 112512138 | 112512139 | Human |
| 628569009 | GWAS2477238_H | glycerophospholipid measurement QTL GWAS2477238 (human) | | 6e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114485362 | 114485363 | Human |
| 628569008 | GWAS2477237_H | glycerophospholipid measurement QTL GWAS2477237 (human) | | 5e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114550195 | 114550196 | Human |
| 407375488 | GWAS1024464_H | bipolar disorder QTL GWAS1024464 (human) | | 0.000005 | bipolar disorder | | 4 | 122589611 | 122589612 | Human |
| 406900364 | GWAS549340_H | susceptibility to scarlet fever measurement QTL GWAS549340 (human) | | 0.000003 | susceptibility to scarlet fever measurement | | 4 | 109403118 | 109403119 | Human |
| 406900365 | GWAS549341_H | susceptibility to scarlet fever measurement QTL GWAS549341 (human) | | 0.000009 | susceptibility to scarlet fever measurement | | 4 | 109544415 | 109544416 | Human |
| 616952328 | GWAS1969827_H | adenosine monophosphate measurement QTL GWAS1969827 (human) | | 0.000009 | adenosine monophosphate measurement | | 4 | 116035124 | 116035125 | Human |
| 598013300 | GWAS1732599_H | GLB1/GUSB protein level ratio in blood QTL GWAS1732599 (human) | | 7e-50 | GLB1/GUSB protein level ratio in blood | | 4 | 118808670 | 118808671 | Human |
| 628437927 | GWAS2346156_H | endometriosis QTL GWAS2346156 (human) | | 0.0000008 | uterus integrity trait (VT:0010575) | | 4 | 114744719 | 114744720 | Human |
| 628569007 | GWAS2477236_H | glycerophospholipid measurement QTL GWAS2477236 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114539953 | 114539954 | Human |
| 628569006 | GWAS2477235_H | glycerophospholipid measurement QTL GWAS2477235 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114540944 | 114540945 | Human |
| 628569005 | GWAS2477234_H | glycerophospholipid measurement QTL GWAS2477234 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114492647 | 114492648 | Human |
| 628569004 | GWAS2477233_H | glycerophospholipid measurement QTL GWAS2477233 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114492457 | 114492458 | Human |
| 598095229 | GWAS1812622_H | blood glucose amount QTL GWAS1812622 (human) | | 0.000006 | blood glucose amount | | 4 | 120880635 | 120880636 | Human |
| 628585386 | GWAS2493615_H | carotid artery thickness QTL GWAS2493615 (human) | | 0.000002 | carotid artery thickness | | 4 | 107366087 | 107366088 | Human |
| 616526434 | GWAS1923017_H | corticoliberin measurement QTL GWAS1923017 (human) | | 1e-15 | corticoliberin measurement | | 4 | 108425227 | 108425228 | Human |
| 617050650 | GWAS2068149_H | gestational age QTL GWAS2068149 (human) | | 0.000007 | gestational age | | 4 | 112357355 | 112357356 | Human |
| 597390661 | GWAS1486735_H | appendicular lean mass QTL GWAS1486735 (human) | | 1e-09 | appendicular lean mass | | 4 | 119455163 | 119455164 | Human |
| 597275974 | GWAS1372048_H | testosterone measurement QTL GWAS1372048 (human) | | 2e-08 | testosterone measurement | | 4 | 109108768 | 109108769 | Human |
| 407162532 | GWAS811508_H | coronary artery disease QTL GWAS811508 (human) | | 6e-14 | coronary artery disease | | 4 | 119980181 | 119980182 | Human |
| 628405141 | GWAS2313370_H | erythrocyte count QTL GWAS2313370 (human) | | 1e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598669 | 114598670 | Human |
| 597980486 | GWAS1699785_H | facial hair thickness QTL GWAS1699785 (human) | | 0.000004 | facial hair thickness | | 4 | 120705958 | 120705959 | Human |
| 598095173 | GWAS1812566_H | hip bone mineral density, fat pad mass QTL GWAS1812566 (human) | | 6e-09 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 129257175 | 129257176 | Human |
| 597374323 | GWAS1470397_H | reticulocyte count QTL GWAS1470397 (human) | | 1e-09 | reticulocyte count | | 4 | 128330896 | 128330897 | Human |
| 597292405 | GWAS1388479_H | size QTL GWAS1388479 (human) | | 5e-08 | size | | 4 | 118204297 | 118204298 | Human |
| 628978576 | GWAS2886805_H | triglyceride measurement QTL GWAS2886805 (human) | | 1e-33 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
| 407326389 | GWAS975365_H | testosterone measurement QTL GWAS975365 (human) | | 6e-17 | testosterone measurement | | 4 | 124126476 | 124126477 | Human |
| 406998710 | GWAS647686_H | BMI-adjusted waist circumference QTL GWAS647686 (human) | | 5e-08 | BMI-adjusted waist circumference | | 4 | 121696338 | 121696339 | Human |
| 406998711 | GWAS647687_H | BMI-adjusted waist circumference QTL GWAS647687 (human) | | 1e-14 | BMI-adjusted waist circumference | | 4 | 119354508 | 119354509 | Human |
| 617034299 | GWAS2051798_H | Parkinson disease QTL GWAS2051798 (human) | | 3e-11 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
| 597030251 | GWAS1126325_H | atrial fibrillation QTL GWAS1126325 (human) | | 7e-71 | atrial fibrillation | | 4 | 110735436 | 110735437 | Human |
| 617017912 | GWAS2035411_H | calcium measurement, diet measurement QTL GWAS2035411 (human) | | 0.000006 | calcium measurement, diet measurement | | 4 | 111131258 | 111131259 | Human |
| 628831109 | GWAS2739338_H | platelet count QTL GWAS2739338 (human) | | 3e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123837618 | 123837619 | Human |
| 407244615 | GWAS893591_H | carotid artery intima media thickness QTL GWAS893591 (human) | | 0.000002 | carotid artery intima media thickness | | 4 | 107366087 | 107366088 | Human |
| 616559550 | GWAS1956133_H | acid sphingomyelinase-like phosphodiesterase 3a measurement QTL GWAS1956133 (human) | | 1e-20 | acid sphingomyelinase-like phosphodiesterase 3a measurement | | 4 | 118842717 | 118842718 | Human |
| 407129927 | GWAS778903_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS778903 (human) | | 1e-09 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 628732543 | GWAS2640772_H | systolic blood pressure QTL GWAS2640772 (human) | | 6e-12 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110319122 | 110319123 | Human |
| 628732542 | GWAS2640771_H | systolic blood pressure QTL GWAS2640771 (human) | | 2e-10 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 108117498 | 108117499 | Human |
| 597406866 | GWAS1502940_H | total blood protein measurement QTL GWAS1502940 (human) | | 6e-20 | total blood protein measurement | | 4 | 119206905 | 119206906 | Human |
| 407261001 | GWAS909977_H | Brugada syndrome QTL GWAS909977 (human) | | 2e-08 | Brugada syndrome | | 4 | 113523590 | 113523591 | Human |
| 598111401 | GWAS1820284_H | oligodendroglioma QTL GWAS1820284 (human) | | 0.000002 | oligodendroglioma | | 4 | 132099972 | 132099973 | Human |
| 628748907 | GWAS2657136_H | atrial fibrillation QTL GWAS2657136 (human) | | 5e-27 | atrial fibrillation | | 4 | 109738763 | 109738764 | Human |
| 628470369 | GWAS2378598_H | CRKL/EGF protein level ratio in blood QTL GWAS2378598 (human) | | 3e-202 | CRKL/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 628748909 | GWAS2657138_H | atrial fibrillation QTL GWAS2657138 (human) | | 2e-31 | atrial fibrillation | | 4 | 112000965 | 112000966 | Human |
| 407392092 | GWAS1041068_H | BMI-adjusted waist circumference QTL GWAS1041068 (human) | | 1e-08 | BMI-adjusted waist circumference | | 4 | 119503425 | 119503426 | Human |
| 628748908 | GWAS2657137_H | atrial fibrillation QTL GWAS2657137 (human) | | 5e-305 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407392093 | GWAS1041069_H | BMI-adjusted waist circumference QTL GWAS1041069 (human) | | 2e-14 | BMI-adjusted waist circumference | | 4 | 119674620 | 119674621 | Human |
| 407392094 | GWAS1041070_H | BMI-adjusted waist circumference QTL GWAS1041070 (human) | | 5e-10 | BMI-adjusted waist circumference | | 4 | 119761309 | 119761310 | Human |
| 628748911 | GWAS2657140_H | atrial fibrillation QTL GWAS2657140 (human) | | 3e-08 | atrial fibrillation | | 4 | 120802562 | 120802563 | Human |
| 407048021 | GWAS696997_H | obesity QTL GWAS696997 (human) | | 0.0000002 | obesity | | 4 | 129810129 | 129810130 | Human |
| 407048020 | GWAS696996_H | obesity QTL GWAS696996 (human) | | 0.000001 | eating behavior trait (VT:0001431) | | 4 | 112390634 | 112390635 | Human |
| 628748910 | GWAS2657139_H | atrial fibrillation QTL GWAS2657139 (human) | | 3e-34 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 407392095 | GWAS1041071_H | BMI-adjusted waist circumference QTL GWAS1041071 (human) | | 4e-09 | BMI-adjusted waist circumference | | 4 | 119805780 | 119805781 | Human |
| 407392083 | GWAS1041059_H | complement factor I measurement QTL GWAS1041059 (human) | | 9e-37 | complement factor I measurement | | 4 | 109735574 | 109735575 | Human |
| 407015264 | GWAS664240_H | myocardial infarction QTL GWAS664240 (human) | | 0.000009 | myocardial infarction | | 4 | 118789266 | 118789267 | Human |
| 628830803 | GWAS2739032_H | body height QTL GWAS2739032 (human) | | 8e-10 | body height | | 4 | 108355674 | 108355675 | Human |
| 598144142 | GWAS1830870_H | bone tissue density QTL GWAS1830870 (human) | | 4e-107 | bone tissue density | | 4 | 119246472 | 119246473 | Human |
| 628961878 | GWAS2870107_H | Barrett's esophagus QTL GWAS2870107 (human) | | 1e-15 | Barrett's esophagus | | 4 | 123628089 | 123628090 | Human |
| 628912720 | GWAS2820949_H | docosahexaenoic acid to total fatty acids percentage QTL GWAS2820949 (human) | | 2e-09 | fatty acid amount (VT:0010046) | | 4 | 109321740 | 109321741 | Human |
| 628912721 | GWAS2820950_H | docosahexaenoic acid to total fatty acids percentage QTL GWAS2820950 (human) | | 7e-12 | fatty acid amount (VT:0010046) | | 4 | 109717668 | 109717669 | Human |
| 628798039 | GWAS2706268_H | atrial fibrillation QTL GWAS2706268 (human) | | 2e-210 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 597226677 | GWAS1322751_H | asthma, age at onset QTL GWAS1322751 (human) | | 5e-08 | asthma, age at onset | | 4 | 122432277 | 122432278 | Human |
| 616526737 | GWAS1923320_H | platelet crit QTL GWAS1923320 (human) | | 4e-46 | platelet crit | | 4 | 109927638 | 109927639 | Human |
| 628666956 | GWAS2575185_H | bone tissue density QTL GWAS2575185 (human) | | 1e-12 | bone tissue density | | 4 | 115936664 | 115936665 | Human |
| 628585025 | GWAS2493254_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS2493254 (human) | | 8e-12 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 597472426 | GWAS1568500_H | hemorrhoid QTL GWAS1568500 (human) | | 4e-09 | hemorrhoid | | 4 | 123825222 | 123825223 | Human |
| 597472427 | GWAS1568501_H | hemorrhoid QTL GWAS1568501 (human) | | 3e-11 | hemorrhoid | | 4 | 126003844 | 126003845 | Human |
| 597341344 | GWAS1437418_H | breast density QTL GWAS1437418 (human) | | 0.000005 | breast density | | 4 | 120803641 | 120803642 | Human |
| 406998911 | GWAS647887_H | body mass index QTL GWAS647887 (human) | | 3e-08 | body mass index | | 4 | 112335581 | 112335582 | Human |
| 407228280 | GWAS877256_H | atopic eczema QTL GWAS877256 (human) | | 0.000004 | atopic eczema | | 4 | 122576542 | 122576543 | Human |
| 597980390 | GWAS1699689_H | cerebrospinal fluid composition attribute, beta-amyloid 1-42 measurement QTL GWAS1699689 (human) | | 0.0000006 | cerebrospinal fluid composition attribute, beta-amyloid 1-42 measurement | | 4 | 124819554 | 124819555 | Human |
| 407277313 | GWAS926289_H | hair color QTL GWAS926289 (human) | | 3e-20 | hair color | | 4 | 108556952 | 108556953 | Human |
| 597619926 | GWAS1676786_H | triglyceride measurement QTL GWAS1676786 (human) | | 5e-19 | triglyceride measurement | | 4 | 109657070 | 109657071 | Human |
| 597112030 | GWAS1208104_H | protein measurement QTL GWAS1208104 (human) | | 5e-10 | protein amount (VT:0010120) | | 4 | 118904979 | 118904980 | Human |
| 597456087 | GWAS1552161_H | COVID-19 QTL GWAS1552161 (human) | | 0.000006 | COVID-19 | | 4 | 106867781 | 106867782 | Human |
| 597439692 | GWAS1535766_H | eye color QTL GWAS1535766 (human) | | 0.000008 | iris pigmentation trait (VT:0005102) | | 4 | 110379206 | 110379207 | Human |
| 597193930 | GWAS1290004_H | cortical thickness QTL GWAS1290004 (human) | | 1e-13 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120793484 | 120793485 | Human |
| 628994601 | GWAS2902830_H | platelet count QTL GWAS2902830 (human) | | 2e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119653719 | 119653720 | Human |
| 628994600 | GWAS2902829_H | platelet count QTL GWAS2902829 (human) | | 4e-34 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109912954 | 109912955 | Human |
| 597439689 | GWAS1535763_H | eye color QTL GWAS1535763 (human) | | 0.000002 | iris pigmentation trait (VT:0005102) | | 4 | 110457206 | 110457207 | Human |
| 407195408 | GWAS844384_H | gut microbiome measurement, bone density QTL GWAS844384 (human) | | 2e-09 | gut microbiome measurement, bone density | | 4 | 116039953 | 116039954 | Human |
| 628830755 | GWAS2738984_H | triglyceride measurement QTL GWAS2738984 (human) | | 2e-25 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
| 597030095 | GWAS1126169_H | balding measurement QTL GWAS1126169 (human) | | 3e-16 | balding measurement | | 4 | 106961911 | 106961912 | Human |
| 597144781 | GWAS1240855_H | age of onset of childhood onset asthma QTL GWAS1240855 (human) | | 6e-16 | age of onset of childhood onset asthma | | 4 | 122307075 | 122307076 | Human |
| 617280406 | GWAS2217182_H | degree of unsaturation measurement QTL GWAS2217182 (human) | | 4e-11 | degree of unsaturation measurement | | 4 | 109603883 | 109603884 | Human |
| 628634151 | GWAS2542380_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2542380 (human) | | 4e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 125466935 | 125466936 | Human |
| 597128438 | GWAS1224512_H | sleep measurement QTL GWAS1224512 (human) | | 0.000006 | sleep measurement | | 4 | 118160921 | 118160922 | Human |
| 597128435 | GWAS1224509_H | sleep measurement QTL GWAS1224509 (human) | | 0.000005 | sleep measurement | | 4 | 118053665 | 118053666 | Human |
| 628584978 | GWAS2493207_H | calcium measurement, diet measurement QTL GWAS2493207 (human) | | 0.000009 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 111131258 | 111131259 | Human |
| 597308659 | GWAS1404733_H | total blood protein measurement QTL GWAS1404733 (human) | | 8e-13 | total blood protein measurement | | 4 | 122243645 | 122243646 | Human |
| 628617757 | GWAS2525986_H | appendicitis QTL GWAS2525986 (human) | | 2e-23 | appendicitis | | 4 | 110799841 | 110799842 | Human |
| 628945431 | GWAS2853660_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2853660 (human) | | 1e-08 | fatty acid amount (VT:0010046) | | 4 | 109345757 | 109345758 | Human |
| 406933293 | GWAS582269_H | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation QTL GWAS582269 (human) | | 1e-09 | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation | | 4 | 117452280 | 117452281 | Human |
| 406900526 | GWAS549502_H | pulse pressure measurement QTL GWAS549502 (human) | | 0.0000007 | pulse pressure measurement | | 4 | 122671579 | 122671580 | Human |
| 597488883 | GWAS1584957_H | phosphatidylcholine measurement QTL GWAS1584957 (human) | | 4e-08 | phosphatidylcholine measurement | | 4 | 112567861 | 112567862 | Human |
| 598095059 | GWAS1812452_H | fat pad mass QTL GWAS1812452 (human) | | 0.000005 | fat pad mass | | 4 | 124429906 | 124429907 | Human |
| 597341408 | GWAS1437482_H | asthma QTL GWAS1437482 (human) | | 2e-26 | asthma | | 4 | 122146653 | 122146654 | Human |
| 628470287 | GWAS2378516_H | major depressive disorder QTL GWAS2378516 (human) | | 3e-24 | major depressive disorder | | 4 | 122201701 | 122201702 | Human |
| 597603557 | GWAS1660417_H | mean platelet volume QTL GWAS1660417 (human) | | 7e-27 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 406949693 | GWAS598669_H | trait in response to cytarabine QTL GWAS598669 (human) | | 0.000007 | trait in response to cytarabine | | 4 | 119691563 | 119691564 | Human |
| 628683269 | GWAS2591498_H | diastolic blood pressure QTL GWAS2591498 (human) | | 5e-17 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110461529 | 110461530 | Human |
| 597456098 | GWAS1552172_H | diastolic blood pressure QTL GWAS1552172 (human) | | 1e-12 | diastolic blood pressure | | 4 | 110430068 | 110430069 | Human |
| 628699896 | GWAS2608125_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2608125 (human) | | 3e-14 | glioma pathogenesis-related protein 1 measurement | | 4 | 117846456 | 117846457 | Human |
| 597177373 | GWAS1273447_H | spermidine measurement QTL GWAS1273447 (human) | | 4e-08 | spermidine measurement | | 4 | 109176399 | 109176400 | Human |
| 628437744 | GWAS2345973_H | Alzheimer disease QTL GWAS2345973 (human) | | 0.000001 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 407293889 | GWAS942865_H | epidermal growth factor measurement QTL GWAS942865 (human) | | 5e-17 | epidermal growth factor measurement | | 4 | 109961320 | 109961321 | Human |
| 406949833 | GWAS598809_H | body mass index QTL GWAS598809 (human) | | 0.0000003 | body mass index | | 4 | 129895905 | 129895906 | Human |
| 628912885 | GWAS2821114_H | body height QTL GWAS2821114 (human) | | 2e-11 | body height | | 4 | 119840636 | 119840637 | Human |
| 628978417 | GWAS2886646_H | body height QTL GWAS2886646 (human) | | 4e-12 | body height | | 4 | 125766158 | 125766159 | Human |
| 616477491 | GWAS1874074_H | blood protein amount QTL GWAS1874074 (human) | | 2e-83 | blood protein amount | | 4 | 106943827 | 106943828 | Human |
| 616379180 | GWAS1859422_H | obsolete_blood protein measurement QTL GWAS1859422 (human) | | 2e-83 | obsolete_blood protein measurement | | 4 | 106943827 | 106943828 | Human |
| 597521420 | GWAS1617494_H | open-angle glaucoma QTL GWAS1617494 (human) | | 7e-09 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 616559404 | GWAS1955987_H | hypertension QTL GWAS1955987 (human) | | 3e-12 | hypertension | | 4 | 110510288 | 110510289 | Human |
| 628912872 | GWAS2821101_H | body height QTL GWAS2821101 (human) | | 4e-13 | body height | | 4 | 124017347 | 124017348 | Human |
| 628437731 | GWAS2345960_H | Alzheimer disease QTL GWAS2345960 (human) | | 0.000003 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 628683488 | GWAS2591717_H | open-angle glaucoma QTL GWAS2591717 (human) | | 8e-09 | eye integrity trait (VT:0011107) | | 4 | 111039218 | 111039219 | Human |
| 616952669 | GWAS1970168_H | intelligence QTL GWAS1970168 (human) | | 0.0000009 | intelligence | | 4 | 117956978 | 117956979 | Human |
| 628912871 | GWAS2821100_H | body height QTL GWAS2821100 (human) | | 1e-10 | body height | | 4 | 121817966 | 121817967 | Human |
| 628470505 | GWAS2378734_H | clostridium difficile infection QTL GWAS2378734 (human) | | 0.000003 | response to bacterial infection trait (VT:0010435) | | 4 | 120516660 | 120516661 | Human |
| 616526622 | GWAS1923205_H | platelet crit QTL GWAS1923205 (human) | | 5e-12 | platelet crit | | 4 | 123857901 | 123857902 | Human |
| 597177402 | GWAS1273476_H | protein measurement QTL GWAS1273476 (human) | | 2e-152 | protein measurement | | 4 | 110510288 | 110510289 | Human |
| 628830937 | GWAS2739166_H | platelet crit QTL GWAS2739166 (human) | | 5e-12 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 123857901 | 123857902 | Human |
| 597177403 | GWAS1273477_H | protein measurement QTL GWAS1273477 (human) | | 1e-149 | protein measurement | | 4 | 110489326 | 110489327 | Human |
| 406933477 | GWAS582453_H | smoking status measurement QTL GWAS582453 (human) | | 6e-10 | smoking status measurement | | 4 | 111485805 | 111485806 | Human |
| 628962008 | GWAS2870237_H | parasitic infection QTL GWAS2870237 (human) | | 7e-12 | parasitic infection | | 4 | 108582778 | 108582779 | Human |
| 598144000 | GWAS1830728_H | bone tissue density QTL GWAS1830728 (human) | | 1e-194 | bone tissue density | | 4 | 107799654 | 107799655 | Human |
| 596964414 | GWAS1083933_H | gut microbiome measurement, bone density QTL GWAS1083933 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116019324 | 116019325 | Human |
| 596964415 | GWAS1083934_H | gut microbiome measurement, bone density QTL GWAS1083934 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116034483 | 116034484 | Human |
| 598144010 | GWAS1830738_H | bone tissue density QTL GWAS1830738 (human) | | 4e-186 | bone tissue density | | 4 | 107807550 | 107807551 | Human |
| 617034601 | GWAS2052100_H | smoking initiation QTL GWAS2052100 (human) | | 2e-11 | smoking initiation | | 4 | 111546456 | 111546457 | Human |
| 616952683 | GWAS1970182_H | body mass index QTL GWAS1970182 (human) | | 0.000001 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129895905 | 129895906 | Human |
| 628568775 | GWAS2477004_H | glycerophospholipid measurement QTL GWAS2477004 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114480417 | 114480418 | Human |
| 616362765 | GWAS1847480_H | height growth attribute QTL GWAS1847480 (human) | | 0.000003 | height growth attribute | | 4 | 108080989 | 108080990 | Human |
| 628568774 | GWAS2477003_H | glycerophospholipid measurement QTL GWAS2477003 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114480357 | 114480358 | Human |
| 628568773 | GWAS2477002_H | glycerophospholipid measurement QTL GWAS2477002 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114511670 | 114511671 | Human |
| 407048177 | GWAS697153_H | executive function measurement QTL GWAS697153 (human) | | 0.000002 | executive function measurement | | 4 | 130874841 | 130874842 | Human |
| 628568772 | GWAS2477001_H | glycerophospholipid measurement QTL GWAS2477001 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114479772 | 114479773 | Human |
| 628568771 | GWAS2477000_H | glycerophospholipid measurement QTL GWAS2477000 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114519788 | 114519789 | Human |
| 597111843 | GWAS1207917_H | platelet count QTL GWAS1207917 (human) | | 7e-11 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 628667084 | GWAS2575313_H | body fat percentage QTL GWAS2575313 (human) | | 3e-08 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 4 | 123822104 | 123822105 | Human |
| 597111842 | GWAS1207916_H | platelet count QTL GWAS1207916 (human) | | 3e-27 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109966833 | 109966834 | Human |
| 407015418 | GWAS664394_H | Ischemic stroke QTL GWAS664394 (human) | | 3e-14 | Ischemic stroke | | 4 | 110755885 | 110755886 | Human |
| 617100144 | GWAS2117643_H | lymphocyte percentage of leukocytes QTL GWAS2117643 (human) | | 3e-21 | lymphocyte percentage of leukocytes | | 4 | 112142370 | 112142371 | Human |
| 597292064 | GWAS1388138_H | respiratory system disease QTL GWAS1388138 (human) | | 5e-36 | respiratory system disease | | 4 | 122432277 | 122432278 | Human |
| 597062700 | GWAS1158774_H | fat body mass QTL GWAS1158774 (human) | | 0.000005 | fat body mass | | 4 | 124429906 | 124429907 | Human |
| 597390368 | GWAS1486442_H | triglyceride measurement QTL GWAS1486442 (human) | | 2e-09 | triglyceride measurement | | 4 | 123822104 | 123822105 | Human |
| 406949885 | GWAS598861_H | body mass index QTL GWAS598861 (human) | | 0.0000007 | body mass index | | 4 | 122841742 | 122841743 | Human |
| 628568777 | GWAS2477006_H | glycerophospholipid measurement QTL GWAS2477006 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114480792 | 114480793 | Human |
| 628568776 | GWAS2477005_H | glycerophospholipid measurement QTL GWAS2477005 (human) | | 4e-10 | blood phospholipid amount (VT:0006084) | | 4 | 114495770 | 114495771 | Human |
| 628945598 | GWAS2853827_H | serum gamma-glutamyl transferase measurement QTL GWAS2853827 (human) | | 3e-08 | blood gamma-glutamyltransferase amount (VT:0010607) | serum gamma-glutamyltransferase activity level (CMO:0002241) | 4 | 111793842 | 111793843 | Human |
| 597455960 | GWAS1552034_H | childhood trauma measurement, alcohol consumption measurement QTL GWAS1552034 (human) | | 1e-08 | childhood trauma measurement, alcohol consumption measurement | | 4 | 126655945 | 126655946 | Human |
| 597455961 | GWAS1552035_H | childhood trauma measurement, alcohol consumption measurement QTL GWAS1552035 (human) | | 8e-09 | childhood trauma measurement, alcohol consumption measurement | | 4 | 127440030 | 127440031 | Human |
| 628650686 | GWAS2558915_H | inflammatory bowel disease QTL GWAS2558915 (human) | | 1e-08 | intestine integrity trait (VT:0010554) | | 4 | 122354400 | 122354401 | Human |
| 598094944 | GWAS1812337_H | fat pad mass QTL GWAS1812337 (human) | | 0.000003 | fat pad mass | | 4 | 129885831 | 129885832 | Human |
| 597128287 | GWAS1224361_H | glycerophospholipid measurement QTL GWAS1224361 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114515499 | 114515500 | Human |
| 596980831 | GWAS1100350_H | memory performance, sex interaction measurement QTL GWAS1100350 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109131697 | 109131698 | Human |
| 628863665 | GWAS2771894_H | smoking initiation QTL GWAS2771894 (human) | | 3e-11 | behavior trait (VT:0010442) | | 4 | 131604639 | 131604640 | Human |
| 596980830 | GWAS1100349_H | memory performance, sex interaction measurement QTL GWAS1100349 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109134293 | 109134294 | Human |
| 628863664 | GWAS2771893_H | smoking initiation QTL GWAS2771893 (human) | | 5e-09 | behavior trait (VT:0010442) | | 4 | 130533359 | 130533360 | Human |
| 628748981 | GWAS2657210_H | atrial fibrillation QTL GWAS2657210 (human) | | 5e-11 | atrial fibrillation | | 4 | 121877258 | 121877259 | Human |
| 628454072 | GWAS2362301_H | atrial fibrillation QTL GWAS2362301 (human) | | 7e-443 | atrial fibrillation | | 4 | 110778529 | 110778530 | Human |
| 628748983 | GWAS2657212_H | atrial fibrillation QTL GWAS2657212 (human) | | 1e-08 | atrial fibrillation | | 4 | 128544334 | 128544335 | Human |
| 628748982 | GWAS2657211_H | atrial fibrillation QTL GWAS2657211 (human) | | 2e-09 | atrial fibrillation | | 4 | 122917603 | 122917604 | Human |
| 597423179 | GWAS1519253_H | atrial fibrillation QTL GWAS1519253 (human) | | 3e-81 | atrial fibrillation | | 4 | 110674360 | 110674361 | Human |
| 628863659 | GWAS2771888_H | smoking initiation QTL GWAS2771888 (human) | | 4e-09 | behavior trait (VT:0010442) | | 4 | 117868703 | 117868704 | Human |
| 597423178 | GWAS1519252_H | atrial fibrillation QTL GWAS1519252 (human) | | 3e-19 | atrial fibrillation | | 4 | 110665288 | 110665289 | Human |
| 628863658 | GWAS2771887_H | smoking initiation QTL GWAS2771887 (human) | | 3e-12 | behavior trait (VT:0010442) | | 4 | 115630160 | 115630161 | Human |
| 597423177 | GWAS1519251_H | atrial fibrillation QTL GWAS1519251 (human) | | 8e-20 | atrial fibrillation | | 4 | 110659017 | 110659018 | Human |
| 628863657 | GWAS2771886_H | smoking initiation QTL GWAS2771886 (human) | | 2e-10 | behavior trait (VT:0010442) | | 4 | 115079942 | 115079943 | Human |
| 628978351 | GWAS2886580_H | body weight QTL GWAS2886580 (human) | | 3e-10 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 124018099 | 124018100 | Human |
| 597423176 | GWAS1519250_H | atrial fibrillation QTL GWAS1519250 (human) | | 1e-11 | atrial fibrillation | | 4 | 110639637 | 110639638 | Human |
| 628863656 | GWAS2771885_H | smoking initiation QTL GWAS2771885 (human) | | 6e-26 | behavior trait (VT:0010442) | | 4 | 111500989 | 111500990 | Human |
| 617116443 | GWAS2133942_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2133942 (human) | | 3e-14 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 117846456 | 117846457 | Human |
| 597423183 | GWAS1519257_H | atrial fibrillation QTL GWAS1519257 (human) | | 6e-305 | atrial fibrillation | | 4 | 110743002 | 110743003 | Human |
| 596964416 | GWAS1083935_H | gut microbiome measurement, bone density QTL GWAS1083935 (human) | | 2e-09 | gut microbiome measurement, bone density | | 4 | 116039953 | 116039954 | Human |
| 597046338 | GWAS1142412_H | erythrocyte count QTL GWAS1142412 (human) | | 4e-09 | erythrocyte count | | 4 | 127869642 | 127869643 | Human |
| 628863663 | GWAS2771892_H | smoking initiation QTL GWAS2771892 (human) | | 8e-16 | behavior trait (VT:0010442) | | 4 | 129269203 | 129269204 | Human |
| 597423182 | GWAS1519256_H | atrial fibrillation QTL GWAS1519256 (human) | | 1e-70 | atrial fibrillation | | 4 | 110735436 | 110735437 | Human |
| 407146385 | GWAS795361_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS795361 (human) | | 0.000002 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 123047357 | 123047358 | Human |
| 597423181 | GWAS1519255_H | atrial fibrillation QTL GWAS1519255 (human) | | 3e-11 | atrial fibrillation | | 4 | 110716779 | 110716780 | Human |
| 628863661 | GWAS2771890_H | smoking initiation QTL GWAS2771890 (human) | | 3e-10 | behavior trait (VT:0010442) | | 4 | 126727157 | 126727158 | Human |
| 597423180 | GWAS1519254_H | atrial fibrillation QTL GWAS1519254 (human) | | 4e-31 | atrial fibrillation | | 4 | 110714136 | 110714137 | Human |
| 628863660 | GWAS2771889_H | smoking initiation QTL GWAS2771889 (human) | | 8e-12 | behavior trait (VT:0010442) | | 4 | 122105714 | 122105715 | Human |
| 597423171 | GWAS1519245_H | atrial fibrillation QTL GWAS1519245 (human) | | 2e-12 | atrial fibrillation | | 4 | 110524540 | 110524541 | Human |
| 597423170 | GWAS1519244_H | atrial fibrillation QTL GWAS1519244 (human) | | 5e-09 | atrial fibrillation | | 4 | 110485340 | 110485341 | Human |
| 597210179 | GWAS1306253_H | hip bone mineral density, fat body mass QTL GWAS1306253 (human) | | 6e-09 | hip bone mineral density, fat body mass | | 4 | 129257175 | 129257176 | Human |
| 597423175 | GWAS1519249_H | atrial fibrillation QTL GWAS1519249 (human) | | 3e-17 | atrial fibrillation | | 4 | 110609843 | 110609844 | Human |
| 616526691 | GWAS1923274_H | eosinophil percentage of leukocytes QTL GWAS1923274 (human) | | 3e-19 | eosinophil percentage of leukocytes | | 4 | 122698534 | 122698535 | Human |
| 628961953 | GWAS2870182_H | hemoglobin measurement QTL GWAS2870182 (human) | | 3e-14 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 124004016 | 124004017 | Human |
| 407080863 | GWAS729839_H | X-26054 measurement QTL GWAS729839 (human) | | 3e-168 | X-26054 measurement | | 4 | 129109789 | 129109790 | Human |
| 597423174 | GWAS1519248_H | atrial fibrillation QTL GWAS1519248 (human) | | 1e-36 | atrial fibrillation | | 4 | 110589415 | 110589416 | Human |
| 597423173 | GWAS1519247_H | atrial fibrillation QTL GWAS1519247 (human) | | 3e-12 | atrial fibrillation | | 4 | 110574086 | 110574087 | Human |
| 597423172 | GWAS1519246_H | atrial fibrillation QTL GWAS1519246 (human) | | 4e-09 | atrial fibrillation | | 4 | 110546303 | 110546304 | Human |
| 597455939 | GWAS1552013_H | mean corpuscular volume QTL GWAS1552013 (human) | | 4e-16 | mean corpuscular volume | | 4 | 127534974 | 127534975 | Human |
| 617083687 | GWAS2101186_H | sexual dimorphism measurement QTL GWAS2101186 (human) | | 4e-12 | sexual dimorphism measurement | | 4 | 121774530 | 121774531 | Human |
| 628732568 | GWAS2640797_H | BMI-adjusted hip circumference QTL GWAS2640797 (human) | | 1e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 119821103 | 119821104 | Human |
| 597390458 | GWAS1486532_H | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis QTL GWAS1486532 (human) | | 3e-08 | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | | 4 | 122639784 | 122639785 | Human |
| 628421264 | GWAS2329493_H | appendicular lean mass QTL GWAS2329493 (human) | | 1e-09 | body lean mass (VT:0010483) | | 4 | 119455163 | 119455164 | Human |
| 597619832 | GWAS1676692_H | mental or behavioural disorder QTL GWAS1676692 (human) | | 4e-13 | mental or behavioural disorder | | 4 | 126106138 | 126106139 | Human |
| 628568733 | GWAS2476962_H | clear cell renal carcinoma QTL GWAS2476962 (human) | | 8e-11 | clear cell renal carcinoma | | 4 | 108791438 | 108791439 | Human |
| 616952623 | GWAS1970122_H | medication adherence behavior QTL GWAS1970122 (human) | | 0.000001 | behavior trait (VT:0010442) | | 4 | 111199502 | 111199503 | Human |
| 597095547 | GWAS1191621_H | emphysema imaging measurement QTL GWAS1191621 (human) | | 0.0000009 | lung integrity trait (VT:0010906) | | 4 | 122028914 | 122028915 | Human |
| 407015341 | GWAS664317_H | myocardial infarction QTL GWAS664317 (human) | | 0.0000006 | myocardial infarction | | 4 | 118789266 | 118789267 | Human |
| 597128295 | GWAS1224369_H | glycerophospholipid measurement QTL GWAS1224369 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114502041 | 114502042 | Human |
| 597128294 | GWAS1224368_H | glycerophospholipid measurement QTL GWAS1224368 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114494754 | 114494755 | Human |
| 597128293 | GWAS1224367_H | glycerophospholipid measurement QTL GWAS1224367 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582848 | 114582849 | Human |
| 628732555 | GWAS2640784_H | BMI-adjusted hip circumference QTL GWAS2640784 (human) | | 4e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 119798713 | 119798714 | Human |
| 407015344 | GWAS664320_H | spine bone mineral density QTL GWAS664320 (human) | | 0.0000003 | spine bone mineral density | | 4 | 125801465 | 125801466 | Human |
| 597128292 | GWAS1224366_H | glycerophospholipid measurement QTL GWAS1224366 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114531582 | 114531583 | Human |
| 628732554 | GWAS2640783_H | BMI-adjusted hip circumference QTL GWAS2640783 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 119820087 | 119820088 | Human |
| 597128291 | GWAS1224365_H | glycerophospholipid measurement QTL GWAS1224365 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114495098 | 114495099 | Human |
| 628732557 | GWAS2640786_H | BMI-adjusted hip circumference QTL GWAS2640786 (human) | | 1e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 121824574 | 121824575 | Human |
| 596980832 | GWAS1100351_H | memory performance, sex interaction measurement QTL GWAS1100351 (human) | | 0.000003 | memory performance, sex interaction measurement | | 4 | 109132717 | 109132718 | Human |
| 597128290 | GWAS1224364_H | glycerophospholipid measurement QTL GWAS1224364 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114528667 | 114528668 | Human |
| 628863630 | GWAS2771859_H | information processing speed, response to cranial radiation therapy QTL GWAS2771859 (human) | | 0.000004 | cognitive behavior trait (VT:0010450) | | 4 | 117423051 | 117423052 | Human |
| 628732556 | GWAS2640785_H | BMI-adjusted hip circumference QTL GWAS2640785 (human) | | 3e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 121774530 | 121774531 | Human |
| 598029392 | GWAS1748691_H | facial morphology trait QTL GWAS1748691 (human) | | 4e-11 | facial morphology trait | | 4 | 126014320 | 126014321 | Human |
| 406982580 | GWAS631556_H | depressive symptom measurement, stressful life event measurement QTL GWAS631556 (human) | | 0.000008 | depressive symptom measurement, stressful life event measurement | | 4 | 110061116 | 110061117 | Human |
| 597128289 | GWAS1224363_H | glycerophospholipid measurement QTL GWAS1224363 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582806 | 114582807 | Human |
| 596980834 | GWAS1100353_H | memory performance, sex interaction measurement QTL GWAS1100353 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109129061 | 109129062 | Human |
| 597128288 | GWAS1224362_H | glycerophospholipid measurement QTL GWAS1224362 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582721 | 114582722 | Human |
| 628732558 | GWAS2640787_H | BMI-adjusted hip circumference QTL GWAS2640787 (human) | | 3e-12 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 121792708 | 121792709 | Human |
| 628585103 | GWAS2493332_H | epidermal growth factor measurement QTL GWAS2493332 (human) | | 3e-25 | epidermal growth factor measurement | | 4 | 109967851 | 109967852 | Human |
| 628732545 | GWAS2640774_H | systolic blood pressure QTL GWAS2640774 (human) | | 5e-17 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110414448 | 110414449 | Human |
| 628732544 | GWAS2640773_H | systolic blood pressure QTL GWAS2640773 (human) | | 1e-10 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110368093 | 110368094 | Human |
| 597128301 | GWAS1224375_H | glycerophospholipid measurement QTL GWAS1224375 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114479168 | 114479169 | Human |
| 628732547 | GWAS2640776_H | systolic blood pressure QTL GWAS2640776 (human) | | 5e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 119996191 | 119996192 | Human |
| 597128300 | GWAS1224374_H | glycerophospholipid measurement QTL GWAS1224374 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114569301 | 114569302 | Human |
| 617067324 | GWAS2084823_H | able to hear with hearing aids QTL GWAS2084823 (human) | | 0.0000003 | able to hear with hearing aids | | 4 | 116261685 | 116261686 | Human |
| 628732546 | GWAS2640775_H | systolic blood pressure QTL GWAS2640775 (human) | | 7e-11 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 119633559 | 119633560 | Human |
| 597128299 | GWAS1224373_H | glycerophospholipid measurement QTL GWAS1224373 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114557814 | 114557815 | Human |
| 597439584 | GWAS1535658_H | celiac disease QTL GWAS1535658 (human) | | 2e-38 | celiac disease | | 4 | 122629959 | 122629960 | Human |
| 597128298 | GWAS1224372_H | glycerophospholipid measurement QTL GWAS1224372 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114484294 | 114484295 | Human |
| 597587043 | GWAS1643903_H | eosinophil count QTL GWAS1643903 (human) | | 5e-16 | eosinophil count | | 4 | 122663791 | 122663792 | Human |
| 628732548 | GWAS2640777_H | systolic blood pressure QTL GWAS2640777 (human) | | 2e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 123878327 | 123878328 | Human |
| 597128297 | GWAS1224371_H | glycerophospholipid measurement QTL GWAS1224371 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114483807 | 114483808 | Human |
| 597128296 | GWAS1224370_H | glycerophospholipid measurement QTL GWAS1224370 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114495078 | 114495079 | Human |
| 407146427 | GWAS795403_H | allergic disease QTL GWAS795403 (human) | | 4e-08 | allergic disease | | 4 | 122408207 | 122408208 | Human |
| 597408667 | GWAS1504741_H | uric acid measurement QTL GWAS1504741 (human) | | 3e-08 | uric acid measurement | | 4 | 127173154 | 127173155 | Human |
| 628768120 | GWAS2676349_H | open-angle glaucoma QTL GWAS2676349 (human) | | 2e-09 | eye integrity trait (VT:0011107) | | 4 | 127549411 | 127549412 | Human |
| 407044160 | GWAS693136_H | cortical thickness QTL GWAS693136 (human) | | 8e-11 | cortical thickness | | 4 | 120708831 | 120708832 | Human |
| 597162899 | GWAS1258973_H | factor XI measurement, Ischemic stroke QTL GWAS1258973 (human) | | 2e-16 | factor XI measurement, Ischemic stroke | | 4 | 110775495 | 110775496 | Human |
| 628817279 | GWAS2725508_H | erythrocyte volume QTL GWAS2725508 (human) | | 3e-20 | erythrocyte volume | | 4 | 127690477 | 127690478 | Human |
| 628620657 | GWAS2528886_H | body height QTL GWAS2528886 (human) | | 2e-10 | body height | | 4 | 119636718 | 119636719 | Human |
| 628620656 | GWAS2528885_H | body height QTL GWAS2528885 (human) | | 4e-09 | body height | | 4 | 119356945 | 119356946 | Human |
| 628637040 | GWAS2545269_H | gut microbiome measurement, environmental exposure measurement QTL GWAS2545269 (human) | | 3e-08 | gut microbiome measurement, environmental exposure measurement | | 4 | 120561055 | 120561056 | Human |
| 628555135 | GWAS2463364_H | level of sphingomyelin phosphodiesterase in blood QTL GWAS2463364 (human) | | 4e-15 | level of sphingomyelin phosphodiesterase in blood | | 4 | 118868269 | 118868270 | Human |
| 407142478 | GWAS791454_H | sex interaction measurement, bilirubin measurement QTL GWAS791454 (human) | | 0.000005 | sex interaction measurement, bilirubin measurement | | 4 | 109805166 | 109805167 | Human |
| 407011400 | GWAS660376_H | sex hormone-binding globulin measurement QTL GWAS660376 (human) | | 3e-17 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 597228435 | GWAS1324509_H | blood protein measurement QTL GWAS1324509 (human) | | 1e-336 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 597080987 | GWAS1177061_H | gut microbiome measurement QTL GWAS1177061 (human) | | 0.000008 | gut microbiome measurement | | 4 | 118360545 | 118360546 | Human |
| 407289931 | GWAS938907_H | cortical thickness QTL GWAS938907 (human) | | 9e-16 | cortical thickness | | 4 | 120645452 | 120645453 | Human |
| 597310357 | GWAS1406431_H | glomerular filtration rate QTL GWAS1406431 (human) | | 9e-15 | glomerular filtration rate | | 4 | 108772770 | 108772771 | Human |
| 407355479 | GWAS1004455_H | BMI-adjusted waist circumference QTL GWAS1004455 (human) | | 2e-11 | BMI-adjusted waist circumference | | 4 | 119213641 | 119213642 | Human |
| 626457921 | GWAS2271854_H | hematocrit QTL GWAS2271854 (human) | | 2e-09 | hematocrit | | 4 | 124004016 | 124004017 | Human |
| 628620655 | GWAS2528884_H | body height QTL GWAS2528884 (human) | | 7e-09 | body height | | 4 | 119085821 | 119085822 | Human |
| 597425027 | GWAS1521101_H | platelet-to-lymphocyte ratio QTL GWAS1521101 (human) | | 5e-08 | platelet-to-lymphocyte ratio | | 4 | 121774530 | 121774531 | Human |
| 597195648 | GWAS1291722_H | memory performance QTL GWAS1291722 (human) | | 0.000006 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124895966 | 124895967 | Human |
| 628620654 | GWAS2528883_H | body height QTL GWAS2528883 (human) | | 3e-09 | body height | | 4 | 118235326 | 118235327 | Human |
| 407011416 | GWAS660392_H | rheumatoid arthritis QTL GWAS660392 (human) | | 4e-08 | rheumatoid arthritis | | 4 | 112286121 | 112286122 | Human |
| 628620653 | GWAS2528882_H | body height QTL GWAS2528882 (human) | | 1e-15 | body height | | 4 | 113968218 | 113968219 | Human |
| 597195650 | GWAS1291724_H | memory performance QTL GWAS1291724 (human) | | 0.000006 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124897660 | 124897661 | Human |
| 597162892 | GWAS1258966_H | heart failure QTL GWAS1258966 (human) | | 9e-17 | heart failure | | 4 | 110776497 | 110776498 | Human |
| 628620652 | GWAS2528881_H | body height QTL GWAS2528881 (human) | | 8e-11 | body height | | 4 | 113824425 | 113824426 | Human |
| 628620651 | GWAS2528880_H | body height QTL GWAS2528880 (human) | | 2e-10 | body height | | 4 | 109834165 | 109834166 | Human |
| 628620650 | GWAS2528879_H | body height QTL GWAS2528879 (human) | | 1e-32 | body height | | 4 | 108535458 | 108535459 | Human |
| 597195653 | GWAS1291727_H | memory performance QTL GWAS1291727 (human) | | 0.000006 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124885712 | 124885713 | Human |
| 628620649 | GWAS2528878_H | body height QTL GWAS2528878 (human) | | 1e-16 | body height | | 4 | 108355674 | 108355675 | Human |
| 628620648 | GWAS2528877_H | body height QTL GWAS2528877 (human) | | 1e-14 | body height | | 4 | 108180849 | 108180850 | Human |
| 628505942 | GWAS2414171_H | diastolic blood pressure QTL GWAS2414171 (human) | | 0.0000007 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 123873489 | 123873490 | Human |
| 596966320 | GWAS1085839_H | diastolic blood pressure QTL GWAS1085839 (human) | | 1e-13 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 617020642 | GWAS2038141_H | protein measurement QTL GWAS2038141 (human) | | 2e-15 | protein amount (VT:0010120) | | 4 | 121395817 | 121395818 | Human |
| 407027818 | GWAS676794_H | sex hormone-binding globulin measurement QTL GWAS676794 (human) | | 7e-23 | sex hormone-binding globulin measurement | | 4 | 109321740 | 109321741 | Human |
| 598096782 | GWAS1814175_H | sleep quality QTL GWAS1814175 (human) | | 0.000006 | sleep quality | | 4 | 118160921 | 118160922 | Human |
| 597294002 | GWAS1390076_H | body height QTL GWAS1390076 (human) | | 5e-14 | body height | | 4 | 119501252 | 119501253 | Human |
| 407126127 | GWAS775103_H | color vision disorder QTL GWAS775103 (human) | | 0.000003 | color vision disorder | | 4 | 124815973 | 124815974 | Human |
| 617135333 | GWAS2152832_H | level of BPI fold-containing family B member 2 in blood QTL GWAS2152832 (human) | | 2e-38 | level of BPI fold-containing family B member 2 in blood | | 4 | 109603883 | 109603884 | Human |
| 598096779 | GWAS1814172_H | sleep quality QTL GWAS1814172 (human) | | 0.000005 | sleep quality | | 4 | 118053665 | 118053666 | Human |
| 407404646 | GWAS1053622_H | cortical surface area measurement QTL GWAS1053622 (human) | | 8e-10 | cortical surface area measurement | | 4 | 120653052 | 120653053 | Human |
| 598113161 | GWAS1822044_H | pain measurement QTL GWAS1822044 (human) | | 2e-08 | pain measurement | | 4 | 129322917 | 129322918 | Human |
| 597588911 | GWAS1645771_H | retinopathy QTL GWAS1645771 (human) | | 3e-12 | retinopathy | | 4 | 109764664 | 109764665 | Human |
| 406896754 | GWAS545730_H | platelet measurement QTL GWAS545730 (human) | | 0.0000002 | platelet measurement | | 4 | 109952770 | 109952771 | Human |
| 628407622 | GWAS2315851_H | Erythema nodosum QTL GWAS2315851 (human) | | 5e-08 | Erythema nodosum | | 4 | 117413463 | 117413464 | Human |
| 407126129 | GWAS775105_H | color vision disorder QTL GWAS775105 (human) | | 0.000003 | color vision disorder | | 4 | 108200574 | 108200575 | Human |
| 406896757 | GWAS545733_H | platelet measurement QTL GWAS545733 (human) | | 4e-52 | platelet measurement | | 4 | 110008970 | 110008971 | Human |
| 407224446 | GWAS873422_H | blood protein measurement QTL GWAS873422 (human) | | 6e-894 | blood protein measurement | | 4 | 119309995 | 119309996 | Human |
| 407076989 | GWAS725965_H | treatment resistant depression, response to antidepressant QTL GWAS725965 (human) | | 0.000004 | treatment resistant depression, response to antidepressant | | 4 | 130496927 | 130496928 | Human |
| 628456759 | GWAS2364988_H | asthma QTL GWAS2364988 (human) | | 3e-09 | asthma | | 4 | 122134546 | 122134549 | Human |
| 597162965 | GWAS1259039_H | lipid measurement QTL GWAS1259039 (human) | | 6e-08 | lipid measurement | | 4 | 124266893 | 124266894 | Human |
| 617118860 | GWAS2136359_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2136359 (human) | | 4e-24 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 107844119 | 107844120 | Human |
| 597507033 | GWAS1603107_H | C-reactive protein measurement QTL GWAS1603107 (human) | | 4e-08 | C-reactive protein measurement | | 4 | 111731920 | 111731921 | Human |
| 406929417 | GWAS578393_H | alcohol consumption measurement QTL GWAS578393 (human) | | 7e-12 | alcohol consumption measurement | | 4 | 112674713 | 112674714 | Human |
| 628669744 | GWAS2577973_H | atopic eczema QTL GWAS2577973 (human) | | 1e-14 | atopic eczema | | 4 | 122263256 | 122263257 | Human |
| 406929416 | GWAS578392_H | alcohol consumption measurement QTL GWAS578392 (human) | | 4e-10 | alcohol consumption measurement | | 4 | 112392830 | 112392831 | Human |
| 406929419 | GWAS578395_H | alcohol consumption measurement QTL GWAS578395 (human) | | 4e-10 | alcohol consumption measurement | | 4 | 128811970 | 128811971 | Human |
| 406929418 | GWAS578394_H | alcohol consumption measurement QTL GWAS578394 (human) | | 4e-09 | alcohol consumption measurement | | 4 | 117942113 | 117942114 | Human |
| 406929421 | GWAS578397_H | alcohol consumption measurement QTL GWAS578397 (human) | | 2e-11 | alcohol consumption measurement | | 4 | 129324733 | 129324734 | Human |
| 628423994 | GWAS2332223_H | asthma exacerbation measurement QTL GWAS2332223 (human) | | 0.000008 | bronchoconstriction trait (VT:0001945) | | 4 | 125651718 | 125651719 | Human |
| 407404560 | GWAS1053536_H | obsolete_red blood cell distribution width QTL GWAS1053536 (human) | | 8e-08 | obsolete_red blood cell distribution width | | 4 | 121820188 | 121820189 | Human |
| 628538671 | GWAS2446900_H | reticulocyte amount QTL GWAS2446900 (human) | | 8e-13 | reticulocyte amount | | 4 | 109970517 | 109970518 | Human |
| 407404561 | GWAS1053537_H | obsolete_red blood cell distribution width QTL GWAS1053537 (human) | | 2e-09 | obsolete_red blood cell distribution width | | 4 | 122438414 | 122438415 | Human |
| 597982206 | GWAS1701505_H | visceral adipose tissue quantity, body mass index QTL GWAS1701505 (human) | | 0.000008 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 117158751 | 117158752 | Human |
| 407404562 | GWAS1053538_H | obsolete_red blood cell distribution width QTL GWAS1053538 (human) | | 1e-20 | obsolete_red blood cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 597588933 | GWAS1645793_H | degeneration of macula and posterior pole QTL GWAS1645793 (human) | | 1e-18 | degeneration of macula and posterior pole | | 4 | 109764664 | 109764665 | Human |
| 617020573 | GWAS2038072_H | leukocyte quantity QTL GWAS2038072 (human) | | 4e-12 | leukocyte quantity | | 4 | 119409000 | 119409001 | Human |
| 597375936 | GWAS1472010_H | type 1 diabetes mellitus QTL GWAS1472010 (human) | | 0.000002 | type 1 diabetes mellitus | | 4 | 122277280 | 122277281 | Human |
| 597146570 | GWAS1242644_H | COVID-19 QTL GWAS1242644 (human) | | 4e-08 | COVID-19 | | 4 | 108838313 | 108838314 | Human |
| 598031300 | GWAS1750599_H | phospholipids:total lipids ratio, blood VLDL cholesterol amount QTL GWAS1750599 (human) | | 6e-13 | phospholipids:total lipids ratio, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 597392378 | GWAS1488452_H | balding measurement QTL GWAS1488452 (human) | | 4e-12 | balding measurement | | 4 | 124209285 | 124209286 | Human |
| 597375992 | GWAS1472066_H | vital capacity QTL GWAS1472066 (human) | | 0.000004 | lung capacity (VT:0001942) | | 4 | 107194065 | 107194066 | Human |
| 597818317 | GWAS1685708_H | phospholipids:total lipids ratio QTL GWAS1685708 (human) | | 1e-11 | total cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 617036970 | GWAS2054469_H | COVID-19 QTL GWAS2054469 (human) | | 0.000006 | COVID-19 | | 4 | 106867781 | 106867782 | Human |
| 616987816 | GWAS2005315_H | age at menarche QTL GWAS2005315 (human) | | 7e-08 | age at menarche | | 4 | 129809917 | 129809918 | Human |
| 407404602 | GWAS1053578_H | unipolar depression QTL GWAS1053578 (human) | | 8e-21 | unipolar depression | | 4 | 122265238 | 122265239 | Human |
| 597588964 | GWAS1645824_H | blood coagulation disease QTL GWAS1645824 (human) | | 2e-11 | blood coagulation disease | | 4 | 110761735 | 110761736 | Human |
| 628899074 | GWAS2807303_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS2807303 (human) | | 8e-08 | joint integrity trait (VT:0010548) | | 4 | 108140462 | 108140463 | Human |
| 598031322 | GWAS1750621_H | body height QTL GWAS1750621 (human) | | 5e-14 | body height | | 4 | 119501252 | 119501253 | Human |
| 628571639 | GWAS2479868_H | body mass index QTL GWAS2479868 (human) | | 2e-14 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129810129 | 129810130 | Human |
| 628571638 | GWAS2479867_H | body mass index QTL GWAS2479867 (human) | | 1e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 114202933 | 114202934 | Human |
| 597490461 | GWAS1586535_H | response to calcium channel blocker QTL GWAS1586535 (human) | | 0.000002 | response to calcium channel blocker | | 4 | 119116902 | 119116903 | Human |
| 407290055 | GWAS939031_H | glomerular filtration rate QTL GWAS939031 (human) | | 3e-11 | glomerular filtration rate | | 4 | 127288162 | 127288163 | Human |
| 628571637 | GWAS2479866_H | body mass index QTL GWAS2479866 (human) | | 7e-12 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 111770620 | 111770621 | Human |
| 628997625 | GWAS2905854_H | platelet count QTL GWAS2905854 (human) | | 4e-36 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109927496 | 109927497 | Human |
| 628997627 | GWAS2905856_H | platelet count QTL GWAS2905856 (human) | | 3e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123835365 | 123835366 | Human |
| 628997626 | GWAS2905855_H | platelet count QTL GWAS2905855 (human) | | 4e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119439096 | 119439097 | Human |
| 616496185 | GWAS1892768_H | threonate measurement QTL GWAS1892768 (human) | | 0.000006 | threonate measurement | | 4 | 123844287 | 123844288 | Human |
| 617118784 | GWAS2136283_H | platelet count QTL GWAS2136283 (human) | | 4e-16 | platelet count | | 4 | 119439096 | 119439097 | Human |
| 407290063 | GWAS939039_H | high density lipoprotein cholesterol measurement QTL GWAS939039 (human) | | 7e-09 | high density lipoprotein cholesterol measurement | | 4 | 109603883 | 109603884 | Human |
| 407142605 | GWAS791581_H | mean corpuscular volume QTL GWAS791581 (human) | | 1e-08 | mean corpuscular volume | | 4 | 121766083 | 121766084 | Human |
| 617118785 | GWAS2136284_H | platelet count QTL GWAS2136284 (human) | | 3e-12 | platelet count | | 4 | 123835365 | 123835366 | Human |
| 616987723 | GWAS2005222_H | trait in response to zonisamide, motor function measurement, response to levodopa QTL GWAS2005222 (human) | | 0.000006 | trait in response to zonisamide, motor function measurement, response to levodopa | | 4 | 130211377 | 130211378 | Human |
| 598096681 | GWAS1814074_H | blood immunoglobulin amount QTL GWAS1814074 (human) | | 0.0000008 | blood immunoglobulin amount | | 4 | 110793733 | 110793734 | Human |
| 407240914 | GWAS889890_H | high density lipoprotein cholesterol measurement QTL GWAS889890 (human) | | 2e-11 | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 628653551 | GWAS2561780_H | pulse pressure measurement QTL GWAS2561780 (human) | | 0.0000009 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 132110786 | 132110787 | Human |
| 407093466 | GWAS742442_H | erectile dysfunction QTL GWAS742442 (human) | | 0.000009 | erectile dysfunction | | 4 | 123943461 | 123943462 | Human |
| 597113614 | GWAS1209688_H | major depressive disorder QTL GWAS1209688 (human) | | 2e-10 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
| 597113613 | GWAS1209687_H | major depressive disorder QTL GWAS1209687 (human) | | 8e-21 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
| 597588738 | GWAS1645598_H | encounter with health service QTL GWAS1645598 (human) | | 9e-14 | encounter with health service | | 4 | 110796911 | 110796912 | Human |
| 628588008 | GWAS2496237_H | cholesterol:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS2496237 (human) | | 8e-10 | blood IDL cholesterol amount (VT:0010503) | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 4 | 109657070 | 109657071 | Human |
| 628440554 | GWAS2348783_H | childhood onset asthma QTL GWAS2348783 (human) | | 8e-11 | childhood onset asthma | | 4 | 122451978 | 122451979 | Human |
| 597293880 | GWAS1389954_H | ceramide measurement QTL GWAS1389954 (human) | | 4e-08 | ceramide measurement | | 4 | 114407538 | 114407539 | Human |
| 597441341 | GWAS1537415_H | lipid measurement QTL GWAS1537415 (human) | | 0.000006 | lipid measurement | | 4 | 130393791 | 130393792 | Human |
| 598047491 | GWAS1766790_H | blood VLDL cholesterol amount QTL GWAS1766790 (human) | | 1e-08 | blood VLDL cholesterol amount | | 4 | 109717709 | 109717710 | Human |
| 628702675 | GWAS2610904_H | vaginal microbiome measurement QTL GWAS2610904 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 123235757 | 123235758 | Human |
| 617020522 | GWAS2038021_H | Red cell distribution width QTL GWAS2038021 (human) | | 7e-19 | erythrocyte size trait (VT:0000248) | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
| 406913260 | GWAS562236_H | bipolar disorder QTL GWAS562236 (human) | | 5e-09 | bipolar disorder | | 4 | 117534962 | 117534963 | Human |
| 597097273 | GWAS1193347_H | sex hormone-binding globulin measurement QTL GWAS1193347 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
| 628817354 | GWAS2725583_H | Calcium channel blocker use measurement QTL GWAS2725583 (human) | | 8e-14 | Calcium channel blocker use measurement | | 4 | 110465042 | 110465043 | Human |
| 407404794 | GWAS1053770_H | venous thromboembolism, response to antineoplastic agent QTL GWAS1053770 (human) | | 0.000004 | venous thromboembolism, response to antineoplastic agent | | 4 | 129240194 | 129240195 | Human |
| 617053311 | GWAS2070810_H | osteoarthritis, hip QTL GWAS2070810 (human) | | 3e-09 | osteoarthritis, hip | | 4 | 123863724 | 123863725 | Human |
| 616987772 | GWAS2005271_H | BMI-adjusted waist-hip ratio QTL GWAS2005271 (human) | | 9e-12 | BMI-adjusted waist-hip ratio | | 4 | 121705035 | 121705036 | Human |
| 597359393 | GWAS1455467_H | platelet count QTL GWAS1455467 (human) | | 3e-09 | platelet count | | 4 | 123806369 | 123806370 | Human |
| 597162838 | GWAS1258912_H | chronic bronchitis QTL GWAS1258912 (human) | | 2e-08 | chronic bronchitis | | 4 | 113635275 | 113635276 | Human |
| 407224461 | GWAS873437_H | triacylglycerol 52:4 measurement QTL GWAS873437 (human) | | 0.000006 | blood triglyceride amount (VT:0002644) | | 4 | 131018374 | 131018375 | Human |
| 628702642 | GWAS2610871_H | vaginal microbiome measurement QTL GWAS2610871 (human) | | 0.000004 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
| 596949849 | GWAS1069368_H | pelvic organ prolapse QTL GWAS1069368 (human) | | 2e-23 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
| 628817320 | GWAS2725549_H | serum creatinine amount QTL GWAS2725549 (human) | | 3e-09 | serum creatinine amount | | 4 | 128603358 | 128603359 | Human |
| 407077015 | GWAS725991_H | balding measurement QTL GWAS725991 (human) | | 1e-09 | balding measurement | | 4 | 106449528 | 106449529 | Human |
| 407077017 | GWAS725993_H | balding measurement QTL GWAS725993 (human) | | 2e-25 | balding measurement | | 4 | 107131838 | 107131839 | Human |
| 407044249 | GWAS693225_H | sexual dimorphism measurement QTL GWAS693225 (human) | | 4e-12 | sexual dimorphism measurement | | 4 | 121774530 | 121774531 | Human |
| 407077016 | GWAS725992_H | balding measurement QTL GWAS725992 (human) | | 3e-16 | balding measurement | | 4 | 106961911 | 106961912 | Human |
| 628817318 | GWAS2725547_H | serum creatinine amount QTL GWAS2725547 (human) | | 1e-13 | serum creatinine amount | | 4 | 127243324 | 127243325 | Human |
| 628784548 | GWAS2692777_H | response to antiviral drug, cirrhosis of liver QTL GWAS2692777 (human) | | 0.000005 | liver integrity trait (VT:0010547) | | 4 | 114986399 | 114986400 | Human |
| 597162825 | GWAS1258899_H | oleoylcarnitine measurement QTL GWAS1258899 (human) | | 0.000002 | oleoylcarnitine measurement | | 4 | 116466224 | 116466225 | Human |
| 628817317 | GWAS2725546_H | serum creatinine amount QTL GWAS2725546 (human) | | 2e-15 | serum creatinine amount | | 4 | 108782393 | 108782394 | Human |
| 597375812 | GWAS1471886_H | gut microbiome measurement QTL GWAS1471886 (human) | | 0.0000004 | gut microbiome measurement | | 4 | 116053081 | 116053082 | Human |
| 628440490 | GWAS2348719_H | major depressive disorder QTL GWAS2348719 (human) | | 2e-10 | depression-related behavior trait (VT:0015015) | | 4 | 122201701 | 122201702 | Human |
| 407371945 | GWAS1020921_H | chronotype measurement QTL GWAS1020921 (human) | | 1e-08 | chronotype measurement | | 4 | 113069787 | 113069788 | Human |
| 628653465 | GWAS2561694_H | heart failure QTL GWAS2561694 (human) | | 2e-09 | heart integrity trait (VT:0010757) | | 4 | 113463172 | 113463173 | Human |
| 617020452 | GWAS2037951_H | body mass index QTL GWAS2037951 (human) | | 7e-12 | body mass index | | 4 | 111770620 | 111770621 | Human |
| 617020453 | GWAS2037952_H | body mass index QTL GWAS2037952 (human) | | 2e-14 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 628735391 | GWAS2643620_H | glomerular filtration rate QTL GWAS2643620 (human) | | 1e-11 | glomerular filtration rate | | 4 | 127420965 | 127420966 | Human |
| 597195647 | GWAS1291721_H | memory performance QTL GWAS1291721 (human) | | 0.000006 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124893791 | 124893792 | Human |
| 597179249 | GWAS1275323_H | protein measurement QTL GWAS1275323 (human) | | 5e-47 | protein measurement | | 4 | 119501939 | 119501940 | Human |
| 617085998 | GWAS2103497_H | COVID-19 QTL GWAS2103497 (human) | | 0.000008 | COVID-19 | | 4 | 129389669 | 129389670 | Human |
| 597179250 | GWAS1275324_H | protein measurement QTL GWAS1275324 (human) | | 1e-162 | protein measurement | | 4 | 119635312 | 119635313 | Human |
| 596949886 | GWAS1069405_H | pelvic organ prolapse QTL GWAS1069405 (human) | | 1e-11 | pelvic organ prolapse | | 4 | 126146934 | 126146935 | Human |
| 597179251 | GWAS1275325_H | protein measurement QTL GWAS1275325 (human) | | 2e-78 | protein measurement | | 4 | 119638137 | 119638138 | Human |
| 598096717 | GWAS1814110_H | fibroblast growth factor 2 amount QTL GWAS1814110 (human) | | 6e-39 | fibroblast growth factor 2 amount | | 4 | 122836593 | 122836594 | Human |
| 597359478 | GWAS1455552_H | Cleft palate, cleft lip QTL GWAS1455552 (human) | | 0.0000009 | Cleft palate, cleft lip | | 4 | 123789429 | 123789430 | Human |
| 597277557 | GWAS1373631_H | testosterone measurement QTL GWAS1373631 (human) | | 6e-15 | testosterone measurement | | 4 | 124126476 | 124126477 | Human |
| 597179253 | GWAS1275327_H | protein measurement QTL GWAS1275327 (human) | | 4e-75 | protein measurement | | 4 | 119501939 | 119501940 | Human |
| 406913199 | GWAS562175_H | celiac disease QTL GWAS562175 (human) | | 2e-38 | celiac disease | | 4 | 122629959 | 122629960 | Human |
| 628440453 | GWAS2348682_H | childhood onset asthma QTL GWAS2348682 (human) | | 9e-12 | childhood onset asthma | | 4 | 122219915 | 122219916 | Human |
| 628440452 | GWAS2348681_H | childhood onset asthma QTL GWAS2348681 (human) | | 3e-13 | childhood onset asthma | | 4 | 122639784 | 122639785 | Human |
| 407011504 | GWAS660480_H | refractive error QTL GWAS660480 (human) | | 3e-12 | refractive error | | 4 | 119987548 | 119987549 | Human |
| 616971316 | GWAS1988815_H | smoking status measurement, systolic blood pressure QTL GWAS1988815 (human) | | 0.000006 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 123660107 | 123660108 | Human |
| 597130084 | GWAS1226158_H | cortical surface area measurement QTL GWAS1226158 (human) | | 1e-17 | cortical surface area measurement | | 4 | 118393759 | 118393760 | Human |
| 406896827 | GWAS545803_H | atrial fibrillation QTL GWAS545803 (human) | | 4e-08 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 406896829 | GWAS545805_H | atrial fibrillation QTL GWAS545805 (human) | | 8e-57 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 616954936 | GWAS1972435_H | neuroticism measurement QTL GWAS1972435 (human) | | 0.000004 | behavior trait (VT:0010442) | | 4 | 124054077 | 124054078 | Human |
| 406929596 | GWAS578572_H | Hepatitis QTL GWAS578572 (human) | | 1e-09 | Hepatitis | | 4 | 125282172 | 125282173 | Human |
| 406896962 | GWAS545938_H | atrial fibrillation QTL GWAS545938 (human) | | 2e-62 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407306561 | GWAS955537_H | lean body mass QTL GWAS955537 (human) | | 4e-13 | lean body mass | | 4 | 123145793 | 123145794 | Human |
| 617070031 | GWAS2087530_H | systolic blood pressure QTL GWAS2087530 (human) | | 6e-17 | systolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 597457548 | GWAS1553622_H | serum gamma-glutamyl transferase measurement QTL GWAS1553622 (human) | | 1e-08 | serum gamma-glutamyl transferase measurement | | 4 | 111793842 | 111793843 | Human |
| 628489317 | GWAS2397546_H | body mass index QTL GWAS2397546 (human) | | 7e-13 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
| 628489316 | GWAS2397545_H | body mass index QTL GWAS2397545 (human) | | 1e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112335581 | 112335582 | Human |
| 628489318 | GWAS2397547_H | body mass index QTL GWAS2397547 (human) | | 4e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 130102129 | 130102130 | Human |
| 597621384 | GWAS1678244_H | pericarditis QTL GWAS1678244 (human) | | 3e-12 | pericarditis | | 4 | 108935005 | 108935006 | Human |
| 628489315 | GWAS2397544_H | body mass index QTL GWAS2397544 (human) | | 1e-10 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 111765198 | 111765199 | Human |
| 617070033 | GWAS2087532_H | systolic blood pressure QTL GWAS2087532 (human) | | 9e-09 | systolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 617070032 | GWAS2087531_H | systolic blood pressure QTL GWAS2087531 (human) | | 3e-24 | systolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 407126364 | GWAS775340_H | cardioembolic stroke QTL GWAS775340 (human) | | 0.0000009 | cardioembolic stroke | | 4 | 110778170 | 110778171 | Human |
| 596966031 | GWAS1085550_H | systolic blood pressure QTL GWAS1085550 (human) | | 6e-09 | systolic blood pressure | | 4 | 108328807 | 108328808 | Human |
| 407257437 | GWAS906413_H | glomerular filtration rate QTL GWAS906413 (human) | | 7e-17 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 617020890 | GWAS2038389_H | sex hormone-binding globulin measurement QTL GWAS2038389 (human) | | 3e-12 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 598096570 | GWAS1813963_H | facial morphology trait QTL GWAS1813963 (human) | | 9e-12 | facial morphology trait | | 4 | 126901674 | 126901675 | Human |
| 617020889 | GWAS2038388_H | sex hormone-binding globulin measurement QTL GWAS2038388 (human) | | 1e-10 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 597195448 | GWAS1291522_H | memory performance QTL GWAS1291522 (human) | | 0.000007 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124885712 | 124885713 | Human |
| 597179066 | GWAS1275140_H | underweight body mass index status QTL GWAS1275140 (human) | | 0.000006 | underweight body mass index status | | 4 | 113088430 | 113088431 | Human |
| 628620383 | GWAS2528612_H | alcohol consumption quality QTL GWAS2528612 (human) | | 0.000008 | alcohol consumption quality | | 4 | 108819029 | 108819030 | Human |
| 597277361 | GWAS1373435_H | age-related macular degeneration, COVID-19 QTL GWAS1373435 (human) | | 4e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
| 628849746 | GWAS2757975_H | R-6-hydroxywarfarin measurement QTL GWAS2757975 (human) | | 0.000005 | R-6-hydroxywarfarin measurement | | 4 | 123651871 | 123651872 | Human |
| 596966078 | GWAS1085597_H | diastolic blood pressure QTL GWAS1085597 (human) | | 5e-17 | diastolic blood pressure | | 4 | 110461529 | 110461530 | Human |
| 628505692 | GWAS2413921_H | diastolic blood pressure QTL GWAS2413921 (human) | | 3e-08 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119037654 | 119037655 | Human |
| 597228210 | GWAS1324284_H | eye colour measurement QTL GWAS1324284 (human) | | 0.000007 | eye colour measurement | | 4 | 121396276 | 121396277 | Human |
| 628505693 | GWAS2413922_H | diastolic blood pressure QTL GWAS2413922 (human) | | 3e-21 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
| 628505690 | GWAS2413919_H | diastolic blood pressure QTL GWAS2413919 (human) | | 2e-27 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110416708 | 110416709 | Human |
| 628505691 | GWAS2413920_H | diastolic blood pressure QTL GWAS2413920 (human) | | 5e-27 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110461529 | 110461530 | Human |
| 597162682 | GWAS1258756_H | myocardial infarction QTL GWAS1258756 (human) | | 2e-09 | myocardial infarction | | 4 | 119979127 | 119979128 | Human |
| 597129914 | GWAS1225988_H | body height QTL GWAS1225988 (human) | | 4e-13 | body height | | 4 | 124017347 | 124017348 | Human |
| 628505688 | GWAS2413917_H | diastolic blood pressure QTL GWAS2413917 (human) | | 7e-12 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 108146742 | 108146743 | Human |
| 597129913 | GWAS1225987_H | body height QTL GWAS1225987 (human) | | 1e-10 | body height | | 4 | 121817966 | 121817967 | Human |
| 597621424 | GWAS1678284_H | body weight QTL GWAS1678284 (human) | | 3e-15 | body weight | | 4 | 129824994 | 129824995 | Human |
| 628505689 | GWAS2413918_H | diastolic blood pressure QTL GWAS2413918 (human) | | 2e-16 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110319122 | 110319123 | Human |
| 597129912 | GWAS1225986_H | body height QTL GWAS1225986 (human) | | 2e-11 | body height | | 4 | 119840636 | 119840637 | Human |
| 597195447 | GWAS1291521_H | memory performance QTL GWAS1291521 (human) | | 0.000007 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124897660 | 124897661 | Human |
| 628816968 | GWAS2725197_H | bipolar disorder, glomerular filtration rate QTL GWAS2725197 (human) | | 3e-08 | bipolar disorder, glomerular filtration rate | | 4 | 122596491 | 122596492 | Human |
| 407208316 | GWAS857292_H | cytokine measurement QTL GWAS857292 (human) | | 0.000003 | cytokine measurement | | 4 | 113030253 | 113030254 | Human |
| 597392034 | GWAS1488108_H | heel bone mineral density QTL GWAS1488108 (human) | | 3e-09 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 118869362 | 118869363 | Human |
| 597506726 | GWAS1602800_H | information processing speed, response to cranial radiation therapy QTL GWAS1602800 (human) | | 0.000004 | information processing speed, response to cranial radiation therapy | | 4 | 117423051 | 117423052 | Human |
| 406896896 | GWAS545872_H | atrial fibrillation QTL GWAS545872 (human) | | 3e-155 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 598014692 | GWAS1733991_H | cerebral cortex area attribute QTL GWAS1733991 (human) | | 4e-10 | cerebral cortex area attribute | | 4 | 112495627 | 112495628 | Human |
| 598014693 | GWAS1733992_H | cerebral cortex area attribute QTL GWAS1733992 (human) | | 0.0000006 | cerebral cortex area attribute | | 4 | 126616579 | 126616580 | Human |
| 616971655 | GWAS1989154_H | alcohol use disorder measurement, response to trauma exposure QTL GWAS1989154 (human) | | 3e-08 | stress-related behavior trait (VT:0010451) | | 4 | 129416904 | 129416905 | Human |
| 616562168 | GWAS1958751_H | alpha-L-iduronidase measurement QTL GWAS1958751 (human) | | 2e-12 | alpha-L-iduronidase measurement | | 4 | 109603883 | 109603884 | Human |
| 407126284 | GWAS775260_H | type 1 diabetes mellitus QTL GWAS775260 (human) | | 0.000003 | type 1 diabetes mellitus | | 4 | 122408207 | 122408208 | Human |
| 597605077 | GWAS1661937_H | mean platelet volume QTL GWAS1661937 (human) | | 7e-21 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 617102723 | GWAS2120222_H | gut microbiome measurement QTL GWAS2120222 (human) | | 4e-08 | gut microbiome measurement | | 4 | 130031153 | 130031154 | Human |
| 407191817 | GWAS840793_H | glycerophospholipid measurement QTL GWAS840793 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480417 | 114480418 | Human |
| 407191819 | GWAS840795_H | glycerophospholipid measurement QTL GWAS840795 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480792 | 114480793 | Human |
| 407191818 | GWAS840794_H | glycerophospholipid measurement QTL GWAS840794 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114495770 | 114495771 | Human |
| 628603943 | GWAS2512172_H | atrial fibrillation QTL GWAS2512172 (human) | | 6e-306 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 628816941 | GWAS2725170_H | Ischemic stroke QTL GWAS2725170 (human) | | 1e-15 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 407126291 | GWAS775267_H | type 2 diabetes mellitus QTL GWAS775267 (human) | | 0.000009 | type 2 diabetes mellitus | | 4 | 121744359 | 121744360 | Human |
| 597474044 | GWAS1570118_H | smoking status measurement QTL GWAS1570118 (human) | | 1e-10 | smoking status measurement | | 4 | 111546456 | 111546457 | Human |
| 628587542 | GWAS2495771_H | phospholipids:total lipids ratio, blood VLDL cholesterol amount QTL GWAS2495771 (human) | | 1e-11 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 109657070 | 109657071 | Human |
| 597228281 | GWAS1324355_H | protein measurement QTL GWAS1324355 (human) | | 6e-10 | protein amount (VT:0010120) | | 4 | 131061544 | 131061545 | Human |
| 597048050 | GWAS1144124_H | neuroticism measurement QTL GWAS1144124 (human) | | 3e-08 | neuroticism measurement | | 4 | 118263414 | 118263415 | Human |
| 407109921 | GWAS758897_H | reticulocyte count QTL GWAS758897 (human) | | 3e-18 | reticulocyte count | | 4 | 109944309 | 109944310 | Human |
| 628898842 | GWAS2807071_H | testosterone measurement QTL GWAS2807071 (human) | | 1e-16 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 124126476 | 124126477 | Human |
| 407109922 | GWAS758898_H | reticulocyte count QTL GWAS758898 (human) | | 3e-12 | reticulocyte count | | 4 | 128330896 | 128330897 | Human |
| 406946088 | GWAS595064_H | white matter hyperintensity measurement QTL GWAS595064 (human) | | 0.000002 | white matter hyperintensity measurement | | 4 | 113089932 | 113089933 | Human |
| 628702226 | GWAS2610455_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2610455 (human) | | 1e-17 | glioma pathogenesis-related protein 1 measurement | | 4 | 130146820 | 130146821 | Human |
| 626441274 | GWAS2255207_H | obsolete_anxiety QTL GWAS2255207 (human) | | 2e-08 | obsolete_anxiety | | 4 | 118133633 | 118133634 | Human |
| 628833302 | GWAS2741531_H | factor XI measurement, Ischemic stroke QTL GWAS2741531 (human) | | 2e-16 | blood coagulation trait (VT:0002551) | | 4 | 110775495 | 110775496 | Human |
| 597408501 | GWAS1504575_H | systolic blood pressure QTL GWAS1504575 (human) | | 2e-12 | systolic blood pressure | | 4 | 110416322 | 110416323 | Human |
| 628603910 | GWAS2512139_H | Ventricular arrhythmia QTL GWAS2512139 (human) | | 2e-10 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
| 598112980 | GWAS1821863_H | systolic blood pressure QTL GWAS1821863 (human) | | 1e-09 | systolic blood pressure | | 4 | 110510288 | 110510289 | Human |
| 597129956 | GWAS1226030_H | body height QTL GWAS1226030 (human) | | 5e-08 | body height | | 4 | 119517147 | 119517148 | Human |
| 628833288 | GWAS2741517_H | circulating fibrinogen levels, coronary artery disease QTL GWAS2741517 (human) | | 1e-11 | coronary artery integrity trait (VT:0010746) | | 4 | 119988346 | 119988347 | Human |
| 597129955 | GWAS1226029_H | body height QTL GWAS1226029 (human) | | 3e-08 | body height | | 4 | 113901423 | 113901424 | Human |
| 597129954 | GWAS1226028_H | body height QTL GWAS1226028 (human) | | 1e-09 | body height | | 4 | 112488114 | 112488115 | Human |
| 598080210 | GWAS1799509_H | platelet volume QTL GWAS1799509 (human) | | 7e-27 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 407372081 | GWAS1021057_H | atrial fibrillation QTL GWAS1021057 (human) | | 9e-09 | atrial fibrillation | | 4 | 111683665 | 111683666 | Human |
| 628833281 | GWAS2741510_H | serum creatinine amount QTL GWAS2741510 (human) | | 2e-14 | serum creatinine amount | | 4 | 128601363 | 128601364 | Human |
| 626457643 | GWAS2271576_H | erythrocyte volume QTL GWAS2271576 (human) | | 2e-18 | erythrocyte volume | | 4 | 109975446 | 109975447 | Human |
| 597146135 | GWAS1242209_H | osteoarthritis, knee QTL GWAS1242209 (human) | | 1e-08 | osteoarthritis, knee | | 4 | 129381399 | 129381400 | Human |
| 628456695 | GWAS2364924_H | post-traumatic stress disorder QTL GWAS2364924 (human) | | 7e-09 | behavior trait (VT:0010442) | | 4 | 122265238 | 122265239 | Human |
| 628866303 | GWAS2774532_H | Hypoxanthine measurement QTL GWAS2774532 (human) | | 3e-08 | Hypoxanthine measurement | | 4 | 131223983 | 131223984 | Human |
| 407011783 | GWAS660759_H | benign prostatic hyperplasia QTL GWAS660759 (human) | | 0.000001 | benign prostatic hyperplasia | | 4 | 110180390 | 110180395 | Human |
| 598145569 | GWAS1832297_H | bone tissue density QTL GWAS1832297 (human) | | 2e-10 | bone tissue density | | 4 | 122897478 | 122897479 | Human |
| 597211665 | GWAS1307739_H | balding measurement QTL GWAS1307739 (human) | | 1e-13 | balding measurement | | 4 | 106940792 | 106940793 | Human |
| 628456703 | GWAS2364932_H | generalized anxiety disorder QTL GWAS2364932 (human) | | 4e-08 | generalized anxiety disorder | | 4 | 122265238 | 122265239 | Human |
| 597588501 | GWAS1645361_H | macular degeneration QTL GWAS1645361 (human) | | 1e-25 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 617102662 | GWAS2120161_H | lymphocyte count QTL GWAS2120161 (human) | | 3e-17 | lymphocyte count | | 4 | 122656905 | 122656906 | Human |
| 407028179 | GWAS677155_H | stroke QTL GWAS677155 (human) | | 0.0000002 | stroke | | 4 | 110796911 | 110796912 | Human |
| 616987991 | GWAS2005490_H | bipolar I disorder QTL GWAS2005490 (human) | | 0.0000006 | bipolar I disorder | | 4 | 117624232 | 117624233 | Human |
| 407011799 | GWAS660775_H | body mass index QTL GWAS660775 (human) | | 2e-09 | body mass index | | 4 | 119292875 | 119292876 | Human |
| 407028180 | GWAS677156_H | stroke QTL GWAS677156 (human) | | 3e-16 | stroke | | 4 | 110796911 | 110796912 | Human |
| 617053520 | GWAS2071019_H | cup-to-disc ratio measurement QTL GWAS2071019 (human) | | 4e-08 | cup-to-disc ratio measurement | | 4 | 111904784 | 111904785 | Human |
| 628817122 | GWAS2725351_H | cardioembolic stroke QTL GWAS2725351 (human) | | 2e-47 | joint integrity trait (VT:0010548) | | 4 | 110793263 | 110793264 | Human |
| 626441420 | GWAS2255353_H | obsolete_leukopenia QTL GWAS2255353 (human) | | 0.000003 | obsolete_leukopenia | | 4 | 112406922 | 112406923 | Human |
| 598014521 | GWAS1733820_H | brain attribute QTL GWAS1733820 (human) | | 9e-09 | brain attribute | | 4 | 112432129 | 112432130 | Human |
| 616987992 | GWAS2005491_H | bipolar I disorder QTL GWAS2005491 (human) | | 0.0000008 | bipolar I disorder | | 4 | 117548415 | 117548416 | Human |
| 628899043 | GWAS2807272_H | diastolic blood pressure QTL GWAS2807272 (human) | | 3e-10 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 108096372 | 108096373 | Human |
| 628817114 | GWAS2725343_H | Ischemic stroke QTL GWAS2725343 (human) | | 1e-08 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
| 628817112 | GWAS2725341_H | Ischemic stroke QTL GWAS2725341 (human) | | 5e-14 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 407388640 | GWAS1037616_H | allergic disease QTL GWAS1037616 (human) | | 4e-11 | allergic disease | | 4 | 122496409 | 122496410 | Human |
| 628817107 | GWAS2725336_H | Ischemic stroke QTL GWAS2725336 (human) | | 0.0000001 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
| 597097020 | GWAS1193094_H | testosterone measurement QTL GWAS1193094 (human) | | 2e-08 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
| 407257581 | GWAS906557_H | vaginal microbiome measurement QTL GWAS906557 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 121763984 | 121763985 | Human |
| 407224808 | GWAS873784_H | aspartate measurement QTL GWAS873784 (human) | | 0.000004 | aspartate measurement | | 4 | 118018897 | 118018898 | Human |
| 407044590 | GWAS693566_H | open-angle glaucoma QTL GWAS693566 (human) | | 1e-09 | open-angle glaucoma | | 4 | 125994594 | 125994595 | Human |
| 407142890 | GWAS791866_H | type 2 diabetes mellitus QTL GWAS791866 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 121739095 | 121739096 | Human |
| 616988009 | GWAS2005508_H | schizophrenia QTL GWAS2005508 (human) | | 8e-09 | schizophrenia | | 4 | 117906596 | 117906597 | Human |
| 597359146 | GWAS1455220_H | Cleft palate, cleft lip QTL GWAS1455220 (human) | | 4e-08 | Cleft palate, cleft lip | | 4 | 123985102 | 123985103 | Human |
| 407044595 | GWAS693571_H | open-angle glaucoma QTL GWAS693571 (human) | | 1e-08 | open-angle glaucoma | | 4 | 127613850 | 127613851 | Human |
| 407028211 | GWAS677187_H | leukopenia QTL GWAS677187 (human) | | 0.000003 | leukopenia | | 4 | 112406922 | 112406923 | Human |
| 625818879 | GWAS2239801_H | nephrolithiasis QTL GWAS2239801 (human) | | 3e-15 | nephrolithiasis | | 4 | 114577301 | 114577302 | Human |
| 598096401 | GWAS1813794_H | fibroblast growth factor 2 amount QTL GWAS1813794 (human) | | 8e-667 | fibroblast growth factor 2 amount | | 4 | 122827461 | 122827462 | Human |
| 597162543 | GWAS1258617_H | Ischemic stroke, von Willebrand factor measurement QTL GWAS1258617 (human) | | 5e-16 | Ischemic stroke, von Willebrand factor measurement | | 4 | 110775495 | 110775496 | Human |
| 628931772 | GWAS2840001_H | bilirubin measurement QTL GWAS2840001 (human) | | 1e-14 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 123882996 | 123882997 | Human |
| 597621340 | GWAS1678200_H | bundle branch block QTL GWAS1678200 (human) | | 4e-11 | bundle branch block | | 4 | 114685927 | 114685928 | Human |
| 407044486 | GWAS693462_H | cortical thickness QTL GWAS693462 (human) | | 2e-08 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
| 597604944 | GWAS1661804_H | heart rate QTL GWAS1661804 (human) | | 7e-21 | heart rate | | 4 | 110796911 | 110796912 | Human |
| 597195336 | GWAS1291410_H | systolic blood pressure QTL GWAS1291410 (human) | | 2e-08 | systolic blood pressure | | 4 | 120018118 | 120018119 | Human |
| 628505767 | GWAS2413996_H | pulse pressure measurement, sex interaction measurement QTL GWAS2413996 (human) | | 0.000007 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 110755885 | 110755886 | Human |
| 598096503 | GWAS1813896_H | facial morphology trait QTL GWAS1813896 (human) | | 2e-09 | facial morphology trait | | 4 | 126014320 | 126014321 | Human |
| 597359176 | GWAS1455250_H | ulcerative colitis QTL GWAS1455250 (human) | | 0.0000008 | ulcerative colitis | | 4 | 116929300 | 116929301 | Human |
| 628915366 | GWAS2823595_H | ethanolamine measurement, serum creatinine amount QTL GWAS2823595 (human) | | 8e-16 | ethanolamine measurement, serum creatinine amount | | 4 | 108795684 | 108795685 | Human |
| 407372178 | GWAS1021154_H | clostridium difficile infection QTL GWAS1021154 (human) | | 0.000003 | clostridium difficile infection | | 4 | 120516660 | 120516661 | Human |
| 597195333 | GWAS1291407_H | systolic blood pressure QTL GWAS1291407 (human) | | 8e-15 | systolic blood pressure | | 4 | 108146742 | 108146743 | Human |
| 597195334 | GWAS1291408_H | systolic blood pressure QTL GWAS1291408 (human) | | 6e-17 | systolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 597195335 | GWAS1291409_H | systolic blood pressure QTL GWAS1291409 (human) | | 6e-09 | systolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 597310073 | GWAS1406147_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1406147 (human) | | 4e-13 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110485340 | 110485341 | Human |
| 597473912 | GWAS1569986_H | protein measurement QTL GWAS1569986 (human) | | 1e-08 | protein measurement | | 4 | 107913373 | 107913374 | Human |
| 407060902 | GWAS709878_H | systemic lupus erythematosus QTL GWAS709878 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122631659 | 122631660 | Human |
| 597277310 | GWAS1373384_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1373384 (human) | | 4e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 122122507 | 122122508 | Human |
| 617119008 | GWAS2136507_H | annexin A5 measurement QTL GWAS2136507 (human) | | 5e-36 | annexin A5 measurement | | 4 | 121673919 | 121673920 | Human |
| 407126446 | GWAS775422_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS775422 (human) | | 2e-30 | Eczematoid dermatitis, allergic rhinitis | | 4 | 122432277 | 122432278 | Human |
| 628997271 | GWAS2905500_H | joint disease QTL GWAS2905500 (human) | | 1e-11 | joint disease | | 4 | 123048237 | 123048238 | Human |
| 597080701 | GWAS1176775_H | myeloid white cell count QTL GWAS1176775 (human) | | 3e-11 | myeloid white cell count | | 4 | 109931303 | 109931304 | Human |
| 628882576 | GWAS2790805_H | cardioembolic stroke QTL GWAS2790805 (human) | | 9e-59 | joint integrity trait (VT:0010548) | | 4 | 110775495 | 110775496 | Human |
| 628702356 | GWAS2610585_H | glomerular filtration rate QTL GWAS2610585 (human) | | 7e-17 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 407372197 | GWAS1021173_H | gut microbiome measurement QTL GWAS1021173 (human) | | 3e-09 | gut microbiome measurement | | 4 | 126415447 | 126415448 | Human |
| 597195383 | GWAS1291457_H | platelet count QTL GWAS1291457 (human) | | 5e-62 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110003178 | 110003179 | Human |
| 628472964 | GWAS2381193_H | EGF/TNFSF14 protein level ratio in blood QTL GWAS2381193 (human) | | 2e-152 | EGF/TNFSF14 protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 407355839 | GWAS1004815_H | systolic blood pressure QTL GWAS1004815 (human) | | 7e-09 | systolic blood pressure | | 4 | 119996191 | 119996192 | Human |
| 407126461 | GWAS775437_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS775437 (human) | | 6e-20 | Eczematoid dermatitis, allergic rhinitis | | 4 | 122219915 | 122219916 | Human |
| 617135413 | GWAS2152912_H | Barrett's esophagus QTL GWAS2152912 (human) | | 6e-14 | Barrett's esophagus | | 4 | 123628089 | 123628090 | Human |
| 628916092 | GWAS2824321_H | body height QTL GWAS2824321 (human) | | 5e-13 | body height | | 4 | 122917603 | 122917604 | Human |
| 628916093 | GWAS2824322_H | body height QTL GWAS2824322 (human) | | 1e-08 | body height | | 4 | 123987076 | 123987077 | Human |
| 597031319 | GWAS1127393_H | atrial fibrillation QTL GWAS1127393 (human) | | 2e-340 | atrial fibrillation | | 4 | 110737238 | 110737239 | Human |
| 628916094 | GWAS2824323_H | body height QTL GWAS2824323 (human) | | 7e-09 | body height | | 4 | 132314995 | 132314996 | Human |
| 598047142 | GWAS1766441_H | platelet quantity QTL GWAS1766441 (human) | | 0.0000002 | platelet quantity | | 4 | 109952770 | 109952771 | Human |
| 628916088 | GWAS2824317_H | body height QTL GWAS2824317 (human) | | 5e-20 | body height | | 4 | 113901423 | 113901424 | Human |
| 628473712 | GWAS2381941_H | EGF/GP6 protein level ratio in blood QTL GWAS2381941 (human) | | 1e-336 | EGF/GP6 protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 628916089 | GWAS2824318_H | body height QTL GWAS2824318 (human) | | 0.0000003 | body height | | 4 | 119645235 | 119645236 | Human |
| 628916090 | GWAS2824319_H | body height QTL GWAS2824319 (human) | | 2e-12 | body height | | 4 | 119840636 | 119840637 | Human |
| 628916091 | GWAS2824320_H | body height QTL GWAS2824320 (human) | | 2e-13 | body height | | 4 | 121799844 | 121799845 | Human |
| 407011915 | GWAS660891_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS660891 (human) | | 4e-09 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110420710 | 110420711 | Human |
| 628916086 | GWAS2824315_H | body height QTL GWAS2824315 (human) | | 3e-19 | body height | | 4 | 108540829 | 108540830 | Human |
| 628899702 | GWAS2807931_H | QRS duration QTL GWAS2807931 (human) | | 2e-09 | QRS duration | | 4 | 123829743 | 123829744 | Human |
| 628916087 | GWAS2824316_H | body height QTL GWAS2824316 (human) | | 0.000002 | body height | | 4 | 109079519 | 109079520 | Human |
| 628801393 | GWAS2709622_H | COVID-19 QTL GWAS2709622 (human) | | 0.000007 | COVID-19 | | 4 | 117237956 | 117237957 | Human |
| 597375383 | GWAS1471457_H | triacylglycerol 54:1 measurement QTL GWAS1471457 (human) | | 0.000001 | triacylglycerol 54:1 measurement | | 4 | 122671701 | 122671702 | Human |
| 407224905 | GWAS873881_H | gluteofemoral adipose tissue measurement QTL GWAS873881 (human) | | 3e-08 | gluteofemoral adipose tissue measurement | | 4 | 122891032 | 122891033 | Human |
| 598047144 | GWAS1766443_H | platelet quantity QTL GWAS1766443 (human) | | 4e-52 | platelet quantity | | 4 | 110008970 | 110008971 | Human |
| 597260692 | GWAS1356766_H | dementia QTL GWAS1356766 (human) | | 0.000009 | dementia | | 4 | 129535320 | 129535321 | Human |
| 597293462 | GWAS1389536_H | lymphocyte measurement, neutrophil measurement QTL GWAS1389536 (human) | | 6e-12 | lymphocyte measurement, neutrophil measurement | | 4 | 109980042 | 109980043 | Human |
| 617037526 | GWAS2055025_H | body mass index QTL GWAS2055025 (human) | | 4e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597064066 | GWAS1160140_H | BMI-adjusted waist-hip ratio QTL GWAS1160140 (human) | | 0.000001 | body size trait (VT:0100005) | | 4 | 110022364 | 110022365 | Human |
| 617070290 | GWAS2087789_H | open-angle glaucoma QTL GWAS2087789 (human) | | 2e-09 | open-angle glaucoma | | 4 | 127549411 | 127549412 | Human |
| 407224915 | GWAS873891_H | right ventricular systolic volume measurement QTL GWAS873891 (human) | | 7e-08 | right ventricular systolic volume measurement | | 4 | 113507558 | 113507559 | Human |
| 617053919 | GWAS2071418_H | vaginal microbiome measurement QTL GWAS2071418 (human) | | 0.00001 | vaginal microbiome measurement | | 4 | 126069793 | 126069794 | Human |
| 597440901 | GWAS1536975_H | body mass index QTL GWAS1536975 (human) | | 2e-14 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 407208542 | GWAS857518_H | Eczematoid dermatitis QTL GWAS857518 (human) | | 2e-26 | Eczematoid dermatitis | | 4 | 122219915 | 122219916 | Human |
| 597195139 | GWAS1291213_H | memory performance QTL GWAS1291213 (human) | | 0.000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124861110 | 124861111 | Human |
| 597195140 | GWAS1291214_H | memory performance QTL GWAS1291214 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124869106 | 124869107 | Human |
| 617070298 | GWAS2087797_H | open-angle glaucoma QTL GWAS2087797 (human) | | 7e-09 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 597195141 | GWAS1291215_H | memory performance QTL GWAS1291215 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124870671 | 124870672 | Human |
| 598079931 | GWAS1799230_H | cerebral cortex area attribute QTL GWAS1799230 (human) | | 6e-10 | cerebral cortex area attribute | | 4 | 112496345 | 112496346 | Human |
| 617103063 | GWAS2120562_H | gut microbiome measurement, breastfeeding duration QTL GWAS2120562 (human) | | 4e-10 | gut microbiome measurement, breastfeeding duration | | 4 | 121972794 | 121972795 | Human |
| 407306851 | GWAS955827_H | lymphocyte count QTL GWAS955827 (human) | | 2e-14 | lymphocyte count | | 4 | 122760001 | 122760002 | Human |
| 407306850 | GWAS955826_H | lymphocyte count QTL GWAS955826 (human) | | 1e-25 | lymphocyte count | | 4 | 112152543 | 112152544 | Human |
| 407306849 | GWAS955825_H | lymphocyte count QTL GWAS955825 (human) | | 6e-20 | lymphocyte count | | 4 | 109914892 | 109914893 | Human |
| 407208547 | GWAS857523_H | Eczematoid dermatitis QTL GWAS857523 (human) | | 1e-37 | Eczematoid dermatitis | | 4 | 122415763 | 122415764 | Human |
| 406897255 | GWAS546231_H | opioid dependence QTL GWAS546231 (human) | | 0.0000006 | opioid dependence | | 4 | 125271758 | 125271759 | Human |
| 407388768 | GWAS1037744_H | autosomal dominant compelling helio-ophthalmic outburst syndrome QTL GWAS1037744 (human) | | 3e-31 | autosomal dominant compelling helio-ophthalmic outburst syndrome | | 4 | 111737998 | 111737999 | Human |
| 628637523 | GWAS2545752_H | gut microbiome measurement, number of siblings QTL GWAS2545752 (human) | | 0.0000003 | gut microbiome measurement, number of siblings | | 4 | 112947027 | 112947028 | Human |
| 597195187 | GWAS1291261_H | memory performance QTL GWAS1291261 (human) | | 0.000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 113305092 | 113305093 | Human |
| 597277106 | GWAS1373180_H | testosterone measurement QTL GWAS1373180 (human) | | 6e-17 | testosterone measurement | | 4 | 124126476 | 124126477 | Human |
| 597408183 | GWAS1504257_H | erythrocyte count QTL GWAS1504257 (human) | | 6e-14 | erythrocyte count | | 4 | 114598115 | 114598116 | Human |
| 628604760 | GWAS2512989_H | myocardial infarction QTL GWAS2512989 (human) | | 2e-09 | heart integrity trait (VT:0010757) | | 4 | 119979127 | 119979128 | Human |
| 407077490 | GWAS726466_H | total blood protein measurement QTL GWAS726466 (human) | | 8e-13 | total blood protein measurement | | 4 | 122243645 | 122243646 | Human |
| 598096279 | GWAS1813672_H | fibroblast growth factor 2 amount QTL GWAS1813672 (human) | | 6e-36 | fibroblast growth factor 2 amount | | 4 | 122827461 | 122827462 | Human |
| 628473671 | GWAS2381900_H | EGF/MPIG6B protein level ratio in blood QTL GWAS2381900 (human) | | 5e-348 | EGF/MPIG6B protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 628752202 | GWAS2660431_H | vascular dementia QTL GWAS2660431 (human) | | 0.000009 | vascular dementia | | 4 | 117625893 | 117625894 | Human |
| 597146020 | GWAS1242094_H | osteoarthritis, knee QTL GWAS1242094 (human) | | 5e-09 | osteoarthritis, knee | | 4 | 120672441 | 120672442 | Human |
| 616972017 | GWAS1989516_H | cystatin C measurement QTL GWAS1989516 (human) | | 4e-09 | cystatin C measurement | | 4 | 119754004 | 119754005 | Human |
| 628473677 | GWAS2381906_H | EGF/PPIB protein level ratio in blood QTL GWAS2381906 (human) | | 2e-272 | EGF/PPIB protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 407126652 | GWAS775628_H | Ischemic stroke QTL GWAS775628 (human) | | 5e-08 | Ischemic stroke | | 4 | 110789013 | 110789014 | Human |
| 407126653 | GWAS775629_H | Ischemic stroke QTL GWAS775629 (human) | | 5e-09 | Ischemic stroke | | 4 | 110744760 | 110744761 | Human |
| 616513157 | GWAS1909740_H | reticulocyte amount QTL GWAS1909740 (human) | | 1e-09 | reticulocyte amount | | 4 | 127789418 | 127789419 | Human |
| 616513156 | GWAS1909739_H | reticulocyte amount QTL GWAS1909739 (human) | | 2e-12 | reticulocyte amount | | 4 | 109944309 | 109944310 | Human |
| 596965801 | GWAS1085320_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS1085320 (human) | | 0.0000009 | diet measurement, sex hormone-binding globulin measurement | | 4 | 127714844 | 127714845 | Human |
| 598096280 | GWAS1813673_H | fibroblast growth factor 2 amount QTL GWAS1813673 (human) | | 2e-11 | fibroblast growth factor 2 amount | | 4 | 122682145 | 122682146 | Human |
| 628997940 | GWAS2906169_H | mean corpuscular hemoglobin concentration QTL GWAS2906169 (human) | | 5e-14 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121827841 | 121827842 | Human |
| 597162457 | GWAS1258531_H | asthma QTL GWAS1258531 (human) | | 2e-14 | asthma | | 4 | 122415763 | 122415764 | Human |
| 596949466 | GWAS1068985_H | celiac disease QTL GWAS1068985 (human) | | 1e-08 | intestine integrity trait (VT:0010554) | | 4 | 122451978 | 122451979 | Human |
| 597211607 | GWAS1307681_H | empathy measurement QTL GWAS1307681 (human) | | 0.000008 | empathy measurement | | 4 | 111486019 | 111486020 | Human |
| 407224852 | GWAS873828_H | mosquito bite reaction itch intensity measurement QTL GWAS873828 (human) | | 3e-13 | mosquito bite reaction itch intensity measurement | | 4 | 122806140 | 122806141 | Human |
| 628637485 | GWAS2545714_H | household income QTL GWAS2545714 (human) | | 3e-10 | household income | | 4 | 122175535 | 122175536 | Human |
| 407224851 | GWAS873827_H | mosquito bite reaction itch intensity measurement QTL GWAS873827 (human) | | 2e-37 | mosquito bite reaction itch intensity measurement | | 4 | 122690387 | 122690388 | Human |
| 597359052 | GWAS1455126_H | neuroticism measurement QTL GWAS1455126 (human) | | 0.000004 | neuroticism measurement | | 4 | 124054077 | 124054078 | Human |
| 597490117 | GWAS1586191_H | educational attainment QTL GWAS1586191 (human) | | 0.000001 | educational attainment | | 4 | 121774163 | 121774164 | Human |
| 407388690 | GWAS1037666_H | protein measurement QTL GWAS1037666 (human) | | 3e-08 | protein measurement | | 4 | 121520144 | 121520146 | Human |
| 407077400 | GWAS726376_H | response to antidepressant QTL GWAS726376 (human) | | 0.0000005 | response to antidepressant | | 4 | 117580003 | 117580004 | Human |
| 407323163 | GWAS972139_H | high density lipoprotein cholesterol measurement QTL GWAS972139 (human) | | 3e-09 | high density lipoprotein cholesterol measurement | | 4 | 109717608 | 109717609 | Human |
| 597031371 | GWAS1127445_H | asthma, allergic disease QTL GWAS1127445 (human) | | 3e-12 | asthma, allergic disease | | 4 | 122441954 | 122441955 | Human |
| 597441021 | GWAS1537095_H | creatine measurement QTL GWAS1537095 (human) | | 0.0000006 | creatine measurement | | 4 | 110523020 | 110523021 | Human |
| 597522937 | GWAS1619011_H | intelligence QTL GWAS1619011 (human) | | 6e-09 | intelligence | | 4 | 112699050 | 112699051 | Human |
| 597522936 | GWAS1619010_H | intelligence QTL GWAS1619010 (human) | | 6e-09 | intelligence | | 4 | 112573451 | 112573452 | Human |
| 597146097 | GWAS1242171_H | self reported educational attainment QTL GWAS1242171 (human) | | 4e-09 | self reported educational attainment | | 4 | 111485805 | 111485806 | Human |
| 597031422 | GWAS1127496_H | asthma, allergic disease QTL GWAS1127496 (human) | | 4e-10 | asthma, allergic disease | | 4 | 122219899 | 122219900 | Human |
| 628834071 | GWAS2742300_H | diastolic blood pressure QTL GWAS2742300 (human) | | 2e-09 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
| 628834070 | GWAS2742299_H | diastolic blood pressure QTL GWAS2742299 (human) | | 1e-12 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110430068 | 110430069 | Human |
| 628408091 | GWAS2316320_H | gut microbiome measurement QTL GWAS2316320 (human) | | 0.000007 | gut microbiome measurement | | 4 | 108743511 | 108743512 | Human |
| 597375465 | GWAS1471539_H | platelet count QTL GWAS1471539 (human) | | 2e-25 | platelet count | | 4 | 119337052 | 119337053 | Human |
| 407224887 | GWAS873863_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS873863 (human) | | 0.0000007 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122806140 | 122806141 | Human |
| 407224886 | GWAS873862_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS873862 (human) | | 5e-13 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692515 | 122692516 | Human |
| 407257650 | GWAS906626_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS906626 (human) | | 7e-14 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | | 4 | 109657070 | 109657071 | Human |
| 628899594 | GWAS2807823_H | diastolic blood pressure QTL GWAS2807823 (human) | | 2e-13 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
| 407241275 | GWAS890251_H | testosterone measurement QTL GWAS890251 (human) | | 3e-13 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 407241412 | GWAS890388_H | rheumatoid arthritis QTL GWAS890388 (human) | | 4e-08 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
| 597129491 | GWAS1225565_H | wellbeing measurement, alcohol consumption measurement QTL GWAS1225565 (human) | | 5e-08 | wellbeing measurement, alcohol consumption measurement | | 4 | 121669289 | 121669290 | Human |
| 616988224 | GWAS2005723_H | Alzheimer disease QTL GWAS2005723 (human) | | 0.0000007 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 407126732 | GWAS775708_H | color vision disorder QTL GWAS775708 (human) | | 1e-10 | color vision disorder | | 4 | 109831805 | 109831806 | Human |
| 407388870 | GWAS1037846_H | chin morphology measurement QTL GWAS1037846 (human) | | 1e-08 | chin morphology measurement | | 4 | 126033497 | 126033498 | Human |
| 628883435 | GWAS2791664_H | healthspan QTL GWAS2791664 (human) | | 0.000002 | wellness/fitness trait (VT:1000152) | | 4 | 110234426 | 110234427 | Human |
| 628490213 | GWAS2398442_H | body height QTL GWAS2398442 (human) | | 4e-19 | body height | | 4 | 119834940 | 119834941 | Human |
| 597063942 | GWAS1160016_H | perceived unattractiveness to mosquitos measurement QTL GWAS1160016 (human) | | 0.000007 | perceived unattractiveness to mosquitos measurement | | 4 | 122817391 | 122817392 | Human |
| 628490212 | GWAS2398441_H | body height QTL GWAS2398441 (human) | | 2e-08 | body height | | 4 | 119700262 | 119700263 | Human |
| 628490215 | GWAS2398444_H | body height QTL GWAS2398444 (human) | | 4e-44 | body height | | 4 | 121800257 | 121800258 | Human |
| 628490214 | GWAS2398443_H | body height QTL GWAS2398443 (human) | | 9e-08 | body height | | 4 | 121657567 | 121657568 | Human |
| 597063941 | GWAS1160015_H | perceived unattractiveness to mosquitos measurement QTL GWAS1160015 (human) | | 2e-23 | perceived unattractiveness to mosquitos measurement | | 4 | 122695667 | 122695668 | Human |
| 597031169 | GWAS1127243_H | atrial fibrillation QTL GWAS1127243 (human) | | 2e-427 | atrial fibrillation | | 4 | 110775495 | 110775496 | Human |
| 597391630 | GWAS1487704_H | response to diuretic, low density lipoprotein cholesterol measurement QTL GWAS1487704 (human) | | 0.0000008 | response to diuretic, low density lipoprotein cholesterol measurement | | 4 | 107388616 | 107388617 | Human |
| 407077589 | GWAS726565_H | nicotine withdrawal symptom count QTL GWAS726565 (human) | | 0.000003 | nicotine withdrawal symptom count | | 4 | 107843866 | 107843867 | Human |
| 407110355 | GWAS759331_H | autoimmune disease QTL GWAS759331 (human) | | 1e-09 | autoimmune disease | | 4 | 122633552 | 122633553 | Human |
| 597375233 | GWAS1471307_H | lymphocyte count QTL GWAS1471307 (human) | | 8e-23 | lymphocyte count | | 4 | 122760001 | 122760002 | Human |
| 628490217 | GWAS2398446_H | body height QTL GWAS2398446 (human) | | 5e-13 | body height | | 4 | 123228081 | 123228082 | Human |
| 628883430 | GWAS2791659_H | healthspan QTL GWAS2791659 (human) | | 0.000003 | wellness/fitness trait (VT:1000152) | | 4 | 110234426 | 110234427 | Human |
| 628490216 | GWAS2398445_H | body height QTL GWAS2398445 (human) | | 2e-24 | body height | | 4 | 122904764 | 122904765 | Human |
| 628785124 | GWAS2693353_H | asthma QTL GWAS2693353 (human) | | 3e-14 | asthma | | 4 | 122148495 | 122148496 | Human |
| 598096184 | GWAS1813577_H | fibroblast growth factor 2 amount QTL GWAS1813577 (human) | | 9e-18 | fibroblast growth factor 2 amount | | 4 | 122836593 | 122836594 | Human |
| 628490219 | GWAS2398448_H | body height QTL GWAS2398448 (human) | | 2e-08 | body height | | 4 | 128700411 | 128700412 | Human |
| 628490218 | GWAS2398447_H | body height QTL GWAS2398447 (human) | | 5e-16 | body height | | 4 | 123987076 | 123987077 | Human |
| 628752345 | GWAS2660574_H | dementia QTL GWAS2660574 (human) | | 0.000009 | dementia | | 4 | 129535320 | 129535321 | Human |
| 406995681 | GWAS644657_H | smoking cessation QTL GWAS644657 (human) | | 1e-10 | smoking cessation | | 4 | 112087702 | 112087703 | Human |
| 626458610 | GWAS2272543_H | mean corpuscular hemoglobin concentration QTL GWAS2272543 (human) | | 1e-09 | mean corpuscular hemoglobin concentration | | 4 | 109996470 | 109996471 | Human |
| 598145281 | GWAS1832009_H | bone tissue density QTL GWAS1832009 (human) | | 4e-11 | bone tissue density | | 4 | 108147096 | 108147097 | Human |
| 407028456 | GWAS677432_H | testosterone measurement QTL GWAS677432 (human) | | 2e-11 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 597031231 | GWAS1127305_H | glomerular filtration rate QTL GWAS1127305 (human) | | 4e-16 | glomerular filtration rate | | 4 | 108782393 | 108782394 | Human |
| 628883409 | GWAS2791638_H | diet measurement QTL GWAS2791638 (human) | | 3e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 112402274 | 112402275 | Human |
| 407225065 | GWAS874041_H | osteoarthritis, knee QTL GWAS874041 (human) | | 1e-08 | osteoarthritis, knee | | 4 | 129381399 | 129381400 | Human |
| 626442214 | GWAS2256147_H | eosinophil count QTL GWAS2256147 (human) | | 1e-23 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122639784 | 122639785 | Human |
| 628867017 | GWAS2775246_H | forced expiratory volume, body mass index QTL GWAS2775246 (human) | | 9e-09 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 107935137 | 107935138 | Human |
| 406995697 | GWAS644673_H | smoking cessation QTL GWAS644673 (human) | | 9e-13 | smoking cessation | | 4 | 112122274 | 112122275 | Human |
| 626442213 | GWAS2256146_H | eosinophil count QTL GWAS2256146 (human) | | 9e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122265396 | 122265397 | Human |
| 628604867 | GWAS2513096_H | uterine prolapse QTL GWAS2513096 (human) | | 4e-17 | uterus integrity trait (VT:0010575) | | 4 | 126003911 | 126003912 | Human |
| 598046992 | GWAS1766291_H | QRS duration QTL GWAS1766291 (human) | | 4e-09 | QRS duration | | 4 | 124797072 | 124797073 | Human |
| 597031212 | GWAS1127286_H | atrial fibrillation QTL GWAS1127286 (human) | | 6e-113 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
| 597309728 | GWAS1405802_H | vaginal microbiome measurement QTL GWAS1405802 (human) | | 0.000005 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 407028472 | GWAS677448_H | testosterone measurement QTL GWAS677448 (human) | | 3e-08 | testosterone measurement | | 4 | 113038028 | 113038029 | Human |
| 407225087 | GWAS874063_H | uric acid measurement QTL GWAS874063 (human) | | 0.000006 | uric acid measurement | | 4 | 124261535 | 124261536 | Human |
| 407225086 | GWAS874062_H | uric acid measurement QTL GWAS874062 (human) | | 0.000003 | blood uric acid amount (VT:0010302) | blood uric acid level (CMO:0000501) | 4 | 125055497 | 125055498 | Human |
| 407012095 | GWAS661071_H | hemoglobin measurement QTL GWAS661071 (human) | | 1e-09 | hemoglobin measurement | | 4 | 114596387 | 114596388 | Human |
| 617020934 | GWAS2038433_H | comparative body size at age 10, self-reported QTL GWAS2038433 (human) | | 1e-11 | body size trait (VT:0100005) | | 4 | 129819249 | 129819250 | Human |
| 617037318 | GWAS2054817_H | Beta blocking agent use measurement QTL GWAS2054817 (human) | | 1e-19 | Beta blocking agent use measurement | | 4 | 110789765 | 110789766 | Human |
| 597244251 | GWAS1340325_H | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS1340325 (human) | | 0.000009 | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel | | 4 | 113992588 | 113992589 | Human |
| 616382071 | GWAS1862313_H | obsolete_serum alanine aminotransferase measurement QTL GWAS1862313 (human) | | 0.000004 | obsolete_serum alanine aminotransferase measurement | | 4 | 115087321 | 115087322 | Human |
| 597277011 | GWAS1373085_H | diet measurement QTL GWAS1373085 (human) | | 3e-08 | diet measurement | | 4 | 122050021 | 122050022 | Human |
| 598112620 | GWAS1821503_H | depressive symptom measurement QTL GWAS1821503 (human) | | 6e-09 | depressive symptom measurement | | 4 | 122237168 | 122237170 | Human |
| 598112621 | GWAS1821504_H | depressive symptom measurement QTL GWAS1821504 (human) | | 1e-10 | depressive symptom measurement | | 4 | 122258745 | 122258746 | Human |
| 407274125 | GWAS923101_H | asthma, age at diagnosis QTL GWAS923101 (human) | | 0.0000002 | asthma, age at diagnosis | | 4 | 122680257 | 122680258 | Human |
| 407290506 | GWAS939482_H | platelet crit QTL GWAS939482 (human) | | 2e-10 | platelet crit | | 4 | 124004110 | 124004111 | Human |
| 597473617 | GWAS1569691_H | heel bone mineral density QTL GWAS1569691 (human) | | 8e-14 | heel bone mineral density | | 4 | 126607237 | 126607238 | Human |
| 597473618 | GWAS1569692_H | heel bone mineral density QTL GWAS1569692 (human) | | 3e-15 | heel bone mineral density | | 4 | 126607351 | 126607352 | Human |
| 616545899 | GWAS1942482_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1942482 (human) | | 1e-17 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 130146820 | 130146821 | Human |
| 616545897 | GWAS1942480_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1942480 (human) | | 3e-12 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 116507955 | 116507956 | Human |
| 616545892 | GWAS1942475_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1942475 (human) | | 2e-23 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 112358525 | 112358526 | Human |
| 407257754 | GWAS906730_H | vaginal microbiome measurement QTL GWAS906730 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 110167303 | 110167304 | Human |
| 597145975 | GWAS1242049_H | osteoarthritis, knee QTL GWAS1242049 (human) | | 8e-08 | osteoarthritis, knee | | 4 | 121786965 | 121786966 | Human |
| 628539286 | GWAS2447515_H | body height QTL GWAS2447515 (human) | | 1e-09 | body height | | 4 | 124056504 | 124056505 | Human |
| 628899740 | GWAS2807969_H | testosterone measurement QTL GWAS2807969 (human) | | 6e-17 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 124126476 | 124126477 | Human |
| 596982132 | GWAS1101651_H | memory performance QTL GWAS1101651 (human) | | 0.0000004 | memory performance | | 4 | 124883182 | 124883183 | Human |
| 597080436 | GWAS1176510_H | monocyte count QTL GWAS1176510 (human) | | 2e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109966833 | 109966834 | Human |
| 628539284 | GWAS2447513_H | body height QTL GWAS2447513 (human) | | 7e-12 | body height | | 4 | 123329379 | 123329380 | Human |
| 596982135 | GWAS1101654_H | memory performance QTL GWAS1101654 (human) | | 0.0000005 | memory performance | | 4 | 124882886 | 124882887 | Human |
| 628539285 | GWAS2447514_H | body height QTL GWAS2447514 (human) | | 6e-09 | body height | | 4 | 123991477 | 123991478 | Human |
| 596982134 | GWAS1101653_H | memory performance QTL GWAS1101653 (human) | | 0.0000005 | memory performance | | 4 | 124882027 | 124882028 | Human |
| 616988194 | GWAS2005693_H | Abnormality of refraction QTL GWAS2005693 (human) | | 1e-08 | Abnormality of refraction | | 4 | 111208199 | 111208200 | Human |
| 628522898 | GWAS2431127_H | BMI-adjusted waist circumference QTL GWAS2431127 (human) | | 5e-10 | body size trait (VT:0100005) | | 4 | 119761309 | 119761310 | Human |
| 597113203 | GWAS1209277_H | protein measurement QTL GWAS1209277 (human) | | 2e-09 | protein amount (VT:0010120) | | 4 | 120939887 | 120939888 | Human |
| 628539282 | GWAS2447511_H | body height QTL GWAS2447511 (human) | | 1e-10 | body height | | 4 | 123091613 | 123091614 | Human |
| 597342590 | GWAS1438664_H | brain measurement QTL GWAS1438664 (human) | | 8e-13 | brain measurement | | 4 | 123179401 | 123179402 | Human |
| 597244285 | GWAS1340359_H | IGF-1 measurement QTL GWAS1340359 (human) | | 2e-09 | IGF-1 measurement | | 4 | 127882004 | 127882005 | Human |
| 617037346 | GWAS2054845_H | Ventricular arrhythmia QTL GWAS2054845 (human) | | 2e-10 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
| 628522899 | GWAS2431128_H | BMI-adjusted waist circumference QTL GWAS2431128 (human) | | 4e-09 | body size trait (VT:0100005) | | 4 | 119805780 | 119805781 | Human |
| 628539283 | GWAS2447512_H | body height QTL GWAS2447512 (human) | | 2e-21 | body height | | 4 | 123159557 | 123159558 | Human |
| 628522896 | GWAS2431125_H | BMI-adjusted waist circumference QTL GWAS2431125 (human) | | 1e-08 | body size trait (VT:0100005) | | 4 | 119503425 | 119503426 | Human |
| 628539280 | GWAS2447509_H | body height QTL GWAS2447509 (human) | | 3e-24 | body height | | 4 | 122904764 | 122904765 | Human |
| 628522897 | GWAS2431126_H | BMI-adjusted waist circumference QTL GWAS2431126 (human) | | 2e-14 | body size trait (VT:0100005) | | 4 | 119674620 | 119674621 | Human |
| 628539281 | GWAS2447510_H | body height QTL GWAS2447510 (human) | | 7e-16 | body height | | 4 | 123077298 | 123077299 | Human |
| 407028395 | GWAS677371_H | adiponectin measurement QTL GWAS677371 (human) | | 0.000003 | blood adiponectin amount (VT:0010545) | blood adiponectin level (CMO:0000485) | 4 | 110043206 | 110043207 | Human |
| 596982136 | GWAS1101655_H | memory performance QTL GWAS1101655 (human) | | 0.0000005 | memory performance | | 4 | 124883368 | 124883369 | Human |
| 598030666 | GWAS1749965_H | phospholipid measurement, blood VLDL cholesterol amount QTL GWAS1749965 (human) | | 8e-09 | phospholipid measurement, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 597817683 | GWAS1685074_H | lifestyle measurement QTL GWAS1685074 (human) | | 8e-08 | lifestyle measurement, anxiety disorder measurement | | 4 | 127457977 | 127457978 | Human |
| 407372477 | GWAS1021453_H | blood protein measurement QTL GWAS1021453 (human) | | 2e-239 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 597621097 | GWAS1677957_H | Right bundle branch block QTL GWAS1677957 (human) | | 4e-16 | Right bundle branch block | | 4 | 114640717 | 114640718 | Human |
| 616988222 | GWAS2005721_H | Alzheimer disease QTL GWAS2005721 (human) | | 0.000006 | Alzheimer disease | | 4 | 119130833 | 119130834 | Human |
| 628539278 | GWAS2447507_H | body height QTL GWAS2447507 (human) | | 2e-09 | body height | | 4 | 122663442 | 122663443 | Human |
| 617053759 | GWAS2071258_H | bilirubin measurement QTL GWAS2071258 (human) | | 7e-11 | bilirubin measurement | | 4 | 123849638 | 123849639 | Human |
| 628522895 | GWAS2431124_H | BMI-adjusted waist circumference QTL GWAS2431124 (human) | | 2e-11 | body size trait (VT:0100005) | | 4 | 119213641 | 119213642 | Human |
| 628539279 | GWAS2447508_H | body height QTL GWAS2447508 (human) | | 6e-12 | body height | | 4 | 122823209 | 122823210 | Human |
| 628539276 | GWAS2447505_H | body height QTL GWAS2447505 (human) | | 4e-14 | body height | | 4 | 121878306 | 121878307 | Human |
| 407143103 | GWAS792079_H | Ischemic stroke QTL GWAS792079 (human) | | 0.0000001 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
| 628539277 | GWAS2447506_H | body height QTL GWAS2447506 (human) | | 7e-09 | body height | | 4 | 121897844 | 121897845 | Human |
| 628539274 | GWAS2447503_H | body height QTL GWAS2447503 (human) | | 2e-17 | body height | | 4 | 119833061 | 119833062 | Human |
| 628539275 | GWAS2447504_H | body height QTL GWAS2447504 (human) | | 8e-33 | body height | | 4 | 121801213 | 121801214 | Human |
| 628539273 | GWAS2447502_H | body height QTL GWAS2447502 (human) | | 8e-09 | body height | | 4 | 119745118 | 119745119 | Human |
| 617021380 | GWAS2038879_H | monoclonal gammopathy QTL GWAS2038879 (human) | | 0.000005 | monoclonal gammopathy | | 4 | 107881225 | 107881226 | Human |
| 407372618 | GWAS1021594_H | blood protein measurement QTL GWAS1021594 (human) | | 4e-34 | blood protein measurement | | 4 | 109737911 | 109737912 | Human |
| 628866680 | GWAS2774909_H | disorder of pharynx QTL GWAS2774909 (human) | | 2e-08 | disorder of pharynx | | 4 | 112220279 | 112220280 | Human |
| 597031058 | GWAS1127132_H | alcohol consumption measurement QTL GWAS1127132 (human) | | 0.000008 | alcohol consumption measurement | | 4 | 108819029 | 108819030 | Human |
| 628768371 | GWAS2676600_H | open-angle glaucoma QTL GWAS2676600 (human) | | 7e-09 | eye integrity trait (VT:0011107) | | 4 | 111042563 | 111042564 | Human |
| 616972234 | GWAS1989733_H | bipolar disorder QTL GWAS1989733 (human) | | 5e-09 | bipolar disorder | | 4 | 117534962 | 117534963 | Human |
| 597047450 | GWAS1143524_H | BMI-adjusted waist-hip ratio QTL GWAS1143524 (human) | | 2e-08 | BMI-adjusted waist-hip ratio | | 4 | 123118168 | 123118169 | Human |
| 597047448 | GWAS1143522_H | BMI-adjusted waist-hip ratio QTL GWAS1143522 (human) | | 1e-13 | BMI-adjusted waist-hip ratio | | 4 | 123002800 | 123002801 | Human |
| 616529840 | GWAS1926423_H | IGF-1 measurement QTL GWAS1926423 (human) | | 3e-13 | IGF-1 measurement | | 4 | 120801880 | 120801886 | Human |
| 597047449 | GWAS1143523_H | BMI-adjusted waist-hip ratio QTL GWAS1143523 (human) | | 6e-09 | BMI-adjusted waist-hip ratio | | 4 | 122854222 | 122854223 | Human |
| 406946640 | GWAS595616_H | protein measurement QTL GWAS595616 (human) | | 4e-13 | protein measurement | | 4 | 108004097 | 108004098 | Human |
| 628522596 | GWAS2430825_H | atrial fibrillation QTL GWAS2430825 (human) | | 6e-13 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 628522594 | GWAS2430823_H | atrial fibrillation QTL GWAS2430823 (human) | | 1e-12 | atrial fibrillation | | 4 | 111172387 | 111172388 | Human |
| 628522595 | GWAS2430824_H | atrial fibrillation QTL GWAS2430824 (human) | | 2e-08 | atrial fibrillation | | 4 | 111257689 | 111257690 | Human |
| 628522592 | GWAS2430821_H | atrial fibrillation QTL GWAS2430821 (human) | | 5e-29 | atrial fibrillation | | 4 | 110401104 | 110401105 | Human |
| 628522593 | GWAS2430822_H | atrial fibrillation QTL GWAS2430822 (human) | | 7e-13 | atrial fibrillation | | 4 | 111085761 | 111085762 | Human |
| 617136080 | GWAS2153579_H | chronic laryngitis QTL GWAS2153579 (human) | | 4e-12 | chronic laryngitis | | 4 | 129677938 | 129677939 | Human |
| 406946654 | GWAS595630_H | hemoglobin measurement QTL GWAS595630 (human) | | 2e-10 | hemoglobin measurement | | 4 | 123846352 | 123846353 | Human |
| 617054168 | GWAS2071667_H | vaginal microbiome measurement QTL GWAS2071667 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132191469 | 132191470 | Human |
| 628653656 | GWAS2561885_H | systemic lupus erythematosus QTL GWAS2561885 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122631659 | 122631660 | Human |
| 628686425 | GWAS2594654_H | body height QTL GWAS2594654 (human) | | 2e-37 | body height | | 4 | 121801213 | 121801214 | Human |
| 598112389 | GWAS1821272_H | psoriasis QTL GWAS1821272 (human) | | 1e-08 | psoriasis | | 4 | 121246451 | 121246452 | Human |
| 626458227 | GWAS2272160_H | hemoglobin measurement QTL GWAS2272160 (human) | | 1e-16 | hemoglobin measurement | | 4 | 110021958 | 110021959 | Human |
| 616382358 | GWAS1862600_H | obsolete_blood protein measurement QTL GWAS1862600 (human) | | 5e-62 | obsolete_blood protein measurement | | 4 | 109965187 | 109965188 | Human |
| 597162170 | GWAS1258244_H | mean corpuscular volume QTL GWAS1258244 (human) | | 2e-09 | mean corpuscular volume | | 4 | 121773981 | 121773982 | Human |
| 598145160 | GWAS1831888_H | bone tissue density QTL GWAS1831888 (human) | | 2e-09 | bone tissue density | | 4 | 108138358 | 108138359 | Human |
| 597162169 | GWAS1258243_H | mean corpuscular volume QTL GWAS1258243 (human) | | 2e-11 | mean corpuscular volume | | 4 | 109979991 | 109979992 | Human |
| 617005046 | GWAS2022545_H | mathematical ability QTL GWAS2022545 (human) | | 4e-08 | mathematical ability | | 4 | 111950250 | 111950251 | Human |
| 628866635 | GWAS2774864_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS2774864 (human) | | 1e-12 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129113772 | 129113775 | Human |
| 617103356 | GWAS2120855_H | gut microbiome measurement, breastfeeding duration QTL GWAS2120855 (human) | | 3e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 114769596 | 114769597 | Human |
| 598112403 | GWAS1821286_H | psoriasis QTL GWAS1821286 (human) | | 4e-09 | psoriasis | | 4 | 122689551 | 122689552 | Human |
| 597358764 | GWAS1454838_H | loneliness measurement QTL GWAS1454838 (human) | | 0.000004 | emotion/affect behavior trait (VT:0002572) | | 4 | 120523895 | 120523896 | Human |
| 616955891 | GWAS1973390_H | neuropsychological test QTL GWAS1973390 (human) | | 0.000006 | neuropsychological test | | 4 | 125505540 | 125505541 | Human |
| 628866637 | GWAS2774866_H | N-acetylgalactosamine measurement, N-acetylglucosamine measurement QTL GWAS2774866 (human) | | 3e-12 | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | | 4 | 129143723 | 129143724 | Human |
| 597997724 | GWAS1717023_H | social inhibition quality, attention deficit hyperactivity disorder, substance abuse QTL GWAS1717023 (human) | | 2e-23 | social inhibition quality, attention deficit hyperactivity disorder, substance abuse | | 4 | 111485805 | 111485806 | Human |
| 616497030 | GWAS1893613_H | 1,2-dilinoleoyl-GPC (18:2/18:2) measurement QTL GWAS1893613 (human) | | 0.000008 | glycerophosphocholine amount (VT:0011004) | | 4 | 111650646 | 111650647 | Human |
| 597997725 | GWAS1717024_H | social inhibition quality, attention deficit hyperactivity disorder, substance abuse QTL GWAS1717024 (human) | | 1e-09 | social inhibition quality, attention deficit hyperactivity disorder, substance abuse | | 4 | 129484578 | 129484579 | Human |
| 406913914 | GWAS562890_H | preeclampsia QTL GWAS562890 (human) | | 0.000003 | preeclampsia | | 4 | 112913825 | 112913826 | Human |
| 617037818 | GWAS2055317_H | physical activity measurement QTL GWAS2055317 (human) | | 3e-09 | physical activity measurement | | 4 | 108177667 | 108177668 | Human |
| 617037816 | GWAS2055315_H | serum albumin amount QTL GWAS2055315 (human) | | 3e-09 | serum albumin amount | | 4 | 123779234 | 123779235 | Human |
| 628997693 | GWAS2905922_H | humerus fracture QTL GWAS2905922 (human) | | 7e-12 | humerus fracture | | 4 | 113504938 | 113504939 | Human |
| 598096100 | GWAS1813493_H | facial morphology trait QTL GWAS1813493 (human) | | 1e-19 | facial morphology trait | | 4 | 127005360 | 127005361 | Human |
| 407028491 | GWAS677467_H | sex hormone-binding globulin measurement QTL GWAS677467 (human) | | 5e-25 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 617103234 | GWAS2120733_H | gut microbiome measurement, breastfeeding duration QTL GWAS2120733 (human) | | 8e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 115599484 | 115599485 | Human |
| 407257869 | GWAS906845_H | high density lipoprotein cholesterol measurement QTL GWAS906845 (human) | | 2e-31 | high density lipoprotein cholesterol measurement | | 4 | 109174464 | 109174465 | Human |
| 406897419 | GWAS546395_H | susceptibility to hepatitis B infection measurement QTL GWAS546395 (human) | | 0.000003 | susceptibility to hepatitis B infection measurement | | 4 | 110859685 | 110859686 | Human |
| 617021325 | GWAS2038824_H | periodontitis QTL GWAS2038824 (human) | | 0.000009 | periodontitis | | 4 | 110885393 | 110885394 | Human |
| 597620945 | GWAS1677805_H | hypertrophic cardiomyopathy QTL GWAS1677805 (human) | | 8e-13 | hypertrophic cardiomyopathy | | 4 | 108196857 | 108196858 | Human |
| 628751914 | GWAS2660143_H | HbA1c measurement QTL GWAS2660143 (human) | | 0.000001 | blood hemoglobin amount (VT:0001588) | blood hemoglobin A1c level (CMO:0002786) | 4 | 109980042 | 109980043 | Human |
| 628424231 | GWAS2332460_H | intelligence QTL GWAS2332460 (human) | | 0.000001 | intelligence | | 4 | 130143535 | 130143536 | Human |
| 625819161 | GWAS2240083_H | health trait QTL GWAS2240083 (human) | | 1e-09 | size | | 4 | 119820087 | 119820088 | Human |
| 625819160 | GWAS2240082_H | health trait QTL GWAS2240082 (human) | | 2e-10 | health trait | | 4 | 118717973 | 118717974 | Human |
| 625819163 | GWAS2240085_H | health trait QTL GWAS2240085 (human) | | 4e-12 | health trait | | 4 | 123991477 | 123991478 | Human |
| 625819162 | GWAS2240084_H | health trait QTL GWAS2240084 (human) | | 1e-15 | health trait | | 4 | 121801213 | 121801214 | Human |
| 597440710 | GWAS1536784_H | amino acid measurement QTL GWAS1536784 (human) | | 0.000003 | amino acid measurement | | 4 | 111130223 | 111130224 | Human |
| 407257882 | GWAS906858_H | testosterone measurement QTL GWAS906858 (human) | | 4e-09 | testosterone measurement | | 4 | 108146742 | 108146743 | Human |
| 597178564 | GWAS1274638_H | QRS-T angle QTL GWAS1274638 (human) | | 3e-31 | QRS-T angle | | 4 | 113523590 | 113523591 | Human |
| 616972186 | GWAS1989685_H | gastric carcinoma QTL GWAS1989685 (human) | | 9e-10 | stomach integrity trait (VT:0010603) | | 4 | 124535968 | 124535969 | Human |
| 628457001 | GWAS2365230_H | hypertrophic cardiomyopathy QTL GWAS2365230 (human) | | 0.0000006 | heart integrity trait (VT:0010757) | | 4 | 130926839 | 130926840 | Human |
| 597227718 | GWAS1323792_H | schizophrenia QTL GWAS1323792 (human) | | 4e-08 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
| 407290649 | GWAS939625_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS939625 (human) | | 1e-10 | total cholesterol measurement, high density lipoprotein cholesterol measurement | | 4 | 109603883 | 109603884 | Human |
| 597178567 | GWAS1274641_H | QRS-T angle QTL GWAS1274641 (human) | | 4e-09 | QRS-T angle | | 4 | 110635274 | 110635275 | Human |
| 617086886 | GWAS2104385_H | cerebral cortex area attribute QTL GWAS2104385 (human) | | 6e-10 | cerebral cortex area attribute | | 4 | 112496345 | 112496346 | Human |
| 597162229 | GWAS1258303_H | lipid measurement QTL GWAS1258303 (human) | | 0.000002 | lipid measurement | | 4 | 123250547 | 123250548 | Human |
| 597293306 | GWAS1389380_H | body mass index QTL GWAS1389380 (human) | | 1e-11 | body mass index | | 4 | 122906887 | 122906888 | Human |
| 597162228 | GWAS1258302_H | lipid measurement QTL GWAS1258302 (human) | | 0.000006 | lipid measurement | | 4 | 122960709 | 122960710 | Human |
| 628686363 | GWAS2594592_H | brain attribute QTL GWAS2594592 (human) | | 9e-44 | brain attribute | | 4 | 123332634 | 123332635 | Human |
| 617037730 | GWAS2055229_H | lipid measurement QTL GWAS2055229 (human) | | 0.000003 | lipid measurement | | 4 | 131492574 | 131492575 | Human |
| 628997658 | GWAS2905887_H | heart rate QTL GWAS2905887 (human) | | 2e-12 | heart rate | | 4 | 128289982 | 128289983 | Human |
| 628833811 | GWAS2742040_H | Ischemic stroke, circulating fibrinogen levels QTL GWAS2742040 (human) | | 1e-15 | Ischemic stroke, circulating fibrinogen levels | | 4 | 110775495 | 110775496 | Human |
| 597489908 | GWAS1585982_H | smoking initiation QTL GWAS1585982 (human) | | 4e-09 | smoking initiation | | 4 | 117868703 | 117868704 | Human |
| 597489909 | GWAS1585983_H | smoking initiation QTL GWAS1585983 (human) | | 3e-10 | smoking initiation | | 4 | 126727157 | 126727158 | Human |
| 598096079 | GWAS1813472_H | facial morphology trait QTL GWAS1813472 (human) | | 2e-09 | facial morphology trait | | 4 | 127005360 | 127005361 | Human |
| 598096074 | GWAS1813467_H | facial morphology trait QTL GWAS1813467 (human) | | 3e-10 | facial morphology trait | | 4 | 127027041 | 127027042 | Human |
| 407307063 | GWAS956039_H | pelvic organ prolapse QTL GWAS956039 (human) | | 1e-10 | pelvic organ prolapse | | 4 | 126155033 | 126155034 | Human |
| 628899341 | GWAS2807570_H | diastolic blood pressure QTL GWAS2807570 (human) | | 1e-10 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119336584 | 119336585 | Human |
| 616480712 | GWAS1877295_H | blood protein amount QTL GWAS1877295 (human) | | 8e-54 | blood protein amount | | 4 | 109737911 | 109737912 | Human |
| 617086896 | GWAS2104395_H | cerebral cortex area attribute QTL GWAS2104395 (human) | | 5e-15 | cerebral cortex area attribute | | 4 | 112496345 | 112496346 | Human |
| 407307056 | GWAS956032_H | pelvic organ prolapse QTL GWAS956032 (human) | | 2e-22 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
| 407405360 | GWAS1054336_H | cortical thickness QTL GWAS1054336 (human) | | 7e-17 | cortical thickness | | 4 | 112512138 | 112512139 | Human |
| 617070527 | GWAS2088026_H | bone tissue density QTL GWAS2088026 (human) | | 8e-15 | bone tissue density | | 4 | 132222891 | 132222892 | Human |
| 407405361 | GWAS1054337_H | cortical thickness QTL GWAS1054337 (human) | | 1e-08 | cortical thickness | | 4 | 120653051 | 120653052 | Human |
| 597211362 | GWAS1307436_H | triglyceride measurement QTL GWAS1307436 (human) | | 1e-12 | triglyceride measurement | | 4 | 109717608 | 109717609 | Human |
| 626441772 | GWAS2255705_H | obsolete_anxiety QTL GWAS2255705 (human) | | 7e-09 | obsolete_anxiety | | 4 | 118015036 | 118015037 | Human |
| 616955839 | GWAS1973338_H | smoking behavior QTL GWAS1973338 (human) | | 0.000009 | smoking behavior | | 4 | 125510764 | 125510765 | Human |
| 406897469 | GWAS546445_H | cardiovascular age measurement QTL GWAS546445 (human) | | 3e-14 | cardiovascular age measurement | | 4 | 113465982 | 113465983 | Human |
| 406897470 | GWAS546446_H | systolic blood pressure QTL GWAS546446 (human) | | 2e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 119588124 | 119588125 | Human |
| 617086788 | GWAS2104287_H | sex hormone-binding globulin measurement QTL GWAS2104287 (human) | | 9e-09 | sex hormone-binding globulin measurement | | 4 | 123871744 | 123871745 | Human |
| 596965392 | GWAS1084911_H | total cholesterol measurement, diet measurement QTL GWAS1084911 (human) | | 0.000004 | total cholesterol measurement, diet measurement | | 4 | 118492283 | 118492284 | Human |
| 628637437 | GWAS2545666_H | osteoarthritis, hip QTL GWAS2545666 (human) | | 3e-09 | joint integrity trait (VT:0010548) | | 4 | 123863724 | 123863725 | Human |
| 616988480 | GWAS2005979_H | brain connectivity attribute QTL GWAS2005979 (human) | | 6e-11 | brain connectivity attribute | | 4 | 125820645 | 125820646 | Human |
| 626458334 | GWAS2272267_H | erythrocyte count QTL GWAS2272267 (human) | | 9e-28 | erythrocyte count | | 4 | 114598194 | 114598195 | Human |
| 617054030 | GWAS2071529_H | systolic blood pressure QTL GWAS2071529 (human) | | 2e-12 | systolic blood pressure | | 4 | 110416322 | 110416323 | Human |
| 628883184 | GWAS2791413_H | forced expiratory volume QTL GWAS2791413 (human) | | 1e-11 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 106578647 | 106578648 | Human |
| 597473296 | GWAS1569370_H | heel bone mineral density QTL GWAS1569370 (human) | | 8e-11 | heel bone mineral density | | 4 | 123613837 | 123613838 | Human |
| 597473297 | GWAS1569371_H | heel bone mineral density QTL GWAS1569371 (human) | | 8e-13 | heel bone mineral density | | 4 | 124619337 | 124619338 | Human |
| 628784874 | GWAS2693103_H | corneal resistance factor QTL GWAS2693103 (human) | | 7e-11 | cornea morphology trait (VT:0001312) | | 4 | 118816705 | 118816706 | Human |
| 596965381 | GWAS1084900_H | calcium measurement, diet measurement QTL GWAS1084900 (human) | | 0.000006 | calcium measurement, diet measurement | | 4 | 111131258 | 111131259 | Human |
| 597473294 | GWAS1569368_H | heel bone mineral density QTL GWAS1569368 (human) | | 3e-09 | heel bone mineral density | | 4 | 108249911 | 108249912 | Human |
| 597473295 | GWAS1569369_H | heel bone mineral density QTL GWAS1569369 (human) | | 5e-09 | heel bone mineral density | | 4 | 118868269 | 118868270 | Human |
| 628883183 | GWAS2791412_H | forced expiratory volume QTL GWAS2791412 (human) | | 8e-12 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 106356882 | 106356883 | Human |
| 628752099 | GWAS2660328_H | dementia QTL GWAS2660328 (human) | | 0.000002 | dementia | | 4 | 120519704 | 120519705 | Human |
| 616988508 | GWAS2006007_H | BMI-adjusted waist-hip ratio QTL GWAS2006007 (human) | | 1e-11 | BMI-adjusted waist-hip ratio | | 4 | 124270608 | 124270609 | Human |
| 597309446 | GWAS1405520_H | vaginal microbiome measurement QTL GWAS1405520 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 626458315 | GWAS2272248_H | erythrocyte count QTL GWAS2272248 (human) | | 3e-11 | erythrocyte count | | 4 | 127869642 | 127869643 | Human |
| 407307235 | GWAS956211_H | type 2 diabetes mellitus QTL GWAS956211 (human) | | 3e-08 | type 2 diabetes mellitus | | 4 | 128258303 | 128258304 | Human |
| 628719324 | GWAS2627553_H | vaginal microbiome measurement QTL GWAS2627553 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 121763984 | 121763985 | Human |
| 616972142 | GWAS1989641_H | intelligence QTL GWAS1989641 (human) | | 0.000007 | intelligence | | 4 | 112683802 | 112683803 | Human |
| 406930408 | GWAS579384_H | smoking cessation QTL GWAS579384 (human) | | 3e-12 | smoking cessation | | 4 | 112123310 | 112123311 | Human |
| 628408030 | GWAS2316259_H | high density lipoprotein cholesterol measurement QTL GWAS2316259 (human) | | 3e-13 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109648464 | 109648465 | Human |
| 628801232 | GWAS2709461_H | COVID-19 QTL GWAS2709461 (human) | | 0.000005 | COVID-19 | | 4 | 113911048 | 113911049 | Human |
| 597456944 | GWAS1553018_H | pelvic organ prolapse QTL GWAS1553018 (human) | | 2e-23 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
| 616972138 | GWAS1989637_H | intelligence QTL GWAS1989637 (human) | | 0.000007 | intelligence | | 4 | 129813235 | 129813236 | Human |
| 407045102 | GWAS694078_H | open-angle glaucoma QTL GWAS694078 (human) | | 7e-15 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 628539076 | GWAS2447305_H | body height QTL GWAS2447305 (human) | | 2e-08 | body height | | 4 | 119476617 | 119476618 | Human |
| 628539077 | GWAS2447306_H | body height QTL GWAS2447306 (human) | | 3e-11 | body height | | 4 | 119716698 | 119716699 | Human |
| 407045111 | GWAS694087_H | platelet count QTL GWAS694087 (human) | | 2e-40 | platelet count | | 4 | 110035176 | 110035177 | Human |
| 628539074 | GWAS2447303_H | body height QTL GWAS2447303 (human) | | 1e-11 | body height | | 4 | 119174845 | 119174846 | Human |
| 628539075 | GWAS2447304_H | body height QTL GWAS2447304 (human) | | 5e-11 | body height | | 4 | 119458551 | 119458552 | Human |
| 628539072 | GWAS2447301_H | body height QTL GWAS2447301 (human) | | 5e-09 | body height | | 4 | 118235326 | 118235327 | Human |
| 628539073 | GWAS2447302_H | body height QTL GWAS2447302 (human) | | 4e-08 | body height | | 4 | 119145484 | 119145485 | Human |
| 597342247 | GWAS1438321_H | sarcoidosis QTL GWAS1438321 (human) | | 0.000004 | sarcoidosis | | 4 | 122800348 | 122800349 | Human |
| 407225339 | GWAS874315_H | beta-aminoisobutyric acid measurement QTL GWAS874315 (human) | | 0.0000006 | beta-aminoisobutyric acid measurement | | 4 | 107577683 | 107577684 | Human |
| 407077885 | GWAS726861_H | appendicitis QTL GWAS726861 (human) | | 2e-23 | appendicitis | | 4 | 110799841 | 110799842 | Human |
| 616529789 | GWAS1926372_H | level of cytokine receptor-like factor 1 in blood serum QTL GWAS1926372 (human) | | 7e-13 | level of cytokine receptor-like factor 1 in blood serum | | 4 | 109976379 | 109976380 | Human |
| 597047380 | GWAS1143454_H | BMI-adjusted waist-hip ratio QTL GWAS1143454 (human) | | 1e-09 | BMI-adjusted waist-hip ratio | | 4 | 119185193 | 119185194 | Human |
| 407372685 | GWAS1021661_H | adolescent idiopathic scoliosis QTL GWAS1021661 (human) | | 0.000001 | adolescent idiopathic scoliosis | | 4 | 130877448 | 130877449 | Human |
| 597047377 | GWAS1143451_H | BMI-adjusted waist-hip ratio QTL GWAS1143451 (human) | | 9e-12 | waist-hip ratio | | 4 | 121705035 | 121705036 | Human |
| 628539070 | GWAS2447299_H | body height QTL GWAS2447299 (human) | | 7e-10 | body height | | 4 | 113800031 | 113800032 | Human |
| 628539071 | GWAS2447300_H | body height QTL GWAS2447300 (human) | | 3e-13 | body height | | 4 | 113968498 | 113968499 | Human |
| 628539068 | GWAS2447297_H | body height QTL GWAS2447297 (human) | | 5e-09 | body height | | 4 | 108530315 | 108530316 | Human |
| 628539069 | GWAS2447298_H | body height QTL GWAS2447298 (human) | | 4e-28 | body height | | 4 | 108535458 | 108535459 | Human |
| 628539066 | GWAS2447295_H | body height QTL GWAS2447295 (human) | | 6e-09 | body height | | 4 | 108441767 | 108441768 | Human |
| 628539067 | GWAS2447296_H | body height QTL GWAS2447296 (human) | | 3e-08 | body height | | 4 | 108525913 | 108525914 | Human |
| 628653749 | GWAS2561978_H | heart failure QTL GWAS2561978 (human) | | 4e-29 | heart integrity trait (VT:0010757) | | 4 | 110748064 | 110748065 | Human |
| 628539064 | GWAS2447293_H | body height QTL GWAS2447293 (human) | | 1e-08 | body height | | 4 | 108146742 | 108146743 | Human |
| 628539065 | GWAS2447294_H | body height QTL GWAS2447294 (human) | | 6e-11 | body height | | 4 | 108361577 | 108361578 | Human |
| 628915885 | GWAS2824114_H | trait in response to apixaban QTL GWAS2824114 (human) | | 0.000005 | trait in response to apixaban | | 4 | 120963437 | 120963438 | Human |
| 407126935 | GWAS775911_H | color vision disorder QTL GWAS775911 (human) | | 0.000008 | color vision disorder | | 4 | 129487149 | 129487150 | Human |
| 407126928 | GWAS775904_H | color vision disorder QTL GWAS775904 (human) | | 0.000006 | color vision disorder | | 4 | 125161562 | 125161563 | Human |
| 407372702 | GWAS1021678_H | adolescent idiopathic scoliosis QTL GWAS1021678 (human) | | 9e-12 | adolescent idiopathic scoliosis | | 4 | 116480238 | 116480239 | Human |
| 628948651 | GWAS2856880_H | serum albumin amount QTL GWAS2856880 (human) | | 1e-09 | serum albumin amount | | 4 | 109113640 | 109113641 | Human |
| 597194831 | GWAS1290905_H | cortical surface area measurement QTL GWAS1290905 (human) | | 5e-15 | cortical surface area measurement | | 4 | 112496345 | 112496346 | Human |
| 598095998 | GWAS1813391_H | facial morphology trait QTL GWAS1813391 (human) | | 2e-08 | facial morphology trait | | 4 | 126939204 | 126939205 | Human |
| 596965454 | GWAS1084973_H | lipoprotein A measurement, diet measurement QTL GWAS1084973 (human) | | 0.000002 | lipoprotein A measurement, diet measurement | | 4 | 129572458 | 129572459 | Human |
| 597063757 | GWAS1159831_H | body height QTL GWAS1159831 (human) | | 0.000003 | body height | | 4 | 109118612 | 109118613 | Human |
| 407372691 | GWAS1021667_H | adolescent idiopathic scoliosis QTL GWAS1021667 (human) | | 9e-37 | adolescent idiopathic scoliosis | | 4 | 114347014 | 114347015 | Human |
| 617070363 | GWAS2087862_H | diastolic blood pressure QTL GWAS2087862 (human) | | 0.0000007 | diastolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 617070362 | GWAS2087861_H | diastolic blood pressure QTL GWAS2087861 (human) | | 2e-27 | diastolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 617070361 | GWAS2087860_H | diastolic blood pressure QTL GWAS2087860 (human) | | 2e-16 | diastolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 407372695 | GWAS1021671_H | adolescent idiopathic scoliosis QTL GWAS1021671 (human) | | 2e-16 | adolescent idiopathic scoliosis | | 4 | 129325525 | 129325526 | Human |
| 597489788 | GWAS1585862_H | educational attainment QTL GWAS1585862 (human) | | 0.000009 | educational attainment | | 4 | 107916747 | 107916748 | Human |
| 597145719 | GWAS1241793_H | prostate carcinoma QTL GWAS1241793 (human) | | 3e-08 | prostate carcinoma | | 4 | 109889343 | 109889344 | Human |
| 597489789 | GWAS1585863_H | educational attainment QTL GWAS1585863 (human) | | 5e-08 | educational attainment | | 4 | 117355510 | 117355511 | Human |
| 597489790 | GWAS1585864_H | educational attainment QTL GWAS1585864 (human) | | 3e-10 | educational attainment | | 4 | 117508319 | 117508320 | Human |
| 407405482 | GWAS1054458_H | small vessel stroke QTL GWAS1054458 (human) | | 0.000008 | small vessel stroke | | 4 | 125014098 | 125014099 | Human |
| 598112325 | GWAS1821208_H | psoriasis QTL GWAS1821208 (human) | | 3e-08 | psoriasis | | 4 | 122680942 | 122680943 | Human |
| 617103148 | GWAS2120647_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2120647 (human) | | 4e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 111174542 | 111174543 | Human |
| 628702878 | GWAS2611107_H | vaginal microbiome measurement QTL GWAS2611107 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 131705323 | 131705324 | Human |
| 407405472 | GWAS1054448_H | BMI-adjusted waist circumference QTL GWAS1054448 (human) | | 2e-13 | BMI-adjusted waist circumference | | 4 | 119649123 | 119649124 | Human |
| 407405473 | GWAS1054449_H | BMI-adjusted waist circumference QTL GWAS1054449 (human) | | 2e-09 | BMI-adjusted waist circumference | | 4 | 119768762 | 119768763 | Human |
| 598030411 | GWAS1749710_H | phospholipids:total lipids ratio, blood VLDL cholesterol amount QTL GWAS1749710 (human) | | 1e-08 | phospholipids:total lipids ratio, blood VLDL cholesterol amount | | 4 | 109717668 | 109717669 | Human |
| 597145720 | GWAS1241794_H | prostate carcinoma QTL GWAS1241794 (human) | | 4e-08 | prostate carcinoma | | 4 | 109927496 | 109927497 | Human |
| 407389104 | GWAS1038080_H | gut microbiome measurement, taxonomic microbiome measurement QTL GWAS1038080 (human) | | 4e-08 | gut microbiome measurement, taxonomic microbiome measurement | | 4 | 130578414 | 130578415 | Human |
| 628555405 | GWAS2463634_H | cortical thickness QTL GWAS2463634 (human) | | 2e-08 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120741206 | 120741207 | Human |
| 407094339 | GWAS743315_H | small vessel stroke QTL GWAS743315 (human) | | 0.0000007 | small vessel stroke | | 4 | 113472094 | 113472095 | Human |
| 597229464 | GWAS1325538_H | Hypermetropia, Myopia QTL GWAS1325538 (human) | | 0.0000007 | Hypermetropia, Myopia | | 4 | 119987548 | 119987549 | Human |
| 597589916 | GWAS1646776_H | atrial fibrillation QTL GWAS1646776 (human) | | 1e-33 | atrial fibrillation | | 4 | 110793263 | 110793264 | Human |
| 597426073 | GWAS1522147_H | urate measurement QTL GWAS1522147 (human) | | 3e-11 | urate measurement | | 4 | 119599549 | 119599550 | Human |
| 628898171 | GWAS2806400_H | JT interval QTL GWAS2806400 (human) | | 2e-08 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 4 | 113464520 | 113464521 | Human |
| 597376914 | GWAS1472988_H | celiac disease QTL GWAS1472988 (human) | | 1e-14 | intestine integrity trait (VT:0010554) | | 4 | 122588266 | 122588267 | Human |
| 597065626 | GWAS1161700_H | congenital heart disease QTL GWAS1161700 (human) | | 0.000008 | heart integrity trait (VT:0010757) | | 4 | 118330002 | 118330003 | Human |
| 598065065 | GWAS1784364_H | cerebral cortex area attribute QTL GWAS1784364 (human) | | 3e-15 | cerebral cortex area attribute | | 4 | 123326251 | 123326252 | Human |
| 617134277 | GWAS2151776_H | erythrocyte volume QTL GWAS2151776 (human) | | 3e-20 | erythrocyte volume | | 4 | 127690477 | 127690478 | Human |
| 597016474 | GWAS1112548_H | cognitive decline measurement QTL GWAS1112548 (human) | | 0.000004 | cognitive decline measurement | | 4 | 110589931 | 110589932 | Human |
| 616560815 | GWAS1957398_H | level of stanniocalcin-2 in blood serum QTL GWAS1957398 (human) | | 1e-12 | level of stanniocalcin-2 in blood serum | | 4 | 109973957 | 109973958 | Human |
| 628849003 | GWAS2757232_H | X-24422 measurement QTL GWAS2757232 (human) | | 3e-13 | X-24422 measurement | | 4 | 122894208 | 122894209 | Human |
| 598097847 | GWAS1815240_H | atrial fibrillation QTL GWAS1815240 (human) | | 5e-30 | atrial fibrillation | | 4 | 110271840 | 110271841 | Human |
| 628455783 | GWAS2364012_H | epidermal growth factor measurement QTL GWAS2364012 (human) | | 1e-21 | epidermal growth factor measurement | | 4 | 109960338 | 109960339 | Human |
| 407372890 | GWAS1021866_H | chronotype measurement QTL GWAS1021866 (human) | | 1e-10 | chronotype measurement | | 4 | 129982356 | 129982357 | Human |
| 597409678 | GWAS1505752_H | cortical thickness QTL GWAS1505752 (human) | | 6e-19 | cortical thickness | | 4 | 112512138 | 112512139 | Human |
| 596967309 | GWAS1086828_H | systolic blood pressure QTL GWAS1086828 (human) | | 4e-08 | systolic blood pressure | | 4 | 120018331 | 120018332 | Human |
| 628898150 | GWAS2806379_H | rheumatoid arthritis QTL GWAS2806379 (human) | | 4e-14 | joint integrity trait (VT:0010548) | | 4 | 108140462 | 108140463 | Human |
| 616560804 | GWAS1957387_H | level of inactive C-alpha-formylglycine-generating enzyme 2 in blood serum QTL GWAS1957387 (human) | | 8e-16 | level of inactive C-alpha-formylglycine-generating enzyme 2 in blood serum | | 4 | 118813029 | 118813030 | Human |
| 598097850 | GWAS1815243_H | atrial fibrillation QTL GWAS1815243 (human) | | 5e-16 | atrial fibrillation | | 4 | 112102428 | 112102429 | Human |
| 597278597 | GWAS1374671_H | testosterone measurement QTL GWAS1374671 (human) | | 1e-16 | testosterone measurement | | 4 | 124126476 | 124126477 | Human |
| 628439401 | GWAS2347630_H | BMI-adjusted waist-hip ratio QTL GWAS2347630 (human) | | 1e-11 | body size trait (VT:0100005) | | 4 | 124270608 | 124270609 | Human |
| 597016456 | GWAS1112530_H | cognitive decline measurement QTL GWAS1112530 (human) | | 0.0000009 | cognitive decline measurement | | 4 | 110589931 | 110589932 | Human |
| 597049227 | GWAS1145301_H | cervical carcinoma QTL GWAS1145301 (human) | | 0.000001 | cervical carcinoma | | 4 | 113726137 | 113726138 | Human |
| 598097848 | GWAS1815241_H | atrial fibrillation QTL GWAS1815241 (human) | | 2e-1141 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 628439403 | GWAS2347632_H | BMI-adjusted waist-hip ratio QTL GWAS2347632 (human) | | 2e-10 | body size trait (VT:0100005) | | 4 | 124118741 | 124118742 | Human |
| 598097849 | GWAS1815242_H | atrial fibrillation QTL GWAS1815242 (human) | | 5e-17 | atrial fibrillation | | 4 | 111394878 | 111394879 | Human |
| 597344186 | GWAS1440260_H | body mass index QTL GWAS1440260 (human) | | 0.000001 | body mass index | | 4 | 129895905 | 129895906 | Human |
| 617036004 | GWAS2053503_H | Ventricular arrhythmia QTL GWAS2053503 (human) | | 4e-11 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
| 596967356 | GWAS1086875_H | cortical thickness QTL GWAS1086875 (human) | | 8e-09 | cortical thickness | | 4 | 119920489 | 119920490 | Human |
| 628652368 | GWAS2560597_H | pain measurement QTL GWAS2560597 (human) | | 9e-09 | nociception system physiology trait (VT:0015100) | | 4 | 129311323 | 129311324 | Human |
| 596967357 | GWAS1086876_H | cortical thickness QTL GWAS1086876 (human) | | 3e-11 | cortical thickness | | 4 | 120773757 | 120773758 | Human |
| 628930896 | GWAS2839125_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2839125 (human) | | 9e-09 | fatty acid amount (VT:0010046) | | 4 | 109657070 | 109657071 | Human |
| 597180328 | GWAS1276402_H | alcohol consumption measurement QTL GWAS1276402 (human) | | 9e-13 | alcohol consumption measurement | | 4 | 112386757 | 112386758 | Human |
| 597180329 | GWAS1276403_H | alcohol consumption measurement QTL GWAS1276403 (human) | | 1e-10 | alcohol consumption measurement | | 4 | 128806522 | 128806523 | Human |
| 597180330 | GWAS1276404_H | alcohol consumption measurement QTL GWAS1276404 (human) | | 5e-14 | alcohol consumption measurement | | 4 | 129324733 | 129324734 | Human |
| 407028849 | GWAS677825_H | age-related macular degeneration QTL GWAS677825 (human) | | 7e-11 | retina integrity trait (VT:0010771) | | 4 | 109669323 | 109669324 | Human |
| 597589927 | GWAS1646787_H | cardiac arrhythmia QTL GWAS1646787 (human) | | 3e-19 | cardiac arrhythmia | | 4 | 110774266 | 110774267 | Human |
| 597245915 | GWAS1341989_H | blood protein measurement QTL GWAS1341989 (human) | | 3e-12 | blood protein measurement | | 4 | 119503425 | 119503426 | Human |
| 617035908 | GWAS2053407_H | Ischemic stroke QTL GWAS2053407 (human) | | 5e-08 | Ischemic stroke | | 4 | 110789013 | 110789014 | Human |
| 597589978 | GWAS1646838_H | appendicitis QTL GWAS1646838 (human) | | 4e-19 | appendicitis | | 4 | 110804662 | 110804663 | Human |
| 407372813 | GWAS1021789_H | blood protein measurement QTL GWAS1021789 (human) | | 2e-272 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628783423 | GWAS2691652_H | cleft lip QTL GWAS2691652 (human) | | 0.000001 | cleft lip | | 4 | 125904223 | 125904224 | Human |
| 597589976 | GWAS1646836_H | disorder of appendix QTL GWAS1646836 (human) | | 4e-21 | disorder of appendix | | 4 | 110810809 | 110810810 | Human |
| 597589977 | GWAS1646837_H | appendicitis QTL GWAS1646837 (human) | | 1e-20 | appendicitis | | 4 | 110810809 | 110810810 | Human |
| 597049311 | GWAS1145385_H | major depressive disorder QTL GWAS1145385 (human) | | 2e-10 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
| 596983775 | GWAS1103294_H | memory performance QTL GWAS1103294 (human) | | 0.0000004 | memory performance | | 4 | 124882027 | 124882028 | Human |
| 598097896 | GWAS1815289_H | psoriasis QTL GWAS1815289 (human) | | 3e-12 | psoriasis | | 4 | 122618699 | 122618700 | Human |
| 407372807 | GWAS1021783_H | blood protein measurement QTL GWAS1021783 (human) | | 5e-348 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 597999595 | GWAS1718894_H | wellbeing measurement, alcohol consumption quality QTL GWAS1718894 (human) | | 5e-08 | wellbeing measurement, alcohol consumption quality | | 4 | 121669289 | 121669290 | Human |
| 407192597 | GWAS841573_H | lipid measurement QTL GWAS841573 (human) | | 0.000003 | lipid measurement | | 4 | 112764648 | 112764649 | Human |
| 407258134 | GWAS907110_H | glomerular filtration rate QTL GWAS907110 (human) | | 1e-16 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 628422951 | GWAS2331180_H | body mass index QTL GWAS2331180 (human) | | 2e-10 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 111731920 | 111731921 | Human |
| 628848943 | GWAS2757172_H | triglyceride measurement QTL GWAS2757172 (human) | | 6e-10 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 123895285 | 123895286 | Human |
| 628848942 | GWAS2757171_H | triglyceride measurement QTL GWAS2757171 (human) | | 6e-27 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109603883 | 109603884 | Human |
| 407372829 | GWAS1021805_H | mathematical ability QTL GWAS1021805 (human) | | 4e-08 | mathematical ability | | 4 | 111950250 | 111950251 | Human |
| 628963626 | GWAS2871855_H | blood coagulation disease QTL GWAS2871855 (human) | | 5e-19 | blood coagulation disease | | 4 | 110784139 | 110784140 | Human |
| 598097919 | GWAS1815312_H | atrial fibrillation QTL GWAS1815312 (human) | | 7e-09 | atrial fibrillation | | 4 | 109606131 | 109606132 | Human |
| 407176216 | GWAS825192_H | multiple sclerosis QTL GWAS825192 (human) | | 1e-10 | multiple sclerosis | | 4 | 121198294 | 121198295 | Human |
| 628996380 | GWAS2904609_H | skin disease QTL GWAS2904609 (human) | | 2e-11 | skin disease | | 4 | 124660603 | 124660604 | Human |
| 628832537 | GWAS2740766_H | Ischemic stroke, factor VII measurement QTL GWAS2740766 (human) | | 1e-16 | blood coagulation trait (VT:0002551) | | 4 | 110775495 | 110775496 | Human |
| 628570389 | GWAS2478618_H | gestational age QTL GWAS2478618 (human) | | 0.00001 | gestational age | | 4 | 112354624 | 112354625 | Human |
| 407307299 | GWAS956275_H | cortical surface area change measurement QTL GWAS956275 (human) | | 0.000005 | cortical surface area change measurement | | 4 | 109118383 | 109118384 | Human |
| 628603155 | GWAS2511384_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS2511384 (human) | | 3e-11 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109603883 | 109603884 | Human |
| 598032320 | GWAS1751619_H | blood cobalt amount QTL GWAS1751619 (human) | | 0.000009 | blood cobalt amount | | 4 | 121015640 | 121015641 | Human |
| 596983794 | GWAS1103313_H | memory performance QTL GWAS1103313 (human) | | 0.00001 | memory performance | | 4 | 124888134 | 124888135 | Human |
| 628865298 | GWAS2773527_H | glycolithocholate sulfate measurement QTL GWAS2773527 (human) | | 0.0000001 | glycolithocholate sulfate measurement | | 4 | 124486812 | 124486813 | Human |
| 597164029 | GWAS1260103_H | lipid measurement QTL GWAS1260103 (human) | | 0.000003 | lipid measurement | | 4 | 112764648 | 112764649 | Human |
| 617052330 | GWAS2069829_H | glomerular filtration rate QTL GWAS2069829 (human) | | 1e-12 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 617052343 | GWAS2069842_H | glomerular filtration rate QTL GWAS2069842 (human) | | 3e-11 | glomerular filtration rate | | 4 | 127288162 | 127288163 | Human |
| 597049316 | GWAS1145390_H | low density lipoprotein cholesterol measurement QTL GWAS1145390 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | | 4 | 108720535 | 108720536 | Human |
| 596983777 | GWAS1103296_H | memory performance QTL GWAS1103296 (human) | | 0.0000004 | memory performance | | 4 | 124883368 | 124883369 | Human |
| 596983776 | GWAS1103295_H | memory performance QTL GWAS1103295 (human) | | 0.0000004 | memory performance | | 4 | 124882886 | 124882887 | Human |
| 598065107 | GWAS1784406_H | brain attribute QTL GWAS1784406 (human) | | 6e-11 | brain attribute | | 4 | 107131838 | 107131839 | Human |
| 597491684 | GWAS1587758_H | educational attainment QTL GWAS1587758 (human) | | 2e-09 | educational attainment | | 4 | 129621796 | 129621797 | Human |
| 597491685 | GWAS1587759_H | educational attainment QTL GWAS1587759 (human) | | 1e-11 | educational attainment | | 4 | 129713268 | 129713269 | Human |
| 616380615 | GWAS1860857_H | obsolete_thyroxine measurement QTL GWAS1860857 (human) | | 0.000005 | obsolete_thyroxine measurement | | 4 | 112622996 | 112622997 | Human |
| 407110718 | GWAS759694_H | waist-hip ratio QTL GWAS759694 (human) | | 0.0000006 | waist-hip ratio | | 4 | 119495290 | 119495291 | Human |
| 597262307 | GWAS1358381_H | mean corpuscular hemoglobin QTL GWAS1358381 (human) | | 5e-10 | mean corpuscular hemoglobin | | 4 | 121870446 | 121870447 | Human |
| 597491686 | GWAS1587760_H | educational attainment QTL GWAS1587760 (human) | | 1e-08 | educational attainment | | 4 | 129875770 | 129875771 | Human |
| 597491687 | GWAS1587761_H | educational attainment QTL GWAS1587761 (human) | | 3e-09 | educational attainment | | 4 | 130394262 | 130394263 | Human |
| 596967186 | GWAS1086705_H | cortical thickness QTL GWAS1086705 (human) | | 9e-10 | cortical thickness | | 4 | 120654416 | 120654417 | Human |
| 598064930 | GWAS1784229_H | brain attribute QTL GWAS1784229 (human) | | 7e-10 | brain attribute | | 4 | 124015375 | 124015376 | Human |
| 628439549 | GWAS2347778_H | BMI-adjusted waist-hip ratio QTL GWAS2347778 (human) | | 2e-08 | body size trait (VT:0100005) | | 4 | 123118168 | 123118169 | Human |
| 628439548 | GWAS2347777_H | BMI-adjusted waist-hip ratio QTL GWAS2347777 (human) | | 6e-09 | body size trait (VT:0100005) | | 4 | 122854222 | 122854223 | Human |
| 616970316 | GWAS1987815_H | BMI-adjusted hip circumference QTL GWAS1987815 (human) | | 0.000003 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 110946968 | 110946969 | Human |
| 598081321 | GWAS1800620_H | serum creatinine amount QTL GWAS1800620 (human) | | 1e-11 | serum creatinine amount | | 4 | 108787299 | 108787300 | Human |
| 626457050 | GWAS2270983_H | hemoglobin measurement QTL GWAS2270983 (human) | | 2e-09 | hemoglobin measurement | | 4 | 114559972 | 114559973 | Human |
| 628439547 | GWAS2347776_H | BMI-adjusted waist-hip ratio QTL GWAS2347776 (human) | | 1e-13 | body size trait (VT:0100005) | | 4 | 123002800 | 123002801 | Human |
| 598081322 | GWAS1800621_H | serum creatinine amount QTL GWAS1800621 (human) | | 4e-12 | serum creatinine amount | | 4 | 127291035 | 127291036 | Human |
| 628816362 | GWAS2724591_H | mean reticulocyte volume QTL GWAS2724591 (human) | | 5e-13 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 122155413 | 122155414 | Human |
| 617117785 | GWAS2135284_H | fibroblast growth factor 2 amount QTL GWAS2135284 (human) | | 4e-50 | fibroblast growth factor 2 amount | | 4 | 123210593 | 123210594 | Human |
| 617117786 | GWAS2135285_H | fibroblast growth factor 2 amount QTL GWAS2135285 (human) | | 2e-14 | fibroblast growth factor 2 amount | | 4 | 122792575 | 122792576 | Human |
| 407160023 | GWAS808999_H | glomerular filtration rate QTL GWAS808999 (human) | | 4e-13 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 617117787 | GWAS2135286_H | fibroblast growth factor 2 amount QTL GWAS2135286 (human) | | 2e-22 | fibroblast growth factor 2 amount | | 4 | 122820831 | 122820832 | Human |
| 617117788 | GWAS2135287_H | fibroblast growth factor 2 amount QTL GWAS2135287 (human) | | 2e-72 | fibroblast growth factor 2 amount | | 4 | 123006761 | 123006762 | Human |
| 596983553 | GWAS1103072_H | memory performance QTL GWAS1103072 (human) | | 0.000004 | memory performance | | 4 | 124869106 | 124869107 | Human |
| 617117789 | GWAS2135288_H | fibroblast growth factor 2 amount QTL GWAS2135288 (human) | | 2e-26 | fibroblast growth factor 2 amount | | 4 | 123218415 | 123218416 | Human |
| 596983552 | GWAS1103071_H | memory performance QTL GWAS1103071 (human) | | 0.000003 | memory performance | | 4 | 124861110 | 124861111 | Human |
| 617117790 | GWAS2135289_H | fibroblast growth factor 2 amount QTL GWAS2135289 (human) | | 7e-18 | fibroblast growth factor 2 amount | | 4 | 123310196 | 123310197 | Human |
| 628701666 | GWAS2609895_H | vaginal microbiome measurement QTL GWAS2609895 (human) | | 0.000005 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 628439529 | GWAS2347758_H | BMI-adjusted waist-hip ratio QTL GWAS2347758 (human) | | 1e-09 | body size trait (VT:0100005) | | 4 | 119185193 | 119185194 | Human |
| 617117781 | GWAS2135280_H | fibroblast growth factor 2 amount QTL GWAS2135280 (human) | | 1e-18 | fibroblast growth factor 2 amount | | 4 | 123649214 | 123649215 | Human |
| 617117782 | GWAS2135281_H | fibroblast growth factor 2 amount QTL GWAS2135281 (human) | | 2e-24 | fibroblast growth factor 2 amount | | 4 | 122680969 | 122680970 | Human |
| 628701670 | GWAS2609899_H | vaginal microbiome measurement QTL GWAS2609899 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 118330002 | 118330003 | Human |
| 617117783 | GWAS2135282_H | fibroblast growth factor 2 amount QTL GWAS2135282 (human) | | 1e-20 | fibroblast growth factor 2 amount | | 4 | 123619151 | 123619152 | Human |
| 597409595 | GWAS1505669_H | platelet count QTL GWAS1505669 (human) | | 5e-16 | platelet count | | 4 | 119464317 | 119464318 | Human |
| 407307495 | GWAS956471_H | type 2 diabetes mellitus QTL GWAS956471 (human) | | 1e-08 | type 2 diabetes mellitus | | 4 | 129865191 | 129865192 | Human |
| 626457079 | GWAS2271012_H | erythrocyte volume QTL GWAS2271012 (human) | | 3e-09 | erythrocyte volume | | 4 | 121795671 | 121795672 | Human |
| 616380441 | GWAS1860683_H | obsolete_blood protein measurement QTL GWAS1860683 (human) | | 4e-34 | obsolete_blood protein measurement | | 4 | 109737911 | 109737912 | Human |
| 628586963 | GWAS2495192_H | total cholesterol measurement, diet measurement QTL GWAS2495192 (human) | | 0.000003 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 118490708 | 118490709 | Human |
| 597098289 | GWAS1194363_H | protein measurement QTL GWAS1194363 (human) | | 1e-09 | protein amount (VT:0010120) | | 4 | 120939887 | 120939888 | Human |
| 597409596 | GWAS1505670_H | platelet count QTL GWAS1505670 (human) | | 1e-13 | platelet count | | 4 | 123837618 | 123837619 | Human |
| 597262131 | GWAS1358205_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1358205 (human) | | 4e-08 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 597409590 | GWAS1505664_H | vaginal microbiome measurement QTL GWAS1505664 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132191469 | 132191470 | Human |
| 617035894 | GWAS2053393_H | peptic ulcer disease QTL GWAS2053393 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616812 | 123616813 | Human |
| 628505026 | GWAS2413255_H | AIFM1/EGF protein level ratio in blood QTL GWAS2413255 (human) | | 9e-124 | AIFM1/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 598032144 | GWAS1751443_H | body height QTL GWAS1751443 (human) | | 3e-28 | body height | | 4 | 108535458 | 108535459 | Human |
| 597327661 | GWAS1423735_H | breast density QTL GWAS1423735 (human) | | 0.000001 | breast density | | 4 | 124653133 | 124653134 | Human |
| 597163823 | GWAS1259897_H | heart valve disease QTL GWAS1259897 (human) | | 5e-22 | heart valve disease | | 4 | 110725811 | 110725812 | Human |
| 597229346 | GWAS1325420_H | asthma QTL GWAS1325420 (human) | | 6e-19 | asthma | | 4 | 122219915 | 122219916 | Human |
| 597229348 | GWAS1325422_H | asthma QTL GWAS1325422 (human) | | 2e-21 | asthma | | 4 | 122432277 | 122432278 | Human |
| 597229349 | GWAS1325423_H | asthma QTL GWAS1325423 (human) | | 2e-18 | asthma | | 4 | 122438414 | 122438415 | Human |
| 616495107 | GWAS1891690_H | serum metabolite level QTL GWAS1891690 (human) | | 7e-22 | serum metabolite level | | 4 | 129113772 | 129113775 | Human |
| 628996547 | GWAS2904776_H | prothrombin time measurement QTL GWAS2904776 (human) | | 6e-36 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110780277 | 110780278 | Human |
| 407291015 | GWAS939991_H | schizophrenia QTL GWAS939991 (human) | | 2e-09 | schizophrenia | | 4 | 117931831 | 117931832 | Human |
| 407323780 | GWAS972756_H | diastolic blood pressure QTL GWAS972756 (human) | | 3e-16 | diastolic blood pressure | | 4 | 110414448 | 110414449 | Human |
| 597065554 | GWAS1161628_H | eye color QTL GWAS1161628 (human) | | 0.000004 | iris pigmentation trait (VT:0005102) | | 4 | 110478442 | 110478443 | Human |
| 617117709 | GWAS2135208_H | body mass index QTL GWAS2135208 (human) | | 2e-28 | body mass index | | 4 | 129818987 | 129818988 | Human |
| 628734385 | GWAS2642614_H | thyroxine level QTL GWAS2642614 (human) | | 5e-08 | thyroxine level | | 4 | 123563112 | 123563113 | Human |
| 407258255 | GWAS907231_H | vaginal microbiome measurement QTL GWAS907231 (human) | | 0.000005 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 628996529 | GWAS2904758_H | platelet count QTL GWAS2904758 (human) | | 1e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119439096 | 119439097 | Human |
| 407323787 | GWAS972763_H | Premature atrial contractions QTL GWAS972763 (human) | | 0.0000004 | Premature atrial contractions | | 4 | 121039245 | 121039246 | Human |
| 628996528 | GWAS2904757_H | platelet count QTL GWAS2904757 (human) | | 3e-25 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109927496 | 109927497 | Human |
| 407323786 | GWAS972762_H | Premature atrial contractions QTL GWAS972762 (human) | | 0.0000005 | Premature atrial contractions | | 4 | 121016813 | 121016815 | Human |
| 598065000 | GWAS1784299_H | brain attribute QTL GWAS1784299 (human) | | 1e-10 | brain attribute | | 4 | 124548568 | 124548569 | Human |
| 597016408 | GWAS1112482_H | body mass index QTL GWAS1112482 (human) | | 0.0000003 | body mass index | | 4 | 129895905 | 129895906 | Human |
| 628504996 | GWAS2413225_H | FABP1/FABP2 protein level ratio in blood QTL GWAS2413225 (human) | | 1e-289 | FABP1/FABP2 protein level ratio in blood | | 4 | 119309995 | 119309996 | Human |
| 407110807 | GWAS759783_H | leukocyte count QTL GWAS759783 (human) | | 4e-11 | leukocyte count | | 4 | 109932621 | 109932622 | Human |
| 628423075 | GWAS2331304_H | hip bone mineral density QTL GWAS2331304 (human) | | 0.000006 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 128365448 | 128365449 | Human |
| 617068573 | GWAS2086072_H | IGFBP-3 measurement QTL GWAS2086072 (human) | | 0.0000002 | IGFBP-3 measurement | | 4 | 123840924 | 123840925 | Human |
| 407110808 | GWAS759784_H | leukocyte count QTL GWAS759784 (human) | | 1e-10 | leukocyte count | | 4 | 119343841 | 119343842 | Human |
| 616986650 | GWAS2004149_H | hemoglobin measurement QTL GWAS2004149 (human) | | 2e-11 | hemoglobin measurement | | 4 | 123844107 | 123844108 | Human |
| 407078046 | GWAS727022_H | body height QTL GWAS727022 (human) | | 3e-08 | body height | | 4 | 111755929 | 111755930 | Human |
| 406897822 | GWAS546798_H | sudden cardiac arrest QTL GWAS546798 (human) | | 0.0000004 | heart integrity trait (VT:0010757) | | 4 | 116333133 | 116333134 | Human |
| 597032821 | GWAS1128895_H | blood protein measurement QTL GWAS1128895 (human) | | 4e-34 | blood protein measurement | | 4 | 109737911 | 109737912 | Human |
| 616495198 | GWAS1891781_H | X-23587 measurement QTL GWAS1891781 (human) | | 0.000005 | X-23587 measurement | | 4 | 115261042 | 115261043 | Human |
| 617052198 | GWAS2069697_H | body height QTL GWAS2069697 (human) | | 5e-08 | body height | | 4 | 128687133 | 128687134 | Human |
| 597229435 | GWAS1325509_H | blood protein measurement QTL GWAS1325509 (human) | | 2e-272 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 617052196 | GWAS2069695_H | body height QTL GWAS2069695 (human) | | 2e-14 | body height | | 4 | 119796398 | 119796399 | Human |
| 597311356 | GWAS1407430_H | vaginal microbiome measurement QTL GWAS1407430 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 628750737 | GWAS2658966_H | size QTL GWAS2658966 (human) | | 5e-08 | size | | 4 | 118204297 | 118204298 | Human |
| 598032204 | GWAS1751503_H | obsolete_fibroblast growth factor 2 measurement QTL GWAS1751503 (human) | | 6e-39 | obsolete_fibroblast growth factor 2 measurement | | 4 | 122836593 | 122836594 | Human |
| 628865425 | GWAS2773654_H | epidermal growth factor measurement QTL GWAS2773654 (human) | | 5e-08 | epidermal growth factor measurement | | 4 | 109973293 | 109973294 | Human |
| 597376881 | GWAS1472955_H | inflammatory bowel disease QTL GWAS1472955 (human) | | 3e-13 | intestine integrity trait (VT:0010554) | | 4 | 122240464 | 122240465 | Human |
| 597229427 | GWAS1325501_H | blood protein measurement QTL GWAS1325501 (human) | | 2e-239 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 596967295 | GWAS1086814_H | diastolic blood pressure QTL GWAS1086814 (human) | | 3e-17 | diastolic blood pressure | | 4 | 110510288 | 110510289 | Human |
| 598015817 | GWAS1735116_H | myeloid leukocyte count QTL GWAS1735116 (human) | | 3e-11 | myeloid leukocyte count | | 4 | 109931303 | 109931304 | Human |
| 628963728 | GWAS2871957_H | atrial fibrillation QTL GWAS2871957 (human) | | 3e-33 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597229430 | GWAS1325504_H | blood protein measurement QTL GWAS1325504 (human) | | 5e-348 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628488603 | GWAS2396832_H | body mass index QTL GWAS2396832 (human) | | 3e-10 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112392830 | 112392831 | Human |
| 598015818 | GWAS1735117_H | myeloid leukocyte count QTL GWAS1735117 (human) | | 1e-15 | myeloid leukocyte count | | 4 | 119342160 | 119342161 | Human |
| 628963727 | GWAS2871956_H | atrial fibrillation QTL GWAS2871956 (human) | | 6e-56 | atrial fibrillation | | 4 | 110787848 | 110787849 | Human |
| 407405757 | GWAS1054733_H | mammographic density percentage QTL GWAS1054733 (human) | | 2e-08 | mammographic density percentage | | 4 | 127271525 | 127271526 | Human |
| 597344109 | GWAS1440183_H | color vision disorder QTL GWAS1440183 (human) | | 0.000002 | color vision disorder | | 4 | 107331993 | 107331994 | Human |
| 597213026 | GWAS1309100_H | mathematical ability QTL GWAS1309100 (human) | | 4e-10 | mathematical ability | | 4 | 115118452 | 115118453 | Human |
| 597213027 | GWAS1309101_H | mathematical ability QTL GWAS1309101 (human) | | 5e-10 | mathematical ability | | 4 | 122105714 | 122105715 | Human |
| 597213028 | GWAS1309102_H | mathematical ability QTL GWAS1309102 (human) | | 5e-08 | mathematical ability | | 4 | 130364875 | 130364876 | Human |
| 407323834 | GWAS972810_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS972810 (human) | | 8e-09 | very low density lipoprotein cholesterol measurement, phospholipid measurement | | 4 | 109657070 | 109657071 | Human |
| 597098344 | GWAS1194418_H | body height QTL GWAS1194418 (human) | | 1e-08 | body height | | 4 | 112402274 | 112402275 | Human |
| 407405750 | GWAS1054726_H | mammographic density measurement QTL GWAS1054726 (human) | | 6e-10 | mammographic density measurement | | 4 | 126851213 | 126851214 | Human |
| 597163671 | GWAS1259745_H | fibrinogen measurement, coronary artery disease QTL GWAS1259745 (human) | | 1e-11 | fibrinogen measurement, coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 407373130 | GWAS1022106_H | smoking status measurement QTL GWAS1022106 (human) | | 1e-10 | smoking status measurement | | 4 | 111546456 | 111546457 | Human |
| 598064807 | GWAS1784106_H | cerebral cortex area attribute QTL GWAS1784106 (human) | | 6e-14 | cerebral cortex area attribute | | 4 | 112497482 | 112497483 | Human |
| 597048981 | GWAS1145055_H | cervical carcinoma QTL GWAS1145055 (human) | | 0.0000007 | cervical carcinoma | | 4 | 113726137 | 113726138 | Human |
| 597425821 | GWAS1521895_H | electrocardiography QTL GWAS1521895 (human) | | 4e-11 | electrocardiography | | 4 | 113463172 | 113463173 | Human |
| 407094596 | GWAS743572_H | balding measurement QTL GWAS743572 (human) | | 7e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 107493233 | 107493234 | Human |
| 617036237 | GWAS2053736_H | severe acute respiratory syndrome, COVID-19 QTL GWAS2053736 (human) | | 0.000002 | severe acute respiratory syndrome, COVID-19 | | 4 | 119432971 | 119432972 | Human |
| 597606037 | GWAS1662897_H | obesity QTL GWAS1662897 (human) | | 4e-13 | obesity | | 4 | 129818987 | 129818988 | Human |
| 407094606 | GWAS743582_H | balding measurement QTL GWAS743582 (human) | | 2e-10 | balding measurement | | 4 | 123610267 | 123610268 | Human |
| 628799605 | GWAS2707834_H | COVID-19 QTL GWAS2707834 (human) | | 0.000001 | COVID-19 | | 4 | 113129435 | 113129436 | Human |
| 628602983 | GWAS2511212_H | high density lipoprotein cholesterol measurement QTL GWAS2511212 (human) | | 7e-09 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109603883 | 109603884 | Human |
| 628832363 | GWAS2740592_H | Ischemic stroke, von Willebrand factor quality QTL GWAS2740592 (human) | | 5e-16 | Ischemic stroke, von Willebrand factor quality | | 4 | 110775495 | 110775496 | Human |
| 628619366 | GWAS2527595_H | glomerular filtration rate QTL GWAS2527595 (human) | | 3e-14 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 597163653 | GWAS1259727_H | Ischemic stroke, fibrinogen measurement QTL GWAS1259727 (human) | | 1e-15 | Ischemic stroke, fibrinogen measurement | | 4 | 110775495 | 110775496 | Human |
| 406914387 | GWAS563363_H | P wave duration QTL GWAS563363 (human) | | 4e-08 | P wave duration | | 4 | 113467664 | 113467665 | Human |
| 628996206 | GWAS2904435_H | triglyceride measurement QTL GWAS2904435 (human) | | 2e-15 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
| 628701293 | GWAS2609522_H | fibroblast growth factor 2 level QTL GWAS2609522 (human) | | 3e-16 | fibroblast growth factor 2 level | | 4 | 123081630 | 123081631 | Human |
| 628701292 | GWAS2609521_H | fibroblast growth factor 2 level QTL GWAS2609521 (human) | | 1e-18 | fibroblast growth factor 2 level | | 4 | 123649214 | 123649215 | Human |
| 597081742 | GWAS1177816_H | mean platelet volume QTL GWAS1177816 (human) | | 1e-32 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 407094617 | GWAS743593_H | cardioembolic stroke QTL GWAS743593 (human) | | 2e-47 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597081741 | GWAS1177815_H | mean platelet volume QTL GWAS1177815 (human) | | 2e-10 | mean platelet volume | | 4 | 121336787 | 121336788 | Human |
| 598081211 | GWAS1800510_H | socioeconomic status QTL GWAS1800510 (human) | | 9e-09 | socioeconomic status | | 4 | 122105714 | 122105715 | Human |
| 628373611 | GWAS2294455_H | cesarean section, Anxiety QTL GWAS2294455 (human) | | 1e-09 | cesarean section, Anxiety | | 4 | 106962429 | 106962430 | Human |
| 406963553 | GWAS612529_H | atrial fibrillation QTL GWAS612529 (human) | | 1e-126 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 406963554 | GWAS612530_H | atrial fibrillation QTL GWAS612530 (human) | | 2e-34 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
| 628930648 | GWAS2838877_H | platelet count QTL GWAS2838877 (human) | | 4e-162 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110020646 | 110020647 | Human |
| 598048385 | GWAS1767684_H | brain physiology trait QTL GWAS1767684 (human) | | 7e-09 | brain physiology trait | | 4 | 116995997 | 116995998 | Human |
| 628668508 | GWAS2576737_H | major depressive disorder QTL GWAS2576737 (human) | | 5e-12 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
| 628668509 | GWAS2576738_H | major depressive disorder QTL GWAS2576738 (human) | | 2e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
| 628455506 | GWAS2363735_H | gut microbiome measurement QTL GWAS2363735 (human) | | 0.0000003 | gut microbiome measurement | | 4 | 112357355 | 112357356 | Human |
| 617085420 | GWAS2102919_H | vascular endothelial function measurement QTL GWAS2102919 (human) | | 8e-08 | vascular endothelial function measurement | | 4 | 132241773 | 132241774 | Human |
| 406996334 | GWAS645310_H | vascular endothelial function measurement QTL GWAS645310 (human) | | 8e-08 | vascular endothelial function measurement | | 4 | 132241773 | 132241774 | Human |
| 628635735 | GWAS2543964_H | gut microbiome measurement, breastfeeding duration QTL GWAS2543964 (human) | | 2e-09 | lactation duration (VT:1000653) | | 4 | 112409784 | 112409785 | Human |
| 596950692 | GWAS1070211_H | Red cell distribution width QTL GWAS1070211 (human) | | 2e-23 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 628652105 | GWAS2560334_H | pain measurement QTL GWAS2560334 (human) | | 2e-08 | nociception system physiology trait (VT:0015100) | | 4 | 129322917 | 129322919 | Human |
| 628832335 | GWAS2740564_H | serum creatinine amount QTL GWAS2740564 (human) | | 5e-13 | serum creatinine amount | | 4 | 127312122 | 127312123 | Human |
| 628979787 | GWAS2888016_H | leukocyte quantity QTL GWAS2888016 (human) | | 8e-12 | leukocyte quantity | | 4 | 109912954 | 109912955 | Human |
| 628815949 | GWAS2724178_H | mean reticulocyte volume QTL GWAS2724178 (human) | | 9e-67 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 121808257 | 121808258 | Human |
| 406947193 | GWAS596169_H | coronary artery disease QTL GWAS596169 (human) | | 0.000005 | coronary artery integrity trait (VT:0010746) | | 4 | 110812980 | 110812981 | Human |
| 617019903 | GWAS2037402_H | cytokine measurement QTL GWAS2037402 (human) | | 0.000003 | cytokine measurement | | 4 | 113030253 | 113030254 | Human |
| 406979965 | GWAS628941_H | dental caries QTL GWAS628941 (human) | | 0.000003 | dental caries | | 4 | 112605916 | 112605917 | Human |
| 597524185 | GWAS1620259_H | bone density QTL GWAS1620259 (human) | | 9e-11 | bone density | | 4 | 119112788 | 119112789 | Human |
| 616987009 | GWAS2004508_H | erythrocyte count QTL GWAS2004508 (human) | | 4e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 127869642 | 127869643 | Human |
| 628766771 | GWAS2675000_H | hemorrhoid QTL GWAS2675000 (human) | | 3e-11 | anorectal integrity trait (VT:0010734) | | 4 | 126003844 | 126003845 | Human |
| 598032111 | GWAS1751410_H | body height QTL GWAS1751410 (human) | | 2e-14 | body height | | 4 | 119759795 | 119759796 | Human |
| 628619323 | GWAS2527552_H | type 2 diabetes mellitus QTL GWAS2527552 (human) | | 0.0000005 | type 2 diabetes mellitus | | 4 | 128605841 | 128605842 | Human |
| 597098180 | GWAS1194254_H | body height QTL GWAS1194254 (human) | | 3e-08 | body height | | 4 | 111755929 | 111755930 | Human |
| 598064887 | GWAS1784186_H | cerebral cortex area attribute QTL GWAS1784186 (human) | | 4e-09 | cerebral cortex area attribute | | 4 | 120653052 | 120653053 | Human |
| 598146805 | GWAS1833533_H | urate measurement, bone tissue density QTL GWAS1833533 (human) | | 8e-09 | urate measurement, bone tissue density | | 4 | 113560916 | 113560917 | Human |
| 617118107 | GWAS2135606_H | fibroblast growth factor 2 amount QTL GWAS2135606 (human) | | 1e-15 | fibroblast growth factor 2 amount | | 4 | 121830362 | 121830363 | Human |
| 617118108 | GWAS2135607_H | fibroblast growth factor 2 amount QTL GWAS2135607 (human) | | 9e-16 | fibroblast growth factor 2 amount | | 4 | 122773901 | 122773902 | Human |
| 617118109 | GWAS2135608_H | fibroblast growth factor 2 amount QTL GWAS2135608 (human) | | 2e-32 | fibroblast growth factor 2 amount | | 4 | 122807694 | 122807695 | Human |
| 628832301 | GWAS2740530_H | factor XI measurement, coronary artery disease QTL GWAS2740530 (human) | | 2e-11 | coronary artery integrity trait (VT:0010746) | | 4 | 119988346 | 119988347 | Human |
| 617118110 | GWAS2135609_H | fibroblast growth factor 2 amount QTL GWAS2135609 (human) | | 7e-15 | fibroblast growth factor 2 amount | | 4 | 122834463 | 122834464 | Human |
| 407160083 | GWAS809059_H | gut microbiome measurement QTL GWAS809059 (human) | | 0.000002 | gut microbiome measurement | | 4 | 121059316 | 121059317 | Human |
| 617118111 | GWAS2135610_H | fibroblast growth factor 2 amount QTL GWAS2135610 (human) | | 6e-13 | fibroblast growth factor 2 amount | | 4 | 124215762 | 124215763 | Human |
| 597229248 | GWAS1325322_H | blood protein measurement QTL GWAS1325322 (human) | | 6e-894 | blood protein measurement | | 4 | 119309995 | 119309996 | Human |
| 406963480 | GWAS612456_H | alopecia areata QTL GWAS612456 (human) | | 4e-08 | alopecia areata | | 4 | 122602720 | 122602721 | Human |
| 407258395 | GWAS907371_H | vaginal microbiome measurement QTL GWAS907371 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
| 617118120 | GWAS2135619_H | fibroblast growth factor 2 amount QTL GWAS2135619 (human) | | 6e-18 | fibroblast growth factor 2 amount | | 4 | 122786283 | 122786284 | Human |
| 617118121 | GWAS2135620_H | fibroblast growth factor 2 amount QTL GWAS2135620 (human) | | 3e-13 | fibroblast growth factor 2 amount | | 4 | 122807648 | 122807649 | Human |
| 617118122 | GWAS2135621_H | fibroblast growth factor 2 amount QTL GWAS2135621 (human) | | 3e-18 | fibroblast growth factor 2 amount | | 4 | 122718148 | 122718149 | Human |
| 617118123 | GWAS2135622_H | fibroblast growth factor 2 amount QTL GWAS2135622 (human) | | 4e-13 | fibroblast growth factor 2 amount | | 4 | 122652747 | 122652748 | Human |
| 597524217 | GWAS1620291_H | bone density QTL GWAS1620291 (human) | | 2e-44 | bone density | | 4 | 111086102 | 111086103 | Human |
| 617118124 | GWAS2135623_H | fibroblast growth factor 2 amount QTL GWAS2135623 (human) | | 6e-22 | fibroblast growth factor 2 amount | | 4 | 122785605 | 122785606 | Human |
| 617052578 | GWAS2070077_H | retinal vasculature measurement QTL GWAS2070077 (human) | | 7e-58 | retinal vasculature measurement | | 4 | 119356945 | 119356946 | Human |
| 617118125 | GWAS2135624_H | fibroblast growth factor 2 amount QTL GWAS2135624 (human) | | 4e-17 | fibroblast growth factor 2 amount | | 4 | 122769150 | 122769151 | Human |
| 617118126 | GWAS2135625_H | fibroblast growth factor 2 amount QTL GWAS2135625 (human) | | 1e-35 | fibroblast growth factor 2 amount | | 4 | 122495046 | 122495047 | Human |
| 617118127 | GWAS2135626_H | fibroblast growth factor 2 amount QTL GWAS2135626 (human) | | 2e-22 | fibroblast growth factor 2 amount | | 4 | 122685018 | 122685019 | Human |
| 617118112 | GWAS2135611_H | fibroblast growth factor 2 amount QTL GWAS2135611 (human) | | 1e-38 | fibroblast growth factor 2 amount | | 4 | 122711350 | 122711351 | Human |
| 616970670 | GWAS1988169_H | gut microbiome measurement QTL GWAS1988169 (human) | | 0.000004 | gut microbiome measurement | | 4 | 125703884 | 125703885 | Human |
| 617118113 | GWAS2135612_H | fibroblast growth factor 2 amount QTL GWAS2135612 (human) | | 1e-11 | fibroblast growth factor 2 amount | | 4 | 122813836 | 122813837 | Human |
| 596983548 | GWAS1103067_H | memory performance QTL GWAS1103067 (human) | | 0.000003 | memory performance | | 4 | 124861382 | 124861383 | Human |
| 617118114 | GWAS2135613_H | fibroblast growth factor 2 amount QTL GWAS2135613 (human) | | 3e-12 | fibroblast growth factor 2 amount | | 4 | 122764765 | 122764766 | Human |
| 628602908 | GWAS2511137_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2511137 (human) | | 4e-13 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 628439070 | GWAS2347299_H | schizophrenia QTL GWAS2347299 (human) | | 8e-09 | schizophrenia | | 4 | 117906596 | 117906597 | Human |
| 597049085 | GWAS1145159_H | neuroticism measurement QTL GWAS1145159 (human) | | 2e-08 | neuroticism measurement | | 4 | 118015036 | 118015037 | Human |
| 617118115 | GWAS2135614_H | fibroblast growth factor 2 amount QTL GWAS2135614 (human) | | 2e-14 | fibroblast growth factor 2 amount | | 4 | 122971709 | 122971710 | Human |
| 617118116 | GWAS2135615_H | fibroblast growth factor 2 amount QTL GWAS2135615 (human) | | 5e-13 | fibroblast growth factor 2 amount | | 4 | 121760907 | 121760908 | Human |
| 617003434 | GWAS2020933_H | gastric carcinoma QTL GWAS2020933 (human) | | 3e-11 | gastric carcinoma | | 4 | 124530209 | 124530210 | Human |
| 617118117 | GWAS2135616_H | fibroblast growth factor 2 amount QTL GWAS2135616 (human) | | 9e-165 | fibroblast growth factor 2 amount | | 4 | 122842746 | 122842747 | Human |
| 598113995 | GWAS1822878_H | pain measurement QTL GWAS1822878 (human) | | 2e-08 | pain measurement | | 4 | 129322917 | 129322919 | Human |
| 597327604 | GWAS1423678_H | X-14189--leucylalanine measurement QTL GWAS1423678 (human) | | 6e-12 | X-14189--leucylalanine measurement | | 4 | 110510288 | 110510289 | Human |
| 617118119 | GWAS2135618_H | fibroblast growth factor 2 amount QTL GWAS2135618 (human) | | 5e-15 | fibroblast growth factor 2 amount | | 4 | 122496141 | 122496142 | Human |
| 617085363 | GWAS2102862_H | schizophrenia QTL GWAS2102862 (human) | | 2e-09 | schizophrenia | | 4 | 117931831 | 117931832 | Human |
| 407192881 | GWAS841857_H | mean corpuscular volume QTL GWAS841857 (human) | | 2e-09 | mean corpuscular volume | | 4 | 121773981 | 121773982 | Human |
| 407192880 | GWAS841856_H | mean corpuscular volume QTL GWAS841856 (human) | | 2e-11 | mean corpuscular volume | | 4 | 109979991 | 109979992 | Human |
| 628619264 | GWAS2527493_H | treatment resistant depression, response to antidepressant QTL GWAS2527493 (human) | | 0.000004 | treatment resistant depression, response to antidepressant | | 4 | 130515632 | 130515633 | Human |
| 617118129 | GWAS2135628_H | fibroblast growth factor 2 amount QTL GWAS2135628 (human) | | 5e-34 | fibroblast growth factor 2 amount | | 4 | 123107513 | 123107514 | Human |
| 617118130 | GWAS2135629_H | fibroblast growth factor 2 amount QTL GWAS2135629 (human) | | 5e-17 | fibroblast growth factor 2 amount | | 4 | 122424054 | 122424055 | Human |
| 617118131 | GWAS2135630_H | fibroblast growth factor 2 amount QTL GWAS2135630 (human) | | 2e-20 | fibroblast growth factor 2 amount | | 4 | 122663955 | 122663956 | Human |
| 597409510 | GWAS1505584_H | radiation-induced disorder QTL GWAS1505584 (human) | | 0.000006 | radiation-induced disorder | | 4 | 118888417 | 118888418 | Human |
| 406979900 | GWAS628876_H | temporal horn of lateral ventricle volume measurement QTL GWAS628876 (human) | | 0.0000005 | temporal horn of lateral ventricle volume measurement | | 4 | 121297822 | 121297823 | Human |
| 597523997 | GWAS1620071_H | smoking initiation QTL GWAS1620071 (human) | | 6e-10 | smoking initiation | | 4 | 117807381 | 117807382 | Human |
| 597523996 | GWAS1620070_H | smoking initiation QTL GWAS1620070 (human) | | 3e-14 | smoking initiation | | 4 | 115629116 | 115629117 | Human |
| 597523999 | GWAS1620073_H | smoking initiation QTL GWAS1620073 (human) | | 3e-09 | smoking initiation | | 4 | 126727157 | 126727158 | Human |
| 597523998 | GWAS1620072_H | smoking initiation QTL GWAS1620072 (human) | | 2e-13 | smoking initiation | | 4 | 120650494 | 120650495 | Human |
| 616986946 | GWAS2004445_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS2004445 (human) | | 4e-12 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 4 | 111202547 | 111202548 | Human |
| 407373260 | GWAS1022236_H | heel bone mineral density QTL GWAS1022236 (human) | | 8e-14 | heel bone mineral density | | 4 | 126607237 | 126607238 | Human |
| 406914500 | GWAS563476_H | systemic lupus erythematosus QTL GWAS563476 (human) | | 4e-11 | systemic lupus erythematosus | | 4 | 108125804 | 108125805 | Human |
| 628750588 | GWAS2658817_H | size QTL GWAS2658817 (human) | | 2e-10 | size | | 4 | 123999891 | 123999892 | Human |
| 407373261 | GWAS1022237_H | heel bone mineral density QTL GWAS1022237 (human) | | 3e-15 | heel bone mineral density | | 4 | 126607351 | 126607352 | Human |
| 617101645 | GWAS2119144_H | serum creatinine amount QTL GWAS2119144 (human) | | 5e-13 | serum creatinine amount | | 4 | 127312122 | 127312123 | Human |
| 596983314 | GWAS1102833_H | memory performance QTL GWAS1102833 (human) | | 0.000006 | memory performance | | 4 | 124891420 | 124891421 | Human |
| 597163536 | GWAS1259610_H | insomnia measurement QTL GWAS1259610 (human) | | 2e-08 | insomnia measurement | | 4 | 129592716 | 129592717 | Human |
| 597065247 | GWAS1161321_H | type 1 diabetes mellitus QTL GWAS1161321 (human) | | 6e-13 | type 1 diabetes mellitus | | 4 | 122322441 | 122322442 | Human |
| 597294612 | GWAS1390686_H | ceramide measurement QTL GWAS1390686 (human) | | 3e-13 | ceramide measurement | | 4 | 114553199 | 114553200 | Human |
| 597360148 | GWAS1456222_H | chronic lymphocytic leukemia QTL GWAS1456222 (human) | | 3e-09 | leukocyte integrity trait (VT:0010898) | | 4 | 113762688 | 113762689 | Human |
| 597294615 | GWAS1390689_H | ceramide measurement QTL GWAS1390689 (human) | | 2e-09 | ceramide measurement | | 4 | 114559783 | 114559784 | Human |
| 406947282 | GWAS596258_H | malignant epithelial tumor of ovary QTL GWAS596258 (human) | | 2e-08 | malignant epithelial tumor of ovary | | 4 | 119028805 | 119028806 | Human |
| 597294605 | GWAS1390679_H | ceramide measurement QTL GWAS1390679 (human) | | 1e-08 | ceramide measurement | | 4 | 114573629 | 114573630 | Human |
| 598048305 | GWAS1767604_H | brain physiology trait QTL GWAS1767604 (human) | | 5e-09 | brain physiology trait | | 4 | 116998865 | 116998866 | Human |
| 597294607 | GWAS1390681_H | ceramide measurement QTL GWAS1390681 (human) | | 1e-11 | ceramide measurement | | 4 | 114725282 | 114725283 | Human |
| 598064691 | GWAS1783990_H | brain attribute QTL GWAS1783990 (human) | | 1e-20 | brain attribute | | 4 | 127076729 | 127076730 | Human |
| 597294606 | GWAS1390680_H | ceramide measurement QTL GWAS1390680 (human) | | 3e-18 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
| 616986974 | GWAS2004473_H | erythrocyte count QTL GWAS2004473 (human) | | 8e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598115 | 114598116 | Human |
| 597229056 | GWAS1325130_H | BMI-adjusted waist-hip ratio QTL GWAS1325130 (human) | | 1e-09 | BMI-adjusted waist-hip ratio | | 4 | 119607172 | 119607173 | Human |
| 596950540 | GWAS1070059_H | major depressive disorder QTL GWAS1070059 (human) | | 2e-10 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
| 628439279 | GWAS2347508_H | BMI-adjusted waist-hip ratio QTL GWAS2347508 (human) | | 9e-12 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 121705035 | 121705036 | Human |
| 597327367 | GWAS1423441_H | alcohol consumption measurement QTL GWAS1423441 (human) | | 0.000006 | alcohol consumption measurement | | 4 | 131688192 | 131688193 | Human |
| 598031876 | GWAS1751175_H | body height QTL GWAS1751175 (human) | | 2e-10 | body height | | 4 | 121736832 | 121736833 | Human |
| 628504785 | GWAS2413014_H | lung carcinoma QTL GWAS2413014 (human) | | 0.0000005 | lung integrity trait (VT:0010906) | | 4 | 128666151 | 128666152 | Human |
| 628734160 | GWAS2642389_H | clostridium difficile infection QTL GWAS2642389 (human) | | 0.000008 | response to bacterial infection trait (VT:0010435) | | 4 | 108850323 | 108850324 | Human |
| 597392946 | GWAS1489020_H | lifestyle measurement QTL GWAS1489020 (human) | | 8e-09 | lifestyle measurement | | 4 | 129365346 | 129365348 | Human |
| 597392945 | GWAS1489019_H | lifestyle measurement QTL GWAS1489019 (human) | | 3e-09 | lifestyle measurement | | 4 | 117436249 | 117436250 | Human |
| 406980081 | GWAS629057_H | caudal anterior cingulate cortex volume measurement QTL GWAS629057 (human) | | 0.000002 | caudal anterior cingulate cortex volume measurement | | 4 | 125708052 | 125708053 | Human |
| 597016098 | GWAS1112172_H | pulse pressure measurement QTL GWAS1112172 (human) | | 0.0000007 | pulse pressure measurement | | 4 | 122671579 | 122671580 | Human |
| 616560901 | GWAS1957484_H | level of sphingomyelin phosphodiesterase in blood serum QTL GWAS1957484 (human) | | 4e-24 | level of sphingomyelin phosphodiesterase in blood serum | | 4 | 109717668 | 109717669 | Human |
| 597048874 | GWAS1144948_H | non-small cell lung carcinoma QTL GWAS1144948 (human) | | 0.000004 | non-small cell lung carcinoma | | 4 | 121873960 | 121873961 | Human |
| 597311015 | GWAS1407089_H | vaginal microbiome measurement QTL GWAS1407089 (human) | | 0.000001 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 598064664 | GWAS1783963_H | cerebral cortex area attribute QTL GWAS1783963 (human) | | 3e-18 | cerebral cortex area attribute | | 4 | 118359012 | 118359013 | Human |
| 407225733 | GWAS874709_H | body height QTL GWAS874709 (human) | | 4e-44 | body height | | 4 | 121800257 | 121800258 | Human |
| 407192964 | GWAS841940_H | body mass index QTL GWAS841940 (human) | | 6e-11 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 597081684 | GWAS1177758_H | lymphocyte count QTL GWAS1177758 (human) | | 6e-10 | lymphocyte count | | 4 | 122579931 | 122579932 | Human |
| 407192967 | GWAS841943_H | body mass index QTL GWAS841943 (human) | | 2e-12 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 407225734 | GWAS874710_H | body height QTL GWAS874710 (human) | | 5e-16 | body height | | 4 | 123987076 | 123987077 | Human |
| 597081682 | GWAS1177756_H | lymphocyte count QTL GWAS1177756 (human) | | 6e-20 | lymphocyte count | | 4 | 109914892 | 109914893 | Human |
| 597081683 | GWAS1177757_H | lymphocyte count QTL GWAS1177757 (human) | | 1e-25 | lymphocyte count | | 4 | 112152543 | 112152544 | Human |
| 597196381 | GWAS1292455_H | memory performance QTL GWAS1292455 (human) | | 0.000008 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124893791 | 124893792 | Human |
| 407307649 | GWAS956625_H | high density lipoprotein cholesterol measurement QTL GWAS956625 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | | 4 | 109717608 | 109717609 | Human |
| 407225731 | GWAS874707_H | body height QTL GWAS874707 (human) | | 2e-08 | body height | | 4 | 119700262 | 119700263 | Human |
| 597196382 | GWAS1292456_H | memory performance QTL GWAS1292456 (human) | | 0.000008 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124895966 | 124895967 | Human |
| 628537535 | GWAS2445764_H | level of liver carboxylesterase 1 in blood QTL GWAS2445764 (human) | | 1e-27 | level of liver carboxylesterase 1 in blood | | 4 | 118865819 | 118865820 | Human |
| 617134339 | GWAS2151838_H | body mass index QTL GWAS2151838 (human) | | 2e-25 | body mass index | | 4 | 129824994 | 129824995 | Human |
| 598081129 | GWAS1800428_H | platelet volume QTL GWAS1800428 (human) | | 7e-21 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 617101573 | GWAS2119072_H | prostate specific antigen amount QTL GWAS2119072 (human) | | 3e-16 | prostate specific antigen amount | | 4 | 109877415 | 109877416 | Human |
| 617101574 | GWAS2119073_H | prostate specific antigen amount QTL GWAS2119073 (human) | | 2e-13 | prostate specific antigen amount | | 4 | 111519061 | 111519062 | Human |
| 617101575 | GWAS2119074_H | prostate specific antigen amount QTL GWAS2119074 (human) | | 8e-09 | prostate specific antigen amount | | 4 | 123950358 | 123950359 | Human |
| 628816042 | GWAS2724271_H | stroke QTL GWAS2724271 (human) | | 2e-15 | brain integrity trait (VT:0010579) | | 4 | 110793263 | 110793264 | Human |
| 626456711 | GWAS2270644_H | serum albumin amount QTL GWAS2270644 (human) | | 6e-20 | serum albumin amount | | 4 | 128155663 | 128155664 | Human |
| 597048898 | GWAS1144972_H | allergic rhinitis QTL GWAS1144972 (human) | | 3e-15 | allergic rhinitis | | 4 | 122496409 | 122496410 | Human |
| 617036050 | GWAS2053549_H | lipid measurement QTL GWAS2053549 (human) | | 6e-08 | lipid measurement | | 4 | 124266893 | 124266894 | Human |
| 407389598 | GWAS1038574_H | trefoil factor 3 measurement QTL GWAS1038574 (human) | | 3e-09 | trefoil factor 3 measurement | | 4 | 120726405 | 120726406 | Human |
| 597982844 | GWAS1702143_H | platelet volume QTL GWAS1702143 (human) | | 2e-10 | platelet volume | | 4 | 121336787 | 121336788 | Human |
| 616495462 | GWAS1892045_H | body mass index QTL GWAS1892045 (human) | | 8e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597982845 | GWAS1702144_H | platelet volume QTL GWAS1702144 (human) | | 1e-32 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 616986911 | GWAS2004410_H | bipolar I disorder QTL GWAS2004410 (human) | | 0.0000001 | bipolar I disorder | | 4 | 122588558 | 122588559 | Human |
| 407192985 | GWAS841961_H | body mass index QTL GWAS841961 (human) | | 1e-10 | body mass index | | 4 | 111765198 | 111765199 | Human |
| 617036059 | GWAS2053558_H | lipid measurement QTL GWAS2053558 (human) | | 0.000005 | lipid measurement | | 4 | 126630119 | 126630120 | Human |
| 628570282 | GWAS2478511_H | gestational age QTL GWAS2478511 (human) | | 0.000007 | gestational age | | 4 | 112357355 | 112357356 | Human |
| 628373674 | GWAS2294518_H | thyroxine level QTL GWAS2294518 (human) | | 5e-08 | thyroxine level | | 4 | 123563112 | 123563113 | Human |
| 597147208 | GWAS1243282_H | prostate carcinoma QTL GWAS1243282 (human) | | 0.000001 | prostate carcinoma | | 4 | 109927496 | 109927497 | Human |
| 407242151 | GWAS891127_H | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS891127 (human) | | 2e-09 | fatty acid measurement | | 4 | 109657070 | 109657071 | Human |
| 617036070 | GWAS2053569_H | atrial fibrillation QTL GWAS2053569 (human) | | 2e-101 | atrial fibrillation | | 4 | 110789946 | 110789947 | Human |
| 597032564 | GWAS1128638_H | bipolar disorder QTL GWAS1128638 (human) | | 0.000006 | bipolar disorder | | 4 | 117740497 | 117740498 | Human |
| 597343867 | GWAS1439941_H | color vision disorder QTL GWAS1439941 (human) | | 0.000008 | color vision disorder | | 4 | 129487149 | 129487150 | Human |
| 597999174 | GWAS1718473_H | wellbeing measurement, alcohol consumption quality QTL GWAS1718473 (human) | | 2e-08 | wellbeing measurement, alcohol consumption quality | | 4 | 117309754 | 117309755 | Human |
| 617101611 | GWAS2119110_H | lipoprotein measurement QTL GWAS2119110 (human) | | 1e-13 | lipoprotein measurement | | 4 | 109717608 | 109717609 | Human |
| 597999175 | GWAS1718474_H | wellbeing measurement, alcohol consumption quality QTL GWAS1718474 (human) | | 3e-08 | wellbeing measurement, alcohol consumption quality | | 4 | 121662557 | 121662558 | Human |
| 406914470 | GWAS563446_H | diastolic blood pressure QTL GWAS563446 (human) | | 1e-10 | diastolic blood pressure | | 4 | 119336584 | 119336585 | Human |
| 616986926 | GWAS2004425_H | leukocyte quantity QTL GWAS2004425 (human) | | 1e-10 | leukocyte quantity | | 4 | 119343841 | 119343842 | Human |
| 597081727 | GWAS1177801_H | gut microbiome measurement QTL GWAS1177801 (human) | | 0.000004 | gut microbiome measurement | | 4 | 118997805 | 118997806 | Human |
| 407143862 | GWAS792838_H | coronary artery calcification QTL GWAS792838 (human) | | 0.000006 | coronary artery calcification | | 4 | 117351922 | 117351923 | Human |
| 628996238 | GWAS2904467_H | body weight QTL GWAS2904467 (human) | | 4e-19 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129818987 | 129818988 | Human |
| 597163619 | GWAS1259693_H | Ischemic stroke, factor VII measurement QTL GWAS1259693 (human) | | 1e-16 | Ischemic stroke, tissue plasminogen activator measurement | | 4 | 110775495 | 110775496 | Human |
| 598015568 | GWAS1734867_H | red blood cell density QTL GWAS1734867 (human) | | 2e-15 | red blood cell density | | 4 | 114598115 | 114598116 | Human |
| 407406000 | GWAS1054976_H | mean reticulocyte volume QTL GWAS1054976 (human) | | 6e-11 | mean reticulocyte volume | | 4 | 122215361 | 122215362 | Human |
| 407406001 | GWAS1054977_H | mean reticulocyte volume QTL GWAS1054977 (human) | | 3e-10 | mean reticulocyte volume | | 4 | 127552302 | 127552303 | Human |
| 597098095 | GWAS1194169_H | sex hormone-binding globulin measurement QTL GWAS1194169 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 4 | 128110633 | 128110634 | Human |
| 597245538 | GWAS1341612_H | sex hormone-binding globulin measurement QTL GWAS1341612 (human) | | 1e-11 | sex hormone-binding globulin measurement | | 4 | 109104450 | 109104451 | Human |
| 407078335 | GWAS727311_H | body mass index QTL GWAS727311 (human) | | 1e-14 | body mass index | | 4 | 129805678 | 129805679 | Human |
| 617052472 | GWAS2069971_H | erythrocyte count QTL GWAS2069971 (human) | | 6e-14 | erythrocyte count | | 4 | 114598115 | 114598116 | Human |
| 597032554 | GWAS1128628_H | body height QTL GWAS1128628 (human) | | 1e-10 | body height | | 4 | 124024877 | 124024878 | Human |
| 597999014 | GWAS1718313_H | obsolete_sleep measurement QTL GWAS1718313 (human) | | 0.000005 | obsolete_sleep measurement | | 4 | 118053665 | 118053666 | Human |
| 616970947 | GWAS1988446_H | gut microbiome measurement QTL GWAS1988446 (human) | | 0.0000004 | gut microbiome measurement | | 4 | 116053081 | 116053082 | Human |
| 597294494 | GWAS1390568_H | ceramide measurement QTL GWAS1390568 (human) | | 2e-11 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
| 407209549 | GWAS858525_H | lymphocyte percentage of leukocytes QTL GWAS858525 (human) | | 6e-19 | lymphocyte percentage of leukocytes | | 4 | 122760001 | 122760002 | Human |
| 407389762 | GWAS1038738_H | atrial fibrillation QTL GWAS1038738 (human) | | 2e-134 | atrial fibrillation | | 4 | 110793733 | 110793734 | Human |
| 597163421 | GWAS1259495_H | guanosine measurement QTL GWAS1259495 (human) | | 0.00001 | guanosine measurement | | 4 | 113514721 | 113514722 | Human |
| 597999017 | GWAS1718316_H | obsolete_sleep measurement QTL GWAS1718316 (human) | | 0.000006 | obsolete_sleep measurement | | 4 | 118160921 | 118160922 | Human |
| 596966788 | GWAS1086307_H | body mass index QTL GWAS1086307 (human) | | 1e-08 | body mass index | | 4 | 119738082 | 119738083 | Human |
| 617020114 | GWAS2037613_H | smoking status measurement QTL GWAS2037613 (human) | | 1e-10 | smoking status measurement | | 4 | 111546456 | 111546457 | Human |
| 616528555 | GWAS1925138_H | lymphocyte percentage of leukocytes QTL GWAS1925138 (human) | | 3e-21 | lymphocyte percentage of leukocytes | | 4 | 112142370 | 112142371 | Human |
| 597228941 | GWAS1325015_H | childhood trauma measurement QTL GWAS1325015 (human) | | 1e-08 | childhood trauma measurement | | 4 | 118266477 | 118266478 | Human |
| 597425539 | GWAS1521613_H | depressive symptom measurement, stressful life event measurement QTL GWAS1521613 (human) | | 0.000008 | depressive symptom measurement, stressful life event measurement | | 4 | 110061116 | 110061117 | Human |
| 617036509 | GWAS2054008_H | COVID-19 QTL GWAS2054008 (human) | | 0.0000006 | COVID-19 | | 4 | 107888805 | 107888806 | Human |
| 407225946 | GWAS874922_H | response to carboplatin QTL GWAS874922 (human) | | 0.000006 | response to carboplatin | | 4 | 115920168 | 115920169 | Human |
| 628456277 | GWAS2364506_H | electrocardiography QTL GWAS2364506 (human) | | 2e-08 | electrocardiography | | 4 | 115646453 | 115646454 | Human |
| 628702041 | GWAS2610270_H | fibroblast growth factor 2 level QTL GWAS2610270 (human) | | 5e-13 | fibroblast growth factor 2 level | | 4 | 121760907 | 121760908 | Human |
| 628702040 | GWAS2610269_H | fibroblast growth factor 2 level QTL GWAS2610269 (human) | | 2e-14 | fibroblast growth factor 2 level | | 4 | 122971709 | 122971710 | Human |
| 597196217 | GWAS1292291_H | glomerular filtration rate QTL GWAS1292291 (human) | | 4e-09 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 596983223 | GWAS1102742_H | memory performance QTL GWAS1102742 (human) | | 0.000006 | memory performance | | 4 | 124897660 | 124897661 | Human |
| 628423510 | GWAS2331739_H | asthma exacerbation measurement QTL GWAS2331739 (human) | | 0.000002 | bronchoconstriction trait (VT:0001945) | | 4 | 129344890 | 129344891 | Human |
| 628456278 | GWAS2364507_H | electrocardiography QTL GWAS2364507 (human) | | 1e-08 | electrocardiography | | 4 | 115646453 | 115646454 | Human |
| 597048757 | GWAS1144831_H | squamous cell lung carcinoma QTL GWAS1144831 (human) | | 0.0000005 | squamous cell lung carcinoma | | 4 | 121873960 | 121873961 | Human |
| 628702042 | GWAS2610271_H | fibroblast growth factor 2 level QTL GWAS2610271 (human) | | 9e-40 | fibroblast growth factor 2 level | | 4 | 122868214 | 122868215 | Human |
| 597343673 | GWAS1439747_H | color vision disorder QTL GWAS1439747 (human) | | 0.000006 | color vision disorder | | 4 | 125161562 | 125161563 | Human |
| 407062119 | GWAS711095_H | epidermal growth factor measurement QTL GWAS711095 (human) | | 1e-21 | epidermal growth factor measurement | | 4 | 109960338 | 109960339 | Human |
| 628882269 | GWAS2790498_H | complement factor I measurement QTL GWAS2790498 (human) | | 3e-66 | complement protein amount (VT:0010033) | | 4 | 109742841 | 109742842 | Human |
| 628702033 | GWAS2610262_H | fibroblast growth factor 2 level QTL GWAS2610262 (human) | | 7e-15 | fibroblast growth factor 2 level | | 4 | 122834463 | 122834464 | Human |
| 617118433 | GWAS2135932_H | prothrombin time measurement QTL GWAS2135932 (human) | | 1e-16 | prothrombin time measurement | | 4 | 110791530 | 110791531 | Human |
| 628702032 | GWAS2610261_H | fibroblast growth factor 2 level QTL GWAS2610261 (human) | | 2e-22 | fibroblast growth factor 2 level | | 4 | 123434666 | 123434667 | Human |
| 596983228 | GWAS1102747_H | memory performance QTL GWAS1102747 (human) | | 0.000006 | memory performance | | 4 | 124885712 | 124885713 | Human |
| 597327280 | GWAS1423354_H | fibrinopeptide A measurement QTL GWAS1423354 (human) | | 1e-12 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 407111278 | GWAS760254_H | mathematical ability QTL GWAS760254 (human) | | 5e-09 | mathematical ability | | 4 | 114994461 | 114994462 | Human |
| 628702035 | GWAS2610264_H | fibroblast growth factor 2 level QTL GWAS2610264 (human) | | 1e-38 | fibroblast growth factor 2 level | | 4 | 122711350 | 122711351 | Human |
| 597327281 | GWAS1423355_H | fibrinopeptide A measurement QTL GWAS1423355 (human) | | 1e-42 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 628964182 | GWAS2872411_H | blood coagulation disease QTL GWAS2872411 (human) | | 8e-29 | blood coagulation disease | | 4 | 110784139 | 110784140 | Human |
| 628702034 | GWAS2610263_H | fibroblast growth factor 2 level QTL GWAS2610263 (human) | | 6e-13 | fibroblast growth factor 2 level | | 4 | 124215762 | 124215763 | Human |
| 407111279 | GWAS760255_H | mathematical ability QTL GWAS760255 (human) | | 4e-13 | mathematical ability | | 4 | 128819435 | 128819436 | Human |
| 628702037 | GWAS2610266_H | fibroblast growth factor 2 level QTL GWAS2610266 (human) | | 3e-12 | fibroblast growth factor 2 level | | 4 | 122764765 | 122764766 | Human |
| 597015992 | GWAS1112066_H | late-onset Alzheimers disease QTL GWAS1112066 (human) | | 0.000002 | late-onset Alzheimers disease | | 4 | 109373310 | 109373311 | Human |
| 628702036 | GWAS2610265_H | fibroblast growth factor 2 level QTL GWAS2610265 (human) | | 1e-11 | fibroblast growth factor 2 level | | 4 | 122813836 | 122813837 | Human |
| 628472667 | GWAS2380896_H | EDAR/EGF protein level ratio in blood QTL GWAS2380896 (human) | | 1e-98 | EDAR/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 628702039 | GWAS2610268_H | fibroblast growth factor 2 level QTL GWAS2610268 (human) | | 6e-13 | fibroblast growth factor 2 level | | 4 | 122830982 | 122830983 | Human |
| 628702038 | GWAS2610267_H | fibroblast growth factor 2 level QTL GWAS2610267 (human) | | 1e-15 | fibroblast growth factor 2 level | | 4 | 122808855 | 122808856 | Human |
| 628718409 | GWAS2626638_H | stanniocalcin-2 measurement QTL GWAS2626638 (human) | | 1e-12 | stanniocalcin-2 measurement | | 4 | 109973957 | 109973958 | Human |
| 597409195 | GWAS1505269_H | Ischemic stroke QTL GWAS1505269 (human) | | 5e-14 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 617118456 | GWAS2135955_H | fibroblast growth factor 2 amount QTL GWAS2135955 (human) | | 6e-15 | fibroblast growth factor 2 amount | | 4 | 123433862 | 123433863 | Human |
| 617118457 | GWAS2135956_H | fibroblast growth factor 2 amount QTL GWAS2135956 (human) | | 6e-16 | fibroblast growth factor 2 amount | | 4 | 122834403 | 122834404 | Human |
| 597409193 | GWAS1505267_H | cardioembolic stroke QTL GWAS1505267 (human) | | 5e-41 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 617118458 | GWAS2135957_H | fibroblast growth factor 2 amount QTL GWAS2135957 (human) | | 5e-13 | fibroblast growth factor 2 amount | | 4 | 122640324 | 122640325 | Human |
| 617118459 | GWAS2135958_H | fibroblast growth factor 2 amount QTL GWAS2135958 (human) | | 7e-12 | fibroblast growth factor 2 amount | | 4 | 122083028 | 122083029 | Human |
| 598031766 | GWAS1751065_H | body height QTL GWAS1751065 (human) | | 6e-23 | body height | | 4 | 122904764 | 122904765 | Human |
| 597327278 | GWAS1423352_H | fibrinopeptide A measurement QTL GWAS1423352 (human) | | 3e-15 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 407094903 | GWAS743879_H | cognitive function measurement QTL GWAS743879 (human) | | 0.000005 | cognitive function measurement | | 4 | 114569532 | 114569533 | Human |
| 628554562 | GWAS2462791_H | acid sphingomyelinase-like phosphodiesterase 3a measurement QTL GWAS2462791 (human) | | 1e-20 | acid sphingomyelinase-like phosphodiesterase 3a measurement | | 4 | 118842717 | 118842718 | Human |
| 597327279 | GWAS1423353_H | fibrinopeptide A measurement QTL GWAS1423353 (human) | | 8e-15 | fibrinopeptide A measurement | | 4 | 110485340 | 110485341 | Human |
| 628702031 | GWAS2610260_H | fibroblast growth factor 2 level QTL GWAS2610260 (human) | | 2e-32 | fibroblast growth factor 2 level | | 4 | 122807694 | 122807695 | Human |
| 628702030 | GWAS2610259_H | fibroblast growth factor 2 level QTL GWAS2610259 (human) | | 9e-16 | fibroblast growth factor 2 level | | 4 | 122773901 | 122773902 | Human |
| 598113681 | GWAS1822564_H | uterine prolapse QTL GWAS1822564 (human) | | 2e-15 | uterine prolapse | | 4 | 126003529 | 126003530 | Human |
| 597294497 | GWAS1390571_H | ceramide measurement QTL GWAS1390571 (human) | | 2e-08 | ceramide measurement | | 4 | 114553199 | 114553200 | Human |
| 407373426 | GWAS1022402_H | smoking cessation QTL GWAS1022402 (human) | | 1e-08 | smoking cessation | | 4 | 111500989 | 111500990 | Human |
| 628882246 | GWAS2790475_H | type 2 diabetes mellitus QTL GWAS2790475 (human) | | 2e-18 | type 2 diabetes mellitus | | 4 | 119146548 | 119146549 | Human |
| 617118454 | GWAS2135953_H | fibroblast growth factor 2 amount QTL GWAS2135953 (human) | | 5e-21 | fibroblast growth factor 2 amount | | 4 | 122629385 | 122629386 | Human |
| 597114280 | GWAS1210354_H | reticulocyte count QTL GWAS1210354 (human) | | 3e-18 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109944309 | 109944310 | Human |
| 617118455 | GWAS2135954_H | fibroblast growth factor 2 amount QTL GWAS2135954 (human) | | 2e-22 | fibroblast growth factor 2 amount | | 4 | 122843079 | 122843080 | Human |
| 628816699 | GWAS2724928_H | Diuretic use measurement QTL GWAS2724928 (human) | | 4e-10 | Diuretic use measurement | | 4 | 110465271 | 110465272 | Human |
| 628702008 | GWAS2610237_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2610237 (human) | | 1e-15 | glioma pathogenesis-related protein 1 measurement | | 4 | 132115969 | 132115970 | Human |
| 597212634 | GWAS1308708_H | celiac disease QTL GWAS1308708 (human) | | 4e-11 | celiac disease | | 4 | 122345366 | 122345367 | Human |
| 617118348 | GWAS2135847_H | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement QTL GWAS2135847 (human) | | 2e-27 | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | | 4 | 123872632 | 123872633 | Human |
| 617118349 | GWAS2135848_H | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement QTL GWAS2135848 (human) | | 5e-18 | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | | 4 | 123849566 | 123849567 | Human |
| 596983251 | GWAS1102770_H | memory performance QTL GWAS1102770 (human) | | 0.0000003 | memory performance | | 4 | 128552943 | 128552944 | Human |
| 628947764 | GWAS2855993_H | serum albumin amount QTL GWAS2855993 (human) | | 2e-10 | serum albumin amount | | 4 | 123867301 | 123867302 | Human |
| 628636466 | GWAS2544695_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS2544695 (human) | | 4e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 125560481 | 125560482 | Human |
| 407406104 | GWAS1055080_H | cystatin C measurement QTL GWAS1055080 (human) | | 4e-09 | cystatin C measurement | | 4 | 119754004 | 119754005 | Human |
| 617069202 | GWAS2086701_H | neuroimaging measurement QTL GWAS2086701 (human) | | 2e-09 | neuroimaging measurement | | 4 | 114732469 | 114732470 | Human |
| 616528617 | GWAS1925200_H | IGF-1 measurement QTL GWAS1925200 (human) | | 2e-13 | IGF-1 measurement | | 4 | 127821409 | 127821410 | Human |
| 628423459 | GWAS2331688_H | eosinophil count QTL GWAS2331688 (human) | | 3e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 123311945 | 123311946 | Human |
| 628980517 | GWAS2888746_H | diastolic blood pressure QTL GWAS2888746 (human) | | 7e-34 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110417121 | 110417122 | Human |
| 616495846 | GWAS1892429_H | X-23782 measurement QTL GWAS1892429 (human) | | 0.000003 | X-23782 measurement | | 4 | 128953341 | 128953342 | Human |
| 406914587 | GWAS563563_H | gestational diabetes QTL GWAS563563 (human) | | 0.000001 | gestational diabetes | | 4 | 106609371 | 106609372 | Human |
| 407340569 | GWAS989545_H | hemoglobin measurement QTL GWAS989545 (human) | | 1e-10 | hemoglobin measurement | | 4 | 124004016 | 124004017 | Human |
| 407258649 | GWAS907625_H | vaginal microbiome measurement QTL GWAS907625 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 407340568 | GWAS989544_H | hemoglobin measurement QTL GWAS989544 (human) | | 3e-11 | hemoglobin measurement | | 4 | 114551415 | 114551416 | Human |
| 597130696 | GWAS1226770_H | wellbeing measurement, alcohol consumption measurement QTL GWAS1226770 (human) | | 2e-08 | wellbeing measurement, alcohol consumption measurement | | 4 | 117309754 | 117309755 | Human |
| 407258662 | GWAS907638_H | vaginal microbiome measurement QTL GWAS907638 (human) | | 0.000002 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 597278200 | GWAS1374274_H | low density lipoprotein cholesterol measurement QTL GWAS1374274 (human) | | 4e-08 | low density lipoprotein cholesterol measurement | | 4 | 109997531 | 109997532 | Human |
| 597278203 | GWAS1374277_H | age-related macular degeneration, COVID-19 QTL GWAS1374277 (human) | | 2e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
| 598048199 | GWAS1767498_H | alcohol consumption quality QTL GWAS1767498 (human) | | 9e-13 | alcohol consumption quality | | 4 | 112386757 | 112386758 | Human |
| 597327353 | GWAS1423427_H | testicular hydrocele, filarial elephantiasis QTL GWAS1423427 (human) | | 0.0000009 | testicular hydrocele, filarial elephantiasis | | 4 | 112132236 | 112132237 | Human |
| 406914597 | GWAS563573_H | gestational diabetes QTL GWAS563573 (human) | | 0.000003 | gestational diabetes | | 4 | 118370662 | 118370663 | Human |
| 407012903 | GWAS661879_H | open-angle glaucoma QTL GWAS661879 (human) | | 4e-15 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 598064576 | GWAS1783875_H | brain attribute QTL GWAS1783875 (human) | | 3e-30 | brain attribute | | 4 | 112512138 | 112512139 | Human |
| 597999041 | GWAS1718340_H | childhood trauma measurement, alcohol consumption quality QTL GWAS1718340 (human) | | 8e-09 | childhood trauma measurement, alcohol consumption quality | | 4 | 127440030 | 127440031 | Human |
| 407389742 | GWAS1038718_H | atrial fibrillation QTL GWAS1038718 (human) | | 7e-136 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 616495832 | GWAS1892415_H | X-24334 measurement QTL GWAS1892415 (human) | | 0.000007 | X-24334 measurement | | 4 | 124556058 | 124556059 | Human |
| 407389743 | GWAS1038719_H | atrial fibrillation QTL GWAS1038719 (human) | | 8e-46 | atrial fibrillation | | 4 | 110767596 | 110767597 | Human |
| 598064578 | GWAS1783877_H | brain attribute QTL GWAS1783877 (human) | | 5e-30 | brain attribute | | 4 | 118393759 | 118393760 | Human |
| 598048204 | GWAS1767503_H | alcohol consumption quality QTL GWAS1767503 (human) | | 5e-14 | alcohol consumption quality | | 4 | 129324733 | 129324734 | Human |
| 598048201 | GWAS1767500_H | alcohol consumption quality QTL GWAS1767500 (human) | | 9e-11 | alcohol consumption quality | | 4 | 112673525 | 112673526 | Human |
| 598048200 | GWAS1767499_H | alcohol consumption quality QTL GWAS1767499 (human) | | 8e-11 | alcohol consumption quality | | 4 | 112673472 | 112673473 | Human |
| 628833045 | GWAS2741274_H | calcium measurement QTL GWAS2741274 (human) | | 1e-12 | calcium amount (VT:0010499) | blood calcium level (CMO:0000502) | 4 | 114469815 | 114469816 | Human |
| 407127594 | GWAS776570_H | QT interval QTL GWAS776570 (human) | | 0.0000008 | QT interval | | 4 | 117411099 | 117411100 | Human |
| 598048203 | GWAS1767502_H | alcohol consumption quality QTL GWAS1767502 (human) | | 1e-10 | alcohol consumption quality | | 4 | 128806522 | 128806523 | Human |
| 598048202 | GWAS1767501_H | alcohol consumption quality QTL GWAS1767501 (human) | | 1e-10 | alcohol consumption quality | | 4 | 117942113 | 117942114 | Human |
| 407258665 | GWAS907641_H | vaginal microbiome measurement QTL GWAS907641 (human) | | 0.000004 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
| 597376489 | GWAS1472563_H | gut microbiome measurement QTL GWAS1472563 (human) | | 0.000004 | gut microbiome measurement | | 4 | 125703884 | 125703885 | Human |
| 596983265 | GWAS1102784_H | memory performance QTL GWAS1102784 (human) | | 0.000001 | memory performance | | 4 | 124874941 | 124874942 | Human |
| 596983277 | GWAS1102796_H | memory performance QTL GWAS1102796 (human) | | 0.000003 | memory performance | | 4 | 124858709 | 124858710 | Human |
| 407406128 | GWAS1055104_H | creatinine measurement QTL GWAS1055104 (human) | | 3e-12 | cystatin C measurement | | 4 | 127420965 | 127420966 | Human |
| 597114350 | GWAS1210424_H | protein measurement QTL GWAS1210424 (human) | | 1e-11 | protein amount (VT:0010120) | | 4 | 131061544 | 131061545 | Human |
| 406898234 | GWAS547210_H | juvenile idiopathic arthritis QTL GWAS547210 (human) | | 0.0000007 | juvenile idiopathic arthritis | | 4 | 122535302 | 122535303 | Human |
| 596983279 | GWAS1102798_H | memory performance QTL GWAS1102798 (human) | | 0.000003 | memory performance | | 4 | 124862465 | 124862466 | Human |
| 628833030 | GWAS2741259_H | Ischemic stroke, plasminogen activator inhibitor 1 measurement QTL GWAS2741259 (human) | | 6e-17 | blood plasminogen activator inhibitor 1 amount (VT:0010926) | blood plasminogen activator inhibitor 1 level (CMO:0003034) | 4 | 110775495 | 110775496 | Human |
| 597442018 | GWAS1538092_H | platelet count QTL GWAS1538092 (human) | | 1e-43 | platelet count | | 4 | 110020646 | 110020647 | Human |
| 596983275 | GWAS1102794_H | memory performance QTL GWAS1102794 (human) | | 0.000002 | memory performance | | 4 | 124856977 | 124856978 | Human |
| 407406280 | GWAS1055256_H | cleft lip QTL GWAS1055256 (human) | | 0.000001 | cleft lip | | 4 | 125904223 | 125904224 | Human |
| 407373504 | GWAS1022480_H | blood protein measurement QTL GWAS1022480 (human) | | 1e-336 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628472804 | GWAS2381033_H | EGF/MANF protein level ratio in blood QTL GWAS2381033 (human) | | 3e-195 | EGF/MANF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 597097731 | GWAS1193805_H | testosterone measurement QTL GWAS1193805 (human) | | 2e-11 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 109717668 | 109717669 | Human |
| 628702191 | GWAS2610420_H | vaginal microbiome measurement QTL GWAS2610420 (human) | | 0.0000007 | vaginal microbiome measurement | | 4 | 116138019 | 116138020 | Human |
| 628472813 | GWAS2381042_H | EGF/MGLL protein level ratio in blood QTL GWAS2381042 (human) | | 2e-239 | EGF/MGLL protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 597327104 | GWAS1423178_H | fibrinopeptide A measurement QTL GWAS1423178 (human) | | 7e-15 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 597327105 | GWAS1423179_H | fibrinopeptide A measurement QTL GWAS1423179 (human) | | 6e-17 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 597130506 | GWAS1226580_H | wellbeing measurement, alcohol consumption measurement QTL GWAS1226580 (human) | | 3e-08 | wellbeing measurement, alcohol consumption measurement | | 4 | 121662557 | 121662558 | Human |
| 597343493 | GWAS1439567_H | forced expiratory volume QTL GWAS1439567 (human) | | 3e-13 | forced expiratory volume | | 4 | 127731072 | 127731073 | Human |
| 597015860 | GWAS1111934_H | intraocular pressure measurement QTL GWAS1111934 (human) | | 3e-10 | intraocular pressure measurement | | 4 | 111042563 | 111042564 | Human |
| 628571088 | GWAS2479317_H | osteoarthritis QTL GWAS2479317 (human) | | 5e-09 | osteoarthritis | | 4 | 120663127 | 120663128 | Human |
| 406947562 | GWAS596538_H | visceral adipose tissue measurement, body mass index QTL GWAS596538 (human) | | 0.000008 | visceral adipose tissue measurement, body mass index | | 4 | 117158751 | 117158752 | Human |
| 628702153 | GWAS2610382_H | glomerular filtration rate QTL GWAS2610382 (human) | | 9e-15 | glomerular filtration rate | | 4 | 108772770 | 108772771 | Human |
| 597032228 | GWAS1128302_H | waist-hip ratio QTL GWAS1128302 (human) | | 0.0000006 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 119495290 | 119495291 | Human |
| 597277992 | GWAS1374066_H | insomnia QTL GWAS1374066 (human) | | 5e-09 | insomnia | | 4 | 125465671 | 125465672 | Human |
| 597228844 | GWAS1324918_H | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement QTL GWAS1324918 (human) | | 0.000004 | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | | 4 | 119026891 | 119026892 | Human |
| 598064401 | GWAS1783700_H | level of tyrosine-protein kinase Mer in blood QTL GWAS1783700 (human) | | 3e-08 | level of tyrosine-protein kinase Mer in blood | | 4 | 121520144 | 121520146 | Human |
| 597392685 | GWAS1488759_H | pulse pressure measurement QTL GWAS1488759 (human) | | 1e-08 | pulse pressure measurement | | 4 | 110465042 | 110465043 | Human |
| 616561155 | GWAS1957738_H | level of odontogenic ameloblast-associated protein in blood QTL GWAS1957738 (human) | | 3e-15 | level of odontogenic ameloblast-associated protein in blood | | 4 | 111864198 | 111864199 | Human |
| 407389834 | GWAS1038810_H | atrial fibrillation QTL GWAS1038810 (human) | | 7e-92 | atrial fibrillation | | 4 | 110789386 | 110789387 | Human |
| 597982580 | GWAS1701879_H | diet measurement, blood insulin amount QTL GWAS1701879 (human) | | 0.000009 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 109806404 | 109806405 | Human |
| 598080893 | GWAS1800192_H | platelet volume QTL GWAS1800192 (human) | | 3e-27 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 628620203 | GWAS2528432_H | BMI-adjusted waist-hip ratio QTL GWAS2528432 (human) | | 6e-13 | body size trait (VT:0100005) | | 4 | 124261535 | 124261536 | Human |
| 407193249 | GWAS842225_H | large artery stroke QTL GWAS842225 (human) | | 0.000002 | large artery stroke | | 4 | 107143047 | 107143048 | Human |
| 597261693 | GWAS1357767_H | free cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1357767 (human) | | 7e-09 | free cholesterol measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597998913 | GWAS1718212_H | body height QTL GWAS1718212 (human) | | 2e-14 | body height | | 4 | 119501252 | 119501253 | Human |
| 407275171 | GWAS924147_H | vaso-occlusive pain measurement QTL GWAS924147 (human) | | 6e-08 | vaso-occlusive pain measurement | | 4 | 122088578 | 122088579 | Human |
| 628669330 | GWAS2577559_H | schizophrenia QTL GWAS2577559 (human) | | 2e-11 | schizophrenia | | 4 | 117906596 | 117906597 | Human |
| 597179764 | GWAS1275838_H | response to sertraline, psychotic symptom measurement, response to olanzapine QTL GWAS1275838 (human) | | 0.000004 | response to sertraline, psychotic symptom measurement, response to olanzapine | | 4 | 119092116 | 119092117 | Human |
| 597523825 | GWAS1619899_H | sexual dimorphism measurement QTL GWAS1619899 (human) | | 5e-09 | sexual dimorphism measurement | | 4 | 121792708 | 121792709 | Human |
| 617069099 | GWAS2086598_H | body fat percentage QTL GWAS2086598 (human) | | 3e-08 | body fat percentage | | 4 | 123822104 | 123822105 | Human |
| 407275177 | GWAS924153_H | susceptibility to cold sores measurement QTL GWAS924153 (human) | | 0.000004 | susceptibility to cold sores measurement | | 4 | 120332709 | 120332710 | Human |
| 597048674 | GWAS1144748_H | anxiety QTL GWAS1144748 (human) | | 7e-09 | anxiety | | 4 | 118015036 | 118015037 | Human |
| 406898357 | GWAS547333_H | heart failure QTL GWAS547333 (human) | | 2e-18 | heart failure | | 4 | 110843816 | 110843817 | Human |
| 597196128 | GWAS1292202_H | memory performance QTL GWAS1292202 (human) | | 0.0000005 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124882027 | 124882028 | Human |
| 597196129 | GWAS1292203_H | memory performance QTL GWAS1292203 (human) | | 0.0000005 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124882886 | 124882887 | Human |
| 597196130 | GWAS1292204_H | memory performance QTL GWAS1292204 (human) | | 0.0000005 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124883368 | 124883369 | Human |
| 628603786 | GWAS2512015_H | mean corpuscular hemoglobin QTL GWAS2512015 (human) | | 5e-10 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121870446 | 121870447 | Human |
| 628898690 | GWAS2806919_H | diastolic blood pressure QTL GWAS2806919 (human) | | 2e-11 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110319122 | 110319123 | Human |
| 628947577 | GWAS2855806_H | body weight QTL GWAS2855806 (human) | | 3e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 119212719 | 119212720 | Human |
| 596982943 | GWAS1102462_H | memory performance QTL GWAS1102462 (human) | | 0.000006 | memory performance | | 4 | 124893791 | 124893792 | Human |
| 616545205 | GWAS1941788_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1941788 (human) | | 1e-15 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 132115969 | 132115970 | Human |
| 597310602 | GWAS1406676_H | vaginal microbiome measurement QTL GWAS1406676 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 597998772 | GWAS1718071_H | erythrocyte volume QTL GWAS1718071 (human) | | 8e-44 | erythrocyte volume | | 4 | 121875762 | 121875763 | Human |
| 597228680 | GWAS1324754_H | appendicular lean mass QTL GWAS1324754 (human) | | 3e-22 | appendicular lean mass | | 4 | 124035957 | 124035958 | Human |
| 597310601 | GWAS1406675_H | vaginal microbiome measurement QTL GWAS1406675 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 597032070 | GWAS1128144_H | glomerular filtration rate QTL GWAS1128144 (human) | | 3e-14 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 617020370 | GWAS2037869_H | self reported educational attainment QTL GWAS2037869 (human) | | 4e-08 | self reported educational attainment | | 4 | 130401277 | 130401278 | Human |
| 617020368 | GWAS2037867_H | self reported educational attainment QTL GWAS2037867 (human) | | 1e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
| 616954835 | GWAS1972334_H | forced expiratory volume, response to bronchodilator QTL GWAS1972334 (human) | | 0.000003 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 122596078 | 122596079 | Human |
| 617020369 | GWAS2037868_H | self reported educational attainment QTL GWAS2037868 (human) | | 1e-08 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 407160668 | GWAS809644_H | Parkinson disease QTL GWAS809644 (human) | | 5e-11 | Parkinson disease | | 4 | 113439216 | 113439217 | Human |
| 628701793 | GWAS2610022_H | fibroblast growth factor 2 level QTL GWAS2610022 (human) | | 7e-18 | fibroblast growth factor 2 level | | 4 | 123310196 | 123310197 | Human |
| 616512422 | GWAS1909005_H | reticulocyte amount QTL GWAS1909005 (human) | | 2e-10 | reticulocyte amount | | 4 | 119185193 | 119185194 | Human |
| 628701792 | GWAS2610021_H | fibroblast growth factor 2 level QTL GWAS2610021 (human) | | 2e-26 | fibroblast growth factor 2 level | | 4 | 123218415 | 123218416 | Human |
| 628701794 | GWAS2610023_H | fibroblast growth factor 2 level QTL GWAS2610023 (human) | | 1e-15 | fibroblast growth factor 2 level | | 4 | 121830362 | 121830363 | Human |
| 407013215 | GWAS662191_H | electroencephalogram measurement QTL GWAS662191 (human) | | 0.000005 | electroencephalogram measurement | | 4 | 107150343 | 107150344 | Human |
| 406898525 | GWAS547501_H | intelligence, response to cranial radiation therapy QTL GWAS547501 (human) | | 0.000001 | intelligence, response to cranial radiation therapy | | 4 | 120035508 | 120035509 | Human |
| 597228679 | GWAS1324753_H | appendicular lean mass QTL GWAS1324753 (human) | | 3e-11 | appendicular lean mass | | 4 | 107939926 | 107939927 | Human |
| 628963933 | GWAS2872162_H | lymphocyte count QTL GWAS2872162 (human) | | 3e-11 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109916511 | 109916512 | Human |
| 597064886 | GWAS1160960_H | alopecia areata QTL GWAS1160960 (human) | | 0.000001 | alopecia areata | | 4 | 122473886 | 122473887 | Human |
| 628701785 | GWAS2610014_H | fibroblast growth factor 2 level QTL GWAS2610014 (human) | | 2e-24 | fibroblast growth factor 2 level | | 4 | 122680969 | 122680970 | Human |
| 597245115 | GWAS1341189_H | neonatal abstinence syndrome QTL GWAS1341189 (human) | | 0.000003 | neonatal abstinence syndrome | | 4 | 115468815 | 115468816 | Human |
| 628701786 | GWAS2610015_H | fibroblast growth factor 2 level QTL GWAS2610015 (human) | | 1e-20 | fibroblast growth factor 2 level | | 4 | 123619151 | 123619152 | Human |
| 597310654 | GWAS1406728_H | glomerular filtration rate QTL GWAS1406728 (human) | | 7e-17 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 628701789 | GWAS2610018_H | fibroblast growth factor 2 level QTL GWAS2610018 (human) | | 2e-14 | fibroblast growth factor 2 level | | 4 | 122792575 | 122792576 | Human |
| 628701788 | GWAS2610017_H | fibroblast growth factor 2 level QTL GWAS2610017 (human) | | 4e-50 | fibroblast growth factor 2 level | | 4 | 123210593 | 123210594 | Human |
| 628800092 | GWAS2708321_H | triglyceride measurement QTL GWAS2708321 (human) | | 7e-11 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109648464 | 109648465 | Human |
| 628701791 | GWAS2610020_H | fibroblast growth factor 2 level QTL GWAS2610020 (human) | | 2e-72 | fibroblast growth factor 2 level | | 4 | 123006761 | 123006762 | Human |
| 628701790 | GWAS2610019_H | fibroblast growth factor 2 level QTL GWAS2610019 (human) | | 2e-22 | fibroblast growth factor 2 level | | 4 | 122820831 | 122820832 | Human |
| 596950205 | GWAS1069724_H | COVID-19 QTL GWAS1069724 (human) | | 0.000003 | COVID-19 | | 4 | 120985638 | 120985639 | Human |
| 617069550 | GWAS2087049_H | glomerular filtration rate QTL GWAS2087049 (human) | | 2e-20 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 617069549 | GWAS2087048_H | glomerular filtration rate QTL GWAS2087048 (human) | | 2e-08 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 617069548 | GWAS2087047_H | glomerular filtration rate QTL GWAS2087047 (human) | | 1e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
| 597064888 | GWAS1160962_H | alopecia areata QTL GWAS1160962 (human) | | 5e-09 | alopecia areata | | 4 | 122602871 | 122602872 | Human |
| 406996845 | GWAS645821_H | sex hormone-binding globulin measurement QTL GWAS645821 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
| 407373688 | GWAS1022664_H | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation QTL GWAS1022664 (human) | | 0.000001 | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | | 4 | 128638644 | 128638645 | Human |
| 597179561 | GWAS1275635_H | N-acetylneuraminate measurement QTL GWAS1275635 (human) | | 2e-08 | N-acetylneuraminate measurement | | 4 | 110098606 | 110098607 | Human |
| 628963918 | GWAS2872147_H | fatty acid amount QTL GWAS2872147 (human) | | 3e-08 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 616971250 | GWAS1988749_H | platelet count QTL GWAS1988749 (human) | | 8e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123749526 | 123749527 | Human |
| 596982944 | GWAS1102463_H | memory performance QTL GWAS1102463 (human) | | 0.000006 | memory performance | | 4 | 124895966 | 124895967 | Human |
| 616971249 | GWAS1988748_H | platelet count QTL GWAS1988748 (human) | | 1e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
| 407177085 | GWAS826061_H | waist-hip ratio QTL GWAS826061 (human) | | 5e-08 | waist-hip ratio | | 4 | 121702910 | 121702911 | Human |
| 617135092 | GWAS2152591_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS2152591 (human) | | 4e-13 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119502654 | 119502655 | Human |
| 597998744 | GWAS1718043_H | erythrocyte volume QTL GWAS1718043 (human) | | 4e-16 | erythrocyte volume | | 4 | 127534974 | 127534975 | Human |
| 628800071 | GWAS2708300_H | COVID-19 QTL GWAS2708300 (human) | | 0.00001 | COVID-19 | | 4 | 107157415 | 107157416 | Human |
| 617135093 | GWAS2152592_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS2152592 (human) | | 1e-12 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119508517 | 119508518 | Human |
| 617135094 | GWAS2152593_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS2152593 (human) | | 1e-17 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119424923 | 119424924 | Human |
| 597327013 | GWAS1423087_H | body mass index QTL GWAS1423087 (human) | | 6e-11 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 617135095 | GWAS2152594_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS2152594 (human) | | 2e-12 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119380081 | 119380082 | Human |
| 407160581 | GWAS809557_H | BMI-adjusted waist-hip ratio QTL GWAS809557 (human) | | 0.000005 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
| 407389962 | GWAS1038938_H | serum gamma-glutamyl transferase measurement QTL GWAS1038938 (human) | | 7e-13 | serum gamma-glutamyl transferase measurement | | 4 | 111793842 | 111793843 | Human |
| 407160582 | GWAS809558_H | BMI-adjusted waist-hip ratio QTL GWAS809558 (human) | | 0.0000003 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
| 406914819 | GWAS563795_H | smoking behavior QTL GWAS563795 (human) | | 0.000009 | smoking behavior | | 4 | 125510764 | 125510765 | Human |
| 628914750 | GWAS2822979_H | cystatin C measurement QTL GWAS2822979 (human) | | 9e-15 | blood cystatin C amount (VT:0010743) | blood cystatin C level (CMO:0002777) | 4 | 127176068 | 127176069 | Human |
| 628914751 | GWAS2822980_H | cystatin C measurement QTL GWAS2822980 (human) | | 2e-08 | blood cystatin C amount (VT:0010743) | blood cystatin C level (CMO:0002777) | 4 | 128611038 | 128611039 | Human |
| 628800052 | GWAS2708281_H | right ventricular systolic volume measurement QTL GWAS2708281 (human) | | 1e-08 | right ventricular systolic volume measurement | | 4 | 119517499 | 119517500 | Human |
| 628718123 | GWAS2626352_H | BH3-interacting domain death agonist measurement QTL GWAS2626352 (human) | | 9e-13 | BH3-interacting domain death agonist measurement | | 4 | 109746434 | 109746435 | Human |
| 597310665 | GWAS1406739_H | vaginal microbiome measurement QTL GWAS1406739 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 131705323 | 131705324 | Human |
| 597294285 | GWAS1390359_H | complement factor I measurement QTL GWAS1390359 (human) | | 2e-17 | complement factor I measurement | | 4 | 109735574 | 109735575 | Human |
| 616987538 | GWAS2005037_H | Alzheimer disease QTL GWAS2005037 (human) | | 0.000003 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 597408961 | GWAS1505035_H | vaginal microbiome measurement QTL GWAS1505035 (human) | | 0.000001 | vaginal microbiome measurement | | 4 | 113045828 | 113045829 | Human |
| 628505133 | GWAS2413362_H | attention deficit hyperactivity disorder, risk-taking behaviour QTL GWAS2413362 (human) | | 7e-11 | exploratory behavior trait (VT:0010471) | | 4 | 111296367 | 111296368 | Human |
| 626457101 | GWAS2271034_H | hematocrit QTL GWAS2271034 (human) | | 1e-21 | hematocrit | | 4 | 114598670 | 114598671 | Human |
| 407226139 | GWAS875115_H | asthma, response to diisocyanate QTL GWAS875115 (human) | | 0.000001 | asthma, response to diisocyanate | | 4 | 123742201 | 123742202 | Human |
| 628701721 | GWAS2609950_H | vaginal microbiome measurement QTL GWAS2609950 (human) | | 0.0000004 | vaginal microbiome measurement | | 4 | 107383042 | 107383043 | Human |
| 597097718 | GWAS1193792_H | testosterone measurement QTL GWAS1193792 (human) | | 1e-19 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
| 628701720 | GWAS2609949_H | vaginal microbiome measurement QTL GWAS2609949 (human) | | 3e-10 | vaginal microbiome measurement | | 4 | 107261570 | 107261571 | Human |
| 628701722 | GWAS2609951_H | vaginal microbiome measurement QTL GWAS2609951 (human) | | 0.0000004 | vaginal microbiome measurement | | 4 | 107467275 | 107467276 | Human |
| 597294330 | GWAS1390404_H | cardiac troponin T measurement QTL GWAS1390404 (human) | | 0.0000001 | cardiac troponin T measurement | | 4 | 118958433 | 118958434 | Human |
| 597114111 | GWAS1210185_H | behavioural disinhibition measurement QTL GWAS1210185 (human) | | 0.0000009 | behavior trait (VT:0010442) | | 4 | 113934816 | 113934817 | Human |
| 628505119 | GWAS2413348_H | major depressive disorder QTL GWAS2413348 (human) | | 3e-09 | major depressive disorder | | 4 | 130315312 | 130315313 | Human |
| 597294325 | GWAS1390399_H | cardiac troponin T measurement QTL GWAS1390399 (human) | | 0.0000008 | cardiac troponin T measurement | | 4 | 118958433 | 118958434 | Human |
| 406964014 | GWAS612990_H | COVID-19 QTL GWAS612990 (human) | | 0.0000006 | COVID-19 | | 4 | 107888805 | 107888806 | Human |
| 628685335 | GWAS2593564_H | body height QTL GWAS2593564 (human) | | 1e-12 | body height | | 4 | 108362858 | 108362859 | Human |
| 407226164 | GWAS875140_H | unipolar depression QTL GWAS875140 (human) | | 0.000007 | unipolar depression | | 4 | 115213661 | 115213662 | Human |
| 597097700 | GWAS1193774_H | sex hormone-binding globulin measurement QTL GWAS1193774 (human) | | 9e-41 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 598047953 | GWAS1767252_H | obsolete_facial morphology quality QTL GWAS1767252 (human) | | 4e-08 | obsolete_facial morphology quality | | 4 | 125199979 | 125199980 | Human |
| 598047952 | GWAS1767251_H | obsolete_facial morphology quality QTL GWAS1767251 (human) | | 3e-08 | obsolete_facial morphology quality | | 4 | 125220568 | 125220569 | Human |
| 628423169 | GWAS2331398_H | triglyceride change measurement, trait in response to fatty acid QTL GWAS2331398 (human) | | 0.000001 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 128638644 | 128638645 | Human |
| 406898486 | GWAS547462_H | heart failure QTL GWAS547462 (human) | | 9e-12 | heart failure | | 4 | 110665822 | 110665823 | Human |
| 597441770 | GWAS1537844_H | lifestyle measurement, alcohol consumption measurement QTL GWAS1537844 (human) | | 8e-08 | lifestyle measurement, anxiety disorder measurement | | 4 | 127457977 | 127457978 | Human |
| 598047954 | GWAS1767253_H | obsolete_facial morphology quality QTL GWAS1767253 (human) | | 5e-08 | obsolete_facial morphology quality | | 4 | 125202598 | 125202599 | Human |
| 406898488 | GWAS547464_H | heart failure QTL GWAS547464 (human) | | 5e-42 | heart failure | | 4 | 110787848 | 110787849 | Human |
| 628800000 | GWAS2708229_H | body height QTL GWAS2708229 (human) | | 3e-08 | body height | | 4 | 119693141 | 119693142 | Human |
| 628800001 | GWAS2708230_H | body height QTL GWAS2708230 (human) | | 1e-09 | body height | | 4 | 121739866 | 121739867 | Human |
| 616496067 | GWAS1892650_H | level of phosphatidylcholine QTL GWAS1892650 (human) | | 2e-08 | level of phosphatidylcholine | | 4 | 126274953 | 126274954 | Human |
| 597359642 | GWAS1455716_H | eosinophil percentage of leukocytes QTL GWAS1455716 (human) | | 5e-09 | eosinophil percentage of leukocytes | | 4 | 122639784 | 122639785 | Human |
| 597130263 | GWAS1226337_H | cortical surface area measurement QTL GWAS1226337 (human) | | 2e-17 | cortical surface area measurement | | 4 | 123326251 | 123326252 | Human |
| 597130262 | GWAS1226336_H | cortical surface area measurement QTL GWAS1226336 (human) | | 8e-10 | cortical surface area measurement | | 4 | 120653052 | 120653053 | Human |
| 616545085 | GWAS1941668_H | level of beta-glucuronidase in blood serum QTL GWAS1941668 (human) | | 5e-46 | level of beta-glucuronidase in blood serum | | 4 | 118842717 | 118842718 | Human |
| 597408799 | GWAS1504873_H | cortical thickness QTL GWAS1504873 (human) | | 9e-16 | cortical thickness | | 4 | 120645452 | 120645453 | Human |
| 598113314 | GWAS1822197_H | pain measurement QTL GWAS1822197 (human) | | 9e-09 | pain measurement | | 4 | 129311323 | 129311324 | Human |
| 628423411 | GWAS2331640_H | eosinophil count QTL GWAS2331640 (human) | | 5e-23 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122263256 | 122263257 | Human |
| 597244945 | GWAS1341019_H | BMI-adjusted waist-hip ratio QTL GWAS1341019 (human) | | 2e-11 | BMI-adjusted waist-hip ratio | | 4 | 123124286 | 123124287 | Human |
| 597244944 | GWAS1341018_H | BMI-adjusted waist-hip ratio QTL GWAS1341018 (human) | | 5e-08 | BMI-adjusted waist-hip ratio | | 4 | 122860717 | 122860718 | Human |
| 597244947 | GWAS1341021_H | BMI-adjusted waist-hip ratio QTL GWAS1341021 (human) | | 1e-08 | BMI-adjusted waist-hip ratio | | 4 | 124118741 | 124118742 | Human |
| 628816625 | GWAS2724854_H | Beta blocking agent use measurement QTL GWAS2724854 (human) | | 1e-19 | Beta blocking agent use measurement | | 4 | 110789765 | 110789766 | Human |
| 597244946 | GWAS1341020_H | BMI-adjusted waist-hip ratio QTL GWAS1341020 (human) | | 1e-11 | BMI-adjusted waist-hip ratio | | 4 | 123166618 | 123166619 | Human |
| 407324620 | GWAS973596_H | BMI-adjusted waist-hip ratio QTL GWAS973596 (human) | | 1e-08 | BMI-adjusted waist-hip ratio | | 4 | 124118741 | 124118742 | Human |
| 407324619 | GWAS973595_H | BMI-adjusted waist-hip ratio QTL GWAS973595 (human) | | 5e-08 | BMI-adjusted waist-hip ratio | | 4 | 122860717 | 122860718 | Human |
| 407324618 | GWAS973594_H | BMI-adjusted waist-hip ratio QTL GWAS973594 (human) | | 6e-09 | BMI-adjusted waist-hip ratio | | 4 | 121702910 | 121702911 | Human |
| 407324617 | GWAS973593_H | BMI-adjusted waist-hip ratio QTL GWAS973593 (human) | | 2e-08 | BMI-adjusted waist-hip ratio | | 4 | 119591353 | 119591354 | Human |
| 628833012 | GWAS2741241_H | serum creatinine amount QTL GWAS2741241 (human) | | 4e-17 | serum creatinine amount | | 4 | 108792999 | 108793000 | Human |
| 628488954 | GWAS2397183_H | blood protein amount QTL GWAS2397183 (human) | | 5e-62 | blood protein amount | | 4 | 109965187 | 109965188 | Human |
| 407324616 | GWAS973592_H | BMI-adjusted waist-hip ratio QTL GWAS973592 (human) | | 2e-10 | BMI-adjusted waist-hip ratio | | 4 | 119213641 | 119213642 | Human |
| 407193557 | GWAS842533_H | glycerophospholipid measurement QTL GWAS842533 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114571532 | 114571533 | Human |
| 407193556 | GWAS842532_H | glycerophospholipid measurement QTL GWAS842532 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114570559 | 114570560 | Human |
| 597081095 | GWAS1177169_H | neutrophil count QTL GWAS1177169 (human) | | 1e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 4 | 119234651 | 119234652 | Human |
| 407193559 | GWAS842535_H | glycerophospholipid measurement QTL GWAS842535 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114514205 | 114514206 | Human |
| 407193558 | GWAS842534_H | glycerophospholipid measurement QTL GWAS842534 (human) | | 4e-22 | glycerophospholipid measurement | | 4 | 114571876 | 114571877 | Human |
| 407193553 | GWAS842529_H | glycerophospholipid measurement QTL GWAS842529 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114544945 | 114544946 | Human |
| 597244941 | GWAS1341015_H | BMI-adjusted waist-hip ratio QTL GWAS1341015 (human) | | 2e-08 | BMI-adjusted waist-hip ratio | | 4 | 119591353 | 119591354 | Human |
| 407128016 | GWAS776992_H | eosinophil count QTL GWAS776992 (human) | | 3e-10 | eosinophil count | | 4 | 123311945 | 123311946 | Human |
| 597474312 | GWAS1570386_H | cytokine measurement QTL GWAS1570386 (human) | | 0.000001 | cytokine measurement | | 4 | 125803384 | 125803385 | Human |
| 597244940 | GWAS1341014_H | BMI-adjusted waist-hip ratio QTL GWAS1341014 (human) | | 2e-10 | BMI-adjusted waist-hip ratio | | 4 | 119213641 | 119213642 | Human |
| 407193555 | GWAS842531_H | glycerophospholipid measurement QTL GWAS842531 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114568870 | 114568871 | Human |
| 597294095 | GWAS1390169_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS1390169 (human) | | 4e-12 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119320694 | 119320695 | Human |
| 597244943 | GWAS1341017_H | BMI-adjusted waist-hip ratio QTL GWAS1341017 (human) | | 6e-09 | BMI-adjusted waist-hip ratio | | 4 | 121702910 | 121702911 | Human |
| 407193554 | GWAS842530_H | glycerophospholipid measurement QTL GWAS842530 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114564575 | 114564576 | Human |
| 628865772 | GWAS2774001_H | colorectal cancer QTL GWAS2774001 (human) | | 2e-08 | colorectal cancer | | 4 | 114581250 | 114581251 | Human |
| 616512296 | GWAS1908879_H | blood urea nitrogen amount QTL GWAS1908879 (human) | | 4e-08 | blood urea nitrogen amount | | 4 | 119076757 | 119076758 | Human |
| 597244942 | GWAS1341016_H | BMI-adjusted waist-hip ratio QTL GWAS1341016 (human) | | 2e-09 | BMI-adjusted waist-hip ratio | | 4 | 119763897 | 119763898 | Human |
| 617020241 | GWAS2037740_H | protein measurement QTL GWAS2037740 (human) | | 1e-08 | protein amount (VT:0010120) | | 4 | 132318854 | 132318855 | Human |
| 617134929 | GWAS2152428_H | level of pancreatic triacylglycerol lipase in blood serum QTL GWAS2152428 (human) | | 1e-17 | level of pancreatic triacylglycerol lipase in blood serum | | 4 | 109933893 | 109933894 | Human |
| 407193560 | GWAS842536_H | glycerophospholipid measurement QTL GWAS842536 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114571551 | 114571552 | Human |
| 628898530 | GWAS2806759_H | testosterone measurement QTL GWAS2806759 (human) | | 1e-14 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 124126476 | 124126477 | Human |
| 597294139 | GWAS1390213_H | mean corpuscular hemoglobin QTL GWAS1390213 (human) | | 5e-51 | mean corpuscular hemoglobin | | 4 | 121875762 | 121875763 | Human |
| 406996961 | GWAS645937_H | psoriasis QTL GWAS645937 (human) | | 3e-19 | psoriasis | | 4 | 121833304 | 121833305 | Human |
| 628685532 | GWAS2593761_H | asthma QTL GWAS2593761 (human) | | 2e-26 | asthma | | 4 | 122146653 | 122146654 | Human |
| 628636380 | GWAS2544609_H | depressive symptom measurement QTL GWAS2544609 (human) | | 6e-09 | depression-related behavior trait (VT:0015015) | | 4 | 122237168 | 122237170 | Human |
| 406996967 | GWAS645943_H | alcohol consumption measurement QTL GWAS645943 (human) | | 9e-13 | alcohol consumption measurement | | 4 | 112386757 | 112386758 | Human |
| 598146051 | GWAS1832779_H | bone tissue density QTL GWAS1832779 (human) | | 9e-11 | bone tissue density | | 4 | 119112788 | 119112789 | Human |
| 628636381 | GWAS2544610_H | depressive symptom measurement QTL GWAS2544610 (human) | | 1e-10 | depression-related behavior trait (VT:0015015) | | 4 | 122258745 | 122258746 | Human |
| 596966460 | GWAS1085979_H | systolic blood pressure QTL GWAS1085979 (human) | | 1e-14 | systolic blood pressure | | 4 | 110414448 | 110414449 | Human |
| 407373792 | GWAS1022768_H | asthma QTL GWAS1022768 (human) | | 6e-19 | asthma | | 4 | 122219915 | 122219916 | Human |
| 628947669 | GWAS2855898_H | potassium deficiency disease QTL GWAS2855898 (human) | | 3e-11 | potassium deficiency disease | | 4 | 108140367 | 108140368 | Human |
| 406996968 | GWAS645944_H | alcohol consumption measurement QTL GWAS645944 (human) | | 8e-11 | alcohol consumption measurement | | 4 | 112673472 | 112673473 | Human |
| 597064764 | GWAS1160838_H | type 2 diabetes mellitus QTL GWAS1160838 (human) | | 0.0000005 | type 2 diabetes mellitus | | 4 | 128605841 | 128605842 | Human |
| 597031998 | GWAS1128072_H | body mass index QTL GWAS1128072 (human) | | 4e-10 | body mass index | | 4 | 119398279 | 119398280 | Human |
| 628816599 | GWAS2724828_H | cardioembolic stroke QTL GWAS2724828 (human) | | 5e-41 | joint integrity trait (VT:0010548) | | 4 | 110793263 | 110793264 | Human |
| 406996972 | GWAS645948_H | alcohol consumption measurement QTL GWAS645948 (human) | | 9e-11 | alcohol consumption measurement | | 4 | 112673525 | 112673526 | Human |
| 617036649 | GWAS2054148_H | urolithiasis QTL GWAS2054148 (human) | | 1e-09 | urolithiasis | | 4 | 114460763 | 114460764 | Human |
| 628783828 | GWAS2692057_H | platelet-to-lymphocyte ratio QTL GWAS2692057 (human) | | 5e-08 | platelet quantity (VT:0003179) | | 4 | 121774530 | 121774531 | Human |
| 628898514 | GWAS2806743_H | testosterone measurement QTL GWAS2806743 (human) | | 6e-15 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 124126476 | 124126477 | Human |
| 406996973 | GWAS645949_H | alcohol consumption measurement QTL GWAS645949 (human) | | 1e-10 | alcohol consumption measurement | | 4 | 117942113 | 117942114 | Human |
| 406996979 | GWAS645955_H | alcohol consumption measurement QTL GWAS645955 (human) | | 1e-10 | alcohol consumption measurement | | 4 | 128806522 | 128806523 | Human |
| 407144438 | GWAS793414_H | stroke QTL GWAS793414 (human) | | 0.000001 | stroke | | 4 | 112810934 | 112810935 | Human |
| 617036659 | GWAS2054158_H | uterine prolapse QTL GWAS2054158 (human) | | 4e-17 | uterine prolapse | | 4 | 126003911 | 126003912 | Human |
| 628947657 | GWAS2855886_H | macular degeneration QTL GWAS2855886 (human) | | 2e-11 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 406996981 | GWAS645957_H | alcohol consumption measurement QTL GWAS645957 (human) | | 5e-14 | alcohol consumption measurement | | 4 | 129324733 | 129324734 | Human |
| 406931448 | GWAS580424_H | brain volume measurement QTL GWAS580424 (human) | | 4e-09 | brain volume measurement | | 4 | 120722084 | 120722085 | Human |
| 407144446 | GWAS793422_H | stroke QTL GWAS793422 (human) | | 0.0000004 | stroke | | 4 | 112810934 | 112810935 | Human |
| 596966447 | GWAS1085966_H | body height QTL GWAS1085966 (human) | | 4e-08 | body height | | 4 | 128700992 | 128700993 | Human |
| 628587211 | GWAS2495440_H | high density lipoprotein cholesterol measurement QTL GWAS2495440 (human) | | 2e-11 | blood lipid amount (VT:0003949) | blood cholesterol level (CMO:0002280) | 4 | 109657070 | 109657071 | Human |
| 616495875 | GWAS1892458_H | tartronate (hydroxymalonate) measurement QTL GWAS1892458 (human) | | 0.00001 | tartronate (hydroxymalonate) measurement | | 4 | 113469102 | 113469103 | Human |
| 628718279 | GWAS2626508_H | level of inactive C-alpha-formylglycine-generating enzyme 2 in blood QTL GWAS2626508 (human) | | 8e-16 | level of inactive C-alpha-formylglycine-generating enzyme 2 in blood | | 4 | 118813029 | 118813030 | Human |
| 597031978 | GWAS1128052_H | mood instability measurement QTL GWAS1128052 (human) | | 3e-08 | mood instability measurement | | 4 | 122258745 | 122258746 | Human |
| 628570807 | GWAS2479036_H | gout QTL GWAS2479036 (human) | | 5e-08 | joint integrity trait (VT:0010548) | | 4 | 123815050 | 123815051 | Human |
| 407291783 | GWAS940759_H | aminoadipic acid measurement QTL GWAS940759 (human) | | 0.000001 | aminoadipic acid measurement | | 4 | 117057786 | 117057787 | Human |
| 597032023 | GWAS1128097_H | glomerular filtration rate QTL GWAS1128097 (human) | | 1e-15 | glomerular filtration rate | | 4 | 108772770 | 108772771 | Human |
| 628538037 | GWAS2446266_H | complement factor B measurement QTL GWAS2446266 (human) | | 8e-12 | complement protein amount (VT:0010033) | | 4 | 109737911 | 109737912 | Human |
| 407373707 | GWAS1022683_H | quality of life during menstruation measurement, decreased attention QTL GWAS1022683 (human) | | 0.000003 | quality of life during menstruation measurement, decreased attention | | 4 | 125938393 | 125938394 | Human |
| 597277789 | GWAS1373863_H | age-related macular degeneration, COVID-19 QTL GWAS1373863 (human) | | 3e-18 | age-related macular degeneration, COVID-19 | | 4 | 109737911 | 109737912 | Human |
| 616971008 | GWAS1988507_H | monocyte count QTL GWAS1988507 (human) | | 3e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 119447401 | 119447402 | Human |
| 407193485 | GWAS842461_H | mean corpuscular hemoglobin QTL GWAS842461 (human) | | 5e-10 | mean corpuscular hemoglobin | | 4 | 121870446 | 121870447 | Human |
| 407226249 | GWAS875225_H | QT interval QTL GWAS875225 (human) | | 1e-11 | QT interval | | 4 | 113504778 | 113504779 | Human |
| 628423353 | GWAS2331582_H | reaction time measurement QTL GWAS2331582 (human) | | 0.000004 | cognitive behavior trait (VT:0010450) | | 4 | 109249480 | 109249481 | Human |
| 628423354 | GWAS2331583_H | reaction time measurement QTL GWAS2331583 (human) | | 0.000001 | cognitive behavior trait (VT:0010450) | | 4 | 110649067 | 110649068 | Human |
| 628423355 | GWAS2331584_H | reaction time measurement QTL GWAS2331584 (human) | | 0.0000002 | cognitive behavior trait (VT:0010450) | | 4 | 117419552 | 117419553 | Human |
| 628636330 | GWAS2544559_H | osteoarthritis, knee QTL GWAS2544559 (human) | | 1e-11 | joint integrity trait (VT:0010548) | | 4 | 120722084 | 120722085 | Human |
| 597392457 | GWAS1488531_H | asthma, Eczematoid dermatitis, allergic rhinitis QTL GWAS1488531 (human) | | 1e-29 | asthma, Eczematoid dermatitis, allergic rhinitis | | 4 | 122465565 | 122465566 | Human |
| 597212236 | GWAS1308310_H | heart rate QTL GWAS1308310 (human) | | 0.000003 | heart rate | | 4 | 114106683 | 114106684 | Human |
| 617003793 | GWAS2021292_H | DNA methylation QTL GWAS2021292 (human) | | 3e-09 | DNA methylation | | 4 | 119957380 | 119957381 | Human |
| 628587179 | GWAS2495408_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2495408 (human) | | 2e-18 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 628554411 | GWAS2462640_H | level of receptor-type tyrosine-protein phosphatase F in blood QTL GWAS2462640 (human) | | 8e-18 | level of receptor-type tyrosine-protein phosphatase F in blood | | 4 | 108873562 | 108873563 | Human |
| 628423338 | GWAS2331567_H | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation QTL GWAS2331567 (human) | | 1e-09 | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation | | 4 | 117452280 | 117452281 | Human |
| 407259047 | GWAS908023_H | sarcoidosis QTL GWAS908023 (human) | | 0.000004 | sarcoidosis | | 4 | 122800348 | 122800349 | Human |
| 628521620 | GWAS2429849_H | platelet count QTL GWAS2429849 (human) | | 2e-19 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109945564 | 109945565 | Human |
| 628996767 | GWAS2904996_H | prothrombin time measurement QTL GWAS2904996 (human) | | 1e-16 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110791530 | 110791531 | Human |
| 628996762 | GWAS2904991_H | prothrombin time measurement QTL GWAS2904991 (human) | | 7e-37 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110780277 | 110780278 | Human |
| 616381269 | GWAS1861511_H | obsolete_C-C motif chemokine 7 measurement QTL GWAS1861511 (human) | | 0.000002 | obsolete_C-C motif chemokine 7 measurement | | 4 | 110137551 | 110137552 | Human |
| 407390113 | GWAS1039089_H | ulcerative colitis QTL GWAS1039089 (human) | | 0.0000008 | ulcerative colitis | | 4 | 116929300 | 116929301 | Human |
| 597228660 | GWAS1324734_H | blood protein measurement QTL GWAS1324734 (human) | | 2e-152 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 597163131 | GWAS1259205_H | leukocyte count QTL GWAS1259205 (human) | | 1e-10 | leukocyte count | | 4 | 109996470 | 109996471 | Human |
| 616987432 | GWAS2004931_H | atopic asthma QTL GWAS2004931 (human) | | 1e-14 | atopic asthma | | 4 | 122639784 | 122639785 | Human |
| 616987433 | GWAS2004932_H | atopic asthma QTL GWAS2004932 (human) | | 8e-19 | atopic asthma | | 4 | 122084379 | 122084380 | Human |
| 597195880 | GWAS1291954_H | memory performance QTL GWAS1291954 (human) | | 0.0000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124882027 | 124882028 | Human |
| 407373753 | GWAS1022729_H | systemic lupus erythematosus QTL GWAS1022729 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122470309 | 122470310 | Human |
| 597195881 | GWAS1291955_H | memory performance QTL GWAS1291955 (human) | | 0.0000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124882886 | 124882887 | Human |
| 597195882 | GWAS1291956_H | memory performance QTL GWAS1291956 (human) | | 0.0000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124883368 | 124883369 | Human |
| 628734602 | GWAS2642831_H | HbA1c measurement QTL GWAS2642831 (human) | | 6e-10 | blood hemoglobin amount (VT:0001588) | blood hemoglobin A1c level (CMO:0002786) | 4 | 116926523 | 116926524 | Human |
| 407324593 | GWAS973569_H | sex hormone-binding globulin measurement QTL GWAS973569 (human) | | 1e-11 | sex hormone-binding globulin measurement | | 4 | 109104450 | 109104451 | Human |
| 597228654 | GWAS1324728_H | blood protein measurement QTL GWAS1324728 (human) | | 3e-195 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628636289 | GWAS2544518_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS2544518 (human) | | 2e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 110905034 | 110905035 | Human |
| 597425250 | GWAS1521324_H | complement factor H-related protein 3 measurement QTL GWAS1521324 (human) | | 0.000009 | complement factor H-related protein 3 measurement | | 4 | 128538939 | 128538940 | Human |
| 626457260 | GWAS2271193_H | anthropometric measurement QTL GWAS2271193 (human) | | 3e-09 | anthropometric measurement | | 4 | 108368032 | 108368033 | Human |
| 628374153 | GWAS2294997_H | Pain QTL GWAS2294997 (human) | | 6e-10 | Pain | | 4 | 111582716 | 111582717 | Human |
| 626457257 | GWAS2271190_H | anthropometric measurement QTL GWAS2271190 (human) | | 2e-08 | anthropometric measurement | | 4 | 119230297 | 119230298 | Human |
| 597195879 | GWAS1291953_H | memory performance QTL GWAS1291953 (human) | | 0.0000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124883182 | 124883183 | Human |
| 628770170 | GWAS2678399_H | cerebral cortex area attribute QTL GWAS2678399 (human) | | 6e-12 | cerebral cortex area attribute | | 4 | 112495627 | 112495628 | Human |
| 617071812 | GWAS2089311_H | body height QTL GWAS2089311 (human) | | 7e-90 | body height | | 4 | 119652067 | 119652068 | Human |
| 617071811 | GWAS2089310_H | body height QTL GWAS2089310 (human) | | 3e-09 | body height | | 4 | 119494521 | 119494522 | Human |
| 617071810 | GWAS2089309_H | body height QTL GWAS2089309 (human) | | 4e-28 | body height | | 4 | 119474818 | 119474819 | Human |
| 617071809 | GWAS2089308_H | body height QTL GWAS2089308 (human) | | 2e-10 | body height | | 4 | 114683908 | 114683909 | Human |
| 617071808 | GWAS2089307_H | body height QTL GWAS2089307 (human) | | 3e-13 | body height | | 4 | 112538249 | 112538250 | Human |
| 617071823 | GWAS2089322_H | body height QTL GWAS2089322 (human) | | 0.00001 | body height | | 4 | 108342899 | 108342900 | Human |
| 617071822 | GWAS2089321_H | body height QTL GWAS2089321 (human) | | 2e-31 | body height | | 4 | 108330552 | 108330553 | Human |
| 407402561 | GWAS1051537_H | celiac disease QTL GWAS1051537 (human) | | 4e-11 | celiac disease | | 4 | 122345366 | 122345367 | Human |
| 617071821 | GWAS2089320_H | body height QTL GWAS2089320 (human) | | 6e-13 | body height | | 4 | 108198626 | 108198627 | Human |
| 598082476 | GWAS1801775_H | socioeconomic status QTL GWAS1801775 (human) | | 9e-11 | socioeconomic status | | 4 | 122042189 | 122042190 | Human |
| 617071820 | GWAS2089319_H | body height QTL GWAS2089319 (human) | | 8e-18 | body height | | 4 | 107970830 | 107970831 | Human |
| 598082477 | GWAS1801776_H | socioeconomic status QTL GWAS1801776 (human) | | 1e-08 | socioeconomic status | | 4 | 122105714 | 122105715 | Human |
| 617071819 | GWAS2089318_H | body height QTL GWAS2089318 (human) | | 2e-19 | body height | | 4 | 106649253 | 106649254 | Human |
| 406976589 | GWAS625565_H | reticulocyte count QTL GWAS625565 (human) | | 5e-10 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109990411 | 109990412 | Human |
| 598082474 | GWAS1801773_H | socioeconomic status QTL GWAS1801773 (human) | | 2e-08 | socioeconomic status | | 4 | 111500989 | 111500990 | Human |
| 598082475 | GWAS1801774_H | socioeconomic status QTL GWAS1801774 (human) | | 1e-08 | socioeconomic status | | 4 | 121774163 | 121774164 | Human |
| 628884850 | GWAS2793079_H | age-related macular degeneration, COVID-19 QTL GWAS2793079 (human) | | 4e-18 | retina integrity trait (VT:0010771) | | 4 | 109737911 | 109737912 | Human |
| 617104582 | GWAS2122081_H | gut microbiome measurement, breastfeeding duration QTL GWAS2122081 (human) | | 2e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 129911920 | 129911921 | Human |
| 616498351 | GWAS1894934_H | behenoyl dihydrosphingomyelin (d18:0/22:0) measurement QTL GWAS1894934 (human) | | 0.000007 | behenoyl dihydrosphingomyelin (d18:0/22:0) measurement | | 4 | 109084015 | 109084016 | Human |
| 628753768 | GWAS2661997_H | heart failure QTL GWAS2661997 (human) | | 3e-55 | heart integrity trait (VT:0010757) | | 4 | 110776497 | 110776498 | Human |
| 628901225 | GWAS2809454_H | rheumatoid arthritis QTL GWAS2809454 (human) | | 5e-14 | joint integrity trait (VT:0010548) | | 4 | 108140462 | 108140463 | Human |
| 617186526 | GWAS2166966_H | body mass index QTL GWAS2166966 (human) | | 7e-13 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 628606295 | GWAS2514524_H | body height QTL GWAS2514524 (human) | | 1e-12 | body height | | 4 | 108494980 | 108494981 | Human |
| 628671832 | GWAS2580061_H | intelligence QTL GWAS2580061 (human) | | 5e-09 | intelligence | | 4 | 112490199 | 112490200 | Human |
| 617006310 | GWAS2023809_H | BMI-adjusted waist circumference QTL GWAS2023809 (human) | | 0.000009 | body size trait (VT:0100005) | | 4 | 124199191 | 124199192 | Human |
| 617039078 | GWAS2056577_H | Antithrombotic agent use measurement QTL GWAS2056577 (human) | | 6e-19 | Antithrombotic agent use measurement | | 4 | 110791080 | 110791081 | Human |
| 616989924 | GWAS2007423_H | glycerophospholipid measurement QTL GWAS2007423 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493245 | 114493246 | Human |
| 616989925 | GWAS2007424_H | glycerophospholipid measurement QTL GWAS2007424 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493830 | 114493831 | Human |
| 596968374 | GWAS1087893_H | cortical thickness QTL GWAS1087893 (human) | | 4e-11 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
| 628737365 | GWAS2645594_H | platelet count QTL GWAS2645594 (human) | | 4e-18 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109973957 | 109973958 | Human |
| 628507994 | GWAS2416223_H | restless legs syndrome QTL GWAS2416223 (human) | | 8e-11 | central nervous system integrity trait (VT:0010772) | | 4 | 115033802 | 115033803 | Human |
| 628507995 | GWAS2416224_H | restless legs syndrome QTL GWAS2416224 (human) | | 5e-08 | central nervous system integrity trait (VT:0010772) | | 4 | 118105491 | 118105492 | Human |
| 597492659 | GWAS1588733_H | systolic blood pressure QTL GWAS1588733 (human) | | 6e-09 | systolic blood pressure | | 4 | 110427909 | 110427910 | Human |
| 616481937 | GWAS1878520_H | blood protein amount QTL GWAS1878520 (human) | | 1e-164 | blood protein amount | | 4 | 106917957 | 106917958 | Human |
| 407009389 | GWAS658365_H | sex hormone-binding globulin measurement QTL GWAS658365 (human) | | 2e-13 | sex hormone-binding globulin measurement | | 4 | 119185611 | 119185612 | Human |
| 628606296 | GWAS2514525_H | body height QTL GWAS2514525 (human) | | 2e-09 | body height | | 4 | 124024877 | 124024878 | Human |
| 597590959 | GWAS1647819_H | response to stimulus QTL GWAS1647819 (human) | | 4e-11 | response to stimulus | | 4 | 106731302 | 106731303 | Human |
| 597492654 | GWAS1588728_H | diastolic blood pressure QTL GWAS1588728 (human) | | 6e-12 | diastolic blood pressure | | 4 | 110427909 | 110427910 | Human |
| 628573506 | GWAS2481735_H | lymphocyte count QTL GWAS2481735 (human) | | 1e-14 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109919540 | 109919541 | Human |
| 628573505 | GWAS2481734_H | lymphocyte count QTL GWAS2481734 (human) | | 7e-23 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 110020646 | 110020647 | Human |
| 616498311 | GWAS1894894_H | ascorbic acid 3-sulfate measurement QTL GWAS1894894 (human) | | 0.000009 | ascorbic acid 3-sulfate measurement | | 4 | 118983105 | 118983106 | Human |
| 407156863 | GWAS805839_H | BMI-adjusted waist-hip ratio QTL GWAS805839 (human) | | 2e-11 | BMI-adjusted waist-hip ratio | | 4 | 123124286 | 123124287 | Human |
| 407025790 | GWAS674766_H | exercise test QTL GWAS674766 (human) | | 0.000003 | exercise test | | 4 | 109878941 | 109878942 | Human |
| 596968361 | GWAS1087880_H | cortical thickness QTL GWAS1087880 (human) | | 6e-09 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
| 407402614 | GWAS1051590_H | Parkinson's disease symptom measurement QTL GWAS1051590 (human) | | 0.000006 | Parkinson's disease symptom measurement | | 4 | 115200194 | 115200195 | Human |
| 597476259 | GWAS1572333_H | DNA methylation QTL GWAS1572333 (human) | | 3e-09 | DNA methylation | | 4 | 119957380 | 119957381 | Human |
| 596951979 | GWAS1071498_H | body mass index QTL GWAS1071498 (human) | | 1e-11 | body mass index | | 4 | 122906887 | 122906888 | Human |
| 407402506 | GWAS1051482_H | protein measurement QTL GWAS1051482 (human) | | 2e-08 | protein measurement | | 4 | 116050074 | 116050075 | Human |
| 626459924 | GWAS2273857_H | body weight QTL GWAS2273857 (human) | | 3e-08 | body weight | | 4 | 112524760 | 112524761 | Human |
| 628671803 | GWAS2580032_H | peak expiratory flow QTL GWAS2580032 (human) | | 4e-08 | pulmonary ventilation trait (VT:0002338) | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 4 | 118203565 | 118203566 | Human |
| 597115860 | GWAS1211934_H | self reported educational attainment QTL GWAS1211934 (human) | | 1e-08 | self reported educational attainment | | 4 | 128884001 | 128884002 | Human |
| 597115859 | GWAS1211933_H | self reported educational attainment QTL GWAS1211933 (human) | | 6e-12 | self reported educational attainment | | 4 | 122105714 | 122105715 | Human |
| 617137293 | GWAS2154792_H | BH3-interacting domain death agonist measurement QTL GWAS2154792 (human) | | 9e-13 | BH3-interacting domain death agonist measurement | | 4 | 109746434 | 109746435 | Human |
| 597115858 | GWAS1211932_H | self reported educational attainment QTL GWAS1211932 (human) | | 1e-08 | self reported educational attainment | | 4 | 118084947 | 118084948 | Human |
| 597115857 | GWAS1211931_H | self reported educational attainment QTL GWAS1211931 (human) | | 2e-09 | self reported educational attainment | | 4 | 111500989 | 111500990 | Human |
| 407156751 | GWAS805727_H | sex hormone-binding globulin measurement QTL GWAS805727 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 597312470 | GWAS1408544_H | vaginal microbiome measurement QTL GWAS1408544 (human) | | 5e-09 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 406960141 | GWAS609117_H | body mass index QTL GWAS609117 (human) | | 4e-12 | body mass index | | 4 | 111792280 | 111792281 | Human |
| 617071754 | GWAS2089253_H | gestational diabetes QTL GWAS2089253 (human) | | 0.000001 | gestational diabetes | | 4 | 106609371 | 106609372 | Human |
| 597312471 | GWAS1408545_H | vaginal microbiome measurement QTL GWAS1408545 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 123235757 | 123235758 | Human |
| 406960143 | GWAS609119_H | body mass index QTL GWAS609119 (human) | | 7e-10 | body mass index | | 4 | 112392830 | 112392831 | Human |
| 406960144 | GWAS609120_H | body mass index QTL GWAS609120 (human) | | 6e-10 | body mass index | | 4 | 119372621 | 119372622 | Human |
| 597214155 | GWAS1310229_H | blood protein measurement QTL GWAS1310229 (human) | | 5e-08 | blood protein measurement | | 4 | 110079447 | 110079448 | Human |
| 616957077 | GWAS1974576_H | age-related macular degeneration QTL GWAS1974576 (human) | | 0.000002 | retina integrity trait (VT:0010771) | | 4 | 116003028 | 116003029 | Human |
| 616383723 | GWAS1863965_H | testosterone measurement QTL GWAS1863965 (human) | | 9e-16 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 597263299 | GWAS1359373_H | complement factor I measurement QTL GWAS1359373 (human) | | 3e-66 | complement factor I measurement | | 4 | 109742841 | 109742842 | Human |
| 597279683 | GWAS1375757_H | calcium measurement QTL GWAS1375757 (human) | | 1e-12 | calcium measurement | | 4 | 114469815 | 114469816 | Human |
| 628720930 | GWAS2629159_H | whole body water mass QTL GWAS2629159 (human) | | 1e-20 | whole body water mass | | 4 | 122904764 | 122904765 | Human |
| 597492672 | GWAS1588746_H | sexual dimorphism measurement QTL GWAS1588746 (human) | | 4e-12 | sexual dimorphism measurement | | 4 | 121774530 | 121774531 | Human |
| 628770075 | GWAS2678304_H | bipolar disorder, inflammatory bowel disease QTL GWAS2678304 (human) | | 8e-14 | intestine integrity trait (VT:0010554) | | 4 | 122154852 | 122154853 | Human |
| 628884766 | GWAS2792995_H | diet measurement QTL GWAS2792995 (human) | | 2e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 129906935 | 129906936 | Human |
| 597050355 | GWAS1146429_H | endometriosis QTL GWAS1146429 (human) | | 0.0000008 | endometriosis | | 4 | 114744719 | 114744720 | Human |
| 628851996 | GWAS2760225_H | smoking cessation QTL GWAS2760225 (human) | | 3e-12 | smoking cessation | | 4 | 112123310 | 112123311 | Human |
| 597361650 | GWAS1457724_H | atrial fibrillation QTL GWAS1457724 (human) | | 7e-92 | atrial fibrillation | | 4 | 110789386 | 110789387 | Human |
| 597427190 | GWAS1523264_H | gestational age QTL GWAS1523264 (human) | | 0.000007 | gestational age | | 4 | 112357355 | 112357356 | Human |
| 628917520 | GWAS2825749_H | high density lipoprotein cholesterol measurement QTL GWAS2825749 (human) | | 2e-33 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 628720917 | GWAS2629146_H | whole body water mass QTL GWAS2629146 (human) | | 9e-12 | whole body water mass | | 4 | 122848013 | 122848014 | Human |
| 407386148 | GWAS1035124_H | waist-hip ratio QTL GWAS1035124 (human) | | 8e-12 | waist-hip ratio | | 4 | 124299553 | 124299554 | Human |
| 626459962 | GWAS2273895_H | body height QTL GWAS2273895 (human) | | 4e-10 | body height | | 4 | 108536277 | 108536278 | Human |
| 628442394 | GWAS2350623_H | intelligence QTL GWAS2350623 (human) | | 0.0000001 | intelligence | | 4 | 118088064 | 118088065 | Human |
| 628983049 | GWAS2891278_H | body height QTL GWAS2891278 (human) | | 1e-49 | body height | | 4 | 108535458 | 108535459 | Human |
| 407025720 | GWAS674696_H | ulcerative colitis QTL GWAS674696 (human) | | 0.0000009 | intestine integrity trait (VT:0010554) | | 4 | 122408207 | 122408208 | Human |
| 617006268 | GWAS2023767_H | pulse pressure measurement QTL GWAS2023767 (human) | | 0.0000007 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 122671579 | 122671580 | Human |
| 407304250 | GWAS953226_H | serum metabolite measurement QTL GWAS953226 (human) | | 7e-22 | serum metabolite measurement | | 4 | 129113772 | 129113775 | Human |
| 617088181 | GWAS2105680_H | body height QTL GWAS2105680 (human) | | 2e-10 | body height | | 4 | 121736832 | 121736833 | Human |
| 628868602 | GWAS2776831_H | citrulline measurement QTL GWAS2776831 (human) | | 0.0000006 | blood L-citrulline amount (VT:0010986) | blood amino acid measurement (CMO:0003730) | 4 | 108524921 | 108524922 | Human |
| 628671993 | GWAS2580222_H | glioblastoma multiforme QTL GWAS2580222 (human) | | 0.000008 | brain integrity trait (VT:0010579) | | 4 | 108697554 | 108697555 | Human |
| 628770299 | GWAS2678528_H | bipolar disorder, ulcerative colitis QTL GWAS2678528 (human) | | 2e-12 | intestine integrity trait (VT:0010554) | | 4 | 122154852 | 122154853 | Human |
| 597164827 | GWAS1260901_H | factor VIII measurement, Ischemic stroke QTL GWAS1260901 (human) | | 9e-17 | factor VIII measurement, Ischemic stroke | | 4 | 110775495 | 110775496 | Human |
| 407402699 | GWAS1051675_H | asthma QTL GWAS1051675 (human) | | 5e-14 | asthma | | 4 | 122219915 | 122219916 | Human |
| 617104461 | GWAS2121960_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2121960 (human) | | 0.0000006 | gut microbiome measurement, allergen exposure measurement | | 4 | 121979374 | 121979375 | Human |
| 597426969 | GWAS1523043_H | gout QTL GWAS1523043 (human) | | 3e-08 | gout | | 4 | 123815050 | 123815051 | Human |
| 597476122 | GWAS1572196_H | electroencephalogram measurement QTL GWAS1572196 (human) | | 0.000005 | electroencephalogram measurement | | 4 | 107150343 | 107150344 | Human |
| 617104462 | GWAS2121961_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2121961 (human) | | 0.0000004 | gut microbiome measurement, allergen exposure measurement | | 4 | 121979374 | 121979375 | Human |
| 597148447 | GWAS1244521_H | thyroid stimulating hormone measurement QTL GWAS1244521 (human) | | 2e-19 | thyroid stimulating hormone measurement | | 4 | 121691318 | 121691319 | Human |
| 628426237 | GWAS2334466_H | atopic asthma QTL GWAS2334466 (human) | | 9e-13 | atopic asthma | | 4 | 122466445 | 122466446 | Human |
| 628426236 | GWAS2334465_H | atopic asthma QTL GWAS2334465 (human) | | 1e-14 | atopic asthma | | 4 | 122639784 | 122639785 | Human |
| 628426239 | GWAS2334468_H | atopic asthma QTL GWAS2334468 (human) | | 5e-08 | atopic asthma | | 4 | 122387310 | 122387311 | Human |
| 628426238 | GWAS2334467_H | atopic asthma QTL GWAS2334467 (human) | | 8e-19 | atopic asthma | | 4 | 122084379 | 122084380 | Human |
| 407140559 | GWAS789535_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS789535 (human) | | 2e-11 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692515 | 122692516 | Human |
| 406911181 | GWAS560157_H | breast density QTL GWAS560157 (human) | | 0.000006 | breast density | | 4 | 121949054 | 121949055 | Human |
| 628426235 | GWAS2334464_H | atopic asthma QTL GWAS2334464 (human) | | 5e-16 | atopic asthma | | 4 | 122219915 | 122219916 | Human |
| 597164823 | GWAS1260897_H | Ischemic stroke, plasminogen activator inhibitor 1 measurement QTL GWAS1260897 (human) | | 6e-17 | Ischemic stroke, plasminogen activator inhibitor 1 measurement | | 4 | 110775495 | 110775496 | Human |
| 628819444 | GWAS2727673_H | body height QTL GWAS2727673 (human) | | 8e-15 | body height | | 4 | 113968498 | 113968499 | Human |
| 616514608 | GWAS1911191_H | body mass index QTL GWAS1911191 (human) | | 4e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 617137243 | GWAS2154742_H | prothrombin time measurement QTL GWAS2154742 (human) | | 6e-52 | prothrombin time measurement | | 4 | 110791530 | 110791531 | Human |
| 597361423 | GWAS1457497_H | atrial fibrillation QTL GWAS1457497 (human) | | 8e-57 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597361422 | GWAS1457496_H | atrial fibrillation QTL GWAS1457496 (human) | | 4e-08 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 596968205 | GWAS1087724_H | cortical thickness QTL GWAS1087724 (human) | | 2e-08 | cortical thickness | | 4 | 120741206 | 120741207 | Human |
| 407386320 | GWAS1035296_H | asthma exacerbation measurement QTL GWAS1035296 (human) | | 0.000002 | asthma exacerbation measurement | | 4 | 129344890 | 129344891 | Human |
| 628819430 | GWAS2727659_H | body height QTL GWAS2727659 (human) | | 4e-10 | body height | | 4 | 108146742 | 108146743 | Human |
| 617038937 | GWAS2056436_H | insomnia QTL GWAS2056436 (human) | | 2e-12 | insomnia | | 4 | 111901237 | 111901238 | Human |
| 407189723 | GWAS838699_H | myocardial infarction QTL GWAS838699 (human) | | 2e-09 | myocardial infarction | | 4 | 119979127 | 119979128 | Human |
| 616957017 | GWAS1974516_H | atrial fibrillation QTL GWAS1974516 (human) | | 2e-74 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
| 617038936 | GWAS2056435_H | insomnia QTL GWAS2056435 (human) | | 1e-09 | insomnia | | 4 | 111871413 | 111871414 | Human |
| 616989798 | GWAS2007297_H | glycerophospholipid measurement QTL GWAS2007297 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114490891 | 114490892 | Human |
| 617038951 | GWAS2056450_H | smoking initiation QTL GWAS2056450 (human) | | 2e-13 | smoking initiation | | 4 | 120650494 | 120650495 | Human |
| 616989799 | GWAS2007298_H | glycerophospholipid measurement QTL GWAS2007298 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493571 | 114493572 | Human |
| 617038950 | GWAS2056449_H | smoking initiation QTL GWAS2056449 (human) | | 6e-10 | smoking initiation | | 4 | 117807381 | 117807382 | Human |
| 616989796 | GWAS2007295_H | glycerophospholipid measurement QTL GWAS2007295 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114489752 | 114489753 | Human |
| 617038949 | GWAS2056448_H | smoking initiation QTL GWAS2056448 (human) | | 3e-14 | smoking initiation | | 4 | 115629116 | 115629117 | Human |
| 616989797 | GWAS2007296_H | glycerophospholipid measurement QTL GWAS2007296 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114509770 | 114509771 | Human |
| 628606420 | GWAS2514649_H | body mass index QTL GWAS2514649 (human) | | 1e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129838492 | 129838493 | Human |
| 407107815 | GWAS756791_H | platelet crit QTL GWAS756791 (human) | | 4e-10 | platelet crit | | 4 | 110012720 | 110012721 | Human |
| 628606419 | GWAS2514648_H | body mass index QTL GWAS2514648 (human) | | 3e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 114269666 | 114269667 | Human |
| 616989794 | GWAS2007293_H | glycerophospholipid measurement QTL GWAS2007293 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114491902 | 114491903 | Human |
| 407107814 | GWAS756790_H | platelet crit QTL GWAS756790 (human) | | 2e-36 | platelet crit | | 4 | 109966833 | 109966834 | Human |
| 628606418 | GWAS2514647_H | body mass index QTL GWAS2514647 (human) | | 9e-10 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
| 616989795 | GWAS2007294_H | glycerophospholipid measurement QTL GWAS2007294 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114484592 | 114484593 | Human |
| 616989792 | GWAS2007291_H | glycerophospholipid measurement QTL GWAS2007291 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114492246 | 114492247 | Human |
| 616989793 | GWAS2007292_H | glycerophospholipid measurement QTL GWAS2007292 (human) | | 3e-13 | glycerophospholipid measurement | | 4 | 114492288 | 114492289 | Human |
| 407107817 | GWAS756793_H | platelet crit QTL GWAS756793 (human) | | 1e-13 | platelet crit | | 4 | 123749526 | 123749527 | Human |
| 616989800 | GWAS2007299_H | glycerophospholipid measurement QTL GWAS2007299 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493734 | 114493735 | Human |
| 628721111 | GWAS2629340_H | glomerular filtration rate QTL GWAS2629340 (human) | | 3e-11 | glomerular filtration rate | | 4 | 127288162 | 127288163 | Human |
| 617038952 | GWAS2056451_H | smoking initiation QTL GWAS2056451 (human) | | 3e-09 | smoking initiation | | 4 | 126727157 | 126727158 | Human |
| 628491718 | GWAS2399947_H | Calcium channel blocker use measurement QTL GWAS2399947 (human) | | 5e-08 | Calcium channel blocker use measurement | | 4 | 108081403 | 108081404 | Human |
| 628524480 | GWAS2432709_H | atrial fibrillation QTL GWAS2432709 (human) | | 3e-12 | atrial fibrillation | | 4 | 110574086 | 110574087 | Human |
| 407189759 | GWAS838735_H | lipid measurement QTL GWAS838735 (human) | | 0.000008 | lipid measurement | | 4 | 122878832 | 122878833 | Human |
| 407238904 | GWAS887880_H | apolipoprotein A 1 measurement QTL GWAS887880 (human) | | 9e-13 | apolipoprotein A 1 measurement | | 4 | 109717608 | 109717609 | Human |
| 597099306 | GWAS1195380_H | alkaline phosphatase measurement QTL GWAS1195380 (human) | | 1e-08 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 109788119 | 109788120 | Human |
| 628524470 | GWAS2432699_H | atrial fibrillation QTL GWAS2432699 (human) | | 4e-31 | atrial fibrillation | | 4 | 110714136 | 110714137 | Human |
| 597361499 | GWAS1457573_H | atrial fibrillation QTL GWAS1457573 (human) | | 7e-136 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 628524471 | GWAS2432700_H | atrial fibrillation QTL GWAS2432700 (human) | | 3e-11 | atrial fibrillation | | 4 | 110716779 | 110716780 | Human |
| 407156869 | GWAS805845_H | BMI-adjusted waist-hip ratio QTL GWAS805845 (human) | | 1e-11 | BMI-adjusted waist-hip ratio | | 4 | 123166618 | 123166619 | Human |
| 596984660 | GWAS1104179_H | platelet count QTL GWAS1104179 (human) | | 3e-09 | platelet count | | 4 | 123806369 | 123806370 | Human |
| 628524468 | GWAS2432697_H | atrial fibrillation QTL GWAS2432697 (human) | | 3e-19 | atrial fibrillation | | 4 | 110665288 | 110665289 | Human |
| 406960259 | GWAS609235_H | trait in response to carbamazepine QTL GWAS609235 (human) | | 0.0000009 | trait in response to carbamazepine | | 4 | 127124380 | 127124381 | Human |
| 628524469 | GWAS2432698_H | atrial fibrillation QTL GWAS2432698 (human) | | 3e-81 | atrial fibrillation | | 4 | 110674360 | 110674361 | Human |
| 628606388 | GWAS2514617_H | alkaline phosphatase measurement QTL GWAS2514617 (human) | | 4e-19 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 128065247 | 128065248 | Human |
| 628606387 | GWAS2514616_H | alkaline phosphatase measurement QTL GWAS2514616 (human) | | 8e-16 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110190912 | 110190913 | Human |
| 628524466 | GWAS2432695_H | atrial fibrillation QTL GWAS2432695 (human) | | 1e-11 | atrial fibrillation | | 4 | 110639637 | 110639638 | Human |
| 597361503 | GWAS1457577_H | atrial fibrillation QTL GWAS1457577 (human) | | 3e-155 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 628901305 | GWAS2809534_H | testosterone measurement QTL GWAS2809534 (human) | | 2e-08 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 109108768 | 109108769 | Human |
| 628524467 | GWAS2432696_H | atrial fibrillation QTL GWAS2432696 (human) | | 8e-20 | atrial fibrillation | | 4 | 110659017 | 110659018 | Human |
| 628524464 | GWAS2432693_H | atrial fibrillation QTL GWAS2432693 (human) | | 1e-36 | atrial fibrillation | | 4 | 110589415 | 110589416 | Human |
| 628524465 | GWAS2432694_H | atrial fibrillation QTL GWAS2432694 (human) | | 3e-17 | atrial fibrillation | | 4 | 110609843 | 110609844 | Human |
| 616514680 | GWAS1911263_H | body mass index QTL GWAS1911263 (human) | | 2e-12 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 628524478 | GWAS2432707_H | atrial fibrillation QTL GWAS2432707 (human) | | 9e-35 | atrial fibrillation | | 4 | 110823850 | 110823851 | Human |
| 407173260 | GWAS822236_H | atopic eczema QTL GWAS822236 (human) | | 1e-62 | atopic eczema | | 4 | 122465565 | 122465566 | Human |
| 628524479 | GWAS2432708_H | atrial fibrillation QTL GWAS2432708 (human) | | 7e-109 | atrial fibrillation | | 4 | 110844339 | 110844340 | Human |
| 628524476 | GWAS2432705_H | atrial fibrillation QTL GWAS2432705 (human) | | 9e-57 | atrial fibrillation | | 4 | 110809291 | 110809292 | Human |
| 628524477 | GWAS2432706_H | atrial fibrillation QTL GWAS2432706 (human) | | 4e-14 | atrial fibrillation | | 4 | 110822697 | 110822698 | Human |
| 628737458 | GWAS2645687_H | serum creatinine amount QTL GWAS2645687 (human) | | 3e-12 | blood cystatin C amount (VT:0010743) | blood cystatin C level (CMO:0002777) | 4 | 127420965 | 127420966 | Human |
| 628524474 | GWAS2432703_H | atrial fibrillation QTL GWAS2432703 (human) | | 2e-18 | atrial fibrillation | | 4 | 110766821 | 110766822 | Human |
| 628524475 | GWAS2432704_H | atrial fibrillation QTL GWAS2432704 (human) | | 6e-35 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
| 628524472 | GWAS2432701_H | atrial fibrillation QTL GWAS2432701 (human) | | 1e-70 | atrial fibrillation | | 4 | 110735436 | 110735437 | Human |
| 628524473 | GWAS2432702_H | atrial fibrillation QTL GWAS2432702 (human) | | 6e-305 | atrial fibrillation | | 4 | 110743002 | 110743003 | Human |
| 407255177 | GWAS904153_H | metabolite measurement QTL GWAS904153 (human) | | 7e-18 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 597377867 | GWAS1473941_H | systemic lupus erythematosus QTL GWAS1473941 (human) | | 0.000001 | systemic lupus erythematosus | | 4 | 108801970 | 108801971 | Human |
| 597295944 | GWAS1392018_H | venous thromboembolism QTL GWAS1392018 (human) | | 0.0000007 | venous thromboembolism | | 4 | 122619586 | 122619587 | Human |
| 407369876 | GWAS1018852_H | systemic juvenile idiopathic arthritis QTL GWAS1018852 (human) | | 0.000003 | systemic juvenile idiopathic arthritis | | 4 | 115655118 | 115655119 | Human |
| 597115712 | GWAS1211786_H | electroencephalogram measurement QTL GWAS1211786 (human) | | 0.000002 | electroencephalogram measurement | | 4 | 121613423 | 121613424 | Human |
| 628999589 | GWAS2907818_H | potassium measurement QTL GWAS2907818 (human) | | 4e-15 | blood potassium amount (VT:0002668) | blood potassium level (CMO:0000496) | 4 | 108140367 | 108140368 | Human |
| 597164867 | GWAS1260941_H | lipid measurement QTL GWAS1260941 (human) | | 0.000003 | lipid measurement | | 4 | 116458669 | 116458670 | Human |
| 628458926 | GWAS2367155_H | gut microbiome measurement QTL GWAS2367155 (human) | | 3e-09 | gut microbiome measurement | | 4 | 126415447 | 126415448 | Human |
| 597295942 | GWAS1392016_H | BMI-adjusted hip circumference QTL GWAS1392016 (human) | | 5e-09 | BMI-adjusted hip circumference | | 4 | 119820087 | 119820088 | Human |
| 616531043 | GWAS1927626_H | platelet count QTL GWAS1927626 (human) | | 9e-16 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 597295943 | GWAS1392017_H | BMI-adjusted hip circumference QTL GWAS1392017 (human) | | 4e-10 | BMI-adjusted hip circumference | | 4 | 119798713 | 119798714 | Human |
| 597295941 | GWAS1392015_H | BMI-adjusted hip circumference QTL GWAS1392015 (human) | | 1e-08 | BMI-adjusted hip circumference | | 4 | 119821103 | 119821104 | Human |
| 407419049 | GWAS1068025_H | systolic blood pressure QTL GWAS1068025 (human) | | 6e-09 | systolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 628852120 | GWAS2760349_H | pulmonary embolism QTL GWAS2760349 (human) | | 8e-17 | pulmonary embolism | | 4 | 119320747 | 119320748 | Human |
| 407419051 | GWAS1068027_H | systolic blood pressure QTL GWAS1068027 (human) | | 2e-08 | systolic blood pressure | | 4 | 120018118 | 120018119 | Human |
| 597508985 | GWAS1605059_H | eosinophil count QTL GWAS1605059 (human) | | 8e-11 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 596984688 | GWAS1104207_H | Cleft palate, cleft lip QTL GWAS1104207 (human) | | 0.0000009 | Cleft palate, cleft lip | | 4 | 123789429 | 123789430 | Human |
| 407419053 | GWAS1068029_H | systolic blood pressure QTL GWAS1068029 (human) | | 9e-09 | systolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 616973347 | GWAS1990846_H | cystatin C measurement QTL GWAS1990846 (human) | | 3e-12 | serum creatinine amount | | 4 | 127420965 | 127420966 | Human |
| 407271599 | GWAS920575_H | forced expiratory volume QTL GWAS920575 (human) | | 4e-09 | forced expiratory volume | | 4 | 120683279 | 120683280 | Human |
| 407271597 | GWAS920573_H | maximal voluntary ventilation, pulmonary function measurement QTL GWAS920573 (human) | | 2e-09 | vital capacity | | 4 | 120683279 | 120683280 | Human |
| 628852119 | GWAS2760348_H | RS-10-hydroxywarfarin to RS-warfarin ratio measurement QTL GWAS2760348 (human) | | 0.000003 | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | | 4 | 121903623 | 121903624 | Human |
| 406911148 | GWAS560124_H | body mass index QTL GWAS560124 (human) | | 4e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597459825 | GWAS1555899_H | leukocyte count QTL GWAS1555899 (human) | | 6e-14 | leukocyte count | | 4 | 110020646 | 110020647 | Human |
| 628819350 | GWAS2727579_H | level of phosphatidylcholine QTL GWAS2727579 (human) | | 4e-08 | level of phosphatidylcholine | | 4 | 112567861 | 112567862 | Human |
| 597279607 | GWAS1375681_H | X-26054 measurement QTL GWAS1375681 (human) | | 1e-125 | X-26054 measurement | | 4 | 129143723 | 129143724 | Human |
| 407419047 | GWAS1068023_H | systolic blood pressure QTL GWAS1068023 (human) | | 1e-24 | systolic blood pressure | | 4 | 110461529 | 110461530 | Human |
| 628639127 | GWAS2547356_H | osteoarthritis QTL GWAS2547356 (human) | | 7e-15 | osteoarthritis | | 4 | 120700994 | 120700995 | Human |
| 597115749 | GWAS1211823_H | apolipoprotein A 1 measurement QTL GWAS1211823 (human) | | 3e-67 | apolipoprotein A 1 measurement | | 4 | 109717668 | 109717669 | Human |
| 597115748 | GWAS1211822_H | apolipoprotein A 1 measurement QTL GWAS1211822 (human) | | 3e-23 | apolipoprotein A 1 measurement | | 4 | 109717608 | 109717609 | Human |
| 407222461 | GWAS871437_H | rheumatoid arthritis QTL GWAS871437 (human) | | 0.000004 | rheumatoid arthritis | | 4 | 122478336 | 122478337 | Human |
| 597361506 | GWAS1457580_H | atrial fibrillation QTL GWAS1457580 (human) | | 2e-62 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407402674 | GWAS1051650_H | corneal resistance factor QTL GWAS1051650 (human) | | 2e-08 | corneal resistance factor | | 4 | 118802505 | 118802506 | Human |
| 597050220 | GWAS1146294_H | BMI-adjusted waist-hip ratio QTL GWAS1146294 (human) | | 1e-11 | BMI-adjusted waist-hip ratio | | 4 | 124270608 | 124270609 | Human |
| 597050221 | GWAS1146295_H | BMI-adjusted waist-hip ratio QTL GWAS1146295 (human) | | 2e-10 | BMI-adjusted waist-hip ratio | | 4 | 124118741 | 124118742 | Human |
| 597017449 | GWAS1113523_H | facial morphology measurement QTL GWAS1113523 (human) | | 2e-08 | facial morphology measurement | | 4 | 126939204 | 126939205 | Human |
| 407320902 | GWAS969878_H | cardioembolic stroke QTL GWAS969878 (human) | | 0.0000003 | cardioembolic stroke | | 4 | 110841700 | 110841701 | Human |
| 407320901 | GWAS969877_H | cardioembolic stroke QTL GWAS969877 (human) | | 3e-48 | cardioembolic stroke | | 4 | 110775495 | 110775496 | Human |
| 407320900 | GWAS969876_H | cardioembolic stroke QTL GWAS969876 (human) | | 5e-08 | cardioembolic stroke | | 4 | 110673205 | 110673206 | Human |
| 598098597 | GWAS1815990_H | facial morphology trait QTL GWAS1815990 (human) | | 3e-08 | facial morphology trait | | 4 | 125211057 | 125211058 | Human |
| 628606067 | GWAS2514296_H | insomnia measurement QTL GWAS2514296 (human) | | 2e-08 | sleep behavior trait (VT:0001501) | | 4 | 129592716 | 129592717 | Human |
| 407320898 | GWAS969874_H | cardioembolic stroke QTL GWAS969874 (human) | | 9e-59 | cardioembolic stroke | | 4 | 110775495 | 110775496 | Human |
| 628524158 | GWAS2432387_H | atrial fibrillation QTL GWAS2432387 (human) | | 2e-12 | atrial fibrillation | | 4 | 110524540 | 110524541 | Human |
| 628524159 | GWAS2432388_H | atrial fibrillation QTL GWAS2432388 (human) | | 4e-09 | atrial fibrillation | | 4 | 110546303 | 110546304 | Human |
| 628524157 | GWAS2432386_H | atrial fibrillation QTL GWAS2432386 (human) | | 5e-09 | atrial fibrillation | | 4 | 110485340 | 110485341 | Human |
| 617022935 | GWAS2040434_H | protein measurement QTL GWAS2040434 (human) | | 1e-08 | protein measurement | | 4 | 107913373 | 107913374 | Human |
| 407206229 | GWAS855205_H | mean corpuscular volume QTL GWAS855205 (human) | | 8e-44 | mean corpuscular volume | | 4 | 121875762 | 121875763 | Human |
| 617104857 | GWAS2122356_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2122356 (human) | | 2e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 106567633 | 106567634 | Human |
| 596951687 | GWAS1071206_H | HbA1c measurement QTL GWAS1071206 (human) | | 0.000001 | HbA1c measurement | | 4 | 109980042 | 109980043 | Human |
| 628753513 | GWAS2661742_H | psoriasis QTL GWAS2661742 (human) | | 1e-08 | psoriasis | | 4 | 121246451 | 121246452 | Human |
| 407206230 | GWAS855206_H | mean corpuscular volume QTL GWAS855206 (human) | | 4e-16 | mean corpuscular volume | | 4 | 127534974 | 127534975 | Human |
| 597262991 | GWAS1359065_H | aspartate measurement QTL GWAS1359065 (human) | | 0.0000001 | aspartate measurement | | 4 | 110477052 | 110477053 | Human |
| 597459594 | GWAS1555668_H | body height QTL GWAS1555668 (human) | | 4e-08 | body height | | 4 | 112647388 | 112647389 | Human |
| 407140690 | GWAS789666_H | emphysema imaging measurement QTL GWAS789666 (human) | | 0.0000009 | emphysema imaging measurement | | 4 | 122028914 | 122028915 | Human |
| 406927702 | GWAS576678_H | age-related macular degeneration QTL GWAS576678 (human) | | 9e-09 | retina integrity trait (VT:0010771) | | 4 | 109737911 | 109737912 | Human |
| 597525121 | GWAS1621195_H | alcohol consumption measurement QTL GWAS1621195 (human) | | 8e-11 | alcohol consumption measurement | | 4 | 112673472 | 112673473 | Human |
| 597525123 | GWAS1621197_H | alcohol consumption measurement QTL GWAS1621197 (human) | | 1e-10 | alcohol consumption measurement | | 4 | 117942113 | 117942114 | Human |
| 597525122 | GWAS1621196_H | alcohol consumption measurement QTL GWAS1621196 (human) | | 9e-11 | alcohol consumption measurement | | 4 | 112673525 | 112673526 | Human |
| 617006566 | GWAS2024065_H | mosquito bite reaction size measurement QTL GWAS2024065 (human) | | 0.000004 | mosquito bite reaction size measurement | | 4 | 123350979 | 123350980 | Human |
| 598000261 | GWAS1719560_H | serum creatinine amount QTL GWAS1719560 (human) | | 3e-12 | cystatin C measurement | | 4 | 127420965 | 127420966 | Human |
| 617006565 | GWAS2024064_H | mosquito bite reaction size measurement QTL GWAS2024064 (human) | | 3e-39 | mosquito bite reaction size measurement | | 4 | 122707847 | 122707848 | Human |
| 407288175 | GWAS937151_H | vaginal microbiome measurement QTL GWAS937151 (human) | | 5e-09 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 597476017 | GWAS1572091_H | blood protein measurement QTL GWAS1572091 (human) | | 1e-164 | blood protein measurement | | 4 | 106917957 | 106917958 | Human |
| 628999248 | GWAS2907477_H | mean corpuscular hemoglobin concentration QTL GWAS2907477 (human) | | 7e-14 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121827841 | 121827842 | Human |
| 628671573 | GWAS2579802_H | forced expiratory volume QTL GWAS2579802 (human) | | 6e-13 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 123917030 | 123917031 | Human |
| 616957416 | GWAS1974915_H | exercise test QTL GWAS1974915 (human) | | 0.000003 | exercise test | | 4 | 109878941 | 109878942 | Human |
| 628802634 | GWAS2710863_H | Thyroid stimulating hormone level QTL GWAS2710863 (human) | | 2e-19 | Thyroid stimulating hormone level | | 4 | 121691318 | 121691319 | Human |
| 616498571 | GWAS1895154_H | kynurenine measurement QTL GWAS1895154 (human) | | 0.000009 | amino acid metabolism trait (VT:0010631) | | 4 | 124920273 | 124920274 | Human |
| 617072127 | GWAS2089626_H | body height QTL GWAS2089626 (human) | | 8e-74 | body height | | 4 | 108355674 | 108355675 | Human |
| 597066414 | GWAS1162488_H | susceptibility to Mycobacterium tuberculosis infection measurement QTL GWAS1162488 (human) | | 0.000003 | response to bacterial infection trait (VT:0010435) | | 4 | 120002322 | 120002323 | Human |
| 617121265 | GWAS2138764_H | blood coagulation disease QTL GWAS2138764 (human) | | 1e-13 | blood coagulation disease | | 4 | 110796911 | 110796912 | Human |
| 597312163 | GWAS1408237_H | vaginal microbiome measurement QTL GWAS1408237 (human) | | 0.000002 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 617121267 | GWAS2138766_H | blood coagulation disease QTL GWAS2138766 (human) | | 8e-29 | blood coagulation disease | | 4 | 110784139 | 110784140 | Human |
| 628753466 | GWAS2661695_H | oligodendroglioma QTL GWAS2661695 (human) | | 0.000003 | oligodendroglioma | | 4 | 107054820 | 107054821 | Human |
| 406960384 | GWAS609360_H | systolic blood pressure QTL GWAS609360 (human) | | 2e-11 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110510288 | 110510289 | Human |
| 407222535 | GWAS871511_H | atrial fibrillation QTL GWAS871511 (human) | | 4e-15 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 628786226 | GWAS2694455_H | cortical thickness QTL GWAS2694455 (human) | | 5e-09 | cerebral cortex morphology trait (VT:0000788) | | 4 | 127101149 | 127101150 | Human |
| 628786224 | GWAS2694453_H | cortical thickness QTL GWAS2694453 (human) | | 1e-08 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120653051 | 120653052 | Human |
| 628786225 | GWAS2694454_H | cortical thickness QTL GWAS2694454 (human) | | 9e-10 | cerebral cortex morphology trait (VT:0000788) | | 4 | 123181336 | 123181337 | Human |
| 406894860 | GWAS543836_H | smoking initiation QTL GWAS543836 (human) | | 6e-26 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
| 628540474 | GWAS2448703_H | facial morphology trait QTL GWAS2448703 (human) | | 5e-08 | facial morphology trait | | 4 | 123252480 | 123252481 | Human |
| 406894861 | GWAS543837_H | smoking initiation QTL GWAS543837 (human) | | 2e-10 | smoking initiation | | 4 | 115079942 | 115079943 | Human |
| 616383984 | GWAS1864226_H | amount of iron in brain QTL GWAS1864226 (human) | | 4e-08 | amount of iron in brain | | 4 | 119210489 | 119210490 | Human |
| 406894862 | GWAS543838_H | smoking initiation QTL GWAS543838 (human) | | 3e-12 | smoking initiation | | 4 | 115630160 | 115630161 | Human |
| 406894863 | GWAS543839_H | smoking initiation QTL GWAS543839 (human) | | 4e-09 | smoking initiation | | 4 | 117868703 | 117868704 | Human |
| 628687926 | GWAS2596155_H | uric acid measurement QTL GWAS2596155 (human) | | 3e-08 | blood uric acid amount (VT:0010302) | blood uric acid level (CMO:0000501) | 4 | 127173154 | 127173155 | Human |
| 406894864 | GWAS543840_H | smoking initiation QTL GWAS543840 (human) | | 1e-12 | smoking initiation | | 4 | 120722571 | 120722572 | Human |
| 406894865 | GWAS543841_H | smoking initiation QTL GWAS543841 (human) | | 8e-12 | smoking initiation | | 4 | 122105714 | 122105715 | Human |
| 598049524 | GWAS1768823_H | body height QTL GWAS1768823 (human) | | 4e-08 | body height | | 4 | 122841742 | 122841743 | Human |
| 407304468 | GWAS953444_H | triglyceride measurement QTL GWAS953444 (human) | | 1e-12 | triglyceride measurement | | 4 | 109717608 | 109717609 | Human |
| 406894866 | GWAS543842_H | smoking initiation QTL GWAS543842 (human) | | 3e-10 | smoking initiation | | 4 | 126727157 | 126727158 | Human |
| 597295817 | GWAS1391891_H | body height QTL GWAS1391891 (human) | | 4e-15 | body height | | 4 | 122823209 | 122823210 | Human |
| 406894867 | GWAS543843_H | smoking initiation QTL GWAS543843 (human) | | 8e-16 | smoking initiation | | 4 | 129269203 | 129269204 | Human |
| 628786222 | GWAS2694451_H | cortical thickness QTL GWAS2694451 (human) | | 7e-17 | cerebral cortex morphology trait (VT:0000788) | | 4 | 112512138 | 112512139 | Human |
| 406894868 | GWAS543844_H | smoking initiation QTL GWAS543844 (human) | | 5e-09 | smoking initiation | | 4 | 130533359 | 130533360 | Human |
| 628786223 | GWAS2694452_H | cortical thickness QTL GWAS2694452 (human) | | 2e-16 | cerebral cortex morphology trait (VT:0000788) | | 4 | 118393759 | 118393760 | Human |
| 406894869 | GWAS543845_H | smoking initiation QTL GWAS543845 (human) | | 3e-11 | smoking initiation | | 4 | 131604639 | 131604640 | Human |
| 407320860 | GWAS969836_H | rheumatoid arthritis QTL GWAS969836 (human) | | 4e-14 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
| 617121171 | GWAS2138670_H | erythrocyte count QTL GWAS2138670 (human) | | 5e-16 | erythrocyte count | | 4 | 114598115 | 114598116 | Human |
| 616498659 | GWAS1895242_H | alpha-fetoprotein amount QTL GWAS1895242 (human) | | 1e-10 | alpha-fetoprotein amount | | 4 | 108743359 | 108743360 | Human |
| 617203092 | GWAS2183532_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2183532 (human) | | 6e-12 | glioma pathogenesis-related protein 1 measurement | | 4 | 125992444 | 125992445 | Human |
| 597607104 | GWAS1663964_H | systolic blood pressure QTL GWAS1663964 (human) | | 6e-13 | systolic blood pressure | | 4 | 110791276 | 110791277 | Human |
| 628507670 | GWAS2415899_H | restless legs syndrome QTL GWAS2415899 (human) | | 7e-10 | central nervous system integrity trait (VT:0010772) | | 4 | 118382649 | 118382650 | Human |
| 596968181 | GWAS1087700_H | cortical thickness QTL GWAS1087700 (human) | | 3e-08 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
| 628507671 | GWAS2415900_H | restless legs syndrome QTL GWAS2415900 (human) | | 3e-09 | central nervous system integrity trait (VT:0010772) | | 4 | 130726717 | 130726718 | Human |
| 407370021 | GWAS1018997_H | forced expiratory volume, response to bronchodilator QTL GWAS1018997 (human) | | 0.000005 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 122584901 | 122584902 | Human |
| 596968183 | GWAS1087702_H | cortical thickness QTL GWAS1087702 (human) | | 3e-08 | cortical thickness | | 4 | 126550097 | 126550098 | Human |
| 628507669 | GWAS2415898_H | restless legs syndrome QTL GWAS2415898 (human) | | 2e-09 | central nervous system integrity trait (VT:0010772) | | 4 | 115033802 | 115033803 | Human |
| 596984561 | GWAS1104080_H | memory performance, sex interaction measurement QTL GWAS1104080 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109128713 | 109128714 | Human |
| 596984560 | GWAS1104079_H | memory performance, sex interaction measurement QTL GWAS1104079 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109135631 | 109135632 | Human |
| 616957347 | GWAS1974846_H | serum IgG glycosylation measurement QTL GWAS1974846 (human) | | 0.000006 | serum IgG glycosylation measurement | | 4 | 110306660 | 110306661 | Human |
| 596984563 | GWAS1104082_H | memory performance, sex interaction measurement QTL GWAS1104082 (human) | | 0.000005 | memory performance, sex interaction measurement | | 4 | 125584117 | 125584118 | Human |
| 596984562 | GWAS1104081_H | memory performance, sex interaction measurement QTL GWAS1104081 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109128952 | 109128953 | Human |
| 597082879 | GWAS1178953_H | reticulocyte measurement QTL GWAS1178953 (human) | | 2e-10 | reticulocyte measurement | | 4 | 119185193 | 119185194 | Human |
| 628491290 | GWAS2399519_H | monoclonal gammopathy QTL GWAS2399519 (human) | | 0.000005 | monoclonal gammopathy | | 4 | 107881225 | 107881226 | Human |
| 406976813 | GWAS625789_H | sleep latency QTL GWAS625789 (human) | | 0.000001 | sleep latency | | 4 | 122626441 | 122626442 | Human |
| 597476080 | GWAS1572154_H | sex hormone-binding globulin measurement QTL GWAS1572154 (human) | | 3e-12 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 597050104 | GWAS1146178_H | endometriosis QTL GWAS1146178 (human) | | 0.0000006 | endometriosis | | 4 | 114744719 | 114744720 | Human |
| 628687880 | GWAS2596109_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2596109 (human) | | 6e-12 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
| 597476079 | GWAS1572153_H | sex hormone-binding globulin measurement QTL GWAS1572153 (human) | | 1e-10 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 617055668 | GWAS2073167_H | amount of iron in brain QTL GWAS2073167 (human) | | 4e-08 | amount of iron in brain | | 4 | 119210489 | 119210490 | Human |
| 597492462 | GWAS1588536_H | COVID-19 QTL GWAS1588536 (human) | | 0.000007 | COVID-19 | | 4 | 122087606 | 122087607 | Human |
| 616957365 | GWAS1974864_H | serum IgG glycosylation measurement QTL GWAS1974864 (human) | | 0.000005 | serum IgG glycosylation measurement | | 4 | 127545545 | 127545546 | Human |
| 597066464 | GWAS1162538_H | vaso-occlusive pain measurement QTL GWAS1162538 (human) | | 6e-08 | vaso-occlusive pain measurement | | 4 | 122088578 | 122088579 | Human |
| 617104816 | GWAS2122315_H | fibroblast growth factor 2 amount QTL GWAS2122315 (human) | | 4e-11 | fibroblast growth factor 2 amount | | 4 | 120649137 | 120649138 | Human |
| 628376589 | GWAS2296813_H | cortical thickness QTL GWAS2296813 (human) | | 0.0000001 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
| 597263075 | GWAS1359149_H | body height QTL GWAS1359149 (human) | | 1e-12 | body height | | 4 | 108494980 | 108494981 | Human |
| 617039292 | GWAS2056791_H | smoking initiation QTL GWAS2056791 (human) | | 8e-11 | smoking initiation | | 4 | 129681552 | 129681553 | Human |
| 628671492 | GWAS2579721_H | intelligence QTL GWAS2579721 (human) | | 6e-09 | intelligence | | 4 | 112573451 | 112573452 | Human |
| 596968168 | GWAS1087687_H | cortical thickness QTL GWAS1087687 (human) | | 2e-10 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 617104821 | GWAS2122320_H | gut microbiome measurement, breastfeeding duration QTL GWAS2122320 (human) | | 4e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 123562675 | 123562676 | Human |
| 597263076 | GWAS1359150_H | body height QTL GWAS1359150 (human) | | 2e-09 | body height | | 4 | 124024877 | 124024878 | Human |
| 628917251 | GWAS2825480_H | triglyceride measurement QTL GWAS2825480 (human) | | 5e-29 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109717668 | 109717669 | Human |
| 628671495 | GWAS2579724_H | intelligence QTL GWAS2579724 (human) | | 6e-09 | intelligence | | 4 | 112699050 | 112699051 | Human |
| 597983780 | GWAS1703079_H | erythrocyte volume QTL GWAS1703079 (human) | | 1e-17 | erythrocyte volume | | 4 | 109933275 | 109933276 | Human |
| 597983781 | GWAS1703080_H | erythrocyte volume QTL GWAS1703080 (human) | | 1e-79 | erythrocyte volume | | 4 | 121814898 | 121814899 | Human |
| 616957250 | GWAS1974749_H | age-related macular degeneration QTL GWAS1974749 (human) | | 0.000001 | retina integrity trait (VT:0010771) | | 4 | 116012923 | 116012924 | Human |
| 598032937 | GWAS1752236_H | body height QTL GWAS1752236 (human) | | 2e-16 | body height | | 4 | 108560745 | 108560746 | Human |
| 626443482 | GWAS2257415_H | circulating cell free DNA measurement QTL GWAS2257415 (human) | | 0.000007 | circulating cell free DNA measurement | | 4 | 119406669 | 119406670 | Human |
| 628819177 | GWAS2727406_H | venous thromboembolism QTL GWAS2727406 (human) | | 0.0000007 | blood integrity trait (VT:0010779) | | 4 | 122619586 | 122619587 | Human |
| 628442336 | GWAS2350565_H | lymphocyte count QTL GWAS2350565 (human) | | 2e-19 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 122760001 | 122760002 | Human |
| 597590537 | GWAS1647397_H | blood coagulation disease QTL GWAS1647397 (human) | | 5e-19 | blood coagulation disease | | 4 | 110784139 | 110784140 | Human |
| 597230094 | GWAS1326168_H | alpha synuclein measurement QTL GWAS1326168 (human) | | 0.000005 | alpha synuclein measurement | | 4 | 119884972 | 119884973 | Human |
| 617055582 | GWAS2073081_H | S-7-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS2073081 (human) | | 0.000009 | S-7-hydroxywarfarin to S-warfarin ratio measurement | | 4 | 126276324 | 126276325 | Human |
| 596984335 | GWAS1103854_H | memory performance QTL GWAS1103854 (human) | | 0.000009 | memory performance | | 4 | 131259522 | 131259523 | Human |
| 617006426 | GWAS2023925_H | lung carcinoma QTL GWAS2023925 (human) | | 0.0000005 | lung carcinoma | | 4 | 128666151 | 128666152 | Human |
| 616383778 | GWAS1864020_H | Complete right bundle branch block QTL GWAS1864020 (human) | | 4e-16 | Complete right bundle branch block | | 4 | 114640717 | 114640718 | Human |
| 596967946 | GWAS1087465_H | cortical thickness QTL GWAS1087465 (human) | | 4e-12 | cortical thickness | | 4 | 120758655 | 120758656 | Human |
| 597377595 | GWAS1473669_H | systolic blood pressure QTL GWAS1473669 (human) | | 7e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110460482 | 110460483 | Human |
| 407353831 | GWAS1002807_H | diastolic blood pressure QTL GWAS1002807 (human) | | 2e-09 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 628622553 | GWAS2530782_H | asthma, allergic disease QTL GWAS2530782 (human) | | 4e-10 | asthma, allergic disease | | 4 | 122219899 | 122219900 | Human |
| 616957285 | GWAS1974784_H | cardiovascular disease biomarker measurement, ankle brachial index QTL GWAS1974784 (human) | | 0.000007 | arterial blood pressure trait (VT:2000000) | | 4 | 126012137 | 126012138 | Human |
| 406911460 | GWAS560436_H | body height QTL GWAS560436 (human) | | 4e-08 | body height | | 4 | 122841742 | 122841743 | Human |
| 597983745 | GWAS1703044_H | erythrocyte volume QTL GWAS1703044 (human) | | 1e-10 | erythrocyte volume | | 4 | 121774530 | 121774531 | Human |
| 407337441 | GWAS986417_H | leukocyte count QTL GWAS986417 (human) | | 3e-13 | leukocyte count | | 4 | 110021121 | 110021122 | Human |
| 597377596 | GWAS1473670_H | diastolic blood pressure QTL GWAS1473670 (human) | | 9e-09 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110460482 | 110460483 | Human |
| 597262910 | GWAS1358984_H | amino acid measurement QTL GWAS1358984 (human) | | 0.0000004 | amino acid measurement | | 4 | 125452415 | 125452416 | Human |
| 628606175 | GWAS2514404_H | total cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS2514404 (human) | | 3e-11 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 628442335 | GWAS2350564_H | lymphocyte count QTL GWAS2350564 (human) | | 3e-25 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112192759 | 112192760 | Human |
| 628442334 | GWAS2350563_H | lymphocyte count QTL GWAS2350563 (human) | | 6e-25 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109921984 | 109921985 | Human |
| 597262901 | GWAS1358975_H | lymphocyte count QTL GWAS1358975 (human) | | 3e-09 | lymphocyte count | | 4 | 110003204 | 110003205 | Human |
| 597377591 | GWAS1473665_H | hypertension QTL GWAS1473665 (human) | | 0.000006 | hypertension | | 4 | 112002081 | 112002082 | Human |
| 407402983 | GWAS1051959_H | smoking status measurement QTL GWAS1051959 (human) | | 2e-15 | smoking status measurement | | 4 | 111500989 | 111500990 | Human |
| 407321079 | GWAS970055_H | ceramide measurement QTL GWAS970055 (human) | | 2e-20 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
| 617104760 | GWAS2122259_H | gut microbiome measurement, environmental exposure measurement QTL GWAS2122259 (human) | | 3e-08 | gut microbiome measurement, environmental exposure measurement | | 4 | 116169734 | 116169735 | Human |
| 628589766 | GWAS2497995_H | diet measurement, bilirubin measurement QTL GWAS2497995 (human) | | 0.000002 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 114333088 | 114333089 | Human |
| 407321078 | GWAS970054_H | ceramide measurement QTL GWAS970054 (human) | | 6e-13 | ceramide measurement | | 4 | 114469978 | 114469979 | Human |
| 617203064 | GWAS2183504_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2183504 (human) | | 3e-12 | glioma pathogenesis-related protein 1 measurement | | 4 | 116507955 | 116507956 | Human |
| 406944244 | GWAS593220_H | bone mineral content measurement QTL GWAS593220 (human) | | 0.000001 | bone mineral content measurement | | 4 | 106982388 | 106982389 | Human |
| 628425934 | GWAS2334163_H | Alzheimer disease QTL GWAS2334163 (human) | | 0.0000007 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 628425928 | GWAS2334157_H | Alzheimer disease QTL GWAS2334157 (human) | | 0.000006 | Alzheimer disease | | 4 | 119130833 | 119130834 | Human |
| 596967976 | GWAS1087495_H | cortical thickness QTL GWAS1087495 (human) | | 1e-12 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 616957191 | GWAS1974690_H | respiratory quotient QTL GWAS1974690 (human) | | 0.000008 | respiration trait (VT:0001943) | | 4 | 127420965 | 127420966 | Human |
| 617202954 | GWAS2183394_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2183394 (human) | | 4e-24 | glioma pathogenesis-related protein 1 measurement | | 4 | 107844119 | 107844120 | Human |
| 597131857 | GWAS1227931_H | erythrocyte count QTL GWAS1227931 (human) | | 1e-12 | blood hemoglobin amount (VT:0001588) | blood hemoglobin A1c level (CMO:0002786) | 4 | 109996470 | 109996471 | Human |
| 598065772 | GWAS1785071_H | brain attribute QTL GWAS1785071 (human) | | 9e-44 | brain attribute | | 4 | 123332634 | 123332635 | Human |
| 626459805 | GWAS2273738_H | obesity QTL GWAS2273738 (human) | | 3e-08 | obesity | | 4 | 114213612 | 114213613 | Human |
| 407239054 | GWAS888030_H | bone density QTL GWAS888030 (human) | | 1e-194 | bone density | | 4 | 107799654 | 107799655 | Human |
| 596951647 | GWAS1071166_H | dementia QTL GWAS1071166 (human) | | 0.000002 | dementia | | 4 | 120519704 | 120519705 | Human |
| 597394006 | GWAS1490080_H | bipolar I disorder QTL GWAS1490080 (human) | | 0.0000001 | bipolar I disorder | | 4 | 122588558 | 122588559 | Human |
| 597230153 | GWAS1326227_H | brain measurement QTL GWAS1326227 (human) | | 9e-09 | brain measurement | | 4 | 112432129 | 112432130 | Human |
| 626443398 | GWAS2257331_H | eosinophil count QTL GWAS2257331 (human) | | 5e-27 | eosinophil count | | 4 | 122680359 | 122680360 | Human |
| 597295688 | GWAS1391762_H | renin measurement, hypertension QTL GWAS1391762 (human) | | 0.000006 | renin measurement, hypertension | | 4 | 108375058 | 108375059 | Human |
| 628491428 | GWAS2399657_H | DNA methylation QTL GWAS2399657 (human) | | 3e-09 | DNA methylation | | 4 | 120727011 | 120727012 | Human |
| 626443396 | GWAS2257329_H | eosinophil count QTL GWAS2257329 (human) | | 1e-18 | eosinophil count | | 4 | 122111201 | 122111202 | Human |
| 626443397 | GWAS2257330_H | eosinophil count QTL GWAS2257330 (human) | | 1e-40 | eosinophil count | | 4 | 122451978 | 122451979 | Human |
| 617039124 | GWAS2056623_H | body weight QTL GWAS2056623 (human) | | 2e-12 | body weight | | 4 | 129838492 | 129838493 | Human |
| 628540579 | GWAS2448808_H | glycine measurement QTL GWAS2448808 (human) | | 4e-11 | blood glycine amount (VT:0010965) | blood amino acid measurement (CMO:0003730) | 4 | 110510288 | 110510289 | Human |
| 597393991 | GWAS1490065_H | bipolar I disorder QTL GWAS1490065 (human) | | 0.0000008 | bipolar I disorder | | 4 | 117548415 | 117548416 | Human |
| 617039131 | GWAS2056630_H | facial morphology trait QTL GWAS2056630 (human) | | 4e-11 | facial morphology trait | | 4 | 126014320 | 126014321 | Human |
| 617006362 | GWAS2023861_H | fat pad mass QTL GWAS2023861 (human) | | 0.000003 | fat pad mass | | 4 | 129885831 | 129885832 | Human |
| 597393990 | GWAS1490064_H | bipolar I disorder QTL GWAS1490064 (human) | | 0.0000006 | bipolar I disorder | | 4 | 117624232 | 117624233 | Human |
| 407026083 | GWAS675059_H | episodic memory QTL GWAS675059 (human) | | 0.000002 | episodic memory | | 4 | 114002480 | 114002481 | Human |
| 617039141 | GWAS2056640_H | atrial fibrillation QTL GWAS2056640 (human) | | 6e-306 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 407206311 | GWAS855287_H | amyloid-beta measurement QTL GWAS855287 (human) | | 0.000009 | amyloid-beta measurement | | 4 | 129232535 | 129232536 | Human |
| 628589714 | GWAS2497943_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS2497943 (human) | | 2e-12 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 628688031 | GWAS2596260_H | body mass index QTL GWAS2596260 (human) | | 1e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 119738082 | 119738083 | Human |
| 597983811 | GWAS1703110_H | erythrocyte volume QTL GWAS1703110 (human) | | 8e-26 | erythrocyte volume | | 4 | 127647811 | 127647812 | Human |
| 628524190 | GWAS2432419_H | strand of hair color QTL GWAS2432419 (human) | | 6e-11 | strand of hair color | | 4 | 108107769 | 108107770 | Human |
| 628933776 | GWAS2842005_H | saturated fatty acids to total fatty acids percentage QTL GWAS2842005 (human) | | 1e-18 | fatty acid amount (VT:0010046) | | 4 | 110191454 | 110191455 | Human |
| 616957224 | GWAS1974723_H | serum IgG glycosylation measurement QTL GWAS1974723 (human) | | 0.000003 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
| 596968059 | GWAS1087578_H | body mass index QTL GWAS1087578 (human) | | 6e-09 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 628458631 | GWAS2366860_H | aortic vascular smooth muscle cell calcification attribute QTL GWAS2366860 (human) | | 3e-08 | aortic vascular smooth muscle cell calcification attribute | | 4 | 118880492 | 118880493 | Human |
| 628933775 | GWAS2842004_H | saturated fatty acids to total fatty acids percentage QTL GWAS2842004 (human) | | 3e-09 | fatty acid amount (VT:0010046) | | 4 | 110151902 | 110151903 | Human |
| 407189937 | GWAS838913_H | nucleotide measurement QTL GWAS838913 (human) | | 0.000003 | nucleotide measurement | | 4 | 110518121 | 110518122 | Human |
| 406976949 | GWAS625925_H | hemoglobin measurement QTL GWAS625925 (human) | | 1e-09 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114647874 | 114647875 | Human |
| 598000210 | GWAS1719509_H | glomerular filtration rate QTL GWAS1719509 (human) | | 1e-11 | glomerular filtration rate | | 4 | 127420965 | 127420966 | Human |
| 628934524 | GWAS2842753_H | saturated fatty acids to total fatty acids percentage QTL GWAS2842753 (human) | | 1e-10 | fatty acid amount (VT:0010046) | | 4 | 110191454 | 110191455 | Human |
| 407337543 | GWAS986519_H | insomnia QTL GWAS986519 (human) | | 2e-08 | insomnia | | 4 | 112329113 | 112329114 | Human |
| 597229977 | GWAS1326051_H | blood protein measurement QTL GWAS1326051 (human) | | 1e-289 | blood protein measurement | | 4 | 119309995 | 119309996 | Human |
| 407321158 | GWAS970134_H | mean arterial pressure QTL GWAS970134 (human) | | 1e-11 | mean arterial pressure | | 4 | 110427909 | 110427910 | Human |
| 598081952 | GWAS1801251_H | serum creatinine amount QTL GWAS1801251 (human) | | 1e-13 | serum creatinine amount | | 4 | 127243324 | 127243325 | Human |
| 597279134 | GWAS1375208_H | hypertension, COVID-19 QTL GWAS1375208 (human) | | 5e-08 | hypertension, COVID-19 | | 4 | 110493243 | 110493244 | Human |
| 598081953 | GWAS1801252_H | serum creatinine amount QTL GWAS1801252 (human) | | 3e-09 | serum creatinine amount | | 4 | 128603358 | 128603359 | Human |
| 597508501 | GWAS1604575_H | self reported educational attainment QTL GWAS1604575 (human) | | 1e-08 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 597508500 | GWAS1604574_H | self reported educational attainment QTL GWAS1604574 (human) | | 1e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
| 407206476 | GWAS855452_H | calcium measurement QTL GWAS855452 (human) | | 0.000003 | calcium measurement | | 4 | 119895428 | 119895429 | Human |
| 407206478 | GWAS855454_H | magnesium measurement QTL GWAS855454 (human) | | 0.000004 | magnesium measurement | | 4 | 112431743 | 112431744 | Human |
| 597508502 | GWAS1604576_H | self reported educational attainment QTL GWAS1604576 (human) | | 4e-08 | self reported educational attainment | | 4 | 130401277 | 130401278 | Human |
| 407140937 | GWAS789913_H | myocardial infarction QTL GWAS789913 (human) | | 0.000007 | myocardial infarction | | 4 | 118770469 | 118770470 | Human |
| 597033369 | GWAS1129443_H | balding measurement QTL GWAS1129443 (human) | | 9e-15 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106348870 | 106348871 | Human |
| 407337544 | GWAS986520_H | insomnia QTL GWAS986520 (human) | | 2e-10 | insomnia | | 4 | 129856909 | 129856910 | Human |
| 597066118 | GWAS1162192_H | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis QTL GWAS1162192 (human) | | 6e-11 | joint integrity trait (VT:0010548) | | 4 | 122466445 | 122466446 | Human |
| 597098886 | GWAS1194960_H | gut microbiome measurement QTL GWAS1194960 (human) | | 0.000009 | gut microbiome measurement | | 4 | 112858735 | 112858736 | Human |
| 597393793 | GWAS1489867_H | gut microbiome measurement QTL GWAS1489867 (human) | | 0.000001 | gut microbiome measurement | | 4 | 106920747 | 106920748 | Human |
| 629000033 | GWAS2908262_H | body height QTL GWAS2908262 (human) | | 2e-128 | body height | | 4 | 119834940 | 119834941 | Human |
| 629000032 | GWAS2908261_H | body height QTL GWAS2908261 (human) | | 6e-09 | body height | | 4 | 119774304 | 119774305 | Human |
| 597590462 | GWAS1647322_H | blood coagulation disease QTL GWAS1647322 (human) | | 1e-13 | blood coagulation disease | | 4 | 110796911 | 110796912 | Human |
| 628950879 | GWAS2859108_H | platelet count QTL GWAS2859108 (human) | | 6e-283 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110020646 | 110020647 | Human |
| 629000031 | GWAS2908260_H | body height QTL GWAS2908260 (human) | | 6e-46 | body height | | 4 | 119733676 | 119733677 | Human |
| 629000030 | GWAS2908259_H | body height QTL GWAS2908259 (human) | | 7e-88 | body height | | 4 | 119680576 | 119680577 | Human |
| 597361074 | GWAS1457148_H | atrial fibrillation QTL GWAS1457148 (human) | | 1e-126 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597475765 | GWAS1571839_H | alcohol consumption measurement QTL GWAS1571839 (human) | | 2e-08 | alcohol consumption measurement | | 4 | 112674713 | 112674714 | Human |
| 628459356 | GWAS2367585_H | childhood trauma measurement QTL GWAS2367585 (human) | | 1e-08 | childhood trauma measurement | | 4 | 118266477 | 118266478 | Human |
| 407190121 | GWAS839097_H | cortical surface area measurement QTL GWAS839097 (human) | | 2e-17 | cortical surface area measurement | | 4 | 123326251 | 123326252 | Human |
| 597361077 | GWAS1457151_H | atrial fibrillation QTL GWAS1457151 (human) | | 2e-134 | atrial fibrillation | | 4 | 110793733 | 110793734 | Human |
| 626460537 | GWAS2274470_H | waist circumference QTL GWAS2274470 (human) | | 1e-08 | waist circumference | | 4 | 131517122 | 131517123 | Human |
| 628885331 | GWAS2793560_H | age-related macular degeneration, COVID-19 QTL GWAS2793560 (human) | | 3e-18 | retina integrity trait (VT:0010771) | | 4 | 109737911 | 109737912 | Human |
| 628901710 | GWAS2809939_H | blood VLDL cholesterol amount QTL GWAS2809939 (human) | | 1e-08 | blood VLDL cholesterol amount | | 4 | 109717709 | 109717710 | Human |
| 628623179 | GWAS2531408_H | cardiovascular disease QTL GWAS2531408 (human) | | 7e-13 | cardiovascular disease | | 4 | 110467945 | 110467946 | Human |
| 598081951 | GWAS1801250_H | serum creatinine amount QTL GWAS1801250 (human) | | 2e-15 | serum creatinine amount | | 4 | 108782393 | 108782394 | Human |
| 597131693 | GWAS1227767_H | memory performance QTL GWAS1227767 (human) | | 0.000009 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109134293 | 109134294 | Human |
| 597344672 | GWAS1440746_H | color vision disorder QTL GWAS1440746 (human) | | 1e-10 | color vision disorder | | 4 | 109831805 | 109831806 | Human |
| 617039495 | GWAS2056994_H | lip morphology trait QTL GWAS2056994 (human) | | 1e-08 | lip morphology trait | | 4 | 121076949 | 121076950 | Human |
| 597590492 | GWAS1647352_H | encounter with health service QTL GWAS1647352 (human) | | 7e-141 | encounter with health service | | 4 | 110778170 | 110778171 | Human |
| 597311967 | GWAS1408041_H | vaginal microbiome measurement QTL GWAS1408041 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 118330002 | 118330003 | Human |
| 597311965 | GWAS1408039_H | vaginal microbiome measurement QTL GWAS1408039 (human) | | 0.000005 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 598065641 | GWAS1784940_H | brain attribute QTL GWAS1784940 (human) | | 4e-12 | brain attribute | | 4 | 120306999 | 120307000 | Human |
| 617088645 | GWAS2106144_H | intelligence QTL GWAS2106144 (human) | | 6e-09 | intelligence | | 4 | 112573451 | 112573452 | Human |
| 617088646 | GWAS2106145_H | intelligence QTL GWAS2106145 (human) | | 6e-09 | intelligence | | 4 | 112699050 | 112699051 | Human |
| 597262806 | GWAS1358880_H | type 2 diabetes mellitus QTL GWAS1358880 (human) | | 2e-18 | type 2 diabetes mellitus | | 4 | 119146548 | 119146549 | Human |
| 628918060 | GWAS2826289_H | erythrocyte volume QTL GWAS2826289 (human) | | 3e-09 | erythrocyte volume | | 4 | 121795671 | 121795672 | Human |
| 597508556 | GWAS1604630_H | physical activity measurement QTL GWAS1604630 (human) | | 3e-09 | physical activity measurement | | 4 | 108177667 | 108177668 | Human |
| 628541223 | GWAS2449452_H | aging rate QTL GWAS2449452 (human) | | 7e-08 | aging rate | | 4 | 123010723 | 123010724 | Human |
| 407386649 | GWAS1035625_H | asthma exacerbation measurement QTL GWAS1035625 (human) | | 0.000008 | asthma exacerbation measurement | | 4 | 125651718 | 125651719 | Human |
| 628541220 | GWAS2449449_H | aging rate QTL GWAS2449449 (human) | | 4e-09 | aging rate | | 4 | 123122397 | 123122398 | Human |
| 628541221 | GWAS2449450_H | aging rate QTL GWAS2449450 (human) | | 3e-08 | aging rate | | 4 | 123350987 | 123350988 | Human |
| 628541219 | GWAS2449448_H | aging rate QTL GWAS2449448 (human) | | 5e-10 | aging rate | | 4 | 123250668 | 123250669 | Human |
| 597410253 | GWAS1506327_H | reaction time measurement QTL GWAS1506327 (human) | | 0.0000002 | reaction time measurement | | 4 | 117419552 | 117419553 | Human |
| 628918055 | GWAS2826284_H | erythrocyte count QTL GWAS2826284 (human) | | 5e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 110023574 | 110023575 | Human |
| 598065662 | GWAS1784961_H | cerebral cortex area attribute QTL GWAS1784961 (human) | | 1e-09 | cerebral cortex area attribute | | 4 | 126658527 | 126658528 | Human |
| 628541226 | GWAS2449455_H | aging rate QTL GWAS2449455 (human) | | 0.000001 | aging rate | | 4 | 122984812 | 122984813 | Human |
| 407255579 | GWAS904555_H | myocardial infarction QTL GWAS904555 (human) | | 0.0000002 | myocardial infarction | | 4 | 119988346 | 119988347 | Human |
| 407075358 | GWAS724334_H | urinary metabolite measurement QTL GWAS724334 (human) | | 6e-18 | urinary metabolite measurement | | 4 | 129118729 | 129118730 | Human |
| 597131721 | GWAS1227795_H | body height QTL GWAS1227795 (human) | | 8e-09 | body height | | 4 | 119834940 | 119834941 | Human |
| 597131720 | GWAS1227794_H | body height QTL GWAS1227794 (human) | | 1e-10 | body height | | 4 | 119600883 | 119600884 | Human |
| 628508438 | GWAS2416667_H | preeclampsia QTL GWAS2416667 (human) | | 0.000003 | blood pressure trait (VT:0000183) | | 4 | 112913825 | 112913826 | Human |
| 628672281 | GWAS2580510_H | glioblastoma multiforme QTL GWAS2580510 (human) | | 0.000007 | brain integrity trait (VT:0010579) | | 4 | 117476867 | 117476868 | Human |
| 597410300 | GWAS1506374_H | Alzheimer disease QTL GWAS1506374 (human) | | 0.0000007 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 407255598 | GWAS904574_H | aspartate measurement QTL GWAS904574 (human) | | 0.0000001 | aspartate measurement | | 4 | 110477052 | 110477053 | Human |
| 596967933 | GWAS1087452_H | cortical thickness QTL GWAS1087452 (human) | | 3e-08 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
| 407386656 | GWAS1035632_H | eosinophil count QTL GWAS1035632 (human) | | 1e-21 | eosinophil count | | 4 | 122365072 | 122365073 | Human |
| 597311987 | GWAS1408061_H | vaginal microbiome measurement QTL GWAS1408061 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 110167303 | 110167304 | Human |
| 597410294 | GWAS1506368_H | Alzheimer disease QTL GWAS1506368 (human) | | 0.000006 | Alzheimer disease | | 4 | 119130833 | 119130834 | Human |
| 617203364 | GWAS2183804_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2183804 (human) | | 1e-17 | glioma pathogenesis-related protein 1 measurement | | 4 | 130146820 | 130146821 | Human |
| 616531664 | GWAS1928247_H | hematocrit QTL GWAS1928247 (human) | | 1e-23 | hematocrit | | 4 | 109717668 | 109717669 | Human |
| 407403070 | GWAS1052046_H | cocaine dependence QTL GWAS1052046 (human) | | 0.000006 | cocaine dependence | | 4 | 116685914 | 116685915 | Human |
| 617088688 | GWAS2106187_H | 1-oleoylglycerophosphocholine measurement QTL GWAS2106187 (human) | | 0.0000008 | 1-oleoylglycerophosphocholine measurement | | 4 | 130062033 | 130062034 | Human |
| 596984296 | GWAS1103815_H | memory performance, sex interaction measurement QTL GWAS1103815 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 109129261 | 109129262 | Human |
| 407042623 | GWAS691599_H | cortical thickness QTL GWAS691599 (human) | | 3e-09 | cortical thickness | | 4 | 120704578 | 120704579 | Human |
| 628836346 | GWAS2744575_H | body weight QTL GWAS2744575 (human) | | 2e-12 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129838492 | 129838493 | Human |
| 407239366 | GWAS888342_H | bone density QTL GWAS888342 (human) | | 4e-186 | bone density | | 4 | 107807550 | 107807551 | Human |
| 617104974 | GWAS2122473_H | fibroblast growth factor 2 amount QTL GWAS2122473 (human) | | 8e-09 | fibroblast growth factor 2 amount | | 4 | 121394587 | 121394588 | Human |
| 407304897 | GWAS953873_H | hippocampus volume change measurement QTL GWAS953873 (human) | | 0.000001 | hippocampus volume change measurement | | 4 | 117571720 | 117571722 | Human |
| 598081838 | GWAS1801137_H | leukocyte quantity QTL GWAS1801137 (human) | | 3e-13 | leukocyte quantity | | 4 | 110021121 | 110021122 | Human |
| 628688881 | GWAS2597110_H | body mass index QTL GWAS2597110 (human) | | 6e-09 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
| 617121345 | GWAS2138844_H | disturbances of sensation of smell and taste QTL GWAS2138844 (human) | | 9e-12 | disturbances of sensation of smell and taste | | 4 | 125832302 | 125832303 | Human |
| 628934643 | GWAS2842872_H | body mass index QTL GWAS2842872 (human) | | 6e-09 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 119405930 | 119405931 | Human |
| 407222998 | GWAS871974_H | adenosine monophosphate measurement QTL GWAS871974 (human) | | 0.000009 | adenosine monophosphate measurement | | 4 | 116035124 | 116035125 | Human |
| 597393677 | GWAS1489751_H | bipolar disorder QTL GWAS1489751 (human) | | 0.0000001 | bipolar disorder | | 4 | 117551578 | 117551579 | Human |
| 407370448 | GWAS1019424_H | smoking initiation QTL GWAS1019424 (human) | | 3e-09 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
| 617088607 | GWAS2106106_H | systemic lupus erythematosus QTL GWAS2106106 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122631659 | 122631660 | Human |
| 597508357 | GWAS1604431_H | diastolic blood pressure QTL GWAS1604431 (human) | | 3e-16 | diastolic blood pressure | | 4 | 110414448 | 110414449 | Human |
| 598081855 | GWAS1801154_H | serum creatinine amount QTL GWAS1801154 (human) | | 1e-11 | serum creatinine amount | | 4 | 108783863 | 108783864 | Human |
| 597459206 | GWAS1555280_H | dementia QTL GWAS1555280 (human) | | 0.000002 | dementia | | 4 | 120519704 | 120519705 | Human |
| 598049028 | GWAS1768327_H | obsolete_facial morphology quality QTL GWAS1768327 (human) | | 3e-08 | obsolete_facial morphology quality | | 4 | 125219863 | 125219864 | Human |
| 616957540 | GWAS1975039_H | QT interval QTL GWAS1975039 (human) | | 0.0000008 | heart electrical impulse conduction trait (VT:2000017) | QT interval (CMO:0000235) | 4 | 117411099 | 117411100 | Human |
| 598049030 | GWAS1768329_H | obsolete_facial morphology quality QTL GWAS1768329 (human) | | 3e-08 | obsolete_facial morphology quality | | 4 | 125210511 | 125210512 | Human |
| 598049025 | GWAS1768324_H | obsolete_facial morphology quality QTL GWAS1768324 (human) | | 3e-08 | obsolete_facial morphology quality | | 4 | 125198542 | 125198543 | Human |
| 407223008 | GWAS871984_H | chronic lymphocytic leukemia QTL GWAS871984 (human) | | 3e-09 | chronic lymphocytic leukemia | | 4 | 113762688 | 113762689 | Human |
| 598049027 | GWAS1768326_H | obsolete_facial morphology quality QTL GWAS1768326 (human) | | 3e-08 | obsolete_facial morphology quality | | 4 | 125217310 | 125217311 | Human |
| 596967730 | GWAS1087249_H | cortical thickness QTL GWAS1087249 (human) | | 2e-14 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 598049026 | GWAS1768325_H | obsolete_facial morphology quality QTL GWAS1768325 (human) | | 3e-08 | obsolete_facial morphology quality | | 4 | 125198582 | 125198583 | Human |
| 626444284 | GWAS2258217_H | obsolete_anxiety QTL GWAS2258217 (human) | | 2e-09 | obsolete_anxiety | | 4 | 131717648 | 131717649 | Human |
| 628541405 | GWAS2449634_H | cathepsin F measurement QTL GWAS2449634 (human) | | 1e-17 | cathepsin F measurement | | 4 | 109657070 | 109657071 | Human |
| 598049033 | GWAS1768332_H | obsolete_facial morphology quality QTL GWAS1768332 (human) | | 3e-08 | obsolete_facial morphology quality | | 4 | 125211057 | 125211058 | Human |
| 407370474 | GWAS1019450_H | atrial fibrillation QTL GWAS1019450 (human) | | 7e-443 | atrial fibrillation | | 4 | 110778529 | 110778530 | Human |
| 407337715 | GWAS986691_H | mean corpuscular volume QTL GWAS986691 (human) | | 8e-17 | mean corpuscular volume | | 4 | 127625245 | 127625246 | Human |
| 407337714 | GWAS986690_H | mean corpuscular volume QTL GWAS986690 (human) | | 2e-52 | mean corpuscular volume | | 4 | 121877258 | 121877259 | Human |
| 617203324 | GWAS2183764_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2183764 (human) | | 1e-15 | glioma pathogenesis-related protein 1 measurement | | 4 | 132115969 | 132115970 | Human |
| 616531464 | GWAS1928047_H | platelet count QTL GWAS1928047 (human) | | 4e-14 | platelet count | | 4 | 123749526 | 123749527 | Human |
| 407239421 | GWAS888397_H | bone density QTL GWAS888397 (human) | | 5e-18 | bone density | | 4 | 110503132 | 110503133 | Human |
| 628541391 | GWAS2449620_H | cathepsin F measurement QTL GWAS2449620 (human) | | 7e-36 | cathepsin F measurement | | 4 | 118811292 | 118811293 | Human |
| 597016879 | GWAS1112953_H | mosquito bite reaction itch intensity measurement QTL GWAS1112953 (human) | | 8e-08 | mosquito bite reaction itch intensity measurement | | 4 | 123350979 | 123350980 | Human |
| 597115179 | GWAS1211253_H | DNA methylation QTL GWAS1211253 (human) | | 3e-09 | DNA methylation | | 4 | 120727011 | 120727012 | Human |
| 628787131 | GWAS2695360_H | body weight QTL GWAS2695360 (human) | | 5e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 121338887 | 121338888 | Human |
| 616973828 | GWAS1991327_H | cerebral cortex area attribute QTL GWAS1991327 (human) | | 0.0000006 | cerebral cortex area attribute | | 4 | 126616579 | 126616580 | Human |
| 617072130 | GWAS2089629_H | body height QTL GWAS2089629 (human) | | 3e-10 | body height | | 4 | 109411761 | 109411762 | Human |
| 616973827 | GWAS1991326_H | cerebral cortex area attribute QTL GWAS1991326 (human) | | 4e-10 | cerebral cortex area attribute | | 4 | 112495627 | 112495628 | Human |
| 617072129 | GWAS2089628_H | body height QTL GWAS2089628 (human) | | 4e-144 | body height | | 4 | 108554818 | 108554819 | Human |
| 617072128 | GWAS2089627_H | body height QTL GWAS2089627 (human) | | 1e-277 | body height | | 4 | 108540829 | 108540830 | Human |
| 598032738 | GWAS1752037_H | trait in response to warfarin QTL GWAS1752037 (human) | | 0.0000006 | trait in response to warfarin | | 4 | 130374797 | 130374798 | Human |
| 628508604 | GWAS2416833_H | atrial fibrillation QTL GWAS2416833 (human) | | 3e-08 | atrial fibrillation | | 4 | 110742777 | 110742778 | Human |
| 628885431 | GWAS2793660_H | insomnia QTL GWAS2793660 (human) | | 5e-09 | sleep behavior trait (VT:0001501) | | 4 | 125465671 | 125465672 | Human |
| 597213526 | GWAS1309600_H | high density lipoprotein cholesterol measurement QTL GWAS1309600 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | | 4 | 109717608 | 109717609 | Human |
| 407124619 | GWAS773595_H | type 1 diabetes mellitus QTL GWAS773595 (human) | | 0.000006 | type 1 diabetes mellitus | | 4 | 122408207 | 122408208 | Human |
| 597393739 | GWAS1489813_H | hematocrit QTL GWAS1489813 (human) | | 1e-10 | hematocrit | | 4 | 123846352 | 123846353 | Human |
| 597393738 | GWAS1489812_H | hematocrit QTL GWAS1489812 (human) | | 2e-16 | hematocrit | | 4 | 114598115 | 114598116 | Human |
| 628426663 | GWAS2334892_H | hematocrit QTL GWAS2334892 (human) | | 1e-10 | erythrocyte morphology trait (VT:0002447) | hematocrit (CMO:0000037) | 4 | 123846352 | 123846353 | Human |
| 628426662 | GWAS2334891_H | hematocrit QTL GWAS2334891 (human) | | 2e-16 | erythrocyte morphology trait (VT:0002447) | hematocrit (CMO:0000037) | 4 | 114598115 | 114598116 | Human |
| 406960789 | GWAS609765_H | breast carcinoma QTL GWAS609765 (human) | | 0.000002 | mammary gland integrity trait (VT:0010552) | | 4 | 121189820 | 121189821 | Human |
| 406960788 | GWAS609764_H | breast carcinoma QTL GWAS609764 (human) | | 0.000002 | mammary gland integrity trait (VT:0010552) | | 4 | 121205653 | 121205654 | Human |
| 628672430 | GWAS2580659_H | neuroimaging measurement QTL GWAS2580659 (human) | | 2e-09 | nervous system morphology trait (VT:0003632) | | 4 | 114732469 | 114732470 | Human |
| 616990239 | GWAS2007738_H | glycerophospholipid measurement QTL GWAS2007738 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114492457 | 114492458 | Human |
| 407026331 | GWAS675307_H | body height QTL GWAS675307 (human) | | 5e-13 | body height | | 4 | 123228081 | 123228082 | Human |
| 406960797 | GWAS609773_H | breast carcinoma QTL GWAS609773 (human) | | 0.000002 | mammary gland integrity trait (VT:0010552) | | 4 | 121222509 | 121222510 | Human |
| 407239320 | GWAS888296_H | amino acid measurement QTL GWAS888296 (human) | | 0.000009 | amino acid measurement | | 4 | 118154781 | 118154782 | Human |
| 597377348 | GWAS1473422_H | glycine measurement QTL GWAS1473422 (human) | | 0.000003 | glycine measurement | | 4 | 107930418 | 107930419 | Human |
| 616990246 | GWAS2007745_H | glycerophospholipid measurement QTL GWAS2007745 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114494754 | 114494755 | Human |
| 616990247 | GWAS2007746_H | glycerophospholipid measurement QTL GWAS2007746 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114502041 | 114502042 | Human |
| 616990244 | GWAS2007743_H | glycerophospholipid measurement QTL GWAS2007743 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114495098 | 114495099 | Human |
| 628803480 | GWAS2711709_H | body mass index QTL GWAS2711709 (human) | | 6e-09 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 130097733 | 130097734 | Human |
| 616990245 | GWAS2007744_H | glycerophospholipid measurement QTL GWAS2007744 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114501793 | 114501794 | Human |
| 616384089 | GWAS1864331_H | obsolete_phospholipid measurement, blood VLDL cholesterol amount QTL GWAS1864331 (human) | | 8e-09 | obsolete_phospholipid measurement, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 616990242 | GWAS2007741_H | glycerophospholipid measurement QTL GWAS2007741 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114479583 | 114479584 | Human |
| 616990243 | GWAS2007742_H | glycerophospholipid measurement QTL GWAS2007742 (human) | | 1e-10 | glycerophospholipid measurement | | 4 | 114481442 | 114481443 | Human |
| 407419566 | GWAS1068542_H | diastolic blood pressure QTL GWAS1068542 (human) | | 7e-12 | diastolic blood pressure | | 4 | 108146742 | 108146743 | Human |
| 597361021 | GWAS1457095_H | autosomal dominant compelling helio-ophthalmic outburst syndrome QTL GWAS1457095 (human) | | 3e-31 | autosomal dominant compelling helio-ophthalmic outburst syndrome | | 4 | 111737998 | 111737999 | Human |
| 616990240 | GWAS2007739_H | glycerophospholipid measurement QTL GWAS2007739 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114492647 | 114492648 | Human |
| 597131633 | GWAS1227707_H | cortical thickness QTL GWAS1227707 (human) | | 9e-10 | cortical thickness | | 4 | 123181336 | 123181337 | Human |
| 616990241 | GWAS2007740_H | glycerophospholipid measurement QTL GWAS2007740 (human) | | 6e-10 | glycerophospholipid measurement | | 4 | 114485362 | 114485363 | Human |
| 597131632 | GWAS1227706_H | cortical thickness QTL GWAS1227706 (human) | | 1e-08 | cortical thickness | | 4 | 120653051 | 120653052 | Human |
| 628459410 | GWAS2367639_H | Bell's palsy QTL GWAS2367639 (human) | | 0.000006 | Bell's palsy | | 4 | 123516321 | 123516322 | Human |
| 597393788 | GWAS1489862_H | gut microbiome measurement QTL GWAS1489862 (human) | | 0.000005 | gut microbiome measurement | | 4 | 127613641 | 127613642 | Human |
| 628803475 | GWAS2711704_H | body mass index QTL GWAS2711704 (human) | | 7e-10 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 118298754 | 118298755 | Human |
| 616990252 | GWAS2007751_H | glycerophospholipid measurement QTL GWAS2007751 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114479168 | 114479169 | Human |
| 597983560 | GWAS1702859_H | erythrocyte volume QTL GWAS1702859 (human) | | 9e-14 | erythrocyte volume | | 4 | 109933275 | 109933276 | Human |
| 616990250 | GWAS2007749_H | glycerophospholipid measurement QTL GWAS2007749 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114598115 | 114598116 | Human |
| 628803478 | GWAS2711707_H | body mass index QTL GWAS2711707 (human) | | 1e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129399809 | 129399810 | Human |
| 616990251 | GWAS2007750_H | glycerophospholipid measurement QTL GWAS2007750 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114484294 | 114484295 | Human |
| 597983561 | GWAS1702860_H | erythrocyte volume QTL GWAS1702860 (human) | | 4e-73 | erythrocyte volume | | 4 | 121814898 | 121814899 | Human |
| 628803479 | GWAS2711708_H | body mass index QTL GWAS2711708 (human) | | 9e-21 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129810129 | 129810130 | Human |
| 616990248 | GWAS2007747_H | glycerophospholipid measurement QTL GWAS2007747 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114495078 | 114495079 | Human |
| 628803476 | GWAS2711705_H | body mass index QTL GWAS2711705 (human) | | 8e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 119292875 | 119292876 | Human |
| 597983562 | GWAS1702861_H | erythrocyte volume QTL GWAS1702861 (human) | | 2e-28 | mean corpuscular hemoglobin concentration | | 4 | 127625245 | 127625246 | Human |
| 616990249 | GWAS2007748_H | glycerophospholipid measurement QTL GWAS2007748 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114483807 | 114483808 | Human |
| 628803477 | GWAS2711706_H | body mass index QTL GWAS2711706 (human) | | 3e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 121743168 | 121743169 | Human |
| 407419576 | GWAS1068552_H | diastolic blood pressure QTL GWAS1068552 (human) | | 3e-21 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 597229930 | GWAS1326004_H | endometriosis, major depressive disorder QTL GWAS1326004 (human) | | 5e-08 | endometriosis, major depressive disorder | | 4 | 130288732 | 130288733 | Human |
| 407222961 | GWAS871937_H | blood protein measurement QTL GWAS871937 (human) | | 1e-289 | blood protein measurement | | 4 | 119309995 | 119309996 | Human |
| 407239345 | GWAS888321_H | von Willebrand factor measurement, coronary artery disease QTL GWAS888321 (human) | | 2e-11 | factor XI measurement, coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 597131631 | GWAS1227705_H | cortical thickness QTL GWAS1227705 (human) | | 2e-16 | cortical thickness | | 4 | 118393759 | 118393760 | Human |
| 407419569 | GWAS1068545_H | diastolic blood pressure QTL GWAS1068545 (human) | | 2e-16 | diastolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 597279072 | GWAS1375146_H | QT interval QTL GWAS1375146 (human) | | 2e-09 | QT interval | | 4 | 113464520 | 113464521 | Human |
| 407419572 | GWAS1068548_H | diastolic blood pressure QTL GWAS1068548 (human) | | 2e-27 | diastolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 407419573 | GWAS1068549_H | diastolic blood pressure QTL GWAS1068549 (human) | | 0.0000007 | diastolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 407419574 | GWAS1068550_H | diastolic blood pressure QTL GWAS1068550 (human) | | 5e-27 | diastolic blood pressure | | 4 | 110461529 | 110461530 | Human |
| 407419575 | GWAS1068551_H | diastolic blood pressure QTL GWAS1068551 (human) | | 3e-08 | diastolic blood pressure | | 4 | 119037654 | 119037655 | Human |
| 616482751 | GWAS1879334_H | thyroxine amount QTL GWAS1879334 (human) | | 5e-08 | thyroxine amount | | 4 | 123563112 | 123563113 | Human |
| 597409945 | GWAS1506019_H | Alzheimer disease QTL GWAS1506019 (human) | | 0.000001 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 406895427 | GWAS544403_H | glycolithocholate sulfate measurement QTL GWAS544403 (human) | | 0.0000001 | glycolithocholate sulfate measurement | | 4 | 124486812 | 124486813 | Human |
| 628655740 | GWAS2563969_H | body mass index QTL GWAS2563969 (human) | | 8e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
| 406928205 | GWAS577181_H | diastolic blood pressure, systolic blood pressure QTL GWAS577181 (human) | | 0.000007 | diastolic blood pressure, systolic blood pressure | | 4 | 119856151 | 119856152 | Human |
| 406993749 | GWAS642725_H | acne QTL GWAS642725 (human) | | 0.000008 | acne | | 4 | 123213554 | 123213555 | Human |
| 407403347 | GWAS1052323_H | lifestyle measurement, anxiety disorder measurement QTL GWAS1052323 (human) | | 5e-13 | lifestyle measurement, anxiety disorder measurement | | 4 | 122322628 | 122322629 | Human |
| 597016714 | GWAS1112788_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1112788 (human) | | 0.0000006 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 123865108 | 123865109 | Human |
| 628852314 | GWAS2760543_H | facial morphology trait QTL GWAS2760543 (human) | | 1e-19 | facial morphology trait | | 4 | 127005360 | 127005361 | Human |
| 597164218 | GWAS1260292_H | androsterone sulfate measurement QTL GWAS1260292 (human) | | 0.000004 | androsterone sulfate measurement | | 4 | 119318723 | 119318724 | Human |
| 628770393 | GWAS2678622_H | CD40LG/EGF protein level ratio in blood QTL GWAS2678622 (human) | | 3e-289 | CD40LG/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 628721244 | GWAS2629473_H | level of agrin in blood QTL GWAS2629473 (human) | | 2e-53 | level of agrin in blood | | 4 | 118378823 | 118378824 | Human |
| 406895465 | GWAS544441_H | Hypoxanthine measurement QTL GWAS544441 (human) | | 3e-08 | Hypoxanthine measurement | | 4 | 131223983 | 131223984 | Human |
| 407206761 | GWAS855737_H | triglyceride measurement QTL GWAS855737 (human) | | 2e-17 | triglyceride measurement | | 4 | 109717608 | 109717609 | Human |
| 597164212 | GWAS1260286_H | carbohydrate measurement QTL GWAS1260286 (human) | | 0.000004 | carbohydrate measurement | | 4 | 110062423 | 110062424 | Human |
| 407206762 | GWAS855738_H | triglyceride measurement QTL GWAS855738 (human) | | 1e-38 | high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 596967589 | GWAS1087108_H | cortical thickness QTL GWAS1087108 (human) | | 4e-13 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
| 628770378 | GWAS2678607_H | cortical thickness QTL GWAS2678607 (human) | | 6e-12 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120793484 | 120793485 | Human |
| 598098068 | GWAS1815461_H | atrial fibrillation QTL GWAS1815461 (human) | | 2e-24 | atrial fibrillation | | 4 | 113528563 | 113528564 | Human |
| 628409920 | GWAS2318149_H | cardioembolic stroke QTL GWAS2318149 (human) | | 2e-25 | joint integrity trait (VT:0010548) | | 4 | 110793263 | 110793264 | Human |
| 597344431 | GWAS1440505_H | color vision disorder QTL GWAS1440505 (human) | | 0.0000002 | color vision disorder | | 4 | 130864190 | 130864191 | Human |
| 628835907 | GWAS2744136_H | lipid measurement QTL GWAS2744136 (human) | | 0.000007 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 107039415 | 107039416 | Human |
| 407337855 | GWAS986831_H | triglyceride measurement QTL GWAS986831 (human) | | 9e-33 | triglyceride measurement | | 4 | 109717668 | 109717669 | Human |
| 616957950 | GWAS1975449_H | stroke QTL GWAS1975449 (human) | | 0.0000002 | brain integrity trait (VT:0010579) | | 4 | 110796911 | 110796912 | Human |
| 597524645 | GWAS1620719_H | body mass index QTL GWAS1620719 (human) | | 6e-10 | body mass index | | 4 | 119372621 | 119372622 | Human |
| 407337854 | GWAS986830_H | triglyceride measurement QTL GWAS986830 (human) | | 7e-26 | triglyceride measurement | | 4 | 109174464 | 109174465 | Human |
| 616957951 | GWAS1975450_H | stroke QTL GWAS1975450 (human) | | 3e-16 | brain integrity trait (VT:0010579) | | 4 | 110796911 | 110796912 | Human |
| 407092090 | GWAS741066_H | chromosome-type aberration frequency QTL GWAS741066 (human) | | 0.000004 | chromosome-type aberration frequency | | 4 | 131649836 | 131649837 | Human |
| 628475470 | GWAS2383699_H | schizophrenia QTL GWAS2383699 (human) | | 4e-08 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
| 597377184 | GWAS1473258_H | lymphocyte percentage of leukocytes QTL GWAS1473258 (human) | | 6e-19 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 4 | 122760001 | 122760002 | Human |
| 597524646 | GWAS1620720_H | body mass index QTL GWAS1620720 (human) | | 3e-15 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 596951209 | GWAS1070728_H | dementia QTL GWAS1070728 (human) | | 0.000009 | dementia | | 4 | 129535320 | 129535321 | Human |
| 626460264 | GWAS2274197_H | platelet count QTL GWAS2274197 (human) | | 4e-162 | platelet count | | 4 | 110020646 | 110020647 | Human |
| 407239546 | GWAS888522_H | Ventricular arrhythmia QTL GWAS888522 (human) | | 4e-11 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
| 628409931 | GWAS2318160_H | small vessel stroke QTL GWAS2318160 (human) | | 1e-08 | artery integrity trait (VT:0010639) | | 4 | 113480773 | 113480774 | Human |
| 628409908 | GWAS2318137_H | cardioembolic stroke QTL GWAS2318137 (human) | | 3e-25 | joint integrity trait (VT:0010548) | | 4 | 110793263 | 110793264 | Human |
| 628409910 | GWAS2318139_H | cardioembolic stroke QTL GWAS2318139 (human) | | 6e-24 | joint integrity trait (VT:0010548) | | 4 | 110793263 | 110793264 | Human |
| 628770366 | GWAS2678595_H | cerebral cortex area attribute QTL GWAS2678595 (human) | | 2e-09 | cerebral cortex area attribute | | 4 | 112495282 | 112495283 | Human |
| 598032608 | GWAS1751907_H | trait in response to warfarin QTL GWAS1751907 (human) | | 0.000007 | trait in response to warfarin | | 4 | 112988363 | 112988364 | Human |
| 628852286 | GWAS2760515_H | Hepatitis QTL GWAS2760515 (human) | | 1e-09 | Hepatitis | | 4 | 125282172 | 125282173 | Human |
| 628835901 | GWAS2744130_H | oleoylcarnitine measurement QTL GWAS2744130 (human) | | 0.000002 | oleoylcarnitine measurement | | 4 | 116466224 | 116466225 | Human |
| 617105295 | GWAS2122794_H | gut microbiome measurement, breastfeeding duration QTL GWAS2122794 (human) | | 1e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 115599484 | 115599485 | Human |
| 628409913 | GWAS2318142_H | cardioembolic stroke QTL GWAS2318142 (human) | | 2e-21 | joint integrity trait (VT:0010548) | | 4 | 110793263 | 110793264 | Human |
| 617203588 | GWAS2184028_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2184028 (human) | | 6e-14 | glioma pathogenesis-related protein 1 measurement | | 4 | 124228421 | 124228422 | Human |
| 628885036 | GWAS2793265_H | cardioembolic stroke QTL GWAS2793265 (human) | | 3e-48 | joint integrity trait (VT:0010548) | | 4 | 110775495 | 110775496 | Human |
| 628655660 | GWAS2563889_H | body mass index QTL GWAS2563889 (human) | | 6e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
| 628917800 | GWAS2826029_H | erythrocyte count QTL GWAS2826029 (human) | | 4e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598194 | 114598195 | Human |
| 597311695 | GWAS1407769_H | vaginal microbiome measurement QTL GWAS1407769 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 121763984 | 121763985 | Human |
| 628655661 | GWAS2563890_H | body mass index QTL GWAS2563890 (human) | | 2e-12 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
| 617072542 | GWAS2090041_H | body mass index QTL GWAS2090041 (human) | | 6e-09 | body mass index | | 4 | 130097733 | 130097734 | Human |
| 617072541 | GWAS2090040_H | body mass index QTL GWAS2090040 (human) | | 9e-21 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 617203602 | GWAS2184042_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2184042 (human) | | 2e-23 | glioma pathogenesis-related protein 1 measurement | | 4 | 112358525 | 112358526 | Human |
| 617072540 | GWAS2090039_H | body mass index QTL GWAS2090039 (human) | | 1e-08 | body mass index | | 4 | 129399809 | 129399810 | Human |
| 628753959 | GWAS2662188_H | atrial fibrillation QTL GWAS2662188 (human) | | 7e-09 | atrial fibrillation | | 4 | 109606131 | 109606132 | Human |
| 407403285 | GWAS1052261_H | hip bone mineral density, fat body mass QTL GWAS1052261 (human) | | 6e-09 | hip bone mineral density, fat body mass | | 4 | 129257175 | 129257176 | Human |
| 628721181 | GWAS2629410_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2629410 (human) | | 2e-23 | glioma pathogenesis-related protein 1 measurement | | 4 | 112358525 | 112358526 | Human |
| 628835869 | GWAS2744098_H | deoxycholate measurement QTL GWAS2744098 (human) | | 0.000001 | deoxycholate measurement | | 4 | 119855597 | 119855598 | Human |
| 407223074 | GWAS872050_H | alcohol dependence QTL GWAS872050 (human) | | 0.000004 | alcohol dependence | | 4 | 130091985 | 130091986 | Human |
| 626460223 | GWAS2274156_H | erythrocyte count QTL GWAS2274156 (human) | | 5e-12 | erythrocyte count | | 4 | 110023574 | 110023575 | Human |
| 597426420 | GWAS1522494_H | glycerophospholipid measurement QTL GWAS1522494 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114536699 | 114536700 | Human |
| 597999820 | GWAS1719119_H | cerebral cortex area attribute QTL GWAS1719119 (human) | | 8e-10 | cerebral cortex area attribute | | 4 | 120653052 | 120653053 | Human |
| 628852243 | GWAS2760472_H | smoking initiation QTL GWAS2760472 (human) | | 3e-16 | behavior trait (VT:0010442) | | 4 | 120722571 | 120722572 | Human |
| 407403297 | GWAS1052273_H | open-angle glaucoma QTL GWAS1052273 (human) | | 6e-10 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 628852242 | GWAS2760471_H | smoking initiation QTL GWAS2760471 (human) | | 2e-13 | behavior trait (VT:0010442) | | 4 | 120650494 | 120650495 | Human |
| 407370541 | GWAS1019517_H | blood protein measurement QTL GWAS1019517 (human) | | 2e-152 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628852241 | GWAS2760470_H | smoking initiation QTL GWAS2760470 (human) | | 6e-10 | behavior trait (VT:0010442) | | 4 | 117807381 | 117807382 | Human |
| 407370540 | GWAS1019516_H | blood protein measurement QTL GWAS1019516 (human) | | 3e-195 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628852240 | GWAS2760469_H | smoking initiation QTL GWAS2760469 (human) | | 3e-09 | behavior trait (VT:0010442) | | 4 | 117028412 | 117028413 | Human |
| 597377271 | GWAS1473345_H | atrial fibrillation QTL GWAS1473345 (human) | | 3e-41 | atrial fibrillation | | 4 | 110789013 | 110789014 | Human |
| 597426416 | GWAS1522490_H | glycerophospholipid measurement QTL GWAS1522490 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114598194 | 114598195 | Human |
| 628852247 | GWAS2760476_H | smoking initiation QTL GWAS2760476 (human) | | 4e-11 | behavior trait (VT:0010442) | | 4 | 129534689 | 129534690 | Human |
| 597999817 | GWAS1719116_H | cerebral cortex area attribute QTL GWAS1719116 (human) | | 2e-08 | cerebral cortex area attribute | | 4 | 107131838 | 107131839 | Human |
| 628590106 | GWAS2498335_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS2498335 (human) | | 0.0000007 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 127714844 | 127714845 | Human |
| 628852246 | GWAS2760475_H | smoking initiation QTL GWAS2760475 (human) | | 8e-15 | behavior trait (VT:0010442) | | 4 | 129269203 | 129269204 | Human |
| 628688407 | GWAS2596636_H | systolic blood pressure QTL GWAS2596636 (human) | | 1e-14 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110414448 | 110414449 | Human |
| 597999818 | GWAS1719117_H | cerebral cortex area attribute QTL GWAS1719117 (human) | | 2e-13 | cerebral cortex area attribute | | 4 | 112509596 | 112509597 | Human |
| 628852245 | GWAS2760474_H | smoking initiation QTL GWAS2760474 (human) | | 3e-09 | behavior trait (VT:0010442) | | 4 | 126727157 | 126727158 | Human |
| 597426419 | GWAS1522493_H | glycerophospholipid measurement QTL GWAS1522493 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114491050 | 114491051 | Human |
| 626460216 | GWAS2274149_H | erythrocyte count QTL GWAS2274149 (human) | | 4e-11 | erythrocyte count | | 4 | 114598194 | 114598195 | Human |
| 597999819 | GWAS1719118_H | cerebral cortex area attribute QTL GWAS1719118 (human) | | 1e-17 | cerebral cortex area attribute | | 4 | 118393759 | 118393760 | Human |
| 628885011 | GWAS2793240_H | diet measurement QTL GWAS2793240 (human) | | 3e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 122050021 | 122050022 | Human |
| 628852244 | GWAS2760473_H | smoking initiation QTL GWAS2760473 (human) | | 5e-11 | behavior trait (VT:0010442) | | 4 | 122105714 | 122105715 | Human |
| 628852235 | GWAS2760464_H | smoking initiation QTL GWAS2760464 (human) | | 4e-09 | behavior trait (VT:0010442) | | 4 | 114063555 | 114063556 | Human |
| 597426412 | GWAS1522486_H | glycerophospholipid measurement QTL GWAS1522486 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114598400 | 114598401 | Human |
| 616957878 | GWAS1975377_H | serum IgG glycosylation measurement QTL GWAS1975377 (human) | | 0.000002 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
| 628852234 | GWAS2760463_H | smoking initiation QTL GWAS2760463 (human) | | 6e-24 | behavior trait (VT:0010442) | | 4 | 111500989 | 111500990 | Human |
| 597426413 | GWAS1522487_H | glycerophospholipid measurement QTL GWAS1522487 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114549757 | 114549758 | Human |
| 597426414 | GWAS1522488_H | glycerophospholipid measurement QTL GWAS1522488 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495590 | 114495591 | Human |
| 597426415 | GWAS1522489_H | glycerophospholipid measurement QTL GWAS1522489 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114495600 | 114495601 | Human |
| 628852239 | GWAS2760468_H | smoking initiation QTL GWAS2760468 (human) | | 3e-14 | behavior trait (VT:0010442) | | 4 | 115629116 | 115629117 | Human |
| 628475392 | GWAS2383621_H | cytokine measurement QTL GWAS2383621 (human) | | 0.000003 | cytokine amount (VT:0008713) | blood cytokine measurement (CMO:0001924) | 4 | 113030253 | 113030254 | Human |
| 597426409 | GWAS1522483_H | glycerophospholipid measurement QTL GWAS1522483 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114564528 | 114564529 | Human |
| 628852238 | GWAS2760467_H | smoking initiation QTL GWAS2760467 (human) | | 2e-16 | behavior trait (VT:0010442) | | 4 | 115062097 | 115062098 | Human |
| 628606465 | GWAS2514694_H | urolithiasis QTL GWAS2514694 (human) | | 1e-09 | urolithiasis | | 4 | 114460763 | 114460764 | Human |
| 628852237 | GWAS2760466_H | smoking initiation QTL GWAS2760466 (human) | | 2e-16 | behavior trait (VT:0010442) | | 4 | 115060393 | 115060394 | Human |
| 628852236 | GWAS2760465_H | smoking initiation QTL GWAS2760465 (human) | | 2e-16 | behavior trait (VT:0010442) | | 4 | 115058312 | 115058313 | Human |
| 617023420 | GWAS2040919_H | blood immunoglobulin amount QTL GWAS2040919 (human) | | 0.0000008 | blood immunoglobulin amount | | 4 | 110793733 | 110793734 | Human |
| 597295335 | GWAS1391409_H | ceramide measurement QTL GWAS1391409 (human) | | 2e-25 | ceramide measurement | | 4 | 114549176 | 114549177 | Human |
| 407092029 | GWAS741005_H | BMI-adjusted waist-hip ratio QTL GWAS741005 (human) | | 7e-08 | BMI-adjusted waist-hip ratio | | 4 | 119441806 | 119441807 | Human |
| 407010242 | GWAS659218_H | chronotype measurement QTL GWAS659218 (human) | | 1e-08 | chronotype measurement | | 4 | 131590963 | 131590964 | Human |
| 407026624 | GWAS675600_H | ulcerative colitis QTL GWAS675600 (human) | | 5e-10 | ulcerative colitis | | 4 | 122240464 | 122240465 | Human |
| 597147667 | GWAS1243741_H | right ventricular systolic volume measurement QTL GWAS1243741 (human) | | 1e-08 | right ventricular systolic volume measurement | | 4 | 119517499 | 119517500 | Human |
| 407370691 | GWAS1019667_H | motor function measurement, response to zonisamide, response to levodopa QTL GWAS1019667 (human) | | 0.000006 | motor function measurement, response to zonisamide, response to levodopa | | 4 | 130211377 | 130211378 | Human |
| 407157697 | GWAS806673_H | body height QTL GWAS806673 (human) | | 2e-15 | body height | | 4 | 108494980 | 108494981 | Human |
| 597377053 | GWAS1473127_H | creatinine measurement QTL GWAS1473127 (human) | | 0.000008 | creatinine measurement | | 4 | 106565904 | 106565905 | Human |
| 616974144 | GWAS1991643_H | hemoglobin measurement QTL GWAS1991643 (human) | | 1e-12 | hemoglobin measurement | | 4 | 114598669 | 114598670 | Human |
| 616974145 | GWAS1991644_H | hemoglobin measurement QTL GWAS1991644 (human) | | 3e-10 | hemoglobin measurement | | 4 | 123844107 | 123844108 | Human |
| 617105218 | GWAS2122717_H | colorectal cancer, tea consumption measurement QTL GWAS2122717 (human) | | 0.000006 | colorectal cancer, tea consumption measurement | | 4 | 131412330 | 131412331 | Human |
| 597999656 | GWAS1718955_H | childhood trauma measurement, alcohol consumption quality QTL GWAS1718955 (human) | | 1e-08 | childhood trauma measurement, alcohol consumption quality | | 4 | 126655945 | 126655946 | Human |
| 597377046 | GWAS1473120_H | atrial fibrillation QTL GWAS1473120 (human) | | 3e-28 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 406928348 | GWAS577324_H | body height QTL GWAS577324 (human) | | 5e-13 | body height | | 4 | 122917603 | 122917604 | Human |
| 406928351 | GWAS577327_H | body height QTL GWAS577327 (human) | | 1e-08 | body height | | 4 | 123987076 | 123987077 | Human |
| 617105239 | GWAS2122738_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS2122738 (human) | | 4e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 125560481 | 125560482 | Human |
| 597393471 | GWAS1489545_H | high density lipoprotein cholesterol measurement QTL GWAS1489545 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | | 4 | 119112961 | 119112962 | Human |
| 407288803 | GWAS937779_H | serum albumin measurement QTL GWAS937779 (human) | | 3e-09 | serum albumin measurement | | 4 | 123779234 | 123779235 | Human |
| 628410067 | GWAS2318296_H | cardioembolic stroke QTL GWAS2318296 (human) | | 4e-20 | joint integrity trait (VT:0010548) | | 4 | 110793263 | 110793264 | Human |
| 406928358 | GWAS577334_H | body height QTL GWAS577334 (human) | | 7e-09 | body height | | 4 | 132314995 | 132314996 | Human |
| 628524766 | GWAS2432995_H | atrial fibrillation QTL GWAS2432995 (human) | | 7e-12 | atrial fibrillation | | 4 | 110978126 | 110978127 | Human |
| 628524767 | GWAS2432996_H | atrial fibrillation QTL GWAS2432996 (human) | | 5e-09 | atrial fibrillation | | 4 | 110992909 | 110992910 | Human |
| 628524764 | GWAS2432993_H | atrial fibrillation QTL GWAS2432993 (human) | | 5e-18 | atrial fibrillation | | 4 | 110908811 | 110908812 | Human |
| 628524765 | GWAS2432994_H | atrial fibrillation QTL GWAS2432994 (human) | | 8e-21 | atrial fibrillation | | 4 | 110941992 | 110941993 | Human |
| 628524763 | GWAS2432992_H | atrial fibrillation QTL GWAS2432992 (human) | | 3e-35 | atrial fibrillation | | 4 | 110882594 | 110882595 | Human |
| 628623050 | GWAS2531279_H | glomerular filtration rate QTL GWAS2531279 (human) | | 4e-13 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 628573891 | GWAS2482120_H | leukocyte quantity QTL GWAS2482120 (human) | | 6e-14 | leukocyte quantity | | 4 | 110020646 | 110020647 | Human |
| 597032994 | GWAS1129068_H | smoking behaviour measurement QTL GWAS1129068 (human) | | 2e-11 | smoking behaviour measurement | | 4 | 111500989 | 111500990 | Human |
| 596983849 | GWAS1103368_H | memory performance QTL GWAS1103368 (human) | | 0.000004 | memory performance | | 4 | 124870671 | 124870672 | Human |
| 407223174 | GWAS872150_H | medication adherence behavior QTL GWAS872150 (human) | | 0.000001 | medication adherence behavior | | 4 | 111199502 | 111199503 | Human |
| 628934329 | GWAS2842558_H | saturated fatty acids to total fatty acids percentage QTL GWAS2842558 (human) | | 6e-09 | fatty acid amount (VT:0010046) | | 4 | 110191632 | 110191633 | Human |
| 407337856 | GWAS986832_H | triglyceride measurement QTL GWAS986832 (human) | | 2e-09 | triglyceride measurement | | 4 | 123720672 | 123720673 | Human |
| 628606655 | GWAS2514884_H | heart failure QTL GWAS2514884 (human) | | 9e-17 | heart integrity trait (VT:0010757) | | 4 | 110776497 | 110776498 | Human |
| 598065263 | GWAS1784562_H | cerebral cortex area attribute QTL GWAS1784562 (human) | | 4e-08 | cerebral cortex area attribute | | 4 | 127191068 | 127191069 | Human |
| 628934327 | GWAS2842556_H | saturated fatty acids to total fatty acids percentage QTL GWAS2842556 (human) | | 2e-09 | fatty acid amount (VT:0010046) | | 4 | 110191632 | 110191633 | Human |
| 407141258 | GWAS790234_H | type 2 diabetes mellitus QTL GWAS790234 (human) | | 0.0000001 | type 2 diabetes mellitus | | 4 | 121739095 | 121739096 | Human |
| 597344330 | GWAS1440404_H | color vision disorder QTL GWAS1440404 (human) | | 0.000003 | color vision disorder | | 4 | 124815973 | 124815974 | Human |
| 597360713 | GWAS1456787_H | rheumatoid arthritis, celiac disease QTL GWAS1456787 (human) | | 6e-09 | intestine integrity trait (VT:0010554) | | 4 | 122117140 | 122117141 | Human |
| 406928277 | GWAS577253_H | body height QTL GWAS577253 (human) | | 0.000002 | body height | | 4 | 109079519 | 109079520 | Human |
| 406928278 | GWAS577254_H | body height QTL GWAS577254 (human) | | 5e-20 | body height | | 4 | 113901423 | 113901424 | Human |
| 626443918 | GWAS2257851_H | frailty measurement QTL GWAS2257851 (human) | | 5e-09 | frailty measurement | | 4 | 119228681 | 119228682 | Human |
| 406928280 | GWAS577256_H | body height QTL GWAS577256 (human) | | 0.0000003 | body height | | 4 | 119645235 | 119645236 | Human |
| 626443917 | GWAS2257850_H | frailty measurement QTL GWAS2257850 (human) | | 1e-16 | frailty measurement | | 4 | 110466703 | 110466704 | Human |
| 406928282 | GWAS577258_H | body height QTL GWAS577258 (human) | | 2e-12 | body height | | 4 | 119840636 | 119840637 | Human |
| 617105171 | GWAS2122670_H | fibroblast growth factor 2 amount QTL GWAS2122670 (human) | | 2e-08 | fibroblast growth factor 2 amount | | 4 | 120247814 | 120247815 | Human |
| 617105172 | GWAS2122671_H | fibroblast growth factor 2 amount QTL GWAS2122671 (human) | | 6e-14 | fibroblast growth factor 2 amount | | 4 | 121977042 | 121977043 | Human |
| 617121578 | GWAS2139077_H | blood coagulation disease QTL GWAS2139077 (human) | | 5e-19 | blood coagulation disease | | 4 | 110784139 | 110784140 | Human |
| 597999686 | GWAS1718985_H | cerebral cortex area attribute QTL GWAS1718985 (human) | | 2e-17 | cerebral cortex area attribute | | 4 | 123326251 | 123326252 | Human |
| 596967542 | GWAS1087061_H | cortical thickness QTL GWAS1087061 (human) | | 3e-08 | cortical thickness | | 4 | 120748941 | 120748942 | Human |
| 597999687 | GWAS1718986_H | cerebral cortex area attribute QTL GWAS1718986 (human) | | 1e-10 | cerebral cortex area attribute | | 4 | 126658527 | 126658528 | Human |
| 628721308 | GWAS2629537_H | vaginal microbiome measurement QTL GWAS2629537 (human) | | 0.00001 | vaginal microbiome measurement | | 4 | 126069793 | 126069794 | Human |
| 406944680 | GWAS593656_H | protein measurement QTL GWAS593656 (human) | | 7e-1675 | protein measurement | | 4 | 119342003 | 119342004 | Human |
| 597262455 | GWAS1358529_H | sucrose measurement QTL GWAS1358529 (human) | | 0.000002 | sucrose measurement | | 4 | 111477457 | 111477458 | Human |
| 617072424 | GWAS2089923_H | triglyceride measurement QTL GWAS2089923 (human) | | 2e-09 | triglyceride measurement | | 4 | 123720672 | 123720673 | Human |
| 406944689 | GWAS593665_H | protein measurement QTL GWAS593665 (human) | | 1e-146 | protein measurement | | 4 | 119446728 | 119446729 | Human |
| 407124917 | GWAS773893_H | apolipoprotein A 1 measurement QTL GWAS773893 (human) | | 2e-08 | apolipoprotein A 1 measurement | | 4 | 108637907 | 108637908 | Human |
| 628622988 | GWAS2531217_H | autoimmune disease QTL GWAS2531217 (human) | | 1e-09 | autoimmune disease | | 4 | 122633552 | 122633553 | Human |
| 628852366 | GWAS2760595_H | COVID-19 QTL GWAS2760595 (human) | | 4e-08 | COVID-19 | | 4 | 108838313 | 108838314 | Human |
| 628737676 | GWAS2645905_H | complement factor H-related protein 3 measurement QTL GWAS2645905 (human) | | 0.000009 | complement factor H-related protein 3 measurement | | 4 | 128538939 | 128538940 | Human |
| 598032472 | GWAS1751771_H | bipolar disorder, glomerular filtration rate QTL GWAS1751771 (human) | | 3e-08 | bipolar disorder, glomerular filtration rate | | 4 | 122596491 | 122596492 | Human |
| 628998527 | GWAS2906756_H | body height QTL GWAS2906756 (human) | | 4e-78 | body height | | 4 | 123987076 | 123987077 | Human |
| 628588916 | GWAS2497145_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS2497145 (human) | | 7e-14 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 109657070 | 109657071 | Human |
| 628998526 | GWAS2906755_H | body height QTL GWAS2906755 (human) | | 8e-35 | body height | | 4 | 123891742 | 123891743 | Human |
| 628441456 | GWAS2349685_H | metabolic syndrome QTL GWAS2349685 (human) | | 1e-11 | metabolic syndrome | | 4 | 129810129 | 129810130 | Human |
| 628687230 | GWAS2595459_H | level of glutamyl aminopeptidase in blood serum QTL GWAS2595459 (human) | | 3e-16 | level of glutamyl aminopeptidase in blood serum | | 4 | 110520270 | 110520271 | Human |
| 407206989 | GWAS855965_H | gut microbiome measurement QTL GWAS855965 (human) | | 0.0000003 | gut microbiome measurement | | 4 | 112357355 | 112357356 | Human |
| 407075915 | GWAS724891_H | mannitol measurement, sorbitol measurement QTL GWAS724891 (human) | | 0.000003 | mannitol measurement, sorbitol measurement | | 4 | 112447703 | 112447704 | Human |
| 598083503 | GWAS1802802_H | body height QTL GWAS1802802 (human) | | 3e-28 | body height | | 4 | 108503691 | 108503692 | Human |
| 598017961 | GWAS1737260_H | erythrocyte volume QTL GWAS1737260 (human) | | 2e-58 | erythrocyte volume | | 4 | 121877258 | 121877259 | Human |
| 407239752 | GWAS888728_H | apolipoprotein A 1 measurement QTL GWAS888728 (human) | | 3e-15 | apolipoprotein A 1 measurement | | 4 | 109648464 | 109648465 | Human |
| 598017960 | GWAS1737259_H | erythrocyte volume QTL GWAS1737259 (human) | | 9e-33 | erythrocyte volume | | 4 | 109947179 | 109947180 | Human |
| 598017962 | GWAS1737261_H | erythrocyte volume QTL GWAS1737261 (human) | | 1e-10 | erythrocyte volume | | 4 | 128082220 | 128082221 | Human |
| 617267416 | GWAS2204192_H | fatty acid amount QTL GWAS2204192 (human) | | 4e-08 | fatty acid amount | | 4 | 109174464 | 109174465 | Human |
| 617267417 | GWAS2204193_H | fatty acid amount QTL GWAS2204193 (human) | | 9e-11 | fatty acid amount | | 4 | 109657070 | 109657071 | Human |
| 598034352 | GWAS1753651_H | body height QTL GWAS1753651 (human) | | 4e-08 | body height | | 4 | 128700992 | 128700993 | Human |
| 598083504 | GWAS1802803_H | body height QTL GWAS1802803 (human) | | 1e-13 | body height | | 4 | 119665953 | 119665954 | Human |
| 597264270 | GWAS1360344_H | cortical thickness QTL GWAS1360344 (human) | | 2e-14 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 598083505 | GWAS1802804_H | body height QTL GWAS1802804 (human) | | 8e-14 | body height | | 4 | 121876108 | 121876109 | Human |
| 597411715 | GWAS1507789_H | smoking status measurement QTL GWAS1507789 (human) | | 5e-08 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
| 628441453 | GWAS2349682_H | metabolic syndrome QTL GWAS2349682 (human) | | 1e-08 | metabolic syndrome | | 4 | 111770620 | 111770621 | Human |
| 628441455 | GWAS2349684_H | metabolic syndrome QTL GWAS2349684 (human) | | 4e-08 | metabolic syndrome | | 4 | 119318723 | 119318724 | Human |
| 628441454 | GWAS2349683_H | metabolic syndrome QTL GWAS2349683 (human) | | 2e-09 | metabolic syndrome | | 4 | 118238526 | 118238527 | Human |
| 616972518 | GWAS1990017_H | mean corpuscular hemoglobin concentration QTL GWAS1990017 (human) | | 2e-10 | mean corpuscular hemoglobin concentration | | 4 | 123835365 | 123835366 | Human |
| 616972519 | GWAS1990018_H | mean corpuscular hemoglobin concentration QTL GWAS1990018 (human) | | 4e-31 | mean corpuscular hemoglobin concentration | | 4 | 127878475 | 127878476 | Human |
| 597149620 | GWAS1245694_H | lipoprotein A measurement, diet measurement QTL GWAS1245694 (human) | | 0.000002 | lipoprotein A measurement, diet measurement | | 4 | 129572458 | 129572459 | Human |
| 597034928 | GWAS1131002_H | body height QTL GWAS1131002 (human) | | 2e-15 | body height | | 4 | 108494980 | 108494981 | Human |
| 628670815 | GWAS2579044_H | sclerosing cholangitis QTL GWAS2579044 (human) | | 2e-10 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
| 597346226 | GWAS1442300_H | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement QTL GWAS1442300 (human) | | 0.0000003 | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | | 4 | 127602809 | 127602810 | Human |
| 597051324 | GWAS1147398_H | response to anticonvulsant QTL GWAS1147398 (human) | | 0.0000001 | response to anticonvulsant | | 4 | 113140380 | 113140381 | Human |
| 597510065 | GWAS1606139_H | electrocardiography QTL GWAS1606139 (human) | | 7e-12 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 597510064 | GWAS1606138_H | electrocardiography QTL GWAS1606138 (human) | | 3e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 617103590 | GWAS2121089_H | gut microbiome measurement, breastfeeding duration QTL GWAS2121089 (human) | | 4e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 120360504 | 120360505 | Human |
| 597510066 | GWAS1606140_H | electrocardiography QTL GWAS1606140 (human) | | 1e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 628818260 | GWAS2726489_H | glomerular filtration rate QTL GWAS2726489 (human) | | 1e-16 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 597018533 | GWAS1114607_H | household income QTL GWAS1114607 (human) | | 4e-08 | household income | | 4 | 131729441 | 131729442 | Human |
| 597051303 | GWAS1147377_H | facial morphology measurement QTL GWAS1147377 (human) | | 3e-10 | facial morphology measurement | | 4 | 127027041 | 127027042 | Human |
| 597034912 | GWAS1130986_H | high density lipoprotein cholesterol measurement QTL GWAS1130986 (human) | | 3e-13 | high density lipoprotein cholesterol measurement | | 4 | 109648464 | 109648465 | Human |
| 597051307 | GWAS1147381_H | facial morphology measurement QTL GWAS1147381 (human) | | 2e-09 | facial morphology measurement | | 4 | 127005360 | 127005361 | Human |
| 617103606 | GWAS2121105_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS2121105 (human) | | 6e-09 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 110961148 | 110961149 | Human |
| 406994045 | GWAS643021_H | mean corpuscular hemoglobin concentration QTL GWAS643021 (human) | | 5e-15 | mean corpuscular hemoglobin concentration | | 4 | 109944312 | 109944313 | Human |
| 597100503 | GWAS1196577_H | sex hormone-binding globulin measurement QTL GWAS1196577 (human) | | 2e-18 | sex hormone-binding globulin measurement | | 4 | 119185611 | 119185612 | Human |
| 597493727 | GWAS1589801_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1589801 (human) | | 2e-19 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119349548 | 119349549 | Human |
| 407272451 | GWAS921427_H | hemoglobin measurement QTL GWAS921427 (human) | | 5e-17 | hemoglobin measurement | | 4 | 114577301 | 114577302 | Human |
| 628654399 | GWAS2562628_H | testosterone measurement QTL GWAS2562628 (human) | | 2e-11 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
| 596985821 | GWAS1105340_H | lymphocyte count QTL GWAS1105340 (human) | | 1e-14 | lymphocyte count | | 4 | 109919540 | 109919541 | Human |
| 596985820 | GWAS1105339_H | lymphocyte count QTL GWAS1105339 (human) | | 7e-23 | lymphocyte count | | 4 | 110020646 | 110020647 | Human |
| 617021582 | GWAS2039081_H | protein measurement QTL GWAS2039081 (human) | | 2e-08 | protein amount (VT:0010120) | | 4 | 116050074 | 116050075 | Human |
| 597247957 | GWAS1344031_H | response to antiviral drug, cirrhosis of liver QTL GWAS1344031 (human) | | 0.000005 | response to antiviral drug, cirrhosis of liver | | 4 | 114986399 | 114986400 | Human |
| 407174153 | GWAS823129_H | sex hormone-binding globulin measurement QTL GWAS823129 (human) | | 3e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 407010323 | GWAS659299_H | Abnormality of refraction QTL GWAS659299 (human) | | 5e-18 | Abnormality of refraction | | 4 | 119980371 | 119980372 | Human |
| 597084098 | GWAS1180172_H | white matter hyperintensity measurement QTL GWAS1180172 (human) | | 0.000002 | brain morphology trait (VT:0002152) | | 4 | 113089932 | 113089933 | Human |
| 596969408 | GWAS1088927_H | major depressive disorder QTL GWAS1088927 (human) | | 3e-16 | major depressive disorder | | 4 | 122467738 | 122467739 | Human |
| 407026712 | GWAS675688_H | serum IgG glycosylation measurement QTL GWAS675688 (human) | | 0.0000004 | serum IgG glycosylation measurement | | 4 | 109976429 | 109976430 | Human |
| 407092249 | GWAS741225_H | stroke QTL GWAS741225 (human) | | 2e-15 | stroke | | 4 | 110793263 | 110793264 | Human |
| 597362624 | GWAS1458698_H | basophil count, eosinophil count QTL GWAS1458698 (human) | | 4e-09 | basophil count, eosinophil count | | 4 | 122678166 | 122678167 | Human |
| 597313479 | GWAS1409553_H | cortical thickness QTL GWAS1409553 (human) | | 6e-18 | cortical thickness | | 4 | 118393759 | 118393760 | Human |
| 628687143 | GWAS2595372_H | body height QTL GWAS2595372 (human) | | 1e-13 | body height | | 4 | 108560745 | 108560746 | Human |
| 616497376 | GWAS1893959_H | metabolite measurement QTL GWAS1893959 (human) | | 0.000008 | metabolite measurement | | 4 | 125761303 | 125761304 | Human |
| 597313534 | GWAS1409608_H | cortical thickness QTL GWAS1409608 (human) | | 5e-10 | cortical thickness | | 4 | 127022223 | 127022224 | Human |
| 628490526 | GWAS2398755_H | BMI-adjusted waist-hip ratio QTL GWAS2398755 (human) | | 1e-14 | body size trait (VT:0100005) | | 4 | 121702910 | 121702911 | Human |
| 628834577 | GWAS2742806_H | lysophosphatidylcholine 20:2 measurement QTL GWAS2742806 (human) | | 2e-08 | lysophosphatidylcholine 20:2 measurement | | 4 | 126651788 | 126651789 | Human |
| 628424985 | GWAS2333214_H | appendicular lean mass QTL GWAS2333214 (human) | | 9e-13 | body lean mass (VT:0010483) | | 4 | 119206606 | 119206607 | Human |
| 628834583 | GWAS2742812_H | lysophosphatidylcholine 20:2 measurement QTL GWAS2742812 (human) | | 4e-09 | lysophosphatidylcholine 20:2 measurement | | 4 | 126754772 | 126754773 | Human |
| 406912045 | GWAS561021_H | reaction time measurement QTL GWAS561021 (human) | | 0.000001 | reaction time measurement | | 4 | 110649067 | 110649068 | Human |
| 597510130 | GWAS1606204_H | QRS duration QTL GWAS1606204 (human) | | 2e-09 | QRS duration | | 4 | 123829743 | 123829744 | Human |
| 628752648 | GWAS2660877_H | neutrophil measurement, lymphocyte amount QTL GWAS2660877 (human) | | 6e-12 | neutrophil physiology trait (VT:0002463) | | 4 | 109980042 | 109980043 | Human |
| 628867342 | GWAS2775571_H | response to cranial radiation therapy, short-term memory QTL GWAS2775571 (human) | | 0.0000007 | learning/memory/conditioning trait (VT:0002063) | | 4 | 120035508 | 120035509 | Human |
| 616988851 | GWAS2006350_H | FEV/FVC ratio QTL GWAS2006350 (human) | | 1e-20 | FEV/FVC ratio | | 4 | 123898452 | 123898453 | Human |
| 407125052 | GWAS774028_H | age-related macular degeneration QTL GWAS774028 (human) | | 0.000001 | age-related macular degeneration | | 4 | 116012923 | 116012924 | Human |
| 597198816 | GWAS1294890_H | memory performance QTL GWAS1294890 (human) | | 0.000002 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124856977 | 124856978 | Human |
| 597198818 | GWAS1294892_H | memory performance QTL GWAS1294892 (human) | | 0.000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124858709 | 124858710 | Human |
| 407125048 | GWAS774024_H | age-related macular degeneration QTL GWAS774024 (human) | | 0.000002 | age-related macular degeneration | | 4 | 116003028 | 116003029 | Human |
| 597198820 | GWAS1294894_H | memory performance QTL GWAS1294894 (human) | | 0.000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124861382 | 124861383 | Human |
| 617267380 | GWAS2204156_H | fatty acid amount QTL GWAS2204156 (human) | | 5e-10 | fatty acid amount | | 4 | 109603883 | 109603884 | Human |
| 406944831 | GWAS593807_H | gut microbiome measurement QTL GWAS593807 (human) | | 0.000004 | gut microbiome measurement | | 4 | 118997805 | 118997806 | Human |
| 628703495 | GWAS2611724_H | glomerular filtration rate QTL GWAS2611724 (human) | | 1e-12 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 616988857 | GWAS2006356_H | brain connectivity attribute QTL GWAS2006356 (human) | | 2e-11 | brain connectivity attribute | | 4 | 125825074 | 125825075 | Human |
| 407305412 | GWAS954388_H | type 2 diabetes mellitus QTL GWAS954388 (human) | | 9e-09 | type 2 diabetes mellitus | | 4 | 128103118 | 128103119 | Human |
| 407387342 | GWAS1036318_H | interleukin 16 measurement QTL GWAS1036318 (human) | | 0.0000007 | interleukin 16 measurement | | 4 | 112649483 | 112649484 | Human |
| 407370959 | GWAS1019935_H | birth weight, parental genotype effect measurement QTL GWAS1019935 (human) | | 9e-09 | birth weight, parental genotype effect measurement | | 4 | 119695650 | 119695651 | Human |
| 616497205 | GWAS1893788_H | blood protein amount QTL GWAS1893788 (human) | | 4e-34 | blood protein amount | | 4 | 109737911 | 109737912 | Human |
| 407387330 | GWAS1036306_H | mean platelet volume QTL GWAS1036306 (human) | | 8e-10 | mean platelet volume | | 4 | 122263672 | 122263673 | Human |
| 407157972 | GWAS806948_H | sex hormone-binding globulin measurement QTL GWAS806948 (human) | | 6e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 617021525 | GWAS2039024_H | sex hormone-binding globulin measurement QTL GWAS2039024 (human) | | 0.000002 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 616988754 | GWAS2006253_H | Red cell distribution width QTL GWAS2006253 (human) | | 1e-20 | erythrocyte size trait (VT:0000248) | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
| 597100289 | GWAS1196363_H | protein measurement QTL GWAS1196363 (human) | | 2e-08 | protein amount (VT:0010120) | | 4 | 112377272 | 112377273 | Human |
| 617021531 | GWAS2039030_H | sex hormone-binding globulin measurement QTL GWAS2039030 (human) | | 3e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 617037926 | GWAS2055425_H | smoking cessation QTL GWAS2055425 (human) | | 9e-13 | smoking cessation | | 4 | 112122274 | 112122275 | Human |
| 617037925 | GWAS2055424_H | smoking cessation QTL GWAS2055424 (human) | | 1e-10 | smoking cessation | | 4 | 112087702 | 112087703 | Human |
| 407256293 | GWAS905269_H | brain measurement QTL GWAS905269 (human) | | 6e-11 | brain measurement | | 4 | 107131838 | 107131839 | Human |
| 407076069 | GWAS725045_H | systolic blood pressure QTL GWAS725045 (human) | | 6e-18 | systolic blood pressure | | 4 | 110416322 | 110416323 | Human |
| 597411644 | GWAS1507718_H | endometriosis QTL GWAS1507718 (human) | | 0.000006 | endometriosis | | 4 | 126617656 | 126617657 | Human |
| 628949461 | GWAS2857690_H | degree of unsaturation measurement QTL GWAS2857690 (human) | | 7e-09 | degree of unsaturation measurement | | 4 | 109345757 | 109345758 | Human |
| 628605407 | GWAS2513636_H | asthma QTL GWAS2513636 (human) | | 2e-14 | asthma | | 4 | 122415763 | 122415764 | Human |
| 597133118 | GWAS1229192_H | 2-O-methylascorbic acid measurement, sex interaction measurement QTL GWAS1229192 (human) | | 0.0000008 | 2-O-methylascorbic acid measurement, sex interaction measurement | | 4 | 113095111 | 113095112 | Human |
| 597411634 | GWAS1507708_H | Alzheimer disease QTL GWAS1507708 (human) | | 0.000003 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 597034812 | GWAS1130886_H | triglyceride measurement QTL GWAS1130886 (human) | | 6e-12 | triglyceride:HDL cholesterol ratio | | 4 | 109648464 | 109648465 | Human |
| 628949462 | GWAS2857691_H | degree of unsaturation measurement QTL GWAS2857691 (human) | | 4e-11 | degree of unsaturation measurement | | 4 | 109603883 | 109603884 | Human |
| 597296936 | GWAS1393010_H | acylcarnitine measurement QTL GWAS1393010 (human) | | 6e-08 | acylcarnitine measurement | | 4 | 130265205 | 130265206 | Human |
| 597198637 | GWAS1294711_H | memory performance QTL GWAS1294711 (human) | | 0.000006 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124891420 | 124891421 | Human |
| 407076085 | GWAS725061_H | response to selective serotonin reuptake inhibitor QTL GWAS725061 (human) | | 0.000005 | response to selective serotonin reuptake inhibitor | | 4 | 117586197 | 117586198 | Human |
| 597591849 | GWAS1648709_H | Eosinophilia QTL GWAS1648709 (human) | | 2e-12 | Eosinophilia | | 4 | 108762086 | 108762087 | Human |
| 628752834 | GWAS2661063_H | neutrophil measurement, lymphocyte amount QTL GWAS2661063 (human) | | 3e-14 | neutrophil physiology trait (VT:0002463) | | 4 | 122707302 | 122707305 | Human |
| 407043320 | GWAS692296_H | unipolar depression, irritable bowel syndrome QTL GWAS692296 (human) | | 3e-09 | unipolar depression, irritable bowel syndrome | | 4 | 122201701 | 122201702 | Human |
| 628752833 | GWAS2661062_H | neutrophil measurement, lymphocyte amount QTL GWAS2661062 (human) | | 2e-14 | neutrophil physiology trait (VT:0002463) | | 4 | 112190016 | 112190017 | Human |
| 597378906 | GWAS1474980_H | age-related macular degeneration QTL GWAS1474980 (human) | | 0.000001 | age-related macular degeneration | | 4 | 116012923 | 116012924 | Human |
| 597280605 | GWAS1376679_H | hemoglobin A1 measurement QTL GWAS1376679 (human) | | 2e-17 | hemoglobin A1 measurement | | 4 | 109908302 | 109908303 | Human |
| 406977671 | GWAS626647_H | gut microbiome measurement QTL GWAS626647 (human) | | 0.0000009 | gut microbiome measurement | | 4 | 112858735 | 112858736 | Human |
| 407026821 | GWAS675797_H | response to sertraline, psychotic symptom measurement, response to olanzapine QTL GWAS675797 (human) | | 0.000004 | response to sertraline, psychotic symptom measurement, response to olanzapine | | 4 | 119092116 | 119092117 | Human |
| 406912140 | GWAS561116_H | diastolic blood pressure QTL GWAS561116 (human) | | 7e-13 | diastolic blood pressure | | 4 | 110414566 | 110414567 | Human |
| 407239829 | GWAS888805_H | testosterone measurement QTL GWAS888805 (human) | | 2e-13 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 407403674 | GWAS1052650_H | BMI-adjusted waist-hip ratio QTL GWAS1052650 (human) | | 2e-09 | BMI-adjusted waist-hip ratio | | 4 | 119763897 | 119763898 | Human |
| 407141522 | GWAS790498_H | smoking behavior, BMI-adjusted waist-hip ratio QTL GWAS790498 (human) | | 0.000008 | smoking behavior, BMI-adjusted waist-hip ratio | | 4 | 123145793 | 123145794 | Human |
| 628949418 | GWAS2857647_H | body height QTL GWAS2857647 (human) | | 5e-11 | body height | | 4 | 110360797 | 110360798 | Human |
| 597083982 | GWAS1180056_H | lymphocyte percentage of leukocytes QTL GWAS1180056 (human) | | 3e-21 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 4 | 112190016 | 112190017 | Human |
| 597280576 | GWAS1376650_H | rheumatoid arthritis QTL GWAS1376650 (human) | | 4e-14 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
| 597411652 | GWAS1507726_H | endometriosis QTL GWAS1507726 (human) | | 0.000007 | endometriosis | | 4 | 126617656 | 126617657 | Human |
| 617054243 | GWAS2071742_H | forced expiratory volume, 25-hydroxyvitamin D3 measurement QTL GWAS2071742 (human) | | 1e-08 | forced expiratory volume, 25-hydroxyvitamin D3 measurement | | 4 | 123996704 | 123996705 | Human |
| 597378943 | GWAS1475017_H | cardiovascular disease biomarker measurement, ankle brachial index QTL GWAS1475017 (human) | | 0.000007 | cardiovascular disease biomarker measurement, ankle brachial index | | 4 | 126012137 | 126012138 | Human |
| 598017859 | GWAS1737158_H | erythrocyte volume QTL GWAS1737158 (human) | | 4e-11 | erythrocyte volume | | 4 | 109717668 | 109717669 | Human |
| 406912168 | GWAS561144_H | restless legs syndrome QTL GWAS561144 (human) | | 2e-09 | restless legs syndrome | | 4 | 115033802 | 115033803 | Human |
| 628867472 | GWAS2775701_H | intelligence, response to cranial radiation therapy QTL GWAS2775701 (human) | | 0.000001 | intelligence, response to cranial radiation therapy | | 4 | 120035508 | 120035509 | Human |
| 406912172 | GWAS561148_H | restless legs syndrome QTL GWAS561148 (human) | | 3e-09 | restless legs syndrome | | 4 | 130726717 | 130726718 | Human |
| 597084027 | GWAS1180101_H | coronary artery disease QTL GWAS1180101 (human) | | 1e-14 | coronary artery integrity trait (VT:0010746) | | 4 | 119979127 | 119979128 | Human |
| 406912174 | GWAS561150_H | restless legs syndrome QTL GWAS561150 (human) | | 7e-10 | restless legs syndrome | | 4 | 118382649 | 118382650 | Human |
| 616562736 | GWAS1959319_H | alpha-L-iduronidase measurement QTL GWAS1959319 (human) | | 7e-12 | alpha-L-iduronidase measurement | | 4 | 118864074 | 118864075 | Human |
| 628998537 | GWAS2906766_H | body height QTL GWAS2906766 (human) | | 7e-11 | body height | | 4 | 129860515 | 129860516 | Human |
| 628851087 | GWAS2759316_H | smoking initiation QTL GWAS2759316 (human) | | 8e-12 | behavior trait (VT:0010442) | | 4 | 131635724 | 131635725 | Human |
| 628720013 | GWAS2628242_H | vaginal microbiome measurement QTL GWAS2628242 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132191469 | 132191470 | Human |
| 597395310 | GWAS1491384_H | drug allergy, trait in response to platinum QTL GWAS1491384 (human) | | 0.000004 | drug allergy, trait in response to platinum | | 4 | 113445575 | 113445576 | Human |
| 628998536 | GWAS2906765_H | body height QTL GWAS2906765 (human) | | 2e-24 | body height | | 4 | 128708095 | 128708096 | Human |
| 628851086 | GWAS2759315_H | smoking initiation QTL GWAS2759315 (human) | | 1e-11 | behavior trait (VT:0010442) | | 4 | 130542181 | 130542182 | Human |
| 628851085 | GWAS2759314_H | smoking initiation QTL GWAS2759314 (human) | | 2e-11 | behavior trait (VT:0010442) | | 4 | 130541408 | 130541409 | Human |
| 628851084 | GWAS2759313_H | smoking initiation QTL GWAS2759313 (human) | | 8e-11 | behavior trait (VT:0010442) | | 4 | 129681552 | 129681553 | Human |
| 628998538 | GWAS2906767_H | body height QTL GWAS2906767 (human) | | 2e-20 | body height | | 4 | 131543872 | 131543873 | Human |
| 628572559 | GWAS2480788_H | platelet count QTL GWAS2480788 (human) | | 4e-24 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109924690 | 109924691 | Human |
| 407059643 | GWAS708619_H | heart failure QTL GWAS708619 (human) | | 6e-20 | heart failure | | 4 | 110747470 | 110747471 | Human |
| 406895800 | GWAS544776_H | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis QTL GWAS544776 (human) | | 6e-11 | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | | 4 | 122466445 | 122466446 | Human |
| 628998533 | GWAS2906762_H | body height QTL GWAS2906762 (human) | | 9e-20 | body height | | 4 | 127073768 | 127073769 | Human |
| 628998532 | GWAS2906761_H | body height QTL GWAS2906761 (human) | | 3e-29 | body height | | 4 | 126054046 | 126054047 | Human |
| 616955964 | GWAS1973463_H | pulmonary function measurement QTL GWAS1973463 (human) | | 0.000001 | respiratory function trait (VT:0002327) | | 4 | 108296773 | 108296774 | Human |
| 628572557 | GWAS2480786_H | platelet count QTL GWAS2480786 (human) | | 9e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109813770 | 109813771 | Human |
| 628998535 | GWAS2906764_H | body height QTL GWAS2906764 (human) | | 1e-18 | body height | | 4 | 128691709 | 128691710 | Human |
| 628998534 | GWAS2906763_H | body height QTL GWAS2906763 (human) | | 0.0000004 | body height | | 4 | 128239161 | 128239162 | Human |
| 628572555 | GWAS2480784_H | platelet count QTL GWAS2480784 (human) | | 3e-40 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110027510 | 110027511 | Human |
| 628998529 | GWAS2906758_H | body height QTL GWAS2906758 (human) | | 0.0000008 | body height | | 4 | 125346842 | 125346843 | Human |
| 596952937 | GWAS1072456_H | size QTL GWAS1072456 (human) | | 2e-10 | size | | 4 | 123999891 | 123999892 | Human |
| 628998528 | GWAS2906757_H | body height QTL GWAS2906757 (human) | | 4e-17 | body height | | 4 | 124666406 | 124666407 | Human |
| 628998531 | GWAS2906760_H | body height QTL GWAS2906760 (human) | | 5e-15 | body height | | 4 | 125767588 | 125767589 | Human |
| 628490632 | GWAS2398861_H | lung carcinoma, family history of lung cancer QTL GWAS2398861 (human) | | 0.000008 | lung integrity trait (VT:0010906) | | 4 | 131748595 | 131748596 | Human |
| 628998530 | GWAS2906759_H | body height QTL GWAS2906759 (human) | | 4e-17 | body height | | 4 | 125758137 | 125758138 | Human |
| 407223620 | GWAS872596_H | atopic eczema QTL GWAS872596 (human) | | 0.0000001 | atopic eczema | | 4 | 122089432 | 122089433 | Human |
| 628768889 | GWAS2677118_H | Brugada syndrome QTL GWAS2677118 (human) | | 2e-08 | Brugada syndrome | | 4 | 113523590 | 113523591 | Human |
| 597493401 | GWAS1589475_H | pulse pressure measurement QTL GWAS1589475 (human) | | 0.0000009 | pulse pressure measurement | | 4 | 132110786 | 132110787 | Human |
| 597608091 | GWAS1664951_H | triglyceride measurement QTL GWAS1664951 (human) | | 4e-37 | triglyceride measurement | | 4 | 109657070 | 109657071 | Human |
| 407403854 | GWAS1052830_H | facial morphology measurement QTL GWAS1052830 (human) | | 8e-09 | facial morphology measurement | | 4 | 119407511 | 119407512 | Human |
| 407387457 | GWAS1036433_H | acute myeloid leukemia QTL GWAS1036433 (human) | | 4e-25 | acute myeloid leukemia | | 4 | 112776849 | 112776850 | Human |
| 628867185 | GWAS2775414_H | irritable bowel syndrome QTL GWAS2775414 (human) | | 3e-08 | intestine integrity trait (VT:0010554) | | 4 | 122201701 | 122201702 | Human |
| 596985502 | GWAS1105021_H | atrial fibrillation QTL GWAS1105021 (human) | | 3e-155 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407043406 | GWAS692382_H | open-angle glaucoma QTL GWAS692382 (human) | | 1e-09 | open-angle glaucoma | | 4 | 125451587 | 125451588 | Human |
| 597509778 | GWAS1605852_H | COVID-19 QTL GWAS1605852 (human) | | 0.00001 | COVID-19 | | 4 | 107157415 | 107157416 | Human |
| 407043405 | GWAS692381_H | open-angle glaucoma QTL GWAS692381 (human) | | 4e-12 | open-angle glaucoma | | 4 | 111886876 | 111886877 | Human |
| 596985476 | GWAS1104995_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS1104995 (human) | | 5e-08 | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | | 4 | 122629959 | 122629960 | Human |
| 597214849 | GWAS1310923_H | body height QTL GWAS1310923 (human) | | 2e-12 | body height | | 4 | 107793654 | 107793655 | Human |
| 596985484 | GWAS1105003_H | atrial fibrillation QTL GWAS1105003 (human) | | 8e-57 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597214850 | GWAS1310924_H | body height QTL GWAS1310924 (human) | | 2e-48 | body height | | 4 | 108125804 | 108125805 | Human |
| 597214851 | GWAS1310925_H | body height QTL GWAS1310925 (human) | | 2e-31 | body height | | 4 | 108330552 | 108330553 | Human |
| 597214852 | GWAS1310926_H | body height QTL GWAS1310926 (human) | | 0.00001 | body height | | 4 | 108342899 | 108342900 | Human |
| 628686948 | GWAS2595177_H | inflammatory bowel disease QTL GWAS2595177 (human) | | 4e-11 | intestine integrity trait (VT:0010554) | | 4 | 122523884 | 122523885 | Human |
| 407321945 | GWAS970921_H | triglyceride measurement QTL GWAS970921 (human) | | 7e-11 | triglyceride measurement | | 4 | 109648464 | 109648465 | Human |
| 596985483 | GWAS1105002_H | atrial fibrillation QTL GWAS1105002 (human) | | 4e-08 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 628539479 | GWAS2447708_H | body height QTL GWAS2447708 (human) | | 1e-09 | body height | | 4 | 128700992 | 128700993 | Human |
| 597591739 | GWAS1648599_H | blood coagulation disease QTL GWAS1648599 (human) | | 8e-29 | blood coagulation disease | | 4 | 110784139 | 110784140 | Human |
| 617021922 | GWAS2039421_H | body height QTL GWAS2039421 (human) | | 2e-10 | body height | | 4 | 129838492 | 129838493 | Human |
| 617021921 | GWAS2039420_H | body height QTL GWAS2039420 (human) | | 3e-08 | body height | | 4 | 111755929 | 111755930 | Human |
| 628490320 | GWAS2398549_H | mood instability measurement QTL GWAS2398549 (human) | | 3e-08 | emotion/affect behavior trait (VT:0002572) | | 4 | 122258745 | 122258746 | Human |
| 597214897 | GWAS1310971_H | body mass index QTL GWAS1310971 (human) | | 2e-09 | body mass index | | 4 | 119292875 | 119292876 | Human |
| 626458744 | GWAS2272677_H | platelet count QTL GWAS2272677 (human) | | 6e-283 | platelet count | | 4 | 110020646 | 110020647 | Human |
| 598017687 | GWAS1736986_H | platelet volume QTL GWAS1736986 (human) | | 2e-13 | platelet volume | | 4 | 122258745 | 122258746 | Human |
| 597526191 | GWAS1622265_H | bone density QTL GWAS1622265 (human) | | 1e-21 | bone density | | 4 | 128419095 | 128419096 | Human |
| 406895988 | GWAS544964_H | tooth agenesis QTL GWAS544964 (human) | | 6e-10 | tooth agenesis | | 4 | 108350621 | 108350622 | Human |
| 596985504 | GWAS1105023_H | atrial fibrillation QTL GWAS1105023 (human) | | 2e-62 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597051054 | GWAS1147128_H | mood disorder, major depressive disorder QTL GWAS1147128 (human) | | 1e-10 | mood disorder, major depressive disorder | | 4 | 122201701 | 122201702 | Human |
| 597214881 | GWAS1310955_H | BMI-adjusted waist-hip ratio QTL GWAS1310955 (human) | | 5e-09 | BMI-adjusted waist-hip ratio | | 4 | 119607172 | 119607173 | Human |
| 628817986 | GWAS2726215_H | level of phosphatidylethanolamine QTL GWAS2726215 (human) | | 2e-08 | level of phosphatidylethanolamine | | 4 | 126594255 | 126594256 | Human |
| 617103858 | GWAS2121357_H | X-24334 measurement QTL GWAS2121357 (human) | | 0.000007 | X-24334 measurement | | 4 | 124556058 | 124556059 | Human |
| 597329569 | GWAS1425643_H | aspartate measurement QTL GWAS1425643 (human) | | 9e-31 | aspartate measurement | | 4 | 110510288 | 110510289 | Human |
| 407027071 | GWAS676047_H | fasting blood glucose measurement QTL GWAS676047 (human) | | 0.000006 | fasting blood glucose measurement | | 4 | 120880635 | 120880636 | Human |
| 598017688 | GWAS1736987_H | platelet volume QTL GWAS1736987 (human) | | 3e-24 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 597591712 | GWAS1648572_H | seborrheic keratosis QTL GWAS1648572 (human) | | 2e-20 | seborrheic keratosis | | 4 | 124698876 | 124698877 | Human |
| 598066917 | GWAS1786216_H | obsolete_fibroblast growth factor 2 measurement QTL GWAS1786216 (human) | | 2e-11 | obsolete_fibroblast growth factor 2 measurement | | 4 | 122682145 | 122682146 | Human |
| 406994178 | GWAS643154_H | estradiol measurement QTL GWAS643154 (human) | | 0.000009 | estradiol measurement | | 4 | 127399753 | 127399754 | Human |
| 617021830 | GWAS2039329_H | protein measurement QTL GWAS2039329 (human) | | 1e-08 | protein amount (VT:0010120) | | 4 | 131591604 | 131591605 | Human |
| 597296856 | GWAS1392930_H | cardiac troponin I measurement QTL GWAS1392930 (human) | | 0.0000004 | cardiac troponin I measurement | | 4 | 118958433 | 118958434 | Human |
| 407272708 | GWAS921684_H | coronary artery disease QTL GWAS921684 (human) | | 1e-14 | coronary artery disease | | 4 | 119979127 | 119979128 | Human |
| 597116626 | GWAS1212700_H | atopic eczema QTL GWAS1212700 (human) | | 9e-11 | atopic eczema | | 4 | 122219899 | 122219900 | Human |
| 617103759 | GWAS2121258_H | gut microbiome measurement, environmental exposure measurement QTL GWAS2121258 (human) | | 0.000008 | gut microbiome measurement, environmental exposure measurement | | 4 | 113407959 | 113407960 | Human |
| 407026952 | GWAS675928_H | serum IgG glycosylation measurement QTL GWAS675928 (human) | | 0.000005 | serum IgG glycosylation measurement | | 4 | 109976429 | 109976430 | Human |
| 407158030 | GWAS807006_H | Eczematoid dermatitis QTL GWAS807006 (human) | | 0.000002 | Eczematoid dermatitis | | 4 | 122109428 | 122109429 | Human |
| 628719666 | GWAS2627895_H | level of agrin in blood QTL GWAS2627895 (human) | | 4e-28 | level of agrin in blood | | 4 | 118434249 | 118434250 | Human |
| 407190792 | GWAS839768_H | hair colour measurement QTL GWAS839768 (human) | | 6e-11 | hair colour measurement | | 4 | 108107769 | 108107770 | Human |
| 406945036 | GWAS594012_H | eosinophil percentage of leukocytes QTL GWAS594012 (human) | | 2e-22 | eosinophil percentage of leukocytes | | 4 | 122680542 | 122680543 | Human |
| 617103750 | GWAS2121249_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS2121249 (human) | | 5e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 116882110 | 116882111 | Human |
| 616989064 | GWAS2006563_H | myeloid leukocyte count QTL GWAS2006563 (human) | | 6e-13 | myeloid leukocyte count | | 4 | 119342160 | 119342161 | Human |
| 407158026 | GWAS807002_H | RS-10-hydroxywarfarin to RS-warfarin ratio measurement QTL GWAS807002 (human) | | 0.000003 | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | | 4 | 121903623 | 121903624 | Human |
| 598066923 | GWAS1786222_H | obsolete_fibroblast growth factor 2 measurement QTL GWAS1786222 (human) | | 6e-36 | obsolete_fibroblast growth factor 2 measurement | | 4 | 122827461 | 122827462 | Human |
| 597345994 | GWAS1442068_H | body mass index QTL GWAS1442068 (human) | | 3e-08 | body mass index | | 4 | 112335581 | 112335582 | Human |
| 617087384 | GWAS2104883_H | alcohol consumption quality QTL GWAS2104883 (human) | | 9e-11 | alcohol consumption quality | | 4 | 112673525 | 112673526 | Human |
| 617087385 | GWAS2104884_H | alcohol consumption quality QTL GWAS2104884 (human) | | 1e-10 | alcohol consumption quality | | 4 | 117942113 | 117942114 | Human |
| 617087386 | GWAS2104885_H | alcohol consumption quality QTL GWAS2104885 (human) | | 5e-14 | alcohol consumption quality | | 4 | 129324733 | 129324734 | Human |
| 628506659 | GWAS2414888_H | gestational diabetes QTL GWAS2414888 (human) | | 0.000003 | gestational diabetes | | 4 | 118370662 | 118370663 | Human |
| 407158033 | GWAS807009_H | Eczematoid dermatitis QTL GWAS807009 (human) | | 3e-13 | Eczematoid dermatitis | | 4 | 122415763 | 122415764 | Human |
| 628506656 | GWAS2414885_H | gestational diabetes QTL GWAS2414885 (human) | | 0.000001 | gestational diabetes | | 4 | 106609371 | 106609372 | Human |
| 628719663 | GWAS2627892_H | level of agrin in blood QTL GWAS2627892 (human) | | 6e-12 | level of agrin in blood | | 4 | 118386005 | 118386006 | Human |
| 407026964 | GWAS675940_H | response to sertraline, psychotic symptom measurement, response to olanzapine QTL GWAS675940 (human) | | 0.000005 | response to sertraline, psychotic symptom measurement, response to olanzapine | | 4 | 119052935 | 119052936 | Human |
| 617202078 | GWAS2182518_H | polypeptide N-acetylgalactosaminyltransferase 3 measurement QTL GWAS2182518 (human) | | 3e-14 | polypeptide N-acetylgalactosaminyltransferase 3 measurement | | 4 | 109948090 | 109948091 | Human |
| 616956316 | GWAS1973815_H | stroke QTL GWAS1973815 (human) | | 2e-10 | brain integrity trait (VT:0010579) | | 4 | 110789013 | 110789014 | Human |
| 407108893 | GWAS757869_H | erythrocyte count QTL GWAS757869 (human) | | 5e-14 | erythrocyte count | | 4 | 121811061 | 121811062 | Human |
| 617087383 | GWAS2104882_H | alcohol consumption quality QTL GWAS2104882 (human) | | 8e-11 | alcohol consumption quality | | 4 | 112673472 | 112673473 | Human |
| 406994211 | GWAS643187_H | histidine measurement QTL GWAS643187 (human) | | 0.0000004 | histidine measurement | | 4 | 115340263 | 115340264 | Human |
| 597231355 | GWAS1327429_H | blood protein measurement QTL GWAS1327429 (human) | | 6e-375 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 597034741 | GWAS1130815_H | brain volume measurement QTL GWAS1130815 (human) | | 4e-09 | brain volume measurement | | 4 | 120722084 | 120722085 | Human |
| 628916248 | GWAS2824477_H | irritable bowel syndrome, chronic bronchitis QTL GWAS2824477 (human) | | 2e-08 | lung integrity trait (VT:0010906) | | 4 | 111582716 | 111582717 | Human |
| 407338287 | GWAS987263_H | chylomicron measurement, very low density lipoprotein cholesterol measurement QTL GWAS987263 (human) | | 1e-10 | chylomicron measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597509873 | GWAS1605947_H | Calcium channel blocker use measurement QTL GWAS1605947 (human) | | 6e-12 | Calcium channel blocker use measurement | | 4 | 110467945 | 110467946 | Human |
| 407026991 | GWAS675967_H | serum IgG glycosylation measurement QTL GWAS675967 (human) | | 0.000001 | serum IgG glycosylation measurement | | 4 | 109976429 | 109976430 | Human |
| 628555802 | GWAS2464031_H | cortical thickness QTL GWAS2464031 (human) | | 2e-14 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120722571 | 120722572 | Human |
| 628654088 | GWAS2562317_H | testosterone measurement QTL GWAS2562317 (human) | | 3e-08 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 113038028 | 113038029 | Human |
| 407239989 | GWAS888965_H | blood protein measurement QTL GWAS888965 (human) | | 7e-50 | blood protein measurement | | 4 | 118808670 | 118808671 | Human |
| 597821136 | GWAS1688527_H | total cholesterol measurement QTL GWAS1688527 (human) | | 4e-08 | total cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 626458661 | GWAS2272594_H | anthropometric measurement QTL GWAS2272594 (human) | | 1e-26 | anthropometric measurement | | 4 | 121827153 | 121827154 | Human |
| 407010612 | GWAS659588_H | hemoglobin measurement QTL GWAS659588 (human) | | 2e-11 | hemoglobin measurement | | 4 | 123844107 | 123844108 | Human |
| 597051105 | GWAS1147179_H | appendicular lean mass QTL GWAS1147179 (human) | | 2e-08 | appendicular lean mass | | 4 | 119742494 | 119742495 | Human |
| 407026997 | GWAS675973_H | sex hormone-binding globulin measurement QTL GWAS675973 (human) | | 2e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 406977850 | GWAS626826_H | gut microbiome measurement QTL GWAS626826 (human) | | 0.000009 | gut microbiome measurement | | 4 | 112858735 | 112858736 | Human |
| 628932615 | GWAS2840844_H | body mass index QTL GWAS2840844 (human) | | 2e-16 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129838492 | 129838493 | Human |
| 407190981 | GWAS839957_H | glycerophospholipid measurement QTL GWAS839957 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114538112 | 114538113 | Human |
| 407190980 | GWAS839956_H | glycerophospholipid measurement QTL GWAS839956 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114581520 | 114581521 | Human |
| 407190983 | GWAS839959_H | glycerophospholipid measurement QTL GWAS839959 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511785 | 114511786 | Human |
| 407190982 | GWAS839958_H | glycerophospholipid measurement QTL GWAS839958 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511945 | 114511946 | Human |
| 407190977 | GWAS839953_H | glycerophospholipid measurement QTL GWAS839953 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114566454 | 114566455 | Human |
| 407190976 | GWAS839952_H | glycerophospholipid measurement QTL GWAS839952 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114581427 | 114581428 | Human |
| 407190979 | GWAS839955_H | glycerophospholipid measurement QTL GWAS839955 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114519018 | 114519019 | Human |
| 407010756 | GWAS659732_H | hemoglobin measurement QTL GWAS659732 (human) | | 3e-09 | hemoglobin measurement | | 4 | 114647874 | 114647875 | Human |
| 407190978 | GWAS839954_H | glycerophospholipid measurement QTL GWAS839954 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114548111 | 114548112 | Human |
| 407076292 | GWAS725268_H | BMI-adjusted waist-hip ratio QTL GWAS725268 (human) | | 1e-13 | BMI-adjusted waist-hip ratio | | 4 | 124299553 | 124299554 | Human |
| 597493269 | GWAS1589343_H | Antihypertensive use measurement QTL GWAS1589343 (human) | | 1e-17 | Antihypertensive use measurement | | 4 | 110469660 | 110469661 | Human |
| 407190989 | GWAS839965_H | glycerophospholipid measurement QTL GWAS839965 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493734 | 114493735 | Human |
| 407190988 | GWAS839964_H | glycerophospholipid measurement QTL GWAS839964 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493571 | 114493572 | Human |
| 597378578 | GWAS1474652_H | age-related macular degeneration QTL GWAS1474652 (human) | | 0.000002 | age-related macular degeneration | | 4 | 116003028 | 116003029 | Human |
| 628867314 | GWAS2775543_H | protein measurement QTL GWAS2775543 (human) | | 2e-78 | protein amount (VT:0010120) | | 4 | 119638137 | 119638138 | Human |
| 407190991 | GWAS839967_H | glycerophospholipid measurement QTL GWAS839967 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493830 | 114493831 | Human |
| 628867313 | GWAS2775542_H | protein measurement QTL GWAS2775542 (human) | | 1e-162 | protein amount (VT:0010120) | | 4 | 119635312 | 119635313 | Human |
| 598099500 | GWAS1816893_H | facial morphology trait QTL GWAS1816893 (human) | | 3e-08 | facial morphology trait | | 4 | 125219863 | 125219864 | Human |
| 407190990 | GWAS839966_H | glycerophospholipid measurement QTL GWAS839966 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114493245 | 114493246 | Human |
| 628867312 | GWAS2775541_H | protein measurement QTL GWAS2775541 (human) | | 5e-47 | protein amount (VT:0010120) | | 4 | 119501939 | 119501940 | Human |
| 598099501 | GWAS1816894_H | facial morphology trait QTL GWAS1816894 (human) | | 3e-08 | facial morphology trait | | 4 | 125210511 | 125210512 | Human |
| 407190985 | GWAS839961_H | glycerophospholipid measurement QTL GWAS839961 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511985 | 114511986 | Human |
| 406912460 | GWAS561436_H | lobe attachment QTL GWAS561436 (human) | | 0.000002 | lobe attachment | | 4 | 121212944 | 121212945 | Human |
| 598099498 | GWAS1816891_H | facial morphology trait QTL GWAS1816891 (human) | | 3e-08 | facial morphology trait | | 4 | 125198582 | 125198583 | Human |
| 407190984 | GWAS839960_H | glycerophospholipid measurement QTL GWAS839960 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114511787 | 114511788 | Human |
| 598099499 | GWAS1816892_H | facial morphology trait QTL GWAS1816892 (human) | | 3e-08 | facial morphology trait | | 4 | 125217310 | 125217311 | Human |
| 597100058 | GWAS1196132_H | sex hormone-binding globulin measurement QTL GWAS1196132 (human) | | 6e-16 | sex hormone-binding globulin measurement | | 4 | 128110633 | 128110634 | Human |
| 597607952 | GWAS1664812_H | triglyceride measurement QTL GWAS1664812 (human) | | 1e-33 | triglyceride measurement | | 4 | 109657070 | 109657071 | Human |
| 616956232 | GWAS1973731_H | serum copper measurement QTL GWAS1973731 (human) | | 0.000001 | serum copper measurement | | 4 | 113027634 | 113027635 | Human |
| 598001194 | GWAS1720493_H | urate measurement, bone density QTL GWAS1720493 (human) | | 8e-09 | urate measurement, bone density | | 4 | 113560916 | 113560917 | Human |
| 407190987 | GWAS839963_H | glycerophospholipid measurement QTL GWAS839963 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114490891 | 114490892 | Human |
| 598099496 | GWAS1816889_H | facial morphology trait QTL GWAS1816889 (human) | | 3e-08 | facial morphology trait | | 4 | 125198542 | 125198543 | Human |
| 407190986 | GWAS839962_H | glycerophospholipid measurement QTL GWAS839962 (human) | | 1e-11 | glycerophospholipid measurement | | 4 | 114512090 | 114512091 | Human |
| 628867316 | GWAS2775545_H | protein measurement QTL GWAS2775545 (human) | | 4e-75 | protein amount (VT:0010120) | | 4 | 119501939 | 119501940 | Human |
| 626458823 | GWAS2272756_H | anthropometric measurement QTL GWAS2272756 (human) | | 3e-22 | anthropometric measurement | | 4 | 108540829 | 108540830 | Human |
| 407207381 | GWAS856357_H | body weight QTL GWAS856357 (human) | | 5e-08 | body weight | | 4 | 121338887 | 121338888 | Human |
| 628818153 | GWAS2726382_H | hypertension QTL GWAS2726382 (human) | | 3e-12 | blood pressure trait (VT:0000183) | | 4 | 110510288 | 110510289 | Human |
| 407190993 | GWAS839969_H | glycerophospholipid measurement QTL GWAS839969 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114572686 | 114572687 | Human |
| 407190992 | GWAS839968_H | glycerophospholipid measurement QTL GWAS839968 (human) | | 2e-11 | glycerophospholipid measurement | | 4 | 114548870 | 114548871 | Human |
| 626442432 | GWAS2256365_H | eosinophil count QTL GWAS2256365 (human) | | 1e-21 | eosinophil count | | 4 | 122365072 | 122365073 | Human |
| 407190994 | GWAS839970_H | glycerophospholipid measurement QTL GWAS839970 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114576580 | 114576581 | Human |
| 407371229 | GWAS1020205_H | unipolar depression QTL GWAS1020205 (human) | | 3e-24 | unipolar depression | | 4 | 122201701 | 122201702 | Human |
| 628998374 | GWAS2906603_H | Shock QTL GWAS2906603 (human) | | 9e-12 | Shock | | 4 | 108255692 | 108255693 | Human |
| 596952591 | GWAS1072110_H | hypertension QTL GWAS1072110 (human) | | 6e-12 | hypertension | | 4 | 110484920 | 110484925 | Human |
| 597591554 | GWAS1648414_H | skin disease QTL GWAS1648414 (human) | | 2e-14 | skin disease | | 4 | 124698876 | 124698877 | Human |
| 616497441 | GWAS1894024_H | 1,7-dimethylurate measurement QTL GWAS1894024 (human) | | 0.000006 | 1,7-dimethylurate measurement | | 4 | 127532481 | 127532482 | Human |
| 597411384 | GWAS1507458_H | cardioembolic stroke QTL GWAS1507458 (human) | | 4e-20 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597050930 | GWAS1147004_H | hip bone mineral density, hip bone size QTL GWAS1147004 (human) | | 5e-09 | hip bone mineral density, hip bone size | | 4 | 129257175 | 129257176 | Human |
| 617120111 | GWAS2137610_H | level of agrin in blood serum QTL GWAS2137610 (human) | | 6e-12 | level of agrin in blood serum | | 4 | 118386005 | 118386006 | Human |
| 628424924 | GWAS2333153_H | appendicular lean mass QTL GWAS2333153 (human) | | 5e-10 | body lean mass (VT:0010483) | | 4 | 110660471 | 110660472 | Human |
| 628867277 | GWAS2775506_H | calcium/calmodulin-dependent protein kinase type II subunit delta measurement QTL GWAS2775506 (human) | | 2e-12 | calcium/calmodulin-dependent protein kinase type II subunit delta measurement | | 4 | 113747320 | 113747321 | Human |
| 597034542 | GWAS1130616_H | TPE interval measurement QTL GWAS1130616 (human) | | 3e-10 | TPE interval measurement | | 4 | 113535350 | 113535351 | Human |
| 628654273 | GWAS2562502_H | sex hormone-binding globulin measurement QTL GWAS2562502 (human) | | 5e-25 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 597378651 | GWAS1474725_H | adenosine monophosphate measurement QTL GWAS1474725 (human) | | 0.000009 | adenosine monophosphate measurement | | 4 | 116035124 | 116035125 | Human |
| 628424885 | GWAS2333114_H | appendicular lean mass QTL GWAS2333114 (human) | | 1e-11 | body lean mass (VT:0010483) | | 4 | 124044107 | 124044108 | Human |
| 598066789 | GWAS1786088_H | body height QTL GWAS1786088 (human) | | 1e-08 | body height | | 4 | 128547347 | 128547348 | Human |
| 407027075 | GWAS676051_H | fasting blood glucose measurement QTL GWAS676051 (human) | | 0.000005 | fasting blood glucose measurement | | 4 | 120880635 | 120880636 | Human |
| 598066788 | GWAS1786087_H | body height QTL GWAS1786087 (human) | | 2e-09 | body height | | 4 | 123557804 | 123557805 | Human |
| 628424886 | GWAS2333115_H | appendicular lean mass QTL GWAS2333115 (human) | | 2e-12 | body lean mass (VT:0010483) | | 4 | 119325534 | 119325535 | Human |
| 598066790 | GWAS1786089_H | body height QTL GWAS1786089 (human) | | 5e-10 | body height | | 4 | 128751543 | 128751544 | Human |
| 598066785 | GWAS1786084_H | body height QTL GWAS1786084 (human) | | 8e-23 | body height | | 4 | 113826994 | 113826995 | Human |
| 628408497 | GWAS2316726_H | smoking behavior trait QTL GWAS2316726 (human) | | 2e-11 | smoking behavior trait | | 4 | 111500989 | 111500990 | Human |
| 598066784 | GWAS1786083_H | body height QTL GWAS1786083 (human) | | 3e-14 | body height | | 4 | 112431472 | 112431473 | Human |
| 598066787 | GWAS1786086_H | body height QTL GWAS1786086 (human) | | 1e-19 | body height | | 4 | 123398036 | 123398037 | Human |
| 598066786 | GWAS1786085_H | body height QTL GWAS1786085 (human) | | 3e-42 | body height | | 4 | 121840699 | 121840700 | Human |
| 617054472 | GWAS2071971_H | vaginal microbiome measurement QTL GWAS2071971 (human) | | 0.0000007 | vaginal microbiome measurement | | 4 | 116138019 | 116138020 | Human |
| 407240086 | GWAS889062_H | apolipoprotein A 1 measurement QTL GWAS889062 (human) | | 2e-08 | free cholesterol measurement, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 628555940 | GWAS2464169_H | level of sphingomyelin phosphodiesterase in blood QTL GWAS2464169 (human) | | 4e-24 | level of sphingomyelin phosphodiesterase in blood | | 4 | 109717668 | 109717669 | Human |
| 597050949 | GWAS1147023_H | protein measurement QTL GWAS1147023 (human) | | 1e-08 | protein measurement | | 4 | 109735574 | 109735575 | Human |
| 628424864 | GWAS2333093_H | response to norepinephrine-dopamine reuptake inhibitor QTL GWAS2333093 (human) | | 0.000006 | response to norepinephrine-dopamine reuptake inhibitor | | 4 | 120701163 | 120701164 | Human |
| 597296719 | GWAS1392793_H | glomerular filtration rate QTL GWAS1392793 (human) | | 9e-09 | glomerular filtration rate | | 4 | 128246249 | 128246250 | Human |
| 597018179 | GWAS1114253_H | eosinophil count QTL GWAS1114253 (human) | | 1e-21 | eosinophil count | | 4 | 122365072 | 122365073 | Human |
| 628621472 | GWAS2529701_H | asthma, allergic disease QTL GWAS2529701 (human) | | 3e-12 | asthma, allergic disease | | 4 | 122441954 | 122441955 | Human |
| 617038107 | GWAS2055606_H | erythrocyte volume QTL GWAS2055606 (human) | | 2e-09 | erythrocyte volume | | 4 | 121773981 | 121773982 | Human |
| 628850854 | GWAS2759083_H | S-7-hydroxywarfarin measurement QTL GWAS2759083 (human) | | 0.000009 | S-7-hydroxywarfarin measurement | | 4 | 121518134 | 121518135 | Human |
| 628506773 | GWAS2415002_H | left atrium capacity QTL GWAS2415002 (human) | | 2e-08 | left atrium capacity | | 4 | 110744627 | 110744628 | Human |
| 616956197 | GWAS1973696_H | HVA measurement, MHPG measurement QTL GWAS1973696 (human) | | 0.000009 | tissue homovanillic acid amount (VT:0010835) | | 4 | 130105333 | 130105334 | Human |
| 597116529 | GWAS1212603_H | benign prostatic hyperplasia QTL GWAS1212603 (human) | | 0.000001 | benign prostatic hyperplasia | | 4 | 110180390 | 110180395 | Human |
| 407272877 | GWAS921853_H | depressive symptom measurement QTL GWAS921853 (human) | | 3e-09 | depressive symptom measurement | | 4 | 122265238 | 122265239 | Human |
| 628555929 | GWAS2464158_H | cortical thickness QTL GWAS2464158 (human) | | 3e-08 | cerebral cortex morphology trait (VT:0000788) | | 4 | 126550097 | 126550098 | Human |
| 628801685 | GWAS2709914_H | COVID-19 QTL GWAS2709914 (human) | | 0.000008 | COVID-19 | | 4 | 129389669 | 129389670 | Human |
| 407403960 | GWAS1052936_H | asthma QTL GWAS1052936 (human) | | 3e-09 | asthma | | 4 | 122134546 | 122134549 | Human |
| 616530254 | GWAS1926837_H | level of glutamyl aminopeptidase in blood serum QTL GWAS1926837 (human) | | 2e-25 | level of glutamyl aminopeptidase in blood serum | | 4 | 110510288 | 110510289 | Human |
| 628506759 | GWAS2414988_H | left atrium capacity QTL GWAS2414988 (human) | | 1e-08 | left atrium capacity | | 4 | 110744627 | 110744628 | Human |
| 407387577 | GWAS1036553_H | acute myeloid leukemia QTL GWAS1036553 (human) | | 9e-18 | acute myeloid leukemia | | 4 | 112776849 | 112776850 | Human |
| 597313122 | GWAS1409196_H | vaginal microbiome measurement QTL GWAS1409196 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 598066783 | GWAS1786082_H | body height QTL GWAS1786082 (human) | | 3e-15 | body height | | 4 | 112381201 | 112381202 | Human |
| 407190975 | GWAS839951_H | glycerophospholipid measurement QTL GWAS839951 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114554497 | 114554498 | Human |
| 407190974 | GWAS839950_H | glycerophospholipid measurement QTL GWAS839950 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114556583 | 114556584 | Human |
| 407289414 | GWAS938390_H | vaginal microbiome measurement QTL GWAS938390 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 597591454 | GWAS1648314_H | Barrett's esophagus QTL GWAS1648314 (human) | | 1e-15 | Barrett's esophagus | | 4 | 123628089 | 123628090 | Human |
| 628687736 | GWAS2595965_H | Abnormality of the skeletal system QTL GWAS2595965 (human) | | 3e-12 | Abnormality of the skeletal system | | 4 | 110641459 | 110641460 | Human |
| 617087689 | GWAS2105188_H | aging rate QTL GWAS2105188 (human) | | 3e-08 | aging rate | | 4 | 123350987 | 123350988 | Human |
| 628540277 | GWAS2448506_H | facial morphology trait QTL GWAS2448506 (human) | | 9e-12 | facial morphology trait | | 4 | 126901674 | 126901675 | Human |
| 407256645 | GWAS905621_H | metabolite measurement QTL GWAS905621 (human) | | 1e-21 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 628540275 | GWAS2448504_H | facial morphology trait QTL GWAS2448504 (human) | | 2e-09 | facial morphology trait | | 4 | 126014320 | 126014321 | Human |
| 597460379 | GWAS1556453_H | response to antidepressant QTL GWAS1556453 (human) | | 0.0000005 | response to antidepressant | | 4 | 117580003 | 117580004 | Human |
| 597460375 | GWAS1556449_H | atrial fibrillation QTL GWAS1556449 (human) | | 3e-525 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 407240265 | GWAS889241_H | lifestyle measurement, depressive symptom measurement QTL GWAS889241 (human) | | 3e-08 | lifestyle measurement, depressive symptom measurement | | 4 | 117961493 | 117961494 | Human |
| 628507494 | GWAS2415723_H | electrocardiography, magnetic resonance imaging of the heart QTL GWAS2415723 (human) | | 4e-31 | electrocardiography, magnetic resonance imaging of the heart | | 4 | 113508251 | 113508252 | Human |
| 407387737 | GWAS1036713_H | acute myeloid leukemia QTL GWAS1036713 (human) | | 8e-13 | leukocyte integrity trait (VT:0010898) | | 4 | 113047052 | 113047053 | Human |
| 597116294 | GWAS1212368_H | DNA methylation QTL GWAS1212368 (human) | | 2e-08 | DNA methylation | | 4 | 124761267 | 124761268 | Human |
| 407387738 | GWAS1036714_H | acute myeloid leukemia QTL GWAS1036714 (human) | | 0.0000002 | leukocyte integrity trait (VT:0010898) | | 4 | 113047052 | 113047053 | Human |
| 628818793 | GWAS2727022_H | glomerular filtration rate QTL GWAS2727022 (human) | | 5e-13 | glomerular filtration rate | | 4 | 128601363 | 128601364 | Human |
| 628507493 | GWAS2415722_H | electrocardiography, magnetic resonance imaging of the heart QTL GWAS2415722 (human) | | 2e-08 | electrocardiography, magnetic resonance imaging of the heart | | 4 | 110782354 | 110782355 | Human |
| 407387739 | GWAS1036715_H | acute myeloid leukemia QTL GWAS1036715 (human) | | 6e-23 | leukocyte integrity trait (VT:0010898) | | 4 | 115155558 | 115155559 | Human |
| 407387740 | GWAS1036716_H | acute myeloid leukemia QTL GWAS1036716 (human) | | 5e-14 | leukocyte integrity trait (VT:0010898) | | 4 | 115155558 | 115155559 | Human |
| 628917096 | GWAS2825325_H | glomerular filtration rate QTL GWAS2825325 (human) | | 4e-08 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 628687724 | GWAS2595953_H | Abnormality of the skeletal system QTL GWAS2595953 (human) | | 3e-26 | Abnormality of the skeletal system | | 4 | 119325127 | 119325128 | Human |
| 628917097 | GWAS2825326_H | glomerular filtration rate QTL GWAS2825326 (human) | | 4e-20 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 628917098 | GWAS2825327_H | glomerular filtration rate QTL GWAS2825327 (human) | | 5e-12 | glomerular filtration rate | | 4 | 128601363 | 128601364 | Human |
| 626459456 | GWAS2273389_H | platelet count QTL GWAS2273389 (human) | | 5e-16 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 617186001 | GWAS2166441_H | longitudinal BMI measurement QTL GWAS2166441 (human) | | 0.000009 | body mass (VT:0001259) | body mass index (BMI) (CMO:0000105) | 4 | 118506802 | 118506803 | Human |
| 628704096 | GWAS2612325_H | tenascin measurement QTL GWAS2612325 (human) | | 9e-13 | tenascin measurement | | 4 | 123739489 | 123739490 | Human |
| 597525894 | GWAS1621968_H | bone density QTL GWAS1621968 (human) | | 6e-24 | bone density | | 4 | 107818840 | 107818841 | Human |
| 628917095 | GWAS2825324_H | glomerular filtration rate QTL GWAS2825324 (human) | | 3e-10 | glomerular filtration rate | | 4 | 108792494 | 108792495 | Human |
| 597820862 | GWAS1688253_H | lipid measurement QTL GWAS1688253 (human) | | 5e-11 | lipid measurement | | 4 | 109657070 | 109657071 | Human |
| 628654937 | GWAS2563166_H | platelet count QTL GWAS2563166 (human) | | 4e-19 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110027510 | 110027511 | Human |
| 628687704 | GWAS2595933_H | Abnormality of the skeletal system QTL GWAS2595933 (human) | | 1e-16 | Abnormality of the skeletal system | | 4 | 119742494 | 119742495 | Human |
| 616956651 | GWAS1974150_H | hypertension QTL GWAS1974150 (human) | | 0.000006 | blood pressure trait (VT:0000183) | | 4 | 112002081 | 112002082 | Human |
| 597116345 | GWAS1212419_H | DNA methylation QTL GWAS1212419 (human) | | 3e-09 | DNA methylation | | 4 | 109836068 | 109836069 | Human |
| 628998989 | GWAS2907218_H | potassium measurement QTL GWAS2907218 (human) | | 2e-12 | blood potassium amount (VT:0002668) | blood potassium level (CMO:0000496) | 4 | 108140367 | 108140368 | Human |
| 617005815 | GWAS2023314_H | primary biliary cirrhosis QTL GWAS2023314 (human) | | 4e-13 | liver integrity trait (VT:0010547) | | 4 | 122667371 | 122667372 | Human |
| 407158390 | GWAS807366_H | S-7-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS807366 (human) | | 0.000009 | S-7-hydroxywarfarin to S-warfarin ratio measurement | | 4 | 126276324 | 126276325 | Human |
| 407256689 | GWAS905665_H | brain measurement QTL GWAS905665 (human) | | 7e-10 | brain measurement | | 4 | 124015375 | 124015376 | Human |
| 407404144 | GWAS1053120_H | congestive heart failure QTL GWAS1053120 (human) | | 1e-08 | congestive heart failure | | 4 | 110783043 | 110783044 | Human |
| 617104115 | GWAS2121614_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2121614 (human) | | 4e-09 | gut microbiome measurement, allergen exposure measurement | | 4 | 111174542 | 111174543 | Human |
| 617005816 | GWAS2023315_H | primary biliary cirrhosis QTL GWAS2023315 (human) | | 1e-11 | liver integrity trait (VT:0010547) | | 4 | 122628544 | 122628545 | Human |
| 628720441 | GWAS2628670_H | whole body water mass QTL GWAS2628670 (human) | | 1e-11 | whole body water mass | | 4 | 109834165 | 109834166 | Human |
| 597984740 | GWAS1704039_H | decreased attention, quality of life QTL GWAS1704039 (human) | | 0.000003 | decreased attention, quality of life | | 4 | 125938393 | 125938394 | Human |
| 406912514 | GWAS561490_H | progressive supranuclear palsy QTL GWAS561490 (human) | | 0.0000001 | progressive supranuclear palsy | | 4 | 122557561 | 122557562 | Human |
| 407010817 | GWAS659793_H | Parkinson disease QTL GWAS659793 (human) | | 0.0000005 | Parkinson disease | | 4 | 113422713 | 113422714 | Human |
| 597476831 | GWAS1572905_H | protein measurement QTL GWAS1572905 (human) | | 7e-09 | protein measurement | | 4 | 132286668 | 132286669 | Human |
| 407092743 | GWAS741719_H | balding measurement QTL GWAS741719 (human) | | 2e-14 | balding measurement | | 4 | 123825222 | 123825223 | Human |
| 597067218 | GWAS1163292_H | susceptibility to vaginal yeast infection measurement QTL GWAS1163292 (human) | | 0.000001 | response to fungal infection trait (VT:0010436) | | 4 | 128039093 | 128039112 | Human |
| 628441917 | GWAS2350146_H | neuroticism measurement QTL GWAS2350146 (human) | | 2e-08 | behavior trait (VT:0010442) | | 4 | 118015036 | 118015037 | Human |
| 406945293 | GWAS594269_H | hematocrit QTL GWAS594269 (human) | | 1e-10 | hematocrit | | 4 | 123846352 | 123846353 | Human |
| 406896141 | GWAS545117_H | body surface area QTL GWAS545117 (human) | | 5e-15 | body surface area | | 4 | 121792708 | 121792709 | Human |
| 406896142 | GWAS545118_H | body surface area QTL GWAS545118 (human) | | 3e-11 | body surface area | | 4 | 122906887 | 122906888 | Human |
| 597214679 | GWAS1310753_H | epidermal growth factor measurement QTL GWAS1310753 (human) | | 1e-21 | epidermal growth factor measurement | | 4 | 109960338 | 109960339 | Human |
| 617005716 | GWAS2023215_H | hemorrhoid QTL GWAS2023215 (human) | | 4e-09 | hemorrhoid | | 4 | 123825222 | 123825223 | Human |
| 617005717 | GWAS2023216_H | hemorrhoid QTL GWAS2023216 (human) | | 3e-11 | hemorrhoid | | 4 | 126003844 | 126003845 | Human |
| 616989333 | GWAS2006832_H | Alzheimer disease QTL GWAS2006832 (human) | | 0.000001 | Alzheimer disease | | 4 | 128702401 | 128702402 | Human |
| 406994454 | GWAS643430_H | mean corpuscular hemoglobin concentration QTL GWAS643430 (human) | | 5e-72 | mean corpuscular hemoglobin concentration | | 4 | 121870446 | 121870447 | Human |
| 597493191 | GWAS1589265_H | alcohol consumption measurement QTL GWAS1589265 (human) | | 4e-09 | alcohol consumption measurement | | 4 | 117942113 | 117942114 | Human |
| 597493190 | GWAS1589264_H | alcohol consumption measurement QTL GWAS1589264 (human) | | 7e-12 | alcohol consumption measurement | | 4 | 112674713 | 112674714 | Human |
| 407174681 | GWAS823657_H | type 1 diabetes mellitus QTL GWAS823657 (human) | | 1e-08 | type 1 diabetes mellitus | | 4 | 124578751 | 124578752 | Human |
| 628654887 | GWAS2563116_H | atopic eczema QTL GWAS2563116 (human) | | 6e-11 | atopic eczema | | 4 | 122111486 | 122111487 | Human |
| 407289382 | GWAS938358_H | body height QTL GWAS938358 (human) | | 3e-15 | body height | | 4 | 112381201 | 112381202 | Human |
| 407289383 | GWAS938359_H | body height QTL GWAS938359 (human) | | 3e-14 | body height | | 4 | 112431472 | 112431473 | Human |
| 616989351 | GWAS2006850_H | red blood cell density QTL GWAS2006850 (human) | | 2e-15 | red blood cell density | | 4 | 114598115 | 114598116 | Human |
| 628753179 | GWAS2661408_H | psoriasis QTL GWAS2661408 (human) | | 4e-09 | psoriasis | | 4 | 122689551 | 122689552 | Human |
| 628409111 | GWAS2317340_H | gut microbiome measurement QTL GWAS2317340 (human) | | 0.000003 | gut microbiome measurement | | 4 | 119309995 | 119309996 | Human |
| 598099394 | GWAS1816787_H | facial morphology trait QTL GWAS1816787 (human) | | 5e-08 | facial morphology trait | | 4 | 125202598 | 125202599 | Human |
| 598017472 | GWAS1736771_H | platelet volume QTL GWAS1736771 (human) | | 4e-13 | platelet volume | | 4 | 122061968 | 122061969 | Human |
| 597263871 | GWAS1359945_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1359945 (human) | | 1e-12 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 598099392 | GWAS1816785_H | facial morphology trait QTL GWAS1816785 (human) | | 3e-08 | facial morphology trait | | 4 | 125220568 | 125220569 | Human |
| 597116400 | GWAS1212474_H | reaction time measurement QTL GWAS1212474 (human) | | 0.0000004 | reaction time measurement | | 4 | 124836622 | 124836623 | Human |
| 598099393 | GWAS1816786_H | facial morphology trait QTL GWAS1816786 (human) | | 4e-08 | facial morphology trait | | 4 | 125199979 | 125199980 | Human |
| 407289390 | GWAS938366_H | body height QTL GWAS938366 (human) | | 1e-19 | body height | | 4 | 123398036 | 123398037 | Human |
| 407289391 | GWAS938367_H | body height QTL GWAS938367 (human) | | 2e-09 | body height | | 4 | 123557804 | 123557805 | Human |
| 407010862 | GWAS659838_H | lifestyle measurement QTL GWAS659838 (human) | | 3e-09 | lifestyle measurement | | 4 | 117436249 | 117436250 | Human |
| 407289386 | GWAS938362_H | body height QTL GWAS938362 (human) | | 3e-42 | body height | | 4 | 121840699 | 121840700 | Human |
| 407289384 | GWAS938360_H | body height QTL GWAS938360 (human) | | 8e-23 | body height | | 4 | 113826994 | 113826995 | Human |
| 407404070 | GWAS1053046_H | gut microbiome measurement QTL GWAS1053046 (human) | | 7e-08 | gut microbiome measurement | | 4 | 117122262 | 117122263 | Human |
| 616989352 | GWAS2006851_H | red blood cell density QTL GWAS2006851 (human) | | 2e-16 | red blood cell density | | 4 | 121804148 | 121804149 | Human |
| 628654870 | GWAS2563099_H | sex hormone-binding globulin measurement QTL GWAS2563099 (human) | | 2e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 407387704 | GWAS1036680_H | forced expiratory volume, response to bronchodilator QTL GWAS1036680 (human) | | 0.000003 | forced expiratory volume, response to bronchodilator | | 4 | 122596078 | 122596079 | Human |
| 616989364 | GWAS2006863_H | Red cell distribution width QTL GWAS2006863 (human) | | 2e-23 | erythrocyte size trait (VT:0000248) | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 128306129 | 128306130 | Human |
| 407043638 | GWAS692614_H | body weight QTL GWAS692614 (human) | | 0.000001 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 120941346 | 120941347 | Human |
| 407289394 | GWAS938370_H | body height QTL GWAS938370 (human) | | 5e-10 | body height | | 4 | 128751543 | 128751544 | Human |
| 597100002 | GWAS1196076_H | sex hormone-binding globulin measurement QTL GWAS1196076 (human) | | 2e-52 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 628441856 | GWAS2350085_H | eosinophil percentage of leukocytes QTL GWAS2350085 (human) | | 2e-22 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122680542 | 122680543 | Human |
| 407289392 | GWAS938368_H | body height QTL GWAS938368 (human) | | 1e-08 | body height | | 4 | 128547347 | 128547348 | Human |
| 597296611 | GWAS1392685_H | ceramide measurement QTL GWAS1392685 (human) | | 3e-08 | ceramide measurement | | 4 | 114533531 | 114533532 | Human |
| 407404083 | GWAS1053059_H | conotruncal heart malformations QTL GWAS1053059 (human) | | 0.000003 | conotruncal heart malformations | | 4 | 111868878 | 111868879 | Human |
| 597050858 | GWAS1146932_H | hip bone size QTL GWAS1146932 (human) | | 7e-09 | hip bone size | | 4 | 129257175 | 129257176 | Human |
| 628917244 | GWAS2825473_H | high density lipoprotein cholesterol measurement QTL GWAS2825473 (human) | | 3e-08 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 121771802 | 121771803 | Human |
| 407027398 | GWAS676374_H | testosterone measurement QTL GWAS676374 (human) | | 6e-16 | testosterone measurement | | 4 | 109345757 | 109345758 | Human |
| 628655101 | GWAS2563330_H | vital capacity QTL GWAS2563330 (human) | | 2e-09 | lung capacity (VT:0001942) | | 4 | 108545191 | 108545192 | Human |
| 616497722 | GWAS1894305_H | sphingomyelin (d18:0/20:0, d16:0/22:0) measurement QTL GWAS1894305 (human) | | 0.000005 | sphingomyelin (d18:0/20:0, d16:0/22:0) measurement | | 4 | 109111508 | 109111509 | Human |
| 628589552 | GWAS2497781_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2497781 (human) | | 4e-15 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 597493013 | GWAS1589087_H | mean arterial pressure QTL GWAS1589087 (human) | | 1e-11 | mean arterial pressure | | 4 | 110427909 | 110427910 | Human |
| 407273166 | GWAS922142_H | alcohol use disorder measurement, response to trauma exposure QTL GWAS922142 (human) | | 3e-08 | alcohol use disorder measurement, response to trauma exposure | | 4 | 129416904 | 129416905 | Human |
| 406896332 | GWAS545308_H | alpha fetoprotein measurement QTL GWAS545308 (human) | | 1e-10 | alpha fetoprotein measurement | | 4 | 108743359 | 108743360 | Human |
| 628638709 | GWAS2546938_H | osteoarthritis, hip, osteoarthritis, knee QTL GWAS2546938 (human) | | 5e-10 | joint integrity trait (VT:0010548) | | 4 | 120722084 | 120722085 | Human |
| 406994636 | GWAS643612_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS643612 (human) | | 6e-58 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119373929 | 119373930 | Human |
| 628491257 | GWAS2399486_H | Calcium channel blocker use measurement QTL GWAS2399486 (human) | | 5e-10 | Calcium channel blocker use measurement | | 4 | 110510288 | 110510289 | Human |
| 616956503 | GWAS1974002_H | atrial fibrillation QTL GWAS1974002 (human) | | 3e-41 | atrial fibrillation | | 4 | 110789013 | 110789014 | Human |
| 407076561 | GWAS725537_H | late-onset Alzheimers disease QTL GWAS725537 (human) | | 0.000004 | late-onset Alzheimers disease | | 4 | 109534350 | 109534351 | Human |
| 407191249 | GWAS840225_H | glycerophospholipid measurement QTL GWAS840225 (human) | | 4e-11 | glycerophospholipid measurement | | 4 | 114551237 | 114551238 | Human |
| 628687840 | GWAS2596069_H | systolic blood pressure QTL GWAS2596069 (human) | | 9e-17 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110510288 | 110510289 | Human |
| 617087570 | GWAS2105069_H | body height QTL GWAS2105069 (human) | | 4e-08 | body height | | 4 | 128700992 | 128700993 | Human |
| 597984568 | GWAS1703867_H | triglyceride change measurement, trait in response to fatty acid QTL GWAS1703867 (human) | | 0.000001 | triglyceride change measurement, trait in response to fatty acid | | 4 | 128638644 | 128638645 | Human |
| 597198087 | GWAS1294161_H | body height QTL GWAS1294161 (human) | | 7e-09 | body height | | 4 | 121772597 | 121772598 | Human |
| 628704216 | GWAS2612445_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2612445 (human) | | 4e-24 | glioma pathogenesis-related protein 1 measurement | | 4 | 107844119 | 107844120 | Human |
| 407092962 | GWAS741938_H | hair color QTL GWAS741938 (human) | | 3e-15 | coat/hair pigmentation trait (VT:0010463) | | 4 | 108136248 | 108136249 | Human |
| 617022054 | GWAS2039553_H | systolic blood pressure QTL GWAS2039553 (human) | | 5e-09 | systolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 407240423 | GWAS889399_H | carbohydrate measurement QTL GWAS889399 (human) | | 0.000004 | carbohydrate measurement | | 4 | 110062423 | 110062424 | Human |
| 597312825 | GWAS1408899_H | cortical surface area measurement QTL GWAS1408899 (human) | | 6e-14 | cortical surface area measurement | | 4 | 112497482 | 112497483 | Human |
| 617054817 | GWAS2072316_H | facial morphology trait QTL GWAS2072316 (human) | | 2e-09 | facial morphology trait | | 4 | 126014320 | 126014321 | Human |
| 597083440 | GWAS1179514_H | venous thromboembolism, response to antineoplastic agent QTL GWAS1179514 (human) | | 0.000004 | blood integrity trait (VT:0010779) | | 4 | 129240194 | 129240195 | Human |
| 597460283 | GWAS1556357_H | thyroxine measurement QTL GWAS1556357 (human) | | 5e-08 | thyroxine measurement | | 4 | 123563112 | 123563113 | Human |
| 597984524 | GWAS1703823_H | platelet volume QTL GWAS1703823 (human) | | 3e-29 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 628425692 | GWAS2333921_H | allergic rhinitis QTL GWAS2333921 (human) | | 3e-15 | allergic rhinitis | | 4 | 122496409 | 122496410 | Human |
| 598033675 | GWAS1752974_H | body height QTL GWAS1752974 (human) | | 8e-15 | body height | | 4 | 113968498 | 113968499 | Human |
| 407125748 | GWAS774724_H | fetal hemoglobin measurement QTL GWAS774724 (human) | | 0.000007 | blood hemoglobin amount (VT:0001588) | | 4 | 120041230 | 120041231 | Human |
| 407387896 | GWAS1036872_H | acute myeloid leukemia QTL GWAS1036872 (human) | | 5e-20 | acute myeloid leukemia | | 4 | 121985860 | 121985861 | Human |
| 597476653 | GWAS1572727_H | appendicular lean mass QTL GWAS1572727 (human) | | 7e-22 | appendicular lean mass | | 4 | 119221151 | 119221152 | Human |
| 407387897 | GWAS1036873_H | acute myeloid leukemia QTL GWAS1036873 (human) | | 1e-13 | acute myeloid leukemia | | 4 | 121985860 | 121985861 | Human |
| 597476654 | GWAS1572728_H | appendicular lean mass QTL GWAS1572728 (human) | | 3e-26 | appendicular lean mass | | 4 | 121792708 | 121792709 | Human |
| 617054835 | GWAS2072334_H | vaginal microbiome measurement QTL GWAS2072334 (human) | | 0.000008 | vaginal microbiome measurement | | 4 | 120143632 | 120143633 | Human |
| 597984529 | GWAS1703828_H | optic disc size trait QTL GWAS1703828 (human) | | 2e-13 | optic disc size trait | | 4 | 111481402 | 111481403 | Human |
| 407404287 | GWAS1053263_H | unipolar depression QTL GWAS1053263 (human) | | 3e-16 | unipolar depression | | 4 | 122467738 | 122467739 | Human |
| 617087600 | GWAS2105099_H | systolic blood pressure QTL GWAS2105099 (human) | | 6e-09 | systolic blood pressure | | 4 | 108328807 | 108328808 | Human |
| 597132591 | GWAS1228665_H | bone density QTL GWAS1228665 (human) | | 6e-12 | bone density | | 4 | 122289915 | 122289916 | Human |
| 406912762 | GWAS561738_H | eye color QTL GWAS561738 (human) | | 0.000004 | eye color | | 4 | 110478442 | 110478443 | Human |
| 597820697 | GWAS1688088_H | phospholipid measurement QTL GWAS1688088 (human) | | 8e-09 | phospholipid measurement | | 4 | 109657070 | 109657071 | Human |
| 597099819 | GWAS1195893_H | sex hormone-binding globulin measurement QTL GWAS1195893 (human) | | 0.0000007 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
| 406912766 | GWAS561742_H | eye color QTL GWAS561742 (human) | | 0.000002 | eye color | | 4 | 110457206 | 110457207 | Human |
| 406961919 | GWAS610895_H | pain QTL GWAS610895 (human) | | 6e-10 | pain | | 4 | 111582716 | 111582717 | Human |
| 628851652 | GWAS2759881_H | S-7-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS2759881 (human) | | 0.000009 | S-7-hydroxywarfarin to S-warfarin ratio measurement | | 4 | 126276324 | 126276325 | Human |
| 628622264 | GWAS2530493_H | age at menarche QTL GWAS2530493 (human) | | 7e-08 | estrous cycle trait (VT:0001927) | | 4 | 129809917 | 129809918 | Human |
| 597034327 | GWAS1130401_H | smoking behavior QTL GWAS1130401 (human) | | 3e-10 | smoking behavior | | 4 | 111500989 | 111500990 | Human |
| 628786107 | GWAS2694336_H | wellbeing measurement, alcohol consumption quality QTL GWAS2694336 (human) | | 2e-08 | wellness/fitness trait (VT:1000152) | | 4 | 117309754 | 117309755 | Human |
| 628622265 | GWAS2530494_H | age at menarche QTL GWAS2530494 (human) | | 1e-10 | estrous cycle trait (VT:0001927) | | 4 | 131843326 | 131843327 | Human |
| 628786108 | GWAS2694337_H | wellbeing measurement, alcohol consumption quality QTL GWAS2694337 (human) | | 3e-08 | wellness/fitness trait (VT:1000152) | | 4 | 121662557 | 121662558 | Human |
| 407158409 | GWAS807385_H | Parkinson disease QTL GWAS807385 (human) | | 1e-12 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
| 628933554 | GWAS2841783_H | saturated fatty acids to total fatty acids percentage QTL GWAS2841783 (human) | | 1e-13 | fatty acid amount (VT:0010046) | | 4 | 110191454 | 110191455 | Human |
| 628622263 | GWAS2530492_H | age at menarche QTL GWAS2530492 (human) | | 1e-08 | estrous cycle trait (VT:0001927) | | 4 | 115075517 | 115075518 | Human |
| 597034311 | GWAS1130385_H | body height QTL GWAS1130385 (human) | | 2e-10 | body height | | 4 | 109834165 | 109834166 | Human |
| 617103897 | GWAS2121396_H | gut microbiome measurement, breastfeeding duration QTL GWAS2121396 (human) | | 5e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 117990855 | 117990856 | Human |
| 597296459 | GWAS1392533_H | blood cobalt measurement QTL GWAS1392533 (human) | | 0.000009 | blood cobalt measurement | | 4 | 121015640 | 121015641 | Human |
| 616956432 | GWAS1973931_H | atrial fibrillation QTL GWAS1973931 (human) | | 1e-14 | atrial fibrillation | | 4 | 110789013 | 110789014 | Human |
| 406994580 | GWAS643556_H | pathological myopia QTL GWAS643556 (human) | | 0.000002 | pathological myopia | | 4 | 111781479 | 111781480 | Human |
| 406994581 | GWAS643557_H | pathological myopia QTL GWAS643557 (human) | | 8e-13 | pathological myopia | | 4 | 111690594 | 111690595 | Human |
| 628671407 | GWAS2579636_H | sleep duration trait QTL GWAS2579636 (human) | | 0.0000003 | sleep duration trait | | 4 | 115085956 | 115085957 | Human |
| 616383077 | GWAS1863319_H | obsolete_fatty acid measurement QTL GWAS1863319 (human) | | 3e-08 | obsolete_fatty acid measurement | | 4 | 109657070 | 109657071 | Human |
| 597034314 | GWAS1130388_H | body height QTL GWAS1130388 (human) | | 7e-09 | body height | | 4 | 119085821 | 119085822 | Human |
| 597034315 | GWAS1130389_H | body height QTL GWAS1130389 (human) | | 2e-10 | body height | | 4 | 119636718 | 119636719 | Human |
| 597034312 | GWAS1130386_H | body height QTL GWAS1130386 (human) | | 1e-15 | body height | | 4 | 113968218 | 113968219 | Human |
| 616956441 | GWAS1973940_H | atrial fibrillation QTL GWAS1973940 (human) | | 4e-63 | atrial fibrillation | | 4 | 110787131 | 110787132 | Human |
| 597034313 | GWAS1130387_H | body height QTL GWAS1130387 (human) | | 3e-09 | body height | | 4 | 118235326 | 118235327 | Human |
| 617005593 | GWAS2023092_H | body height QTL GWAS2023092 (human) | | 0.000001 | body height | | 4 | 119687809 | 119687810 | Human |
| 597198202 | GWAS1294276_H | memory performance QTL GWAS1294276 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124891420 | 124891421 | Human |
| 407387822 | GWAS1036798_H | acute myeloid leukemia QTL GWAS1036798 (human) | | 2e-19 | acute myeloid leukemia | | 4 | 117598611 | 117598612 | Human |
| 597443962 | GWAS1540036_H | lipid measurement QTL GWAS1540036 (human) | | 0.000003 | lipid measurement | | 4 | 131492574 | 131492575 | Human |
| 407387823 | GWAS1036799_H | acute myeloid leukemia QTL GWAS1036799 (human) | | 5e-08 | acute myeloid leukemia | | 4 | 117598611 | 117598612 | Human |
| 598033740 | GWAS1753039_H | obsolete_facial morphology quality QTL GWAS1753039 (human) | | 9e-12 | obsolete_facial morphology quality | | 4 | 126901674 | 126901675 | Human |
| 407174830 | GWAS823806_H | sex hormone-binding globulin measurement QTL GWAS823806 (human) | | 1e-10 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 598033738 | GWAS1753037_H | obsolete_facial morphology quality QTL GWAS1753037 (human) | | 2e-09 | obsolete_facial morphology quality | | 4 | 126014320 | 126014321 | Human |
| 407191221 | GWAS840197_H | glycerophospholipid measurement QTL GWAS840197 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114492647 | 114492648 | Human |
| 628933517 | GWAS2841746_H | saturated fatty acids to total fatty acids percentage QTL GWAS2841746 (human) | | 7e-13 | fatty acid amount (VT:0010046) | | 4 | 110189522 | 110189523 | Human |
| 407191220 | GWAS840196_H | glycerophospholipid measurement QTL GWAS840196 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114492457 | 114492458 | Human |
| 625820604 | GWAS2241526_H | health trait QTL GWAS2241526 (human) | | 5e-08 | health trait | | 4 | 118196105 | 118196106 | Human |
| 407191223 | GWAS840199_H | glycerophospholipid measurement QTL GWAS840199 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114539953 | 114539954 | Human |
| 407191222 | GWAS840198_H | glycerophospholipid measurement QTL GWAS840198 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114540944 | 114540945 | Human |
| 625820603 | GWAS2241525_H | health trait QTL GWAS2241525 (human) | | 9e-11 | health trait | | 4 | 118084947 | 118084948 | Human |
| 625820602 | GWAS2241524_H | health trait QTL GWAS2241524 (human) | | 1e-08 | health trait | | 4 | 108552413 | 108552414 | Human |
| 597230958 | GWAS1327032_H | blood protein measurement QTL GWAS1327032 (human) | | 9e-124 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 407191229 | GWAS840205_H | glycerophospholipid measurement QTL GWAS840205 (human) | | 9e-10 | glycerophospholipid measurement | | 4 | 114551671 | 114551672 | Human |
| 407387824 | GWAS1036800_H | acute myeloid leukemia QTL GWAS1036800 (human) | | 6e-12 | leukocyte integrity trait (VT:0010898) | | 4 | 119601017 | 119601018 | Human |
| 597099886 | GWAS1195960_H | alopecia QTL GWAS1195960 (human) | | 2e-09 | alopecia | | 4 | 106967631 | 106967632 | Human |
| 407191228 | GWAS840204_H | glycerophospholipid measurement QTL GWAS840204 (human) | | 8e-10 | glycerophospholipid measurement | | 4 | 114510521 | 114510522 | Human |
| 628654978 | GWAS2563207_H | cesarean section, Anxiety QTL GWAS2563207 (human) | | 1e-09 | cesarean section, Anxiety | | 4 | 106962429 | 106962430 | Human |
| 406961850 | GWAS610826_H | chronic obstructive pulmonary disease QTL GWAS610826 (human) | | 0.0000007 | lung integrity trait (VT:0010906) | | 4 | 128969635 | 128969636 | Human |
| 407191225 | GWAS840201_H | glycerophospholipid measurement QTL GWAS840201 (human) | | 6e-10 | glycerophospholipid measurement | | 4 | 114485362 | 114485363 | Human |
| 407191224 | GWAS840200_H | glycerophospholipid measurement QTL GWAS840200 (human) | | 5e-10 | glycerophospholipid measurement | | 4 | 114550195 | 114550196 | Human |
| 407191227 | GWAS840203_H | glycerophospholipid measurement QTL GWAS840203 (human) | | 8e-10 | glycerophospholipid measurement | | 4 | 114580888 | 114580889 | Human |
| 407191226 | GWAS840202_H | glycerophospholipid measurement QTL GWAS840202 (human) | | 7e-10 | glycerophospholipid measurement | | 4 | 114514506 | 114514507 | Human |
| 616989241 | GWAS2006740_H | hypothyroidism QTL GWAS2006740 (human) | | 8e-10 | hypothyroidism | | 4 | 122625127 | 122625128 | Human |
| 628474485 | GWAS2382714_H | heel bone mineral density QTL GWAS2382714 (human) | | 8e-14 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 126607237 | 126607238 | Human |
| 628474484 | GWAS2382713_H | heel bone mineral density QTL GWAS2382713 (human) | | 8e-13 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 124619337 | 124619338 | Human |
| 628474481 | GWAS2382710_H | heel bone mineral density QTL GWAS2382710 (human) | | 3e-09 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 108249911 | 108249912 | Human |
| 596984977 | GWAS1104496_H | trait in response to cytarabine QTL GWAS1104496 (human) | | 0.000007 | trait in response to cytarabine | | 4 | 119691563 | 119691564 | Human |
| 597197981 | GWAS1294055_H | glomerular filtration rate QTL GWAS1294055 (human) | | 1e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
| 597197982 | GWAS1294056_H | glomerular filtration rate QTL GWAS1294056 (human) | | 2e-08 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 628474483 | GWAS2382712_H | heel bone mineral density QTL GWAS2382712 (human) | | 8e-11 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 123613837 | 123613838 | Human |
| 628474482 | GWAS2382711_H | heel bone mineral density QTL GWAS2382711 (human) | | 5e-09 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 118868269 | 118868270 | Human |
| 597197983 | GWAS1294057_H | glomerular filtration rate QTL GWAS1294057 (human) | | 4e-08 | glomerular filtration rate | | 4 | 125673826 | 125673827 | Human |
| 407125836 | GWAS774812_H | alopecia QTL GWAS774812 (human) | | 1e-10 | alopecia | | 4 | 106590268 | 106590269 | Human |
| 407125837 | GWAS774813_H | alopecia QTL GWAS774813 (human) | | 6e-10 | alopecia | | 4 | 106706914 | 106706915 | Human |
| 628507260 | GWAS2415489_H | bone tissue density QTL GWAS2415489 (human) | | 1e-300 | bone tissue density | | 4 | 116998483 | 116998484 | Human |
| 628507261 | GWAS2415490_H | bone tissue density QTL GWAS2415490 (human) | | 1e-300 | bone tissue density | | 4 | 130129906 | 130129907 | Human |
| 628507259 | GWAS2415488_H | bone tissue density QTL GWAS2415488 (human) | | 1e-300 | bone tissue density | | 4 | 113769407 | 113769408 | Human |
| 407109454 | GWAS758430_H | protein measurement QTL GWAS758430 (human) | | 2e-08 | protein measurement | | 4 | 118048334 | 118048335 | Human |
| 407387973 | GWAS1036949_H | acute myeloid leukemia QTL GWAS1036949 (human) | | 0.000003 | leukocyte integrity trait (VT:0010898) | | 4 | 130195033 | 130195034 | Human |
| 617071561 | GWAS2089060_H | memory performance QTL GWAS2089060 (human) | | 0.000001 | learning/memory/conditioning trait (VT:0002063) | | 4 | 125709483 | 125709484 | Human |
| 407387974 | GWAS1036950_H | acute myeloid leukemia QTL GWAS1036950 (human) | | 0.000006 | leukocyte integrity trait (VT:0010898) | | 4 | 130195033 | 130195034 | Human |
| 617071560 | GWAS2089059_H | memory performance QTL GWAS2089059 (human) | | 0.000001 | learning/memory/conditioning trait (VT:0002063) | | 4 | 125705326 | 125705327 | Human |
| 628753001 | GWAS2661230_H | blood immunoglobulin amount QTL GWAS2661230 (human) | | 0.0000008 | blood immunoglobulin amount | | 4 | 110793733 | 110793734 | Human |
| 406962013 | GWAS610989_H | thyroxine measurement QTL GWAS610989 (human) | | 0.000005 | thyroxine measurement | | 4 | 112622996 | 112622997 | Human |
| 628867674 | GWAS2775903_H | caproate 6:0 measurement QTL GWAS2775903 (human) | | 0.000005 | caproate 6:0 measurement | | 4 | 132246564 | 132246565 | Human |
| 407289700 | GWAS938676_H | cortical thickness QTL GWAS938676 (human) | | 6e-18 | cortical thickness | | 4 | 118393759 | 118393760 | Human |
| 596952247 | GWAS1071766_H | COVID-19 QTL GWAS1071766 (human) | | 0.000006 | COVID-19 | | 4 | 106867781 | 106867782 | Human |
| 628851293 | GWAS2759522_H | brain physiology trait QTL GWAS2759522 (human) | | 5e-09 | brain physiology trait | | 4 | 116998865 | 116998866 | Human |
| 626459263 | GWAS2273196_H | erythrocyte count QTL GWAS2273196 (human) | | 9e-26 | erythrocyte count | | 4 | 109999015 | 109999016 | Human |
| 617055211 | GWAS2072710_H | pain measurement QTL GWAS2072710 (human) | | 2e-08 | pain measurement | | 4 | 129322917 | 129322918 | Human |
| 616989685 | GWAS2007184_H | gout QTL GWAS2007184 (human) | | 3e-08 | gout | | 4 | 123815050 | 123815051 | Human |
| 597116066 | GWAS1212140_H | response to selective serotonin reuptake inhibitor, openness measurement QTL GWAS1212140 (human) | | 0.0000004 | response to selective serotonin reuptake inhibitor, openness measurement | | 4 | 129115280 | 129115281 | Human |
| 407256945 | GWAS905921_H | metabolite measurement QTL GWAS905921 (human) | | 7e-57 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 596968620 | GWAS1088139_H | cortical thickness QTL GWAS1088139 (human) | | 4e-08 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 407076733 | GWAS725709_H | treatment resistant depression, response to antidepressant QTL GWAS725709 (human) | | 0.0000001 | treatment resistant depression, response to antidepressant | | 4 | 130459962 | 130459963 | Human |
| 626459240 | GWAS2273173_H | anthropometric measurement QTL GWAS2273173 (human) | | 5e-11 | anthropometric measurement | | 4 | 123981152 | 123981153 | Human |
| 597099735 | GWAS1195809_H | cardiac arrhythmia QTL GWAS1195809 (human) | | 6e-37 | heart integrity trait (VT:0010757) | | 4 | 110809256 | 110809257 | Human |
| 406912769 | GWAS561745_H | eye color QTL GWAS561745 (human) | | 0.000008 | eye color | | 4 | 110379206 | 110379207 | Human |
| 597099733 | GWAS1195807_H | cardiac arrhythmia QTL GWAS1195807 (human) | | 3e-41 | heart integrity trait (VT:0010757) | | 4 | 110840331 | 110840332 | Human |
| 616989568 | GWAS2007067_H | carotid artery disease QTL GWAS2007067 (human) | | 1e-16 | carotid artery disease | | 4 | 106712535 | 106712536 | Human |
| 597247198 | GWAS1343272_H | asthma QTL GWAS1343272 (human) | | 3e-14 | asthma | | 4 | 122148495 | 122148496 | Human |
| 597378257 | GWAS1474331_H | celiac disease QTL GWAS1474331 (human) | | 3e-13 | intestine integrity trait (VT:0010554) | | 4 | 122588266 | 122588267 | Human |
| 616383473 | GWAS1863715_H | testosterone measurement QTL GWAS1863715 (human) | | 4e-11 | testosterone measurement | | 4 | 109321740 | 109321741 | Human |
| 616383474 | GWAS1863716_H | testosterone measurement QTL GWAS1863716 (human) | | 1e-12 | testosterone measurement | | 4 | 110002761 | 110002762 | Human |
| 628900399 | GWAS2808628_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS2808628 (human) | | 4e-08 | joint integrity trait (VT:0010548) | | 4 | 122122507 | 122122508 | Human |
| 628376103 | GWAS2296327_H | depressive symptom measurement QTL GWAS2296327 (human) | | 2e-10 | depressive symptom measurement | | 4 | 122201701 | 122201702 | Human |
| 407043862 | GWAS692838_H | cortical thickness QTL GWAS692838 (human) | | 6e-11 | cortical thickness | | 4 | 120708831 | 120708832 | Human |
| 598033661 | GWAS1752960_H | body height QTL GWAS1752960 (human) | | 4e-10 | body height | | 4 | 108146742 | 108146743 | Human |
| 617137044 | GWAS2154543_H | chronic pancreatitis QTL GWAS2154543 (human) | | 2e-12 | chronic pancreatitis | | 4 | 116090374 | 116090375 | Human |
| 597443776 | GWAS1539850_H | carotid artery intima media thickness QTL GWAS1539850 (human) | | 0.000006 | carotid artery intima media thickness | | 4 | 118504756 | 118504757 | Human |
| 617038745 | GWAS2056244_H | Beta blocking agent use measurement QTL GWAS2056244 (human) | | 1e-12 | Beta blocking agent use measurement | | 4 | 110789013 | 110789014 | Human |
| 597591295 | GWAS1648155_H | parasitic infection QTL GWAS1648155 (human) | | 7e-12 | parasitic infection | | 4 | 108582778 | 108582779 | Human |
| 407207716 | GWAS856692_H | brain measurement QTL GWAS856692 (human) | | 2e-09 | brain measurement | | 4 | 123226927 | 123226928 | Human |
| 597411065 | GWAS1507139_H | cardioembolic stroke QTL GWAS1507139 (human) | | 2e-25 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 628589076 | GWAS2497305_H | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS2497305 (human) | | 5e-10 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 109657070 | 109657071 | Human |
| 597411064 | GWAS1507138_H | cardioembolic stroke QTL GWAS1507138 (human) | | 2e-21 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597394686 | GWAS1490760_H | balding measurement QTL GWAS1490760 (human) | | 2e-18 | balding measurement | | 4 | 106652584 | 106652585 | Human |
| 407027498 | GWAS676474_H | sex hormone-binding globulin measurement QTL GWAS676474 (human) | | 9e-09 | sex hormone-binding globulin measurement | | 4 | 123871744 | 123871745 | Human |
| 407158573 | GWAS807549_H | serum non-albumin protein measurement QTL GWAS807549 (human) | | 8e-11 | serum non-albumin protein measurement | | 4 | 119210489 | 119210490 | Human |
| 617202592 | GWAS2183032_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2183032 (human) | | 7e-18 | glioma pathogenesis-related protein 1 measurement | | 4 | 119810601 | 119810602 | Human |
| 628687378 | GWAS2595607_H | body height QTL GWAS2595607 (human) | | 5e-32 | body height | | 4 | 108536277 | 108536278 | Human |
| 597411063 | GWAS1507137_H | cardioembolic stroke QTL GWAS1507137 (human) | | 6e-24 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597411062 | GWAS1507136_H | cardioembolic stroke QTL GWAS1507136 (human) | | 3e-25 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 407191339 | GWAS840315_H | cardiovascular disease QTL GWAS840315 (human) | | 9e-09 | cardiovascular disease | | 4 | 110764459 | 110764460 | Human |
| 617055158 | GWAS2072657_H | white matter lesion progression measurement QTL GWAS2072657 (human) | | 0.000006 | white matter lesion progression measurement | | 4 | 128668470 | 128668471 | Human |
| 597509355 | GWAS1605429_H | fibroblast growth factor 2 measurement QTL GWAS1605429 (human) | | 2e-11 | fibroblast growth factor 2 measurement | | 4 | 122682145 | 122682146 | Human |
| 598017235 | GWAS1736534_H | erythrocyte volume QTL GWAS1736534 (human) | | 8e-25 | erythrocyte volume | | 4 | 128177881 | 128177882 | Human |
| 598017234 | GWAS1736533_H | erythrocyte volume QTL GWAS1736533 (human) | | 2e-58 | erythrocyte volume | | 4 | 121875762 | 121875763 | Human |
| 407125816 | GWAS774792_H | color vision disorder QTL GWAS774792 (human) | | 0.000002 | color vision disorder | | 4 | 107331993 | 107331994 | Human |
| 406994749 | GWAS643725_H | alkaline phosphatase measurement QTL GWAS643725 (human) | | 1e-08 | alkaline phosphatase measurement | | 4 | 109788119 | 109788120 | Human |
| 617055040 | GWAS2072539_H | glomerular filtration rate QTL GWAS2072539 (human) | | 0.0000001 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 407355343 | GWAS1004319_H | BMI-adjusted hip circumference QTL GWAS1004319 (human) | | 3e-12 | BMI-adjusted hip circumference | | 4 | 121792708 | 121792709 | Human |
| 407355342 | GWAS1004318_H | BMI-adjusted hip circumference QTL GWAS1004318 (human) | | 1e-09 | BMI-adjusted hip circumference | | 4 | 121824574 | 121824575 | Human |
| 407355341 | GWAS1004317_H | BMI-adjusted hip circumference QTL GWAS1004317 (human) | | 3e-11 | BMI-adjusted hip circumference | | 4 | 121774530 | 121774531 | Human |
| 628441855 | GWAS2350084_H | eosinophil percentage of leukocytes QTL GWAS2350084 (human) | | 3e-41 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122263256 | 122263257 | Human |
| 628441854 | GWAS2350083_H | eosinophil percentage of leukocytes QTL GWAS2350083 (human) | | 6e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122111201 | 122111202 | Human |
| 407076815 | GWAS725791_H | late-onset Alzheimers disease QTL GWAS725791 (human) | | 0.0000008 | late-onset Alzheimers disease | | 4 | 109251730 | 109251731 | Human |
| 407191497 | GWAS840473_H | testicular hydrocele, filarial elephantiasis QTL GWAS840473 (human) | | 0.0000009 | testicular hydrocele, filarial elephantiasis | | 4 | 112132236 | 112132237 | Human |
| 628441848 | GWAS2350077_H | intelligence QTL GWAS2350077 (human) | | 0.000008 | intelligence | | 4 | 128544541 | 128544542 | Human |
| 616956758 | GWAS1974257_H | neutrophil count QTL GWAS1974257 (human) | | 0.000008 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 4 | 117730668 | 117730669 | Human |
| 597165066 | GWAS1261140_H | deoxycholate measurement QTL GWAS1261140 (human) | | 0.000001 | deoxycholate measurement | | 4 | 119855597 | 119855598 | Human |
| 626459333 | GWAS2273266_H | platelet count QTL GWAS2273266 (human) | | 8e-14 | platelet count | | 4 | 128241378 | 128241379 | Human |
| 616514346 | GWAS1910929_H | alpha-fetoprotein amount QTL GWAS1910929 (human) | | 9e-12 | alpha-fetoprotein amount | | 4 | 108749156 | 108749157 | Human |
| 628818668 | GWAS2726897_H | eosinophil percentage of leukocytes QTL GWAS2726897 (human) | | 2e-29 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122263256 | 122263257 | Human |
| 407191517 | GWAS840493_H | glycerophospholipid measurement QTL GWAS840493 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114533303 | 114533304 | Human |
| 407191516 | GWAS840492_H | glycerophospholipid measurement QTL GWAS840492 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114596387 | 114596388 | Human |
| 597296131 | GWAS1392205_H | BMI-adjusted hip circumference QTL GWAS1392205 (human) | | 1e-09 | BMI-adjusted hip circumference | | 4 | 121824574 | 121824575 | Human |
| 407191519 | GWAS840495_H | glycerophospholipid measurement QTL GWAS840495 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114501231 | 114501232 | Human |
| 407191518 | GWAS840494_H | glycerophospholipid measurement QTL GWAS840494 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114516461 | 114516462 | Human |
| 616530724 | GWAS1927307_H | mean corpuscular hemoglobin QTL GWAS1927307 (human) | | 5e-23 | mean corpuscular hemoglobin | | 4 | 128046010 | 128046011 | Human |
| 407404501 | GWAS1053477_H | glucose metabolism measurement, age-related hearing impairment QTL GWAS1053477 (human) | | 0.000007 | glucose metabolism measurement, age-related hearing impairment | | 4 | 120558243 | 120558244 | Human |
| 617022296 | GWAS2039795_H | sex hormone-binding globulin measurement QTL GWAS2039795 (human) | | 3e-17 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 407191525 | GWAS840501_H | glycerophospholipid measurement QTL GWAS840501 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114535359 | 114535360 | Human |
| 407191524 | GWAS840500_H | glycerophospholipid measurement QTL GWAS840500 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114508383 | 114508384 | Human |
| 628900573 | GWAS2808802_H | forced expiratory volume QTL GWAS2808802 (human) | | 5e-13 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 123891170 | 123891171 | Human |
| 597525567 | GWAS1621641_H | pulse pressure measurement QTL GWAS1621641 (human) | | 0.0000008 | pulse pressure measurement | | 4 | 110416708 | 110416709 | Human |
| 407191527 | GWAS840503_H | glycerophospholipid measurement QTL GWAS840503 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114530264 | 114530265 | Human |
| 628900574 | GWAS2808803_H | forced expiratory volume QTL GWAS2808803 (human) | | 5e-08 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 124118741 | 124118742 | Human |
| 407191526 | GWAS840502_H | glycerophospholipid measurement QTL GWAS840502 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114535366 | 114535367 | Human |
| 617104235 | GWAS2121734_H | metabolite measurement QTL GWAS2121734 (human) | | 0.000008 | metabolite measurement | | 4 | 125761303 | 125761304 | Human |
| 628605651 | GWAS2513880_H | chronic bronchitis QTL GWAS2513880 (human) | | 2e-08 | lung integrity trait (VT:0010906) | | 4 | 113635275 | 113635276 | Human |
| 407191521 | GWAS840497_H | glycerophospholipid measurement QTL GWAS840497 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114523566 | 114523567 | Human |
| 597820423 | GWAS1687814_H | free cholesterol measurement QTL GWAS1687814 (human) | | 7e-09 | free cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407060454 | GWAS709430_H | stroke QTL GWAS709430 (human) | | 3e-08 | brain integrity trait (VT:0010579) | | 4 | 110778170 | 110778171 | Human |
| 407191520 | GWAS840496_H | glycerophospholipid measurement QTL GWAS840496 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114528134 | 114528135 | Human |
| 407191523 | GWAS840499_H | glycerophospholipid measurement QTL GWAS840499 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114480704 | 114480705 | Human |
| 628753117 | GWAS2661346_H | heart failure QTL GWAS2661346 (human) | | 1e-13 | heart integrity trait (VT:0010757) | | 4 | 113507558 | 113507559 | Human |
| 407191522 | GWAS840498_H | glycerophospholipid measurement QTL GWAS840498 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114495706 | 114495707 | Human |
| 407191533 | GWAS840509_H | glycerophospholipid measurement QTL GWAS840509 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114519788 | 114519789 | Human |
| 407191532 | GWAS840508_H | glycerophospholipid measurement QTL GWAS840508 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114532438 | 114532439 | Human |
| 407191535 | GWAS840511_H | glycerophospholipid measurement QTL GWAS840511 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114511670 | 114511671 | Human |
| 628507357 | GWAS2415586_H | electrocardiography QTL GWAS2415586 (human) | | 2e-29 | electrocardiography | | 4 | 113504778 | 113504779 | Human |
| 407191534 | GWAS840510_H | glycerophospholipid measurement QTL GWAS840510 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114479772 | 114479773 | Human |
| 407191529 | GWAS840505_H | glycerophospholipid measurement QTL GWAS840505 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114569441 | 114569442 | Human |
| 407191528 | GWAS840504_H | glycerophospholipid measurement QTL GWAS840504 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114487736 | 114487737 | Human |
| 407191531 | GWAS840507_H | glycerophospholipid measurement QTL GWAS840507 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114522914 | 114522915 | Human |
| 407191530 | GWAS840506_H | glycerophospholipid measurement QTL GWAS840506 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114506467 | 114506468 | Human |
| 598033425 | GWAS1752724_H | body height QTL GWAS1752724 (human) | | 4e-15 | body height | | 4 | 122823209 | 122823210 | Human |
| 628671181 | GWAS2579410_H | Insulin resistance QTL GWAS2579410 (human) | | 0.000001 | Insulin resistance | | 4 | 112927886 | 112927887 | Human |
| 407191536 | GWAS840512_H | glycerophospholipid measurement QTL GWAS840512 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480357 | 114480358 | Human |
| 597361710 | GWAS1457784_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS1457784 (human) | | 5e-08 | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | | 4 | 122629959 | 122629960 | Human |
| 628818637 | GWAS2726866_H | eosinophil count QTL GWAS2726866 (human) | | 9e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122698534 | 122698535 | Human |
| 596968482 | GWAS1088001_H | systolic blood pressure QTL GWAS1088001 (human) | | 9e-17 | systolic blood pressure | | 4 | 110510288 | 110510289 | Human |
| 407371772 | GWAS1020748_H | atrial fibrillation QTL GWAS1020748 (human) | | 3e-09 | atrial fibrillation | | 4 | 111533139 | 111533140 | Human |
| 628720322 | GWAS2628551_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2628551 (human) | | 6e-12 | glioma pathogenesis-related protein 1 measurement | | 4 | 125992444 | 125992445 | Human |
| 597296161 | GWAS1392235_H | lysophosphatidylcholine 20:2 measurement QTL GWAS1392235 (human) | | 4e-09 | lysophosphatidylcholine 20:2 measurement | | 4 | 126754772 | 126754773 | Human |
| 407371771 | GWAS1020747_H | atrial fibrillation QTL GWAS1020747 (human) | | 8e-18 | atrial fibrillation | | 4 | 111244056 | 111244057 | Human |
| 407371770 | GWAS1020746_H | atrial fibrillation QTL GWAS1020746 (human) | | 2e-18 | atrial fibrillation | | 4 | 111004500 | 111004501 | Human |
| 628916929 | GWAS2825158_H | irritable bowel syndrome, chronic obstructive pulmonary disease QTL GWAS2825158 (human) | | 6e-12 | lung integrity trait (VT:0010906) | | 4 | 111450477 | 111450478 | Human |
| 407371769 | GWAS1020745_H | atrial fibrillation QTL GWAS1020745 (human) | | 9e-11 | atrial fibrillation | | 4 | 110675204 | 110675205 | Human |
| 628900547 | GWAS2808776_H | QT interval QTL GWAS2808776 (human) | | 1e-11 | heart electrical impulse conduction trait (VT:2000017) | QT interval (CMO:0000235) | 4 | 113504778 | 113504779 | Human |
| 407126011 | GWAS774987_H | smoking initiation QTL GWAS774987 (human) | | 0.0000005 | behavior trait (VT:0010442) | | 4 | 121686023 | 121686024 | Human |
| 597476445 | GWAS1572519_H | thyroid carcinoma QTL GWAS1572519 (human) | | 0.0000006 | thyroid carcinoma | | 4 | 112649292 | 112649293 | Human |
| 628458160 | GWAS2366389_H | psoriasis QTL GWAS2366389 (human) | | 3e-19 | psoriasis | | 4 | 121833304 | 121833305 | Human |
| 598033507 | GWAS1752806_H | facial morphology trait QTL GWAS1752806 (human) | | 5e-08 | facial morphology trait | | 4 | 123252480 | 123252481 | Human |
| 628474546 | GWAS2382775_H | heel bone mineral density QTL GWAS2382775 (human) | | 3e-15 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 126607351 | 126607352 | Human |
| 628982453 | GWAS2890682_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2890682 (human) | | 3e-12 | fatty acid amount (VT:0010046) | | 4 | 109345757 | 109345758 | Human |
| 406994827 | GWAS643803_H | protein measurement QTL GWAS643803 (human) | | 2e-09 | protein measurement | | 4 | 120939887 | 120939888 | Human |
| 406945675 | GWAS594651_H | gut microbiome measurement QTL GWAS594651 (human) | | 0.000008 | gut microbiome measurement | | 4 | 118360545 | 118360546 | Human |
| 628769456 | GWAS2677685_H | cerebral cortex area attribute QTL GWAS2677685 (human) | | 4e-11 | cerebral cortex area attribute | | 4 | 118376502 | 118376503 | Human |
| 628703923 | GWAS2612152_H | tumor necrosis factor receptor superfamily member 8 amount QTL GWAS2612152 (human) | | 5e-13 | tumor necrosis factor receptor superfamily member 8 amount | | 4 | 122216079 | 122216080 | Human |
| 628982454 | GWAS2890683_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2890683 (human) | | 4e-15 | fatty acid amount (VT:0010046) | | 4 | 109717668 | 109717669 | Human |
| 597034074 | GWAS1130148_H | lean body mass QTL GWAS1130148 (human) | | 0.0000002 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 4 | 122904764 | 122904765 | Human |
| 617054998 | GWAS2072497_H | cortical thickness QTL GWAS2072497 (human) | | 9e-16 | cortical thickness | | 4 | 120645452 | 120645453 | Human |
| 597050436 | GWAS1146510_H | Eczematoid dermatitis QTL GWAS1146510 (human) | | 1e-37 | Eczematoid dermatitis | | 4 | 122415763 | 122415764 | Human |
| 407404444 | GWAS1053420_H | urate measurement, bone density QTL GWAS1053420 (human) | | 8e-09 | urate measurement, bone density | | 4 | 113560916 | 113560917 | Human |
| 597050435 | GWAS1146509_H | Eczematoid dermatitis QTL GWAS1146509 (human) | | 2e-26 | Eczematoid dermatitis | | 4 | 122219915 | 122219916 | Human |
| 597328973 | GWAS1425047_H | atrial fibrillation QTL GWAS1425047 (human) | | 3e-08 | atrial fibrillation | | 4 | 110742777 | 110742778 | Human |
| 617038608 | GWAS2056107_H | C-reactive protein measurement QTL GWAS2056107 (human) | | 4e-08 | C-reactive protein measurement | | 4 | 111731920 | 111731921 | Human |
| 407011227 | GWAS660203_H | intelligence QTL GWAS660203 (human) | | 0.0000001 | intelligence | | 4 | 118088064 | 118088065 | Human |
| 628884135 | GWAS2792364_H | aminoadipic acid measurement QTL GWAS2792364 (human) | | 0.000001 | amino acid metabolism trait (VT:0010631) | | 4 | 117057786 | 117057787 | Human |
| 597525568 | GWAS1621642_H | pulse pressure measurement QTL GWAS1621642 (human) | | 0.0000006 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 110461529 | 110461530 | Human |
| 617022234 | GWAS2039733_H | coffee consumption measurement QTL GWAS2039733 (human) | | 0.000003 | drinking behavior trait (VT:0001422) | | 4 | 117421219 | 117421220 | Human |
| 617038617 | GWAS2056116_H | COVID-19 QTL GWAS2056116 (human) | | 0.000007 | COVID-19 | | 4 | 122087606 | 122087607 | Human |
| 628949666 | GWAS2857895_H | body height QTL GWAS2857895 (human) | | 8e-09 | body height | | 4 | 130259605 | 130259606 | Human |
| 407224229 | GWAS873205_H | atrial fibrillation QTL GWAS873205 (human) | | 1e-13 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 406929312 | GWAS578288_H | balding measurement QTL GWAS578288 (human) | | 2e-33 | balding measurement | | 4 | 107131838 | 107131839 | Human |
| 597296248 | GWAS1392322_H | ceramide measurement QTL GWAS1392322 (human) | | 2e-13 | ceramide measurement | | 4 | 114549176 | 114549177 | Human |
| 628900511 | GWAS2808740_H | testosterone measurement QTL GWAS2808740 (human) | | 7e-09 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 109108768 | 109108769 | Human |
| 628900502 | GWAS2808731_H | testosterone measurement QTL GWAS2808731 (human) | | 1e-09 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 124046883 | 124046884 | Human |
| 596952185 | GWAS1071704_H | COVID-19 QTL GWAS1071704 (human) | | 0.0000009 | COVID-19 | | 4 | 107808529 | 107808530 | Human |
| 407224232 | GWAS873208_H | cardioembolic stroke QTL GWAS873208 (human) | | 5e-11 | cardioembolic stroke | | 4 | 113507558 | 113507559 | Human |
| 596968571 | GWAS1088090_H | cortical thickness QTL GWAS1088090 (human) | | 3e-12 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 597591148 | GWAS1648008_H | atrial fibrillation QTL GWAS1648008 (human) | | 3e-33 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 628998799 | GWAS2907028_H | knee fracture QTL GWAS2907028 (human) | | 7e-13 | knee fracture | | 4 | 117485221 | 117485222 | Human |
| 597591147 | GWAS1648007_H | atrial fibrillation QTL GWAS1648007 (human) | | 6e-56 | atrial fibrillation | | 4 | 110787848 | 110787849 | Human |
| 628490892 | GWAS2399121_H | body mass index QTL GWAS2399121 (human) | | 4e-10 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 119398279 | 119398280 | Human |
| 407285831 | GWAS934807_H | vaginal microbiome measurement QTL GWAS934807 (human) | | 0.0000002 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 597068692 | GWAS1164766_H | fat body mass QTL GWAS1164766 (human) | | 0.0000001 | fat body mass | | 4 | 114674241 | 114674242 | Human |
| 628428151 | GWAS2336380_H | eosinophil count QTL GWAS2336380 (human) | | 1e-18 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122111201 | 122111202 | Human |
| 626462034 | GWAS2275967_H | low density lipoprotein cholesterol measurement QTL GWAS2275967 (human) | | 3e-12 | low density lipoprotein cholesterol measurement | | 4 | 110021440 | 110021441 | Human |
| 597412766 | GWAS1508840_H | adolescent idiopathic scoliosis QTL GWAS1508840 (human) | | 2e-09 | adolescent idiopathic scoliosis | | 4 | 119337052 | 119337053 | Human |
| 617041088 | GWAS2058587_H | HbA1c measurement QTL GWAS2058587 (human) | | 6e-10 | HbA1c measurement | | 4 | 116926523 | 116926524 | Human |
| 617024719 | GWAS2042218_H | alcohol consumption quality QTL GWAS2042218 (human) | | 2e-08 | alcohol consumption quality | | 4 | 112674713 | 112674714 | Human |
| 616500403 | GWAS1896986_H | level of receptor-type tyrosine-protein phosphatase F in blood QTL GWAS1896986 (human) | | 8e-18 | level of receptor-type tyrosine-protein phosphatase F in blood | | 4 | 108873562 | 108873563 | Human |
| 407105615 | GWAS754591_H | protein measurement QTL GWAS754591 (human) | | 9e-14 | protein measurement | | 4 | 120729320 | 120729321 | Human |
| 628428152 | GWAS2336381_H | eosinophil count QTL GWAS2336381 (human) | | 1e-40 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122451978 | 122451979 | Human |
| 597478290 | GWAS1574364_H | platelet crit QTL GWAS1574364 (human) | | 9e-20 | platelet crit | | 4 | 119336584 | 119336585 | Human |
| 597478291 | GWAS1574365_H | platelet crit QTL GWAS1574365 (human) | | 1e-13 | platelet crit | | 4 | 123749526 | 123749527 | Human |
| 407187542 | GWAS836518_H | cortical thickness QTL GWAS836518 (human) | | 9e-10 | cortical thickness | | 4 | 123181336 | 123181337 | Human |
| 616991954 | GWAS2009453_H | BMI-adjusted waist-hip ratio QTL GWAS2009453 (human) | | 1e-14 | BMI-adjusted waist-hip ratio | | 4 | 121702910 | 121702911 | Human |
| 617106653 | GWAS2124152_H | body height QTL GWAS2124152 (human) | | 6e-09 | body height | | 4 | 119774304 | 119774305 | Human |
| 626445632 | GWAS2259565_H | body height QTL GWAS2259565 (human) | | 4e-08 | body height | | 4 | 112647388 | 112647389 | Human |
| 617106654 | GWAS2124153_H | body height QTL GWAS2124153 (human) | | 2e-128 | body height | | 4 | 119834940 | 119834941 | Human |
| 617106655 | GWAS2124154_H | body height QTL GWAS2124154 (human) | | 9e-12 | body height | | 4 | 119937025 | 119937026 | Human |
| 597412748 | GWAS1508822_H | hip bone mineral density QTL GWAS1508822 (human) | | 0.000006 | hip bone mineral density | | 4 | 128365448 | 128365449 | Human |
| 628444527 | GWAS2352756_H | asthma QTL GWAS2352756 (human) | | 5e-20 | asthma | | 4 | 122527407 | 122527408 | Human |
| 407269478 | GWAS918454_H | body height QTL GWAS918454 (human) | | 1e-08 | body height | | 4 | 113079800 | 113079801 | Human |
| 407269476 | GWAS918452_H | body height QTL GWAS918452 (human) | | 3e-13 | body height | | 4 | 112538249 | 112538250 | Human |
| 597101492 | GWAS1197566_H | cognitive function measurement QTL GWAS1197566 (human) | | 0.000005 | cognitive behavior trait (VT:0010450) | | 4 | 114569532 | 114569533 | Human |
| 597265338 | GWAS1361412_H | cortical thickness QTL GWAS1361412 (human) | | 1e-12 | smoking initiation | | 4 | 120722571 | 120722572 | Human |
| 597478328 | GWAS1574402_H | atrial fibrillation QTL GWAS1574402 (human) | | 9e-09 | atrial fibrillation | | 4 | 111683665 | 111683666 | Human |
| 628411729 | GWAS2319958_H | apolipoprotein A 1 measurement QTL GWAS2319958 (human) | | 3e-20 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109648464 | 109648465 | Human |
| 407007335 | GWAS656311_H | monocyte count QTL GWAS656311 (human) | | 4e-20 | monocyte count | | 4 | 109959208 | 109959209 | Human |
| 406925412 | GWAS574388_H | appendicular lean mass QTL GWAS574388 (human) | | 2e-12 | appendicular lean mass | | 4 | 119325534 | 119325535 | Human |
| 407269486 | GWAS918462_H | body height QTL GWAS918462 (human) | | 3e-56 | body height | | 4 | 113958625 | 113958626 | Human |
| 617106656 | GWAS2124155_H | body height QTL GWAS2124155 (human) | | 7e-18 | body height | | 4 | 120068926 | 120068927 | Human |
| 597052350 | GWAS1148424_H | childhood onset asthma QTL GWAS1148424 (human) | | 9e-12 | childhood onset asthma | | 4 | 122219915 | 122219916 | Human |
| 407269487 | GWAS918463_H | body height QTL GWAS918463 (human) | | 2e-89 | body height | | 4 | 113970601 | 113970602 | Human |
| 617106657 | GWAS2124156_H | body height QTL GWAS2124156 (human) | | 4e-49 | body height | | 4 | 121772932 | 121772933 | Human |
| 597052351 | GWAS1148425_H | childhood onset asthma QTL GWAS1148425 (human) | | 8e-11 | childhood onset asthma | | 4 | 122451978 | 122451979 | Human |
| 617106658 | GWAS2124157_H | body height QTL GWAS2124157 (human) | | 1e-12 | body height | | 4 | 122600025 | 122600026 | Human |
| 597478327 | GWAS1574401_H | atrial fibrillation QTL GWAS1574401 (human) | | 8e-18 | atrial fibrillation | | 4 | 111244056 | 111244057 | Human |
| 617090275 | GWAS2107774_H | Cleft palate, cleft lip QTL GWAS2107774 (human) | | 0.00001 | Cleft palate, cleft lip | | 4 | 112223293 | 112223294 | Human |
| 407154799 | GWAS803775_H | blood protein measurement QTL GWAS803775 (human) | | 4e-16 | blood protein measurement | | 4 | 119210489 | 119210490 | Human |
| 617106659 | GWAS2124158_H | body height QTL GWAS2124158 (human) | | 8e-20 | body height | | 4 | 122626386 | 122626387 | Human |
| 597380023 | GWAS1476097_H | histidine measurement QTL GWAS1476097 (human) | | 0.0000004 | blood L-hisitidine amount (VT:0010976) | blood amino acid measurement (CMO:0003730) | 4 | 115340263 | 115340264 | Human |
| 617106660 | GWAS2124159_H | body height QTL GWAS2124159 (human) | | 2e-19 | body height | | 4 | 123707660 | 123707661 | Human |
| 617106661 | GWAS2124160_H | erosive tooth wear attribute QTL GWAS2124160 (human) | | 3e-08 | erosive tooth wear attribute | | 4 | 117643607 | 117643608 | Human |
| 407269480 | GWAS918456_H | body height QTL GWAS918456 (human) | | 2e-12 | body height | | 4 | 113740525 | 113740526 | Human |
| 617204967 | GWAS2185407_H | level of sphingomyelin phosphodiesterase in blood QTL GWAS2185407 (human) | | 4e-15 | level of sphingomyelin phosphodiesterase in blood | | 4 | 118868269 | 118868270 | Human |
| 407269481 | GWAS918457_H | body height QTL GWAS918457 (human) | | 2e-105 | body height | | 4 | 113901423 | 113901424 | Human |
| 616975606 | GWAS1993105_H | electrocardiography QTL GWAS1993105 (human) | | 1e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 597429164 | GWAS1525238_H | protein measurement QTL GWAS1525238 (human) | | 1e-32 | protein measurement | | 4 | 121025981 | 121025982 | Human |
| 628641096 | GWAS2549325_H | colorectal cancer, tea consumption measurement QTL GWAS2549325 (human) | | 0.000006 | drinking behavior trait (VT:0001422) | drink intake measurement (CMO:0000771) | 4 | 131412330 | 131412331 | Human |
| 628936013 | GWAS2844242_H | body weight QTL GWAS2844242 (human) | | 3e-20 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 121792708 | 121792709 | Human |
| 597461933 | GWAS1558007_H | Eczematoid dermatitis QTL GWAS1558007 (human) | | 0.000002 | Eczematoid dermatitis | | 4 | 122109428 | 122109429 | Human |
| 617073909 | GWAS2091408_H | cortical thickness QTL GWAS2091408 (human) | | 3e-08 | cortical thickness | | 4 | 126550097 | 126550098 | Human |
| 617057523 | GWAS2075022_H | Alzheimer disease QTL GWAS2075022 (human) | | 1e-10 | Alzheimer disease | | 4 | 108219159 | 108219160 | Human |
| 407105659 | GWAS754635_H | platelet count QTL GWAS754635 (human) | | 3e-27 | platelet count | | 4 | 109966833 | 109966834 | Human |
| 407220349 | GWAS869325_H | serum metabolite measurement QTL GWAS869325 (human) | | 8e-11 | serum metabolite measurement | | 4 | 110430068 | 110430069 | Human |
| 407220348 | GWAS869324_H | serum metabolite measurement QTL GWAS869324 (human) | | 5e-13 | serum metabolite measurement | | 4 | 110414566 | 110414567 | Human |
| 628804928 | GWAS2713157_H | body mass index QTL GWAS2713157 (human) | | 4e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 114132729 | 114132730 | Human |
| 616500356 | GWAS1896939_H | level of pancreatic triacylglycerol lipase in blood serum QTL GWAS1896939 (human) | | 1e-17 | level of pancreatic triacylglycerol lipase in blood serum | | 4 | 109933893 | 109933894 | Human |
| 407335036 | GWAS984012_H | monocyte count QTL GWAS984012 (human) | | 2e-18 | monocyte count | | 4 | 110024100 | 110024101 | Human |
| 407105663 | GWAS754639_H | platelet count QTL GWAS754639 (human) | | 8e-12 | platelet count | | 4 | 123882996 | 123882997 | Human |
| 407105662 | GWAS754638_H | platelet count QTL GWAS754638 (human) | | 2e-11 | platelet count | | 4 | 123749526 | 123749527 | Human |
| 597592992 | GWAS1649852_H | platelet count QTL GWAS1649852 (human) | | 4e-12 | platelet count | | 4 | 109916511 | 109916512 | Human |
| 407105661 | GWAS754637_H | platelet count QTL GWAS754637 (human) | | 7e-11 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 407105660 | GWAS754636_H | platelet count QTL GWAS754636 (human) | | 1e-17 | platelet count | | 4 | 119342213 | 119342215 | Human |
| 598035354 | GWAS1754653_H | glomerular filtration rate QTL GWAS1754653 (human) | | 0.0000001 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 598019044 | GWAS1738343_H | myeloid leukocyte count QTL GWAS1738343 (human) | | 6e-13 | myeloid leukocyte count | | 4 | 119342160 | 119342161 | Human |
| 407154694 | GWAS803670_H | response to anticonvulsant QTL GWAS803670 (human) | | 0.0000001 | response to anticonvulsant | | 4 | 113140380 | 113140381 | Human |
| 628804926 | GWAS2713155_H | body mass index QTL GWAS2713155 (human) | | 2e-18 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 111781479 | 111781480 | Human |
| 407269378 | GWAS918354_H | body height QTL GWAS918354 (human) | | 2e-19 | body height | | 4 | 120734912 | 120734913 | Human |
| 406908932 | GWAS557908_H | fat body mass QTL GWAS557908 (human) | | 0.000003 | fat body mass | | 4 | 129885831 | 129885832 | Human |
| 628804927 | GWAS2713156_H | body mass index QTL GWAS2713156 (human) | | 1e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112339309 | 112339310 | Human |
| 628837694 | GWAS2745923_H | FEV/FVC ratio QTL GWAS2745923 (human) | | 7e-12 | lung capacity (VT:0001942) | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 123898452 | 123898453 | Human |
| 598019043 | GWAS1738342_H | myeloid leukocyte count QTL GWAS1738342 (human) | | 9e-13 | myeloid leukocyte count | | 4 | 110024810 | 110024811 | Human |
| 628804925 | GWAS2713154_H | body mass index QTL GWAS2713154 (human) | | 8e-09 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 110683327 | 110683328 | Human |
| 628772147 | GWAS2680376_H | cortical thickness QTL GWAS2680376 (human) | | 2e-09 | cerebral cortex morphology trait (VT:0000788) | | 4 | 114517484 | 114517485 | Human |
| 628411709 | GWAS2319938_H | gut microbiome measurement QTL GWAS2319938 (human) | | 0.000008 | gut microbiome measurement | | 4 | 119132069 | 119132070 | Human |
| 407253003 | GWAS901979_H | low density lipoprotein cholesterol measurement QTL GWAS901979 (human) | | 6e-09 | low density lipoprotein cholesterol measurement | | 4 | 119206905 | 119206906 | Human |
| 628526392 | GWAS2434621_H | mean arterial pressure QTL GWAS2434621 (human) | | 1e-15 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 110430068 | 110430069 | Human |
| 407220235 | GWAS869211_H | cortex volume change measurement, age at assessment QTL GWAS869211 (human) | | 0.000003 | cortex volume change measurement, age at assessment | | 4 | 111512339 | 111512340 | Human |
| 628510008 | GWAS2418237_H | systemic lupus erythematosus QTL GWAS2418237 (human) | | 1e-09 | systemic lupus erythematosus | | 4 | 122587346 | 122587347 | Human |
| 628526375 | GWAS2434604_H | acne QTL GWAS2434604 (human) | | 6e-16 | acne | | 4 | 123258364 | 123258365 | Human |
| 626461956 | GWAS2275889_H | obesity QTL GWAS2275889 (human) | | 2e-08 | obesity | | 4 | 111788834 | 111788835 | Human |
| 617090203 | GWAS2107702_H | hematocrit QTL GWAS2107702 (human) | | 6e-12 | hematocrit | | 4 | 114598669 | 114598670 | Human |
| 597265357 | GWAS1361431_H | cortical thickness QTL GWAS1361431 (human) | | 3e-11 | cortical thickness | | 4 | 120773757 | 120773758 | Human |
| 597265356 | GWAS1361430_H | cortical thickness QTL GWAS1361430 (human) | | 8e-09 | cortical thickness | | 4 | 119920489 | 119920490 | Human |
| 628477226 | GWAS2385455_H | triglyceride measurement QTL GWAS2385455 (human) | | 1e-12 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109717608 | 109717609 | Human |
| 628919582 | GWAS2827811_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2827811 (human) | | 8e-09 | fatty acid amount (VT:0010046) | | 4 | 109603883 | 109603884 | Human |
| 406941735 | GWAS590711_H | QRS-T angle QTL GWAS590711 (human) | | 3e-26 | QRS-T angle | | 4 | 113523590 | 113523591 | Human |
| 628821267 | GWAS2729496_H | hypertension QTL GWAS2729496 (human) | | 3e-15 | blood pressure trait (VT:0000183) | | 4 | 110434637 | 110434638 | Human |
| 628837654 | GWAS2745883_H | lipid measurement QTL GWAS2745883 (human) | | 0.000003 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 112764648 | 112764649 | Human |
| 628903187 | GWAS2811416_H | Premature atrial contractions QTL GWAS2811416 (human) | | 0.0000005 | Premature atrial contractions | | 4 | 121016813 | 121016815 | Human |
| 406958132 | GWAS607108_H | calcium/calmodulin-dependent protein kinase type II subunit delta measurement QTL GWAS607108 (human) | | 2e-12 | calcium/calmodulin-dependent protein kinase type II subunit delta measurement | | 4 | 113747320 | 113747321 | Human |
| 407367729 | GWAS1016705_H | platelet count QTL GWAS1016705 (human) | | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119528655 | 119528656 | Human |
| 597822420 | GWAS1689811_H | coronary artery disease QTL GWAS1689811 (human) | | 1e-11 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 597412845 | GWAS1508919_H | brain connectivity measurement QTL GWAS1508919 (human) | | 2e-11 | brain connectivity measurement | | 4 | 125825074 | 125825075 | Human |
| 628624641 | GWAS2532870_H | chronotype measurement QTL GWAS2532870 (human) | | 4e-09 | sleep behavior trait (VT:0001501) | | 4 | 117394404 | 117394405 | Human |
| 596986857 | GWAS1106376_H | systolic blood pressure QTL GWAS1106376 (human) | | 3e-12 | systolic blood pressure | | 4 | 110417121 | 110417122 | Human |
| 626462163 | GWAS2276096_H | leukocyte quantity QTL GWAS2276096 (human) | | 2e-31 | leukocyte quantity | | 4 | 110001340 | 110001341 | Human |
| 597822250 | GWAS1689641_H | Ischemic stroke QTL GWAS1689641 (human) | | 5e-16 | Ischemic stroke | | 4 | 110775495 | 110775496 | Human |
| 597150494 | GWAS1246568_H | post-traumatic stress disorder QTL GWAS1246568 (human) | | 0.000001 | post-traumatic stress disorder | | 4 | 106417893 | 106417894 | Human |
| 628624882 | GWAS2533111_H | strand of hair color QTL GWAS2533111 (human) | | 1e-15 | strand of hair color | | 4 | 108327206 | 108327207 | Human |
| 597494551 | GWAS1590625_H | Ischemic stroke QTL GWAS1590625 (human) | | 5e-08 | Ischemic stroke | | 4 | 110789013 | 110789014 | Human |
| 628624883 | GWAS2533112_H | strand of hair color QTL GWAS2533112 (human) | | 9e-38 | strand of hair color | | 4 | 108429724 | 108429725 | Human |
| 628624884 | GWAS2533113_H | strand of hair color QTL GWAS2533113 (human) | | 5e-23 | strand of hair color | | 4 | 108561329 | 108561330 | Human |
| 597396245 | GWAS1492319_H | cup-to-disc ratio measurement QTL GWAS1492319 (human) | | 4e-08 | cup-to-disc ratio measurement | | 4 | 111904784 | 111904785 | Human |
| 407204043 | GWAS853019_H | corneal resistance factor QTL GWAS853019 (human) | | 7e-11 | corneal resistance factor | | 4 | 118816705 | 118816706 | Human |
| 406892752 | GWAS541728_H | BMI-adjusted waist-hip ratio QTL GWAS541728 (human) | | 5e-19 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
| 597265161 | GWAS1361235_H | lower face morphology measurement QTL GWAS1361235 (human) | | 5e-08 | lower face morphology measurement | | 4 | 123252480 | 123252481 | Human |
| 407171285 | GWAS820261_H | glycerophospholipid measurement QTL GWAS820261 (human) | | 6e-41 | glycerophospholipid measurement | | 4 | 114483120 | 114483121 | Human |
| 407171286 | GWAS820262_H | glycerophospholipid measurement QTL GWAS820262 (human) | | 6e-41 | glycerophospholipid measurement | | 4 | 114507972 | 114507973 | Human |
| 407171287 | GWAS820263_H | glycerophospholipid measurement QTL GWAS820263 (human) | | 7e-41 | glycerophospholipid measurement | | 4 | 114515190 | 114515191 | Human |
| 407204054 | GWAS853030_H | cortical surface area measurement QTL GWAS853030 (human) | | 3e-15 | cortical surface area measurement | | 4 | 123326251 | 123326252 | Human |
| 628870639 | GWAS2778868_H | chronotype measurement, sun exposure measurement QTL GWAS2778868 (human) | | 0.0000002 | sleep behavior trait (VT:0001501) | | 4 | 114197705 | 114197706 | Human |
| 597445385 | GWAS1541459_H | calcium measurement, diet measurement QTL GWAS1541459 (human) | | 0.000006 | calcium measurement, diet measurement | | 4 | 111131258 | 111131259 | Human |
| 407253200 | GWAS902176_H | total blood protein measurement QTL GWAS902176 (human) | | 6e-20 | total blood protein measurement | | 4 | 119206905 | 119206906 | Human |
| 407171292 | GWAS820268_H | glycerophospholipid measurement QTL GWAS820268 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114546303 | 114546304 | Human |
| 628805088 | GWAS2713317_H | self reported educational attainment QTL GWAS2713317 (human) | | 4e-09 | self reported educational attainment | | 4 | 111485805 | 111485806 | Human |
| 597150476 | GWAS1246550_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1246550 (human) | | 2e-18 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407171288 | GWAS820264_H | glycerophospholipid measurement QTL GWAS820264 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114560759 | 114560760 | Human |
| 407007455 | GWAS656431_H | chronotype measurement QTL GWAS656431 (human) | | 4e-09 | chronotype measurement | | 4 | 113518738 | 113518739 | Human |
| 407171289 | GWAS820265_H | glycerophospholipid measurement QTL GWAS820265 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114487644 | 114487645 | Human |
| 628641254 | GWAS2549483_H | atrial fibrillation QTL GWAS2549483 (human) | | 1e-30 | atrial fibrillation | | 4 | 110793733 | 110793734 | Human |
| 407171290 | GWAS820266_H | glycerophospholipid measurement QTL GWAS820266 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114488433 | 114488434 | Human |
| 407171291 | GWAS820267_H | glycerophospholipid measurement QTL GWAS820267 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114486174 | 114486175 | Human |
| 617090152 | GWAS2107651_H | platelet count QTL GWAS2107651 (human) | | 1e-13 | platelet count | | 4 | 123837618 | 123837619 | Human |
| 597379896 | GWAS1475970_H | pathological myopia QTL GWAS1475970 (human) | | 8e-13 | eye integrity trait (VT:0011107) | | 4 | 111690594 | 111690595 | Human |
| 616516629 | GWAS1913212_H | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement QTL GWAS1913212 (human) | | 5e-18 | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | | 4 | 123849566 | 123849567 | Human |
| 616516627 | GWAS1913210_H | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement QTL GWAS1913210 (human) | | 2e-27 | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | | 4 | 123872632 | 123872633 | Human |
| 628936145 | GWAS2844374_H | diastolic blood pressure QTL GWAS2844374 (human) | | 6e-14 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119512652 | 119512653 | Human |
| 597134136 | GWAS1230210_H | memory performance QTL GWAS1230210 (human) | | 0.000002 | learning/memory/conditioning trait (VT:0002063) | | 4 | 125664944 | 125664945 | Human |
| 407384295 | GWAS1033271_H | intelligence QTL GWAS1033271 (human) | | 0.000001 | intelligence | | 4 | 130143535 | 130143536 | Human |
| 597478188 | GWAS1574262_H | arterial stiffness measurement QTL GWAS1574262 (human) | | 0.000006 | arterial stiffness measurement | | 4 | 128552943 | 128552944 | Human |
| 628362694 | GWAS2283538_H | creatine level QTL GWAS2283538 (human) | | 0.0000006 | creatine level | | 4 | 110523020 | 110523021 | Human |
| 407023862 | GWAS672838_H | stroke QTL GWAS672838 (human) | | 2e-10 | stroke | | 4 | 110789013 | 110789014 | Human |
| 628837837 | GWAS2746066_H | apolipoprotein A 1 measurement QTL GWAS2746066 (human) | | 1e-13 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109717608 | 109717609 | Human |
| 597150496 | GWAS1246570_H | post-traumatic stress disorder QTL GWAS1246570 (human) | | 0.000002 | post-traumatic stress disorder | | 4 | 106419681 | 106419682 | Human |
| 407089402 | GWAS738378_H | atrial fibrillation QTL GWAS738378 (human) | | 5e-88 | atrial fibrillation | | 4 | 110631977 | 110631978 | Human |
| 628952519 | GWAS2860748_H | systolic blood pressure QTL GWAS2860748 (human) | | 5e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 119154068 | 119154069 | Human |
| 628772288 | GWAS2680517_H | bipolar disorder, Crohn's disease QTL GWAS2680517 (human) | | 4e-12 | intestine integrity trait (VT:0010554) | | 4 | 122154852 | 122154853 | Human |
| 597363495 | GWAS1459569_H | acute myeloid leukemia QTL GWAS1459569 (human) | | 4e-25 | acute myeloid leukemia | | 4 | 112776849 | 112776850 | Human |
| 598067993 | GWAS1787292_H | obsolete_facial morphology quality QTL GWAS1787292 (human) | | 1e-19 | obsolete_facial morphology quality | | 4 | 127005360 | 127005361 | Human |
| 407286009 | GWAS934985_H | metabolite measurement QTL GWAS934985 (human) | | 3e-52 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 597298010 | GWAS1394084_H | body mass index QTL GWAS1394084 (human) | | 7e-12 | body mass index | | 4 | 111770620 | 111770621 | Human |
| 597298011 | GWAS1394085_H | body mass index QTL GWAS1394085 (human) | | 1e-08 | body mass index | | 4 | 114202933 | 114202934 | Human |
| 597199711 | GWAS1295785_H | bone density QTL GWAS1295785 (human) | | 2e-10 | bone density | | 4 | 122897478 | 122897479 | Human |
| 407072906 | GWAS721882_H | systolic blood pressure QTL GWAS721882 (human) | | 2e-08 | systolic blood pressure | | 4 | 110439533 | 110439534 | Human |
| 598035311 | GWAS1754610_H | chromosome, telomeric region length QTL GWAS1754610 (human) | | 0.000009 | chromosome, telomeric region length | | 4 | 110290116 | 110290117 | Human |
| 628673971 | GWAS2582200_H | urate measurement QTL GWAS2582200 (human) | | 6e-09 | urate measurement | blood uric acid level (CMO:0000501) | 4 | 127147534 | 127147535 | Human |
| 616533106 | GWAS1929689_H | platelet crit QTL GWAS1929689 (human) | | 3e-16 | platelet crit | | 4 | 123749526 | 123749527 | Human |
| 597134169 | GWAS1230243_H | glomerular filtration rate QTL GWAS1230243 (human) | | 0.0000002 | glomerular filtration rate | | 4 | 125673826 | 125673827 | Human |
| 407007373 | GWAS656349_H | sex hormone-binding globulin measurement QTL GWAS656349 (human) | | 2e-18 | sex hormone-binding globulin measurement | | 4 | 119185611 | 119185612 | Human |
| 628690347 | GWAS2598576_H | brain attribute QTL GWAS2598576 (human) | | 3e-30 | brain attribute | | 4 | 112512138 | 112512139 | Human |
| 628690349 | GWAS2598578_H | brain attribute QTL GWAS2598578 (human) | | 5e-30 | brain attribute | | 4 | 118393759 | 118393760 | Human |
| 597265231 | GWAS1361305_H | high density lipoprotein cholesterol measurement QTL GWAS1361305 (human) | | 2e-31 | high density lipoprotein cholesterol measurement | | 4 | 109174464 | 109174465 | Human |
| 617188382 | GWAS2168822_H | carotid artery thickness QTL GWAS2168822 (human) | | 0.000006 | carotid artery thickness | | 4 | 118504756 | 118504757 | Human |
| 628428205 | GWAS2336434_H | eosinophil count QTL GWAS2336434 (human) | | 5e-27 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122680359 | 122680360 | Human |
| 626462094 | GWAS2276027_H | obesity QTL GWAS2276027 (human) | | 7e-14 | obesity | | 4 | 129809917 | 129809918 | Human |
| 616959005 | GWAS1976504_H | pathological myopia QTL GWAS1976504 (human) | | 0.000002 | eye integrity trait (VT:0011107) | | 4 | 111781479 | 111781480 | Human |
| 628510102 | GWAS2418331_H | total cholesterol measurement QTL GWAS2418331 (human) | | 2e-08 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 127977878 | 127977879 | Human |
| 407285925 | GWAS934901_H | vaginal microbiome measurement QTL GWAS934901 (human) | | 0.000008 | vaginal microbiome measurement | | 4 | 120143632 | 120143633 | Human |
| 597314431 | GWAS1410505_H | vaginal microbiome measurement QTL GWAS1410505 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 597281660 | GWAS1377734_H | insomnia QTL GWAS1377734 (human) | | 5e-09 | insomnia | | 4 | 118318250 | 118318251 | Human |
| 407367855 | GWAS1016831_H | attention deficit hyperactivity disorder, bipolar disorder QTL GWAS1016831 (human) | | 1e-08 | attention deficit hyperactivity disorder, bipolar disorder | | 4 | 122589611 | 122589612 | Human |
| 617122848 | GWAS2140347_H | bilirubin measurement QTL GWAS2140347 (human) | | 1e-12 | bilirubin measurement | | 4 | 123882996 | 123882997 | Human |
| 597068671 | GWAS1164745_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1164745 (human) | | 0.0000006 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692161 | 122692162 | Human |
| 628493702 | GWAS2401931_H | cocaine dependence QTL GWAS2401931 (human) | | 0.000006 | cocaine dependence | | 4 | 116685914 | 116685915 | Human |
| 597216105 | GWAS1312179_H | protein measurement QTL GWAS1312179 (human) | | 2e-08 | protein amount (VT:0010120) | | 4 | 131061544 | 131061545 | Human |
| 597101413 | GWAS1197487_H | platelet component distribution width QTL GWAS1197487 (human) | | 1e-18 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 4 | 109970517 | 109970518 | Human |
| 617040946 | GWAS2058445_H | conotruncal heart malformations QTL GWAS2058445 (human) | | 0.000003 | conotruncal heart malformations | | 4 | 111868878 | 111868879 | Human |
| 628919686 | GWAS2827915_H | hemoglobin measurement QTL GWAS2827915 (human) | | 2e-09 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114559972 | 114559973 | Human |
| 628657542 | GWAS2565771_H | breast carcinoma QTL GWAS2565771 (human) | | 0.000003 | mammary gland integrity trait (VT:0010552) | | 4 | 116639835 | 116639836 | Human |
| 628460938 | GWAS2369167_H | systemic lupus erythematosus QTL GWAS2369167 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122470309 | 122470310 | Human |
| 406909250 | GWAS558226_H | breast density QTL GWAS558226 (human) | | 0.000005 | breast density | | 4 | 120803641 | 120803642 | Human |
| 597396115 | GWAS1492189_H | retinal vasculature measurement QTL GWAS1492189 (human) | | 7e-58 | retinal vasculature measurement | | 4 | 119356945 | 119356946 | Human |
| 597494420 | GWAS1590494_H | insomnia QTL GWAS1590494 (human) | | 3e-10 | insomnia | | 4 | 130028211 | 130028212 | Human |
| 597494419 | GWAS1590493_H | insomnia QTL GWAS1590493 (human) | | 2e-11 | insomnia | | 4 | 129856909 | 129856910 | Human |
| 407253329 | GWAS902305_H | glomerular filtration rate QTL GWAS902305 (human) | | 1e-12 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 407384400 | GWAS1033376_H | eosinophil count QTL GWAS1033376 (human) | | 9e-10 | eosinophil count | | 4 | 122265396 | 122265397 | Human |
| 628411502 | GWAS2319731_H | gut microbiome measurement QTL GWAS2319731 (human) | | 0.000006 | gut microbiome measurement | | 4 | 123354475 | 123354476 | Human |
| 617024987 | GWAS2042486_H | testosterone measurement QTL GWAS2042486 (human) | | 2e-10 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 113035247 | 113035248 | Human |
| 597379719 | GWAS1475793_H | phosphatidylcholine 38:2 measurement QTL GWAS1475793 (human) | | 0.000006 | phosphatidylcholine 38:2 measurement | | 4 | 117433671 | 117433672 | Human |
| 628935773 | GWAS2844002_H | triglyceride measurement QTL GWAS2844002 (human) | | 4e-37 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
| 617090538 | GWAS2108037_H | body height QTL GWAS2108037 (human) | | 2e-16 | body height | | 4 | 108560745 | 108560746 | Human |
| 597265085 | GWAS1361159_H | diastolic blood pressure QTL GWAS1361159 (human) | | 2e-11 | diastolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 616959457 | GWAS1976956_H | balding measurement QTL GWAS1976956 (human) | | 4e-12 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 124209285 | 124209286 | Human |
| 406958440 | GWAS607416_H | type 1 diabetes mellitus QTL GWAS607416 (human) | | 0.0000005 | type 1 diabetes mellitus | | 4 | 122456825 | 122456826 | Human |
| 597428918 | GWAS1524992_H | protein measurement QTL GWAS1524992 (human) | | 1e-40 | protein measurement | | 4 | 106826356 | 106826357 | Human |
| 407007592 | GWAS656568_H | BMI-adjusted waist-hip ratio QTL GWAS656568 (human) | | 3e-08 | BMI-adjusted waist-hip ratio | | 4 | 119607172 | 119607173 | Human |
| 407335276 | GWAS984252_H | erythrocyte count QTL GWAS984252 (human) | | 3e-15 | erythrocyte count | | 4 | 121827841 | 121827842 | Human |
| 598018699 | GWAS1737998_H | myeloid leukocyte count QTL GWAS1737998 (human) | | 6e-11 | myeloid leukocyte count | | 4 | 110020646 | 110020647 | Human |
| 407007596 | GWAS656572_H | BMI-adjusted waist-hip ratio QTL GWAS656572 (human) | | 1e-09 | BMI-adjusted waist-hip ratio | | 4 | 119607172 | 119607173 | Human |
| 597412532 | GWAS1508606_H | brain connectivity measurement QTL GWAS1508606 (human) | | 6e-11 | brain connectivity measurement | | 4 | 125820645 | 125820646 | Human |
| 617090555 | GWAS2108054_H | body height QTL GWAS2108054 (human) | | 8e-10 | body height | | 4 | 108355674 | 108355675 | Human |
| 407253375 | GWAS902351_H | vaginal microbiome measurement QTL GWAS902351 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 407253371 | GWAS902347_H | cardioembolic stroke QTL GWAS902347 (human) | | 8e-237 | cardioembolic stroke | | 4 | 110743002 | 110743003 | Human |
| 628837445 | GWAS2745674_H | body mass index QTL GWAS2745674 (human) | | 8e-12 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
| 628739129 | GWAS2647358_H | childhood trauma measurement, alcohol consumption quality QTL GWAS2647358 (human) | | 1e-08 | childhood trauma measurement, alcohol consumption quality | | 4 | 126655945 | 126655946 | Human |
| 407286021 | GWAS934997_H | complement factor I measurement QTL GWAS934997 (human) | | 5e-12 | complement factor I measurement | | 4 | 109799365 | 109799366 | Human |
| 628739130 | GWAS2647359_H | childhood trauma measurement, alcohol consumption quality QTL GWAS2647359 (human) | | 8e-09 | childhood trauma measurement, alcohol consumption quality | | 4 | 127440030 | 127440031 | Human |
| 628821055 | GWAS2729284_H | high density lipoprotein cholesterol measurement QTL GWAS2729284 (human) | | 5e-22 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 628952117 | GWAS2860346_H | systolic blood pressure QTL GWAS2860346 (human) | | 2e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 127144496 | 127144497 | Human |
| 628624435 | GWAS2532664_H | Eczematoid dermatitis QTL GWAS2532664 (human) | | 2e-26 | Eczematoid dermatitis | | 4 | 122219915 | 122219916 | Human |
| 628493370 | GWAS2401599_H | electroencephalogram measurement QTL GWAS2401599 (human) | | 0.000005 | electroencephalogram measurement | brain activity measurement (CMO:0001737) | 4 | 107150343 | 107150344 | Human |
| 628624436 | GWAS2532665_H | Eczematoid dermatitis QTL GWAS2532665 (human) | | 1e-37 | Eczematoid dermatitis | | 4 | 122415763 | 122415764 | Human |
| 407204105 | GWAS853081_H | protein measurement QTL GWAS853081 (human) | | 6e-10 | protein measurement | | 4 | 132286668 | 132286669 | Human |
| 407269643 | GWAS918619_H | body height QTL GWAS918619 (human) | | 1e-277 | body height | | 4 | 108540829 | 108540830 | Human |
| 407269655 | GWAS918631_H | body height QTL GWAS918631 (human) | | 0.000002 | body height | | 4 | 108823766 | 108823767 | Human |
| 597117638 | GWAS1213712_H | mathematical ability QTL GWAS1213712 (human) | | 4e-13 | mathematical ability | | 4 | 128819435 | 128819436 | Human |
| 597297864 | GWAS1393938_H | hematocrit QTL GWAS1393938 (human) | | 6e-12 | hematocrit | | 4 | 114598669 | 114598670 | Human |
| 597117637 | GWAS1213711_H | mathematical ability QTL GWAS1213711 (human) | | 5e-09 | mathematical ability | | 4 | 114994461 | 114994462 | Human |
| 628689963 | GWAS2598192_H | total cholesterol measurement QTL GWAS2598192 (human) | | 4e-10 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 119185611 | 119185612 | Human |
| 597019335 | GWAS1115409_H | BMI-adjusted waist-hip ratio QTL GWAS1115409 (human) | | 5e-09 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
| 617024917 | GWAS2042416_H | protein measurement QTL GWAS2042416 (human) | | 6e-10 | protein amount (VT:0010120) | | 4 | 132286668 | 132286669 | Human |
| 407269651 | GWAS918627_H | body height QTL GWAS918627 (human) | | 4e-144 | body height | | 4 | 108554818 | 108554819 | Human |
| 406892822 | GWAS541798_H | body mass index QTL GWAS541798 (human) | | 4e-08 | body mass index | | 4 | 112390634 | 112390635 | Human |
| 628935723 | GWAS2843952_H | body weight QTL GWAS2843952 (human) | | 4e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 110523790 | 110523791 | Human |
| 407171356 | GWAS820332_H | glycerophospholipid measurement QTL GWAS820332 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114496527 | 114496528 | Human |
| 597412547 | GWAS1508621_H | childhood onset asthma QTL GWAS1508621 (human) | | 3e-13 | childhood onset asthma | | 4 | 122639784 | 122639785 | Human |
| 407269663 | GWAS918639_H | body height QTL GWAS918639 (human) | | 3e-23 | body height | | 4 | 120882137 | 120882138 | Human |
| 628739107 | GWAS2647336_H | glucose metabolism trait, age-related hearing impairment QTL GWAS2647336 (human) | | 0.000007 | hearing physiology trait (VT:0002104) | | 4 | 120558243 | 120558244 | Human |
| 407269658 | GWAS918634_H | body height QTL GWAS918634 (human) | | 2e-44 | body height | | 4 | 108458572 | 108458573 | Human |
| 628886561 | GWAS2794790_H | age-related macular degeneration, COVID-19 QTL GWAS2794790 (human) | | 2e-18 | retina integrity trait (VT:0010771) | | 4 | 109737911 | 109737912 | Human |
| 407171353 | GWAS820329_H | glycerophospholipid measurement QTL GWAS820329 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114482122 | 114482123 | Human |
| 407171354 | GWAS820330_H | glycerophospholipid measurement QTL GWAS820330 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114482175 | 114482176 | Human |
| 407171355 | GWAS820331_H | glycerophospholipid measurement QTL GWAS820331 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114526022 | 114526023 | Human |
| 407269670 | GWAS918646_H | body height QTL GWAS918646 (human) | | 1e-12 | body height | | 4 | 122600025 | 122600026 | Human |
| 407269671 | GWAS918647_H | body height QTL GWAS918647 (human) | | 8e-20 | body height | | 4 | 122626386 | 122626387 | Human |
| 407269668 | GWAS918644_H | body height QTL GWAS918644 (human) | | 4e-49 | body height | | 4 | 121772932 | 121772933 | Human |
| 407269669 | GWAS918645_H | body height QTL GWAS918645 (human) | | 9e-190 | body height | | 4 | 121799844 | 121799845 | Human |
| 407269667 | GWAS918643_H | body height QTL GWAS918643 (human) | | 7e-19 | body height | | 4 | 121693600 | 121693601 | Human |
| 628902938 | GWAS2811167_H | systolic blood pressure QTL GWAS2811167 (human) | | 6e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110427909 | 110427910 | Human |
| 628673566 | GWAS2581795_H | glioblastoma multiforme QTL GWAS2581795 (human) | | 0.000006 | brain integrity trait (VT:0010579) | | 4 | 123019629 | 123019630 | Human |
| 407269676 | GWAS918652_H | body height QTL GWAS918652 (human) | | 1e-32 | body height | | 4 | 123312229 | 123312230 | Human |
| 407269677 | GWAS918653_H | body height QTL GWAS918653 (human) | | 2e-19 | body height | | 4 | 123707660 | 123707661 | Human |
| 617057707 | GWAS2075206_H | calcium measurement QTL GWAS2075206 (human) | | 1e-12 | calcium measurement | | 4 | 114469815 | 114469816 | Human |
| 407269674 | GWAS918650_H | body height QTL GWAS918650 (human) | | 2e-96 | body height | | 4 | 122830862 | 122830863 | Human |
| 407269675 | GWAS918651_H | body height QTL GWAS918651 (human) | | 7e-150 | body height | | 4 | 122917603 | 122917604 | Human |
| 407269672 | GWAS918648_H | body height QTL GWAS918648 (human) | | 2e-37 | body height | | 4 | 122757847 | 122757848 | Human |
| 407269673 | GWAS918649_H | body height QTL GWAS918649 (human) | | 0.0000001 | body height | | 4 | 122824456 | 122824457 | Human |
| 597412587 | GWAS1508661_H | atopic asthma QTL GWAS1508661 (human) | | 1e-14 | atopic asthma | | 4 | 122639784 | 122639785 | Human |
| 407007537 | GWAS656513_H | asthma QTL GWAS656513 (human) | | 2e-26 | asthma | | 4 | 122146653 | 122146654 | Human |
| 617024946 | GWAS2042445_H | cytokine measurement QTL GWAS2042445 (human) | | 0.000001 | cytokine amount (VT:0008713) | blood cytokine measurement (CMO:0001924) | 4 | 125803384 | 125803385 | Human |
| 598002387 | GWAS1721686_H | spleen volume QTL GWAS1721686 (human) | | 4e-14 | spleen volume | | 4 | 109912954 | 109912955 | Human |
| 597412588 | GWAS1508662_H | atopic asthma QTL GWAS1508662 (human) | | 8e-19 | atopic asthma | | 4 | 122084379 | 122084380 | Human |
| 407236914 | GWAS885890_H | bone density QTL GWAS885890 (human) | | 4e-08 | bone density | | 4 | 131155333 | 131155334 | Human |
| 596953623 | GWAS1073142_H | alcohol consumption measurement QTL GWAS1073142 (human) | | 0.000006 | alcohol consumption measurement | | 4 | 131688192 | 131688193 | Human |
| 597248529 | GWAS1344603_H | magnesium measurement QTL GWAS1344603 (human) | | 0.000004 | magnesium measurement | | 4 | 112431743 | 112431744 | Human |
| 597248528 | GWAS1344602_H | calcium measurement QTL GWAS1344602 (human) | | 0.000003 | calcium measurement | | 4 | 119895428 | 119895429 | Human |
| 628624627 | GWAS2532856_H | strand of hair color QTL GWAS2532856 (human) | | 5e-12 | strand of hair color | | 4 | 108003401 | 108003402 | Human |
| 628624628 | GWAS2532857_H | strand of hair color QTL GWAS2532857 (human) | | 1e-17 | strand of hair color | | 4 | 108163945 | 108163946 | Human |
| 597461521 | GWAS1557595_H | smoking status measurement QTL GWAS1557595 (human) | | 2e-10 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
| 406909393 | GWAS558369_H | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer QTL GWAS558369 (human) | | 0.0000001 | life span trait (VT:0005372) | ratio of deaths to total study population during a period of time (CMO:0001023) | 4 | 110810780 | 110810781 | Human |
| 598034993 | GWAS1754292_H | glomerular filtration rate QTL GWAS1754292 (human) | | 9e-15 | glomerular filtration rate | | 4 | 108772770 | 108772771 | Human |
| 597379598 | GWAS1475672_H | QT interval QTL GWAS1475672 (human) | | 0.0000008 | QT interval | | 4 | 117411099 | 117411100 | Human |
| 628903146 | GWAS2811375_H | diastolic blood pressure QTL GWAS2811375 (human) | | 6e-12 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110427909 | 110427910 | Human |
| 616959312 | GWAS1976811_H | electrocardiography QTL GWAS1976811 (human) | | 5e-09 | electrocardiography | | 4 | 110793263 | 110793264 | Human |
| 407138770 | GWAS787746_H | Alzheimer disease QTL GWAS787746 (human) | | 0.000008 | Alzheimer disease | | 4 | 122647254 | 122647255 | Human |
| 597264899 | GWAS1360973_H | BMI-adjusted hip circumference QTL GWAS1360973 (human) | | 2e-09 | BMI-adjusted hip circumference | | 4 | 123145793 | 123145794 | Human |
| 597264898 | GWAS1360972_H | BMI-adjusted hip circumference QTL GWAS1360972 (human) | | 1e-08 | BMI-adjusted hip circumference | | 4 | 119759405 | 119759406 | Human |
| 598035001 | GWAS1754300_H | glomerular filtration rate QTL GWAS1754300 (human) | | 7e-17 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 628657370 | GWAS2565599_H | sex hormone-binding globulin measurement QTL GWAS2565599 (human) | | 7e-09 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
| 407302629 | GWAS951605_H | colorectal cancer QTL GWAS951605 (human) | | 0.000003 | colorectal cancer | | 4 | 123587620 | 123587621 | Human |
| 597019186 | GWAS1115260_H | body mass index QTL GWAS1115260 (human) | | 0.0000007 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 122841742 | 122841743 | Human |
| 628722899 | GWAS2631128_H | vaginal microbiome measurement QTL GWAS2631128 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 628493530 | GWAS2401759_H | Diuretic use measurement QTL GWAS2401759 (human) | | 9e-09 | Diuretic use measurement | | 4 | 110504739 | 110504740 | Human |
| 616992119 | GWAS2009618_H | schizophrenia QTL GWAS2009618 (human) | | 0.000003 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
| 628788431 | GWAS2696660_H | protein measurement QTL GWAS2696660 (human) | | 5e-32 | protein amount (VT:0010120) | | 4 | 109915408 | 109915409 | Human |
| 407302640 | GWAS951616_H | childhood onset asthma QTL GWAS951616 (human) | | 6e-36 | childhood onset asthma | | 4 | 122432277 | 122432278 | Human |
| 628821187 | GWAS2729416_H | glomerular filtration rate QTL GWAS2729416 (human) | | 1e-13 | glomerular filtration rate | | 4 | 127272519 | 127272520 | Human |
| 407384561 | GWAS1033537_H | body mass index QTL GWAS1033537 (human) | | 2e-10 | body mass index | | 4 | 111731920 | 111731921 | Human |
| 407155195 | GWAS804171_H | BMI-adjusted waist circumference QTL GWAS804171 (human) | | 4e-08 | BMI-adjusted waist circumference | | 4 | 123169108 | 123169109 | Human |
| 597215832 | GWAS1311906_H | body height QTL GWAS1311906 (human) | | 4e-10 | body height | | 4 | 109096050 | 109096051 | Human |
| 407269764 | GWAS918740_H | cholesterol:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS918740 (human) | | 8e-10 | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | | 4 | 109657070 | 109657071 | Human |
| 597314136 | GWAS1410210_H | cortical surface area measurement QTL GWAS1410210 (human) | | 4e-09 | cortical surface area measurement | | 4 | 120653052 | 120653053 | Human |
| 597396063 | GWAS1492137_H | cardioembolic stroke QTL GWAS1492137 (human) | | 5e-11 | cardioembolic stroke | | 4 | 113507558 | 113507559 | Human |
| 597822055 | GWAS1689446_H | phospholipids:total lipids ratio QTL GWAS1689446 (human) | | 6e-13 | phospholipids:total lipids ratio | | 4 | 109657070 | 109657071 | Human |
| 597281372 | GWAS1377446_H | QT interval QTL GWAS1377446 (human) | | 1e-11 | QT interval | | 4 | 113504778 | 113504779 | Human |
| 407269774 | GWAS918750_H | body height QTL GWAS918750 (human) | | 6e-22 | body height | | 4 | 119033555 | 119033556 | Human |
| 597117534 | GWAS1213608_H | systemic lupus erythematosus QTL GWAS1213608 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122470309 | 122470310 | Human |
| 407269772 | GWAS918748_H | body height QTL GWAS918748 (human) | | 2e-10 | body height | | 4 | 114683908 | 114683909 | Human |
| 628870327 | GWAS2778556_H | protein measurement QTL GWAS2778556 (human) | | 4e-13 | protein amount (VT:0010120) | | 4 | 108004097 | 108004098 | Human |
| 597215828 | GWAS1311902_H | body height QTL GWAS1311902 (human) | | 2e-44 | body height | | 4 | 108458572 | 108458573 | Human |
| 597215829 | GWAS1311903_H | body height QTL GWAS1311903 (human) | | 0.000002 | body height | | 4 | 108823766 | 108823767 | Human |
| 407269771 | GWAS918747_H | body height QTL GWAS918747 (human) | | 1e-12 | body height | | 4 | 114398989 | 114398990 | Human |
| 407302539 | GWAS951515_H | type 2 diabetes mellitus QTL GWAS951515 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 122911999 | 122912000 | Human |
| 597215830 | GWAS1311904_H | body height QTL GWAS1311904 (human) | | 6e-21 | body height | | 4 | 108860632 | 108860633 | Human |
| 617041161 | GWAS2058660_H | thyroxine amount QTL GWAS2058660 (human) | | 5e-08 | thyroxine amount | | 4 | 123563112 | 123563113 | Human |
| 407400838 | GWAS1049814_H | arterial stiffness measurement QTL GWAS1049814 (human) | | 0.000006 | arterial stiffness measurement | | 4 | 128552943 | 128552944 | Human |
| 597215831 | GWAS1311905_H | body height QTL GWAS1311905 (human) | | 1e-25 | body height | | 4 | 109096026 | 109096027 | Human |
| 407269781 | GWAS918757_H | body height QTL GWAS918757 (human) | | 4e-17 | body height | | 4 | 118815641 | 118815642 | Human |
| 407220630 | GWAS869606_H | cytokine measurement QTL GWAS869606 (human) | | 0.000001 | cytokine measurement | | 4 | 128887051 | 128887052 | Human |
| 407269778 | GWAS918754_H | body height QTL GWAS918754 (human) | | 2e-17 | body height | | 4 | 118088739 | 118088740 | Human |
| 616549738 | GWAS1946321_H | hypertension QTL GWAS1946321 (human) | | 3e-15 | hypertension | | 4 | 110434637 | 110434638 | Human |
| 407269779 | GWAS918755_H | body height QTL GWAS918755 (human) | | 3e-09 | body height | | 4 | 118718546 | 118718547 | Human |
| 407269776 | GWAS918752_H | body height QTL GWAS918752 (human) | | 2e-11 | body height | | 4 | 115342108 | 115342109 | Human |
| 407286160 | GWAS935136_H | eosinophil count QTL GWAS935136 (human) | | 8e-11 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 597609032 | GWAS1665892_H | schizophrenia, family history QTL GWAS1665892 (human) | | 3e-15 | schizophrenia, family history | | 4 | 126055086 | 126055087 | Human |
| 407269777 | GWAS918753_H | body height QTL GWAS918753 (human) | | 0.000001 | body height | | 4 | 117055123 | 117055124 | Human |
| 407417232 | GWAS1066208_H | hematocrit QTL GWAS1066208 (human) | | 6e-12 | hematocrit | | 4 | 114598669 | 114598670 | Human |
| 597019213 | GWAS1115287_H | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment QTL GWAS1115287 (human) | | 7e-08 | body size trait (VT:0100005) | | 4 | 123145793 | 123145794 | Human |
| 617041182 | GWAS2058681_H | Ischemic stroke QTL GWAS2058681 (human) | | 1e-15 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 597330499 | GWAS1426573_H | body mass index QTL GWAS1426573 (human) | | 2e-08 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 407089565 | GWAS738541_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS738541 (human) | | 6e-12 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 407056804 | GWAS705780_H | hippocampal amigdala transition area volume QTL GWAS705780 (human) | | 5e-08 | hippocampal amigdala transition area volume | | 4 | 110099246 | 110099247 | Human |
| 617041184 | GWAS2058683_H | Ischemic stroke QTL GWAS2058683 (human) | | 5e-14 | Ischemic stroke | | 4 | 110793263 | 110793264 | Human |
| 407155114 | GWAS804090_H | gut microbiome measurement QTL GWAS804090 (human) | | 0.0000001 | gut microbiome measurement | | 4 | 126368923 | 126368924 | Human |
| 407171508 | GWAS820484_H | glycerophospholipid measurement QTL GWAS820484 (human) | | 2e-31 | glycerophospholipid measurement | | 4 | 114527990 | 114527991 | Human |
| 597445229 | GWAS1541303_H | open-angle glaucoma QTL GWAS1541303 (human) | | 4e-15 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 407171509 | GWAS820485_H | glycerophospholipid measurement QTL GWAS820485 (human) | | 2e-31 | glycerophospholipid measurement | | 4 | 114531300 | 114531301 | Human |
| 597445230 | GWAS1541304_H | open-angle glaucoma QTL GWAS1541304 (human) | | 1e-08 | open-angle glaucoma | | 4 | 111886876 | 111886877 | Human |
| 407171510 | GWAS820486_H | glycerophospholipid measurement QTL GWAS820486 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114531393 | 114531394 | Human |
| 407024049 | GWAS673025_H | atrial fibrillation QTL GWAS673025 (human) | | 1e-14 | atrial fibrillation | | 4 | 110789013 | 110789014 | Human |
| 407171511 | GWAS820487_H | glycerophospholipid measurement QTL GWAS820487 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114564528 | 114564529 | Human |
| 597445231 | GWAS1541305_H | open-angle glaucoma QTL GWAS1541305 (human) | | 8e-10 | open-angle glaucoma | | 4 | 126000490 | 126000491 | Human |
| 407171504 | GWAS820480_H | glycerophospholipid measurement QTL GWAS820480 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114546112 | 114546113 | Human |
| 597297774 | GWAS1393848_H | fibroblast growth factor 2 measurement QTL GWAS1393848 (human) | | 6e-39 | fibroblast growth factor 2 measurement | | 4 | 122836593 | 122836594 | Human |
| 407171505 | GWAS820481_H | glycerophospholipid measurement QTL GWAS820481 (human) | | 1e-32 | glycerophospholipid measurement | | 4 | 114518110 | 114518111 | Human |
| 407171506 | GWAS820482_H | glycerophospholipid measurement QTL GWAS820482 (human) | | 2e-32 | glycerophospholipid measurement | | 4 | 114527690 | 114527691 | Human |
| 407171507 | GWAS820483_H | glycerophospholipid measurement QTL GWAS820483 (human) | | 2e-32 | glycerophospholipid measurement | | 4 | 114527831 | 114527832 | Human |
| 407171516 | GWAS820492_H | glycerophospholipid measurement QTL GWAS820492 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114490374 | 114490375 | Human |
| 407171517 | GWAS820493_H | glycerophospholipid measurement QTL GWAS820493 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114490577 | 114490578 | Human |
| 628640898 | GWAS2549127_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2549127 (human) | | 6e-09 | gut microbiome measurement, allergen exposure measurement | | 4 | 123477380 | 123477381 | Human |
| 407171515 | GWAS820491_H | glycerophospholipid measurement QTL GWAS820491 (human) | | 1e-28 | glycerophospholipid measurement | | 4 | 114520865 | 114520866 | Human |
| 407286342 | GWAS935318_H | vaginal microbiome measurement QTL GWAS935318 (human) | | 3e-10 | vaginal microbiome measurement | | 4 | 107261570 | 107261571 | Human |
| 407286343 | GWAS935319_H | vaginal microbiome measurement QTL GWAS935319 (human) | | 0.0000004 | vaginal microbiome measurement | | 4 | 107383042 | 107383043 | Human |
| 616992453 | GWAS2009952_H | response to selective serotonin reuptake inhibitor QTL GWAS2009952 (human) | | 0.000005 | response to xenobiotic stimulus trait (VT:0010487) | | 4 | 117586197 | 117586198 | Human |
| 628445041 | GWAS2353270_H | lymphocyte count QTL GWAS2353270 (human) | | 1e-25 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109914892 | 109914893 | Human |
| 628903800 | GWAS2812029_H | Premature atrial contractions QTL GWAS2812029 (human) | | 0.0000004 | Premature atrial contractions | | 4 | 121039245 | 121039246 | Human |
| 628445043 | GWAS2353272_H | lymphocyte count QTL GWAS2353272 (human) | | 8e-23 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 122760001 | 122760002 | Human |
| 628445042 | GWAS2353271_H | lymphocyte count QTL GWAS2353271 (human) | | 6e-27 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112192759 | 112192760 | Human |
| 407286344 | GWAS935320_H | vaginal microbiome measurement QTL GWAS935320 (human) | | 0.0000004 | vaginal microbiome measurement | | 4 | 107467275 | 107467276 | Human |
| 407106129 | GWAS755105_H | waist-hip ratio QTL GWAS755105 (human) | | 2e-10 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 123166618 | 123166619 | Human |
| 597166476 | GWAS1262550_H | open-angle glaucoma QTL GWAS1262550 (human) | | 1e-09 | open-angle glaucoma | | 4 | 125451587 | 125451588 | Human |
| 407368274 | GWAS1017250_H | loneliness measurement QTL GWAS1017250 (human) | | 0.000004 | loneliness measurement | | 4 | 120523895 | 120523896 | Human |
| 597821877 | GWAS1689268_H | phospholipids:total lipids ratio QTL GWAS1689268 (human) | | 1e-08 | phospholipids:total lipids ratio | | 4 | 109717668 | 109717669 | Human |
| 628428642 | GWAS2336871_H | hematocrit QTL GWAS2336871 (human) | | 9e-16 | erythrocyte morphology trait (VT:0002447) | hematocrit (CMO:0000037) | 4 | 114577301 | 114577302 | Human |
| 617123537 | GWAS2141036_H | triglyceride measurement QTL GWAS2141036 (human) | | 2e-25 | triglyceride measurement | | 4 | 109657070 | 109657071 | Human |
| 407302747 | GWAS951723_H | fat body mass QTL GWAS951723 (human) | | 0.000005 | fat body mass | | 4 | 124429906 | 124429907 | Human |
| 597248390 | GWAS1344464_H | complement factor H-related protein 2 measurement QTL GWAS1344464 (human) | | 0.000009 | complement factor H-related protein 2 measurement | | 4 | 127922325 | 127922326 | Human |
| 628608849 | GWAS2517078_H | lipid measurement QTL GWAS2517078 (human) | | 0.000009 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 107039415 | 107039416 | Human |
| 407155304 | GWAS804280_H | body height QTL GWAS804280 (human) | | 1e-10 | body height | | 4 | 124024877 | 124024878 | Human |
| 628903757 | GWAS2811986_H | mean arterial pressure QTL GWAS2811986 (human) | | 1e-11 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 110427909 | 110427910 | Human |
| 407319158 | GWAS968134_H | glomerular filtration rate QTL GWAS968134 (human) | | 0.0000001 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 598051217 | GWAS1770516_H | sleep latency QTL GWAS1770516 (human) | | 0.000001 | sleep latency | | 4 | 122626441 | 122626442 | Human |
| 628641600 | GWAS2549829_H | fibroblast growth factor 2 level QTL GWAS2549829 (human) | | 5e-141 | fibroblast growth factor 2 level | | 4 | 122776139 | 122776140 | Human |
| 617025278 | GWAS2042777_H | corneal topography QTL GWAS2042777 (human) | | 1e-18 | cornea curvature trait (VT:0006151) | | 4 | 127192269 | 127192270 | Human |
| 628821830 | GWAS2730059_H | body fat percentage QTL GWAS2730059 (human) | | 3e-12 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 4 | 129803747 | 129803748 | Human |
| 628412213 | GWAS2320442_H | apolipoprotein B measurement QTL GWAS2320442 (human) | | 1e-10 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 4 | 123837618 | 123837619 | Human |
| 628805432 | GWAS2713661_H | prostate carcinoma QTL GWAS2713661 (human) | | 4e-08 | prostate integrity trait (VT:0010571) | | 4 | 109927496 | 109927497 | Human |
| 628608820 | GWAS2517049_H | guanosine measurement QTL GWAS2517049 (human) | | 0.00001 | guanosine measurement | | 4 | 113514721 | 113514722 | Human |
| 407155200 | GWAS804176_H | BMI-adjusted waist circumference QTL GWAS804176 (human) | | 3e-11 | BMI-adjusted waist circumference | | 4 | 123124286 | 123124287 | Human |
| 628641596 | GWAS2549825_H | fibroblast growth factor 2 level QTL GWAS2549825 (human) | | 3e-08 | fibroblast growth factor 2 level | | 4 | 123380906 | 123380907 | Human |
| 407155201 | GWAS804177_H | BMI-adjusted waist circumference QTL GWAS804177 (human) | | 5e-12 | BMI-adjusted waist circumference | | 4 | 123166618 | 123166619 | Human |
| 628641598 | GWAS2549827_H | fibroblast growth factor 2 level QTL GWAS2549827 (human) | | 6e-14 | fibroblast growth factor 2 level | | 4 | 121977042 | 121977043 | Human |
| 407155202 | GWAS804178_H | BMI-adjusted waist circumference QTL GWAS804178 (human) | | 8e-09 | BMI-adjusted waist circumference | | 4 | 123359695 | 123359696 | Human |
| 407007754 | GWAS656730_H | monocyte count QTL GWAS656730 (human) | | 3e-10 | monocyte count | | 4 | 110020646 | 110020647 | Human |
| 596953566 | GWAS1073085_H | Red cell distribution width QTL GWAS1073085 (human) | | 6e-21 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 407286282 | GWAS935258_H | vaginal microbiome measurement QTL GWAS935258 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 628805431 | GWAS2713660_H | prostate carcinoma QTL GWAS2713660 (human) | | 3e-08 | prostate integrity trait (VT:0010571) | | 4 | 109889343 | 109889344 | Human |
| 617057941 | GWAS2075440_H | multiple sclerosis QTL GWAS2075440 (human) | | 4e-08 | multiple sclerosis | | 4 | 108174396 | 108174397 | Human |
| 628952879 | GWAS2861108_H | fatty acid amount QTL GWAS2861108 (human) | | 2e-12 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 628952878 | GWAS2861107_H | fatty acid amount QTL GWAS2861107 (human) | | 8e-10 | fatty acid amount | | 4 | 109345757 | 109345758 | Human |
| 628641580 | GWAS2549809_H | gut microbiome measurement, breastfeeding duration QTL GWAS2549809 (human) | | 0.0000004 | lactation duration (VT:1000653) | | 4 | 109916364 | 109916365 | Human |
| 628444961 | GWAS2353190_H | allergic rhinitis QTL GWAS2353190 (human) | | 5e-15 | allergic rhinitis | | 4 | 122415763 | 122415764 | Human |
| 628641583 | GWAS2549812_H | fibroblast growth factor 2 level QTL GWAS2549812 (human) | | 8e-09 | fibroblast growth factor 2 level | | 4 | 121394587 | 121394588 | Human |
| 628772643 | GWAS2680872_H | alkaline phosphatase measurement QTL GWAS2680872 (human) | | 8e-15 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 128168289 | 128168290 | Human |
| 597101004 | GWAS1197078_H | monocyte count QTL GWAS1197078 (human) | | 6e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 119506334 | 119506335 | Human |
| 597101003 | GWAS1197077_H | monocyte count QTL GWAS1197077 (human) | | 9e-22 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109966833 | 109966834 | Human |
| 407253528 | GWAS902504_H | brain measurement QTL GWAS902504 (human) | | 1e-10 | brain measurement | | 4 | 124548568 | 124548569 | Human |
| 407269924 | GWAS918900_H | 4-ethylphenylsulfate measurement QTL GWAS918900 (human) | | 0.000004 | 4-ethylphenylsulfate measurement | | 4 | 108059616 | 108059617 | Human |
| 597166588 | GWAS1262662_H | urolithiasis QTL GWAS1262662 (human) | | 1e-09 | urolithiasis | | 4 | 114460763 | 114460764 | Human |
| 596953587 | GWAS1073106_H | respiratory system disease QTL GWAS1073106 (human) | | 5e-36 | respiratory system disease | | 4 | 122432277 | 122432278 | Human |
| 628821779 | GWAS2730008_H | hemoglobin measurement QTL GWAS2730008 (human) | | 3e-11 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114551415 | 114551416 | Human |
| 617090721 | GWAS2108220_H | forced expiratory volume QTL GWAS2108220 (human) | | 6e-13 | forced expiratory volume | | 4 | 123917030 | 123917031 | Human |
| 597395957 | GWAS1492031_H | Antithrombotic agent use measurement QTL GWAS1492031 (human) | | 4e-20 | Antithrombotic agent use measurement | | 4 | 110784139 | 110784140 | Human |
| 628608793 | GWAS2517022_H | 3-methyl-2-oxobutyrate measurement QTL GWAS2517022 (human) | | 0.000009 | 3-methyl-2-oxobutyrate measurement | | 4 | 124716785 | 124716786 | Human |
| 628821780 | GWAS2730009_H | hemoglobin measurement QTL GWAS2730009 (human) | | 1e-10 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 124004016 | 124004017 | Human |
| 407269942 | GWAS918918_H | body height QTL GWAS918918 (human) | | 1e-25 | body height | | 4 | 109096026 | 109096027 | Human |
| 407089715 | GWAS738691_H | atrial fibrillation QTL GWAS738691 (human) | | 2e-39 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
| 407155254 | GWAS804230_H | anxiety QTL GWAS804230 (human) | | 2e-09 | anxiety | | 4 | 131717648 | 131717649 | Human |
| 407269941 | GWAS918917_H | body height QTL GWAS918917 (human) | | 6e-21 | body height | | 4 | 108860632 | 108860633 | Human |
| 407089719 | GWAS738695_H | atrial fibrillation QTL GWAS738695 (human) | | 8e-12 | atrial fibrillation | | 4 | 110733185 | 110733186 | Human |
| 598002129 | GWAS1721428_H | body height QTL GWAS1721428 (human) | | 1e-10 | body height | | 4 | 124024877 | 124024878 | Human |
| 616992444 | GWAS2009943_H | heel bone mineral density QTL GWAS2009943 (human) | | 4e-14 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 126607237 | 126607238 | Human |
| 407269946 | GWAS918922_H | body height QTL GWAS918922 (human) | | 3e-10 | body height | | 4 | 109411761 | 109411762 | Human |
| 628657925 | GWAS2566154_H | testosterone measurement QTL GWAS2566154 (human) | | 6e-16 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 109345757 | 109345758 | Human |
| 616992443 | GWAS2009942_H | heel bone mineral density QTL GWAS2009942 (human) | | 4e-14 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 123706225 | 123706226 | Human |
| 407269944 | GWAS918920_H | body height QTL GWAS918920 (human) | | 4e-10 | body height | | 4 | 109096050 | 109096051 | Human |
| 597477858 | GWAS1573932_H | comparative body size at age 10, self-reported QTL GWAS1573932 (human) | | 1e-11 | comparative body size at age 10, self-reported | | 4 | 129819249 | 129819250 | Human |
| 406975169 | GWAS624145_H | trait in response to paliperidone, schizophrenia symptom severity measurement QTL GWAS624145 (human) | | 0.000003 | trait in response to paliperidone, schizophrenia symptom severity measurement | | 4 | 119504060 | 119504061 | Human |
| 628412407 | GWAS2320636_H | body height QTL GWAS2320636 (human) | | 2e-15 | body height | | 4 | 108494980 | 108494981 | Human |
| 626462673 | GWAS2276606_H | body height QTL GWAS2276606 (human) | | 4e-63 | body height | | 4 | 121800257 | 121800258 | Human |
| 597084433 | GWAS1180507_H | serum metabolite measurement QTL GWAS1180507 (human) | | 7e-22 | serum metabolite measurement | | 4 | 129113772 | 129113775 | Human |
| 628871154 | GWAS2779383_H | QRS-T angle QTL GWAS2779383 (human) | | 3e-26 | heart excitatory physiology trait (VT:0000231) | | 4 | 113523590 | 113523591 | Human |
| 598083887 | GWAS1803186_H | bone density QTL GWAS1803186 (human) | | 5e-133 | bone density | | 4 | 120625611 | 120625612 | Human |
| 598034732 | GWAS1754031_H | body height QTL GWAS1754031 (human) | | 1e-34 | body height | | 4 | 121801213 | 121801214 | Human |
| 628674545 | GWAS2582774_H | glioblastoma multiforme QTL GWAS2582774 (human) | | 0.00001 | brain integrity trait (VT:0010579) | | 4 | 123310516 | 123310517 | Human |
| 407335629 | GWAS984605_H | mean corpuscular hemoglobin QTL GWAS984605 (human) | | 3e-17 | mean corpuscular hemoglobin | | 4 | 127625245 | 127625246 | Human |
| 407188175 | GWAS837151_H | white matter lesion progression measurement QTL GWAS837151 (human) | | 0.000006 | white matter lesion progression measurement | | 4 | 128668470 | 128668471 | Human |
| 628985847 | GWAS2894076_H | systemic inflammatory response syndrome QTL GWAS2894076 (human) | | 1e-11 | systemic inflammatory response syndrome | | 4 | 131864363 | 131864364 | Human |
| 407335628 | GWAS984604_H | mean corpuscular hemoglobin QTL GWAS984604 (human) | | 5e-51 | mean corpuscular hemoglobin | | 4 | 121875762 | 121875763 | Human |
| 628641781 | GWAS2550010_H | fibroblast growth factor 2 level QTL GWAS2550010 (human) | | 1e-19 | fibroblast growth factor 2 level | | 4 | 126345135 | 126345136 | Human |
| 598083894 | GWAS1803193_H | bone density QTL GWAS1803193 (human) | | 1e-130 | bone density | | 4 | 119406123 | 119406124 | Human |
| 616533550 | GWAS1930133_H | level of sphingomyelin phosphodiesterase in blood serum QTL GWAS1930133 (human) | | 4e-15 | level of sphingomyelin phosphodiesterase in blood serum | | 4 | 118868269 | 118868270 | Human |
| 407171799 | GWAS820775_H | glycerophospholipid measurement QTL GWAS820775 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114512224 | 114512225 | Human |
| 597379342 | GWAS1475416_H | aspartate measurement QTL GWAS1475416 (human) | | 0.000004 | blood L-aspartic acid amount (VT:0010969) | | 4 | 118018897 | 118018898 | Human |
| 407302865 | GWAS951841_H | able to hear with hearing aids QTL GWAS951841 (human) | | 0.0000003 | able to hear with hearing aids | | 4 | 116261685 | 116261686 | Human |
| 407171804 | GWAS820780_H | glycerophospholipid measurement QTL GWAS820780 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114577512 | 114577513 | Human |
| 407171805 | GWAS820781_H | glycerophospholipid measurement QTL GWAS820781 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114493876 | 114493877 | Human |
| 407171800 | GWAS820776_H | glycerophospholipid measurement QTL GWAS820776 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114512391 | 114512392 | Human |
| 407171801 | GWAS820777_H | glycerophospholipid measurement QTL GWAS820777 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114537012 | 114537013 | Human |
| 407171802 | GWAS820778_H | glycerophospholipid measurement QTL GWAS820778 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114522147 | 114522148 | Human |
| 407171803 | GWAS820779_H | glycerophospholipid measurement QTL GWAS820779 (human) | | 4e-27 | glycerophospholipid measurement | | 4 | 114522087 | 114522088 | Human |
| 628412372 | GWAS2320601_H | cup-to-disc ratio measurement QTL GWAS2320601 (human) | | 3e-10 | optic disc morphology trait (VT:0006215) | | 4 | 125475115 | 125475116 | Human |
| 628510677 | GWAS2418906_H | breast density QTL GWAS2418906 (human) | | 0.000005 | breast density | | 4 | 120803641 | 120803642 | Human |
| 597477684 | GWAS1573758_H | sex hormone-binding globulin measurement QTL GWAS1573758 (human) | | 3e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 617057902 | GWAS2075401_H | body mass index QTL GWAS2075401 (human) | | 0.000002 | body mass index | | 4 | 132108281 | 132108282 | Human |
| 628477915 | GWAS2386144_H | BMI-adjusted waist-hip ratio QTL GWAS2386144 (human) | | 3e-08 | body size trait (VT:0100005) | | 4 | 119607172 | 119607173 | Human |
| 407155435 | GWAS804411_H | gut microbiome measurement QTL GWAS804411 (human) | | 0.000001 | gut microbiome measurement | | 4 | 106920747 | 106920748 | Human |
| 407155444 | GWAS804420_H | gut microbiome measurement QTL GWAS804420 (human) | | 0.000006 | gut microbiome measurement | | 4 | 128732972 | 128732973 | Human |
| 628985804 | GWAS2894033_H | high density lipoprotein cholesterol measurement QTL GWAS2894033 (human) | | 5e-37 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 597215529 | GWAS1311603_H | bone density QTL GWAS1311603 (human) | | 1e-300 | bone density | | 4 | 113769407 | 113769408 | Human |
| 597215531 | GWAS1311605_H | bone density QTL GWAS1311605 (human) | | 1e-300 | bone density | | 4 | 116998483 | 116998484 | Human |
| 597215532 | GWAS1311606_H | bone density QTL GWAS1311606 (human) | | 1e-300 | bone density | | 4 | 130129906 | 130129907 | Human |
| 628576194 | GWAS2484423_H | apolipoprotein A 1 measurement QTL GWAS2484423 (human) | | 3e-67 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109717668 | 109717669 | Human |
| 617025138 | GWAS2042637_H | chronotype measurement QTL GWAS2042637 (human) | | 1e-08 | chronotype measurement | | 4 | 113069787 | 113069788 | Human |
| 628576193 | GWAS2484422_H | apolipoprotein A 1 measurement QTL GWAS2484422 (human) | | 3e-23 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109717608 | 109717609 | Human |
| 617008764 | GWAS2026263_H | atrial fibrillation QTL GWAS2026263 (human) | | 6e-38 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
| 406958842 | GWAS607818_H | erythrocyte count QTL GWAS607818 (human) | | 1e-12 | HbA1c measurement | | 4 | 109996470 | 109996471 | Human |
| 598034713 | GWAS1754012_H | body height QTL GWAS1754012 (human) | | 8e-10 | body height | | 4 | 108355674 | 108355675 | Human |
| 616975992 | GWAS1993491_H | urate measurement, spine bone mineral density QTL GWAS1993491 (human) | | 0.000001 | urate measurement, spine bone mineral density | | 4 | 123516413 | 123516414 | Human |
| 628690872 | GWAS2599101_H | cardiovascular disease QTL GWAS2599101 (human) | | 1e-08 | cardiovascular disease | | 4 | 109616095 | 109616096 | Human |
| 597166427 | GWAS1262501_H | lipoprotein measurement QTL GWAS1262501 (human) | | 3e-10 | lipoprotein measurement | | 4 | 109657070 | 109657071 | Human |
| 628494261 | GWAS2402490_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS2402490 (human) | | 4e-09 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110420710 | 110420711 | Human |
| 597477727 | GWAS1573801_H | clostridium difficile infection QTL GWAS1573801 (human) | | 0.000003 | clostridium difficile infection | | 4 | 120516660 | 120516661 | Human |
| 628576179 | GWAS2484408_H | glycerophospholipid measurement QTL GWAS2484408 (human) | | 5e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114494051 | 114494052 | Human |
| 628576178 | GWAS2484407_H | glycerophospholipid measurement QTL GWAS2484407 (human) | | 5e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114552321 | 114552322 | Human |
| 407384717 | GWAS1033693_H | intelligence QTL GWAS1033693 (human) | | 0.000008 | intelligence | | 4 | 128544541 | 128544542 | Human |
| 628576177 | GWAS2484406_H | glycerophospholipid measurement QTL GWAS2484406 (human) | | 5e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114553935 | 114553936 | Human |
| 407188099 | GWAS837075_H | lipid measurement QTL GWAS837075 (human) | | 0.000003 | lipid measurement | | 4 | 116458669 | 116458670 | Human |
| 628576176 | GWAS2484405_H | glycerophospholipid measurement QTL GWAS2484405 (human) | | 5e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114493994 | 114493995 | Human |
| 407270031 | GWAS919007_H | body height QTL GWAS919007 (human) | | 4e-28 | body height | | 4 | 119474818 | 119474819 | Human |
| 617123330 | GWAS2140829_H | eosinophil count QTL GWAS2140829 (human) | | 6e-18 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122680359 | 122680360 | Human |
| 407302793 | GWAS951769_H | sex hormone-binding globulin measurement QTL GWAS951769 (human) | | 9e-41 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 617041416 | GWAS2058915_H | esophageal adenocarcinoma, Barrett's esophagus QTL GWAS2058915 (human) | | 6e-13 | esophageal adenocarcinoma, Barrett's esophagus | | 4 | 123640998 | 123640999 | Human |
| 628576167 | GWAS2484396_H | glycerophospholipid measurement QTL GWAS2484396 (human) | | 4e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114553424 | 114553425 | Human |
| 597264713 | GWAS1360787_H | 1-palmitoylglycerophosphocholine measurement QTL GWAS1360787 (human) | | 0.0000003 | 2-palmitoylglycerophosphocholine measurement | | 4 | 122051907 | 122051908 | Human |
| 628576166 | GWAS2484395_H | glycerophospholipid measurement QTL GWAS2484395 (human) | | 4e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114493217 | 114493218 | Human |
| 628576165 | GWAS2484394_H | glycerophospholipid measurement QTL GWAS2484394 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114558326 | 114558327 | Human |
| 597264715 | GWAS1360789_H | skin aging measurement QTL GWAS1360789 (human) | | 0.000001 | skin aging measurement | | 4 | 122984812 | 122984813 | Human |
| 628576164 | GWAS2484393_H | glycerophospholipid measurement QTL GWAS2484393 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114554137 | 114554138 | Human |
| 628576163 | GWAS2484392_H | glycerophospholipid measurement QTL GWAS2484392 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114552518 | 114552519 | Human |
| 407270034 | GWAS919010_H | body height QTL GWAS919010 (human) | | 7e-90 | body height | | 4 | 119652067 | 119652068 | Human |
| 628576162 | GWAS2484391_H | glycerophospholipid measurement QTL GWAS2484391 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114526758 | 114526759 | Human |
| 617041426 | GWAS2058925_H | Barrett's esophagus QTL GWAS2058925 (human) | | 3e-09 | Barrett's esophagus | | 4 | 123619833 | 123619834 | Human |
| 617090589 | GWAS2108088_H | pelvic organ prolapse QTL GWAS2108088 (human) | | 2e-23 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
| 628576161 | GWAS2484390_H | glycerophospholipid measurement QTL GWAS2484390 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114538869 | 114538870 | Human |
| 628576160 | GWAS2484389_H | glycerophospholipid measurement QTL GWAS2484389 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114598194 | 114598195 | Human |
| 407270033 | GWAS919009_H | body height QTL GWAS919009 (human) | | 3e-09 | body height | | 4 | 119494521 | 119494522 | Human |
| 628576175 | GWAS2484404_H | glycerophospholipid measurement QTL GWAS2484404 (human) | | 5e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114552206 | 114552207 | Human |
| 628576174 | GWAS2484403_H | glycerophospholipid measurement QTL GWAS2484403 (human) | | 5e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114573271 | 114573272 | Human |
| 628658081 | GWAS2566310_H | forced expiratory volume QTL GWAS2566310 (human) | | 3e-13 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 127731072 | 127731073 | Human |
| 628576173 | GWAS2484402_H | glycerophospholipid measurement QTL GWAS2484402 (human) | | 5e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114541864 | 114541865 | Human |
| 628576172 | GWAS2484401_H | glycerophospholipid measurement QTL GWAS2484401 (human) | | 4e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114547331 | 114547332 | Human |
| 628576171 | GWAS2484400_H | glycerophospholipid measurement QTL GWAS2484400 (human) | | 4e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114563925 | 114563926 | Human |
| 628576170 | GWAS2484399_H | glycerophospholipid measurement QTL GWAS2484399 (human) | | 4e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114553520 | 114553521 | Human |
| 628576169 | GWAS2484398_H | glycerophospholipid measurement QTL GWAS2484398 (human) | | 4e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114546019 | 114546020 | Human |
| 628576168 | GWAS2484397_H | glycerophospholipid measurement QTL GWAS2484397 (human) | | 4e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114493059 | 114493060 | Human |
| 628543390 | GWAS2451619_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2451619 (human) | | 1e-09 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
| 406958761 | GWAS607737_H | electrocardiography QTL GWAS607737 (human) | | 2e-08 | electrocardiography | | 4 | 110782354 | 110782355 | Human |
| 628576159 | GWAS2484388_H | glycerophospholipid measurement QTL GWAS2484388 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114563572 | 114563573 | Human |
| 617025069 | GWAS2042568_H | systemic lupus erythematosus QTL GWAS2042568 (human) | | 2e-09 | systemic lupus erythematosus | | 4 | 108190649 | 108190650 | Human |
| 406958762 | GWAS607738_H | electrocardiography QTL GWAS607738 (human) | | 4e-31 | electrocardiography | | 4 | 113508251 | 113508252 | Human |
| 617008685 | GWAS2026184_H | electroencephalogram measurement QTL GWAS2026184 (human) | | 0.000002 | electroencephalogram measurement | | 4 | 121613423 | 121613424 | Human |
| 628445081 | GWAS2353310_H | hemoglobin measurement QTL GWAS2353310 (human) | | 5e-17 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114577301 | 114577302 | Human |
| 407204521 | GWAS853497_H | protein measurement QTL GWAS853497 (human) | | 1e-11 | protein measurement | | 4 | 131061544 | 131061545 | Human |
| 628445082 | GWAS2353311_H | hemoglobin measurement QTL GWAS2353311 (human) | | 2e-10 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 123846352 | 123846353 | Human |
| 407253686 | GWAS902662_H | facial width measurement QTL GWAS902662 (human) | | 0.000004 | facial width measurement | | 4 | 130195033 | 130195034 | Human |
| 628805516 | GWAS2713745_H | systolic blood pressure QTL GWAS2713745 (human) | | 0.0000001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 132120954 | 132120955 | Human |
| 406926008 | GWAS574984_H | insulin sensitivity measurement, glucose homeostasis measurement QTL GWAS574984 (human) | | 0.0000005 | insulin sensitivity measurement, glucose homeostasis measurement | | 4 | 127922325 | 127922326 | Human |
| 597313891 | GWAS1409965_H | X-26054 measurement QTL GWAS1409965 (human) | | 5e-87 | X-26054 measurement | | 4 | 129143723 | 129143724 | Human |
| 628707202 | GWAS2615431_H | fibroblast growth factor 2 level QTL GWAS2615431 (human) | | 6e-15 | fibroblast growth factor 2 level | | 4 | 123433862 | 123433863 | Human |
| 597592419 | GWAS1649279_H | high density lipoprotein cholesterol measurement QTL GWAS1649279 (human) | | 5e-37 | high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407401142 | GWAS1050118_H | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement QTL GWAS1050118 (human) | | 2e-23 | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | | 4 | 111485805 | 111485806 | Human |
| 617123382 | GWAS2140881_H | serum creatinine amount QTL GWAS2140881 (human) | | 2e-14 | serum creatinine amount | | 4 | 128601363 | 128601364 | Human |
| 598050981 | GWAS1770280_H | body height QTL GWAS1770280 (human) | | 2e-22 | body height | | 4 | 108503691 | 108503692 | Human |
| 617123784 | GWAS2141283_H | prothrombin time measurement QTL GWAS2141283 (human) | | 1e-33 | prothrombin time measurement | | 4 | 110796911 | 110796912 | Human |
| 628854395 | GWAS2762624_H | body mass index QTL GWAS2762624 (human) | | 6e-10 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 119372621 | 119372622 | Human |
| 628854394 | GWAS2762623_H | body mass index QTL GWAS2762623 (human) | | 7e-10 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112392830 | 112392831 | Human |
| 598050983 | GWAS1770282_H | body height QTL GWAS1770282 (human) | | 3e-14 | body height | | 4 | 121876108 | 121876109 | Human |
| 628854392 | GWAS2762621_H | body mass index QTL GWAS2762621 (human) | | 4e-12 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 111792280 | 111792281 | Human |
| 598050982 | GWAS1770281_H | body height QTL GWAS1770281 (human) | | 6e-13 | body height | | 4 | 119709781 | 119709782 | Human |
| 628641404 | GWAS2549633_H | gut microbiome measurement, birth weight QTL GWAS2549633 (human) | | 0.0000003 | body mass (VT:0001259) | neonatal body weight (CMO:0002079) | 4 | 130900217 | 130900218 | Human |
| 628887161 | GWAS2795390_H | beverage consumption measurement QTL GWAS2795390 (human) | | 1e-08 | drinking behavior trait (VT:0001422) | drink intake measurement (CMO:0000771) | 4 | 128935692 | 128935693 | Human |
| 628854396 | GWAS2762625_H | body mass index QTL GWAS2762625 (human) | | 3e-15 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129810129 | 129810130 | Human |
| 628412028 | GWAS2320257_H | cup-to-disc ratio measurement QTL GWAS2320257 (human) | | 0.0000002 | optic disc morphology trait (VT:0006215) | | 4 | 125475115 | 125475116 | Human |
| 407089994 | GWAS738970_H | atrial fibrillation QTL GWAS738970 (human) | | 1e-38 | atrial fibrillation | | 4 | 110859850 | 110859851 | Human |
| 617009099 | GWAS2026598_H | gut microbiome measurement QTL GWAS2026598 (human) | | 0.000003 | gut microbiome measurement | | 4 | 119309995 | 119309996 | Human |
| 597051547 | GWAS1147621_H | response to norepinephrine-dopamine reuptake inhibitor QTL GWAS1147621 (human) | | 0.000006 | response to norepinephrine-dopamine reuptake inhibitor | | 4 | 120701163 | 120701164 | Human |
| 628543099 | GWAS2451328_H | lymphocyte count QTL GWAS2451328 (human) | | 2e-13 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 122579931 | 122579932 | Human |
| 628543096 | GWAS2451325_H | lymphocyte count QTL GWAS2451325 (human) | | 2e-18 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112198650 | 112198651 | Human |
| 616992712 | GWAS2010211_H | heel bone mineral density QTL GWAS2010211 (human) | | 1e-09 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 127363808 | 127363809 | Human |
| 616976340 | GWAS1993839_H | platelet-to-lymphocyte ratio QTL GWAS1993839 (human) | | 5e-08 | platelet-to-lymphocyte ratio | | 4 | 121774530 | 121774531 | Human |
| 407090000 | GWAS738976_H | atrial fibrillation QTL GWAS738976 (human) | | 1e-15 | atrial fibrillation | | 4 | 110815726 | 110815727 | Human |
| 628543074 | GWAS2451303_H | platelet count QTL GWAS2451303 (human) | | 6e-10 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
| 628543075 | GWAS2451304_H | platelet count QTL GWAS2451304 (human) | | 1e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123837618 | 123837619 | Human |
| 628543072 | GWAS2451301_H | platelet count QTL GWAS2451301 (human) | | 1e-52 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110024810 | 110024811 | Human |
| 628903530 | GWAS2811759_H | neuroimaging measurement QTL GWAS2811759 (human) | | 4e-09 | nervous system morphology trait (VT:0003632) | | 4 | 118376502 | 118376503 | Human |
| 628641390 | GWAS2549619_H | fibroblast growth factor 2 level QTL GWAS2549619 (human) | | 4e-11 | fibroblast growth factor 2 level | | 4 | 120649137 | 120649138 | Human |
| 407024468 | GWAS673444_H | neuropsychological test QTL GWAS673444 (human) | | 0.000006 | neuropsychological test | | 4 | 125505540 | 125505541 | Human |
| 628543073 | GWAS2451302_H | platelet count QTL GWAS2451302 (human) | | 5e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119464317 | 119464318 | Human |
| 616517542 | GWAS1914125_H | mean corpuscular hemoglobin QTL GWAS1914125 (human) | | 2e-66 | mean corpuscular hemoglobin | | 4 | 121870446 | 121870447 | Human |
| 626462283 | GWAS2276216_H | triglyceride measurement QTL GWAS2276216 (human) | | 5e-29 | triglyceride measurement | | 4 | 109717668 | 109717669 | Human |
| 628428393 | GWAS2336622_H | intelligence QTL GWAS2336622 (human) | | 0.000007 | intelligence | | 4 | 112683802 | 112683803 | Human |
| 628493930 | GWAS2402159_H | response to selective serotonin reuptake inhibitor, openness measurement QTL GWAS2402159 (human) | | 0.0000004 | response to xenobiotic stimulus trait (VT:0010487) | | 4 | 129115280 | 129115281 | Human |
| 617058265 | GWAS2075764_H | irritable bowel syndrome, chronic bronchitis QTL GWAS2075764 (human) | | 2e-08 | irritable bowel syndrome, chronic bronchitis | | 4 | 111582716 | 111582717 | Human |
| 407319399 | GWAS968375_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS968375 (human) | | 3e-11 | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | | 4 | 109603883 | 109603884 | Human |
| 597477565 | GWAS1573639_H | monoclonal gammopathy QTL GWAS1573639 (human) | | 0.000005 | monoclonal gammopathy | | 4 | 107881225 | 107881226 | Human |
| 597412031 | GWAS1508105_H | body height QTL GWAS1508105 (human) | | 1e-14 | body height | | 4 | 108180849 | 108180850 | Human |
| 407139168 | GWAS788144_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS788144 (human) | | 1e-08 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122690387 | 122690388 | Human |
| 628690513 | GWAS2598742_H | brain attribute QTL GWAS2598742 (human) | | 1e-20 | brain attribute | | 4 | 127076729 | 127076730 | Human |
| 628428380 | GWAS2336609_H | intelligence QTL GWAS2336609 (human) | | 0.000007 | intelligence | | 4 | 129813235 | 129813236 | Human |
| 628821591 | GWAS2729820_H | seasonal allergic rhinitis QTL GWAS2729820 (human) | | 6e-14 | seasonal allergic rhinitis | | 4 | 122307977 | 122307978 | Human |
| 406991727 | GWAS640703_H | sex hormone-binding globulin measurement QTL GWAS640703 (human) | | 3e-12 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 597477554 | GWAS1573628_H | systolic blood pressure QTL GWAS1573628 (human) | | 5e-09 | systolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 597985419 | GWAS1704718_H | brain attribute, neuroimaging measurement QTL GWAS1704718 (human) | | 3e-08 | brain attribute, neuroimaging measurement | | 4 | 112509596 | 112509597 | Human |
| 597379241 | GWAS1475315_H | serum IgG glycosylation measurement QTL GWAS1475315 (human) | | 0.000005 | serum IgG glycosylation measurement | | 4 | 127545545 | 127545546 | Human |
| 406991728 | GWAS640704_H | sex hormone-binding globulin measurement QTL GWAS640704 (human) | | 2e-08 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
| 628903496 | GWAS2811725_H | neuroimaging measurement QTL GWAS2811725 (human) | | 2e-11 | nervous system morphology trait (VT:0003632) | | 4 | 112495627 | 112495628 | Human |
| 617025520 | GWAS2043019_H | corneal topography QTL GWAS2043019 (human) | | 8e-09 | cornea curvature trait (VT:0006151) | | 4 | 127192269 | 127192270 | Human |
| 617025534 | GWAS2043033_H | gut microbiome measurement QTL GWAS2043033 (human) | | 0.0000003 | gut microbiome measurement | | 4 | 112357355 | 112357356 | Human |
| 597231778 | GWAS1327852_H | smoking cessation QTL GWAS1327852 (human) | | 1e-08 | smoking cessation | | 4 | 111500989 | 111500990 | Human |
| 597379239 | GWAS1475313_H | serum IgG glycosylation measurement QTL GWAS1475313 (human) | | 0.000003 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
| 407122809 | GWAS771785_H | asthma, Eczematoid dermatitis, allergic rhinitis QTL GWAS771785 (human) | | 1e-29 | asthma, Eczematoid dermatitis, allergic rhinitis | | 4 | 122465565 | 122465566 | Human |
| 628477514 | GWAS2385743_H | BMI-adjusted waist-hip ratio QTL GWAS2385743 (human) | | 5e-09 | body size trait (VT:0100005) | | 4 | 119607172 | 119607173 | Human |
| 628788795 | GWAS2697024_H | magnesium measurement QTL GWAS2697024 (human) | | 0.000004 | blood magnesium amount (VT:0001771) | serum magnesium level (CMO:0000541) | 4 | 112431743 | 112431744 | Human |
| 407040769 | GWAS689745_H | white matter integrity QTL GWAS689745 (human) | | 0.000004 | brain integrity trait (VT:0010579) | | 4 | 113458223 | 113458224 | Human |
| 628788793 | GWAS2697022_H | calcium measurement QTL GWAS2697022 (human) | | 0.000003 | calcium amount (VT:0010499) | blood calcium level (CMO:0000502) | 4 | 119895428 | 119895429 | Human |
| 628854332 | GWAS2762561_H | chronic obstructive pulmonary disease QTL GWAS2762561 (human) | | 5e-19 | lung integrity trait (VT:0010906) | | 4 | 123900578 | 123900579 | Human |
| 407237389 | GWAS886365_H | Crohn's disease QTL GWAS886365 (human) | | 0.0000007 | Crohn's disease | | 4 | 113154532 | 113154533 | Human |
| 597412050 | GWAS1508124_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1508124 (human) | | 4e-12 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 4 | 111202547 | 111202548 | Human |
| 597477585 | GWAS1573659_H | systemic lupus erythematosus QTL GWAS1573659 (human) | | 2e-09 | systemic lupus erythematosus | | 4 | 108190649 | 108190650 | Human |
| 597067973 | GWAS1164047_H | mean corpuscular volume QTL GWAS1164047 (human) | | 7e-10 | mean corpuscular volume | | 4 | 109977659 | 109977660 | Human |
| 407073559 | GWAS722535_H | hypertension QTL GWAS722535 (human) | | 3e-08 | hypertension | | 4 | 110409934 | 110409935 | Human |
| 628870701 | GWAS2778930_H | reduced glutathione measurement QTL GWAS2778930 (human) | | 4e-08 | kidney glutathione amount (VT:0010706) | | 4 | 124355648 | 124355649 | Human |
| 617107359 | GWAS2124858_H | atrial fibrillation QTL GWAS2124858 (human) | | 2e-210 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 407057172 | GWAS706148_H | lymphocyte count QTL GWAS706148 (human) | | 6e-10 | lymphocyte count | | 4 | 122579931 | 122579932 | Human |
| 628969002 | GWAS2877231_H | erythrocyte count QTL GWAS2877231 (human) | | 3e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 127869642 | 127869643 | Human |
| 597412035 | GWAS1508109_H | body height QTL GWAS1508109 (human) | | 4e-09 | body height | | 4 | 119356945 | 119356946 | Human |
| 597149902 | GWAS1245976_H | smoking status measurement QTL GWAS1245976 (human) | | 6e-10 | smoking status measurement | | 4 | 111485805 | 111485806 | Human |
| 597412034 | GWAS1508108_H | body height QTL GWAS1508108 (human) | | 8e-11 | body height | | 4 | 113824425 | 113824426 | Human |
| 597412033 | GWAS1508107_H | body height QTL GWAS1508107 (human) | | 1e-32 | body height | | 4 | 108535458 | 108535459 | Human |
| 617041821 | GWAS2059320_H | bipolar disorder, glomerular filtration rate QTL GWAS2059320 (human) | | 3e-08 | bipolar disorder, glomerular filtration rate | | 4 | 122596491 | 122596492 | Human |
| 597412032 | GWAS1508106_H | body height QTL GWAS1508106 (human) | | 1e-16 | body height | | 4 | 108355674 | 108355675 | Human |
| 628444718 | GWAS2352947_H | asthma QTL GWAS2352947 (human) | | 3e-19 | asthma | | 4 | 122120316 | 122120317 | Human |
| 628608554 | GWAS2516783_H | blood urea nitrogen amount QTL GWAS2516783 (human) | | 4e-08 | blood urea nitrogen amount | | 4 | 119076757 | 119076758 | Human |
| 407270182 | GWAS919158_H | fibrinogen measurement, coronary artery disease QTL GWAS919158 (human) | | 1e-11 | fibrinogen measurement, coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 407368484 | GWAS1017460_H | blood protein measurement QTL GWAS1017460 (human) | | 3e-202 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 597412083 | GWAS1508157_H | cancer QTL GWAS1508157 (human) | | 0.0000006 | cancer | | 4 | 122660080 | 122660081 | Human |
| 597412082 | GWAS1508156_H | cancer QTL GWAS1508156 (human) | | 0.0000007 | cancer | | 4 | 106909104 | 106909105 | Human |
| 596986108 | GWAS1105627_H | body mass index QTL GWAS1105627 (human) | | 2e-14 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 617107362 | GWAS2124861_H | atrial fibrillation QTL GWAS2124861 (human) | | 2e-249 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 616533972 | GWAS1930555_H | properdin measurement QTL GWAS1930555 (human) | | 3e-16 | properdin measurement | | 4 | 109793426 | 109793427 | Human |
| 407335723 | GWAS984699_H | uric acid measurement QTL GWAS984699 (human) | | 3e-08 | uric acid measurement | | 4 | 127173154 | 127173155 | Human |
| 596986107 | GWAS1105626_H | body mass index QTL GWAS1105626 (human) | | 1e-08 | body mass index | | 4 | 114202933 | 114202934 | Human |
| 628706839 | GWAS2615068_H | galanin peptides measurement QTL GWAS2615068 (human) | | 3e-14 | galanin peptides measurement | | 4 | 123255634 | 123255635 | Human |
| 596986106 | GWAS1105625_H | body mass index QTL GWAS1105625 (human) | | 7e-12 | body mass index | | 4 | 111770620 | 111770621 | Human |
| 597182697 | GWAS1278771_H | disorder of pharynx QTL GWAS1278771 (human) | | 2e-08 | disorder of pharynx | | 4 | 112220279 | 112220280 | Human |
| 628805135 | GWAS2713364_H | osteoarthritis, knee QTL GWAS2713364 (human) | | 8e-08 | joint integrity trait (VT:0010548) | | 4 | 121786965 | 121786966 | Human |
| 407073589 | GWAS722565_H | mean arterial pressure QTL GWAS722565 (human) | | 0.000002 | mean arterial pressure | | 4 | 110460482 | 110460483 | Human |
| 597592297 | GWAS1649157_H | high density lipoprotein cholesterol measurement QTL GWAS1649157 (human) | | 4e-30 | high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 616370117 | GWAS1850359_H | cortical thickness QTL GWAS1850359 (human) | | 2e-09 | cortical thickness | | 4 | 114517484 | 114517485 | Human |
| 597199075 | GWAS1295149_H | electrocardiography QTL GWAS1295149 (human) | | 2e-29 | electrocardiography | | 4 | 113504778 | 113504779 | Human |
| 628772357 | GWAS2680586_H | blood protein amount QTL GWAS2680586 (human) | | 4e-16 | blood protein amount | | 4 | 119210489 | 119210490 | Human |
| 617041735 | GWAS2059234_H | esophageal adenocarcinoma QTL GWAS2059234 (human) | | 1e-08 | esophageal adenocarcinoma | | 4 | 123623035 | 123623036 | Human |
| 597395482 | GWAS1491556_H | leukocyte count QTL GWAS1491556 (human) | | 3e-13 | leukocyte count | | 4 | 110021121 | 110021122 | Human |
| 407221191 | GWAS870167_H | lymphocyte count QTL GWAS870167 (human) | | 3e-25 | lymphocyte count | | 4 | 112192759 | 112192760 | Human |
| 407221190 | GWAS870166_H | lymphocyte count QTL GWAS870166 (human) | | 6e-25 | lymphocyte count | | 4 | 109921984 | 109921985 | Human |
| 407188422 | GWAS837398_H | monocyte count QTL GWAS837398 (human) | | 5e-10 | monocyte count | | 4 | 110035176 | 110035177 | Human |
| 407270338 | GWAS919314_H | Obsessive-compulsive trait QTL GWAS919314 (human) | | 0.000009 | Obsessive-compulsive trait | | 4 | 107836793 | 107836794 | Human |
| 596953105 | GWAS1072624_H | size QTL GWAS1072624 (human) | | 1e-09 | size | | 4 | 119820087 | 119820088 | Human |
| 597461019 | GWAS1557093_H | body mass index QTL GWAS1557093 (human) | | 3e-11 | body mass index | | 4 | 111826763 | 111826764 | Human |
| 407221192 | GWAS870168_H | lymphocyte count QTL GWAS870168 (human) | | 2e-19 | lymphocyte count | | 4 | 122760001 | 122760002 | Human |
| 407172061 | GWAS821037_H | glycerophospholipid measurement QTL GWAS821037 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114499194 | 114499195 | Human |
| 407172062 | GWAS821038_H | glycerophospholipid measurement QTL GWAS821038 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114534955 | 114534956 | Human |
| 407172063 | GWAS821039_H | glycerophospholipid measurement QTL GWAS821039 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114535080 | 114535081 | Human |
| 628510445 | GWAS2418674_H | breast density QTL GWAS2418674 (human) | | 0.000006 | breast density | | 4 | 121949054 | 121949055 | Human |
| 407237598 | GWAS886574_H | sex hormone-binding globulin measurement QTL GWAS886574 (human) | | 3e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 407172068 | GWAS821044_H | glycerophospholipid measurement QTL GWAS821044 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114531061 | 114531062 | Human |
| 407172069 | GWAS821045_H | glycerophospholipid measurement QTL GWAS821045 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114493973 | 114493974 | Human |
| 407172070 | GWAS821046_H | glycerophospholipid measurement QTL GWAS821046 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114556972 | 114556973 | Human |
| 628723418 | GWAS2631647_H | vaginal microbiome measurement QTL GWAS2631647 (human) | | 0.000001 | vaginal microbiome measurement | | 4 | 113045828 | 113045829 | Human |
| 407172071 | GWAS821047_H | glycerophospholipid measurement QTL GWAS821047 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114488186 | 114488187 | Human |
| 407172064 | GWAS821040_H | glycerophospholipid measurement QTL GWAS821040 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114534996 | 114534997 | Human |
| 626446066 | GWAS2259999_H | eosinophil count QTL GWAS2259999 (human) | | 4e-21 | eosinophil count | | 4 | 122408207 | 122408208 | Human |
| 407172065 | GWAS821041_H | glycerophospholipid measurement QTL GWAS821041 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114493975 | 114493976 | Human |
| 407172066 | GWAS821042_H | glycerophospholipid measurement QTL GWAS821042 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114527954 | 114527955 | Human |
| 407172067 | GWAS821043_H | glycerophospholipid measurement QTL GWAS821043 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114574339 | 114574340 | Human |
| 628969178 | GWAS2877407_H | erythrocyte count QTL GWAS2877407 (human) | | 9e-28 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598194 | 114598195 | Human |
| 406959078 | GWAS608054_H | sclerosing cholangitis QTL GWAS608054 (human) | | 1e-13 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
| 407172072 | GWAS821048_H | glycerophospholipid measurement QTL GWAS821048 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114579576 | 114579577 | Human |
| 616353554 | GWAS1838269_H | gut microbiome measurement, breastfeeding duration QTL GWAS1838269 (human) | | 0.0000005 | gut microbiome measurement, breastfeeding duration | | 4 | 112409784 | 112409785 | Human |
| 616550160 | GWAS1946743_H | Red cell distribution width QTL GWAS1946743 (human) | | 2e-21 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 628592344 | GWAS2500573_H | memory performance QTL GWAS2500573 (human) | | 0.0000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 130946957 | 130946958 | Human |
| 407221237 | GWAS870213_H | sex hormone-binding globulin measurement QTL GWAS870213 (human) | | 6e-26 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 407401468 | GWAS1050444_H | self reported educational attainment QTL GWAS1050444 (human) | | 2e-09 | self reported educational attainment | | 4 | 111500989 | 111500990 | Human |
| 407401469 | GWAS1050445_H | self reported educational attainment QTL GWAS1050445 (human) | | 6e-12 | self reported educational attainment | | 4 | 122105714 | 122105715 | Human |
| 628838093 | GWAS2746322_H | lipid measurement QTL GWAS2746322 (human) | | 6e-08 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 124266893 | 124266894 | Human |
| 628674255 | GWAS2582484_H | glioblastoma multiforme QTL GWAS2582484 (human) | | 0.000005 | brain integrity trait (VT:0010579) | | 4 | 128287977 | 128287978 | Human |
| 628870851 | GWAS2779080_H | QRS-T angle QTL GWAS2779080 (human) | | 9e-11 | heart excitatory physiology trait (VT:0000231) | | 4 | 110650661 | 110650662 | Human |
| 407254015 | GWAS902991_H | vaginal microbiome measurement QTL GWAS902991 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 617025405 | GWAS2042904_H | chronotype measurement QTL GWAS2042904 (human) | | 1e-08 | chronotype measurement | | 4 | 131590963 | 131590964 | Human |
| 407401459 | GWAS1050435_H | post-traumatic stress disorder QTL GWAS1050435 (human) | | 7e-09 | post-traumatic stress disorder | | 4 | 122265238 | 122265239 | Human |
| 628821703 | GWAS2729932_H | eosinophil percentage of leukocytes QTL GWAS2729932 (human) | | 3e-19 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 4 | 122698534 | 122698535 | Human |
| 628526792 | GWAS2435021_H | monocyte count QTL GWAS2435021 (human) | | 2e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 110024100 | 110024101 | Human |
| 617025281 | GWAS2042780_H | corneal topography QTL GWAS2042780 (human) | | 0.0000003 | cornea curvature trait (VT:0006151) | | 4 | 127192269 | 127192270 | Human |
| 597018706 | GWAS1114780_H | eosinophil count QTL GWAS1114780 (human) | | 5e-27 | eosinophil count | | 4 | 122680359 | 122680360 | Human |
| 407237506 | GWAS886482_H | lipid measurement QTL GWAS886482 (human) | | 0.000003 | lipid measurement | | 4 | 131492574 | 131492575 | Human |
| 628838064 | GWAS2746293_H | androsterone sulfate measurement QTL GWAS2746293 (human) | | 0.000004 | androsterone sulfate measurement | | 4 | 119318723 | 119318724 | Human |
| 597149788 | GWAS1245862_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS1245862 (human) | | 0.0000009 | diet measurement, sex hormone-binding globulin measurement | | 4 | 127714844 | 127714845 | Human |
| 407106446 | GWAS755422_H | platelet component distribution width QTL GWAS755422 (human) | | 1e-18 | platelet component distribution width | | 4 | 109970517 | 109970518 | Human |
| 598034536 | GWAS1753835_H | glomerular filtration rate QTL GWAS1753835 (human) | | 1e-12 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 407319432 | GWAS968408_H | phosphatidylethanolamine measurement QTL GWAS968408 (human) | | 2e-08 | phosphatidylethanolamine measurement | | 4 | 126594255 | 126594256 | Human |
| 596953205 | GWAS1072724_H | size QTL GWAS1072724 (human) | | 5e-08 | size | | 4 | 118204297 | 118204298 | Human |
| 597493884 | GWAS1589958_H | R-6-hydroxywarfarin measurement QTL GWAS1589958 (human) | | 0.000005 | R-6-hydroxywarfarin measurement | | 4 | 123651871 | 123651872 | Human |
| 617205546 | GWAS2185986_H | body fat percentage QTL GWAS2185986 (human) | | 3e-12 | body fat percentage | | 4 | 129803747 | 129803748 | Human |
| 597395581 | GWAS1491655_H | Calcium channel blocker use measurement QTL GWAS1491655 (human) | | 8e-14 | Calcium channel blocker use measurement | | 4 | 110465042 | 110465043 | Human |
| 597985346 | GWAS1704645_H | foot muscle strength trait QTL GWAS1704645 (human) | | 0.0000008 | foot muscle strength trait | | 4 | 123234042 | 123234043 | Human |
| 597264497 | GWAS1360571_H | skin aging measurement QTL GWAS1360571 (human) | | 7e-08 | skin aging measurement | | 4 | 123010723 | 123010724 | Human |
| 597280886 | GWAS1376960_H | pelvic organ prolapse QTL GWAS1376960 (human) | | 1e-11 | pelvic organ prolapse | | 4 | 126146934 | 126146935 | Human |
| 628641416 | GWAS2549645_H | gut microbiome measurement, breastfeeding duration QTL GWAS2549645 (human) | | 3e-08 | lactation duration (VT:1000653) | | 4 | 114769596 | 114769597 | Human |
| 407401406 | GWAS1050382_H | asthma QTL GWAS1050382 (human) | | 3e-14 | asthma | | 4 | 122148495 | 122148496 | Human |
| 597264495 | GWAS1360569_H | skin aging measurement QTL GWAS1360569 (human) | | 4e-09 | skin aging measurement | | 4 | 123122397 | 123122398 | Human |
| 628657806 | GWAS2566035_H | vital capacity QTL GWAS2566035 (human) | | 8e-11 | lung capacity (VT:0001942) | | 4 | 124209285 | 124209286 | Human |
| 597264494 | GWAS1360568_H | skin aging measurement QTL GWAS1360568 (human) | | 5e-10 | skin aging measurement | | 4 | 123250668 | 123250669 | Human |
| 617123632 | GWAS2141131_H | level of desmoglein-4 in blood serum QTL GWAS2141131 (human) | | 4e-12 | level of desmoglein-4 in blood serum | | 4 | 106786338 | 106786339 | Human |
| 628936324 | GWAS2844553_H | leukocyte quantity QTL GWAS2844553 (human) | | 9e-09 | leukocyte quantity | | 4 | 107777822 | 107777823 | Human |
| 628526732 | GWAS2434961_H | hemoglobin measurement QTL GWAS2434961 (human) | | 1e-11 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114422087 | 114422088 | Human |
| 407253946 | GWAS902922_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS902922 (human) | | 4e-15 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 628936323 | GWAS2844552_H | leukocyte quantity QTL GWAS2844552 (human) | | 1e-08 | leukocyte quantity | | 4 | 119342160 | 119342161 | Human |
| 597069719 | GWAS1165793_H | lean body mass QTL GWAS1165793 (human) | | 0.000004 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 4 | 130920623 | 130920624 | Human |
| 626461010 | GWAS2274943_H | body height QTL GWAS2274943 (human) | | 4e-08 | body height | | 4 | 113877699 | 113877700 | Human |
| 407319631 | GWAS968607_H | low density lipoprotein cholesterol measurement QTL GWAS968607 (human) | | 4e-08 | low density lipoprotein cholesterol measurement | | 4 | 109997531 | 109997532 | Human |
| 597053340 | GWAS1149414_H | household income QTL GWAS1149414 (human) | | 5e-09 | household income | | 4 | 122175535 | 122175536 | Human |
| 617105625 | GWAS2123124_H | carotid artery thickness QTL GWAS2123124 (human) | | 0.000006 | carotid artery thickness | | 4 | 118504756 | 118504757 | Human |
| 628558181 | GWAS2466410_H | cognitive function measurement QTL GWAS2466410 (human) | | 0.000009 | cognitive behavior trait (VT:0010450) | | 4 | 119010553 | 119010554 | Human |
| 628656494 | GWAS2564723_H | free androgen index QTL GWAS2564723 (human) | | 4e-09 | free androgen index | | 4 | 109174464 | 109174465 | Human |
| 617072849 | GWAS2090348_H | body mass index QTL GWAS2090348 (human) | | 2e-18 | body mass index | | 4 | 111781479 | 111781480 | Human |
| 597299134 | GWAS1395208_H | glomerular filtration rate QTL GWAS1395208 (human) | | 5e-09 | glomerular filtration rate | | 4 | 125483011 | 125483012 | Human |
| 617269487 | GWAS2206263_H | fatty acid amount QTL GWAS2206263 (human) | | 1e-08 | fatty acid amount | | 4 | 109603883 | 109603884 | Human |
| 407073893 | GWAS722869_H | cognitive function measurement QTL GWAS722869 (human) | | 0.000006 | cognitive function measurement | | 4 | 126558097 | 126558098 | Human |
| 596971453 | GWAS1090972_H | glomerular filtration rate, bipolar disorder QTL GWAS1090972 (human) | | 3e-08 | glomerular filtration rate, bipolar disorder | | 4 | 122596491 | 122596492 | Human |
| 406959209 | GWAS608185_H | body mass index QTL GWAS608185 (human) | | 3e-15 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 407286893 | GWAS935869_H | fibroblast growth factor 2 measurement QTL GWAS935869 (human) | | 9e-18 | fibroblast growth factor 2 measurement | | 4 | 122836593 | 122836594 | Human |
| 597135291 | GWAS1231365_H | memory performance, sex interaction measurement QTL GWAS1231365 (human) | | 0.000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109132717 | 109132718 | Human |
| 597135290 | GWAS1231364_H | memory performance, sex interaction measurement QTL GWAS1231364 (human) | | 0.000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109131697 | 109131698 | Human |
| 597135289 | GWAS1231363_H | memory performance, sex interaction measurement QTL GWAS1231363 (human) | | 0.000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109134293 | 109134294 | Human |
| 616990953 | GWAS2008452_H | size QTL GWAS2008452 (human) | | 1e-09 | size | | 4 | 119820087 | 119820088 | Human |
| 597135271 | GWAS1231345_H | diastolic blood pressure QTL GWAS1231345 (human) | | 7e-12 | diastolic blood pressure | | 4 | 108146742 | 108146743 | Human |
| 628869451 | GWAS2777680_H | QRS-T angle QTL GWAS2777680 (human) | | 3e-31 | heart excitatory physiology trait (VT:0000231) | | 4 | 113523590 | 113523591 | Human |
| 628869450 | GWAS2777679_H | QRS-T angle QTL GWAS2777679 (human) | | 4e-09 | heart excitatory physiology trait (VT:0000231) | | 4 | 110635274 | 110635275 | Human |
| 626444647 | GWAS2258580_H | eosinophil count QTL GWAS2258580 (human) | | 5e-23 | eosinophil count | | 4 | 122263256 | 122263257 | Human |
| 628623693 | GWAS2531922_H | atrial fibrillation QTL GWAS2531922 (human) | | 8e-12 | atrial fibrillation | | 4 | 110733185 | 110733186 | Human |
| 628754758 | GWAS2662987_H | atrial fibrillation QTL GWAS2662987 (human) | | 2e-24 | atrial fibrillation | | 4 | 113528563 | 113528564 | Human |
| 628754756 | GWAS2662985_H | atrial fibrillation QTL GWAS2662985 (human) | | 5e-17 | atrial fibrillation | | 4 | 111394878 | 111394879 | Human |
| 597135273 | GWAS1231347_H | diastolic blood pressure QTL GWAS1231347 (human) | | 3e-08 | diastolic blood pressure | | 4 | 119037654 | 119037655 | Human |
| 626444648 | GWAS2258581_H | eosinophil count QTL GWAS2258581 (human) | | 3e-10 | eosinophil count | | 4 | 123311945 | 123311946 | Human |
| 597135272 | GWAS1231346_H | diastolic blood pressure QTL GWAS1231346 (human) | | 2e-16 | diastolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 628509001 | GWAS2417230_H | Ischemic stroke QTL GWAS2417230 (human) | | 5e-08 | Ischemic stroke | | 4 | 110789013 | 110789014 | Human |
| 628754757 | GWAS2662986_H | atrial fibrillation QTL GWAS2662986 (human) | | 5e-16 | atrial fibrillation | | 4 | 112102428 | 112102429 | Human |
| 597397467 | GWAS1493541_H | atrial fibrillation QTL GWAS1493541 (human) | | 1e-13 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 407401480 | GWAS1050456_H | heart rate QTL GWAS1050456 (human) | | 0.000003 | heart rate | | 4 | 114106683 | 114106684 | Human |
| 407008262 | GWAS657238_H | celiac disease QTL GWAS657238 (human) | | 3e-36 | celiac disease | | 4 | 122629959 | 122629960 | Human |
| 616958082 | GWAS1975581_H | estradiol measurement QTL GWAS1975581 (human) | | 0.000009 | blood estradiol amount (VT:0005183) | blood estradiol level (CMO:0000513) | 4 | 127399753 | 127399754 | Human |
| 628410674 | GWAS2318903_H | gut microbiome measurement QTL GWAS2318903 (human) | | 0.000002 | gut microbiome measurement | | 4 | 121059316 | 121059317 | Human |
| 407401487 | GWAS1050463_H | self reported educational attainment QTL GWAS1050463 (human) | | 3e-08 | self reported educational attainment | | 4 | 111402093 | 111402094 | Human |
| 628721970 | GWAS2630199_H | vaginal microbiome measurement QTL GWAS2630199 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 110167303 | 110167304 | Human |
| 628836656 | GWAS2744885_H | lipid measurement QTL GWAS2744885 (human) | | 0.000003 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 124732439 | 124732440 | Human |
| 597020633 | GWAS1116707_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1116707 (human) | | 0.000005 | lung capacity (VT:0001942) | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 109767656 | 109767657 | Human |
| 628492602 | GWAS2400831_H | benign prostatic hyperplasia QTL GWAS2400831 (human) | | 0.000001 | prostate integrity trait (VT:0010571) | | 4 | 110180390 | 110180395 | Human |
| 597331924 | GWAS1427998_H | colorectal cancer QTL GWAS1427998 (human) | | 0.0000005 | colorectal cancer | | 4 | 120052597 | 120052598 | Human |
| 407221269 | GWAS870245_H | reticulocyte measurement QTL GWAS870245 (human) | | 8e-09 | reticulocyte measurement | | 4 | 119770233 | 119770234 | Human |
| 406975505 | GWAS624481_H | inflammatory bowel disease QTL GWAS624481 (human) | | 3e-13 | inflammatory bowel disease | | 4 | 122240464 | 122240465 | Human |
| 628656425 | GWAS2564654_H | testosterone measurement QTL GWAS2564654 (human) | | 4e-09 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108146742 | 108146743 | Human |
| 407368723 | GWAS1017699_H | spleen volume QTL GWAS1017699 (human) | | 4e-14 | spleen volume | | 4 | 109912954 | 109912955 | Human |
| 407401488 | GWAS1050464_H | self reported educational attainment QTL GWAS1050464 (human) | | 1e-11 | self reported educational attainment | | 4 | 122105714 | 122105715 | Human |
| 597528514 | GWAS1624588_H | FEV/FVC ratio QTL GWAS1624588 (human) | | 3e-18 | FEV/FVC ratio | | 4 | 123898452 | 123898453 | Human |
| 596971509 | GWAS1091028_H | major depressive disorder QTL GWAS1091028 (human) | | 2e-10 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
| 407221286 | GWAS870262_H | hematocrit QTL GWAS870262 (human) | | 9e-16 | hematocrit | | 4 | 114577301 | 114577302 | Human |
| 407008289 | GWAS657265_H | balding measurement QTL GWAS657265 (human) | | 4e-12 | balding measurement | | 4 | 124209285 | 124209286 | Human |
| 617121966 | GWAS2139465_H | serum creatinine amount QTL GWAS2139465 (human) | | 4e-12 | serum creatinine amount | | 4 | 127291035 | 127291036 | Human |
| 628590864 | GWAS2499093_H | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2499093 (human) | | 2e-10 | fatty acid amount (VT:0010046) | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
| 596971506 | GWAS1091025_H | major depressive disorder QTL GWAS1091025 (human) | | 8e-21 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
| 597512180 | GWAS1608254_H | vascular endothelial function measurement QTL GWAS1608254 (human) | | 8e-08 | vascular endothelial function measurement | | 4 | 132241773 | 132241774 | Human |
| 628902158 | GWAS2810387_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS2810387 (human) | | 2e-19 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119349548 | 119349549 | Human |
| 628558095 | GWAS2466324_H | cortical thickness QTL GWAS2466324 (human) | | 1e-12 | behavior trait (VT:0010442) | | 4 | 120722571 | 120722572 | Human |
| 406893627 | GWAS542603_H | mean platelet volume QTL GWAS542603 (human) | | 2e-10 | mean platelet volume | | 4 | 122595396 | 122595397 | Human |
| 598085594 | GWAS1804893_H | bone density QTL GWAS1804893 (human) | | 1e-300 | bone density | | 4 | 116998483 | 116998484 | Human |
| 628820231 | GWAS2728460_H | celiac disease QTL GWAS2728460 (human) | | 1e-14 | intestine integrity trait (VT:0010554) | | 4 | 122629959 | 122629960 | Human |
| 598085595 | GWAS1804894_H | bone density QTL GWAS1804894 (human) | | 1e-300 | bone density | | 4 | 130129906 | 130129907 | Human |
| 598085593 | GWAS1804892_H | bone density QTL GWAS1804892 (human) | | 1e-300 | bone density | | 4 | 113769407 | 113769408 | Human |
| 597282585 | GWAS1378659_H | body height QTL GWAS1378659 (human) | | 6e-23 | body height | | 4 | 122904764 | 122904765 | Human |
| 617007175 | GWAS2024674_H | trait in response to venlafaxine QTL GWAS2024674 (human) | | 0.000006 | trait in response to venlafaxine | | 4 | 113431725 | 113431726 | Human |
| 617089098 | GWAS2106597_H | cardiac troponin I measurement QTL GWAS2106597 (human) | | 0.000006 | cardiac troponin I measurement | | 4 | 110926834 | 110926835 | Human |
| 597249819 | GWAS1345893_H | corneal resistance factor QTL GWAS1345893 (human) | | 2e-08 | corneal resistance factor | | 4 | 118802505 | 118802506 | Human |
| 628836860 | GWAS2745089_H | forced expiratory volume QTL GWAS2745089 (human) | | 1e-12 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 123898452 | 123898453 | Human |
| 406975688 | GWAS624664_H | ovarian carcinoma QTL GWAS624664 (human) | | 0.000003 | ovarian carcinoma | | 4 | 119028805 | 119028806 | Human |
| 628640243 | GWAS2548472_H | saturated fatty acids to total fatty acids percentage QTL GWAS2548472 (human) | | 3e-11 | fatty acid amount (VT:0010046) | | 4 | 110189522 | 110189523 | Human |
| 597233429 | GWAS1329503_H | major depressive disorder QTL GWAS1329503 (human) | | 3e-24 | major depressive disorder | | 4 | 122201701 | 122201702 | Human |
| 406893775 | GWAS542751_H | smoking status measurement, diastolic blood pressure QTL GWAS542751 (human) | | 3e-08 | smoking status measurement, diastolic blood pressure | | 4 | 123660107 | 123660108 | Human |
| 407368916 | GWAS1017892_H | electroencephalogram measurement QTL GWAS1017892 (human) | | 0.000002 | electroencephalogram measurement | | 4 | 121613423 | 121613424 | Human |
| 596987648 | GWAS1107167_H | leukocyte count QTL GWAS1107167 (human) | | 6e-14 | leukocyte count | | 4 | 110020646 | 110020647 | Human |
| 617023582 | GWAS2041081_H | sex hormone-binding globulin measurement QTL GWAS2041081 (human) | | 2e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 628591082 | GWAS2499311_H | lipid measurement, blood VLDL cholesterol amount, chylomicron amount QTL GWAS2499311 (human) | | 5e-11 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 109657070 | 109657071 | Human |
| 597430017 | GWAS1526091_H | sex hormone-binding globulin measurement QTL GWAS1526091 (human) | | 2e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 628607465 | GWAS2515694_H | blood urea nitrogen amount QTL GWAS2515694 (human) | | 2e-09 | blood urea nitrogen amount | | 4 | 119092116 | 119092117 | Human |
| 406959328 | GWAS608304_H | androgenetic alopecia QTL GWAS608304 (human) | | 7e-10 | androgenetic alopecia | | 4 | 106961892 | 106961893 | Human |
| 616990823 | GWAS2008322_H | vascular dementia QTL GWAS2008322 (human) | | 0.000009 | vascular dementia | | 4 | 117625893 | 117625894 | Human |
| 597135158 | GWAS1231232_H | glomerular filtration rate QTL GWAS1231232 (human) | | 2e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
| 628804059 | GWAS2712288_H | body mass index QTL GWAS2712288 (human) | | 4e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129803585 | 129803586 | Human |
| 597086005 | GWAS1182079_H | electrocardiography QTL GWAS1182079 (human) | | 6e-09 | electrocardiography | | 4 | 113489984 | 113489985 | Human |
| 616974434 | GWAS1991933_H | age at first sexual intercourse measurement QTL GWAS1991933 (human) | | 4e-16 | age at first sexual intercourse measurement | | 4 | 111582716 | 111582717 | Human |
| 406992103 | GWAS641079_H | mean corpuscular hemoglobin concentration QTL GWAS641079 (human) | | 1e-11 | mean corpuscular hemoglobin concentration | | 4 | 121870446 | 121870447 | Human |
| 406910182 | GWAS559158_H | unipolar depression, bipolar disorder QTL GWAS559158 (human) | | 0.000008 | unipolar depression, bipolar disorder | | 4 | 125438301 | 125438302 | Human |
| 407401697 | GWAS1050673_H | generalized anxiety disorder QTL GWAS1050673 (human) | | 4e-08 | generalized anxiety disorder | | 4 | 122265238 | 122265239 | Human |
| 597102397 | GWAS1198471_H | alkaline phosphatase measurement QTL GWAS1198471 (human) | | 1e-13 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 128110416 | 128110417 | Human |
| 597102396 | GWAS1198470_H | alkaline phosphatase measurement QTL GWAS1198470 (human) | | 3e-11 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110207431 | 110207432 | Human |
| 407270634 | GWAS919610_H | diastolic blood pressure, systolic blood pressure QTL GWAS919610 (human) | | 0.000003 | diastolic blood pressure, systolic blood pressure | | 4 | 113264849 | 113264850 | Human |
| 406910192 | GWAS559168_H | neuroimaging measurement QTL GWAS559168 (human) | | 5e-09 | neuroimaging measurement | | 4 | 114719632 | 114719636 | Human |
| 598036245 | GWAS1755544_H | glomerular filtration rate QTL GWAS1755544 (human) | | 3e-11 | glomerular filtration rate | | 4 | 127288162 | 127288163 | Human |
| 597462829 | GWAS1558903_H | coronary artery disease QTL GWAS1558903 (human) | | 3e-08 | coronary artery disease | | 4 | 119980181 | 119980182 | Human |
| 597610287 | GWAS1667147_H | mean platelet volume QTL GWAS1667147 (human) | | 2e-13 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 407336190 | GWAS985166_H | mean corpuscular volume QTL GWAS985166 (human) | | 2e-09 | mean corpuscular volume | | 4 | 119629914 | 119629915 | Human |
| 407336189 | GWAS985165_H | mean corpuscular volume QTL GWAS985165 (human) | | 3e-13 | mean corpuscular volume | | 4 | 109921984 | 109921985 | Human |
| 628509130 | GWAS2417359_H | Ischemic stroke QTL GWAS2417359 (human) | | 5e-09 | Ischemic stroke | | 4 | 110744760 | 110744761 | Human |
| 597479202 | GWAS1575276_H | protein measurement QTL GWAS1575276 (human) | | 1e-08 | protein measurement | | 4 | 132318854 | 132318855 | Human |
| 628754875 | GWAS2663104_H | oligodendroglioma QTL GWAS2663104 (human) | | 0.000005 | oligodendroglioma | | 4 | 122853801 | 122853802 | Human |
| 617023493 | GWAS2040992_H | hippocampus volume change measurement QTL GWAS2040992 (human) | | 0.000001 | hippocampus volume change measurement | | 4 | 117571720 | 117571722 | Human |
| 628820414 | GWAS2728643_H | serum gamma-glutamyl transferase measurement QTL GWAS2728643 (human) | | 1e-08 | blood gamma-glutamyltransferase amount (VT:0010607) | serum gamma-glutamyltransferase activity level (CMO:0002241) | 4 | 111793842 | 111793843 | Human |
| 628574640 | GWAS2482869_H | Crohn's disease QTL GWAS2482869 (human) | | 0.0000007 | intestine integrity trait (VT:0010554) | | 4 | 113154532 | 113154533 | Human |
| 597086046 | GWAS1182120_H | mean platelet volume QTL GWAS1182120 (human) | | 4e-13 | mean platelet volume | | 4 | 122061968 | 122061969 | Human |
| 406975626 | GWAS624602_H | forced expiratory volume QTL GWAS624602 (human) | | 6e-13 | forced expiratory volume | | 4 | 123917030 | 123917031 | Human |
| 628443557 | GWAS2351786_H | mean corpuscular hemoglobin concentration QTL GWAS2351786 (human) | | 2e-10 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 123835365 | 123835366 | Human |
| 628443556 | GWAS2351785_H | mean corpuscular hemoglobin concentration QTL GWAS2351785 (human) | | 5e-64 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121854912 | 121854913 | Human |
| 628410791 | GWAS2319020_H | triglyceride measurement QTL GWAS2319020 (human) | | 6e-12 | blood triglyceride amount (VT:0002644) | blood triglyceride level (CMO:0000118) | 4 | 109648464 | 109648465 | Human |
| 628443558 | GWAS2351787_H | mean corpuscular hemoglobin concentration QTL GWAS2351787 (human) | | 4e-31 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 127878475 | 127878476 | Human |
| 407057558 | GWAS706534_H | cesarean section, anxiety QTL GWAS706534 (human) | | 1e-09 | cesarean section, anxiety | | 4 | 106962429 | 106962430 | Human |
| 598019965 | GWAS1739264_H | glucose metabolism trait, age-related hearing impairment QTL GWAS1739264 (human) | | 0.000007 | glucose metabolism trait, age-related hearing impairment | | 4 | 120558243 | 120558244 | Human |
| 616515686 | GWAS1912269_H | asthma QTL GWAS1912269 (human) | | 2e-17 | asthma | | 4 | 122123526 | 122123527 | Human |
| 597020494 | GWAS1116568_H | forced expiratory volume, response to bronchodilator QTL GWAS1116568 (human) | | 0.000003 | forced expiratory volume, response to bronchodilator | | 4 | 122596078 | 122596079 | Human |
| 597397312 | GWAS1493386_H | facial morphology measurement QTL GWAS1493386 (human) | | 2e-09 | facial morphology measurement | | 4 | 126014320 | 126014321 | Human |
| 617072678 | GWAS2090177_H | triglyceride measurement QTL GWAS2090177 (human) | | 7e-11 | triglyceride measurement | | 4 | 123720672 | 123720673 | Human |
| 597446527 | GWAS1542601_H | glomerular filtration rate QTL GWAS1542601 (human) | | 1e-11 | glomerular filtration rate | | 4 | 127420965 | 127420966 | Human |
| 597610363 | GWAS1667223_H | leukocyte count QTL GWAS1667223 (human) | | 8e-12 | leukocyte count | | 4 | 109912954 | 109912955 | Human |
| 597512059 | GWAS1608133_H | testosterone measurement QTL GWAS1608133 (human) | | 3e-08 | testosterone measurement | | 4 | 113038028 | 113038029 | Human |
| 628525456 | GWAS2433685_H | BMI-adjusted waist circumference QTL GWAS2433685 (human) | | 9e-11 | body size trait (VT:0100005) | | 4 | 123166618 | 123166619 | Human |
| 628427164 | GWAS2335393_H | eosinophil count QTL GWAS2335393 (human) | | 1e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122365072 | 122365073 | Human |
| 628820369 | GWAS2728598_H | renin measurement, hypertension QTL GWAS2728598 (human) | | 0.000006 | blood pressure trait (VT:0000183) | | 4 | 108375058 | 108375059 | Human |
| 617121826 | GWAS2139325_H | reticulocyte count QTL GWAS2139325 (human) | | 7e-17 | reticulocyte count | | 4 | 109970517 | 109970518 | Human |
| 628918678 | GWAS2826907_H | hemoglobin measurement QTL GWAS2826907 (human) | | 1e-16 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 110021958 | 110021959 | Human |
| 597249907 | GWAS1345981_H | body weight QTL GWAS1345981 (human) | | 5e-08 | body weight | | 4 | 121338887 | 121338888 | Human |
| 596955007 | GWAS1074526_H | triglyceride:HDL cholesterol ratio QTL GWAS1074526 (human) | | 6e-12 | triglyceride:HDL cholesterol ratio | | 4 | 109648464 | 109648465 | Human |
| 616564780 | GWAS1961363_H | N-acylethanolamine-hydrolyzing acid amidase measurement QTL GWAS1961363 (human) | | 3e-14 | N-acylethanolamine-hydrolyzing acid amidase measurement | | 4 | 118842717 | 118842718 | Human |
| 597266292 | GWAS1362366_H | cortical thickness QTL GWAS1362366 (human) | | 2e-08 | cortical thickness | | 4 | 120741206 | 120741207 | Human |
| 407073971 | GWAS722947_H | atopic eczema QTL GWAS722947 (human) | | 6e-11 | atopic eczema | | 4 | 122111486 | 122111487 | Human |
| 406959283 | GWAS608259_H | breast carcinoma QTL GWAS608259 (human) | | 0.0000003 | mammary gland integrity trait (VT:0010552) | | 4 | 121205653 | 121205654 | Human |
| 617039924 | GWAS2057423_H | amino acid measurement QTL GWAS2057423 (human) | | 0.000003 | amino acid measurement | | 4 | 111130223 | 111130224 | Human |
| 628525455 | GWAS2433684_H | BMI-adjusted waist circumference QTL GWAS2433684 (human) | | 3e-08 | body size trait (VT:0100005) | | 4 | 123121264 | 123121265 | Human |
| 616974396 | GWAS1991895_H | glomerular filtration rate QTL GWAS1991895 (human) | | 1e-11 | glomerular filtration rate | | 4 | 127420965 | 127420966 | Human |
| 597266278 | GWAS1362352_H | cup-to-disc ratio measurement QTL GWAS1362352 (human) | | 2e-09 | cup-to-disc ratio measurement | | 4 | 111478355 | 111478356 | Human |
| 625821773 | GWAS2242695_H | body height QTL GWAS2242695 (human) | | 6e-09 | body height | | 4 | 123991477 | 123991478 | Human |
| 597266072 | GWAS1362146_H | cortical thickness QTL GWAS1362146 (human) | | 4e-08 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 625821772 | GWAS2242694_H | body height QTL GWAS2242694 (human) | | 7e-12 | body height | | 4 | 123329379 | 123329380 | Human |
| 625821775 | GWAS2242697_H | body height QTL GWAS2242697 (human) | | 1e-09 | body height | | 4 | 128700992 | 128700993 | Human |
| 625821774 | GWAS2242696_H | body height QTL GWAS2242696 (human) | | 1e-09 | body height | | 4 | 124056504 | 124056505 | Human |
| 625821769 | GWAS2242691_H | body height QTL GWAS2242691 (human) | | 7e-16 | body height | | 4 | 123077298 | 123077299 | Human |
| 617040322 | GWAS2057821_H | facial morphology trait QTL GWAS2057821 (human) | | 2e-09 | facial morphology trait | | 4 | 110922515 | 110922516 | Human |
| 625821768 | GWAS2242690_H | body height QTL GWAS2242690 (human) | | 3e-24 | body height | | 4 | 122904764 | 122904765 | Human |
| 625821771 | GWAS2242693_H | body height QTL GWAS2242693 (human) | | 2e-21 | body height | | 4 | 123159557 | 123159558 | Human |
| 597036689 | GWAS1132763_H | temporal horn of lateral ventricle volume measurement QTL GWAS1132763 (human) | | 0.0000005 | temporal horn of lateral ventricle volume measurement | | 4 | 121297822 | 121297823 | Human |
| 625821770 | GWAS2242692_H | body height QTL GWAS2242692 (human) | | 1e-10 | body height | | 4 | 123091613 | 123091614 | Human |
| 407041358 | GWAS690334_H | survival time, non-small cell lung carcinoma QTL GWAS690334 (human) | | 0.0000003 | lung integrity trait (VT:0010906) | | 4 | 113625548 | 113625549 | Human |
| 628508793 | GWAS2417022_H | breast density QTL GWAS2417022 (human) | | 0.000001 | breast density | | 4 | 124653133 | 124653134 | Human |
| 406975825 | GWAS624801_H | rheumatoid arthritis QTL GWAS624801 (human) | | 0.0000007 | rheumatoid arthritis | | 4 | 122297158 | 122297159 | Human |
| 628689003 | GWAS2597232_H | systolic blood pressure QTL GWAS2597232 (human) | | 6e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 108328807 | 108328808 | Human |
| 616974814 | GWAS1992313_H | hematocrit QTL GWAS1992313 (human) | | 2e-12 | hematocrit | | 4 | 114598669 | 114598670 | Human |
| 406910299 | GWAS559275_H | neuroimaging measurement QTL GWAS559275 (human) | | 2e-09 | neuroimaging measurement | | 4 | 114732469 | 114732470 | Human |
| 407139674 | GWAS788650_H | emphysema imaging measurement QTL GWAS788650 (human) | | 0.000001 | emphysema imaging measurement | | 4 | 122028172 | 122028173 | Human |
| 597528249 | GWAS1624323_H | systolic blood pressure QTL GWAS1624323 (human) | | 9e-09 | systolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 597528248 | GWAS1624322_H | systolic blood pressure QTL GWAS1624322 (human) | | 1e-24 | systolic blood pressure | | 4 | 110461529 | 110461530 | Human |
| 617204192 | GWAS2184632_H | level of pancreatic triacylglycerol lipase in blood QTL GWAS2184632 (human) | | 1e-17 | level of pancreatic triacylglycerol lipase in blood | | 4 | 109933893 | 109933894 | Human |
| 597528247 | GWAS1624321_H | systolic blood pressure QTL GWAS1624321 (human) | | 3e-24 | systolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 617040361 | GWAS2057860_H | insomnia QTL GWAS2057860 (human) | | 2e-10 | insomnia | | 4 | 129856909 | 129856910 | Human |
| 597151416 | GWAS1247490_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1247490 (human) | | 4e-20 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 626460775 | GWAS2274708_H | obesity QTL GWAS2274708 (human) | | 4e-11 | obesity | | 4 | 119629930 | 119629931 | Human |
| 597364394 | GWAS1460468_H | dental caries QTL GWAS1460468 (human) | | 0.000003 | dental caries | | 4 | 112605916 | 112605917 | Human |
| 597364393 | GWAS1460467_H | dental caries QTL GWAS1460467 (human) | | 0.000003 | dental caries | | 4 | 111359586 | 111359587 | Human |
| 597986967 | GWAS1706266_H | leukocyte quantity QTL GWAS1706266 (human) | | 4e-12 | leukocyte quantity | | 4 | 119409000 | 119409001 | Human |
| 628623436 | GWAS2531665_H | BMI-adjusted waist-hip ratio QTL GWAS2531665 (human) | | 7e-08 | body size trait (VT:0100005) | | 4 | 119441806 | 119441807 | Human |
| 629000265 | GWAS2908494_H | body height QTL GWAS2908494 (human) | | 1e-32 | body height | | 4 | 123312229 | 123312230 | Human |
| 629000264 | GWAS2908493_H | body height QTL GWAS2908493 (human) | | 7e-150 | body height | | 4 | 122917603 | 122917604 | Human |
| 407287152 | GWAS936128_H | complement factor I measurement QTL GWAS936128 (human) | | 3e-66 | complement factor I measurement | | 4 | 109742841 | 109742842 | Human |
| 628787276 | GWAS2695505_H | corneal resistance factor QTL GWAS2695505 (human) | | 2e-09 | cornea morphology trait (VT:0001312) | | 4 | 111768358 | 111768359 | Human |
| 629000266 | GWAS2908495_H | body height QTL GWAS2908495 (human) | | 2e-19 | body height | | 4 | 123707660 | 123707661 | Human |
| 597315234 | GWAS1411308_H | vaginal microbiome measurement QTL GWAS1411308 (human) | | 0.0000004 | vaginal microbiome measurement | | 4 | 107383042 | 107383043 | Human |
| 628623424 | GWAS2531653_H | glomerular filtration rate QTL GWAS2531653 (human) | | 1e-15 | glomerular filtration rate | | 4 | 108772770 | 108772771 | Human |
| 597266081 | GWAS1362155_H | cortical thickness QTL GWAS1362155 (human) | | 4e-12 | cortical thickness | | 4 | 120758655 | 120758656 | Human |
| 629000261 | GWAS2908490_H | body height QTL GWAS2908490 (human) | | 2e-37 | body height | | 4 | 122757847 | 122757848 | Human |
| 597315235 | GWAS1411309_H | vaginal microbiome measurement QTL GWAS1411309 (human) | | 0.0000004 | vaginal microbiome measurement | | 4 | 107467275 | 107467276 | Human |
| 629000260 | GWAS2908489_H | body height QTL GWAS2908489 (human) | | 8e-20 | body height | | 4 | 122626386 | 122626387 | Human |
| 629000263 | GWAS2908492_H | body height QTL GWAS2908492 (human) | | 2e-96 | body height | | 4 | 122830862 | 122830863 | Human |
| 629000262 | GWAS2908491_H | body height QTL GWAS2908491 (human) | | 0.0000001 | body height | | 4 | 122824456 | 122824457 | Human |
| 626460779 | GWAS2274712_H | obesity QTL GWAS2274712 (human) | | 3e-08 | obesity | | 4 | 112392830 | 112392831 | Human |
| 597266085 | GWAS1362159_H | cortical thickness QTL GWAS1362159 (human) | | 2e-10 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 629000257 | GWAS2908486_H | body height QTL GWAS2908486 (human) | | 4e-49 | body height | | 4 | 121772932 | 121772933 | Human |
| 629000256 | GWAS2908485_H | body height QTL GWAS2908485 (human) | | 7e-19 | body height | | 4 | 121693600 | 121693601 | Human |
| 597593760 | GWAS1650620_H | potassium measurement QTL GWAS1650620 (human) | | 8e-14 | potassium measurement | | 4 | 108140367 | 108140368 | Human |
| 629000259 | GWAS2908488_H | body height QTL GWAS2908488 (human) | | 1e-12 | body height | | 4 | 122600025 | 122600026 | Human |
| 629000258 | GWAS2908487_H | body height QTL GWAS2908487 (human) | | 9e-190 | body height | | 4 | 121799844 | 121799845 | Human |
| 629000253 | GWAS2908482_H | body height QTL GWAS2908482 (human) | | 7e-18 | body height | | 4 | 120068926 | 120068927 | Human |
| 629000252 | GWAS2908481_H | body height QTL GWAS2908481 (human) | | 9e-12 | body height | | 4 | 119937025 | 119937026 | Human |
| 629000255 | GWAS2908484_H | body height QTL GWAS2908484 (human) | | 3e-23 | body height | | 4 | 120882137 | 120882138 | Human |
| 617105802 | GWAS2123301_H | gluteofemoral adipose tissue measurement QTL GWAS2123301 (human) | | 3e-08 | gluteofemoral adipose tissue measurement | | 4 | 122891032 | 122891033 | Human |
| 598003431 | GWAS1722730_H | brain volume QTL GWAS1722730 (human) | | 4e-09 | brain volume | | 4 | 120722084 | 120722085 | Human |
| 629000254 | GWAS2908483_H | body height QTL GWAS2908483 (human) | | 2e-19 | body height | | 4 | 120734912 | 120734913 | Human |
| 628852797 | GWAS2761026_H | severe acute respiratory syndrome, COVID-19 QTL GWAS2761026 (human) | | 0.000002 | severe acute respiratory syndrome, COVID-19 | | 4 | 119432971 | 119432972 | Human |
| 597118673 | GWAS1214747_H | bipolar disorder, ulcerative colitis QTL GWAS1214747 (human) | | 2e-12 | bipolar disorder, ulcerative colitis | | 4 | 122154852 | 122154853 | Human |
| 406893831 | GWAS542807_H | epidermal growth factor measurement QTL GWAS542807 (human) | | 3e-25 | epidermal growth factor measurement | | 4 | 109967851 | 109967852 | Human |
| 597397200 | GWAS1493274_H | vaginal microbiome measurement QTL GWAS1493274 (human) | | 0.000008 | vaginal microbiome measurement | | 4 | 120143632 | 120143633 | Human |
| 628951091 | GWAS2859320_H | systolic blood pressure QTL GWAS2859320 (human) | | 3e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 120306899 | 120306900 | Human |
| 597102279 | GWAS1198353_H | platelet count QTL GWAS1198353 (human) | | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109979991 | 109979992 | Human |
| 597151430 | GWAS1247504_H | lifestyle measurement, anxiety disorder measurement QTL GWAS1247504 (human) | | 5e-13 | lifestyle measurement, anxiety disorder measurement | | 4 | 122322628 | 122322629 | Human |
| 617040276 | GWAS2057775_H | body mass index QTL GWAS2057775 (human) | | 1e-11 | body mass index | | 4 | 129838492 | 129838493 | Human |
| 617040275 | GWAS2057774_H | body mass index QTL GWAS2057774 (human) | | 3e-08 | body mass index | | 4 | 114269666 | 114269667 | Human |
| 628426784 | GWAS2335013_H | hemoglobin measurement QTL GWAS2335013 (human) | | 1e-12 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 123835365 | 123835366 | Human |
| 597823220 | GWAS1690611_H | age-related hearing impairment QTL GWAS1690611 (human) | | 0.000007 | age-related hearing impairment | | 4 | 120558243 | 120558244 | Human |
| 628443182 | GWAS2351411_H | hematocrit QTL GWAS2351411 (human) | | 2e-12 | erythrocyte morphology trait (VT:0002447) | hematocrit (CMO:0000037) | 4 | 114598669 | 114598670 | Human |
| 597298887 | GWAS1394961_H | platelet count QTL GWAS1394961 (human) | | 4e-24 | platelet count | | 4 | 109924690 | 109924691 | Human |
| 616384992 | GWAS1865234_H | obsolete_blood urea nitrogen measurement QTL GWAS1865234 (human) | | 2e-09 | obsolete_blood urea nitrogen measurement | | 4 | 119092116 | 119092117 | Human |
| 628688935 | GWAS2597164_H | diastolic blood pressure QTL GWAS2597164 (human) | | 1e-13 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
| 597298885 | GWAS1394959_H | platelet count QTL GWAS1394959 (human) | | 3e-40 | platelet count | | 4 | 110027510 | 110027511 | Human |
| 597364475 | GWAS1460549_H | hemoglobin measurement QTL GWAS1460549 (human) | | 1e-12 | hemoglobin measurement | | 4 | 123835365 | 123835366 | Human |
| 597593853 | GWAS1650713_H | potassium measurement QTL GWAS1650713 (human) | | 1e-16 | potassium measurement | | 4 | 108140367 | 108140368 | Human |
| 407368994 | GWAS1017970_H | biological sex QTL GWAS1017970 (human) | | 5e-13 | biological sex | | 4 | 111485805 | 111485806 | Human |
| 617105824 | GWAS2123323_H | Alzheimer disease, family history of Alzheimer’s disease QTL GWAS2123323 (human) | | 5e-10 | Alzheimer disease, family history of Alzheimer’s disease | | 4 | 114959008 | 114959009 | Human |
| 628426783 | GWAS2335012_H | hemoglobin measurement QTL GWAS2335012 (human) | | 2e-18 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114616986 | 114616987 | Human |
| 598019785 | GWAS1739084_H | strand of hair color QTL GWAS1739084 (human) | | 6e-11 | strand of hair color | | 4 | 108107769 | 108107770 | Human |
| 406943023 | GWAS591999_H | fibroblast growth factor 2 measurement QTL GWAS591999 (human) | | 8e-667 | fibroblast growth factor 2 measurement | | 4 | 122827461 | 122827462 | Human |
| 628918285 | GWAS2826514_H | X-16935 measurement QTL GWAS2826514 (human) | | 0.000007 | X-16935 measurement | | 4 | 128729697 | 128729698 | Human |
| 407254323 | GWAS903299_H | glomerular filtration rate QTL GWAS903299 (human) | | 9e-15 | glomerular filtration rate | | 4 | 108772770 | 108772771 | Human |
| 616958387 | GWAS1975886_H | obesity QTL GWAS1975886 (human) | | 0.0000002 | eating behavior trait (VT:0001431) | | 4 | 129810129 | 129810130 | Human |
| 597511915 | GWAS1607989_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1607989 (human) | | 4e-09 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110420710 | 110420711 | Human |
| 628557825 | GWAS2466054_H | cortical thickness QTL GWAS2466054 (human) | | 4e-08 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120722571 | 120722572 | Human |
| 597397223 | GWAS1493297_H | vaginal microbiome measurement QTL GWAS1493297 (human) | | 0.0000007 | vaginal microbiome measurement | | 4 | 116138019 | 116138020 | Human |
| 407270712 | GWAS919688_H | gut microbiome measurement QTL GWAS919688 (human) | | 0.000004 | gut microbiome measurement | | 4 | 125703884 | 125703885 | Human |
| 597413405 | GWAS1509479_H | mean corpuscular volume QTL GWAS1509479 (human) | | 1e-08 | mean corpuscular volume | | 4 | 121766083 | 121766084 | Human |
| 406926790 | GWAS575766_H | insulin sensitivity measurement, glucose homeostasis measurement QTL GWAS575766 (human) | | 0.000003 | insulin sensitivity measurement, glucose homeostasis measurement | | 4 | 127922325 | 127922326 | Human |
| 597167635 | GWAS1263709_H | brain measurement QTL GWAS1263709 (human) | | 2e-09 | brain measurement | | 4 | 123226927 | 123226928 | Human |
| 407369163 | GWAS1018139_H | venous thromboembolism QTL GWAS1018139 (human) | | 0.0000009 | blood integrity trait (VT:0010779) | | 4 | 131174124 | 131174125 | Human |
| 407074254 | GWAS723230_H | bipolar I disorder QTL GWAS723230 (human) | | 0.0000001 | bipolar I disorder | | 4 | 122588558 | 122588559 | Human |
| 598003241 | GWAS1722540_H | sexual activity behaviour attribute QTL GWAS1722540 (human) | | 4e-10 | sexual activity behaviour attribute | | 4 | 129108051 | 129108052 | Human |
| 406910414 | GWAS559390_H | HVA measurement, MHPG measurement QTL GWAS559390 (human) | | 0.000009 | HVA measurement, MHPG measurement | | 4 | 130105333 | 130105334 | Human |
| 628492519 | GWAS2400748_H | DNA methylation QTL GWAS2400748 (human) | | 3e-09 | DNA methylation | | 4 | 109836068 | 109836069 | Human |
| 598068785 | GWAS1788084_H | body height QTL GWAS1788084 (human) | | 3e-08 | body height | | 4 | 119693141 | 119693142 | Human |
| 597282317 | GWAS1378391_H | COVID-19 QTL GWAS1378391 (human) | | 0.000003 | COVID-19 | | 4 | 120985638 | 120985639 | Human |
| 626460866 | GWAS2274799_H | body mass index QTL GWAS2274799 (human) | | 4e-11 | body mass index | | 4 | 112389479 | 112389480 | Human |
| 598068787 | GWAS1788086_H | body height QTL GWAS1788086 (human) | | 1e-09 | body height | | 4 | 121739866 | 121739867 | Human |
| 628410604 | GWAS2318833_H | gut microbiome measurement QTL GWAS2318833 (human) | | 0.0000001 | gut microbiome measurement | | 4 | 126368923 | 126368924 | Human |
| 407074266 | GWAS723242_H | lung carcinoma, family history of lung cancer QTL GWAS723242 (human) | | 0.000008 | lung carcinoma, family history of lung cancer | | 4 | 131748595 | 131748596 | Human |
| 406910427 | GWAS559403_H | systemic lupus erythematosus QTL GWAS559403 (human) | | 0.000002 | systemic lupus erythematosus | | 4 | 108125804 | 108125805 | Human |
| 617089385 | GWAS2106884_H | venous thromboembolism QTL GWAS2106884 (human) | | 0.0000007 | venous thromboembolism | | 4 | 122619586 | 122619587 | Human |
| 597331513 | GWAS1427587_H | Tinnitus QTL GWAS1427587 (human) | | 0.0000004 | Tinnitus | | 4 | 110681577 | 110681578 | Human |
| 597413438 | GWAS1509512_H | quality of life during menstruation measurement, decreased attention QTL GWAS1509512 (human) | | 0.000003 | quality of life during menstruation measurement, decreased attention | | 4 | 125938393 | 125938394 | Human |
| 628623568 | GWAS2531797_H | balding measurement QTL GWAS2531797 (human) | | 2e-25 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 107131838 | 107131839 | Human |
| 616548631 | GWAS1945214_H | body height QTL GWAS1945214 (human) | | 4e-22 | body height | | 4 | 122904764 | 122904765 | Human |
| 628607198 | GWAS2515427_H | leukocyte quantity QTL GWAS2515427 (human) | | 1e-10 | leukocyte quantity | | 4 | 109996470 | 109996471 | Human |
| 628623569 | GWAS2531798_H | balding measurement QTL GWAS2531798 (human) | | 2e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 124156708 | 124156709 | Human |
| 597413431 | GWAS1509505_H | metabolic syndrome QTL GWAS1509505 (human) | | 1e-11 | metabolic syndrome | | 4 | 129810129 | 129810130 | Human |
| 628623574 | GWAS2531803_H | balding measurement QTL GWAS2531803 (human) | | 3e-16 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106961911 | 106961912 | Human |
| 597511731 | GWAS1607805_H | total cholesterol measurement QTL GWAS1607805 (human) | | 3e-09 | total cholesterol measurement | | 4 | 119202262 | 119202263 | Human |
| 628754635 | GWAS2662864_H | psoriasis QTL GWAS2662864 (human) | | 3e-08 | psoriasis | | 4 | 122680942 | 122680943 | Human |
| 407156214 | GWAS805190_H | gut microbiome measurement QTL GWAS805190 (human) | | 0.000003 | gut microbiome measurement | | 4 | 119309995 | 119309996 | Human |
| 597216812 | GWAS1312886_H | body height QTL GWAS1312886 (human) | | 2e-89 | body height | | 4 | 113970601 | 113970602 | Human |
| 407188989 | GWAS837965_H | guanosine measurement QTL GWAS837965 (human) | | 0.00001 | guanosine measurement | | 4 | 113514721 | 113514722 | Human |
| 597216801 | GWAS1312875_H | body height QTL GWAS1312875 (human) | | 2e-10 | body height | | 4 | 114683908 | 114683909 | Human |
| 597216802 | GWAS1312876_H | body height QTL GWAS1312876 (human) | | 2e-11 | body height | | 4 | 115342108 | 115342109 | Human |
| 617122162 | GWAS2139661_H | obesity QTL GWAS2139661 (human) | | 4e-13 | obesity | | 4 | 129818987 | 129818988 | Human |
| 617105779 | GWAS2123278_H | atrial fibrillation QTL GWAS2123278 (human) | | 4e-714 | atrial fibrillation | | 4 | 110789811 | 110789812 | Human |
| 597216803 | GWAS1312877_H | body height QTL GWAS1312877 (human) | | 0.000001 | body height | | 4 | 117055123 | 117055124 | Human |
| 626460907 | GWAS2274840_H | low density lipoprotein cholesterol measurement QTL GWAS2274840 (human) | | 5e-09 | low density lipoprotein cholesterol measurement | | 4 | 112294031 | 112294032 | Human |
| 597216804 | GWAS1312878_H | body height QTL GWAS1312878 (human) | | 2e-17 | body height | | 4 | 118088739 | 118088740 | Human |
| 628410568 | GWAS2318797_H | high density lipoprotein cholesterol measurement QTL GWAS2318797 (human) | | 2e-08 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 119112961 | 119112962 | Human |
| 597216805 | GWAS1312879_H | body height QTL GWAS1312879 (human) | | 3e-09 | body height | | 4 | 118718546 | 118718547 | Human |
| 407074302 | GWAS723278_H | body height QTL GWAS723278 (human) | | 2e-10 | body height | | 4 | 119636718 | 119636719 | Human |
| 407074301 | GWAS723277_H | body height QTL GWAS723277 (human) | | 1e-32 | body height | | 4 | 108535458 | 108535459 | Human |
| 597216806 | GWAS1312880_H | body height QTL GWAS1312880 (human) | | 6e-22 | body height | | 4 | 119033555 | 119033556 | Human |
| 597216807 | GWAS1312881_H | body height QTL GWAS1312881 (human) | | 7e-90 | body height | | 4 | 119652067 | 119652068 | Human |
| 628721849 | GWAS2630078_H | vaginal microbiome measurement QTL GWAS2630078 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 597823074 | GWAS1690465_H | gut microbiome measurement QTL GWAS1690465 (human) | | 2e-08 | gut microbiome measurement | | 4 | 116034483 | 116034484 | Human |
| 597823075 | GWAS1690466_H | gut microbiome measurement QTL GWAS1690466 (human) | | 2e-09 | gut microbiome measurement | | 4 | 116039953 | 116039954 | Human |
| 407287170 | GWAS936146_H | epidermal growth factor measurement QTL GWAS936146 (human) | | 5e-25 | epidermal growth factor measurement | | 4 | 109938419 | 109938420 | Human |
| 597216850 | GWAS1312924_H | childhood onset asthma QTL GWAS1312924 (human) | | 6e-36 | childhood onset asthma | | 4 | 122432277 | 122432278 | Human |
| 597200468 | GWAS1296542_H | left atrial volume measurement QTL GWAS1296542 (human) | | 1e-08 | left atrial volume measurement | | 4 | 110744627 | 110744628 | Human |
| 597823087 | GWAS1690478_H | gut microbiome measurement QTL GWAS1690478 (human) | | 2e-08 | gut microbiome measurement | | 4 | 116019324 | 116019325 | Human |
| 628754613 | GWAS2662842_H | atrial fibrillation QTL GWAS2662842 (human) | | 2e-1141 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 617072917 | GWAS2090416_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS2090416 (human) | | 2e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 110905034 | 110905035 | Human |
| 406893970 | GWAS542946_H | smoking status measurement, diastolic blood pressure QTL GWAS542946 (human) | | 4e-08 | smoking status measurement, diastolic blood pressure | | 4 | 123660107 | 123660108 | Human |
| 406959509 | GWAS608485_H | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel QTL GWAS608485 (human) | | 0.000009 | progression free survival, response to carboplatin, ovarian carcinoma, trait in response to paclitaxel | | 4 | 113992588 | 113992589 | Human |
| 628508846 | GWAS2417075_H | cardioembolic stroke QTL GWAS2417075 (human) | | 0.0000009 | joint integrity trait (VT:0010548) | | 4 | 110778170 | 110778171 | Human |
| 628361391 | GWAS2282235_H | life span determination trait QTL GWAS2282235 (human) | | 0.000009 | life span determination trait | | 4 | 124576758 | 124576759 | Human |
| 626460854 | GWAS2274787_H | body height QTL GWAS2274787 (human) | | 7e-17 | body height | | 4 | 121801951 | 121801952 | Human |
| 598036038 | GWAS1755337_H | obsolete_upper face morphology measurement QTL GWAS1755337 (human) | | 2e-09 | obsolete_upper face morphology measurement | | 4 | 110922515 | 110922516 | Human |
| 597413503 | GWAS1509577_H | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation QTL GWAS1509577 (human) | | 1e-09 | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation | | 4 | 117452280 | 117452281 | Human |
| 628738206 | GWAS2646435_H | bipolar disorder QTL GWAS2646435 (human) | | 2e-09 | emotion/affect behavior trait (VT:0002572) | | 4 | 122154852 | 122154853 | Human |
| 598036044 | GWAS1755343_H | nose morphology trait QTL GWAS1755343 (human) | | 4e-08 | nose morphology trait | | 4 | 108373433 | 108373434 | Human |
| 597266032 | GWAS1362106_H | triglyceride measurement QTL GWAS1362106 (human) | | 1e-44 | triglyceride measurement | | 4 | 109717668 | 109717669 | Human |
| 628623509 | GWAS2531738_H | atrial fibrillation QTL GWAS2531738 (human) | | 3e-525 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 597495408 | GWAS1591482_H | platelet count QTL GWAS1591482 (human) | | 1e-09 | platelet count | | 4 | 119334573 | 119334574 | Human |
| 407139753 | GWAS788729_H | mosquito bite reaction size measurement QTL GWAS788729 (human) | | 3e-39 | mosquito bite reaction size measurement | | 4 | 122707847 | 122707848 | Human |
| 628770964 | GWAS2679193_H | cerebral cortex area attribute QTL GWAS2679193 (human) | | 4e-08 | cerebral cortex area attribute | | 4 | 118351658 | 118351659 | Human |
| 597036646 | GWAS1132720_H | body mass index QTL GWAS1132720 (human) | | 3e-10 | body mass index | | 4 | 112392830 | 112392831 | Human |
| 628770959 | GWAS2679188_H | cerebral cortex area attribute QTL GWAS2679188 (human) | | 4e-11 | cerebral cortex area attribute | | 4 | 128406387 | 128406388 | Human |
| 628623502 | GWAS2531731_H | atrial fibrillation QTL GWAS2531731 (human) | | 7e-71 | atrial fibrillation | | 4 | 110735436 | 110735437 | Human |
| 628820108 | GWAS2728337_H | eosinophil count QTL GWAS2728337 (human) | | 8e-20 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122639784 | 122639785 | Human |
| 617007409 | GWAS2024908_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS2024908 (human) | | 0.0000006 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 123865108 | 123865109 | Human |
| 628984701 | GWAS2892930_H | connective tissue disease QTL GWAS2892930 (human) | | 2e-14 | connective tissue disease | | 4 | 129687742 | 129687743 | Human |
| 597364122 | GWAS1460196_H | sleep latency QTL GWAS1460196 (human) | | 0.000001 | sleep latency | | 4 | 122626441 | 122626442 | Human |
| 617089738 | GWAS2107237_H | level of tyrosine-protein kinase Mer in blood QTL GWAS2107237 (human) | | 3e-08 | level of tyrosine-protein kinase Mer in blood | | 4 | 121520144 | 121520146 | Human |
| 597396888 | GWAS1492962_H | glomerular filtration rate QTL GWAS1492962 (human) | | 3e-11 | glomerular filtration rate | | 4 | 127288162 | 127288163 | Human |
| 628657022 | GWAS2565251_H | response to sertraline, psychotic symptom measurement, response to olanzapine QTL GWAS2565251 (human) | | 0.000004 | cognitive behavior trait (VT:0010450) | | 4 | 119092116 | 119092117 | Human |
| 628951930 | GWAS2860159_H | potassium measurement QTL GWAS2860159 (human) | | 8e-14 | blood potassium amount (VT:0002668) | blood potassium level (CMO:0000496) | 4 | 108140367 | 108140368 | Human |
| 628755325 | GWAS2663554_H | atrial fibrillation QTL GWAS2663554 (human) | | 5e-30 | atrial fibrillation | | 4 | 110271840 | 110271841 | Human |
| 597314973 | GWAS1411047_H | retinal vasculature measurement QTL GWAS1411047 (human) | | 4e-08 | retinal vasculature measurement | | 4 | 119151914 | 119151915 | Human |
| 597265822 | GWAS1361896_H | cup-to-disc ratio measurement QTL GWAS1361896 (human) | | 1e-11 | cup-to-disc ratio measurement | | 4 | 125318831 | 125318832 | Human |
| 407090761 | GWAS739737_H | late-onset Alzheimers disease QTL GWAS739737 (human) | | 0.000002 | late-onset Alzheimers disease | | 4 | 109373310 | 109373311 | Human |
| 617040589 | GWAS2058088_H | lipid measurement QTL GWAS2058088 (human) | | 0.000006 | lipid measurement | | 4 | 130393791 | 130393792 | Human |
| 597101976 | GWAS1198050_H | coronary artery disease QTL GWAS1198050 (human) | | 2e-08 | coronary artery integrity trait (VT:0010746) | | 4 | 120015426 | 120015427 | Human |
| 407270997 | GWAS919973_H | asthma QTL GWAS919973 (human) | | 5e-20 | asthma | | 4 | 122527407 | 122527408 | Human |
| 628444001 | GWAS2352230_H | multiple sclerosis QTL GWAS2352230 (human) | | 1e-10 | multiple sclerosis | | 4 | 121198294 | 121198295 | Human |
| 597265804 | GWAS1361878_H | triglyceride measurement QTL GWAS1361878 (human) | | 3e-33 | triglyceride measurement | | 4 | 109174464 | 109174465 | Human |
| 628460373 | GWAS2368602_H | asthma QTL GWAS2368602 (human) | | 6e-19 | asthma | | 4 | 122219915 | 122219916 | Human |
| 628460375 | GWAS2368604_H | asthma QTL GWAS2368604 (human) | | 2e-18 | asthma | | 4 | 122438414 | 122438415 | Human |
| 597134773 | GWAS1230847_H | memory performance, sex interaction measurement QTL GWAS1230847 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 125584117 | 125584118 | Human |
| 628460374 | GWAS2368603_H | asthma QTL GWAS2368603 (human) | | 2e-21 | asthma | | 4 | 122432277 | 122432278 | Human |
| 628509521 | GWAS2417750_H | systemic lupus erythematosus QTL GWAS2417750 (human) | | 9e-12 | systemic lupus erythematosus | | 4 | 122089432 | 122089433 | Human |
| 597102015 | GWAS1198089_H | Obsessive-compulsive trait QTL GWAS1198089 (human) | | 0.000009 | Obsessive-compulsive trait | | 4 | 107836793 | 107836794 | Human |
| 628607839 | GWAS2516068_H | heart valve disease QTL GWAS2516068 (human) | | 5e-22 | heart integrity trait (VT:0010757) | | 4 | 110725811 | 110725812 | Human |
| 597593527 | GWAS1650387_H | macular degeneration QTL GWAS1650387 (human) | | 9e-27 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 407320172 | GWAS969148_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS969148 (human) | | 8e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 4 | 108140462 | 108140463 | Human |
| 598035860 | GWAS1755159_H | aging rate QTL GWAS1755159 (human) | | 0.000001 | aging rate | | 4 | 122984812 | 122984813 | Human |
| 598085013 | GWAS1804312_H | bone density QTL GWAS1804312 (human) | | 5e-16 | bone density | | 4 | 131691474 | 131691475 | Human |
| 597462440 | GWAS1558514_H | insular cortex volume measurement QTL GWAS1558514 (human) | | 0.000003 | insular cortex volume measurement | | 4 | 125775267 | 125775268 | Human |
| 597593510 | GWAS1650370_H | macular degeneration QTL GWAS1650370 (human) | | 5e-13 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 407139964 | GWAS788940_H | cognitive decline measurement QTL GWAS788940 (human) | | 0.0000009 | cognitive decline measurement | | 4 | 110589931 | 110589932 | Human |
| 407418480 | GWAS1067456_H | erythrocyte count QTL GWAS1067456 (human) | | 6e-14 | erythrocyte count | | 4 | 114598115 | 114598116 | Human |
| 598085020 | GWAS1804319_H | bone density QTL GWAS1804319 (human) | | 8e-16 | bone density | | 4 | 107727835 | 107727836 | Human |
| 597200292 | GWAS1296366_H | restless legs syndrome QTL GWAS1296366 (human) | | 8e-11 | restless legs syndrome | | 4 | 115033802 | 115033803 | Human |
| 597429664 | GWAS1525738_H | platelet count QTL GWAS1525738 (human) | | 1e-17 | platelet count | | 4 | 119342213 | 119342215 | Human |
| 628869958 | GWAS2778187_H | epidermal growth factor measurement QTL GWAS2778187 (human) | | 3e-14 | epidermal growth factor measurement | | 4 | 109933388 | 109933389 | Human |
| 597200293 | GWAS1296367_H | restless legs syndrome QTL GWAS1296367 (human) | | 5e-08 | restless legs syndrome | | 4 | 118105491 | 118105492 | Human |
| 597429665 | GWAS1525739_H | platelet count QTL GWAS1525739 (human) | | 2e-11 | platelet count | | 4 | 123749526 | 123749527 | Human |
| 597429666 | GWAS1525740_H | platelet count QTL GWAS1525740 (human) | | 8e-12 | platelet count | | 4 | 123882996 | 123882997 | Human |
| 616548992 | GWAS1945575_H | body weight QTL GWAS1945575 (human) | | 2e-13 | body weight | | 4 | 121829906 | 121829907 | Human |
| 616991366 | GWAS2008865_H | glycerophospholipid measurement QTL GWAS2008865 (human) | | 2e-23 | glycerophospholipid measurement | | 4 | 114485894 | 114485895 | Human |
| 628460341 | GWAS2368570_H | adult onset asthma QTL GWAS2368570 (human) | | 8e-10 | adult onset asthma | | 4 | 122438414 | 122438415 | Human |
| 407303686 | GWAS952662_H | BMI-adjusted waist circumference QTL GWAS952662 (human) | | 0.000009 | BMI-adjusted waist circumference | | 4 | 124199191 | 124199192 | Human |
| 628902716 | GWAS2810945_H | major depressive disorder QTL GWAS2810945 (human) | | 1e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
| 616991367 | GWAS2008866_H | glycerophospholipid measurement QTL GWAS2008866 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490871 | 114490872 | Human |
| 616991364 | GWAS2008863_H | glycerophospholipid measurement QTL GWAS2008863 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114486755 | 114486756 | Human |
| 616991365 | GWAS2008864_H | glycerophospholipid measurement QTL GWAS2008864 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114487028 | 114487029 | Human |
| 616991362 | GWAS2008861_H | glycerophospholipid measurement QTL GWAS2008861 (human) | | 6e-25 | glycerophospholipid measurement | | 4 | 114494469 | 114494470 | Human |
| 616991363 | GWAS2008862_H | glycerophospholipid measurement QTL GWAS2008862 (human) | | 3e-24 | glycerophospholipid measurement | | 4 | 114484189 | 114484190 | Human |
| 407287296 | GWAS936272_H | high density lipoprotein cholesterol measurement QTL GWAS936272 (human) | | 1e-21 | high density lipoprotein cholesterol measurement | | 4 | 109174464 | 109174465 | Human |
| 616991360 | GWAS2008859_H | glycerophospholipid measurement QTL GWAS2008859 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114490374 | 114490375 | Human |
| 628902714 | GWAS2810943_H | major depressive disorder QTL GWAS2810943 (human) | | 3e-08 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
| 628460339 | GWAS2368568_H | childhood onset asthma QTL GWAS2368568 (human) | | 6e-36 | childhood onset asthma | | 4 | 122432277 | 122432278 | Human |
| 407287297 | GWAS936273_H | high density lipoprotein cholesterol measurement QTL GWAS936273 (human) | | 1e-25 | high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 616991361 | GWAS2008860_H | glycerophospholipid measurement QTL GWAS2008860 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114490577 | 114490578 | Human |
| 597396956 | GWAS1493030_H | cortical thickness QTL GWAS1493030 (human) | | 3e-08 | cortical thickness | | 4 | 126550097 | 126550098 | Human |
| 616991374 | GWAS2008873_H | glycerophospholipid measurement QTL GWAS2008873 (human) | | 3e-27 | glycerophospholipid measurement | | 4 | 114496527 | 114496528 | Human |
| 407287310 | GWAS936286_H | fibroblast growth factor 2 measurement QTL GWAS936286 (human) | | 6e-36 | fibroblast growth factor 2 measurement | | 4 | 122827461 | 122827462 | Human |
| 616991375 | GWAS2008874_H | glycerophospholipid measurement QTL GWAS2008874 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114598684 | 114598685 | Human |
| 407287311 | GWAS936287_H | fibroblast growth factor 2 measurement QTL GWAS936287 (human) | | 2e-11 | fibroblast growth factor 2 measurement | | 4 | 122682145 | 122682146 | Human |
| 616991372 | GWAS2008871_H | glycerophospholipid measurement QTL GWAS2008871 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114482122 | 114482123 | Human |
| 616991373 | GWAS2008872_H | glycerophospholipid measurement QTL GWAS2008872 (human) | | 6e-28 | glycerophospholipid measurement | | 4 | 114482175 | 114482176 | Human |
| 616991370 | GWAS2008869_H | glycerophospholipid measurement QTL GWAS2008869 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490702 | 114490703 | Human |
| 616991371 | GWAS2008870_H | glycerophospholipid measurement QTL GWAS2008870 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114503010 | 114503011 | Human |
| 616991368 | GWAS2008867_H | glycerophospholipid measurement QTL GWAS2008867 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114490912 | 114490913 | Human |
| 616499952 | GWAS1896535_H | neutrophil measurement, lymphocyte amount QTL GWAS1896535 (human) | | 2e-14 | neutrophil measurement, lymphocyte amount | | 4 | 112190016 | 112190017 | Human |
| 616991369 | GWAS2008868_H | glycerophospholipid measurement QTL GWAS2008868 (human) | | 1e-22 | glycerophospholipid measurement | | 4 | 114491050 | 114491051 | Human |
| 407303703 | GWAS952679_H | platelet count QTL GWAS952679 (human) | | 3e-09 | platelet count | | 4 | 109979991 | 109979992 | Human |
| 597282248 | GWAS1378322_H | hemoglobin measurement QTL GWAS1378322 (human) | | 1e-10 | hemoglobin measurement | | 4 | 124004016 | 124004017 | Human |
| 407074321 | GWAS723297_H | 2-linoleoyl-GPC (18:2) measurement QTL GWAS723297 (human) | | 1e-08 | 2-linoleoyl-GPC (18:2) measurement | | 4 | 107543736 | 107543737 | Human |
| 597183949 | GWAS1280023_H | smoking cessation QTL GWAS1280023 (human) | | 9e-13 | smoking cessation | | 4 | 112122274 | 112122275 | Human |
| 616991376 | GWAS2008875_H | glycerophospholipid measurement QTL GWAS2008875 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114493876 | 114493877 | Human |
| 616991377 | GWAS2008876_H | glycerophospholipid measurement QTL GWAS2008876 (human) | | 8e-27 | glycerophospholipid measurement | | 4 | 114499194 | 114499195 | Human |
| 616499942 | GWAS1896525_H | neutrophil measurement, lymphocyte amount QTL GWAS1896525 (human) | | 6e-12 | neutrophil measurement, lymphocyte amount | | 4 | 109980042 | 109980043 | Human |
| 598035967 | GWAS1755266_H | lip morphology trait QTL GWAS1755266 (human) | | 1e-08 | lip morphology trait | | 4 | 121076949 | 121076950 | Human |
| 628738850 | GWAS2647079_H | wellbeing measurement, alcohol consumption quality QTL GWAS2647079 (human) | | 5e-08 | wellness/fitness trait (VT:1000152) | | 4 | 121669289 | 121669290 | Human |
| 616368864 | GWAS1849106_H | obsolete_lymphocyte measurement, neutrophil measurement QTL GWAS1849106 (human) | | 6e-12 | obsolete_lymphocyte measurement, neutrophil measurement | | 4 | 109980042 | 109980043 | Human |
| 597282247 | GWAS1378321_H | hemoglobin measurement QTL GWAS1378321 (human) | | 3e-11 | hemoglobin measurement | | 4 | 114551415 | 114551416 | Human |
| 616549086 | GWAS1945669_H | Abnormality of the skeletal system QTL GWAS1945669 (human) | | 3e-12 | Abnormality of the skeletal system | | 4 | 110641459 | 110641460 | Human |
| 597085684 | GWAS1181758_H | mean platelet volume QTL GWAS1181758 (human) | | 3e-29 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 628722461 | GWAS2630690_H | vaginal microbiome measurement QTL GWAS2630690 (human) | | 0.000002 | vaginal microbiome measurement | | 4 | 113348345 | 113348346 | Human |
| 407090730 | GWAS739706_H | protein measurement QTL GWAS739706 (human) | | 1e-08 | protein measurement | | 4 | 132318854 | 132318855 | Human |
| 616549074 | GWAS1945657_H | Abnormality of the skeletal system QTL GWAS1945657 (human) | | 3e-26 | Abnormality of the skeletal system | | 4 | 119325127 | 119325128 | Human |
| 628624136 | GWAS2532365_H | atrial fibrillation QTL GWAS2532365 (human) | | 1e-38 | atrial fibrillation | | 4 | 110859850 | 110859851 | Human |
| 597167593 | GWAS1263667_H | nose morphology measurement QTL GWAS1263667 (human) | | 4e-08 | nose morphology measurement | | 4 | 108373433 | 108373434 | Human |
| 406910514 | GWAS559490_H | systemic lupus erythematosus QTL GWAS559490 (human) | | 0.000001 | systemic lupus erythematosus | | 4 | 108801970 | 108801971 | Human |
| 616991413 | GWAS2008912_H | smoking status measurement QTL GWAS2008912 (human) | | 2e-10 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
| 616516299 | GWAS1912882_H | level of BPI fold-containing family B member 2 in blood QTL GWAS1912882 (human) | | 2e-38 | level of BPI fold-containing family B member 2 in blood | | 4 | 109603883 | 109603884 | Human |
| 628624143 | GWAS2532372_H | atrial fibrillation QTL GWAS2532372 (human) | | 1e-15 | atrial fibrillation | | 4 | 110815726 | 110815727 | Human |
| 628673280 | GWAS2581509_H | fibrinopeptide A measurement QTL GWAS2581509 (human) | | 3e-15 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 628673281 | GWAS2581510_H | fibrinopeptide A measurement QTL GWAS2581510 (human) | | 8e-15 | fibrinopeptide A measurement | | 4 | 110485340 | 110485341 | Human |
| 628673282 | GWAS2581511_H | fibrinopeptide A measurement QTL GWAS2581511 (human) | | 1e-12 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 628673283 | GWAS2581512_H | fibrinopeptide A measurement QTL GWAS2581512 (human) | | 2e-25 | fibrinopeptide A measurement | | 4 | 110434637 | 110434638 | Human |
| 628673284 | GWAS2581513_H | fibrinopeptide A measurement QTL GWAS2581513 (human) | | 1e-42 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 628624133 | GWAS2532362_H | atrial fibrillation QTL GWAS2532362 (human) | | 5e-88 | atrial fibrillation | | 4 | 110631977 | 110631978 | Human |
| 407336653 | GWAS985629_H | mean corpuscular hemoglobin concentration QTL GWAS985629 (human) | | 5e-12 | mean corpuscular hemoglobin concentration | | 4 | 109921984 | 109921985 | Human |
| 628460517 | GWAS2368746_H | adult onset asthma QTL GWAS2368746 (human) | | 2e-10 | adult onset asthma | | 4 | 122432277 | 122432278 | Human |
| 628804587 | GWAS2712816_H | osteoarthritis, knee QTL GWAS2712816 (human) | | 1e-08 | joint integrity trait (VT:0010548) | | 4 | 129381399 | 129381400 | Human |
| 597593357 | GWAS1650217_H | platelet count QTL GWAS1650217 (human) | | 5e-39 | platelet count | | 4 | 109927496 | 109927497 | Human |
| 628476897 | GWAS2385126_H | high density lipoprotein cholesterol measurement QTL GWAS2385126 (human) | | 2e-08 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717608 | 109717609 | Human |
| 597511433 | GWAS1607507_H | triglyceride measurement QTL GWAS1607507 (human) | | 7e-11 | triglyceride measurement | | 4 | 123720672 | 123720673 | Human |
| 597396739 | GWAS1492813_H | total cholesterol measurement QTL GWAS1492813 (human) | | 6e-10 | total cholesterol measurement | | 4 | 119192945 | 119192946 | Human |
| 616958558 | GWAS1976057_H | alopecia areata QTL GWAS1976057 (human) | | 4e-08 | alopecia areata | | 4 | 122602720 | 122602721 | Human |
| 597069071 | GWAS1165145_H | susceptibility to hepatitis B infection measurement QTL GWAS1165145 (human) | | 0.000003 | response to viral infection trait (VT:0010439) | | 4 | 110859685 | 110859686 | Human |
| 407058138 | GWAS707114_H | triglyceride measurement QTL GWAS707114 (human) | | 0.000005 | triglyceride measurement | | 4 | 125211924 | 125211925 | Human |
| 597331206 | GWAS1427280_H | appendicitis QTL GWAS1427280 (human) | | 2e-11 | appendicitis | | 4 | 110799841 | 110799842 | Human |
| 628804582 | GWAS2712811_H | osteoarthritis, knee QTL GWAS2712811 (human) | | 5e-09 | joint integrity trait (VT:0010548) | | 4 | 120672441 | 120672442 | Human |
| 628886497 | GWAS2794726_H | cardioembolic stroke QTL GWAS2794726 (human) | | 0.0000003 | joint integrity trait (VT:0010548) | | 4 | 110841700 | 110841701 | Human |
| 628444117 | GWAS2352346_H | multiple sclerosis QTL GWAS2352346 (human) | | 2e-11 | multiple sclerosis | | 4 | 108137562 | 108137563 | Human |
| 617040485 | GWAS2057984_H | peptic ulcer disease QTL GWAS2057984 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616965 | 123616966 | Human |
| 628886495 | GWAS2794724_H | cardioembolic stroke QTL GWAS2794724 (human) | | 5e-08 | joint integrity trait (VT:0010548) | | 4 | 110673205 | 110673206 | Human |
| 596987190 | GWAS1106709_H | memory performance QTL GWAS1106709 (human) | | 0.000001 | memory performance | | 4 | 125705326 | 125705327 | Human |
| 617007717 | GWAS2025216_H | type 2 diabetes mellitus QTL GWAS2025216 (human) | | 0.0000005 | type 2 diabetes mellitus | | 4 | 128605841 | 128605842 | Human |
| 597216560 | GWAS1312634_H | body height QTL GWAS1312634 (human) | | 1e-22 | body height | | 4 | 109940771 | 109940772 | Human |
| 597216561 | GWAS1312635_H | body height QTL GWAS1312635 (human) | | 1e-20 | body height | | 4 | 110649067 | 110649068 | Human |
| 616958575 | GWAS1976074_H | HIV viral set point measurement QTL GWAS1976074 (human) | | 0.000006 | response to viral infection trait (VT:0010439) | | 4 | 120120131 | 120120132 | Human |
| 596987196 | GWAS1106715_H | memory performance QTL GWAS1106715 (human) | | 0.000002 | memory performance | | 4 | 125664944 | 125664945 | Human |
| 597216562 | GWAS1312636_H | body height QTL GWAS1312636 (human) | | 1e-08 | body height | | 4 | 113079800 | 113079801 | Human |
| 597216563 | GWAS1312637_H | body height QTL GWAS1312637 (human) | | 2e-12 | body height | | 4 | 113740525 | 113740526 | Human |
| 628706261 | GWAS2614490_H | polypeptide N-acetylgalactosaminyltransferase 3 measurement QTL GWAS2614490 (human) | | 3e-14 | polypeptide N-acetylgalactosaminyltransferase 3 measurement | | 4 | 109948090 | 109948091 | Human |
| 597216564 | GWAS1312638_H | body height QTL GWAS1312638 (human) | | 2e-105 | body height | | 4 | 113901423 | 113901424 | Human |
| 597216565 | GWAS1312639_H | body height QTL GWAS1312639 (human) | | 3e-56 | body height | | 4 | 113958625 | 113958626 | Human |
| 596987194 | GWAS1106713_H | memory performance QTL GWAS1106713 (human) | | 0.000001 | memory performance | | 4 | 125709483 | 125709484 | Human |
| 628493255 | GWAS2401484_H | Thyroid preparation use measurement QTL GWAS2401484 (human) | | 8e-10 | hypothyroidism | | 4 | 122625127 | 122625128 | Human |
| 407041777 | GWAS690753_H | intelligence QTL GWAS690753 (human) | | 0.0000009 | intelligence | | 4 | 117956978 | 117956979 | Human |
| 407205616 | GWAS854592_H | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement QTL GWAS854592 (human) | | 1e-09 | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | | 4 | 129484578 | 129484579 | Human |
| 617122431 | GWAS2139930_H | Abnormality of the skeletal system QTL GWAS2139930 (human) | | 3e-26 | Abnormality of the skeletal system | | 4 | 119325127 | 119325128 | Human |
| 616991358 | GWAS2008857_H | glycerophospholipid measurement QTL GWAS2008857 (human) | | 2e-36 | glycerophospholipid measurement | | 4 | 114486174 | 114486175 | Human |
| 616991359 | GWAS2008858_H | glycerophospholipid measurement QTL GWAS2008858 (human) | | 3e-31 | glycerophospholipid measurement | | 4 | 114598670 | 114598671 | Human |
| 597527844 | GWAS1623918_H | level of N-acetylgalactosamine in blood, level of N-acetylglucosamine in blood QTL GWAS1623918 (human) | | 7e-31 | level of N-acetylgalactosamine in blood, level of N-acetylglucosamine in blood | | 4 | 129109789 | 129109790 | Human |
| 597429542 | GWAS1525616_H | protein measurement QTL GWAS1525616 (human) | | 5e-32 | protein measurement | | 4 | 109915408 | 109915409 | Human |
| 597347616 | GWAS1443690_H | pulse pressure measurement, sex interaction measurement QTL GWAS1443690 (human) | | 0.000007 | pulse pressure measurement, sex interaction measurement | | 4 | 110755885 | 110755886 | Human |
| 616991356 | GWAS2008855_H | glycerophospholipid measurement QTL GWAS2008855 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114487644 | 114487645 | Human |
| 616991357 | GWAS2008856_H | glycerophospholipid measurement QTL GWAS2008856 (human) | | 8e-41 | glycerophospholipid measurement | | 4 | 114488433 | 114488434 | Human |
| 616991354 | GWAS2008853_H | glycerophospholipid measurement QTL GWAS2008853 (human) | | 6e-41 | glycerophospholipid measurement | | 4 | 114483120 | 114483121 | Human |
| 616991355 | GWAS2008854_H | glycerophospholipid measurement QTL GWAS2008854 (human) | | 6e-41 | glycerophospholipid measurement | | 4 | 114507972 | 114507973 | Human |
| 407189124 | GWAS838100_H | glycerophospholipid measurement QTL GWAS838100 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114509770 | 114509771 | Human |
| 597069141 | GWAS1165215_H | susceptibility to scarlet fever measurement QTL GWAS1165215 (human) | | 0.000009 | response to bacterial infection trait (VT:0010435) | | 4 | 109544415 | 109544416 | Human |
| 597200223 | GWAS1296297_H | left atrial volume measurement QTL GWAS1296297 (human) | | 2e-08 | left atrial volume measurement | | 4 | 110744627 | 110744628 | Human |
| 628673458 | GWAS2581687_H | neuroimaging measurement QTL GWAS2581687 (human) | | 5e-09 | nervous system morphology trait (VT:0003632) | | 4 | 114719632 | 114719636 | Human |
| 628460479 | GWAS2368708_H | diastolic blood pressure QTL GWAS2368708 (human) | | 3e-09 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119037654 | 119037655 | Human |
| 616516209 | GWAS1912792_H | platelet component distribution width QTL GWAS1912792 (human) | | 9e-21 | platelet component distribution width | | 4 | 109989924 | 109989925 | Human |
| 407058061 | GWAS707037_H | systemic lupus erythematosus QTL GWAS707037 (human) | | 1e-09 | systemic lupus erythematosus | | 4 | 122587346 | 122587347 | Human |
| 407090833 | GWAS739809_H | atrial fibrillation QTL GWAS739809 (human) | | 2e-340 | atrial fibrillation | | 4 | 110737238 | 110737239 | Human |
| 628722602 | GWAS2630831_H | glomerular filtration rate QTL GWAS2630831 (human) | | 0.0000001 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 617007632 | GWAS2025131_H | mosquito bite reaction itch intensity measurement QTL GWAS2025131 (human) | | 8e-08 | mosquito bite reaction itch intensity measurement | | 4 | 123350979 | 123350980 | Human |
| 597495108 | GWAS1591182_H | tiglylcarnitine (C5:1-DC) measurement QTL GWAS1591182 (human) | | 6e-08 | tiglylcarnitine (C5:1-DC) measurement | | 4 | 110977273 | 110977274 | Human |
| 597232965 | GWAS1329039_H | brain measurement QTL GWAS1329039 (human) | | 2e-08 | brain measurement | | 4 | 123335936 | 123335937 | Human |
| 598035781 | GWAS1755080_H | aging rate QTL GWAS1755080 (human) | | 7e-08 | aging rate | | 4 | 123010723 | 123010724 | Human |
| 596954486 | GWAS1074005_H | coronary artery disease QTL GWAS1074005 (human) | | 4e-08 | coronary artery disease | | 4 | 110757945 | 110757946 | Human |
| 598035777 | GWAS1755076_H | aging rate QTL GWAS1755076 (human) | | 5e-10 | aging rate | | 4 | 123250668 | 123250669 | Human |
| 628624285 | GWAS2532514_H | glomerular filtration rate QTL GWAS2532514 (human) | | 4e-16 | glomerular filtration rate | | 4 | 108782393 | 108782394 | Human |
| 597265788 | GWAS1361862_H | low density lipoprotein cholesterol measurement QTL GWAS1361862 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | | 4 | 127741641 | 127741642 | Human |
| 598035779 | GWAS1755078_H | aging rate QTL GWAS1755078 (human) | | 3e-08 | aging rate | | 4 | 123350987 | 123350988 | Human |
| 598035778 | GWAS1755077_H | aging rate QTL GWAS1755077 (human) | | 4e-09 | aging rate | | 4 | 123122397 | 123122398 | Human |
| 617122336 | GWAS2139835_H | heart rate QTL GWAS2139835 (human) | | 7e-21 | heart rate | | 4 | 110796911 | 110796912 | Human |
| 626461627 | GWAS2275560_H | systolic blood pressure QTL GWAS2275560 (human) | | 1e-08 | systolic blood pressure | | 4 | 110467945 | 110467946 | Human |
| 597314934 | GWAS1411008_H | cortical thickness QTL GWAS1411008 (human) | | 1e-11 | cortical thickness | | 4 | 123258359 | 123258360 | Human |
| 628919182 | GWAS2827411_H | triglyceride measurement QTL GWAS2827411 (human) | | 4e-08 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 112187786 | 112187787 | Human |
| 628919178 | GWAS2827407_H | triglyceride measurement QTL GWAS2827407 (human) | | 4e-08 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 126247400 | 126247401 | Human |
| 597593446 | GWAS1650306_H | disturbances of sensation of smell and taste QTL GWAS1650306 (human) | | 9e-12 | disturbances of sensation of smell and taste | | 4 | 125832302 | 125832303 | Human |
| 628722563 | GWAS2630792_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2630792 (human) | | 1e-26 | glioma pathogenesis-related protein 1 measurement | | 4 | 125365950 | 125365951 | Human |
| 407320252 | GWAS969228_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS969228 (human) | | 4e-13 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 628657027 | GWAS2565256_H | response to sertraline, psychotic symptom measurement, response to olanzapine QTL GWAS2565256 (human) | | 0.000005 | cognitive behavior trait (VT:0010450) | | 4 | 119052935 | 119052936 | Human |
| 597527905 | GWAS1623979_H | fibrinopeptide A, des-ala(1) measurement QTL GWAS1623979 (human) | | 2e-14 | fibrinopeptide A, des-ala(1) measurement | | 4 | 110446685 | 110446686 | Human |
| 617106376 | GWAS2123875_H | body height QTL GWAS2123875 (human) | | 1e-18 | body height | | 4 | 128691709 | 128691710 | Human |
| 617106377 | GWAS2123876_H | body height QTL GWAS2123876 (human) | | 2e-24 | body height | | 4 | 128708095 | 128708096 | Human |
| 617106378 | GWAS2123877_H | body height QTL GWAS2123877 (human) | | 7e-11 | body height | | 4 | 129860515 | 129860516 | Human |
| 617106379 | GWAS2123878_H | body height QTL GWAS2123878 (human) | | 2e-20 | body height | | 4 | 131543872 | 131543873 | Human |
| 628787838 | GWAS2696067_H | protein measurement QTL GWAS2696067 (human) | | 2e-23 | protein amount (VT:0010120) | | 4 | 110510288 | 110510289 | Human |
| 407238464 | GWAS887440_H | phospholipids:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS887440 (human) | | 7e-13 | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | | 4 | 109657070 | 109657071 | Human |
| 628771453 | GWAS2679682_H | atrial fibrillation QTL GWAS2679682 (human) | | 1e-48 | atrial fibrillation | | 4 | 110707883 | 110707884 | Human |
| 597380252 | GWAS1476326_H | serum IgG glycosylation measurement QTL GWAS1476326 (human) | | 0.000002 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
| 597232787 | GWAS1328861_H | Ischemic stroke QTL GWAS1328861 (human) | | 0.000002 | Ischemic stroke | | 4 | 110308365 | 110308366 | Human |
| 628804208 | GWAS2712437_H | age of onset of childhood onset asthma QTL GWAS2712437 (human) | | 6e-16 | age of onset of childhood onset asthma | | 4 | 122307075 | 122307076 | Human |
| 617106372 | GWAS2123871_H | body height QTL GWAS2123871 (human) | | 8e-35 | body height | | 4 | 123891742 | 123891743 | Human |
| 617106373 | GWAS2123872_H | body height QTL GWAS2123872 (human) | | 4e-17 | body height | | 4 | 125758137 | 125758138 | Human |
| 617106374 | GWAS2123873_H | body height QTL GWAS2123873 (human) | | 5e-15 | body height | | 4 | 125767588 | 125767589 | Human |
| 617106375 | GWAS2123874_H | body height QTL GWAS2123874 (human) | | 9e-20 | body height | | 4 | 127073768 | 127073769 | Human |
| 597052551 | GWAS1148625_H | leukocyte count QTL GWAS1148625 (human) | | 4e-11 | leukocyte count | | 4 | 109932621 | 109932622 | Human |
| 597167242 | GWAS1263316_H | brain measurement QTL GWAS1263316 (human) | | 1e-10 | brain measurement | | 4 | 123263477 | 123263478 | Human |
| 597396616 | GWAS1492690_H | skin aging measurement QTL GWAS1492690 (human) | | 3e-08 | skin aging measurement | | 4 | 123350987 | 123350988 | Human |
| 616516519 | GWAS1913102_H | platelet count QTL GWAS1913102 (human) | | 7e-38 | platelet count | | 4 | 109966833 | 109966834 | Human |
| 597462144 | GWAS1558218_H | body mass index QTL GWAS1558218 (human) | | 7e-13 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 617040858 | GWAS2058357_H | cardioembolic stroke QTL GWAS2058357 (human) | | 5e-41 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 628935266 | GWAS2843495_H | triglyceride measurement QTL GWAS2843495 (human) | | 6e-10 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 123849710 | 123849711 | Human |
| 628492886 | GWAS2401115_H | Calcium channel blocker use measurement QTL GWAS2401115 (human) | | 6e-12 | Calcium channel blocker use measurement | | 4 | 110467945 | 110467946 | Human |
| 406910818 | GWAS559794_H | heart failure QTL GWAS559794 (human) | | 2e-15 | heart failure | | 4 | 110787848 | 110787849 | Human |
| 597429438 | GWAS1525512_H | pelvic organ prolapse QTL GWAS1525512 (human) | | 2e-22 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
| 628886110 | GWAS2794339_H | retinal drusen QTL GWAS2794339 (human) | | 0.00001 | retina integrity trait (VT:0010771) | | 4 | 128129997 | 128129998 | Human |
| 617040867 | GWAS2058366_H | cardioembolic stroke QTL GWAS2058366 (human) | | 2e-47 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 617040866 | GWAS2058365_H | stroke QTL GWAS2058365 (human) | | 2e-13 | stroke | | 4 | 110793263 | 110793264 | Human |
| 617139182 | GWAS2156681_H | N-acylethanolamine-hydrolyzing acid amidase measurement QTL GWAS2156681 (human) | | 3e-12 | N-acylethanolamine-hydrolyzing acid amidase measurement | | 4 | 109657070 | 109657071 | Human |
| 597265599 | GWAS1361673_H | cortical thickness QTL GWAS1361673 (human) | | 4e-13 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
| 407238499 | GWAS887475_H | platelet-to-lymphocyte ratio QTL GWAS887475 (human) | | 5e-08 | platelet-to-lymphocyte ratio | | 4 | 121774530 | 121774531 | Human |
| 616991725 | GWAS2009224_H | body mass index QTL GWAS2009224 (human) | | 2e-14 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129843450 | 129843451 | Human |
| 617057256 | GWAS2074755_H | psoriasis QTL GWAS2074755 (human) | | 3e-08 | psoriasis | | 4 | 122680942 | 122680943 | Human |
| 628935247 | GWAS2843476_H | low density lipoprotein cholesterol measurement QTL GWAS2843476 (human) | | 5e-09 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 112294031 | 112294032 | Human |
| 407091056 | GWAS740032_H | osteoarthritis, knee QTL GWAS740032 (human) | | 8e-08 | osteoarthritis, knee | | 4 | 121786965 | 121786966 | Human |
| 407418751 | GWAS1067727_H | systolic blood pressure QTL GWAS1067727 (human) | | 8e-15 | systolic blood pressure | | 4 | 108146742 | 108146743 | Human |
| 628673088 | GWAS2581317_H | astrocytoma QTL GWAS2581317 (human) | | 0.000005 | astrocytoma | | 4 | 120634028 | 120634029 | Human |
| 597593252 | GWAS1650112_H | platelet count QTL GWAS1650112 (human) | | 2e-61 | platelet count | | 4 | 109927496 | 109927497 | Human |
| 628886086 | GWAS2794315_H | Alzheimer disease, polygenic risk score QTL GWAS2794315 (human) | | 7e-09 | Alzheimer disease, polygenic risk score | | 4 | 118306104 | 118306105 | Human |
| 407385970 | GWAS1034946_H | asthma QTL GWAS1034946 (human) | | 3e-19 | asthma | | 4 | 122120316 | 122120317 | Human |
| 617008006 | GWAS2025505_H | appendicular lean mass QTL GWAS2025505 (human) | | 3e-11 | appendicular lean mass | | 4 | 107939926 | 107939927 | Human |
| 597478620 | GWAS1574694_H | atrial fibrillation QTL GWAS1574694 (human) | | 3e-09 | atrial fibrillation | | 4 | 111533139 | 111533140 | Human |
| 597413082 | GWAS1509156_H | adolescent idiopathic scoliosis QTL GWAS1509156 (human) | | 9e-37 | adolescent idiopathic scoliosis | | 4 | 114347014 | 114347015 | Human |
| 617008007 | GWAS2025506_H | appendicular lean mass QTL GWAS2025506 (human) | | 3e-22 | appendicular lean mass | | 4 | 124035957 | 124035958 | Human |
| 597265624 | GWAS1361698_H | facial morphology measurement QTL GWAS1361698 (human) | | 9e-12 | facial morphology measurement | | 4 | 126901674 | 126901675 | Human |
| 628492853 | GWAS2401082_H | DNA methylation QTL GWAS2401082 (human) | | 2e-08 | DNA methylation | | 4 | 124761267 | 124761268 | Human |
| 407385870 | GWAS1034846_H | blood protein measurement QTL GWAS1034846 (human) | | 6e-205 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 597478618 | GWAS1574692_H | atrial fibrillation QTL GWAS1574692 (human) | | 1e-28 | atrial fibrillation | | 4 | 110603473 | 110603474 | Human |
| 617122703 | GWAS2140202_H | prothrombin time measurement QTL GWAS2140202 (human) | | 2e-36 | prothrombin time measurement | | 4 | 110796911 | 110796912 | Human |
| 597478619 | GWAS1574693_H | atrial fibrillation QTL GWAS1574693 (human) | | 2e-18 | atrial fibrillation | | 4 | 111004500 | 111004501 | Human |
| 616991629 | GWAS2009128_H | response to antidepressant QTL GWAS2009128 (human) | | 0.0000005 | response to antidepressant | | 4 | 117580003 | 117580004 | Human |
| 407140104 | GWAS789080_H | perceived unattractiveness to mosquitos measurement QTL GWAS789080 (human) | | 2e-23 | perceived unattractiveness to mosquitos measurement | | 4 | 122695667 | 122695668 | Human |
| 628820534 | GWAS2728763_H | asthma QTL GWAS2728763 (human) | | 2e-17 | asthma | | 4 | 122123526 | 122123527 | Human |
| 407140105 | GWAS789081_H | perceived unattractiveness to mosquitos measurement QTL GWAS789081 (human) | | 0.000007 | perceived unattractiveness to mosquitos measurement | | 4 | 122817391 | 122817392 | Human |
| 628722231 | GWAS2630460_H | vaginal microbiome measurement QTL GWAS2630460 (human) | | 0.000003 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 406959889 | GWAS608865_H | BMI-adjusted waist-hip ratio QTL GWAS608865 (human) | | 1e-13 | BMI-adjusted waist-hip ratio | | 4 | 123002800 | 123002801 | Human |
| 628460070 | GWAS2368299_H | smoking status measurement QTL GWAS2368299 (human) | | 1e-10 | smoking status measurement | | 4 | 111546456 | 111546457 | Human |
| 597363919 | GWAS1459993_H | acute myeloid leukemia QTL GWAS1459993 (human) | | 1e-13 | acute myeloid leukemia | | 4 | 121985860 | 121985861 | Human |
| 596970689 | GWAS1090208_H | heel bone mineral density QTL GWAS1090208 (human) | | 4e-14 | heel bone mineral density | | 4 | 123706225 | 123706226 | Human |
| 628722221 | GWAS2630450_H | vaginal microbiome measurement QTL GWAS2630450 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
| 597363918 | GWAS1459992_H | acute myeloid leukemia QTL GWAS1459992 (human) | | 5e-20 | acute myeloid leukemia | | 4 | 121985860 | 121985861 | Human |
| 597363917 | GWAS1459991_H | acute myeloid leukemia QTL GWAS1459991 (human) | | 5e-08 | acute myeloid leukemia | | 4 | 117598611 | 117598612 | Human |
| 406959895 | GWAS608871_H | BMI-adjusted waist-hip ratio QTL GWAS608871 (human) | | 2e-08 | BMI-adjusted waist-hip ratio | | 4 | 123118168 | 123118169 | Human |
| 407074581 | GWAS723557_H | Hallux valgus QTL GWAS723557 (human) | | 0.000001 | Hallux valgus | | 4 | 125790890 | 125790891 | Human |
| 617122704 | GWAS2140203_H | prothrombin time measurement QTL GWAS2140203 (human) | | 2e-20 | prothrombin time measurement | | 4 | 110796911 | 110796912 | Human |
| 407222045 | GWAS871021_H | atopic eczema QTL GWAS871021 (human) | | 0.000001 | atopic eczema | | 4 | 122576542 | 122576543 | Human |
| 407074587 | GWAS723563_H | Hallux valgus QTL GWAS723563 (human) | | 0.000003 | Hallux valgus | | 4 | 126494361 | 126494362 | Human |
| 628623906 | GWAS2532135_H | atrial fibrillation QTL GWAS2532135 (human) | | 2e-39 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
| 597331136 | GWAS1427210_H | sleep duration QTL GWAS1427210 (human) | | 0.0000003 | sleep duration | | 4 | 115085956 | 115085957 | Human |
| 597396731 | GWAS1492805_H | systolic blood pressure QTL GWAS1492805 (human) | | 6e-09 | systolic blood pressure | | 4 | 108328807 | 108328808 | Human |
| 597347578 | GWAS1443652_H | nephrolithiasis QTL GWAS1443652 (human) | | 3e-14 | nephrolithiasis | | 4 | 114667805 | 114667806 | Human |
| 407025443 | GWAS674419_H | atrial fibrillation QTL GWAS674419 (human) | | 7e-11 | atrial fibrillation | | 4 | 110799605 | 110799606 | Human |
| 616975266 | GWAS1992765_H | electrocardiography QTL GWAS1992765 (human) | | 7e-12 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 407222049 | GWAS871025_H | atopic eczema, psoriasis QTL GWAS871025 (human) | | 0.000001 | atopic eczema, psoriasis | | 4 | 122335010 | 122335011 | Human |
| 407041831 | GWAS690807_H | longitudinal BMI measurement QTL GWAS690807 (human) | | 0.000009 | longitudinal BMI measurement | | 4 | 118506802 | 118506803 | Human |
| 407025444 | GWAS674420_H | atrial fibrillation QTL GWAS674420 (human) | | 3e-41 | atrial fibrillation | | 4 | 110789013 | 110789014 | Human |
| 616975265 | GWAS1992764_H | electrocardiography QTL GWAS1992764 (human) | | 3e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 628787730 | GWAS2695959_H | cystatin C measurement QTL GWAS2695959 (human) | | 4e-09 | blood cystatin C amount (VT:0010743) | blood cystatin C level (CMO:0002777) | 4 | 119754004 | 119754005 | Human |
| 617073582 | GWAS2091081_H | low density lipoprotein cholesterol measurement QTL GWAS2091081 (human) | | 6e-09 | low density lipoprotein cholesterol measurement | | 4 | 119206905 | 119206906 | Human |
| 628673045 | GWAS2581274_H | fibrinopeptide A measurement QTL GWAS2581274 (human) | | 7e-15 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 628673046 | GWAS2581275_H | fibrinopeptide A measurement QTL GWAS2581275 (human) | | 6e-17 | fibrinopeptide A measurement | | 4 | 110510288 | 110510289 | Human |
| 598084822 | GWAS1804121_H | glomerular filtration rate QTL GWAS1804121 (human) | | 2e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
| 406976305 | GWAS625281_H | mean corpuscular hemoglobin QTL GWAS625281 (human) | | 6e-18 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121808258 | 121808259 | Human |
| 597511404 | GWAS1607478_H | diastolic blood pressure QTL GWAS1607478 (human) | | 1e-10 | diastolic blood pressure | | 4 | 119336584 | 119336585 | Human |
| 598084823 | GWAS1804122_H | glomerular filtration rate QTL GWAS1804122 (human) | | 0.0000002 | glomerular filtration rate | | 4 | 125673826 | 125673827 | Human |
| 628935182 | GWAS2843411_H | body mass index QTL GWAS2843411 (human) | | 2e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 114207408 | 114207409 | Human |
| 406976306 | GWAS625282_H | mean corpuscular hemoglobin QTL GWAS625282 (human) | | 3e-09 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 127647811 | 127647812 | Human |
| 597396717 | GWAS1492791_H | systolic blood pressure QTL GWAS1492791 (human) | | 1e-14 | systolic blood pressure | | 4 | 110414448 | 110414449 | Human |
| 407009083 | GWAS658059_H | testosterone measurement QTL GWAS658059 (human) | | 1e-19 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 628492811 | GWAS2401040_H | DNA methylation QTL GWAS2401040 (human) | | 3e-09 | DNA methylation | | 4 | 119957380 | 119957381 | Human |
| 407336761 | GWAS985737_H | total cholesterol measurement QTL GWAS985737 (human) | | 4e-10 | total cholesterol measurement | | 4 | 119185611 | 119185612 | Human |
| 598084824 | GWAS1804123_H | glomerular filtration rate QTL GWAS1804123 (human) | | 3e-15 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 628607496 | GWAS2515725_H | lymphocyte count QTL GWAS2515725 (human) | | 3e-09 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 110003204 | 110003205 | Human |
| 597052649 | GWAS1148723_H | anxiety QTL GWAS1148723 (human) | | 2e-08 | anxiety | | 4 | 118133633 | 118133634 | Human |
| 628673275 | GWAS2581504_H | astrocytoma QTL GWAS2581504 (human) | | 0.000008 | astrocytoma | | 4 | 125560531 | 125560532 | Human |
| 628443889 | GWAS2352118_H | multiple sclerosis QTL GWAS2352118 (human) | | 0.0000002 | multiple sclerosis | | 4 | 112153589 | 112153590 | Human |
| 597593112 | GWAS1649972_H | retinopathy QTL GWAS1649972 (human) | | 1e-11 | retinopathy | | 4 | 109764664 | 109764665 | Human |
| 617057100 | GWAS2074599_H | gut microbiome measurement, bone tissue density QTL GWAS2074599 (human) | | 2e-09 | gut microbiome measurement, bone tissue density | | 4 | 116039953 | 116039954 | Human |
| 407369676 | GWAS1018652_H | celiac disease QTL GWAS1018652 (human) | | 1e-08 | intestine integrity trait (VT:0010554) | | 4 | 122340375 | 122340376 | Human |
| 617057099 | GWAS2074598_H | gut microbiome measurement, bone tissue density QTL GWAS2074598 (human) | | 2e-08 | gut microbiome measurement, bone tissue density | | 4 | 116034483 | 116034484 | Human |
| 597199892 | GWAS1295966_H | post-traumatic stress disorder QTL GWAS1295966 (human) | | 7e-09 | post-traumatic stress disorder | | 4 | 122265238 | 122265239 | Human |
| 628591354 | GWAS2499583_H | blood VLDL cholesterol amount, chylomicron amount QTL GWAS2499583 (human) | | 1e-10 | blood VLDL cholesterol amount, chylomicron amount | | 4 | 109657070 | 109657071 | Human |
| 628804343 | GWAS2712572_H | smoking status measurement QTL GWAS2712572 (human) | | 6e-10 | smoking status measurement | | 4 | 111485805 | 111485806 | Human |
| 617057098 | GWAS2074597_H | gut microbiome measurement, bone tissue density QTL GWAS2074597 (human) | | 2e-08 | gut microbiome measurement, bone tissue density | | 4 | 116019324 | 116019325 | Human |
| 617089881 | GWAS2107380_H | platelet count QTL GWAS2107380 (human) | | 5e-16 | platelet count | | 4 | 119464317 | 119464318 | Human |
| 617089882 | GWAS2107381_H | platelet count QTL GWAS2107381 (human) | | 6e-10 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 407025620 | GWAS674596_H | hair morphology QTL GWAS674596 (human) | | 0.000009 | coat/hair morphology trait (VT:0000367) | coat/hair morphological measurement (CMO:0001807) | 4 | 109904478 | 109904479 | Human |
| 407140317 | GWAS789293_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS789293 (human) | | 0.000001 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 4 | 123994124 | 123994125 | Human |
| 597593092 | GWAS1649952_H | retinal degeneration QTL GWAS1649952 (human) | | 2e-11 | retinal degeneration | | 4 | 114161723 | 114161724 | Human |
| 597183490 | GWAS1279564_H | reduced glutathione measurement QTL GWAS1279564 (human) | | 4e-08 | reduced glutathione measurement | | 4 | 124355648 | 124355649 | Human |
| 617106259 | GWAS2123758_H | level of phosphatidylcholine QTL GWAS2123758 (human) | | 2e-08 | level of phosphatidylcholine | | 4 | 126274953 | 126274954 | Human |
| 597363718 | GWAS1459792_H | acute myeloid leukemia QTL GWAS1459792 (human) | | 9e-18 | acute myeloid leukemia | | 4 | 112776849 | 112776850 | Human |
| 616500002 | GWAS1896585_H | neutrophil measurement, lymphocyte amount QTL GWAS1896585 (human) | | 3e-14 | neutrophil measurement, lymphocyte amount | | 4 | 122707302 | 122707305 | Human |
| 628689624 | GWAS2597853_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS2597853 (human) | | 6e-58 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119373929 | 119373930 | Human |
| 407205859 | GWAS854835_H | pulmonary function measurement QTL GWAS854835 (human) | | 0.000003 | pulmonary function measurement | | 4 | 130774276 | 130774277 | Human |
| 596970557 | GWAS1090076_H | heel bone mineral density QTL GWAS1090076 (human) | | 2e-10 | heel bone mineral density | | 4 | 118871804 | 118871805 | Human |
| 617007979 | GWAS2025478_H | blood protein amount QTL GWAS2025478 (human) | | 1e-164 | blood protein amount | | 4 | 106917957 | 106917958 | Human |
| 597380141 | GWAS1476215_H | Red cell distribution width QTL GWAS1476215 (human) | | 1e-20 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 616516359 | GWAS1912942_H | mean reticulocyte volume QTL GWAS1912942 (human) | | 5e-13 | mean reticulocyte volume | | 4 | 122155413 | 122155414 | Human |
| 628935365 | GWAS2843594_H | systolic blood pressure QTL GWAS2843594 (human) | | 6e-13 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110791276 | 110791277 | Human |
| 597445669 | GWAS1541743_H | diet measurement, bilirubin measurement QTL GWAS1541743 (human) | | 0.000002 | diet measurement, bilirubin measurement | | 4 | 114333088 | 114333089 | Human |
| 628837063 | GWAS2745292_H | carbohydrate measurement QTL GWAS2745292 (human) | | 0.000004 | blood carbohydrate or carbohydrate derivative amount (VT:0010903) | | 4 | 110062423 | 110062424 | Human |
| 407386100 | GWAS1035076_H | obsolete_red blood cell distribution width QTL GWAS1035076 (human) | | 2e-23 | obsolete_red blood cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 407369722 | GWAS1018698_H | chronic lymphocytic leukemia QTL GWAS1018698 (human) | | 6e-10 | leukocyte integrity trait (VT:0010898) | | 4 | 113777540 | 113777541 | Human |
| 597822563 | GWAS1689954_H | Ischemic stroke QTL GWAS1689954 (human) | | 1e-15 | Ischemic stroke | | 4 | 110775495 | 110775496 | Human |
| 597986405 | GWAS1705704_H | obsolete_facial morphology quality QTL GWAS1705704 (human) | | 2e-09 | obsolete_facial morphology quality | | 4 | 121076949 | 121076950 | Human |
| 597609562 | GWAS1666422_H | monocyte count QTL GWAS1666422 (human) | | 3e-14 | monocyte count | | 4 | 109927496 | 109927497 | Human |
| 406992772 | GWAS641748_H | waist circumference QTL GWAS641748 (human) | | 0.000009 | waist circumference | | 4 | 129883949 | 129883950 | Human |
| 407091076 | GWAS740052_H | atrial fibrillation QTL GWAS740052 (human) | | 7e-71 | atrial fibrillation | | 4 | 110735436 | 110735437 | Human |
| 616991502 | GWAS2009001_H | glycerophospholipid measurement QTL GWAS2009001 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496530 | 114496531 | Human |
| 616991503 | GWAS2009002_H | glycerophospholipid measurement QTL GWAS2009002 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114495803 | 114495804 | Human |
| 616991500 | GWAS2008999_H | glycerophospholipid measurement QTL GWAS2008999 (human) | | 6e-14 | glycerophospholipid measurement | | 4 | 114489100 | 114489101 | Human |
| 407140238 | GWAS789214_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS789214 (human) | | 0.000002 | 3-hydroxypropylmercapturic acid measurement | | 4 | 121999890 | 121999891 | Human |
| 616991501 | GWAS2009000_H | glycerophospholipid measurement QTL GWAS2009000 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114491625 | 114491626 | Human |
| 628640435 | GWAS2548664_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2548664 (human) | | 0.0000007 | gut microbiome measurement, allergen exposure measurement | | 4 | 130688068 | 130688069 | Human |
| 617089796 | GWAS2107295_H | anthropometric measurement QTL GWAS2107295 (human) | | 3e-10 | anthropometric measurement | | 4 | 108565997 | 108565998 | Human |
| 616991498 | GWAS2008997_H | glycerophospholipid measurement QTL GWAS2008997 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114493973 | 114493974 | Human |
| 407418757 | GWAS1067733_H | systolic blood pressure QTL GWAS1067733 (human) | | 6e-17 | systolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 628951728 | GWAS2859957_H | systolic blood pressure QTL GWAS2859957 (human) | | 2e-36 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110417121 | 110417122 | Human |
| 616991499 | GWAS2008998_H | glycerophospholipid measurement QTL GWAS2008998 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114488186 | 114488187 | Human |
| 616991496 | GWAS2008995_H | glycerophospholipid measurement QTL GWAS2008995 (human) | | 9e-27 | glycerophospholipid measurement | | 4 | 114493975 | 114493976 | Human |
| 407418759 | GWAS1067735_H | systolic blood pressure QTL GWAS1067735 (human) | | 3e-24 | systolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 616991497 | GWAS2008996_H | glycerophospholipid measurement QTL GWAS2008996 (human) | | 1e-26 | glycerophospholipid measurement | | 4 | 114598400 | 114598401 | Human |
| 616991510 | GWAS2009009_H | glycerophospholipid measurement QTL GWAS2009009 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114493188 | 114493189 | Human |
| 407156628 | GWAS805604_H | gut microbiome measurement QTL GWAS805604 (human) | | 0.000005 | gut microbiome measurement | | 4 | 127613641 | 127613642 | Human |
| 616991511 | GWAS2009010_H | glycerophospholipid measurement QTL GWAS2009010 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495414 | 114495415 | Human |
| 616991508 | GWAS2009007_H | glycerophospholipid measurement QTL GWAS2009007 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114492998 | 114492999 | Human |
| 616991509 | GWAS2009008_H | glycerophospholipid measurement QTL GWAS2009008 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114493049 | 114493050 | Human |
| 628673195 | GWAS2581424_H | neuroimaging measurement QTL GWAS2581424 (human) | | 6e-09 | nervous system morphology trait (VT:0003632) | | 4 | 120199264 | 120199265 | Human |
| 597593162 | GWAS1650022_H | degeneration of macula and posterior pole QTL GWAS1650022 (human) | | 3e-16 | degeneration of macula and posterior pole | | 4 | 109764664 | 109764665 | Human |
| 616991506 | GWAS2009005_H | glycerophospholipid measurement QTL GWAS2009005 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496204 | 114496205 | Human |
| 628673196 | GWAS2581425_H | neuroimaging measurement QTL GWAS2581425 (human) | | 0.000001 | nervous system morphology trait (VT:0003632) | | 4 | 120211752 | 120211753 | Human |
| 616991507 | GWAS2009006_H | glycerophospholipid measurement QTL GWAS2009006 (human) | | 4e-26 | glycerophospholipid measurement | | 4 | 114494204 | 114494205 | Human |
| 616991504 | GWAS2009003_H | glycerophospholipid measurement QTL GWAS2009003 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114495902 | 114495903 | Human |
| 616991505 | GWAS2009004_H | glycerophospholipid measurement QTL GWAS2009004 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114496175 | 114496176 | Human |
| 406927254 | GWAS576230_H | neuroimaging measurement QTL GWAS576230 (human) | | 4e-09 | neuroimaging measurement | | 4 | 118376502 | 118376503 | Human |
| 616991518 | GWAS2009017_H | glycerophospholipid measurement QTL GWAS2009017 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114493059 | 114493060 | Human |
| 616991519 | GWAS2009018_H | glycerophospholipid measurement QTL GWAS2009018 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114493994 | 114493995 | Human |
| 598051967 | GWAS1771266_H | ethanolamine measurement, serum creatinine amount QTL GWAS1771266 (human) | | 8e-16 | ethanolamine measurement, serum creatinine amount | | 4 | 108795684 | 108795685 | Human |
| 616991516 | GWAS2009015_H | glycerophospholipid measurement QTL GWAS2009015 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114598194 | 114598195 | Human |
| 628411055 | GWAS2319284_H | TPE interval measurement QTL GWAS2319284 (human) | | 3e-10 | heart excitatory physiology trait (VT:0000231) | S wave amplitude (CMO:0000272) | 4 | 113535350 | 113535351 | Human |
| 616991517 | GWAS2009016_H | glycerophospholipid measurement QTL GWAS2009016 (human) | | 4e-25 | glycerophospholipid measurement | | 4 | 114493217 | 114493218 | Human |
| 616991514 | GWAS2009013_H | glycerophospholipid measurement QTL GWAS2009013 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114495600 | 114495601 | Human |
| 616991515 | GWAS2009014_H | glycerophospholipid measurement QTL GWAS2009014 (human) | | 3e-25 | glycerophospholipid measurement | | 4 | 114490021 | 114490022 | Human |
| 616991512 | GWAS2009011_H | glycerophospholipid measurement QTL GWAS2009011 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495547 | 114495548 | Human |
| 616991513 | GWAS2009012_H | glycerophospholipid measurement QTL GWAS2009012 (human) | | 2e-25 | glycerophospholipid measurement | | 4 | 114495590 | 114495591 | Human |
| 628640408 | GWAS2548637_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2548637 (human) | | 5e-10 | gut microbiome measurement, allergen exposure measurement | | 4 | 112965969 | 112965970 | Human |
| 406894497 | GWAS543473_H | platelet crit QTL GWAS543473 (human) | | 9e-20 | platelet crit | | 4 | 119336584 | 119336585 | Human |
| 617057062 | GWAS2074561_H | R-6-hydroxywarfarin measurement QTL GWAS2074561 (human) | | 0.000005 | R-6-hydroxywarfarin measurement | | 4 | 123651871 | 123651872 | Human |
| 617122602 | GWAS2140101_H | Barrett's esophagus QTL GWAS2140101 (human) | | 1e-15 | Barrett's esophagus | | 4 | 123628089 | 123628090 | Human |
| 616991520 | GWAS2009019_H | glycerophospholipid measurement QTL GWAS2009019 (human) | | 5e-25 | glycerophospholipid measurement | | 4 | 114494051 | 114494052 | Human |
| 628558494 | GWAS2466723_H | complement factor I measurement QTL GWAS2466723 (human) | | 9e-37 | complement protein amount (VT:0010033) | | 4 | 109735574 | 109735575 | Human |
| 406910890 | GWAS559866_H | pulmonary function measurement QTL GWAS559866 (human) | | 0.000001 | pulmonary function measurement | | 4 | 108296773 | 108296774 | Human |
| 628837009 | GWAS2745238_H | lipid measurement QTL GWAS2745238 (human) | | 0.000008 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 122878832 | 122878833 | Human |
| 616516436 | GWAS1913019_H | lipoprotein measurement QTL GWAS1913019 (human) | | 1e-13 | lipoprotein measurement | | 4 | 109717608 | 109717609 | Human |
| 597019769 | GWAS1115843_H | body mass index QTL GWAS1115843 (human) | | 4e-08 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112390634 | 112390635 | Human |
| 597363817 | GWAS1459891_H | acute myeloid leukemia QTL GWAS1459891 (human) | | 2e-19 | acute myeloid leukemia | | 4 | 117598611 | 117598612 | Human |
| 597429353 | GWAS1525427_H | sex hormone-binding globulin measurement QTL GWAS1525427 (human) | | 4e-18 | sex hormone-binding globulin measurement | | 4 | 109345757 | 109345758 | Human |
| 617073466 | GWAS2090965_H | chronic obstructive pulmonary disease QTL GWAS2090965 (human) | | 5e-19 | chronic obstructive pulmonary disease | | 4 | 123900578 | 123900579 | Human |
| 407332932 | GWAS981908_H | high density lipoprotein cholesterol measurement QTL GWAS981908 (human) | | 5e-22 | high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597267357 | GWAS1363431_H | triglyceride measurement QTL GWAS1363431 (human) | | 7e-26 | triglyceride measurement | | 4 | 109174464 | 109174465 | Human |
| 406923332 | GWAS572308_H | pulse pressure measurement QTL GWAS572308 (human) | | 0.0000009 | pulse pressure measurement | | 4 | 132110786 | 132110787 | Human |
| 597267358 | GWAS1363432_H | triglyceride measurement QTL GWAS1363432 (human) | | 9e-33 | triglyceride measurement | | 4 | 109717668 | 109717669 | Human |
| 617206976 | GWAS2187416_H | atrial fibrillation QTL GWAS2187416 (human) | | 1e-30 | atrial fibrillation | | 4 | 110793733 | 110793734 | Human |
| 407185487 | GWAS834463_H | nose morphology measurement QTL GWAS834463 (human) | | 4e-08 | nose morphology measurement | | 4 | 108373433 | 108373434 | Human |
| 616961229 | GWAS1978728_H | body mass index QTL GWAS1978728 (human) | | 4e-12 | body mass index | | 4 | 129805678 | 129805679 | Human |
| 596972440 | GWAS1091959_H | radiation-induced disorder QTL GWAS1091959 (human) | | 0.000006 | radiation-induced disorder | | 4 | 118888417 | 118888418 | Human |
| 407185482 | GWAS834458_H | upper face morphology measurement QTL GWAS834458 (human) | | 2e-09 | upper face morphology measurement | | 4 | 110922515 | 110922516 | Human |
| 597414795 | GWAS1510869_H | breast carcinoma QTL GWAS1510869 (human) | | 7e-10 | breast carcinoma | | 4 | 125922349 | 125922350 | Human |
| 407267413 | GWAS916389_H | childhood onset asthma QTL GWAS916389 (human) | | 2e-14 | childhood onset asthma | | 4 | 122456327 | 122456328 | Human |
| 406988886 | GWAS637862_H | creatinine measurement QTL GWAS637862 (human) | | 0.000008 | creatinine measurement | | 4 | 106565904 | 106565905 | Human |
| 597201806 | GWAS1297880_H | gestational diabetes QTL GWAS1297880 (human) | | 0.000003 | gestational diabetes | | 4 | 118370662 | 118370663 | Human |
| 407300186 | GWAS949162_H | asthma, age at onset QTL GWAS949162 (human) | | 5e-08 | asthma, age at onset | | 4 | 122432277 | 122432278 | Human |
| 597611455 | GWAS1668315_H | mean platelet volume QTL GWAS1668315 (human) | | 2e-12 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 407136358 | GWAS785334_H | glomerular filtration rate QTL GWAS785334 (human) | | 1e-15 | glomerular filtration rate | | 4 | 108772770 | 108772771 | Human |
| 616994016 | GWAS2011515_H | late-onset Alzheimers disease QTL GWAS2011515 (human) | | 0.000002 | late-onset Alzheimers disease | | 4 | 109373310 | 109373311 | Human |
| 407005291 | GWAS654267_H | serum copper measurement QTL GWAS654267 (human) | | 0.000001 | serum copper measurement | | 4 | 113027634 | 113027635 | Human |
| 407005288 | GWAS654264_H | mean corpuscular hemoglobin QTL GWAS654264 (human) | | 3e-51 | mean corpuscular hemoglobin | | 4 | 121818028 | 121818029 | Human |
| 407087208 | GWAS736184_H | worry measurement QTL GWAS736184 (human) | | 4e-08 | worry measurement | | 4 | 118048732 | 118048733 | Human |
| 407005289 | GWAS654265_H | mean corpuscular hemoglobin QTL GWAS654265 (human) | | 3e-27 | mean corpuscular hemoglobin | | 4 | 128177881 | 128177882 | Human |
| 407070828 | GWAS719804_H | diastolic blood pressure QTL GWAS719804 (human) | | 7e-09 | diastolic blood pressure | | 4 | 110422107 | 110422108 | Human |
| 407365736 | GWAS1014712_H | protein measurement QTL GWAS1014712 (human) | | 7e-09 | protein measurement | | 4 | 132286668 | 132286669 | Human |
| 406988915 | GWAS637891_H | blood protein measurement QTL GWAS637891 (human) | | 5e-62 | blood protein measurement | | 4 | 109965187 | 109965188 | Human |
| 628495683 | GWAS2403912_H | balding measurement QTL GWAS2403912 (human) | | 1e-13 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106940792 | 106940793 | Human |
| 406923380 | GWAS572356_H | neuroimaging measurement QTL GWAS572356 (human) | | 6e-09 | neuroimaging measurement | | 4 | 120199264 | 120199265 | Human |
| 628430146 | GWAS2338375_H | adolescent idiopathic scoliosis QTL GWAS2338375 (human) | | 2e-09 | adolescent idiopathic scoliosis | | 4 | 119337052 | 119337053 | Human |
| 407152755 | GWAS801731_H | response to norepinephrine-dopamine reuptake inhibitor QTL GWAS801731 (human) | | 0.000006 | response to norepinephrine-dopamine reuptake inhibitor | | 4 | 120701163 | 120701164 | Human |
| 597087150 | GWAS1183224_H | allergic disease, age at onset QTL GWAS1183224 (human) | | 2e-08 | allergic disease, age at onset | | 4 | 122219915 | 122219916 | Human |
| 406923386 | GWAS572362_H | neuroimaging measurement QTL GWAS572362 (human) | | 0.000001 | neuroimaging measurement | | 4 | 120211752 | 120211753 | Human |
| 407414900 | GWAS1063876_H | sucrose measurement QTL GWAS1063876 (human) | | 0.000002 | sucrose measurement | | 4 | 111477457 | 111477458 | Human |
| 407300216 | GWAS949192_H | asthma QTL GWAS949192 (human) | | 2e-21 | asthma | | 4 | 122432277 | 122432278 | Human |
| 628643142 | GWAS2551371_H | psoriasis QTL GWAS2551371 (human) | | 3e-12 | psoriasis | | 4 | 122618699 | 122618700 | Human |
| 407300217 | GWAS949193_H | asthma QTL GWAS949193 (human) | | 2e-18 | asthma | | 4 | 122438414 | 122438415 | Human |
| 628364597 | GWAS2285441_H | platelet-derived growth factor complex BB dimer (human) level QTL GWAS2285441 (human) | | 0.000002 | platelet-derived growth factor complex BB dimer (human) level | | 4 | 111263595 | 111263596 | Human |
| 407365644 | GWAS1014620_H | rheumatoid arthritis, celiac disease QTL GWAS1014620 (human) | | 6e-09 | rheumatoid arthritis, celiac disease | | 4 | 122117140 | 122117141 | Human |
| 628610363 | GWAS2518592_H | lipid measurement QTL GWAS2518592 (human) | | 0.000003 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 116458669 | 116458670 | Human |
| 628430136 | GWAS2338365_H | adolescent idiopathic scoliosis QTL GWAS2338365 (human) | | 5e-11 | adolescent idiopathic scoliosis | | 4 | 112239118 | 112239119 | Human |
| 628446523 | GWAS2354752_H | mean corpuscular hemoglobin concentration QTL GWAS2354752 (human) | | 1e-11 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121870446 | 121870447 | Human |
| 407300116 | GWAS949092_H | body height QTL GWAS949092 (human) | | 0.000001 | body height | | 4 | 119687809 | 119687810 | Human |
| 596956096 | GWAS1075615_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075615 (human) | | 3e-14 | lymphocyte measurement, neutrophil measurement | | 4 | 122707302 | 122707305 | Human |
| 596956097 | GWAS1075616_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075616 (human) | | 2e-14 | lymphocyte measurement, neutrophil measurement | | 4 | 112190016 | 112190017 | Human |
| 407185427 | GWAS834403_H | glomerular filtration rate QTL GWAS834403 (human) | | 5e-09 | glomerular filtration rate | | 4 | 125483011 | 125483012 | Human |
| 597988344 | GWAS1707643_H | serum IgE amount QTL GWAS1707643 (human) | | 0.000008 | serum IgE amount | | 4 | 118942321 | 118942322 | Human |
| 407349274 | GWAS998250_H | asthma, allergic disease QTL GWAS998250 (human) | | 4e-10 | asthma, allergic disease | | 4 | 122219899 | 122219900 | Human |
| 628577559 | GWAS2485788_H | glycerophospholipid measurement QTL GWAS2485788 (human) | | 8e-41 | blood phospholipid amount (VT:0006084) | | 4 | 114560759 | 114560760 | Human |
| 628577558 | GWAS2485787_H | glycerophospholipid measurement QTL GWAS2485787 (human) | | 7e-41 | blood phospholipid amount (VT:0006084) | | 4 | 114515190 | 114515191 | Human |
| 628577557 | GWAS2485786_H | glycerophospholipid measurement QTL GWAS2485786 (human) | | 6e-41 | blood phospholipid amount (VT:0006084) | | 4 | 114507972 | 114507973 | Human |
| 628577556 | GWAS2485785_H | glycerophospholipid measurement QTL GWAS2485785 (human) | | 6e-41 | blood phospholipid amount (VT:0006084) | | 4 | 114483120 | 114483121 | Human |
| 597398520 | GWAS1494594_H | vaginal microbiome measurement QTL GWAS1494594 (human) | | 0.000004 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
| 406972453 | GWAS621429_H | trait in response to paliperidone, schizophrenia symptom severity measurement QTL GWAS621429 (human) | | 0.000009 | trait in response to paliperidone, schizophrenia symptom severity measurement | | 4 | 116607403 | 116607404 | Human |
| 597988288 | GWAS1707587_H | trait in response to hydrochlorothiazide, obsolete_fasting blood glucose measurement QTL GWAS1707587 (human) | | 0.000004 | trait in response to hydrochlorothiazide, obsolete_fasting blood glucose measurement | | 4 | 128775066 | 128775067 | Human |
| 628806943 | GWAS2715172_H | erythrocyte volume QTL GWAS2715172 (human) | | 2e-28 | erythrocyte volume | | 4 | 109933275 | 109933276 | Human |
| 616551639 | GWAS1948222_H | Abnormality of the skeletal system QTL GWAS1948222 (human) | | 6e-16 | Abnormality of the skeletal system | | 4 | 119326939 | 119326940 | Human |
| 628806930 | GWAS2715159_H | erythrocyte volume QTL GWAS2715159 (human) | | 1e-56 | erythrocyte volume | | 4 | 121877258 | 121877259 | Human |
| 628692240 | GWAS2600469_H | systolic blood pressure QTL GWAS2600469 (human) | | 2e-12 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110416322 | 110416323 | Human |
| 597087228 | GWAS1183302_H | platelet count QTL GWAS1183302 (human) | | 2e-40 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110035176 | 110035177 | Human |
| 628577565 | GWAS2485794_H | glycerophospholipid measurement QTL GWAS2485794 (human) | | 1e-32 | blood phospholipid amount (VT:0006084) | | 4 | 114518110 | 114518111 | Human |
| 597513207 | GWAS1609281_H | colorectal cancer QTL GWAS1609281 (human) | | 0.0000007 | colorectal cancer | | 4 | 123506329 | 123506330 | Human |
| 628577564 | GWAS2485793_H | glycerophospholipid measurement QTL GWAS2485793 (human) | | 2e-36 | blood phospholipid amount (VT:0006084) | | 4 | 114546112 | 114546113 | Human |
| 596956152 | GWAS1075671_H | anti-Epstein Barr virus antibody measurement QTL GWAS1075671 (human) | | 0.0000008 | anti-Epstein Barr virus antibody measurement | | 4 | 110793733 | 110793734 | Human |
| 628577563 | GWAS2485792_H | glycerophospholipid measurement QTL GWAS2485792 (human) | | 2e-36 | blood phospholipid amount (VT:0006084) | | 4 | 114546303 | 114546304 | Human |
| 628577562 | GWAS2485791_H | glycerophospholipid measurement QTL GWAS2485791 (human) | | 2e-36 | blood phospholipid amount (VT:0006084) | | 4 | 114486174 | 114486175 | Human |
| 628577561 | GWAS2485790_H | glycerophospholipid measurement QTL GWAS2485790 (human) | | 8e-41 | blood phospholipid amount (VT:0006084) | | 4 | 114488433 | 114488434 | Human |
| 597267447 | GWAS1363521_H | cortical thickness QTL GWAS1363521 (human) | | 3e-12 | cortical thickness | | 4 | 120722571 | 120722572 | Human |
| 407005229 | GWAS654205_H | fibroblast growth factor basic measurement QTL GWAS654205 (human) | | 0.000002 | fibroblast growth factor basic measurement | | 4 | 107833368 | 107833369 | Human |
| 628577560 | GWAS2485789_H | glycerophospholipid measurement QTL GWAS2485789 (human) | | 8e-41 | blood phospholipid amount (VT:0006084) | | 4 | 114487644 | 114487645 | Human |
| 597267435 | GWAS1363509_H | cortical thickness QTL GWAS1363509 (human) | | 6e-09 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
| 597087205 | GWAS1183279_H | bone mineral content measurement QTL GWAS1183279 (human) | | 0.000001 | bone mineral mass (VT:0005007) | | 4 | 106982388 | 106982389 | Human |
| 628708621 | GWAS2616850_H | level of TP53-binding protein 1 in blood QTL GWAS2616850 (human) | | 7e-12 | level of TP53-binding protein 1 in blood | | 4 | 122618282 | 122618284 | Human |
| 597414894 | GWAS1510968_H | Parkinson disease QTL GWAS1510968 (human) | | 1e-12 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
| 626464033 | GWAS2277966_H | body height QTL GWAS2277966 (human) | | 5e-11 | body height | | 4 | 110360797 | 110360798 | Human |
| 616977599 | GWAS1995098_H | asthma, response to diisocyanate QTL GWAS1995098 (human) | | 0.000001 | asthma, response to diisocyanate | | 4 | 123742201 | 123742202 | Human |
| 628724992 | GWAS2633221_H | age at onset, major depressive disorder QTL GWAS2633221 (human) | | 0.000007 | age at onset, major depressive disorder | | 4 | 127602809 | 127602810 | Human |
| 597267431 | GWAS1363505_H | cortical thickness QTL GWAS1363505 (human) | | 4e-11 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
| 597201688 | GWAS1297762_H | memory performance, sex interaction measurement QTL GWAS1297762 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109128952 | 109128953 | Human |
| 628495862 | GWAS2404091_H | asthma QTL GWAS2404091 (human) | | 0.000008 | asthma | | 4 | 122456327 | 122456328 | Human |
| 597201689 | GWAS1297763_H | memory performance, sex interaction measurement QTL GWAS1297763 (human) | | 0.000005 | learning/memory/conditioning trait (VT:0002063) | | 4 | 125584117 | 125584118 | Human |
| 628643322 | GWAS2551551_H | gut microbiome measurement, breastfeeding duration QTL GWAS2551551 (human) | | 0.0000001 | lactation duration (VT:1000653) | | 4 | 118957068 | 118957069 | Human |
| 597086994 | GWAS1183068_H | platelet count QTL GWAS1183068 (human) | | 3e-27 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119622957 | 119622958 | Human |
| 628479472 | GWAS2387701_H | coronary artery disease QTL GWAS2387701 (human) | | 3e-15 | coronary artery integrity trait (VT:0010746) | | 4 | 119988346 | 119988347 | Human |
| 597086995 | GWAS1183069_H | platelet count QTL GWAS1183069 (human) | | 1e-11 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 597267216 | GWAS1363290_H | cortical thickness QTL GWAS1363290 (human) | | 3e-08 | cortical thickness | | 4 | 120730658 | 120730659 | Human |
| 597316369 | GWAS1412443_H | vaginal microbiome measurement QTL GWAS1412443 (human) | | 0.000009 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 597234453 | GWAS1330527_H | blood protein measurement QTL GWAS1330527 (human) | | 6e-54 | blood protein measurement | | 4 | 118376502 | 118376503 | Human |
| 617043019 | GWAS2060518_H | BMI-adjusted waist-hip ratio QTL GWAS2060518 (human) | | 6e-10 | BMI-adjusted waist-hip ratio | | 4 | 119763897 | 119763898 | Human |
| 597201685 | GWAS1297759_H | memory performance, sex interaction measurement QTL GWAS1297759 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109129261 | 109129262 | Human |
| 597201686 | GWAS1297760_H | memory performance, sex interaction measurement QTL GWAS1297760 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109135631 | 109135632 | Human |
| 597201687 | GWAS1297761_H | memory performance, sex interaction measurement QTL GWAS1297761 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109128713 | 109128714 | Human |
| 617092167 | GWAS2109666_H | level of phosphatidylethanolamine QTL GWAS2109666 (human) | | 2e-08 | level of phosphatidylethanolamine | | 4 | 126594255 | 126594256 | Human |
| 597054214 | GWAS1150288_H | asthma QTL GWAS1150288 (human) | | 5e-20 | asthma | | 4 | 122527407 | 122527408 | Human |
| 597054223 | GWAS1150297_H | multiple sclerosis QTL GWAS1150297 (human) | | 1e-10 | multiple sclerosis | | 4 | 121198294 | 121198295 | Human |
| 628413928 | GWAS2322157_H | Parkinson disease QTL GWAS2322157 (human) | | 0.0000005 | Parkinson disease | | 4 | 113422713 | 113422714 | Human |
| 616977508 | GWAS1995007_H | type 1 diabetes mellitus QTL GWAS1995007 (human) | | 1e-08 | type 1 diabetes mellitus | | 4 | 124578751 | 124578752 | Human |
| 407005413 | GWAS654389_H | inflammatory bowel disease QTL GWAS654389 (human) | | 0.0000001 | inflammatory bowel disease | | 4 | 122430276 | 122430277 | Human |
| 628479453 | GWAS2387682_H | late-onset Alzheimers disease QTL GWAS2387682 (human) | | 0.000004 | brain integrity trait (VT:0010579) | | 4 | 109534350 | 109534351 | Human |
| 628463069 | GWAS2371298_H | electrocardiography QTL GWAS2371298 (human) | | 3e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 597349170 | GWAS1445244_H | preeclampsia QTL GWAS1445244 (human) | | 0.000003 | preeclampsia | | 4 | 112913825 | 112913826 | Human |
| 407218412 | GWAS867388_H | low density lipoprotein cholesterol measurement QTL GWAS867388 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | | 4 | 108720535 | 108720536 | Human |
| 628463071 | GWAS2371300_H | electrocardiography QTL GWAS2371300 (human) | | 1e-10 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 628463070 | GWAS2371299_H | electrocardiography QTL GWAS2371299 (human) | | 7e-12 | electrocardiography | | 4 | 110791530 | 110791531 | Human |
| 628577735 | GWAS2485964_H | glycerophospholipid measurement QTL GWAS2485964 (human) | | 8e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114493876 | 114493877 | Human |
| 628430276 | GWAS2338505_H | adolescent idiopathic scoliosis QTL GWAS2338505 (human) | | 0.0000002 | adolescent idiopathic scoliosis | | 4 | 113329637 | 113329638 | Human |
| 628577734 | GWAS2485963_H | glycerophospholipid measurement QTL GWAS2485963 (human) | | 8e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114598684 | 114598685 | Human |
| 628577733 | GWAS2485962_H | glycerophospholipid measurement QTL GWAS2485962 (human) | | 4e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114577512 | 114577513 | Human |
| 628577732 | GWAS2485961_H | glycerophospholipid measurement QTL GWAS2485961 (human) | | 4e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114522087 | 114522088 | Human |
| 628577731 | GWAS2485960_H | glycerophospholipid measurement QTL GWAS2485960 (human) | | 4e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114522147 | 114522148 | Human |
| 407267571 | GWAS916547_H | amino acid measurement QTL GWAS916547 (human) | | 0.000003 | amino acid measurement | | 4 | 111130223 | 111130224 | Human |
| 628577730 | GWAS2485959_H | glycerophospholipid measurement QTL GWAS2485959 (human) | | 3e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114537012 | 114537013 | Human |
| 628577729 | GWAS2485958_H | glycerophospholipid measurement QTL GWAS2485958 (human) | | 3e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114512391 | 114512392 | Human |
| 628577728 | GWAS2485957_H | glycerophospholipid measurement QTL GWAS2485957 (human) | | 3e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114512224 | 114512225 | Human |
| 628839874 | GWAS2748103_H | nucleotide measurement QTL GWAS2748103 (human) | | 0.000003 | nucleotide metabolism trait (VT:0003806) | | 4 | 110518121 | 110518122 | Human |
| 628790721 | GWAS2698950_H | protein measurement QTL GWAS2698950 (human) | | 1e-40 | protein amount (VT:0010120) | | 4 | 106826356 | 106826357 | Human |
| 407267581 | GWAS916557_H | amino acid measurement QTL GWAS916557 (human) | | 0.0000004 | amino acid measurement | | 4 | 125452415 | 125452416 | Human |
| 597381927 | GWAS1478001_H | autoimmune disease QTL GWAS1478001 (human) | | 1e-09 | autoimmune disease | | 4 | 122633552 | 122633553 | Human |
| 407038207 | GWAS687183_H | myeloid white cell count QTL GWAS687183 (human) | | 6e-11 | myeloid white cell count | | 4 | 110020646 | 110020647 | Human |
| 616977531 | GWAS1995030_H | pursuit maintenance gain measurement QTL GWAS1995030 (human) | | 0.000003 | eye physiology trait (VT:0005253) | | 4 | 110340886 | 110340887 | Human |
| 406907134 | GWAS556110_H | congenital heart disease QTL GWAS556110 (human) | | 0.000008 | congenital heart disease | | 4 | 118330002 | 118330003 | Human |
| 626447767 | GWAS2261700_H | obsolete_pain QTL GWAS2261700 (human) | | 6e-10 | obsolete_pain | | 4 | 111582716 | 111582717 | Human |
| 628577718 | GWAS2485947_H | glycerophospholipid measurement QTL GWAS2485947 (human) | | 3e-31 | blood phospholipid amount (VT:0006084) | | 4 | 114598670 | 114598671 | Human |
| 406988931 | GWAS637907_H | cyclic adenosine monophosphate measurement QTL GWAS637907 (human) | | 0.000002 | cyclic adenosine monophosphate measurement | | 4 | 121525001 | 121525002 | Human |
| 628577717 | GWAS2485946_H | glycerophospholipid measurement QTL GWAS2485946 (human) | | 3e-31 | blood phospholipid amount (VT:0006084) | | 4 | 114564528 | 114564529 | Human |
| 628577716 | GWAS2485945_H | glycerophospholipid measurement QTL GWAS2485945 (human) | | 3e-31 | blood phospholipid amount (VT:0006084) | | 4 | 114531393 | 114531394 | Human |
| 628577715 | GWAS2485944_H | glycerophospholipid measurement QTL GWAS2485944 (human) | | 2e-31 | blood phospholipid amount (VT:0006084) | | 4 | 114531300 | 114531301 | Human |
| 628577714 | GWAS2485943_H | glycerophospholipid measurement QTL GWAS2485943 (human) | | 2e-31 | blood phospholipid amount (VT:0006084) | | 4 | 114527990 | 114527991 | Human |
| 628577713 | GWAS2485942_H | glycerophospholipid measurement QTL GWAS2485942 (human) | | 2e-32 | blood phospholipid amount (VT:0006084) | | 4 | 114527831 | 114527832 | Human |
| 616518777 | GWAS1915360_H | platelet crit QTL GWAS1915360 (human) | | 7e-12 | platelet crit | | 4 | 123849566 | 123849567 | Human |
| 406939783 | GWAS588759_H | reduced glutathione measurement QTL GWAS588759 (human) | | 4e-08 | reduced glutathione measurement | | 4 | 124355648 | 124355649 | Human |
| 628577712 | GWAS2485941_H | glycerophospholipid measurement QTL GWAS2485941 (human) | | 2e-32 | blood phospholipid amount (VT:0006084) | | 4 | 114527690 | 114527691 | Human |
| 628577727 | GWAS2485956_H | glycerophospholipid measurement QTL GWAS2485956 (human) | | 3e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114496527 | 114496528 | Human |
| 628577726 | GWAS2485955_H | glycerophospholipid measurement QTL GWAS2485955 (human) | | 3e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114526022 | 114526023 | Human |
| 406923403 | GWAS572379_H | apolipoprotein A 1 measurement QTL GWAS572379 (human) | | 3e-20 | apolipoprotein A 1 measurement | | 4 | 109648464 | 109648465 | Human |
| 628577725 | GWAS2485954_H | glycerophospholipid measurement QTL GWAS2485954 (human) | | 6e-28 | blood phospholipid amount (VT:0006084) | | 4 | 114482175 | 114482176 | Human |
| 628577724 | GWAS2485953_H | glycerophospholipid measurement QTL GWAS2485953 (human) | | 6e-28 | blood phospholipid amount (VT:0006084) | | 4 | 114482122 | 114482123 | Human |
| 628676019 | GWAS2584248_H | colorectal cancer QTL GWAS2584248 (human) | | 0.0000007 | colorectal cancer | | 4 | 123506329 | 123506330 | Human |
| 628430270 | GWAS2338499_H | adolescent idiopathic scoliosis QTL GWAS2338499 (human) | | 0.0000001 | adolescent idiopathic scoliosis | | 4 | 123733416 | 123733417 | Human |
| 628577723 | GWAS2485952_H | glycerophospholipid measurement QTL GWAS2485952 (human) | | 6e-28 | blood phospholipid amount (VT:0006084) | | 4 | 114490577 | 114490578 | Human |
| 628577722 | GWAS2485951_H | glycerophospholipid measurement QTL GWAS2485951 (human) | | 6e-28 | blood phospholipid amount (VT:0006084) | | 4 | 114490374 | 114490375 | Human |
| 628577721 | GWAS2485950_H | glycerophospholipid measurement QTL GWAS2485950 (human) | | 1e-28 | blood phospholipid amount (VT:0006084) | | 4 | 114520865 | 114520866 | Human |
| 616551534 | GWAS1948117_H | body height QTL GWAS1948117 (human) | | 5e-32 | body height | | 4 | 108536277 | 108536278 | Human |
| 597152582 | GWAS1248656_H | memory performance QTL GWAS1248656 (human) | | 0.0000003 | memory performance | | 4 | 130946957 | 130946958 | Human |
| 597152581 | GWAS1248655_H | memory performance QTL GWAS1248655 (human) | | 0.0000005 | memory performance | | 4 | 109067562 | 109067563 | Human |
| 407021712 | GWAS670688_H | bone density QTL GWAS670688 (human) | | 6e-12 | bone density | | 4 | 122289915 | 122289916 | Human |
| 407349397 | GWAS998373_H | cancer QTL GWAS998373 (human) | | 0.0000006 | cancer | | 4 | 122660080 | 122660081 | Human |
| 407349396 | GWAS998372_H | cancer QTL GWAS998372 (human) | | 0.0000007 | cancer | | 4 | 106909104 | 106909105 | Human |
| 597070658 | GWAS1166732_H | BMI-adjusted hip circumference QTL GWAS1166732 (human) | | 0.0000005 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 4 | 113634919 | 113634920 | Human |
| 597496651 | GWAS1592725_H | hip geometry QTL GWAS1592725 (human) | | 5e-09 | body size trait (VT:0100005) | hip circumference (CMO:0000014) | 4 | 126753016 | 126753017 | Human |
| 617042974 | GWAS2060473_H | diastolic blood pressure QTL GWAS2060473 (human) | | 2e-13 | diastolic blood pressure | | 4 | 110400371 | 110400372 | Human |
| 617042973 | GWAS2060472_H | diastolic blood pressure QTL GWAS2060472 (human) | | 2e-13 | diastolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 628676002 | GWAS2584231_H | colorectal cancer QTL GWAS2584231 (human) | | 0.0000005 | colorectal cancer | | 4 | 120052597 | 120052598 | Human |
| 407054488 | GWAS703464_H | gut microbiome measurement QTL GWAS703464 (human) | | 0.000006 | gut microbiome measurement | | 4 | 126828799 | 126828800 | Human |
| 407316635 | GWAS965611_H | schizophrenia QTL GWAS965611 (human) | | 0.0000005 | schizophrenia | | 4 | 117697551 | 117697552 | Human |
| 597316420 | GWAS1412494_H | white matter lesion progression measurement QTL GWAS1412494 (human) | | 0.000006 | white matter lesion progression measurement | | 4 | 128668470 | 128668471 | Human |
| 406890656 | GWAS539632_H | DNA methylation QTL GWAS539632 (human) | | 3e-09 | DNA methylation | | 4 | 119957380 | 119957381 | Human |
| 598037319 | GWAS1756618_H | Ischemic stroke, circulating fibrinogen levels QTL GWAS1756618 (human) | | 1e-15 | Ischemic stroke, circulating fibrinogen levels | | 4 | 110775495 | 110775496 | Human |
| 597447550 | GWAS1543624_H | sex hormone-binding globulin measurement QTL GWAS1543624 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 597447551 | GWAS1543625_H | sex hormone-binding globulin measurement QTL GWAS1543625 (human) | | 3e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 406923431 | GWAS572407_H | atopic asthma QTL GWAS572407 (human) | | 1e-14 | atopic asthma | | 4 | 122639784 | 122639785 | Human |
| 406923433 | GWAS572409_H | atopic asthma QTL GWAS572409 (human) | | 5e-08 | atopic asthma | | 4 | 122387310 | 122387311 | Human |
| 626169275 | GWAS2253711_H | atrial fibrillation QTL GWAS2253711 (human) | | 8e-27 | atrial fibrillation | | 4 | 109738763 | 109738764 | Human |
| 406923432 | GWAS572408_H | atopic asthma QTL GWAS572408 (human) | | 9e-13 | atopic asthma | | 4 | 122466445 | 122466446 | Human |
| 597332848 | GWAS1428922_H | R-warfarin measurement QTL GWAS1428922 (human) | | 0.000009 | R-warfarin measurement | | 4 | 108984279 | 108984280 | Human |
| 626169276 | GWAS2253712_H | atrial fibrillation QTL GWAS2253712 (human) | | 2e-305 | atrial fibrillation | | 4 | 110789386 | 110789387 | Human |
| 597087097 | GWAS1183171_H | type 2 diabetes mellitus QTL GWAS1183171 (human) | | 3e-09 | type 2 diabetes mellitus | | 4 | 120844633 | 120844634 | Human |
| 596988773 | GWAS1108292_H | monocyte count QTL GWAS1108292 (human) | | 2e-26 | monocyte count | | 4 | 110035176 | 110035177 | Human |
| 628413829 | GWAS2322058_H | apolipoprotein A 1 measurement QTL GWAS2322058 (human) | | 2e-08 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 108637907 | 108637908 | Human |
| 596988775 | GWAS1108294_H | monocyte count QTL GWAS1108294 (human) | | 5e-16 | monocyte count | | 4 | 109926568 | 109926569 | Human |
| 597037925 | GWAS1133999_H | gut microbiome measurement QTL GWAS1133999 (human) | | 0.0000001 | gut microbiome measurement | | 4 | 126368923 | 126368924 | Human |
| 616535113 | GWAS1931696_H | lymphocyte count QTL GWAS1931696 (human) | | 3e-17 | lymphocyte count | | 4 | 122656905 | 122656906 | Human |
| 628659585 | GWAS2567814_H | alcohol use disorder measurement QTL GWAS2567814 (human) | | 3e-12 | response to alcohol trait (VT:0010489) | | 4 | 111546456 | 111546457 | Human |
| 597513060 | GWAS1609134_H | sex hormone-binding globulin measurement QTL GWAS1609134 (human) | | 9e-09 | sex hormone-binding globulin measurement | | 4 | 123871744 | 123871745 | Human |
| 406907069 | GWAS556045_H | BMI-adjusted waist-hip ratio QTL GWAS556045 (human) | | 0.000001 | BMI-adjusted waist-hip ratio | | 4 | 110022364 | 110022365 | Human |
| 407251129 | GWAS900105_H | asthma QTL GWAS900105 (human) | | 1e-28 | asthma | | 4 | 122394921 | 122394922 | Human |
| 597103252 | GWAS1199326_H | gut microbiome measurement QTL GWAS1199326 (human) | | 0.0000009 | gut microbiome measurement | | 4 | 112858735 | 112858736 | Human |
| 407021894 | GWAS670870_H | bone density QTL GWAS670870 (human) | | 1e-12 | bone density | | 4 | 115936664 | 115936665 | Human |
| 617027010 | GWAS2044509_H | life span trait QTL GWAS2044509 (human) | | 0.000009 | life span trait | | 4 | 124576758 | 124576759 | Human |
| 628937850 | GWAS2846079_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS2846079 (human) | | 8e-11 | milk polyunsaturated fatty acid amount (VT:0010374) | milk polyunsaturated fatty acid measurement (CMO:0000821) | 4 | 110191454 | 110191455 | Human |
| 628364412 | GWAS2285256_H | Decreased total leukocyte count QTL GWAS2285256 (human) | | 0.000003 | Decreased total leukocyte count | | 4 | 112406922 | 112406923 | Human |
| 407218510 | GWAS867486_H | smoking status measurement QTL GWAS867486 (human) | | 7e-12 | smoking status measurement | | 4 | 111500989 | 111500990 | Human |
| 407136585 | GWAS785561_H | glomerular filtration rate QTL GWAS785561 (human) | | 3e-14 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 597070488 | GWAS1166562_H | susceptibility to mononucleosis measurement QTL GWAS1166562 (human) | | 0.000008 | response to viral infection trait (VT:0010439) | | 4 | 124860479 | 124860480 | Human |
| 628986994 | GWAS2895223_H | pericarditis QTL GWAS2895223 (human) | | 3e-12 | pericarditis | | 4 | 108935005 | 108935006 | Human |
| 628888691 | GWAS2796920_H | atrial fibrillation QTL GWAS2796920 (human) | | 1e-09 | atrial fibrillation | | 4 | 110743002 | 110743003 | Human |
| 616977878 | GWAS1995377_H | smoking status measurement, diastolic blood pressure QTL GWAS1995377 (human) | | 4e-08 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 123660107 | 123660108 | Human |
| 597381768 | GWAS1477842_H | myeloid white cell count QTL GWAS1477842 (human) | | 1e-15 | myeloid white cell count | | 4 | 119342160 | 119342161 | Human |
| 407185745 | GWAS834721_H | blood protein measurement QTL GWAS834721 (human) | | 2e-43 | blood protein measurement | | 4 | 118376502 | 118376503 | Human |
| 597070467 | GWAS1166541_H | susceptibility to mononucleosis measurement QTL GWAS1166541 (human) | | 0.000008 | response to viral infection trait (VT:0010439) | | 4 | 121625333 | 121625334 | Human |
| 597365389 | GWAS1461463_H | eosinophil count QTL GWAS1461463 (human) | | 1e-23 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 597480075 | GWAS1576149_H | brain measurement QTL GWAS1576149 (human) | | 4e-12 | brain measurement | | 4 | 120306999 | 120307000 | Human |
| 628413550 | GWAS2321779_H | brain volume QTL GWAS2321779 (human) | | 4e-09 | brain volume | | 4 | 120722084 | 120722085 | Human |
| 628823143 | GWAS2731372_H | leukocyte quantity QTL GWAS2731372 (human) | | 3e-13 | leukocyte quantity | | 4 | 110021121 | 110021122 | Human |
| 617043431 | GWAS2060930_H | serum creatinine amount QTL GWAS2060930 (human) | | 1e-13 | serum creatinine amount | | 4 | 127243324 | 127243325 | Human |
| 407333222 | GWAS982198_H | triglyceride measurement QTL GWAS982198 (human) | | 7e-11 | triglyceride measurement | | 4 | 123720672 | 123720673 | Human |
| 407333221 | GWAS982197_H | triglyceride measurement QTL GWAS982197 (human) | | 1e-44 | triglyceride measurement | | 4 | 109717668 | 109717669 | Human |
| 407333220 | GWAS982196_H | triglyceride measurement QTL GWAS982196 (human) | | 3e-33 | triglyceride measurement | | 4 | 109174464 | 109174465 | Human |
| 616535452 | GWAS1932035_H | lymphocyte count QTL GWAS1932035 (human) | | 3e-16 | lymphocyte count | | 4 | 109967851 | 109967852 | Human |
| 597578429 | GWAS1635289_H | prothrombin time measurement QTL GWAS1635289 (human) | | 2e-31 | prothrombin time measurement | | 4 | 110791276 | 110791277 | Human |
| 597414579 | GWAS1510653_H | Abnormality of refraction QTL GWAS1510653 (human) | | 1e-08 | Abnormality of refraction | | 4 | 111208199 | 111208200 | Human |
| 616961518 | GWAS1979017_H | body mass index QTL GWAS1979017 (human) | | 2e-10 | body mass index | | 4 | 111731920 | 111731921 | Human |
| 597021369 | GWAS1117443_H | Crohn's disease QTL GWAS1117443 (human) | | 0.0000009 | intestine integrity trait (VT:0010554) | | 4 | 122430276 | 122430277 | Human |
| 617027050 | GWAS2044549_H | alopecia QTL GWAS2044549 (human) | | 6e-10 | alopecia | | 4 | 106706914 | 106706915 | Human |
| 628773975 | GWAS2682204_H | heel bone mineral density, urate measurement QTL GWAS2682204 (human) | | 4e-08 | bone mineral mass (VT:0005007) | blood uric acid level (CMO:0000501) | 4 | 107158166 | 107158167 | Human |
| 617027049 | GWAS2044548_H | alopecia QTL GWAS2044548 (human) | | 1e-10 | alopecia | | 4 | 106590268 | 106590269 | Human |
| 617043432 | GWAS2060931_H | serum creatinine amount QTL GWAS2060931 (human) | | 3e-09 | serum creatinine amount | | 4 | 128603358 | 128603359 | Human |
| 628593735 | GWAS2501964_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2501964 (human) | | 1e-12 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 597512876 | GWAS1608950_H | body mass index QTL GWAS1608950 (human) | | 4e-11 | body mass index | | 4 | 114132729 | 114132730 | Human |
| 616355210 | GWAS1839925_H | gut microbiome measurement, environmental exposure measurement QTL GWAS1839925 (human) | | 0.000008 | gut microbiome measurement, environmental exposure measurement | | 4 | 113407959 | 113407960 | Human |
| 598053522 | GWAS1772821_H | body height QTL GWAS1772821 (human) | | 8e-23 | body height | | 4 | 108536277 | 108536278 | Human |
| 597430948 | GWAS1527022_H | attention deficit hyperactivity disorder, bipolar disorder QTL GWAS1527022 (human) | | 1e-08 | attention deficit hyperactivity disorder, bipolar disorder | | 4 | 122589611 | 122589612 | Human |
| 628839490 | GWAS2747719_H | lipid measurement QTL GWAS2747719 (human) | | 0.000003 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 131492574 | 131492575 | Human |
| 625824781 | GWAS2245703_H | body height QTL GWAS2245703 (human) | | 6e-12 | body height | | 4 | 122823209 | 122823210 | Human |
| 625824780 | GWAS2245702_H | body height QTL GWAS2245702 (human) | | 2e-09 | body height | | 4 | 122663442 | 122663443 | Human |
| 407218438 | GWAS867414_H | facial morphology measurement QTL GWAS867414 (human) | | 2e-09 | facial morphology measurement | | 4 | 121076949 | 121076950 | Human |
| 616961410 | GWAS1978909_H | hair color QTL GWAS1978909 (human) | | 3e-20 | coat/hair pigmentation trait (VT:0010463) | | 4 | 108556952 | 108556953 | Human |
| 625824777 | GWAS2245699_H | body height QTL GWAS2245699 (human) | | 8e-33 | body height | | 4 | 121801213 | 121801214 | Human |
| 625824776 | GWAS2245698_H | body height QTL GWAS2245698 (human) | | 2e-17 | body height | | 4 | 119833061 | 119833062 | Human |
| 625824779 | GWAS2245701_H | body height QTL GWAS2245701 (human) | | 7e-09 | body height | | 4 | 121897844 | 121897845 | Human |
| 625824778 | GWAS2245700_H | body height QTL GWAS2245700 (human) | | 4e-14 | body height | | 4 | 121878306 | 121878307 | Human |
| 625824773 | GWAS2245695_H | body height QTL GWAS2245695 (human) | | 3e-11 | body height | | 4 | 119716698 | 119716699 | Human |
| 625824772 | GWAS2245694_H | body height QTL GWAS2245694 (human) | | 2e-08 | body height | | 4 | 119476617 | 119476618 | Human |
| 625824775 | GWAS2245697_H | body height QTL GWAS2245697 (human) | | 8e-09 | body height | | 4 | 119745118 | 119745119 | Human |
| 597086940 | GWAS1183014_H | type 2 diabetes mellitus QTL GWAS1183014 (human) | | 9e-09 | type 2 diabetes mellitus | | 4 | 128103118 | 128103119 | Human |
| 625824769 | GWAS2245691_H | body height QTL GWAS2245691 (human) | | 4e-08 | body height | | 4 | 119145484 | 119145485 | Human |
| 597578451 | GWAS1635311_H | high density lipoprotein cholesterol measurement QTL GWAS1635311 (human) | | 5e-17 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 625824768 | GWAS2245690_H | body height QTL GWAS2245690 (human) | | 5e-09 | body height | | 4 | 118235326 | 118235327 | Human |
| 625824771 | GWAS2245693_H | body height QTL GWAS2245693 (human) | | 5e-11 | body height | | 4 | 119458551 | 119458552 | Human |
| 597201623 | GWAS1297697_H | bone density QTL GWAS1297697 (human) | | 2e-09 | bone density | | 4 | 108138358 | 108138359 | Human |
| 625824770 | GWAS2245692_H | body height QTL GWAS2245692 (human) | | 1e-11 | body height | | 4 | 119174845 | 119174846 | Human |
| 598037233 | GWAS1756532_H | Ischemic stroke, von Willebrand factor quality QTL GWAS1756532 (human) | | 5e-16 | Ischemic stroke, von Willebrand factor quality | | 4 | 110775495 | 110775496 | Human |
| 628937764 | GWAS2845993_H | body mass index QTL GWAS2845993 (human) | | 1e-23 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 112402274 | 112402275 | Human |
| 616371681 | GWAS1851923_H | cerebral cortex area attribute QTL GWAS1851923 (human) | | 6e-12 | cerebral cortex area attribute | | 4 | 112495627 | 112495628 | Human |
| 597021386 | GWAS1117460_H | ovarian carcinoma QTL GWAS1117460 (human) | | 0.000003 | ovarian carcinoma | | 4 | 119028805 | 119028806 | Human |
| 628888601 | GWAS2796830_H | right ventricular systolic volume measurement QTL GWAS2796830 (human) | | 7e-08 | right ventricular systolic volume measurement | | 4 | 113507558 | 113507559 | Human |
| 628806674 | GWAS2714903_H | level of tyrosine-protein kinase Mer in blood QTL GWAS2714903 (human) | | 3e-08 | level of tyrosine-protein kinase Mer in blood | | 4 | 121520144 | 121520146 | Human |
| 616994222 | GWAS2011721_H | BMI-adjusted waist-hip ratio QTL GWAS2011721 (human) | | 6e-13 | BMI-adjusted waist-hip ratio | | 4 | 124261535 | 124261536 | Human |
| 407071018 | GWAS719994_H | heel bone mineral density QTL GWAS719994 (human) | | 1e-09 | heel bone mineral density | | 4 | 127363808 | 127363809 | Human |
| 407071017 | GWAS719993_H | heel bone mineral density QTL GWAS719993 (human) | | 4e-14 | heel bone mineral density | | 4 | 126607237 | 126607238 | Human |
| 597431024 | GWAS1527098_H | testosterone measurement QTL GWAS1527098 (human) | | 6e-09 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 109321740 | 109321741 | Human |
| 617026987 | GWAS2044486_H | BMI-adjusted waist-hip ratio QTL GWAS2044486 (human) | | 4e-15 | body size trait (VT:0100005) | | 4 | 121702910 | 121702911 | Human |
| 597431025 | GWAS1527099_H | testosterone measurement QTL GWAS1527099 (human) | | 2e-10 | testosterone measurement | | 4 | 113035247 | 113035248 | Human |
| 407316790 | GWAS965766_H | non-high density lipoprotein cholesterol measurement QTL GWAS965766 (human) | | 2e-13 | non-high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 407316789 | GWAS965765_H | non-high density lipoprotein cholesterol measurement QTL GWAS965765 (human) | | 3e-10 | non-high density lipoprotein cholesterol measurement | | 4 | 109174464 | 109174465 | Human |
| 597086948 | GWAS1183022_H | atopic eczema QTL GWAS1183022 (human) | | 1e-08 | atopic eczema | | 4 | 122576542 | 122576543 | Human |
| 596955874 | GWAS1075393_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075393 (human) | | 6e-12 | lymphocyte measurement, neutrophil measurement | | 4 | 109980042 | 109980043 | Human |
| 628626432 | GWAS2534661_H | vital capacity QTL GWAS2534661 (human) | | 0.0000001 | lung capacity (VT:0001942) | | 4 | 112674713 | 112674714 | Human |
| 597431014 | GWAS1527088_H | carotid artery disease QTL GWAS1527088 (human) | | 1e-16 | carotid artery disease | | 4 | 106712535 | 106712536 | Human |
| 628937734 | GWAS2845963_H | prothrombin time measurement QTL GWAS2845963 (human) | | 2e-20 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110796911 | 110796912 | Human |
| 628626434 | GWAS2534663_H | vital capacity QTL GWAS2534663 (human) | | 2e-10 | lung capacity (VT:0001942) | | 4 | 122906887 | 122906888 | Human |
| 628626435 | GWAS2534664_H | vital capacity QTL GWAS2534664 (human) | | 8e-12 | lung capacity (VT:0001942) | | 4 | 124209285 | 124209286 | Human |
| 628626436 | GWAS2534665_H | vital capacity QTL GWAS2534665 (human) | | 4e-11 | lung capacity (VT:0001942) | | 4 | 127731072 | 127731073 | Human |
| 597217819 | GWAS1313893_H | adult onset asthma QTL GWAS1313893 (human) | | 2e-10 | adult onset asthma | | 4 | 122432277 | 122432278 | Human |
| 407398860 | GWAS1047836_H | brain measurement QTL GWAS1047836 (human) | | 3e-30 | brain measurement | | 4 | 112512138 | 112512139 | Human |
| 628692221 | GWAS2600450_H | lymphocyte percentage of leukocytes QTL GWAS2600450 (human) | | 7e-19 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 4 | 122760001 | 122760002 | Human |
| 597824042 | GWAS1691433_H | childhood trauma measurement QTL GWAS1691433 (human) | | 8e-09 | childhood trauma measurement | | 4 | 127440030 | 127440031 | Human |
| 597037598 | GWAS1133672_H | treatment resistant depression, response to antidepressant QTL GWAS1133672 (human) | | 0.000004 | treatment resistant depression, response to antidepressant | | 4 | 130515632 | 130515633 | Human |
| 407349709 | GWAS998685_H | balding measurement QTL GWAS998685 (human) | | 2e-10 | balding measurement | | 4 | 124156708 | 124156709 | Human |
| 407349708 | GWAS998684_H | balding measurement QTL GWAS998684 (human) | | 3e-22 | balding measurement | | 4 | 106645118 | 106645119 | Human |
| 597824041 | GWAS1691432_H | childhood trauma measurement QTL GWAS1691432 (human) | | 1e-08 | childhood trauma measurement | | 4 | 126655945 | 126655946 | Human |
| 407005646 | GWAS654622_H | tumor necrosis factor-alpha measurement QTL GWAS654622 (human) | | 0.0000008 | tumor necrosis factor-alpha measurement | | 4 | 123440293 | 123440294 | Human |
| 597824047 | GWAS1691438_H | wellbeing measurement QTL GWAS1691438 (human) | | 3e-08 | wellbeing measurement | | 4 | 121662557 | 121662558 | Human |
| 407202250 | GWAS851226_H | lipoprotein A measurement QTL GWAS851226 (human) | | 1e-11 | lipoprotein A measurement | | 4 | 109717668 | 109717669 | Human |
| 617092443 | GWAS2109942_H | total blood protein measurement QTL GWAS2109942 (human) | | 7e-20 | total blood protein measurement | | 4 | 119206905 | 119206906 | Human |
| 616535338 | GWAS1931921_H | level of liver carboxylesterase 1 in blood serum QTL GWAS1931921 (human) | | 1e-27 | level of liver carboxylesterase 1 in blood serum | | 4 | 118865819 | 118865820 | Human |
| 628593890 | GWAS2502119_H | lifestyle measurement, anxiety disorder measurement QTL GWAS2502119 (human) | | 5e-13 | anxiety-related behavior trait (VT:0010716) | | 4 | 122322628 | 122322629 | Human |
| 597234176 | GWAS1330250_H | blood protein measurement QTL GWAS1330250 (human) | | 7e-50 | blood protein measurement | | 4 | 118808670 | 118808671 | Human |
| 597119499 | GWAS1215573_H | high density lipoprotein cholesterol measurement QTL GWAS1215573 (human) | | 2e-44 | high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 597119498 | GWAS1215572_H | high density lipoprotein cholesterol measurement QTL GWAS1215572 (human) | | 2e-17 | triglyceride measurement | | 4 | 109717608 | 109717609 | Human |
| 407382485 | GWAS1031461_H | atopic eczema QTL GWAS1031461 (human) | | 1e-08 | atopic eczema | | 4 | 122576542 | 122576543 | Human |
| 617092438 | GWAS2109937_H | total blood protein measurement QTL GWAS2109937 (human) | | 4e-14 | total blood protein measurement | | 4 | 122625127 | 122625128 | Human |
| 597103159 | GWAS1199233_H | myocardial infarction QTL GWAS1199233 (human) | | 0.0000002 | heart integrity trait (VT:0010757) | | 4 | 119988346 | 119988347 | Human |
| 597070390 | GWAS1166464_H | mosquito bite reaction size measurement QTL GWAS1166464 (human) | | 4e-11 | mosquito bite reaction size measurement | | 4 | 123250679 | 123250680 | Human |
| 597070391 | GWAS1166465_H | mosquito bite reaction size measurement QTL GWAS1166465 (human) | | 0.000003 | mosquito bite reaction size measurement | | 4 | 130874394 | 130874395 | Human |
| 598053383 | GWAS1772682_H | body height QTL GWAS1772682 (human) | | 5e-29 | body height | | 4 | 108503691 | 108503692 | Human |
| 597512763 | GWAS1608837_H | anthropometric measurement QTL GWAS1608837 (human) | | 3e-10 | anthropometric measurement | | 4 | 108565997 | 108565998 | Human |
| 616977772 | GWAS1995271_H | autosomal dominant compelling helio-ophthalmic outburst syndrome QTL GWAS1995271 (human) | | 3e-31 | autosomal dominant compelling helio-ophthalmic outburst syndrome | | 4 | 111737998 | 111737999 | Human |
| 597135932 | GWAS1232006_H | juvenile idiopathic arthritis QTL GWAS1232006 (human) | | 0.0000007 | juvenile idiopathic arthritis | | 4 | 122535302 | 122535303 | Human |
| 598053385 | GWAS1772684_H | body height QTL GWAS1772684 (human) | | 1e-13 | body height | | 4 | 121876108 | 121876109 | Human |
| 597824015 | GWAS1691406_H | wellbeing measurement QTL GWAS1691406 (human) | | 2e-08 | wellbeing measurement | | 4 | 117309754 | 117309755 | Human |
| 598053384 | GWAS1772683_H | body height QTL GWAS1772683 (human) | | 2e-13 | body height | | 4 | 119696257 | 119696258 | Human |
| 597070374 | GWAS1166448_H | mosquito bite reaction size measurement QTL GWAS1166448 (human) | | 0.0000002 | mosquito bite reaction size measurement | | 4 | 123041811 | 123041812 | Human |
| 597447213 | GWAS1543287_H | total cholesterol measurement, diet measurement QTL GWAS1543287 (human) | | 0.000003 | total cholesterol measurement, diet measurement | | 4 | 118490708 | 118490709 | Human |
| 407169526 | GWAS818502_H | alkaline phosphatase measurement QTL GWAS818502 (human) | | 4e-23 | alkaline phosphatase measurement | | 4 | 110199010 | 110199011 | Human |
| 597070372 | GWAS1166446_H | mosquito bite reaction size measurement QTL GWAS1166446 (human) | | 0.0000003 | mosquito bite reaction size measurement | | 4 | 122182953 | 122182955 | Human |
| 617043317 | GWAS2060816_H | coronary artery calcification QTL GWAS2060816 (human) | | 0.0000002 | coronary artery calcification | | 4 | 128541212 | 128541213 | Human |
| 597070373 | GWAS1166447_H | mosquito bite reaction size measurement QTL GWAS1166447 (human) | | 4e-08 | mosquito bite reaction size measurement | | 4 | 122852424 | 122852425 | Human |
| 628495565 | GWAS2403794_H | heart rate QTL GWAS2403794 (human) | | 0.000003 | heart rate | | 4 | 114106683 | 114106684 | Human |
| 616994171 | GWAS2011670_H | chronic kidney disease QTL GWAS2011670 (human) | | 0.0000009 | kidney integrity trait (VT:0010580) | | 4 | 117920116 | 117920117 | Human |
| 597266983 | GWAS1363057_H | cortical thickness QTL GWAS1363057 (human) | | 3e-08 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
| 628937917 | GWAS2846146_H | potassium measurement QTL GWAS2846146 (human) | | 1e-16 | blood potassium amount (VT:0002668) | blood potassium level (CMO:0000496) | 4 | 108140367 | 108140368 | Human |
| 597365338 | GWAS1461412_H | insomnia measurement QTL GWAS1461412 (human) | | 3e-08 | insomnia measurement | | 4 | 111901575 | 111901576 | Human |
| 626463893 | GWAS2277826_H | high density lipoprotein cholesterol measurement QTL GWAS2277826 (human) | | 3e-08 | high density lipoprotein cholesterol measurement | | 4 | 121771802 | 121771803 | Human |
| 406923650 | GWAS572626_H | systemic lupus erythematosus QTL GWAS572626 (human) | | 2e-09 | systemic lupus erythematosus | | 4 | 108190649 | 108190650 | Human |
| 597463647 | GWAS1559721_H | Barrett's esophagus QTL GWAS1559721 (human) | | 3e-09 | Barrett's esophagus | | 4 | 123619833 | 123619834 | Human |
| 628905144 | GWAS2813373_H | platelet quantity QTL GWAS2813373 (human) | | 4e-52 | platelet quantity | | 4 | 110008970 | 110008971 | Human |
| 407071110 | GWAS720086_H | smoking behavior QTL GWAS720086 (human) | | 3e-10 | smoking behavior | | 4 | 111500989 | 111500990 | Human |
| 407218563 | GWAS867539_H | total brain volume change measurement, age at assessment QTL GWAS867539 (human) | | 0.000002 | total brain volume change measurement, age at assessment | | 4 | 111512339 | 111512340 | Human |
| 597348946 | GWAS1445020_H | restless legs syndrome QTL GWAS1445020 (human) | | 3e-09 | restless legs syndrome | | 4 | 130726717 | 130726718 | Human |
| 617092353 | GWAS2109852_H | body mass index QTL GWAS2109852 (human) | | 6e-09 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 628905142 | GWAS2813371_H | platelet quantity QTL GWAS2813371 (human) | | 0.0000002 | platelet quantity | | 4 | 109952770 | 109952771 | Human |
| 406940043 | GWAS589019_H | protein measurement QTL GWAS589019 (human) | | 6e-17 | protein measurement | | 4 | 110555545 | 110555546 | Human |
| 597348944 | GWAS1445018_H | restless legs syndrome QTL GWAS1445018 (human) | | 2e-09 | restless legs syndrome | | 4 | 115033802 | 115033803 | Human |
| 406940042 | GWAS589018_H | protein measurement QTL GWAS589018 (human) | | 2e-152 | protein measurement | | 4 | 110510288 | 110510289 | Human |
| 597348945 | GWAS1445019_H | restless legs syndrome QTL GWAS1445019 (human) | | 7e-10 | restless legs syndrome | | 4 | 118382649 | 118382650 | Human |
| 406940044 | GWAS589020_H | protein measurement QTL GWAS589020 (human) | | 1e-149 | protein measurement | | 4 | 110489326 | 110489327 | Human |
| 628823221 | GWAS2731450_H | glomerular filtration rate QTL GWAS2731450 (human) | | 9e-09 | glomerular filtration rate | | 4 | 128246249 | 128246250 | Human |
| 406940046 | GWAS589022_H | protein measurement QTL GWAS589022 (human) | | 9e-46 | protein measurement | | 4 | 110414448 | 110414449 | Human |
| 628987058 | GWAS2895287_H | keratoconus QTL GWAS2895287 (human) | | 2e-12 | keratoconus | | 4 | 117877256 | 117877257 | Human |
| 407153043 | GWAS802019_H | appendicular lean mass QTL GWAS802019 (human) | | 1e-11 | appendicular lean mass | | 4 | 124044107 | 124044108 | Human |
| 597103183 | GWAS1199257_H | cortical surface area measurement QTL GWAS1199257 (human) | | 7e-10 | cortical surface area measurement | | 4 | 118328680 | 118328681 | Human |
| 617075999 | GWAS2093498_H | body height QTL GWAS2093498 (human) | | 0.0000003 | body height | | 4 | 119645235 | 119645236 | Human |
| 617075998 | GWAS2093497_H | body height QTL GWAS2093497 (human) | | 3e-19 | body height | | 4 | 108540829 | 108540830 | Human |
| 597021256 | GWAS1117330_H | fibroblast growth factor basic measurement QTL GWAS1117330 (human) | | 0.000002 | fibroblast growth factor basic measurement | | 4 | 107833368 | 107833369 | Human |
| 407251353 | GWAS900329_H | hemoglobin measurement QTL GWAS900329 (human) | | 0.000008 | hemoglobin measurement | | 4 | 120850980 | 120850981 | Human |
| 628921500 | GWAS2829729_H | degree of unsaturation measurement QTL GWAS2829729 (human) | | 3e-09 | degree of unsaturation measurement | | 4 | 109657070 | 109657071 | Human |
| 628987039 | GWAS2895268_H | bundle branch block QTL GWAS2895268 (human) | | 4e-11 | bundle branch block | | 4 | 114685927 | 114685928 | Human |
| 597381753 | GWAS1477827_H | mammographic density percentage QTL GWAS1477827 (human) | | 2e-08 | mammographic density percentage | | 4 | 127271525 | 127271526 | Human |
| 628987032 | GWAS2895261_H | Complete right bundle branch block QTL GWAS2895261 (human) | | 4e-16 | Complete right bundle branch block | | 4 | 114640717 | 114640718 | Human |
| 597987906 | GWAS1707205_H | body height QTL GWAS1707205 (human) | | 6e-15 | body height | | 4 | 108487452 | 108487453 | Human |
| 617076001 | GWAS2093500_H | body height QTL GWAS2093500 (human) | | 7e-09 | body height | | 4 | 132314995 | 132314996 | Human |
| 617076000 | GWAS2093499_H | body height QTL GWAS2093499 (human) | | 2e-12 | body height | | 4 | 119840636 | 119840637 | Human |
| 597054077 | GWAS1150151_H | smoking status measurement QTL GWAS1150151 (human) | | 7e-12 | smoking status measurement | | 4 | 111500989 | 111500990 | Human |
| 407202217 | GWAS851193_H | sex hormone-binding globulin measurement QTL GWAS851193 (human) | | 3e-16 | sex hormone-binding globulin measurement | | 4 | 109717608 | 109717609 | Human |
| 597529200 | GWAS1625274_H | body mass index QTL GWAS1625274 (human) | | 2e-12 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597381749 | GWAS1477823_H | mammographic density measurement QTL GWAS1477823 (human) | | 6e-10 | mammary gland morphology trait (VT:0000627) | | 4 | 126851213 | 126851214 | Human |
| 407202218 | GWAS851194_H | sex hormone-binding globulin measurement QTL GWAS851194 (human) | | 2e-52 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 597398132 | GWAS1494206_H | Beta blocking agent use measurement QTL GWAS1494206 (human) | | 1e-19 | Beta blocking agent use measurement | | 4 | 110789765 | 110789766 | Human |
| 597250678 | GWAS1346752_H | corneal resistance factor QTL GWAS1346752 (human) | | 4e-08 | corneal resistance factor | | 4 | 118802505 | 118802506 | Human |
| 628970632 | GWAS2878861_H | hematocrit QTL GWAS2878861 (human) | | 2e-09 | erythrocyte morphology trait (VT:0002447) | hematocrit (CMO:0000037) | 4 | 124004016 | 124004017 | Human |
| 597824090 | GWAS1691481_H | attention deficit hyperactivity disorder, substance abuse QTL GWAS1691481 (human) | | 2e-23 | attention deficit hyperactivity disorder, substance abuse | | 4 | 111485805 | 111485806 | Human |
| 597824091 | GWAS1691482_H | attention deficit hyperactivity disorder, substance abuse QTL GWAS1691482 (human) | | 1e-09 | attention deficit hyperactivity disorder, substance abuse | | 4 | 129484578 | 129484579 | Human |
| 597463650 | GWAS1559724_H | esophageal adenocarcinoma, Barrett's esophagus QTL GWAS1559724 (human) | | 6e-13 | esophageal adenocarcinoma, Barrett's esophagus | | 4 | 123640998 | 123640999 | Human |
| 407349830 | GWAS998806_H | feeling "fed-up" measurement QTL GWAS998806 (human) | | 5e-08 | feeling "fed-up" measurement | | 4 | 122465996 | 122465997 | Human |
| 628823930 | GWAS2732159_H | acylcarnitine measurement QTL GWAS2732159 (human) | | 6e-08 | blood protein amount (VT:0005416) | | 4 | 130265205 | 130265206 | Human |
| 628987775 | GWAS2896004_H | artificial cardiac pacemaker QTL GWAS2896004 (human) | | 1e-16 | artificial cardiac pacemaker | | 4 | 110780642 | 110780643 | Human |
| 407349829 | GWAS998805_H | feeling "fed-up" measurement QTL GWAS998805 (human) | | 2e-08 | feeling "fed-up" measurement | | 4 | 122201701 | 122201702 | Human |
| 628578175 | GWAS2486404_H | glycerophospholipid measurement QTL GWAS2486404 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114484592 | 114484593 | Human |
| 628578174 | GWAS2486403_H | glycerophospholipid measurement QTL GWAS2486403 (human) | | 1e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114512809 | 114512810 | Human |
| 407005771 | GWAS654747_H | tumor necrosis factor-alpha measurement QTL GWAS654747 (human) | | 0.000009 | tumor necrosis factor-alpha measurement | | 4 | 123921955 | 123921960 | Human |
| 628987767 | GWAS2895996_H | corneal ulcer QTL GWAS2895996 (human) | | 2e-11 | corneal ulcer | | 4 | 112325350 | 112325351 | Human |
| 628578173 | GWAS2486402_H | glycerophospholipid measurement QTL GWAS2486402 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114491902 | 114491903 | Human |
| 628578172 | GWAS2486401_H | glycerophospholipid measurement QTL GWAS2486401 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114513555 | 114513556 | Human |
| 628578171 | GWAS2486400_H | glycerophospholipid measurement QTL GWAS2486400 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114513322 | 114513323 | Human |
| 628578170 | GWAS2486399_H | glycerophospholipid measurement QTL GWAS2486399 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114492288 | 114492289 | Human |
| 628578169 | GWAS2486398_H | glycerophospholipid measurement QTL GWAS2486398 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114492246 | 114492247 | Human |
| 407186006 | GWAS834982_H | lipid measurement QTL GWAS834982 (human) | | 0.000007 | lipid measurement | | 4 | 107039415 | 107039416 | Human |
| 407186001 | GWAS834977_H | oleoylcarnitine measurement QTL GWAS834977 (human) | | 0.000002 | oleoylcarnitine measurement | | 4 | 116466224 | 116466225 | Human |
| 626169670 | GWAS2254106_H | atrial fibrillation QTL GWAS2254106 (human) | | 3e-08 | atrial fibrillation | | 4 | 120802562 | 120802563 | Human |
| 628578147 | GWAS2486376_H | atopic eczema QTL GWAS2486376 (human) | | 9e-11 | atopic eczema | | 4 | 122219899 | 122219900 | Human |
| 626169671 | GWAS2254107_H | atrial fibrillation QTL GWAS2254107 (human) | | 5e-11 | atrial fibrillation | | 4 | 121877258 | 121877259 | Human |
| 626169672 | GWAS2254108_H | atrial fibrillation QTL GWAS2254108 (human) | | 2e-09 | atrial fibrillation | | 4 | 122917603 | 122917604 | Human |
| 626169673 | GWAS2254109_H | atrial fibrillation QTL GWAS2254109 (human) | | 1e-08 | atrial fibrillation | | 4 | 128544334 | 128544335 | Human |
| 628643685 | GWAS2551914_H | gut microbiome measurement, environmental exposure measurement QTL GWAS2551914 (human) | | 0.000008 | gut microbiome measurement, environmental exposure measurement | | 4 | 113313524 | 113313525 | Human |
| 628971362 | GWAS2879591_H | body mass index QTL GWAS2879591 (human) | | 2e-25 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129824994 | 129824995 | Human |
| 597021108 | GWAS1117182_H | sclerosing cholangitis QTL GWAS1117182 (human) | | 1e-13 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
| 406891105 | GWAS540081_H | smoking status measurement, systolic blood pressure QTL GWAS540081 (human) | | 0.000006 | smoking status measurement, systolic blood pressure | | 4 | 123660107 | 123660108 | Human |
| 407284323 | GWAS933299_H | glomerular filtration rate QTL GWAS933299 (human) | | 2e-24 | glomerular filtration rate | | 4 | 108782393 | 108782394 | Human |
| 628807504 | GWAS2715733_H | erythrocyte volume QTL GWAS2715733 (human) | | 2e-14 | erythrocyte volume | | 4 | 110066281 | 110066282 | Human |
| 616552085 | GWAS1948668_H | bilirubin measurement QTL GWAS1948668 (human) | | 1e-12 | bilirubin measurement | | 4 | 123882996 | 123882997 | Human |
| 626464634 | GWAS2278567_H | body mass index QTL GWAS2278567 (human) | | 1e-23 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 628954956 | GWAS2863185_H | serum albumin amount QTL GWAS2863185 (human) | | 2e-12 | serum albumin amount | | 4 | 110027510 | 110027511 | Human |
| 616994548 | GWAS2012047_H | body mass index QTL GWAS2012047 (human) | | 3e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 111826763 | 111826764 | Human |
| 597479850 | GWAS1575924_H | body height QTL GWAS1575924 (human) | | 3e-28 | body height | | 4 | 108535458 | 108535459 | Human |
| 597316002 | GWAS1412076_H | testosterone measurement QTL GWAS1412076 (human) | | 5e-13 | testosterone measurement | | 4 | 114419750 | 114419751 | Human |
| 597266852 | GWAS1362926_H | epidermal growth factor measurement QTL GWAS1362926 (human) | | 5e-25 | epidermal growth factor measurement | | 4 | 109938419 | 109938420 | Human |
| 617059974 | GWAS2077473_H | serum creatinine amount QTL GWAS2077473 (human) | | 2e-15 | serum creatinine amount | | 4 | 127146530 | 127146531 | Human |
| 617059973 | GWAS2077472_H | serum creatinine amount QTL GWAS2077472 (human) | | 7e-09 | serum creatinine amount | | 4 | 123414226 | 123414227 | Human |
| 617059972 | GWAS2077471_H | serum creatinine amount QTL GWAS2077471 (human) | | 3e-08 | serum creatinine amount | | 4 | 114597722 | 114597723 | Human |
| 617059971 | GWAS2077470_H | serum creatinine amount QTL GWAS2077470 (human) | | 4e-13 | serum creatinine amount | | 4 | 108792494 | 108792495 | Human |
| 628627261 | GWAS2535490_H | respiratory system disease QTL GWAS2535490 (human) | | 6e-17 | lung integrity trait (VT:0010906) | | 4 | 122432277 | 122432278 | Human |
| 597135825 | GWAS1231899_H | bone density QTL GWAS1231899 (human) | | 4e-107 | bone density | | 4 | 119246472 | 119246473 | Human |
| 597316060 | GWAS1412134_H | diastolic blood pressure QTL GWAS1412134 (human) | | 1e-13 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 407382528 | GWAS1031504_H | obsolete_red blood cell distribution width QTL GWAS1031504 (human) | | 6e-21 | obsolete_red blood cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 628938550 | GWAS2846779_H | body weight QTL GWAS2846779 (human) | | 3e-13 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 112335581 | 112335582 | Human |
| 407054862 | GWAS703838_H | household income QTL GWAS703838 (human) | | 4e-08 | household income | | 4 | 131729441 | 131729442 | Human |
| 628905778 | GWAS2814007_H | atrial flutter QTL GWAS2814007 (human) | | 3e-21 | atrial flutter | | 4 | 110791080 | 110791081 | Human |
| 406940175 | GWAS589151_H | chronotype measurement, sun exposure measurement QTL GWAS589151 (human) | | 0.0000002 | chronotype measurement, sun exposure measurement | | 4 | 114197705 | 114197706 | Human |
| 597365204 | GWAS1461278_H | eosinophil percentage of leukocytes QTL GWAS1461278 (human) | | 2e-22 | eosinophil percentage of leukocytes | | 4 | 122680542 | 122680543 | Human |
| 628578104 | GWAS2486333_H | reaction time measurement QTL GWAS2486333 (human) | | 0.0000004 | cognitive behavior trait (VT:0010450) | | 4 | 124836622 | 124836623 | Human |
| 628578087 | GWAS2486316_H | glycerophospholipid measurement QTL GWAS2486316 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114495590 | 114495591 | Human |
| 598036981 | GWAS1756280_H | circulating fibrinogen levels, coronary artery disease QTL GWAS1756280 (human) | | 1e-11 | circulating fibrinogen levels, coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 628578086 | GWAS2486315_H | glycerophospholipid measurement QTL GWAS2486315 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114495547 | 114495548 | Human |
| 628971311 | GWAS2879540_H | erythrocyte count QTL GWAS2879540 (human) | | 9e-26 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 109999015 | 109999016 | Human |
| 626169600 | GWAS2254036_H | atrial fibrillation QTL GWAS2254036 (human) | | 3e-34 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 628578085 | GWAS2486314_H | glycerophospholipid measurement QTL GWAS2486314 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114549757 | 114549758 | Human |
| 407087633 | GWAS736609_H | erosive tooth wear measurement QTL GWAS736609 (human) | | 3e-08 | erosive tooth wear measurement | | 4 | 117643607 | 117643608 | Human |
| 628578084 | GWAS2486313_H | glycerophospholipid measurement QTL GWAS2486313 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114532641 | 114532642 | Human |
| 628578083 | GWAS2486312_H | glycerophospholipid measurement QTL GWAS2486312 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114495414 | 114495415 | Human |
| 628578082 | GWAS2486311_H | glycerophospholipid measurement QTL GWAS2486311 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114532620 | 114532621 | Human |
| 628578081 | GWAS2486310_H | glycerophospholipid measurement QTL GWAS2486310 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114532551 | 114532552 | Human |
| 628578080 | GWAS2486309_H | glycerophospholipid measurement QTL GWAS2486309 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114532477 | 114532478 | Human |
| 628365102 | GWAS2285946_H | tumor necrosis factor alpha level QTL GWAS2285946 (human) | | 0.000009 | tumor necrosis factor alpha level | | 4 | 123921955 | 123921960 | Human |
| 407071262 | GWAS720238_H | hypertension QTL GWAS720238 (human) | | 0.000005 | hypertension | | 4 | 110460482 | 110460483 | Human |
| 628660006 | GWAS2568235_H | Parkinson disease QTL GWAS2568235 (human) | | 3e-11 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
| 628905763 | GWAS2813992_H | atrial fibrillation QTL GWAS2813992 (human) | | 7e-70 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 628578088 | GWAS2486317_H | glycerophospholipid measurement QTL GWAS2486317 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114495600 | 114495601 | Human |
| 597316090 | GWAS1412164_H | BMI-adjusted waist circumference QTL GWAS1412164 (human) | | 2e-11 | BMI-adjusted waist circumference | | 4 | 119213641 | 119213642 | Human |
| 597316091 | GWAS1412165_H | BMI-adjusted waist circumference QTL GWAS1412165 (human) | | 1e-08 | BMI-adjusted waist circumference | | 4 | 119503425 | 119503426 | Human |
| 407284261 | GWAS933237_H | Ventricular arrhythmia QTL GWAS933237 (human) | | 2e-10 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
| 596972022 | GWAS1091541_H | major depressive disorder QTL GWAS1091541 (human) | | 0.0000004 | major depressive disorder | | 4 | 130232015 | 130232016 | Human |
| 597316094 | GWAS1412168_H | BMI-adjusted waist circumference QTL GWAS1412168 (human) | | 4e-09 | BMI-adjusted waist circumference | | 4 | 119805780 | 119805781 | Human |
| 406907429 | GWAS556405_H | bipolar disorder QTL GWAS556405 (human) | | 0.0000001 | bipolar disorder | | 4 | 117551578 | 117551579 | Human |
| 597103090 | GWAS1199164_H | foot muscle strength measurement QTL GWAS1199164 (human) | | 0.0000008 | foot muscle strength measurement | | 4 | 123234042 | 123234043 | Human |
| 597316092 | GWAS1412166_H | BMI-adjusted waist circumference QTL GWAS1412166 (human) | | 2e-14 | BMI-adjusted waist circumference | | 4 | 119674620 | 119674621 | Human |
| 597316093 | GWAS1412167_H | BMI-adjusted waist circumference QTL GWAS1412167 (human) | | 5e-10 | BMI-adjusted waist circumference | | 4 | 119761309 | 119761310 | Human |
| 628578079 | GWAS2486308_H | glycerophospholipid measurement QTL GWAS2486308 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114493188 | 114493189 | Human |
| 628578078 | GWAS2486307_H | glycerophospholipid measurement QTL GWAS2486307 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114493049 | 114493050 | Human |
| 628578077 | GWAS2486306_H | glycerophospholipid measurement QTL GWAS2486306 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114492998 | 114492999 | Human |
| 628578076 | GWAS2486305_H | glycerophospholipid measurement QTL GWAS2486305 (human) | | 2e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114552771 | 114552772 | Human |
| 597823945 | GWAS1691336_H | wellbeing measurement QTL GWAS1691336 (human) | | 5e-08 | wellbeing measurement | | 4 | 121669289 | 121669290 | Human |
| 628578075 | GWAS2486304_H | glycerophospholipid measurement QTL GWAS2486304 (human) | | 4e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114494204 | 114494205 | Human |
| 597348855 | GWAS1444929_H | atopic eczema QTL GWAS1444929 (human) | | 1e-14 | atopic eczema | | 4 | 122263256 | 122263257 | Human |
| 597496306 | GWAS1592380_H | hip geometry QTL GWAS1592380 (human) | | 3e-08 | hip geometry | | 4 | 121074997 | 121074998 | Human |
| 628741910 | GWAS2650139_H | IGF-1 measurement QTL GWAS2650139 (human) | | 2e-09 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 4 | 127882004 | 127882005 | Human |
| 625825599 | GWAS2246521_H | response to statin, LDL cholesterol change measurement QTL GWAS2246521 (human) | | 2e-08 | response to statin, LDL cholesterol change measurement | | 4 | 108720535 | 108720536 | Human |
| 407202359 | GWAS851335_H | cortical surface area measurement QTL GWAS851335 (human) | | 2e-13 | cortical surface area measurement | | 4 | 112509596 | 112509597 | Human |
| 407202358 | GWAS851334_H | cortical surface area measurement QTL GWAS851334 (human) | | 2e-08 | cortical surface area measurement | | 4 | 107131838 | 107131839 | Human |
| 597152228 | GWAS1248302_H | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1248302 (human) | | 2e-10 | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 626464557 | GWAS2278490_H | systolic blood pressure QTL GWAS2278490 (human) | | 2e-36 | systolic blood pressure | | 4 | 110417121 | 110417122 | Human |
| 407202360 | GWAS851336_H | cortical surface area measurement QTL GWAS851336 (human) | | 1e-17 | cortical surface area measurement | | 4 | 118393759 | 118393760 | Human |
| 407202363 | GWAS851339_H | cortical surface area measurement QTL GWAS851339 (human) | | 1e-10 | cortical surface area measurement | | 4 | 126658527 | 126658528 | Human |
| 628447217 | GWAS2355446_H | hemoglobin measurement QTL GWAS2355446 (human) | | 1e-12 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 114598669 | 114598670 | Human |
| 597528859 | GWAS1624933_H | aspartate measurement QTL GWAS1624933 (human) | | 4e-18 | aspartate measurement | | 4 | 110414566 | 110414567 | Human |
| 616977984 | GWAS1995483_H | initial pursuit acceleration QTL GWAS1995483 (human) | | 0.000005 | eye physiology trait (VT:0005253) | | 4 | 130399088 | 130399089 | Human |
| 628447218 | GWAS2355447_H | hemoglobin measurement QTL GWAS2355447 (human) | | 3e-10 | blood hemoglobin amount (VT:0001588) | hemoglobin measurement (CMO:0000508) | 4 | 123844107 | 123844108 | Human |
| 597299474 | GWAS1395548_H | body height QTL GWAS1395548 (human) | | 5e-08 | body height | | 4 | 128687133 | 128687134 | Human |
| 597037340 | GWAS1133414_H | caudate nucleus volume QTL GWAS1133414 (human) | | 0.000004 | caudate nucleus morphology trait (VT:0004078) | | 4 | 122735253 | 122735254 | Human |
| 597299472 | GWAS1395546_H | body height QTL GWAS1395546 (human) | | 2e-09 | body height | | 4 | 126045727 | 126045728 | Human |
| 628856822 | GWAS2765051_H | Antihypertensive use measurement QTL GWAS2765051 (human) | | 1e-17 | Antihypertensive use measurement | | 4 | 110469660 | 110469661 | Human |
| 628856821 | GWAS2765050_H | Antihypertensive use measurement QTL GWAS2765050 (human) | | 2e-10 | Antihypertensive use measurement | | 4 | 108123712 | 108123713 | Human |
| 597299467 | GWAS1395541_H | body height QTL GWAS1395541 (human) | | 3e-14 | body height | | 4 | 113975748 | 113975749 | Human |
| 407399129 | GWAS1048105_H | ceramide measurement QTL GWAS1048105 (human) | | 1e-16 | ceramide measurement | | 4 | 114598115 | 114598116 | Human |
| 628430822 | GWAS2339051_H | household income QTL GWAS2339051 (human) | | 4e-08 | household income | | 4 | 131729441 | 131729442 | Human |
| 597299470 | GWAS1395544_H | body height QTL GWAS1395544 (human) | | 1e-17 | body height | | 4 | 122906887 | 122906888 | Human |
| 597299471 | GWAS1395545_H | body height QTL GWAS1395545 (human) | | 1e-14 | body height | | 4 | 124018099 | 124018100 | Human |
| 597299468 | GWAS1395542_H | body height QTL GWAS1395542 (human) | | 2e-14 | body height | | 4 | 119796398 | 119796399 | Human |
| 597299469 | GWAS1395543_H | body height QTL GWAS1395543 (human) | | 2e-21 | body height | | 4 | 121829906 | 121829907 | Human |
| 616994398 | GWAS2011897_H | lung adenocarcinoma, family history of lung cancer QTL GWAS2011897 (human) | | 0.000009 | lung integrity trait (VT:0010906) | | 4 | 111828356 | 111828357 | Human |
| 597987644 | GWAS1706943_H | cerebral cortex area attribute QTL GWAS1706943 (human) | | 7e-10 | cerebral cortex area attribute | | 4 | 118328680 | 118328681 | Human |
| 407055066 | GWAS704042_H | gut microbiome measurement QTL GWAS704042 (human) | | 0.0000004 | gut microbiome measurement | | 4 | 116053081 | 116053082 | Human |
| 597987586 | GWAS1706885_H | insulin sensitivity measurement, glucose homeostasis trait QTL GWAS1706885 (human) | | 0.0000005 | insulin sensitivity measurement, glucose homeostasis trait | calculated blood insulin level (CMO:0000353) | 4 | 127922325 | 127922326 | Human |
| 406989547 | GWAS638523_H | comparative body size at age 10, self-reported QTL GWAS638523 (human) | | 1e-11 | comparative body size at age 10, self-reported | | 4 | 129819249 | 129819250 | Human |
| 406907626 | GWAS556602_H | bipolar disorder QTL GWAS556602 (human) | | 0.000006 | bipolar disorder | | 4 | 117740497 | 117740498 | Human |
| 597594420 | GWAS1651280_H | body mass index QTL GWAS1651280 (human) | | 2e-25 | body mass index | | 4 | 129824994 | 129824995 | Human |
| 597987594 | GWAS1706893_H | insulin sensitivity measurement, glucose homeostasis trait QTL GWAS1706893 (human) | | 0.000003 | insulin sensitivity measurement, glucose homeostasis trait | calculated blood insulin level (CMO:0000353) | 4 | 127922325 | 127922326 | Human |
| 628545497 | GWAS2453726_H | epidermal growth factor measurement QTL GWAS2453726 (human) | | 4e-18 | epidermal growth factor measurement | | 4 | 110012720 | 110012721 | Human |
| 628938700 | GWAS2846929_H | fatty acid amount QTL GWAS2846929 (human) | | 1e-08 | fatty acid amount | | 4 | 109603883 | 109603884 | Human |
| 406891248 | GWAS540224_H | DNA methylation QTL GWAS540224 (human) | | 3e-09 | DNA methylation | | 4 | 109836068 | 109836069 | Human |
| 407104241 | GWAS753217_H | mathematical ability QTL GWAS753217 (human) | | 4e-10 | mathematical ability | | 4 | 115118452 | 115118453 | Human |
| 407284469 | GWAS933445_H | cup-to-disc ratio measurement QTL GWAS933445 (human) | | 2e-18 | cup-to-disc ratio measurement | | 4 | 125478843 | 125478844 | Human |
| 407366388 | GWAS1015364_H | endometriosis, unipolar depression QTL GWAS1015364 (human) | | 5e-08 | endometriosis, unipolar depression | | 4 | 130288732 | 130288733 | Human |
| 597315884 | GWAS1411958_H | vaginal microbiome measurement QTL GWAS1411958 (human) | | 0.0000002 | vaginal microbiome measurement | | 4 | 109225176 | 109225177 | Human |
| 628496320 | GWAS2404549_H | celiac disease QTL GWAS2404549 (human) | | 4e-11 | intestine integrity trait (VT:0010554) | | 4 | 122345366 | 122345367 | Human |
| 406891258 | GWAS540234_H | DNA methylation QTL GWAS540234 (human) | | 2e-08 | DNA methylation | | 4 | 124761267 | 124761268 | Human |
| 617076348 | GWAS2093847_H | body height QTL GWAS2093847 (human) | | 2e-11 | body height | | 4 | 119840636 | 119840637 | Human |
| 617076347 | GWAS2093846_H | body height QTL GWAS2093846 (human) | | 1e-09 | body height | | 4 | 112488114 | 112488115 | Human |
| 407071361 | GWAS720337_H | heel bone mineral density QTL GWAS720337 (human) | | 2e-15 | heel bone mineral density | | 4 | 126527797 | 126527798 | Human |
| 406923906 | GWAS572882_H | hypertension QTL GWAS572882 (human) | | 0.000006 | hypertension | | 4 | 112002081 | 112002082 | Human |
| 597447000 | GWAS1543074_H | sex hormone-binding globulin measurement QTL GWAS1543074 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 407087751 | GWAS736727_H | corneal topography QTL GWAS736727 (human) | | 1e-18 | corneal topography | | 4 | 127192269 | 127192270 | Human |
| 597021008 | GWAS1117082_H | inflammatory bowel disease QTL GWAS1117082 (human) | | 0.0000001 | intestine integrity trait (VT:0010554) | | 4 | 122430276 | 122430277 | Human |
| 597119312 | GWAS1215386_H | sex hormone-binding globulin measurement QTL GWAS1215386 (human) | | 3e-16 | sex hormone-binding globulin measurement | | 4 | 109717608 | 109717609 | Human |
| 406891146 | GWAS540122_H | obesity QTL GWAS540122 (human) | | 0.000003 | eating behavior trait (VT:0001431) | | 4 | 117171981 | 117171982 | Human |
| 628987830 | GWAS2896059_H | sinoatrial node disorder QTL GWAS2896059 (human) | | 1e-17 | sinoatrial node disorder | | 4 | 110774266 | 110774267 | Human |
| 597446999 | GWAS1543073_H | sex hormone-binding globulin measurement QTL GWAS1543073 (human) | | 6e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 617010701 | GWAS2028200_H | eosinophil count QTL GWAS2028200 (human) | | 1e-23 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 597463376 | GWAS1559450_H | stroke QTL GWAS1559450 (human) | | 1e-13 | stroke | | 4 | 110791276 | 110791277 | Human |
| 597168468 | GWAS1264542_H | blood urea nitrogen measurement QTL GWAS1264542 (human) | | 2e-09 | blood urea nitrogen measurement | | 4 | 119092116 | 119092117 | Human |
| 407235209 | GWAS884185_H | selective IgA deficiency disease QTL GWAS884185 (human) | | 0.000001 | selective IgA deficiency disease | | 4 | 122571262 | 122571263 | Human |
| 597397844 | GWAS1493918_H | vaginal microbiome measurement QTL GWAS1493918 (human) | | 3e-10 | vaginal microbiome measurement | | 4 | 107261570 | 107261571 | Human |
| 597266761 | GWAS1362835_H | cortical thickness QTL GWAS1362835 (human) | | 3e-08 | cortical thickness | | 4 | 120748941 | 120748942 | Human |
| 407300759 | GWAS949735_H | body mass index QTL GWAS949735 (human) | | 2e-08 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 628594604 | GWAS2502833_H | Alzheimer disease, educational attainment QTL GWAS2502833 (human) | | 0.0000004 | Alzheimer disease, educational attainment | | 4 | 129748953 | 129748954 | Human |
| 597266756 | GWAS1362830_H | cortical thickness QTL GWAS1362830 (human) | | 9e-10 | cortical thickness | | 4 | 120654416 | 120654417 | Human |
| 597119304 | GWAS1215378_H | body height QTL GWAS1215378 (human) | | 2e-14 | body height | | 4 | 119501252 | 119501253 | Human |
| 597447039 | GWAS1543113_H | serum non-albumin protein measurement QTL GWAS1543113 (human) | | 8e-11 | serum non-albumin protein measurement | | 4 | 119210489 | 119210490 | Human |
| 626464692 | GWAS2278625_H | triglyceride measurement QTL GWAS2278625 (human) | | 6e-10 | triglyceride measurement | | 4 | 123849710 | 123849711 | Human |
| 597037426 | GWAS1133500_H | rostral anterior cingulate cortex volume measurement QTL GWAS1133500 (human) | | 0.000009 | rostral anterior cingulate cortex volume measurement | | 4 | 129254856 | 129254857 | Human |
| 406923944 | GWAS572920_H | facial morphology measurement QTL GWAS572920 (human) | | 3e-08 | facial morphology measurement | | 4 | 125220568 | 125220569 | Human |
| 406923947 | GWAS572923_H | facial morphology measurement QTL GWAS572923 (human) | | 5e-08 | facial morphology measurement | | 4 | 125202598 | 125202599 | Human |
| 406923946 | GWAS572922_H | facial morphology measurement QTL GWAS572922 (human) | | 4e-08 | facial morphology measurement | | 4 | 125199979 | 125199980 | Human |
| 628594587 | GWAS2502816_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2502816 (human) | | 4e-20 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 598004052 | GWAS1723351_H | body height QTL GWAS1723351 (human) | | 2e-15 | body height | | 4 | 108494980 | 108494981 | Human |
| 407104179 | GWAS753155_H | reticulocyte measurement QTL GWAS753155 (human) | | 4e-17 | reticulocyte measurement | | 4 | 109944309 | 109944310 | Human |
| 628627339 | GWAS2535568_H | FEV/FVC ratio QTL GWAS2535568 (human) | | 2e-08 | lung capacity (VT:0001942) | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 108429724 | 108429725 | Human |
| 628627340 | GWAS2535569_H | FEV/FVC ratio QTL GWAS2535569 (human) | | 1e-20 | lung capacity (VT:0001942) | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 123898452 | 123898453 | Human |
| 407104180 | GWAS753156_H | reticulocyte measurement QTL GWAS753156 (human) | | 4e-12 | reticulocyte measurement | | 4 | 128330896 | 128330897 | Human |
| 597496165 | GWAS1592239_H | hip geometry QTL GWAS1592239 (human) | | 4e-08 | hip geometry | | 4 | 126569184 | 126569185 | Human |
| 628987782 | GWAS2896011_H | artificial cardiac pacemaker QTL GWAS2896011 (human) | | 3e-12 | artificial cardiac pacemaker | | 4 | 110780642 | 110780643 | Human |
| 628577911 | GWAS2486140_H | glycerophospholipid measurement QTL GWAS2486140 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114578518 | 114578519 | Human |
| 628577910 | GWAS2486139_H | glycerophospholipid measurement QTL GWAS2486139 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114560232 | 114560233 | Human |
| 628577909 | GWAS2486138_H | glycerophospholipid measurement QTL GWAS2486138 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114542537 | 114542538 | Human |
| 628577908 | GWAS2486137_H | glycerophospholipid measurement QTL GWAS2486137 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114542460 | 114542461 | Human |
| 628577907 | GWAS2486136_H | glycerophospholipid measurement QTL GWAS2486136 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114541220 | 114541221 | Human |
| 628577906 | GWAS2486135_H | glycerophospholipid measurement QTL GWAS2486135 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114576504 | 114576505 | Human |
| 628577905 | GWAS2486134_H | glycerophospholipid measurement QTL GWAS2486134 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114546228 | 114546229 | Human |
| 628627071 | GWAS2535300_H | systolic blood pressure QTL GWAS2535300 (human) | | 5e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 108146742 | 108146743 | Human |
| 628577904 | GWAS2486133_H | glycerophospholipid measurement QTL GWAS2486133 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114579403 | 114579404 | Human |
| 598069422 | GWAS1788721_H | thyroid stimulating hormone amount QTL GWAS1788721 (human) | | 2e-19 | thyroid stimulating hormone amount | | 4 | 121691318 | 121691319 | Human |
| 628987507 | GWAS2895736_H | hypertrophic cardiomyopathy QTL GWAS2895736 (human) | | 8e-13 | heart integrity trait (VT:0010757) | | 4 | 108196857 | 108196858 | Human |
| 628577912 | GWAS2486141_H | glycerophospholipid measurement QTL GWAS2486141 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114578461 | 114578462 | Human |
| 628577895 | GWAS2486124_H | glycerophospholipid measurement QTL GWAS2486124 (human) | | 9e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114574339 | 114574340 | Human |
| 597512333 | GWAS1608407_H | peptic ulcer disease QTL GWAS1608407 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616812 | 123616813 | Human |
| 628577894 | GWAS2486123_H | glycerophospholipid measurement QTL GWAS2486123 (human) | | 9e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114527954 | 114527955 | Human |
| 597299336 | GWAS1395410_H | lymphocyte count QTL GWAS1395410 (human) | | 1e-18 | lymphocyte count | | 4 | 109921984 | 109921985 | Human |
| 628577893 | GWAS2486122_H | glycerophospholipid measurement QTL GWAS2486122 (human) | | 9e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114493975 | 114493976 | Human |
| 596988039 | GWAS1107558_H | memory performance, sex interaction measurement QTL GWAS1107558 (human) | | 0.000004 | memory performance, sex interaction measurement | | 4 | 125584117 | 125584118 | Human |
| 597299337 | GWAS1395411_H | lymphocyte count QTL GWAS1395411 (human) | | 6e-16 | lymphocyte count | | 4 | 112153589 | 112153590 | Human |
| 628577892 | GWAS2486121_H | glycerophospholipid measurement QTL GWAS2486121 (human) | | 8e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114534996 | 114534997 | Human |
| 628577891 | GWAS2486120_H | glycerophospholipid measurement QTL GWAS2486120 (human) | | 8e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114535080 | 114535081 | Human |
| 628577890 | GWAS2486119_H | glycerophospholipid measurement QTL GWAS2486119 (human) | | 8e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114534955 | 114534956 | Human |
| 597381262 | GWAS1477336_H | platelet count QTL GWAS1477336 (human) | | 8e-16 | platelet count | | 4 | 123749526 | 123749527 | Human |
| 597381261 | GWAS1477335_H | platelet count QTL GWAS1477335 (human) | | 2e-63 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110021121 | 110021122 | Human |
| 628577889 | GWAS2486118_H | glycerophospholipid measurement QTL GWAS2486118 (human) | | 8e-27 | blood phospholipid amount (VT:0006084) | | 4 | 114499194 | 114499195 | Human |
| 616994769 | GWAS2012268_H | BMI-adjusted waist-hip ratio QTL GWAS2012268 (human) | | 1e-13 | body size trait (VT:0100005) | | 4 | 124299553 | 124299554 | Human |
| 628577903 | GWAS2486132_H | glycerophospholipid measurement QTL GWAS2486132 (human) | | 2e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114560598 | 114560599 | Human |
| 628643424 | GWAS2551653_H | pain measurement QTL GWAS2551653 (human) | | 2e-08 | nociception system physiology trait (VT:0015100) | | 4 | 129322917 | 129322918 | Human |
| 628577902 | GWAS2486131_H | glycerophospholipid measurement QTL GWAS2486131 (human) | | 1e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114555226 | 114555227 | Human |
| 628577901 | GWAS2486130_H | glycerophospholipid measurement QTL GWAS2486130 (human) | | 1e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114579576 | 114579577 | Human |
| 628692579 | GWAS2600808_H | total blood protein measurement QTL GWAS2600808 (human) | | 8e-13 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 122243645 | 122243646 | Human |
| 597512327 | GWAS1608401_H | peptic ulcer disease QTL GWAS1608401 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616965 | 123616966 | Human |
| 628577900 | GWAS2486129_H | glycerophospholipid measurement QTL GWAS2486129 (human) | | 1e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114488186 | 114488187 | Human |
| 628692578 | GWAS2600807_H | total blood protein measurement QTL GWAS2600807 (human) | | 6e-20 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 119206905 | 119206906 | Human |
| 617060316 | GWAS2077815_H | S-7-hydroxywarfarin measurement QTL GWAS2077815 (human) | | 0.000009 | S-7-hydroxywarfarin measurement | | 4 | 121518134 | 121518135 | Human |
| 628577899 | GWAS2486128_H | glycerophospholipid measurement QTL GWAS2486128 (human) | | 1e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114556972 | 114556973 | Human |
| 628577898 | GWAS2486127_H | glycerophospholipid measurement QTL GWAS2486127 (human) | | 1e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114493973 | 114493974 | Human |
| 628463211 | GWAS2371440_H | familial sick sinus syndrome QTL GWAS2371440 (human) | | 2e-15 | sick sinus syndrome | | 4 | 110782354 | 110782355 | Human |
| 628577897 | GWAS2486126_H | glycerophospholipid measurement QTL GWAS2486126 (human) | | 1e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114598400 | 114598401 | Human |
| 628414058 | GWAS2322287_H | triglyceride measurement QTL GWAS2322287 (human) | | 2e-09 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 123822104 | 123822105 | Human |
| 628577896 | GWAS2486125_H | glycerophospholipid measurement QTL GWAS2486125 (human) | | 1e-26 | blood phospholipid amount (VT:0006084) | | 4 | 114531061 | 114531062 | Human |
| 616372130 | GWAS1852372_H | obsolete_blood protein measurement QTL GWAS1852372 (human) | | 4e-16 | obsolete_blood protein measurement | | 4 | 119210489 | 119210490 | Human |
| 406940513 | GWAS589489_H | annexin A5 measurement QTL GWAS589489 (human) | | 2e-11 | annexin A5 measurement | | 4 | 121698791 | 121698792 | Human |
| 406940512 | GWAS589488_H | annexin A5 measurement QTL GWAS589488 (human) | | 2e-57 | annexin A5 measurement | | 4 | 121695708 | 121695709 | Human |
| 616994789 | GWAS2012288_H | Cleft palate QTL GWAS2012288 (human) | | 0.000004 | Cleft palate | | 4 | 116802931 | 116802932 | Human |
| 597135537 | GWAS1231611_H | memory performance, sex interaction measurement QTL GWAS1231611 (human) | | 0.000004 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109129061 | 109129062 | Human |
| 597414076 | GWAS1510150_H | adolescent idiopathic scoliosis QTL GWAS1510150 (human) | | 0.0000005 | adolescent idiopathic scoliosis | | 4 | 119460368 | 119460369 | Human |
| 407300961 | GWAS949937_H | type 1 diabetes mellitus QTL GWAS949937 (human) | | 6e-13 | type 1 diabetes mellitus | | 4 | 122322441 | 122322442 | Human |
| 616552342 | GWAS1948925_H | forced expiratory volume QTL GWAS1948925 (human) | | 1e-12 | forced expiratory volume | | 4 | 123898452 | 123898453 | Human |
| 406924141 | GWAS573117_H | celiac disease QTL GWAS573117 (human) | | 2e-27 | intestine integrity trait (VT:0010554) | | 4 | 122194347 | 122194348 | Human |
| 597414071 | GWAS1510145_H | adolescent idiopathic scoliosis QTL GWAS1510145 (human) | | 0.0000001 | adolescent idiopathic scoliosis | | 4 | 123733416 | 123733417 | Human |
| 616355729 | GWAS1840444_H | gut microbiome measurement, breastfeeding duration QTL GWAS1840444 (human) | | 0.0000005 | gut microbiome measurement, breastfeeding duration | | 4 | 115471326 | 115471327 | Human |
| 616355730 | GWAS1840445_H | gut microbiome measurement, breastfeeding duration QTL GWAS1840445 (human) | | 8e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 115599484 | 115599485 | Human |
| 628364891 | GWAS2285735_H | Anxiety QTL GWAS2285735 (human) | | 7e-09 | Anxiety | | 4 | 118015036 | 118015037 | Human |
| 597135523 | GWAS1231597_H | diastolic blood pressure QTL GWAS1231597 (human) | | 3e-21 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 597266605 | GWAS1362679_H | fibroblast growth factor 2 measurement QTL GWAS1362679 (human) | | 9e-18 | fibroblast growth factor 2 measurement | | 4 | 122836593 | 122836594 | Human |
| 628676175 | GWAS2584404_H | color vision disorder QTL GWAS2584404 (human) | | 0.000002 | color vision disorder | | 4 | 107331993 | 107331994 | Human |
| 617191422 | GWAS2171862_H | cytokine receptor-like factor 1 measurement QTL GWAS2171862 (human) | | 7e-13 | cytokine receptor-like factor 1 measurement | | 4 | 109976379 | 109976380 | Human |
| 628905540 | GWAS2813769_H | QT interval QTL GWAS2813769 (human) | | 4e-08 | heart electrical impulse conduction trait (VT:2000017) | QT interval (CMO:0000235) | 4 | 113523545 | 113523546 | Human |
| 628676163 | GWAS2584392_H | color vision disorder QTL GWAS2584392 (human) | | 1e-10 | color vision disorder | | 4 | 109831805 | 109831806 | Human |
| 616962043 | GWAS1979542_H | body height QTL GWAS1979542 (human) | | 1e-14 | body height | | 4 | 108180849 | 108180850 | Human |
| 597069993 | GWAS1166067_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1166067 (human) | | 2e-11 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692515 | 122692516 | Human |
| 597217501 | GWAS1313575_H | bone density QTL GWAS1313575 (human) | | 4e-186 | bone density | | 4 | 107807550 | 107807551 | Human |
| 628479538 | GWAS2387767_H | late-onset Alzheimers disease QTL GWAS2387767 (human) | | 0.0000008 | brain integrity trait (VT:0010579) | | 4 | 109251730 | 109251731 | Human |
| 407120643 | GWAS769619_H | chronotype measurement QTL GWAS769619 (human) | | 4e-09 | chronotype measurement | | 4 | 117394404 | 117394405 | Human |
| 597250258 | GWAS1346332_H | apolipoprotein A 1 measurement QTL GWAS1346332 (human) | | 9e-13 | apolipoprotein A 1 measurement | | 4 | 109717608 | 109717609 | Human |
| 597217493 | GWAS1313567_H | bone density QTL GWAS1313567 (human) | | 1e-194 | bone density | | 4 | 107799654 | 107799655 | Human |
| 597168341 | GWAS1264415_H | alkaline phosphatase measurement QTL GWAS1264415 (human) | | 8e-16 | alkaline phosphatase measurement | | 4 | 110190912 | 110190913 | Human |
| 597168342 | GWAS1264416_H | alkaline phosphatase measurement QTL GWAS1264416 (human) | | 4e-19 | alkaline phosphatase measurement | | 4 | 128065247 | 128065248 | Human |
| 626169346 | GWAS2253782_H | HOMA-IR QTL GWAS2253782 (human) | | 0.000008 | HOMA-IR | Homeostatic Model Assessment of Insulin Resistance (CMO:0003002) | 4 | 109970387 | 109970388 | Human |
| 616519660 | GWAS1916243_H | platelet count QTL GWAS1916243 (human) | | 3e-14 | platelet count | | 4 | 123837618 | 123837619 | Human |
| 628364844 | GWAS2285688_H | platelet-derived growth factor complex BB dimer (human) level QTL GWAS2285688 (human) | | 0.000009 | platelet-derived growth factor complex BB dimer (human) level | | 4 | 116687083 | 116687084 | Human |
| 616372197 | GWAS1852439_H | cerebral cortex area attribute QTL GWAS1852439 (human) | | 4e-08 | cerebral cortex area attribute | | 4 | 118351658 | 118351659 | Human |
| 406907672 | GWAS556648_H | Crohn's disease QTL GWAS556648 (human) | | 6e-09 | Crohn's disease | | 4 | 122420959 | 122420960 | Human |
| 597151950 | GWAS1248024_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1248024 (human) | | 2e-08 | apolipoprotein A 1 measurement | | 4 | 109657070 | 109657071 | Human |
| 616372192 | GWAS1852434_H | cerebral cortex area attribute QTL GWAS1852434 (human) | | 4e-11 | cerebral cortex area attribute | | 4 | 128406387 | 128406388 | Human |
| 406956832 | GWAS605808_H | HbA1c measurement QTL GWAS605808 (human) | | 1e-09 | HbA1c measurement | | 4 | 110020646 | 110020647 | Human |
| 597283071 | GWAS1379145_H | glycine measurement QTL GWAS1379145 (human) | | 4e-11 | glycine measurement | | 4 | 110510288 | 110510289 | Human |
| 407382816 | GWAS1031792_H | mean platelet volume QTL GWAS1031792 (human) | | 4e-13 | mean platelet volume | | 4 | 122061968 | 122061969 | Human |
| 407333678 | GWAS982654_H | free cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS982654 (human) | | 7e-09 | free cholesterol measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597528813 | GWAS1624887_H | opioid use disorder QTL GWAS1624887 (human) | | 1e-11 | opioid use disorder | | 4 | 111546456 | 111546457 | Human |
| 626169379 | GWAS2253815_H | atrial fibrillation QTL GWAS2253815 (human) | | 1e-31 | atrial fibrillation | | 4 | 112093836 | 112093837 | Human |
| 597070055 | GWAS1166129_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1166129 (human) | | 1e-08 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122690387 | 122690388 | Human |
| 407333684 | GWAS982660_H | IGF-1 measurement QTL GWAS982660 (human) | | 2e-09 | IGF-1 measurement | | 4 | 127882004 | 127882005 | Human |
| 626169382 | GWAS2253818_H | atrial fibrillation QTL GWAS2253818 (human) | | 2e-10 | atrial fibrillation | | 4 | 121839813 | 121839814 | Human |
| 626169383 | GWAS2253819_H | atrial fibrillation QTL GWAS2253819 (human) | | 1e-10 | atrial fibrillation | | 4 | 122917603 | 122917604 | Human |
| 626169380 | GWAS2253816_H | atrial fibrillation QTL GWAS2253816 (human) | | 4e-34 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 626169381 | GWAS2253817_H | atrial fibrillation QTL GWAS2253817 (human) | | 3e-08 | atrial fibrillation | | 4 | 115260980 | 115260981 | Human |
| 616552392 | GWAS1948975_H | annexin A5 measurement QTL GWAS1948975 (human) | | 9e-51 | annexin A5 measurement | | 4 | 121659570 | 121659571 | Human |
| 616552391 | GWAS1948974_H | annexin A5 measurement QTL GWAS1948974 (human) | | 5e-36 | annexin A5 measurement | | 4 | 121673919 | 121673920 | Human |
| 628430349 | GWAS2338578_H | adolescent idiopathic scoliosis QTL GWAS2338578 (human) | | 0.000001 | adolescent idiopathic scoliosis | | 4 | 130877448 | 130877449 | Human |
| 626169384 | GWAS2253820_H | atrial fibrillation QTL GWAS2253820 (human) | | 4e-10 | atrial fibrillation | | 4 | 128545263 | 128545264 | Human |
| 626169385 | GWAS2253821_H | atrial fibrillation QTL GWAS2253821 (human) | | 4e-08 | atrial fibrillation | | 4 | 129810129 | 129810130 | Human |
| 407087935 | GWAS736911_H | atrial fibrillation QTL GWAS736911 (human) | | 6e-113 | atrial fibrillation | | 4 | 110840331 | 110840332 | Human |
| 628430345 | GWAS2338574_H | adolescent idiopathic scoliosis QTL GWAS2338574 (human) | | 0.0000005 | adolescent idiopathic scoliosis | | 4 | 119460368 | 119460369 | Human |
| 597397531 | GWAS1493605_H | creatinine measurement QTL GWAS1493605 (human) | | 1e-13 | creatinine measurement | | 4 | 127243324 | 127243325 | Human |
| 617273166 | GWAS2209942_H | fatty acid amount QTL GWAS2209942 (human) | | 6e-09 | fatty acid amount | | 4 | 109657070 | 109657071 | Human |
| 406956996 | GWAS605972_H | resistin measurement QTL GWAS605972 (human) | | 6e-18 | resistin measurement | | 4 | 115275150 | 115275151 | Human |
| 597118993 | GWAS1215067_H | bipolar disorder, inflammatory bowel disease QTL GWAS1215067 (human) | | 8e-14 | bipolar disorder, inflammatory bowel disease | | 4 | 122154852 | 122154853 | Human |
| 406907847 | GWAS556823_H | mosquito bite reaction size measurement QTL GWAS556823 (human) | | 4e-08 | mosquito bite reaction size measurement | | 4 | 122852424 | 122852425 | Human |
| 628905718 | GWAS2813947_H | cardiac arrhythmia QTL GWAS2813947 (human) | | 1e-26 | heart integrity trait (VT:0010757) | | 4 | 110739038 | 110739039 | Human |
| 407153614 | GWAS802590_H | Alzheimer disease, APOE carrier status QTL GWAS802590 (human) | | 0.000006 | Alzheimer disease, APOE carrier status | | 4 | 129588615 | 129588616 | Human |
| 617043788 | GWAS2061287_H | trait in response to carbamazepine QTL GWAS2061287 (human) | | 0.0000009 | trait in response to carbamazepine | | 4 | 127124380 | 127124381 | Human |
| 407366603 | GWAS1015579_H | monoclonal gammopathy QTL GWAS1015579 (human) | | 0.000005 | monoclonal gammopathy | | 4 | 107881225 | 107881226 | Human |
| 597151746 | GWAS1247820_H | cholesteryl ester measurement, high density lipoprotein cholesterol measurement QTL GWAS1247820 (human) | | 8e-12 | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597135374 | GWAS1231448_H | memory performance QTL GWAS1231448 (human) | | 0.000009 | learning/memory/conditioning trait (VT:0002063) | | 4 | 131259522 | 131259523 | Human |
| 406957023 | GWAS605999_H | facial morphology measurement QTL GWAS605999 (human) | | 2e-09 | facial morphology measurement | | 4 | 127005360 | 127005361 | Human |
| 628643559 | GWAS2551788_H | gut microbiome measurement, breastfeeding duration QTL GWAS2551788 (human) | | 7e-09 | lactation duration (VT:1000653) | | 4 | 112425037 | 112425038 | Human |
| 407104487 | GWAS753463_H | self reported educational attainment QTL GWAS753463 (human) | | 1e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
| 598085634 | GWAS1804933_H | brain attribute QTL GWAS1804933 (human) | | 8e-13 | brain attribute | | 4 | 123179401 | 123179402 | Human |
| 597217343 | GWAS1313417_H | adult onset asthma QTL GWAS1313417 (human) | | 8e-10 | adult onset asthma | | 4 | 122438414 | 122438415 | Human |
| 407104491 | GWAS753467_H | self reported educational attainment QTL GWAS753467 (human) | | 1e-08 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 407383009 | GWAS1031985_H | depressive symptom measurement QTL GWAS1031985 (human) | | 2e-09 | depressive symptom measurement | | 4 | 122467738 | 122467739 | Human |
| 616552214 | GWAS1948797_H | total blood protein measurement QTL GWAS1948797 (human) | | 4e-14 | total blood protein measurement | | 4 | 122625127 | 122625128 | Human |
| 407104490 | GWAS753466_H | self reported educational attainment QTL GWAS753466 (human) | | 1e-08 | self reported educational attainment | | 4 | 128884001 | 128884002 | Human |
| 407104488 | GWAS753464_H | self reported educational attainment QTL GWAS753464 (human) | | 1e-08 | self reported educational attainment | | 4 | 118084947 | 118084948 | Human |
| 626169599 | GWAS2254035_H | atrial fibrillation QTL GWAS2254035 (human) | | 2e-31 | atrial fibrillation | | 4 | 112000965 | 112000966 | Human |
| 617092965 | GWAS2110464_H | body height QTL GWAS2110464 (human) | | 8e-09 | body height | | 4 | 119834940 | 119834941 | Human |
| 407104492 | GWAS753468_H | self reported educational attainment QTL GWAS753468 (human) | | 4e-08 | self reported educational attainment | | 4 | 130401277 | 130401278 | Human |
| 597053478 | GWAS1149552_H | asthma QTL GWAS1149552 (human) | | 3e-19 | asthma | | 4 | 122120316 | 122120317 | Human |
| 628692680 | GWAS2600909_H | Crohn's disease QTL GWAS2600909 (human) | | 2e-16 | intestine integrity trait (VT:0010554) | | 4 | 122523884 | 122523885 | Human |
| 617142138 | GWAS2159637_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2159637 (human) | | 3e-13 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 115961513 | 115961514 | Human |
| 628790984 | GWAS2699213_H | protein measurement QTL GWAS2699213 (human) | | 2e-183 | protein amount (VT:0010120) | | 4 | 119360222 | 119360223 | Human |
| 616371977 | GWAS1852219_H | cortical thickness QTL GWAS1852219 (human) | | 6e-12 | cortical thickness | | 4 | 120793484 | 120793485 | Human |
| 597413935 | GWAS1510009_H | Hallux valgus QTL GWAS1510009 (human) | | 0.000003 | Hallux valgus | | 4 | 126494361 | 126494362 | Human |
| 597413933 | GWAS1510007_H | Hallux valgus QTL GWAS1510007 (human) | | 0.000001 | Hallux valgus | | 4 | 125790890 | 125790891 | Human |
| 628512449 | GWAS2420678_H | interleukin 10 measurement QTL GWAS2420678 (human) | | 2e-08 | blood interleukin-10 amount (VT:0008590) | | 4 | 106774728 | 106774729 | Human |
| 628905675 | GWAS2813904_H | atrial flutter, atrial fibrillation QTL GWAS2813904 (human) | | 2e-75 | atrial flutter, atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407235570 | GWAS884546_H | coronary artery disease QTL GWAS884546 (human) | | 0.0000009 | coronary artery disease | | 4 | 124978810 | 124978811 | Human |
| 407153660 | GWAS802636_H | gut microbiome measurement QTL GWAS802636 (human) | | 0.000007 | gut microbiome measurement | | 4 | 108743511 | 108743512 | Human |
| 628823746 | GWAS2731975_H | glomerular filtration rate QTL GWAS2731975 (human) | | 5e-09 | glomerular filtration rate | | 4 | 125483011 | 125483012 | Human |
| 597332005 | GWAS1428079_H | S-7-hydroxywarfarin to S-warfarin ratio measurement QTL GWAS1428079 (human) | | 0.000009 | S-7-hydroxywarfarin to S-warfarin ratio measurement | | 4 | 126276324 | 126276325 | Human |
| 628479671 | GWAS2387900_H | coronary artery disease QTL GWAS2387900 (human) | | 0.0000009 | coronary artery integrity trait (VT:0010746) | | 4 | 124978810 | 124978811 | Human |
| 597512286 | GWAS1608360_H | vital capacity QTL GWAS1608360 (human) | | 2e-09 | vital capacity | | 4 | 108545191 | 108545192 | Human |
| 626464404 | GWAS2278337_H | body mass index QTL GWAS2278337 (human) | | 5e-08 | body mass index | | 4 | 128248889 | 128248890 | Human |
| 407382924 | GWAS1031900_H | blood protein measurement QTL GWAS1031900 (human) | | 3e-289 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 597463124 | GWAS1559198_H | diastolic blood pressure QTL GWAS1559198 (human) | | 2e-21 | diastolic blood pressure | | 4 | 110414448 | 110414449 | Human |
| 597463125 | GWAS1559199_H | diastolic blood pressure QTL GWAS1559199 (human) | | 1e-08 | diastolic blood pressure | | 4 | 119037654 | 119037655 | Human |
| 628922031 | GWAS2830260_H | body weight QTL GWAS2830260 (human) | | 3e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 112524760 | 112524761 | Human |
| 407038870 | GWAS687846_H | self reported educational attainment QTL GWAS687846 (human) | | 0.000007 | self reported educational attainment | | 4 | 119344104 | 119344105 | Human |
| 616978206 | GWAS1995705_H | body mass index QTL GWAS1995705 (human) | | 0.0000003 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129895905 | 129895906 | Human |
| 597315652 | GWAS1411726_H | body mass index QTL GWAS1411726 (human) | | 2e-09 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 407088036 | GWAS737012_H | corneal topography QTL GWAS737012 (human) | | 0.0000003 | corneal topography | | 4 | 127192269 | 127192270 | Human |
| 628922005 | GWAS2830234_H | systolic blood pressure QTL GWAS2830234 (human) | | 1e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110467945 | 110467946 | Human |
| 626464446 | GWAS2278379_H | body height QTL GWAS2278379 (human) | | 3e-09 | body height | | 4 | 128700992 | 128700993 | Human |
| 628528796 | GWAS2437025_H | mean corpuscular hemoglobin QTL GWAS2437025 (human) | | 5e-51 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121875762 | 121875763 | Human |
| 628528797 | GWAS2437026_H | mean corpuscular hemoglobin QTL GWAS2437026 (human) | | 3e-17 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 127625245 | 127625246 | Human |
| 616961837 | GWAS1979336_H | reticulocyte count QTL GWAS1979336 (human) | | 1e-09 | reticulocyte count | | 4 | 128330896 | 128330897 | Human |
| 407219115 | GWAS868091_H | thyroid carcinoma QTL GWAS868091 (human) | | 0.0000006 | thyroid carcinoma | | 4 | 112649292 | 112649293 | Human |
| 616552272 | GWAS1948855_H | body height QTL GWAS1948855 (human) | | 2e-37 | body height | | 4 | 121801213 | 121801214 | Human |
| 628725387 | GWAS2633616_H | level of beta-glucuronidase in blood QTL GWAS2633616 (human) | | 5e-46 | level of beta-glucuronidase in blood | | 4 | 118842717 | 118842718 | Human |
| 617076530 | GWAS2094029_H | chromosome, telomeric region length QTL GWAS2094029 (human) | | 0.000009 | chromosome, telomeric region length | | 4 | 110290116 | 110290117 | Human |
| 407301040 | GWAS950016_H | alpha synuclein measurement QTL GWAS950016 (human) | | 0.000005 | alpha synuclein measurement | | 4 | 119884972 | 119884973 | Human |
| 597299309 | GWAS1395383_H | body height QTL GWAS1395383 (human) | | 3e-19 | body height | | 4 | 108508323 | 108508324 | Human |
| 628627072 | GWAS2535301_H | systolic blood pressure QTL GWAS2535301 (human) | | 2e-16 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110416708 | 110416709 | Human |
| 628627073 | GWAS2535302_H | systolic blood pressure QTL GWAS2535302 (human) | | 7e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 119996191 | 119996192 | Human |
| 626448045 | GWAS2261978_H | cesarean section, obsolete_anxiety QTL GWAS2261978 (human) | | 1e-09 | cesarean section, obsolete_anxiety | | 4 | 106962429 | 106962430 | Human |
| 597610597 | GWAS1667457_H | monocyte count QTL GWAS1667457 (human) | | 1e-14 | monocyte count | | 4 | 109966833 | 109966834 | Human |
| 407186501 | GWAS835477_H | platelet count QTL GWAS835477 (human) | | 1e-43 | platelet count | | 4 | 110020646 | 110020647 | Human |
| 407415880 | GWAS1064856_H | 3-methyl-2-oxobutyrate measurement QTL GWAS1064856 (human) | | 0.000009 | 3-methyl-2-oxobutyrate measurement | | 4 | 124716785 | 124716786 | Human |
| 617091272 | GWAS2108771_H | glomerular filtration rate QTL GWAS2108771 (human) | | 5e-13 | glomerular filtration rate | | 4 | 128601363 | 128601364 | Human |
| 626463063 | GWAS2276996_H | body mass index QTL GWAS2276996 (human) | | 2e-16 | body mass index | | 4 | 129838492 | 129838493 | Human |
| 597481373 | GWAS1577447_H | brain measurement QTL GWAS1577447 (human) | | 1e-10 | brain measurement | | 4 | 124548568 | 124548569 | Human |
| 617205965 | GWAS2186405_H | body mass index QTL GWAS2186405 (human) | | 8e-12 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 616960206 | GWAS1977705_H | heel bone mineral density QTL GWAS1977705 (human) | | 2e-15 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 126527797 | 126527798 | Human |
| 616960205 | GWAS1977704_H | heel bone mineral density QTL GWAS1977704 (human) | | 3e-11 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 124600184 | 124600185 | Human |
| 598054825 | GWAS1774124_H | erythrocyte volume QTL GWAS1774124 (human) | | 8e-30 | erythrocyte volume | | 4 | 121854912 | 121854913 | Human |
| 597497744 | GWAS1593818_H | diastolic blood pressure QTL GWAS1593818 (human) | | 7e-13 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 110414566 | 110414567 | Human |
| 616960203 | GWAS1977702_H | heel bone mineral density QTL GWAS1977702 (human) | | 4e-11 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 123613837 | 123613838 | Human |
| 406907982 | GWAS556958_H | body height QTL GWAS556958 (human) | | 4e-19 | body height | | 4 | 119834940 | 119834941 | Human |
| 407235669 | GWAS884645_H | bone density QTL GWAS884645 (human) | | 6e-24 | bone density | | 4 | 107818840 | 107818841 | Human |
| 628494690 | GWAS2402919_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS2402919 (human) | | 2e-12 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110485340 | 110485341 | Human |
| 597137283 | GWAS1233357_H | glycolithocholate sulfate measurement QTL GWAS1233357 (human) | | 0.0000001 | glycolithocholate sulfate measurement | | 4 | 124486812 | 124486813 | Human |
| 616353961 | GWAS1838676_H | gut microbiome measurement, breastfeeding duration QTL GWAS1838676 (human) | | 1e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 115599484 | 115599485 | Human |
| 598054835 | GWAS1774134_H | erythrocyte volume QTL GWAS1774134 (human) | | 2e-33 | erythrocyte volume | | 4 | 121854912 | 121854913 | Human |
| 628707681 | GWAS2615910_H | fibroblast growth factor 2 level QTL GWAS2615910 (human) | | 2e-55 | fibroblast growth factor 2 level | | 4 | 121996120 | 121996121 | Human |
| 597514117 | GWAS1610191_H | systemic lupus erythematosus QTL GWAS1610191 (human) | | 2e-08 | systemic lupus erythematosus | | 4 | 122631659 | 122631660 | Human |
| 628707680 | GWAS2615909_H | fibroblast growth factor 2 level QTL GWAS2615909 (human) | | 2e-22 | fibroblast growth factor 2 level | | 4 | 122685018 | 122685019 | Human |
| 406940763 | GWAS589739_H | smoking initiation QTL GWAS589739 (human) | | 2e-16 | smoking initiation | | 4 | 115060393 | 115060394 | Human |
| 406940765 | GWAS589741_H | smoking initiation QTL GWAS589741 (human) | | 3e-14 | smoking initiation | | 4 | 115629116 | 115629117 | Human |
| 617058523 | GWAS2076022_H | alcohol consumption quality QTL GWAS2076022 (human) | | 2e-11 | alcohol consumption quality | | 4 | 129324733 | 129324734 | Human |
| 406940764 | GWAS589740_H | smoking initiation QTL GWAS589740 (human) | | 2e-16 | smoking initiation | | 4 | 115062097 | 115062098 | Human |
| 617058522 | GWAS2076021_H | alcohol consumption quality QTL GWAS2076021 (human) | | 4e-09 | alcohol consumption quality | | 4 | 117942113 | 117942114 | Human |
| 617058521 | GWAS2076020_H | alcohol consumption quality QTL GWAS2076020 (human) | | 7e-12 | alcohol consumption quality | | 4 | 112674713 | 112674714 | Human |
| 406940767 | GWAS589743_H | smoking initiation QTL GWAS589743 (human) | | 6e-10 | smoking initiation | | 4 | 117807381 | 117807382 | Human |
| 406940766 | GWAS589742_H | smoking initiation QTL GWAS589742 (human) | | 3e-09 | smoking initiation | | 4 | 117028412 | 117028413 | Human |
| 597202872 | GWAS1298946_H | alpha fetoprotein measurement QTL GWAS1298946 (human) | | 1e-10 | alpha fetoprotein measurement | | 4 | 108743359 | 108743360 | Human |
| 597383099 | GWAS1479173_H | monocyte count QTL GWAS1479173 (human) | | 3e-09 | monocyte count | | 4 | 119447401 | 119447402 | Human |
| 406940769 | GWAS589745_H | smoking initiation QTL GWAS589745 (human) | | 3e-16 | smoking initiation | | 4 | 120722571 | 120722572 | Human |
| 628707673 | GWAS2615902_H | fibroblast growth factor 2 level QTL GWAS2615902 (human) | | 6e-18 | fibroblast growth factor 2 level | | 4 | 122786283 | 122786284 | Human |
| 406940768 | GWAS589744_H | smoking initiation QTL GWAS589744 (human) | | 2e-13 | smoking initiation | | 4 | 120650494 | 120650495 | Human |
| 628707672 | GWAS2615901_H | fibroblast growth factor 2 level QTL GWAS2615901 (human) | | 5e-15 | fibroblast growth factor 2 level | | 4 | 122496141 | 122496142 | Human |
| 628707675 | GWAS2615904_H | fibroblast growth factor 2 level QTL GWAS2615904 (human) | | 3e-18 | fibroblast growth factor 2 level | | 4 | 122718148 | 122718149 | Human |
| 406940771 | GWAS589747_H | smoking initiation QTL GWAS589747 (human) | | 3e-09 | smoking initiation | | 4 | 126727157 | 126727158 | Human |
| 406940770 | GWAS589746_H | smoking initiation QTL GWAS589746 (human) | | 5e-11 | smoking initiation | | 4 | 122105714 | 122105715 | Human |
| 628707674 | GWAS2615903_H | fibroblast growth factor 2 level QTL GWAS2615903 (human) | | 3e-13 | fibroblast growth factor 2 level | | 4 | 122807648 | 122807649 | Human |
| 628707677 | GWAS2615906_H | fibroblast growth factor 2 level QTL GWAS2615906 (human) | | 6e-22 | fibroblast growth factor 2 level | | 4 | 122785605 | 122785606 | Human |
| 406940773 | GWAS589749_H | smoking initiation QTL GWAS589749 (human) | | 4e-11 | smoking initiation | | 4 | 129534689 | 129534690 | Human |
| 628707676 | GWAS2615905_H | fibroblast growth factor 2 level QTL GWAS2615905 (human) | | 4e-13 | fibroblast growth factor 2 level | | 4 | 122652747 | 122652748 | Human |
| 406940772 | GWAS589748_H | smoking initiation QTL GWAS589748 (human) | | 8e-15 | smoking initiation | | 4 | 129269203 | 129269204 | Human |
| 628707679 | GWAS2615908_H | fibroblast growth factor 2 level QTL GWAS2615908 (human) | | 1e-35 | fibroblast growth factor 2 level | | 4 | 122495046 | 122495047 | Human |
| 628707678 | GWAS2615907_H | fibroblast growth factor 2 level QTL GWAS2615907 (human) | | 4e-17 | fibroblast growth factor 2 level | | 4 | 122769150 | 122769151 | Human |
| 628724049 | GWAS2632278_H | level of hydroxyacyl-coenzyme A dehydrogenase, mitochondrial in blood QTL GWAS2632278 (human) | | 5e-18 | level of hydroxyacyl-coenzyme A dehydrogenase, mitochondrial in blood | | 4 | 107991560 | 107991561 | Human |
| 628707667 | GWAS2615896_H | fibroblast growth factor 2 level QTL GWAS2615896 (human) | | 2e-12 | fibroblast growth factor 2 level | | 4 | 121789225 | 121789226 | Human |
| 628822352 | GWAS2730581_H | cardiac troponin T measurement QTL GWAS2730581 (human) | | 0.0000008 | heart molecular composition trait (VT:0010755) | blood troponin T level (CMO:0001284) | 4 | 118958433 | 118958434 | Human |
| 628707666 | GWAS2615895_H | fibroblast growth factor 2 level QTL GWAS2615895 (human) | | 4e-40 | fibroblast growth factor 2 level | | 4 | 122826155 | 122826156 | Human |
| 617107683 | GWAS2125182_H | threonate measurement QTL GWAS2125182 (human) | | 0.000006 | threonate measurement | | 4 | 123844287 | 123844288 | Human |
| 628707669 | GWAS2615898_H | fibroblast growth factor 2 level QTL GWAS2615898 (human) | | 9e-165 | fibroblast growth factor 2 level | | 4 | 122842746 | 122842747 | Human |
| 407235689 | GWAS884665_H | bone density QTL GWAS884665 (human) | | 6e-24 | bone density | | 4 | 129519676 | 129519677 | Human |
| 628707670 | GWAS2615899_H | fibroblast growth factor 2 level QTL GWAS2615899 (human) | | 5e-157 | fibroblast growth factor 2 level | | 4 | 122859108 | 122859109 | Human |
| 406891632 | GWAS540608_H | pursuit maintenance gain measurement QTL GWAS540608 (human) | | 0.000003 | pursuit maintenance gain measurement | | 4 | 110340886 | 110340887 | Human |
| 628576583 | GWAS2484812_H | electrocardiography QTL GWAS2484812 (human) | | 4e-11 | electrocardiography | | 4 | 113463172 | 113463173 | Human |
| 628461893 | GWAS2370122_H | mathematical ability QTL GWAS2370122 (human) | | 5e-10 | cognitive behavior trait (VT:0010450) | | 4 | 122105714 | 122105715 | Human |
| 628461892 | GWAS2370121_H | mathematical ability QTL GWAS2370121 (human) | | 4e-10 | cognitive behavior trait (VT:0010450) | | 4 | 115118452 | 115118453 | Human |
| 628461894 | GWAS2370123_H | mathematical ability QTL GWAS2370123 (human) | | 5e-08 | cognitive behavior trait (VT:0010450) | | 4 | 130364875 | 130364876 | Human |
| 628724032 | GWAS2632261_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2632261 (human) | | 3e-12 | glioma pathogenesis-related protein 1 measurement | | 4 | 116507955 | 116507956 | Human |
| 626463084 | GWAS2277017_H | body height QTL GWAS2277017 (human) | | 4e-12 | body height | | 4 | 125766158 | 125766159 | Human |
| 597153707 | GWAS1249781_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1249781 (human) | | 1e-11 | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597432224 | GWAS1528298_H | sex hormone-binding globulin measurement QTL GWAS1528298 (human) | | 3e-17 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 616993017 | GWAS2010516_H | waist-hip ratio QTL GWAS2010516 (human) | | 5e-08 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 121702910 | 121702911 | Human |
| 628576565 | GWAS2484794_H | sex hormone-binding globulin measurement QTL GWAS2484794 (human) | | 3e-16 | sex hormone-binding globulin measurement | | 4 | 109717608 | 109717609 | Human |
| 598071265 | GWAS1790564_H | alcohol consumption quality QTL GWAS1790564 (human) | | 0.000006 | alcohol consumption quality | | 4 | 131688192 | 131688193 | Human |
| 628740401 | GWAS2648630_H | high density lipoprotein cholesterol measurement QTL GWAS2648630 (human) | | 3e-09 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717608 | 109717609 | Human |
| 628986164 | GWAS2894393_H | high density lipoprotein cholesterol measurement QTL GWAS2894393 (human) | | 4e-30 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 628658482 | GWAS2566711_H | FEV/FVC ratio QTL GWAS2566711 (human) | | 3e-18 | lung capacity (VT:0001942) | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 123898452 | 123898453 | Human |
| 407006223 | GWAS655199_H | atrial fibrillation QTL GWAS655199 (human) | | 2e-13 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 597055449 | GWAS1151523_H | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation QTL GWAS1151523 (human) | | 0.000001 | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | | 4 | 128638644 | 128638645 | Human |
| 597481420 | GWAS1577494_H | level of glutamyl aminopeptidase in blood serum QTL GWAS1577494 (human) | | 3e-16 | level of glutamyl aminopeptidase in blood serum | | 4 | 110520270 | 110520271 | Human |
| 596973509 | GWAS1093028_H | major depressive disorder QTL GWAS1093028 (human) | | 1e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
| 597579724 | GWAS1636584_H | high density lipoprotein cholesterol measurement QTL GWAS1636584 (human) | | 9e-18 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 626462979 | GWAS2276912_H | systolic blood pressure QTL GWAS2276912 (human) | | 2e-09 | systolic blood pressure | | 4 | 127144496 | 127144497 | Human |
| 406940692 | GWAS589668_H | smoking initiation QTL GWAS589668 (human) | | 6e-24 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
| 406940695 | GWAS589671_H | smoking initiation QTL GWAS589671 (human) | | 2e-16 | smoking initiation | | 4 | 115058312 | 115058313 | Human |
| 596973507 | GWAS1093026_H | major depressive disorder QTL GWAS1093026 (human) | | 3e-08 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
| 406940694 | GWAS589670_H | smoking initiation QTL GWAS589670 (human) | | 4e-09 | smoking initiation | | 4 | 114063555 | 114063556 | Human |
| 597170113 | GWAS1266187_H | smoking initiation QTL GWAS1266187 (human) | | 2e-11 | smoking initiation | | 4 | 130541408 | 130541409 | Human |
| 616960156 | GWAS1977655_H | platelet crit QTL GWAS1977655 (human) | | 1e-13 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 123749526 | 123749527 | Human |
| 597170114 | GWAS1266188_H | smoking initiation QTL GWAS1266188 (human) | | 1e-11 | smoking initiation | | 4 | 130542181 | 130542182 | Human |
| 407415827 | GWAS1064803_H | blood protein measurement QTL GWAS1064803 (human) | | 8e-54 | blood protein measurement | | 4 | 109737911 | 109737912 | Human |
| 597170115 | GWAS1266189_H | smoking initiation QTL GWAS1266189 (human) | | 8e-12 | smoking initiation | | 4 | 131635724 | 131635725 | Human |
| 597465025 | GWAS1561099_H | mean arterial pressure QTL GWAS1561099 (human) | | 0.000002 | mean arterial pressure | | 4 | 110460482 | 110460483 | Human |
| 616960155 | GWAS1977654_H | platelet crit QTL GWAS1977654 (human) | | 9e-20 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 119336584 | 119336585 | Human |
| 597088203 | GWAS1184277_H | type 2 diabetes mellitus QTL GWAS1184277 (human) | | 3e-08 | type 2 diabetes mellitus | | 4 | 128258303 | 128258304 | Human |
| 616386781 | GWAS1867023_H | HbA1c measurement QTL GWAS1867023 (human) | | 2e-23 | HbA1c measurement | | 4 | 110035176 | 110035177 | Human |
| 628527382 | GWAS2435611_H | gut microbiome measurement, bone tissue density QTL GWAS2435611 (human) | | 2e-08 | gut microbiome measurement, bone tissue density | | 4 | 116034483 | 116034484 | Human |
| 617025703 | GWAS2043202_H | eye colour measurement QTL GWAS2043202 (human) | | 0.000007 | eye colour measurement | | 4 | 121396276 | 121396277 | Human |
| 597334008 | GWAS1430082_H | smoking cessation QTL GWAS1430082 (human) | | 3e-12 | smoking cessation | | 4 | 112123310 | 112123311 | Human |
| 628838681 | GWAS2746910_H | amino acid measurement QTL GWAS2746910 (human) | | 0.000009 | blood amino acid amount (VT:0005311) | | 4 | 118154781 | 118154782 | Human |
| 628527381 | GWAS2435610_H | gut microbiome measurement, bone tissue density QTL GWAS2435610 (human) | | 2e-08 | gut microbiome measurement, bone tissue density | | 4 | 116019324 | 116019325 | Human |
| 628805913 | GWAS2714142_H | body height QTL GWAS2714142 (human) | | 4e-08 | body height | | 4 | 122841742 | 122841743 | Human |
| 407022628 | GWAS671604_H | serum IgG glycosylation measurement QTL GWAS671604 (human) | | 0.000006 | serum IgG glycosylation measurement | | 4 | 110306660 | 110306661 | Human |
| 628953370 | GWAS2861599_H | serum creatinine amount QTL GWAS2861599 (human) | | 4e-12 | serum creatinine amount | | 4 | 123424648 | 123424649 | Human |
| 598087631 | GWAS1806930_H | bone density QTL GWAS1806930 (human) | | 4e-08 | bone density | | 4 | 131155333 | 131155334 | Human |
| 628494618 | GWAS2402847_H | Inhalant adrenergic use measurement QTL GWAS2402847 (human) | | 2e-14 | Inhalant adrenergic use measurement | | 4 | 122446734 | 122446735 | Human |
| 616354000 | GWAS1838715_H | gut microbiome measurement, breastfeeding duration QTL GWAS1838715 (human) | | 0.0000005 | gut microbiome measurement, breastfeeding duration | | 4 | 122820505 | 122820506 | Human |
| 597448691 | GWAS1544765_H | total cholesterol measurement, diet measurement QTL GWAS1544765 (human) | | 0.000004 | total cholesterol measurement, diet measurement | | 4 | 118492283 | 118492284 | Human |
| 628363524 | GWAS2284368_H | beta-nerve growth factor level QTL GWAS2284368 (human) | | 0.000008 | beta-nerve growth factor level | | 4 | 123921959 | 123921960 | Human |
| 597039076 | GWAS1135150_H | apolipoprotein A 1 measurement QTL GWAS1135150 (human) | | 2e-08 | apolipoprotein A 1 measurement | | 4 | 108637907 | 108637908 | Human |
| 617140410 | GWAS2157909_H | level of hypoxia up-regulated protein 1 in blood serum QTL GWAS2157909 (human) | | 1e-11 | level of hypoxia up-regulated protein 1 in blood serum | | 4 | 110420710 | 110420711 | Human |
| 407284787 | GWAS933763_H | atrial fibrillation QTL GWAS933763 (human) | | 1e-09 | atrial fibrillation | | 4 | 110743002 | 110743003 | Human |
| 628445440 | GWAS2353669_H | asthma, Eczematoid dermatitis, allergic rhinitis QTL GWAS2353669 (human) | | 1e-29 | asthma, Eczematoid dermatitis, allergic rhinitis | | 4 | 122465565 | 122465566 | Human |
| 407202877 | GWAS851853_H | endothelial growth factor measurement QTL GWAS851853 (human) | | 3e-105 | endothelial growth factor measurement | | 4 | 109924607 | 109924608 | Human |
| 628674820 | GWAS2583049_H | oligodendroglioma QTL GWAS2583049 (human) | | 0.000004 | oligodendroglioma | | 4 | 116139159 | 116139160 | Human |
| 407071806 | GWAS720782_H | balding measurement QTL GWAS720782 (human) | | 2e-18 | balding measurement | | 4 | 106652584 | 106652585 | Human |
| 597366757 | GWAS1462831_H | cognitive function measurement QTL GWAS1462831 (human) | | 0.000006 | cognitive function measurement | | 4 | 126558097 | 126558098 | Human |
| 406973635 | GWAS622611_H | epidermal growth factor measurement QTL GWAS622611 (human) | | 3e-14 | epidermal growth factor measurement | | 4 | 109933388 | 109933389 | Human |
| 597382943 | GWAS1479017_H | cardiovascular disease QTL GWAS1479017 (human) | | 7e-13 | cardiovascular disease | | 4 | 110467945 | 110467946 | Human |
| 407006410 | GWAS655386_H | FEV/FVC ratio QTL GWAS655386 (human) | | 3e-18 | FEV/FVC ratio | | 4 | 123898452 | 123898453 | Human |
| 407121102 | GWAS770078_H | hair colour measurement QTL GWAS770078 (human) | | 5e-12 | hair colour measurement | | 4 | 108003401 | 108003402 | Human |
| 407416002 | GWAS1064978_H | pulse pressure measurement QTL GWAS1064978 (human) | | 0.0000008 | pulse pressure measurement | | 4 | 110416708 | 110416709 | Human |
| 407121103 | GWAS770079_H | hair colour measurement QTL GWAS770079 (human) | | 1e-17 | hair colour measurement | | 4 | 108163945 | 108163946 | Human |
| 407416003 | GWAS1064979_H | pulse pressure measurement QTL GWAS1064979 (human) | | 0.0000006 | pulse pressure measurement | | 4 | 110461529 | 110461530 | Human |
| 617074764 | GWAS2092263_H | pain measurement QTL GWAS2092263 (human) | | 2e-08 | pain measurement | | 4 | 129322917 | 129322919 | Human |
| 407416005 | GWAS1064981_H | pulse pressure measurement QTL GWAS1064981 (human) | | 1e-13 | pulse pressure measurement | | 4 | 120018118 | 120018119 | Human |
| 407022802 | GWAS671778_H | sex hormone-binding globulin measurement QTL GWAS671778 (human) | | 7e-09 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
| 628527591 | GWAS2435820_H | gut microbiome measurement, bone tissue density QTL GWAS2435820 (human) | | 2e-09 | gut microbiome measurement, bone tissue density | | 4 | 116039953 | 116039954 | Human |
| 597399305 | GWAS1495379_H | diastolic blood pressure QTL GWAS1495379 (human) | | 5e-17 | diastolic blood pressure | | 4 | 110461529 | 110461530 | Human |
| 407121104 | GWAS770080_H | hair colour measurement QTL GWAS770080 (human) | | 1e-15 | hair colour measurement | | 4 | 108327206 | 108327207 | Human |
| 597317390 | GWAS1413464_H | triglyceride measurement QTL GWAS1413464 (human) | | 6e-27 | triglyceride measurement | | 4 | 109603883 | 109603884 | Human |
| 407235792 | GWAS884768_H | response to antiviral drug, cirrhosis of liver QTL GWAS884768 (human) | | 0.000005 | response to antiviral drug, cirrhosis of liver | | 4 | 114986399 | 114986400 | Human |
| 616353834 | GWAS1838549_H | gut microbiome measurement, breastfeeding duration QTL GWAS1838549 (human) | | 3e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 114769596 | 114769597 | Human |
| 628412909 | GWAS2321138_H | gut microbiome measurement QTL GWAS2321138 (human) | | 0.000001 | gut microbiome measurement | | 4 | 106920747 | 106920748 | Human |
| 617009244 | GWAS2026743_H | asthma QTL GWAS2026743 (human) | | 4e-15 | asthma | | 4 | 122084379 | 122084380 | Human |
| 628888034 | GWAS2796263_H | systolic blood pressure QTL GWAS2796263 (human) | | 1e-11 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110485340 | 110485341 | Human |
| 617074791 | GWAS2092290_H | dental caries QTL GWAS2092290 (human) | | 0.000003 | dental caries | | 4 | 129415045 | 129415046 | Human |
| 407334117 | GWAS983093_H | executive function measurement QTL GWAS983093 (human) | | 1e-08 | executive function measurement | | 4 | 118025394 | 118025395 | Human |
| 628412886 | GWAS2321115_H | gut microbiome measurement QTL GWAS2321115 (human) | | 0.000005 | gut microbiome measurement | | 4 | 127613641 | 127613642 | Human |
| 617025634 | GWAS2043133_H | pelvic organ prolapse QTL GWAS2043133 (human) | | 2e-22 | pelvic organ prolapse | | 4 | 126003529 | 126003530 | Human |
| 597366576 | GWAS1462650_H | balding measurement QTL GWAS1462650 (human) | | 2e-10 | balding measurement | | 4 | 123610267 | 123610268 | Human |
| 617009268 | GWAS2026767_H | cardioembolic stroke QTL GWAS2026767 (human) | | 4e-20 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 617107578 | GWAS2125077_H | socioeconomic status QTL GWAS2125077 (human) | | 3e-08 | socioeconomic status | | 4 | 121774163 | 121774164 | Human |
| 628609477 | GWAS2517706_H | lipid measurement QTL GWAS2517706 (human) | | 0.000005 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 126630119 | 126630120 | Human |
| 628838856 | GWAS2747085_H | amino acid measurement QTL GWAS2747085 (human) | | 0.000003 | blood amino acid amount (VT:0005311) | | 4 | 111130223 | 111130224 | Human |
| 617042035 | GWAS2059534_H | systolic blood pressure QTL GWAS2059534 (human) | | 2e-08 | systolic blood pressure | | 4 | 123878327 | 123878328 | Human |
| 617042034 | GWAS2059533_H | systolic blood pressure QTL GWAS2059533 (human) | | 6e-12 | systolic blood pressure | | 4 | 110319122 | 110319123 | Human |
| 407301363 | GWAS950339_H | colorectal cancer QTL GWAS950339 (human) | | 0.0000005 | colorectal cancer | | 4 | 120052597 | 120052598 | Human |
| 628675022 | GWAS2583251_H | fibrinopeptide A, des-ala(1) measurement QTL GWAS2583251 (human) | | 2e-14 | fibrinopeptide A, des-ala(1) measurement | | 4 | 110446685 | 110446686 | Human |
| 597137185 | GWAS1233259_H | bone density QTL GWAS1233259 (human) | | 7e-82 | bone density | | 4 | 124697561 | 124697562 | Human |
| 628675023 | GWAS2583252_H | fibrinopeptide A, des-ala(1) measurement QTL GWAS2583252 (human) | | 1e-21 | fibrinopeptide A, des-ala(1) measurement | | 4 | 110510288 | 110510289 | Human |
| 596989740 | GWAS1109259_H | platelet count QTL GWAS1109259 (human) | | 9e-11 | platelet count | | 4 | 109813770 | 109813771 | Human |
| 597235490 | GWAS1331564_H | blood protein measurement QTL GWAS1331564 (human) | | 3e-202 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 596989738 | GWAS1109257_H | platelet count QTL GWAS1109257 (human) | | 3e-40 | platelet count | | 4 | 110027510 | 110027511 | Human |
| 628642236 | GWAS2550465_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2550465 (human) | | 4e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 111174542 | 111174543 | Human |
| 628494768 | GWAS2402997_H | childhood onset asthma QTL GWAS2402997 (human) | | 2e-14 | childhood onset asthma | | 4 | 122456327 | 122456328 | Human |
| 407399552 | GWAS1048528_H | C-reactive protein measurement QTL GWAS1048528 (human) | | 4e-08 | C-reactive protein measurement | | 4 | 111731920 | 111731921 | Human |
| 597055322 | GWAS1151396_H | systolic blood pressure QTL GWAS1151396 (human) | | 5e-08 | systolic blood pressure | | 4 | 108146742 | 108146743 | Human |
| 597055323 | GWAS1151397_H | systolic blood pressure QTL GWAS1151397 (human) | | 7e-09 | systolic blood pressure | | 4 | 119996191 | 119996192 | Human |
| 407383174 | GWAS1032150_H | mean platelet volume QTL GWAS1032150 (human) | | 2e-13 | mean platelet volume | | 4 | 122258745 | 122258746 | Human |
| 407383175 | GWAS1032151_H | mean platelet volume QTL GWAS1032151 (human) | | 3e-24 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 597464905 | GWAS1560979_H | beta-nerve growth factor measurement QTL GWAS1560979 (human) | | 0.000008 | beta-nerve growth factor measurement | | 4 | 123921959 | 123921960 | Human |
| 597448522 | GWAS1544596_H | blood protein measurement QTL GWAS1544596 (human) | | 4e-16 | blood protein measurement | | 4 | 119210489 | 119210490 | Human |
| 597481281 | GWAS1577355_H | glucose-dependent insulinotropic peptide measurement QTL GWAS1577355 (human) | | 4e-10 | glucose-dependent insulinotropic peptide measurement | | 4 | 123717198 | 123717199 | Human |
| 617189399 | GWAS2169839_H | level of carboxypeptidase A1 in blood QTL GWAS2169839 (human) | | 2e-14 | level of carboxypeptidase A1 in blood | | 4 | 109921984 | 109921985 | Human |
| 597383035 | GWAS1479109_H | electrocardiography QTL GWAS1479109 (human) | | 5e-09 | electrocardiography | | 4 | 110793263 | 110793264 | Human |
| 407317679 | GWAS966655_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS966655 (human) | | 3e-14 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 598087500 | GWAS1806799_H | bone density QTL GWAS1806799 (human) | | 4e-107 | bone density | | 4 | 119246472 | 119246473 | Human |
| 597366633 | GWAS1462707_H | heel bone mineral density QTL GWAS1462707 (human) | | 2e-15 | heel bone mineral density | | 4 | 126527797 | 126527798 | Human |
| 597366632 | GWAS1462706_H | heel bone mineral density QTL GWAS1462706 (human) | | 3e-11 | heel bone mineral density | | 4 | 124600184 | 124600185 | Human |
| 407415996 | GWAS1064972_H | pulse pressure measurement QTL GWAS1064972 (human) | | 0.0000002 | pulse pressure measurement | | 4 | 108146742 | 108146743 | Human |
| 407415997 | GWAS1064973_H | pulse pressure measurement QTL GWAS1064973 (human) | | 0.000002 | pulse pressure measurement | | 4 | 110319122 | 110319123 | Human |
| 407137470 | GWAS786446_H | telomere length QTL GWAS786446 (human) | | 5e-08 | telomere length | | 4 | 107383042 | 107383043 | Human |
| 597366631 | GWAS1462705_H | heel bone mineral density QTL GWAS1462705 (human) | | 4e-11 | heel bone mineral density | | 4 | 123613837 | 123613838 | Human |
| 597120874 | GWAS1216948_H | lipoprotein A measurement QTL GWAS1216948 (human) | | 1e-11 | lipoprotein A measurement | | 4 | 109717668 | 109717669 | Human |
| 598087513 | GWAS1806812_H | bone density QTL GWAS1806812 (human) | | 7e-82 | bone density | | 4 | 124697561 | 124697562 | Human |
| 598005412 | GWAS1724711_H | smoking behavior trait QTL GWAS1724711 (human) | | 2e-11 | smoking behavior trait | | 4 | 111500989 | 111500990 | Human |
| 616354236 | GWAS1838951_H | gut microbiome measurement, breastfeeding duration QTL GWAS1838951 (human) | | 0.0000002 | gut microbiome measurement, breastfeeding duration | | 4 | 115471326 | 115471327 | Human |
| 628478068 | GWAS2386297_H | BMI-adjusted waist-hip ratio QTL GWAS2386297 (human) | | 1e-09 | body size trait (VT:0100005) | | 4 | 119607172 | 119607173 | Human |
| 628576369 | GWAS2484598_H | high density lipoprotein cholesterol measurement QTL GWAS2484598 (human) | | 2e-44 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
| 597513883 | GWAS1609957_H | body mass index QTL GWAS1609957 (human) | | 9e-21 | body mass index | | 4 | 129810129 | 129810130 | Human |
| 628576368 | GWAS2484597_H | high density lipoprotein cholesterol measurement QTL GWAS2484597 (human) | | 2e-17 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109717608 | 109717609 | Human |
| 597513882 | GWAS1609956_H | body mass index QTL GWAS1609956 (human) | | 3e-08 | body mass index | | 4 | 121743168 | 121743169 | Human |
| 628887675 | GWAS2795904_H | X-26054 measurement QTL GWAS2795904 (human) | | 1e-125 | X-26054 measurement | | 4 | 129143723 | 129143724 | Human |
| 597202576 | GWAS1298650_H | lean body mass QTL GWAS1298650 (human) | | 4e-13 | lean body mass | | 4 | 123145793 | 123145794 | Human |
| 628609148 | GWAS2517377_H | alkaline phosphatase measurement QTL GWAS2517377 (human) | | 1e-22 | blood alkaline phosphatase amount (VT:0000202) | blood alkaline phosphatase activity level (CMO:0000576) | 4 | 110201006 | 110201007 | Human |
| 597087878 | GWAS1183952_H | mean platelet volume QTL GWAS1183952 (human) | | 3e-24 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 617042389 | GWAS2059888_H | stroke QTL GWAS2059888 (human) | | 1e-13 | stroke | | 4 | 110791276 | 110791277 | Human |
| 597087877 | GWAS1183951_H | mean platelet volume QTL GWAS1183951 (human) | | 2e-13 | mean platelet volume | | 4 | 122258745 | 122258746 | Human |
| 617091547 | GWAS2109046_H | glomerular filtration rate QTL GWAS2109046 (human) | | 1e-13 | glomerular filtration rate | | 4 | 127272519 | 127272520 | Human |
| 407072091 | GWAS721067_H | depressive symptom measurement, response to ketamine QTL GWAS721067 (human) | | 0.000006 | response to xenobiotic stimulus trait (VT:0010487) | | 4 | 130998547 | 130998548 | Human |
| 628707431 | GWAS2615660_H | fibroblast growth factor 2 level QTL GWAS2615660 (human) | | 3e-15 | fibroblast growth factor 2 level | | 4 | 123258267 | 123258268 | Human |
| 628707430 | GWAS2615659_H | fibroblast growth factor 2 level QTL GWAS2615659 (human) | | 6e-16 | fibroblast growth factor 2 level | | 4 | 122834403 | 122834404 | Human |
| 628920413 | GWAS2828642_H | bilirubin measurement QTL GWAS2828642 (human) | | 9e-12 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 109985415 | 109985416 | Human |
| 616534430 | GWAS1931013_H | erythrocyte volume QTL GWAS1931013 (human) | | 3e-70 | erythrocyte volume | | 4 | 121870446 | 121870447 | Human |
| 407252324 | GWAS901300_H | lymphocyte count QTL GWAS901300 (human) | | 6e-27 | lymphocyte count | | 4 | 112192759 | 112192760 | Human |
| 597513919 | GWAS1609993_H | X-26054 measurement QTL GWAS1609993 (human) | | 3e-168 | X-26054 measurement | | 4 | 129109789 | 129109790 | Human |
| 597464766 | GWAS1560840_H | waist circumference QTL GWAS1560840 (human) | | 0.000009 | waist circumference | | 4 | 129883949 | 129883950 | Human |
| 407252325 | GWAS901301_H | lymphocyte count QTL GWAS901301 (human) | | 8e-23 | lymphocyte count | | 4 | 122760001 | 122760002 | Human |
| 407252323 | GWAS901299_H | lymphocyte count QTL GWAS901299 (human) | | 1e-25 | lymphocyte count | | 4 | 109914892 | 109914893 | Human |
| 628609118 | GWAS2517347_H | serum albumin amount QTL GWAS2517347 (human) | | 3e-09 | serum albumin amount | | 4 | 123779234 | 123779235 | Human |
| 626462843 | GWAS2276776_H | leukocyte quantity QTL GWAS2276776 (human) | | 9e-09 | leukocyte quantity | | 4 | 107777822 | 107777823 | Human |
| 628707413 | GWAS2615642_H | fibroblast growth factor 2 level QTL GWAS2615642 (human) | | 5e-13 | fibroblast growth factor 2 level | | 4 | 122640324 | 122640325 | Human |
| 626462842 | GWAS2276775_H | leukocyte quantity QTL GWAS2276775 (human) | | 1e-08 | leukocyte quantity | | 4 | 119342160 | 119342161 | Human |
| 628707415 | GWAS2615644_H | fibroblast growth factor 2 level QTL GWAS2615644 (human) | | 4e-43 | fibroblast growth factor 2 level | | 4 | 122430398 | 122430399 | Human |
| 617058793 | GWAS2076292_H | diet measurement QTL GWAS2076292 (human) | | 2e-08 | diet measurement | | 4 | 129906935 | 129906936 | Human |
| 628707414 | GWAS2615643_H | fibroblast growth factor 2 level QTL GWAS2615643 (human) | | 7e-12 | fibroblast growth factor 2 level | | 4 | 122083028 | 122083029 | Human |
| 616354189 | GWAS1838904_H | gut microbiome measurement, environmental exposure measurement QTL GWAS1838904 (human) | | 0.000005 | gut microbiome measurement, environmental exposure measurement | | 4 | 123477380 | 123477381 | Human |
| 617091578 | GWAS2109077_H | sex hormone-binding globulin measurement QTL GWAS2109077 (human) | | 2e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 597317292 | GWAS1413366_H | glomerular filtration rate QTL GWAS1413366 (human) | | 0.0000001 | glomerular filtration rate | | 4 | 128619238 | 128619239 | Human |
| 617058692 | GWAS2076191_H | serum gamma-glutamyl transferase measurement QTL GWAS2076191 (human) | | 1e-08 | serum gamma-glutamyl transferase measurement | | 4 | 111793842 | 111793843 | Human |
| 597464792 | GWAS1560866_H | mean arterial pressure QTL GWAS1560866 (human) | | 7e-09 | mean arterial pressure | | 4 | 110422107 | 110422108 | Human |
| 597284574 | GWAS1380648_H | response to warfarin QTL GWAS1380648 (human) | | 0.000007 | response to warfarin | | 4 | 112988363 | 112988364 | Human |
| 628494373 | GWAS2402602_H | Beta blocking agent use measurement QTL GWAS2402602 (human) | | 5e-09 | Beta blocking agent use measurement | | 4 | 110743002 | 110743003 | Human |
| 628789295 | GWAS2697524_H | protein measurement QTL GWAS2697524 (human) | | 1e-32 | protein amount (VT:0010120) | | 4 | 121025981 | 121025982 | Human |
| 597071567 | GWAS1167641_H | platelet count QTL GWAS1167641 (human) | | 2e-28 | platelet count | | 4 | 110010783 | 110010784 | Human |
| 406891802 | GWAS540778_H | initial pursuit acceleration QTL GWAS540778 (human) | | 0.000005 | initial pursuit acceleration | | 4 | 130399088 | 130399089 | Human |
| 597399232 | GWAS1495306_H | vaginal microbiome measurement QTL GWAS1495306 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132000696 | 132000697 | Human |
| 597071563 | GWAS1167637_H | sclerosing cholangitis QTL GWAS1167637 (human) | | 9e-13 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
| 407219480 | GWAS868456_H | cytokine measurement QTL GWAS868456 (human) | | 0.000001 | cytokine measurement | | 4 | 125803384 | 125803385 | Human |
| 628412458 | GWAS2320687_H | diet measurement QTL GWAS2320687 (human) | | 3e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 4 | 112518056 | 112518057 | Human |
| 628838426 | GWAS2746655_H | lipid measurement QTL GWAS2746655 (human) | | 0.000002 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 123250547 | 123250548 | Human |
| 597120758 | GWAS1216832_H | gut microbiome measurement QTL GWAS1216832 (human) | | 3e-09 | gut microbiome measurement | | 4 | 126415447 | 126415448 | Human |
| 617107882 | GWAS2125381_H | rheumatoid arthritis QTL GWAS2125381 (human) | | 0.000002 | rheumatoid arthritis | | 4 | 108192758 | 108192759 | Human |
| 628838425 | GWAS2746654_H | lipid measurement QTL GWAS2746654 (human) | | 0.000006 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 122960709 | 122960710 | Human |
| 407203110 | GWAS852086_H | FEV/FVC ratio QTL GWAS852086 (human) | | 2e-08 | FEV/FVC ratio | | 4 | 108429724 | 108429725 | Human |
| 407252258 | GWAS901234_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS901234 (human) | | 3e-11 | schizophrenia, intelligence, self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 597186288 | GWAS1282362_H | educational attainment QTL GWAS1282362 (human) | | 0.000002 | educational attainment | | 4 | 115489506 | 115489507 | Human |
| 597186290 | GWAS1282364_H | educational attainment QTL GWAS1282364 (human) | | 6e-10 | educational attainment | | 4 | 119987548 | 119987549 | Human |
| 407252267 | GWAS901243_H | type 2 diabetes mellitus QTL GWAS901243 (human) | | 3e-09 | type 2 diabetes mellitus | | 4 | 120844633 | 120844634 | Human |
| 407203112 | GWAS852088_H | FEV/FVC ratio QTL GWAS852088 (human) | | 1e-20 | FEV/FVC ratio | | 4 | 123898452 | 123898453 | Human |
| 628641800 | GWAS2550029_H | fibroblast growth factor 2 level QTL GWAS2550029 (human) | | 1e-09 | fibroblast growth factor 2 level | | 4 | 118377173 | 118377174 | Human |
| 628641802 | GWAS2550031_H | fibroblast growth factor 2 level QTL GWAS2550031 (human) | | 1e-10 | fibroblast growth factor 2 level | | 4 | 119087072 | 119087073 | Human |
| 597186283 | GWAS1282357_H | educational attainment QTL GWAS1282357 (human) | | 4e-10 | educational attainment | | 4 | 109603314 | 109603315 | Human |
| 597235434 | GWAS1331508_H | lung carcinoma QTL GWAS1331508 (human) | | 0.0000005 | lung carcinoma | | 4 | 128666151 | 128666152 | Human |
| 597186284 | GWAS1282358_H | educational attainment QTL GWAS1282358 (human) | | 1e-11 | educational attainment | | 4 | 111489199 | 111489200 | Human |
| 597186285 | GWAS1282359_H | educational attainment QTL GWAS1282359 (human) | | 1e-10 | educational attainment | | 4 | 112220279 | 112220280 | Human |
| 628641806 | GWAS2550035_H | gut microbiome measurement, allergen exposure measurement QTL GWAS2550035 (human) | | 4e-09 | gut microbiome measurement, allergen exposure measurement | | 4 | 111174542 | 111174543 | Human |
| 597186286 | GWAS1282360_H | educational attainment QTL GWAS1282360 (human) | | 4e-11 | educational attainment | | 4 | 114059072 | 114059073 | Human |
| 407317808 | GWAS966784_H | cortical surface area measurement QTL GWAS966784 (human) | | 6e-14 | cortical surface area measurement | | 4 | 112497482 | 112497483 | Human |
| 597186287 | GWAS1282361_H | educational attainment QTL GWAS1282361 (human) | | 2e-08 | educational attainment | | 4 | 115086647 | 115086648 | Human |
| 617107888 | GWAS2125387_H | rheumatoid arthritis QTL GWAS2125387 (human) | | 0.000005 | rheumatoid arthritis | | 4 | 124601887 | 124601888 | Human |
| 628641796 | GWAS2550025_H | fibroblast growth factor 2 level QTL GWAS2550025 (human) | | 2e-08 | fibroblast growth factor 2 level | | 4 | 120247814 | 120247815 | Human |
| 596973289 | GWAS1092808_H | irritable bowel syndrome, major depressive disorder QTL GWAS1092808 (human) | | 3e-09 | irritable bowel syndrome, major depressive disorder | | 4 | 122201701 | 122201702 | Human |
| 597382887 | GWAS1478961_H | lymphocyte count QTL GWAS1478961 (human) | | 2e-14 | lymphocyte count | | 4 | 122760001 | 122760002 | Human |
| 628641798 | GWAS2550027_H | fibroblast growth factor 2 level QTL GWAS2550027 (human) | | 4e-11 | fibroblast growth factor 2 level | | 4 | 122518815 | 122518816 | Human |
| 597399067 | GWAS1495141_H | waist-hip ratio QTL GWAS1495141 (human) | | 0.00001 | waist-hip ratio | | 4 | 108607724 | 108607725 | Human |
| 628723963 | GWAS2632192_H | level of hypoxia up-regulated protein 1 in blood QTL GWAS2632192 (human) | | 1e-11 | level of hypoxia up-regulated protein 1 in blood | | 4 | 110420710 | 110420711 | Human |
| 407236038 | GWAS885014_H | sleep measurement QTL GWAS885014 (human) | | 0.000006 | sleep measurement | | 4 | 118160921 | 118160922 | Human |
| 628429046 | GWAS2337275_H | household income QTL GWAS2337275 (human) | | 5e-09 | household income | | 4 | 122175535 | 122175536 | Human |
| 407236035 | GWAS885011_H | sleep measurement QTL GWAS885011 (human) | | 0.000005 | sleep measurement | | 4 | 118053665 | 118053666 | Human |
| 617075008 | GWAS2092507_H | systolic blood pressure QTL GWAS2092507 (human) | | 0.0000001 | systolic blood pressure | | 4 | 132120954 | 132120955 | Human |
| 407186893 | GWAS835869_H | lipid measurement QTL GWAS835869 (human) | | 0.000009 | lipid measurement | | 4 | 107039415 | 107039416 | Human |
| 597612055 | GWAS1668915_H | systemic inflammatory response syndrome QTL GWAS1668915 (human) | | 1e-11 | systemic inflammatory response syndrome | | 4 | 131864363 | 131864364 | Human |
| 596973081 | GWAS1092600_H | age at onset, major depressive disorder QTL GWAS1092600 (human) | | 0.000007 | age at onset, major depressive disorder | | 4 | 127602809 | 127602810 | Human |
| 617107801 | GWAS2125300_H | cardiovascular disease QTL GWAS2125300 (human) | | 3e-12 | cardiovascular disease | | 4 | 110787848 | 110787849 | Human |
| 628592869 | GWAS2501098_H | memory performance QTL GWAS2501098 (human) | | 0.0000005 | learning/memory/conditioning trait (VT:0002063) | | 4 | 109067562 | 109067563 | Human |
| 407268830 | GWAS917806_H | body height QTL GWAS917806 (human) | | 6e-13 | body height | | 4 | 108198626 | 108198627 | Human |
| 628625632 | GWAS2533861_H | bipolar disorder QTL GWAS2533861 (human) | | 0.0000001 | bipolar disorder | | 4 | 117551578 | 117551579 | Human |
| 407268828 | GWAS917804_H | body height QTL GWAS917804 (human) | | 8e-18 | body height | | 4 | 107970830 | 107970831 | Human |
| 628986087 | GWAS2894316_H | atrial fibrillation QTL GWAS2894316 (human) | | 1e-323 | atrial fibrillation | | 4 | 110720030 | 110720031 | Human |
| 616993116 | GWAS2010615_H | body mass index QTL GWAS2010615 (human) | | 4e-08 | body mass index | | 4 | 130102129 | 130102130 | Human |
| 407268829 | GWAS917805_H | body height QTL GWAS917805 (human) | | 2e-48 | body height | | 4 | 108125804 | 108125805 | Human |
| 597399040 | GWAS1495114_H | body mass index QTL GWAS1495114 (human) | | 6e-09 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 407268826 | GWAS917802_H | body height QTL GWAS917802 (human) | | 2e-19 | body height | | 4 | 106649253 | 106649254 | Human |
| 616993114 | GWAS2010613_H | body mass index QTL GWAS2010613 (human) | | 1e-10 | body mass index | | 4 | 111765198 | 111765199 | Human |
| 407268827 | GWAS917803_H | body height QTL GWAS917803 (human) | | 2e-12 | body height | | 4 | 107793654 | 107793655 | Human |
| 616993115 | GWAS2010614_H | body mass index QTL GWAS2010614 (human) | | 7e-13 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 628592855 | GWAS2501084_H | cardiovascular age measurement QTL GWAS2501084 (human) | | 3e-11 | cardiovascular age measurement | | 4 | 113465982 | 113465983 | Human |
| 597988868 | GWAS1708167_H | optic disc area QTL GWAS1708167 (human) | | 2e-08 | optic disc area | | 4 | 114560759 | 114560760 | Human |
| 628543698 | GWAS2451927_H | level of desmoglein-4 in blood serum QTL GWAS2451927 (human) | | 4e-12 | level of desmoglein-4 in blood serum | | 4 | 106786338 | 106786339 | Human |
| 597464630 | GWAS1560704_H | response to selective serotonin reuptake inhibitor QTL GWAS1560704 (human) | | 0.000005 | response to selective serotonin reuptake inhibitor | | 4 | 117586197 | 117586198 | Human |
| 407072238 | GWAS721214_H | anthropometric measurement QTL GWAS721214 (human) | | 3e-10 | anthropometric measurement | | 4 | 108565997 | 108565998 | Human |
| 628707531 | GWAS2615760_H | X-26054 measurement QTL GWAS2615760 (human) | | 5e-87 | X-26054 measurement | | 4 | 129143723 | 129143724 | Human |
| 407236095 | GWAS885071_H | sex hormone-binding globulin measurement QTL GWAS885071 (human) | | 3e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 407285243 | GWAS934219_H | physical activity measurement QTL GWAS934219 (human) | | 3e-09 | physical activity measurement | | 4 | 108177667 | 108177668 | Human |
| 628609225 | GWAS2517454_H | lipid measurement QTL GWAS2517454 (human) | | 0.000006 | lipid amount (VT:0001547) | blood lipid measurement (CMO:0000050) | 4 | 130393791 | 130393792 | Human |
| 616993031 | GWAS2010530_H | body height QTL GWAS2010530 (human) | | 4e-19 | body height | | 4 | 119834940 | 119834941 | Human |
| 407039363 | GWAS688339_H | allergic sensitization measurement QTL GWAS688339 (human) | | 6e-10 | allergic sensitization measurement | | 4 | 122432277 | 122432278 | Human |
| 628609205 | GWAS2517434_H | 4-ethylphenylsulfate measurement QTL GWAS2517434 (human) | | 0.000004 | 4-ethylphenylsulfate measurement | | 4 | 108059616 | 108059617 | Human |
| 407383437 | GWAS1032413_H | insomnia measurement QTL GWAS1032413 (human) | | 3e-08 | insomnia measurement | | 4 | 111901575 | 111901576 | Human |
| 628494515 | GWAS2402744_H | electroencephalogram measurement QTL GWAS2402744 (human) | | 0.000002 | electroencephalogram measurement | brain activity measurement (CMO:0001737) | 4 | 121613423 | 121613424 | Human |
| 616993027 | GWAS2010526_H | waist-hip ratio QTL GWAS2010526 (human) | | 5e-08 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 124299553 | 124299554 | Human |
| 617206028 | GWAS2186468_H | body mass index QTL GWAS2186468 (human) | | 2e-12 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597579347 | GWAS1636207_H | high density lipoprotein cholesterol measurement QTL GWAS1636207 (human) | | 1e-14 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 616386928 | GWAS1867170_H | obsolete_blood urea nitrogen measurement QTL GWAS1867170 (human) | | 4e-08 | obsolete_blood urea nitrogen measurement | | 4 | 119076757 | 119076758 | Human |
| 597464658 | GWAS1560732_H | caudal anterior cingulate cortex volume measurement QTL GWAS1560732 (human) | | 0.000002 | caudal anterior cingulate cortex volume measurement | | 4 | 125708052 | 125708053 | Human |
| 616993032 | GWAS2010531_H | body height QTL GWAS2010531 (human) | | 2e-08 | body height | | 4 | 128700411 | 128700412 | Human |
| 407039378 | GWAS688354_H | body mass index QTL GWAS688354 (human) | | 0.0000005 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 109057975 | 109057976 | Human |
| 597415499 | GWAS1511573_H | self reported educational attainment QTL GWAS1511573 (human) | | 4e-09 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 597415498 | GWAS1511572_H | self reported educational attainment QTL GWAS1511572 (human) | | 2e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
| 407072150 | GWAS721126_H | waist-hip ratio QTL GWAS721126 (human) | | 5e-08 | waist-hip ratio | | 4 | 124299553 | 124299554 | Human |
| 617058585 | GWAS2076084_H | cystatin C measurement QTL GWAS2076084 (human) | | 2e-08 | cystatin C measurement | | 4 | 128611038 | 128611039 | Human |
| 628527273 | GWAS2435502_H | level of carboxypeptidase A1 in blood QTL GWAS2435502 (human) | | 2e-14 | level of carboxypeptidase A1 in blood | | 4 | 109921984 | 109921985 | Human |
| 617058584 | GWAS2076083_H | cystatin C measurement QTL GWAS2076083 (human) | | 9e-15 | cystatin C measurement | | 4 | 127176068 | 127176069 | Human |
| 617189677 | GWAS2170117_H | level of liver carboxylesterase 1 in blood QTL GWAS2170117 (human) | | 1e-27 | level of liver carboxylesterase 1 in blood | | 4 | 118865819 | 118865820 | Human |
| 617025826 | GWAS2043325_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS2043325 (human) | | 3e-11 | schizophrenia, intelligence, self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 626446513 | GWAS2260446_H | age at menarche QTL GWAS2260446 (human) | | 7e-08 | age at menarche | | 4 | 129809917 | 129809918 | Human |
| 597169777 | GWAS1265851_H | body mass index QTL GWAS1265851 (human) | | 9e-10 | body mass index | | 4 | 112402274 | 112402275 | Human |
| 617009455 | GWAS2026954_H | apolipoprotein B measurement QTL GWAS2026954 (human) | | 1e-10 | apolipoprotein B measurement | | 4 | 123837618 | 123837619 | Human |
| 597169778 | GWAS1265852_H | body mass index QTL GWAS1265852 (human) | | 3e-08 | body mass index | | 4 | 114269666 | 114269667 | Human |
| 616960300 | GWAS1977799_H | erythrocyte volume QTL GWAS1977799 (human) | | 1e-10 | erythrocyte volume | | 4 | 121774530 | 121774531 | Human |
| 617206050 | GWAS2186490_H | attention deficit hyperactivity disorder, bipolar disorder QTL GWAS2186490 (human) | | 1e-08 | behavior trait (VT:0010442) | | 4 | 122589611 | 122589612 | Human |
| 597366384 | GWAS1462458_H | intelligence QTL GWAS1462458 (human) | | 0.000007 | intelligence | | 4 | 129813235 | 129813236 | Human |
| 597988936 | GWAS1708235_H | optic disc area QTL GWAS1708235 (human) | | 0.0000004 | optic disc area | | 4 | 114560759 | 114560760 | Human |
| 597481072 | GWAS1577146_H | ceramide measurement QTL GWAS1577146 (human) | | 5e-38 | ceramide measurement | | 4 | 114564528 | 114564529 | Human |
| 597481073 | GWAS1577147_H | ceramide measurement QTL GWAS1577147 (human) | | 1e-16 | ceramide measurement | | 4 | 114598115 | 114598116 | Human |
| 597366388 | GWAS1462462_H | intelligence QTL GWAS1462462 (human) | | 0.000007 | intelligence | | 4 | 112683802 | 112683803 | Human |
| 597530216 | GWAS1626290_H | fibrinopeptide A measurement QTL GWAS1626290 (human) | | 2e-25 | fibrinopeptide A measurement | | 4 | 110434637 | 110434638 | Human |
| 597382764 | GWAS1478838_H | Red cell distribution width QTL GWAS1478838 (human) | | 2e-23 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 598005337 | GWAS1724636_H | leukocyte quantity QTL GWAS1724636 (human) | | 4e-11 | leukocyte quantity | | 4 | 109932621 | 109932622 | Human |
| 616354113 | GWAS1838828_H | gut microbiome measurement, breastfeeding duration QTL GWAS1838828 (human) | | 2e-11 | gut microbiome measurement, breastfeeding duration | | 4 | 110717326 | 110717327 | Human |
| 407268795 | GWAS917771_H | treprostinil dose measurement QTL GWAS917771 (human) | | 0.000005 | treprostinil dose measurement | | 4 | 113625548 | 113625549 | Human |
| 598005338 | GWAS1724637_H | leukocyte quantity QTL GWAS1724637 (human) | | 1e-10 | leukocyte quantity | | 4 | 119343841 | 119343842 | Human |
| 597267865 | GWAS1363939_H | cardioembolic stroke QTL GWAS1363939 (human) | | 9e-59 | cardioembolic stroke | | 4 | 110775495 | 110775496 | Human |
| 628986751 | GWAS2894980_H | atrial flutter QTL GWAS2894980 (human) | | 7e-207 | atrial flutter | | 4 | 110793263 | 110793264 | Human |
| 597497246 | GWAS1593320_H | memory performance QTL GWAS1593320 (human) | | 0.000008 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124874941 | 124874942 | Human |
| 616567498 | GWAS1964081_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1964081 (human) | | 3e-14 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 117846456 | 117846457 | Human |
| 616370870 | GWAS1851112_H | cerebral cortex area attribute QTL GWAS1851112 (human) | | 4e-11 | cerebral cortex area attribute | | 4 | 118376502 | 118376503 | Human |
| 407072334 | GWAS721310_H | hair color QTL GWAS721310 (human) | | 3e-20 | coat/hair pigmentation trait (VT:0010463) | | 4 | 108429724 | 108429725 | Human |
| 597464467 | GWAS1560541_H | esophageal adenocarcinoma QTL GWAS1560541 (human) | | 1e-08 | esophageal adenocarcinoma | | 4 | 123623035 | 123623036 | Human |
| 597611919 | GWAS1668779_H | abnormal result of function studies QTL GWAS1668779 (human) | | 2e-11 | abnormal result of function studies | | 4 | 131498407 | 131498408 | Human |
| 597611914 | GWAS1668774_H | Barrett's esophagus QTL GWAS1668774 (human) | | 6e-14 | Barrett's esophagus | | 4 | 123628089 | 123628090 | Human |
| 628937579 | GWAS2845808_H | disturbances of sensation of smell and taste QTL GWAS2845808 (human) | | 9e-12 | disturbances of sensation of smell and taste | | 4 | 125832302 | 125832303 | Human |
| 628839267 | GWAS2747496_H | sucrose measurement QTL GWAS2747496 (human) | | 0.000002 | sucrose measurement | | 4 | 111477457 | 111477458 | Human |
| 628904806 | GWAS2813035_H | chronic lymphocytic leukemia QTL GWAS2813035 (human) | | 2e-11 | leukocyte integrity trait (VT:0010898) | | 4 | 108168668 | 108168669 | Human |
| 617026268 | GWAS2043767_H | atrial fibrillation QTL GWAS2043767 (human) | | 3e-09 | atrial fibrillation | | 4 | 111533139 | 111533140 | Human |
| 628937568 | GWAS2845797_H | prothrombin time measurement QTL GWAS2845797 (human) | | 2e-36 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 4 | 110796911 | 110796912 | Human |
| 617026267 | GWAS2043766_H | atrial fibrillation QTL GWAS2043766 (human) | | 8e-18 | atrial fibrillation | | 4 | 111244056 | 111244057 | Human |
| 617026266 | GWAS2043765_H | atrial fibrillation QTL GWAS2043765 (human) | | 2e-18 | atrial fibrillation | | 4 | 111004500 | 111004501 | Human |
| 617026265 | GWAS2043764_H | atrial fibrillation QTL GWAS2043764 (human) | | 1e-28 | atrial fibrillation | | 4 | 110603473 | 110603474 | Human |
| 617026264 | GWAS2043763_H | atrial fibrillation QTL GWAS2043763 (human) | | 8e-11 | atrial fibrillation | | 4 | 110334761 | 110334762 | Human |
| 597497218 | GWAS1593292_H | hip geometry QTL GWAS1593292 (human) | | 3e-08 | body size trait (VT:0100005) | hip circumference (CMO:0000014) | 4 | 114237534 | 114237535 | Human |
| 628724568 | GWAS2632797_H | alpha-L-iduronidase measurement QTL GWAS2632797 (human) | | 2e-12 | alpha-L-iduronidase measurement | | 4 | 109603883 | 109603884 | Human |
| 628642652 | GWAS2550881_H | gut microbiome measurement, environmental exposure measurement QTL GWAS2550881 (human) | | 3e-08 | gut microbiome measurement, environmental exposure measurement | | 4 | 116169734 | 116169735 | Human |
| 597169598 | GWAS1265672_H | rheumatoid arthritis QTL GWAS1265672 (human) | | 4e-08 | rheumatoid arthritis | | 4 | 108140462 | 108140463 | Human |
| 626463615 | GWAS2277548_H | triglyceride measurement QTL GWAS2277548 (human) | | 4e-08 | triglyceride measurement | | 4 | 126247400 | 126247401 | Human |
| 617075437 | GWAS2092936_H | uterine prolapse QTL GWAS2092936 (human) | | 2e-15 | uterine prolapse | | 4 | 126003529 | 126003530 | Human |
| 598037902 | GWAS1757201_H | free cholesterol measurement, blood VLDL cholesterol amount QTL GWAS1757201 (human) | | 7e-09 | free cholesterol measurement, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 628593479 | GWAS2501708_H | phospholipids:total lipids ratio, blood VLDL cholesterol amount QTL GWAS2501708 (human) | | 1e-08 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 626463585 | GWAS2277518_H | body height QTL GWAS2277518 (human) | | 3e-08 | neuroticism measurement | | 4 | 118263414 | 118263415 | Human |
| 597366188 | GWAS1462262_H | hemoglobin measurement QTL GWAS1462262 (human) | | 2e-10 | hemoglobin measurement | | 4 | 123846352 | 123846353 | Human |
| 628790081 | GWAS2698310_H | complement factor H-related protein 2 measurement QTL GWAS2698310 (human) | | 0.000009 | complement factor H-related protein 2 measurement | | 4 | 127922325 | 127922326 | Human |
| 597235111 | GWAS1331185_H | blood protein measurement QTL GWAS1331185 (human) | | 4e-192 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 407400055 | GWAS1049031_H | protein measurement QTL GWAS1049031 (human) | | 2e-08 | protein measurement | | 4 | 124985713 | 124985714 | Human |
| 597071319 | GWAS1167393_H | serum non-albumin protein measurement QTL GWAS1167393 (human) | | 2e-10 | serum non-albumin protein measurement | | 4 | 109984820 | 109984821 | Human |
| 626447127 | GWAS2261060_H | eosinophil count QTL GWAS2261060 (human) | | 8e-11 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 407236096 | GWAS885072_H | sex hormone-binding globulin measurement QTL GWAS885072 (human) | | 0.000005 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
| 617075329 | GWAS2092828_H | body height QTL GWAS2092828 (human) | | 1e-09 | body height | | 4 | 121739866 | 121739867 | Human |
| 597071312 | GWAS1167386_H | mosquito bite reaction itch intensity measurement QTL GWAS1167386 (human) | | 2e-11 | mosquito bite reaction itch intensity measurement | | 4 | 123047357 | 123047358 | Human |
| 617075328 | GWAS2092827_H | body height QTL GWAS2092827 (human) | | 3e-08 | body height | | 4 | 119693141 | 119693142 | Human |
| 597071313 | GWAS1167387_H | mosquito bite reaction itch intensity measurement QTL GWAS1167387 (human) | | 1e-10 | mosquito bite reaction itch intensity measurement | | 4 | 123249252 | 123249253 | Human |
| 407301646 | GWAS950622_H | colorectal cancer QTL GWAS950622 (human) | | 0.0000007 | colorectal cancer | | 4 | 123506329 | 123506330 | Human |
| 407186959 | GWAS835935_H | waist-hip ratio QTL GWAS835935 (human) | | 0.00001 | waist-hip ratio | | 4 | 108607724 | 108607725 | Human |
| 597153221 | GWAS1249295_H | phospholipids:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS1249295 (human) | | 7e-13 | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | | 4 | 109657070 | 109657071 | Human |
| 628511522 | GWAS2419751_H | response to calcium channel blocker QTL GWAS2419751 (human) | | 0.000002 | response to calcium channel blocker | | 4 | 119116902 | 119116903 | Human |
| 628478752 | GWAS2386981_H | coronary artery disease QTL GWAS2386981 (human) | | 6e-14 | coronary artery integrity trait (VT:0010746) | | 4 | 119980181 | 119980182 | Human |
| 628953899 | GWAS2862128_H | serum creatinine amount QTL GWAS2862128 (human) | | 4e-11 | serum creatinine amount | | 4 | 114577301 | 114577302 | Human |
| 616551143 | GWAS1947726_H | erythrocyte count QTL GWAS1947726 (human) | | 5e-16 | erythrocyte count | | 4 | 114598115 | 114598116 | Human |
| 597431748 | GWAS1527822_H | protein measurement QTL GWAS1527822 (human) | | 1e-08 | protein measurement | | 4 | 121980476 | 121980477 | Human |
| 628478765 | GWAS2386994_H | cancer QTL GWAS2386994 (human) | | 0.0000006 | cancer | | 4 | 122660080 | 122660081 | Human |
| 597071310 | GWAS1167384_H | mosquito bite reaction itch intensity measurement QTL GWAS1167384 (human) | | 2e-37 | mosquito bite reaction itch intensity measurement | | 4 | 122690387 | 122690388 | Human |
| 598005244 | GWAS1724543_H | brain connectivity attribute QTL GWAS1724543 (human) | | 6e-11 | brain connectivity attribute | | 4 | 125820645 | 125820646 | Human |
| 628478764 | GWAS2386993_H | cancer QTL GWAS2386993 (human) | | 0.0000007 | cancer | | 4 | 106909104 | 106909105 | Human |
| 628364077 | GWAS2284921_H | fibroblast growth factor 2 level QTL GWAS2284921 (human) | | 0.000002 | fibroblast growth factor 2 level | | 4 | 107833368 | 107833369 | Human |
| 407072282 | GWAS721258_H | cognitive function measurement QTL GWAS721258 (human) | | 0.000005 | cognitive behavior trait (VT:0010450) | | 4 | 120770925 | 120770926 | Human |
| 597071311 | GWAS1167385_H | mosquito bite reaction itch intensity measurement QTL GWAS1167385 (human) | | 3e-13 | mosquito bite reaction itch intensity measurement | | 4 | 122806140 | 122806141 | Human |
| 407186975 | GWAS835951_H | glycerophospholipid measurement QTL GWAS835951 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582721 | 114582722 | Human |
| 406990360 | GWAS639336_H | sex hormone-binding globulin measurement QTL GWAS639336 (human) | | 0.0000007 | sex hormone-binding globulin measurement | | 4 | 119185193 | 119185194 | Human |
| 597071308 | GWAS1167382_H | mosquito bite reaction itch intensity measurement QTL GWAS1167382 (human) | | 3e-09 | mosquito bite reaction itch intensity measurement | | 4 | 122182953 | 122182955 | Human |
| 407236127 | GWAS885103_H | bone density QTL GWAS885103 (human) | | 1e-21 | bone density | | 4 | 128419095 | 128419096 | Human |
| 597071309 | GWAS1167383_H | mosquito bite reaction itch intensity measurement QTL GWAS1167383 (human) | | 4e-09 | mosquito bite reaction itch intensity measurement | | 4 | 122359705 | 122359706 | Human |
| 597136843 | GWAS1232917_H | neuroimaging measurement QTL GWAS1232917 (human) | | 2e-11 | neuroimaging measurement | | 4 | 112495627 | 112495628 | Human |
| 628970274 | GWAS2878503_H | platelet count QTL GWAS2878503 (human) | | 5e-39 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109927496 | 109927497 | Human |
| 407186980 | GWAS835956_H | glycerophospholipid measurement QTL GWAS835956 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582806 | 114582807 | Human |
| 617124525 | GWAS2142024_H | body height QTL GWAS2142024 (human) | | 1e-12 | body height | | 4 | 108362858 | 108362859 | Human |
| 616370904 | GWAS1851146_H | cerebral cortex area attribute QTL GWAS1851146 (human) | | 2e-09 | cerebral cortex area attribute | | 4 | 112495282 | 112495283 | Human |
| 597431802 | GWAS1527876_H | attempted suicide QTL GWAS1527876 (human) | | 0.000004 | behavior trait (VT:0010442) | | 4 | 110362552 | 110362553 | Human |
| 628560656 | GWAS2468885_H | cortical thickness QTL GWAS2468885 (human) | | 4e-13 | cerebral cortex morphology trait (VT:0000788) | | 4 | 120730658 | 120730659 | Human |
| 617190049 | GWAS2170489_H | level of carboxypeptidase Q in blood QTL GWAS2170489 (human) | | 2e-14 | level of carboxypeptidase Q in blood | | 4 | 118868269 | 118868270 | Human |
| 407350830 | GWAS999806_H | hair colour measurement QTL GWAS999806 (human) | | 5e-23 | hair colour measurement | | 4 | 108561329 | 108561330 | Human |
| 407186987 | GWAS835963_H | glycerophospholipid measurement QTL GWAS835963 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114582848 | 114582849 | Human |
| 407383590 | GWAS1032566_H | allergic disease, age at onset QTL GWAS1032566 (human) | | 2e-17 | allergic disease, age at onset | | 4 | 122481853 | 122481854 | Human |
| 407383591 | GWAS1032567_H | allergic disease, age at onset QTL GWAS1032567 (human) | | 2e-08 | allergic disease, age at onset | | 4 | 122219915 | 122219916 | Human |
| 597366260 | GWAS1462334_H | balding measurement QTL GWAS1462334 (human) | | 2e-14 | balding measurement | | 4 | 123825222 | 123825223 | Human |
| 407318070 | GWAS967046_H | cortical surface area measurement QTL GWAS967046 (human) | | 3e-18 | cortical surface area measurement | | 4 | 118359012 | 118359013 | Human |
| 616567477 | GWAS1964060_H | level of polypeptide N-acetylgalactosaminyltransferase 3 in blood serum QTL GWAS1964060 (human) | | 3e-14 | level of polypeptide N-acetylgalactosaminyltransferase 3 in blood serum | | 4 | 109948090 | 109948091 | Human |
| 407285299 | GWAS934275_H | glomerular filtration rate QTL GWAS934275 (human) | | 1e-13 | glomerular filtration rate | | 4 | 127272519 | 127272520 | Human |
| 628970251 | GWAS2878480_H | leukocyte quantity QTL GWAS2878480 (human) | | 2e-31 | leukocyte quantity | | 4 | 110001340 | 110001341 | Human |
| 407285310 | GWAS934286_H | glomerular filtration rate QTL GWAS934286 (human) | | 5e-13 | glomerular filtration rate | | 4 | 128601363 | 128601364 | Human |
| 597824984 | GWAS1692375_H | urate measurement QTL GWAS1692375 (human) | | 8e-09 | urate measurement | | 4 | 113560916 | 113560917 | Human |
| 597431776 | GWAS1527850_H | Red cell distribution width QTL GWAS1527850 (human) | | 7e-19 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 628364043 | GWAS2284887_H | phospholipid level, blood VLDL cholesterol amount QTL GWAS2284887 (human) | | 8e-09 | phospholipid level, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 597234969 | GWAS1331043_H | brain measurement QTL GWAS1331043 (human) | | 4e-10 | brain measurement | | 4 | 118393759 | 118393760 | Human |
| 407269063 | GWAS918039_H | body height QTL GWAS918039 (human) | | 8e-74 | body height | | 4 | 108355674 | 108355675 | Human |
| 597136661 | GWAS1232735_H | neuroimaging measurement QTL GWAS1232735 (human) | | 4e-09 | neuroimaging measurement | | 4 | 118376502 | 118376503 | Human |
| 616354366 | GWAS1839081_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1839081 (human) | | 0.0000006 | gut microbiome measurement, allergen exposure measurement | | 4 | 121979374 | 121979375 | Human |
| 597251354 | GWAS1347428_H | corneal resistance factor QTL GWAS1347428 (human) | | 7e-11 | corneal resistance factor | | 4 | 118816705 | 118816706 | Human |
| 628593649 | GWAS2501878_H | testosterone measurement QTL GWAS2501878 (human) | | 3e-13 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
| 628626431 | GWAS2534660_H | vital capacity QTL GWAS2534660 (human) | | 5e-08 | lung capacity (VT:0001942) | | 4 | 108557833 | 108557834 | Human |
| 628904951 | GWAS2813180_H | alpha-fetoprotein level QTL GWAS2813180 (human) | | 9e-12 | alpha-fetoprotein level | | 4 | 108749156 | 108749157 | Human |
| 616993357 | GWAS2010856_H | waist circumference QTL GWAS2010856 (human) | | 0.000009 | waist circumference | | 4 | 129883949 | 129883950 | Human |
| 597038362 | GWAS1134436_H | gut microbiome measurement QTL GWAS1134436 (human) | | 0.000002 | gut microbiome measurement | | 4 | 121059316 | 121059317 | Human |
| 616976971 | GWAS1994470_H | insomnia measurement QTL GWAS1994470 (human) | | 3e-08 | sleep behavior trait (VT:0001501) | | 4 | 111901575 | 111901576 | Human |
| 407006930 | GWAS655906_H | eye colour measurement QTL GWAS655906 (human) | | 0.000007 | eye colour measurement | | 4 | 121396276 | 121396277 | Human |
| 407301847 | GWAS950823_H | mean corpuscular volume QTL GWAS950823 (human) | | 1e-10 | mean corpuscular volume | | 4 | 121774530 | 121774531 | Human |
| 407023312 | GWAS672288_H | educational attainment QTL GWAS672288 (human) | | 0.000001 | educational attainment | | 4 | 121774163 | 121774164 | Human |
| 407269077 | GWAS918053_H | body height QTL GWAS918053 (human) | | 7e-88 | body height | | 4 | 119680576 | 119680577 | Human |
| 407023313 | GWAS672289_H | educational attainment QTL GWAS672289 (human) | | 6e-10 | educational attainment | | 4 | 119987548 | 119987549 | Human |
| 628872175 | GWAS2780404_H | N-acetylneuraminate measurement QTL GWAS2780404 (human) | | 2e-08 | N-acetylneuraminate measurement | | 4 | 110098606 | 110098607 | Human |
| 617206365 | GWAS2186805_H | body mass index QTL GWAS2186805 (human) | | 8e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 406925015 | GWAS573991_H | fetal hemoglobin measurement QTL GWAS573991 (human) | | 0.000006 | blood hemoglobin amount (VT:0001588) | | 4 | 120592060 | 120592061 | Human |
| 628806618 | GWAS2714847_H | COVID-19 QTL GWAS2714847 (human) | | 0.000006 | COVID-19 | | 4 | 106867781 | 106867782 | Human |
| 628806619 | GWAS2714848_H | COVID-19 QTL GWAS2714848 (human) | | 0.0000009 | COVID-19 | | 4 | 107808529 | 107808530 | Human |
| 597022000 | GWAS1118074_H | stromal cell-derived factor 1 alpha measurement QTL GWAS1118074 (human) | | 0.000002 | chemokine amount (VT:0008721) | | 4 | 115146334 | 115146335 | Human |
| 597464378 | GWAS1560452_H | lung carcinoma, family history of lung cancer QTL GWAS1560452 (human) | | 0.000008 | lung carcinoma, family history of lung cancer | | 4 | 131748595 | 131748596 | Human |
| 597054769 | GWAS1150843_H | multiple sclerosis QTL GWAS1150843 (human) | | 2e-11 | multiple sclerosis | | 4 | 108137562 | 108137563 | Human |
| 628773842 | GWAS2682071_H | sex hormone-binding globulin measurement QTL GWAS2682071 (human) | | 1e-11 | sex hormone-binding globulin measurement | | 4 | 109104450 | 109104451 | Human |
| 617124448 | GWAS2141947_H | hematocrit QTL GWAS2141947 (human) | | 1e-23 | hematocrit | | 4 | 109717668 | 109717669 | Human |
| 628822994 | GWAS2731223_H | fibroblast growth factor 2 level QTL GWAS2731223 (human) | | 6e-39 | fibroblast growth factor 2 level | | 4 | 122836593 | 122836594 | Human |
| 407187183 | GWAS836159_H | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS836159 (human) | | 5e-10 | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597153083 | GWAS1249157_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1249157 (human) | | 7e-14 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | | 4 | 109657070 | 109657071 | Human |
| 616501778 | GWAS1898361_H | inactive pancreatic lipase-related protein 1 measurement QTL GWAS1898361 (human) | | 3e-12 | inactive pancreatic lipase-related protein 1 measurement | | 4 | 109902959 | 109902960 | Human |
| 597185845 | GWAS1281919_H | major depressive disorder QTL GWAS1281919 (human) | | 5e-12 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
| 628478939 | GWAS2387168_H | feeling "fed-up" measurement QTL GWAS2387168 (human) | | 5e-08 | emotion/affect behavior trait (VT:0002572) | | 4 | 122465996 | 122465997 | Human |
| 597185846 | GWAS1281920_H | major depressive disorder QTL GWAS1281920 (human) | | 2e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
| 628478938 | GWAS2387167_H | feeling "fed-up" measurement QTL GWAS2387167 (human) | | 2e-08 | emotion/affect behavior trait (VT:0002572) | | 4 | 122201701 | 122201702 | Human |
| 625824765 | GWAS2245687_H | body height QTL GWAS2245687 (human) | | 4e-28 | body height | | 4 | 108535458 | 108535459 | Human |
| 597988629 | GWAS1707928_H | chromosome, telomeric region length QTL GWAS1707928 (human) | | 5e-08 | chromosome, telomeric region length | | 4 | 107383042 | 107383043 | Human |
| 625824764 | GWAS2245686_H | body height QTL GWAS2245686 (human) | | 5e-09 | body height | | 4 | 108530315 | 108530316 | Human |
| 407400185 | GWAS1049161_H | BMI-adjusted waist-hip ratio QTL GWAS1049161 (human) | | 6e-10 | BMI-adjusted waist-hip ratio | | 4 | 119763897 | 119763898 | Human |
| 407039731 | GWAS688707_H | chronic obstructive pulmonary disease QTL GWAS688707 (human) | | 5e-19 | chronic obstructive pulmonary disease | | 4 | 123900578 | 123900579 | Human |
| 625824767 | GWAS2245689_H | body height QTL GWAS2245689 (human) | | 3e-13 | body height | | 4 | 113968498 | 113968499 | Human |
| 625824766 | GWAS2245688_H | body height QTL GWAS2245688 (human) | | 7e-10 | body height | | 4 | 113800031 | 113800032 | Human |
| 407023351 | GWAS672327_H | sclerosing cholangitis QTL GWAS672327 (human) | | 2e-10 | sclerosing cholangitis | | 4 | 122578590 | 122578591 | Human |
| 597611814 | GWAS1668674_H | platelet count QTL GWAS1668674 (human) | | 3e-25 | platelet count | | 4 | 109927496 | 109927497 | Human |
| 597611815 | GWAS1668675_H | platelet count QTL GWAS1668675 (human) | | 1e-13 | platelet count | | 4 | 119439096 | 119439097 | Human |
| 616370694 | GWAS1850936_H | obsolete_thyroxine measurement QTL GWAS1850936 (human) | | 5e-08 | obsolete_thyroxine measurement | | 4 | 123563112 | 123563113 | Human |
| 407318266 | GWAS967242_H | testosterone measurement QTL GWAS967242 (human) | | 6e-15 | testosterone measurement | | 4 | 124126476 | 124126477 | Human |
| 597153110 | GWAS1249184_H | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS1249184 (human) | | 2e-09 | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | | 4 | 109657070 | 109657071 | Human |
| 597251419 | GWAS1347493_H | rheumatoid arthritis QTL GWAS1347493 (human) | | 0.0000007 | rheumatoid arthritis | | 4 | 122297158 | 122297159 | Human |
| 407400076 | GWAS1049052_H | empathy measurement QTL GWAS1049052 (human) | | 0.000008 | empathy measurement | | 4 | 111486019 | 111486020 | Human |
| 407137928 | GWAS786904_H | cognitive decline measurement QTL GWAS786904 (human) | | 0.000004 | cognitive decline measurement | | 4 | 110589931 | 110589932 | Human |
| 407023247 | GWAS672223_H | educational attainment QTL GWAS672223 (human) | | 0.000009 | educational attainment | | 4 | 107916747 | 107916748 | Human |
| 628446138 | GWAS2354367_H | mean corpuscular hemoglobin concentration QTL GWAS2354367 (human) | | 5e-72 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121870446 | 121870447 | Human |
| 407023250 | GWAS672226_H | educational attainment QTL GWAS672226 (human) | | 1e-10 | educational attainment | | 4 | 112220279 | 112220280 | Human |
| 597251400 | GWAS1347474_H | HbA1c measurement QTL GWAS1347474 (human) | | 0.000001 | HbA1c measurement | | 4 | 109980042 | 109980043 | Human |
| 407023251 | GWAS672227_H | educational attainment QTL GWAS672227 (human) | | 4e-11 | educational attainment | | 4 | 114059072 | 114059073 | Human |
| 407023248 | GWAS672224_H | educational attainment QTL GWAS672224 (human) | | 4e-10 | educational attainment | | 4 | 109603314 | 109603315 | Human |
| 407023249 | GWAS672225_H | educational attainment QTL GWAS672225 (human) | | 1e-11 | educational attainment | | 4 | 111489199 | 111489200 | Human |
| 597448008 | GWAS1544082_H | clostridium difficile infection QTL GWAS1544082 (human) | | 0.000008 | clostridium difficile infection | | 4 | 108850323 | 108850324 | Human |
| 626463619 | GWAS2277552_H | triglyceride measurement QTL GWAS2277552 (human) | | 4e-08 | triglyceride measurement | | 4 | 112187786 | 112187787 | Human |
| 407023254 | GWAS672230_H | educational attainment QTL GWAS672230 (human) | | 5e-08 | educational attainment | | 4 | 117355510 | 117355511 | Human |
| 597464392 | GWAS1560466_H | body mass index QTL GWAS1560466 (human) | | 1e-14 | body mass index | | 4 | 129805678 | 129805679 | Human |
| 407023255 | GWAS672231_H | educational attainment QTL GWAS672231 (human) | | 3e-10 | educational attainment | | 4 | 117508319 | 117508320 | Human |
| 616354409 | GWAS1839124_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1839124 (human) | | 0.0000004 | gut microbiome measurement, allergen exposure measurement | | 4 | 121979374 | 121979375 | Human |
| 407023252 | GWAS672228_H | educational attainment QTL GWAS672228 (human) | | 2e-08 | educational attainment | | 4 | 115086647 | 115086648 | Human |
| 407023253 | GWAS672229_H | educational attainment QTL GWAS672229 (human) | | 0.000002 | educational attainment | | 4 | 115489506 | 115489507 | Human |
| 407023258 | GWAS672234_H | exploratory eye movement measurement QTL GWAS672234 (human) | | 0.000008 | exploratory eye movement measurement | | 4 | 114477044 | 114477045 | Human |
| 628577198 | GWAS2485427_H | triglyceride measurement QTL GWAS2485427 (human) | | 1e-38 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109717668 | 109717669 | Human |
| 597382466 | GWAS1478540_H | age at menarche QTL GWAS1478540 (human) | | 7e-08 | age at menarche | | 4 | 129809917 | 129809918 | Human |
| 597136717 | GWAS1232791_H | bone density QTL GWAS1232791 (human) | | 9e-74 | bone density | | 4 | 116630743 | 116630744 | Human |
| 597595460 | GWAS1652320_H | body mass index QTL GWAS1652320 (human) | | 2e-28 | body mass index | | 4 | 129818987 | 129818988 | Human |
| 597316934 | GWAS1413008_H | cognitive function measurement QTL GWAS1413008 (human) | | 0.000009 | cognitive function measurement | | 4 | 119010553 | 119010554 | Human |
| 597611841 | GWAS1668701_H | exostosis QTL GWAS1668701 (human) | | 4e-11 | exostosis | | 4 | 125701864 | 125701865 | Human |
| 597529981 | GWAS1626055_H | glomerular filtration rate QTL GWAS1626055 (human) | | 3e-15 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 407269026 | GWAS918002_H | atrial fibrillation QTL GWAS918002 (human) | | 2e-101 | atrial fibrillation | | 4 | 110789946 | 110789947 | Human |
| 628642717 | GWAS2550946_H | gut microbiome measurement, environmental exposure measurement QTL GWAS2550946 (human) | | 4e-08 | gut microbiome measurement, environmental exposure measurement | | 4 | 123477905 | 123477906 | Human |
| 597022077 | GWAS1118151_H | tumor necrosis factor-alpha measurement QTL GWAS1118151 (human) | | 0.0000008 | tumor necrosis factor-alpha measurement | | 4 | 123440293 | 123440294 | Human |
| 628462488 | GWAS2370717_H | systolic blood pressure QTL GWAS2370717 (human) | | 5e-09 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 123873489 | 123873490 | Human |
| 628609926 | GWAS2518155_H | apolipoprotein A 1 measurement QTL GWAS2518155 (human) | | 2e-41 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 4 | 109717668 | 109717669 | Human |
| 597480815 | GWAS1576889_H | mean arterial pressure QTL GWAS1576889 (human) | | 1e-15 | mean arterial pressure | | 4 | 110430068 | 110430069 | Human |
| 617042483 | GWAS2059982_H | Antithrombotic agent use measurement QTL GWAS2059982 (human) | | 4e-20 | Antithrombotic agent use measurement | | 4 | 110784139 | 110784140 | Human |
| 407088821 | GWAS737797_H | corneal topography QTL GWAS737797 (human) | | 8e-09 | corneal topography | | 4 | 127192269 | 127192270 | Human |
| 626463663 | GWAS2277596_H | platelet count QTL GWAS2277596 (human) | | 1e-28 | platelet count | | 4 | 119622957 | 119622958 | Human |
| 407269055 | GWAS918031_H | body height QTL GWAS918031 (human) | | 0.00001 | body height | | 4 | 108342899 | 108342900 | Human |
| 407400113 | GWAS1049089_H | mathematical ability QTL GWAS1049089 (human) | | 1e-08 | mathematical ability | | 4 | 111859867 | 111859868 | Human |
| 407269052 | GWAS918028_H | body height QTL GWAS918028 (human) | | 5e-36 | body height | | 4 | 108315298 | 108315299 | Human |
| 597169506 | GWAS1265580_H | acne QTL GWAS1265580 (human) | | 6e-16 | acne | | 4 | 123258364 | 123258365 | Human |
| 407400114 | GWAS1049090_H | mathematical ability QTL GWAS1049090 (human) | | 1e-08 | mathematical ability | | 4 | 132101754 | 132101755 | Human |
| 407269053 | GWAS918029_H | body height QTL GWAS918029 (human) | | 2e-31 | body height | | 4 | 108330552 | 108330553 | Human |
| 598054233 | GWAS1773532_H | erythrocyte volume QTL GWAS1773532 (human) | | 6e-33 | erythrocyte volume | | 4 | 121854912 | 121854913 | Human |
| 597398887 | GWAS1494961_H | age at onset, major depressive disorder QTL GWAS1494961 (human) | | 0.000007 | age at onset, major depressive disorder | | 4 | 127602809 | 127602810 | Human |
| 628740998 | GWAS2649227_H | BMI-adjusted waist circumference QTL GWAS2649227 (human) | | 8e-09 | body size trait (VT:0100005) | | 4 | 123359695 | 123359696 | Human |
| 617059271 | GWAS2076770_H | glomerular filtration rate QTL GWAS2076770 (human) | | 5e-12 | glomerular filtration rate | | 4 | 128601363 | 128601364 | Human |
| 597513372 | GWAS1609446_H | sex hormone-binding globulin measurement QTL GWAS1609446 (human) | | 7e-23 | sex hormone-binding globulin measurement | | 4 | 109321740 | 109321741 | Human |
| 617059270 | GWAS2076769_H | glomerular filtration rate QTL GWAS2076769 (human) | | 4e-20 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 617059269 | GWAS2076768_H | glomerular filtration rate QTL GWAS2076768 (human) | | 4e-08 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 616567755 | GWAS1964338_H | N-acylethanolamine-hydrolyzing acid amidase measurement QTL GWAS1964338 (human) | | 3e-12 | N-acylethanolamine-hydrolyzing acid amidase measurement | | 4 | 109657070 | 109657071 | Human |
| 597103772 | GWAS1199846_H | amyloid-beta measurement QTL GWAS1199846 (human) | | 0.000009 | serum amyloid protein amount (VT:0010037) | | 4 | 129232535 | 129232536 | Human |
| 628839030 | GWAS2747259_H | gut microbiome measurement QTL GWAS2747259 (human) | | 9e-09 | gut microbiome measurement | | 4 | 126866560 | 126866561 | Human |
| 597578896 | GWAS1635756_H | prothrombin time measurement QTL GWAS1635756 (human) | | 5e-51 | prothrombin time measurement | | 4 | 110784139 | 110784140 | Human |
| 628839029 | GWAS2747258_H | gut microbiome measurement QTL GWAS2747258 (human) | | 3e-08 | gut microbiome measurement | | 4 | 126866560 | 126866561 | Human |
| 407056208 | GWAS705184_H | acne QTL GWAS705184 (human) | | 2e-09 | acne | | 4 | 123332634 | 123332635 | Human |
| 617108444 | GWAS2125943_H | low density lipoprotein cholesterol measurement QTL GWAS2125943 (human) | | 1e-09 | low density lipoprotein cholesterol measurement | | 4 | 119202262 | 119202263 | Human |
| 616387496 | GWAS1867738_H | Increased total eosinophil count QTL GWAS1867738 (human) | | 2e-12 | Increased total eosinophil count | | 4 | 108762086 | 108762087 | Human |
| 617010131 | GWAS2027630_H | neuroticism measurement QTL GWAS2027630 (human) | | 3e-08 | neuroticism measurement | | 4 | 118263414 | 118263415 | Human |
| 628462179 | GWAS2370408_H | renal transplant outcome measurement, glomerular filtration rate, donor genotype effect measurement QTL GWAS2370408 (human) | | 0.000004 | renal transplant outcome measurement, glomerular filtration rate, donor genotype effect measurement | | 4 | 119026891 | 119026892 | Human |
| 597087360 | GWAS1183434_H | allergic disease, age at onset QTL GWAS1183434 (human) | | 2e-17 | allergic disease, age at onset | | 4 | 122481853 | 122481854 | Human |
| 626463311 | GWAS2277244_H | body height QTL GWAS2277244 (human) | | 1e-49 | body height | | 4 | 108535458 | 108535459 | Human |
| 406908760 | GWAS557736_H | intelligence QTL GWAS557736 (human) | | 9e-08 | intelligence | | 4 | 130212336 | 130212337 | Human |
| 625824337 | GWAS2245259_H | body height QTL GWAS2245259 (human) | | 6e-11 | body height | | 4 | 108361577 | 108361578 | Human |
| 597496961 | GWAS1593035_H | memory performance QTL GWAS1593035 (human) | | 0.000001 | memory performance | | 4 | 125709483 | 125709484 | Human |
| 617206741 | GWAS2187181_H | body mass index QTL GWAS2187181 (human) | | 4e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 625824336 | GWAS2245258_H | body height QTL GWAS2245258 (human) | | 1e-08 | body height | | 4 | 108146742 | 108146743 | Human |
| 616354721 | GWAS1839436_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS1839436 (human) | | 6e-09 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 110961148 | 110961149 | Human |
| 597283972 | GWAS1380046_H | trefoil factor 3 measurement QTL GWAS1380046 (human) | | 3e-09 | trefoil factor 3 measurement | | 4 | 120726405 | 120726406 | Human |
| 597496960 | GWAS1593034_H | memory performance QTL GWAS1593034 (human) | | 0.000001 | memory performance | | 4 | 125705326 | 125705327 | Human |
| 625824339 | GWAS2245261_H | body height QTL GWAS2245261 (human) | | 3e-08 | body height | | 4 | 108525913 | 108525914 | Human |
| 625824338 | GWAS2245260_H | body height QTL GWAS2245260 (human) | | 6e-09 | body height | | 4 | 108441767 | 108441768 | Human |
| 407383914 | GWAS1032890_H | allergic disease QTL GWAS1032890 (human) | | 5e-22 | allergic disease | | 4 | 122481853 | 122481854 | Human |
| 407187303 | GWAS836279_H | insomnia measurement QTL GWAS836279 (human) | | 2e-08 | insomnia measurement | | 4 | 129592716 | 129592717 | Human |
| 628478544 | GWAS2386773_H | serum copper measurement QTL GWAS2386773 (human) | | 0.000001 | blood copper amount (VT:0010907) | serum copper level (CMO:0003465) | 4 | 113027634 | 113027635 | Human |
| 406941542 | GWAS590518_H | QRS-T angle QTL GWAS590518 (human) | | 9e-11 | QRS-T angle | | 4 | 110650661 | 110650662 | Human |
| 597284016 | GWAS1380090_H | high density lipoprotein cholesterol measurement QTL GWAS1380090 (human) | | 5e-22 | high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597054655 | GWAS1150729_H | multiple sclerosis QTL GWAS1150729 (human) | | 0.0000002 | multiple sclerosis | | 4 | 112153589 | 112153590 | Human |
| 597038264 | GWAS1134338_H | gut microbiome measurement QTL GWAS1134338 (human) | | 0.000006 | gut microbiome measurement | | 4 | 128732972 | 128732973 | Human |
| 597267625 | GWAS1363699_H | cardioembolic stroke QTL GWAS1363699 (human) | | 0.0000003 | cardioembolic stroke | | 4 | 110841700 | 110841701 | Human |
| 598004884 | GWAS1724183_H | brain connectivity attribute QTL GWAS1724183 (human) | | 2e-11 | brain connectivity attribute | | 4 | 125825074 | 125825075 | Human |
| 616961013 | GWAS1978512_H | facial morphology trait QTL GWAS1978512 (human) | | 2e-09 | facial morphology trait | | 4 | 121076949 | 121076950 | Human |
| 617026548 | GWAS2044047_H | self reported educational attainment QTL GWAS2044047 (human) | | 4e-09 | self reported educational attainment | | 4 | 129748953 | 129748954 | Human |
| 617026547 | GWAS2044046_H | self reported educational attainment QTL GWAS2044046 (human) | | 2e-08 | self reported educational attainment | | 4 | 117593081 | 117593082 | Human |
| 617190398 | GWAS2170838_H | level of glutamyl aminopeptidase in blood QTL GWAS2170838 (human) | | 2e-25 | level of glutamyl aminopeptidase in blood | | 4 | 110510288 | 110510289 | Human |
| 617092095 | GWAS2109594_H | body height QTL GWAS2109594 (human) | | 2e-14 | body height | | 4 | 119759795 | 119759796 | Human |
| 597267623 | GWAS1363697_H | cardioembolic stroke QTL GWAS1363697 (human) | | 5e-08 | cardioembolic stroke | | 4 | 110673205 | 110673206 | Human |
| 407023484 | GWAS672460_H | unipolar depression QTL GWAS672460 (human) | | 0.000007 | unipolar depression | | 4 | 124494379 | 124494380 | Human |
| 616993671 | GWAS2011170_H | body mass index QTL GWAS2011170 (human) | | 4e-10 | body mass index | | 4 | 119398279 | 119398280 | Human |
| 628363830 | GWAS2284674_H | Anxiety QTL GWAS2284674 (human) | | 2e-08 | Anxiety | | 4 | 118133633 | 118133634 | Human |
| 407056132 | GWAS705108_H | eosinophil count QTL GWAS705108 (human) | | 5e-27 | eosinophil count | | 4 | 122680359 | 122680360 | Human |
| 597578965 | GWAS1635825_H | prothrombin time measurement QTL GWAS1635825 (human) | | 1e-54 | prothrombin time measurement | | 4 | 110796911 | 110796912 | Human |
| 597611730 | GWAS1668590_H | esophageal ulcer QTL GWAS1668590 (human) | | 1e-11 | esophageal ulcer | | 4 | 130688376 | 130688377 | Human |
| 597464275 | GWAS1560349_H | glucose metabolism measurement, age-related hearing impairment QTL GWAS1560349 (human) | | 0.000007 | glucose metabolism measurement, age-related hearing impairment | | 4 | 120558243 | 120558244 | Human |
| 597497037 | GWAS1593111_H | hip geometry QTL GWAS1593111 (human) | | 3e-09 | body size trait (VT:0100005) | hip circumference (CMO:0000014) | 4 | 108377273 | 108377274 | Human |
| 628593186 | GWAS2501415_H | lipoprotein measurement QTL GWAS2501415 (human) | | 3e-10 | blood lipoprotein particle size (VT:0010702) | blood lipoprotein measurement (CMO:0002690) | 4 | 109657070 | 109657071 | Human |
| 597021901 | GWAS1117975_H | C-C motif chemokine 7 measurement QTL GWAS1117975 (human) | | 0.000002 | C-C motif chemokine 7 measurement | | 4 | 110137551 | 110137552 | Human |
| 407367454 | GWAS1016430_H | protein measurement QTL GWAS1016430 (human) | | 6e-10 | protein measurement | | 4 | 131061544 | 131061545 | Human |
| 597513415 | GWAS1609489_H | smoking cessation QTL GWAS1609489 (human) | | 1e-10 | smoking cessation | | 4 | 112087702 | 112087703 | Human |
| 407400212 | GWAS1049188_H | age at first sexual intercourse measurement QTL GWAS1049188 (human) | | 4e-16 | age at first sexual intercourse measurement | | 4 | 111582716 | 111582717 | Human |
| 597578944 | GWAS1635804_H | potassium deficiency disease QTL GWAS1635804 (human) | | 3e-11 | potassium deficiency disease | | 4 | 108140367 | 108140368 | Human |
| 597365956 | GWAS1462030_H | hair color QTL GWAS1462030 (human) | | 3e-20 | hair color | | 4 | 108556952 | 108556953 | Human |
| 407252761 | GWAS901737_H | asthma QTL GWAS901737 (human) | | 5e-25 | asthma | | 4 | 122432277 | 122432278 | Human |
| 616960932 | GWAS1978431_H | monocyte count QTL GWAS1978431 (human) | | 4e-20 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109959208 | 109959209 | Human |
| 597300473 | GWAS1396547_H | complement factor I measurement QTL GWAS1396547 (human) | | 9e-37 | complement factor I measurement | | 4 | 109735574 | 109735575 | Human |
| 597103857 | GWAS1199931_H | alopecia QTL GWAS1199931 (human) | | 0.000005 | alopecia | | 4 | 106961892 | 106961893 | Human |
| 597398768 | GWAS1494842_H | Diuretic use measurement QTL GWAS1494842 (human) | | 4e-10 | Diuretic use measurement | | 4 | 110465271 | 110465272 | Human |
| 597202164 | GWAS1298238_H | bone density QTL GWAS1298238 (human) | | 4e-11 | bone density | | 4 | 108147096 | 108147097 | Human |
| 407138088 | GWAS787064_H | right ventricular systolic volume measurement QTL GWAS787064 (human) | | 1e-08 | right ventricular systolic volume measurement | | 4 | 119517499 | 119517500 | Human |
| 407269170 | GWAS918146_H | body height QTL GWAS918146 (human) | | 1e-22 | body height | | 4 | 109940771 | 109940772 | Human |
| 597038306 | GWAS1134380_H | gut microbiome measurement QTL GWAS1134380 (human) | | 0.000008 | gut microbiome measurement | | 4 | 119132069 | 119132070 | Human |
| 407269171 | GWAS918147_H | body height QTL GWAS918147 (human) | | 1e-20 | body height | | 4 | 110649067 | 110649068 | Human |
| 597120239 | GWAS1216313_H | major depressive disorder QTL GWAS1216313 (human) | | 3e-09 | major depressive disorder | | 4 | 130315312 | 130315313 | Human |
| 628445708 | GWAS2353937_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS2353937 (human) | | 6e-20 | Eczematoid dermatitis, allergic rhinitis | | 4 | 122219915 | 122219916 | Human |
| 407220031 | GWAS869007_H | coronary artery disease QTL GWAS869007 (human) | | 2e-08 | coronary artery disease | | 4 | 120015426 | 120015427 | Human |
| 597234914 | GWAS1330988_H | blood protein measurement QTL GWAS1330988 (human) | | 3e-289 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628642307 | GWAS2550536_H | gut microbiome measurement, breastfeeding duration QTL GWAS2550536 (human) | | 2e-08 | lactation duration (VT:1000653) | | 4 | 123477905 | 123477906 | Human |
| 597218532 | GWAS1314606_H | COVID-19 QTL GWAS1314606 (human) | | 0.000009 | COVID-19 | | 4 | 109566395 | 109566396 | Human |
| 628445705 | GWAS2353934_H | Eczematoid dermatitis, allergic rhinitis QTL GWAS2353934 (human) | | 2e-30 | Eczematoid dermatitis, allergic rhinitis | | 4 | 122432277 | 122432278 | Human |
| 407367622 | GWAS1016598_H | blood protein measurement QTL GWAS1016598 (human) | | 6e-375 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 406941635 | GWAS590611_H | trait in response to allopurinol, uric acid measurement QTL GWAS590611 (human) | | 0.000009 | trait in response to allopurinol, uric acid measurement | | 4 | 115481897 | 115481898 | Human |
| 628986613 | GWAS2894842_H | congestive heart failure QTL GWAS2894842 (human) | | 6e-16 | heart integrity trait (VT:0010757) | | 4 | 110737902 | 110737903 | Human |
| 628675315 | GWAS2583544_H | oligodendroglioma QTL GWAS2583544 (human) | | 0.000002 | oligodendroglioma | | 4 | 132099972 | 132099973 | Human |
| 407400388 | GWAS1049364_H | hypertrophic cardiomyopathy QTL GWAS1049364 (human) | | 0.0000006 | hypertrophic cardiomyopathy | | 4 | 130926839 | 130926840 | Human |
| 628839158 | GWAS2747387_H | amino acid measurement QTL GWAS2747387 (human) | | 0.0000004 | blood amino acid amount (VT:0005311) | | 4 | 125452415 | 125452416 | Human |
| 597283854 | GWAS1379928_H | diastolic blood pressure QTL GWAS1379928 (human) | | 2e-09 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 407138259 | GWAS787235_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS787235 (human) | | 0.0000006 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 122692161 | 122692162 | Human |
| 628740833 | GWAS2649062_H | BMI-adjusted waist circumference QTL GWAS2649062 (human) | | 2e-09 | body size trait (VT:0100005) | | 4 | 119768762 | 119768763 | Human |
| 628740832 | GWAS2649061_H | BMI-adjusted waist circumference QTL GWAS2649061 (human) | | 2e-13 | body size trait (VT:0100005) | | 4 | 119649123 | 119649124 | Human |
| 628740835 | GWAS2649064_H | BMI-adjusted waist circumference QTL GWAS2649064 (human) | | 5e-09 | body size trait (VT:0100005) | | 4 | 122858186 | 122858187 | Human |
| 628740834 | GWAS2649063_H | BMI-adjusted waist circumference QTL GWAS2649063 (human) | | 1e-09 | body size trait (VT:0100005) | | 4 | 121700964 | 121700965 | Human |
| 628740837 | GWAS2649066_H | BMI-adjusted waist circumference QTL GWAS2649066 (human) | | 4e-08 | body size trait (VT:0100005) | | 4 | 123169108 | 123169109 | Human |
| 628822758 | GWAS2730987_H | cardiac troponin I measurement QTL GWAS2730987 (human) | | 0.0000004 | heart molecular composition trait (VT:0010755) | blood troponin T level (CMO:0001284) | 4 | 118958433 | 118958434 | Human |
| 628740839 | GWAS2649068_H | BMI-adjusted waist circumference QTL GWAS2649068 (human) | | 5e-12 | body size trait (VT:0100005) | | 4 | 123166618 | 123166619 | Human |
| 628740838 | GWAS2649067_H | BMI-adjusted waist circumference QTL GWAS2649067 (human) | | 3e-11 | body size trait (VT:0100005) | | 4 | 123124286 | 123124287 | Human |
| 407089121 | GWAS738097_H | atrial fibrillation QTL GWAS738097 (human) | | 2e-427 | atrial fibrillation | | 4 | 110775495 | 110775496 | Human |
| 407089120 | GWAS738096_H | atrial fibrillation QTL GWAS738096 (human) | | 4e-427 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 407220193 | GWAS869169_H | adolescent idiopathic scoliosis QTL GWAS869169 (human) | | 0.0000005 | adolescent idiopathic scoliosis | | 4 | 119460368 | 119460369 | Human |
| 628740831 | GWAS2649060_H | BMI-adjusted waist circumference QTL GWAS2649060 (human) | | 4e-11 | body size trait (VT:0100005) | | 4 | 119213641 | 119213642 | Human |
| 597087295 | GWAS1183369_H | allergic disease QTL GWAS1183369 (human) | | 5e-22 | allergic disease | | 4 | 122481853 | 122481854 | Human |
| 597464117 | GWAS1560191_H | neurofibrillary tangles measurement QTL GWAS1560191 (human) | | 0.000003 | brain integrity trait (VT:0010579) | | 4 | 129358580 | 129358581 | Human |
| 597038143 | GWAS1134217_H | treatment resistant depression, response to antidepressant QTL GWAS1134217 (human) | | 0.000004 | treatment resistant depression, response to antidepressant | | 4 | 130496927 | 130496928 | Human |
| 597038140 | GWAS1134214_H | treatment resistant depression, response to antidepressant QTL GWAS1134214 (human) | | 0.0000001 | treatment resistant depression, response to antidepressant | | 4 | 130459962 | 130459963 | Human |
| 597087293 | GWAS1183367_H | allergic disease QTL GWAS1183367 (human) | | 7e-13 | asthma | | 4 | 122219915 | 122219916 | Human |
| 616354572 | GWAS1839287_H | delivery measurement, gut microbiome measurement QTL GWAS1839287 (human) | | 0.000002 | delivery measurement, gut microbiome measurement | | 4 | 110717326 | 110717327 | Human |
| 407269364 | GWAS918340_H | body height QTL GWAS918340 (human) | | 9e-12 | body height | | 4 | 119937025 | 119937026 | Human |
| 407269365 | GWAS918341_H | body height QTL GWAS918341 (human) | | 7e-18 | body height | | 4 | 120068926 | 120068927 | Human |
| 407269362 | GWAS918338_H | body height QTL GWAS918338 (human) | | 6e-09 | body height | | 4 | 119774304 | 119774305 | Human |
| 407269363 | GWAS918339_H | body height QTL GWAS918339 (human) | | 2e-128 | body height | | 4 | 119834940 | 119834941 | Human |
| 598021136 | GWAS1740435_H | obsolete_fat body mass, hip bone mineral density QTL GWAS1740435 (human) | | 6e-09 | obsolete_fat body mass, hip bone mineral density | | 4 | 129257175 | 129257176 | Human |
| 407269360 | GWAS918336_H | body height QTL GWAS918336 (human) | | 6e-46 | body height | | 4 | 119733676 | 119733677 | Human |
| 616354567 | GWAS1839282_H | gut microbiome measurement QTL GWAS1839282 (human) | | 4e-08 | gut microbiome measurement | | 4 | 130031153 | 130031154 | Human |
| 597169188 | GWAS1265262_H | facial morphology measurement QTL GWAS1265262 (human) | | 3e-29 | facial morphology measurement | | 4 | 127007438 | 127007439 | Human |
| 597103703 | GWAS1199777_H | diastolic blood pressure, systolic blood pressure QTL GWAS1199777 (human) | | 0.000003 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 113264849 | 113264850 | Human |
| 406957959 | GWAS606935_H | carotid plaque build QTL GWAS606935 (human) | | 0.000001 | artery integrity trait (VT:0010639) | | 4 | 109034785 | 109034786 | Human |
| 597333085 | GWAS1429159_H | neuroimaging measurement QTL GWAS1429159 (human) | | 5e-09 | neuroimaging measurement | | 4 | 114719632 | 114719636 | Human |
| 597578839 | GWAS1635699_H | macular degeneration QTL GWAS1635699 (human) | | 2e-11 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 407236492 | GWAS885468_H | gut microbiome measurement QTL GWAS885468 (human) | | 9e-09 | gut microbiome measurement | | 4 | 126866560 | 126866561 | Human |
| 597021791 | GWAS1117865_H | platelet-derived growth factor BB measurement QTL GWAS1117865 (human) | | 0.000009 | platelet-derived growth factor BB measurement | | 4 | 116687083 | 116687084 | Human |
| 597333073 | GWAS1429147_H | neuroimaging measurement QTL GWAS1429147 (human) | | 2e-09 | neuroimaging measurement | | 4 | 114732469 | 114732470 | Human |
| 597038171 | GWAS1134245_H | gut microbiome measurement QTL GWAS1134245 (human) | | 0.000006 | gut microbiome measurement | | 4 | 123354475 | 123354476 | Human |
| 407236491 | GWAS885467_H | gut microbiome measurement QTL GWAS885467 (human) | | 3e-08 | gut microbiome measurement | | 4 | 126866560 | 126866561 | Human |
| 597120071 | GWAS1216145_H | triglyceride measurement QTL GWAS1216145 (human) | | 1e-38 | high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 628708008 | GWAS2616237_H | fibroblast growth factor 2 level QTL GWAS2616237 (human) | | 5e-34 | fibroblast growth factor 2 level | | 4 | 123107513 | 123107514 | Human |
| 407400345 | GWAS1049321_H | protein measurement QTL GWAS1049321 (human) | | 7e-09 | protein measurement | | 4 | 132318854 | 132318855 | Human |
| 628806318 | GWAS2714547_H | protein measurement QTL GWAS2714547 (human) | | 1e-146 | protein amount (VT:0010120) | | 4 | 119446728 | 119446729 | Human |
| 628806317 | GWAS2714546_H | protein measurement QTL GWAS2714546 (human) | | 7e-1675 | protein amount (VT:0010120) | | 4 | 119342003 | 119342004 | Human |
| 628806307 | GWAS2714536_H | fibroblast growth factor 2 level QTL GWAS2714536 (human) | | 8e-667 | fibroblast growth factor 2 level | | 4 | 122827461 | 122827462 | Human |
| 597464128 | GWAS1560202_H | lung adenocarcinoma, family history of lung cancer QTL GWAS1560202 (human) | | 0.000009 | lung adenocarcinoma, family history of lung cancer | | 4 | 111828356 | 111828357 | Human |
| 616960793 | GWAS1978292_H | pulse pressure measurement QTL GWAS1978292 (human) | | 3e-73 | pulse pressure measurement | | 4 | 115629004 | 115629005 | Human |
| 628707993 | GWAS2616222_H | fibroblast growth factor 2 level QTL GWAS2616222 (human) | | 5e-21 | fibroblast growth factor 2 level | | 4 | 122629385 | 122629386 | Human |
| 616960806 | GWAS1978305_H | erectile dysfunction QTL GWAS1978305 (human) | | 0.000009 | erectile dysfunction | | 4 | 123943461 | 123943462 | Human |
| 628707992 | GWAS2616221_H | fibroblast growth factor 2 level QTL GWAS2616221 (human) | | 2e-20 | fibroblast growth factor 2 level | | 4 | 122663955 | 122663956 | Human |
| 628707994 | GWAS2616223_H | fibroblast growth factor 2 level QTL GWAS2616223 (human) | | 2e-22 | fibroblast growth factor 2 level | | 4 | 122843079 | 122843080 | Human |
| 617091887 | GWAS2109386_H | intelligence QTL GWAS2109386 (human) | | 5e-09 | intelligence | | 4 | 112490199 | 112490200 | Human |
| 617009962 | GWAS2027461_H | smoking status measurement QTL GWAS2027461 (human) | | 5e-08 | smoking status measurement | | 4 | 111582716 | 111582717 | Human |
| 597202037 | GWAS1298111_H | electrocardiography QTL GWAS1298111 (human) | | 2e-08 | electrocardiography | | 4 | 110782354 | 110782355 | Human |
| 597202038 | GWAS1298112_H | electrocardiography QTL GWAS1298112 (human) | | 4e-31 | electrocardiography | | 4 | 113508251 | 113508252 | Human |
| 628707991 | GWAS2616220_H | fibroblast growth factor 2 level QTL GWAS2616220 (human) | | 5e-17 | fibroblast growth factor 2 level | | 4 | 122424054 | 122424055 | Human |
| 628707990 | GWAS2616219_H | fibroblast growth factor 2 level QTL GWAS2616219 (human) | | 2e-33 | fibroblast growth factor 2 level | | 4 | 122815622 | 122815623 | Human |
| 407383995 | GWAS1032971_H | erythrocyte count QTL GWAS1032971 (human) | | 8e-17 | erythrocyte count | | 4 | 114598115 | 114598116 | Human |
| 597333100 | GWAS1429174_H | atrial fibrillation QTL GWAS1429174 (human) | | 6e-47 | atrial fibrillation | | 4 | 110776497 | 110776498 | Human |
| 616960828 | GWAS1978327_H | chronotype measurement QTL GWAS1978327 (human) | | 4e-09 | chronotype measurement | | 4 | 117394404 | 117394405 | Human |
| 407171007 | GWAS819983_H | self reported educational attainment QTL GWAS819983 (human) | | 9e-12 | self reported educational attainment | | 4 | 122042189 | 122042190 | Human |
| 597824605 | GWAS1691996_H | renal transplant outcome measurement, donor genotype effect measurement QTL GWAS1691996 (human) | | 0.000004 | renal transplant outcome measurement, donor genotype effect measurement | | 4 | 119026891 | 119026892 | Human |
| 616979652 | GWAS1997151_H | glycerophospholipid measurement QTL GWAS1997151 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480792 | 114480793 | Human |
| 616979650 | GWAS1997149_H | glycerophospholipid measurement QTL GWAS1997149 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480417 | 114480418 | Human |
| 628825470 | GWAS2733699_H | reticulocyte count QTL GWAS2733699 (human) | | 7e-17 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 4 | 109970517 | 109970518 | Human |
| 597138322 | GWAS1234396_H | platelet measurement QTL GWAS1234396 (human) | | 4e-52 | platelet measurement | | 4 | 110008970 | 110008971 | Human |
| 616979651 | GWAS1997150_H | glycerophospholipid measurement QTL GWAS1997150 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114495770 | 114495771 | Human |
| 616979648 | GWAS1997147_H | glycerophospholipid measurement QTL GWAS1997147 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114479772 | 114479773 | Human |
| 597138320 | GWAS1234394_H | platelet measurement QTL GWAS1234394 (human) | | 0.0000002 | platelet measurement | | 4 | 109952770 | 109952771 | Human |
| 616979649 | GWAS1997148_H | glycerophospholipid measurement QTL GWAS1997148 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114480357 | 114480358 | Human |
| 628956538 | GWAS2864767_H | mean corpuscular hemoglobin concentration QTL GWAS2864767 (human) | | 1e-36 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121854912 | 121854913 | Human |
| 597040028 | GWAS1136102_H | urinary metabolite measurement QTL GWAS1136102 (human) | | 6e-18 | urinary metabolite measurement | | 4 | 129118729 | 129118730 | Human |
| 617143490 | GWAS2160989_H | body weight QTL GWAS2160989 (human) | | 4e-19 | body weight | | 4 | 129818987 | 129818988 | Human |
| 596990878 | GWAS1110397_H | type 1 diabetes mellitus QTL GWAS1110397 (human) | | 0.000002 | type 1 diabetes mellitus | | 4 | 122277280 | 122277281 | Human |
| 616537267 | GWAS1933850_H | reticulocyte amount QTL GWAS1933850 (human) | | 8e-13 | reticulocyte amount | | 4 | 109970517 | 109970518 | Human |
| 628694388 | GWAS2602617_H | erythrocyte volume QTL GWAS2602617 (human) | | 3e-70 | erythrocyte volume | | 4 | 121870446 | 121870447 | Human |
| 597990313 | GWAS1709612_H | obsolete_fat body mass QTL GWAS1709612 (human) | | 0.000005 | obsolete_fat body mass | | 4 | 124429906 | 124429907 | Human |
| 598006697 | GWAS1725996_H | obsolete_facial morphology quality QTL GWAS1725996 (human) | | 2e-08 | obsolete_facial morphology quality | | 4 | 126939204 | 126939205 | Human |
| 625827136 | GWAS2248058_H | atrial fibrillation QTL GWAS2248058 (human) | | 1e-08 | atrial fibrillation | | 4 | 128544334 | 128544335 | Human |
| 597498765 | GWAS1594839_H | bone density QTL GWAS1594839 (human) | | 1e-12 | bone density | | 4 | 115936664 | 115936665 | Human |
| 597171081 | GWAS1267155_H | QRS-T angle QTL GWAS1267155 (human) | | 9e-11 | QRS-T angle | | 4 | 110650661 | 110650662 | Human |
| 597171082 | GWAS1267156_H | QRS-T angle QTL GWAS1267156 (human) | | 3e-26 | QRS-T angle | | 4 | 113523590 | 113523591 | Human |
| 407167056 | GWAS816032_H | lipid measurement QTL GWAS816032 (human) | | 6e-08 | lipid measurement | | 4 | 124266893 | 124266894 | Human |
| 617127134 | GWAS2144633_H | erythrocyte volume QTL GWAS2144633 (human) | | 2e-28 | erythrocyte volume | | 4 | 109933275 | 109933276 | Human |
| 596990851 | GWAS1110370_H | atrial fibrillation QTL GWAS1110370 (human) | | 2e-74 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
| 626466113 | GWAS2280046_H | body height QTL GWAS2280046 (human) | | 1e-26 | body height | | 4 | 113894181 | 113894182 | Human |
| 628825440 | GWAS2733669_H | platelet volume QTL GWAS2733669 (human) | | 3e-37 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 406986846 | GWAS635822_H | attempted suicide QTL GWAS635822 (human) | | 0.000004 | attempted suicide | | 4 | 110362552 | 110362553 | Human |
| 407052383 | GWAS701359_H | hemoglobin measurement QTL GWAS701359 (human) | | 1e-12 | hemoglobin measurement | | 4 | 114598669 | 114598670 | Human |
| 597138315 | GWAS1234389_H | Premature atrial contractions QTL GWAS1234389 (human) | | 0.0000004 | Premature atrial contractions | | 4 | 121039245 | 121039246 | Human |
| 597138314 | GWAS1234388_H | Premature atrial contractions QTL GWAS1234388 (human) | | 0.0000005 | Premature atrial contractions | | 4 | 121016813 | 121016815 | Human |
| 617061594 | GWAS2079093_H | insomnia QTL GWAS2079093 (human) | | 3e-10 | insomnia | | 4 | 130028211 | 130028212 | Human |
| 617061593 | GWAS2079092_H | insomnia QTL GWAS2079092 (human) | | 2e-11 | insomnia | | 4 | 129856909 | 129856910 | Human |
| 406986845 | GWAS635821_H | attempted suicide QTL GWAS635821 (human) | | 0.000004 | attempted suicide | | 4 | 110361260 | 110361261 | Human |
| 628825439 | GWAS2733668_H | platelet volume QTL GWAS2733668 (human) | | 1e-29 | platelet volume | | 4 | 122265238 | 122265239 | Human |
| 407298147 | GWAS947123_H | BMI-adjusted waist circumference QTL GWAS947123 (human) | | 4e-08 | BMI-adjusted waist circumference | | 4 | 108556623 | 108556624 | Human |
| 598006671 | GWAS1725970_H | obsolete_facial morphology quality QTL GWAS1725970 (human) | | 3e-10 | obsolete_facial morphology quality | | 4 | 127027041 | 127027042 | Human |
| 597367735 | GWAS1463809_H | heel bone mineral density QTL GWAS1463809 (human) | | 1e-09 | heel bone mineral density | | 4 | 127363808 | 127363809 | Human |
| 617192676 | GWAS2173116_H | total cholesterol measurement, diet measurement QTL GWAS2173116 (human) | | 0.000003 | total cholesterol measurement, diet measurement | | 4 | 118490708 | 118490709 | Human |
| 597367734 | GWAS1463808_H | heel bone mineral density QTL GWAS1463808 (human) | | 4e-14 | heel bone mineral density | | 4 | 126607237 | 126607238 | Human |
| 598039435 | GWAS1758734_H | leukocyte quantity QTL GWAS1758734 (human) | | 6e-14 | leukocyte quantity | | 4 | 110020646 | 110020647 | Human |
| 598023051 | GWAS1742350_H | aortic vascular smooth muscle cell calcification attribute QTL GWAS1742350 (human) | | 3e-08 | aortic vascular smooth muscle cell calcification attribute | | 4 | 118880492 | 118880493 | Human |
| 597367733 | GWAS1463807_H | heel bone mineral density QTL GWAS1463807 (human) | | 4e-14 | heel bone mineral density | | 4 | 123706225 | 123706226 | Human |
| 597367732 | GWAS1463806_H | heel bone mineral density QTL GWAS1463806 (human) | | 2e-10 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 118871804 | 118871805 | Human |
| 628530502 | GWAS2438731_H | properdin measurement QTL GWAS2438731 (human) | | 3e-15 | complement protein amount (VT:0010033) | | 4 | 109737911 | 109737912 | Human |
| 598006676 | GWAS1725975_H | obsolete_facial morphology quality QTL GWAS1725975 (human) | | 2e-09 | obsolete_facial morphology quality | | 4 | 127005360 | 127005361 | Human |
| 617127162 | GWAS2144661_H | neutrophil percentage of leukocytes QTL GWAS2144661 (human) | | 9e-17 | neutrophil percentage of leukocytes | | 4 | 112142370 | 112142371 | Human |
| 617209082 | GWAS2189522_H | complement C1r subcomponent-like protein measurement QTL GWAS2189522 (human) | | 1e-11 | complement C1r subcomponent-like protein measurement | | 4 | 109657070 | 109657071 | Human |
| 628530501 | GWAS2438730_H | complement factor I measurement QTL GWAS2438730 (human) | | 8e-26 | complement protein amount (VT:0010033) | | 4 | 109732855 | 109732856 | Human |
| 628825416 | GWAS2733645_H | stroke QTL GWAS2733645 (human) | | 2e-13 | brain integrity trait (VT:0010579) | | 4 | 110793263 | 110793264 | Human |
| 616357001 | GWAS1841716_H | gut microbiome measurement, breastfeeding duration QTL GWAS1841716 (human) | | 1e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 107900280 | 107900281 | Human |
| 628530499 | GWAS2438728_H | complement factor I measurement QTL GWAS2438728 (human) | | 1e-11 | complement protein amount (VT:0010033) | | 4 | 109815148 | 109815149 | Human |
| 407150707 | GWAS799683_H | memory impairment QTL GWAS799683 (human) | | 0.000009 | memory impairment | | 4 | 125446831 | 125446832 | Human |
| 628677954 | GWAS2586183_H | appendicitis QTL GWAS2586183 (human) | | 2e-11 | appendicitis | | 4 | 110799841 | 110799842 | Human |
| 597335003 | GWAS1431077_H | pulmonary embolism QTL GWAS1431077 (human) | | 8e-17 | pulmonary embolism | | 4 | 119320747 | 119320748 | Human |
| 597040084 | GWAS1136158_H | risk-taking behaviour QTL GWAS1136158 (human) | | 2e-08 | risk-taking behaviour | | 4 | 109690042 | 109690043 | Human |
| 628481335 | GWAS2389564_H | albumin:globulin ratio measurement QTL GWAS2389564 (human) | | 2e-11 | blood globulin amount (VT:0010628) | | 4 | 110003204 | 110003205 | Human |
| 597203933 | GWAS1300007_H | asthma QTL GWAS1300007 (human) | | 3e-09 | asthma | | 4 | 122134546 | 122134549 | Human |
| 628874557 | GWAS2782786_H | spermidine measurement QTL GWAS2782786 (human) | | 4e-08 | spermidine measurement | | 4 | 109176399 | 109176400 | Human |
| 597318620 | GWAS1414694_H | functional brain measurement QTL GWAS1414694 (human) | | 7e-09 | functional brain measurement | | 4 | 116995997 | 116995998 | Human |
| 407101450 | GWAS750426_H | age at menarche QTL GWAS750426 (human) | | 1e-10 | age at menarche | | 4 | 131843326 | 131843327 | Human |
| 407101449 | GWAS750425_H | age at menarche QTL GWAS750425 (human) | | 7e-08 | age at menarche | | 4 | 129809917 | 129809918 | Human |
| 407101448 | GWAS750424_H | age at menarche QTL GWAS750424 (human) | | 1e-08 | age at menarche | | 4 | 115075517 | 115075518 | Human |
| 597580755 | GWAS1637615_H | lymphocyte count QTL GWAS1637615 (human) | | 6e-14 | lymphocyte count | | 4 | 112198650 | 112198651 | Human |
| 628612409 | GWAS2520638_H | rheumatoid arthritis QTL GWAS2520638 (human) | | 4e-08 | joint integrity trait (VT:0010548) | | 4 | 108140462 | 108140463 | Human |
| 628841769 | GWAS2749998_H | triglyceride measurement QTL GWAS2749998 (human) | | 7e-11 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 123720672 | 123720673 | Human |
| 628841768 | GWAS2749997_H | triglyceride measurement QTL GWAS2749997 (human) | | 1e-44 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109717668 | 109717669 | Human |
| 616979614 | GWAS1997113_H | schizophrenia QTL GWAS1997113 (human) | | 4e-08 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
| 407052312 | GWAS701288_H | vital capacity QTL GWAS701288 (human) | | 8e-12 | vital capacity | | 4 | 124209285 | 124209286 | Human |
| 598039545 | GWAS1758844_H | blood VLDL cholesterol amount, chylomicron amount QTL GWAS1758844 (human) | | 1e-10 | blood VLDL cholesterol amount, chylomicron amount | | 4 | 109657070 | 109657071 | Human |
| 628907296 | GWAS2815525_H | electrocardiography QTL GWAS2815525 (human) | | 3e-10 | electrocardiography | | 4 | 113508251 | 113508252 | Human |
| 617012378 | GWAS2029877_H | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation QTL GWAS2029877 (human) | | 1e-09 | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation | | 4 | 117452280 | 117452281 | Human |
| 628579606 | GWAS2487835_H | monocyte count QTL GWAS2487835 (human) | | 5e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109926568 | 109926569 | Human |
| 597269496 | GWAS1365570_H | telomere length QTL GWAS1365570 (human) | | 0.000009 | telomere length | | 4 | 110290116 | 110290117 | Human |
| 597990341 | GWAS1709640_H | body height QTL GWAS1709640 (human) | | 0.000001 | body height | | 4 | 119687809 | 119687810 | Human |
| 597138420 | GWAS1234494_H | alpha fetoprotein measurement QTL GWAS1234494 (human) | | 9e-12 | alpha fetoprotein measurement | | 4 | 108749156 | 108749157 | Human |
| 597335033 | GWAS1431107_H | COVID-19 QTL GWAS1431107 (human) | | 0.000005 | COVID-19 | | 4 | 113129435 | 113129436 | Human |
| 626449714 | GWAS2263647_H | body mass index, vital capacity QTL GWAS2263647 (human) | | 5e-08 | body mass index, vital capacity | | 4 | 107934672 | 107934673 | Human |
| 407216161 | GWAS865137_H | apolipoprotein A 1 measurement QTL GWAS865137 (human) | | 3e-67 | apolipoprotein A 1 measurement | | 4 | 109717668 | 109717669 | Human |
| 617110700 | GWAS2128199_H | level of glutamyl aminopeptidase in blood serum QTL GWAS2128199 (human) | | 2e-25 | level of glutamyl aminopeptidase in blood serum | | 4 | 110510288 | 110510289 | Human |
| 407216160 | GWAS865136_H | apolipoprotein A 1 measurement QTL GWAS865136 (human) | | 3e-23 | apolipoprotein A 1 measurement | | 4 | 109717608 | 109717609 | Human |
| 628579615 | GWAS2487844_H | monocyte count QTL GWAS2487844 (human) | | 2e-26 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 110035176 | 110035177 | Human |
| 407167020 | GWAS815996_H | factor VIII measurement, Ischemic stroke QTL GWAS815996 (human) | | 9e-17 | factor VIII measurement, Ischemic stroke | | 4 | 110775495 | 110775496 | Human |
| 597105660 | GWAS1201734_H | reticulocyte measurement QTL GWAS1201734 (human) | | 8e-09 | reticulocyte measurement | | 4 | 119770233 | 119770234 | Human |
| 597105659 | GWAS1201733_H | reticulocyte measurement QTL GWAS1201733 (human) | | 4e-17 | reticulocyte measurement | | 4 | 109944309 | 109944310 | Human |
| 407330858 | GWAS979834_H | non-high density lipoprotein cholesterol measurement QTL GWAS979834 (human) | | 5e-12 | non-high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 628776215 | GWAS2684444_H | erythrocyte volume QTL GWAS2684444 (human) | | 4e-16 | erythrocyte volume | | 4 | 127534974 | 127534975 | Human |
| 407330857 | GWAS979833_H | non-high density lipoprotein cholesterol measurement QTL GWAS979833 (human) | | 5e-10 | non-high density lipoprotein cholesterol measurement | | 4 | 109174464 | 109174465 | Human |
| 625827133 | GWAS2248055_H | atrial fibrillation QTL GWAS2248055 (human) | | 3e-08 | atrial fibrillation | | 4 | 120802562 | 120802563 | Human |
| 625827132 | GWAS2248054_H | atrial fibrillation QTL GWAS2248054 (human) | | 3e-34 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 597335016 | GWAS1431090_H | asthma QTL GWAS1431090 (human) | | 4e-09 | asthma | | 4 | 122451978 | 122451979 | Human |
| 625827135 | GWAS2248057_H | atrial fibrillation QTL GWAS2248057 (human) | | 2e-09 | atrial fibrillation | | 4 | 122917603 | 122917604 | Human |
| 625827134 | GWAS2248056_H | atrial fibrillation QTL GWAS2248056 (human) | | 5e-11 | atrial fibrillation | | 4 | 121877258 | 121877259 | Human |
| 625827129 | GWAS2248051_H | atrial fibrillation QTL GWAS2248051 (human) | | 5e-27 | atrial fibrillation | | 4 | 109738763 | 109738764 | Human |
| 407134256 | GWAS783232_H | asthma, allergic disease QTL GWAS783232 (human) | | 3e-12 | asthma, allergic disease | | 4 | 122441954 | 122441955 | Human |
| 628579586 | GWAS2487815_H | apolipoprotein A 1 measurement QTL GWAS2487815 (human) | | 2e-08 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109657070 | 109657071 | Human |
| 625827131 | GWAS2248053_H | atrial fibrillation QTL GWAS2248053 (human) | | 2e-31 | atrial fibrillation | | 4 | 112000965 | 112000966 | Human |
| 625827130 | GWAS2248052_H | atrial fibrillation QTL GWAS2248052 (human) | | 5e-305 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 616979646 | GWAS1997145_H | glycerophospholipid measurement QTL GWAS1997145 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114487736 | 114487737 | Human |
| 616979647 | GWAS1997146_H | glycerophospholipid measurement QTL GWAS1997146 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114506467 | 114506468 | Human |
| 597449701 | GWAS1545775_H | coronary artery calcification QTL GWAS1545775 (human) | | 0.0000002 | coronary artery calcification | | 4 | 128541212 | 128541213 | Human |
| 616979644 | GWAS1997143_H | glycerophospholipid measurement QTL GWAS1997143 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114480704 | 114480705 | Human |
| 597580772 | GWAS1637632_H | mean corpuscular hemoglobin concentration QTL GWAS1637632 (human) | | 2e-11 | mean corpuscular hemoglobin concentration | | 4 | 121827841 | 121827842 | Human |
| 616979645 | GWAS1997144_H | glycerophospholipid measurement QTL GWAS1997144 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114508383 | 114508384 | Human |
| 597580771 | GWAS1637631_H | mean corpuscular hemoglobin concentration QTL GWAS1637631 (human) | | 2e-14 | mean corpuscular hemoglobin concentration | | 4 | 109934399 | 109934400 | Human |
| 616979643 | GWAS1997142_H | glycerophospholipid measurement QTL GWAS1997142 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114495706 | 114495707 | Human |
| 597318629 | GWAS1414703_H | functional brain measurement QTL GWAS1414703 (human) | | 5e-09 | functional brain measurement | | 4 | 116998865 | 116998866 | Human |
| 616963142 | GWAS1980641_H | balding measurement QTL GWAS1980641 (human) | | 4e-32 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106635172 | 106635173 | Human |
| 616979527 | GWAS1997026_H | smoking status measurement, diastolic blood pressure QTL GWAS1997026 (human) | | 3e-08 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 123660107 | 123660108 | Human |
| 597596956 | GWAS1653816_H | prothrombin time measurement QTL GWAS1653816 (human) | | 6e-52 | prothrombin time measurement | | 4 | 110791530 | 110791531 | Human |
| 616356927 | GWAS1841642_H | gut microbiome measurement, breastfeeding duration QTL GWAS1841642 (human) | | 2e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 112409784 | 112409785 | Human |
| 597334814 | GWAS1430888_H | facial morphology measurement QTL GWAS1430888 (human) | | 1e-19 | facial morphology measurement | | 4 | 127005360 | 127005361 | Human |
| 617012303 | GWAS2029802_H | adolescent idiopathic scoliosis QTL GWAS2029802 (human) | | 2e-09 | adolescent idiopathic scoliosis | | 4 | 119337052 | 119337053 | Human |
| 617012299 | GWAS2029798_H | BMI-adjusted waist circumference QTL GWAS2029798 (human) | | 6e-11 | BMI-adjusted waist circumference | | 4 | 119759795 | 119759796 | Human |
| 617012297 | GWAS2029796_H | BMI-adjusted waist circumference QTL GWAS2029796 (human) | | 1e-14 | BMI-adjusted waist circumference | | 4 | 119354508 | 119354509 | Human |
| 406921425 | GWAS570401_H | RR interval QTL GWAS570401 (human) | | 0.0000004 | heart excitatory physiology trait (VT:0000231) | RR interval (CMO:0000232) | 4 | 130216606 | 130216607 | Human |
| 597056260 | GWAS1152334_H | hair colour measurement QTL GWAS1152334 (human) | | 9e-38 | hair colour measurement | | 4 | 108429724 | 108429725 | Human |
| 626466245 | GWAS2280178_H | body mass index QTL GWAS2280178 (human) | | 2e-11 | body mass index | | 4 | 114207408 | 114207409 | Human |
| 617012309 | GWAS2029808_H | adolescent idiopathic scoliosis QTL GWAS2029808 (human) | | 2e-16 | adolescent idiopathic scoliosis | | 4 | 129325525 | 129325526 | Human |
| 597056258 | GWAS1152332_H | hair colour measurement QTL GWAS1152332 (human) | | 1e-17 | hair colour measurement | | 4 | 108163945 | 108163946 | Human |
| 597056259 | GWAS1152333_H | hair colour measurement QTL GWAS1152333 (human) | | 1e-15 | hair colour measurement | | 4 | 108327206 | 108327207 | Human |
| 626449859 | GWAS2263792_H | treatment-resistant hypertension QTL GWAS2263792 (human) | | 0.00001 | treatment-resistant hypertension | | 4 | 108640537 | 108640538 | Human |
| 617012307 | GWAS2029806_H | adolescent idiopathic scoliosis QTL GWAS2029806 (human) | | 9e-37 | adolescent idiopathic scoliosis | | 4 | 114347014 | 114347015 | Human |
| 616537129 | GWAS1933712_H | creatine amount QTL GWAS1933712 (human) | | 0.0000006 | creatine amount | | 4 | 110523020 | 110523021 | Human |
| 406937815 | GWAS586791_H | multiple sclerosis QTL GWAS586791 (human) | | 0.000002 | multiple sclerosis | | 4 | 130869346 | 130869347 | Human |
| 597056257 | GWAS1152331_H | hair colour measurement QTL GWAS1152331 (human) | | 5e-12 | hair colour measurement | | 4 | 108003401 | 108003402 | Human |
| 407281887 | GWAS930863_H | facial morphology measurement QTL GWAS930863 (human) | | 9e-12 | facial morphology measurement | | 4 | 126901674 | 126901675 | Human |
| 628432367 | GWAS2340596_H | rosacea severity measurement QTL GWAS2340596 (human) | | 0.000004 | rosacea severity measurement | | 4 | 122146898 | 122146899 | Human |
| 407281885 | GWAS930861_H | facial morphology measurement QTL GWAS930861 (human) | | 2e-09 | facial morphology measurement | | 4 | 126014320 | 126014321 | Human |
| 407363813 | GWAS1012789_H | BMI-adjusted waist-hip ratio QTL GWAS1012789 (human) | | 5e-09 | BMI-adjusted waist-hip ratio | | 4 | 121701445 | 121701446 | Human |
| 616963171 | GWAS1980670_H | systolic blood pressure QTL GWAS1980670 (human) | | 6e-18 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110416322 | 110416323 | Human |
| 628891099 | GWAS2799328_H | schizophrenia QTL GWAS2799328 (human) | | 0.000002 | schizophrenia | | 4 | 122467361 | 122467362 | Human |
| 617045103 | GWAS2062602_H | atrial fibrillation QTL GWAS2062602 (human) | | 3e-35 | atrial fibrillation | | 4 | 110882594 | 110882595 | Human |
| 617045102 | GWAS2062601_H | atrial fibrillation QTL GWAS2062601 (human) | | 6e-35 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
| 617045101 | GWAS2062600_H | atrial fibrillation QTL GWAS2062600 (human) | | 3e-17 | atrial fibrillation | | 4 | 110609843 | 110609844 | Human |
| 617045100 | GWAS2062599_H | atrial fibrillation QTL GWAS2062599 (human) | | 1e-36 | atrial fibrillation | | 4 | 110589415 | 110589416 | Human |
| 617045099 | GWAS2062598_H | atrial fibrillation QTL GWAS2062598 (human) | | 3e-12 | atrial fibrillation | | 4 | 110574086 | 110574087 | Human |
| 617045098 | GWAS2062597_H | atrial fibrillation QTL GWAS2062597 (human) | | 4e-09 | atrial fibrillation | | 4 | 110546303 | 110546304 | Human |
| 407363817 | GWAS1012793_H | BMI-adjusted waist-hip ratio QTL GWAS1012793 (human) | | 7e-09 | BMI-adjusted waist-hip ratio | | 4 | 124118741 | 124118742 | Human |
| 597203767 | GWAS1299841_H | hypertrophic cardiomyopathy QTL GWAS1299841 (human) | | 0.0000006 | hypertrophic cardiomyopathy | | 4 | 130926839 | 130926840 | Human |
| 597302057 | GWAS1398131_H | brain measurement QTL GWAS1398131 (human) | | 5e-30 | brain measurement | | 4 | 118393759 | 118393760 | Human |
| 617045107 | GWAS2062606_H | atrial fibrillation QTL GWAS2062606 (human) | | 5e-09 | atrial fibrillation | | 4 | 110992909 | 110992910 | Human |
| 617045106 | GWAS2062605_H | atrial fibrillation QTL GWAS2062605 (human) | | 7e-12 | atrial fibrillation | | 4 | 110978126 | 110978127 | Human |
| 617045105 | GWAS2062604_H | atrial fibrillation QTL GWAS2062604 (human) | | 8e-21 | atrial fibrillation | | 4 | 110941992 | 110941993 | Human |
| 617045104 | GWAS2062603_H | atrial fibrillation QTL GWAS2062603 (human) | | 5e-18 | atrial fibrillation | | 4 | 110908811 | 110908812 | Human |
| 597302051 | GWAS1398125_H | glomerular filtration rate QTL GWAS1398125 (human) | | 1e-16 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 407036152 | GWAS685128_H | myeloid white cell count QTL GWAS685128 (human) | | 9e-13 | myeloid white cell count | | 4 | 110024810 | 110024811 | Human |
| 616553477 | GWAS1950060_H | body fat percentage QTL GWAS1950060 (human) | | 3e-12 | body fat percentage | | 4 | 129803747 | 129803748 | Human |
| 597383969 | GWAS1480043_H | body mass index QTL GWAS1480043 (human) | | 4e-12 | body mass index | | 4 | 129805678 | 129805679 | Human |
| 407036153 | GWAS685129_H | myeloid white cell count QTL GWAS685129 (human) | | 6e-13 | myeloid white cell count | | 4 | 119342160 | 119342161 | Human |
| 407363835 | GWAS1012811_H | interleukin 10 measurement QTL GWAS1012811 (human) | | 2e-08 | interleukin 10 measurement | | 4 | 106774728 | 106774729 | Human |
| 597138218 | GWAS1234292_H | bone density QTL GWAS1234292 (human) | | 6e-24 | bone density | | 4 | 129519676 | 129519677 | Human |
| 617208842 | GWAS2189282_H | body mass index QTL GWAS2189282 (human) | | 6e-09 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 617110528 | GWAS2128027_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2128027 (human) | | 1e-17 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 130146820 | 130146821 | Human |
| 407232652 | GWAS881628_H | bone density QTL GWAS881628 (human) | | 2e-44 | bone density | | 4 | 111086102 | 111086103 | Human |
| 616553588 | GWAS1950171_H | erythrocyte count QTL GWAS1950171 (human) | | 4e-18 | erythrocyte count | | 4 | 121808257 | 121808258 | Human |
| 597990248 | GWAS1709547_H | obsolete_fat body mass QTL GWAS1709547 (human) | | 0.0000001 | obsolete_fat body mass | | 4 | 114674241 | 114674242 | Human |
| 628596154 | GWAS2504383_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS2504383 (human) | | 2e-13 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 109657070 | 109657071 | Human |
| 407019663 | GWAS668639_H | body height QTL GWAS668639 (human) | | 1e-10 | body height | | 4 | 119600883 | 119600884 | Human |
| 597498706 | GWAS1594780_H | memory performance QTL GWAS1594780 (human) | | 0.000003 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124862465 | 124862466 | Human |
| 628481445 | GWAS2389674_H | osteoarthritis, knee QTL GWAS2389674 (human) | | 0.000001 | joint integrity trait (VT:0010548) | | 4 | 115123255 | 115123256 | Human |
| 617045014 | GWAS2062513_H | uric acid measurement QTL GWAS2062513 (human) | | 3e-08 | uric acid measurement | | 4 | 127173154 | 127173155 | Human |
| 407019664 | GWAS668640_H | body height QTL GWAS668640 (human) | | 8e-09 | body height | | 4 | 119834940 | 119834941 | Human |
| 597252941 | GWAS1349015_H | alkaline phosphatase measurement QTL GWAS1349015 (human) | | 8e-17 | alkaline phosphatase measurement | | 4 | 110191454 | 110191455 | Human |
| 407314576 | GWAS963552_H | body weight QTL GWAS963552 (human) | | 2e-12 | body weight | | 4 | 129838492 | 129838493 | Human |
| 628989347 | GWAS2897576_H | gastric ulcer, hemorrhage QTL GWAS2897576 (human) | | 2e-11 | stomach integrity trait (VT:0010603) | | 4 | 115240446 | 115240447 | Human |
| 597318468 | GWAS1414542_H | opioid dependence QTL GWAS1414542 (human) | | 0.0000006 | opioid dependence | | 4 | 125271758 | 125271759 | Human |
| 407052454 | GWAS701430_H | pelvic organ prolapse QTL GWAS701430 (human) | | 5e-16 | pelvic organ prolapse | | 4 | 126037217 | 126037218 | Human |
| 407019684 | GWAS668660_H | bone density QTL GWAS668660 (human) | | 2e-14 | bone density | | 4 | 111670693 | 111670694 | Human |
| 617126945 | GWAS2144444_H | complement factor I measurement QTL GWAS2144444 (human) | | 8e-26 | complement factor I measurement | | 4 | 109732855 | 109732856 | Human |
| 407052461 | GWAS701437_H | disease progression measurement, Crohn's disease QTL GWAS701437 (human) | | 0.000005 | intestine integrity trait (VT:0010554) | disease progression measurement (CMO:0001110) | 4 | 116341004 | 116341005 | Human |
| 597334891 | GWAS1430965_H | COVID-19 QTL GWAS1430965 (human) | | 0.000008 | COVID-19 | | 4 | 110000832 | 110000833 | Human |
| 597105509 | GWAS1201583_H | cortical surface area change measurement QTL GWAS1201583 (human) | | 0.000005 | cortical surface area change measurement | | 4 | 109118383 | 109118384 | Human |
| 597269354 | GWAS1365428_H | metabolite measurement QTL GWAS1365428 (human) | | 7e-57 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 628792718 | GWAS2700947_H | HbA1c measurement QTL GWAS2700947 (human) | | 7e-15 | blood hemoglobin amount (VT:0001588) | blood hemoglobin A1c level (CMO:0002786) | 4 | 110010783 | 110010784 | Human |
| 597072750 | GWAS1168824_H | feeling miserable measurement QTL GWAS1168824 (human) | | 1e-08 | feeling miserable measurement | | 4 | 122265238 | 122265239 | Human |
| 597072751 | GWAS1168825_H | feeling miserable measurement QTL GWAS1168825 (human) | | 3e-08 | feeling miserable measurement | | 4 | 122465996 | 122465997 | Human |
| 598088541 | GWAS1807840_H | bone density QTL GWAS1807840 (human) | | 9e-74 | bone density | | 4 | 116630743 | 116630744 | Human |
| 597269348 | GWAS1365422_H | metabolite measurement QTL GWAS1365422 (human) | | 1e-21 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 597416603 | GWAS1512677_H | glycerophospholipid measurement QTL GWAS1512677 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114479772 | 114479773 | Human |
| 597416602 | GWAS1512676_H | glycerophospholipid measurement QTL GWAS1512676 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114495706 | 114495707 | Human |
| 616521149 | GWAS1917732_H | lymphocyte count QTL GWAS1917732 (human) | | 2e-18 | lymphocyte count | | 4 | 112198650 | 112198651 | Human |
| 597416601 | GWAS1512675_H | glycerophospholipid measurement QTL GWAS1512675 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114501231 | 114501232 | Human |
| 597416600 | GWAS1512674_H | glycerophospholipid measurement QTL GWAS1512674 (human) | | 3e-10 | glycerophospholipid measurement | | 4 | 114595467 | 114595468 | Human |
| 598006439 | GWAS1725738_H | hip bone mineral density, hip bone size QTL GWAS1725738 (human) | | 5e-09 | hip bone mineral density, hip bone size | | 4 | 129257175 | 129257176 | Human |
| 597416606 | GWAS1512680_H | glycerophospholipid measurement QTL GWAS1512680 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114598115 | 114598116 | Human |
| 597416605 | GWAS1512679_H | glycerophospholipid measurement QTL GWAS1512679 (human) | | 2e-10 | glycerophospholipid measurement | | 4 | 114501793 | 114501794 | Human |
| 597416604 | GWAS1512678_H | glycerophospholipid measurement QTL GWAS1512678 (human) | | 4e-10 | glycerophospholipid measurement | | 4 | 114495770 | 114495771 | Human |
| 597072529 | GWAS1168603_H | worry measurement QTL GWAS1168603 (human) | | 4e-08 | worry measurement | | 4 | 118048732 | 118048733 | Human |
| 406888776 | GWAS537752_H | atrial fibrillation QTL GWAS537752 (human) | | 6e-38 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
| 597416595 | GWAS1512669_H | glycerophospholipid measurement QTL GWAS1512669 (human) | | 2e-12 | glycerophospholipid measurement | | 4 | 114564668 | 114564669 | Human |
| 617143744 | GWAS2161243_H | body height QTL GWAS2161243 (human) | | 2e-09 | body height | | 4 | 123557804 | 123557805 | Human |
| 407052618 | GWAS701594_H | mean platelet volume QTL GWAS701594 (human) | | 3e-29 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 617143745 | GWAS2161244_H | body height QTL GWAS2161244 (human) | | 1e-08 | body height | | 4 | 128547347 | 128547348 | Human |
| 597219987 | GWAS1316061_H | corneal resistance factor QTL GWAS1316061 (human) | | 2e-09 | corneal resistance factor | | 4 | 111768358 | 111768359 | Human |
| 597416599 | GWAS1512673_H | glycerophospholipid measurement QTL GWAS1512673 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114495902 | 114495903 | Human |
| 597416598 | GWAS1512672_H | glycerophospholipid measurement QTL GWAS1512672 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114495803 | 114495804 | Human |
| 617127366 | GWAS2144865_H | response to stimulus QTL GWAS2144865 (human) | | 4e-11 | response to stimulus | | 4 | 106731302 | 106731303 | Human |
| 597416597 | GWAS1512671_H | glycerophospholipid measurement QTL GWAS1512671 (human) | | 1e-13 | glycerophospholipid measurement | | 4 | 114561897 | 114561898 | Human |
| 616537521 | GWAS1934104_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1934104 (human) | | 5e-13 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 128282916 | 128282917 | Human |
| 406905167 | GWAS554143_H | COVID-19 QTL GWAS554143 (human) | | 0.000005 | COVID-19 | | 4 | 113129435 | 113129436 | Human |
| 597416596 | GWAS1512670_H | glycerophospholipid measurement QTL GWAS1512670 (human) | | 3e-22 | glycerophospholipid measurement | | 4 | 114564575 | 114564576 | Human |
| 406888785 | GWAS537761_H | atrial fibrillation QTL GWAS537761 (human) | | 2e-74 | atrial fibrillation | | 4 | 110784612 | 110784613 | Human |
| 628939880 | GWAS2848109_H | platelet count QTL GWAS2848109 (human) | | 1e-28 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119622957 | 119622958 | Human |
| 617143773 | GWAS2161272_H | congenital anomaly of cardiovascular system QTL GWAS2161272 (human) | | 3e-11 | congenital anomaly of cardiovascular system | | 4 | 112981089 | 112981090 | Human |
| 407052630 | GWAS701606_H | mean platelet volume QTL GWAS701606 (human) | | 1e-32 | mean platelet volume | | 4 | 122271085 | 122271086 | Human |
| 407019860 | GWAS668836_H | bone density QTL GWAS668836 (human) | | 8e-15 | bone density | | 4 | 132222891 | 132222892 | Human |
| 597203599 | GWAS1299673_H | familial sick sinus syndrome QTL GWAS1299673 (human) | | 2e-15 | sick sinus syndrome | | 4 | 110782354 | 110782355 | Human |
| 597432964 | GWAS1529038_H | protein measurement QTL GWAS1529038 (human) | | 2e-23 | protein measurement | | 4 | 110510288 | 110510289 | Human |
| 597580421 | GWAS1637281_H | lymphocyte count QTL GWAS1637281 (human) | | 2e-11 | lymphocyte count | | 4 | 112183886 | 112183887 | Human |
| 597301894 | GWAS1397968_H | ceramide measurement QTL GWAS1397968 (human) | | 2e-20 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
| 597301893 | GWAS1397967_H | ceramide measurement QTL GWAS1397967 (human) | | 6e-13 | ceramide measurement | | 4 | 114469978 | 114469979 | Human |
| 406921568 | GWAS570544_H | cardioembolic stroke QTL GWAS570544 (human) | | 3e-25 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 628595797 | GWAS2504026_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS2504026 (human) | | 4e-10 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109657070 | 109657071 | Human |
| 598137476 | GWAS1824204_H | gut microbiome measurement, bone tissue density QTL GWAS1824204 (human) | | 2e-08 | gut microbiome measurement, bone tissue density | | 4 | 116034483 | 116034484 | Human |
| 406921570 | GWAS570546_H | cardioembolic stroke QTL GWAS570546 (human) | | 6e-24 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 598137477 | GWAS1824205_H | gut microbiome measurement, bone tissue density QTL GWAS1824205 (human) | | 2e-09 | gut microbiome measurement, bone tissue density | | 4 | 116039953 | 116039954 | Human |
| 598137475 | GWAS1824203_H | gut microbiome measurement, bone tissue density QTL GWAS1824203 (human) | | 2e-08 | gut microbiome measurement, bone tissue density | | 4 | 116019324 | 116019325 | Human |
| 406921575 | GWAS570551_H | cardioembolic stroke QTL GWAS570551 (human) | | 2e-21 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597613241 | GWAS1670101_H | skin disease QTL GWAS1670101 (human) | | 1e-11 | skin disease | | 4 | 130491526 | 130491527 | Human |
| 406921577 | GWAS570553_H | cardioembolic stroke QTL GWAS570553 (human) | | 2e-25 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597334699 | GWAS1430773_H | R-warfarin measurement QTL GWAS1430773 (human) | | 5e-09 | R-warfarin measurement | | 4 | 112902858 | 112902859 | Human |
| 406921586 | GWAS570562_H | small vessel stroke QTL GWAS570562 (human) | | 1e-08 | small vessel stroke | | 4 | 113480773 | 113480774 | Human |
| 407298421 | GWAS947397_H | brain measurement QTL GWAS947397 (human) | | 8e-13 | brain measurement | | 4 | 123179401 | 123179402 | Human |
| 407183729 | GWAS832705_H | heart valve disease QTL GWAS832705 (human) | | 5e-22 | heart valve disease | | 4 | 110725811 | 110725812 | Human |
| 598055571 | GWAS1774870_H | platelet volume QTL GWAS1774870 (human) | | 2e-12 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 616357250 | GWAS1841965_H | gut microbiome measurement, breastfeeding duration QTL GWAS1841965 (human) | | 5e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 108743511 | 108743512 | Human |
| 597301924 | GWAS1397998_H | glomerular filtration rate QTL GWAS1397998 (human) | | 2e-24 | glomerular filtration rate | | 4 | 108782393 | 108782394 | Human |
| 406987008 | GWAS635984_H | body height QTL GWAS635984 (human) | | 1e-08 | body height | | 4 | 112402274 | 112402275 | Human |
| 406987009 | GWAS635985_H | body height QTL GWAS635985 (human) | | 2e-10 | body height | | 4 | 129838492 | 129838493 | Human |
| 407150849 | GWAS799825_H | HbA1c measurement QTL GWAS799825 (human) | | 7e-15 | HbA1c measurement | | 4 | 110010783 | 110010784 | Human |
| 407413006 | GWAS1061982_H | complement factor I measurement QTL GWAS1061982 (human) | | 7e-21 | complement factor I measurement | | 4 | 109737700 | 109737701 | Human |
| 407413007 | GWAS1061983_H | complement factor I measurement QTL GWAS1061983 (human) | | 4e-20 | complement factor I measurement | | 4 | 109737911 | 109737912 | Human |
| 628825148 | GWAS2733377_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS2733377 (human) | | 4e-13 | Agents acting on the renin-angiotensin system use measurement | | 4 | 110485340 | 110485341 | Human |
| 617274752 | GWAS2211528_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS2211528 (human) | | 8e-11 | polyunsaturated fatty acid measurement | | 4 | 110191454 | 110191455 | Human |
| 616963468 | GWAS1980967_H | exploratory eye movement measurement QTL GWAS1980967 (human) | | 0.000008 | eye physiology trait (VT:0005253) | eye physiological measurement (CMO:0003652) | 4 | 114477044 | 114477045 | Human |
| 597236434 | GWAS1332508_H | blood protein measurement QTL GWAS1332508 (human) | | 6e-205 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628857904 | GWAS2766133_H | C-reactive protein measurement QTL GWAS2766133 (human) | | 4e-08 | C-reactive protein amount (VT:0010036) | blood C-reactive protein level (CMO:0003160) | 4 | 111731920 | 111731921 | Human |
| 597072600 | GWAS1168674_H | schizophrenia QTL GWAS1168674 (human) | | 0.000003 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
| 407134474 | GWAS783450_H | BMI-adjusted waist-hip ratio QTL GWAS783450 (human) | | 1e-14 | BMI-adjusted waist-hip ratio | | 4 | 121702910 | 121702911 | Human |
| 628907048 | GWAS2815277_H | migraine disorder QTL GWAS2815277 (human) | | 0.0000003 | migraine disorder | | 4 | 121006381 | 121006382 | Human |
| 617094556 | GWAS2112055_H | body mass index QTL GWAS2112055 (human) | | 6e-19 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129818987 | 129818988 | Human |
| 407085333 | GWAS734309_H | sex hormone-binding globulin measurement QTL GWAS734309 (human) | | 8e-21 | sex hormone-binding globulin measurement | | 4 | 109345757 | 109345758 | Human |
| 406987035 | GWAS636011_H | mean corpuscular volume QTL GWAS636011 (human) | | 9e-14 | mean corpuscular volume | | 4 | 109933275 | 109933276 | Human |
| 616963487 | GWAS1980986_H | cognitive decline measurement QTL GWAS1980986 (human) | | 0.000004 | cognitive behavior trait (VT:0010450) | | 4 | 110589931 | 110589932 | Human |
| 407167262 | GWAS816238_H | Ischemic stroke, von Willebrand factor measurement QTL GWAS816238 (human) | | 5e-16 | Ischemic stroke, von Willebrand factor measurement | | 4 | 110775495 | 110775496 | Human |
| 626449421 | GWAS2263354_H | forced expiratory volume, body mass index QTL GWAS2263354 (human) | | 9e-09 | forced expiratory volume, body mass index | | 4 | 107935137 | 107935138 | Human |
| 628939815 | GWAS2848044_H | body height QTL GWAS2848044 (human) | | 6e-18 | body height | | 4 | 119831901 | 119831902 | Human |
| 617061786 | GWAS2079285_H | brain attribute QTL GWAS2079285 (human) | | 4e-12 | brain attribute | | 4 | 120306999 | 120307000 | Human |
| 406987036 | GWAS636012_H | mean corpuscular volume QTL GWAS636012 (human) | | 4e-73 | mean corpuscular volume | | 4 | 121814898 | 121814899 | Human |
| 628677670 | GWAS2585899_H | type 1 diabetes mellitus QTL GWAS2585899 (human) | | 6e-12 | type 1 diabetes mellitus | | 4 | 122554824 | 122554825 | Human |
| 616996249 | GWAS2013748_H | cerebral cortex area attribute QTL GWAS2013748 (human) | | 2e-09 | cerebral cortex area attribute | | 4 | 112495282 | 112495283 | Human |
| 406987037 | GWAS636013_H | mean corpuscular volume QTL GWAS636013 (human) | | 2e-28 | mean corpuscular hemoglobin concentration | | 4 | 127625245 | 127625246 | Human |
| 628939804 | GWAS2848033_H | body height QTL GWAS2848033 (human) | | 3e-16 | body height | | 4 | 112647388 | 112647389 | Human |
| 406905123 | GWAS554099_H | R-warfarin measurement QTL GWAS554099 (human) | | 5e-09 | R-warfarin measurement | | 4 | 112902858 | 112902859 | Human |
| 597285616 | GWAS1381690_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1381690 (human) | | 6e-12 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109717668 | 109717669 | Human |
| 596990719 | GWAS1110238_H | serum IgG glycosylation measurement QTL GWAS1110238 (human) | | 0.000002 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
| 597383920 | GWAS1479994_H | erythrocyte count QTL GWAS1479994 (human) | | 8e-17 | erythrocyte count | | 4 | 114598115 | 114598116 | Human |
| 628612121 | GWAS2520350_H | lip morphology trait QTL GWAS2520350 (human) | | 1e-08 | lip morphology trait | | 4 | 121076949 | 121076950 | Human |
| 617127354 | GWAS2144853_H | parasitic infection QTL GWAS2144853 (human) | | 7e-12 | parasitic infection | | 4 | 108582778 | 108582779 | Human |
| 616996275 | GWAS2013774_H | calcium measurement QTL GWAS2013774 (human) | | 4e-09 | calcium measurement | | 4 | 114458289 | 114458290 | Human |
| 406905143 | GWAS554119_H | citrulline measurement QTL GWAS554119 (human) | | 0.0000006 | citrulline measurement | | 4 | 108524921 | 108524922 | Human |
| 407396657 | GWAS1045633_H | complement factor I measurement QTL GWAS1045633 (human) | | 2e-17 | complement factor I measurement | | 4 | 109735574 | 109735575 | Human |
| 597285603 | GWAS1381677_H | small vessel stroke QTL GWAS1381677 (human) | | 0.0000007 | small vessel stroke | | 4 | 113472094 | 113472095 | Human |
| 596990699 | GWAS1110218_H | pulmonary function measurement QTL GWAS1110218 (human) | | 0.000001 | pulmonary function measurement | | 4 | 108296773 | 108296774 | Human |
| 597203686 | GWAS1299760_H | coronary artery disease QTL GWAS1299760 (human) | | 3e-08 | coronary artery integrity trait (VT:0010746) | | 4 | 119988346 | 119988347 | Human |
| 616963396 | GWAS1980895_H | bipolar disorder QTL GWAS1980895 (human) | | 0.0000001 | bipolar disorder | | 4 | 117551578 | 117551579 | Human |
| 628661498 | GWAS2569727_H | peptic ulcer disease QTL GWAS2569727 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616812 | 123616813 | Human |
| 617192778 | GWAS2173218_H | apolipoprotein A 1 measurement QTL GWAS2173218 (human) | | 2e-41 | apolipoprotein A 1 measurement | | 4 | 109717668 | 109717669 | Human |
| 597236250 | GWAS1332324_H | blood protein measurement QTL GWAS1332324 (human) | | 1e-98 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628677886 | GWAS2586115_H | brain attribute QTL GWAS2586115 (human) | | 8e-13 | brain attribute | | 4 | 123179401 | 123179402 | Human |
| 406954438 | GWAS603414_H | Cleft palate, cleft lip QTL GWAS603414 (human) | | 0.0000009 | Cleft palate, cleft lip | | 4 | 123789429 | 123789430 | Human |
| 597449232 | GWAS1545306_H | Alzheimer disease, educational attainment QTL GWAS1545306 (human) | | 0.0000004 | Alzheimer disease, educational attainment | | 4 | 129748953 | 129748954 | Human |
| 628595960 | GWAS2504189_H | testosterone measurement QTL GWAS2504189 (human) | | 0.000004 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
| 616521008 | GWAS1917591_H | alkaline phosphatase measurement QTL GWAS1917591 (human) | | 1e-22 | alkaline phosphatase measurement | | 4 | 110201006 | 110201007 | Human |
| 628989170 | GWAS2897399_H | bladder calculus QTL GWAS2897399 (human) | | 4e-17 | bladder calculus | | 4 | 114696462 | 114696463 | Human |
| 597056007 | GWAS1152081_H | asthma exacerbation measurement QTL GWAS1152081 (human) | | 0.000008 | asthma exacerbation measurement | | 4 | 125651718 | 125651719 | Human |
| 628940014 | GWAS2848243_H | polyunsaturated fatty acids to total fatty acids percentage QTL GWAS2848243 (human) | | 5e-08 | fatty acid amount (VT:0010046) | | 4 | 107486430 | 107486431 | Human |
| 407200215 | GWAS849191_H | appendectomy QTL GWAS849191 (human) | | 4e-12 | appendectomy | | 4 | 111904289 | 111904290 | Human |
| 407396828 | GWAS1045804_H | self reported educational attainment QTL GWAS1045804 (human) | | 4e-09 | self reported educational attainment | | 4 | 111485805 | 111485806 | Human |
| 598039088 | GWAS1758387_H | gut microbiome measurement, bone density QTL GWAS1758387 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116019324 | 116019325 | Human |
| 616570198 | GWAS1966781_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1966781 (human) | | 3e-15 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 112179581 | 112179582 | Human |
| 407200210 | GWAS849186_H | appendicitis QTL GWAS849186 (human) | | 5e-58 | appendicitis | | 4 | 110810780 | 110810781 | Human |
| 598039090 | GWAS1758389_H | gut microbiome measurement, bone density QTL GWAS1758389 (human) | | 2e-09 | gut microbiome measurement, bone density | | 4 | 116039953 | 116039954 | Human |
| 617045343 | GWAS2062842_H | stroke QTL GWAS2062842 (human) | | 2e-15 | stroke | | 4 | 110793263 | 110793264 | Human |
| 597400065 | GWAS1496139_H | cortex volume change measurement, age at assessment QTL GWAS1496139 (human) | | 0.000003 | cortex volume change measurement, age at assessment | | 4 | 111512339 | 111512340 | Human |
| 597334528 | GWAS1430602_H | R-warfarin measurement QTL GWAS1430602 (human) | | 0.000005 | R-warfarin measurement | | 4 | 129054159 | 129054160 | Human |
| 407200222 | GWAS849198_H | appendectomy QTL GWAS849198 (human) | | 6e-34 | appendectomy | | 4 | 110799663 | 110799664 | Human |
| 597268997 | GWAS1365071_H | diastolic blood pressure QTL GWAS1365071 (human) | | 2e-13 | diastolic blood pressure | | 4 | 119588124 | 119588125 | Human |
| 597367303 | GWAS1463377_H | lymphocyte count QTL GWAS1463377 (human) | | 2e-19 | lymphocyte count | | 4 | 122760001 | 122760002 | Human |
| 628661476 | GWAS2569705_H | color vision disorder QTL GWAS2569705 (human) | | 0.000009 | color vision disorder | | 4 | 129061664 | 129061665 | Human |
| 406888926 | GWAS537902_H | bipolar disorder QTL GWAS537902 (human) | | 0.000007 | bipolar disorder | | 4 | 119514966 | 119514967 | Human |
| 628595945 | GWAS2504174_H | lifestyle measurement, anxiety disorder measurement QTL GWAS2504174 (human) | | 8e-08 | anxiety-related behavior trait (VT:0010716) | | 4 | 127457977 | 127457978 | Human |
| 617078118 | GWAS2095617_H | intelligence, response to cranial radiation therapy QTL GWAS2095617 (human) | | 0.000001 | intelligence, response to cranial radiation therapy | | 4 | 120035508 | 120035509 | Human |
| 597613116 | GWAS1669976_H | platelet count QTL GWAS1669976 (human) | | 2e-14 | platelet count | | 4 | 119653719 | 119653720 | Human |
| 628939999 | GWAS2848228_H | body height QTL GWAS2848228 (human) | | 3e-09 | body height | | 4 | 128700992 | 128700993 | Human |
| 628956377 | GWAS2864606_H | fatty acid amount QTL GWAS2864606 (human) | | 3e-08 | fatty acid amount | | 4 | 110186345 | 110186346 | Human |
| 407232993 | GWAS881969_H | bone density QTL GWAS881969 (human) | | 8e-29 | bone density | | 4 | 131238783 | 131238784 | Human |
| 628956376 | GWAS2864605_H | fatty acid amount QTL GWAS2864605 (human) | | 3e-17 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 597613115 | GWAS1669975_H | platelet count QTL GWAS1669975 (human) | | 4e-34 | platelet count | | 4 | 109912954 | 109912955 | Human |
| 628956378 | GWAS2864607_H | fatty acid amount QTL GWAS2864607 (human) | | 2e-08 | fatty acid amount (VT:0010046) | | 4 | 110191632 | 110191633 | Human |
| 597236273 | GWAS1332347_H | biological sex QTL GWAS1332347 (human) | | 5e-13 | biological sex | | 4 | 111485805 | 111485806 | Human |
| 407364078 | GWAS1013054_H | triglyceride measurement QTL GWAS1013054 (human) | | 3e-20 | triglyceride measurement | | 4 | 109603883 | 109603884 | Human |
| 617192800 | GWAS2173240_H | total cholesterol measurement, diet measurement QTL GWAS2173240 (human) | | 0.000004 | total cholesterol measurement, diet measurement | | 4 | 118492283 | 118492284 | Human |
| 616979823 | GWAS1997322_H | gout QTL GWAS1997322 (human) | | 5e-08 | gout | | 4 | 123815050 | 123815051 | Human |
| 628956375 | GWAS2864604_H | fatty acid amount QTL GWAS2864604 (human) | | 8e-14 | fatty acid amount | | 4 | 109174464 | 109174465 | Human |
| 598006287 | GWAS1725586_H | strand of hair color QTL GWAS1725586 (human) | | 5e-23 | strand of hair color | | 4 | 108561329 | 108561330 | Human |
| 407314932 | GWAS963908_H | high density lipoprotein cholesterol measurement QTL GWAS963908 (human) | | 4e-08 | high density lipoprotein cholesterol measurement | | 4 | 109648464 | 109648465 | Human |
| 597826065 | GWAS1693456_H | inflammatory bowel disease QTL GWAS1693456 (human) | | 1e-08 | inflammatory bowel disease | | 4 | 122354400 | 122354401 | Human |
| 628907209 | GWAS2815438_H | allergic conjunctivitis QTL GWAS2815438 (human) | | 2e-08 | allergic conjunctivitis | | 4 | 114728111 | 114728112 | Human |
| 597105185 | GWAS1201259_H | cytokine measurement QTL GWAS1201259 (human) | | 0.000001 | cytokine amount (VT:0008713) | blood cytokine measurement (CMO:0001924) | 4 | 128887051 | 128887052 | Human |
| 407183869 | GWAS832845_H | phenylalanine measurement QTL GWAS832845 (human) | | 1e-08 | phenylalanine measurement | | 4 | 122052538 | 122052539 | Human |
| 407183868 | GWAS832844_H | methionine measurement QTL GWAS832844 (human) | | 0.0000002 | methionine measurement | | 4 | 122052538 | 122052539 | Human |
| 597383712 | GWAS1479786_H | type 2 diabetes mellitus QTL GWAS1479786 (human) | | 1e-08 | type 2 diabetes mellitus | | 4 | 129865191 | 129865192 | Human |
| 628841669 | GWAS2749898_H | total cholesterol measurement QTL GWAS2749898 (human) | | 9e-10 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 128078464 | 128078465 | Human |
| 628841668 | GWAS2749897_H | total cholesterol measurement QTL GWAS2749897 (human) | | 6e-10 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 119192945 | 119192946 | Human |
| 596990544 | GWAS1110063_H | resistin measurement QTL GWAS1110063 (human) | | 6e-18 | resistin measurement | | 4 | 115275150 | 115275151 | Human |
| 597154399 | GWAS1250473_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1250473 (human) | | 4e-15 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 616390005 | GWAS1870247_H | irritable bowel syndrome, chronic obstructive pulmonary disease QTL GWAS1870247 (human) | | 6e-12 | irritable bowel syndrome, chronic obstructive pulmonary disease | | 4 | 111450477 | 111450478 | Human |
| 596990559 | GWAS1110078_H | serum IgG glycosylation measurement QTL GWAS1110078 (human) | | 0.000005 | serum IgG glycosylation measurement | | 4 | 127545545 | 127545546 | Human |
| 407052680 | GWAS701656_H | cortical surface area measurement QTL GWAS701656 (human) | | 4e-10 | cortical surface area measurement | | 4 | 112495627 | 112495628 | Human |
| 596990558 | GWAS1110077_H | serum IgG glycosylation measurement QTL GWAS1110077 (human) | | 0.000003 | serum IgG glycosylation measurement | | 4 | 116928293 | 116928294 | Human |
| 628923575 | GWAS2831804_H | ubiquitin+1, truncated mutation for UBB measurement QTL GWAS2831804 (human) | | 2e-22 | ubiquitin+1, truncated mutation for UBB measurement | | 4 | 119349548 | 119349549 | Human |
| 407183753 | GWAS832729_H | unipolar depression, age at onset QTL GWAS832729 (human) | | 0.000007 | unipolar depression, age at onset | | 4 | 127602809 | 127602810 | Human |
| 406987151 | GWAS636127_H | sex hormone-binding globulin measurement QTL GWAS636127 (human) | | 0.000002 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
| 628989107 | GWAS2897336_H | chronic pancreatitis QTL GWAS2897336 (human) | | 2e-12 | chronic pancreatitis | | 4 | 116090374 | 116090375 | Human |
| 406987148 | GWAS636124_H | sex hormone-binding globulin measurement QTL GWAS636124 (human) | | 0.000002 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 628972713 | GWAS2880942_H | fatty acid amount QTL GWAS2880942 (human) | | 5e-10 | fatty acid amount | | 4 | 109603883 | 109603884 | Human |
| 407134621 | GWAS783597_H | seasonal gut microbiome measurement QTL GWAS783597 (human) | | 0.000007 | seasonal gut microbiome measurement | | 4 | 108464247 | 108464248 | Human |
| 628841633 | GWAS2749862_H | triglyceride measurement QTL GWAS2749862 (human) | | 3e-33 | triglyceride amount (VT:0000187) | blood triglyceride level (CMO:0000118) | 4 | 109174464 | 109174465 | Human |
| 616521058 | GWAS1917641_H | platelet count QTL GWAS1917641 (human) | | 1e-13 | platelet count | | 4 | 123849566 | 123849567 | Human |
| 628645029 | GWAS2553258_H | body mass index QTL GWAS2553258 (human) | | 0.000001 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 131333599 | 131333600 | Human |
| 598022779 | GWAS1742078_H | CLEC1B/EGF protein level ratio in blood QTL GWAS1742078 (human) | | 6e-375 | CLEC1B/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 597137992 | GWAS1234066_H | bone density QTL GWAS1234066 (human) | | 5e-133 | bone density | | 4 | 120625611 | 120625612 | Human |
| 628530326 | GWAS2438555_H | lymphocyte count QTL GWAS2438555 (human) | | 1e-18 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 109921984 | 109921985 | Human |
| 628530327 | GWAS2438556_H | lymphocyte count QTL GWAS2438556 (human) | | 6e-16 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112153589 | 112153590 | Human |
| 407314853 | GWAS963829_H | type 2 diabetes mellitus QTL GWAS963829 (human) | | 2e-18 | type 2 diabetes mellitus | | 4 | 119146548 | 119146549 | Human |
| 628825241 | GWAS2733470_H | cGMP-specific 3',5'-cyclic phosphodiesterase measurement QTL GWAS2733470 (human) | | 4e-12 | cGMP-specific 3',5'-cyclic phosphodiesterase measurement | | 4 | 119320694 | 119320695 | Human |
| 407413164 | GWAS1062140_H | atrial fibrillation QTL GWAS1062140 (human) | | 4e-714 | atrial fibrillation | | 4 | 110789811 | 110789812 | Human |
| 407232928 | GWAS881904_H | bone density QTL GWAS881904 (human) | | 4e-40 | bone density | | 4 | 126002708 | 126002709 | Human |
| 406938025 | GWAS587001_H | neuroticism measurement QTL GWAS587001 (human) | | 3e-08 | neuroticism measurement | | 4 | 118263414 | 118263415 | Human |
| 628530328 | GWAS2438557_H | lymphocyte count QTL GWAS2438557 (human) | | 5e-15 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 122760001 | 122760002 | Human |
| 628628619 | GWAS2536848_H | smoking status measurement QTL GWAS2536848 (human) | | 7e-12 | smoking status measurement | | 4 | 111500989 | 111500990 | Human |
| 406970805 | GWAS619781_H | sporadic amyotrophic lateral sclerosis QTL GWAS619781 (human) | | 0.000003 | sporadic amyotrophic lateral sclerosis | | 4 | 108038126 | 108038127 | Human |
| 597416559 | GWAS1512633_H | bipolar disorder QTL GWAS1512633 (human) | | 5e-09 | bipolar disorder | | 4 | 117534962 | 117534963 | Human |
| 407134641 | GWAS783617_H | pelvic organ prolapse QTL GWAS783617 (human) | | 0.000002 | pelvic organ prolapse | | 4 | 123466324 | 123466325 | Human |
| 628595853 | GWAS2504082_H | free cholesterol measurement, blood VLDL cholesterol amount QTL GWAS2504082 (human) | | 7e-09 | blood cholesterol amount (VT:0000180) | blood cholesterol level (CMO:0002280) | 4 | 109657070 | 109657071 | Human |
| 407036483 | GWAS685459_H | myeloid white cell count QTL GWAS685459 (human) | | 3e-11 | myeloid white cell count | | 4 | 109931303 | 109931304 | Human |
| 406921792 | GWAS570768_H | BMI-adjusted waist-hip ratio QTL GWAS570768 (human) | | 1e-09 | BMI-adjusted waist-hip ratio | | 4 | 119185193 | 119185194 | Human |
| 407200326 | GWAS849302_H | pulse pressure measurement, sex interaction measurement QTL GWAS849302 (human) | | 0.000007 | pulse pressure measurement, sex interaction measurement | | 4 | 110755885 | 110755886 | Human |
| 617111244 | GWAS2128743_H | tenascin measurement QTL GWAS2128743 (human) | | 9e-13 | tenascin measurement | | 4 | 123739489 | 123739490 | Human |
| 407036484 | GWAS685460_H | myeloid white cell count QTL GWAS685460 (human) | | 1e-15 | myeloid white cell count | | 4 | 119342160 | 119342161 | Human |
| 597137809 | GWAS1233883_H | bone density QTL GWAS1233883 (human) | | 8e-29 | bone density | | 4 | 131238783 | 131238784 | Human |
| 626450271 | GWAS2264204_H | treatment-resistant hypertension QTL GWAS2264204 (human) | | 0.000005 | treatment-resistant hypertension | | 4 | 129450485 | 129450486 | Human |
| 597416337 | GWAS1512411_H | gout QTL GWAS1512411 (human) | | 5e-08 | gout | | 4 | 123815050 | 123815051 | Human |
| 616963786 | GWAS1981285_H | autoimmune thyroid disease, type 1 diabetes mellitus QTL GWAS1981285 (human) | | 4e-10 | autoimmune thyroid disease, type 1 diabetes mellitus | | 4 | 121392885 | 121392886 | Human |
| 596957592 | GWAS1077111_H | thyroxine measurement QTL GWAS1077111 (human) | | 5e-08 | thyroxine measurement | | 4 | 123563112 | 123563113 | Human |
| 407282262 | GWAS931238_H | brain measurement QTL GWAS931238 (human) | | 5e-30 | brain measurement | | 4 | 118393759 | 118393760 | Human |
| 628367205 | GWAS2288049_H | lung carcinoma QTL GWAS2288049 (human) | | 0.0000006 | lung carcinoma | | 4 | 117059518 | 117059519 | Human |
| 628662121 | GWAS2570350_H | color vision disorder QTL GWAS2570350 (human) | | 0.0000009 | color vision disorder | | 4 | 131063773 | 131063774 | Human |
| 628809582 | GWAS2717811_H | prostate carcinoma QTL GWAS2717811 (human) | | 0.000001 | prostate integrity trait (VT:0010571) | | 4 | 109927496 | 109927497 | Human |
| 616521384 | GWAS1917967_H | hemoglobin measurement QTL GWAS1917967 (human) | | 1e-11 | hemoglobin measurement | | 4 | 114422087 | 114422088 | Human |
| 597285249 | GWAS1381323_H | cardiovascular disease QTL GWAS1381323 (human) | | 1e-08 | cardiovascular disease | | 4 | 109616095 | 109616096 | Human |
| 598038973 | GWAS1758272_H | gut microbiome measurement, bone density QTL GWAS1758272 (human) | | 2e-08 | gut microbiome measurement, bone density | | 4 | 116034483 | 116034484 | Human |
| 598071742 | GWAS1791041_H | obsolete_fibroblast growth factor 2 measurement QTL GWAS1791041 (human) | | 8e-667 | obsolete_fibroblast growth factor 2 measurement | | 4 | 122827461 | 122827462 | Human |
| 406889052 | GWAS538028_H | DNA methylation QTL GWAS538028 (human) | | 3e-09 | DNA methylation | | 4 | 120727011 | 120727012 | Human |
| 628924257 | GWAS2832486_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2832486 (human) | | 4e-08 | fatty acid amount (VT:0010046) | | 4 | 109603883 | 109603884 | Human |
| 628842331 | GWAS2750560_H | insomnia QTL GWAS2750560 (human) | | 3e-10 | sleep behavior trait (VT:0001501) | | 4 | 130028211 | 130028212 | Human |
| 628842330 | GWAS2750559_H | insomnia QTL GWAS2750559 (human) | | 2e-11 | sleep behavior trait (VT:0001501) | | 4 | 129856909 | 129856910 | Human |
| 628842329 | GWAS2750558_H | insomnia QTL GWAS2750558 (human) | | 5e-09 | sleep behavior trait (VT:0001501) | | 4 | 118318250 | 118318251 | Human |
| 628694876 | GWAS2603105_H | cortical thickness QTL GWAS2603105 (human) | | 1e-11 | cerebral cortex morphology trait (VT:0000788) | | 4 | 123258359 | 123258360 | Human |
| 597170622 | GWAS1266696_H | complement factor I measurement QTL GWAS1266696 (human) | | 7e-85 | complement factor I measurement | | 4 | 109735574 | 109735575 | Human |
| 628989773 | GWAS2898002_H | disorder of appendix QTL GWAS2898002 (human) | | 2e-21 | disorder of appendix | | 4 | 110810809 | 110810810 | Human |
| 406921841 | GWAS570817_H | suicide QTL GWAS570817 (human) | | 0.000004 | suicide | | 4 | 125969849 | 125969850 | Human |
| 628498246 | GWAS2406475_H | arterial stiffness measurement QTL GWAS2406475 (human) | | 0.000006 | artery integrity trait (VT:0010639) | pulse wave velocity (CMO:0003717) | 4 | 128552943 | 128552944 | Human |
| 596973990 | GWAS1093509_H | memory performance QTL GWAS1093509 (human) | | 0.000004 | memory performance | | 4 | 124891420 | 124891421 | Human |
| 597137839 | GWAS1233913_H | bone density QTL GWAS1233913 (human) | | 5e-18 | bone density | | 4 | 110503132 | 110503133 | Human |
| 597055919 | GWAS1151993_H | asthma exacerbation measurement QTL GWAS1151993 (human) | | 0.000002 | asthma exacerbation measurement | | 4 | 129344890 | 129344891 | Human |
| 628891463 | GWAS2799692_H | high density lipoprotein cholesterol measurement QTL GWAS2799692 (human) | | 2e-31 | blood HDL cholesterol amount (VT:0000184) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 109174464 | 109174465 | Human |
| 407085570 | GWAS734546_H | cardioembolic stroke QTL GWAS734546 (human) | | 5e-41 | cardioembolic stroke | | 4 | 110793263 | 110793264 | Human |
| 597416408 | GWAS1512482_H | celiac disease QTL GWAS1512482 (human) | | 3e-36 | celiac disease | | 4 | 122629959 | 122629960 | Human |
| 617029249 | GWAS2046748_H | protein measurement QTL GWAS2046748 (human) | | 2e-09 | protein amount (VT:0010120) | | 4 | 110722577 | 110722578 | Human |
| 628825905 | GWAS2734134_H | bilirubin measurement QTL GWAS2734134 (human) | | 1e-12 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 123882996 | 123882997 | Human |
| 628416319 | GWAS2324548_H | facial morphology trait QTL GWAS2324548 (human) | | 2e-09 | facial morphology trait | | 4 | 127005360 | 127005361 | Human |
| 617127558 | GWAS2145057_H | platelet count QTL GWAS2145057 (human) | | 4e-14 | platelet count | | 4 | 123749526 | 123749527 | Human |
| 616357619 | GWAS1842334_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS1842334 (human) | | 4e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 125560481 | 125560482 | Human |
| 616570515 | GWAS1967098_H | fibroblast growth factor 2 amount QTL GWAS1967098 (human) | | 1e-18 | fibroblast growth factor 2 amount | | 4 | 123649214 | 123649215 | Human |
| 406905364 | GWAS554340_H | COVID-19 QTL GWAS554340 (human) | | 0.000007 | COVID-19 | | 4 | 122087606 | 122087607 | Human |
| 407314963 | GWAS963939_H | testosterone measurement QTL GWAS963939 (human) | | 1e-09 | testosterone measurement | | 4 | 124046883 | 124046884 | Human |
| 406921748 | GWAS570724_H | diet measurement QTL GWAS570724 (human) | | 3e-08 | diet measurement | | 4 | 112518056 | 112518057 | Human |
| 597613003 | GWAS1669863_H | mean corpuscular hemoglobin concentration QTL GWAS1669863 (human) | | 7e-14 | mean corpuscular hemoglobin concentration | | 4 | 121827841 | 121827842 | Human |
| 597498304 | GWAS1594378_H | HbA1c measurement QTL GWAS1594378 (human) | | 1e-09 | blood hemoglobin amount (VT:0001588) | blood hemoglobin A1c level (CMO:0002786) | 4 | 110020646 | 110020647 | Human |
| 407347736 | GWAS996712_H | atrial fibrillation QTL GWAS996712 (human) | | 3e-525 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 617111214 | GWAS2128713_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2128713 (human) | | 1e-15 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 132115969 | 132115970 | Human |
| 596990461 | GWAS1109980_H | celiac disease QTL GWAS1109980 (human) | | 1e-14 | celiac disease | | 4 | 122588266 | 122588267 | Human |
| 616980142 | GWAS1997641_H | heel bone mineral density QTL GWAS1997641 (human) | | 3e-15 | heel bone mineral density | | 4 | 126607351 | 126607352 | Human |
| 407036459 | GWAS685435_H | mean reticulocyte volume QTL GWAS685435 (human) | | 1e-09 | mean reticulocyte volume | | 4 | 128306129 | 128306130 | Human |
| 407036456 | GWAS685432_H | mean reticulocyte volume QTL GWAS685432 (human) | | 6e-57 | mean reticulocyte volume | | 4 | 121877258 | 121877259 | Human |
| 616980140 | GWAS1997639_H | heel bone mineral density QTL GWAS1997639 (human) | | 8e-13 | heel bone mineral density | | 4 | 124619337 | 124619338 | Human |
| 616570539 | GWAS1967122_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1967122 (human) | | 7e-18 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 119810601 | 119810602 | Human |
| 616980141 | GWAS1997640_H | heel bone mineral density QTL GWAS1997640 (human) | | 8e-14 | heel bone mineral density | | 4 | 126607237 | 126607238 | Human |
| 616980138 | GWAS1997637_H | heel bone mineral density QTL GWAS1997637 (human) | | 3e-09 | heel bone mineral density | | 4 | 108249911 | 108249912 | Human |
| 616980139 | GWAS1997638_H | heel bone mineral density QTL GWAS1997638 (human) | | 8e-11 | heel bone mineral density | | 4 | 123613837 | 123613838 | Human |
| 616521423 | GWAS1918006_H | cathepsin F measurement QTL GWAS1918006 (human) | | 1e-17 | cathepsin F measurement | | 4 | 109657070 | 109657071 | Human |
| 407347767 | GWAS996743_H | lobe attachment QTL GWAS996743 (human) | | 0.000004 | lobe attachment | | 4 | 124943164 | 124943165 | Human |
| 407347766 | GWAS996742_H | lobe attachment QTL GWAS996742 (human) | | 0.0000001 | lobe attachment | | 4 | 124806384 | 124806385 | Human |
| 626466597 | GWAS2280530_H | body height QTL GWAS2280530 (human) | | 3e-16 | body height | | 4 | 112647388 | 112647389 | Human |
| 617078452 | GWAS2095951_H | response to cranial radiation therapy, short-term memory QTL GWAS2095951 (human) | | 0.0000007 | response to cranial radiation therapy, short-term memory | | 4 | 120035508 | 120035509 | Human |
| 407200305 | GWAS849281_H | monocyte count QTL GWAS849281 (human) | | 2e-18 | monocyte count | | 4 | 109966833 | 109966834 | Human |
| 617029297 | GWAS2046796_H | erythrocyte count QTL GWAS2046796 (human) | | 1e-15 | erythrocyte count | | 4 | 114598669 | 114598670 | Human |
| 407200306 | GWAS849282_H | monocyte count QTL GWAS849282 (human) | | 3e-09 | monocyte count | | 4 | 119447401 | 119447402 | Human |
| 597989852 | GWAS1709151_H | body height QTL GWAS1709151 (human) | | 0.000003 | body height | | 4 | 109118612 | 109118613 | Human |
| 617291443 | GWAS2228219_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2228219 (human) | | 9e-09 | polyunsaturated fatty acids to monounsaturated fatty acids ratio | | 4 | 109657070 | 109657071 | Human |
| 597514725 | GWAS1610799_H | sex hormone-binding globulin measurement QTL GWAS1610799 (human) | | 2e-11 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 407249469 | GWAS898445_H | major depressive disorder QTL GWAS898445 (human) | | 3e-09 | major depressive disorder | | 4 | 130315312 | 130315313 | Human |
| 617094838 | GWAS2112337_H | celiac disease QTL GWAS2112337 (human) | | 1e-14 | celiac disease | | 4 | 122629959 | 122629960 | Human |
| 407003709 | GWAS652685_H | Parkinson disease QTL GWAS652685 (human) | | 3e-11 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
| 407347768 | GWAS996744_H | lobe attachment QTL GWAS996744 (human) | | 0.000009 | lobe attachment | | 4 | 125111064 | 125111065 | Human |
| 626450390 | GWAS2264323_H | treatment-resistant hypertension QTL GWAS2264323 (human) | | 0.000005 | treatment-resistant hypertension | | 4 | 115972928 | 115972929 | Human |
| 628514806 | GWAS2423035_H | sexual dimorphism measurement QTL GWAS2423035 (human) | | 5e-09 | sexual dimorphism measurement | | 4 | 121792708 | 121792709 | Human |
| 628629497 | GWAS2537726_H | obesity QTL GWAS2537726 (human) | | 0.000003 | eating behavior trait (VT:0001431) | | 4 | 131830983 | 131830984 | Human |
| 407020224 | GWAS669200_H | attention deficit hyperactivity disorder QTL GWAS669200 (human) | | 0.000008 | behavior trait (VT:0010442) | | 4 | 110105771 | 110105772 | Human |
| 407216838 | GWAS865814_H | heart failure QTL GWAS865814 (human) | | 2e-24 | heart failure | | 4 | 110780277 | 110780278 | Human |
| 406905540 | GWAS554516_H | diastolic blood pressure QTL GWAS554516 (human) | | 3e-15 | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 119588124 | 119588125 | Human |
| 596990224 | GWAS1109743_H | atrial fibrillation QTL GWAS1109743 (human) | | 4e-63 | atrial fibrillation | | 4 | 110787131 | 110787132 | Human |
| 597104927 | GWAS1201001_H | neutrophil percentage of leukocytes QTL GWAS1201001 (human) | | 1e-16 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 4 | 112183604 | 112183605 | Human |
| 616537655 | GWAS1934238_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1934238 (human) | | 6e-12 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 125992444 | 125992445 | Human |
| 597088543 | GWAS1184617_H | mean corpuscular volume QTL GWAS1184617 (human) | | 2e-58 | mean corpuscular volume | | 4 | 121875762 | 121875763 | Human |
| 407102154 | GWAS751130_H | color vision disorder QTL GWAS751130 (human) | | 0.0000009 | color vision disorder | | 4 | 131063773 | 131063774 | Human |
| 407118542 | GWAS767518_H | peptic ulcer disease QTL GWAS767518 (human) | | 1e-08 | peptic ulcer disease | | 4 | 123616812 | 123616813 | Human |
| 625827779 | GWAS2248701_H | forced expiratory volume QTL GWAS2248701 (human) | | 1e-11 | forced expiratory volume | | 4 | 106578647 | 106578648 | Human |
| 625827778 | GWAS2248700_H | forced expiratory volume QTL GWAS2248700 (human) | | 8e-12 | forced expiratory volume | | 4 | 106356882 | 106356883 | Human |
| 626450375 | GWAS2264308_H | Alzheimer disease, dementia, family history of Alzheimer’s disease QTL GWAS2264308 (human) | | 0.000006 | Alzheimer disease, dementia, family history of Alzheimer’s disease | | 4 | 108841377 | 108841378 | Human |
| 628531173 | GWAS2439402_H | HbA1c measurement QTL GWAS2439402 (human) | | 9e-20 | blood hemoglobin amount (VT:0001588) | blood hemoglobin A1c level (CMO:0002786) | 4 | 109906786 | 109906787 | Human |
| 617029204 | GWAS2046703_H | cognitive function measurement QTL GWAS2046703 (human) | | 0.000006 | cognitive behavior trait (VT:0010450) | | 4 | 126558097 | 126558098 | Human |
| 626450370 | GWAS2264303_H | Alzheimer disease, dementia, family history of Alzheimer’s disease QTL GWAS2264303 (human) | | 0.000002 | Alzheimer disease, dementia, family history of Alzheimer’s disease | | 4 | 107969240 | 107969241 | Human |
| 597055746 | GWAS1151820_H | respiratory system disease QTL GWAS1151820 (human) | | 6e-17 | respiratory system disease | | 4 | 122432277 | 122432278 | Human |
| 407364305 | GWAS1013281_H | attention deficit hyperactivity disorder, risk-taking behaviour QTL GWAS1013281 (human) | | 7e-11 | attention deficit hyperactivity disorder, risk-taking behaviour | | 4 | 111296367 | 111296368 | Human |
| 406938326 | GWAS587302_H | adolescent idiopathic scoliosis QTL GWAS587302 (human) | | 5e-11 | adolescent idiopathic scoliosis | | 4 | 112239118 | 112239119 | Human |
| 628908004 | GWAS2816233_H | dilated cardiomyopathy QTL GWAS2816233 (human) | | 0.0000001 | heart integrity trait (VT:0010757) | | 4 | 110796911 | 110796912 | Human |
| 407347931 | GWAS996907_H | lobe attachment QTL GWAS996907 (human) | | 0.0000007 | lobe attachment | | 4 | 121107629 | 121107630 | Human |
| 628432853 | GWAS2341082_H | cervical carcinoma QTL GWAS2341082 (human) | | 0.000001 | uterus integrity trait (VT:0010575) | | 4 | 113726137 | 113726138 | Human |
| 407134950 | GWAS783926_H | response to antiviral drug QTL GWAS783926 (human) | | 0.000002 | response to antiviral drug | | 4 | 110212212 | 110212213 | Human |
| 616357403 | GWAS1842118_H | gut microbiome measurement, breastfeeding duration QTL GWAS1842118 (human) | | 2e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 121972794 | 121972795 | Human |
| 628367324 | GWAS2288168_H | facial morphology QTL GWAS2288168 (human) | | 2e-09 | facial morphology | | 4 | 126030047 | 126030049 | Human |
| 407003883 | GWAS652859_H | adult onset asthma QTL GWAS652859 (human) | | 2e-10 | adult onset asthma | | 4 | 122432277 | 122432278 | Human |
| 628367325 | GWAS2288169_H | facial morphology QTL GWAS2288169 (human) | | 6e-11 | facial morphology | | 4 | 126889660 | 126889661 | Human |
| 628367326 | GWAS2288170_H | facial morphology QTL GWAS2288170 (human) | | 1e-16 | facial morphology | | 4 | 127062308 | 127062309 | Human |
| 628367321 | GWAS2288165_H | facial morphology QTL GWAS2288165 (human) | | 6e-10 | facial morphology | | 4 | 110796911 | 110796912 | Human |
| 628367322 | GWAS2288166_H | facial morphology QTL GWAS2288166 (human) | | 1e-09 | facial morphology | | 4 | 111751467 | 111751468 | Human |
| 406889198 | GWAS538174_H | type 1 diabetes mellitus QTL GWAS538174 (human) | | 5e-13 | type 1 diabetes mellitus | | 4 | 122211337 | 122211338 | Human |
| 628367323 | GWAS2288167_H | facial morphology QTL GWAS2288167 (human) | | 1e-09 | facial morphology | | 4 | 121076949 | 121076950 | Human |
| 407216884 | GWAS865860_H | leukocyte count QTL GWAS865860 (human) | | 4e-12 | leukocyte count | | 4 | 119409000 | 119409001 | Human |
| 407053041 | GWAS702017_H | household income QTL GWAS702017 (human) | | 5e-09 | household income | | 4 | 122175535 | 122175536 | Human |
| 617029235 | GWAS2046734_H | platelet count QTL GWAS2046734 (human) | | 8e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123882996 | 123882997 | Human |
| 617029234 | GWAS2046733_H | platelet count QTL GWAS2046733 (human) | | 2e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 123749526 | 123749527 | Human |
| 597449002 | GWAS1545076_H | calcium measurement, diet measurement QTL GWAS1545076 (human) | | 0.000009 | calcium measurement, diet measurement | | 4 | 111131258 | 111131259 | Human |
| 617029233 | GWAS2046732_H | platelet count QTL GWAS2046732 (human) | | 7e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 122595396 | 122595397 | Human |
| 597088544 | GWAS1184618_H | mean corpuscular volume QTL GWAS1184618 (human) | | 8e-25 | mean corpuscular volume | | 4 | 128177881 | 128177882 | Human |
| 628662223 | GWAS2570452_H | smoking initiation QTL GWAS2570452 (human) | | 2e-11 | behavior trait (VT:0010442) | | 4 | 111546456 | 111546457 | Human |
| 617029232 | GWAS2046731_H | platelet count QTL GWAS2046731 (human) | | 1e-17 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119342213 | 119342215 | Human |
| 407167739 | GWAS816715_H | creatine measurement QTL GWAS816715 (human) | | 0.0000006 | creatine measurement | | 4 | 110523020 | 110523021 | Human |
| 628367293 | GWAS2288137_H | lymphoid neoplasm QTL GWAS2288137 (human) | | 3e-08 | lymphoid neoplasm | | 4 | 108066714 | 108066715 | Human |
| 617209347 | GWAS2189787_H | level of agrin in blood QTL GWAS2189787 (human) | | 2e-53 | level of agrin in blood | | 4 | 118378823 | 118378824 | Human |
| 597072221 | GWAS1168295_H | albumin:globulin ratio measurement QTL GWAS1168295 (human) | | 2e-11 | albumin:globulin ratio measurement | | 4 | 110003204 | 110003205 | Human |
| 597580112 | GWAS1636972_H | lymphocyte count QTL GWAS1636972 (human) | | 3e-11 | lymphocyte count | | 4 | 109916511 | 109916512 | Human |
| 628629430 | GWAS2537659_H | pulse pressure measurement QTL GWAS2537659 (human) | | 3e-73 | arterial blood pressure trait (VT:2000000) | pulse pressure (CMO:0000292) | 4 | 115629004 | 115629005 | Human |
| 617045512 | GWAS2063011_H | total cholesterol measurement QTL GWAS2063011 (human) | | 2e-09 | total cholesterol measurement | | 4 | 119210489 | 119210490 | Human |
| 628793258 | GWAS2701487_H | platelet count QTL GWAS2701487 (human) | | 9e-21 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109945564 | 109945565 | Human |
| 628957088 | GWAS2865317_H | lymphocyte count QTL GWAS2865317 (human) | | 6e-14 | lymphocyte quantity (VT:0000717) | blood lymphocyte count (CMO:0000031) | 4 | 112198650 | 112198651 | Human |
| 407020188 | GWAS669164_H | vital capacity QTL GWAS669164 (human) | | 0.000004 | vital capacity | | 4 | 107194065 | 107194066 | Human |
| 407249560 | GWAS898536_H | cytokine measurement QTL GWAS898536 (human) | | 0.000003 | cytokine measurement | | 4 | 113032921 | 113032922 | Human |
| 617078311 | GWAS2095810_H | protein measurement QTL GWAS2095810 (human) | | 6e-17 | protein measurement | | 4 | 110555545 | 110555546 | Human |
| 596990326 | GWAS1109845_H | systemic lupus erythematosus QTL GWAS1109845 (human) | | 0.000001 | systemic lupus erythematosus | | 4 | 108801970 | 108801971 | Human |
| 628531089 | GWAS2439318_H | IGF-1 measurement QTL GWAS2439318 (human) | | 2e-13 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 4 | 127821409 | 127821410 | Human |
| 628514718 | GWAS2422947_H | executive function measurement QTL GWAS2422947 (human) | | 0.000002 | cognitive behavior trait (VT:0010450) | | 4 | 130874841 | 130874842 | Human |
| 597072252 | GWAS1168326_H | osteoarthritis, knee QTL GWAS1168326 (human) | | 0.000001 | osteoarthritis, knee | | 4 | 115123255 | 115123256 | Human |
| 597334385 | GWAS1430459_H | COVID-19 QTL GWAS1430459 (human) | | 0.000001 | COVID-19 | | 4 | 113129435 | 113129436 | Human |
| 407118511 | GWAS767487_H | gut microbiome measurement QTL GWAS767487 (human) | | 0.000006 | gut microbiome measurement | | 4 | 123354475 | 123354476 | Human |
| 616357456 | GWAS1842171_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1842171 (human) | | 4e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 125466935 | 125466936 | Human |
| 596973947 | GWAS1093466_H | major depressive disorder QTL GWAS1093466 (human) | | 2e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
| 596973946 | GWAS1093465_H | major depressive disorder QTL GWAS1093465 (human) | | 5e-12 | major depressive disorder | | 4 | 122265238 | 122265239 | Human |
| 407347894 | GWAS996870_H | atrial fibrillation QTL GWAS996870 (human) | | 6e-09 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 407184055 | GWAS833031_H | chronic bronchitis QTL GWAS833031 (human) | | 2e-08 | chronic bronchitis | | 4 | 113635275 | 113635276 | Human |
| 406905524 | GWAS554500_H | alopecia areata QTL GWAS554500 (human) | | 5e-09 | alopecia areata | | 4 | 122602871 | 122602872 | Human |
| 597268845 | GWAS1364919_H | facial width measurement QTL GWAS1364919 (human) | | 0.000004 | facial width measurement | | 4 | 130195033 | 130195034 | Human |
| 597465451 | GWAS1561525_H | erosive tooth wear measurement QTL GWAS1561525 (human) | | 3e-08 | erosive tooth wear measurement | | 4 | 117643607 | 117643608 | Human |
| 597580134 | GWAS1636994_H | lymphocyte count QTL GWAS1636994 (human) | | 2e-12 | lymphocyte count | | 4 | 109927496 | 109927497 | Human |
| 597580135 | GWAS1636995_H | lymphocyte count QTL GWAS1636995 (human) | | 3e-13 | lymphocyte count | | 4 | 112198650 | 112198651 | Human |
| 406905529 | GWAS554505_H | alopecia areata QTL GWAS554505 (human) | | 0.000001 | alopecia areata | | 4 | 122473886 | 122473887 | Human |
| 617193011 | GWAS2173451_H | apolipoprotein A 1 measurement QTL GWAS2173451 (human) | | 1e-13 | apolipoprotein A 1 measurement | | 4 | 109717608 | 109717609 | Human |
| 626466732 | GWAS2280665_H | body height QTL GWAS2280665 (human) | | 6e-18 | body height | | 4 | 119831901 | 119831902 | Human |
| 616357447 | GWAS1842162_H | gut microbiome measurement, breastfeeding duration QTL GWAS1842162 (human) | | 3e-13 | gut microbiome measurement, breastfeeding duration | | 4 | 121369093 | 121369094 | Human |
| 406938433 | GWAS587409_H | cortical thickness QTL GWAS587409 (human) | | 0.0000001 | cortical thickness | | 4 | 120722084 | 120722085 | Human |
| 616570819 | GWAS1967402_H | fibroblast growth factor 2 amount QTL GWAS1967402 (human) | | 3e-16 | fibroblast growth factor 2 amount | | 4 | 123081630 | 123081631 | Human |
| 407118656 | GWAS767632_H | smoking status measurement QTL GWAS767632 (human) | | 5e-08 | smoking status measurement | | 4 | 120722084 | 120722085 | Human |
| 616570820 | GWAS1967403_H | fibroblast growth factor 2 amount QTL GWAS1967403 (human) | | 2e-24 | fibroblast growth factor 2 amount | | 4 | 122680969 | 122680970 | Human |
| 616570821 | GWAS1967404_H | fibroblast growth factor 2 amount QTL GWAS1967404 (human) | | 1e-20 | fibroblast growth factor 2 amount | | 4 | 123619151 | 123619152 | Human |
| 616570823 | GWAS1967406_H | fibroblast growth factor 2 amount QTL GWAS1967406 (human) | | 4e-50 | fibroblast growth factor 2 amount | | 4 | 123210593 | 123210594 | Human |
| 616570824 | GWAS1967407_H | fibroblast growth factor 2 amount QTL GWAS1967407 (human) | | 2e-14 | fibroblast growth factor 2 amount | | 4 | 122792575 | 122792576 | Human |
| 628825714 | GWAS2733943_H | stroke QTL GWAS2733943 (human) | | 0.0000004 | brain integrity trait (VT:0010579) | | 4 | 112810934 | 112810935 | Human |
| 616570825 | GWAS1967408_H | fibroblast growth factor 2 amount QTL GWAS1967408 (human) | | 2e-22 | fibroblast growth factor 2 amount | | 4 | 122820831 | 122820832 | Human |
| 616570826 | GWAS1967409_H | fibroblast growth factor 2 amount QTL GWAS1967409 (human) | | 2e-72 | fibroblast growth factor 2 amount | | 4 | 123006761 | 123006762 | Human |
| 616570827 | GWAS1967410_H | fibroblast growth factor 2 amount QTL GWAS1967410 (human) | | 2e-26 | fibroblast growth factor 2 amount | | 4 | 123218415 | 123218416 | Human |
| 616570828 | GWAS1967411_H | fibroblast growth factor 2 amount QTL GWAS1967411 (human) | | 7e-18 | fibroblast growth factor 2 amount | | 4 | 123310196 | 123310197 | Human |
| 617258951 | GWAS2195727_H | fatty acid amount QTL GWAS2195727 (human) | | 2e-12 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 616570829 | GWAS1967412_H | fibroblast growth factor 2 amount QTL GWAS1967412 (human) | | 1e-15 | fibroblast growth factor 2 amount | | 4 | 121830362 | 121830363 | Human |
| 616570830 | GWAS1967413_H | fibroblast growth factor 2 amount QTL GWAS1967413 (human) | | 9e-16 | fibroblast growth factor 2 amount | | 4 | 122773901 | 122773902 | Human |
| 628645494 | GWAS2553723_H | body mass index QTL GWAS2553723 (human) | | 0.000002 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 132108281 | 132108282 | Human |
| 616570831 | GWAS1967414_H | fibroblast growth factor 2 amount QTL GWAS1967414 (human) | | 2e-32 | fibroblast growth factor 2 amount | | 4 | 122807694 | 122807695 | Human |
| 616570832 | GWAS1967415_H | fibroblast growth factor 2 amount QTL GWAS1967415 (human) | | 2e-22 | fibroblast growth factor 2 amount | | 4 | 123434666 | 123434667 | Human |
| 616570833 | GWAS1967416_H | fibroblast growth factor 2 amount QTL GWAS1967416 (human) | | 7e-15 | fibroblast growth factor 2 amount | | 4 | 122834463 | 122834464 | Human |
| 407167830 | GWAS816806_H | body height QTL GWAS816806 (human) | | 1e-12 | body height | | 4 | 108494980 | 108494981 | Human |
| 616570834 | GWAS1967417_H | fibroblast growth factor 2 amount QTL GWAS1967417 (human) | | 6e-13 | fibroblast growth factor 2 amount | | 4 | 124215762 | 124215763 | Human |
| 617062356 | GWAS2079855_H | systolic blood pressure QTL GWAS2079855 (human) | | 3e-12 | systolic blood pressure | | 4 | 110417121 | 110417122 | Human |
| 616570835 | GWAS1967418_H | fibroblast growth factor 2 amount QTL GWAS1967418 (human) | | 1e-38 | fibroblast growth factor 2 amount | | 4 | 122711350 | 122711351 | Human |
| 407167831 | GWAS816807_H | body height QTL GWAS816807 (human) | | 2e-09 | body height | | 4 | 124024877 | 124024878 | Human |
| 597383311 | GWAS1479385_H | leukocyte count QTL GWAS1479385 (human) | | 1e-10 | leukocyte count | | 4 | 119343841 | 119343842 | Human |
| 616570836 | GWAS1967419_H | fibroblast growth factor 2 amount QTL GWAS1967419 (human) | | 1e-11 | fibroblast growth factor 2 amount | | 4 | 122813836 | 122813837 | Human |
| 616570837 | GWAS1967420_H | fibroblast growth factor 2 amount QTL GWAS1967420 (human) | | 3e-12 | fibroblast growth factor 2 amount | | 4 | 122764765 | 122764766 | Human |
| 616570838 | GWAS1967421_H | fibroblast growth factor 2 amount QTL GWAS1967421 (human) | | 1e-15 | fibroblast growth factor 2 amount | | 4 | 122808855 | 122808856 | Human |
| 616570839 | GWAS1967422_H | fibroblast growth factor 2 amount QTL GWAS1967422 (human) | | 6e-13 | fibroblast growth factor 2 amount | | 4 | 122830982 | 122830983 | Human |
| 616570840 | GWAS1967423_H | fibroblast growth factor 2 amount QTL GWAS1967423 (human) | | 2e-14 | fibroblast growth factor 2 amount | | 4 | 122971709 | 122971710 | Human |
| 616570841 | GWAS1967424_H | fibroblast growth factor 2 amount QTL GWAS1967424 (human) | | 5e-13 | fibroblast growth factor 2 amount | | 4 | 121760907 | 121760908 | Human |
| 597301377 | GWAS1397451_H | carotid artery intima media thickness QTL GWAS1397451 (human) | | 0.000002 | carotid artery intima media thickness | | 4 | 107366087 | 107366088 | Human |
| 617127891 | GWAS2145390_H | platelet crit QTL GWAS2145390 (human) | | 5e-12 | platelet crit | | 4 | 123857901 | 123857902 | Human |
| 407216984 | GWAS865960_H | gastric carcinoma QTL GWAS865960 (human) | | 9e-10 | gastric carcinoma | | 4 | 124535968 | 124535969 | Human |
| 628809305 | GWAS2717534_H | COVID-19 QTL GWAS2717534 (human) | | 0.000003 | COVID-19 | | 4 | 120985638 | 120985639 | Human |
| 597039285 | GWAS1135359_H | obesity QTL GWAS1135359 (human) | | 0.000003 | obesity | | 4 | 131830983 | 131830984 | Human |
| 617144303 | GWAS2161802_H | acid sphingomyelinase-like phosphodiesterase 3a measurement QTL GWAS2161802 (human) | | 1e-19 | acid sphingomyelinase-like phosphodiesterase 3a measurement | | 4 | 109657070 | 109657071 | Human |
| 407053161 | GWAS702137_H | mean corpuscular hemoglobin QTL GWAS702137 (human) | | 2e-09 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 122058283 | 122058284 | Human |
| 406938477 | GWAS587453_H | adolescent idiopathic scoliosis QTL GWAS587453 (human) | | 0.0000002 | adolescent idiopathic scoliosis | | 4 | 113329637 | 113329638 | Human |
| 406954865 | GWAS603841_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS603841 (human) | | 5e-08 | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | | 4 | 122629959 | 122629960 | Human |
| 406954864 | GWAS603840_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS603840 (human) | | 7e-20 | intestine integrity trait (VT:0010554) | | 4 | 122531076 | 122531077 | Human |
| 407167856 | GWAS816832_H | cardiac troponin I measurement QTL GWAS816832 (human) | | 0.000006 | cardiac troponin I measurement | | 4 | 110926834 | 110926835 | Human |
| 598055057 | GWAS1774356_H | body height QTL GWAS1774356 (human) | | 8e-09 | body height | | 4 | 119834940 | 119834941 | Human |
| 407200625 | GWAS849601_H | brain measurement QTL GWAS849601 (human) | | 9e-44 | brain measurement | | 4 | 123332634 | 123332635 | Human |
| 598055056 | GWAS1774355_H | body height QTL GWAS1774355 (human) | | 1e-10 | body height | | 4 | 119600883 | 119600884 | Human |
| 597530792 | GWAS1626866_H | body surface area QTL GWAS1626866 (human) | | 5e-15 | body surface area | | 4 | 121792708 | 121792709 | Human |
| 628989511 | GWAS2897740_H | nephrolithiasis QTL GWAS2897740 (human) | | 3e-16 | kidney integrity trait (VT:0010580) | | 4 | 114696462 | 114696463 | Human |
| 597366951 | GWAS1463025_H | pulse pressure measurement QTL GWAS1463025 (human) | | 3e-73 | pulse pressure measurement | | 4 | 115629004 | 115629005 | Human |
| 407233403 | GWAS882379_H | bone density QTL GWAS882379 (human) | | 7e-82 | bone density | | 4 | 124697561 | 124697562 | Human |
| 628612680 | GWAS2520909_H | facial morphology trait QTL GWAS2520909 (human) | | 3e-29 | facial morphology trait | | 4 | 127007438 | 127007439 | Human |
| 596990122 | GWAS1109641_H | HVA measurement, MHPG measurement QTL GWAS1109641 (human) | | 0.000009 | HVA measurement, MHPG measurement | | 4 | 130105333 | 130105334 | Human |
| 597481688 | GWAS1577762_H | brain measurement QTL GWAS1577762 (human) | | 6e-11 | brain measurement | | 4 | 107131838 | 107131839 | Human |
| 597154002 | GWAS1250076_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1250076 (human) | | 1e-16 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 617062280 | GWAS2079779_H | caproate 6:0 measurement QTL GWAS2079779 (human) | | 0.000005 | caproate 6:0 measurement | | 4 | 132246564 | 132246565 | Human |
| 597465294 | GWAS1561368_H | hypertension QTL GWAS1561368 (human) | | 0.000005 | hypertension | | 4 | 110460482 | 110460483 | Human |
| 597334211 | GWAS1430285_H | gluteofemoral adipose tissue measurement QTL GWAS1430285 (human) | | 3e-08 | gluteofemoral adipose tissue measurement | | 4 | 122891032 | 122891033 | Human |
| 628629029 | GWAS2537258_H | smoking behavior QTL GWAS2537258 (human) | | 3e-10 | smoking behavior | | 4 | 111500989 | 111500990 | Human |
| 617095083 | GWAS2112582_H | body mass index QTL GWAS2112582 (human) | | 8e-12 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 406938407 | GWAS587383_H | adolescent idiopathic scoliosis QTL GWAS587383 (human) | | 2e-09 | adolescent idiopathic scoliosis | | 4 | 119337052 | 119337053 | Human |
| 597481723 | GWAS1577797_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS1577797 (human) | | 6e-58 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119373929 | 119373930 | Human |
| 597104895 | GWAS1200969_H | platelet crit QTL GWAS1200969 (human) | | 2e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 124004110 | 124004111 | Human |
| 597104894 | GWAS1200968_H | platelet crit QTL GWAS1200968 (human) | | 4e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 110012720 | 110012721 | Human |
| 597104893 | GWAS1200967_H | platelet crit QTL GWAS1200967 (human) | | 2e-36 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 4 | 109966833 | 109966834 | Human |
| 628596252 | GWAS2504481_H | sex hormone-binding globulin measurement QTL GWAS2504481 (human) | | 0.000005 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
| 628497946 | GWAS2406175_H | smoking initiation QTL GWAS2406175 (human) | | 3e-09 | behavior trait (VT:0010442) | | 4 | 111500989 | 111500990 | Human |
| 628596251 | GWAS2504480_H | sex hormone-binding globulin measurement QTL GWAS2504480 (human) | | 3e-10 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 628596250 | GWAS2504479_H | sex hormone-binding globulin measurement QTL GWAS2504479 (human) | | 4e-08 | sex hormone-binding globulin measurement | | 4 | 119202262 | 119202263 | Human |
| 628694548 | GWAS2602777_H | brain attribute QTL GWAS2602777 (human) | | 7e-10 | brain attribute | | 4 | 124015375 | 124015376 | Human |
| 628530694 | GWAS2438923_H | properdin measurement QTL GWAS2438923 (human) | | 3e-16 | complement protein amount (VT:0010033) | | 4 | 109793426 | 109793427 | Human |
| 406938417 | GWAS587393_H | adolescent idiopathic scoliosis QTL GWAS587393 (human) | | 0.0000001 | adolescent idiopathic scoliosis | | 4 | 123733416 | 123733417 | Human |
| 407233335 | GWAS882311_H | type 2 diabetes mellitus QTL GWAS882311 (human) | | 0.0000005 | type 2 diabetes mellitus | | 4 | 128605841 | 128605842 | Human |
| 406922034 | GWAS571010_H | TPE interval measurement QTL GWAS571010 (human) | | 3e-10 | TPE interval measurement | | 4 | 113535350 | 113535351 | Human |
| 626449954 | GWAS2263887_H | treatment-resistant hypertension QTL GWAS2263887 (human) | | 0.00001 | treatment-resistant hypertension | | 4 | 118839735 | 118839736 | Human |
| 597317870 | GWAS1413944_H | BMI-adjusted waist circumference QTL GWAS1413944 (human) | | 9e-11 | BMI-adjusted waist circumference | | 4 | 123166618 | 123166619 | Human |
| 597317869 | GWAS1413943_H | BMI-adjusted waist circumference QTL GWAS1413943 (human) | | 3e-08 | BMI-adjusted waist circumference | | 4 | 123121264 | 123121265 | Human |
| 407184189 | GWAS833165_H | atrial fibrillation QTL GWAS833165 (human) | | 6e-306 | atrial fibrillation | | 4 | 110795357 | 110795358 | Human |
| 616964030 | GWAS1981529_H | spine bone mineral density QTL GWAS1981529 (human) | | 0.0000003 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 4 | 125801465 | 125801466 | Human |
| 597432548 | GWAS1528622_H | protein measurement QTL GWAS1528622 (human) | | 1e-08 | protein measurement | | 4 | 131591604 | 131591605 | Human |
| 628514313 | GWAS2422542_H | systolic blood pressure QTL GWAS2422542 (human) | | 3e-12 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 110417121 | 110417122 | Human |
| 407053255 | GWAS702231_H | BMI-adjusted waist circumference QTL GWAS702231 (human) | | 7e-11 | BMI-adjusted waist circumference | | 4 | 119820812 | 119820813 | Human |
| 407053254 | GWAS702230_H | BMI-adjusted waist circumference QTL GWAS702230 (human) | | 6e-11 | BMI-adjusted waist circumference | | 4 | 119759795 | 119759796 | Human |
| 617013059 | GWAS2030558_H | hip bone mineral density QTL GWAS2030558 (human) | | 0.000006 | hip bone mineral density | | 4 | 128365448 | 128365449 | Human |
| 628678399 | GWAS2586628_H | X-14189--leucylalanine measurement QTL GWAS2586628 (human) | | 6e-12 | X-14189--leucylalanine measurement | | 4 | 110510288 | 110510289 | Human |
| 407053256 | GWAS702232_H | BMI-adjusted waist circumference QTL GWAS702232 (human) | | 3e-11 | BMI-adjusted waist circumference | | 4 | 108535458 | 108535459 | Human |
| 596989977 | GWAS1109496_H | platelet count QTL GWAS1109496 (human) | | 4e-24 | platelet count | | 4 | 109924690 | 109924691 | Human |
| 597399575 | GWAS1495649_H | low density lipoprotein cholesterol measurement QTL GWAS1495649 (human) | | 1e-09 | low density lipoprotein cholesterol measurement | | 4 | 119202262 | 119202263 | Human |
| 597186581 | GWAS1282655_H | peak expiratory flow QTL GWAS1282655 (human) | | 4e-08 | peak expiratory flow | | 4 | 118203565 | 118203566 | Human |
| 597219351 | GWAS1315425_H | platelet count QTL GWAS1315425 (human) | | 4e-18 | platelet count | | 4 | 109973957 | 109973958 | Human |
| 406922190 | GWAS571166_H | irritable bowel syndrome QTL GWAS571166 (human) | | 3e-08 | irritable bowel syndrome | | 4 | 122201701 | 122201702 | Human |
| 628612839 | GWAS2521068_H | facial morphology trait QTL GWAS2521068 (human) | | 2e-09 | facial morphology trait | | 4 | 110922515 | 110922516 | Human |
| 597055495 | GWAS1151569_H | FEV/FVC ratio QTL GWAS1151569 (human) | | 2e-08 | FEV/FVC ratio | | 4 | 108429724 | 108429725 | Human |
| 598087735 | GWAS1807034_H | body height QTL GWAS1807034 (human) | | 7e-09 | body height | | 4 | 121772597 | 121772598 | Human |
| 597039109 | GWAS1135183_H | systolic blood pressure QTL GWAS1135183 (human) | | 2e-08 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 108099542 | 108099543 | Human |
| 407266258 | GWAS915234_H | body height QTL GWAS915234 (human) | | 5e-15 | body height | | 4 | 125767588 | 125767589 | Human |
| 407266257 | GWAS915233_H | body height QTL GWAS915233 (human) | | 0.0000008 | body height | | 4 | 125346842 | 125346843 | Human |
| 597383171 | GWAS1479245_H | serum metabolite measurement QTL GWAS1479245 (human) | | 5e-13 | serum metabolite measurement | | 4 | 110414566 | 110414567 | Human |
| 597989436 | GWAS1708735_H | obsolete_fat body mass QTL GWAS1708735 (human) | | 0.000003 | obsolete_fat body mass | | 4 | 129885831 | 129885832 | Human |
| 407266271 | GWAS915247_H | body height QTL GWAS915247 (human) | | 4e-17 | body height | | 4 | 125758137 | 125758138 | Human |
| 628612845 | GWAS2521074_H | nose morphology trait QTL GWAS2521074 (human) | | 4e-08 | nose morphology trait | | 4 | 108373433 | 108373434 | Human |
| 628694755 | GWAS2602984_H | coronary artery disease QTL GWAS2602984 (human) | | 2e-09 | coronary artery integrity trait (VT:0010746) | | 4 | 109616095 | 109616096 | Human |
| 617094997 | GWAS2112496_H | eosinophil count QTL GWAS2112496 (human) | | 7e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 4 | 122680542 | 122680543 | Human |
| 628678373 | GWAS2586602_H | color vision disorder QTL GWAS2586602 (human) | | 0.000003 | color vision disorder | | 4 | 124815973 | 124815974 | Human |
| 407266267 | GWAS915243_H | body height QTL GWAS915243 (human) | | 3e-29 | body height | | 4 | 126054046 | 126054047 | Human |
| 628678374 | GWAS2586603_H | color vision disorder QTL GWAS2586603 (human) | | 0.000003 | color vision disorder | | 4 | 108200574 | 108200575 | Human |
| 597383172 | GWAS1479246_H | serum metabolite measurement QTL GWAS1479246 (human) | | 8e-11 | serum metabolite measurement | | 4 | 110430068 | 110430069 | Human |
| 407348184 | GWAS997160_H | schizophrenia QTL GWAS997160 (human) | | 0.000003 | schizophrenia | | 4 | 117998342 | 117998343 | Human |
| 598087686 | GWAS1806985_H | glomerular filtration rate QTL GWAS1806985 (human) | | 2e-08 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 407315430 | GWAS964406_H | hypertension, COVID-19 QTL GWAS964406 (human) | | 5e-08 | hypertension, COVID-19 | | 4 | 110493243 | 110493244 | Human |
| 598087687 | GWAS1806986_H | glomerular filtration rate QTL GWAS1806986 (human) | | 4e-08 | glomerular filtration rate | | 4 | 125673826 | 125673827 | Human |
| 598087684 | GWAS1806983_H | glomerular filtration rate QTL GWAS1806983 (human) | | 1e-12 | glomerular filtration rate | | 4 | 108783751 | 108783752 | Human |
| 597170234 | GWAS1266308_H | epidermal growth factor measurement QTL GWAS1266308 (human) | | 3e-14 | epidermal growth factor measurement | | 4 | 109933388 | 109933389 | Human |
| 598087685 | GWAS1806984_H | glomerular filtration rate QTL GWAS1806984 (human) | | 1e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
| 407053285 | GWAS702261_H | cortical surface area measurement QTL GWAS702261 (human) | | 0.0000006 | cortical surface area measurement | | 4 | 126616579 | 126616580 | Human |
| 407413728 | GWAS1062704_H | schizophrenia QTL GWAS1062704 (human) | | 0.000002 | schizophrenia | | 4 | 113059651 | 113059652 | Human |
| 617013103 | GWAS2030602_H | systolic blood pressure QTL GWAS2030602 (human) | | 2e-16 | systolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 597202996 | GWAS1299070_H | psoriasis QTL GWAS1299070 (human) | | 3e-19 | psoriasis | | 4 | 121833304 | 121833305 | Human |
| 406922220 | GWAS571196_H | functional brain measurement QTL GWAS571196 (human) | | 5e-09 | functional brain measurement | | 4 | 116998865 | 116998866 | Human |
| 598087688 | GWAS1806987_H | glomerular filtration rate QTL GWAS1806987 (human) | | 2e-20 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 597317674 | GWAS1413748_H | diastolic blood pressure QTL GWAS1413748 (human) | | 3e-17 | diastolic blood pressure | | 4 | 110510288 | 110510289 | Human |
| 616963957 | GWAS1981456_H | schizophrenia QTL GWAS1981456 (human) | | 3e-08 | schizophrenia | | 4 | 117725752 | 117725753 | Human |
| 597383208 | GWAS1479282_H | BMI-adjusted waist circumference QTL GWAS1479282 (human) | | 0.000009 | BMI-adjusted waist circumference | | 4 | 124199191 | 124199192 | Human |
| 628498115 | GWAS2406344_H | gastric carcinoma QTL GWAS2406344 (human) | | 3e-11 | stomach integrity trait (VT:0010603) | | 4 | 124530209 | 124530210 | Human |
| 407364594 | GWAS1013570_H | mathematical ability QTL GWAS1013570 (human) | | 5e-08 | mathematical ability | | 4 | 130364875 | 130364876 | Human |
| 407364593 | GWAS1013569_H | mathematical ability QTL GWAS1013569 (human) | | 5e-10 | mathematical ability | | 4 | 122105714 | 122105715 | Human |
| 628989643 | GWAS2897872_H | skin disease QTL GWAS2897872 (human) | | 1e-11 | skin disease | | 4 | 130491526 | 130491527 | Human |
| 597301293 | GWAS1397367_H | epidermal growth factor measurement QTL GWAS1397367 (human) | | 3e-25 | epidermal growth factor measurement | | 4 | 109967851 | 109967852 | Human |
| 616537858 | GWAS1934441_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS1934441 (human) | | 1e-26 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 125365950 | 125365951 | Human |
| 616996731 | GWAS2014230_H | arterial stiffness measurement QTL GWAS2014230 (human) | | 0.000006 | arterial stiffness measurement | | 4 | 128552943 | 128552944 | Human |
| 628793029 | GWAS2701258_H | Alzheimer disease, APOE carrier status QTL GWAS2701258 (human) | | 0.000006 | Alzheimer disease, APOE carrier status | | 4 | 129588615 | 129588616 | Human |
| 597235800 | GWAS1331874_H | blood protein measurement QTL GWAS1331874 (human) | | 2e-43 | blood protein measurement | | 4 | 118376502 | 118376503 | Human |
| 626466454 | GWAS2280387_H | diastolic blood pressure QTL GWAS2280387 (human) | | 6e-14 | diastolic blood pressure | | 4 | 119512652 | 119512653 | Human |
| 597481566 | GWAS1577640_H | mathematical ability QTL GWAS1577640 (human) | | 4e-08 | mathematical ability | | 4 | 111950250 | 111950251 | Human |
| 597284954 | GWAS1381028_H | response to warfarin QTL GWAS1381028 (human) | | 0.0000006 | response to warfarin | | 4 | 130374797 | 130374798 | Human |
| 597235807 | GWAS1331881_H | atrial fibrillation QTL GWAS1331881 (human) | | 1e-48 | atrial fibrillation | | 4 | 110707883 | 110707884 | Human |
| 597137489 | GWAS1233563_H | Hypoxanthine measurement QTL GWAS1233563 (human) | | 3e-08 | Hypoxanthine measurement | | 4 | 131223983 | 131223984 | Human |
| 407397275 | GWAS1046251_H | BMI-adjusted hip circumference QTL GWAS1046251 (human) | | 1e-08 | BMI-adjusted hip circumference | | 4 | 119759405 | 119759406 | Human |
| 597514312 | GWAS1610386_H | vital capacity QTL GWAS1610386 (human) | | 8e-11 | vital capacity | | 4 | 124209285 | 124209286 | Human |
| 616521576 | GWAS1918159_H | serum creatinine amount QTL GWAS1918159 (human) | | 4e-17 | serum creatinine amount | | 4 | 108792999 | 108793000 | Human |
| 617062174 | GWAS2079673_H | cerebral cortex area attribute QTL GWAS2079673 (human) | | 1e-09 | cerebral cortex area attribute | | 4 | 126658527 | 126658528 | Human |
| 407315356 | GWAS964332_H | unipolar depression QTL GWAS964332 (human) | | 1e-09 | unipolar depression | | 4 | 130316226 | 130316227 | Human |
| 597383236 | GWAS1479310_H | monocyte count QTL GWAS1479310 (human) | | 3e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 110020646 | 110020647 | Human |
| 407184294 | GWAS833270_H | facial morphology measurement QTL GWAS833270 (human) | | 3e-29 | facial morphology measurement | | 4 | 127007438 | 127007439 | Human |
| 626466483 | GWAS2280416_H | body mass index QTL GWAS2280416 (human) | | 1e-09 | body mass index | | 4 | 110523790 | 110523791 | Human |
| 407331758 | GWAS980734_H | systolic blood pressure QTL GWAS980734 (human) | | 6e-09 | systolic blood pressure | | 4 | 110427909 | 110427910 | Human |
| 628809360 | GWAS2717589_H | underweight body mass index status QTL GWAS2717589 (human) | | 0.000006 | underweight body mass index status | body mass index (BMI) (CMO:0000105) | 4 | 113088430 | 113088431 | Human |
| 628645522 | GWAS2553751_H | uterine prolapse QTL GWAS2553751 (human) | | 2e-15 | uterus integrity trait (VT:0010575) | | 4 | 126003529 | 126003530 | Human |
| 407217067 | GWAS866043_H | sex hormone-binding globulin measurement QTL GWAS866043 (human) | | 1e-34 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 597383284 | GWAS1479358_H | Red cell distribution width QTL GWAS1479358 (human) | | 6e-21 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 616996661 | GWAS2014160_H | alopecia areata QTL GWAS2014160 (human) | | 5e-09 | alopecia areata | | 4 | 122602871 | 122602872 | Human |
| 617144124 | GWAS2161623_H | hypertrophic cardiomyopathy QTL GWAS2161623 (human) | | 8e-13 | hypertrophic cardiomyopathy | | 4 | 108196857 | 108196858 | Human |
| 597153891 | GWAS1249965_H | cholesterol:total lipids ratio, intermediate density lipoprotein measurement QTL GWAS1249965 (human) | | 8e-10 | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | | 4 | 109657070 | 109657071 | Human |
| 406971317 | GWAS620293_H | opioid use disorder QTL GWAS620293 (human) | | 1e-11 | opioid use disorder | | 4 | 111546456 | 111546457 | Human |
| 597465192 | GWAS1561266_H | small vessel stroke QTL GWAS1561266 (human) | | 0.000008 | artery integrity trait (VT:0010639) | | 4 | 125155988 | 125155989 | Human |
| 628465289 | GWAS2373518_H | blood protein amount QTL GWAS2373518 (human) | | 5e-08 | blood protein amount | | 4 | 110079447 | 110079448 | Human |
| 628481672 | GWAS2389901_H | late-onset Alzheimers disease QTL GWAS2389901 (human) | | 0.000002 | brain integrity trait (VT:0010579) | | 4 | 109373310 | 109373311 | Human |
| 628956803 | GWAS2865032_H | encounter with health service QTL GWAS2865032 (human) | | 9e-14 | encounter with health service | | 4 | 110796911 | 110796912 | Human |
| 597385115 | GWAS1481189_H | body mass index QTL GWAS1481189 (human) | | 2e-10 | body mass index | | 4 | 111731920 | 111731921 | Human |
| 596991892 | GWAS1111411_H | balding measurement QTL GWAS1111411 (human) | | 2e-33 | balding measurement | | 4 | 107131838 | 107131839 | Human |
| 598056864 | GWAS1776163_H | body height QTL GWAS1776163 (human) | | 1e-08 | body height | | 4 | 123987076 | 123987077 | Human |
| 406905930 | GWAS554906_H | R-warfarin measurement QTL GWAS554906 (human) | | 0.000005 | R-warfarin measurement | | 4 | 129054159 | 129054160 | Human |
| 628660596 | GWAS2568825_H | opioid use disorder QTL GWAS2568825 (human) | | 1e-11 | conditioned place preference behavior trait (VT:0010723) | | 4 | 111546456 | 111546457 | Human |
| 628676980 | GWAS2585209_H | color vision disorder QTL GWAS2585209 (human) | | 0.000008 | color vision disorder | | 4 | 129487149 | 129487150 | Human |
| 617011403 | GWAS2028902_H | lifestyle measurement, anxiety disorder measurement QTL GWAS2028902 (human) | | 8e-08 | lifestyle measurement, alcohol consumption quality | | 4 | 127457977 | 127457978 | Human |
| 628595065 | GWAS2503294_H | phospholipids:total lipids ratio, blood VLDL cholesterol amount QTL GWAS2503294 (human) | | 6e-13 | phospholipids:total lipids ratio, blood VLDL cholesterol amount | | 4 | 109657070 | 109657071 | Human |
| 407413849 | GWAS1062825_H | age of onset of childhood onset asthma QTL GWAS1062825 (human) | | 6e-16 | age of onset of childhood onset asthma | | 4 | 122307075 | 122307076 | Human |
| 597270410 | GWAS1366484_H | diastolic blood pressure QTL GWAS1366484 (human) | | 3e-10 | diastolic blood pressure | | 4 | 108096372 | 108096373 | Human |
| 628676971 | GWAS2585200_H | colorectal cancer QTL GWAS2585200 (human) | | 0.000003 | colorectal cancer | | 4 | 123587620 | 123587621 | Human |
| 597450635 | GWAS1546709_H | alkaline phosphatase measurement QTL GWAS1546709 (human) | | 4e-23 | alkaline phosphatase measurement | | 4 | 110199010 | 110199011 | Human |
| 628676975 | GWAS2585204_H | color vision disorder QTL GWAS2585204 (human) | | 0.000006 | color vision disorder | | 4 | 125161562 | 125161563 | Human |
| 406889560 | GWAS538536_H | eosinophil count QTL GWAS538536 (human) | | 1e-40 | eosinophil count | | 4 | 122451978 | 122451979 | Human |
| 597286787 | GWAS1382861_H | inflammatory bowel disease QTL GWAS1382861 (human) | | 6e-19 | inflammatory bowel disease | | 4 | 122523884 | 122523885 | Human |
| 628529512 | GWAS2437741_H | hematocrit QTL GWAS2437741 (human) | | 1e-23 | erythrocyte morphology trait (VT:0002447) | hematocrit (CMO:0000037) | 4 | 109717668 | 109717669 | Human |
| 597499835 | GWAS1595909_H | triglyceride measurement QTL GWAS1595909 (human) | | 2e-09 | triglyceride measurement | | 4 | 123720672 | 123720673 | Human |
| 628889940 | GWAS2798169_H | grip strength measurement QTL GWAS2798169 (human) | | 7e-09 | grip strength measurement | | 4 | 118834466 | 118834467 | Human |
| 628824402 | GWAS2732631_H | complement factor I measurement QTL GWAS2732631 (human) | | 2e-17 | complement protein amount (VT:0010033) | | 4 | 109735574 | 109735575 | Human |
| 617027822 | GWAS2045321_H | protein measurement QTL GWAS2045321 (human) | | 7e-09 | protein amount (VT:0010120) | | 4 | 132318854 | 132318855 | Human |
| 628988241 | GWAS2896470_H | stricture QTL GWAS2896470 (human) | | 2e-11 | stricture | | 4 | 114481688 | 114481689 | Human |
| 616372368 | GWAS1852610_H | obsolete_blood protein measurement QTL GWAS1852610 (human) | | 8e-13 | obsolete_blood protein measurement | | 4 | 122625127 | 122625128 | Human |
| 597139385 | GWAS1235459_H | citrulline measurement QTL GWAS1235459 (human) | | 0.0000006 | citrulline measurement | | 4 | 108524921 | 108524922 | Human |
| 616388744 | GWAS1868986_H | amount of iron in brain QTL GWAS1868986 (human) | | 4e-09 | amount of iron in brain | | 4 | 119113317 | 119113318 | Human |
| 597368748 | GWAS1464822_H | longevity QTL GWAS1464822 (human) | | 0.000009 | longevity | | 4 | 124576758 | 124576759 | Human |
| 407200893 | GWAS849869_H | blood protein measurement QTL GWAS849869 (human) | | 1e-164 | blood protein measurement | | 4 | 106917957 | 106917958 | Human |
| 616536199 | GWAS1932782_H | erythrocyte volume QTL GWAS1932782 (human) | | 2e-28 | erythrocyte volume | | 4 | 109933275 | 109933276 | Human |
| 598056861 | GWAS1776160_H | body height QTL GWAS1776160 (human) | | 2e-12 | body height | | 4 | 119840636 | 119840637 | Human |
| 598056860 | GWAS1776159_H | body height QTL GWAS1776159 (human) | | 0.0000003 | body height | | 4 | 119645235 | 119645236 | Human |
| 598056863 | GWAS1776162_H | body height QTL GWAS1776162 (human) | | 5e-13 | body height | | 4 | 122917603 | 122917604 | Human |
| 598056862 | GWAS1776161_H | body height QTL GWAS1776161 (human) | | 2e-13 | body height | | 4 | 121799844 | 121799845 | Human |
| 598056857 | GWAS1776156_H | body height QTL GWAS1776156 (human) | | 3e-19 | body height | | 4 | 108540829 | 108540830 | Human |
| 598056859 | GWAS1776158_H | body height QTL GWAS1776158 (human) | | 5e-20 | body height | | 4 | 113901423 | 113901424 | Human |
| 598056858 | GWAS1776157_H | body height QTL GWAS1776157 (human) | | 0.000002 | body height | | 4 | 109079519 | 109079520 | Human |
| 598007780 | GWAS1727079_H | EDAR/EGF protein level ratio in blood QTL GWAS1727079 (human) | | 1e-98 | EDAR/EGF protein level ratio in blood | | 4 | 109912954 | 109912955 | Human |
| 628578615 | GWAS2486844_H | glycerophospholipid measurement QTL GWAS2486844 (human) | | 3e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114571532 | 114571533 | Human |
| 628578614 | GWAS2486843_H | glycerophospholipid measurement QTL GWAS2486843 (human) | | 3e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114570559 | 114570560 | Human |
| 628578613 | GWAS2486842_H | glycerophospholipid measurement QTL GWAS2486842 (human) | | 3e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114568870 | 114568871 | Human |
| 597188570 | GWAS1284644_H | educational attainment QTL GWAS1284644 (human) | | 5e-10 | educational attainment | | 4 | 121851158 | 121851159 | Human |
| 628578612 | GWAS2486841_H | glycerophospholipid measurement QTL GWAS2486841 (human) | | 3e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114564575 | 114564576 | Human |
| 597188571 | GWAS1284645_H | educational attainment QTL GWAS1284645 (human) | | 4e-20 | educational attainment | | 4 | 122105714 | 122105715 | Human |
| 628578611 | GWAS2486840_H | glycerophospholipid measurement QTL GWAS2486840 (human) | | 3e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114544945 | 114544946 | Human |
| 597188572 | GWAS1284646_H | educational attainment QTL GWAS1284646 (human) | | 5e-11 | educational attainment | | 4 | 122259374 | 122259375 | Human |
| 628578610 | GWAS2486839_H | glycerophospholipid measurement QTL GWAS2486839 (human) | | 3e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114544338 | 114544339 | Human |
| 597188573 | GWAS1284647_H | educational attainment QTL GWAS1284647 (human) | | 2e-10 | educational attainment | | 4 | 122480614 | 122480615 | Human |
| 407102470 | GWAS751446_H | FEV/FVC ratio, response to bronchodilator QTL GWAS751446 (human) | | 0.000002 | FEV/FVC ratio, response to bronchodilator | | 4 | 129479620 | 129479621 | Human |
| 628578609 | GWAS2486838_H | glycerophospholipid measurement QTL GWAS2486838 (human) | | 3e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114536699 | 114536700 | Human |
| 597188574 | GWAS1284648_H | educational attainment QTL GWAS1284648 (human) | | 2e-08 | educational attainment | | 4 | 126904030 | 126904031 | Human |
| 628578608 | GWAS2486837_H | glycerophospholipid measurement QTL GWAS2486837 (human) | | 1e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114549176 | 114549177 | Human |
| 597188575 | GWAS1284649_H | educational attainment QTL GWAS1284649 (human) | | 2e-15 | educational attainment | | 4 | 128836670 | 128836671 | Human |
| 596975580 | GWAS1095099_H | stroke QTL GWAS1095099 (human) | | 2e-13 | stroke | | 4 | 110793263 | 110793264 | Human |
| 598089711 | GWAS1809010_H | glomerular filtration rate QTL GWAS1809010 (human) | | 1e-16 | glomerular filtration rate | | 4 | 114577301 | 114577302 | Human |
| 407315465 | GWAS964441_H | calcium measurement QTL GWAS964441 (human) | | 1e-12 | calcium measurement | | 4 | 114469815 | 114469816 | Human |
| 628578599 | GWAS2486828_H | glycerophospholipid measurement QTL GWAS2486828 (human) | | 4e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114545757 | 114545758 | Human |
| 628840747 | GWAS2748976_H | fibroblast growth factor 2 level QTL GWAS2748976 (human) | | 2e-11 | fibroblast growth factor 2 level | | 4 | 122682145 | 122682146 | Human |
| 628578598 | GWAS2486827_H | glycerophospholipid measurement QTL GWAS2486827 (human) | | 4e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114541947 | 114541948 | Human |
| 628578597 | GWAS2486826_H | glycerophospholipid measurement QTL GWAS2486826 (human) | | 4e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114540109 | 114540110 | Human |
| 628578596 | GWAS2486825_H | glycerophospholipid measurement QTL GWAS2486825 (human) | | 4e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114540002 | 114540003 | Human |
| 628578595 | GWAS2486824_H | glycerophospholipid measurement QTL GWAS2486824 (human) | | 3e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114528894 | 114528895 | Human |
| 628578594 | GWAS2486823_H | glycerophospholipid measurement QTL GWAS2486823 (human) | | 3e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114487028 | 114487029 | Human |
| 628578593 | GWAS2486822_H | glycerophospholipid measurement QTL GWAS2486822 (human) | | 3e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114486755 | 114486756 | Human |
| 628955435 | GWAS2863664_H | schizophrenia, family history QTL GWAS2863664 (human) | | 3e-15 | schizophrenia, family history | | 4 | 126055086 | 126055087 | Human |
| 628578592 | GWAS2486821_H | glycerophospholipid measurement QTL GWAS2486821 (human) | | 3e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114484189 | 114484190 | Human |
| 628578607 | GWAS2486836_H | glycerophospholipid measurement QTL GWAS2486836 (human) | | 1e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114532227 | 114532228 | Human |
| 628578606 | GWAS2486835_H | glycerophospholipid measurement QTL GWAS2486835 (human) | | 1e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114503010 | 114503011 | Human |
| 617126033 | GWAS2143532_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS2143532 (human) | | 7e-228 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119359462 | 119359463 | Human |
| 628365614 | GWAS2286458_H | thyroxine level QTL GWAS2286458 (human) | | 0.000005 | thyroxine level | | 4 | 112622996 | 112622997 | Human |
| 628578605 | GWAS2486834_H | glycerophospholipid measurement QTL GWAS2486834 (human) | | 1e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114490702 | 114490703 | Human |
| 628578604 | GWAS2486833_H | glycerophospholipid measurement QTL GWAS2486833 (human) | | 1e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114491050 | 114491051 | Human |
| 617126035 | GWAS2143534_H | level of fatty acid-binding protein, intestinal in blood serum QTL GWAS2143534 (human) | | 6e-37 | level of fatty acid-binding protein, intestinal in blood serum | | 4 | 119779454 | 119779455 | Human |
| 628578603 | GWAS2486832_H | glycerophospholipid measurement QTL GWAS2486832 (human) | | 1e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114490912 | 114490913 | Human |
| 628578602 | GWAS2486831_H | glycerophospholipid measurement QTL GWAS2486831 (human) | | 1e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114490871 | 114490872 | Human |
| 628578601 | GWAS2486830_H | glycerophospholipid measurement QTL GWAS2486830 (human) | | 2e-23 | blood phospholipid amount (VT:0006084) | | 4 | 114485894 | 114485895 | Human |
| 628578600 | GWAS2486829_H | glycerophospholipid measurement QTL GWAS2486829 (human) | | 4e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114568887 | 114568888 | Human |
| 407315489 | GWAS964465_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS964465 (human) | | 2e-13 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | | 4 | 109657070 | 109657071 | Human |
| 628611344 | GWAS2519573_H | creatine level QTL GWAS2519573 (human) | | 0.0000006 | creatine level | | 4 | 110523020 | 110523021 | Human |
| 616994991 | GWAS2012490_H | body mass index QTL GWAS2012490 (human) | | 1e-14 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 129805678 | 129805679 | Human |
| 597827534 | GWAS1694925_H | schizophrenia QTL GWAS1694925 (human) | | 2e-11 | schizophrenia | | 4 | 117906596 | 117906597 | Human |
| 616519889 | GWAS1916472_H | cystatin-M measurement QTL GWAS1916472 (human) | | 5e-19 | cystatin-M measurement | | 4 | 106848777 | 106848778 | Human |
| 597336053 | GWAS1432127_H | COVID-19 QTL GWAS1432127 (human) | | 0.000008 | COVID-19 | | 4 | 129389669 | 129389670 | Human |
| 597139448 | GWAS1235522_H | major depressive disorder QTL GWAS1235522 (human) | | 1e-09 | major depressive disorder | | 4 | 130316226 | 130316227 | Human |
| 597336041 | GWAS1432115_H | COVID-19 QTL GWAS1432115 (human) | | 0.000005 | COVID-19 | | 4 | 113911048 | 113911049 | Human |
| 598056915 | GWAS1776214_H | body height QTL GWAS1776214 (human) | | 7e-09 | body height | | 4 | 132314995 | 132314996 | Human |
| 406905911 | GWAS554887_H | body height QTL GWAS554887 (human) | | 0.000003 | body height | | 4 | 109118612 | 109118613 | Human |
| 616552648 | GWAS1949231_H | level of agrin in blood serum QTL GWAS1949231 (human) | | 6e-12 | level of agrin in blood serum | | 4 | 118386005 | 118386006 | Human |
| 597188576 | GWAS1284650_H | educational attainment QTL GWAS1284650 (human) | | 2e-09 | educational attainment | | 4 | 129239551 | 129239552 | Human |
| 628480268 | GWAS2388497_H | feeling miserable measurement QTL GWAS2388497 (human) | | 3e-08 | emotion/affect behavior trait (VT:0002572) | | 4 | 122465996 | 122465997 | Human |
| 597188577 | GWAS1284651_H | educational attainment QTL GWAS1284651 (human) | | 1e-10 | educational attainment | | 4 | 129330640 | 129330641 | Human |
| 597188578 | GWAS1284652_H | educational attainment QTL GWAS1284652 (human) | | 1e-08 | educational attainment | | 4 | 129387520 | 129387521 | Human |
| 597188579 | GWAS1284653_H | educational attainment QTL GWAS1284653 (human) | | 5e-08 | educational attainment | | 4 | 129452572 | 129452573 | Human |
| 628988160 | GWAS2896389_H | congestive heart failure QTL GWAS2896389 (human) | | 5e-15 | heart integrity trait (VT:0010757) | | 4 | 110761735 | 110761736 | Human |
| 628480267 | GWAS2388496_H | feeling miserable measurement QTL GWAS2388496 (human) | | 1e-08 | emotion/affect behavior trait (VT:0002572) | | 4 | 122265238 | 122265239 | Human |
| 617142455 | GWAS2159954_H | alpha-L-iduronidase measurement QTL GWAS2159954 (human) | | 2e-12 | alpha-L-iduronidase measurement | | 4 | 109603883 | 109603884 | Human |
| 628955645 | GWAS2863874_H | platelet volume QTL GWAS2863874 (human) | | 2e-12 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 628513271 | GWAS2421500_H | nephrolithiasis QTL GWAS2421500 (human) | | 3e-14 | kidney integrity trait (VT:0010580) | | 4 | 114667805 | 114667806 | Human |
| 629004799 | GWAS2913028_H | body height QTL GWAS2913028 (human) | | 3e-15 | body height | | 4 | 112381201 | 112381202 | Human |
| 628693499 | GWAS2601728_H | erythrocyte count QTL GWAS2601728 (human) | | 6e-14 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 114598115 | 114598116 | Human |
| 617011268 | GWAS2028767_H | adolescent idiopathic scoliosis QTL GWAS2028767 (human) | | 0.0000005 | adolescent idiopathic scoliosis | | 4 | 119460368 | 119460369 | Human |
| 407282884 | GWAS931860_H | uterine prolapse QTL GWAS931860 (human) | | 4e-17 | uterine prolapse | | 4 | 126003911 | 126003912 | Human |
| 597352222 | GWAS1448296_H | body height QTL GWAS1448296 (human) | | 4e-17 | body height | | 4 | 124666406 | 124666407 | Human |
| 628693500 | GWAS2601729_H | erythrocyte count QTL GWAS2601729 (human) | | 3e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 4 | 121827841 | 121827842 | Human |
| 597352223 | GWAS1448297_H | body height QTL GWAS1448297 (human) | | 0.0000008 | body height | | 4 | 125346842 | 125346843 | Human |
| 617011264 | GWAS2028763_H | adolescent idiopathic scoliosis QTL GWAS2028763 (human) | | 0.0000001 | adolescent idiopathic scoliosis | | 4 | 123733416 | 123733417 | Human |
| 628840956 | GWAS2749185_H | fibroblast growth factor 2 level QTL GWAS2749185 (human) | | 6e-36 | fibroblast growth factor 2 level | | 4 | 122827461 | 122827462 | Human |
| 597352221 | GWAS1448295_H | body height QTL GWAS1448295 (human) | | 4e-78 | body height | | 4 | 123987076 | 123987077 | Human |
| 596959004 | GWAS1078523_H | response to warfarin QTL GWAS1078523 (human) | | 0.0000006 | response to warfarin | | 4 | 130374797 | 130374798 | Human |
| 628365823 | GWAS2286667_H | decreased attention, quality of life cycle QTL GWAS2286667 (human) | | 0.000003 | decreased attention, quality of life cycle | | 4 | 125938393 | 125938394 | Human |
| 407037134 | GWAS686110_H | body mass index QTL GWAS686110 (human) | | 0.000001 | body mass index | | 4 | 129895905 | 129895906 | Human |
| 628496888 | GWAS2405117_H | smoking status measurement QTL GWAS2405117 (human) | | 2e-15 | smoking status measurement | | 4 | 111500989 | 111500990 | Human |
| 628496889 | GWAS2405118_H | smoking status measurement QTL GWAS2405118 (human) | | 5e-08 | smoking status measurement | | 4 | 120722084 | 120722085 | Human |
| 617093209 | GWAS2110708_H | mean corpuscular hemoglobin QTL GWAS2110708 (human) | | 5e-23 | mean corpuscular hemoglobin | | 4 | 128046010 | 128046011 | Human |
| 597483272 | GWAS1579346_H | reticulocyte measurement QTL GWAS1579346 (human) | | 4e-12 | reticulocyte measurement | | 4 | 128330896 | 128330897 | Human |
| 628660718 | GWAS2568947_H | bone tissue density QTL GWAS2568947 (human) | | 2e-14 | bone tissue density | | 4 | 111670693 | 111670694 | Human |
| 616994896 | GWAS2012395_H | caudal anterior cingulate cortex volume QTL GWAS2012395 (human) | | 0.000002 | caudal anterior cingulate cortex volume | | 4 | 125708052 | 125708053 | Human |
| 628906469 | GWAS2814698_H | respiratory system disease QTL GWAS2814698 (human) | | 6e-09 | lung integrity trait (VT:0010906) | | 4 | 109137407 | 109137408 | Human |
| 628742624 | GWAS2650853_H | treprostinil dose measurement QTL GWAS2650853 (human) | | 0.000005 | treprostinil dose measurement | | 4 | 113625548 | 113625549 | Human |
| 407299297 | GWAS948273_H | Tinnitus QTL GWAS948273 (human) | | 0.0000004 | Tinnitus | | 4 | 110681577 | 110681578 | Human |
| 596959027 | GWAS1078546_H | facial morphology measurement QTL GWAS1078546 (human) | | 3e-08 | facial morphology measurement | | 4 | 125211057 | 125211058 | Human |
| 628414942 | GWAS2323171_H | body height QTL GWAS2323171 (human) | | 1e-10 | body height | | 4 | 124024877 | 124024878 | Human |
| 628971990 | GWAS2880219_H | skin disease QTL GWAS2880219 (human) | | 2e-14 | skin disease | | 4 | 124698876 | 124698877 | Human |
| 407315692 | GWAS964668_H | ceramide measurement QTL GWAS964668 (human) | | 2e-08 | ceramide measurement | | 4 | 129692156 | 129692157 | Human |
| 597991177 | GWAS1710476_H | erosive tooth wear attribute QTL GWAS1710476 (human) | | 3e-08 | erosive tooth wear attribute | | 4 | 117643607 | 117643608 | Human |
| 628709847 | GWAS2618076_H | metabolite measurement QTL GWAS2618076 (human) | | 2e-22 | metabolite measurement | | 4 | 129118729 | 129118730 | Human |
| 616552464 | GWAS1949047_H | body mass index QTL GWAS1949047 (human) | | 8e-12 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 628578757 | GWAS2486986_H | glycerophospholipid measurement QTL GWAS2486986 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114532837 | 114532838 | Human |
| 628578756 | GWAS2486985_H | glycerophospholipid measurement QTL GWAS2486985 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114532769 | 114532770 | Human |
| 628578755 | GWAS2486984_H | glycerophospholipid measurement QTL GWAS2486984 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114490021 | 114490022 | Human |
| 628578754 | GWAS2486983_H | glycerophospholipid measurement QTL GWAS2486983 (human) | | 3e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114563873 | 114563874 | Human |
| 628578753 | GWAS2486982_H | glycerophospholipid measurement QTL GWAS2486982 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114533453 | 114533454 | Human |
| 596975395 | GWAS1094914_H | body height QTL GWAS1094914 (human) | | 4e-15 | body height | | 4 | 122823209 | 122823210 | Human |
| 628578752 | GWAS2486981_H | glycerophospholipid measurement QTL GWAS2486981 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114533510 | 114533511 | Human |
| 407250161 | GWAS899137_H | inflammatory bowel disease QTL GWAS899137 (human) | | 4e-11 | inflammatory bowel disease | | 4 | 122523884 | 122523885 | Human |
| 597352226 | GWAS1448300_H | body height QTL GWAS1448300 (human) | | 1e-18 | body height | | 4 | 128691709 | 128691710 | Human |
| 628693440 | GWAS2601669_H | mean corpuscular hemoglobin QTL GWAS2601669 (human) | | 2e-66 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 121870446 | 121870447 | Human |
| 597352227 | GWAS1448301_H | body height QTL GWAS1448301 (human) | | 2e-24 | body height | | 4 | 128708095 | 128708096 | Human |
| 406988024 | GWAS637000_H | Ischemic stroke, cardiac embolism QTL GWAS637000 (human) | | 1e-25 | Ischemic stroke, cardiac embolism | | 4 | 110737238 | 110737239 | Human |
| 597352224 | GWAS1448298_H | body height QTL GWAS1448298 (human) | | 3e-29 | body height | | 4 | 126054046 | 126054047 | Human |
| 597352225 | GWAS1448299_H | body height QTL GWAS1448299 (human) | | 0.0000004 | body height | | 4 | 128239161 | 128239162 | Human |
| 406938877 | GWAS587853_H | celiac disease QTL GWAS587853 (human) | | 3e-13 | celiac disease | | 4 | 122588266 | 122588267 | Human |
| 596991785 | GWAS1111304_H | apolipoprotein B measurement QTL GWAS1111304 (human) | | 1e-10 | apolipoprotein B measurement | | 4 | 123837618 | 123837619 | Human |
| 628578743 | GWAS2486972_H | glycerophospholipid measurement QTL GWAS2486972 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114561897 | 114561898 | Human |
| 597499741 | GWAS1595815_H | memory performance QTL GWAS1595815 (human) | | 0.000002 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124874941 | 124874942 | Human |
| 628578742 | GWAS2486971_H | glycerophospholipid measurement QTL GWAS2486971 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114491625 | 114491626 | Human |
| 597499740 | GWAS1595814_H | memory performance QTL GWAS1595814 (human) | | 0.0000003 | memory performance | | 4 | 128552943 | 128552944 | Human |
| 628578741 | GWAS2486970_H | glycerophospholipid measurement QTL GWAS2486970 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114529308 | 114529309 | Human |
| 628578740 | GWAS2486969_H | glycerophospholipid measurement QTL GWAS2486969 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114529420 | 114529421 | Human |
| 628578739 | GWAS2486968_H | glycerophospholipid measurement QTL GWAS2486968 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114529766 | 114529767 | Human |
| 628578738 | GWAS2486967_H | glycerophospholipid measurement QTL GWAS2486967 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114529776 | 114529777 | Human |
| 616536186 | GWAS1932769_H | erythrocyte volume QTL GWAS1932769 (human) | | 1e-56 | erythrocyte volume | | 4 | 121877258 | 121877259 | Human |
| 628578737 | GWAS2486966_H | glycerophospholipid measurement QTL GWAS2486966 (human) | | 6e-14 | blood phospholipid amount (VT:0006084) | | 4 | 114489100 | 114489101 | Human |
| 628578736 | GWAS2486965_H | glycerophospholipid measurement QTL GWAS2486965 (human) | | 6e-14 | blood phospholipid amount (VT:0006084) | | 4 | 114571551 | 114571552 | Human |
| 407282830 | GWAS931806_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS931806 (human) | | 2e-18 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 628578751 | GWAS2486980_H | glycerophospholipid measurement QTL GWAS2486980 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114533531 | 114533532 | Human |
| 407184524 | GWAS833500_H | appendicular lean mass QTL GWAS833500 (human) | | 3e-11 | appendicular lean mass | | 4 | 107939926 | 107939927 | Human |
| 628578750 | GWAS2486979_H | glycerophospholipid measurement QTL GWAS2486979 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114555821 | 114555822 | Human |
| 628578749 | GWAS2486978_H | glycerophospholipid measurement QTL GWAS2486978 (human) | | 3e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114530452 | 114530453 | Human |
| 628578748 | GWAS2486977_H | glycerophospholipid measurement QTL GWAS2486977 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114496204 | 114496205 | Human |
| 628578747 | GWAS2486976_H | glycerophospholipid measurement QTL GWAS2486976 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114496175 | 114496176 | Human |
| 628578746 | GWAS2486975_H | glycerophospholipid measurement QTL GWAS2486975 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114495902 | 114495903 | Human |
| 628578745 | GWAS2486974_H | glycerophospholipid measurement QTL GWAS2486974 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114495803 | 114495804 | Human |
| 597385045 | GWAS1481119_H | myeloid white cell count QTL GWAS1481119 (human) | | 6e-13 | myeloid white cell count | | 4 | 119342160 | 119342161 | Human |
| 628578744 | GWAS2486973_H | glycerophospholipid measurement QTL GWAS2486973 (human) | | 1e-13 | blood phospholipid amount (VT:0006084) | | 4 | 114496530 | 114496531 | Human |
| 598040437 | GWAS1759736_H | carotid artery thickness QTL GWAS1759736 (human) | | 0.000006 | carotid artery thickness | | 4 | 118504756 | 118504757 | Human |
| 616388716 | GWAS1868958_H | trait in response to apixaban QTL GWAS1868958 (human) | | 0.000005 | trait in response to apixaban | | 4 | 120963437 | 120963438 | Human |
| 597434184 | GWAS1530258_H | sex hormone-binding globulin measurement QTL GWAS1530258 (human) | | 0.000002 | sex hormone-binding globulin measurement | | 4 | 123845801 | 123845802 | Human |
| 628988331 | GWAS2896560_H | cardiac arrhythmia QTL GWAS2896560 (human) | | 4e-14 | heart integrity trait (VT:0010757) | | 4 | 110784139 | 110784140 | Human |
| 628578735 | GWAS2486964_H | glycerophospholipid measurement QTL GWAS2486964 (human) | | 6e-14 | blood phospholipid amount (VT:0006084) | | 4 | 114514205 | 114514206 | Human |
| 597073742 | GWAS1169816_H | coronary artery disease QTL GWAS1169816 (human) | | 1e-14 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 628988325 | GWAS2896554_H | cardiac arrest QTL GWAS2896554 (human) | | 2e-12 | cardiac arrest | | 4 | 129618474 | 129618475 | Human |
| 628578734 | GWAS2486963_H | glycerophospholipid measurement QTL GWAS2486963 (human) | | 4e-22 | blood phospholipid amount (VT:0006084) | | 4 | 114571876 | 114571877 | Human |
| 628447663 | GWAS2355892_H | eye colour measurement QTL GWAS2355892 (human) | | 0.000007 | eye pigmentation trait (VT:0001324) | eye morphological measurement (CMO:0003080) | 4 | 121396276 | 121396277 | Human |
| 617011226 | GWAS2028725_H | metabolic syndrome QTL GWAS2028725 (human) | | 1e-11 | metabolic syndrome | | 4 | 129810129 | 129810130 | Human |
| 597434179 | GWAS1530253_H | sex hormone-binding globulin measurement QTL GWAS1530253 (human) | | 8e-21 | sex hormone-binding globulin measurement | | 4 | 109345757 | 109345758 | Human |
| 617011225 | GWAS2028724_H | metabolic syndrome QTL GWAS2028724 (human) | | 1e-08 | metabolic syndrome | | 4 | 111770620 | 111770621 | Human |
| 628890004 | GWAS2798233_H | Alzheimer disease QTL GWAS2798233 (human) | | 1e-10 | Alzheimer disease | | 4 | 108219159 | 108219160 | Human |
| 597385074 | GWAS1481148_H | brain measurement, neuroimaging measurement QTL GWAS1481148 (human) | | 3e-08 | brain measurement, neuroimaging measurement | | 4 | 112509596 | 112509597 | Human |
| 407102632 | GWAS751608_H | irritable bowel syndrome QTL GWAS751608 (human) | | 8e-08 | intestine integrity trait (VT:0010554) | | 4 | 123130312 | 123130313 | Human |
| 617093156 | GWAS2110655_H | platelet count QTL GWAS2110655 (human) | | 9e-16 | platelet count | | 4 | 122595396 | 122595397 | Human |
| 407381158 | GWAS1030134_H | stromal cell-derived factor 1 alpha measurement QTL GWAS1030134 (human) | | 0.000002 | stromal cell-derived factor 1 alpha measurement | | 4 | 115146334 | 115146335 | Human |
| 628791700 | GWAS2699929_H | protein measurement QTL GWAS2699929 (human) | | 3e-27 | protein amount (VT:0010120) | | 4 | 121659570 | 121659571 | Human |
| 597090169 | GWAS1186243_H | myeloid white cell count QTL GWAS1186243 (human) | | 9e-13 | myeloid white cell count | | 4 | 110024810 | 110024811 | Human |
| 597991249 | GWAS1710548_H | level of serum globulin type protein QTL GWAS1710548 (human) | | 2e-10 | level of serum globulin type protein | | 4 | 109984820 | 109984821 | Human |
| 596959074 | GWAS1078593_H | response to warfarin QTL GWAS1078593 (human) | | 0.000007 | response to warfarin | | 4 | 112988363 | 112988364 | Human |
| 616519753 | GWAS1916336_H | body height QTL GWAS1916336 (human) | | 1e-11 | body height | | 4 | 122848013 | 122848014 | Human |
| 628939140 | GWAS2847369_H | macular degeneration QTL GWAS2847369 (human) | | 5e-13 | macular degeneration | | 4 | 109764664 | 109764665 | Human |
| 597335906 | GWAS1431980_H | smoking initiation QTL GWAS1431980 (human) | | 6e-26 | smoking initiation | | 4 | 111500989 | 111500990 | Human |
| 597335907 | GWAS1431981_H | smoking initiation QTL GWAS1431981 (human) | | 2e-10 | smoking initiation | | 4 | 115079942 | 115079943 | Human |
| 597499748 | GWAS1595822_H | memory performance QTL GWAS1595822 (human) | | 0.00001 | learning/memory/conditioning trait (VT:0002063) | | 4 | 124888134 | 124888135 | Human |
| 407135422 | GWAS784398_H | corneal resistance factor QTL GWAS784398 (human) | | 4e-08 | corneal resistance factor | | 4 | 118802505 | 118802506 | Human |
| 617044029 | GWAS2061528_H | total blood protein measurement QTL GWAS2061528 (human) | | 6e-20 | total blood protein measurement | | 4 | 119206905 | 119206906 | Human |
| 406906046 | GWAS555022_H | reaction time measurement QTL GWAS555022 (human) | | 0.0000004 | reaction time measurement | | 4 | 124836622 | 124836623 | Human |
| 597057385 | GWAS1153459_H | intelligence QTL GWAS1153459 (human) | | 0.000001 | intelligence | | 4 | 130143535 | 130143536 | Human |
| 628627576 | GWAS2535805_H | bipolar I disorder QTL GWAS2535805 (human) | | 0.0000001 | emotion/affect behavior trait (VT:0002572) | | 4 | 122588558 | 122588559 | Human |
| 617011652 | GWAS2029151_H | decreased attention, quality of life QTL GWAS2029151 (human) | | 0.000003 | decreased attention, quality of life | | 4 | 125938393 | 125938394 | Human |
| 628496497 | GWAS2404726_H | empathy measurement QTL GWAS2404726 (human) | | 0.000008 | emotion/affect behavior trait (VT:0002572) | | 4 | 111486019 | 111486020 | Human |
| 597614231 | GWAS1671091_H | seborrheic keratosis QTL GWAS1671091 (human) | | 2e-16 | seborrheic keratosis | | 4 | 124698876 | 124698877 | Human |
| 407184712 | GWAS833688_H | 1-palmitoylglycerophosphocholine measurement QTL GWAS833688 (human) | | 0.0000003 | 2-palmitoylglycerophosphocholine measurement | | 4 | 122051907 | 122051908 | Human |
| 406938960 | GWAS587936_H | left atrial volume measurement QTL GWAS587936 (human) | | 1e-08 | left atrial volume measurement | | 4 | 110744627 | 110744628 | Human |
| 406889812 | GWAS538788_H | waist-hip ratio QTL GWAS538788 (human) | | 5e-08 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 4 | 123145793 | 123145794 | Human |
| 596991616 | GWAS1111135_H | pulse pressure measurement QTL GWAS1111135 (human) | | 3e-73 | pulse pressure measurement | | 4 | 115629004 | 115629005 | Human |
| 407283025 | GWAS932001_H | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS932001 (human) | | 2e-10 | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 597073548 | GWAS1169622_H | coronary artery disease QTL GWAS1169622 (human) | | 0.0000009 | coronary artery disease | | 4 | 124978810 | 124978811 | Human |
| 628988000 | GWAS2896229_H | cardiac arrhythmia QTL GWAS2896229 (human) | | 3e-130 | heart integrity trait (VT:0010757) | | 4 | 110796911 | 110796912 | Human |
| 628463720 | GWAS2371949_H | asthma QTL GWAS2371949 (human) | | 5e-14 | asthma | | 4 | 122219915 | 122219916 | Human |
| 407053661 | GWAS702637_H | monocyte count QTL GWAS702637 (human) | | 6e-12 | monocyte count | | 4 | 119506334 | 119506335 | Human |
| 407053665 | GWAS702641_H | cerebral amyloid angiopathy QTL GWAS702641 (human) | | 0.000007 | cerebral amyloid angiopathy | | 4 | 129419725 | 129419726 | Human |
| 597171899 | GWAS1267973_H | protein measurement QTL GWAS1267973 (human) | | 4e-13 | protein measurement | | 4 | 108004097 | 108004098 | Human |
| 628840541 | GWAS2748770_H | non-high density lipoprotein cholesterol measurement QTL GWAS2748770 (human) | | 5e-12 | blood non-HDL cholesterol amount (VT:0010474) | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 4 | 109717668 | 109717669 | Human |
| 628840540 | GWAS2748769_H | non-high density lipoprotein cholesterol measurement QTL GWAS2748769 (human) | | 5e-10 | blood non-HDL cholesterol amount (VT:0010474) | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 4 | 109174464 | 109174465 | Human |
| 628906068 | GWAS2814297_H | serum creatinine amount QTL GWAS2814297 (human) | | 4e-13 | serum creatinine amount | | 4 | 108792494 | 108792495 | Human |
| 616536471 | GWAS1933054_H | properdin measurement QTL GWAS1933054 (human) | | 3e-15 | properdin measurement | | 4 | 109737911 | 109737912 | Human |
| 597450420 | GWAS1546494_H | creatinine measurement QTL GWAS1546494 (human) | | 3e-12 | creatinine measurement | | 4 | 127420965 | 127420966 | Human |
| 616536470 | GWAS1933053_H | complement factor I measurement QTL GWAS1933053 (human) | | 8e-26 | complement factor I measurement | | 4 | 109732855 | 109732856 | Human |
| 628906069 | GWAS2814298_H | serum creatinine amount QTL GWAS2814298 (human) | | 3e-08 | serum creatinine amount | | 4 | 114597722 | 114597723 | Human |
| 407364973 | GWAS1013949_H | schizophrenia QTL GWAS1013949 (human) | | 0.000008 | schizophrenia | | 4 | 117723665 | 117723666 | Human |
| 628906070 | GWAS2814299_H | serum creatinine amount QTL GWAS2814299 (human) | | 7e-09 | serum creatinine amount | | 4 | 123414226 | 123414227 | Human |
| 616536468 | GWAS1933051_H | complement factor I measurement QTL GWAS1933051 (human) | | 1e-11 | complement factor I measurement | | 4 | 109815148 | 109815149 | Human |
| 628906071 | GWAS2814300_H | serum creatinine amount QTL GWAS2814300 (human) | | 2e-15 | serum creatinine amount | | 4 | 127146530 | 127146531 | Human |
| 616536467 | GWAS1933050_H | complement factor I measurement QTL GWAS1933050 (human) | | 9e-78 | complement factor I measurement | | 4 | 109764664 | 109764665 | Human |
| 616536466 | GWAS1933049_H | complement factor I measurement QTL GWAS1933049 (human) | | 4e-210 | complement factor I measurement | | 4 | 109737911 | 109737912 | Human |
| 597089954 | GWAS1186028_H | mean reticulocyte volume QTL GWAS1186028 (human) | | 6e-11 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 122215361 | 122215362 | Human |
| 407266674 | GWAS915650_H | lifestyle measurement, anxiety disorder measurement QTL GWAS915650 (human) | | 8e-08 | lifestyle measurement, alcohol consumption measurement | | 4 | 127457977 | 127457978 | Human |
| 628725839 | GWAS2634068_H | glypican-1 measurement QTL GWAS2634068 (human) | | 1e-13 | glypican-1 measurement | | 4 | 128276344 | 128276345 | Human |
| 597089953 | GWAS1186027_H | mean reticulocyte volume QTL GWAS1186027 (human) | | 6e-57 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 121877258 | 121877259 | Human |
| 628414543 | GWAS2322772_H | urinary metabolite measurement QTL GWAS2322772 (human) | | 6e-18 | urine molecular composition trait (VT:0001757) | | 4 | 129118729 | 129118730 | Human |
| 616356224 | GWAS1840939_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1840939 (human) | | 7e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 129320668 | 129320669 | Human |
| 617109897 | GWAS2127396_H | type 2 diabetes mellitus QTL GWAS2127396 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 129824994 | 129824995 | Human |
| 597532377 | GWAS1628451_H | pain QTL GWAS1628451 (human) | | 6e-10 | pain | | 4 | 111582716 | 111582717 | Human |
| 617093517 | GWAS2111016_H | erythrocyte volume QTL GWAS2111016 (human) | | 2e-14 | erythrocyte volume | | 4 | 110066281 | 110066282 | Human |
| 407266574 | GWAS915550_H | body height QTL GWAS915550 (human) | | 1e-18 | body height | | 4 | 128691709 | 128691710 | Human |
| 407266572 | GWAS915548_H | body height QTL GWAS915548 (human) | | 0.0000004 | body height | | 4 | 128239161 | 128239162 | Human |
| 597532369 | GWAS1628443_H | alcohol use disorder measurement QTL GWAS1628443 (human) | | 3e-12 | alcohol use disorder measurement | | 4 | 111546456 | 111546457 | Human |
| 628987953 | GWAS2896182_H | artificial cardiac pacemaker QTL GWAS2896182 (human) | | 3e-12 | artificial cardiac pacemaker | | 4 | 113504778 | 113504779 | Human |
| 628938801 | GWAS2847030_H | heart rate QTL GWAS2847030 (human) | | 7e-21 | heart rate | | 4 | 110796911 | 110796912 | Human |
| 407266568 | GWAS915544_H | body height QTL GWAS915544 (human) | | 9e-20 | body height | | 4 | 127073768 | 127073769 | Human |
| 628578343 | GWAS2486572_H | glycerophospholipid measurement QTL GWAS2486572 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114566454 | 114566455 | Human |
| 628578342 | GWAS2486571_H | glycerophospholipid measurement QTL GWAS2486571 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114581427 | 114581428 | Human |
| 597466830 | GWAS1562904_H | atrial fibrillation QTL GWAS1562904 (human) | | 9e-09 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 628578341 | GWAS2486570_H | glycerophospholipid measurement QTL GWAS2486570 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114554497 | 114554498 | Human |
| 597466831 | GWAS1562905_H | atrial fibrillation QTL GWAS1562905 (human) | | 2e-09 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 628578340 | GWAS2486569_H | glycerophospholipid measurement QTL GWAS2486569 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114594500 | 114594501 | Human |
| 597434063 | GWAS1530137_H | protein measurement QTL GWAS1530137 (human) | | 3e-27 | protein measurement | | 4 | 121659570 | 121659571 | Human |
| 407151895 | GWAS800871_H | QRS duration QTL GWAS800871 (human) | | 2e-09 | QRS duration | | 4 | 123829743 | 123829744 | Human |
| 406889748 | GWAS538724_H | atrial fibrillation QTL GWAS538724 (human) | | 4e-63 | atrial fibrillation | | 4 | 110787131 | 110787132 | Human |
| 628578339 | GWAS2486568_H | glycerophospholipid measurement QTL GWAS2486568 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114556583 | 114556584 | Human |
| 628578338 | GWAS2486567_H | glycerophospholipid measurement QTL GWAS2486567 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114547620 | 114547621 | Human |
| 628578337 | GWAS2486566_H | glycerophospholipid measurement QTL GWAS2486566 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114566777 | 114566778 | Human |
| 628578336 | GWAS2486565_H | glycerophospholipid measurement QTL GWAS2486565 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114575280 | 114575281 | Human |
| 628365347 | GWAS2286191_H | tumor necrosis factor alpha level QTL GWAS2286191 (human) | | 0.0000008 | tumor necrosis factor alpha level | | 4 | 123440293 | 123440294 | Human |
| 628594731 | GWAS2502960_H | testosterone measurement QTL GWAS2502960 (human) | | 2e-13 | blood testosterone amount (VT:0005180) | serum testosterone level (CMO:0000568) | 4 | 108117498 | 108117499 | Human |
| 406971677 | GWAS620653_H | sporadic amyotrophic lateral sclerosis QTL GWAS620653 (human) | | 0.0000001 | sporadic amyotrophic lateral sclerosis | | 4 | 108706869 | 108706870 | Human |
| 617109909 | GWAS2127408_H | socioeconomic status QTL GWAS2127408 (human) | | 1e-08 | socioeconomic status | | 4 | 121774163 | 121774164 | Human |
| 628578345 | GWAS2486574_H | glycerophospholipid measurement QTL GWAS2486574 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114594055 | 114594056 | Human |
| 628840485 | GWAS2748714_H | schizophrenia QTL GWAS2748714 (human) | | 2e-09 | schizophrenia | | 4 | 117931831 | 117931832 | Human |
| 406971679 | GWAS620655_H | sporadic amyotrophic lateral sclerosis QTL GWAS620655 (human) | | 0.000002 | sporadic amyotrophic lateral sclerosis | | 4 | 119030492 | 119030493 | Human |
| 628578344 | GWAS2486573_H | glycerophospholipid measurement QTL GWAS2486573 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114548111 | 114548112 | Human |
| 628578327 | GWAS2486556_H | glycerophospholipid measurement QTL GWAS2486556 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114556918 | 114556919 | Human |
| 628512790 | GWAS2421019_H | type 2 diabetes mellitus QTL GWAS2421019 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 129824994 | 129824995 | Human |
| 628578326 | GWAS2486555_H | glycerophospholipid measurement QTL GWAS2486555 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114489752 | 114489753 | Human |
| 597270264 | GWAS1366338_H | metabolite measurement QTL GWAS1366338 (human) | | 3e-52 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 628578325 | GWAS2486554_H | glycerophospholipid measurement QTL GWAS2486554 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114514184 | 114514185 | Human |
| 407233831 | GWAS882807_H | monokine induced by gamma interferon measurement QTL GWAS882807 (human) | | 0.000004 | monokine induced by gamma interferon measurement | | 4 | 122707083 | 122707084 | Human |
| 628578324 | GWAS2486553_H | glycerophospholipid measurement QTL GWAS2486553 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114575934 | 114575935 | Human |
| 628578323 | GWAS2486552_H | glycerophospholipid measurement QTL GWAS2486552 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114517650 | 114517651 | Human |
| 407414061 | GWAS1063037_H | body height QTL GWAS1063037 (human) | | 4e-08 | body height | | 4 | 112647388 | 112647389 | Human |
| 628578322 | GWAS2486551_H | glycerophospholipid measurement QTL GWAS2486551 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114512821 | 114512822 | Human |
| 628578335 | GWAS2486564_H | glycerophospholipid measurement QTL GWAS2486564 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114519211 | 114519212 | Human |
| 628578334 | GWAS2486563_H | glycerophospholipid measurement QTL GWAS2486563 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114549280 | 114549281 | Human |
| 628578333 | GWAS2486562_H | glycerophospholipid measurement QTL GWAS2486562 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114583571 | 114583572 | Human |
| 628578332 | GWAS2486561_H | glycerophospholipid measurement QTL GWAS2486561 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114538077 | 114538078 | Human |
| 628578331 | GWAS2486560_H | glycerophospholipid measurement QTL GWAS2486560 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114554629 | 114554630 | Human |
| 616356305 | GWAS1841020_H | gut microbiome measurement, breastfeeding duration QTL GWAS1841020 (human) | | 6e-11 | gut microbiome measurement, breastfeeding duration | | 4 | 110717326 | 110717327 | Human |
| 628578330 | GWAS2486559_H | glycerophospholipid measurement QTL GWAS2486559 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114594792 | 114594793 | Human |
| 628578329 | GWAS2486558_H | glycerophospholipid measurement QTL GWAS2486558 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114564668 | 114564669 | Human |
| 597122809 | GWAS1218883_H | bipolar disorder, Crohn's disease QTL GWAS1218883 (human) | | 4e-12 | bipolar disorder, Crohn's disease | | 4 | 122154852 | 122154853 | Human |
| 628578328 | GWAS2486557_H | glycerophospholipid measurement QTL GWAS2486557 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114557343 | 114557344 | Human |
| 597303016 | GWAS1399090_H | monocyte count QTL GWAS1399090 (human) | | 2e-18 | monocyte count | | 4 | 110024100 | 110024101 | Human |
| 597532398 | GWAS1628472_H | color vision disorder QTL GWAS1628472 (human) | | 0.000003 | color vision disorder | | 4 | 108200574 | 108200575 | Human |
| 617093563 | GWAS2111062_H | body mass index QTL GWAS2111062 (human) | | 3e-21 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129818987 | 129818988 | Human |
| 628824079 | GWAS2732308_H | total blood protein measurement QTL GWAS2732308 (human) | | 7e-20 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 119206905 | 119206906 | Human |
| 407217457 | GWAS866433_H | mean corpuscular hemoglobin concentration QTL GWAS866433 (human) | | 4e-31 | mean corpuscular hemoglobin concentration | | 4 | 127878475 | 127878476 | Human |
| 628463619 | GWAS2371848_H | asthma QTL GWAS2371848 (human) | | 8e-12 | asthma | | 4 | 122432277 | 122432278 | Human |
| 407250238 | GWAS899214_H | coronary artery disease QTL GWAS899214 (human) | | 3e-08 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 617028031 | GWAS2045530_H | reticulocyte amount QTL GWAS2045530 (human) | | 4e-12 | reticulocyte amount | | 4 | 128330896 | 128330897 | Human |
| 617028030 | GWAS2045529_H | reticulocyte amount QTL GWAS2045529 (human) | | 8e-09 | reticulocyte amount | | 4 | 119770233 | 119770234 | Human |
| 407151934 | GWAS800910_H | total cholesterol measurement QTL GWAS800910 (human) | | 2e-09 | total cholesterol measurement | | 4 | 119210489 | 119210490 | Human |
| 628496397 | GWAS2404626_H | celiac disease QTL GWAS2404626 (human) | | 3e-36 | intestine integrity trait (VT:0010554) | | 4 | 122629959 | 122629960 | Human |
| 597532385 | GWAS1628459_H | atopic eczema QTL GWAS1628459 (human) | | 1e-62 | atopic eczema | | 4 | 122465565 | 122465566 | Human |
| 617208244 | GWAS2188684_H | stanniocalcin-2 measurement QTL GWAS2188684 (human) | | 1e-12 | stanniocalcin-2 measurement | | 4 | 109973957 | 109973958 | Human |
| 628824070 | GWAS2732299_H | total blood protein measurement QTL GWAS2732299 (human) | | 4e-14 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 4 | 122625127 | 122625128 | Human |
| 407381450 | GWAS1030426_H | hematocrit QTL GWAS1030426 (human) | | 2e-12 | hematocrit | | 4 | 114598669 | 114598670 | Human |
| 596991516 | GWAS1111035_H | hemoglobin measurement QTL GWAS1111035 (human) | | 2e-10 | hemoglobin measurement | | 4 | 123846352 | 123846353 | Human |
| 628611324 | GWAS2519553_H | body weight QTL GWAS2519553 (human) | | 9e-10 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 122906887 | 122906888 | Human |
| 628611323 | GWAS2519552_H | body weight QTL GWAS2519552 (human) | | 1e-11 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 121792708 | 121792709 | Human |
| 628611322 | GWAS2519551_H | body weight QTL GWAS2519551 (human) | | 1e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 114217955 | 114217956 | Human |
| 628611321 | GWAS2519550_H | body weight QTL GWAS2519550 (human) | | 3e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 109829417 | 109829418 | Human |
| 597057048 | GWAS1153122_H | eosinophil count QTL GWAS1153122 (human) | | 5e-23 | eosinophil count | | 4 | 122263256 | 122263257 | Human |
| 628857076 | GWAS2765305_H | COVID-19 QTL GWAS2765305 (human) | | 0.0000006 | COVID-19 | | 4 | 107888805 | 107888806 | Human |
| 597057049 | GWAS1153123_H | eosinophil count QTL GWAS1153123 (human) | | 3e-10 | eosinophil count | | 4 | 123311945 | 123311946 | Human |
| 628775147 | GWAS2683376_H | urate measurement, bone tissue density QTL GWAS2683376 (human) | | 8e-09 | urate measurement, bone tissue density | blood uric acid level (CMO:0000501) | 4 | 113560916 | 113560917 | Human |
| 597286411 | GWAS1382485_H | Ischemic stroke QTL GWAS1382485 (human) | | 1e-08 | Ischemic stroke | | 4 | 112810934 | 112810935 | Human |
| 628414694 | GWAS2322923_H | Hallux valgus QTL GWAS2322923 (human) | | 0.000001 | Hallux valgus | | 4 | 125790890 | 125790891 | Human |
| 407332307 | GWAS981283_H | diastolic blood pressure QTL GWAS981283 (human) | | 3e-10 | diastolic blood pressure | | 4 | 108096372 | 108096373 | Human |
| 628988136 | GWAS2896365_H | mental or behavioural disorder QTL GWAS2896365 (human) | | 4e-13 | behavior trait (VT:0010442) | | 4 | 126106138 | 126106139 | Human |
| 616569174 | GWAS1965757_H | fibroblast growth factor 19 amount QTL GWAS1965757 (human) | | 2e-12 | fibroblast growth factor 19 amount | | 4 | 109321740 | 109321741 | Human |
| 628922596 | GWAS2830825_H | facial morphology QTL GWAS2830825 (human) | | 6e-11 | facial morphology trait (VT:0003743) | | 4 | 126889660 | 126889661 | Human |
| 628922597 | GWAS2830826_H | facial morphology QTL GWAS2830826 (human) | | 1e-16 | facial morphology trait (VT:0003743) | | 4 | 127062308 | 127062309 | Human |
| 597024268 | GWAS1120342_H | alcohol use disorder measurement, response to trauma exposure QTL GWAS1120342 (human) | | 3e-08 | alcohol use disorder measurement, response to trauma exposure | | 4 | 129416904 | 129416905 | Human |
| 616356134 | GWAS1840849_H | gut microbiome measurement, breastfeeding duration QTL GWAS1840849 (human) | | 4e-10 | gut microbiome measurement, breastfeeding duration | | 4 | 121972794 | 121972795 | Human |
| 628922592 | GWAS2830821_H | facial morphology QTL GWAS2830821 (human) | | 6e-10 | facial morphology trait (VT:0003743) | | 4 | 110796911 | 110796912 | Human |
| 597417479 | GWAS1513553_H | protein measurement QTL GWAS1513553 (human) | | 2e-08 | protein measurement | | 4 | 116050074 | 116050075 | Human |
| 628922593 | GWAS2830822_H | facial morphology QTL GWAS2830822 (human) | | 1e-09 | facial morphology trait (VT:0003743) | | 4 | 111751467 | 111751468 | Human |
| 628922594 | GWAS2830823_H | facial morphology QTL GWAS2830823 (human) | | 1e-09 | facial morphology trait (VT:0003743) | | 4 | 121076949 | 121076950 | Human |
| 407168475 | GWAS817451_H | FEV/FVC ratio, allergen exposure measurement QTL GWAS817451 (human) | | 0.000002 | lung capacity (VT:0001942) | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 4 | 118194762 | 118194763 | Human |
| 628922595 | GWAS2830824_H | facial morphology QTL GWAS2830824 (human) | | 2e-09 | facial morphology trait (VT:0003743) | | 4 | 126030047 | 126030049 | Human |
| 597138998 | GWAS1235072_H | body height QTL GWAS1235072 (human) | | 1e-08 | body height | | 4 | 123987076 | 123987077 | Human |
| 597204538 | GWAS1300612_H | asthma QTL GWAS1300612 (human) | | 5e-14 | asthma | | 4 | 122219915 | 122219916 | Human |
| 597138997 | GWAS1235071_H | body height QTL GWAS1235071 (human) | | 5e-13 | body height | | 4 | 122917603 | 122917604 | Human |
| 616552732 | GWAS1949315_H | whole body water mass QTL GWAS1949315 (human) | | 1e-11 | whole body water mass | | 4 | 109834165 | 109834166 | Human |
| 597138996 | GWAS1235070_H | body height QTL GWAS1235070 (human) | | 2e-13 | body height | | 4 | 121799844 | 121799845 | Human |
| 597138995 | GWAS1235069_H | body height QTL GWAS1235069 (human) | | 2e-12 | body height | | 4 | 119840636 | 119840637 | Human |
| 597138994 | GWAS1235068_H | body height QTL GWAS1235068 (human) | | 0.0000003 | body height | | 4 | 119645235 | 119645236 | Human |
| 597286460 | GWAS1382534_H | eosinophil count QTL GWAS1382534 (human) | | 4e-21 | eosinophil count | | 4 | 122408207 | 122408208 | Human |
| 597138993 | GWAS1235067_H | body height QTL GWAS1235067 (human) | | 5e-20 | body height | | 4 | 113901423 | 113901424 | Human |
| 597138992 | GWAS1235066_H | body height QTL GWAS1235066 (human) | | 0.000002 | body height | | 4 | 109079519 | 109079520 | Human |
| 407004651 | GWAS653627_H | body mass index QTL GWAS653627 (human) | | 8e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597401136 | GWAS1497210_H | spine bone mineral density QTL GWAS1497210 (human) | | 0.0000003 | spine bone mineral density | | 4 | 125801465 | 125801466 | Human |
| 616356112 | GWAS1840827_H | gut microbiome measurement, breastfeeding duration QTL GWAS1840827 (human) | | 4e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 120360504 | 120360505 | Human |
| 617126264 | GWAS2143763_H | body height QTL GWAS2143763 (human) | | 1e-13 | body height | | 4 | 108560745 | 108560746 | Human |
| 598089238 | GWAS1808537_H | bone density QTL GWAS1808537 (human) | | 5e-18 | bone density | | 4 | 110503132 | 110503133 | Human |
| 616372493 | GWAS1852735_H | obsolete_lymphocyte measurement, neutrophil measurement QTL GWAS1852735 (human) | | 2e-14 | obsolete_lymphocyte measurement, neutrophil measurement | | 4 | 112190016 | 112190017 | Human |
| 597302827 | GWAS1398901_H | mean corpuscular hemoglobin concentration QTL GWAS1398901 (human) | | 5e-12 | mean corpuscular hemoglobin concentration | | 4 | 109921984 | 109921985 | Human |
| 407266804 | GWAS915780_H | blood urea nitrogen measurement QTL GWAS915780 (human) | | 2e-09 | blood urea nitrogen measurement | | 4 | 119092116 | 119092117 | Human |
| 616372494 | GWAS1852736_H | obsolete_lymphocyte measurement, neutrophil measurement QTL GWAS1852736 (human) | | 3e-14 | obsolete_lymphocyte measurement, neutrophil measurement | | 4 | 122707302 | 122707305 | Human |
| 616519941 | GWAS1916524_H | eosinophil count QTL GWAS1916524 (human) | | 8e-20 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 597466662 | GWAS1562736_H | body mass index QTL GWAS1562736 (human) | | 2e-14 | body mass index | | 4 | 129843450 | 129843451 | Human |
| 617208183 | GWAS2188623_H | level of inactive C-alpha-formylglycine-generating enzyme 2 in blood QTL GWAS2188623 (human) | | 8e-16 | level of inactive C-alpha-formylglycine-generating enzyme 2 in blood | | 4 | 118813029 | 118813030 | Human |
| 616962310 | GWAS1979809_H | body height QTL GWAS1979809 (human) | | 1e-16 | body height | | 4 | 108355674 | 108355675 | Human |
| 407381384 | GWAS1030360_H | platelet-derived growth factor BB measurement QTL GWAS1030360 (human) | | 0.000002 | platelet-derived growth factor BB measurement | | 4 | 111263595 | 111263596 | Human |
| 628578487 | GWAS2486716_H | glycerophospholipid measurement QTL GWAS2486716 (human) | | 2e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114548870 | 114548871 | Human |
| 628578486 | GWAS2486715_H | glycerophospholipid measurement QTL GWAS2486715 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114519018 | 114519019 | Human |
| 407381385 | GWAS1030361_H | platelet-derived growth factor BB measurement QTL GWAS1030361 (human) | | 0.000009 | platelet-derived growth factor BB measurement | | 4 | 116687083 | 116687084 | Human |
| 406922624 | GWAS571600_H | functional brain measurement QTL GWAS571600 (human) | | 7e-09 | functional brain measurement | | 4 | 116995997 | 116995998 | Human |
| 616962311 | GWAS1979810_H | body height QTL GWAS1979810 (human) | | 4e-09 | body height | | 4 | 119356945 | 119356946 | Human |
| 628578485 | GWAS2486714_H | glycerophospholipid measurement QTL GWAS2486714 (human) | | 2e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114493830 | 114493831 | Human |
| 596991575 | GWAS1111094_H | heel bone mineral density QTL GWAS1111094 (human) | | 4e-11 | heel bone mineral density | | 4 | 123613837 | 123613838 | Human |
| 628578484 | GWAS2486713_H | glycerophospholipid measurement QTL GWAS2486713 (human) | | 2e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114493245 | 114493246 | Human |
| 628644027 | GWAS2552256_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS2552256 (human) | | 5e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 116882110 | 116882111 | Human |
| 617011461 | GWAS2028960_H | bipolar disorder QTL GWAS2028960 (human) | | 0.000006 | bipolar disorder | | 4 | 117740497 | 117740498 | Human |
| 616356216 | GWAS1840931_H | gut microbiome measurement, breastfeeding duration QTL GWAS1840931 (human) | | 4e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 112409784 | 112409785 | Human |
| 628578483 | GWAS2486712_H | glycerophospholipid measurement QTL GWAS2486712 (human) | | 2e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114493734 | 114493735 | Human |
| 628578482 | GWAS2486711_H | glycerophospholipid measurement QTL GWAS2486711 (human) | | 2e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114493571 | 114493572 | Human |
| 628578481 | GWAS2486710_H | glycerophospholipid measurement QTL GWAS2486710 (human) | | 2e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114490891 | 114490892 | Human |
| 407315841 | GWAS964817_H | acylcarnitine measurement QTL GWAS964817 (human) | | 6e-08 | acylcarnitine measurement | | 4 | 130265205 | 130265206 | Human |
| 628578480 | GWAS2486709_H | glycerophospholipid measurement QTL GWAS2486709 (human) | | 1e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114512090 | 114512091 | Human |
| 628578494 | GWAS2486723_H | glycerophospholipid measurement QTL GWAS2486723 (human) | | 2e-24 | blood phospholipid amount (VT:0006084) | | 4 | 114565923 | 114565924 | Human |
| 628578493 | GWAS2486722_H | glycerophospholipid measurement QTL GWAS2486722 (human) | | 6e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114519057 | 114519058 | Human |
| 628578492 | GWAS2486721_H | glycerophospholipid measurement QTL GWAS2486721 (human) | | 6e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114494469 | 114494470 | Human |
| 628578491 | GWAS2486720_H | glycerophospholipid measurement QTL GWAS2486720 (human) | | 6e-25 | blood phospholipid amount (VT:0006084) | | 4 | 114554143 | 114554144 | Human |
| 628578490 | GWAS2486719_H | glycerophospholipid measurement QTL GWAS2486719 (human) | | 4e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114551237 | 114551238 | Human |
| 596991576 | GWAS1111095_H | heel bone mineral density QTL GWAS1111095 (human) | | 3e-11 | heel bone mineral density | | 4 | 124600184 | 124600185 | Human |
| 616520049 | GWAS1916632_H | triglyceride measurement QTL GWAS1916632 (human) | | 2e-25 | triglyceride measurement | | 4 | 109657070 | 109657071 | Human |
| 628578489 | GWAS2486718_H | glycerophospholipid measurement QTL GWAS2486718 (human) | | 4e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114576580 | 114576581 | Human |
| 616962312 | GWAS1979811_H | body height QTL GWAS1979811 (human) | | 2e-10 | body height | | 4 | 119636718 | 119636719 | Human |
| 628578488 | GWAS2486717_H | glycerophospholipid measurement QTL GWAS2486717 (human) | | 2e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114572686 | 114572687 | Human |
| 628955309 | GWAS2863538_H | fatty acid amount QTL GWAS2863538 (human) | | 3e-12 | fatty acid amount | | 4 | 109717668 | 109717669 | Human |
| 598089334 | GWAS1808633_H | bone density QTL GWAS1808633 (human) | | 4e-40 | bone density | | 4 | 126002708 | 126002709 | Human |
| 628955308 | GWAS2863537_H | fatty acid amount QTL GWAS2863537 (human) | | 7e-10 | fatty acid amount | | 4 | 109174464 | 109174465 | Human |
| 406955411 | GWAS604387_H | restless legs syndrome QTL GWAS604387 (human) | | 8e-11 | restless legs syndrome | | 4 | 115033802 | 115033803 | Human |
| 597286476 | GWAS1382550_H | COVID-19 QTL GWAS1382550 (human) | | 0.0000009 | COVID-19 | | 4 | 107808529 | 107808530 | Human |
| 628660397 | GWAS2568626_H | bone tissue density QTL GWAS2568626 (human) | | 8e-15 | bone tissue density | | 4 | 132222891 | 132222892 | Human |
| 628414627 | GWAS2322856_H | Hallux valgus QTL GWAS2322856 (human) | | 0.000003 | Hallux valgus | | 4 | 126494361 | 126494362 | Human |
| 628578479 | GWAS2486708_H | glycerophospholipid measurement QTL GWAS2486708 (human) | | 1e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114511985 | 114511986 | Human |
| 628578478 | GWAS2486707_H | glycerophospholipid measurement QTL GWAS2486707 (human) | | 1e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114511787 | 114511788 | Human |
| 628578477 | GWAS2486706_H | glycerophospholipid measurement QTL GWAS2486706 (human) | | 1e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114511785 | 114511786 | Human |
| 406955419 | GWAS604395_H | restless legs syndrome QTL GWAS604395 (human) | | 5e-08 | restless legs syndrome | | 4 | 118105491 | 118105492 | Human |
| 617011485 | GWAS2028984_H | gut microbiome measurement QTL GWAS2028984 (human) | | 0.000001 | gut microbiome measurement | | 4 | 106920747 | 106920748 | Human |
| 628578476 | GWAS2486705_H | glycerophospholipid measurement QTL GWAS2486705 (human) | | 1e-11 | blood phospholipid amount (VT:0006084) | | 4 | 114511945 | 114511946 | Human |
| 628578475 | GWAS2486704_H | glycerophospholipid measurement QTL GWAS2486704 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114509770 | 114509771 | Human |
| 628578474 | GWAS2486703_H | glycerophospholipid measurement QTL GWAS2486703 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114538112 | 114538113 | Human |
| 628578473 | GWAS2486702_H | glycerophospholipid measurement QTL GWAS2486702 (human) | | 2e-12 | blood phospholipid amount (VT:0006084) | | 4 | 114581520 | 114581521 | Human |
| 616372579 | GWAS1852821_H | obsolete_blood protein measurement QTL GWAS1852821 (human) | | 3e-12 | obsolete_blood protein measurement | | 4 | 119503425 | 119503426 | Human |
| 407020962 | GWAS669938_H | body height QTL GWAS669938 (human) | | 3e-08 | body height | | 4 | 113901423 | 113901424 | Human |
| 407020961 | GWAS669937_H | body height QTL GWAS669937 (human) | | 1e-09 | body height | | 4 | 112488114 | 112488115 | Human |
| 407020966 | GWAS669942_H | body height QTL GWAS669942 (human) | | 1e-10 | body height | | 4 | 121817966 | 121817967 | Human |
| 407020967 | GWAS669943_H | body height QTL GWAS669943 (human) | | 4e-13 | body height | | 4 | 124017347 | 124017348 | Human |
| 407020964 | GWAS669940_H | body height QTL GWAS669940 (human) | | 5e-08 | body height | | 4 | 119517147 | 119517148 | Human |
| 407004581 | GWAS653557_H | neutrophil count QTL GWAS653557 (human) | | 1e-11 | neutrophil count | | 4 | 119234651 | 119234652 | Human |
| 407020965 | GWAS669941_H | body height QTL GWAS669941 (human) | | 2e-11 | body height | | 4 | 119840636 | 119840637 | Human |
| 406988202 | GWAS637178_H | cardiovascular age measurement QTL GWAS637178 (human) | | 3e-11 | cardiovascular age measurement | | 4 | 113465982 | 113465983 | Human |
| 597024381 | GWAS1120455_H | maximal voluntary ventilation, pulmonary function measurement QTL GWAS1120455 (human) | | 2e-09 | lung capacity (VT:0001942) | respiratory system measurement (CMO:0000094) | 4 | 120683279 | 120683280 | Human |
| 628922517 | GWAS2830746_H | obesity QTL GWAS2830746 (human) | | 3e-08 | eating behavior trait (VT:0001431) | | 4 | 112392830 | 112392831 | Human |
| 597499508 | GWAS1595582_H | diastolic blood pressure QTL GWAS1595582 (human) | | 0.0000007 | diastolic blood pressure | | 4 | 123873489 | 123873490 | Human |
| 597024382 | GWAS1120456_H | forced expiratory volume QTL GWAS1120456 (human) | | 4e-09 | lung capacity (VT:0001942) | forced expiratory volume (CMO:0000254) | 4 | 120683279 | 120683280 | Human |
| 628922513 | GWAS2830742_H | obesity QTL GWAS2830742 (human) | | 4e-11 | eating behavior trait (VT:0001431) | | 4 | 119629930 | 119629931 | Human |
| 626170044 | GWAS2254480_H | atrial fibrillation QTL GWAS2254480 (human) | | 5e-27 | atrial fibrillation | | 4 | 109738763 | 109738764 | Human |
| 597499507 | GWAS1595581_H | diastolic blood pressure QTL GWAS1595581 (human) | | 5e-27 | diastolic blood pressure | | 4 | 110461529 | 110461530 | Human |
| 597499506 | GWAS1595580_H | diastolic blood pressure QTL GWAS1595580 (human) | | 2e-27 | diastolic blood pressure | | 4 | 110416708 | 110416709 | Human |
| 626170045 | GWAS2254481_H | atrial fibrillation QTL GWAS2254481 (human) | | 5e-305 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 598089302 | GWAS1808601_H | bone density QTL GWAS1808601 (human) | | 6e-24 | bone density | | 4 | 107818840 | 107818841 | Human |
| 407397816 | GWAS1046792_H | insomnia QTL GWAS1046792 (human) | | 1e-09 | insomnia | | 4 | 111871413 | 111871414 | Human |
| 597614190 | GWAS1671050_H | chronic laryngitis QTL GWAS1671050 (human) | | 7e-14 | chronic laryngitis | | 4 | 114913365 | 114913366 | Human |
| 407397817 | GWAS1046793_H | insomnia QTL GWAS1046793 (human) | | 2e-12 | insomnia | | 4 | 111901237 | 111901238 | Human |
| 597614191 | GWAS1671051_H | chronic laryngitis QTL GWAS1671051 (human) | | 4e-12 | chronic laryngitis | | 4 | 129677938 | 129677939 | Human |
| 628922510 | GWAS2830739_H | obesity QTL GWAS2830739 (human) | | 7e-14 | eating behavior trait (VT:0001431) | | 4 | 129809917 | 129809918 | Human |
| 407086512 | GWAS735488_H | prostate carcinoma QTL GWAS735488 (human) | | 3e-08 | prostate carcinoma | | 4 | 109889343 | 109889344 | Human |
| 598089301 | GWAS1808600_H | bone density QTL GWAS1808600 (human) | | 6e-24 | bone density | | 4 | 129519676 | 129519677 | Human |
| 406955444 | GWAS604420_H | N-acetylneuraminate measurement QTL GWAS604420 (human) | | 2e-08 | N-acetylneuraminate measurement | | 4 | 110098606 | 110098607 | Human |
| 617011504 | GWAS2029003_H | BMI-adjusted waist circumference QTL GWAS2029003 (human) | | 7e-11 | BMI-adjusted waist circumference | | 4 | 119820812 | 119820813 | Human |
| 617011505 | GWAS2029004_H | BMI-adjusted waist circumference QTL GWAS2029004 (human) | | 4e-08 | BMI-adjusted waist circumference | | 4 | 108556623 | 108556624 | Human |
| 628922502 | GWAS2830731_H | obesity QTL GWAS2830731 (human) | | 2e-08 | eating behavior trait (VT:0001431) | | 4 | 111788834 | 111788835 | Human |
| 617011514 | GWAS2029013_H | reaction time measurement QTL GWAS2029013 (human) | | 0.0000002 | reaction time measurement | | 4 | 117419552 | 117419553 | Human |
| 597532257 | GWAS1628331_H | glomerular filtration rate QTL GWAS1628331 (human) | | 3e-14 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 597532256 | GWAS1628330_H | glomerular filtration rate QTL GWAS1628330 (human) | | 3e-19 | glomerular filtration rate | | 4 | 108783751 | 108783752 | Human |
| 628791431 | GWAS2699660_H | total cholesterol measurement QTL GWAS2699660 (human) | | 2e-09 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 4 | 119210489 | 119210490 | Human |
| 598089126 | GWAS1808425_H | glomerular filtration rate QTL GWAS1808425 (human) | | 4e-09 | glomerular filtration rate | | 4 | 123414226 | 123414227 | Human |
| 598089127 | GWAS1808426_H | glomerular filtration rate QTL GWAS1808426 (human) | | 3e-14 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 597826976 | GWAS1694367_H | type 1 diabetes mellitus QTL GWAS1694367 (human) | | 6e-12 | type 1 diabetes mellitus | | 4 | 122554824 | 122554825 | Human |
| 598089125 | GWAS1808424_H | glomerular filtration rate QTL GWAS1808424 (human) | | 3e-19 | glomerular filtration rate | | 4 | 108783751 | 108783752 | Human |
| 407021127 | GWAS670103_H | diastolic blood pressure QTL GWAS670103 (human) | | 9e-09 | diastolic blood pressure | | 4 | 110460482 | 110460483 | Human |
| 617061057 | GWAS2078556_H | ceramide amount QTL GWAS2078556 (human) | | 2e-21 | ceramide amount | | 4 | 114598115 | 114598116 | Human |
| 597319068 | GWAS1415142_H | diastolic blood pressure, systolic blood pressure QTL GWAS1415142 (human) | | 2e-08 | diastolic blood pressure, systolic blood pressure | | 4 | 119856151 | 119856152 | Human |
| 628988795 | GWAS2897024_H | exostosis QTL GWAS2897024 (human) | | 4e-11 | exostosis | | 4 | 125701864 | 125701865 | Human |
| 407168578 | GWAS817554_H | cortical thickness QTL GWAS817554 (human) | | 5e-09 | cortical thickness | | 4 | 127101149 | 127101150 | Human |
| 616962752 | GWAS1980251_H | mean reticulocyte volume QTL GWAS1980251 (human) | | 3e-10 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 127552302 | 127552303 | Human |
| 616962753 | GWAS1980252_H | mean reticulocyte volume QTL GWAS1980252 (human) | | 1e-09 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 4 | 128306129 | 128306130 | Human |
| 407414337 | GWAS1063313_H | systolic blood pressure QTL GWAS1063313 (human) | | 2e-12 | systolic blood pressure | | 4 | 110416322 | 110416323 | Human |
| 617093828 | GWAS2111327_H | platelet count QTL GWAS2111327 (human) | | 1e-13 | platelet count | | 4 | 123849566 | 123849567 | Human |
| 407365194 | GWAS1014170_H | protein measurement QTL GWAS1014170 (human) | | 9e-09 | protein measurement | | 4 | 124985713 | 124985714 | Human |
| 597368213 | GWAS1464287_H | balding measurement QTL GWAS1464287 (human) | | 2e-33 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 107131838 | 107131839 | Human |
| 628956013 | GWAS2864242_H | mean corpuscular hemoglobin concentration QTL GWAS2864242 (human) | | 2e-14 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 109934399 | 109934400 | Human |
| 598039989 | GWAS1759288_H | obsolete_anti-epstein barr virus antibody measurement QTL GWAS1759288 (human) | | 0.0000008 | obsolete_anti-epstein barr virus antibody measurement | | 4 | 110793733 | 110793734 | Human |
| 597204360 | GWAS1300434_H | asthma QTL GWAS1300434 (human) | | 8e-12 | asthma | | 4 | 122432277 | 122432278 | Human |
| 628644713 | GWAS2552942_H | gut microbiome measurement, breastfeeding duration QTL GWAS2552942 (human) | | 5e-09 | lactation duration (VT:1000653) | | 4 | 117990855 | 117990856 | Human |
| 407217751 | GWAS866727_H | open-angle glaucoma QTL GWAS866727 (human) | | 8e-09 | open-angle glaucoma | | 4 | 111039218 | 111039219 | Human |
| 628956014 | GWAS2864243_H | mean corpuscular hemoglobin concentration QTL GWAS2864243 (human) | | 2e-11 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121827841 | 121827842 | Human |
| 407152210 | GWAS801186_H | platelet count QTL GWAS801186 (human) | | 2e-33 | platelet count | | 4 | 110023574 | 110023575 | Human |
| 616979152 | GWAS1996651_H | breast carcinoma QTL GWAS1996651 (human) | | 1e-09 | mammary gland integrity trait (VT:0010552) | | 4 | 125922349 | 125922350 | Human |
| 597433735 | GWAS1529809_H | protein measurement QTL GWAS1529809 (human) | | 2e-183 | protein measurement | | 4 | 119360222 | 119360223 | Human |
| 407070303 | GWAS719279_H | body height QTL GWAS719279 (human) | | 9e-08 | body height | | 4 | 121657567 | 121657568 | Human |
| 628923233 | GWAS2831462_H | lymphoid neoplasm QTL GWAS2831462 (human) | | 3e-08 | lymphoid neoplasm | | 4 | 108066714 | 108066715 | Human |
| 628693862 | GWAS2602091_H | mean corpuscular hemoglobin QTL GWAS2602091 (human) | | 5e-23 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin (CMO:0000290) | 4 | 128046010 | 128046011 | Human |
| 616356509 | GWAS1841224_H | gut microbiome measurement, tobacco smoke exposure measurement QTL GWAS1841224 (human) | | 2e-08 | gut microbiome measurement, tobacco smoke exposure measurement | | 4 | 110905034 | 110905035 | Human |
| 407070304 | GWAS719280_H | body height QTL GWAS719280 (human) | | 2e-08 | body height | | 4 | 128700411 | 128700412 | Human |
| 628677469 | GWAS2585698_H | alcohol consumption quality QTL GWAS2585698 (human) | | 0.000006 | alcohol consumption quality | | 4 | 131688192 | 131688193 | Human |
| 407168622 | GWAS817598_H | alkaline phosphatase measurement QTL GWAS817598 (human) | | 8e-15 | alkaline phosphatase measurement | | 4 | 128168289 | 128168290 | Human |
| 628906839 | GWAS2815068_H | cardiac arrhythmia QTL GWAS2815068 (human) | | 2e-12 | heart integrity trait (VT:0010757) | | 4 | 110750654 | 110750655 | Human |
| 616356495 | GWAS1841210_H | gut microbiome measurement, number of siblings QTL GWAS1841210 (human) | | 8e-10 | gut microbiome measurement, number of siblings | | 4 | 128749842 | 128749843 | Human |
| 596975009 | GWAS1094528_H | 2-O-methylascorbic acid measurement, sex interaction measurement QTL GWAS1094528 (human) | | 0.0000008 | 2-O-methylascorbic acid measurement, sex interaction measurement | | 4 | 113095111 | 113095112 | Human |
| 407086713 | GWAS735689_H | alcohol consumption measurement QTL GWAS735689 (human) | | 0.000008 | alcohol consumption measurement | | 4 | 108819029 | 108819030 | Human |
| 628611917 | GWAS2520146_H | brain attribute QTL GWAS2520146 (human) | | 1e-10 | brain attribute | | 4 | 123263477 | 123263478 | Human |
| 407381622 | GWAS1030598_H | eosinophil count QTL GWAS1030598 (human) | | 1e-18 | eosinophil count | | 4 | 122111201 | 122111202 | Human |
| 597368228 | GWAS1464302_H | balding measurement QTL GWAS1464302 (human) | | 4e-32 | balding measurement | | 4 | 106635172 | 106635173 | Human |
| 628546377 | GWAS2454606_H | white matter lesion progression measurement QTL GWAS2454606 (human) | | 0.000006 | central nervous system integrity trait (VT:0010772) | | 4 | 128668470 | 128668471 | Human |
| 407135748 | GWAS784724_H | glomerular filtration rate QTL GWAS784724 (human) | | 5e-09 | glomerular filtration rate | | 4 | 108772299 | 108772300 | Human |
| 407184903 | GWAS833879_H | body height QTL GWAS833879 (human) | | 2e-14 | body height | | 4 | 119501252 | 119501253 | Human |
| 596975056 | GWAS1094575_H | major depressive disorder QTL GWAS1094575 (human) | | 3e-24 | major depressive disorder | | 4 | 122201701 | 122201702 | Human |
| 597433817 | GWAS1529891_H | body height QTL GWAS1529891 (human) | | 2e-10 | body height | | 4 | 129838492 | 129838493 | Human |
| 616962689 | GWAS1980188_H | mammographic density percentage QTL GWAS1980188 (human) | | 2e-08 | mammary gland morphology trait (VT:0000627) | | 4 | 127271525 | 127271526 | Human |
| 406939157 | GWAS588133_H | hemoglobin measurement QTL GWAS588133 (human) | | 2e-18 | hemoglobin measurement | | 4 | 114616986 | 114616987 | Human |
| 406939158 | GWAS588134_H | hemoglobin measurement QTL GWAS588134 (human) | | 1e-12 | hemoglobin measurement | | 4 | 123835365 | 123835366 | Human |
| 407365151 | GWAS1014127_H | protein measurement QTL GWAS1014127 (human) | | 2e-08 | protein measurement | | 4 | 131061544 | 131061545 | Human |
| 626449205 | GWAS2263138_H | obsolete_insulin resistance QTL GWAS2263138 (human) | | 0.000001 | obsolete_insulin resistance | | 4 | 112927886 | 112927887 | Human |
| 597286397 | GWAS1382471_H | body weight QTL GWAS1382471 (human) | | 3e-08 | body weight | | 4 | 109829417 | 109829418 | Human |
| 597417471 | GWAS1513545_H | reticulocyte count QTL GWAS1513545 (human) | | 3e-12 | reticulocyte count | | 4 | 128330896 | 128330897 | Human |
| 407250464 | GWAS899440_H | susceptibility to vaginal yeast infection measurement QTL GWAS899440 (human) | | 0.000004 | susceptibility to vaginal yeast infection measurement | | 4 | 120477000 | 120477001 | Human |
| 597286399 | GWAS1382473_H | body weight QTL GWAS1382473 (human) | | 9e-10 | body weight | | 4 | 122906887 | 122906888 | Human |
| 628890395 | GWAS2798624_H | cardioembolic stroke QTL GWAS2798624 (human) | | 5e-11 | joint integrity trait (VT:0010548) | | 4 | 113507558 | 113507559 | Human |
| 597286398 | GWAS1382472_H | body weight QTL GWAS1382472 (human) | | 1e-08 | body weight | | 4 | 114217955 | 114217956 | Human |
| 617077408 | GWAS2094907_H | fibroblast growth factor 2 amount QTL GWAS2094907 (human) | | 2e-11 | fibroblast growth factor 2 amount | | 4 | 122682145 | 122682146 | Human |
| 616569511 | GWAS1966094_H | galanin peptides measurement QTL GWAS1966094 (human) | | 3e-14 | galanin peptides measurement | | 4 | 123255634 | 123255635 | Human |
| 597499383 | GWAS1595457_H | glomerular filtration rate QTL GWAS1595457 (human) | | 2e-20 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 597499382 | GWAS1595456_H | glomerular filtration rate QTL GWAS1595456 (human) | | 1e-12 | glomerular filtration rate | | 4 | 108783751 | 108783752 | Human |
| 407234094 | GWAS883070_H | bone density QTL GWAS883070 (human) | | 5e-16 | bone density | | 4 | 131691474 | 131691475 | Human |
| 616536782 | GWAS1933365_H | complement factor B measurement QTL GWAS1933365 (human) | | 8e-12 | complement factor B measurement | | 4 | 109737911 | 109737912 | Human |
| 406971952 | GWAS620928_H | basophil count, eosinophil count QTL GWAS620928 (human) | | 4e-09 | basophil count, eosinophil count | | 4 | 122678166 | 122678167 | Human |
| 597466607 | GWAS1562681_H | atrial fibrillation QTL GWAS1562681 (human) | | 4e-427 | atrial fibrillation | | 4 | 110796911 | 110796912 | Human |
| 597466600 | GWAS1562674_H | atrial fibrillation QTL GWAS1562674 (human) | | 2e-39 | atrial fibrillation | | 4 | 110796991 | 110796992 | Human |
| 597466602 | GWAS1562676_H | atrial fibrillation QTL GWAS1562676 (human) | | 6e-09 | atrial fibrillation | | 4 | 110791276 | 110791277 | Human |
| 406939190 | GWAS588166_H | left atrial volume measurement QTL GWAS588166 (human) | | 2e-08 | left atrial volume measurement | | 4 | 110744627 | 110744628 | Human |
| 628906763 | GWAS2814992_H | Bradycardia QTL GWAS2814992 (human) | | 4e-08 | Bradycardia | | 4 | 110755753 | 110755754 | Human |
| 625826613 | GWAS2247535_H | atrial fibrillation QTL GWAS2247535 (human) | | 4e-08 | atrial fibrillation | | 4 | 129810129 | 129810130 | Human |
| 625826612 | GWAS2247534_H | atrial fibrillation QTL GWAS2247534 (human) | | 4e-10 | atrial fibrillation | | 4 | 128545263 | 128545264 | Human |
| 407021112 | GWAS670088_H | systolic blood pressure QTL GWAS670088 (human) | | 7e-08 | systolic blood pressure | | 4 | 110460482 | 110460483 | Human |
| 597171682 | GWAS1267756_H | annexin A5 measurement QTL GWAS1267756 (human) | | 2e-57 | annexin A5 measurement | | 4 | 121695708 | 121695709 | Human |
| 407168575 | GWAS817551_H | cortical thickness QTL GWAS817551 (human) | | 2e-16 | cortical thickness | | 4 | 118393759 | 118393760 | Human |
| 597171683 | GWAS1267757_H | annexin A5 measurement QTL GWAS1267757 (human) | | 2e-11 | annexin A5 measurement | | 4 | 121698791 | 121698792 | Human |
| 407234105 | GWAS883081_H | bone density QTL GWAS883081 (human) | | 8e-16 | bone density | | 4 | 107727835 | 107727836 | Human |
| 625826609 | GWAS2247531_H | atrial fibrillation QTL GWAS2247531 (human) | | 3e-08 | atrial fibrillation | | 4 | 115260980 | 115260981 | Human |
| 617028282 | GWAS2045781_H | dental caries QTL GWAS2045781 (human) | | 0.000003 | dental caries | | 4 | 111359586 | 111359587 | Human |
| 625826611 | GWAS2247533_H | atrial fibrillation QTL GWAS2247533 (human) | | 1e-10 | atrial fibrillation | | 4 | 122917603 | 122917604 | Human |
| 625826610 | GWAS2247532_H | atrial fibrillation QTL GWAS2247532 (human) | | 2e-10 | atrial fibrillation | | 4 | 121839813 | 121839814 | Human |
| 628972543 | GWAS2880772_H | fatty acid amount QTL GWAS2880772 (human) | | 9e-11 | fatty acid amount | | 4 | 109657070 | 109657071 | Human |
| 628972542 | GWAS2880771_H | fatty acid amount QTL GWAS2880771 (human) | | 4e-08 | fatty acid amount | | 4 | 109174464 | 109174465 | Human |
| 597613851 | GWAS1670711_H | potassium measurement QTL GWAS1670711 (human) | | 2e-12 | potassium measurement | | 4 | 108140367 | 108140368 | Human |
| 407283395 | GWAS932371_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS932371 (human) | | 1e-16 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 407267008 | GWAS915984_H | platelet count QTL GWAS915984 (human) | | 4e-18 | platelet count | | 4 | 109973957 | 109973958 | Human |
| 597040401 | GWAS1136475_H | small vessel stroke QTL GWAS1136475 (human) | | 1e-08 | small vessel stroke | | 4 | 113480773 | 113480774 | Human |
| 597073183 | GWAS1169257_H | feeling "fed-up" measurement QTL GWAS1169257 (human) | | 2e-08 | feeling "fed-up" measurement | | 4 | 122201701 | 122201702 | Human |
| 596974879 | GWAS1094398_H | memory performance QTL GWAS1094398 (human) | | 0.000007 | memory performance | | 4 | 124897660 | 124897661 | Human |
| 597581074 | GWAS1637934_H | type 2 diabetes mellitus QTL GWAS1637934 (human) | | 2e-08 | type 2 diabetes mellitus | | 4 | 129824994 | 129824995 | Human |
| 598039851 | GWAS1759150_H | lipid measurement, blood VLDL cholesterol amount, chylomicron amount QTL GWAS1759150 (human) | | 5e-11 | lipid measurement, blood VLDL cholesterol amount, chylomicron amount | | 4 | 109657070 | 109657071 | Human |
| 597368085 | GWAS1464159_H | asthma QTL GWAS1464159 (human) | | 4e-15 | asthma | | 4 | 122084379 | 122084380 | Human |
| 407283401 | GWAS932377_H | vaginal microbiome measurement QTL GWAS932377 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 132191469 | 132191470 | Human |
| 407398104 | GWAS1047080_H | insomnia QTL GWAS1047080 (human) | | 2e-10 | insomnia | | 4 | 122265238 | 122265239 | Human |
| 628546535 | GWAS2454764_H | dopamine beta-hydroxylase measurement QTL GWAS2454764 (human) | | 5e-24 | dopamine beta-hydroxylase measurement | | 4 | 123844106 | 123844107 | Human |
| 628759531 | GWAS2667760_H | X-26054 measurement QTL GWAS2667760 (human) | | 3e-168 | X-26054 measurement | | 4 | 129109789 | 129109790 | Human |
| 597581068 | GWAS1637928_H | type 2 diabetes mellitus QTL GWAS1637928 (human) | | 1e-12 | type 2 diabetes mellitus | | 4 | 120841248 | 120841249 | Human |
| 628595684 | GWAS2503913_H | lifestyle measurement, depressive symptom measurement QTL GWAS2503913 (human) | | 3e-08 | depression-related behavior trait (VT:0015015) | | 4 | 117961493 | 117961494 | Human |
| 597581069 | GWAS1637929_H | type 2 diabetes mellitus QTL GWAS1637929 (human) | | 1e-08 | type 2 diabetes mellitus | | 4 | 128251968 | 128251969 | Human |
| 628366304 | GWAS2287148_H | Glycerin level QTL GWAS2287148 (human) | | 0.000004 | Glycerin level | | 4 | 125494759 | 125494760 | Human |
| 628890601 | GWAS2798830_H | low density lipoprotein cholesterol measurement QTL GWAS2798830 (human) | | 4e-08 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 109997531 | 109997532 | Human |
| 597581067 | GWAS1637927_H | type 2 diabetes mellitus QTL GWAS1637927 (human) | | 3e-08 | type 2 diabetes mellitus | | 4 | 118071040 | 118071041 | Human |
| 628890602 | GWAS2798831_H | low density lipoprotein cholesterol measurement QTL GWAS2798831 (human) | | 1e-09 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 119202262 | 119202263 | Human |
| 597466372 | GWAS1562446_H | balding measurement QTL GWAS1562446 (human) | | 1e-09 | balding measurement | | 4 | 106449528 | 106449529 | Human |
| 628677600 | GWAS2585829_H | level of N-acetylgalactosamine in blood, level of N-acetylglucosamine in blood QTL GWAS2585829 (human) | | 7e-31 | level of N-acetylgalactosamine in blood, level of N-acetylglucosamine in blood | | 4 | 129109789 | 129109790 | Human |
| 597466373 | GWAS1562447_H | balding measurement QTL GWAS1562447 (human) | | 3e-22 | balding measurement | | 4 | 106645118 | 106645119 | Human |
| 597466374 | GWAS1562448_H | balding measurement QTL GWAS1562448 (human) | | 2e-25 | balding measurement | | 4 | 107131838 | 107131839 | Human |
| 628628451 | GWAS2536680_H | bipolar I disorder QTL GWAS2536680 (human) | | 0.0000006 | emotion/affect behavior trait (VT:0002572) | | 4 | 117624232 | 117624233 | Human |
| 597466375 | GWAS1562449_H | balding measurement QTL GWAS1562449 (human) | | 2e-10 | balding measurement | | 4 | 124156708 | 124156709 | Human |
| 597302534 | GWAS1398608_H | body height QTL GWAS1398608 (human) | | 1e-34 | body height | | 4 | 121801213 | 121801214 | Human |
| 628628454 | GWAS2536683_H | bipolar I disorder QTL GWAS2536683 (human) | | 0.0000008 | emotion/affect behavior trait (VT:0002572) | | 4 | 117548415 | 117548416 | Human |
| 407398103 | GWAS1047079_H | insomnia QTL GWAS1047079 (human) | | 1e-08 | insomnia | | 4 | 122259374 | 122259375 | Human |
| 616552981 | GWAS1949564_H | level of agrin in blood serum QTL GWAS1949564 (human) | | 4e-28 | level of agrin in blood serum | | 4 | 118434249 | 118434250 | Human |
| 407070440 | GWAS719416_H | platelet count QTL GWAS719416 (human) | | 4e-19 | platelet count | | 4 | 110027510 | 110027511 | Human |
| 617126501 | GWAS2144000_H | eosinophil count QTL GWAS2144000 (human) | | 8e-20 | eosinophil count | | 4 | 122639784 | 122639785 | Human |
| 628366298 | GWAS2287142_H | Glycerin level QTL GWAS2287142 (human) | | 0.0000002 | Glycerin level | | 4 | 125351750 | 125351751 | Human |
| 598088980 | GWAS1808279_H | bone density QTL GWAS1808279 (human) | | 2e-44 | bone density | | 4 | 111086102 | 111086103 | Human |
| 628431814 | GWAS2340043_H | optic disc size trait QTL GWAS2340043 (human) | | 2e-13 | optic disc size trait | | 4 | 111481402 | 111481403 | Human |
| 596974880 | GWAS1094399_H | memory performance QTL GWAS1094399 (human) | | 0.000007 | memory performance | | 4 | 124885712 | 124885713 | Human |
| 597073184 | GWAS1169258_H | feeling "fed-up" measurement QTL GWAS1169258 (human) | | 5e-08 | feeling "fed-up" measurement | | 4 | 122465996 | 122465997 | Human |
| 596974893 | GWAS1094412_H | memory performance QTL GWAS1094412 (human) | | 0.000008 | memory performance | | 4 | 124893791 | 124893792 | Human |
| 596974892 | GWAS1094411_H | memory performance QTL GWAS1094411 (human) | | 0.000008 | memory performance | | 4 | 124874941 | 124874942 | Human |
| 596974894 | GWAS1094413_H | memory performance QTL GWAS1094413 (human) | | 0.000008 | memory performance | | 4 | 124895966 | 124895967 | Human |
| 628497354 | GWAS2405583_H | asthma, age at onset QTL GWAS2405583 (human) | | 5e-08 | asthma, age at onset | | 4 | 122432277 | 122432278 | Human |
| 616520194 | GWAS1916777_H | celiac disease QTL GWAS1916777 (human) | | 1e-14 | celiac disease | | 4 | 122629959 | 122629960 | Human |
| 616995332 | GWAS2012831_H | insular cortex volume QTL GWAS2012831 (human) | | 0.000003 | insular cortex volume | | 4 | 125775267 | 125775268 | Human |
| 617110027 | GWAS2127526_H | level of glioma pathogenesis-related protein 1 in blood serum QTL GWAS2127526 (human) | | 3e-15 | level of glioma pathogenesis-related protein 1 in blood serum | | 4 | 112179581 | 112179582 | Human |
| 616962561 | GWAS1980060_H | balding measurement QTL GWAS1980060 (human) | | 2e-18 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 106652584 | 106652585 | Human |
| 597335389 | GWAS1431463_H | episodic memory QTL GWAS1431463 (human) | | 0.000002 | episodic memory | | 4 | 114002480 | 114002481 | Human |
| 597581142 | GWAS1638002_H | monocyte count QTL GWAS1638002 (human) | | 2e-26 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 4 | 109927496 | 109927497 | Human |
| 597613904 | GWAS1670764_H | potassium measurement QTL GWAS1670764 (human) | | 4e-15 | potassium measurement | | 4 | 108140367 | 108140368 | Human |
| 616553073 | GWAS1949656_H | whole body water mass QTL GWAS1949656 (human) | | 1e-20 | whole body water mass | | 4 | 122904764 | 122904765 | Human |
| 616372850 | GWAS1853092_H | obsolete_serum metabolite measurement QTL GWAS1853092 (human) | | 7e-22 | obsolete_serum metabolite measurement | | 4 | 129113772 | 129113775 | Human |
| 616487530 | GWAS1884113_H | blood protein amount QTL GWAS1884113 (human) | | 4e-16 | blood protein amount | | 4 | 119210489 | 119210490 | Human |
| 407185041 | GWAS834017_H | 1-oleoylglycerophosphocholine measurement QTL GWAS834017 (human) | | 0.0000008 | 1-oleoylglycerophosphocholine measurement | | 4 | 130062033 | 130062034 | Human |
| 628988843 | GWAS2897072_H | appendicitis QTL GWAS2897072 (human) | | 3e-21 | appendicitis | | 4 | 110804662 | 110804663 | Human |
| 628988839 | GWAS2897068_H | appendicitis QTL GWAS2897068 (human) | | 6e-20 | appendicitis | | 4 | 110810809 | 110810810 | Human |
| 597171525 | GWAS1267599_H | chronotype measurement, sun exposure measurement QTL GWAS1267599 (human) | | 0.0000002 | chronotype measurement, sun exposure measurement | | 4 | 114197705 | 114197706 | Human |
| 628743079 | GWAS2651308_H | platelet count QTL GWAS2651308 (human) | | 6e-38 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110039895 | 110039896 | Human |
| 628546450 | GWAS2454679_H | level of glutamyl aminopeptidase in blood QTL GWAS2454679 (human) | | 2e-25 | level of glutamyl aminopeptidase in blood | | 4 | 110510288 | 110510289 | Human |
| 628988824 | GWAS2897053_H | pyogenic granuloma QTL GWAS2897053 (human) | | 3e-11 | pyogenic granuloma | | 4 | 117340216 | 117340217 | Human |
| 626465726 | GWAS2279659_H | systolic blood pressure QTL GWAS2279659 (human) | | 5e-09 | systolic blood pressure | | 4 | 119154068 | 119154069 | Human |
| 406972075 | GWAS621051_H | systolic blood pressure QTL GWAS621051 (human) | | 0.0000001 | systolic blood pressure | | 4 | 132120954 | 132120955 | Human |
| 597613941 | GWAS1670801_H | alopecia areata QTL GWAS1670801 (human) | | 1e-11 | alopecia areata | | 4 | 126045378 | 126045379 | Human |
| 597532017 | GWAS1628091_H | color vision disorder QTL GWAS1628091 (human) | | 0.0000004 | color vision disorder | | 4 | 123509639 | 123509640 | Human |
| 407135920 | GWAS784896_H | glomerular filtration rate QTL GWAS784896 (human) | | 4e-16 | glomerular filtration rate | | 4 | 108782393 | 108782394 | Human |
| 597532010 | GWAS1628084_H | cannabis dependence QTL GWAS1628084 (human) | | 8e-11 | cannabis dependence | | 4 | 111546456 | 111546457 | Human |
| 597286254 | GWAS1382328_H | stroke QTL GWAS1382328 (human) | | 0.000001 | stroke | | 4 | 112810934 | 112810935 | Human |
| 626465711 | GWAS2279644_H | systolic blood pressure QTL GWAS2279644 (human) | | 3e-08 | systolic blood pressure | | 4 | 120306899 | 120306900 | Human |
| 628415368 | GWAS2323597_H | Parkinson disease QTL GWAS2323597 (human) | | 1e-12 | Parkinson disease | | 4 | 113447909 | 113447910 | Human |
| 407316154 | GWAS965130_H | diet measurement QTL GWAS965130 (human) | | 3e-08 | diet measurement | | 4 | 122050021 | 122050022 | Human |
| 616995387 | GWAS2012886_H | lung carcinoma, family history of lung cancer QTL GWAS2012886 (human) | | 0.000008 | lung carcinoma, family history of lung cancer | | 4 | 131748595 | 131748596 | Human |
| 407365305 | GWAS1014281_H | blood protein measurement QTL GWAS1014281 (human) | | 9e-124 | blood protein measurement | | 4 | 109912954 | 109912955 | Human |
| 628448139 | GWAS2356368_H | mathematical ability QTL GWAS2356368 (human) | | 8e-10 | cognitive behavior trait (VT:0010450) | | 4 | 129215768 | 129215769 | Human |
| 597220505 | GWAS1316579_H | bipolar I disorder QTL GWAS1316579 (human) | | 2e-09 | bipolar disorder | | 4 | 122154852 | 122154853 | Human |
| 617061318 | GWAS2078817_H | glomerular filtration rate QTL GWAS2078817 (human) | | 3e-15 | glomerular filtration rate | | 4 | 127146530 | 127146531 | Human |
| 617061317 | GWAS2078816_H | glomerular filtration rate QTL GWAS2078816 (human) | | 2e-08 | glomerular filtration rate | | 4 | 119674620 | 119674621 | Human |
| 628939391 | GWAS2847620_H | degeneration of macula and posterior pole QTL GWAS2847620 (human) | | 3e-16 | degeneration of macula and posterior pole | | 4 | 109764664 | 109764665 | Human |
| 616356799 | GWAS1841514_H | gut microbiome measurement, breastfeeding duration QTL GWAS1841514 (human) | | 0.0000008 | gut microbiome measurement, breastfeeding duration | | 4 | 110717326 | 110717327 | Human |
| 616487869 | GWAS1884452_H | blood protein amount QTL GWAS1884452 (human) | | 8e-13 | blood protein amount | | 4 | 122625127 | 122625128 | Human |
| 597023888 | GWAS1119962_H | allergic disease QTL GWAS1119962 (human) | | 9e-27 | allergic disease | | 4 | 122394921 | 122394922 | Human |
| 597089424 | GWAS1185498_H | depressive symptom measurement QTL GWAS1185498 (human) | | 2e-09 | depression-related behavior trait (VT:0015015) | | 4 | 122467738 | 122467739 | Human |
| 626465360 | GWAS2279293_H | body height QTL GWAS2279293 (human) | | 8e-09 | body height | | 4 | 130259605 | 130259606 | Human |
| 597367955 | GWAS1464029_H | apolipoprotein B measurement QTL GWAS1464029 (human) | | 1e-10 | apolipoprotein B measurement | | 4 | 123837618 | 123837619 | Human |
| 596974749 | GWAS1094268_H | endometriosis, major depressive disorder QTL GWAS1094268 (human) | | 5e-08 | endometriosis, major depressive disorder | | 4 | 130288732 | 130288733 | Human |
| 596991132 | GWAS1110651_H | cardiovascular disease biomarker measurement, ankle brachial index QTL GWAS1110651 (human) | | 0.000007 | cardiovascular disease biomarker measurement, ankle brachial index | | 4 | 126012137 | 126012138 | Human |
| 617077707 | GWAS2095206_H | diastolic blood pressure QTL GWAS2095206 (human) | | 1e-10 | diastolic blood pressure | | 4 | 119336584 | 119336585 | Human |
| 617126872 | GWAS2144371_H | platelet volume QTL GWAS2144371 (human) | | 3e-37 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 598088886 | GWAS1808185_H | bone density QTL GWAS1808185 (human) | | 2e-17 | bone density | | 4 | 123616626 | 123616628 | Human |
| 407234391 | GWAS883367_H | lean body mass QTL GWAS883367 (human) | | 0.000004 | lean body mass | | 4 | 130920623 | 130920624 | Human |
| 628480614 | GWAS2388843_H | coronary artery disease QTL GWAS2388843 (human) | | 1e-14 | coronary artery integrity trait (VT:0010746) | | 4 | 119988346 | 119988347 | Human |
| 597597321 | GWAS1654181_H | lymphocyte count QTL GWAS1654181 (human) | | 2e-14 | lymphocyte count | | 4 | 112183886 | 112183887 | Human |
| 407332703 | GWAS981679_H | ceramide measurement QTL GWAS981679 (human) | | 2e-11 | ceramide measurement | | 4 | 114663873 | 114663874 | Human |
| 628529775 | GWAS2438004_H | complement factor I measurement QTL GWAS2438004 (human) | | 9e-78 | complement protein amount (VT:0010033) | | 4 | 109764664 | 109764665 | Human |
| 407332702 | GWAS981678_H | ceramide measurement QTL GWAS981678 (human) | | 5e-38 | ceramide measurement | | 4 | 114564528 | 114564529 | Human |
| 628529773 | GWAS2438002_H | complement factor I measurement QTL GWAS2438002 (human) | | 4e-210 | complement protein amount (VT:0010033) | | 4 | 109737911 | 109737912 | Human |
| 597466242 | GWAS1562316_H | BMI-adjusted waist-hip ratio QTL GWAS1562316 (human) | | 7e-08 | BMI-adjusted waist-hip ratio | | 4 | 119441806 | 119441807 | Human |
| 407005021 | GWAS653997_H | interleukin 16 measurement QTL GWAS653997 (human) | | 0.000003 | interleukin 16 measurement | | 4 | 112762711 | 112762712 | Human |
| 617126871 | GWAS2144370_H | platelet volume QTL GWAS2144370 (human) | | 1e-29 | platelet volume | | 4 | 122265238 | 122265239 | Human |
| 598056069 | GWAS1775368_H | fibroblast growth factor 2 amount QTL GWAS1775368 (human) | | 1e-10 | fibroblast growth factor 2 amount | | 4 | 119087072 | 119087073 | Human |
| 628365909 | GWAS2286753_H | alpha-fetoprotein level QTL GWAS2286753 (human) | | 1e-10 | alpha-fetoprotein level | | 4 | 108743359 | 108743360 | Human |
| 598056068 | GWAS1775367_H | fibroblast growth factor 2 amount QTL GWAS1775367 (human) | | 5e-141 | fibroblast growth factor 2 amount | | 4 | 122776139 | 122776140 | Human |
| 617061350 | GWAS2078849_H | hip geometry QTL GWAS2078849 (human) | | 4e-08 | body size trait (VT:0100005) | hip circumference (CMO:0000014) | 4 | 126569184 | 126569185 | Human |
| 598056071 | GWAS1775370_H | fibroblast growth factor 2 amount QTL GWAS1775370 (human) | | 4e-11 | fibroblast growth factor 2 amount | | 4 | 120649137 | 120649138 | Human |
| 597056693 | GWAS1152767_H | allergic rhinitis QTL GWAS1152767 (human) | | 5e-15 | allergic rhinitis | | 4 | 122415763 | 122415764 | Human |
| 406923106 | GWAS572082_H | facial morphology measurement QTL GWAS572082 (human) | | 3e-08 | facial morphology measurement | | 4 | 125198542 | 125198543 | Human |
| 598056065 | GWAS1775364_H | fibroblast growth factor 2 amount QTL GWAS1775364 (human) | | 4e-11 | fibroblast growth factor 2 amount | | 4 | 122518815 | 122518816 | Human |
| 597367998 | GWAS1464072_H | BMI-adjusted waist circumference QTL GWAS1464072 (human) | | 3e-11 | BMI-adjusted waist circumference | | 4 | 108535458 | 108535459 | Human |
| 616389528 | GWAS1869770_H | irritable bowel syndrome, chronic bronchitis QTL GWAS1869770 (human) | | 2e-08 | irritable bowel syndrome, chronic bronchitis | | 4 | 111582716 | 111582717 | Human |
| 407332706 | GWAS981682_H | ceramide measurement QTL GWAS981682 (human) | | 2e-08 | ceramide measurement | | 4 | 114553199 | 114553200 | Human |
| 406890341 | GWAS539317_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS539317 (human) | | 0.0000006 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 4 | 123865108 | 123865109 | Human |
| 597367997 | GWAS1464071_H | BMI-adjusted waist circumference QTL GWAS1464071 (human) | | 4e-08 | BMI-adjusted waist circumference | | 4 | 108556623 | 108556624 | Human |
| 597499067 | GWAS1595141_H | systolic blood pressure QTL GWAS1595141 (human) | | 3e-12 | systolic blood pressure | | 4 | 110417121 | 110417122 | Human |
| 598056067 | GWAS1775366_H | fibroblast growth factor 2 amount QTL GWAS1775366 (human) | | 1e-09 | fibroblast growth factor 2 amount | | 4 | 118377173 | 118377174 | Human |
| 406923111 | GWAS572087_H | facial morphology measurement QTL GWAS572087 (human) | | 3e-08 | facial morphology measurement | | 4 | 125198582 | 125198583 | Human |
| 597154993 | GWAS1251067_H | diet measurement, sex hormone-binding globulin measurement QTL GWAS1251067 (human) | | 0.0000007 | diet measurement, sex hormone-binding globulin measurement | | 4 | 127714844 | 127714845 | Human |
| 616520600 | GWAS1917183_H | lipoprotein measurement QTL GWAS1917183 (human) | | 2e-41 | lipoprotein measurement | | 4 | 109717668 | 109717669 | Human |
| 598056066 | GWAS1775365_H | fibroblast growth factor 2 amount QTL GWAS1775365 (human) | | 6e-14 | fibroblast growth factor 2 amount | | 4 | 121977042 | 121977043 | Human |
| 598056077 | GWAS1775376_H | fibroblast growth factor 2 amount QTL GWAS1775376 (human) | | 3e-08 | fibroblast growth factor 2 amount | | 4 | 123380906 | 123380907 | Human |
| 407349100 | GWAS998076_H | BMI-adjusted waist-hip ratio QTL GWAS998076 (human) | | 6e-13 | BMI-adjusted waist-hip ratio | | 4 | 124261535 | 124261536 | Human |
| 616569836 | GWAS1966419_H | level of TP53-binding protein 1 in blood QTL GWAS1966419 (human) | | 7e-12 | level of TP53-binding protein 1 in blood | | 4 | 122618282 | 122618284 | Human |
| 597384375 | GWAS1480449_H | FEV/FVC ratio QTL GWAS1480449 (human) | | 1e-20 | FEV/FVC ratio | | 4 | 123898452 | 123898453 | Human |
| 406923117 | GWAS572093_H | facial morphology measurement QTL GWAS572093 (human) | | 3e-08 | facial morphology measurement | | 4 | 125217310 | 125217311 | Human |
| 598056072 | GWAS1775371_H | fibroblast growth factor 2 amount QTL GWAS1775371 (human) | | 1e-19 | fibroblast growth factor 2 amount | | 4 | 126345135 | 126345136 | Human |
| 598056074 | GWAS1775373_H | fibroblast growth factor 2 amount QTL GWAS1775373 (human) | | 8e-09 | fibroblast growth factor 2 amount | | 4 | 121394587 | 121394588 | Human |
| 406923122 | GWAS572098_H | facial morphology measurement QTL GWAS572098 (human) | | 3e-08 | facial morphology measurement | | 4 | 125211057 | 125211058 | Human |
| 626449006 | GWAS2262939_H | Alzheimer disease, dementia, family history of Alzheimer’s disease QTL GWAS2262939 (human) | | 0.000006 | Alzheimer disease, dementia, family history of Alzheimer’s disease | | 4 | 114833170 | 114833171 | Human |
| 616963066 | GWAS1980565_H | type 2 diabetes mellitus QTL GWAS1980565 (human) | | 1e-08 | type 2 diabetes mellitus | | 4 | 129865191 | 129865192 | Human |
| 616356737 | GWAS1841452_H | gut microbiome measurement, breastfeeding duration QTL GWAS1841452 (human) | | 6e-09 | gut microbiome measurement, breastfeeding duration | | 4 | 112407707 | 112407708 | Human |
| 407267076 | GWAS916052_H | body height QTL GWAS916052 (human) | | 2e-24 | body height | | 4 | 128708095 | 128708096 | Human |
| 407267077 | GWAS916053_H | body height QTL GWAS916053 (human) | | 7e-11 | body height | | 4 | 129860515 | 129860516 | Human |
| 616487931 | GWAS1884514_H | blood protein amount QTL GWAS1884514 (human) | | 3e-12 | blood protein amount | | 4 | 119503425 | 119503426 | Human |
| 407348993 | GWAS997969_H | intraocular pressure measurement QTL GWAS997969 (human) | | 3e-10 | intraocular pressure measurement | | 4 | 111042563 | 111042564 | Human |
| 616356859 | GWAS1841574_H | gut microbiome measurement, breastfeeding duration QTL GWAS1841574 (human) | | 4e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 123562675 | 123562676 | Human |
| 407267082 | GWAS916058_H | body height QTL GWAS916058 (human) | | 2e-20 | body height | | 4 | 131543872 | 131543873 | Human |
| 406923027 | GWAS572003_H | cup-to-disc ratio measurement QTL GWAS572003 (human) | | 0.0000002 | cup-to-disc ratio measurement | | 4 | 125475115 | 125475116 | Human |
| 407004945 | GWAS653921_H | C-C motif chemokine 7 measurement QTL GWAS653921 (human) | | 0.000002 | C-C motif chemokine 7 measurement | | 4 | 110137551 | 110137552 | Human |
| 597482703 | GWAS1578777_H | lymphocyte count QTL GWAS1578777 (human) | | 5e-15 | lymphocyte count | | 4 | 122760001 | 122760002 | Human |
| 628890153 | GWAS2798382_H | cardioembolic stroke QTL GWAS2798382 (human) | | 8e-237 | joint integrity trait (VT:0010548) | | 4 | 110743002 | 110743003 | Human |
| 628726316 | GWAS2634545_H | glioma pathogenesis-related protein 1 measurement QTL GWAS2634545 (human) | | 7e-18 | glioma pathogenesis-related protein 1 measurement | | 4 | 119810601 | 119810602 | Human |
| 597105867 | GWAS1201941_H | sex hormone-binding globulin measurement QTL GWAS1201941 (human) | | 2e-08 | sex hormone-binding globulin measurement | | 4 | 128122459 | 128122460 | Human |
| 597105866 | GWAS1201940_H | sex hormone-binding globulin measurement QTL GWAS1201940 (human) | | 1e-34 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 597023944 | GWAS1120018_H | response to darapladib, cardiovascular event measurement QTL GWAS1120018 (human) | | 0.000002 | response to darapladib, cardiovascular event measurement | cardiovascular measurement (CMO:0000001) | 4 | 124644124 | 124644125 | Human |
| 597236935 | GWAS1333009_H | Hypermetropia QTL GWAS1333009 (human) | | 0.000002 | Hypermetropia | | 4 | 108429724 | 108429725 | Human |
| 597023946 | GWAS1120020_H | response to darapladib, cardiovascular event measurement QTL GWAS1120020 (human) | | 6e-09 | response to darapladib, cardiovascular event measurement | cardiovascular measurement (CMO:0000001) | 4 | 124644124 | 124644125 | Human |
| 598056132 | GWAS1775431_H | platelet volume QTL GWAS1775431 (human) | | 2e-13 | platelet volume | | 4 | 122271085 | 122271086 | Human |
| 617094062 | GWAS2111561_H | erythrocyte count QTL GWAS2111561 (human) | | 4e-18 | erythrocyte count | | 4 | 121808257 | 121808258 | Human |
| 406890281 | GWAS539257_H | childhood onset asthma QTL GWAS539257 (human) | | 8e-11 | childhood onset asthma | | 4 | 122451978 | 122451979 | Human |
| 617290657 | GWAS2227433_H | sex interaction measurement QTL GWAS2227433 (human) | | 5e-17 | sex interaction measurement | | 4 | 110744627 | 110744628 | Human |
| 406890283 | GWAS539259_H | allergic sensitization measurement QTL GWAS539259 (human) | | 1e-08 | celiac disease | | 4 | 122451978 | 122451979 | Human |
| 407086895 | GWAS735871_H | albumin:globulin ratio measurement QTL GWAS735871 (human) | | 2e-11 | albumin:globulin ratio measurement | | 4 | 110003204 | 110003205 | Human |
| 617044907 | GWAS2062406_H | complement factor H-related protein 3 measurement QTL GWAS2062406 (human) | | 0.000009 | complement factor H-related protein 3 measurement | | 4 | 128538939 | 128538940 | Human |
| 617290662 | GWAS2227438_H | sex interaction measurement QTL GWAS2227438 (human) | | 3e-20 | sex interaction measurement | | 4 | 110755885 | 110755886 | Human |
| 407185192 | GWAS834168_H | glomerular filtration rate QTL GWAS834168 (human) | | 9e-09 | glomerular filtration rate | | 4 | 128246249 | 128246250 | Human |
| 628742679 | GWAS2650908_H | platelet count QTL GWAS2650908 (human) | | 2e-33 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110023574 | 110023575 | Human |
| 628611608 | GWAS2519837_H | Beta blocking agent use measurement QTL GWAS2519837 (human) | | 1e-12 | Beta blocking agent use measurement | | 4 | 110789013 | 110789014 | Human |
| 597204215 | GWAS1300289_H | protein measurement QTL GWAS1300289 (human) | | 2e-08 | protein amount (VT:0010120) | | 4 | 112377503 | 112377504 | Human |
| 617061288 | GWAS2078787_H | bone tissue density QTL GWAS2078787 (human) | | 2e-17 | bone tissue density | | 4 | 123616626 | 123616628 | Human |
| 407234346 | GWAS883322_H | body fat percentage QTL GWAS883322 (human) | | 3e-08 | body fat percentage | | 4 | 123822104 | 123822105 | Human |
| 617012150 | GWAS2029649_H | lifestyle measurement, depressive symptom measurement QTL GWAS2029649 (human) | | 3e-08 | lifestyle measurement, depressive symptom measurement | | 4 | 117961493 | 117961494 | Human |
| 616356814 | GWAS1841529_H | gut microbiome measurement, allergen exposure measurement QTL GWAS1841529 (human) | | 3e-08 | gut microbiome measurement, allergen exposure measurement | | 4 | 114888640 | 114888641 | Human |
| 628742669 | GWAS2650898_H | platelet count QTL GWAS2650898 (human) | | 1e-21 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109945564 | 109945565 | Human |
| 628742668 | GWAS2650897_H | platelet count QTL GWAS2650897 (human) | | 1e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109938024 | 109938025 | Human |
| 628906506 | GWAS2814735_H | congestive heart failure QTL GWAS2814735 (human) | | 0.0000002 | heart integrity trait (VT:0010757) | | 4 | 110787733 | 110787734 | Human |
| 628742670 | GWAS2650899_H | platelet count QTL GWAS2650899 (human) | | 2e-35 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 109990751 | 109990752 | Human |
| 616979390 | GWAS1996889_H | sleep latency QTL GWAS1996889 (human) | | 0.000001 | sleep latency | | 4 | 122626441 | 122626442 | Human |
| 629004804 | GWAS2913033_H | body height QTL GWAS2913033 (human) | | 2e-09 | body height | | 4 | 123557804 | 123557805 | Human |
| 597515495 | GWAS1611569_H | smoking initiation QTL GWAS1611569 (human) | | 8e-11 | smoking initiation | | 4 | 129681552 | 129681553 | Human |
| 597613796 | GWAS1670656_H | connective tissue disease QTL GWAS1670656 (human) | | 2e-14 | connective tissue disease | | 4 | 129687742 | 129687743 | Human |
| 628726274 | GWAS2634503_H | alpha-L-iduronidase measurement QTL GWAS2634503 (human) | | 7e-12 | alpha-L-iduronidase measurement | | 4 | 118864074 | 118864075 | Human |
| 597023982 | GWAS1120056_H | allergic disease QTL GWAS1120056 (human) | | 5e-14 | allergic disease | | 4 | 122532955 | 122532959 | Human |
| 629004801 | GWAS2913030_H | body height QTL GWAS2913030 (human) | | 8e-23 | body height | | 4 | 113826994 | 113826995 | Human |
| 407283515 | GWAS932491_H | vaginal microbiome measurement QTL GWAS932491 (human) | | 0.000007 | vaginal microbiome measurement | | 4 | 108166673 | 108166674 | Human |
| 629004800 | GWAS2913029_H | body height QTL GWAS2913029 (human) | | 3e-14 | body height | | 4 | 112431472 | 112431473 | Human |
| 629004803 | GWAS2913032_H | body height QTL GWAS2913032 (human) | | 1e-19 | body height | | 4 | 123398036 | 123398037 | Human |
| 629004802 | GWAS2913031_H | body height QTL GWAS2913031 (human) | | 3e-42 | body height | | 4 | 121840699 | 121840700 | Human |
| 617126839 | GWAS2144338_H | neutrophil percentage of leukocytes QTL GWAS2144338 (human) | | 8e-16 | neutrophil percentage of leukocytes | | 4 | 122702286 | 122702287 | Human |
| 628939518 | GWAS2847747_H | body mass index QTL GWAS2847747 (human) | | 1e-09 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 110523790 | 110523791 | Human |
| 598006823 | GWAS1726122_H | strand of hair color QTL GWAS1726122 (human) | | 1e-17 | strand of hair color | | 4 | 108163945 | 108163946 | Human |
| 616962882 | GWAS1980381_H | balding measurement QTL GWAS1980381 (human) | | 2e-14 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 123825222 | 123825223 | Human |
| 616389434 | GWAS1869676_H | testosterone measurement QTL GWAS1869676 (human) | | 5e-15 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 597482517 | GWAS1578591_H | open-angle glaucoma QTL GWAS1578591 (human) | | 6e-10 | open-angle glaucoma | | 4 | 111042563 | 111042564 | Human |
| 596991004 | GWAS1110523_H | hypertension QTL GWAS1110523 (human) | | 0.000006 | hypertension | | 4 | 112002081 | 112002082 | Human |
| 407005131 | GWAS654107_H | beta-nerve growth factor measurement QTL GWAS654107 (human) | | 0.000008 | beta-nerve growth factor measurement | | 4 | 123921959 | 123921960 | Human |
| 407152591 | GWAS801567_H | squamous cell lung carcinoma QTL GWAS801567 (human) | | 0.0000005 | squamous cell lung carcinoma | | 4 | 121873960 | 121873961 | Human |
| 598006824 | GWAS1726123_H | strand of hair color QTL GWAS1726123 (human) | | 1e-15 | strand of hair color | | 4 | 108327206 | 108327207 | Human |
| 407185353 | GWAS834329_H | cognitive function measurement QTL GWAS834329 (human) | | 0.000009 | cognitive function measurement | | 4 | 119010553 | 119010554 | Human |
| 598006825 | GWAS1726124_H | strand of hair color QTL GWAS1726124 (human) | | 9e-38 | strand of hair color | | 4 | 108429724 | 108429725 | Human |
| 617061206 | GWAS2078705_H | tiglylcarnitine (C5:1-DC) measurement QTL GWAS2078705 (human) | | 6e-08 | tiglylcarnitine (C5:1-DC) measurement | | 4 | 110977273 | 110977274 | Human |
| 597335055 | GWAS1431129_H | COVID-19 QTL GWAS1431129 (human) | | 0.00001 | COVID-19 | | 4 | 127789647 | 127789648 | Human |
| 617061200 | GWAS2078699_H | triglyceride measurement QTL GWAS2078699 (human) | | 6e-10 | triglyceride measurement | | 4 | 123895285 | 123895286 | Human |
| 407381968 | GWAS1030944_H | hematocrit QTL GWAS1030944 (human) | | 2e-16 | hematocrit | | 4 | 114598115 | 114598116 | Human |
| 628611822 | GWAS2520051_H | Ventricular arrhythmia QTL GWAS2520051 (human) | | 4e-11 | Ventricular arrhythmia | | 4 | 110791080 | 110791081 | Human |
| 407136221 | GWAS785197_H | coronary artery disease QTL GWAS785197 (human) | | 1e-08 | coronary artery disease | | 4 | 119988346 | 119988347 | Human |
| 597154829 | GWAS1250903_H | high density lipoprotein cholesterol measurement QTL GWAS1250903 (human) | | 2e-11 | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | | 4 | 109657070 | 109657071 | Human |
| 407087065 | GWAS736041_H | osteoarthritis, knee QTL GWAS736041 (human) | | 5e-09 | osteoarthritis, knee | | 4 | 120672441 | 120672442 | Human |
| 597040141 | GWAS1136215_H | apolipoprotein A 1 measurement QTL GWAS1136215 (human) | | 3e-20 | apolipoprotein A 1 measurement | | 4 | 109648464 | 109648465 | Human |
| 597105672 | GWAS1201746_H | sex hormone-binding globulin measurement QTL GWAS1201746 (human) | | 6e-26 | sex hormone-binding globulin measurement | | 4 | 109717668 | 109717669 | Human |
| 626465527 | GWAS2279460_H | body weight QTL GWAS2279460 (human) | | 3e-08 | body weight | | 4 | 119212719 | 119212720 | Human |
| 598006788 | GWAS1726087_H | hip bone size QTL GWAS1726087 (human) | | 7e-09 | hip bone size | | 4 | 129257175 | 129257176 | Human |
| 407267296 | GWAS916272_H | testosterone measurement QTL GWAS916272 (human) | | 0.000004 | testosterone measurement | | 4 | 108117498 | 108117499 | Human |
| 597515323 | GWAS1611397_H | body mass index QTL GWAS1611397 (human) | | 8e-08 | body mass index | | 4 | 129803585 | 129803586 | Human |
| 597826565 | GWAS1693956_H | prostate specific antigen amount QTL GWAS1693956 (human) | | 3e-16 | prostate specific antigen amount | | 4 | 109877415 | 109877416 | Human |
| 617290595 | GWAS2227371_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS2227371 (human) | | 8e-09 | polyunsaturated fatty acids to monounsaturated fatty acids ratio | | 4 | 109603883 | 109603884 | Human |
| 597826574 | GWAS1693965_H | prostate specific antigen amount QTL GWAS1693965 (human) | | 2e-13 | prostate specific antigen amount | | 4 | 111519061 | 111519062 | Human |
| 407381988 | GWAS1030964_H | red blood cell density measurement QTL GWAS1030964 (human) | | 2e-15 | red blood cell density measurement | | 4 | 114598115 | 114598116 | Human |
| 407332842 | GWAS981818_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS981818 (human) | | 6e-13 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | | 4 | 109657070 | 109657071 | Human |
| 598055944 | GWAS1775243_H | fibroblast growth factor 2 amount QTL GWAS1775243 (human) | | 2e-08 | fibroblast growth factor 2 amount | | 4 | 120247814 | 120247815 | Human |
| 597826575 | GWAS1693966_H | prostate specific antigen amount QTL GWAS1693966 (human) | | 2e-13 | prostate specific antigen amount | | 4 | 120805979 | 120805980 | Human |
| 406923246 | GWAS572222_H | facial morphology measurement QTL GWAS572222 (human) | | 3e-08 | facial morphology measurement | | 4 | 125219863 | 125219864 | Human |
| 406923249 | GWAS572225_H | facial morphology measurement QTL GWAS572225 (human) | | 3e-08 | facial morphology measurement | | 4 | 125210511 | 125210512 | Human |
| 597826576 | GWAS1693967_H | prostate specific antigen amount QTL GWAS1693967 (human) | | 1e-15 | prostate specific antigen amount | | 4 | 121854912 | 121854913 | Human |
| 628415174 | GWAS2323403_H | gut microbiome measurement QTL GWAS2323403 (human) | | 0.000006 | gut microbiome measurement | | 4 | 128732972 | 128732973 | Human |
| 597826577 | GWAS1693968_H | prostate specific antigen amount QTL GWAS1693968 (human) | | 8e-09 | prostate specific antigen amount | | 4 | 123950358 | 123950359 | Human |
| 597580842 | GWAS1637702_H | lymphocyte count QTL GWAS1637702 (human) | | 1e-14 | lymphocyte count | | 4 | 112194663 | 112194664 | Human |
| 597580841 | GWAS1637701_H | lymphocyte count QTL GWAS1637701 (human) | | 1e-14 | lymphocyte count | | 4 | 109912954 | 109912955 | Human |
| 628955845 | GWAS2864074_H | mean corpuscular hemoglobin concentration QTL GWAS2864074 (human) | | 7e-12 | erythrocyte hemoglobin amount (VT:0010953) | mean corpuscular hemoglobin concentration (CMO:0000291) | 4 | 121827841 | 121827842 | Human |
| 407349246 | GWAS998222_H | feeling miserable measurement QTL GWAS998222 (human) | | 3e-08 | feeling miserable measurement | | 4 | 122465996 | 122465997 | Human |
| 628497100 | GWAS2405329_H | smoking cessation QTL GWAS2405329 (human) | | 1e-08 | smoking cessation | | 4 | 111500989 | 111500990 | Human |
| 407349245 | GWAS998221_H | feeling miserable measurement QTL GWAS998221 (human) | | 1e-08 | feeling miserable measurement | | 4 | 122265238 | 122265239 | Human |
| 596958292 | GWAS1077811_H | Red cell distribution width QTL GWAS1077811 (human) | | 1e-20 | Red cell distribution width | | 4 | 128306129 | 128306130 | Human |
| 628628154 | GWAS2536383_H | bipolar disorder QTL GWAS2536383 (human) | | 0.000006 | bipolar disorder | | 4 | 117740497 | 117740498 | Human |
| 616553341 | GWAS1949924_H | level of agrin in blood serum QTL GWAS1949924 (human) | | 2e-53 | level of agrin in blood serum | | 4 | 118378823 | 118378824 | Human |
| 596958291 | GWAS1077810_H | Red cell distribution width QTL GWAS1077810 (human) | | 2e-09 | erythrocyte size trait (VT:0000248) | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 122438414 | 122438415 | Human |
| 596991058 | GWAS1110577_H | celiac disease QTL GWAS1110577 (human) | | 3e-13 | celiac disease | | 4 | 122588266 | 122588267 | Human |
| 407316367 | GWAS965343_H | diet measurement QTL GWAS965343 (human) | | 2e-08 | diet measurement | | 4 | 129906935 | 129906936 | Human |
| 628628149 | GWAS2536378_H | bipolar disorder QTL GWAS2536378 (human) | | 0.000005 | bipolar disorder | | 4 | 122589611 | 122589612 | Human |
| 407414680 | GWAS1063656_H | platelet count QTL GWAS1063656 (human) | | 5e-16 | platelet count | | 4 | 119464317 | 119464318 | Human |
| 625826460 | GWAS2247382_H | atrial fibrillation QTL GWAS2247382 (human) | | 4e-34 | atrial fibrillation | | 4 | 113527500 | 113527501 | Human |
| 597056580 | GWAS1152654_H | eosinophil count QTL GWAS1152654 (human) | | 1e-40 | eosinophil count | | 4 | 122451978 | 122451979 | Human |
| 596958279 | GWAS1077798_H | Red cell distribution width QTL GWAS1077798 (human) | | 8e-08 | erythrocyte size trait (VT:0000248) | red blood cell distribution width- standard deviation (CMO:0003232) | 4 | 121820188 | 121820189 | Human |
| 625826457 | GWAS2247379_H | atrial fibrillation QTL GWAS2247379 (human) | | 8e-27 | atrial fibrillation | | 4 | 109738763 | 109738764 | Human |
| 597056579 | GWAS1152653_H | eosinophil count QTL GWAS1152653 (human) | | 1e-18 | eosinophil count | | 4 | 122111201 | 122111202 | Human |
| 625826459 | GWAS2247381_H | atrial fibrillation QTL GWAS2247381 (human) | | 1e-31 | atrial fibrillation | | 4 | 112093836 | 112093837 | Human |
| 629004971 | GWAS2913200_H | body height QTL GWAS2913200 (human) | | 5e-10 | body height | | 4 | 128751543 | 128751544 | Human |
| 625826458 | GWAS2247380_H | atrial fibrillation QTL GWAS2247380 (human) | | 2e-305 | atrial fibrillation | | 4 | 110789386 | 110789387 | Human |
| 628775597 | GWAS2683826_H | level of serum globulin type protein QTL GWAS2683826 (human) | | 8e-11 | level of serum globulin type protein | | 4 | 119210489 | 119210490 | Human |
| 629004970 | GWAS2913199_H | body height QTL GWAS2913199 (human) | | 1e-08 | body height | | 4 | 128547347 | 128547348 | Human |
| 626465423 | GWAS2279356_H | high density lipoprotein cholesterol measurement QTL GWAS2279356 (human) | | 2e-33 | high density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 617044764 | GWAS2062263_H | BMI-adjusted waist-hip ratio QTL GWAS2062263 (human) | | 6e-09 | BMI-adjusted waist-hip ratio | | 4 | 121702910 | 121702911 | Human |
| 597154891 | GWAS1250965_H | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS1250965 (human) | | 5e-10 | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | | 4 | 109657070 | 109657071 | Human |
| 617044763 | GWAS2062262_H | BMI-adjusted waist-hip ratio QTL GWAS2062262 (human) | | 2e-09 | BMI-adjusted waist-hip ratio | | 4 | 119763897 | 119763898 | Human |
| 616356706 | GWAS1841421_H | gut microbiome measurement, breastfeeding duration QTL GWAS1841421 (human) | | 1e-08 | gut microbiome measurement, breastfeeding duration | | 4 | 111640701 | 111640702 | Human |
| 628824740 | GWAS2732969_H | body height QTL GWAS2732969 (human) | | 2e-10 | body height | | 4 | 121736832 | 121736833 | Human |
| 597531773 | GWAS1627847_H | atrial fibrillation QTL GWAS1627847 (human) | | 4e-714 | atrial fibrillation | | 4 | 110789811 | 110789812 | Human |
| 628742809 | GWAS2651038_H | platelet count QTL GWAS2651038 (human) | | 4e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 119502932 | 119502933 | Human |
| 598006853 | GWAS1726152_H | strand of hair color QTL GWAS1726152 (human) | | 5e-12 | strand of hair color | | 4 | 108003401 | 108003402 | Human |
| 628742808 | GWAS2651037_H | platelet count QTL GWAS2651037 (human) | | 2e-100 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 4 | 110008938 | 110008939 | Human |
| 407250855 | GWAS899831_H | total cholesterol measurement QTL GWAS899831 (human) | | 6e-10 | total cholesterol measurement | | 4 | 119192945 | 119192946 | Human |
| 597384314 | GWAS1480388_H | facial morphology measurement QTL GWAS1480388 (human) | | 2e-09 | facial morphology measurement | | 4 | 121076949 | 121076950 | Human |
| 597531774 | GWAS1627848_H | atrial fibrillation QTL GWAS1627848 (human) | | 4e-15 | atrial fibrillation | | 4 | 113507558 | 113507559 | Human |
| 628988569 | GWAS2896798_H | body weight QTL GWAS2896798 (human) | | 3e-15 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 129824994 | 129824995 | Human |
| 597466233 | GWAS1562307_H | hypertension QTL GWAS1562307 (human) | | 3e-08 | hypertension | | 4 | 110409934 | 110409935 | Human |
| 597269630 | GWAS1365704_H | metabolite measurement QTL GWAS1365704 (human) | | 7e-18 | metabolite measurement | | 4 | 129109497 | 129109498 | Human |
| 407332781 | GWAS981757_H | BMI-adjusted waist circumference QTL GWAS981757 (human) | | 5e-09 | BMI-adjusted waist circumference | | 4 | 122858186 | 122858187 | Human |
| 407332780 | GWAS981756_H | BMI-adjusted waist circumference QTL GWAS981756 (human) | | 1e-09 | BMI-adjusted waist circumference | | 4 | 121700964 | 121700965 | Human |
| 407349163 | GWAS998139_H | BMI-adjusted hip circumference QTL GWAS998139 (human) | | 0.000003 | BMI-adjusted hip circumference | | 4 | 110946968 | 110946969 | Human |
| 407332779 | GWAS981755_H | BMI-adjusted waist circumference QTL GWAS981755 (human) | | 2e-08 | BMI-adjusted waist-hip ratio | | 4 | 119595538 | 119595539 | Human |
| 628906641 | GWAS2814870_H | congestive heart failure QTL GWAS2814870 (human) | | 0.0000001 | heart integrity trait (VT:0010757) | | 4 | 110768624 | 110768625 | Human |
| 407332778 | GWAS981754_H | BMI-adjusted waist circumference QTL GWAS981754 (human) | | 4e-11 | BMI-adjusted waist circumference | | 4 | 119213641 | 119213642 | Human |
| 407136170 | GWAS785146_H | glomerular filtration rate QTL GWAS785146 (human) | | 6e-08 | glomerular filtration rate | | 4 | 108772299 | 108772300 | Human |
| 597089400 | GWAS1185474_H | monocyte percentage of leukocytes QTL GWAS1185474 (human) | | 3e-09 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 4 | 109990411 | 109990412 | Human |
| 407250870 | GWAS899846_H | total cholesterol measurement QTL GWAS899846 (human) | | 3e-09 | total cholesterol measurement | | 4 | 119202262 | 119202263 | Human |
| 628873865 | GWAS2782094_H | annexin A5 measurement QTL GWAS2782094 (human) | | 2e-11 | annexin A5 measurement | | 4 | 121698791 | 121698792 | Human |
| 628873864 | GWAS2782093_H | annexin A5 measurement QTL GWAS2782093 (human) | | 2e-57 | annexin A5 measurement | | 4 | 121695708 | 121695709 | Human |
| 407037878 | GWAS686854_H | body mass index QTL GWAS686854 (human) | | 2e-18 | body mass index | | 4 | 111781479 | 111781480 | Human |
| 407316403 | GWAS965379_H | diet measurement QTL GWAS965379 (human) | | 3e-08 | diet measurement | | 4 | 112402274 | 112402275 | Human |
| 407037879 | GWAS686855_H | body mass index QTL GWAS686855 (human) | | 1e-11 | body mass index | | 4 | 112339309 | 112339310 | Human |
| 407037877 | GWAS686853_H | body mass index QTL GWAS686853 (human) | | 8e-09 | body mass index | | 4 | 110683327 | 110683328 | Human |
| 628906629 | GWAS2814858_H | sex interaction measurement, age of onset of cardiac rhythm disease QTL GWAS2814858 (human) | | 3e-20 | sex interaction measurement, age of onset of cardiac rhythm disease | | 4 | 110755885 | 110755886 | Human |
| 616962876 | GWAS1980375_H | balding measurement QTL GWAS1980375 (human) | | 2e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 4 | 123610267 | 123610268 | Human |
| 406906811 | GWAS555787_H | bilirubin measurement QTL GWAS555787 (human) | | 0.000002 | blood bilirubin amount (VT:0001569) | serum total bilirubin level (CMO:0000376) | 4 | 125072347 | 125072348 | Human |
| 628906624 | GWAS2814853_H | sex interaction measurement, age of onset of cardiac rhythm disease QTL GWAS2814853 (human) | | 5e-17 | sex interaction measurement, age of onset of cardiac rhythm disease | | 4 | 110744627 | 110744628 | Human |
| 617044794 | GWAS2062293_H | atrial fibrillation QTL GWAS2062293 (human) | | 2e-08 | atrial fibrillation | | 4 | 111257689 | 111257690 | Human |
| 628742788 | GWAS2651017_H | body mass index QTL GWAS2651017 (human) | | 1e-11 | body size trait (VT:0100005) | body mass index (BMI) (CMO:0000105) | 4 | 122906887 | 122906888 | Human |
| 617044793 | GWAS2062292_H | atrial fibrillation QTL GWAS2062292 (human) | | 1e-12 | atrial fibrillation | | 4 | 111172387 | 111172388 | Human |
| 617044792 | GWAS2062291_H | atrial fibrillation QTL GWAS2062291 (human) | | 7e-13 | atrial fibrillation | | 4 | 111085761 | 111085762 | Human |
| 407037885 | GWAS686861_H | body mass index QTL GWAS686861 (human) | | 4e-11 | body mass index | | 4 | 114132729 | 114132730 | Human |